PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Munro, K; Nash, A; Teng, K; Takeshima, H; Kuhn, PH; Lichtenthaler, S; Perry, E; Audige, M; Gunnersen, J				Munro, K.; Nash, A.; Teng, K.; Takeshima, H.; Kuhn, P. -H.; Lichtenthaler, S.; Perry, E.; Audige, M.; Gunnersen, J.			Seizure-related gene 6 (SEZ6) family proteins regulate excitatory synapses with effects on learning and memory	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Munro, K.; Nash, A.; Teng, K.; Perry, E.; Audige, M.; Gunnersen, J.] Univ Melbourne, Anat & Neurosci, Parkville, Vic 3052, Australia; [Takeshima, H.] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Kuhn, P. -H.; Lichtenthaler, S.] German Ctr Neurodegenerat Dis, DZNE, Munich, Germany								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH09-24	307	307				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300779		
J	Puspitasari, A; Koganezawa, N; Kajita, Y; Shirao, T				Puspitasari, A.; Koganezawa, N.; Kajita, Y.; Shirao, T.			Transient effect of X-irradiation and carbon ion-irradiation on synaptic function	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Puspitasari, A.; Koganezawa, N.; Kajita, Y.; Shirao, T.] Gunma Univ, Grad Sch Med Neurobiol & Behav, Maebashi, Gumma 371, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH09-25	307	307				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300780		
J	Takei, N; Yokomaku, D; Ushiki, T; Nawa, H				Takei, N.; Yokomaku, D.; Ushiki, T.; Nawa, H.			EGF downregulates presynaptic maturation and suppresses synapse formation in vitro and in vivo	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Takei, N.; Yokomaku, D.; Nawa, H.] Niigata Univ, Dept Mol Neurobiol, Brain Res Inst, Niigata, Japan; [Ushiki, T.] Niigata Univ, Grad Sch Med & Dent Sci, Div Microscop Anat & Bioimaging, Niigata, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH09-30	309	309				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300785		
J	Koganezawa, N; Ohara, Y; Yamazaki, H; Roppongi, RT; Sato, K; Sekino, Y; Shirao, T				Koganezawa, N.; Ohara, Y.; Yamazaki, H.; Roppongi, R. T.; Sato, K.; Sekino, Y.; Shirao, T.			Slow axonal growth of human iPSCs-derived neurons	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Koganezawa, N.; Ohara, Y.; Yamazaki, H.; Roppongi, R. T.; Shirao, T.] Gunma Univ, Grad Sch Med, DNBB, Maebashi, Gumma 371, Japan; [Sato, K.; Sekino, Y.] NIHS, Div Pharmacol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH10-03	311	311				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300792		
J	Sobu, Y; Hata, S; Suzuki, T				Sobu, Y.; Hata, S.; Suzuki, T.			Regulation of alcadeina association with kinesin-1 by phosphorylation of the cytoplasmic region	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Sobu, Y.; Hata, S.; Suzuki, T.] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH10-05	312	312				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300794		
J	Oshiro, S; Morioka, MS; Nishiyama, N; Kadowaki, SY; Tanabe, I; Sugasawa, T; Iwasawa, Y; Tanaka, H; Kaburagi, T				Oshiro, S.; Morioka, M. S.; Nishiyama, N.; Kadowaki, S. -Y.; Tanabe, I.; Sugasawa, T.; Iwasawa, Y.; Tanaka, H.; Kaburagi, T.			Proteomic analysis of rat saliva proteins for restraint stress biomarkers	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Oshiro, S.; Nishiyama, N.; Kadowaki, S. -Y.; Tanabe, I.; Iwasawa, Y.] Daito Bunka Univ, BiologyGrad Sch Sports & Hlth Sci, Div Cell Biol, Higashi Matsuyama, Saitama, Japan; [Morioka, M. S.; Tanaka, H.] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Sugasawa, T.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, Tsukuba, Ibaraki, Japan; [Kaburagi, T.] Daito Bunka Univ, Fac Sports & Hlth Sci, Div Nutr, Dept Hlth Sci, Higashi Matsuyama, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH11-15	319	319				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300810		
J	Yabuki, Y; Fukunaga, K				Yabuki, Y.; Fukunaga, K.			Effect of a novel cognitive enhancer on decreased CaMKII activity in Schizophrenia model rats	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Yabuki, Y.; Fukunaga, K.] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH11-19	320	320				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300813		
J	Kimura, A; Suzuki, T				Kimura, A.; Suzuki, T.			A molecular mechanism of shifting the cleavage site of APP by BACE1	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Kimura, A.; Suzuki, T.] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH12-11	324	324				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300825		
J	Matsuura, K; Otani, M; Takano, M; Kadoyama, K; Matsuyama, S				Matsuura, K.; Otani, M.; Takano, M.; Kadoyama, K.; Matsuyama, S.			The influence of chronic nicotine treatment on proteins expressed in the mouse hippocampus and cortex	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Matsuura, K.; Kadoyama, K.; Matsuyama, S.] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Himeji, Hyogo, Japan; [Otani, M.; Takano, M.] Kobe Gakuin Univ, Sch Pharmaceut Sci, Kobe, Hyogo 65121, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH12-18	326	327				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300832		
J	Shiraki, Y; Chiba, K; Hata, S; Suzuki, T				Shiraki, Y.; Chiba, K.; Hata, S.; Suzuki, T.			Kinesin-1 cargo receptor APP and Alcadein alpha transport different type of vesicular cargo to the axonal terminal	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Shiraki, Y.; Chiba, K.; Hata, S.; Suzuki, T.] Hokkaido Univ, Grad Sch Pharmaceut, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH12-24	328	329				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300838		
J	Suzuki, T; Chiba, K; Hata, S				Suzuki, T.; Chiba, K.; Hata, S.			Regulation of axonal transport of app cargos by kinesin-1	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Suzuki, T.; Chiba, K.; Hata, S.] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Neurosci, Sapporo, Hokkaido, Japan							Araki, 2007, EMBO J, V26, P1475; Chiba, 2014, MOL BIOL CELL, V25, P3569; Kawano, 2012, TRAFFIC, V13, P834	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH12-27	329	330				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300841		
J	Fujii, R; Araki, R; Tsukimori, Y				Fujii, R.; Araki, R.; Tsukimori, Y.			D-serine content is elevated in TLS/FUS knockout mice	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Fujii, R.; Araki, R.; Tsukimori, Y.] Hiroshima Bunkyo Womens Univ, Fac Human Sci, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH13-17	336	336				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300860		
J	Matsuda, J; Ono, K; Watanabe, T; Yoneshige, A; Muto, M; Suzuki, A				Matsuda, J.; Ono, K.; Watanabe, T.; Yoneshige, A.; Muto, M.; Suzuki, A.			Central nervous system pathology in the phytosphingolipid-deficient mouse	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Matsuda, J.; Ono, K.] Kawasaki Med Univ, Dept Pediat, Okayama, Japan; [Matsuda, J.; Watanabe, T.; Yoneshige, A.; Muto, M.; Suzuki, A.] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH13-29	340	340				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300872		
J	Ono, K; Muto, M; Yoneshige, A; Yoshimura, S; Matsuda, J				Ono, K.; Muto, M.; Yoneshige, A.; Yoshimura, S.; Matsuda, J.			Role of prosaposin in retinal degeneration	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Ono, K.; Matsuda, J.] Kawasaki Med Univ, Dept Pediat, Kurashiki, Okayama, Japan; [Muto, M.; Yoneshige, A.; Matsuda, J.] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Yoshimura, S.] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH13-34	342	342				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300877		
J	Watase, K; Aikawa, T; Mogushi, K; Iijima, K; Ishikawa, K; Tanaka, H; Mizusawa, H				Watase, K.; Aikawa, T.; Mogushi, K.; Iijima, K.; Ishikawa, K.; Tanaka, H.; Mizusawa, H.			M1-dominant microglial response precedes Prukinje cell loss in the cerebellum of SCA6-knockin mouse models	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Watase, K.; Aikawa, T.; Mizusawa, H.] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan; [Mogushi, K.] Juntendo Univ, Ctr Genom & Regenerat Med, Tokyo, Japan; [Iijima, K.; Tanaka, H.] Tokyo Med & Dent Univ, Dept Bioinformat, Tokyo, Japan; [Ishikawa, K.; Mizusawa, H.] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH13-44	345	346				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300887		
J	Zou, K; Liu, J; Liu, S; Matsumoto, Y; Murakami, S; Sugakawa, Y; Kami, A; Tanabe, C; Maeda, T; Michikawa, M; Komano, H				Zou, K.; Liu, J.; Liu, S.; Matsumoto, Y.; Murakami, S.; Sugakawa, Y.; Kami, A.; Tanabe, C.; Maeda, T.; Michikawa, M.; Komano, H.			Angiotensin type 1A receptor deficiency decreases amyloid beta-protein production and ameliorates brain amyloid pathology	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Zou, K.; Liu, J.; Liu, S.; Matsumoto, Y.; Murakami, S.; Sugakawa, Y.; Kami, A.; Tanabe, C.; Maeda, T.; Komano, H.] Iwate Med Univ, Sch Pharm Iwate, Dept Neurosci, Morioka, Iwate, Japan; [Michikawa, M.] Nagoya City Univ, Sch Med, Dept Biochem, Nagoya, Aichi 467, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH13-49	347	347				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300892		
J	Tsuboi, D; Kuroda, K; Tanaka, M; Namba, T; Taya, S; Ozaki, N; Kaibuchi, K				Tsuboi, D.; Kuroda, K.; Tanaka, M.; Namba, T.; Taya, S.; Ozaki, N.; Kaibuchi, K.			Impairment of molecular transport in a mouse model of Schizophrenia	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Tsuboi, D.; Kuroda, K.; Namba, T.; Kaibuchi, K.] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Tanaka, M.] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4648601, Japan; [Taya, S.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Kodaira, Tokyo 1870031, Japan; [Ozaki, N.] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan			Kuroda, Keisuke/K-5255-2013	Kuroda, Keisuke/0000-0002-6715-5125				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH14-24	356	356				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300915		
J	Kakio, S; Enoki, S; Kobata, K; Funakoshi-Tago, M; Tamura, H				Kakio, S.; Enoki, S.; Kobata, K.; Funakoshi-Tago, M.; Tamura, H.			coffee induces vascular endothelial growth factor expression in human neuroblastoma SH-SY5Y cells	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Kakio, S.; Funakoshi-Tago, M.; Tamura, H.] Keio Univ, Pharmaceut Sci Hyg Chem, Tokyo, Japan; [Enoki, S.; Kobata, K.] Josai Univ, Pharmaceut Sci Clin Dietet & Human Nutr, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH15-08	360	361				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300926		
J	Nakamichi, N; Yamauchi, Y; Masuo, Y; Kato, Y				Nakamichi, N.; Yamauchi, Y.; Masuo, Y.; Kato, Y.			Inhibition of multidrug resistance-associated proteins exerts cytotoxicity to neuroblastoma without neurotoxicity	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Nakamichi, N.; Yamauchi, Y.; Masuo, Y.; Kato, Y.] Kanazawa Univ, Fac Pharm, Lab Mol Pharmacotherapeut, Kanazawa, Ishikawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH16-06	367	368				2	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300944		
J	Ishii, H; Kaizu, Y; Ohara, S; Tobler, P; Tsutsui, KI; Iijima, T				Ishii, H.; Kaizu, Y.; Ohara, S.; Tobler, P.; Tsutsui, K. -I.; Iijima, T.			Outcome-history dependent effects of blocking anterior insular dopamine and serotonin on risky decision making	JOURNAL OF NEUROCHEMISTRY			English	Meeting Abstract	25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society	AUG 23-27, 2015	Cairns, AUSTRALIA	Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc					[Ishii, H.; Kaizu, Y.; Ohara, S.; Tsutsui, K. -I.; Iijima, T.] Tohoku Univ, Div Neurosci, Grad Sch Lifesci, Sendai, Miyagi 980, Japan; [Tobler, P.] Univ Zurich, Dept Econ, Zurich, Switzerland								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134			1	SI	WTH19-04	379	379				1	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP9IA	WOS:000360206300974		
J	Isshiki, S; Tajima, H; Wakayama, N; Tateyama, K				Isshiki, Saiko; Tajima, Hiroyuki; Wakayama, Nozomu; Tateyama, Kohjiro			Idiopathic Intracranial Hypertension: The "Moth-eaten" Skull Base and Encephaloceles	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Editorial Material									[Isshiki, Saiko] Musashi Kosugi Hosp, Nippon Med Sch, Dept Radiol, Kawasaki, Kanagawa 2118533, Japan; [Tajima, Hiroyuki] Musashi Kosugi Hosp, Nippon Med Sch, Ctr Minimally Invas Treatment, Kawasaki, Kanagawa 2118533, Japan; [Wakayama, Nozomu] Musashi Kosugi Hosp, Nippon Med Sch, Dept Otolaryngol, Kawasaki, Kanagawa 2118533, Japan; [Tateyama, Kohjiro] Musashi Kosugi Hosp, Nippon Med Sch, Dept Neurosurg, Kawasaki, Kanagawa 2118533, Japan	Tajima, H (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Ctr Minimally Invas Treatment, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	h-tajima@nms.ac.jp					Maralani PJ, 2012, CLIN RADIOL, V67, P656, DOI 10.1016/j.crad.2011.12.002; Butros SR, 2012, ACTA RADIOL, V53, P682, DOI 10.1258/ar.2012.110705; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Pérez Mario A, 2013, J Neuroophthalmol, V33, P330, DOI 10.1097/WNO.0b013e318299c292	4	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					168	169				2	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700001		
J	Nannol, M; Sawaizurne, T; Kodera, N; Tomore, Y; Takai, S				Nannol, Mitsuhiko; Sawaizurne, Takuya; Kodera, None; Tomore, Yuji; Takai, Shiruro			Transverse Ultrasound Assessment of the Displacement of the Median Nerve in the Carpal Tunnel during Wrist and Finger Motion in Healthy Volunteers	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						median nerve; carpal tunnel; ultrasound; wrist position; finger motion	SUBSYNOVIAL CONNECTIVE-TISSUE; GLIDING CHARACTERISTICS; FLEXOR TENDONS; DEFORMATION; DISORDERS; MOVEMENTS; CADAVER	Purpose: The purpose of this study was to investigate the displacement of the median nerve in the carpal tunnel during finger motion at varied wrist positions using transverse ultrasound in healthy volunteers, in order to clarify the appropriate position of a wrist splint in treating carpal tunnel syndrome. Methods: Fifty wrists of 25 asymptomatic volunteers were evaluated by transverse ultrasound. The location of the median nerve in the carpal tunnel was examined at 5 wrist positions (neutral, 600 dorsiflexion, 60 degrees palmar flexion, 40 degrees ulnar flexion, 100 radial flexion) with all 5 fingers in full extension, all 5 fingers in full flexion, and isolated thumb in full flexion, respectively. Results: The median nerve was located significantly (p<0.05) more dorsally at the wrist dorsal flexion position, more ulnopalmarly at the wrist palmar flexion position, more radially at the wrist radial flexion position, and more radially at the wrist ulnar flexion position than at the wrist neutral position in all 5 fingers at full extension. The median nerve moved the most significantly dorsally among all wrist positions during finger motion at the wrist dorsal flexion position (p<0.05). Conversely, the median nerve moved the most significantly ulnopalmarly at the wrist palmar flexion position with all 5 fingers in full flexion among all wrist positions during finger motion (p<0.05). This latter wrist and finger position induced significant displacement of the median nerve toward the transverse carpal ligament, and compressed it between the flexor tendons and the transverse carpal ligament. Conclusions: This study showed that there is a significant relationship between the median nerve displacement in the carpal tunnel and the motion of the wrist and fingers. This finding suggests that the compression or the shearing stress of the median nerve caused by the movement of the flexor tendons is reduced in the wrist dorsal flexion position compared with other wrist positions. This wrist dorsal flexion position could be the appropriate position for a wrist splint in the treatment for carpal tunnel syndrome. This ultrasound information provides further knowledge and understanding of the biomechanics and pathophysiology of the carpal tunnel. It could also help in the accurate analysis and assessment of diagnostic images and treatment for carpal tunnel syndrome.	[Nannol, Mitsuhiko] Musashi Kosugi Hosp, Nippon Med Sch, Dept Orthopaed Surg, Kawasaki, Kanagawa 2118533, Japan; [Sawaizurne, Takuya; Kodera, None; Tomore, Yuji; Takai, Shiruro] Nippon Med Sch, Dept Orthopaed Surg, Tokyo, Japan	Nannol, M (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Dept Orthopaed Surg, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	nanno-mi@ga2.so-net.ne.jp					Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Ettema AM, 2004, J BONE JOINT SURG AM, V86A, P1458; Yoshii YC, 2008, J ORTHOP RES, V26, P1153, DOI 10.1002/jor.20640; Zhao CF, 2007, J ORTHOP RES, V25, P185, DOI 10.1002/jor.20321; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Szabo RM, 1998, CLIN ORTHOP RELAT R, P78; Ugbolue UC, 2005, CLIN BIOMECH, V20, P50, DOI 10.1016/j.clinbiomech.2004.08.006; Erel E, 2003, J HAND SURG-BRIT EUR, V28B, P439, DOI 10.1016/S0266-7681(03)00107-4; FEUERSTEIN M, 1992, J OCCUP ENVIRON MED, V34, P257, DOI 10.1097/00043764-199203000-00009; Latko WA, 1999, AM J IND MED, V36, P248, DOI 10.1002/(SICI)1097-0274(199908)36:2<248::AID-AJIM4>3.0.CO;2-Q; LLUCH AL, 1992, J HAND SURG-BRIT EUR, V17B, P209, DOI 10.1016/0266-7681(92)90091-F; Tetro AM, 1998, J BONE JOINT SURG BR, V80B, P493, DOI 10.1302/0301-620X.80B3.8208; van Doesburg MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037081; Wang YX, 2014, ACAD RADIOL, V21, P472, DOI 10.1016/j.acra.2013.12.012; Wang YX, 2014, ULTRASOUND MED BIOL, V40, P53, DOI 10.1016/j.ultrasmedbio.2013.09.009; Yoshida A, 2010, Hand Surg, V15, P65; Yoshii Y, 2013, J ORTHOP RES, V31, P1876, DOI 10.1002/jor.22462	18	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					170	179				10	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700002		
J	Imai, T; Takase, M				Imai, Takehide; Takase, Masato			Normative Data and Predictive Equation of Interrupter Airway Resistance in Preschool Children in Japan	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						respiratory function tests; airway resistance; logistic models; predictive equation	REFERENCE VALUES; RESPIRATORY RESISTANCE	Measurement of interrupter airway resistance (R-int) is a convenient alternative to standard spirometry for assessing respiratory function in uncooperative young children. The aim of the present prospective study was to establish the normative data and predictive equation of R-int in Japanese preschool children. A total of 214 children were enrolled from a single kindergarten; however, 129 were excluded because they met at least 1 of the exclusion criteria, such as wheezing history or recent common cold. Expiratory R-int values were assessed in 85 of the children, but technically unsatisfactory measurements were obtained in 5 of them. Thus, 80 healthy Japanese children (39 boys and 41 girls) without any history or symptoms of respiratory tract diseases were evaluated. Their age, body height, and body weight ranges (median) were 1.67 to 6.42 (4.38) years, 79.8 to 120.9 (102.5) cm, and 10.4 to 24.9 (15.8) kg, respectively. The mean R-int, was 0.93 +/- 0.25 kPa/L/s (range=0.46-1.49 kPa/L/s). The R-int tended to decrease with increasing age and body height (r=-0.65; P<0.01), but sex played no significant role (P=0.71). The predictive equation based on body height derived by linear regression was expiratory R-int (kPa/L/s)=2.513 0.01567xbody height (cm) (multiple correlation coefficient=0.653). Because 79 of the 80 measured R-int values were within 140% of the predictive R-int value, we calculated a 140% cut-off for predicting bronchoconstriction. Our results provide a reference value for evaluating the degree of airway obstruction in young Japanese children.	[Imai, Takehide; Takase, Masato] Tama Nagayama Hosp, Nippon Med Sch, Dept Pediat, Tokyo 2068512, Japan	Takase, M (reprint author), Tama Nagayama Hosp, Nippon Med Sch, Dept Pediat, Tama Ku, 1-7-1 Nagayama, Tokyo 2068512, Japan.	mtakase@nms.ac.jp					Luginbuehl M, 2008, SCHOOL PSYCHOL REV, V37, P409; Klug B, 1998, PEDIATR PULM, V25, P322, DOI 10.1002/(SICI)1099-0496(199805)25:5<322::AID-PPUL6>3.0.CO;2-K; Lombardi E, 2001, THORAX, V56, P691, DOI 10.1136/thorax.56.9.691; Rohrig B, 2010, DTSCH ARZTEBL INT, V107, P552, DOI 10.3238/arztebl.2010.0552; Merkus PJFM, 2001, AM J RESP CRIT CARE, V163, P1350; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; CARTER ER, 1994, PEDIATR PULM, V17, P211, DOI 10.1002/ppul.1950170402; Child Frances, 2005, Paediatr Respir Rev, V6, P273, DOI 10.1016/j.prrv.2005.09.011; Hagiwara S, 2014, ALLERGOL INT, V63, P113, DOI 10.2332/allergolint.13-OA-0591; Kazuma N, 2005, J JPN PEDIAT SOC, V109, P38; McKenzie SA, 2002, ARCH DIS CHILD, V87, P248, DOI 10.1136/adc.87.3.248; Merkus PJFM, 2002, EUR RESPIR J, V20, P907, DOI 10.1183/09031936.02.01262001; Nakade Yusuke, 2012, Rinsho Byori, V60, P725; Phagoo SB, 1996, EUR RESPIR J, V9, P1374, DOI 10.1183/09031936.96.09071374; Saito N, 2010, JPN J PEDIAT ALLERGY, V24, P143; Son Bk, 1998, PEDIAT ALLERGY RESP, V8, P198; Song DJ, 2006, PEDIATR PULM, V41, P228, DOI 10.1002/ppul.20340; Watanabe M, 2009, 46 ANN C JAP J PED A, P545	20	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					180	185				6	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700003		
J	Yamada, SM				Yamada, Shoko M.			Too Early Initiation of Enteral Nutrition is Not Nutritionally Advantageous for Comatose Acute Stroke Patients	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						serum albumin; coma; enteral nutrition; stroke; total parenteral nutrition	PARENTERAL-NUTRITION; ISCHEMIC-STROKE; MALNUTRITION; REHABILITATION; OUTCOMES; TUBE; PREVALENCE; ADMISSION; RECOVERY; THERAPY	Background: Comatose acute stroke patients are at high risk of malnutrition, especially hypoproteinemia. However, when to start and how to provide nutrition to these patients are unclear. The purpose of this study was to determine the optimum timing and methods of nutritional supplementation to comatose acute stroke patients. Methods: A total of 273 comatose acute stoke patients who were unable to eat were enrolled. They received peripheral intravenous low-calorie solutions for the first 4 days after admission (days 0-3), and serum protein concentrations were measured on days 2, 3, and 4. From day 4, 5 different nutritional regimens were administered (25 kcal/kg/day), (including enteral nutrition [EN], total parenteral nutrition [TPN], tube feeding of 20% glucose solution, and combinations of these nutritional supplementations),. Serum concentrations of total protein and albumin were measured on days 10, 14, and 21. The patients who had EN until day 21 from day 4 were defined as EN group, and who had TPN were as TPN group. Results: Serum protein concentrations decreased slightly on day 2 and decreased significantly on days 3 and 4. From day 4 to 14, the recovery of serum protein was better in the TPN group than in the EN group. Conversely, after day 14, recovery from hypoproteinemia was better in the EN group than in the TPN group. However, when diarrhea was caused by EN, further hypoproteinemia occurred and caused patients to require TPN. The recovery from hypoproteirtemia was earliest in patients receiving TPN with 20% glucose fed through a nasogastric tube from day 4 to 13 followed by EN after day 14. Hospitalization was statistically shorter for patients with a nutritionally early recovery than for patients with a delayed recovery, but clinical outcome did not differ significantly between the groups. Conclusion: It is nutritionally disadvantageous not to start nutritional support within 3 days after admission in comatose acute stroke patients. However, starting EN too early is not nutritionally beneficial, and TPN with 20% glucose fed through a tube is recommended as adequate nutrition for these patients. However, TPN should not be employed for longer than 10 days, because switching to EN after this period contributes to better nutritional recovery than continuing TPN.	[Yamada, Shoko M.] Teikyo Univ, Mizonokuchi Hosp, Dept Neurosurg, Kawasaki, Kanagawa 2138507, Japan	Yamada, SM (reprint author), Teikyo Univ, Mizonokuchi Hosp, Dept Neurosurg, Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	merrityamada@hotmail.co.jp					ALBIIN N, 1982, ACTA MED SCAND, V212, P151; Dennis M, 2005, LANCET, V365, P2005, DOI 10.1016/S0140-6736(05)66691-3; UNOSSON M, 1994, STROKE, V25, P366; ALVERDY JC, 1988, SURGERY, V104, P185; Kudsk KA, 2002, AM J SURG, V183, P390, DOI 10.1016/S0002-9610(02)00821-8; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Foley NC, 2009, STROKE, V40, pE66, DOI 10.1161/STROKEAHA.108.518910; Belayev L, 2001, STROKE, V32, P553; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Gariballa SE, 1998, AM J CLIN NUTR, V68, P275; Davalos A, 1996, STROKE, V27, P1028; BUCHMAN AL, 1995, JPEN-PARENTER ENTER, V19, P453, DOI 10.1177/0148607195019006453; Aquilani R, 2011, NUTR CLIN PRACT, V26, P339, DOI 10.1177/0884533611405793; Rabadi MH, 2008, NEUROLOGY, V71, P1856, DOI 10.1212/01.wnl.0000327092.39422.3c; Foley NC, 2009, J REHABIL MED, V41, P707, DOI 10.2340/16501977-0415; Dziewas R, 2004, J NEUROL NEUROSUR PS, V75, P852, DOI 10.1136/jnnp.2003.019075; APTAKER RL, 1994, ARCH PHYS MED REHAB, V75, P80; Bouziana SD, 2011, NUTR METAB; Chalela JA, 2004, NEUROCRIT CARE, V1, P331, DOI 10.1385/NCC:1:3:331; DIONIGI R, 1986, GUT, V27, P5, DOI 10.1136/gut.27.Suppl_1.5; Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714; Gariballa SE, 2001, CLIN NUTR, V20, P487, DOI 10.1054/clnu.2001.0477; James R, 2005, ARCH PHYS MED REHAB, V86, pS82, DOI 10.1016/j.apmr.2005.07.314; Mosselman MJ, 2013, J NEUROSCI NURS, V45, P194, DOI 10.1097/JNN.0b013e31829863cb; ROTHSCHI.MA, 1972, NEW ENGL J MED, V286, P816, DOI 10.1056/NEJM197204132861505; Whelan K, 2003, J HUM NUTR DIET, V16, P21, DOI 10.1046/j.1365-277X.2003.00418.x; WILMORE DW, 1991, NEW ENGL J MED, V325, P695; Yoshida M, 1992, JPN J SURG METAB NUT, V26, P390	28	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					186	192				7	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700004		
J	Otsuka, T; Sakai, Y; Ohno, D; Tsuruoka, S				Otsuka, Tomoyuki; Sakai, Yukinao; Ohno, Dai; Tsuruoka, Shuichi			A Case of Cryoglobulinemic Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						membranoproliferative glomerulonephritis; cryoglobulinemia; hepatitis C virus; cryofiltration; hepatitis C virus-related glomerulonephritis	ANTIVIRAL THERAPY; INTERFERON-ALPHA; CRYOFILTRATION APHERESIS; MIXED CRYOGLOBULINEMIA; KIDNEY-DISEASE; RENAL-DISEASE; IFN-ALPHA; INFECTION; HCV; PATIENT	A 61-year-old man with bilateral purpura of the lower limbs and subsequent edema, was hospitalization after renal dysfunction developed. The presence of hepatitis C virus (HCV) RNA and cryoglobulin and the finding of membranoproliferative glomerulonephritis on renal biopsy led to a diagnosis of HCV-related glomerulonephritis due to cryoglobulinernia. Because of the pre-existence of nephrotic syndrome and the continuously increasing serum level of creatinine, treatment with cryofiltration, interferon, and steroids was started. After 5 cryofiltration sessions, the cryocrit level had decreased to 1% and the levels of serum creatinine and proteinuria had also decreased. However, 3 weeks after the start of treatment, nephrotic syndrome developed again and was accompanied by lower-extremity mononeuropathy and renal dysfunction. Thereafter, the patient showed disorientation, an affective disorder, and delirium, and his condition gradually deteriorated. Radiological examination of the head and examination of the cerebrospinal fluid showed no abnormalities. Despite the withdrawal of the interferon therapy and the reduction of the steroid dose, the patient's conditions remained unchanged, and the level of consciousness deteriorated. Although cryofiltration had beneficial effects and plasma exchange was continuously performed, the patient died on the 74th hospital day. Because of the significant changes due to ventilatory support and hemorrhage associated with disseminated intravascular coagulation, the autopsy findings did not allow us to definitively determine whether the symptoms had been caused by the HCV-related membranoproliferative glomerulonephritis or the interferon therapy or both. We have reported this case to provide insight into whether interferon therapy should be administered for HCV-related membranoproliferative glomerulonephritis with marked neurological symptoms due to cryoglobulinemia.	[Otsuka, Tomoyuki; Sakai, Yukinao; Ohno, Dai] Musashi Kosugi Hosp, Nippon Med Sch, Dept Nephrol, Kawasaki, Kanagawa 2118533, Japan; [Tsuruoka, Shuichi] Nippon Med Sch, Grad Sch Med, Dept Nephrol, Tokyo, Japan	Sakai, Y (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Dept Nephrol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	y-sakai@nms.ac.jp					Fabrizi F, 2013, AM J KIDNEY DIS, V61, P623, DOI 10.1053/j.ajkd.2012.08.040; Kimmel PL, 2003, NEPHROL DIAL TRANSPL, V18, P285, DOI 10.1093/ndt/18.2.285; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; GUMBER SC, 1995, ANN INTERN MED, V123, P615; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Raison CL, 2005, BRAIN BEHAV IMMUN, V19, P23, DOI 10.1016/j.bbi.2004.05.001; Kamar N, 2008, CLIN NEPHROL, V69, P149; Dustin LB, 2012, ANTIVIR THER, V17, P1449, DOI 10.3851/IMP2222; Nakajima H, 2014, THER APHER DIAL, V18, P258, DOI 10.1111/1744-9987.12213; Sabbatini A, 1997, CLIN EXP RHEUMATOL, V15, P655; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1053/S0272-6386(03)00828-X; Kamar N, 2006, KIDNEY INT, V69, P436, DOI 10.1038/sj.ki.5000142; De Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Troxell ML, 2011, CLIN NEPHROL, V76, P159, DOI 10.5414/CN106626; DAMICO G, 1995, AM J KIDNEY DIS, V25, P361, DOI 10.1016/0272-6386(95)90095-0; Degasperi Elisabetta, 2014, Hepat Med, V6, P25, DOI 10.2147/HMER.S44375; Donato MF, 2013, INT J ARTIF ORGANS, V36, P367, DOI 10.5301/ijao.5000199; Fabrizi F, 2012, KIDNEY BLOOD PRESS R, V35, P687, DOI 10.1159/000345515; Feng B, 2012, NEPHROL DIAL TRANSPL, V27, P640, DOI 10.1093/ndt/gfr236; Garini Giovanni, 2005, Ann Ital Med Int, V20, P71; Gentile I, 2014, THER CLIN RISK MANAG, V10, P493, DOI 10.2147/TCRM.S66731; Gilli P, 1996, NEPHROL DIAL TRANSPL, V11, P526; Gluhovschi C, 2011, IMMUNOPHARM IMMUNOT, V33, P744, DOI 10.3109/08923973.2010.551129; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kondo Y, 2013, WORLD J GASTROENTERO, V19, P7889, DOI 10.3748/wjg.v19.i44.7889; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; McMurray RW, 1997, SEMIN ARTHRITIS RHEU, V26, P689, DOI 10.1016/S0049-0172(97)80005-4; Michaud M, 2013, JCR-J CLIN RHEUMATOL, V19, P142, DOI 10.1097/RHU.0b013e318289e06e; Migliorini A, 2013, AM J PATHOL, V183, P431, DOI 10.1016/j.ajpath.2013.04.017; Morales JM, 2012, CONTRIB NEPHROL, V176, P10, DOI 10.1159/000333772; Morosetti M, 1996, NEPHROL DIAL TRANSPL, V11, P532; Namba T, 2010, CLIN EXP NEPHROL, V14, P372, DOI 10.1007/s10157-010-0282-3; Nemni R, 2003, J NEUROL NEUROSUR PS, V74, P1267, DOI 10.1136/jnnp.74.9.1267; Neri S, 2006, CLIN DRUG INVEST, V26, P655, DOI 10.2165/00044011-200626110-00005; Pandrangi S, 2008, NAT CLIN PRACT NEPHR, V4, P393, DOI 10.1038/ncpneph0823; Pucillo L P, 1994, Curr Opin Nephrol Hypertens, V3, P465, DOI 10.1097/00041552-199407000-00014; Retamozo S, 2013, ONCOLOGY WILLISTON P, V27, P1110; Retamozo S, 2013, ONCOLOGY-NY, V27, P1098; Sanai T, 2009, INT UROL NEPHROL, V41, P179, DOI 10.1007/s11255-007-9322-7; Sarac E, 1997, AM J KIDNEY DIS, V30, P113, DOI 10.1016/S0272-6386(97)90572-2; Siami FS, 2004, THER APHER DIAL, V8, P398, DOI 10.1111/j.1526-0968.2004.00182.x; SIAMI GA, 1995, ASAIO J, V41, pM315, DOI 10.1097/00002480-199507000-00021; Sumida K, 2010, CLIN NEPHROL, V74, P446, DOI 10.2379/CN106395; Takada S, 2012, MOL MED REP, V6, P3, DOI 10.3892/mmr.2012.861; Tsuboi N, 2010, CLIN EXP NEPHROL, V14, P492, DOI 10.1007/s10157-010-0301-4	46	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					193	201				9	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700005		
J	Yamada, T; Kan, H; Matsumoto, S; Machida, T; Koizumi, M; Shinji, S; Matsuda, A; Yamagishi, A; Yokoyama, Y; Uchida, E				Yamada, Takeshi; Kan, Hayato; Matsumoto, Satoshi; Machida, Tadashi; Koizumi, Michihiro; Shinji, Seiichi; Matsuda, Akihisa; Yamagishi, Aya; Yokoyama, Yasuyuki; Uchida, Eiji			A Case of Portal Venous Gas after Rectal Surgery without Anastomotic Leakage or Bowel Necrosis	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						portal venous gas; rectal cancer		Portal venous gas has traditionally been considered an indicator of a poor prognosis due to bowel necrosis. Portal venous gas has recently been detected in patients with various clinical conditions, such as Crohn's disease, chemotherapy, and blunt abdominal injury without bowel necrosis. We herein report the first case of a patient with rectal cancer in whom portal venous gas developed after low anterior resection without anastomotic leakage or bowel necrosis. A 66-year-old man who had undergone low anterior resection started having severe diarrhea the day after the operation. A fever was present for 2 days after the operation but resolved on postoperative day 3. The patient complained of abdominal pain 5 days postoperatively. Computed tomography showed portal venous gas. Emergency open laparotomy was performed, but only limited ascites fluid without leakage or bowel necrosis was found. We irrigated the abdominal cavity and performed an ileostomy with insertion of a drainage tube in the rectovesical pouch. Only serous ascites was discharged through the drainage tube. The portal venous gas disappeared 3 days after the second operation. The patient was discharged in good condition 21 days after the first operation. Portal venous gas can develop after rectal surgery without anastomotic leakage or bowel necrosis. Conservative treatment is reasonable for patients without signs of bowel necrosis or panperitonitis. However, patients with portal venous gas must be carefully observed because portal venous gas may be life threatening.	[Yamada, Takeshi; Kan, Hayato; Koizumi, Michihiro; Shinji, Seiichi; Yamagishi, Aya; Yokoyama, Yasuyuki; Uchida, Eiji] Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Tokyo 1138602, Japan; [Matsumoto, Satoshi; Matsuda, Akihisa] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan; [Machida, Tadashi] Nippon Med Sch, Dept Radiol, Tokyo 1138602, Japan	Yamada, T (reprint author), Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	y-tak@nms.ac.jp					Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Bobba RK, 2005, DIGEST DIS SCI, V50, P411, DOI 10.1007/s10620-005-1620-2; Hou SK, 2004, AM J EMERG MED, V22, P214, DOI 10.1016/j.ajem.2004.02.017; Inokuchi R, 2014, INTENS CARE MED, V40, P1369, DOI 10.1007/s00134-014-3390-9; Kinoshita H, 2001, ARCH SURG-CHICAGO, V136, P1410, DOI 10.1001/archsurg.136.12.1410; Koami H, 2015, SURG TODAY, V45, P156, DOI 10.1007/s00595-014-0941-1; Mognol P, 2005, OBES SURG, V15, P278, DOI 10.1381/0960892053268480; Pais TP, 2014, J CROHNS COLITIS, V8, P1329, DOI 10.1016/j.crohns.2014.02.023; Sen Indrani, 2013, Arch Trauma Res, V2, P95, DOI 10.5812/atr.10866; Tuite DJ, 2007, AUSTRALAS RADIOL, V51, pB137, DOI 10.1111/j.1440-1673.2007.01848.x; Wu JM, 2009, DIGEST SURG, V26, P119, DOI 10.1159/000206147; Zalinski S, 2009, EJSO-EUR J SURG ONC, V35, P557, DOI 10.1016/j.ejso.2008.09.003	13	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					202	205				4	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700006		
J	Okazaki, H; Hata, N; Shirakabe, A; Tsurumi, M; Shinada, T; Shimizu, W				Okazaki, Hirotake; Hata, Noritake; Shirakabe, Akihiro; Tsurumi, Masafumi; Shinada, Takuro; Shimizu, Wataru			Early Effects of Oral Pulmonary Vasodilators in an Elderly Patient with Critical Thromboembolic Pulmonary Hypertension: A Case Report	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						pulmonary arterial hypertension; chronic thromboembolic pulmonary hypertension; specific pulmonary vasodilators; ambrisentan; tadalafil	ARTERIAL-HYPERTENSION	A 70-year-old woman who had been treated for bipolar disorder and dementia was admitted to the intensive care unit of a university hospital with severe dyspnea; pulmonary arterial hypertension was diagnosed after cardiac catheterization was performed. Computed tomography pulmonary angiography showed typical signs of chronic thrombosis in the proximal pulmonary artery without an adequate amount of fresh thrombi, which appeared to be the cause of the elevation in pulmonary artery pressure, and resulted in severe hypoxemia. Therefore, the pulmonary arterial hypertension was classified as belonging to the chronic thromboembolic pulmonary hypertension subgroup. Although the patient's respiratory condition was classified as World Health Organization class IV, she was treated with the combination of oral ambrisentan and tadalafil, rather than intravenous epoprostenol, which she was unable to tolerate. Consequently, both her symptom and hemodynamic status showed rapid improvement with only oral pulmonary vasodilators. This case demonstrates the efficacy of oral treatment alone in elderly patients with severe chronic thromboembolic pulmonary hypertension.	[Okazaki, Hirotake; Hata, Noritake; Shirakabe, Akihiro; Tsurumi, Masafumi; Shinada, Takuro] Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit, Chiba 2701694, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan	Okazaki, H (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit, 1715 Kamagari, Chiba 2701694, Japan.	s9019@nms.ac.jp					Nishimura R, 2013, CIRC J, V77, P2110, DOI 10.1253/circj.CJ-12-1391; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; Ghofrani HA, 2004, J AM COLL CARDIOL, V44, P1488, DOI 10.1016/j.jacc.2004.06.060; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI 10.1016/j.jacc.2009.04.012; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Suntharalingam J, 2008, CHEST, V134, P229, DOI 10.1378/chest.07-2681; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Ghofrani HA, 2011, INT J CARDIOL, V154, pS20, DOI 10.1016/S0167-5273(11)70490-9; Marini C, 2013, INTERN EMERG MED, V8, P307, DOI 10.1007/s11739-011-0610-y; Wijesuriya S, 2013, CHEST, V143, P1460, DOI 10.1378/chest.12-1384	10	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2015	82	4					206	210				5	Medicine, General & Internal	General & Internal Medicine	CQ3QN	WOS:000360517700007		
J	Qin, XY; Fujii, S; Shimizu, A; Kagechika, H; Kojima, S				Qin, Xian-Yang; Fujii, Shinya; Shimizu, Akitaka; Kagechika, Hiroyuki; Kojima, Soichi			Carboxylic Derivatives of Vitamin K2 Inhibit Hepatocellular Carcinoma Cell Growth through Caspase/Transglutaminase-Related Signaling Pathways	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						vitamin K2; hepatocellular carcinoma; chemoprevention; carboxylic group; isoprene units	POLYPRENOIC ACID; BONE HEALTH; APOPTOSIS; CHEMOPREVENTION; CANCER; RECURRENCE; ACTIVATION; HEPATITIS	Chemoprevention of hepatocellular carcinoma (HCC) is one of the most challenging aspects of medical research. Vitamin K2 (VK2) has been suggested for its chemo-preventive role in treatment of HCC, while inconsistent results in clinical trials have been reported. The present study was initiated to add to our insight into the anti-HCC cell proliferative effect of VK2 and its derivatives from a viewpoint of chemical structure. No significant effect was observed with original VK2, while VK2 derivatives bearing both isoprene units and a carboxyl-terminated side chain dose-dependently inhibited the growth of HCC cells without affecting normal liver cells. Loss-of-function analyses revealed that the anti-HCC cell activity by the VK2 derivatives was not mediated by a VK2 binding protein Bcl-2 homologous antagonist/killer (Bak) but rather associated with caspase/transglutaminase-related signaling pathways. Further studies on the carboxylic derivatives of VK2 bearing isoprene structural units introduced in this study might shed new light on the systemic treatment and prevention of HCC.	[Qin, Xian-Yang; Kojima, Soichi] RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama 3510198, Japan; [Fujii, Shinya; Shimizu, Akitaka; Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Fujii, Shinya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Kojima, S (reprint author), RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama 3510198, Japan.	skojima@postman.riken.go.jp			Japan Society for the Promotion of Science (JSPS) [25-03217]; JSPS Core-to-Core Program, A. Advanced Research Networks; JSPS KAKENHI Grant [25460146, 22136013, 23659051]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [H24-B Drug Discovery-Hepatitis-General-003]	This work was supported by the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers (25-03217) (for X.-Y.Q.), the JSPS Core-to-Core Program, A. Advanced Research Networks (for H.K.), and JSPS KAKENHI Grant No. 25460146 (for S.F.), Nos. 22136013 and 23659051 (for H.K.). This study was also partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (for S.K.) and for the Research on the Innovative Development and the Practical Application of New Drugs for Hepatitis B (H24-B Drug Discovery-Hepatitis-General-003) from the Ministry of Health, Labor and Welfare of Japan (for S.K.).	El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Hamidi MS, 2013, J CLIN DENSITOM, V16, P409, DOI 10.1016/j.jocd.2013.08.017; Steward WP, 2013, BRIT J CANCER, V109, P1, DOI 10.1038/bjc.2013.280; Beulens JWJ, 2013, BRIT J NUTR, V110, P1357, DOI 10.1017/S0007114513001013; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Park MK, 2013, EUR J CANCER, V49, P1692, DOI 10.1016/j.ejca.2012.11.036; Yoshida H, 2011, HEPATOLOGY, V54, P532, DOI 10.1002/hep.24430; Mizuta T, 2006, CANCER, V106, P867, DOI 10.1002/cncr.21667; Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2; Fujii S, 2015, BIOORGAN MED CHEM, V23, P2344, DOI 10.1016/j.bmc.2015.03.070; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; FUKUTOMI Y, 1990, JPN J CANCER RES, V81, P1281; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Habu D, 2004, JAMA-J AM MED ASSOC, V292, P358, DOI 10.1001/jama.292.3.358; Hong WK, 1995, CLIN CANCER RES, V1, P677; Kakizoe T, 2003, JPN J CLIN ONCOL, V33, P421, DOI 10.1093/jjco/hyg090; Kanamori T, 2007, CANCER SCI, V98, P431, DOI 10.1111/j.1349-7006.2006.00384.x; Karasawa S, 2013, MOL PHARMACOL, V83, P613, DOI 10.1124/mol.112.082602; Kitagawa J, 2011, J CANCER RES CLIN, V137, P779, DOI 10.1007/s00432-010-0938-0; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Okita K, 2014, J GASTROENTEROL, V50, P667; Otsuka M, 2004, HEPATOLOGY, V40, P243, DOI 10.1002/hep.20260; Qin XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082860; Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4; Tung-Ping PR, 2000, ANN SURG, V232, P10, DOI DOI 10.1097/00000658-200007000-00003]; Weber P, 2001, NUTRITION, V17, P880, DOI 10.1016/S0899-9007(01)00709-2; Yaguchi M, 1997, LEUKEMIA, V11, P779, DOI 10.1038/sj.leu.2400667; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227	28	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					285	290				6	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400001		
J	Yamada, M; Mochizuki, K; Honma, K; Miyauchi, R; Kasezawa, N; Tohyama, K; Goda, T				Yamada, Masami; Mochizuki, Kazuki; Honma, Kazue; Miyauchi, Rie; Kasezawa, Nobuhiko; Tohyama, Kazushige; Goda, Toshinao			Serum Fatty Acid Binding Protein 4 Concentrations Are Positively and Independently Associated with Blood Pressure and Abdominal Fat among Parameters in Health Check-Ups in Ordinary Middle-Aged Japanese Males	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						FABP4; abdominal fat; Japanese males; blood pressure; CT	VENTRICULAR DIASTOLIC DYSFUNCTION; DIET HISTORY QUESTIONNAIRE; TYPE-2 DIABETIC-PATIENTS; METABOLIC DISEASES; APOLIPOPROTEIN-E; ATHEROSCLEROSIS; ADULTS; MICE; HYPERTENSION; DEFICIENT	We wished to examine potential associations among blood concentrations of fatty acid-binding protein (FABP) 4 and parameters in health check-ups such as abdominal fat area (AFA) and blood pressure (BP) in middle-aged Japanese males. We conducted a cross-sectional study of males who participated in health check-ups in Japan. We excluded participants diagnosed with metabolic diseases by the time of their check-up. A total of 305 subjects (30-64 [mean +/- standard deviation, 47.3 +/- 8.5] y) were recruited. Areas of total-abdominal, visceral and subcutaneous fat were measured using computed tomography. We compared the association of serum concentrations of FABP4 with various clinical parameters by Pearson product-moment correlation coefficient (PPMCC) analyses, and by stepwise multivariate linear regression analyses (MLRA). PPMCC analyses showed that blood concentrations of FABP4 were positively associated with: body mass index; areas of fat (total abdominal, visceral, subcutaneous); systolic BP; diastolic BP; total cholesterol; low-density lipoprotein-cholesterol; triacylglycerol; activities of gamma-glutamyl transpeptidase, aspartate aminotransferase and alanine aminotransferase; white blood cell count; and levels of creatinine. Step-wise MLRA showed that AFAs (visceral and subcutaneous) and diastolic BP were positively and independently associated with serum concentrations of FABP4 among the parameters tested. These data suggest that serum concentrations of FABP4 are independently and positively associated with BP and AFA among parameters measured in health check-ups in middle-aged Japanese males.	[Yamada, Masami; Mochizuki, Kazuki; Honma, Kazue; Miyauchi, Rie; Goda, Toshinao] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan; [Mochizuki, Kazuki] Univ Yamanashi, Fac Life & Environm Sci, Dept Local Produce & Food Sci, Lab Food & Nutr Sci, Yamanashi 4008510, Japan; [Kasezawa, Nobuhiko; Tohyama, Kazushige] SBS Shizuoka Hlth Promot Ctr, Shizuoka 4228033, Japan	Goda, T (reprint author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan.	gouda@u-shizuoka-ken.ac.jp			Global COE Program, the Ministry of Education, Culture, Sports, Science and Technology in Japan,; Takeda Science Foundation	We thank Drs. S. Sasaki and K. Murakami for providing the Brief Self-administered Diet History Questionnaire and for helpful discussions. This work was supported by the Global COE Program, the Ministry of Education, Culture, Sports, Science and Technology in Japan, and by a grant from the Takeda Science Foundation.	Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; Arabshahi S, 2014, EUR J EPIDEMIOL, V29, P311, DOI 10.1007/s10654-014-9911-6; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Park SE, 2012, NUTR METAB CARDIOVAS, V22, P525, DOI 10.1016/j.numecd.2010.09.008; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Mochizuki K, 2012, NUTRITION, V28, P978, DOI 10.1016/j.nut.2011.12.001; Mochizuki K, 2013, J NUTR SCI VITAMINOL, V59, P447, DOI 10.3177/jnsv.59.447; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; [Anonymous], 1998, JPN CIRC J, V62, P431; Baessler A, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.3; Bagheri R, AM J CARDIOL, V106, P1118; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Gelsinger Carmen, 2010, Wien Med Wochenschr, V160, P377, DOI 10.1007/s10354-010-0781-6; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Kim TN, 2013, DIABETES RES CLIN PR, V101, P210, DOI 10.1016/j.diabres.2013.05.014; Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379; Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665; Sasaki S, 1998, J Epidemiol, V8, P203; Scaglione R, 2010, INTERN EMERG MED, V5, P111, DOI 10.1007/s11739-009-0332-6	29	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					291	298				8	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400002		
J	Hashimoto, S; Mizutani, E; Suzuki, M; Yshida, A; Naito, M				Hashimoto, Sayuki; Mizutani, Erika; Suzuki, Maiko; Yshida, Akihiro; Naito, Michitaka			Effects of Aerobic Exercise on Postprandial Carbohydrate and Lipoprotein Metabolism Following Cookie Ingestion in Healthy Young Women	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						triglyceride; remnant; apolipoprotein B-48; insulin; walking	FREE FATTY-ACIDS; INSULIN-RESISTANCE; HOMOGENEOUS ASSAY; CHOLESTEROL; GLUCOSE; PLASMA; HUMANS; ATHEROGENESIS	We examined the acute effects of postprandial aerobic exercise on glucose and lipid metabolism following cookie ingestion. Fifteen healthy young women with a sedentary lifestyle, normal weight and apolipoprotein E3/3 participated. After a 12-h overnight fast, each subject ingested a cookie (1.53 g/kg, Meal Test C) and then performed two trials, one with postprandial exercise (E trial) and one without exercise (C trial), in a randomized crossover design. A single 30-mM bout of walking exercise was performed 20 min after the cookie intake. Venous blood samples were drawn before (0 h) and 20 mm and 1, 2, 4, and 6 h after cookie ingestion. The Delta glucose concentration was not significantly different between the two trials, but the Delta insulin concentration at 1 h and the incremental area under the curve (IAUC) (0-2 h)-insulin in the E trial were significantly lower than in the C trial. The ratio of glucose/insulin at 1 h was significantly higher in the E trial than in the C trial. The Delta ATG, Delta RLP-TG, Delta apoB48 and Delta RemL-C concentrations at 1 h in the E trial were significantly higher than in the C trial. The IAUC (0-2 h)-apoB48 in the E trial was significantly larger than in the C trial. Postprandial exercise showed an insulin-sparing effect following the cookie ingestion by increasing insulin sensitivity. However, postprandial exercise transiently stimulated the secretion of exogenous apoB48-containing lipoprotein during the early period, and no further effects were observed. These results suggest that postprandial aerobic exercise is effective for the promotion of postprandial carbohydrate metabolism, but not lipidemia.	[Hashimoto, Sayuki; Mizutani, Erika; Suzuki, Maiko; Naito, Michitaka] Sugiyama Jogakuen Univ, Grad Sch Life Studies, Chikusa Ku, Nagoya, Aichi 4648662, Japan; [Hashimoto, Sayuki] Kinjo Gakuin Univ, Coll Human Life & Environm, Dept Food & Nutr Environm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Yshida, Akihiro] Nakatsugawa Municipal Gen Hosp, Dept Clin Lab, Nakatsugawa 5088502, Japan	Naito, M (reprint author), Sugiyama Jogakuen Univ, Div Nutr & Hlth, Sch, Chikusa Ku, 17-3 Hoshigaoka Motomachi, Nagoya, Aichi 4648662, Japan.	naito@sugiyama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21300259]	This work was supported by Grants-in-Aid for Scientific Research (Basic Research B No. 21300259) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Mr. Tatsuhiko Furuhashi (Fujirebio) for his technical assistance.	LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Duez H, 2008, CIRCULATION, V117, P2369, DOI 10.1161/CIRCULATIONAHA.107.739888; Fujioka Y, 2009, J ATHEROSCLER THROMB, V16, P145; Westphal S, 2004, AM J CLIN NUTR, V80, P284; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10.1548]; Pavlic M, 2010, DIABETES, V59, P580, DOI 10.2337/db09-1297; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Hashimoto S, 2011, J ATHEROSCLER THROMB, V18, P891; Miyauchi K, 2007, CLIN CHEM, V53, P2128, DOI 10.1373/clinchem.2007.092296; NAKAJIMA K, 1993, CLIN CHIM ACTA, V223, P53, DOI 10.1016/0009-8981(93)90062-9; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Hanada H, 2012, CLIN CHIM ACTA, V413, P160, DOI 10.1016/j.cca.2011.09.013; Harano Y, 2006, ENDOCR J, V53, P173, DOI 10.1507/endocrj.53.173; Hashimoto S, 2013, J ATHEROSCLER THROMB, V20, P204; Ito Y, 2011, CLIN CHEM, V57, P57, DOI 10.1373/clinchem.2010.149559; MINUK HL, 1981, AM J PHYSIOL, V240, pE458; Ooi TC, 2011, CURR VASC PHARMACOL, V9, P302	19	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					299	305				7	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400003		
J	Mineo, S; Noguchi, A; Nagakura, Y; Kobori, K; Ohta, T; Sakaguchi, E; Ichiyanagi, T				Mineo, Shigeru; Noguchi, Akane; Nagakura, Yuta; Kobori, Kinji; Ohta, Tatsuo; Sakaguchi, Ei; Ichiyanagi, Takashi			Boysenberry Polyphenols Suppressed Elevation of Plasma Triglyceride Levels in Rats	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						boysenberry; anti-obesity effect; pancreatic lipase; polyphenol; lipid absorption	HIGH-FAT DIET; TEA CATECHINS; OBESITY; MICE; ANTHOCYANINS; EXTRACT; IDENTIFICATION; RESVERATROL; QUERCETIN; LIVER	Boysenberry, a hybrid Rubus berry, is mainly cultivated in New Zealand. We previously reported that consumption of boysenberry juice (BBJ) exhibited anti-obesity effects in high-fat feeding rats. In this study, we focused on the suppressive effect of BBJ and its fraction on triglyceride absorption from the gastrointestinal tract. BBJ effectively inhibited pancreatic lipase activity in vitro, and was separated into four fractions (Fr1, Fr2, Fr3 and Fr4) by HP-20 column chromatography. Among all the fractions, Fr3, the ellagic acid-rich fraction, showed the most potent inhibition against pancreatic lipase in vitro with Fr2, the anthocyanin-rich fraction, second. Authentic ellagic acid equivalent in Fr3 showed poor activity against pancreatic lipase. Then, each fraction was orally administered with corn oil to rats fitted with a jugular catheter to examine the effects of each fraction on plasma triglyceride levels. Both Fr2 and Fr3 effectively suppressed the plasma triglyceride level elevation at a dose of 1,000 mg/kg body weight. These findings demonstrated that BBJ contains chemical components which inhibit triglyceride absorption from the gastrointestinal tract.	[Mineo, Shigeru; Noguchi, Akane; Nagakura, Yuta; Kobori, Kinji] Bourbon Corp, Bourbon Inst Hlth, Kashiwazaki, Niigata 9458611, Japan; [Ohta, Tatsuo] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata 9568603, Japan; [Sakaguchi, Ei] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Okayama 7008530, Japan; [Ichiyanagi, Takashi] Niigata Inst Technol, Dept Environm Sci, Kashiwazaki, Niigata 9451195, Japan	Ichiyanagi, T (reprint author), Niigata Inst Technol, Dept Environm Sci, 1719 Fujihashi, Kashiwazaki, Niigata 9451195, Japan.	ichiyanagi@niit.ac.jp					Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2; Kawaguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P102; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Kurihara H, 2003, BIOL PHARM BULL, V26, P383, DOI 10.1248/bpb.26.383; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Salgado JM, 2010, J MED FOOD, V13, P1355, DOI 10.1089/jmf.2009.0246; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Wada L, 2002, J AGR FOOD CHEM, V50, P3495, DOI 10.1021/jf011405l; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Tsuda T, 2003, J NUTR, V133, P2125; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; [Anonymous], 2011, NIPPON EIYO SHOKURYO; Furuuchi R, 2011, J AGR FOOD CHEM, V59, P3738, DOI 10.1021/jf104976n; Kool MM, 2010, FOOD CHEM, V119, P1535, DOI 10.1016/j.foodchem.2009.09.039; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Barnett LE, 2007, J MED FOOD, V10, P281, DOI 10.1089/jmf.2006.027; Furuuchi R, 2012, BIOSCI BIOTECH BIOCH, V76, P1694, DOI 10.1271/bbb.120302; Goncalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x; Igarashi K, 2004, BIOFACTORS, V21, P259; Lesperance L., 2009, CONCISE NZ FOOD COMP, P45; Toyoda-Ono Y, 2007, BIOSCI BIOTECH BIOCH, V71, P971, DOI 10.1271/bbb.60635	26	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					306	312				7	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400004		
J	Imai, C; Harazaki, T; Inoue, S; Mochizuki, K; Goda, T				Imai, Chihiro; Harazaki, Tomomi; Inoue, Seiya; Mochizuki, Kazuki; Goda, Toshinao			Treatment with DPP-4I Anagliptin or alpha-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						postprandial hyperglycemia; impaired glucose tolerance; cardiovascular disease; inflammatory cytokines; adhesion molecules	IMPAIRED GLUCOSE-TOLERANCE; SOLUBLE ADHESION MOLECULES; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; INFLAMMATORY CYTOKINES; PERIPHERAL LEUKOCYTES; GLYCEMIC CONTROL; JAPANESE MEN; E-SELECTIN; INHIBITOR	It has been reported that postprandial hyperglycemia from the pre-diabetic stage, especially from the impaired glucose tolerance (IGT) stage, is positively associated with subsequent incidences of cardiovascular diseases (CVD) and type 2 diabetes. In this study, we aimed to investigate whether treatment with a dipeptidyl peptidase-4 inhibitor (DPP-4I) or an alpha-glucosidase inhibitor (alpha-GI), either of which suppresses postprandial hyperglycemia, reduces the expression of CVD risk factors in an IGT animal model. A DPP-4I, anagliptin (1,200 ppm), or an alpha-GI, miglitol (600 ppm), in the diet was administered for 47 wk to Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model for spontaneously-developed type 2 diabetes, at the IGT stage. We examined whether each treatment reduced the expression of CVD risk factors such as inflammatory cytokines/cytokine-like factors in peripheral leukocytes and adhesion molecules in the aortic tissues and circulation. Treatment with either drug reduced IGT development and repressed expression of the interleukin-1 beta, tumor necrosis factor-alpha, S100a9, and S100a11 genes in peripheral leukocytes in the fasting state at weeks 25 and 39. The mRNA levels of E-selectin in aortic tissues and protein levels of the soluble forms of E-selectin and ICAM-1 in arterial blood were significantly lower in the anagliptin and miglitol groups than in the control group. Our results suggest that long-term treatment with anagliptin or miglitol in OLETF rats at the IGT stage suppresses the expression of inflammatory cytokines in peripheral leukocytes and adhesion molecules in aortic tissues.	[Imai, Chihiro; Harazaki, Tomomi; Inoue, Seiya; Mochizuki, Kazuki; Goda, Toshinao] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan; [Mochizuki, Kazuki] Univ Yamanashi, Fac Life & Environm Sci, Dept Local Produce & Food Sci, Lab Food & Nutr Sci, Yamanashi 4008510, Japan	Goda, T (reprint author), Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan.	gouda@u-shizuoka-ken.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26282023, 26282027]; Global COE program; Center of Excellence for Innovation in Human Health Sciences of the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Grants-in-Aid for Scientific Research (26282023, 26282027) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Global COE program, and the Center of Excellence for Innovation in Human Health Sciences of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Nakaya K, 2013, METABOLISM, V62, P939, DOI 10.1016/j.metabol.2013.01.010; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Arakawa M, 2008, METABOLISM, V57, P1299, DOI 10.1016/j.metabol.2008.04.027; Reeves P G, 1997, J Nutr, V127, p838S; Astarci E, 2012, FEBS J, V279, P2966, DOI 10.1111/j.1742-4658.2012.08677.x; Neuhouser ML, 2012, J NUTR, V142, P369, DOI 10.3945/jn.111.149807; Bartzeliotou AI, 2007, CLIN BIOCHEM, V40, P765, DOI 10.1016/j.clinbiochem.2007.01.013; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; Ginn-Pease ME, 1998, FREE RADICAL BIO MED, V25, P346, DOI 10.1016/S0891-5849(98)00067-7; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Matsushita K, 2006, ARTERIOSCL THROM VAS, V26, P871, DOI 10.1161/01.ATV.0000208363.85388.8f; LUCCHESI BR, 1990, ANNU REV PHYSIOL, V52, P561; Niedowicz DM, 2005, CELL BIOCHEM BIOPHYS, V43, P289, DOI 10.1385/CBB:43:2:289; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fukaya N, 2009, EUR J PHARMACOL, V624, P51, DOI 10.1016/j.ejphar.2009.09.048; Goda T, 2007, BRIT J NUTR, V98, P702, DOI 10.1017/S0007114507742678; Haddad JJ, 2002, BIOCHEM BIOPH RES CO, V296, P847, DOI 10.1016/S0006-291X(02)00947-6; Imai C, 2013, BIOSCI BIOTECH BIOCH, V77, P2305, DOI 10.1271/bbb.130451; Kadono Takafumi, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P242; Kowalska I, 2002, METABOLISM, V51, P733, DOI 10.1053/meta.2002.32802; Kusunoki M, 2014, DRUG RES, DOI [10.1055/s-0034-1390419, DOI 10.1055/S-0034-1390419]; Matsumoto K, 2010, METABOLISM, V59, P320, DOI 10.1016/j.metabol.2009.06.011; Mirrahimi A, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0381-1; Misaki Y, 2010, METABOLISM, V59, P1465, DOI 10.1016/j.metabol.2010.01.011; Mochizuki K, 2011, METABOLISM, V60, P1560, DOI 10.1016/j.metabol.2011.03.010; Mudaliar S, 2010, AM J MED, V123, pS19, DOI 10.1016/j.amjmed.2009.12.006; Tajik N, 2013, J ENDOCRINOL INVEST, V36, P211, DOI 10.3275/8465; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397; Zarowitz BJ, 2009, PHARMACOTHERAPY, V29, p55S, DOI 10.1592/phco.29.pt2.55S	36	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					313	321				9	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400005		
J	Katsumata, S; Wolber, FM; Tadaishi, M; Tousen, Y; Ishimi, Y; Kruger, MC				Katsumata, Shinichi; Wolber, Frances M.; Tadaishi, Miki; Tousen, Yuko; Ishimi, Yoshiko; Kruger, Marlena C.			Effect of Kiwifruit on Bone Resorption in Ovariectomized Mice	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						kiwifruit; bone resorption; receptor activator of NF-kappa B ligand; ovariectomized mice	OSTEOCLASTOGENESIS IN-VITRO; INHIBITS OSTEOCLASTOGENESIS; MINERAL DENSITY; GENE-EXPRESSION; CELL-CULTURES; DIFFERENTIATION; VITAMIN-K-2; ACTINIDIA; EQUOL; RATS	Kiwifruit is a good source of dietary components and has beneficial effects for health. In this study, we investigated the effects of two types of kiwifruit, green kiwifruit (GRK) and gold kiwifruit (GOK), on bone metabolism in ovariectomized (OVX) mice. Seven-week-old female Balb/c-strain mice were divided into four groups: sham-operated (sham) group, OVX group, and OVX mice that were fed a GRK-supplemented diet or GOK-supplemented diet. Freeze-dried GRK and GOK were prepared and added in the diet at a concentration of 3 g/100 g. After 9 wk, the mice were sacrificed, and the serum, uterus, and femurs were obtained. Final body weight did not differ significantly among the four groups. Compared to the sham group, uterine weight was significantly lower and serum C-terminal telopeptide of type I collagen (CTx) levels and receptor activator of NF-kappa B ligand (RANKL) mRNA expression of the whole femur were significantly higher in the OVX group. Compared to the OVX group, GRK, but not GOK, reduced serum CTx concentrations and RANKL mRNA expression of the whole femur without changes in uterine weight. These results suggest that the GRK inhibited bone resorption, which might be due to a decrease in RANKL mRNA expression in OVX mice.	[Katsumata, Shinichi; Wolber, Frances M.; Kruger, Marlena C.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North 4442, New Zealand; [Katsumata, Shinichi; Tadaishi, Miki] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Setagaya Ku, Tokyo 1568502, Japan; [Tadaishi, Miki; Tousen, Yuko; Ishimi, Yoshiko] Natl Inst Hlth & Nutr, Dept Food Funct & Labeling, Shinjuku Ku, Tokyo 1628636, Japan	Kruger, MC (reprint author), Massey Univ, Inst Food Nutr & Human Hlth, Private Bag 11222, Palmerston North 4442, New Zealand.	M.C.Kruger@massey.ac.nz			New Zealand (Ministry of Business, Innovation and Employment); Japan (Japanese Science and Technology Agency) of the Strategic Bilateral Agreement Program on Functional Foods	This study was funded by New Zealand (Ministry of Business, Innovation and Employment) and Japan (Japanese Science and Technology Agency) of the Strategic Bilateral Agreement Program on Functional Foods. The authors would like to thank A. Broomfield, K. Wylie, G. Plimmer, Z. Liu, C. Hulls, and S. De (IFNHH, Massey University, Palmerston North, New Zealand) for excellent technical assistance.	Ohtomo T, 2008, EUR J NUTR, V47, P273, DOI 10.1007/s00394-008-0723-x; Yamaguchi M, 2001, MOL CELL BIOCHEM, V228, P39, DOI 10.1023/A:1013360308946; REEVES PG, 1993, J NUTR, V123, P1939; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Koshihara Y, 2003, J ENDOCRINOL, V176, P339, DOI 10.1677/joe.0.1760339; Frenich AG, 2005, J AGR FOOD CHEM, V53, P7371, DOI 10.1021/jf050973o; Akiyama Y, 1999, JPN J PHARMACOL, V80, P67, DOI 10.1254/jjp.80.67; McGhie TK, 2002, J AGR FOOD CHEM, V50, P117, DOI 10.1021/jf010677l; Karlsen A, 2013, J HUM HYPERTENS, V27, P126, DOI 10.1038/jhh.2011.116; Tadaishi M, 2014, J CLIN BIOCHEM NUTR, V54, P109, DOI 10.3164/jcbn.13-94; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Nishiyama I, 2005, J AGR FOOD CHEM, V53, P6403, DOI 10.1021/jf050785y; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Stolina M, 2014, BONE, V67, P305, DOI 10.1016/j.bone.2014.07.031; Han KS, 2011, LETT APPL MICROBIOL, V52, P379, DOI 10.1111/j.1472-765X.2011.03012.x; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1259/JBMR.050307; Drummond L, 2013, ADV FOOD NUTR RES, V68, P33, DOI 10.1016/B978-0-12-394294-4.00003-1; Fiorentino A, 2009, J AGR FOOD CHEM, V57, P4148, DOI 10.1021/jf900210z; Fujita K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-71; Gammon CS, 2013, BRIT J NUTR, V109, P2208, DOI 10.1017/S0007114512004400; GENANT HK, 1989, AM J OBSTET GYNECOL, V161, P1842; Ishii J, 2008, J CELL BIOCHEM, V105, P896, DOI 10.1002/jcb.21886; Lee Yuan Kun, 2012, Microbial Ecology in Health and Disease, V23, P15, DOI 10.3402/mehd.v23i0.18572; Liou SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069468; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; Nishide Y, 2013, J CLIN BIOCHEM NUTR, V53, P41, DOI 10.3164/jcbn.12-123; Scholz-Ahrens K. E., 2001, AM J CLIN NUTR S, V73, P459; Sutherland P, 1999, INT J PLANT SCI, V160, P1099, DOI 10.1086/314196; Takeuchi Y, 2000, BONE, V27, P769, DOI 10.1016/S8756-3282(00)00396-3; Tousen Y, 2014, INT J FOOD SCI NUTR, V65, P360, DOI 10.3109/09637486.2013.858238; U.S. Department of Agriculture Agricultural Research Service, 2014, USDA NAT NUTR DAT ST	33	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					332	337				6	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400008		
J	Taguchi, C; Fukushima, Y; Kishimoto, Y; Saita, E; Suzuki-Sugihara, N; Yoshida, D; Kondo, K				Taguchi, Chie; Fukushima, Yoichi; Kishimoto, Yoshimi; Saita, Emi; Suzuki-Sugihara, Norie; Yoshida, Daishi; Kondo, Kazuo			Polyphenol Intake from Beverages in Japan over an 18-Year Period (1996-2013): Trends by Year, Age, Gender and Season	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						polyphenol; consumption; beverage; age; season	DIETARY-INTAKE; ADULTS	An association between the dietary intake of polyphenols and human health has been shown in many epidemiological studies. Since beverages are rich sources of polyphenols. we aimed to evaluate the polyphenol intake from beverages in Japanese individuals with a focus on differences according to year, age, gender and season. More than 10,000 Japanese male and female subjects aged 1-99 y old participated in this survey every year from 1996 to 2013, and their beverage consumption and amount of polyphenol intake were calculated. Polyphenol intake from beverages in Japan showed no tendency to increase or decrease over the 18-y period, and the major sources of polyphenols in Japanese daily life were coffee and green tea. Polyphenol intake was larger in participants with higher age up to 59 y old in both male and female subjects. There was a slight difference in polyphenol intake by gender, with adult males consuming more. polyphenols than adult females. Polyphenols were consumed slightly more in the winter than the summer, although the seasonal difference in polyphenol intake was not large. Our results suggest that polyphenol intake from beverages is influenced by age rather than gender or season in Japan, and may not have changed over time, at least over the 18-y period beginning in 1996 in Japan.	[Taguchi, Chie; Kishimoto, Yoshimi; Kondo, Kazuo] Ochanomizu Univ, Endowed Res Dept Food Hlth, Bunkyo Ku, Tokyo 1128610, Japan; [Fukushima, Yoichi] Nestle Japan Ltd, Shinagawa Ku, Tokyo 1400002, Japan; [Saita, Emi; Suzuki-Sugihara, Norie; Kondo, Kazuo] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan; [Yoshida, Daishi] Consumer Behav Res Co Ltd, Shibuya Ku, Tokyo 1500002, Japan	Kondo, K (reprint author), Ochanomizu Univ, Endowed Res Dept Food Hlth, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	kondo.kazuo@ocha.ac.jp					Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; Ovaskainen ML, 2008, J NUTR, V138, P562; George S, 2005, J AGR FOOD CHEM, V53, P1370, DOI 10.1021/jf048396b; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Hertog MGL, 1997, LANCET, V349, P699, DOI 10.1016/S0140-6736(05)60135-3; Zujko ME, 2012, ADV MED SCI-POLAND, V57, P375, DOI 10.2478/v10039-012-0026-6; Fukushima Y, 2014, J NUTR SCI, V3, P1; Hertog M.L.H., 1993, LANCET, V324, P1007; Ministry of Health Labour and Walfare, 2012, NAT HLTH NUTR SURV	11	1	1	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					338	344				7	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400009		
J	Shimada, M; Nagano, N; Goto, S; Ito, K; Tsutsui, T; Ando, T; Kamioka, H; Ogawa, T				Shimada, Mikiko; Nagano, Nobuo; Goto, Saori; Ito, Kyoko; Tsutsui, Takaaki; Ando, Tetsuo; Kamioka, Hiroharu; Ogawa, Tetsuya			Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						polydextrose; dietary fiber; stool frequency; hemodialysis; constipation	HEMODIALYSIS-PATIENTS; BOWEL FUNCTION; DIETARY FIBER; TRANSIT-TIME; STOOL FORM; FERMENTATION; PREVALENCE; SYMPTOMS; BACTERIA; PEOPLE	The objective of the present study was to evaluate bowel habits induced by ingestion of 10 g polydextrose (PDX) fed to Japanese hemodialysis (HD) patients. This was a randomized, placebo-controlled, triple-blind, parallel-group controlled, 8-wk study. A total of 50 HD outpatients capable of self-management (51-79 y of age) were recruited at H Clinic. Japan. Inclusion criteria for participation in the study were ingestion of one or more laxative tablets for more than 3 mo and having received HD for more than 6 mo. The participants were randomly assigned to 2 groups: A (0 g polydextrose/d: control), B (10 g polydextrose/d: PDX). The primary outcome measure was stool frequency. Secondary outcomes were stool consistency, abdominal pain, intestinal bloating and clinical biochemistry indexes. PDX had no significant effect on blood biochemistry indexes. The PDX group showed significant improvements in bowel function (stool frequency increased from 3.0 times per week to 7.5 times per week) and reported no laxation problems (abdominal distention, cramps, and diarrhea) (p<0.01). Regular consumption of the PDX products increased dietary fiber intake to recommended levels and improved bowel habits.	[Shimada, Mikiko] Med Corp Hidaka Rehabil Hosp, Takasaki, Gunma 3702104, Japan; [Shimada, Mikiko; Kamioka, Hiroharu] Tokyo Univ Agr, Grad Sch Agr, Setagaya Ku, Tokyo 1568502, Japan; [Nagano, Nobuo; Tsutsui, Takaaki; Ando, Tetsuo] Med Corp Hidaka Hosp, Takasaki, Gunma 3700001, Japan; [Goto, Saori; Ito, Kyoko] Med Corp Heisei Hidaka Clin, Takasaki, Gunma 3700001, Japan; [Ogawa, Tetsuya] Tokyo Womens Med Univ, Dept Med, Med Ctr East, Arakawa, Tokyo 1168567, Japan	Shimada, M (reprint author), Med Corp Hidaka Rehabil Hosp, 2204 Yoshii, Takasaki, Gunma 3702104, Japan.	m2r2.smd@flower.email.ne.jp					ACHOUR L, 1994, AM J CLIN NUTR, V59, P1362; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Mann JI, 2009, NUTR METAB CARDIOVAS, V19, P226, DOI 10.1016/j.numecd.2009.02.002; Lindberg G, 2011, J CLIN GASTROENTEROL, V45, P483, DOI 10.1097/MCG.0b013e31820fb914; Zhong J, 2000, AM J CLIN NUTR, V72, P1503; HEATON KW, 1994, J CLIN GASTROENTEROL, V19, P28, DOI 10.1097/00004836-199407000-00008; Caswell S, 2009, BRIT J NUTR, V102, P1541, DOI 10.1017/S0007114509990808; Frost GS, 2003, EUR J CLIN NUTR, V57, P293, DOI 10.1038/sj.ejcn.1601520; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Yasuda G, 2002, AM J KIDNEY DIS, V39, P1292, DOI 10.1053/ajkd.2002.33407; Probert HM, 2004, APPL ENVIRON MICROB, V70, P4505, DOI 10.1128/AEM.70.8.4505-4511.2004; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; Vuksan V, 2008, AM J CLIN NUTR, V88, P1256, DOI 10.3945/ajcn.2008.25956; Bove A, 2012, WORLD J GASTROENTERO, V18, P1555, DOI 10.3748/wjg.v18.i14.1555; Wu MJ, 2004, AM J KIDNEY DIS, V44, P322, DOI 10.1053/j.ajkd.2004.04.048; Hongisto SM, 2006, EUR J CLIN NUTR, V60, P319, DOI 10.1038/sj.ejcn.1602317; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S; Endo K., 1991, BIFIDOBACTERIA MICRO, V10, P53; Hammer J, 1998, WIEN KLIN WOCHENSCHR, V110, P287; Kamyar K., 2002, REN NUTR, V12, P17; Lee EJ, 2011, GASTROENTEROL NURS, V34, P118, DOI 10.1097/SGA.0b013e3182109405; Makivuokko H, 2007, BIOSCI BIOTECH BIOCH, V71, P1834, DOI 10.1271/bbb.60706; Nakagawa Y, 1990, J JPN SOC NUTR FOOD, V43, P95; Pfizer Inc, 1978, POLYD FOOD ADD PET; Sutton Debbie, 2007, J Ren Care, V33, P174; Trowell HC, 1975, REFINED CARBOHYDRATE, P333; Trumbo T, 2002, J AM DIET ASSOC, V102, P1621; Yoshimura Y., 2010, EXCEL EIYOU KUN ADD	28	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	AUG	2015	61	4					345	353				9	Nutrition & Dietetics	Nutrition & Dietetics	CQ3QU	WOS:000360518400010		
J	Nakajima, R; Maekawa, K; Sonoyama, W; Ueda, A; Kuboki, T				Nakajima, Ryu; Maekawa, Kenji; Sonoyama, Wataru; Ueda, Akihiro; Kuboki, Takuo			Concealed Jiggling Effect: A Novel Risk Factor for Complications of Implant-Supported Fixed Partial Denture	JOURNAL OF ORAL IMPLANTOLOGY			English	Article							TECHNICAL COMPLICATIONS; OBSERVATION PERIOD; TEETH		[Nakajima, Ryu; Maekawa, Kenji; Sonoyama, Wataru; Kuboki, Takuo] Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Ueda, Akihiro] Okayama Univ Hosp, Dent Labs, Hosp Med Technol Part, Okayama, Japan	Kuboki, T (reprint author), Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	kuboki@md.okayama-u.ac.jp					Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P326, DOI 10.1111/j.1600-0501.2005.01105.x; De Boever AL, 2006, J ORAL REHABIL, V33, P833, DOI 10.1111/j.1365-2842.2006.01638.x; Kreissl ME, 2007, CLIN ORAL IMPLAN RES, V18, P720, DOI 10.1111/j.1600-0501.2007.01414.x; Bragger U, 2001, CLIN ORAL IMPLAN RES, V12, P26, DOI 10.1034/j.1600-0501.2001.012001026.x; Wood MR, 2004, J PROSTHET DENT, V92, P447, DOI 10.1016/j.prosdent.2004.08.003; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Kim Y, 2005, CLIN ORAL IMPLAN RES, V16, P26, DOI 10.1111/j.1600-0501.2004.01067.x; ERICSSON I, 1986, J CLIN PERIODONTOL, V13, P307, DOI 10.1111/j.1600-051X.1986.tb02227.x; Noda K, 2013, J ORAL REHABIL, V40, P214, DOI 10.1111/joor.12029; Nyman S R, 1994, Periodontol 2000, V4, P15, DOI 10.1111/j.1600-0757.1994.tb00002.x; Sekine H, 1986, TISSUE INTEGRATION O, P326	11	0	0	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0160-6972	1548-1336		J ORAL IMPLANTOL	J. Oral Implant.	AUG	2015	41	4					491	494		10.1563/AAID-JOI-D-13-00216		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP8QK	WOS:000360159000026		
J	Hosokawa, T; Konuma, N; Ikeda, T; Hashimoto, M; Kaneda, H; Ohashi, K; Matsumoto, T; Koshinaga, T				Hosokawa, Takashi; Konuma, Noriyoshi; Ikeda, Taro; Hashimoto, Makoto; Kaneda, Hide; Ohashi, Kensuke; Matsumoto, Taro; Koshinaga, Tsugumichi			Establishment of a new anal sphincter injury model in rats based on cardiotoxin	JOURNAL OF PEDIATRIC SURGERY			English	Article						Anal sphincter injury; Rat model; Cardiotoxin; Anal sphincter injury model; Manometry measurements; Prospective study	NEUROPATHIC FECAL INCONTINENCE; PELVIC FLOOR MUSCLES; SKELETAL-MUSCLE; PUDENDAL NERVE; ANIMAL-MODEL; CHILDBIRTH INJURY; REGENERATION; MANOMETRY; TRANSECTION; PIGLETS	Background/purpose: Mainstreammodels for anal sphincter injury use large animals. We developed a simple and stable anal sphincter injury model in a small animal (i.e., rats) to obtain manometry measurements by using a miniaturized probe and applying cardiotoxin. Methods: The histological structure of the anal canal was evaluated by using manometry in normal rats (n = 40). We damaged the internal and external anal sphincters by locally administering snake poison (cardiotoxin; 20 uM, 100 mu L 8 points). We evaluated the anal canal function through manometry measurements (n = 5) and examined the histology using hematoxylin-eosin staining (at each time point, n = 3; total n = 15). Results: The manometry parameters and structure of the anal canal of normal rats were similar to those of humans, because rats have resting pressure, rectoanal reflex in the manometry, and an external and internal anal sphincter. After inducing injury, the following findings were observed: rhythmic wave loss and a remarkable reduction in the anal sphincter resting pressure; and local bleeding and advanced infiltration of the inflammatory cells (day 1) and the loss of muscle fibers (day 3). Conclusion: This new rat model will contribute to increasing the knowledge on the anal canal. (C) 2015 Elsevier Inc. All rights reserved.	[Hosokawa, Takashi; Konuma, Noriyoshi; Hashimoto, Makoto; Kaneda, Hide; Ohashi, Kensuke; Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Hosokawa, Takashi; Konuma, Noriyoshi; Hashimoto, Makoto; Matsumoto, Taro] Nihon Univ, Sch Med, Dept Funct Morphol, Div Cell Regenerat & Transplantat, Tokyo, Japan; [Ikeda, Taro] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan	Ikeda, T (reprint author), 1-847 Amanuma Cho,Ohmiya Ku, Saitama, Saitama 3308503, Japan.	jikan-gensyu@hotmail.co.jp; konuma.noriyoshi@nihon-u.ac.jp; ikeda.taro@jichi.ac.jp; monoclonal-antiboby@mail.goo.ne.jp; kaneda.hide@nihon-u.ac.jp; ohashi.kensuke@nihon-u.ac.jp; matsumoto.taro@nihon-u.ac.jp; koshinaga.tsugumichi@nihon-u.ac.jp			JSPS KAKENHI grant [23792034]	This work was supported by the JSPS KAKENHI grant no. 23792034.	Andersen IS, 2005, BRIT J SURG, V92, P1513, DOI 10.1002/bjs.4987; ANDERSON JE, 1991, MUSCLE NERVE, V14, P268, DOI 10.1002/mus.880140311; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Jones MP, 2007, AM J GASTROENTEROL, V102, P850, DOI 10.1111/j.1572-0241.2007.01069.x; Czerwinska AM, 2012, FOLIA HISTOCHEM CYTO, V50, P144, DOI [10.2478/18710, 10.5603/FHC.2012.0021]; Healy CF, 2008, DIS COLON RECTUM, V51, P1619, DOI 10.1007/s10350-008-9283-7; Muller C, 2005, LANGENBECK ARCH SURG, V390, P544, DOI 10.1007/s00423-005-0566-3; Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x; Sun XB, 2009, J PEDIATR SURG, V44, P2384, DOI 10.1016/j.jpedsurg.2009.07.062; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; BENOIT PW, 1970, J ANAT, V107, P547; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; CARLSON BM, 1975, ANAT REC, V183, P47, DOI 10.1002/ar.1091830106; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; ERDOGAN E, 1995, J PEDIATR SURG, V30, P795, DOI 10.1016/0022-3468(95)90750-5; Fernandez-Fraga X, 2002, GASTROENTEROLOGY, V123, P1441, DOI 10.1053/gast.2002.36586; Fletcher JE, 1996, TOXICON, V34, P1301, DOI 10.1016/S0041-0101(96)00105-5; Florisson J M G, 2006, Tech Coloproctol, V10, P17, DOI 10.1007/s10151-006-0245-6; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Healy CF, 2008, DIS COLON RECTUM, V51, P1626; Holmes GM, 1998, J NEUROTRAUM, V15, P451, DOI 10.1089/neu.1998.15.451; Ieronimakis N, 2012, EXP HEMATOL, V40, P238, DOI 10.1016/j.exphem.2011.12.001; Kajbafzadeh AM, 2010, DIS COLON RECTUM, V53, P1415, DOI 10.1007/DCR.0b013e3181e53088; Levitt MA, 2005, CURR OPIN PEDIATR, V17, P394, DOI 10.1097/01.mop.0000163665.36798.ac; Lorenzi B, 2008, DIS COLON RECTUM, V51, P411, DOI 10.1007/s10350-007-9153-8; Mehl JB, 2008, PEDIATR SURG INT, V24, P81, DOI 10.1007/s00383-007-2030-7; Mehl JB, 2008, PEDIATR SURG INT, V24, P87, DOI 10.1007/s00383-007-2031-6; PENA A, 1993, J PEDIATR SURG, V28, P773, DOI 10.1016/0022-3468(93)90323-D; SHAFIK A, 1975, INVEST UROL, V12, P412; SLORS JFM, 1991, EUR SURG RES, V23, P108, DOI 10.1159/000129142; SULTAN AH, 1994, BRIT MED J, V308, P887; VINOGRAD I, 1985, EUR SURG RES, V17, P259, DOI 10.1159/000128476; Zutshi M, 2009, DIS COLON RECTUM, V52, P1321, DOI 10.1007/DCR.0b013e31819f746d	34	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	AUG	2015	50	8					1352	1358		10.1016/j.jpedsurg.2014.12.028		7	Pediatrics; Surgery	Pediatrics; Surgery	CP8DF	WOS:000360121000022		
J	Saito, T; Terui, K; Mitsunaga, T; Nakata, M; Ono, S; Mise, N; Yoshida, H				Saito, Takeshi; Terui, Keita; Mitsunaga, Tetsuya; Nakata, Mitsuyuki; Ono, Sachie; Mise, Naoko; Yoshida, Hideo			Evidence for viral infection as a causative factor of human biliary atresia	JOURNAL OF PEDIATRIC SURGERY			English	Review						Etiology; Reovirus; Rotavirus; Cytomegalovirus; Choledochal cyst; Mouse model	REOVIRUS TYPE-3 INFECTION; POLYMERASE-CHAIN-REACTION; REGULATORY T-CELLS; BILE-DUCT INJURY; CYTOMEGALOVIRUS-INFECTION; NEONATAL CHOLESTASIS; HUMAN-PAPILLOMAVIRUS; INFANTS; MICE; HEPATITIS	Objectives: To explore the evidence for viral infections triggering human biliary atresia (BA) by reviewing archival original articles that analyzed human samples via polymerase chain reaction (PCR) experiments, considering the recent experimental trend of extensive use of rotaviral BA animal models. Methods: A PubMed search retrieved original articles that reported the results of PCR experiments for detecting viral DNA or RNA in patient samples as proof of past infection. Search terms included the often-debated DNA or RNA viruses and BA. Special focus was directed toward PCR analyses that targeted reovirus and rotavirus, where PCR accuracy, specimen characteristics and their interpretations were compared. Results: Nineteen studies were conducted on 16 different kinds of viruses using PCR, with 5 studies on reovirus, 3 on rotavirus, 10 on cytomegalovirus, 5 on Epstein-Barr virus, 4 on parvovirus B19, and so on. Among the papers suggesting a possible viral link to only BA, there was no study on reovirus, 1 on rotavirus, 3 on cytomegalovirus, 1 on EB virus, and 1 on papillomavirus. Of the 6 PCR studies on Reoviridae, 3 on reovirus and 2 on rotavirus were evaluated rigorously for experimental accuracy, including their sensitivity. Two research groups analyzed preoperative stool samples in addition to generic hepatobiliary tissue obtained at surgery. Sample collection timing varied widely, with storage period prior to PCR experimentation not revealed in most reports on Reoviridae. Conclusion: Although a considerable number of PCR studies have sought to clarify a viral role in the pathogenesis of BA using human samples, the findings have been contradictory and have not succeeded in achieving an obvious differentiation between causative and accidental infection of the focused virus. Reproducible and convincing evidence for a causative Reoviridae infection has been lacking based on objective data from highly sensitive PCR experiments. Even though the possibility remains of viral disappearance at the timing of collection, to avoid further ambiguous interpretations of PCR results, rigorous and meticulous collection of large numbers of specimens at carefully planned timing, along with a strictly adjusted and finely tuned PCR system, is strongly recommended for obtaining more reliable and consistent results. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Takeshi; Terui, Keita; Mitsunaga, Tetsuya; Nakata, Mitsuyuki; Ono, Sachie; Mise, Naoko; Yoshida, Hideo] Chiba Univ, Grad Sch Med, Dept Pediat Surg E6, Chiba, Chiba 2608677, Japan	Saito, T (reprint author), Chiba Univ, Grad Sch Med, Dept Pediat Surg E6, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	takk@faculty.chiba-u.jp					Ando H, 1999, J Hepatobiliary Pancreat Surg, V6, P50, DOI 10.1007/s005340050083; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; GLASER JH, 1984, J PEDIATR-US, V105, P912, DOI 10.1016/S0022-3476(84)80076-1; Drut R, 1998, J PEDIATR GASTR NUTR, V27, P530, DOI 10.1097/00005176-199811000-00007; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; MORECKI R, 1982, NEW ENGL J MED, V307, P481, DOI 10.1056/NEJM198208193070806; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; Saito T, 2004, J HEPATOL, V40, P203, DOI 10.1016/j.jhep.2003.10.025; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Fjaer RB, 2005, PEDIATR TRANSPLANT, V9, P68, DOI 10.1111/j.1399-3046.2005.00257.x; De Tommaso AMA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-108; Domiati-Saad R, 2000, PEDIATR DEVEL PATHOL, V3, P367, DOI 10.1007/s100240010045; Balistreri WF, 1996, HEPATOLOGY, V23, P1682, DOI 10.1002/hep.510230652; MORECKI R, 1984, HEPATOLOGY, V4, P1137, DOI 10.1002/hep.1840040608; Soomro GB, 2011, J PAK MED ASSOC, V61, P281; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; DUSSAIX E, 1984, NEW ENGL J MED, V310, P658; Jevon GP, 1999, PEDIATR DEVEL PATHOL, V2, P11, DOI 10.1007/s100249900083; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Fischler B, 1998, J PEDIATR GASTR NUTR, V27, P57, DOI 10.1097/00005176-199807000-00010; Xu Y, 2012, CLIN PEDIATR, V51, P109, DOI 10.1177/0009922811406264; BANGARU B, 1980, LAB INVEST, V43, P456; Bobo L, 1997, PEDIATR RES, V41, P229, DOI 10.1203/00006450-199702000-00013; BROWN WR, 1988, J PEDIATR-US, V113, P670, DOI 10.1016/S0022-3476(88)80376-7; CHANG MH, 1992, GASTROENTEROLOGY, V103, P1022; Harrison SJ, 1999, VIROLOGY, V258, P54, DOI 10.1006/viro.1999.9707; Landing B H, 1974, Prog Pediatr Surg, V6, P113; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Matsumoto Yoshiro, 2002, J Hepatobiliary Pancreat Surg, V9, P45, DOI 10.1007/s005340200004; Rosenthal P, 1995, Am J Gastroenterol, V90, P1895; STEELE MI, 1995, HEPATOLOGY, V21, P697, DOI 10.1016/0270-9139(95)90520-0; Tucker RM, 2013, J HEPATOL, V59, P790, DOI 10.1016/j.jhep.2013.05.010; Wen J, 2015, LAB INVEST, V95, P180, DOI 10.1038/labinvest.2014.148; WIENER JR, 1989, VIROLOGY, V169, P194, DOI 10.1016/0042-6822(89)90055-X; Yaghobi R, 2011, INDIAN J PEDIATR, V78, P478, DOI 10.1007/s12098-010-0309-5	37	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	AUG	2015	50	8					1398	1404		10.1016/j.jpedsurg.2015.04.006		7	Pediatrics; Surgery	Pediatrics; Surgery	CP8DF	WOS:000360121000031		
J	Yoshihara, A; Sugita, N; Iwasaki, M; Wang, YM; Miyazaki, H; Yoshie, H; Nakamura, K				Yoshihara, Akihiro; Sugita, Noriko; Iwasaki, Masanori; Wang, Yanming; Miyazaki, Hideo; Yoshie, Hiromasa; Nakamura, Kazutoshi			The Interaction Between beta-3 Adrenergic Receptor and Peroxisome Proliferator-Activated Receptor Gamma Gene Polymorphism to Periodontal Disease in Community-Dwelling Elderly Japanese	JOURNAL OF PERIODONTOLOGY			English	Article						Epidemiology; obesity; periodontal diseases; peroxisome proliferator-activated receptors; receptors, adrenergic, beta	BODY-MASS INDEX; BROWN ADIPOSE-TISSUE; PRO12ALA POLYMORPHISM; TRP64ARG POLYMORPHISM; PPAR-GAMMA; OBESITY; POPULATION; PROTEIN; UPDATE; RISK	Background: It has been hypothesized that beta-3 adrenergic receptor and peroxisome proliferator-activated receptor gamma (PPARg) might have gene-environmental and gene-gene interactions in periodontal disease. The purpose of this study is to elucidate the interaction between beta-3 adrenergic receptor and PPARg gene polymorphism with periodontal disease. Methods: Three hundred thirty-two postmenopausal females were enrolled, and their serum high-sensitivity C-reactive protein (hsCRP) and hemoglobin A1c (HbA1c) were examined. beta-3 adrenergic receptor and PPARg genotypes were then determined. An oral examination was performed. The number of remaining teeth was counted, and the probing depth (PD) and clinical attachment level (CAL) were measured. Prevalence-rate ratios (PRRs) were calculated by multiple Poisson regression analyses to evaluate the relationship among periodontal disease markers, such as the number of sites with CAL 4 to 5 or >= 6 mm or PD 4 to 5 or >= 6 mm, and beta-3 adrenergic receptor polymorphisms, PPARg polymorphisms, and the interaction term adjusted by age, hsCRP, and HbA1c, after converting the number of remaining teeth (n) to an offset variable. Results: In the participants with body mass index (BMI) >= 25, PRRs of beta-3 adrenergic receptor genotype (Trp/Arg and Arg/Arg) for periodontal disease markers were 0.13 to 0.70 (P <0.0001 to 0.74), those of PPARg genotype (Pro/Pro) were 0.66 to 3.14 (P = 0.01 to 0.68), and those of the interaction term for the two genotypes were 1.69 to 12.61 (P <0.0001 to 0.33). However, in the participants with BMI <25, a constant tendency was not observed. Conclusion: The results confirmed a positive relationship between the interaction term for beta-3 adrenergic receptor genotype and PPARg genotype and various periodontal markers in obese elderly females.	[Yoshihara, Akihiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth & Welf, Chuo Ku, Niigata 9518514, Japan; [Sugita, Noriko; Wang, Yanming; Miyazaki, Hideo; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Niigata 9518514, Japan; [Iwasaki, Masanori] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Niigata 9518514, Japan; [Nakamura, Kazutoshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Community Prevent Med, Niigata 9518514, Japan	Yoshihara, A (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth & Welf, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	akihiro@dent.niigata-u.ac.jp			Ministry of Education, Science, and Culture of Japan [24390470]	This work was supported in part by Ministry of Education, Science, and Culture of Japan Grant-in-Aid for Scientific Research 24390470. The authors report no conflicts of interest related to this study.	Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Garaulet M, 2011, MOL NUTR FOOD RES, V55, P1771, DOI 10.1002/mnfr.201100437; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Nesse W, 2008, J CLIN PERIODONTOL, V35, P668, DOI 10.1111/j.1600-051X.2008.01249.x; Bokhari SAH, 2012, J CLIN PERIODONTOL, V39, P1065, DOI 10.1111/j.1600-051X.2012.01942.x; Masud S, 2003, J MED GENET, V40, P773, DOI 10.1136/jmg.40.10.773; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Altshuler D, 2000, NAT GENET, V26, P76; Malta M, 2010, REV SAUDE PUBL, V44, P559, DOI 10.1590/s0034-89102010000300021; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Barbe P, 1996, BRIT J PHARMACOL, V117, P907; Das Saibal Kumar, 2006, Recent Pat Cardiovasc Drug Discov, V1, P193, DOI 10.2174/157489006777442441; de Luis DA, 2008, ANN NUTR METAB, V52, P267, DOI 10.1159/000144047; Ding Y, 2012, J GENET GENOMICS, V39, P625, DOI 10.1016/j.jgg.2012.08.005; Fuentes E, 2013, MOL MED REP, V8, P1611, DOI 10.3892/mmr.2013.1714; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Greenberg AS, 2006, AM J CLIN NUTR, V83, p461S; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Hirano E, 2010, J PERIODONTOL, V81, P897, DOI 10.1902/jop.2010.090669; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Lambert GW, 2011, J OBES, V2011; Maeda A, 2004, J CLIN LAB ANAL, V18, P317, DOI 10.1002/jcla.20045; Oh EY, 2000, J CLIN ENDOCR METAB, V85, P1801, DOI 10.1210/jc.85.5.1801; Oizumi T, 2001, DIABETES CARE, V24, P1579, DOI 10.2337/diacare.24.9.1579; Ritchie CS, 2007, PERIODONTOL 2000, V44, P154, DOI 10.1111/j.1600-0757.2007.00207.x; Rosner B, 2011, FUNDAMENTALS BIOSTAT, V7th, P352; Sugita N, 2001, J DENT RES, V80, P914; Susanto H, 2011, J PERIODONTOL, V82, P550, DOI 10.1902/jop.2010.100285; Timmons JA, 2009, NEW ENGL J MED, V361, P418; Timmons JA, 2009, NEW ENGL J MED, V361, P415, DOI 10.1056/NEJMc091009; WHO, 1997, OR HLTH SURV BAS MET, P36; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yoshihara A, 2014, J CLIN PERIODONTOL, V41, P460, DOI 10.1111/jcpe.12235; Yoshihara A, 2005, J PERIODONTOL, V76, P250, DOI 10.1902/jop.2005.76.2.250; Yoshihara A, 2001, J DENT RES, V80, P2051	38	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	AUG	2015	86	8					955	963		10.1902/jop.2015.140472		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ2EM	WOS:000360412200005		
J	Wang, CY; Chyuan, IT; Wang, YL; Kuo, MYP; Chang, CW; Wu, KJ; Hsu, PN; Nagasawa, T; Wara-aswapati, N; Chen, YW				Wang, Chen-Ying; Chyuan, I-Tsu; Wang, Ya-Li; Kuo, Mark Yen-Ping; Chang, Ching-Wen; Wu, King-Jean; Hsu, Ping-Ning; Nagasawa, Toshiyuki; Wara-aswapati, Nawarat; Chen, Yi-Wen			beta 2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus	JOURNAL OF PERIODONTOLOGY			English	Article						Antibodies, anticardiolipin; beta 2-glycoprotein I; periodontitis; Porphyromonas gingivalis; systemic lupus erythematosus; Treponema denticola	DISEASE-ACTIVITY INDEX; ANTIPHOSPHOLIPID SYNDROME; AGGRESSIVE PERIODONTITIS; MYOCARDIAL-INFARCTION; CLINICAL-SIGNIFICANCE; ENDOTHELIAL-CELLS; NAIVE MICE; THROMBOSIS; PREVALENCE; MCP-1	Background: It was reported that patients with systemic lupus erythematosus (SLE) exhibited increased levels of anticardiolipin (anti-CL) antibodies, a class of antiphospholipid antibodies associated with thrombosis. beta 2-glycoprotein I (beta 2GPI) has been considered as the actual target antigen for anti-CL antibodies. This study investigates the association of periodontal infection with anti-CL antibodies in patients with SLE. Methods: Fifty-three SLE female patients and 56 healthy female volunteers were recruited in this case-control study. All participants received periodontal examinations. The presence of Porphyromonas gingivalis and Treponema denticola in saliva and plaque samples was detected by polymerase chain reaction. Levels of serum anti-CL and anti-beta 2GPI antibodies were examined using enzyme-linked immunosorbent assay. Results: Patients with SLE exhibited more periodontal attachment loss and increased titers of serum anti-CL and anti-beta 2GPI antibodies compared with healthy controls. Patients with active SLE who harbored P. gingivalis or P. gingivalis together with T. denticola intraorally exhibited significantly higher anti-CL and anti-beta 2GPI antibodies than those without these bacteria. Anti-CL and anti-beta 2GPI antibody levels correlated positively with clinical attachment level. Furthermore, increased anti-beta 2GPI antibody levels were significantly associated with C-reactive protein and erythrocyte sedimentation rate. Conclusions: Elevated anti-CL and anti-beta 2GPI antibody levels were associated with periodontopathic bacteria and periodontal breakdown in patients with SLE. Periodontitis might be a modifiable risk factor for SLE.	[Wang, Chen-Ying; Wang, Ya-Li; Kuo, Mark Yen-Ping; Wu, King-Jean; Chen, Yi-Wen] Natl Taiwan Univ, Grad Inst Clin Dent, Sch Dent, Taipei 10048, Taiwan; [Wang, Chen-Ying; Wang, Ya-Li; Kuo, Mark Yen-Ping; Chang, Ching-Wen; Wu, King-Jean; Chen, Yi-Wen] Natl Taiwan Univ Hosp, Dept Periodontol, Taipei, Taiwan; [Chyuan, I-Tsu] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Hsu, Ping-Ning] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10048, Taiwan; [Hsu, Ping-Ning] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Nagasawa, Toshiyuki] Hlth Sci Univ Hokkaido, Sch Dent, Div Adv Clin Educ, Dept Integrated Dent Educ, Tobetsu, Hokkaido, Japan; [Wara-aswapati, Nawarat] Khon Kaen Univ, Fac Dent, Dept Periodontol, Khon Kaen, Thailand	Chen, YW (reprint author), Natl Taiwan Univ, Grad Inst Clin Dent, Sch Dent, 1 Chang Te St, Taipei 10048, Taiwan.	yiwenchen@ntu.edu.tw			National Taiwan University Hospital Research Grants [101N-1933, 102M-2301]; Professor H.W. Kwan's foundation	The authors thank Dr. Yu-Kang Tu (Institute of Epidemiology and Prevention Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan) for critical comments on this manuscript. This study was supported by National Taiwan University Hospital Research Grants 101N-1933 and 102M-2301 and Professor H.W. Kwan's foundation. The authors report no conflicts of interest related to this study.	Al-Homood IA, 2012, ISRN RHEUMATOL, V2012, DOI DOI 10.5402/2012/428269; Andriankaja OM, 2006, J PERIODONTOL, V77, P1067, DOI 10.1902/jop.2006.050276; Blank M, 2002, J CLIN INVEST, V109, P797, DOI 10.1172/JCI200212337; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Blank M, 2004, J CLIN IMMUNOL, V24, P12, DOI 10.1023/B:JOCI.0000018058.28764.ce; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002/art.10187; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; BLANK M, 1991, P NATL ACAD SCI USA, V88, P3069, DOI 10.1073/pnas.88.8.3069; Tektonidou MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P29, DOI 10.1002/art.24232; Frauenknecht K, 2005, IMMUNOBIOLOGY, V210, P799, DOI 10.1016/j.imbio.2005.10.012; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Bengtsson C, 2012, LUPUS, V21, P452, DOI 10.1177/0961203311425524; McClain MT, 2004, ARTHRITIS RHEUM, V50, P1226, DOI 10.1002/art.20120; Gladman DD, 2002, J RHEUMATOL, V29, P288; Basiri Zahra, 2013, Acta Med Iran, V51, P35; Blank M, 2004, CLIN IMMUNOL, V112, P190, DOI 10.1016/j.clim.2004.02.018; BLANK M, 1994, J AUTOIMMUN, V7, P441, DOI 10.1006/jaut.1994.1032; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chen YW, 2009, J CLIN PERIODONTOL, V36, P830, DOI 10.1111/j.1600-051X.2009.01467.x; Committee on Prognosis Studies, 1986, ARTHRITS RHEUM S, V29, pS93; Delgado Alves J, 2003, RHEUMATOLOGY, V42, P893; Fabbri C, 2014, CLIN RHEUMATOL, V33, P505, DOI 10.1007/s10067-013-2473-2; Farmer-Boatwright MK, 2009, ARTERIOSCL THROM VAS, V29, P321, DOI 10.1161/ATVBAHA.108.182204; GRENIER D, 1992, INFECT IMMUN, V60, P5298; Gunupati S, 2011, J PERIODONTOL, V82, P1657, DOI 10.1902/jop.2011.110002; Kaplanski G, 2000, ARTHRITIS RHEUM, V43, P55, DOI 10.1002/1529-0131(200001)43:1<55::AID-ANR8>3.0.CO;2-M; Kobayashi T, 2003, J PERIODONTOL, V74, P378, DOI 10.1902/jop.2003.74.3.378; Kobayashi T, 2007, J PERIODONTOL, V78, P467, DOI 10.1902/jop.2007.060194; KRAOZ Z, 1993, CLIN EXP IMMUNOL, V93, P265; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; LOVE PE, 1990, ANN INTERN MED, V112, P682; MUTLU S, 1993, COMMUNITY DENT ORAL, V21, P158, DOI 10.1111/j.1600-0528.1993.tb00742.x; Nagler RM, 1999, LUPUS, V8, P770, DOI 10.1191/096120399678840981; Nived O, 2004, LUPUS, V13, P877, DOI 10.1191/0961203304lu2027oa; Pierangeli SS, 2003, LUPUS, V12, P539, DOI 10.1191/961203303lu398oa; Purkall D, 2002, INFECT IMMUN, V70, P6485, DOI 10.1128/IAI.70.11.6485-6488.2002; Schenkein HA, 2003, J DENT RES, V82, P919; Schenkein HA, 2004, J PERIODONTOL, V75, P146, DOI 10.1902/jop.2004.75.1.146; Schenkein HA, 2007, J PERIODONTOL, V78, P459, DOI 10.1902/jop.2007.060305; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, P212, DOI 10.1111/jcpe.12043; Stojan G, 2013, LUPUS, V22, P827, DOI 10.1177/0961203313492578; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Wang D, 2008, ORAL MICROBIOL IMMUN, V23, P401, DOI 10.1111/j.1399-302X.2008.00442.x; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; Woo KS, 2010, KOREAN J LAB MED, V30, P38, DOI 10.3343/kjlm.2010.30.1.38	49	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	AUG	2015	86	8					995	1004		10.1902/jop.2015.140664		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ2EM	WOS:000360412200009		
J	Zhu, Y; Morisato, K; Hasegawa, G; Moitra, N; Kiyomura, T; Kurata, H; Kanamori, K; Nakanishi, K				Zhu, Yang; Morisato, Kei; Hasegawa, George; Moitra, Nirmalya; Kiyomura, Tsutomu; Kurata, Hiroki; Kanamori, Kazuyoshi; Nakanishi, Kazuki			High-performance liquid chromatography separation of unsaturated organic compounds by a monolithic silica column embedded with silver nanoparticles	JOURNAL OF SEPARATION SCIENCE			English	Article						cis/trans Isomers; High-performance liquid chromatography; Monolithic silica columns; Polyaromatic hydrocarbons; Silver nanoparticles	GAS-CHROMATOGRAPHY; GOLD NANOPARTICLES; RETENTION; SUPPORTS; ISOMERS; DISEASE; LIPIDS; PHASE; WINE	The optimization of a porous structure to ensure good separation performances is always a significant issue in high-performance liquid chromatography column design. Recently we reported the homogeneous embedment of Ag nanoparticles in periodic mesoporous silica monolith and the application of such Ag nanoparticles embedded silica monolith for the high-performance liquid chromatography separation of polyaromatic hydrocarbons. However, the separation performance remains to be improved and the retention mechanism as compared with the Ag ion high-performance liquid chromatography technique still needs to be clarified. In this research, Ag nanoparticles were introduced into a macro/mesoporous silica monolith with optimized pore parameters for high-performance liquid chromatography separations. Baseline separation of benzene, naphthalene, anthracene, and pyrene was achieved with the theoretical plate number for analyte naphthalene as 36 000 m(-1). Its separation function was further extended to cis/trans isomers of aromatic compounds where cis/trans stilbenes were chosen as a benchmark. Good separation of cis/trans-stilbene with separation factor as 7 and theoretical plate number as 76 000 m(-1) for cis-stilbene was obtained. The trans isomer, however, is retained more strongly, which contradicts the long-established retention rule of Ag ion chromatography. Such behavior of Ag nanoparticles embedded in a silica column can be attributed to the differences in the molecular geometric configuration of cis/trans stilbenes.	[Zhu, Yang; Hasegawa, George; Moitra, Nirmalya; Kanamori, Kazuyoshi; Nakanishi, Kazuki] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Morisato, Kei] GL Sci, Iruma, Saitama, Japan; [Kiyomura, Tsutomu; Kurata, Hiroki] Kyoto Univ, Inst Chem Res, Uji, Kyoto, Japan	Nakanishi, K (reprint author), Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	kazuki@kuchem.kyoto-u.ac.jp	Nakanishi, Kazuki/A-1814-2012; Hasegawa, George/A-1653-2014; Kanamori, Kazuyoshi/A-5561-2011		Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST)	The present work was financially supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST). The authors thank Mr. Wim Smits for fruitful discussion.	Qian JM, 2006, J EUR CERAM SOC, V26, P1311, DOI 10.1016/j.jeurceramsoc.2005.03.229; Zhu Y, 2013, ACS APPL MATER INTER, V5, P2118, DOI 10.1021/am303163s; Sedlacek O, 2014, J SEP SCI, V37, P798, DOI 10.1002/jssc.201301325; Krenkova J, 2010, ANAL CHEM, V82, P8335, DOI 10.1021/ac1018815; Baptista JAB, 2001, FOOD RES INT, V34, P345, DOI 10.1016/S0963-9969(00)00174-5; Lv YQ, 2012, ANAL CHEM, V84, P8457, DOI 10.1021/ac302438m; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Yang L, 2005, ANAL CHEM, V77, P1840, DOI 10.1021/ac048544x; Karwa M, 2006, ANAL CHEM, V78, P2064, DOI 10.1021/ac052115x; Glausch A, 1998, J CHROMATOGR A, V809, P252, DOI 10.1016/S0021-9673(98)00147-2; MORRIS LJ, 1966, J LIPID RES, V7, P717; Linker R, 2005, CHEMOSPHERE, V61, P652, DOI 10.1016/j.chemosphere.2005.03.034; Zhang ZX, 2008, ANAL BIOANAL CHEM, V391, P925, DOI 10.1007/s00216-008-1930-2; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Poppe H, 2002, J CHROMATOGR A, V948, P3, DOI 10.1016/S0021-9673(01)01372-3; Xu Y, 2010, ANAL CHEM, V82, P3352, DOI 10.1021/ac1002646; Krenkova J, 2011, J SEP SCI, V34, P2106, DOI 10.1002/jssc.201100256; KIRKLAND JJ, 1969, ANAL CHEM, V41, P218, DOI 10.1021/ac60270a054; Chen LX, 2005, J CHROMATOGR A, V1064, P19, DOI 10.1016/j.chroma.2004.11.085; Arrua D., 2013, J CHROMATOGR A, V1311, P121; Arrua D., 2013, J CHROMATOGR A, V1273, P26; Cintron JM, 2002, ANALYST, V127, P701, DOI 10.1039/b203236h; FUKUMOTO T, 1994, J CHROMATOGR A, V672, P237, DOI 10.1016/0021-9673(94)80612-8; GIDDINGS JC, 1964, J CHROMATOGR, V13, P301, DOI 10.1016/S0021-9673(01)95123-4; GOLDBERG DM, 1995, J CHROMATOGR A, V708, P89, DOI 10.1016/0021-9673(95)00368-W; Ihara H, 1998, ANAL SCI, V14, P349, DOI 10.2116/analsci.14.349; Kiraly-Veghely Z., 2004, JPC-J PLANAR CHROMAT, V17, P5; KIRKLAND JJ, 1965, ANAL CHEM, V37, P1458, DOI 10.1021/ac60231a004; Liang XJ, 2014, J SEP SCI, V37, P1371, DOI 10.1002/jssc.201400005; Moliner-Martinez Y, 2011, J CHROMATOGR A, V1218, P2276, DOI 10.1016/j.chroma.2011.02.036; Moulder J F, 1992, HDB XRAY PHOTOELECTR, P182; Nakamoto K., 2009, INFRARED RAMAN SPECT; Nakanishi K., 2000, J HIGH RES CHROMATOG, V23, P106; Nikolova-Damyanova B, 2009, J CHROMATOGR A, V1216, P1815, DOI 10.1016/j.chroma.2008.10.097; Nilsson C, 2006, ANAL CHEM, V78, P6088, DOI 10.1021/ac060526n; Pozun ZD, 2011, J PHYS CHEM C, V115, P1811, DOI 10.1021/jp110579s; Vervoort N, 2004, J CHROMATOGR A, V1030, P177, DOI 10.1016/j.chroma.2003.12.040	37	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	AUG	2015	38	16					2841	2847		10.1002/jssc.201500444		7	Chemistry, Analytical	Chemistry	CP7UB	WOS:000360092700012		
J	Takayanagi, A; Sasaki, M; Kataoka-Sasaki, Y; Kobayashi, K; Matsuda, Y; Oka, S; Masumori, N; Kocsis, JD; Honmou, O				Takayanagi, Akio; Sasaki, Masanori; Kataoka-Sasaki, Yuko; Kobayashi, Ko; Matsuda, Yohei; Oka, Shinichi; Masumori, Naoya; Kocsis, Jeffery D.; Honmou, Osamu			Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury	JOURNAL OF SEXUAL MEDICINE			English	Article						Mesenchymal Stem Cells; Erectile Dysfunction; Transplantation	SPINAL-CORD-INJURY; SPARING RADICAL PROSTATECTOMY; BONE-MARROW; MEDIATED DELIVERY; SEXUAL DESIRE; DYSFUNCTION; STROKE; RECOVERY; CANCER; PRESERVATION	IntroductionWe evaluated the potential preventive effects and mechanisms of intravenously preloaded mesenchymal stem cells (MSCs) for erectile dysfunction (ED) in a cavernous nerve (CN) injury model. MethodsMale Sprague-Dawley (SD) rats were used for this study. Rats were randomized into two groups. One group was intravenously preloaded with MSCs (1.0x10(6) cells in 1mL total fluid volume) and the other was infused with medium alone (1mL Dulbecco's modified Eagle's medium [DMEM]) for sham control, respectively. Crushed CN injury was induced immediately after infusion. The surgeon was blind to the experimental conditions (MSC or medium). Main Outcome MeasuresTo assess erectile function, we measured the intracavernous pressure (ICP) and arterial pressure (AP) at 1 hour and 2 weeks after CN injury. After measuring the initial ICP/AP of pre-injury (normal) male SD rats, they were randomized into the two groups and infused with MSCs or medium. PKH26-labelled MSCs were used for tracking. To investigate the mRNA expression levels of neurotrophins in the major pelvic ganglia (MPG), we performed real-time quantitative real-time polymerase chain reaction. ResultsThe reduction of ICP/AP and area under the curve of ICP (ICP-AUC) in the MSC group was significantly lower than in the DMEM group (P<0.05; P<0.05) at 1 hour. The ICP/AP and ICP-AUC at 2 weeks post-injury in the MSC group was significantly higher than in the DMEM group (P<0.01; P<0.05). The preloaded PKH26-labelled MSCs were detected in the MPG and CN using confocal microscopy indicating homing of the cells to the injured nerve and ganglia. Glia cell-derived neurotrophic factor (GDNF) and neurturin, which are important neurotrophic factors for erection, had expression levels in MPG significantly higher in the MSC group than in the DMEM group (P<0.01, 0.05). ConclusionIntravenous preload of MSCs before a CN injury may prevent or reduce experimental ED. Takayanagi A, Sasaki M, Kataoka-Sasaki Y, Kobayashi K, Matsuda Y, Oka S, Masumori N, Kocsis JD and Honmou O. Intravenous preload of mesenchymal stem cells rescues erectile function in a rat model of cavernous nerve injury. J Sex Med 2015;12:1713-1721.	[Takayanagi, Akio; Kobayashi, Ko; Matsuda, Yohei; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608556, Japan; [Sasaki, Masanori; Kataoka-Sasaki, Yuko; Oka, Shinichi; Honmou, Osamu] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Neural Regenerat Med, Sapporo, Hokkaido 0608556, Japan; [Sasaki, Masanori; Kocsis, Jeffery D.; Honmou, Osamu] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sasaki, Masanori; Kocsis, Jeffery D.; Honmou, Osamu] VA Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res, West Haven, CT USA	Sasaki, M (reprint author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Neural Regenerat Med, Sapporo, Hokkaido 0608556, Japan.	msasaki@sapmed.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs [B7335R, B9260L]; National Multiple Sclerosis Society; CT Stem Cell Research Program [12-SCB-Yale-05];  [25462516]	This work was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology, Grant-in Aid for Scientific Grant-in Aid for Scientific Research (C) to A.T (25462516) and the Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (B7335R, B9260L), the National Multiple Sclerosis Society and the CT Stem Cell Research Program (12-SCB-Yale-05).	Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Salonia A, 2012, EUR UROL, V62, P261, DOI 10.1016/j.eururo.2012.04.046; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Suzuki J, 2013, BRAIN RES, V1497, P15, DOI 10.1016/j.brainres.2012.12.028; Kato R, 2007, GENE THER, V14, P1344, DOI 10.1038/sj.gt.3302990; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Mulhall JP, 2013, J SEX MED, V10, P195, DOI 10.1111/j.1743-6109.2012.02885.x; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Fall PA, 2009, EUR UROL, V56, P716, DOI 10.1016/j.eururo.2008.09.059; Salonia A, 2012, EUR UROL, V62, P273, DOI 10.1016/j.eururo.2012.04.047; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Zimmerlin L, 2013, BIOCHIMIE, V95, P2235, DOI 10.1016/j.biochi.2013.05.010; Fandel TM, 2012, EUR UROL, V61, P201, DOI 10.1016/j.eururo.2011.07.061; Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Burnett AL, 2007, J UROLOGY, V178, P597, DOI 10.1016/j.juro.2007.03.140; Wu CC, 2012, J SEX MED, V9, P2838, DOI 10.1111/j.1743-6109.2012.02881.x; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Brennen WN, 2013, ENDOCR-RELAT CANCER, V20, pR269, DOI 10.1530/ERC-13-0151; Hisasue S, 2005, J UROLOGY, V173, P286, DOI 10.1097/01.ju.0000141578.84536.80; Kato R, 2003, BRAIN RES, V986, P166, DOI 10.1016/S0006-8993(03)03249-9; Kato R, 2008, GENE THER, V16, P26; Kim JH, 2014, BIOMED RES INT, V2014, P1; Kobayashi K, 2011, INT J UROL, V18, P710, DOI 10.1111/j.1442-2042.2011.02823.x; Kocsis JD, 2012, PROG BRAIN RES, V201, P79, DOI 10.1016/B978-0-444-59544-7.00005-6; Lerner MZ, 2014, LARYNGOSCOPE, V124, P2555, DOI 10.1002/lary.24798; Matsushita T, 2015, EXP NEUROL, V267, P152, DOI 10.1016/j.expneurol.2015.03.001; Matthes SM, 2013, BIOMED RES INT, V2013, P1; May F, 2013, INT J UROL, V20, P344, DOI 10.1111/iju.12078; Namiki S, 2012, J SEX MED, V9, P2448, DOI 10.1111/j.1743-6109.2012.02788.x; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Xu YD, 2014, J SEX MED, V11, P2439, DOI 10.1111/jsm.12636; Yamashita S, 2011, J SEX MED, V8, P1957, DOI 10.1111/j.1743-6109.2011.02283.x; Yamashita S, 2009, INT J UROL, V16, P905, DOI 10.1111/j.1442-2042.2009.02382.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12	8					1713	1721		10.1111/jsm.12957		9	Urology & Nephrology	Urology & Nephrology	CP9HV	WOS:000360205700009		
J	Murakami, T; Hiroshima, Y; Zhang, Y; Bouvet, M; Chishima, T; Tanaka, K; Endo, I; Hoffman, RM				Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Bouvet, Michael; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru; Hoffman, Robert M.			Improved disease-free survival and overall survival after fluorescence-guided surgery of liver metastasis in an orthotopic nude mouse model	JOURNAL OF SURGICAL ONCOLOGY			English	Article						fluorescence-guided surgery (FGS); bright-light surgery (BLS); liver metastasis; orthotopic; colon cancer; HT-29; green fluorescent protein (GFP); survival; disease-free survival	ANTI-CEA ANTIBODY; KILLER-REPORTER ADENOVIRUS; HUMAN COLON-CANCER; PANCREATIC-CANCER; COLORECTAL-CANCER; IMAGING-SYSTEM; IN-VIVO; TUMOR; RESECTION; PROTEINS	BackgroundIn the present study, we sought to determine if fluorescence-guided surgery (FGS) would improve survival compared to standard bright light surgery (BLS) in an experimental colorectal liver metastasis nude mouse model. MethodsOrthotopic nude-mouse models of human HT-29-GFP colon cancer liver metastasis were established in the left lobe of the liver of mice. Fourteen mice with a single liver metastasis were randomized into FGS or BLS groups of seven each. FGS of liver metastasis was performed using a hand-held portable fluorescence imaging system (Dino-Lite) to visualize the GFP fluorescence of the metastasis. The BLS- and FGS-treated mice were followed by weekly fluorescence imaging in order to detect recurrence. ResultsThe bright fluorescence of GFP provided sufficient illumination to accurately distinguish the margins of the metastasis within the liver. Recurrence occurred in multiple sites including the liver, lung, and other organs in the BLS-treated mice but was significantly reduced in FGS-treated mice. The FGS-treated mice had significantly prolonged disease-free survival (P=0.001) and overall survival (P=0.027) compared to BLS-treated mice. ConclusionThe results of the present report demonstrate the feasibility and efficacy of FGS for liver metastasis and suggest its important clinical potential. J. Surg. Oncol. 2015 111:119-124. (c) 2015 Wiley Periodicals, Inc.	[Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Murakami, Takashi; Hiroshima, Yukihiko; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Murakami, Takashi; Hiroshima, Yukihiko; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan	Bouvet, M (reprint author), Univ Calif San Diego, Dept Surg, Moores Canc Ctr, 3855 Hlth Sci Dr 0987, La Jolla, CA 92093 USA.	mbouvet@ucsd.edu			US National Cancer Institute [CA126023, CA14266]; Japan JSPS KAKENHI [26830081, 26462070, 24592009]	Grant sponsor: US National Cancer Institute; Grant numbers: CA126023, CA14266; Grant sponsor: Japan JSPS KAKENHI; Grant numbers: 26830081, 26462070, 24592009.	Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Misiakos EP, 2011, WORLD J GASTROENTERO, V17, P4067, DOI 10.3748/wjg.v17.i36.4067; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; STEELE G, 1989, ANN SURG, V210, P127, DOI 10.1097/00000658-198908000-00001; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Sharma S, 2008, J HEPATO-BILIARY-PAN, V15, P570, DOI 10.1007/s00534-008-1350-x; Yano S, 2015, ONCOTARGET, V6, P13133; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Yano S, 2015, MOL THER, V23, P1182, DOI 10.1038/mt.2015.63; Chishima T, 1997, CANCER RES, V57, P2042; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; Bouvet M, 2011, SCI TRANSL MED, V3, P110; Maawy AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121989; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	AUG 1	2015	112	2					119	124		10.1002/jso.23986		6	Oncology; Surgery	Oncology; Surgery	CP7UO	WOS:000360094300001		
J	Azuma, Y; Yokobori, T; Mogi, A; Altan, B; Yajima, T; Kosaka, T; Onozato, R; Yamaki, E; Asao, T; Nishiyama, M; Kuwano, H				Azuma, Yoko; Yokobori, Takehiko; Mogi, Akira; Altan, Bolag; Yajima, Toshiki; Kosaka, Takayuki; Onozato, Ryoichi; Yamaki, Ei; Asao, Takayuki; Nishiyama, Masahiko; Kuwano, Hiroyuki			SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer	JOURNAL OF SURGICAL ONCOLOGY			English	Article						sirtuin; sirtuin 6; autophagy; chemoresistance	METABOLISM; AUTOPHAGY; CARCINOMA; SIRTUINS; ROLES	BackgroundDespite advances in the development of various therapeutic agents, non-small cell lung cancer (NSCLC) is associated with a poor prognosis. To improve the prognosis of patients with NSCLC, new therapeutic targets for overcoming drug resistance are required. The process of autophagy is required to support the tumorigenesis and drug resistance of cancer cells. We investigated the clinical significance of SIRT6, a member of the NAD(+)-dependent deacetylase family, which regulates a variety of cancer-related processes, including autophagy. MethodsImmunohistochemistry analysis of SIRT6 expression and localization in 98 NSCLC clinical specimens and in vitro analysis using SIRT6-knockout lung carcinoma cell lines were performed. ResultsPatients with high cytoplasmic expression and low nuclear expression of SIRT6 (n=33) had more aggressive cancer, shorter overall survival, and shorter recurrence-free survival than did patients with different SIRT6 expression profiles (P<0.05). In vitro analysis revealed that SIRT6 knockdown lung adenocarcinoma cell line improved paclitaxel sensitivity (P<0.05) and reduced the expression levels of both nuclear factor kappaB and autophagy marker Beclin1. ConclusionOur data demonstrated that SIRT6 expression in NSCLC could be a useful prognostic marker and that SIRT6 might represent a novel target gene for predicting sensitivity of chemotherapy in lung adenocarcinoma. J. Surg. Oncol. 2015 111:231-237. (c) 2015 Wiley Periodicals, Inc.	[Azuma, Yoko; Yokobori, Takehiko; Mogi, Akira; Altan, Bolag; Yajima, Toshiki; Kosaka, Takayuki; Onozato, Ryoichi; Yamaki, Ei; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 3718511, Japan; [Yokobori, Takehiko; Nishiyama, Masahiko] Gunma Univ, Grad Sch Med, Dept Pharmacol & Oncol, Maebashi, Gumma 3718511, Japan; [Asao, Takayuki] Gunma Univ, Dept Oncol Clin Dev, Maebashi, Gumma 3718511, Japan	Yokobori, T (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	bori45@gunma-u.ac.jp			Japan Society for the Promotion of Science [21591690, 22591450, 23591857]; Uehara Zaidan, Promotion Plan for the Platform of Human Resource Development for Cancer and New Paradigms-Establishing Centers for Fostering Medical Researchers of the Future programs; Ministry of Education, Culture, Sports, Science and Technology of Japan; Gunma University Initiative for Advanced Research (GIAR); Yakult Honsha Co. Ltd.	Grant sponsor: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; Grant numbers: 21591690, 22591450, 23591857; Grant sponsor: Uehara Zaidan, Promotion Plan for the Platform of Human Resource Development for Cancer and New Paradigms-Establishing Centers for Fostering Medical Researchers of the Future programs.; Grant sponsor: Ministry of Education, Culture, Sports, Science and Technology of Japan.; Grant sponsor: Gunma University Initiative for Advanced Research (GIAR).; Grant sponsor: Yakult Honsha Co. Ltd..	Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Lappas M, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/597514; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Lai CC, 2013, TUMOR BIOL, V34, P1847, DOI 10.1007/s13277-013-0726-y; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Cufer T, 2013, EUR J CANCER, V49, P1216, DOI 10.1016/j.ejca.2012.11.021; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Ardestani PM, 2012, NUCLEUS-AUSTIN, V3, P442, DOI 10.4161/nucl.21134; Zhan ZZ, 2014, AUTOPHAGY, V10, P257, DOI 10.4161/auto.27162; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Jia GX, 2012, MOL CELL BIOCHEM, V364, P345, DOI 10.1007/s11010-012-1236-8; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Liu Y, 2013, PROTEIN CELL; Zhong Lei, 2010, Transcription, V1, P17, DOI 10.4161/trns.1.1.12143	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	AUG 1	2015	112	2					231	237		10.1002/jso.23975		7	Oncology; Surgery	Oncology; Surgery	CP7UO	WOS:000360094300019		
J	Wright, CB; Gardener, H; Dong, CH; Yoshita, M; DeCarli, C; Sacco, RL; Stern, Y; Elkind, MSV				Wright, Clinton B.; Gardener, Hannah; Dong, Chuanhui; Yoshita, Mitsuhiro; DeCarli, Charles; Sacco, Ralph L.; Stern, Yaakov; Elkind, Mitchell S. V.			Infectious Burden and Cognitive Decline in the Northern Manhattan Study	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						infections; bacterial infections; viral infections; cognitive decline; epidemiology	1ST ISCHEMIC-STROKE; CHLAMYDIA-PNEUMONIAE; ALZHEIMERS-DISEASE; CAROTID PLAQUE; RISK; DEMENTIA; SEROPOSITIVITY; HOMOCYSTEINE; PROGRESSION; POPULATION	ObjectivesTo determine whether infectious burden (IB) is associated with worse performance and decline on a battery of neuropsychological tests. DesignProspective cohort study (Northern Manhattan Study (NOMAS)). SettingCommunity. ParticipantsA subsample of 588 stroke-free NOMAS participants with IB and cognitive data (mean age 718, 62% female, 14% white, 16% black, 70% Hispanic) and 419 with repeat cognitive testing. MeasurementsSamples used for IB data were collected at baseline. Two waves of neurocognitive assessments occurred during follow-up. Participants underwent a neuropsychological battery and had repeated testing (mean time span 62years). Using factor analysis-derived domain-specific Z scores for language, memory, executive function, and processing speed, associations between a quantitative stroke risk-weighted IB index (IBI), based on five common infections (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, herpes simplex viruses 1 and 2), and cognitive performance and decline in each domain was examined. ResultsAdjusting for demographic characteristics, socioeconomic status, crystallized cognitive abilities, and vascular risk factors, the IBI was inversely associated with executive function at baseline (beta=-0.10, P=.01) but not with baseline language, memory, or processing speed performance in adjusted analyses. The IBI was associated with cognitive decline in the memory domain, adjusting for demographic and vascular risk factors (P=.02). ConclusionA quantitative stroke risk-weighted measure of IB explained variability in baseline executive function performance and associated with decline in memory. Past exposure to common infections may contribute to vascular cognitive impairment and warrants further study.	[Wright, Clinton B.; Gardener, Hannah; Dong, Chuanhui; Sacco, Ralph L.] Univ Miami, Evelyn F McKnight Brain Inst, Miami, FL 33136 USA; [Wright, Clinton B.; Gardener, Hannah; Dong, Chuanhui; Sacco, Ralph L.] Univ Miami, Dept Neurol, Miami, FL 33136 USA; [Wright, Clinton B.; Sacco, Ralph L.] Univ Miami, Leonard M Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Wright, Clinton B.; Sacco, Ralph L.] Univ Miami, Neurosci Program, Miami, FL 33136 USA; [Yoshita, Mitsuhiro] Hokuriku Natl Hosp, Dept Neurol, Nanto, Toyama, Japan; [DeCarli, Charles] Univ Calif Davis Hlth Syst, Dept Neurol, Sacramento, CA USA; [Stern, Yaakov] Columbia Univ, Coll Phys & Surg, Cognit Neurosci Div, New York, NY USA; [Stern, Yaakov] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA	Wright, CB (reprint author), Univ Miami, Dept Neurol, Miller Sch Med, 1349 Clin Res Bldg,1120 NW 14th St, Miami, FL 33136 USA.	c.wright21@med.miami.edu			National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) [R37 NS 29993, R01 NS 48134]	This work was supported by the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (R37 NS 29993 and R01 NS 48134).	Marquine MJ, 2010, STROKE, V41, P1946, DOI 10.1161/STROKEAHA.110.587717; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Willey JZ, 2009, NEUROLOGY, V73, P1774, DOI 10.1212/WNL.0b013e3181c34b58; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; DelSer T, 1997, BRAIN COGNITION, V33, P343, DOI 10.1006/brcg.1997.0877; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532.5415.2006.00796.x; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Itzhaki RF, 2010, ALZHEIMERS DEMENT, V6, P83, DOI 10.1016/j.jalz.2009.07.136; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Berry DC, 1997, Q J EXP PSYCHOL-A, V50, P1; Dunn Lloyd M., 1997, EXAMINERS MANUAL PEA; Elkind MSV, 2000, STROKE, V31, P1521; Gardener H, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-55; Hammond CJ, 2010, BMC NEUROSCI, V11; Kargman DE, 1999, NEUROEPIDEMIOLOGY, V18, P174, DOI 10.1159/000026209; Katan M, 2013, FUTURE VIROL, V8, P833, DOI 10.2217/fvl.13.74; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Luchsinger José A, 2004, Curr Atheroscler Rep, V6, P261, DOI 10.1007/s11883-004-0056-z; Richards SS, 2000, J AM GERIATR SOC, V48, P1035; Roubaud BC, 2013, J AM GERIATR SOC, V61, P74; Siedlecki KL, 2012, J INT NEUROPSYCH SOC, V18, P223, DOI 10.1017/S135561771100155X; Wallman KK, 1977, STAT REP, V77-110, P450; Wilkinson G., 1993, WIDE RANGE ACHIEVEME	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	AUG	2015	63	8					1540	1545		10.1111/jgs.13557		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CP9IG	WOS:000360207000007		
J	Kagaya, H; Saitoh, E; Shibata, S; Onogi, K; Aoyagi, Y; Inamoto, Y; Ozeki, M; Ota, K				Kagaya, Hitoshi; Saitoh, Eiichi; Shibata, Seiko; Onogi, Keiko; Aoyagi, Yoichiro; Inamoto, Yoko; Ozeki, Megumi; Ota, Kikuo			Delayed Pharyngeal Response in CHEW-SWALLOW Does Not Increase Risk of Aspiration in Individuals with Stroke	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							CONSISTENCY; PENETRATION; TRANSPORT		[Kagaya, Hitoshi; Saitoh, Eiichi; Shibata, Seiko; Onogi, Keiko; Aoyagi, Yoichiro] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi, Japan; [Inamoto, Yoko; Ozeki, Megumi; Ota, Kikuo] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan	Kagaya, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi, Japan.				Japan Society for the Promotion of Science [25350638]	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 25350638.	Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; Oommen ER, 2011, DYSPHAGIA, V26, P318, DOI 10.1007/s00455-010-9314-0; Kim Y, 2007, DYSPHAGIA, V22, P299, DOI 10.1007/s00455-007-9085-4; Ozaki K, 2010, TOHOKU J EXP MED, V220, P41, DOI 10.1620/tjem.220.41; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	AUG	2015	63	8					1698	1699		10.1111/jgs.13570		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CP9IG	WOS:000360207000032		
J	Hanyu, H; Hirose, D; Fukasawa, R; Hatanaka, H; Namioka, N; Sakurai, H				Hanyu, Haruo; Hirose, Daisuke; Fukasawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Sakurai, Hirofumi			Guidelines for the Clinical Diagnosis of Diabetes Mellitus-Related Dementia	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							ALZHEIMERS-DISEASE; RISK		[Hanyu, Haruo; Hirose, Daisuke; Fukasawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Sakurai, Hirofumi] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan	Hanyu, H (reprint author), Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan.						Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Mijnhout GS, 2006, DIABETOLOGIA, V49, P1447, DOI 10.1007/s00125-006-0221-8; Takeuchi J, 2012, DEMENT GERIATR COGN, V34, P112, DOI 10.1159/000341577; Fukasawa R, 2014, GERIATR GERONTOL INT, V14, P229, DOI 10.1111/ggi.12140; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Fukasawa R, 2015, J NEUROL SCI, V349, P45, DOI 10.1016/j.jns.2014.12.023; Fukazawa R, 2013, DEMENT GERIATR COGN, V35, P280, DOI 10.1159/000348407	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	AUG	2015	63	8					1721	1723		10.1111/jgs.13581		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CP9IG	WOS:000360207000049		
J	Ashizawa, K; Okamoto, S; Yamanaka, N; Oki, E; Fumagalli, A; Veeraraghavan, M				Ashizawa, Kunitaka; Okamoto, Satoru; Yamanaka, Naoaki; Oki, Eiji; Fumagalli, Andrea; Veeraraghavan, Malathi			Application-Centric, Energy-Efficient Network Architecture ACTION, Based on Virtual Optical Slice Core and Deterministic Optical Access Network	JOURNAL OF THE OPTICAL SOCIETY OF KOREA			English	Article						Quality of experience; Quality of service; Quality of transport; Flexible elastic network	PERFORMANCE EVALUATION; REACH	The Internet traffic is forecasted to grow at a compound annual rate of 21 % from 2013 to 2018, according to surveys carried out by Cisco [1]. Network resources are significantly over-provisioned in today's networks, and it is quite common to see link utilization in the 30-40% range [2]. Additionally, the multi-media services have widely divergent bandwidth and Quality of Experience (QoE) requirements. Unfortunately, the huge transmission capacity will increase the power consumption of network equipment [3]. Applications Coordinated with Transport, Internet Protocol and Optical Networks (ACTION) [4] has been proposed to realize a multi-QoE, application-centric, and highly energy-efficient network that leverages flexible elastic optical network technologies [5-7]. This paper provides key network technologies for realizing the ACTION, which are a virtual optical slice core network and a Time Division Multiplexing (TDM)-based deterministic active optical access network.	[Ashizawa, Kunitaka; Okamoto, Satoru; Yamanaka, Naoaki] Keio Univ, Dept Informat & Comp Sci, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Okamoto, Satoru; Oki, Eiji] Univ Electrocommun, Chofu, Tokyo 1828585, Japan; [Fumagalli, Andrea] Univ Texas Dallas, Richardson, TX 75080 USA; [Veeraraghavan, Malathi] Univ Virginia, Charlottesville, VA 22904 USA	Ashizawa, K (reprint author), Keio Univ, Dept Informat & Comp Sci, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	Kunitaka.Ashizawa@yamanaka.ics.keio.ac.jp			"ACTION Project" - National Institute of Information and Communications Technology (NICT), Japan; US NSF [CNS-1405171, CNS-1405405]	This work is supported by "ACTION Project" funded by the National Institute of Information and Communications Technology (NICT), Japan, and US NSF grants CNS-1405171 and CNS-1405405.	Gerstel O, 2012, IEEE COMMUN MAG, V50, pS12, DOI 10.1109/MCOM.2012.6146481; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; [Anonymous], 2012, IEEE80232012; Pickavet M, 2008, ANTS: 2008 2ND INTERNATIONAL SYMPOSIUM ON ADVANCED NETWORKS AND TELECOMMUNICATION SYSTEMS, P1; Ashizawa K, 2012, IEICE T COMMUN, VE95B, P730, DOI 10.1587/transcom.E95.B.730; Cisco Systems Inc, 2014, CISC VIS NETW IND FO; Hirao A., 2013, P 10 C LAS EL PAC RI; Ikeda H, 2012, IEICE T COMMUN, VE95B, P696, DOI 10.1587/transcom.E95.B.696; Jain Sushant, 2013, P ACM SIGCOMM 2013 C; Kang BW, 2014, J OPT SOC KOREA, V18, P436, DOI 10.3807/JOSK.2014.18.5.436; Kang BW, 2011, J OPT SOC KOREA, V15, P4, DOI 10.3807/JOSK.2011.15.1.004; Kang BW, 2011, J OPT SOC KOREA, V15, P222, DOI 10.3807/JOSK.2011.15.3.222; Miyagi H, 2008, IEICE T COMMUN, VE91B, P3882, DOI 10.1093/ietcom/e91-b.12.3882; Nashimoto K., 2008, P OFC 2008 SAN DIEG; Okamoto S., 2011, P AS COMM PHOT C ACP; Takeshita H., 2011, P OPT FIB COMM C EXP; Veeraraghavan M., 2014, P IEEE ONDM 2014 KTH; Yamanaka N., 2010, P 9 INT C OPT INT CO, P353; Yamanaka N., 2013, CYBER J MULTIDISCIPL, V3, P7; Yamanaka N., 2014, P COIN 2014 HYATT RE; Yan Z., 2013, INT J ADV INTERNET T, V6; Yonezu H., 2010, P ECOC 2010 CTR C LI; Yonezu H, 2010, 2010 15TH OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE (OECC), P586; Zhang G., 2013, IEEE COMM SURVEY TUT, V15	24	0	0	OPTICAL SOC KOREA	SEOUL	#1610 TAEYOUNG DESSIAN, 560 DOWHA-DONG, MAPO-GU, SEOUL, 121-815, SOUTH KOREA	1226-4776	2093-6885		J OPT SOC KOREA	J. Opt. Soc. Korea.	AUG	2015	19	4					340	345		10.3807/JOSK.2015.19.4.340		6	Optics	Optics	CQ3QG	WOS:000360517000003		
J	Tamura, J; Ishizuka, T; Fukui, S; Oyama, N; Kawase, K; Itami, T; Miyoshi, K; Sano, T; Pasloske, K; Yamashita, K				Tamura, Jun; Ishizuka, Tomohito; Fukui, Sho; Oyama, Norihiko; Kawase, Kodai; Itami, Takaharu; Miyoshi, Kenjiro; Sano, Tadashi; Pasloske, Kirby; Yamashita, Kazuto			Sedative effects of intramuscular alfaxalone administered to cats	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						alfaxalone; feline; intramuscular administration; sedation	DOGS; ANESTHESIA; PROPOFOL; MEDETOMIDINE; INDUCTION; QUALITY; DEXMEDETOMIDINE; ISOFLURANE; RECOVERY; KETAMINE	The sedative effects of intramuscular (IM) alfaxalone in 2-hydroxypropyl-beta-cyclodextrin (alfaxalone-HPCD) were evaluated in cats. The cats were treated with alfaxalone-HPCD in five occasions with a minimum 14-day interval between treatments: an IM injection of 1.0 mg/kg (IM1), 2.5 mg/kg (IM2.5), 5 mg/kg (IM5) or 10 mg/kg (1M10), or an intravenous injection of 5 mg/kg (IV5). The sedative effects were evaluated subjectively using a composite measurement scoring system (a maximum score of 16). Cardio-respiratory variables were measured non-invasively. The median sedation scores peaked at 10 min (score 9), 15 min (score 14), 10 min (score 16), 10 to 20 min (score 16) and 2 to 5 min (score 16) after the IM1, IM2.5, IM5, IM10 and IV5 treatments, respectively. The IM5 treatment produced longer lasting sedation, compared to the IV5 treatment. Durations of maintenance of lateral recumbency after the IM10 treatment (115 +/- 22 min) were longer than those after the IM2.5 (40 +/- 15 min), IM5 (76 +/- 21 min) and IV5 treatments (50 +/- 5 min). Cardio-respiratory variables remained within clinically acceptable ranges, except for each one cat that showed hypotension (<60 mmHg) after the IM10 and IV5 treatments. Tremors, ataxia and opisthotonus-like posture were observed during the early recovery period after the IM2.5, IM5, IM10 and IV5 treatments. In conclusion, IM alfaxalone-HPCD produced dose-dependent and clinically relevant sedative effect at 2.5 to 10 mg/kg in healthy cats. Hypotension may occur at higher IM doses of alfaxalone-HPCD.	[Tamura, Jun; Ishizuka, Tomohito; Fukui, Sho; Oyama, Norihiko; Kawase, Kodai; Itami, Takaharu; Miyoshi, Kenjiro; Yamashita, Kazuto] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan; [Sano, Tadashi] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Nursing Sci, Ebetsu, Hokkaido 0698501, Japan; [Pasloske, Kirby] Jurox Pty Ltd, Rutherford, NSW 2320, Australia	Yamashita, K (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan.	yamasita@rakuno.ac.jp					ALBERTSON TE, 1992, ANESTHESIOLOGY, V77, P488, DOI 10.1097/00000542-199209000-00014; Ambros B, 2008, AM J VET RES, V69, P1391, DOI 10.2460/ajvr.69.11.1391; Selmi AL, 2003, J AM VET MED ASSOC, V222, P37, DOI 10.2460/javma.2003.222.37; YOUNG LE, 1990, J SMALL ANIM PRACT, V31, P554, DOI 10.1111/j.1748-5827.1990.tb00685.x; Smith AA, 2004, JAVMA-J AM VET MED A, V225, P540, DOI 10.2460/javma.2004.225.540; Rodan I, 2011, J FELINE MED SURG, V13, P364, DOI 10.1016/j.jfms.2011.03.012; Karas AZ, 1999, CLIN TECH SMALL AN P, V14, P15, DOI 10.1016/S1096-2867(99)80023-1; Wiese AJ, 2007, J FELINE MED SURG, V9, P150, DOI 10.1016/j.jfms.2006.11.002; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Bednarski R. M., 2007, LUMB JONES VET ANEST, P705; BRANSON K. R., 2007, LUMB JONES VET ANEST, P273; CHILD KJ, 1971, BRIT J ANAESTH, V43, P2, DOI 10.1093/bja/43.1.2-a; Cullen LK, 1996, BRIT VET J, V152, P519, DOI 10.1016/S0007-1935(96)80005-4; DODMAN NH, 1980, VET REC, V107, P481; Ferchichi S., 2013, JOURNAL OF VETERINAR, V40, P655; Goodchild CS, 2000, PAIN, V88, P23, DOI 10.1016/S0304-3959(00)00301-8; Grubb TL, 2013, J FELINE MED SURG, V15, P858, DOI 10.1177/1098612X13478265; Haberman C. E., 2004, International Journal of Applied Research in Veterinary Medicine, V2, P279; Heit M., 2004, Journal of Veterinary Internal Medicine, V18, P432; Heit M, 2004, Journal of Veterinary Internal Medicine, V18, P419; JACOBSON JD, 1992, AM J VET RES, V53, P537; Jimenez CP, 2012, VET ANAESTH ANALG, V39, P151, DOI 10.1111/j.1467-2995.2011.00678.x; Lin HC, 2007, LUMB JONES VET ANEST, P301; Mathis A, 2012, VET ANAESTH ANALG, V39, P282, DOI 10.1111/j.1467-2995.2011.00707.x; Michou JN, 2012, VET ANAESTH ANALG, V39, P275, DOI 10.1111/j.1467-2995.2012.00709.x; Muir W, 2009, VET ANAESTH ANALG, V36, P42, DOI 10.1111/j.1467-2995.2008.00428.x; Muir W, 2008, VET ANAESTH ANALG, V35, P451, DOI 10.1111/j.1467-2995.2008.00406.x; Mutoh T, 2001, AM J VET RES, V62, P311, DOI 10.2460/ajvr.2001.62.311; Pedersen KM, 2002, J AM VET MED ASSOC, V221, P646, DOI 10.2460/javma.2002.221.646; Taboada FM, 2010, VET REC, V167, P85, DOI 10.1136/vr.b4872; Whittem T, 2008, J VET PHARMACOL THER, V31, P571, DOI 10.1111/j.1365-2885.2008.00998.x; Zaki S, 2009, AUST VET J, V87, P82, DOI 10.1111/j.1751-0813.2009.00390.x	33	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					897	904		10.1292/jvms.14-0200		8	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500001		
J	Suzuki, Y; Kobayashi, M; Matsushita, S; Uehara, S; Kato, R; Sato'o, Y; Ono, HK; Sadamasu, K; Kai, A; Kamata, Y				Suzuki, Yasunori; Kobayashi, Makiko; Matsushita, Shigeru; Uehara, Satomi; Kato, Rei; Sato'o, Yusuke; Ono, Hisaya K.; Sadamasu, Kenji; Kai, Akemi; Kamata, Yoichi			Detection of the staphylococcal enterotoxin D-like gene from staphylococcal food poisoning isolates over the last two decades in Tokyo	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						mutant SED; plasmid; staphylococcal enterotoxin; staphylococcal food poisoning; Staphylococcus aureus	COMPREHENSIVE ANALYSIS; INDUCED EMESIS; AUREUS; IDENTIFICATION; TOXINS; SUPERANTIGENS	The plasmid is a very well-known mobile genetic element that participates in the acquisition of virulence genes, such as staphylococcal enterotoxins (SEs), via horizontal transfer. SEs are emetic toxins and causative agents in staphylococcal food poisoning (SFP). We herein identified the types of plasmids harbored by seven SFP isolates and examined their production of plasmid-related SE/SEI to determine whether the new types of plasmid-related SE or SE-like (SEI) toxins (i.e. SEIJ and SER) were involved in SFP. These isolates harbored pIB485-like plasmids, and all, except for one isolate, produced SEIJ and SER. The amount of SER produced by each isolate accounted for the highest or second highest percentage of the total amount of SE/SEI produced. These new types of plasmid-related SE/SEIs as well as classical SE may play a role in SFP. The seven isolates were classified into two SED-production types; a high SED-production type (>500 ng/ml) and no SED-production type. A nucleotide sequencing analysis revealed that three plasmids harbored by the SED-non-producing isolates had a single-base deletion in the red gene with a resulting stop codon (from 233 amino acids of the intact SED to 154 amino acids of the mutant SED (mSED)). A real-time reverse transcription-PCR analysis showed that the mRNA of the msed gene was transcribed in the isolates. If the msed gene was translated as a protein, mSED may act as an emetic toxin instead of intact SED.	[Suzuki, Yasunori; Kamata, Yoichi] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 0208550, Japan; [Suzuki, Yasunori; Kamata, Yoichi] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu 5011193, Japan; [Suzuki, Yasunori; Kobayashi, Makiko; Matsushita, Shigeru; Uehara, Satomi; Kato, Rei; Sadamasu, Kenji; Kai, Akemi] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, Tokyo 1690073, Japan; [Sato'o, Yusuke] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Minami Ku, Hiroshima, Hiroshima 7348551, Japan; [Ono, Hisaya K.] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori 0368562, Japan	Suzuki, Y (reprint author), Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, 3-24-1 Hyakunin Cho, Tokyo 1690073, Japan.	Yasunori_l_Suzuki@member.metro.tokyo.jp					Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16; Sato'o Y, 2014, J CLIN MICROBIOL, V52, P2637, DOI 10.1128/JCM.00661-14; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Thomas DY, 2006, INFECT IMMUN, V74, P4724, DOI 10.1128/IAI.00132-06; Ono HK, 2012, FEMS IMMUNOL MED MIC, V64, P392, DOI 10.1111/j.1574-695X.2011.00924.x; Omoe K, 2005, FEMS MICROBIOL LETT, V246, P191, DOI 10.1016/j.femsle.2005.04.007; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Omoe K, 2013, INFECT IMMUN, V81, P3627, DOI 10.1128/IAI.00550-13; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Argudin MA, 2012, APPL ENVIRON MICROB, V78, P2930, DOI 10.1128/AEM.07487-11; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Ono HK, 2008, INFECT IMMUN, V76, P4999, DOI 10.1128/IAI.00045-08; Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x; TRANTER HS, 1990, LANCET, V336, P1044, DOI 10.1016/0140-6736(90)92500-H; Hu DL, 2014, EUR J PHARMACOL, V722, P95, DOI 10.1016/j.ejphar.2013.08.050; Omoe K, 2005, INFECT IMMUN, V73, P5540, DOI 10.1128/IAI.73.9.5540.5546.2005; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Omoe K, 2003, INFECT IMMUN, V71, P6088, DOI 10.1128/IAI.71.10.6088-6094.2003; Derzelle S, 2009, FOOD MICROBIOL, V26, P896, DOI 10.1016/j.fm.2009.06.007; Schelin J, 2011, VIRULENCE, V2, P580, DOI 10.4161/viru.2.6.18122; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; HARRIS TO, 1995, INFECT IMMUN, V63, P2133; Hu DL, 2009, J INFECT DIS, V199, P302, DOI 10.1086/596065; Maina EK, 2012, PEPTIDES, V38, P1, DOI 10.1016/j.peptides.2012.08.013; SCHAD EM, 1995, EMBO J, V14, P3292; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271	28	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					905	911		10.1292/jvms.15-0028		7	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500002		
J	Aihara, N; Horiuchi, N; Hikichi, N; Ochiai, M; Hosoda, Y; Ishikawa, Y; Shimazaki, Y; Oishi, K				Aihara, Naoyuki; Horiuchi, Noriyuki; Hikichi, Nanase; Ochiai, Mariko; Hosoda, Yuko; Ishikawa, Yoko; Shimazaki, Yoko; Oishi, Koji			Immunoreactivity and morphological changes of bursal follicles in chickens infected with vaccine or wild-type strains of the infectious bursal disease virus	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						bursal follicle; infectious bursal disease; vaccine	B-CELLS; FABRICIUS; IMMUNOSUPPRESSION; CYCLOPHOSPHAMIDE; PATHOGENICITY; INTERMEDIATE; PATHOGENESIS; EFFICACY; IMMUNITY; ANEMIA	Infectious bursal disease (IBD) is characterized by immunosuppression due to the depletion of lymphocytes in the atrophied bursa of Fabricius (BF). We have sometimes encountered contradictory findings: chickens infected with the vaccine IBD virus (IBDV) strain have sometimes exhibited a highly atrophied BF, but not immunosuppression. In this study, chickens administered vaccine or wildtype strains of IBDV were later vaccinated with the B1 strain of the Newcastle disease virus (NDV). Bursal changes were examined histologically with a focus on the bursal follicle. The immunoreactivity to NDV was also evaluated with the hemagglutination inhibition test. In gross examination, we observed a few chickens with a severely atrophied BF in vaccine strain-administered groups (vaccine groups), and the level of severity was the same as that in the wild-type strain-administered group (wild-type group). However, these chickens retained humoral antibody responses to NDV and were revealed to possess a higher number of bursal follicles than those of the wild-type group. These results indicated that macroscopic evaluation dose not accurately reflect the immunoreactivity and degree of bursal damage in IBDV-administered chickens. We also found non-immunosuppressed chickens in the wild-type group. These non-immunosuppressed chickens retained a significantly higher number of normal follicles and total follicles according to our statistical analysis. Furthermore, a high correlation coefficient between the NDV-HI titer and the number of normal follicles was found in the wild-type group. These results implied that the retained number of normal follicles is important for the immunoreactivity of chickens infected with IBDV.	[Aihara, Naoyuki; Horiuchi, Noriyuki; Hikichi, Nanase; Ochiai, Mariko; Hosoda, Yuko; Ishikawa, Yoko; Shimazaki, Yoko; Oishi, Koji] Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, Kokubunji, Tokyo 1858511, Japan; [Horiuchi, Noriyuki] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Obihiro, Hokkaido 0808555, Japan	Horiuchi, N (reprint author), Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, 1-15-1 Tokura, Kokubunji, Tokyo 1858511, Japan.	horiuchi@obihiro.ac.jp					ANDERSON WI, 1977, AVIAN DIS, V21, P637, DOI 10.2307/1589423; Rautenschlein S, 2003, AVIAN DIS, V47, P66, DOI 10.1637/0005-2086(2003)047[0066:CIOMIA]2.0.CO;2; Williams AE, 2005, AVIAN PATHOL, V34, P4, DOI 10.1080/03079450400025364; Withers DR, 2006, IMMUNOLOGY, V117, P558, DOI 10.1111/j.1365-2567.2006.02332.x; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; TANIMURA N, 1995, AVIAN DIS, V39, P9, DOI 10.2307/1591976; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Mahgoub HA, 2012, ARCH VIROL, V157, P2047, DOI 10.1007/s00705-012-1377-9; Sayegh CE, 2000, IMMUNOL REV, V175, P187, DOI 10.1034/j.1600-065X.2000.017507.x; Rautenschlein S, 2005, AVIAN DIS, V49, P231, DOI 10.1637/7310-112204R; CHO B R, 1970, Avian Diseases, V14, P665, DOI 10.2307/1588638; CORRIER DE, 1991, AVIAN DIS, V35, P40, DOI 10.2307/1591292; Eterradossi N., 2008, DIS POULTRY, P185; FADLY AM, 1976, AVIAN DIS, V20, P467, DOI 10.2307/1589379; Hansell C, 2007, J IMMUNOL, V179, P5117; HIRAI K, 1974, AVIAN DIS, V18, P50, DOI 10.2307/1589241; HOUSSAINT E, 1986, IMMUNOLOGY, V58, P43; Ivan J, 2001, VET IMMUNOL IMMUNOP, V79, P235, DOI 10.1016/S0165-2427(01)00267-7; KAUFER I, 1976, AVIAN DIS, V20, P483, DOI 10.2307/1589381; Kim IJ, 2000, J VIROL, V74, P8884, DOI 10.1128/JVI.74.19.8884-8892.2000; Kim IJ, 1999, AVIAN DIS, V43, P401, DOI 10.2307/1592637; Madej JP, 2013, ANAT HISTOL EMBRYOL, V42, P321, DOI 10.1111/ahe.12026; Morimura T, 2001, J IMMUNOL, V166, P3277; MUSKETT JC, 1979, VET REC, V104, P332; PEJKOVSKI C, 1979, AVIAN PATHOL, V8, P95, DOI 10.1080/03079457908418330; Petkov DI, 2009, AVIAN DIS, V53, P347; ROSENBERGER JK, 1978, AVIAN DIS, V22, P95, DOI 10.2307/1589512; ROSENBERGER JK, 1975, AVIAN DIS, V19, P717, DOI 10.2307/1589185; SHARMA JM, 1984, AVIAN DIS, V28, P629, DOI 10.2307/1590231; TOIVANEN P, 1972, J IMMUNOL, V109, P1058; WILMER JL, 1992, MUTAT RES, V268, P115, DOI 10.1016/0027-5107(92)90089-K; Withers DR, 2005, VIRAL IMMUNOL, V18, P127, DOI 10.1089/vim.2005.18.127; WYETH PJ, 1975, VET REC, V96, P238; YUASA N, 1980, AVIAN DIS, V24, P202, DOI 10.2307/1589780	34	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					913	918		10.1292/jvms.14-0599		6	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500003		
J	Mase, M; Kanehira, K				Mase, Masaji; Kanehira, Katsushi			Phylogenetic analysis of avian paramyxovirus serotype-1 in pigeons in Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						avian paramyxovirus serotype-1; phylogeny; pigeon	NEWCASTLE-DISEASE; RACING PIGEONS; VIRUS; VARIANT	To understand the epidemiology of Avian paramyxovirus serotype-1 (APMV-1) in pigeons in Japan, phylogenetic analysis was comprehensively conducted based on partial fusion protein gene using isolate from the surveillance of this virus with previously known Japanese pigeon strains. This surveillance was conducted using feces obtained from domestic pigeons collected in 40 prefectures throughout Japan from June 2011 to March 2013. From a total of 1,021 samples, a single virus (APMV1/pigeon/Japan/Kanagawa/2013: JP/Kanagawapg/2013) was isolated. All Japanese pigeon APMV-1 strains were clustered into a single genetic lineage, which was termed VIb/1 by phylogenetic analysis based on the F gene including the sequence of the cleavage site. These APMV-1 strains were further subdivided into four subgroups identified over 4 separate timeframes: 1984-1995 (group 1), 1995-2000 (group 2), 2001-2007 (group 3) and the novel subgroup isolated in 2013 (group 4). Each subgroup has specific amino acid motifs at a cleavage site of the F protein, namely, (112)GRQKR-F-117(except for one strain), (RRKKR)-R-112-F-117, (112)RRQKR-F-117 and (RNKR)-R-112-F-117, respectively. Our data suggest that Japanese APMV-1 strains from pigeons were diverse and reinforced the possibility that there were multiple introduction routes from foreign countries into Japan.	[Mase, Masaji; Kanehira, Katsushi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Mase, Masaji] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu 5011193, Japan	Mase, M (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	masema@affrc.go.jp			Regulatory Science Project of the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by a Grant-in-Aid from the Regulatory Science Project of the Ministry of Agriculture, Forestry and Fisheries of Japan.	Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; ALEXANDER DJ, 1984, VET REC, V114, P444; Teske L, 2013, AVIAN PATHOL, V42, P557, DOI 10.1080/03079457.2013.852157; Cai SX, 2011, VET MICROBIOL, V152, P46, DOI 10.1016/j.vetmic.2011.04.014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Dortmans JCFM, 2011, J GEN VIROL, V92, P336, DOI 10.1099/vir.0.026344-0; BIANCIFIORI F, 1983, COMP IMMUNOL MICROB, V6, P247, DOI 10.1016/0147-9571(83)90017-6; Imai K., 1986, J JAPANESE SOC POULT, V22, P17; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; Mase M, 2009, J VET MED SCI, V71, P1101, DOI 10.1292/jvms.71.1101; Mase M, 2002, J CLIN MICROBIOL, V40, P3826, DOI 10.1128/JCM.40.10.3826-3830.2002; Mase M., 2014, J VET MED SCI, V77, P381; Miller P.J., 2013, DIS POULTRY, P89; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakai K, 2007, J VET MED SCI, V69, P1307, DOI 10.1292/jvms.69.1307; Shengqing Yu, 2002, Journal of Veterinary Medical Science, V64, P1049, DOI 10.1292/jvms.64.1049; SHIRAI J, 1986, JPN J VET SCI, V48, P1091; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Umali DV, 2014, J VET MED SCI, V76, P423, DOI 10.1292/jvms.13-0539	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					919	923		10.1292/jvms.14-0684		5	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500004		
J	Oishi, Y; Tani, K; Nakazawa, H; Itamoto, K; Haraguchi, T; Taura, Y				Oishi, Yasuhisa; Tani, Kenji; Nakazawa, Hiroshi; Itamoto, Kazuhito; Haraguchi, Tomoya; Taura, Yasuho			Anatomical evaluation of hepatic vascular system in healthy beagles using X-ray contrast computed tomography	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; computed tomography; hepatic artery; hepatic vascular system	CT ANGIOGRAPHY; ARTERY; LIVER; DOGS	Liver contrast X-ray computed tomography (CT) has been used for evaluation of hepatic vessels for liver transplantation, liver lobectomy, interventional radiology and diagnosis of hepatocellular carcinoma in humans. However, there remains scant available anatomical information on normal hepatic vessels in the veterinary field. In this study, visualization of hepatic vessels was evaluated in 32 normal beagle dogs by X-ray contrast CT using triple phase images. The following hepatic vessels were clearly visualized: arterial, portal and hepatic veins. With regards to the running patterns of the portal vein and hepatic vein, there were no significant differences between the dogs. However, the hepatic artery exhibited some differences in each dog. In particular, the hepatic artery of the quadrate lobe and the right lateral lobe had many running patterns. The results of the present study could be useful for veterinary diagnosis, surgery and interventional radiology.	[Oishi, Yasuhisa; Tani, Kenji; Nakazawa, Hiroshi; Taura, Yasuho] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Surg, Yamaguchi, Yamaguchi 7538511, Japan; [Itamoto, Kazuhito; Haraguchi, Tomoya] Yamaguchi Univ, Joint Fac Vet Med, Anim Med Ctr, Yamaguchi, Yamaguchi 7538511, Japan	Tani, K (reprint author), Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Surg, 1677-1 Yoshida, Yamaguchi, Yamaguchi 7538511, Japan.	ktani@yamaguchi-u.ac.jp			JSPS KAKENHI [25234567]	This work was supported by JSPS KAKENHI Grant Number 25234567.	Ursic M, 2007, ANAT HISTOL EMBRYOL, V36, P83, DOI 10.1111/j.1439-0264.2006.00719.x; HIATT JR, 1994, ANN SURG, V220, P50, DOI 10.1097/00000658-199407000-00008; Jeong Y, 2008, J VET SCI, V9, P407; Zwingenberger AL, 2004, VET RADIOL ULTRASOUN, V45, P117, DOI 10.1111/j.1740-8261.2004.04019.x; Covey JL, 2009, VET SURG, V38, P104, DOI 10.1111/j.1532-950X.2008.00467.x; Berent A. C., 2012, VET SURG SMALL ANIMA, V1, P1624; Hall JL, 2015, VET SURG, V44, P27, DOI 10.1111/j.1532-950X.2014.12209.x; Hlaing KPP, 2012, SINGAP MED J, V53, pE186; Katou K., 2003, 3D ANATOMY, P80; Uchida K, 2010, LIVER TRANSPLANT, V16, P1062, DOI 10.1002/lt.22109	10	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					925	929		10.1292/jvms.14-0469		5	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500005		
J	Omura, A; Anzai, W; Koyabu, D; Endo, H				Omura, Ayano; Anzai, Wataru; Koyabu, Daisuke; Endo, Hideki			Ontogenetic changes of trunk muscle structure in the Japanese black salamander (Hynobius nigrescens)	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Japanese black salamander; locomotion; metamorphosis; trunk muscle	FUNCTIONAL-ROLE; HYPAXIAL MUSCULATURE; PLEURODELES WALTL; LOCOMOTION; TERRESTRIAL; EVOLUTION; CAUDATA	We investigated ontogenetic changes in the trunk muscles of the Japanese black salamander (Hynobius nigrescens) before, during and after metamorphosis. Given that amphibians change their locomotive patterns with metamorphosis, we hypothesized that they may also change the structure of their trunk muscles. The trunk muscles were macroscopically observed, and the weight ratios of each trunk muscle group were quantified at six different developmental stages. Immediately after hatching, we found that the lateral hypaxial muscle was composed of one thick M. ventralis, from ventral edge of which M. transversus abdominis arose later, followed by M. obliquus externus and M. rectus abdominis. The weight ratios of the dorsal and abdominal muscles to the trunk muscles increased with growth. We suggest that a single thick and large lateral hypaxial muscle facilitates swimming during early developmental stages. The increase in the weight ratios of the dorsal and abdominal muscles with growth possibly assists with gravity resistance necessary for terrestrial life.	[Omura, Ayano] Univ Tokyo, Univ Museum, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Anzai, Wataru] Univ Tokyo, Univ Museum, Grad Sch Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Omura, Ayano; Anzai, Wataru; Koyabu, Daisuke; Endo, Hideki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Omura, A (reprint author), Univ Tokyo, Univ Museum, Grad Sch Agr & Life Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ayanodesuyoroshiku@yahoo.co.jp			Sasakawa Scientific Research Grant from Japan Science Society [25-539]	We appreciate Dr. Shin-ichiro Kawada of National Museum of Science and Nature, Tokyo, for giving us some specimens. We also thank Dr. Natsuhiko Yoshikawa of Kyoto University, Dr. Yukio Aizawa of Nippon Dental University and Dr. Kenjiro Kinebuchi of Niigata Seiryo University for providing Hynobius nigrescens specimens. We thank Dr. Takenori Sasaki of The University Museum, The University of Tokyo and Mr. Takashi Yoshimine of Microscope Network Co., Ltd. for providing some equipment for functional morphological analysis. The research was financially supported by the Sasakawa Scientific Research Grant (No. 25-539) from The Japan Science Society.	HOFF KV, 1989, CAN J ZOOL, V67, P2756; FROLICH LM, 1992, J EXP BIOL, V162, P107; Deban SM, 2009, J EXP BIOL, V212, P2949, DOI 10.1242/jeb.032961; CARRIER DR, 1993, J EXP BIOL, V180, P75; WASSERSUG RJ, 1989, AM ZOOL, V29, P65; Simons RS, 1999, J MORPHOL, V241, P153, DOI 10.1002/(SICI)1097-4687(199908)241:2<153::AID-JMOR5>3.0.CO;2-E; Omura A, 2014, J VET MED SCI, V76, P159, DOI 10.1292/jvms.13-0211; O'Reilly JC, 2000, AM ZOOL, V40, P123, DOI 10.1668/0003-1569(2000)040[0123:TEOTFR]2.0.CO;2; Bennett WO, 2001, J EXP BIOL, V204, P1979; Bordzilovskaya N. P., 1979, TABLE STAGES NORMAL, VVII; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638; Fujimoto T., 1960, J OKAYAMA MED ASSOC, V611, P2205; IWASAWA H, 1980, Japanese Journal of Herpetology, V8, P73; Kudo T., 1938, NORMEN ENT WIRBEL, V16, P98; Liem Karel F., 2001, FUNCTIONAL ANATOMY V; IWASAWA H, 1991, Japanese Journal of Herpetology, V14, P39; Maurer F., 1892, MORPHOL JB, V18, P76; Omura A., 2015, ACTA ZOOL O IN PRESS; Oyama J., 1930, ZOOL MAG, V42, P465; Preuschoft Holger, 2007, Mertensiella, V16, P59; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; SHI DL, 1995, INT J DEV BIOL, V39, P427; Usui M., 1939, ZOOL MAG, V51, P195	23	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					931	936		10.1292/jvms.15-0011		6	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500006		
J	Maeda, H; Sogawa, K; Sakaguchi, K; Abei, S; Sagizaka, W; Mochizuki, S; Horie, W; Watanabe, T; Shibata, Y; Satoh, M; Sanda, A; Nomura, F; Suzuki, J				Maeda, Hiroto; Sogawa, Kazuyuki; Sakaguchi, Kazuko; Abei, Saori; Sagizaka, Wataru; Mochizuki, Shunsuke; Horie, Waka; Watanabe, Toshifumi; Shibata, Yui; Satoh, Mamoru; Sanda, Akihiro; Nomura, Fumio; Suzuki, Jun			Urinary albumin and transferrin as early diagnostic markers of chronic kidney disease	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						albumin; chronic kidney disease; feline; transferrin; urine	CATS; EXCRETION; PROTEIN; CARBOXYLESTERASE; CAUXIN; FELINE; SERUM	Feline renal diseases are increasingly noted in veterinary practice. It is important to diagnose and identify the pathological basis of renal dysfunction accurately at an early stage, but there are only a few reports on this area in clinical veterinary medicine. We investigated the efficacy of measurement of urinary albumin (u-Alb) and urinary transferrin (u-Tf) for early diagnosis using 5-mu l urine samples collected noninvasively by catheterization from normal (IRIS stage I) cats and cats with stage I chronic kidney disease (CKD). The u-Alb levels in normal and stage I CKD cats were 6.0 +/- 4.5 and 11.2 +/- 8.4 mg/dl, respectively, and the u-Tf levels were 0.09 +/- 0.42 and 0.52 +/- 0.79 mg/dl, respectively. Based on ROC curve analysis, the sensitivity and specificity of u-Alb and u-Tf were higher than those of the currently used biomarker, the plasma creatinine level. The sensitivity of u-Alb was higher than that of u-Tf, whereas the specificity of u-Tf was higher than that of u-Alb. The validity of the threshold albumin level (20 mg/dl) was confirmed by measurements using SDS-PAGE. Since leakage of u-Tf in urine precedes leakage of u-Alb, inclusion of u-Tf in biochemistry tests may be appropriate for IRIS staging as a diagnostic marker of early diagnosis of renal disorder in cats.	[Maeda, Hiroto; Abei, Saori; Horie, Waka] Maeda Vet Hosp, Tomakomai, Hokkaido 0530851, Japan; [Sogawa, Kazuyuki; Shibata, Yui; Sanda, Akihiro] Azabu Univ, Dept Biochem, Sch Life & Environm Sci, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Sakaguchi, Kazuko; Sagizaka, Wataru; Suzuki, Jun] Azabu Univ, Sch Life & Environm Sci, Dept Food Biochem, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Mochizuki, Shunsuke; Watanabe, Toshifumi] Azabu Univ, Vet Teaching Hosp, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Satoh, Mamoru; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chuo Ku, Chiba, Chiba 2608677, Japan	Sogawa, K (reprint author), Azabu Univ, Dept Biochem, Sch Life & Environm Sci, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	sogawa@azabu-u.ac.jp			Azabu University	This research was partially supported by a research project grant awarded by Azabu University.	Jepson RE, 2009, J VET INTERN MED, V23, P806, DOI 10.1111/j.1939-1676.2009.0339.x; Miyazaki M, 2007, RES VET SCI, V82, P76, DOI 10.1016/j.rvsc.2006.06.009; Syme HM, 2007, J SMALL ANIM PRACT, V48, P202, DOI 10.1111/j.1748-5827.2006.00264.x; Syme HM, 2006, J VET INTERN MED, V20, P528, DOI 10.1892/0891-6640(2006)20[528:SOCWNO]2.0.CO;2; Miyazaki M, 2003, BIOCHEM J, V370, P101, DOI 10.1042/BJ20021446; HOWARD RL, 1991, KIDNEY INT, V40, P923, DOI 10.1038/ki.1991.295; Miyazaki M, 2006, COMP BIOCHEM PHYS B, V145, P270, DOI 10.1016/j.cbpb.2006.05.015; King JN, 2007, J VET INTERN MED, V21, P906, DOI 10.1892/0891-6640(2007)21[906:PFICWC]2.0.CO;2; Ghys LFE, 2014, VET CLIN PATH, V43, P226, DOI 10.1111/vcp.12144; Hiratsuka N, 1998, J CLIN LAB ANAL, V12, P351, DOI 10.1002/(SICI)1098-2825(1998)12:6<351::AID-JCLA4>3.0.CO;2-7; Horio M, 1997, CLIN EXP NEPHROL, V11, P110, DOI 10.1007/BF02479909; Kanauchi M, 1995, Nihon Jinzo Gakkai Shi, V37, P649; KORDONOURI O, 1992, SCAND J CLIN LAB INV, V52, P781, DOI 10.3109/00365519209088381; Maeda H., 2010, SEIBUTSU BUTSURI KAG, V54, P1; ODONNELL MJ, 1991, ANN CLIN BIOCHEM, V28, P174; Semba T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-120; Sogawa K, 2011, ALCOHOL CLIN EXP RES, V35, P211, DOI 10.1111/j.1530-0277.2010.01336.x; Tomura S., 1999, JPN J PRIMARY CARE, V22, P37; Vaden SL, 2005, CLIN TECH SMALL AN P, V20, P11, DOI 10.1053/j.ctsap.2004.12.003	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					937	943		10.1292/jvms.14-0427		7	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500007		
J	Hibi, J; Kurosawa, A; Watanabe, T; Kadowaki, H; Watari, M; Makita, K				Hibi, Juni; Kurosawa, Aiko; Watanabe, Takuto; Kadowaki, Hazumu; Watari, Michiko; Makita, Kohei			Post-traumatic stress disorder in participants of foot-and-mouth disease epidemic control in Miyazaki, Japan, in 2010	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						culling; foot-and-mouth disease; IES-R; mental health; Miyazaki; PTSD	VETERINARIANS; IMPACT; RISK	Foot-and-mouth disease (FMD) occurred in Miyazaki, Japan, in 2010, and 290,000 animals were culled. This paper describes the mental distress of the volunteers who had been dispatched to Miyazaki for disease control two years after the epidemic. It also assesses risk factors for post-traumatic stress disorder (PTSD). A participatory appraisal and self-administered questionnaire survey were conducted in 2012 for those who were dispatched to Miyazaki in 2010. The Impact of Event Scale-Revised (IES-R) was used as an indicator of PTSD, and univariate and multivariable analyses were performed. Of the 875 respondents, 1.3% had higher IES-R scores than the cut-off point (25), which is suggestive of PTSD. Mental stresses during and soon after FMD control and after two years were described. Four risk factors associated with high IES-R scores were found: transporting culled animals (P<0.01), stress during FMD control (P<0.01) and at the time of the survey (P<0.01), and lack of someone to talk to about FMD-associated stress at the time of the survey (P<0.01). Veterinarians, livestock technicians and clerical officers involved in FMD control still suffer from mental stress two years later. Public services should provide an opportunity for them to consult with mental health specialists. These findings should be used to better prepare workers who deal with infectious diseases of animals, especially when they must be culled. The establishment of a collaborative framework between veterinary and mental health services is recommended.	[Hibi, Juni; Kurosawa, Aiko; Watanabe, Takuto; Kadowaki, Hazumu; Makita, Kohei] Rakuno Gakuen Univ, Sch Vet Med, Div Hlth & Environm Sci, Vet Epidemiol Unit, Ebetsu, Hokkaido 0698501, Japan; [Watari, Michiko] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878551, Japan	Makita, K (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Div Hlth & Environm Sci, Vet Epidemiol Unit, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	kmakita@rakuno.ac.jp			Integrated Research for Disabled Program, Japan Ministry of Health, Labour and Welfare [201122111A]	The authors also gratefully acknowledge the generous assistance from Miyazaki Prefecture Mental Health Welfare Center and the National Center of Neurology and Psychiatry for advice and data collection. This study was funded by the Integrated Research for Disabled Program, Japan Ministry of Health, Labour and Welfare (grant number 201122111A).	Muroga N, 2012, J VET MED SCI, V74, P399, DOI 10.1292/jvms.11-0271; Whiting TL, 2011, CAN VET J, V52, P794; Hayama Y, 2013, PREV VET MED, V112, P183, DOI 10.1016/j.prevetmed.2013.08.010; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Driijfhout A C, 2005, Tijdschr Diergeneeskd, V130, P82; Hall Molly J, 2004, J Psychiatr Pract, V10, P368, DOI 10.1097/00131746-200411000-00005; Hristovski M., 2010, Macedonian Journal of Medical Sciences, V3, P229, DOI 10.3889/MJMS.1857-5773.2010.0131; Japan Ministry of Health Labour and Welfare, 2014, LOC MENT HLTH MED SE; Makita K, 2014, ENVIRON POLLUT, V3, P1; Mariner J., 2000, MANUAL PARTICIPATORY; Miyazaki Prefecture, 2014, RES REPORT CONTROL M; Noordman JWJ, 2008, TIJDSCHR DIERGENEESK, V133, P1042; Nusbaum KE, 2007, JAVMA-J AM VET MED A, V231, P692, DOI 10.2460/javma.231.5.692; Taylor LH, 2001, PHILOS T ROY SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Watari M., 2014, RES UNDERSTANDING CU; World Health Organization, 1959, 2 WHOFAO; World Organization for Animal Health, 2011, FOOT MOUTH DIS	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					953	959		10.1292/jvms.14-0512		7	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500009		
J	Kondoh, K; Atiba, A; Nagase, K; Ogawa, S; Miwa, T; Katsumata, T; Ueno, H; Uzuka, Y				Kondoh, Kei; Atiba, Ayman; Nagase, Kiyoshi; Ogawa, Shizuko; Miwa, Takashi; Katsumata, Teruya; Ueno, Hiroshi; Uzuka, Yuji			Performance of a new carbon dioxide absorbent, Yabashi lime (R) as compared to conventional carbon dioxide absorbent during sevoflurane anesthesia in dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; compound A; sevoflurane; Yabashi lime (R)	DESICCATED SODA LIME; COMPOUND-A; MONOXIDE PRODUCTION; VOLATILE ANESTHETICS; DEGRADATION; SYSTEM; BARALYME(R); DESFLURANE; ISOFLURANE; AMSORB(R)	In the present study, we compare a new carbon dioxide (CO2) absorbent, Yabashi lime (R) with a conventional CO2 absorbent, Sodasorb (R) as a control CO2 absorbent for Compound A (CA) and Carbon monoxide (CO) productions. Four dogs were anesthetized with sevoflurane. Each dog was anesthetized with four preparations, Yabashi lime (R) with high or low-flow rate of oxygen and control CO2 absorbent with high or low-flow rate. CA and CO concentrations in the anesthetic circuit, canister temperature and carbooxyhemoglobin (COHb) concentration in the blood were measured. Yabashi lime (R) did not produce CA. Control CO2 absorbent generated CA, and its concentration was significantly higher in low-flow rate than a high-flow rate. CO was generated only in low-flow rate groups, but there was no significance between Yabashi lime (R) groups and control CO2 absorbent groups. However, the CO concentration in the circuit could not be detected (<= 5ppm), and no change was found in COHb level. Canister temperature was significantly higher in low-flow rate groups than high-flow rate groups. Furthermore, in low-flow rate groups, the lower layer of canister temperature in control CO2 absorbent group was significantly higher than Yabashi lime (R) group. CA and CO productions are thought to be related to the composition of CO2 absorbent, flow rate and canister temperature. Though CO concentration is equal, it might be safer to use Yabashi lime (R) with sevoflurane anesthesia in dogs than conventional CO2 absorbent at the point of CA production.	[Kondoh, Kei; Atiba, Ayman; Ogawa, Shizuko; Uzuka, Yuji] Gifu Univ, Fac Appl Biol Sci, Lab Vet Clin Radiol, Gifu 5011193, Japan; [Atiba, Ayman] Kafrelsheikh Univ, Fac Vet Med, Dept Surg Anesthesiol & Radiol, Kafrelsheikh 33516, Egypt; [Nagase, Kiyoshi] Gifu Univ, Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan; [Miwa, Takashi; Katsumata, Teruya] YABASHI IND CO LTD, Ogaki, Gifu 5032213, Japan; [Ueno, Hiroshi] Rakuno Gakuen Univ, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan	Uzuka, Y (reprint author), Iwate Univ, Cooperat Dept Vet Med, Lab Vet Diagnost Imaging, Ueda Cho, Morioka, Iwate 0208550, Japan.	ujiiwa@iwate-u.ac.jp					Higuchi H, 2000, ANESTH ANALG, V91, P434; Yamakage M, 2009, ANAESTHESIA, V64, P287, DOI 10.1111/j.1365-2044.2008.05759.x; GONSOWSKI CT, 1994, ANESTHESIOLOGY, V80, P566, DOI 10.1097/00000542-199403000-00013; Baxter PJ, 1998, ANESTHESIOLOGY, V89, P929, DOI 10.1097/00000542-199810000-00018; Bedford RF, 2000, ANESTH ANALG, V90, P505, DOI 10.1097/00000539-200003000-00001; Bito H, 1999, Masui, V48 Suppl, pS172; BITO H, 1995, BRIT J ANAESTH, V74, P667, DOI 10.1093/bja/74.6.667; Coppens MJ, 2006, ANAESTHESIA, V61, P462, DOI 10.1111/j.1365-2044.2006.04536.x; FANG ZX, 1995, ANESTH ANALG, V80, P1187, DOI 10.1097/00000539-199506000-00021; Fang ZX, 1996, ANESTH ANALG, V82, P775, DOI 10.1097/00000539-199604000-00018; Holak EJ, 2003, ANESTH ANALG, V96, P757, DOI 10.1213/01.ANE.0000049584.64886.39; KANDEL L, 1995, ANESTH ANALG, V81, P559, DOI 10.1097/00000539-199509000-00024; Kharasch ED, 2002, ANESTHESIOLOGY, V96, P173, DOI 10.1097/00000542-200201000-00031; Kobayashi S, 2003, J CLIN ANESTH, V15, P33, DOI 10.1016/S0952-8180(02)00478-6; Kobayashi Shunji, 2004, J Anesth, V18, P277, DOI 10.1007/s00540-004-0253-5; Laster MJ, 2005, ANESTH ANALG, V101, P753, DOI 10.1213/01.ane.0000166953.89536.ed; Laster MJ, 1997, ANESTH ANALG, V84, P169, DOI 10.1097/00000539-199701000-00030; Lehmann A, 2007, CAN J ANAESTH, V54, P917; Martin J. L., 2005, MILLERS ANESTHESIA, P231; Mono M., 1992, ANESTHESIOLOGY, V77, P1155; Nagashima K., 2005, JPN J MED INSTRUMEN, V75, P439; Neumann MA, 1999, ANESTH ANALG, V89, P768, DOI 10.1097/00000539-199909000-00046; Osawa M, 1998, CAN J ANAESTH, V45, P1215; Tempia A, 2003, ANESTH ANALG, V96, P1056, DOI 10.1213/01.ANE.0000050558.89090.95; Versichelen L, 2001, BRIT J ANAESTH, V86, P345, DOI 10.1093/bja/86.3.345; Versichelen LFM, 2001, ANESTHESIOLOGY, V95, P750, DOI 10.1097/00000542-200109000-00030; Yuge O., 1997, J ANESTH, V11, P1, DOI 10.1007/BF02479995	27	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					961	965		10.1292/jvms.14-0279		5	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500010		
J	Shyaka, A; Kusumoto, A; Chaisowwong, W; Okouchi, Y; Fukumoto, S; Yoshimura, A; Kawamoto, K				Shyaka, Anselme; Kusumoto, Akiko; Chaisowwong, Warangkhana; Okouchi, Yoshiki; Fukumoto, Shinya; Yoshimura, Aya; Kawamoto, Keiko			Virulence characterization of Campylobacter jejuni isolated from resident wild birds in Tokachi area, Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Campylobacter; Japan; virulence; wild bird	MOLECULAR EPIDEMIOLOGY; FOODBORNE PATHOGEN; PREVALENCE; INFECTION; COLONIZATION; POULTRY; SALMONELLA; RESISTANCE; MOTILITY; FAMILY	The prevalence of Campylobacter jejuni in wild birds is a potential hazard for human and animal health. The aim of this study was to establish the prevalence of C. jejuni in wild birds in Tokachi area, Hokkaido, Japan and investigate their virulence in vitro. In total, 173 cloacal swabs from individual wild birds were collected for the detection of Campylobacter spp. Thirty four samples (19.7%) were positive for Campylobacter of which 94.1% (32/34 samples) were C. jejuni. Additionally, one C. coli and one C. fetus were isolated. Seven C. jejuni isolates (one from crows and the other from pigeons) had important virulence genes including all three CDT genes (cdtA, cdtB and cdtC) and fiaA,flaB, ciaB and cadF, and the other isolates were lacking cdtA gene. Further studies on in vitro virulence-associated phenotypes, such as motility assay on soft agar and invasion assay in Caco-2 cells, were performed. The wild bird C. jejuni isolates adhered and invaded human cells. Although the numbers of viable intracellular bacteria of wild bird isolates were lower than a type strain NCTC11168, they persisted at 48-hr and underwent replication in host cells.	[Shyaka, Anselme; Kusumoto, Akiko; Chaisowwong, Warangkhana; Okouchi, Yoshiki; Kawamoto, Keiko] Obihiro Univ Agr & Vet Med, Diagnost Ctr Anim Hlth & Food Safety, Sect Food Microbiol & Immunol, Obihiro, Hokkaido 0808555, Japan; [Shyaka, Anselme] Univ Rwanda, Coll Agr & Vet Med, Musanze, Rwanda; [Chaisowwong, Warangkhana] Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai 50100, Thailand; [Fukumoto, Shinya; Yoshimura, Aya] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Res Unit Vector Biol, Obihiro, Hokkaido 0808555, Japan	Kawamoto, K (reprint author), Obihiro Univ Agr & Vet Med, Diagnost Ctr Anim Hlth & Food Safety, Sect Food Microbiol & Immunol, 2-11 Inada, Obihiro, Hokkaido 0808555, Japan.	kkeiko@obihiro.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for Promotion of Science; Ministry of Health, Labor and Welfare	This work was funded by a grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT), by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science and by a grant from the Ministry of Health, Labor and Welfare. We are grateful to the Obihiro section, Hokkaido branch of the Japan Hunting Association for sampling wild birds. We would like to thank Ms. Masumi Kagawa, Ms. Mio Yagihashi for their technical assistance. We are thankful to the National BioResource Project for providing Caco-2 cell.	Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Abulreesh Hussein H., 2007, Ringing & Migration, V23, P193; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Hughes LA, 2009, APPL ENVIRON MICROB, V75, P3007, DOI 10.1128/AEM.02458-08; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Allos BM, 2001, CLIN INFECT DIS, V32, P1201; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934; Karlyshev AV, 2002, MICROBIOL-SGM, V148, P473; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28; Fearnley C, 2008, J MED MICROBIOL, V57, P570, DOI 10.1099/jmm.0.47803-0; Chaisowwong W, 2012, J VET MED SCI, V74, P43, DOI 10.1292/jvms.11-0305; MISHU B, 1993, CLIN INFECT DIS, V17, P104; BLACK RE, 1988, J INFECT DIS, V157, P472; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; SHANE SM, 1992, AVIAN PATHOL, V21, P189, DOI 10.1080/03079459208418836; Baker MG, 2007, EPIDEMIOL INFECT, V135, P163, DOI 10.1017/S0950268806006583; Biswas D, 2000, FEMS IMMUNOL MED MIC, V29, P203, DOI 10.1016/S0928-8244(00)00206-6; Bolton FJ, 1999, EPIDEMIOL INFECT, V122, P7, DOI 10.1017/S0950268898001915; Chuma T, 2000, J VET MED SCI, V62, P1291, DOI 10.1292/jvms.62.1291; DEMELO MA, 1989, INFECT IMMUN, V57, P2214; Fukuyama M, 1986, Nihon Juigaku Zasshi, V48, P487; Ichiyama S, 1998, CLIN INFECT DIS, V27, P252, DOI 10.1086/514654; ITO K, 1988, J WILDLIFE DIS, V24, P467; Jones K, 2001, S SER SOC APPL MICRO, V90, p68S; KAPPERUD G, 1983, APPL ENVIRON MICROB, V45, P375; KINJO T, 1983, JPN J VET SCI, V45, P833; MARUYAMA S, 1990, JPN J VET SCI, V52, P1237; MATSUSAKI S, 1986, MICROBIOL IMMUNOL, V30, P1317; MOROOKA T, 1985, J GEN MICROBIOL, V131, P1973; Newell D. G., 2002, INT J INFECT DIS S3, V6, pS53; Newell D. G., 2002, INT J INFECT DIS S3, V6, pS20; Newell DG, 2002, INT J INFECT DIS, V6, pS16, DOI 10.1016/S1201-9712(02)90179-7; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Sprenger H, 2012, Eur J Microbiol Immunol (Bp), V2, P66, DOI 10.1556/EuJMI.2.2012.1.10; Weis AM, 2014, APPL ENVIRON MICROB, V80, P1639, DOI 10.1128/AEM.03393-13; Wieczorek K, 2010, B VET I PULAWY, V54, P563	43	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					967	972		10.1292/jvms.15-0090		6	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500011		
J	Togashi, K; Sasaki, S; Sato, W				Togashi, Katsuhiro; Sasaki, Shiho; Sato, Wataru			A globotetraosylceramide (Gb(4)) receptor-based ELISA for quantitative detection of Shiga toxin 2e	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						ELISA; globotetraosylceramide; porcine edema disease; Shiga toxin 2e	LINKED IMMUNOSORBENT-ASSAY; ESCHERICHIA-COLI STRAIN; EDEMA DISEASE; B-SUBUNIT; VARIANT; VEROTOXIN; GENES; IDENTIFICATION; CLONING; ORIGIN	Currently, no simple assays are available for routine quantitative detection of Escherichia coli-produced Shiga toxin 2e (Stx2e) that causes porcine edema disease. Here, we present a novel quantitative detection method for Stx2e based on the measurement of Stx2e binding to the specific globotetraosylceramide (Gb(4)) receptor by ELISA (Gb(4)-ELISA). No cross-reactivity was found with the other Shiga toxins Stxl and Stx2, indicating high specificity. When the recombinant Stx2eB subunit (Stx2eB) was used, the absorbance measured by Gb(4)-ELISA increased linearly with Stx2eB concentration in the range of 20-2,500 ng/ml. The Gb(4)-ELISA method can be easily performed, suggesting that it would be a useful diagnostic tool for porcine edema disease.	[Togashi, Katsuhiro] Yamagata Integrated Agr Res Ctr Swine Expt Stn, Sakata, Yamagata 9980112, Japan; [Sasaki, Shiho] Yamagata Shonai Livestock Hyg Serv Ctr, Yamagata 9971301, Japan; [Sato, Wataru] Yamagata Mogami Livestock Hyg Serv Ctr, Yamagata 9960002, Japan	Togashi, K (reprint author), Yamagata Integrated Agr Res Ctr Swine Expt Stn, 1 Hamanaka, Sakata, Yamagata 9980112, Japan.	togashikat@pref.yamagata.jp					Yamasaki S, 1996, MICROBIOL IMMUNOL, V40, P345; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Burk C, 2003, J CLIN MICROBIOL, V41, P2106, DOI 10.1128/JCM.41.5.2106-2112.2003; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; ASHKENAZI S, 1989, J CLIN MICROBIOL, V27, P1145; THOMAS A, 1994, EUR J CLIN MICROBIOL, V13, P1074, DOI 10.1007/BF02111832; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223; Franck SM, 1998, J CLIN MICROBIOL, V36, P1795; Fratamico PM, 2004, APPL ENVIRON MICROB, V70, P7173, DOI 10.1128/AEM.70.12.7173-7178.2004; Mainil J, 1999, VET RES, V30, P235; Pierard D, 1998, J CLIN MICROBIOL, V36, P3317; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Leung PHM, 2003, APPL ENVIRON MICROB, V69, P7549, DOI 10.1128/AEM.69.12.7549-7553.2003; CAO CY, 1994, MICROBIOL IMMUNOL, V38, P435; GYLES CL, 1988, MICROB PATHOGENESIS, V5, P419, DOI 10.1016/0882-4010(88)90003-4; Muniesa M, 2000, INFECT IMMUN, V68, P4850, DOI 10.1128/IAI.68.9.4850-4855.2000; PIERARD D, 1991, LANCET, V338, P762, DOI 10.1016/0140-6736(91)91487-F; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966; Zhang W, 2005, APPL ENVIRON MICROB, V71, P558, DOI 10.1128/AEM.71.1.558-561.2005	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					973	976		10.1292/jvms.14-0071		4	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500012		
J	Suzuki, K; Shimamori, T; Sato, A; Tsukano, K; Tsuchiya, M; Lakritz, J				Suzuki, Kazuyuki; Shimamori, Toshio; Sato, Ayano; Tsukano, Kenji; Tsuchiya, Masakazu; Lakritz, Jeffrey			Detecting endotoxin activity in bovine serum using an automated testing system	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cattle; endotoxin; limulus amebocyte lysate; portable test system; serum	GRAM-NEGATIVE BACTERIA; MILK	The aim of the present study was to compare the ability of the commercially available portable test system (PTS (TM)) to detect endotoxin activity in bovine serum, with that of the traditional LAL-kinetic turbidimetric (KT) and chromogenic (KC) assays. Prior to testing, serum samples, which were obtained from endotoxin-challenged cattle, were diluted 1:20 in endotoxin-free water and heated to 80 degrees C for 10 min. The performance of the PTS (TM) was not significantly different from that of the traditional LAL-based assays. The results using PTS (TM) correlated with those using KT (r(2)=0.963, P<0.001) or KC assays (r(2)=0.982, P<0.001). Based on these findings, the PTS (TM) could be applied as a simplified system to assess endotoxin activity in bovine serum.	[Suzuki, Kazuyuki; Shimamori, Toshio; Sato, Ayano; Tsukano, Kenji] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan; [Suzuki, Kazuyuki; Lakritz, Jeffrey] Ohio State Univ, Coll Vet Med Sci, Columbus, OH 43210 USA; [Tsuchiya, Masakazu] Charles River, Endotoxin & Microbial Detect, Charleston, SC 29407 USA	Suzuki, K (reprint author), Rakuno Gakuen Univ, Sch Vet Med, 582 Midorimati, Ebetsu, Hokkaido 0698501, Japan.	kazuyuki@rakuno.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21580393, 26450431]; Rakuno Gakuen University foundation	This study was supported by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 21580393 and 26450431), and by a Grant-in-Aid from Rakuno Gakuen University foundation awarded to K. Suzuki.	Cooper JF, 2010, AM J HEALTH-SYST PH, V67, P280, DOI 10.2146/ajhp090290; COOPER JF, 1971, J LAB CLIN MED, V78, P138; Elin R J, 1985, Prog Clin Biol Res, V189, P307; Fukumori Neuza T O, 2011, J Nucl Med Technol, V39, P121, DOI 10.2967/jnmt.110.081380; Gee AP, 2008, CYTOTHERAPY, V10, P427, DOI 10.1080/14653240802075476; Jimenez Luis, 2010, PDA J Pharm Sci Technol, V64, P211; LEVIN J, 1964, B JOHNS HOPKINS HOSP, V115, P265; SVENSSON A, 1987, J DAIRY RES, V54, P267; Trump D., 2006, J NUCL MED, V47; WAAGE S, 1994, ACTA VET SCAND, V35, P207	10	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					977	979		10.1292/jvms.14-0545		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500013		
J	Matsuda, K; Niki, H; Yukawa, A; Yanagi, M; Souma, K; Masuko, T; Taniyama, H				Matsuda, Kazuya; Niki, Hinako; Yukawa, Airo; Yanagi, Mitsuhiro; Souma, Kousaku; Masuko, Takayoshi; Taniyama, Hiroyuki			First detection of adiaspiromycosis in the lungs of a deer	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						adiaspiromycosis; Emmonsia crescens; Hokkaido sika deer	EMMONSIA-CRESCENS; DOG	Adiaspiromycosis is a pulmonary infection caused by the soil fungi, Emmonsia crescens and E. parva. It primarily affects small mammals and can range from an asymptomatic condition to fatal disseminated disease. We detected a granuloma containing fungal spherules, which were morphologically consistent with the adiaspores of E. crescens in the lungs of a female Hokkaido sika deer. This is the first reported case of adiaspiromycosis involving a cervid in the world.	[Matsuda, Kazuya; Niki, Hinako; Yukawa, Airo; Yanagi, Mitsuhiro; Taniyama, Hiroyuki] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Pathol, Ebetsu, Hokkaido 0698501, Japan; [Souma, Kousaku; Masuko, Takayoshi] Tokyo Univ Agr, Fac Bioind, Dept Bioprod, Abashiri, Hokkaido 0992493, Japan	Matsuda, K (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Pathol, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	kmatsuda@rakuno.ac.jp					ALDOORY Y, 1971, J AM VET MED ASSOC, V159, P87; KOIKE H, 1985, J ARCHAEOL SCI, V12, P443, DOI 10.1016/0305-4403(85)90004-4; ENGLAND DM, 1993, AM J SURG PATHOL, V17, P876, DOI 10.1097/00000478-199309000-00003; Peterson SW, 1998, J CLIN MICROBIOL, V36, P2918; Borman AM, 2009, MYCOPATHOLOGIA, V168, P153, DOI 10.1007/s11046-009-9216-6; Chandler F. W., 1980, COLOR ATLAS TEXT HIS; DVORAK J, 1969, Folia Parasitologica (Ceske Budejovice), V16, P349; JELLISON WL, 1958, MYCOLOGIA, V50, P580, DOI 10.2307/3756120; Jones T. C., 1997, VET PATHOL, V6th, P505; KOLLER LD, 1978, J AM VET MED ASSOC, V173, P80; KOLLER LD, 1976, J AM VET MED ASSOC, V169, P1316; OHBAYASHI M, 1971, Japanese Journal of Veterinary Research, V19, P103; Pusterla N, 2002, EQUINE VET J, V34, P749, DOI 10.2746/042516402776250342; Sigler L, 2005, MED MYCOLOGY TOPLEY, P809; TANIYAMA H, 1985, JPN J VET SCI, V47, P139	15	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					981	983		10.1292/jvms.15-0083		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500014		
J	Otomaru, K; Saito, S; Endo, K; Kohiruimaki, M; Ohtsuka, H				Otomaru, Konosuke; Saito, Shun; Endo, Karura; Kohiruimaki, Masayuki; Ohtsuka, Hiromichi			Effect of supplemental vitamin E on the peripheral blood leukocyte population in Japanese Black calves	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						calf; Japanese Black; leukocyte population; vitamin E	SERUM ALPHA-TOCOPHEROL; HUMAN-LYMPHOCYTES; IMMUNE-RESPONSE; SUBPOPULATIONS; PERFORMANCE; CELLS; MICE	We investigated the effect of supplemental vitamin E on the peripheral blood leukocyte population in Japanese Black calves. Twenty-six calves kept at the same farm were studied. They were divided into two groups; thirteen calves received 300 IU/day of vitamin E orally from 1 to 3 months of age (VE group), and the other thirteen calves did not receive the vitamin E supplement (control group). The YE group showed a higher serum vitamin E concentration at 2 and 3 months of age compared with the control group (P<0.01). The numbers of CD3(+) cells and CD4(+) cells were higher in the VE group than in the control group, and the difference was statistically significant at 3 months of age (P<0.05). The numbers of CD21(+) cells were higher in the YE group than in the control group, and the difference was statistically significant at 2 months of age (P<0.05). The numbers of CD335(+) cells tended to be higher in the YE group than in the control group. The numbers of CD8(+) cells and CD14(+) cells tended to be higher in the YE group than in the control group at 3 and 4 months of age. This study demonstrated that the supplementation of suckling Japanese Black calves with vitamin E might affect the numbers of some immune cell types in the peripheral blood.	[Otomaru, Konosuke] Kagoshima Prefectural Federat Agr Mutual Aid Asso, Kagoshima 8910132, Japan; [Saito, Shun; Ohtsuka, Hiromichi] Kitasato Univ, Vet Med, Aomori 0348628, Japan; [Endo, Karura; Kohiruimaki, Masayuki] Kohiruimaki Anim Med Serv, Aomori 0392683, Japan	Otomaru, K (reprint author), Kagoshima Univ, Joint Fac Vet Med, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	otomaru@vet.kagoshima-u.ac.jp					Adolfsson O, 2001, J IMMUNOL, V167, P3809; Agriculture Factory and Fisheries Research Council Secretariat MAFF, 2008, JAP FEED STAND BEEF; Otomaru K, 2013, J VET MED SCI, V75, P1671, DOI 10.1292/jvms.13-0215; Kampen AH, 2006, VET IMMUNOL IMMUNOP, V113, P53, DOI 10.1016/j.vetimm.2006.04.001; Galyean ML, 1999, J ANIM SCI, V77, P1120; Beharka AA, 1997, MECH AGEING DEV, V93, P59, DOI 10.1016/S0047-6374(96)01819-2; TOPINKA J, 1989, MUTAT RES, V225, P131, DOI 10.1016/0165-7992(89)90130-9; Ohtsuka H, 2011, ANIM SCI J, V82, P93, DOI 10.1111/j.1740-0929.2010.00833.x; Ganheim C, 2005, J VET MED B, V52, P380, DOI 10.1111/j.1439-0450.2005.00882.x; Carroll MC, 1998, SEMIN IMMUNOL, V10, P279, DOI 10.1006/smim.1998.0120; DELEENHEER AP, 1978, CLIN CHEM, V24, P585; Jubri Z, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-2; Lee CYJ, 2000, J NUTR, V130, P2932; Lee CYJ, 2002, BIOL TRACE ELEM RES, V86, P123, DOI 10.1385/BTER:86:2:123; Meydani S. N., MECH AGEING DEV, V34, P191; Meydani SN, 1998, NUTR REV, V56, pS49; Ohtsuka H, 2006, J VET MED SCI, V68, P1161, DOI 10.1292/jvms.68.1161; Otomaru K., 2014, JPN J LARGE ANIM CLI, V5, P185; Rajeesh M, 2008, J ANIM FEED SCI, V17, P19; REDDY PG, 1987, J DAIRY SCI, V70, P993, DOI 10.3168/jds.S0022-0302(87)80104-2; REDDY PG, 1987, J DAIRY SCI, V70, P123; Sule N S, 2001, J Assoc Physicians India, V49, P897	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					985	988		10.1292/jvms.15-0060		4	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500015		
J	Tajima, Y; Sasaki, K; Kashiwagi, N; Yamada, TK				Tajima, Yuko; Sasaki, Kyoko; Kashiwagi, Nobuyuki; Yamada, Tadasu K.			A case of stranded Indo-Pacific bottlenose dolphin (Tursiops aduncus) with lobomycosis-like skin lesions in Kinko-wan, Kagoshima, Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						dolphin; fungal disease; lobomycosis	LOBOS-DISEASE; TRUNCATUS; POPULATION	Lobomycosis is a chronic fungal disease caused by the etiologic agent, Lacazia loboi, in the skin and subcutaneous tissues in humans and dolphins in tropical and transitional tropical climates. An Indo-Pacific bottlenose dolphin (Tursiops aduncus) stranded in Kagoshima, Japan, had severe skin lesions characterized by granulomatous reactions and hyperkeratosis that were similar to those of the lobomycosis, but no fungal organism was observed in the skin lesion. In this paper, we report a stranded Indo-Pacific bottlenose dolphin with lobomycosis-like lesions based on pathological examinations in Japan.	[Tajima, Yuko; Yamada, Tadasu K.] Natl Museum Nat & Sci, Dept Zool, Div Vertebrate, Tsukuba, Ibaraki 3050005, Japan; [Sasaki, Kyoko; Kashiwagi, Nobuyuki] Kagoshima City Aquarium, Kagoshima, Kagoshima 8920814, Japan	Tajima, Y (reprint author), Natl Museum Nat & Sci, Dept Zool, Div Vertebrate, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	yuko-t@kahaku.go.jp			JSPS (KAKENHI) [25340105]	The authors would like to express our gratitude for the great help of the Kagoshima City Office and Kagoshima City Aquarium in collection of the dolphin. This study was supported by JSPS Grant-in-Aid for Scientific Research (KAKENHI), Grant Number 25340105.	Reif JS, 2009, MED MYCOL, V47, P125, DOI 10.1080/13693780802178493; Taborda PR, 1999, J CLIN MICROBIOL, V37, P2031; Van Bressem MF, 2013, MAR MAMMAL SCI, V29, P525, DOI 10.1111/j.1748-7692.2012.00589.x; Murdoch ME, 2008, ECOHEALTH, V5, P289, DOI 10.1007/s10393-008-0187-8; Bermudez L, 2009, EMERG INFECT DIS, V15, P1301, DOI 10.3201/eid1508.090347; MIGAKI G, 1971, J AM VET MED ASSOC, V159, P578; Rotstein DS, 2009, EMERG INFECT DIS, V15, P588, DOI 10.3201/eid1504.081358; Paniz-Mondolfi A, 2012, MYCOSES, V55, P298, DOI 10.1111/j.1439-0507.2012.02184.x; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; Shirakihara M, 2002, MAR MAMMAL SCI, V18, P30, DOI 10.1111/j.1748-7692.2002.tb01016.x; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; CALDWELL DK, 1975, AM J TROP MED HYG, V24, P105; Kiszka J, 2009, DIS AQUAT ORGAN, V84, P151, DOI 10.3354/dao02037; BHAWAN J, 1976, J CUTAN PATHOL, V3, P5, DOI 10.1111/j.1600-0560.1976.tb00841.x; COWAN DF, 1993, J WILDLIFE DIS, V29, P488; Kakuda Tsuneo, 2002, Memoirs of the National Science Museum (Tokyo), V38, P255; Lobo J, 1931, REV MED PERNAMBUCO, V1, P763; Lobo J. O, 1930, BRAS MED, V44, P1227; Mori K, 2013, KAIYO MONTHLY, V45, P253; Opromolla DVA, 2003, INT J DERMATOL, V42, P938, DOI 10.1111/j.1365-4632.2003.01982.x; PECHER SA, 1988, ALLERGOL IMMUNOPATH, V16, P413; Ueda K., 2013, CASE REPORTS VET MED, V2013, P1; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7	23	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					989	992		10.1292/jvms.14-0366		4	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500016		
J	Ogawa, H; Ohnuma, M; Squarre, D; Mweene, AS; Ezaki, T; Fujikura, D; Ohnishi, N; Thomas, Y; Hang'Ombe, BM; Higashi, H				Ogawa, Hirohito; Ohnuma, Miyuki; Squarre, David; Mweene, Aaron Simanyengwe; Ezaki, Takayuki; Fujikura, Daisuke; Ohnishi, Naomi; Thomas, Yuka; Hang'Ombe, Bernard Mudenda; Higashi, Hideaki			Bacillus cereus from the environment is genetically related to the highly pathogenic B. cereus in Zambia	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Bacillus anthracis; Bacillus cereus group; Bacillus thuringiensis; epidemiology	ANTHRACIS; STRAINS; THURINGIENSIS; SEQUENCES	To follow-up anthrax in Zambia since the outbreak in 2011, we have collected samples from the environment and the carcasses of anthrax-suspected animals, and have tried to isolate Bacillus anthracis. In the process of identification of B. anthracis, we collected two isolates, of which colonies were similar to B. anthracis; however, from the results of identification using the molecular-based methods, two isolates were genetically related to the highly pathogenic B. cereus, of which clinical manifestation is severe and fatal (e.g., pneumonia). In this study, we showed the existence of bacteria suspected to be highly pathogenic B. cereus in Zambia, indicating the possibility of an outbreak caused by highly pathogenic B. cereus.	[Ogawa, Hirohito; Thomas, Yuka; Higashi, Hideaki] Univ Zambia, Hokudai Ctr Zoonosis Control Zambia, Sch Vet Med, Lusaka 10101, Zambia; [Ogawa, Hirohito; Mweene, Aaron Simanyengwe; Thomas, Yuka; Higashi, Hideaki] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka 10101, Zambia; [Ohnuma, Miyuki; Fujikura, Daisuke; Ohnishi, Naomi; Higashi, Hideaki] Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Squarre, David] Zambia Wildlife Author ZAWA, Chilanga 10101, Zambia; [Ezaki, Takayuki] Gifu Univ, Grad Sch Med, Dept Microbiol Regenerat & Adv Med Sci, Gifu 5011194, Japan; [Hang'Ombe, Bernard Mudenda] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka 10101, Zambia	Higashi, H (reprint author), Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido 0010020, Japan.	hidea-hi@czc.hokudai.ac.jp	OHNISHI, Naomi/F-6914-2012; Ogawa, Hirohito/F-6918-2012	OHNISHI, Naomi/0000-0002-2382-3152; 	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We thank Evans Mulenga, Ladslav Moonga, Drs. Emiko Nakagawa, Yasuko Orba and Hirofumi Sawa for their tremendous support. We also thank the Zambia Wildlife Authority (ZAWA) and the Conservation Lower Zambezi (CLZ) for providing permission and the enabling environment for sampling in the national park and game management area. This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Agren J, 2013, VIRULENCE, V4, P671, DOI 10.4161/viru.26288; Slamti L, 2004, J BACTERIOL, V186, P3531, DOI 10.1128/JB.186.11.3531-3538.2004; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Zhang JW, 2011, DIAGN MICR INFEC DIS, V70, P307, DOI 10.1016/j.diagmicrobio.2011.02.012; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Ohnishi N., 2014, GENOME ANNOUNC, V2	10	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					993	995		10.1292/jvms.15-0059		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500017		
J	Aita, J; Ichikawa-Seki, M; Kinami, A; Yaita, S; Kumagai, Y; Nishikawa, Y; Itagaki, T				Aita, Junya; Ichikawa-Seki, Madoka; Kinami, Aiko; Yaita, Seiko; Kumagai, Yoshihiro; Nishikawa, Yoshifumi; Itagaki, Tadashi			Molecular characterization of Cryptosporidium parvum detected in Japanese black and Holstein calves in Iwate Prefecture and Tanegashima Island, Kagoshima Prefecture, Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						calf; Czyptosporidium parvum; GP60; Japan; subtyping	ANIMALS; HUMANS; GLYCOPROTEIN; SUBGENOTYPE; ANDERSONI; GENOTYPES; HOKKAIDO	Czyptosporidium oocysts were found in 43 out of 77 calves from two farms in Iwate Prefecture and nine farms on Tanegashima Island, Kagoshima Prefecture, Japan. The DNA fragments of 18S ribosomal RNA (18S rRNA) gene were amplified by a nested PCR from 43 oocyst-positive as well as one oocyst-negative samples. All of them were precisely identified as C. parvum by analyzing the nucleotide sequences of the 18S rRNA gene. C. parvum oocyst-positive calves ranged in age from 6 to 13 days old and significantly have watery diarrhea (P<0.05). Sequences of the gene encoding the 60-kDa glycoprotein (GP60) in 43 Cryptosporidium oocyst-positive samples were identical to that of the zoonotic IIaA15G2R1 subtype. We therefore suggest that calves could be potential sources of C. parvum infections in humans.	[Aita, Junya; Ichikawa-Seki, Madoka; Itagaki, Tadashi] Iwate Univ, Fac Agr, Lab Vet Parasitol, Morioka, Iwate 0208550, Japan; [Yaita, Seiko] Kumage Agr Mutual Aid Assoc, Kagoshima 8913604, Japan; [Kumagai, Yoshihiro] Iwate Prefecture Southern Reg Livestock Hyg Serv, Mizusawa Ku, Oushu, Iwate 0200003, Japan; [Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	Ichikawa-Seki, M (reprint author), Iwate Univ, Fac Agr, Lab Vet Parasitol, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	madoka@iwate-u.ac.jp			National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine	This study was supported in part by a Joint Research Grant from the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (*25-joint-10).	Wu ZL, 2003, APPL ENVIRON MICROB, V69, P4720, DOI 10.1128/AEM.69.8.4720-4726.2003; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Murakoshi F, 2013, J VET MED SCI, V75, P837, DOI 10.1292/jvms.12-0435; Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Broglia A, 2008, VET PARASITOL, V154, P8, DOI 10.1016/j.vetpar.2008.02.029; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Ichikawa-Seki M, 2015, PARASITOL INT, V64, P161, DOI 10.1016/j.parint.2014.11.007; MCNABB SJN, 1985, J CLIN MICROBIOL, V22, P587; Nagano S, 2007, VET PARASITOL, V149, P213, DOI 10.1016/j.vetpar.2007.07.016; Satoh M, 2003, APPL ENVIRON MICROB, V69, P691, DOI 10.1128/AEM.69.1.691-692.2003; Slapeta J, 2013, INT J PARASITOL, V43, P957, DOI 10.1016/j.ijpara.2013.07.005	14	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					997	999		10.1292/jvms.15-0082		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500018		
J	Li, YC; Zhang, Y; Siriguleng; Sato, H				Li, Ying-Chun; Zhang, Yu; Siriguleng; Sato, Hiroshi			Henneguya doneci (Myxosporea: Bivalvulida) in the gill filaments of Prussian carp Carassius gibelio (Bloch) from the upper Yellow River running through Inner Mongolia, China	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Carassius gibelio; China; Henneguya doneci; Myxozoa; Yellow River	MYXOZOA MYXOSPOREA; MYXOBOLUS-BUTSCHLI; SYNOPSIS; PHYLOGENY; N.; SEQUENCES; CHEN; RDNA	We examined 11 Prussian carp, Carassius gibelio (Bloch), from the upper Yellow River running through Inner Mongolia (Wuhai City) to record myxosporean species. Between 6 and 15 elongated cysts of Henneguya doneci were located at the basal part of the gill filaments of 3 carp (27.3%); no more myxosporean plasmodia were found in other organs. Although the morphology and morphometric values of the spores (average measurements of 14 spores in mu m: 11.4 long by 9.2 wide with 7.5 in thickness; 2 polar capsules, equal, 5.5 long by 3.2 wide; and a bifurcated caudal process, 51.6 long) with an evident intercapsular appendix were basically coincident with the species, the dimensions of the spore bodies were marginally larger, and the length of the caudal processes was distinctly longer than previously reported values for H. doneci (44.2-59.2 mu m vs. 26.8-42.6 mu m, respectively). Genetic analysis of the 18S ribosomal RNA gene (rDNA) found few nucleotide substitutions when compared with 3 deposited sequences of H. doneci collected around the Yangtze River (Sichuan and Hubei Provinces), China, indicating that the uniqueness of some of the morphological features exhibited by the present Wuhai isolate should be ascribed to intraspecific variation.	[Li, Ying-Chun; Sato, Hiroshi] Yamaguchi Univ, Dept Vet Clin Sci, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan; [Zhang, Yu; Siriguleng] Inner Mongolia Agr Univ, Fac Anim Sci & Med, Aquaculture Div, Hohhot, Inner Mongolia, Peoples R China; [Sato, Hiroshi] Yamaguchi Univ, Joint Fac Vet Med, Parasitol Lab, Yamaguchi 7538515, Japan	Sato, H (reprint author), Yamaguchi Univ, Joint Fac Vet Med, Parasitol Lab, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	sato7dp4@yamaguchi-u.ac.jp					Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Lom J, 2006, FOLIA PARASIT, V53, P1; Liu Y, 2014, PARASITOL INT, V63, P489, DOI 10.1016/j.parint.2014.01.003; Liu Y, 2014, J FISH DIS, V37, P535, DOI 10.1111/jfd.12141; Holzer AS, 2004, INT J PARASITOL, V34, P1099, DOI 10.1016/j.ijpara.2004.06.002; Eiras JC, 2014, SYST PARASITOL, V88, P11, DOI 10.1007/s11230-014-9484-5; Eiras JC, 2005, SYST PARASITOL, V61, P1, DOI 10.1007/s11230-004-6343-9; Xi BW, 2011, DIS AQUAT ORGAN, V93, P257, DOI 10.3354/dao02297; Zhang JY, 2013, SYST PARASITOL, V86, P235, DOI 10.1007/s11230-013-9449-0; Eiras JC, 2002, SYST PARASITOL, V52, P43, DOI 10.1023/A:1015016312195; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; LOM J, 1989, J FISH DIS, V12, P151, DOI 10.1111/j.1365-2761.1989.tb00287.x; Eszterbauer E, 2004, DIS AQUAT ORGAN, V58, P35, DOI 10.3354/dao058035; Ye LT, 2012, PARASITOL RES, V110, P1509, DOI 10.1007/s00436-011-2655-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Liu Y, 2010, PARASITOL RES, V107, P699, DOI 10.1007/s00436-010-1924-9; Zhang JY, 2010, J FISH DIS, V33, P625, DOI 10.1111/j.1365-2761.2010.01161.x; Liu Y, 2012, PARASITOL RES, V110, P1331, DOI 10.1007/s00436-011-2629-4; Andree KB, 1999, J PARASITOL, V85, P68, DOI 10.2307/3285702; Chen C. L., 1998, FAUNA SINICA MYXOZOA; Fiala I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-228; Li YC, 2012, PARASITOL RES, V111, P819, DOI 10.1007/s00436-012-2904-z; Ma C. L., 1999, J CHONGQING NORM U N, V16, P12; Shulman S. S., 1966, MYXOSPORIDIA USSR; Ye LT, 2014, J FISH DIS, V37, P11, DOI 10.1111/jfd.12026; Yuan S, 2015, PARASITOL RES, V114, P37, DOI 10.1007/s00436-014-4157-5; Zhang JY, 2006, PARASITOL RES, V99, P65, DOI 10.1007/s00436-005-0123-6; Zhang JY, 2010, J FISH DIS, V33, P57, DOI 10.1111/j.1365-2761.2009.01102.x	28	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1001	1005		10.1292/jvms.14-0666		5	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500019		
J	Unno, H; Inada, M; Nakamura, A; Hashimoto, M; Ito, K; Hashimoto, K; Nikaido, M; Hayashi, T; Hata, E; Katsuda, K; Kiku, Y; Tagawa, Y; Kawai, K				Unno, Hirotaka; Inada, Mika; Nakamura, Akiyoshi; Hashimoto, Michie; Ito, Keiko; Hashimoto, Koji; Nikaido, Masaru; Hayashi, Tomohito; Hata, Eiji; Katsuda, Ken; Kiku, Yoshio; Tagawa, Yuichi; Kawai, Kazuhiro			Improved rapid and efficient method for Staphylococcus aureus DNA extraction from milk for identification of mastitis pathogens	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cow milk; DNA chip; DNA extraction; loop-mediated isothermal amplification (LAMP); mastitis; pathogen	SOMATIC-CELL COUNT; BOVINE MASTITIS; DAIRY; MANAGEMENT; COST	A rapid and efficient DNA extraction method was developed for detecting mastitis pathogens in milk. The first critical step involved cell wall disruption by bead-beating, as physical disruption using beads was more effective for DNA extraction from Gram-positive bacteria, such as Staphylococcus aureus, than enzymatic disruption using proteinase K. The second critical step involves the use of acetic acid and ammonium sulfate in the purification process, as these reagents effectively and efficiently remove the lipids and proteins in milk. Using these methods, DNA suitable for loop-mediated isothermal amplification was obtained within 30 mm. Also, the rapid and sensitive detection of S. aureus in milk was possible at levels as low as 200 cfu/ml.	[Unno, Hirotaka; Inada, Mika; Nakamura, Akiyoshi; Hashimoto, Michie; Ito, Keiko; Hashimoto, Koji; Nikaido, Masaru] Toshiba Co Ltd, Saiwai Ku, Kawasaki, Kanagawa 2128582, Japan; [Hayashi, Tomohito; Hata, Eiji; Kiku, Yoshio] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Sapporo, Hokkaido 0620045, Japan; [Katsuda, Ken; Tagawa, Yuichi] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Kawai, Kazuhiro] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Kawai, K (reprint author), Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	kawai@azabu-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan.	SCHUTZ MM, 1994, J DAIRY SCI, V77, P2113; Cha E, 2011, J DAIRY SCI, V94, P4476, DOI 10.3168/jds.2010-4123; Losinger WC, 2005, JAVMA-J AM VET MED A, V226, P1652, DOI 10.2460/javma.2005.226.1652; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; BARTLETT PC, 1990, J DAIRY SCI, V73, P2794; Cremonesi P, 2006, J DAIRY SCI, V89, P163; BECK HS, 1992, J DAIRY RES, V59, P449; Bramley A. J., 1996, CURRENT CONCEPTS BOV, V4th, P11; Goto K, 2007, J MICROBIOL METH, V69, P93, DOI 10.1016/j.mimet.2006.12.009; Hogan JS, 1999, LAB HDB BOVINE MASTI; KERRO D. O., 2002, VET Q, V24, P181; Kurosaki Y., 2010, JPN J FORENSIC SCI T, V15, P135; Morin D E, 1993, J Am Vet Med Assoc, V202, P540; Okada J., 2012, J BIOSENS BIOELECTRO, V3, P126; Volling O, 2008, DEUT TIERARZTL WOCH, V115, P410, DOI 10.2376/0341-6593-115-410	15	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1007	1009		10.1292/jvms.14-0159		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500020		
J	Mekata, H; Murata, S; Mingala, CN; Ohashi, K; Konnai, S				Mekata, Hirohisa; Murata, Shiro; Mingala, Claro Niegos; Ohashi, Kazuhiko; Konnai, Satoru			Expression of regulatory dendritic cell-related cytokines in cattle experimentally infected with Trypanosoma evansi	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cattle; CCL8; IL-10; regulatory DC; Trypanosoma evansi	NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; BRUCEI INFECTIONS; CONGOLENSE; GAMMA; MICE; DIFFERENTIATION; DEFICIENT; RESPONSES; CLONING	Trypanosoma evansi causes wasting disease in many livestock. T. evansi infection gives rise to inflammatory immune responses, which contribute to the development of inflammation-associated tissue injury. We previously reported that regulatory dendritic cells (DCs), which act as potential regulators of inflammation, were activated in infected mice and transfer of regulatory DCs to infected mice prolonged their survival. However, the kinetics of regulatory DCs in cattle, which are natural hosts of T. evansi, remained unclear. In this study, we report that the expressions of CCL8 and IL-10, which promote the development of regulatory DCs, were up-regulated in cattle experimentally infected with T. evansi. This finding is potentially useful for studying the control strategy of T. evansi infection in cattle.	[Mekata, Hirohisa; Murata, Shiro; Ohashi, Kazuhiko; Konnai, Satoru] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Infect Dis Lab, Sapporo, Hokkaido 0600818, Japan; [Mekata, Hirohisa] Miyazaki Univ, Fac Agr, Dept Vet Med, Project Zoonoses Educ & Res, Miyazaki 8892192, Japan; [Mingala, Claro Niegos] Philippine Carabao Ctr Natl Headquarters & Gene P, Anim Hlth Unit, Sci City Of Munoz, Philippines	Konnai, S (reprint author), Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Infect Dis Lab, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	konnai@vetmed.hokudai.ac.jp			JSPS KAKENHI [25257415, 09J04017]	JSPS KAKENHI Grant Numbers 25257415 and 09J04017 supported the research described in this study.	Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI200422104; Amin DN, 2009, J INFECT DIS, V200, P1556, DOI 10.1086/644597; Hertz CJ, 1998, J IMMUNOL, V161, P6775; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/321237; Hoang ATN, 2010, J IMMUNOL, V185, P2360, DOI 10.4049/jimmunol.0903673; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Sumba AL, 1998, MED VET ENTOMOL, V12, P417, DOI 10.1046/j.1365-2915.1998.00131.x; Reid SA, 2002, TRENDS PARASITOL, V18, P219, DOI 10.1016/S1471-4922(02)02250-X; Taylor K., 2004, The trypanosomiases, P331, DOI 10.1079/9780851994758.0331; Konnai S, 2009, INFECT GENET EVOL, V9, P449, DOI 10.1016/j.meegid.2009.01.006; LUN ZR, 1995, PARASITOL TODAY, V11, P131, DOI 10.1016/0169-4758(95)80129-4; MABBOTT N, 1995, INFECT IMMUN, V63, P1563; Magez S, 1999, INFECT IMMUN, V67, P3128; Magez S, 2006, J INFECT DIS, V193, P1575, DOI 10.1086/503808; Magez S, 1997, J CELL BIOL, V137, P715, DOI 10.1083/jcb.137.3.715; Mekata H, 2012, PARASITE IMMUNOL, V34, P318, DOI 10.1111/j.1365-3024.2012.01362.x; Mekata H, 2013, PARASITOL RES, V112, P1513, DOI 10.1007/s00436-013-3297-3; Millar AE, 1999, INFECT IMMUN, V67, P3334; Mingala CN, 2007, COMP IMMUNOL MICROB, V30, P119, DOI 10.1016/j.cimid.2006.11.005; Naessens J, 2004, ACTA TROP, V92, P193, DOI 10.1016/j.actatropica.2004.05.015; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1017	1019		10.1292/jvms.15-0066		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500022		
J	Otomaru, K; Shiga, H; Kanome, J; Yanagita, K				Otomaru, Konosuke; Shiga, Hanae; Kanome, Junko; Yanagita, Kouji			Blood biochemical values in Japanese Black breeding cows in Kagoshima Prefecture, Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						blood biochemical value; breeding stage; Japanese Black cow; retinol	SERUM VITAMIN-A; BODY CONDITION; BETA-CAROTENE; DAIRY-COWS; CATTLE; PERFORMANCE; PARAMETERS	To obtain blood biochemical basic data of Japanese Black breeding cows in Kagoshima Prefecture, Japan, blood samples were obtained from 857 clinically healthy multiparous cows on 71 farms. Cows were divided into three stages: the prepartum stage (between 20 and 80 days before parturition, n=290), lactation stage (between 20 and 80 days after parturition, n=283) and maintenance stage (between 120 and 200 days after parturition, n=284). The mean concentration of total protein and total cholesterol, and the mean activities of aspartate aminotransferase in the lactation stage tended to be higher than those in the prepartum and maintenance stages. The mean concentration of glucose in the prepartum stage tended to be lower than that in the lactation and the maintenance stages. The mean concentration of nonesterified fatty acids and beta-hydroxybutyrate in the prepartum stage tended to be higher than those in the lactation and maintenance stages. The mean concentration of serum retinol was approximately 30 mu g/dl in all stages. These results suggest that the blood biochemical values of multiparous Japanese Black cows vary with breeding stages, and it is considered that the blood parameters obtained in this study are useful as indices for health management of Japanese Black breeding cows.	[Otomaru, Konosuke; Shiga, Hanae; Kanome, Junko; Yanagita, Kouji] Kagoshima Prefectural Federat Agr Mutual Aid Asso, Vet Clin Training Ctr, Kagoshima 8910132, Japan	Otomaru, K (reprint author), Kagoshima Univ, Joint Fac Vet Med, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	otomaru@vet.kagoshima-u.ac.jp					Adachi K, 1996, J VET MED SCI, V58, P461; Agriculture Factory and Fisheries Research Council Secretariat MAFF, 2008, JAP FEED STAND BEEF; Kaneene JB, 1997, PREV VET MED, V31, P59, DOI 10.1016/S0167-5877(96)01141-5; Cavestany D, 2005, J VET MED A, V52, P1, DOI 10.1111/j.1439-0442.2004.00679.x; Kida K, 2002, J VET MED SCI, V64, P1003, DOI 10.1292/jvms.64.1003; Gotoh T, 2009, MEAT SCI, V82, P300, DOI 10.1016/j.meatsci.2009.01.026; Grunwaldt EG, 2005, TROP ANIM HEALTH PRO, V37, P527, DOI 10.1007/s11250-005-2474-5; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P387; Antoncic-Svetina M, 2011, RES VET SCI, V90, P298, DOI 10.1016/j.rvsc.2010.05.022; CHEW BP, 1987, J DAIRY SCI, V70, P2732; FRYE TM, 1991, VET CLIN N AM-FOOD A, V7, P217; Goff JP, 2000, VET CLIN N AM-FOOD A, V16, P319; Katamoto H, 2003, J VET MED SCI, V65, P1001, DOI 10.1292/jvms.65.1001; MANSTON R, 1975, VET REC, V96, P497; Meikle A, 2004, REPRODUCTION, V127, P727, DOI 10.1530/rep.1.00080; Otto F.P., 2000, ISRAEL VET MED ASS, V55, P1; Rafia S, 2012, AM J VET RES, V73, P830, DOI 10.2460/ajvr.73.6.830; RICO AG, 1977, J DAIRY SCI, V60, P1283; Shimada K., 1988, ASIAN AUSTRAL J ANIM, V1, P47; Watanabe U, 2014, J VET SCI, V15, P283, DOI 10.4142/jvs.2014.15.2.283	20	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1021	1023		10.1292/jvms.15-0001		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500023		
J	Kawabe, M; Baba, Y; Tamai, R; Yamamoto, R; Komori, M; Mori, T; Takenaka, S				Kawabe, Mifumi; Baba, Yuta; Tamai, Reo; Yamamoto, Ryohei; Komori, Masayuki; Mori, Takashi; Takenaka, Shigeo			Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine oral malignant melanoma; GC-MS; metabolomics	MALIGNANT-MELANOMA; DOGS; CANCER; METABOLOMICS	Malignant melanoma is one of the most common and aggressive tumors in the oral cavity of dog. The tumor has a poor prognosis, and methods for diagnosis and prediction of prognosis after treatment are required. Here, we examined metabolite profiling using gas chromatography-mass spectrometry (GC-MS) for development of a discriminant model for evaluation of prognosis. Metabolite profiles were evaluated in healthy and melanoma plasma samples using orthogonal projection to latent structure using discriminant analysis (OPLS-DA). Cases that were predicted to be healthy using the OPLS discriminant model had no advanced lesions after radiation therapy. These results indicate that metabolite profiling may be useful in diagnosis and prediction of prognosis of canine malignant melanoma.	[Kawabe, Mifumi; Baba, Yuta; Tamai, Reo; Yamamoto, Ryohei; Komori, Masayuki; Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Izumisano, Osaka 5988531, Japan; [Kawabe, Mifumi; Mori, Takashi] Gifu Univ, Fac Appl Biol Sci, Anim Med Ctr, Gifu 5011193, Japan	Takenaka, S (reprint author), Osaka Prefecture Univ, Lab Cellular & Mol Biol, Div Vet Sci, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan.	takenaka@vet.osakafu-u.ac.jp					TODOROFF RJ, 1979, J AM VET MED ASSOC, V175, P567; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Smith SH, 2002, VET PATHOL, V39, P651, DOI 10.1354/vp.39-6-651; BOLON B, 1990, VET PATHOL, V27, P96; Abaffy T, 2013, METABOLOMICS, V9, P998, DOI 10.1007/s11306-013-0523-z; Bergman PJ, 2007, CLIN TECH SMALL AN P, V22, P55, DOI 10.1053/j.ctsap.2007.03.004; Song H, 2012, BRAZ J MED BIOL RES, V45, P78, DOI [10.1590/S0100-879X2011007500158, 10.1590/S0100-879X2012000100013]; BRADLEY RL, 1984, J AM VET MED ASSOC, V184, P460; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Bando K, 2010, J BIOSCI BIOENG, V110, P491, DOI 10.1016/j.jbiosc.2010.04.010; Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3; HARVEY HJ, 1981, J AM VET MED ASSOC, V178, P580; Williams LE, 2003, J AM VET MED ASSOC, V222, P1234, DOI 10.2460/javma.2003.222.1234; Fu YM, 2003, NUTR CANCER, V45, P60, DOI 10.1207/S15327914NC4501_8; Hasegawa T, 2014, J VET MED SCI, V76, P517, DOI 10.1292/jvms.13-0520; Henry CJ, 1999, J AM ANIM HOSP ASSOC, V35, P236; KONEFAL JB, 1987, RADIOLOGY, V164, P607; Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459; Tamai R, 2014, J VET MED SCI, V76, P1513, DOI 10.1292/jvms.14-0043; Withrow S. J., 2012, SMALL ANIMAL CLIN ON, V5th	20	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1025	1028		10.1292/jvms.14-0641		4	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500024		
J	Suzuta, F; Kimura, K; Urakawa, R; Kusuda, Y; Tanaka, S; Hanafusa, Y; Haritanp, M				Suzuta, Fumiko; Kimura, Kumiko; Urakawa, Ryo; Kusuda, Yukio; Tanaka, Shogo; Hanafusa, Yasuko; Haritanp, Makoto			Variations in the morphology of Rhizomucor pusillus in granulomatous lesions of a Magellanic penguin (Spheniscus magellanicus)	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						gene diagnosis; immunohistochemistry; penguin; Rhizomucor pusillus; sporangiospore	PSITTACUS-ERITHACUS; ASPERGILLOSIS; ZYGOMYCOSIS; PARROT; VENTRICULITIS; MUCORMYCOSIS	This report presents a new case of mucormycosis encountered in penguin characterized by morphological variation of hyphae and presence of sporangia with numerous sporangiospores. A 4.5-year-old Magellanic penguin (Spheniscus magellanicus) died after exhibiting anorexia, poor nutritional condition and dyspnea. Multiple nodular lesions were observed in the thoracic and abdominal regions. Histopathologically, hyphae of various sizes were seen in the lungs, air sac and nodular lesions. Myriad sporangiospores and several sporangia were observed in/around the bronchi or parabronchi. The very narrow and short hyphae in the nodules were not consistent with the characteristics of Mucorales. However, for most hyphae, including those in the nodules, sporangiospores and sporangia, immunohistochemistry revealed Mucorales-positive reactions. In addition, these fungi were identified as Rhizomucor pusillus by gene analysis.	[Suzuta, Fumiko; Urakawa, Ryo] Nagasaki Prefecture Cent Livestock Hyg Serv Ctr, Nagasaki 8540063, Japan; [Kimura, Kumiko; Hanafusa, Yasuko; Haritanp, Makoto] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Kusuda, Yukio] Nagasaki Penguin Aquarium, Nagasaki 8510121, Japan; [Tanaka, Shogo] Natl Agr & Food Res Org NARO, Kyushu Res Stn, Natl Inst Anim Hlth, Kagoshima, Kagoshima 8910105, Japan	Kimura, K (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan.	kumita@affrc.go.jp					FLACH EJ, 1990, VET REC, V126, P81; Tell LA, 2005, MED MYCOL, V43, pS71, DOI 10.1080/13693780400020089; Xavier MO, 2007, BRAZ J MICROBIOL, V38, P480, DOI 10.1590/S1517-83822007000300018; Arné P., 2011, International Journal of Microbiology, V2011, P746356, DOI 10.1155/2011/746356; BIGLAND CH, 1961, AVIAN DIS, V5, P367, DOI 10.2307/1587767; DAWSON CO, 1976, AVIAN DIS, V20, P593, DOI 10.2307/1589394; Desmidt M, 1998, VET REC, V143, P447; JEFFREY JS, 1994, AVIAN DIS, V38, P630, DOI 10.2307/1592090; Kern M. E., 1997, MED MYCOLOGY SELF IN, V2nd, P75; MCCASKEY PC, 1984, AVIAN DIS, V28, P791, DOI 10.2307/1590251; MIGAKI G, 1970, Avian Diseases, V14, P179, DOI 10.2307/1588569; Muir M, 2012, AUST VET J, V90, P277, DOI 10.1111/j.1751-0813.2012.00929.x; Mukaratirwa S, 2006, J VET MED B, V53, P51, DOI 10.1111/j.1439-0450.2006.00910.x; Munday JS, 2006, J VET DIAGN INVEST, V18, P619; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	15	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1029	1031		10.1292/jvms.14-0527		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500025		
J	Iwama, R; Sato, T; Katayama, M; Shimamura, S; Satoh, H; Ichijo, T; Furuhama, K				Iwama, Ryosuke; Sato, Tsubasa; Katayama, Masaaki; Shimamura, Shunsuke; Satoh, Hiroshi; Ichijo, Toshihiro; Furuhama, Kazuhisa			Relationship of glomerular filtration rate based on serum iodixanol clearance to IRIS staging in cats with chronic kidney disease	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						chronic kidney disease; feline; glomerular filtration rate; iodixanol; staging	BLOOD-SAMPLE METHOD	We examined the correlation between the glomerular filtration rate (GFR) estimated from an equation based on the serum iodixanol clearance technique and International Renal Interest Society (IRIS) stages of chronic kidney disease (CKD) in cats. The equation included the injection dose, sampling time, serum concentration and estimated volume of distribution (Vd) of the isotonic, nonionic, contrast medium iodixanol as a test tracer. The percent changes in the median basal GFR values calculated from the equation in CKD cats resembled those of IRIS stages 1-3. These data validate the association between the GFR derived from the simplified equation and IRIS stages based on the serum creatinine concentration in cats with CKD. They describe the GFR ranges determined using single-sample iodixanol clearance for healthy cats and cats with various IRIS stages of CKD.	[Iwama, Ryosuke; Sato, Tsubasa; Satoh, Hiroshi; Ichijo, Toshihiro; Furuhama, Kazuhisa] Iwate Univ, Cooperat Dept Vet Basic Med, Morioka, Iwate 0208550, Japan; [Katayama, Masaaki; Shimamura, Shunsuke] Iwate Univ, Cooperat Dept Vet Clin Med, Morioka, Iwate 0208550, Japan	Satoh, H (reprint author), Iwate Univ, Cooperat Dept Vet Med, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	satohsss@iwate-u.ac.jp					Finch NC, 2013, J VET INTERN MED, V27, P782, DOI 10.1111/jvim.12089; Heglund I F, 1995, Acta Radiol Suppl, V399, P69; Jacobsen P B, 1995, Acta Radiol Suppl, V399, P61; JACOBSSON L, 1983, CLIN PHYSIOL, V3, P297, DOI 10.1111/j.1475-097X.1983.tb00712.x; Japanese Association for Laboratory Animal Science, 1987, EXP ANIM, V3, P285; Katayama M, 2013, J FELINE MED SURG, V15, P1119, DOI 10.1177/1098612X13492165; Katayama M, 2013, J VET INTERN MED, V27, P17, DOI 10.1111/jvim.12017; Katayama R, 2012, AM J VET RES, V73, P1344, DOI 10.2460/ajvr.73.9.1344; Mützel W, 1980, Acta Radiol Suppl, V362, P87; National Kidney Foundation, 2002, AM J KIDNEY DIS, V39, pS76; Polzin D. J., 2005, TXB VET INTERNAL MED, VII, P1756; ROSS LA, 1981, AM J VET RES, V42, P1704; SVALAND MG, 1992, INVEST RADIOL, V27, P130, DOI 10.1097/00004424-199202000-00007; Von Hendy-Willson VE, 2011, VET J, V188, P156, DOI 10.1016/j.tvjl.2010.05.006	14	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	AUG	2015	77	8					1033	1035		10.1292/jvms.14-0494		3	Veterinary Sciences	Veterinary Sciences	CQ0XI	WOS:000360321500026		
J	Funako, T; Chammingkwan, P; Taniike, T; Terano, M				Funako, Toshiki; Chammingkwan, Patchanee; Taniike, Toshiaki; Terano, Minoru			Alternation of Pore Architecture of Ziegler-Natta Catalysts through Modification of Magnesium Ethoxide	MACROMOLECULAR REACTION ENGINEERING			English	Article						crystal structure; microstructure; morphology; wide-angle X-ray scattering (WAXS); Ziegler-Natta polymerization	HETEROGENEOUS CATALYSIS; PARTICLE MORPHOLOGY; SURFACE-AREA; POLYMERIZATION; GROWTH; COPOLYMERIZATION	The present article proposes a simple way to dramatically alter the pore architecture of Mg(OEt)(2)-based Ziegler-Natta catalysts by the addition of a small amount of i-propanol the synthesis of Mg(OEt)(2). The incorporated i-propoxide distorts the crystalline structure of Mg(OEt)(2), finally causing the phase transformation and significant densification of particles. Such modifications completely alternate the pore architecture of resultant catalysts, which contribute to the design of catalytic properties.	[Funako, Toshiki; Chammingkwan, Patchanee; Taniike, Toshiaki; Terano, Minoru] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Taniike, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	taniike@jaist.ac.jp			Research Programme of the Dutch Polymer Institute (DPI), Eindhoven, the Netherlands [753]	The authors appreciate Mitsui Chemicals Inc., Sumitomo Chemical Co., Ltd., Toho Titanium Co., Ltd., Tosoh Finechem Corporation, and Yuki Gousei Kogyo Co., Ltd. for the reagent donation and measurements. This work was implemented as a part of the Research Programme of the Dutch Polymer Institute (DPI), Eindhoven, the Netherlands, project #753.	NATTA G, 1955, J AM CHEM SOC, V77, P1708, DOI 10.1021/ja01611a109; CSICSERY SM, 1984, ZEOLITES, V4, P202, DOI 10.1016/0144-2449(84)90024-1; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Olsbye U, 2012, ANGEW CHEM INT EDIT, V51, P5810, DOI 10.1002/anie.201103657; Weckhuysen BM, 2003, CATAL TODAY, V78, P25, DOI 10.1016/S0920-5861(02)00323-1; Zabeti M, 2009, FUEL PROCESS TECHNOL, V90, P770, DOI 10.1016/j.fuproc.2009.03.010; Dashti A, 2009, POLYM INT, V58, P40, DOI 10.1002/pi.2490; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Senkan S, 2001, ANGEW CHEM INT EDIT, V40, P312, DOI 10.1002/1521-3773(20010119)40:2<312::AID-ANIE312>3.3.CO;2-9; Nejad MH, 2008, J APPL POLYM SCI, V108, P3388, DOI 10.1002/app.27964; KAKUGO M, 1989, MACROMOLECULES, V22, P3172, DOI 10.1021/ma00197a046; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Dil EJ, 2010, POLYM BULL, V64, P445, DOI 10.1007/s00289-009-0156-6; INNES WB, 1957, ANAL CHEM, V29, P1069, DOI 10.1021/ac60127a027; Joseph J, 2009, PARTICUL SCI TECHNOL, V27, P528, DOI 10.1080/02726350903328746; Kaduk JA, 1996, J RES NATL INST STAN, V101, P281, DOI 10.6028/jres.101.029; Marques M., 2010, CHEM CHEM TECHNOL, V4, P291; Martin C, 2002, CHEM ENG J, V87, P89, DOI 10.1016/S1385-8947(01)00205-4; Pokasermsong P., 2009, ENG J, V13, P57; Smit M, 2006, J POLYM SCI POL CHEM, V44, P2883, DOI 10.1002/pola.21399; Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030; Tanase S, 2008, APPL CATAL A-GEN, V350, P197, DOI 10.1016/j.apcata.2008.08.016; Taniike T, 2014, J CATAL, V311, P33, DOI 10.1016/j.jcat.2013.10.023; Taniike T, 2012, APPL CATAL A-GEN, V437, P24, DOI 10.1016/j.apcata.2012.06.006; Zheng XJ, 2006, MACROMOL RAPID COMM, V27, P15, DOI 10.1002/marc.200500664; ZIEGLER K, 1955, ANGEW CHEM INT EDIT, V67, P541, DOI 10.1002/ange.19550671902	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-832X	1862-8338		MACROMOL REACT ENG	Macromol. React. Eng.	AUG	2015	9	4					325	332		10.1002/mren.201400074		8	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CP7UP	WOS:000360094400002		
J	Beaulieu, SE; Sayre-McCord, RT; Mills, SW; Pradillon, F; Watanabe, H				Beaulieu, Stace E.; Sayre-McCord, R. Thomas; Mills, Susan W.; Pradillon, Florence; Watanabe, Hiromi			Swimming speeds of polychaete larvae collected near deep-sea hydrothermal vents	MARINE ECOLOGY-AN EVOLUTIONARY PERSPECTIVE			English	Article						Hydrothermal vent; larval dispersal; Mariana back-arc; swimming behavior	MIDOCEAN RIDGE; BEHAVIOR; TEMPERATURE; SETTLEMENT; DISPERSAL; VELOCITY; SINKING; MODEL	For benthic fauna endemic to hydrothermal vents, larval dispersal in the plankton is required for maintenance of populations and colonization of new vents. Dispersal distances in the plankton are expected to be influenced by vertical positioning into horizontal currents, and larval survival in the plankton as well as encounter rates for settlement cues may be influenced by swimming speed. Here, we present the first quantitative measurements of swimming speeds of polychaete larvae collected near deep-sea hydrothermal vents. We focused on three polychaete larvae of different morphotypes, with two morphotypes identified genetically to Capitellidae and Spionidae. Mean swimming speeds and helical parameters of the deep-sea polychaete larvae (measured at 1 atm) were similar to values reported for shallow-water polychaete larvae, with mean helical 3D swimming speeds ranging from 0.8-1.4 mm.s(-1). To account for swimming that deviated from helical patterns, we developed a new method to reconstruct 3D swimming trajectories, using the 2D track and larval orientation. Speeds were generally faster for downward swimming, with mean vertical displacement speeds ranging from 0.6-0.8 mm.s(-1) downward as compared with 0.2-0.6 mm.s(-1) upward. Mean swimming speeds and helical parameters differed among the individuals. Our results are a first step towards constraining a behavioral component in models of larval dispersal between deep-sea hydrothermal vents.	[Beaulieu, Stace E.; Sayre-McCord, R. Thomas; Mills, Susan W.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Pradillon, Florence] Inst Francais Exploitat Mer, Plouzane, France; [Watanabe, Hiromi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Beaulieu, SE (reprint author), Woods Hole Oceanog Inst, Dept Biol, Mail Stop 34, Woods Hole, MA 02543 USA.	stace@whoi.edu	Beaulieu, Stace/C-8526-2013	Beaulieu, Stace/0000-0002-2609-5453	NSF [OCE-1028862, OISE-1157556]; WHOI; TAIGA; Canon Foundation	We thank Chief Scientist S. Kojima and the Captain and crew of R/V Yokosuka Cruise YK10-11. We thank T. Silva for video conversion. For the empirical test of the 3D reconstruction method, we thank K. Katija Young for video imaging and B. Pernet and S. Irvine for aid in morphologic identification of the larva. We thank H. Jiang, L. Mullineaux, J. Wheeler, two anonymous reviewers and editors A. Metaxas and C. Young for improvements to the manuscript. This project was supported by NSF OCE-1028862 and OISE-1157556 to S.E. Beaulieu, a WHOI Summer Student Fellowship to R.T. Sayre-McCord, TAIGA project support to H. Watanabe and F. Pradillon, and Canon Foundation support to H. Watanabe.	Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Gurarie E, 2011, B MATH BIOL, V73, P1358, DOI 10.1007/s11538-010-9575-7; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; CHIA FS, 1984, CAN J ZOOL, V62, P1205; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Hansen BW, 2010, J EXP BIOL, V213, P3237, DOI 10.1242/jeb.038810; Mullineaux LS, 2013, DEEP-SEA RES PT II, V92, P46, DOI 10.1016/j.dsr2.2013.03.032; Metaxas A, 2009, BIOL BULL-US, V216, P257; Crenshaw HC, 2000, J EXP BIOL, V203, P961; Hadfield MG, 2004, BIOL BULL-US, V207, P28, DOI 10.2307/1543626; Bolton TF, 1997, MAR ECOL PROG SER, V159, P209, DOI 10.3354/meps159209; Brooke SD, 2009, DEEP-SEA RES PT II, V56, P1599, DOI 10.1016/j.dsr2.2009.05.003; McGillicuddy DJ, 2010, DEEP-SEA RES PT I, V57, P880, DOI 10.1016/j.dsr.2010.04.003; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; Schizas NV, 1997, MOL MAR BIOL BIOTECH, V6, P381; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; BUTMAN CA, 1988, OPHELIA, V29, P43; Arellano S.M., 2008, THESIS U OREGON; Boakes DE, 2011, J PLANKTON RES, V33, P641, DOI 10.1093/plankt/fbq136; Chan KYK, 2010, MAR ECOL PROG SER, V415, P49, DOI 10.3354/meps08744; Drescher K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3053242; Epifanio CE, 1999, MAR ECOL PROG SER, V185, P147, DOI 10.3354/meps185147; Guizien K, 2006, MAR ECOL PROG SER, V311, P47, DOI 10.3354/meps311047; Hourdez S, 2006, P BIOL SOC WASH, V119, P592, DOI 10.2988/0006-324X(2006)119[592:MSANSO]2.0.CO;2; Krug PJ, 2000, J EXP BIOL, V203, P1741; Menden-Deuer S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000942; Metaxas A, 2011, MAR ECOL PROG SER, V437, P103, DOI 10.3354/meps09283; Miyake H, 2010, CAH BIOL MAR, V51, P441; Reynolds KC, 2010, BIOL BULL-US, V219, P7; Van Dover C.L., 2011, WORKSH 31 MAY 4 JUN; Van Gaest A.L., 2006, THESIS U OREGON; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; Young CM, 1995, ECOLOGY MARINE INVER, V6, P249	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-9565	1439-0485		MAR ECOL-EVOL PERSP	Mar. Ecol.-Evol. Persp.	AUG	2015	36			1	SI		133	143		10.1111/maec.12207		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CQ1OX	WOS:000360368300010		
J	Kavousi, J; Reimer, JD; Tanaka, Y; Nakamura, T				Kavousi, Javid; Reimer, James Davis; Tanaka, Yasuaki; Nakamura, Takashi			Colony-specific investigations reveal highly variable responses among individual corals to ocean acidification and warming	MARINE ENVIRONMENTAL RESEARCH			English	Article						Scleractinian corals; Colony-specific responses; Ocean acidification; Global warming; Zooxanthellae; Bleaching	GREAT-BARRIER-REEF; SYMBIODINIUM DINOPHYCEAE; SCLERACTINIAN CORALS; GENUS SYMBIODINIUM; ISOTOPIC RESPONSES; BLEACHING EVENT; SKELETAL GROWTH; TISSUE BIOMASS; CALCIFICATION; PORITES	As anthropogenic climate change is an ongoing concern, scientific investigations on its impacts on coral reefs are increasing. Although impacts of combined ocean acidification (OA) and temperature stress (T) on reef-building scleractinian corals have been studied at the genus, species and population levels, there are little data available on how individual corals respond to combined OA and anomalous temperatures. In this study, we exposed individual colonies of Acropora digitifera, Montipora digitata and Porites cylindrica to four pCO(2)-temperature treatments including 400 mu atm-28 degrees C, 400 mu atm-31 degrees C, 1000 mu atm-28 degrees C and 1000 mu atm-31 degrees C for 26 days. Physiological parameters including calcification, protein content, maximum photosynthetic efficiency, Symbiodinium density, and chlorophyll content along with Symbiodinium type of each colony were examined. Along with intercolonial responses, responses of individual colonies versus pooled data to the treatments were investigated. The main results were: 1) responses to either OA or T or their combination were different between individual colonies when considering physiological functions; 2) tolerance to either OA or T was not synonymous with tolerance to the other parameter; 3) tolerance to both OA and T did not necessarily lead to tolerance of OA and T combined (OAT) at the same time; 4) OAT had negative, positive or no impacts on physiological functions of coral colonies; and 5) pooled data were not representative of responses of all individual colonies. Indeed, the pooled data obscured actual responses of individual colonies or presented a response that was not observed in any individual. From the results of this study we recommend improving experimental designs of studies investigating physiological responses of corals to climate change by complementing them with colony-specific examinations. (C) 2015 Elsevier Ltd. All rights reserved.	[Kavousi, Javid; Reimer, James Davis; Nakamura, Takashi] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Reimer, James Davis; Tanaka, Yasuaki; Nakamura, Takashi] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9050227, Japan; [Tanaka, Yasuaki] Univ Brunei Darussalam, Environm & Life Sci, Fac Sci, BE-1410 Gadong, Negara, Brunei	Kavousi, J (reprint author), Univ Ryukyus, Grad Sch Engn & Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	javid.kavousi@gmail.com			AICAL project - Global Environment Research Fund from the Ministry of the Environment of Japan [A-0804]; KAKENHI [23241017, 26220102]; JST/JICA, SATREPS	This study was supported by an AICAL project funded by the Global Environment Research Fund A-0804 from the Ministry of the Environment of Japan and KAKENHI (No. 23241017 and No. 26220102) to Yukihiro Nojiri. This research was also supported by JST/JICA, SATREPS. Protein analyses were performed in Dr. Masaya Morita's laboratory with Mr. Ugwu Stanley Ifeanyi's help. We are grateful to Dr. Kazuhiko Sakai and the staff members of Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus for their assistance.	Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Takahashi A, 2013, CORAL REEFS, V32, P305, DOI 10.1007/s00338-012-0979-8; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1529-8817.2003.00678.x; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Ohki S, 2013, BIOGEOSCIENCES, V10, P6807, DOI 10.5194/bg-10-6807-2013; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Okazaki RR, 2013, CORAL REEFS, V32, P671, DOI 10.1007/s00338-013-1015-3; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Dimond JL, 2012, J EXP BIOL, V215, P2247, DOI 10.1242/jeb.067991; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Loya Y, 2001, ECOL LETT, V4, P122; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Ban SS, 2013, CORAL REEFS, V32, P1, DOI 10.1007/s00338-012-0944-6; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; DAVIES PS, 1989, MAR BIOL, V101, P389; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Hoegh-Guldberg, 2007, SCIENCE, V318, P1737, DOI DOI 10.1126/SCIENCE.1152509; Hunter CL, 1997, P 8 INT COR REEF S, V2, P1599; IPCC, 2013, CONTR WORK GROUP 1 5; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191; Lewis E., 1998, ORNLCDIAC105 US DEP; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Meehl G.A., 2007, CLIM CHANGE, V283; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Rambaut A., 2002, SE AL SEQUENCE ALIGN; Reimer JD, 2006, PHYCOL RES, V54, P122, DOI 10.1111/j.1440-1835.2006.00419.x; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Tanaka Y, 2014, LIMNOL OCEANOGR, V59, P1468, DOI 10.4319/lo.2014.59.5.1468; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	55	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-1136	1879-0291		MAR ENVIRON RES	Mar. Environ. Res.	AUG	2015	109						9	20		10.1016/j.marenvres.2015.05.004		12	Environmental Sciences; Marine & Freshwater Biology; Toxicology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Toxicology	CQ3PH	WOS:000360514300002		
J	Thao, NV; Nozawa, A; Obayashi, Y; Kitamura, SI; Yokokawa, T; Suzuki, S				Thao, Ngo Vy; Nozawa, Akino; Obayashi, Yumiko; Kitamura, Shin-Ichi; Yokokawa, Taichi; Suzuki, Satoru			Extracellular proteases are released by ciliates in defined seawater microcosms	MARINE ENVIRONMENTAL RESEARCH			English	Article						Protease; Ciliate; Bacteria; Pseudomonas aeruginosa; Paranophrys marina; Seawater	G N-SP; PSEUDOMONAS-AERUGINOSA; MARINE ENVIRONMENTS; COASTAL SEAWATER; ATLANTIC-OCEAN; FRESH-WATER; BACTERIAL PRODUCTION; PROTEOLYTIC-ENZYMES; NORTH-ATLANTIC; DINOPHYCEAE	The biodegradation of proteins in seawater requires various proteases which are commonly thought to be mainly derived from heterotrophic bacteria. We, however, found that protists showed a high protease activity and continuously produced trypsin-type enzymes. The free-living marine heterotrophic ciliate Paranophrys marina together with an associated bacterium was isolated and used for microcosm incubation with different concentrations of killed bacteria as food for 10 days. The results showed that the coexistence of the ciliate with its associated bacterium produced a significant protease activity in both cell-associated and cell-free fractions while that in the associated bacterium only microcosm was negligible. The protease profiles are different between cell-associated and cell-free fractions, and a trypsin-type enzyme hydrolyzing Boc-Val-Leu-Lys-MCA was detected throughout the period in the presence of ciliates. This suggests that ciliates release proteases into the surrounding environment which could play a role in protein digestion outside cells. It has been previously suggested that bacteria are the major transformers in seawater. We here present additional data which indicates that protists, or at least ciliates with their specific enzymes, are a potential player in organic matter degradation in water columns. (C) 2015 Elsevier Ltd. All rights reserved.	[Thao, Ngo Vy; Nozawa, Akino; Kitamura, Shin-Ichi; Yokokawa, Taichi; Suzuki, Satoru] Ehime Univ, CMES, Matsuyama, Ehime 7908577, Japan; [Thao, Ngo Vy] Nong Lam Univ, Fac Environm & Resources, Ho Chi Minh City, Vietnam; [Obayashi, Yumiko] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan	Suzuki, S (reprint author), Ehime Univ, CMES, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	ssuzuki@ehime-u.ac.jp			Kakenhi, JSPS; Ehime University	This work was partly supported by Kakenhi, JSPS. Ehime University provided studentship to NVT.	Allison S.D., 2005, ECOL LETT, V8, P625; Arnosti Carol, 2013, Front Microbiol, V4, P318, DOI 10.3389/fmicb.2013.00318; Vaque D, 2001, AQUAT MICROB ECOL, V25, P163, DOI 10.3354/ame025163; Salerno M, 2009, J PHYCOL, V45, P34, DOI 10.1111/j.1529-8817.2008.00622.x; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Arnosti C, 2014, BIOGEOCHEMISTRY, V117, P5, DOI 10.1007/s10533-013-9906-5; Grossart HP, 2007, FEMS MICROBIOL LETT, V266, P194, DOI 10.1111/j.1574-6968.2006.00520.x; SIMEK K, 1992, APPL ENVIRON MICROB, V58, P3715; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; KARNER M, 1994, MAR ECOL PROG SER, V114, P237, DOI 10.3354/meps114237; [Anonymous], 2011, ANNU REV MAR SCI; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Wang H, 2012, INT J SYST EVOL MICR, V62, P223, DOI 10.1099/ijs.0.025536-0; HANCOCK REW, 1981, ANTIMICROB AGENTS CH, V19, P777; Bong CW, 2013, AQUAT MICROB ECOL, V69, P33, DOI 10.3354/ame01618; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Obayashi Y, 2005, LIMNOL OCEANOGR, V50, P722; D'Ambrosio L, 2014, ISME J, V8, P2167, DOI 10.1038/ismej.2014.67; Pantoja S, 1999, MAR CHEM, V63, P273, DOI 10.1016/S0304-4203(98)00067-X; Kimata N, 2004, MICROBIAL ECOL, V47, P41, DOI 10.1007/s00248-003-1032-9; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Mohapatra BR, 2004, AQUAT MICROB ECOL, V34, P129, DOI 10.3354/ame034129; Khan NH, 2007, MICROB ECOL, V53, P173, DOI 10.1007/s00248-006-9059-3; Obayashi Y, 2008, AQUAT MICROB ECOL, V50, P231, DOI 10.3354/ame01169; NAGATA T, 1992, MAR ECOL PROG SER, V83, P233, DOI 10.3354/meps083233; Hahn MW, 2001, FEMS MICROBIOL ECOL, V35, P113, DOI 10.1111/j.1574-6941.2001.tb00794.x; Allison SD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00301; Arnosti C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00425; Biegala IC, 2002, J PHYCOL, V38, P404, DOI 10.1046/j.1529-8817.2002.01045.x; Chrost R., 1990, AQUAT MICROB ECOL, P47; Hoppe HG, 2002, BOOK SOIL P, P73; IMEK K, 2013, ISME J, V7, P1519, DOI [10.1038/ ismej. 2013.57, DOI 10.1038/ISMEJ.2013.57]; Jurgens K, 2000, J EXP MAR BIOL ECOL, V245, P127, DOI 10.1016/S0022-0981(99)00156-2; KARNER M, 1992, MAR BIOL, V113, P341; Kiersztyn B, 2012, FEMS MICROBIOL ECOL, V80, P124, DOI 10.1111/j.1574-6941.2011.01276.x; Maire V, 2012, BIOGEOSCI DISC, V9, P8663; Maki T, 2001, FISHERIES SCI, V67, P794, DOI 10.1046/j.1444-2906.2001.00325.x; MULLER M, 1962, J PROTOZOOL, V9, P98, DOI 10.1111/j.1550-7408.1962.tb02588.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Nonaka L, 2010, ENV MICROBIOL REP, V2, P465, DOI 10.1111/j.1758-2229.2010.00178.x; Obayashi Y, 2010, J OCEANOGR, V66, P513; Parama A, 2004, PARASITOLOGY, V128, P541, DOI 10.1017/S0011382004004883; Sogin M.L., 1990, PCR PROTOCOLS GUIDE; Song WB, 2002, ACTA PROTOZOOL, V41, P263; Steen AD, 2013, AQUAT MICROB ECOL, V69, P93, DOI 10.3354/ame01625; Suzuki S, 1997, MAR ECOL PROG SER, V158, P1, DOI 10.3354/meps158001; Suzuki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00102; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; TAYLOR GT, 1985, MAR ECOL PROG SER, V23, P129, DOI 10.3354/meps023129; THAO NV, 2014, FRONT MAR SCI, V1, P69; THOMPSON JC, 1964, J PROTOZOOL, V11, P378, DOI 10.1111/j.1550-7408.1964.tb01766.x; THOMPSON JESSE C., 1964, VIRGINIA JOUR SCI, V15, P80; THOMPSON JC, 1965, J PROTOZOOL, V12, P527, DOI 10.1111/j.1550-7408.1965.tb03252.x; TRANVIK LJ, 1993, MAR ECOL PROG SER, V92, P301, DOI 10.3354/meps092301; Vaque D, 2014, J PLANKTON RES, V36, P198, DOI 10.1093/plankt/fbt085; Weber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041970; WEISSE T, 1991, MAR ECOL PROG SER, V71, P195, DOI 10.3354/meps071195; Yamada N., 2000, J OCEANOGR, V56, P583, DOI 10.1023/A:1011109329434	60	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-1136	1879-0291		MAR ENVIRON RES	Mar. Environ. Res.	AUG	2015	109						95	102		10.1016/j.marenvres.2015.06.011		8	Environmental Sciences; Marine & Freshwater Biology; Toxicology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Toxicology	CQ3PH	WOS:000360514300009		
J	Yoon, S; Ueji, R; Fujii, H				Yoon, Sungook; Ueji, Rintaro; Fujii, Hidetoshi			Effect of rotation rate on microstructure and texture evolution during friction stir welding of Ti-6Al-4V plates	MATERIALS CHARACTERIZATION			English	Article						Ti-6Al-4V alloy; Friction stir welding; Microstructure; Texture; beta-Transus temperature	MECHANICAL-PROPERTIES; TENSILE PROPERTIES; ZONE MICROSTRUCTURE; GRAIN-STRUCTURE; PURE TITANIUM; ALLOY; JOINTS; ALUMINUM; STEEL; FLOW	Ti-6Al-4V alloy plates with a thickness of 2 mm were successfully friction stir welded (FSW) and the microstructure change in the weld was clarified. The FSW was conducted at the tool rotation rates ranging from 225 to 300 rpm under the constant tool traverse speed of 50 mm/min. The microstructure of the stir zone exhibited inhomogeneous distribution along the plate thickness due to the temperature gradient caused by the lower thermal conductivity. The microstructure of the stir zone consisted of two types of morphologies. The fully lamellar structure was observed near the top surface, while the fully equiaxed structure was observed near the bottom surface. At the intermediate area between the top and the bottom regions, a mixed microstructure having both lamellar and equiaxed a grain morphologies was observed. The change in texture is also quite consistent with the microstructure distributions. This inhomogeneity was mainly due to the change in the microstructure development processes that involve phase transformation or plastic deformation. (C) 2015 Elsevier Inc. All rights reserved.	[Yoon, Sungook; Ueji, Rintaro; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Yoon, S (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	yoon@jwri.osaka-u.ac.jp		Yoon, Sungook/0000-0001-7010-7768	Japan Science and Technology Agency (JST); Global CUE Program; Japan Society for Promotion of Science [24656443]	This study was conducted as a part of the Aerospace Industry Innovation Program-Advanced Materials & Process Development for Next-Generation Aircraft Structures project under contract with the RIMCOF Research Center of Materials Process Technology Center, established by the Ministry of Economy, Trade and Industry (METI) of Japan. Additionally, this study was supported by the Japan Science and Technology Agency (JST) under Collaborative Research Based on the Industrial Demand, "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials," the Global CUE Program and a Grant-in-Aid for Science Research from the Japan Society for Promotion of Science (24656443).	Zhang Y, 2008, MAT SCI ENG A-STRUCT, V485, P448, DOI 10.1016/j.msea.2007.08.051; Mironov S, 2008, SCRIPTA MATER, V59, P27, DOI 10.1016/j.scriptamat.2008.02.014; Ueji R, 2006, MAT SCI ENG A-STRUCT, V423, P324, DOI 10.1016/j.msea.2006.02.038; Park SHC, 2003, SCRIPTA MATER, V49, P161, DOI 10.1016/S1359-6462(03)00210-0; Nandan R, 2007, ACTA MATER, V55, P883, DOI 10.1016/j.actamat.2006.09.009; Liu HJ, 2003, J MATER PROCESS TECH, V142, P692, DOI 10.1016/S0924-0136(03)00806-9; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Rhodes CG, 1997, SCRIPTA MATER, V36, P69, DOI 10.1016/S1359-6462(96)00344-2; Zhou L, 2009, SCRIPTA MATER, V61, P596, DOI 10.1016/j.scriptamat.2009.05.029; Shigematsu I, 2003, J MATER SCI LETT, V22, P353, DOI 10.1023/A:1022688908885; Nandan R, 2008, PROG MATER SCI, V53, P980, DOI 10.1016/j.pmatsci.2008.05.001; Zhou L, 2010, MATER DESIGN, V31, P2631, DOI 10.1016/j.matdes.2009.12.014; Reynolds AP, 2008, SCRIPTA MATER, V58, P338, DOI 10.1016/j.scriptamat.2007.10.048; Kitamura K, 2013, MATER DESIGN, V46, P348, DOI 10.1016/j.matdes.2012.10.051; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Fujii H, 2010, MAT SCI ENG A-STRUCT, V527, P3386, DOI 10.1016/j.msea.2010.02.023; Davies PS, 2011, METALL MATER TRANS A, V42A, P2278, DOI 10.1007/s11661-011-0606-2; Chowdhury SM, 2010, MAT SCI ENG A-STRUCT, V527, P6064, DOI 10.1016/j.msea.2010.06.012; Mironov S, 2009, ACTA MATER, V57, P4519, DOI 10.1016/j.actamat.2009.06.020; Su JQ, 2013, MAT SCI ENG A-STRUCT, V573, P67, DOI 10.1016/j.msea.2013.02.025; Zhang Y, 2008, MAT SCI ENG A-STRUCT, V488, P25, DOI 10.1016/j.msea.2007.10.062; Liu G, 1997, SCRIPTA MATER, V37, P355, DOI 10.1016/S1359-6462(97)00093-6; Wang YN, 2006, SCRIPTA MATER, V55, P637, DOI 10.1016/j.scriptamat.2006.06.005; Kerans W.H., 1982, WELDING HDB, V7th; Lee WB, 2005, MATER LETT, V59, P3315, DOI 10.1016/j.matlet.2005.05.064; Leyens C., 2005, TITANIUM TITANIUM AL; Liu HJ, 2010, MATER DESIGN, V31, P1650, DOI 10.1016/j.matdes.2009.08.025; Lutjering G., 2000, MICROSTRUCTURE MECH; Lutjering G., 2010, TITANIUM, V2nd; Mironov S, 2010, MAT SCI ENG A-STRUCT, V527, P7498, DOI 10.1016/j.msea.2010.08.074; Ramulu M, 2010, MATER DESIGN, V31, P3056, DOI 10.1016/j.matdes.2010.01.023	31	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1044-5803	1873-4189		MATER CHARACT	Mater. Charact.	AUG	2015	106						352	358		10.1016/j.matchar.2015.06.025		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Materials Science, Characterization & Testing	Materials Science; Metallurgy & Metallurgical Engineering	CQ2GE	WOS:000360417200041		
J	Luo, XB; Wan, Y; He, XJ; Mori, K				Luo, Xiongbiao; Wan, Ying; He, Xiangjian; Mori, Kensaku			Observation-driven adaptive differential evolution and its application to accurate and smooth bronchoscope three-dimensional motion tracking	MEDICAL IMAGE ANALYSIS			English	Article						Adaptive differential evolution; Camera 3-D motion tracking; Evolutionary computation; Bronchoscope tracking and navigation; Surgical instrument tracking and navigation	STRUCTURAL SIMILARITY; REGISTRATION; VALIDATION; NAVIGATION; OPTIMIZATION; PHANTOM; SYSTEM	This paper proposes an observation-driven adaptive differential evolution algorithm that fuses bronchoscopic video sequences, electromagnetic sensor measurements, and computed tomography images for accurate and smooth bronchoscope three-dimensional motion tracking. Currently an electromagnetic tracker with a position sensor fixed at the bronchoscope tip is commonly used to estimate bronchoscope movements. The large tracking error from directly using sensor measurements, which may be deteriorated heavily by patient respiratory motion and the magnetic field distortion of the tracker, limits clinical applications. How to effectively use sensor measurements for precise and stable bronchoscope electromagnetic tracking remains challenging. We here exploit an observation-driven adaptive differential evolution framework to address such a challenge and boost the tracking accuracy and smoothness. In our framework, two advantageous points are distinguished from other adaptive differential evolution methods: (1) the current observation including sensor measurements and bronchoscopic video images is used in the mutation equation and the fitness computation, respectively and (2) the mutation factor and the crossover rate are determined adaptively on the basis of the current image observation. The experimental results demonstrate that our framework provides much more accurate and smooth bronchoscope tracking than the state-of-the-art methods. Our approach reduces the tracking error from 3.96 to 2.89 mm, improves the tracking smoothness from 4.08 to 1.62 mm, and increases the visual quality from 0.707 to 0.741. (C) 2015 Elsevier B.V. All rights reserved.	[Luo, Xiongbiao; Mori, Kensaku] Nagoya Univ, Informat & Commun Headquarters, Nagoya, Aichi 4648601, Japan; [Luo, Xiongbiao] Western Univ, Robarts Res Inst, London, ON, Canada; [Wan, Ying; He, Xiangjian] Univ Technol Sydney, Sch Comp & Commun, Sydney, NSW 2007, Australia	Luo, XB (reprint author), Western Univ, Robarts Res Inst, London, ON, Canada.	xluo@robarts.ca; Ying.Wan@student.uts.edu.au; Xiangjian.He@uts.edu.au; kensaku@is.nagoya-u.ac.jp			Kakenhi - Japan Society for the Promotion of Science (JSPS) [25242047]; JSPS	This work was partly supported by the Kakenhi "Modality-seamless navigation for endoscopic diagnosis and surgery assistance based on multi-modality image fusion" (25242047) funded by the Japan Society for the Promotion of Science (JSPS) and JSPS Bilateral International Collaboration Grant.	Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Teo J, 2006, SOFT COMPUT, V10, P673, DOI 10.1007/s00500-005-0537-1; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Mininno E, 2011, IEEE T EVOLUT COMPUT, V15, P32, DOI 10.1109/TEVC.2010.2058120; Schwarz Y, 2006, CHEST, V129, P988, DOI 10.1378/chest.129.4.988; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Mori K, 2005, LECT NOTES COMPUT SC, V3750, P543; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Luo XB, 2014, IEEE T MED IMAGING, V33, P1248, DOI 10.1109/TMI.2014.2307052; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Feuerstein M, 2009, IEEE T MED IMAGING, V28, P951, DOI 10.1109/TMI.2008.2008954; Vasile M, 2011, IEEE T EVOLUT COMPUT, V15, P267, DOI 10.1109/TEVC.2010.2087026; Liu J, 2005, SOFT COMPUT, V9, P448, DOI 10.1007/s00500-004-0363-x; LEVOY M, 1990, IEEE COMPUT GRAPH, V10, P33, DOI 10.1109/38.50671; Chung AJ, 2006, IEEE T MED IMAGING, V25, P503, DOI 10.1109/TMI.2006.871550; Dam E.B., 1998, DIKUTR985 U COP; Deguchi D, 2009, MED IMAGE ANAL, V13, P621, DOI 10.1016/j.media.2009.06.001; Deligianni F, 2006, IEEE T MED IMAGING, V25, P1462, DOI 10.1109/TMI.2006.883452; Gergel I., 2010, P SPIE MI 2010; Helferty JP, 2007, COMPUT VIS IMAGE UND, V108, P171, DOI 10.1016/j.cviu.2006.10.010; Luo X., 2012, P ACCV 2012, P259; Luo X., 2010, P ACCV 10, V6494, P409; Luo X., 2010, P SPIE MI 2010; Luo XB, 2012, INT J COMPUT ASS RAD, V7, P371, DOI 10.1007/s11548-011-0645-6; Luo XB, 2012, MED IMAGE ANAL, V16, P577, DOI 10.1016/j.media.2010.11.001; Mezura-Montes E, 2006, IEEE C EVOL COMPUTAT, P25, DOI 10.1109/CEC.2006.1688286; Price K., 2005, DIFFERENTIAL EVOLUTI; Soper TD, 2010, IEEE T BIO-MED ENG, V57, P736, DOI 10.1109/TBME.2009.2034733; TIEDE U, 1990, IEEE COMPUT GRAPH, V10, P41, DOI 10.1109/38.50672; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	AUG	2015	24	1					282	296		10.1016/j.media.2015.01.002		15	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	CP9YV	WOS:000360252700021		
J	Pal, S; Richardson, JH; Murphy, JR; Krairojananan, P; Kongtak, P; Jaichapor, B; Kankaew, P; Ekanayake, S; Davis, TJ; Maserang, DL; Teng, DHF; Crisp, RJ; Wu, SJL; Coleman, RE; McAvin, JC; Swaby, JA				Pal, Subhamoy; Richardson, Jason H.; Murphy, Jittawadee R.; Krairojananan, Panadda; Kongtak, Patcharee; Jaichapor, Boonsong; Kankaew, Prasan; Ekanayake, Sajeewane; Davis, Timothy J.; Maserang, David L.; Teng, David H. F.; Crisp, Robert J.; Wu, Shuenn-Jue L.; Coleman, Russell E.; McAvin, James C.; Swaby, James A.			Detection of Dengue Virus in Mosquito Extracts and Human Clinical Samples Using a Field Expedient Molecular Platform	MILITARY MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; RAPID IDENTIFICATION; RNA CONTROLS; ARMORED RNA; IMMUNOFLUORESCENCE; ASSAYS; FEVER; HAITI; IRAQ; DNA	Dengue fever occurs in localized outbreaks and can significantly erode troop strength and mission readiness. Timely identification of dengue virus (DENV) provides for rapid and appropriate patient management decisions, such as medical evacuation and supportive therapies, as well as help to promote Force Health Protection through vector control and personal protective measures. The "Ruggedized" Advanced Pathogen Identification Device is a field-friendly PCR (Polymerase Chain Reaction) platform that can be used to facilitate early identification of DENV. We developed a dry-format PCR assay on this platform. The assay demonstrated 100% analytical specificity for detecting dengue using a cross-reactivity panel. We used a panel of 102 acute, DENV isolation positive serum samples and 25 DENV negative samples; the assay demonstrated a clinical sensitivity of 97.1% (95% C.I. 91.6-99.4%) and specificity of 96.0% (95% C.I. 79.7-99.9%) in identifying patients with dengue infection. We also used the assay to test mosquito homogenates from 28 adult female Aedes aegypti. A single DENV infected mosquito was identified using the PCR assay and confirmed using immunofluorescence as a reference method. Much of the testing was performed under austere field conditions. Together, our results demonstrate the utility of this assay for detecting DENV in vector and human samples in field environments.	[Pal, Subhamoy; Ekanayake, Sajeewane; Wu, Shuenn-Jue L.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA; [Richardson, Jason H.; Murphy, Jittawadee R.; Krairojananan, Panadda; Kongtak, Patcharee; Jaichapor, Boonsong; Kankaew, Prasan; McAvin, James C.] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok 10400, Thailand; [Davis, Timothy J.] USAF Sch Aerosp Med, Kadena AB, Okinawa 96368, Japan; [Maserang, David L.] Adv Technol Ctr, San Antonio, TX 78235 USA; [Teng, David H. F.; Crisp, Robert J.] BioFire Diagnost LLC, Salt Lake City, UT 84108 USA; [Coleman, Russell E.] Chem & Biol Def, Joint Programs Execut Off, Ft Detrick, MD 21702 USA	Pal, S (reprint author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Office of the Air Force Surgeon General, Directorate of Modernization, Falls Church, Virginia; Military Infectious Diseases Research Program, USAMRC, Fort Detrick, Maryland [6000.RAD1.L.A0311]	This work was funded in part by the Office of the Air Force Surgeon General, Directorate of Modernization, Falls Church, Virginia, and Military Infectious Diseases Research Program work unit number 6000.RAD1.L.A0311, USAMRC, Fort Detrick, Maryland.	LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545; WalkerPeach CR, 1999, CLIN CHEM, V45, P2079; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176; Mendez F, 2006, AM J TROP MED HYG, V74, P678; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; SHARP TW, 1995, AM J TROP MED HYG, V53, P89; Facchinelli L, 2008, AM J TROP MED HYG, V78, P904; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Centers for Disease Control and Prevention, 2009, DENG FEV; Coleman RE, 2009, J MED ENTOMOL, V46, P649, DOI 10.1603/033.046.0333; Coleman RE, 2009, MIL MED, V174, P904; Drabick JJ, 1997, B WORLD HEALTH ORGAN, V75, P109; Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940; Gu WD, 2004, AM J TROP MED HYG, V71, P636; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533; Mcavin JC, 2009, US Patent, Patent No. [US20090197245, 20090197245]; McAvin JC, 2005, MIL MED, V170, P1053; Pediatric Dengue Vaccine Initiative, 2009, GLOB BURD DENG; Swaby James A, 2008, US Army Med Dep J, P21; Trofa AF, 1997, JAMA-J AM MED ASSOC, V277, P1546, DOI 10.1001/jama.277.19.1546; Wittwer CT, 2013, BIOTECHNIQUES, V54, P314, DOI 10.2144/000114043; World Health Organization, 2009, DENG DENG HEM FEV, P117	30	0	0	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2015	180	9					937	942		10.7205/MILMED-D-14-00428		6	Medicine, General & Internal	General & Internal Medicine	CQ3TL	WOS:000360525600004		
J	Petersen, HO; Hoger, SK; Looso, M; Lengfeld, T; Kuhn, A; Warnken, U; Nishimiya-Fujisawa, C; Schnolzer, M; Kruger, M; Ozbek, S; Simakov, O; Holstein, TW				Petersen, Hendrik O.; Hoeger, Stefanie K.; Looso, Mario; Lengfeld, Tobias; Kuhn, Anne; Warnken, Uwe; Nishimiya-Fujisawa, Chiemi; Schnoelzer, Martina; Krueger, Marcus; Oezbek, Suat; Simakov, Oleg; Holstein, Thomas W.			A Comprehensive Transcriptomic and Proteomic Analysis of Hydra Head Regeneration	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						evolution of regeneration; proteomics and transcriptomics; Hydra; Cnidaria	BETA-CATENIN DEGRADATION; CONTROLS DNA-REPLICATION; STEM-CELLS; EXTRACELLULAR-MATRIX; LIMB REGENERATION; DEVELOPMENTAL MECHANISMS; NEGATIVE REGULATORS; AXON REGENERATION; GENETIC-ANALYSIS; HAIR FOLLICLE	The cnidarian freshwater polyp Hydra sp. exhibits an unparalleled regeneration capacity in the animal kingdom. Using an integrative transcriptomic and stable isotope labeling by amino acids in cell culture proteomic/phosphoproteomic approach, we studied stem cell-based regeneration in Hydra polyps. As major contributors to head regeneration, we identified diverse signaling pathways adopted for the regeneration response as well as enriched novel genes. Our global analysis reveals two distinct molecular cascades: an early injury response and a subsequent, signaling driven patterning of the regenerating tissue. A key factor of the initial injury response is a general stabilization of proteins and a net upregulation of transcripts, which is followed by a subsequent activation cascade of signaling molecules including Wnts and transforming growth factor (TGF) beta-related factors. We observed moderate overlap between the factors contributing to proteomic and transcriptomic responses suggesting a decoupled regulation between the transcriptional and translational levels. Our data also indicate that interstitial stem cells and their derivatives (e.g., neurons) have no major role in Hydra head regeneration. Remarkably, we found an enrichment of evolutionarily more recent genes in the early regeneration response, whereas conserved genes are more enriched in the late phase. In addition, genes specific to the early injury response were enriched in transposon insertions. Genetic dynamicity and taxon-specific factors might therefore play a hitherto underestimated role in Hydra regeneration.	[Petersen, Hendrik O.; Hoeger, Stefanie K.; Lengfeld, Tobias; Kuhn, Anne; Oezbek, Suat; Simakov, Oleg; Holstein, Thomas W.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Looso, Mario; Krueger, Marcus] Max Planck Inst MPI Heart & Lung Res, Bad Nauheim, Germany; [Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, Funct Proteome Anal Unit, Heidelberg, Germany; [Nishimiya-Fujisawa, Chiemi] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 444, Japan; [Krueger, Marcus] Univ Cologne, CECAD, Cologne, Germany; [Simakov, Oleg] Okinawa Inst Sci & Technol, Mol Genet Unit, Okinawa, Japan	Holstein, TW (reprint author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany.	thomas.holstein@cos.uni.heidelberg.de	Simakov, Oleg/G-4572-2015	Simakov, Oleg/0000-0002-3585-4511	Cluster of Excellence Cellular Networks;  [DFG FOR 1036/A1];  [DFG SFB 873/A1]	The authors thank David Ibberson for the library preparations, Elmar Schiebel for his help in culturing Saccharomyces c. YAL6b, Ingrid Lohmann, Jan Lohmann, and Hiroshi Watanabe for critical discussions. The authors also thank Rob Steele for providing the transgenic epithelial Hydra strains, and Volker Eckstein and Anthony Ho for their help with the FACS. This work was supported by grants to T.W.H. (DFG FOR 1036/A1 and DFG SFB 873/A1) and by the Cluster of Excellence Cellular Networks (http://www.cellnetworks.uni-hd.de).	Thadani R, 2012, CURR BIOL, V22, pR1012, DOI 10.1016/j.cub.2012.10.023; Song DH, 2003, J BIOL CHEM, V278, P24018, DOI 10.1074/jbc.M212260200; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Brockes JP, 2001, J ANAT, V199, P3; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Broun M, 1999, DEVELOPMENT, V126, P5245; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Bosch TCG, 2010, DEV GROWTH DIFFER, V52, P15, DOI 10.1111/j.1440-169X.2009.01143.x; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Bork P, 1997, FASEB J, V11, P68; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li YQ, 2006, MOL BIOL REP, V33, P287, DOI 10.1007/s11033-006-9019-5; Ye JY, 2010, J PROTEOME RES, V9, P3561, DOI 10.1021/pr100075x; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; Tran KT, 2004, WOUND REPAIR REGEN, V12, P262, DOI 10.1111/j.1067-1927.2004.012302.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Nakamura Y, 2011, P NATL ACAD SCI USA, V108, P9137, DOI 10.1073/pnas.1018109108; Yaguchi S, 2008, DEV CELL, V14, P97, DOI 10.1016/j.devcel.2007.10.012; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Boser A, 2013, CELL REP, V5, P1142, DOI 10.1016/j.celrep.2013.10.035; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Krishna S, 2013, NUCLEIC ACIDS RES, V41, P599, DOI 10.1093/nar/gks1020; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Smith KM, 1999, DEV BIOL, V212, P392, DOI 10.1006/dbio.1999.9337; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Nandan MO, 2014, DEV BIOL, V387, P191, DOI 10.1016/j.ydbio.2014.01.002; Zhang L, 2011, MOL BIOL CELL, V22, P1617, DOI 10.1091/mbc.E10-12-0985; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Mashanov VS, 2012, DEV DYNAM, V241, P1625, DOI 10.1002/dvdy.23844; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Mattarocci S, 2014, CELL REP, V7, P62, DOI 10.1016/j.celrep.2014.03.010; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI [10.1038/ng940, 10.1038/ng1011]; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Botchkareva NV, 2012, CELL CYCLE, V11, P468, DOI 10.4161/cc.11.3.19058; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; MARCUM BA, 1978, J CELL SCI, V29, P17; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Looso M, 2012, J PROTEOME RES, V11, P4693, DOI 10.1021/pr300521p; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; SUGIYAMA T, 1977, DEV GROWTH DIFFER, V19, P187; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Durut N, 2015, GENE, V556, P7, DOI 10.1016/j.gene.2014.09.023; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Miljkovic-Licina M, 2007, DEVELOPMENT, V134, P1191, DOI 10.1242/dev.02804; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Juliano CE, 2014, P NATL ACAD SCI USA, V111, P337, DOI 10.1073/pnas.1320965111; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lindgens D, 2004, DEVELOPMENT, V131, P191, DOI 10.1242/dev.00903; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Hemmrich G, 2012, MOL BIOL EVOL, V29, P3267, DOI 10.1093/molbev/mss134; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Arvizu F, 2006, DIFFERENTIATION, V74, P305, DOI 10.1111/j.1432-0436.2006.00078.x; BIBB C, 1973, TISSUE CELL, V5, P23, DOI 10.1016/S0040-8166(73)80003-5; Bode HR, 2003, DEV DYNAM, V226, P225, DOI 10.1002/dvdy.10225; Boehm AM, 2012, P NATL ACAD SCI USA, V109, P19697, DOI 10.1073/pnas.1209714109; Brenner DA, 2014, HEPATOLOGY, V59, P19, DOI 10.1002/hep.26637; Bridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011686; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Chen QK, 2005, WORLD J GASTROENTERO, V11, P2462; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Cruciat CM, 2014, CURR OPIN CELL BIOL, V31, P46, DOI 10.1016/j.ceb.2014.08.003; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Dittmer Jürgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBEL S, 1990, J CELL BIOL, V110, P939, DOI 10.1083/jcb.110.4.939; Dubuc TQ, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-24; Fabila Y, 2002, MECH DEVELOP, V119, P157, DOI 10.1016/S0925-4773(02)00351-9; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Galliot B, 2013, DEV GENES EVOL, V223, P39, DOI 10.1007/s00427-012-0411-y; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; GIERER A, 1972, NATURE-NEW BIOL, V239, P98; Gilbert SF, 2014, DEV BIOL; HICKLIN J, 1973, J EMBRYOL EXP MORPH, V30, P741; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Jiang YR, 2014, ELIFE, V3, DOI 10.7554/eLife.05000; Kent CB, 2010, J NEUROSCI, V30, P14059, DOI 10.1523/JNEUROSCI.3883-10.2010; KOBATAKE E, 1989, DEVELOPMENT, V105, P521; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; MACWILLIAMS HK, 1983, DEV BIOL, V96, P239, DOI 10.1016/0012-1606(83)90325-1; MARCUM BA, 1978, J CELL SCI, V32, P233; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Mashanov VS, 2012, MOB GENET ELEMENTS, V2, P244, DOI [10.4161/mge.22644, DOI 10.4161/MGE.22644]; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; McDonnell S, 1999, BIOCHEM SOC T, V27, P734; Meng C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-162; NEWMAN SA, 1974, J EMBRYOL EXP MORPH, V31, P541; de Groot REA, 2014, CELL SIGNAL, V26, P2601, DOI 10.1016/j.cellsig.2014.08.016; Rentzsch F, 2007, P NATL ACAD SCI USA, V104, P3249, DOI 10.1073/pnas.0604501104; SARRAS MP, 1993, DEV BIOL, V157, P383, DOI 10.1006/dbio.1993.1143; SCADDING SR, 1977, J EXP ZOOL, V202, P57, DOI 10.1002/jez.1402020108; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Tardent P., 1978, P69; Technau U, 2000, P NATL ACAD SCI USA, V97, P12127, DOI 10.1073/pnas.97.22.12127; Trembley A, 1744, MEMOIRES SERVIR HIST; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Wenger Y, 2014, SEMIN IMMUNOL, V1, P277; Wisotzkey RG, 2014, MOL BIOL EVOL, V31, P2309, DOI 10.1093/molbev/msu175; WOOD RL, 1980, J ULTRA MOL STRUCT R, V73, P350, DOI 10.1016/S0022-5320(80)90094-5; WOOD RL, 1980, J ULTRA MOL STRUCT R, V70, P104, DOI 10.1016/S0022-5320(80)90026-X; Yaguchi S, 2011, DEVELOPMENT, V138, P4233, DOI 10.1242/dev.069856; Zhu W, 2012, DEV GROWTH DIFFER, V54, P673, DOI 10.1111/j.1440-169X.2012.01368.x	149	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	AUG	2015	32	8					1928	1947		10.1093/molbev/msv079		20	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CQ4PG	WOS:000360586500002		
J	White, MA; Kitano, J; Peichel, CL				White, Michael A.; Kitano, Jun; Peichel, Catherine L.			Purifying Selection Maintains Dosage-Sensitive Genes during Degeneration of the Threespine Stickleback Y Chromosome	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						threespine stickleback; sex chromosome evolution; dosage compensation	MAMMALIAN X-CHROMOSOME; MALE-DRIVEN EVOLUTION; DNA-SEQUENCING DATA; SEX-CHROMOSOMES; SILENE-LATIFOLIA; DIFFERENTIAL EXPRESSION; NINESPINE STICKLEBACKS; REPRODUCTIVE ISOLATION; PHENOTYPIC DIVERGENCE; BIASED EXPRESSION	Sex chromosomes are subject to unique evolutionary forces that cause suppression of recombination, leading to sequence degeneration and the formation of heteromorphic chromosome pairs (i.e., XY or ZW). Although progress has been made in characterizing the outcomes of these evolutionary processes on vertebrate sex chromosomes, it is still unclear how recombination suppression and sequence divergence typically occur and how gene dosage imbalances are resolved in the heterogametic sex. The threespine stickleback fish (Gasterosteus aculeatus) is a powerful model system to explore vertebrate sex chromosome evolution, as it possesses an XY sex chromosome pair at relatively early stages of differentiation. Using a combination of whole-genome and transcriptome sequencing, we characterized sequence evolution and gene expression across the sex chromosomes. We uncovered two distinct evolutionary strata that correspond with known structural rearrangements on the Y chromosome. In the oldest stratum, only a handful of genes remain, and these genes are under strong purifying selection. By comparing sex-linked gene expression with expression of autosomal orthologs in an outgroup, we show that dosage compensation has not evolved in threespine sticklebacks through upregulation of the X chromosome in males. Instead, in the oldest stratum, the genes that still possess a Y chromosome allele are enriched for genes predicted to be dosage sensitive in mammals and yeast. Our results suggest that dosage imbalances may have been avoided at haploinsufficient genes by retaining function of the Y chromosome allele through strong purifying selection.	[White, Michael A.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [White, Michael A.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Shizuoka, Japan	White, MA (reprint author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	mawhite@fhcrc.org			Fred Hutchinson Cancer Research Center; MEXT [23113007, 23113001]	The authors thank Matt Fitzgibbon and the Genomics Shared Resource at The Fred Hutchinson Cancer Research Center for help with sequence analysis, Kohta Yoshida for advice on assembling the Pungitius pungitius sequence, Doris Bachtrog for discussion, and Judith Mank and Mark Kirkpatrick for discussion and comments on a previous version of the manuscript. The threespine stickleback (Gasterosteus aculeatus) sequences are deposited in the National Center for Biotechnology Information Short Sequence Read Archive (PRJNA277770). The ninespine stickleback (Pungitius pungitius) sequences are deposited in DNA Data Bank of Japan (DRA001085 and DRA002524). This work was funded by the Fred Hutchinson Cancer Research Center (C.L.P.) and the MEXT Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) (J.K.). M.A.W. was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Bergero R, 2013, GENETICS, V194, P673, DOI 10.1534/genetics.113.150755; Roesti M, 2013, MOL ECOL, V22, P3014, DOI 10.1111/mec.12322; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Otto SP, 2011, TRENDS GENET, V27, P358, DOI 10.1016/j.tig.2011.05.001; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; CHEN TR, 1970, CYTOGENETICS, V9, P321, DOI 10.1159/000130102; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Mank JE, 2010, EVOLUTION, V64, P663, DOI 10.1111/j.1558-5646.2009.00853.x; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; Mank JE, 2007, GENOME RES, V17, P618, DOI 10.1101/gr.6031907; Leder EH, 2010, MOL BIOL EVOL, V27, P1495, DOI 10.1093/molbev/msq031; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Urton JR, 2011, CYTOGENET GENOME RES, V135, P150, DOI 10.1159/000331232; Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Wright AE, 2014, EVOLUTION, V68, P3281, DOI 10.1111/evo.12493; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Makanae K, 2013, GENOME RES, V23, P300, DOI 10.1101/gr.146662.112; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Naurin S, 2010, TRENDS GENET, V26, P15, DOI 10.1016/j.tig.2009.11.006; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; HOLM S, 1979, SCAND J STAT, V6, P65; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Mank JE, 2013, TRENDS GENET, V29, P677, DOI 10.1016/j.tig.2013.07.005; Charlesworth B, 2000, PHILOS T ROY SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Muyle A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001308; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.2307/2408385; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Rautenberg A, 2010, MOL PHYLOGENET EVOL, V57, P978, DOI 10.1016/j.ympev.2010.08.003; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Lin FQ, 2012, P NATL ACAD SCI USA, V109, P11752, DOI 10.1073/pnas.1201816109; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Dean R, 2014, J EVOLUTION BIOL, V27, P1443, DOI 10.1111/jeb.12345; Meisel RP, 2013, TRENDS GENET, V29, P537, DOI 10.1016/j.tig.2013.05.009; Ross JA, 2008, GENETICS, V179, P2173, DOI 10.1534/genetics.108.088559; Aldenhoven JT, 2010, MOL ECOL, V19, P4061, DOI 10.1111/j.1365-294X.2010.04801.x; Shapiro MD, 2009, CURR BIOL, V19, P1140, DOI 10.1016/j.cub.2009.05.029; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Bull J. J., 1983, EVOLUTION SEX DETERM; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Filatov DA, 2002, MOL BIOL EVOL, V19, P898; Ishikawa A, 2013, J EVOLUTION BIOL, V26, P1417, DOI 10.1111/jeb.12146; Julien P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001328; Kawahara R, 2009, MOL PHYLOGENET EVOL, V50, P401, DOI 10.1016/j.ympev.2008.10.014; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knebel S, 2011, CYTOGENET GENOME RES, V132, P219, DOI 10.1159/000322080; Kvikstad EM, 2009, GENOME RES, V19, P1153, DOI 10.1101/gr.088922.108; Kvikstad EM, 2007, PLOS COMPUT BIOL, V3, P1772, DOI 10.1371/journal.pcbi.0030176; Lange J, 2013, GENOMICS, V102, P257, DOI 10.1016/j.ygeno.2013.04.018; Lemaitre C, 2009, GENOME BIOL EVOL, V1, P56, DOI 10.1093/gbe/evp006; Pessia E, 2012, P NATL ACAD SCI USA, V109, P5346, DOI 10.1073/pnas.1116763109; RICE WR, 1987, GENETICS, V116, P161; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.2307/2408899; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Schultheiss R, 2015, GENOME BIOL EVOL, V7, P581, DOI 10.1093/gbe/evv013; Scotti I, 2006, EVOLUTION, V60, P1793; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Yoshida K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004223	91	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	AUG	2015	32	8					1981	1995		10.1093/molbev/msv078		15	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CQ4PG	WOS:000360586500006		
J	Zeller, M; Heylen, E; Damanka, S; Pietsch, C; Donato, C; Tamura, T; Kulkarni, R; Arora, R; Cunliffe, N; Maunula, L; Potgieter, C; Tamim, S; De Coster, S; Zhirakovskaya, E; Bdour, S; O'Shea, H; Kirkwood, CD; Seheri, M; Nyaga, MM; Mphahlele, J; Chitambar, SD; Dagan, R; Armah, G; Tikunova, N; Van Ranst, M; Matthijnssens, J				Zeller, Mark; Heylen, Elisabeth; Damanka, Susan; Pietsch, Corinna; Donato, Celeste; Tamura, Tsutomu; Kulkarni, Ruta; Arora, Ritu; Cunliffe, Nigel; Maunula, Leena; Potgieter, Christiaan; Tamim, Sana; De Coster, Sarah; Zhirakovskaya, Elena; Bdour, Salwa; O'Shea, Helen; Kirkwood, Carl D.; Seheri, Mapaseka; Nyaga, Martin Monene; Mphahlele, Jeffrey; Chitambar, Shobha D.; Dagan, Ron; Armah, George; Tikunova, Nina; Van Ranst, Marc; Matthijnssens, Jelle			Emerging OP354-Like P[8] Rotaviruses Have Rapidly Dispersed from Asia to Other Continents	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						OP354-like P[8]; rotaviruses; emerging viruses; reassortment	GROUP-A ROTAVIRUS; STRAIN DIVERSITY; VACCINATION PROGRAMS; GLOBAL SPREAD; G12 STRAINS; VP4 GENE; CHILDREN; GENOTYPES; DIARRHEA; BELGIUM	The majority of human group A rotaviruses possess the P[8] VP4 genotype. Recently, a genetically distinct subtype of the P[8] genotype, also known as OP354-like P[8] or lineage P[8]-4, emerged in several countries. However, it is unclear for how long the OP354-like P[8] gene has been circulating in humans and how it has spread. In a global collaborative effort 98 (near-) complete OP354-like P[8] VP4 sequences were obtained and used for phylogeographic analysis to determine the viral migration patterns. During the sampling period, 1988-2012, we found that South and East Asia acted as a source from which strains with the OP354-like P[8] gene were seeded to Africa, Europe, and North America. The time to the most recent common ancestor (TMRCA) of all OP354-like P[8] genes was estimated at 1987. However, most OP354-like P[8] strains were found in three main clusters with TMRCAs estimated between 1996 and 2001. The VP7 gene segment of OP354-like P[8] strains showed evidence of frequent reassortment, even in localized epidemics, suggesting that OP354-like P[8] genes behave in a similar manner on the evolutionary level as other P[8] subtypes. The results of this study suggest that OP354-like P[8] strains have been able to disperse globally in a relatively short time period. This, in combination with a relatively large genetic distance to other P[8] subtypes, might result in a lower vaccine effectiveness, underscoring the need for a continued surveillance of OP354-like P[8] strains, especially in countries where rotavirus vaccination programs are in place.	[Zeller, Mark; Heylen, Elisabeth; De Coster, Sarah; Van Ranst, Marc; Matthijnssens, Jelle] Univ Leuven, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, KU Leuven,Rega Inst Med Res, Leuven, Belgium; [Damanka, Susan; Armah, George] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Legon, Ghana; [Pietsch, Corinna] Univ Leipzig, Inst Virol, D-04109 Leipzig, Germany; [Donato, Celeste; Kirkwood, Carl D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Enter Virus Grp, Melbourne, Vic, Australia; [Tamura, Tsutomu] Niigata Prefectural Inst Publ Hlth & Environm Sci, Dept Virol, Niigata 9502144, Japan; [Kulkarni, Ruta; Arora, Ritu; Chitambar, Shobha D.] Natl Inst Virol, Enter Viruses Grp, Pune, Maharashtra, India; [Cunliffe, Nigel] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Maunula, Leena] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Potgieter, Christiaan] North West Univ, Ctr Human Metabon, Dept Biochem, Potchefstroom, South Africa; [Potgieter, Christiaan] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa; [Tamim, Sana] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Zhirakovskaya, Elena; Tikunova, Nina] Inst Chem Biol & Fundamental Med, Mol Microbiol Lab, Novosibirsk, Russia; [Bdour, Salwa] Univ Jordan, Fac Sci, Dept Biol Sci, Amman, Jordan; [O'Shea, Helen] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Seheri, Mapaseka; Nyaga, Martin Monene; Mphahlele, Jeffrey] Sefako Makgatho Hlth Sci Univ, Fac Hlth Sci, Diarrhoeal Pathogens Res Unit, South African Med Res Council, Pretoria, South Africa; [Dagan, Ron] Soroka Univ, Med Ctr, Beer Sheva, Israel; [Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Zeller, M (reprint author), Univ Leuven, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, KU Leuven,Rega Inst Med Res, Leuven, Belgium.	mark.zeller@uz.kuleuven.ac.be; jelle.matthijnssens@uz.kuleuven.ac.be	Matthijnssens, Jelle/A-6770-2015		Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)	M.Z. was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen).	Amimo JO, 2014, VET MICROBIOL, V175, P195; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Seheri M, 2014, PEDIATR INFECT DIS J, V33, pS76, DOI 10.1097/INF.0000000000000053; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Matthijnssens J, 2014, CLIN MICROBIOL INFEC, V20, pO702, DOI 10.1111/1469-0691.12612; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Tamura T, 2010, JPN J INFECT DIS, V63, P405; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80-8.3801-3810.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; Paulke-Korinek M, 2013, VACCINE, V31, P2686, DOI 10.1016/j.vaccine.2013.04.001; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Braeckman T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4752; da Silva Soares Luana, 2014, J Med Virol, V86, P1065, DOI 10.1002/jmv.23797; Dong Hui-jin, 2011, Chinese Journal of Virology, V27, P565; Estes M, 2007, FIELDS VIROLOGY, V2, P1917; Ghosh S, 2010, SE ASIAN J TROP MED, V41, P1393; Halaihel N, 2010, EPIDEMIOL INFECT, V138, P542, DOI 10.1017/S0950268809990872; Heylen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100953; Ichihara MYT, 2014, VACCINE, V32, P2740, DOI 10.1016/j.vaccine.2014.01.007; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Matthijnssens J, 2010, EMERG INFECT DIS, V16, P625, DOI 10.3201/eid1604.091591; MAUNULA L, 1995, ARCH VIROL, V140, P877, DOI 10.1007/BF01314964; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Nagashima S, 2010, JPN J INFECT DIS, V63, P208; Nguyen TA, 2008, CLIN MICROBIOL INFEC, V14, P235, DOI 10.1111/j.1469-0691.2007.01918.x; Pietsch C, 2011, J CLIN VIROL, V50, P136, DOI 10.1016/j.jcv.2010.10.013; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Zade JK, 2009, EPIDEMIOL INFECT, V137, P936, DOI 10.1017/S0950268808001532; Zhirakovskaya EV, 2012, MOL GENET MICROBIOL+, V27, P174, DOI 10.3103/S0891416812040076	47	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	AUG	2015	32	8					2060	2071		10.1093/molbev/msv088		12	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CQ4PG	WOS:000360586500012		
J	Bennett, TD; Tan, JC; Yue, YZ; Baxter, E; Ducati, C; Terrill, NJ; Yeung, HHM; Zhou, ZF; Chen, WL; Henke, S; Cheetham, AK; Greaves, GN				Bennett, Thomas D.; Tan, Jin-Chong; Yue, Yuanzheng; Baxter, Emma; Ducati, Caterina; Terrill, Nick J.; Yeung, Hamish H-M; Zhou, Zhongfu; Chen, Wenlin; Henke, Sebastian; Cheetham, Anthony K.; Greaves, G. Neville			Hybrid glasses from strong and fragile metal-organic framework liquids	NATURE COMMUNICATIONS			English	Article							ZEOLITIC IMIDAZOLATE FRAMEWORKS; PRESSURE-INDUCED AMORPHIZATION; 2 AMORPHOUS PHASES; FORMING LIQUIDS; 1ST-ORDER TRANSITION; SUPERCOOLED LIQUIDS; ULTRASTABLE GLASSES; THERMODYNAMICS; MODEL; STATE	Hybrid glasses connect the emerging field of metal-organic frameworks (MOFs) with the glass formation, amorphization and melting processes of these chemically versatile systems. Though inorganic zeolites collapse around the glass transition and melt at higher temperatures, the relationship between amorphization and melting has so far not been investigated. Here we show how heating MOFs of zeolitic topology first results in a low density 'perfect' glass, similar to those formed in ice, silicon and disaccharides. This order-order transition leads to a super-strong liquid of low fragility that dynamically controls collapse, before a subsequent order-disorder transition, which creates a more fragile high-density liquid. After crystallization to a dense phase, which can be remelted, subsequent quenching results in a bulk glass, virtually identical to the high-density phase. We provide evidence that the wide-ranging melting temperatures of zeolitic MOFs are related to their network topologies and opens up the possibility of 'melt-casting' MOF glasses.	[Bennett, Thomas D.; Baxter, Emma; Ducati, Caterina; Henke, Sebastian; Cheetham, Anthony K.; Greaves, G. Neville] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Tan, Jin-Chong] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Yue, Yuanzheng] Aalborg Univ, Sect Chem, DK-9220 Aalborg, Denmark; [Yue, Yuanzheng; Greaves, G. Neville] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China; [Terrill, Nick J.] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England; [Yeung, Hamish H-M] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Zhou, Zhongfu; Chen, Wenlin; Greaves, G. Neville] Aberystwyth Univ, Inst Math Phys & Comp Sci, Dept Phys, Aberystwyth SY23 3BZ, Dyfed, Wales; [Henke, Sebastian] Ruhr Univ Bochum, Fak Chem & Biochem, Lehrstuhl Anorgan Chem 2, D-44801 Bochum, Germany	Bennett, TD (reprint author), Univ Cambridge, Dept Mat Sci & Met, Charles Babbage Rd, Cambridge CB3 0FS, England.	tdb35@cam.ac.uk; gng25@cam.ac.uk	Tan, Jin-Chong/A-9378-2010		ERC [259619 PHOTO EM]	The authors would like to thank Trinity Hall (T.D.B.); HRH Sheikh Saud Bin Saqr Al Qasimi (T.D.B. and A.K.C.); Wuhan University of Science and Technology (Y.Z.Y. and G.N.G.), ERC grant number 259619 PHOTO EM (C.D.); the Alexander von Humboldt Foundation (S.H.); The World Premier International Research Center Initiative on Materials Nanoarchitectronics (WPI-MANA) from MEXT, Japan (H.H.M.Y.). We acknowledge the provision of synchrotron access to Beamline I15 (exp. EE9691) and I22 (exp. SM5692) at the Diamond Light Source, Rutherford Appleton Laboratory UK. Dr Philip Chater (Diamond Light Source) and Andrew Cairns (Oxford) are thanked for assistance during the beamtime on I15, as is Professor David Keen (ISIS) for valuable assistance with the data analysis. Professor Seth Cohen and Xiao Yu (University California San Diego) are acknowledged for BET measurements.	Angell A, 1998, NATURE, V393, P521, DOI 10.1038/31110; Angell A., 2012, INT S NON NEW OPT GL; Angell CA, 2000, J NON-CRYST SOLIDS, V274, P319, DOI 10.1016/S0022-3093(00)00222-2; Singh S, 2013, NAT MATER, V12, P139, DOI [10.1038/nmat3521, 10.1038/NMAT3521]; Amann-Winkel K, 2013, P NATL ACAD SCI USA, V110, P17720, DOI 10.1073/pnas.1311718110; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Tan JC, 2015, CRYSTENGCOMM, V17, P375, DOI 10.1039/c4ce01564a; Ornstein LS, 1914, P K AKAD WET-AMSTERD, V17, P793; Greaves GN, 2008, SCIENCE, V322, P566, DOI 10.1126/science.1160766; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Greaves GN, 2003, NAT MATER, V2, P622, DOI 10.1038/nmat963; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Peral I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225502; Greaves GN, 2005, SCIENCE, V308, P1299, DOI 10.1126/science.1109411; Bennett TD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.115503; Novikov VN, 2004, NATURE, V431, P961, DOI 10.1038/nature02947; Rogez G, 2010, ANGEW CHEM INT EDIT, V49, P1921, DOI 10.1002/anie.200906660; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Stevenson JD, 2005, J PHYS CHEM B, V109, P15093, DOI 10.1021/jp052279h; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Bennett TD, 2011, CHEM COMMUN, V47, P7983, DOI 10.1039/c1cc11985k; Chapman KW, 2009, J AM CHEM SOC, V131, P17546, DOI 10.1021/ja908415z; CHEN JS, 1994, ANGEW CHEM INT EDIT, V33, P639, DOI 10.1002/anie.199406391; Mauro JC, 2009, P NATL ACAD SCI USA, V106, P19780, DOI 10.1073/pnas.0911705106; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Greaves GN, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/415102; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Haines J, 2009, J AM CHEM SOC, V131, P12333, DOI 10.1021/ja904054v; Deb SK, 2001, NATURE, V414, P528, DOI 10.1038/35107036; Bennett TD, 2011, ANGEW CHEM INT EDIT, V50, P3067, DOI 10.1002/anie.201007303; Bennett TD, 2014, ACCOUNTS CHEM RES, V47, P1555, DOI 10.1021/ar5000314; Aptekar L. I., 1979, SOV PHYS DOKL, V249, P1099; Bateman JE, 2007, NUCL INSTRUM METH A, V580, P1526, DOI 10.1016/j.nima.2007.07.006; Ding SP, 1996, J THERM ANAL CALORIM, V47, P1391, DOI 10.1007/BF01992835; Hall C. J., 2000, NUCL INSTRUM METH A, V454, P2000; Navrotsky A, 2001, CHEM-EUR J, V7, P769, DOI 10.1002/1521-3765(20010216)7:4<769::AID-CHEM769>3.0.CO;2-J; Perez-Castaneda T, 2014, P NATL ACAD SCI USA, V111, P11275, DOI 10.1073/pnas.1405545111; Poirer J. P., 2000, INTRO PHYS EARTHS IN; RAPOPORT E, 1967, J CHEM PHYS, V46, P2891, DOI 10.1063/1.1841150; Stanley H.F., 1971, INTRO PHASE TRANSITI; Wang LM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2244551; Zhu M, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4922543	43	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8079	10.1038/ncomms9079		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1JN	WOS:000360353700005		
J	Cha, JY; Kim, WY; Kang, SB; Kim, JI; Baek, D; Jung, IJ; Kim, MR; Li, N; Kim, HJ; Nakajima, M; Asami, T; Sabir, JSM; Park, HC; Lee, SY; Bohnert, HJ; Bressan, RA; Pardo, JM; Yun, DJ				Cha, Joon-Yung; Kim, Woe-Yeon; Kang, Sun Bin; Kim, Jeong Im; Baek, Dongwon; Jung, In Jung; Kim, Mi Ri; Li, Ning; Kim, Hyun-Jin; Nakajima, Masatoshi; Asami, Tadao; Sabir, Jamal S. M.; Park, Hyeong Cheol; Lee, Sang Yeol; Bohnert, Hans J.; Bressan, Ray A.; Pardo, Jose M.; Yun, Dae-Jin			A novel thiol-reductase activity of Arabidopsis YUC6 confers drought tolerance independently of auxin biosynthesis	NATURE COMMUNICATIONS			English	Article							DEPENDENT THIOREDOXIN REDUCTASE; FLAVIN MONOOXYGENASES; LEAF SENESCENCE; 2-CYS PEROXIREDOXINS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; STOMATAL CLOSURE; ABIOTIC STRESS; HEAT-SHOCK; PLANTS	YUCCA (YUC) proteins constitute a family of flavin monooxygenases (FMOs), with an important role in auxin (IAA) biosynthesis. Here we report that Arabidopsis plants overexpressing YUC6 display enhanced IAA-related phenotypes and exhibit improved drought stress tolerance, low rate of water loss and controlled ROS accumulation under drought and oxidative stresses. Co-overexpression of an IAA-conjugating enzyme reduces IAA levels but drought stress tolerance is unaffected, indicating that the stress-related phenotype is not based on IAA overproduction. YUC6 contains a previously unrecognized FAD-and NADPH-dependent thiol-reductase activity (TR) that overlaps with the FMO domain involved in IAA biosynthesis. Mutation of a conserved cysteine residue (Cys-85) preserves FMO but suppresses TR activity and stress tolerance, whereas mutating the FAD-and NADPH-binding sites, that are common to TR and FMO domains, abolishes all outputs. We provide a paradigm for a single protein playing a dual role, regulating plant development and conveying stress defence responses.	[Cha, Joon-Yung; Kim, Woe-Yeon; Kang, Sun Bin; Baek, Dongwon; Jung, In Jung; Kim, Mi Ri; Li, Ning; Kim, Hyun-Jin; Lee, Sang Yeol; Yun, Dae-Jin] Gyeongsang Natl Univ, PMBBRC, Div Appl Life Sci BK21Plus, Jinju 660701, South Korea; [Cha, Joon-Yung; Kim, Woe-Yeon; Kang, Sun Bin; Baek, Dongwon; Jung, In Jung; Kim, Mi Ri; Li, Ning; Kim, Hyun-Jin; Lee, Sang Yeol; Yun, Dae-Jin] Gyeongsang Natl Univ, IALS, Jinju 660701, South Korea; [Kim, Jeong Im] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Nakajima, Masatoshi; Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Nakajima, Masatoshi; Asami, Tadao] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Asami, Tadao] King Abdulaziz Univ, Dept Biochem, Jeddah 21589, Saudi Arabia; [Sabir, Jamal S. M.; Bohnert, Hans J.; Bressan, Ray A.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah 21589, Saudi Arabia; [Park, Hyeong Cheol] Natl Inst Ecol, Dept Ecol Adaptat, Seocheon 325813, South Korea; [Bohnert, Hans J.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Bressan, Ray A.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Pardo, Jose M.] CSIC, Inst Recursos Nat & Agrobiol, Seville 41012, Spain	Yun, DJ (reprint author), Gyeongsang Natl Univ, PMBBRC, Div Appl Life Sci BK21Plus, Jinju 660701, South Korea.	djyun@gnu.ac.kr	Pardo, Jose M/B-4652-2009	Pardo, Jose M/0000-0003-4510-8624	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2013R1A2A1A01005170]; Next-Generation BioGreen21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ01106901]; BK21Plus Program, the Ministry of Education, Korea; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST), Japan	We thank Dr Yunde Zhao for generously sharing the quadruple mutant yuc1,2,4,6 seeds and Dr Verena Kriechbaumer for kindly supporting comments for in vitro YUC assay. This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP; 2013R1A2A1A01005170) and Next-Generation BioGreen21 Program (SSAC, PJ01106901), Rural Development Administration, Republic of Korea. J.-Y.C. and M.R.K. were supported by a scholarship from the BK21Plus Program, the Ministry of Education, Korea. M.N. and T.A. were supported by grants from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST), Japan.	Ulmasov T, 1997, PLANT CELL, V9, P1963; Park SK, 2009, PLANT PHYSIOL, V150, P552, DOI 10.1104/pp.109.135426; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; Woodward C, 2005, PLANT PHYSIOL, V139, P192, DOI 10.1104/pp.105.063495; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Lee M, 2012, PLANTA, V235, P923, DOI 10.1007/s00425-011-1552-3; STROTHER S, 1988, GERONTOLOGY, V34, P151; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Tognetti VB, 2012, PLANT CELL ENVIRON, V35, P321, DOI 10.1111/j.1365-3040.2011.02324.x; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Kim JI, 2007, PLANT PHYSIOL, V145, P722, DOI 10.1104/pp.107.104935; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Kriechbaumer V, 2012, PLANT J, V70, P292, DOI 10.1111/j.1365-313X.2011.04866.x; Joo JH, 2005, FEBS LETT, V579, P1243, DOI 10.1016/j.febslet.2005.01.018; Blomster T, 2011, PLANT PHYSIOL, V157, P1866, DOI 10.1104/pp.111.181883; Kim TS, 2011, P NATL ACAD SCI USA, V108, P16843, DOI 10.1073/pnas.1110406108; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Quittenden LJ, 2009, PLANT PHYSIOL, V151, P1130, DOI 10.1104/pp.109.141507; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Cha JY, 2014, PLANT PHYSIOL BIOCH, V80, P184, DOI 10.1016/j.plaphy.2014.04.008; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Kim JI, 2013, MOL PLANT, V6, P337, DOI 10.1093/mp/sss100; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Guan LQM, 2002, PHYSIOL PLANTARUM, V114, P288, DOI 10.1034/j.1399-3054.2002.1140215.x; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Urbanova T, 2013, TALANTA, V112, P85, DOI 10.1016/j.talanta.2013.03.068; Gallavotti A, 2008, P NATL ACAD SCI USA, V105, P15196, DOI 10.1073/pnas.0805596105; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Sanz-Barrio R, 2012, J EXP BOT, V63, P365, DOI 10.1093/jxb/err282; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Chae HB, 2013, MOL PLANT, V6, P323, DOI 10.1093/mp/sss105; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Goda H, 2008, PLANT J, V55, P526, DOI 10.1111/j.0960-7412.2008.03510.x; Bashandy Talaat, 2011, Plant Signal Behav, V6, P117; Cha JY, 2009, CELL STRESS CHAPERON, V14, P233, DOI 10.1007/s12192-008-0077-6; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Gue J.-M., 2010, J AGR FOOD CHEM, V58, P6556; Jannat R, 2011, J PLANT PHYSIOL, V168, P1919, DOI 10.1016/j.jplph.2011.05.006; Jing HC, 2008, PLANT BIOLOGY, V10, P85, DOI 10.1111/j.1438-8677.2008.00087.x; Khokon MAR, 2010, PLANT CELL PHYSIOL, V51, P1915, DOI 10.1093/pcp/pcq145; Lglesias M. J., 2010, PLANT MOL BIOL, V74, P215; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Monoharan R., 2013, FREE RADIC BIOL MED, V63, P313; Rubinovich L, 2010, PLANT J, V64, P1018, DOI 10.1111/j.1365-313X.2010.04390.x; Sakamoto M, 2008, PLANT J, V56, P13, DOI 10.1111/j.1365-313X.2008.03577.x; Woo YM, 2007, PLANT MOL BIOL, V65, P125, DOI 10.1007/s11103-007-9203-6; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	69	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8041	10.1038/ncomms9041		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1JB	WOS:000360352300003		
J	Chavez, JD; Schweppe, DK; Eng, JK; Zheng, CX; Taipale, A; Zhang, YY; Takara, K; Bruce, JE				Chavez, Juan D.; Schweppe, Devin K.; Eng, Jimmy K.; Zheng, Chunxiang; Taipale, Alex; Zhang, Yiyi; Takara, Kohji; Bruce, James E.			Quantitative interactome analysis reveals a chemoresistant edgotype	NATURE COMMUNICATIONS			English	Article							PROTEIN-PROTEIN INTERACTIONS; TOPOISOMERASE-I INHIBITORS; LINKING MASS-SPECTROMETRY; DRUG-RESISTANT PHENOTYPE; CHEMICAL CROSS-LINKING; CANCER CELL-LINE; INTERMEDIATE-FILAMENTS; POSTTRANSLATIONAL MODIFICATIONS; INTERACTION NETWORK; MECHANISMS	Chemoresistance is a common mode of therapy failure for many cancers. Tumours develop resistance to chemotherapeutics through a variety of mechanisms, with proteins serving pivotal roles. Changes in protein conformations and interactions affect the cellular response to environmental conditions contributing to the development of new phenotypes. The ability to understand how protein interaction networks adapt to yield new function or alter phenotype is limited by the inability to determine structural and protein interaction changes on a proteomic scale. Here, chemical crosslinking and mass spectrometry were employed to quantify changes in protein structures and interactions in multidrug-resistant human carcinoma cells. Quantitative analysis of the largest crosslinking-derived, protein interaction network comprising 1,391 crosslinked peptides allows for 'edgotype' analysis in a cell model of chemoresistance. We detect consistent changes to protein interactions and structures, including those involving cytokeratins, topoisomerase-2-alpha, and post-translationally modified histones, which correlate with a chemoresistant phenotype.	[Chavez, Juan D.; Schweppe, Devin K.; Eng, Jimmy K.; Zheng, Chunxiang; Taipale, Alex; Zhang, Yiyi; Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Takara, Kohji] Himeji Dokkoyo Univ, Dept Pharmaceut Sci, Himeji, Hyogo 6708524, Japan	Bruce, JE (reprint author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jimbruce@u.washington.edu			National Institutes of Health [5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775, 1R01HL110879]; UW Proteome Resource [UWPR95794]	We thank all of the members of the Bruce Laboratory and the UWPR for their advice and helpful discussions. We also thank Ron Seifert of the Garvey Imaging Laboratory at the Lynn and Mike Garvey Cell Imaging Lab for advice on the fluorescence microscopy. This work was supported by the National Institutes of Health through grant numbers: 5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775 and 1R01HL110879 and supported in part by the UW Proteome Resource UWPR95794.	Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Hammer E, 2010, PROTEOMICS, V10, P99, DOI 10.1002/pmic.200800626; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Liu F, 2008, LIFE SCI, V83, P496, DOI 10.1016/j.lfs.2008.07.017; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Kaake RM, 2014, MOL CELL PROTEOMICS, V13, P3533, DOI 10.1074/mcp.M114.042630; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Chavez JD, 2013, MOL CELL PROTEOMICS, V12, P1451, DOI 10.1074/mcp.M112.024497; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Takara K, 2009, CANCER LETT, V278, P88, DOI 10.1016/j.canlet.2008.12.033; Garcia H, 2013, CELL REP, V4, P159, DOI 10.1016/j.celrep.2013.06.013; Anderson JM, 1996, CLIN CANCER RES, V2, P97; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI [10.1038/nmeth.1280, 10.1038/NMETH.1280]; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Chavez JD, 2011, J PROTEOME RES, V10, P1528, DOI 10.1021/pr100898e; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Kumari A, 2009, J CELL BIOCHEM, V108, P508, DOI 10.1002/jcb.22280; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Tang XT, 2005, ANAL CHEM, V77, P311, DOI 10.1021/ac0488762; Weisbrod CR, 2013, J PROTEOME RES, V12, P1569, DOI 10.1021/pr3011638; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; BAUMAN PA, 1994, P NATL ACAD SCI USA, V91, P5311, DOI 10.1073/pnas.91.12.5311; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; de Haas EC, 2008, NEOPLASIA, V10, P1041, DOI 10.1593/neo.08620; Stoetzer OJ, 2013, CANCER LETT, V336, P140, DOI 10.1016/j.canlet.2013.04.013; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Zheng CX, 2013, J PROTEOME RES, V12, P1989, DOI 10.1021/pr301162j; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Tang XT, 2010, MOL BIOSYST, V6, P939, DOI 10.1039/b920876c; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Bruce JE, 2012, PROTEOMICS, V12, P1565, DOI 10.1002/pmic.201100516; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Bichat F, 1997, ANTICANCER RES, V17, P3393; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chavez JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019892; Chavez JD, 2012, J PROTEOME RES, V11, P2968, DOI 10.1021/pr300041t; Chen MC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.330; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Cress AE, 1996, CANCER METAST REV, V15, P499, DOI 10.1007/BF00054015; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Navare AT, 2015, STRUCTURE, V23, P762, DOI 10.1016/j.str.2015.01.022; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Schmidt C, 2014, NAT PROTOC, V9, P2224, DOI 10.1038/nprot.2014.144; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; SUGIMOTO Y, 1990, CANCER RES, V50, P7962; Tsurutani J, 2002, LUNG CANCER-J IASLC, V35, P299, DOI 10.1016/S0169-5002(01)00425-1; Weisbrod CR, 2013, J PROTEOMICS, V88, P109, DOI 10.1016/j.jprot.2013.04.009; Zheng C., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M110.006841	70	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7928	10.1038/ncomms8928		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1GT	WOS:000360346000010		
J	Gasser, T; Guivarch, C; Tachiiri, K; Jones, CD; Ciais, P				Gasser, T.; Guivarch, C.; Tachiiri, K.; Jones, C. D.; Ciais, P.			Negative emissions physically needed to keep global warming below 2 degrees C	NATURE COMMUNICATIONS			English	Article							CLIMATE-CHANGE; CO2 EMISSIONS; TEMPERATURE; TARGETS; ENERGY; ECONOMICS; NO	To limit global warming to <2 degrees C we must reduce the net amount of CO2 we release into the atmosphere, either by producing less CO2 (conventional mitigation) or by capturing more CO2 (negative emissions). Here, using state-of-the-art carbon-climate models, we quantify the trade-off between these two options in RCP2.6: an Intergovernmental Panel on Climate Change scenario likely to limit global warming below 2 degrees C. In our best-case illustrative assumption of conventional mitigation, negative emissions of 0.5-3 Gt C (gigatonnes of carbon) per year and storage capacity of 50-250 Gt C are required. In our worst case, those requirements are 7-11 Gt C per year and 1,000-1,600 Gt C, respectively. Because these figures have not been shown to be feasible, we conclude that development of negative emission technologies should be accelerated, but also that conventional mitigation must remain a substantial part of any climate policy aiming at the 2-degrees C target.	[Gasser, T.; Ciais, P.] CEA Orme Merisiers, UVSQ, CEA, CNRS,IPSL,LSCE, F-91191 Gif Sur Yvette, France; [Gasser, T.; Guivarch, C.] AgroParisTech, Ecole Ponts ParisTech, EHESS, CNRS,CIRAD,CIRED, F-94736 Nogent Sur Marne, France; [Tachiiri, K.] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Jones, C. D.] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	Gasser, T (reprint author), CEA Orme Merisiers, UVSQ, CEA, CNRS,IPSL,LSCE, F-91191 Gif Sur Yvette, France.	tgasser@lsce.ipsl.fr	Tachiiri, Kaoru/G-7607-2011		European Research Council Synergy [ERC-2013-SyG-610028 IMBALANCE-P]; Joint UK DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]	We thank W. Dang for constructive discussion about the figures and D. van Vuuren for providing data from the 'original' RCP2.6. We also thank the participants and organizers of the workshops on negative emissions: in Vienna, on April 2013, organized by the International Institute for Applied Systems Analysis (IIASA) and the Global Carbon Project (GCP) and in Tokyo, on December 2013, organized by GCP, IIASA, the Mercator Research Institute on Global Commons and Climate Change and the National Institute for Environmental Studies. T.G. was supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P. C.D.J. was supported by the Joint UK DECC/Defra Met Office Hadley Centre Climate Programme (GA01101).	Allwood J. M., 2013, CLIMATE CHANGE 2014; Edenhofer O, 2010, ENERG J, V31, P11; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; HaDuong M, 1997, NATURE, V390, P270; Obersteiner M, 2001, SCIENCE, V294, P786; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P1, DOI 10.1007/s10584-011-0157-y; Gasser T, 2013, EARTH SYST DYNAM, V4, P171, DOI 10.5194/esd-4-171-2013; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; MacDougall AH, 2013, GEOPHYS RES LETT, V40, P5480, DOI 10.1002/2013GL057467; Anderson K, 2008, PHILOS T R SOC A, V366, P3863, DOI 10.1098/rsta.2008.0138; Davis SJ, 2010, SCIENCE, V329, P1330, DOI 10.1126/science.1188566; Kriegler E, 2013, CLIMATIC CHANGE, V118, P45, DOI 10.1007/s10584-012-0681-4; Pielke R, 2008, NATURE, V452, P531, DOI 10.1038/452531a; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI 10.1007/s10584-011-0152-3; Rogelj J, 2013, NAT CLIM CHANGE, V3, P405, DOI [10.1038/nclimate1758, 10.1038/NCLIMATE1758]; Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1; Azar C, 2010, CLIMATIC CHANGE, V100, P195, DOI 10.1007/s10584-010-9832-7; Azar C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034004; Benson SM, 2012, GLOBAL ENERGY ASSESS, P993; Calvin K., 2009, ENERG ECON, V3, pS107; Cherubini F, 2014, NAT CLIM CHANGE, V4, P983, DOI [10.1038/NCLIMATE2399, 10.1038/nclimate2399]; Ciais P, 2013, CLIMATE CHANGE 2013; Collins M, 2013, CLIMATE CHANGE 2013; Edmonds J, 2013, CLIMATIC CHANGE, V118, P29, DOI 10.1007/s10584-012-0678-z; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/ngeo2248, 10.1038/NGEO2248]; Fuss S, 2014, NAT CLIM CHANGE, V4, P850; Gasser T, 2014, THESIS U P M CURIE; Guivarch C, 2013, GLOBAL ENVIRON CHANG, V23, P179, DOI 10.1016/j.gloenvcha.2012.10.006; Guivarch C, 2011, CLIMATIC CHANGE, V109, P801, DOI 10.1007/s10584-011-0268-5; Kriegler E., 2013, CLIM CHANGE EC, V04; Lomax G, 2015, NAT CLIM CHANGE, V5, P498; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Rosen RA, 2015, TECHNOL FORECAST SOC, V91, P93, DOI 10.1016/j.techfore.2014.01.013; Scott V, 2013, NAT CLIM CHANGE, V3, P105, DOI [10.1038/NCLIMATE1695, 10.1038/nclimate1695]; Smil V, 2008, NATURE, V453, P154, DOI 10.1038/453154a; Tachiiri K, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20586; van der Meer JWM, 2014, SCIENCE, V345, P1130, DOI 10.1126/science.345.6201.1130-a; van Vuuren DP, 2013, CLIMATIC CHANGE, V118, P15, DOI 10.1007/s10584-012-0680-5; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345	42	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7958	10.1038/ncomms8958		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1HA	WOS:000360346700013		
J	Hongu, T; Funakoshi, Y; Fukuhara, S; Suzuki, T; Sakimoto, S; Takakura, N; Ema, M; Takahashi, S; Itoh, S; Kato, M; Hasegawa, H; Mochizuki, N; Kanaho, Y				Hongu, Tsunaki; Funakoshi, Yuji; Fukuhara, Shigetomo; Suzuki, Teruhiko; Sakimoto, Susumu; Takakura, Nobuyuki; Ema, Masatsugu; Takahashi, Satoru; Itoh, Susumu; Kato, Mitsuyasu; Hasegawa, Hiroshi; Mochizuki, Naoki; Kanaho, Yasunori			Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial beta 1 integrin recycling	NATURE COMMUNICATIONS			English	Article							SMALL GTPASE ARF6; MEMBRANE RUFFLE FORMATION; SIGNALING PATHWAY; DOWNSTREAM EFFECTOR; VASCULAR STABILITY; INTEGRIN BETA-1; EXOCYST COMPLEX; MET; CANCER; METASTASIS	Anti-angiogenic drugs targeting vascular endothelial cell growth factor receptor have provided modest clinical benefit, in part, owing to the actions of additional angiogenic factors that stimulate tumour neoangiogenesis in parallel. To overcome this redundancy, approaches targeting these other signalling pathways are required. Here we show, using endothelial cell-targeted mice, that the small GTPase Arf6 is required for hepatocyte growth factor (HGF)-induced tumour neoangiogenesis and growth. Arf6 deletion from endothelial cells abolishes HGF-stimulated beta 1 integrin recycling. Pharmacological inhibition of the Arf6 guanine nucleotide exchange factor (GEF) Grp1 efficiently suppresses tumour vascularization and growth. Grp1 as well as other Arf6 GEFs, such as GEP100, EFA6B and EFA6D, regulates HGF-stimulated b1 integrin recycling. These findings provide insight into the mechanism of HGF-induced tumour angiogenesis and offer the possibility that targeting the HGF-activated Arf6 signalling pathway may synergize with existing anti-angiogenic drugs to improve clinical outcomes.	[Hongu, Tsunaki; Funakoshi, Yuji; Suzuki, Teruhiko; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Fac Med, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan; [Hongu, Tsunaki; Funakoshi, Yuji; Suzuki, Teruhiko; Ema, Masatsugu; Takahashi, Satoru; Itoh, Susumu; Kato, Mitsuyasu; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, Suita, Osaka 5658565, Japan; [Sakimoto, Susumu; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Itoh, Susumu; Kato, Mitsuyasu] Univ Tsukuba, Fac Med, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan	Kanaho, Y (reprint author), Univ Tsukuba, Fac Med, Dept Physiol Chem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ykanaho@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT) [17079008, 20247010, 21700339, 24890028, 25860206]; Japan Society for the Promotion of Science; Sagawa Foundation for Promotion of Cancer Research; Yasuda Medical Foundation; Takeda Science Foundation; YOKOYAMA foundation for Clinical Pharmacology	We thank K. Miyazawa for a generous gift of HGF and K. Araki for supplying FLPe transgenic mice. We also thank O. Ohneda, F. Ito, M. Nagano, Y. Watanabe and C. Aoyama for their technical support. We are grateful to M. A. Frohman and P. ten Dijke for their helpful discussion and critical reading of the manuscript. This work was supported by Grant-in-Aid for Scientific Research (KAKENHI, 17079008 and 20247010 to Y.K., 21700339 to H.H., 24890028 and 25860206 to T.H.) and Special Coordination Funds for Promoting Science and Technology (to H.H.) from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), and Japan Society for the Promotion of Science. This work was also supported by research grants (to Y. F.) from The Sagawa Foundation for Promotion of Cancer Research, The Yasuda Medical Foundation, Takeda Science Foundation and YOKOYAMA foundation for Clinical Pharmacology.	Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.0052; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Akiyama M, 2010, DEV DYNAM, V239, P3416, DOI 10.1002/dvdy.22481; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; BAZZONI G, 1995, J BIOL CHEM, V270, P25570; Distler JHW, 2003, Q J NUCL MED, V47, P149; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; GHERARDI E, 1990, NATURE, V346, P228, DOI 10.1038/346228b0; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1046/j.1600-0854.2003.00150.x; Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Li J, 2012, DEV CELL, V22, P1286, DOI 10.1016/j.devcel.2012.03.004; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Cantelmo AR, 2010, ONCOGENE, V29, P5286, DOI 10.1038/onc.2010.267; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Grepin R, 2010, J ONCOL, V2010, P1, DOI DOI 10.1155/2010/835680; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Nogami M, 2003, FEBS LETT, V536, P71, DOI 10.1016/S0014-5793(03)00013-9; Ribatti D, 2011, CANCER TREAT REV, V37, P344, DOI 10.1016/j.ctrv.2011.02.002; Sakimoto S, 2012, DEVELOPMENT, V139, P1327, DOI 10.1242/dev.072330; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Tang H, 2002, J BIOL CHEM, V277, P5441, DOI 10.1074/jbc.M110673200; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035	59	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7925	10.1038/ncomms8925		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1GT	WOS:000360346000007		
J	Ishii, T; Sato, K; Kakumoto, T; Miura, S; Touhara, K; Takeuchi, S; Nakata, T				Ishii, Tomohiro; Sato, Koji; Kakumoto, Toshiyuki; Miura, Shigenori; Touhara, Kazushige; Takeuchi, Shoji; Nakata, Takao			Light generation of intracellular Ca2+ signals by a genetically encoded protein BACCS	NATURE COMMUNICATIONS			English	Article							CRAC CHANNELS; PHOTORECEPTOR PHOTOTROPIN; MOLECULAR DETERMINANTS; CALCIUM-CHANNELS; ORAI CHANNELS; TRPC CHANNELS; STIM1 BINDS; ENTRY; OPTOGENETICS; DOMAIN	Ca2+ signals are highly regulated in a spatiotemporal manner in numerous cellular physiological events. Here we report a genetically engineered blue light-activated Ca2+ channel switch (BACCS), as an optogenetic tool for generating Ca2+ signals. BACCS opens Ca2+-selective ORAI ion channels in response to light. A BACCS variant, dmBACCS2, combined with Drosophila Orai, elevates the Ca2+ concentration more rapidly, such that Ca2+ elevation in mammalian cells is observed within 1 s on light exposure. Using BACCSs, we successfully control cellular events including NFAT-mediated gene expression. In the mouse olfactory system, BACCS mediates light-dependent electrophysiological responses. Furthermore, we generate BACCS mutants, which exhibit fast and slow recovery of intracellular Ca2+. Thus, BACCSs are a useful optogenetic tool for generating temporally various intracellular Ca2+ signals with a large dynamic range, and will be applicable to both in vitro and in vivo studies.	[Ishii, Tomohiro; Kakumoto, Toshiyuki; Nakata, Takao] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Ishii, Tomohiro; Kakumoto, Toshiyuki; Nakata, Takao] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo 1138510, Japan; [Sato, Koji] Okazaki Inst Integrat Biosci, Div Bioregulatory Signaling, Okazaki, Aichi 4448585, Japan; [Sato, Koji; Miura, Shigenori; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Sato, Koji; Miura, Shigenori; Takeuchi, Shoji] Japan Sci & Technol Agcy, ERATO Takeuchi Biohybrid Innovat Project, Tokyo 1538904, Japan; [Sato, Koji; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Touhara, Kazushige] Univ Tokyo, ERATO Touhara Chemosensory Signal Project, JST, Bunkyo Ku, Tokyo 1138657, Japan	Nakata, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	info.cbio@tmd.ac.jp			JSPS KAKENHI Grant [22700410, 24500456, 15K06735, 25293042, 21680035, 19677002]; Takeda Science Foundation; ERATO Touhara Chemosensory Signal Project; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeuchi Biohybrid Innovation Project; Exploratory Research for Advanced Technology (ERATO); Japan Science and Technology (JST), Japan; Okazaki Institute for Integrative Bioscience	We thank Atsushi Sato, Takuya Tamura and Hitoshi Okazawa for plasmids and Drosophila reagents, Hirofumi Nishizumi for advice on adenovirus infection, Junko Kurokawa and Akihiro Inoue for helpful discussion, Satoko Nakamura for general assistance and Haruto Makiguchi for technical help. This work was supported by JSPS KAKENHI Grant Numbers 22700410, 24500456 and 15K06735 to T.I., a grant from the Takeda Science Foundation to T.I., JSPS KAKENHI Grant Number 25293042 to T.N., JSPS KAKENHI Grant Number 21680035 to K.S., JSPS KAKENHI Grant Number 19677002 and ERATO Touhara Chemosensory Signal Project to K.T. and a Grant-in-Aid for Scientific Research on Innovative Areas 'Fluorescence Live Imaging' of The Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was partly supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan. A part of this work was supported by the Joint Studies Program (2014-2015) of the Okazaki Institute for Integrative Bioscience.	Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Fukuda N, 2014, ACS CHEM BIOL, V9, P1197, DOI 10.1021/cb400849n; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Cai XJ, 2007, J MOL BIOL, V368, P1284, DOI 10.1016/j.jmb.2007.03.022; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; TAKEMURA R, 1992, J CELL SCI, V103, P953; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Cahalan MD, 2010, SCIENCE, V330, P43, DOI 10.1126/science.1196348; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Crabtree G. R., 2009, CELL, V138; Cygnar K. D., 2010, J VIS EXP, P1850, DOI [10.3791/1850, DOI 10.3791/1850]; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Liu X, 2010, CELL, V141, P22, DOI 10.1016/j.cell.2010.03.019; Mills E, 2011, CHEM BIOL, V18, P1611, DOI 10.1016/j.chembiol.2011.09.014; Prakriya M., 2006, NATURE, V443, P10; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074	60	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8021	10.1038/ncomms9021		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1IZ	WOS:000360352000002		
J	Kawai, S; Saito, S; Osumi, S; Yamaguchi, S; Foster, AS; Spijker, P; Meyer, E				Kawai, Shigeki; Saito, Shohei; Osumi, Shinichiro; Yamaguchi, Shigehiro; Foster, Adam S.; Spijker, Peter; Meyer, Ernst			Atomically controlled substitutional boron-doping of graphene nanoribbons	NATURE COMMUNICATIONS			English	Article							TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; DOPED GRAPHENE; FORCE MICROSCOPY; STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURE; BAND-GAP; CARBON; ROUTE; CONDUCTANCE	Boron is a unique element in terms of electron deficiency and Lewis acidity. Incorporation of boron atoms into an aromatic carbon framework offers a wide variety of functionality. However, the intrinsic instability of organoboron compounds against moisture and oxygen has delayed the development. Here, we present boron-doped graphene nanoribbons (B-GNRs) of widths of N = 7, 14 and 21 by on-surface chemical reactions with an employed organoboron precursor. The location of the boron dopant is well defined in the centre of the B-GNR, corresponding to 4.8 atom%, as programmed. The chemical reactivity of B-GNRs is probed by the adsorption of nitric oxide (NO), which is most effectively trapped by the boron sites, demonstrating the Lewis acid character. Structural properties and the chemical nature of the NO-reacted B-GNR are determined by a combination of scanning tunnelling microscopy, high-resolution atomic force microscopy with a CO tip, and density functional and classical computations.	[Kawai, Shigeki; Meyer, Ernst] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Kawai, Shigeki; Saito, Shohei] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Saito, Shohei; Osumi, Shinichiro; Yamaguchi, Shigehiro] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yamaguchi, Shigehiro] Nagoya Univ, Inst Transformat Biomol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yamaguchi, Shigehiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Foster, Adam S.; Spijker, Peter] Aalto Univ, Dept Appl Phys, COMP, FI-00076 Helsinki, Finland	Kawai, S (reprint author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	shigeki.kawai@unibas.ch	Spijker, Peter/K-2547-2012; Foster, Adam/E-1275-2012; Yamaguchi, Shigehiro/D-7120-2012	Spijker, Peter/0000-0003-2538-1981; Foster, Adam/0000-0001-5371-5905; 	Japan Science and Technology Agency (JST) 'Precursory Research for Embryonic Science and Technology (PRESTO)'; JST 'Core Research; Swiss National Science Foundation; NCCR 'Nanoscale Science' of the Swiss National Science Foundation; Academy of Finland through its Centres of Excellence Program [915804]; EU project PAMS [610446]	This work was supported in part by the Japan Science and Technology Agency (JST) 'Precursory Research for Embryonic Science and Technology (PRESTO)' for a project of 'Molecular technology and creation of new functions' to S.K. and S.S, by JST 'Core Research for Evolutional Science and Technology (CREST)' for a project of 'Development of high-performance nanostructures for process integration' to S.Y. and by the Swiss National Science Foundation, by the NCCR 'Nanoscale Science' of the Swiss National Science Foundation. A.S.F. and P.S. have been supported by the Academy of Finland through its Centres of Excellence Program project no. 915804 and EU project PAMS (contract no. 610446) and acknowledge use of the CSC, Helsinki for computational resources.	Panchokarla LS, 2009, ADV MATER, V21, P4726, DOI 10.1002/adma.200901285; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Dou CD, 2012, ANGEW CHEM INT EDIT, V51, P12206, DOI 10.1002/anie.201206699; Koch M, 2012, NAT NANOTECHNOL, V7, P713, DOI [10.1038/nnano.2012.169, 10.1038/NNANO.2012.169]; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Terrones H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/062501; Araneda JF, 2012, ANGEW CHEM INT EDIT, V51, P9977, DOI 10.1002/anie.201205265; Ruffieux P, 2012, ACS NANO, V6, P6930, DOI 10.1021/nn3021376; Treier M, 2011, NAT CHEM, V3, P61, DOI [10.1038/nchem.891, 10.1038/NCHEM.891]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Hoffend C, 2012, CHEM-EUR J, V18, P15394, DOI 10.1002/chem.201202280; Biel B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096803; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Marconcini P, 2012, ACS NANO, V6, P7942, DOI 10.1021/nn3024046; Tang YB, 2012, ACS NANO, V6, P1970, DOI 10.1021/nn3005262; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/nchem.765, 10.1038/NCHEM.765]; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Bennett PB, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4855116; Biel B, 2009, NANO LETT, V9, P2725, DOI 10.1021/nl901226s; Kawai S, 2013, ACS NANO, V7, P9098, DOI 10.1021/nn403672m; Xing MY, 2014, CHEM COMMUN, V50, P6637, DOI 10.1039/c4cc01341g; Wang H, 2013, SMALL, V9, P1316, DOI 10.1002/smll.201203021; Nesterov EE, 2005, J AM CHEM SOC, V127, P10083, DOI 10.1021/ja051936g; Cai JM, 2014, NAT NANOTECHNOL, V9, P896, DOI [10.1038/nnano.2014.184, 10.1038/NNANO.2014.184]; Tang W, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084204; Hofer WA, 2003, REV MOD PHYS, V75, P1287, DOI 10.1103/RevModPhys.75.1287; Chen YC, 2013, ACS NANO, V7, P6123, DOI 10.1021/nn401948e; Bjorkman T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235502; Zhang YM, 2006, J PHYS CHEM B, V110, P4671, DOI 10.1021/jp0602272; Zhao LY, 2013, NANO LETT, V13, P4659, DOI 10.1021/nl401781d; Giessibl FJ, 1998, APPL PHYS LETT, V73, P3956, DOI 10.1063/1.122948; Bronner C, 2013, ANGEW CHEM INT EDIT, V52, P4422, DOI 10.1002/anie.201209735; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Jakle F, 2010, CHEM REV, V110, P3985, DOI 10.1021/cr100026f; Wu ZS, 2011, ACS NANO, V5, P5463, DOI 10.1021/nn2006249; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Luo XY, 2011, J AM CHEM SOC, V133, P16285, DOI 10.1021/ja2072753; Baowan D, 2007, MICRO NANO LETT, V2, P46, DOI 10.1049/mnl:20070041; Bieller S, 2004, ORGANOMETALLICS, V23, P2107, DOI 10.1021/om049954e; Dai JY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272008; Gulans A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201105; Hamalainen SK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.186102; Klimev S.J, 2011, PHYS REV B, V83; Moll N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083023; Requist R, 2014, P NATL ACAD SCI USA, V111, P69, DOI 10.1073/pnas.1322239111; van der Lit J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3023; Welker J, 2012, BEILSTEIN J NANOTECH, V3, P238, DOI 10.3762/bjnano.3.27	51	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8098	10.1038/ncomms9098		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1JW	WOS:000360354700004		
J	Mikheyev, AS; Tin, MMY; Arora, J; Seeley, TD				Mikheyev, Alexander S.; Tin, Mandy M. Y.; Arora, Jatin; Seeley, Thomas D.			Museum samples reveal rapid evolution by wild honey bees exposed to a novel parasite	NATURE COMMUNICATIONS			English	Article							GENERATION SEQUENCING DATA; NORTHEASTERN UNITED-STATES; APIS-MELLIFERA; VARROA-DESTRUCTOR; GENETIC DIVERSITY; ALLELE FREQUENCY; EMERGING DISEASE; WORKER BROOD; POPULATION; COLONIES	Understanding genetic changes caused by novel pathogens and parasites can reveal mechanisms of adaptation and genetic robustness. Using whole-genome sequencing of museum and modern specimens, we describe the genomic changes in a wild population of honey bees in North America following the introduction of the ectoparasitic mite, Varroa destructor. Even though colony density in the study population is the same today as in the past, a major loss of haplotypic diversity occurred, indicative of a drastic mitochondrial bottleneck, caused by massive colony mortality. In contrast, nuclear genetic diversity did not change, though hundreds of genes show signs of selection. The genetic diversity within each bee colony, particularly as a consequence of polyandry by queens, may enable preservation of genetic diversity even during population bottlenecks. These findings suggest that genetically diverse honey bee populations can recover from introduced diseases by evolving rapid tolerance, while maintaining much of the standing genetic variation.	[Mikheyev, Alexander S.; Tin, Mandy M. Y.; Arora, Jatin] Okinawa Inst Sci & Technol, Onna 9040412, Japan; [Mikheyev, Alexander S.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Arora, Jatin] Med Univ Vienna, Dept Paediat & Adolescent Med, A-1090 Vienna, Austria; [Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Mikheyev, AS (reprint author), Okinawa Inst Sci & Technol, 1919-1 Tancha, Onna 9040412, Japan.	sasha@homologo.us			Okinawa Institute of Science and Technology (OIST) Sequencing Center; OIST; JSPS KAKENHI [25221206, 24770034]; Honey Bee Health; North American Pollinator Protection Campaign; OIST Internship Program	We are grateful to S. Aggrawal for help with honey bee morphometrics, and to M. Fumagalli, T. Korneliussen and F. Vieira for assistance with their software packages. We thank J.K. Kelly for discussing his work, and the Cornell University Insect Collection for providing specimens for this study. We are grateful to S.D. Aird for comments on the manuscript. We acknowledge the Okinawa Institute of Science and Technology (OIST) Sequencing Center for its support of our work. We also thank S. Brenner for suggesting the ribo-tailing procedure used in this library preparation method. This work has been funded by the OIST subsidy funding and JSPS KAKENHI 25221206 and 24770034 to A.S.M., and by a Honey Bee Health grant to T.D.S. from the North American Pollinator Protection Campaign. J.A. was supported in part by the OIST Internship Program.	Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; CROZIER RH, 1993, GENETICS, V133, P97; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740; Pritchard JK, 2000, GENETICS, V155, P945; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Kraus B, 1995, ENVIRON ENTOMOL, V24, P1473; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vieira FG, 2013, GENOME RES, V23, P1852, DOI 10.1101/gr.157388.113; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Auwera G. A., 2013, CURR PROTOC BIOINFOR, V11; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Calderon RA, 2012, EXP APPL ACAROL, V58, P279, DOI 10.1007/s10493-012-9579-0; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dujardin J. P., MORPHOMETRICS MED EN; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; Ford E. B., 1947, HEREDITY, V1, P143; FRANKHAM R, 1995, GENET RES, V66, P95; Garrison E., 2012, ARXIV12073907; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Kelly JK, 2013, GENOME BIOL EVOL, V5, P1457, DOI 10.1093/gbe/evt100; Kim SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-231; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Loper G. M., 2006, AM BEE J; MARTIN SJ, 1994, EXP APPL ACAROL, V18, P87, DOI 10.1007/BF00055033; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Pinto MA, 2004, EVOLUTION, V58, P1047; R core team, R LANG ENV STAT COMP; Schlager S., CALCULATIONS VISUALI; Schmidt WM, 1996, NUCLEIC ACIDS RES, V24, P1789, DOI 10.1093/nar/24.9.1789; Seeley TD, 2015, APIDOLOGIE, V46, P654, DOI 10.1007/s13592-015-0355-0; SEELEY TD, 1978, OECOLOGIA, V32, P109, DOI 10.1007/BF00344695; Seeley T.D., 1985, HONEYBEE ECOLOGY STU; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Villa JD, 2008, ANN ENTOMOL SOC AM, V101, P867, DOI 10.1603/0013-8746(2008)101[867:CIHBHA]2.0.CO;2; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	65	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7991	10.1038/ncomms8991		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1IQ	WOS:000360351000001		
J	Nagasaki, M; Yasuda, J; Katsuoka, F; Nariai, N; Kojima, K; Kawai, Y; Yamaguchi-Kabata, Y; Yokozawa, J; Danjoh, I; Saito, S; Sato, Y; Mimori, T; Tsuda, K; Saito, R; Pan, XQ; Nishikawa, S; Ito, S; Kuroki, Y; Tanabe, O; Fuse, N; Kuriyama, S; Kiyomoto, H; Hozawa, A; Minegishi, N; Engel, JD; Kinoshita, K; Kure, S; Yaegashi, N; Yamamoto, M				Nagasaki, Masao; Yasuda, Jun; Katsuoka, Fumiki; Nariai, Naoki; Kojima, Kaname; Kawai, Yosuke; Yamaguchi-Kabata, Yumi; Yokozawa, Junji; Danjoh, Inaho; Saito, Sakae; Sato, Yukuto; Mimori, Takahiro; Tsuda, Kaoru; Saito, Rumiko; Pan, Xiaoqing; Nishikawa, Satoshi; Ito, Shin; Kuroki, Yoko; Tanabe, Osamu; Fuse, Nobuo; Kuriyama, Shinichi; Kiyomoto, Hideyasu; Hozawa, Atsushi; Minegishi, Naoko; Engel, James Douglas; Kinoshita, Kengo; Kure, Shigeo; Yaegashi, Nobuo; Yamamoto, Masayuki		ToMMo Japanese Reference Panel	Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals	NATURE COMMUNICATIONS			English	Article							COPY NUMBER VARIATION; WIDE ASSOCIATION; STRUCTURAL VARIATION; GENETIC-VARIATION; HAPLOTYPE MAP; POPULATION; DISEASE; HLA; LOCI; RESOLUTION	The Tohoku Medical Megabank Organization reports the whole-genome sequences of 1,070 healthy Japanese individuals and construction of a Japanese population reference panel (1KJPN). Here we identify through this high-coverage sequencing (32.4 x on average), 21.2 million, including 12 million novel, single-nucleotide variants (SNVs) at an estimated false discovery rate of <1.0%. This detailed analysis detected signatures for purifying selection on regulatory elements as well as coding regions. We also catalogue structural variants, including 3.4 million insertions and deletions, and 25,923 genic copy-number variants. The 1KJPN was effective for imputing genotypes of the Japanese population genome wide. These data demonstrate the value of high-coverage sequencing for constructing population-specific variant panels, which covers 99.0% SNVs of minor allele frequency >= 0.1%, and its value for identifying causal rare variants of complex human disease phenotypes in genetic association studies.	[Nagasaki, Masao; Yasuda, Jun; Katsuoka, Fumiki; Nariai, Naoki; Kojima, Kaname; Kawai, Yosuke; Yamaguchi-Kabata, Yumi; Yokozawa, Junji; Danjoh, Inaho; Saito, Sakae; Sato, Yukuto; Mimori, Takahiro; Tsuda, Kaoru; Saito, Rumiko; Pan, Xiaoqing; Nishikawa, Satoshi; Ito, Shin; Kuroki, Yoko; Tanabe, Osamu; Fuse, Nobuo; Kuriyama, Shinichi; Kiyomoto, Hideyasu; Hozawa, Atsushi; Minegishi, Naoko; Kinoshita, Kengo; Kure, Shigeo; Yaegashi, Nobuo; Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, Sendai, Miyagi 9808573, Japan; [Nagasaki, Masao; Yasuda, Jun; Katsuoka, Fumiki; Kojima, Kaname; Kawai, Yosuke; Yamaguchi-Kabata, Yumi; Yokozawa, Junji; Danjoh, Inaho; Saito, Sakae; Sato, Yukuto; Tanabe, Osamu; Fuse, Nobuo; Kuriyama, Shinichi; Kiyomoto, Hideyasu; Hozawa, Atsushi; Minegishi, Naoko; Kure, Shigeo; Yaegashi, Nobuo; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Nagasaki, Masao; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kuriyama, Shinichi] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan	Nagasaki, M (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan.	nagasaki@megabank.tohoku.ac.jp; masiyamamoto@med.tohoku.ac.jp			Tohoku Medical Megabank Project	This work was supported (in part) by the Tohoku Medical Megabank Project (Special Account for reconstruction from the Great East Japan Earthquake). All computational resources were provided by the ToMMo supercomputer system (http://sc.megabank.tohoku.ac.jp/en). We are indebted to all volunteers who participated in this ToMMo project. We thank members of ToMMo at the Tohoku University for seminal contribution to the establishment of the genome cohort and biobank and for help in the genome analyses. The member list of ToMMo at the Tohoku University is available in the following website http://www.megabank.tohoku.ac.jp/english/a141201. We thank the members of Iwate ToMMo at the Iwate Medical University, especially Drs Kenji Sobue, Jiro Hitomi and Atsushi Shimizu, for discussion.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Feuchtbaum L, 2012, GENET MED, V14, P937, DOI 10.1038/gim.2012.76; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Jiao S, 2014, HUM MOL GENET, V23, P3898, DOI 10.1093/hmg/ddu087; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Kudo T, 1996, J BIOL CHEM, V271, P9830; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Kojima K, 2014, LECT N BIOINFORMAT, V8542, P107, DOI 10.1007/978-3-319-07953-0_9; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Dahi PB, 2014, BONE MARROW TRANSPL, V49, P1184, DOI 10.1038/bmt.2014.135; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; He MA, 2014, GUT, V63, P143, DOI 10.1136/gutjnl-2012-303434; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Carmi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5835; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Katsuoka F, 2014, ANAL BIOCHEM, V466, P27, DOI 10.1016/j.ab.2014.08.015; Kawai Y., 2015, J HUM GENET, DOI [10.1038/jhg.2015.68, DOI 10.1038/JHG.2015.68]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Liang WS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt865; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; MARKS C, 1983, ANN ROY COLL SURG, V65, P139; Mimori T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S8; MOHR J, 1951, ACTA PATHOL MIC SC, V29, P339; Nariai N, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S7; Noguchi E, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1002171, 10.1371/journal.pgen.1002170]; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Sato Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-664; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Valsesia Armand, 2013, Frontiers in Genetics, V4, P92, DOI 10.3389/fgene.2013.00092; Yamaguchi Seiji, 2008, Ann Acad Med Singapore, V37, P13	69	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8018	10.1038/ncomms9018		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1IW	WOS:000360351700002		
J	Naka, K; Jomen, Y; Ishihara, K; Kim, J; Ishimoto, T; Bae, EJ; Mohney, RP; Stirdivant, SM; Oshima, H; Oshima, M; Kim, DW; Nakauchi, H; Takihara, Y; Kato, Y; Ooshima, A; Kim, SJ				Naka, Kazuhito; Jomen, Yoshie; Ishihara, Kaori; Kim, Junil; Ishimoto, Takahiro; Bae, Eun-Jin; Mohney, Robert P.; Stirdivant, Steven M.; Oshima, Hiroko; Oshima, Masanobu; Kim, Dong-Wook; Nakauchi, Hiromitsu; Takihara, Yoshihiro; Kato, Yukio; Ooshima, Akira; Kim, Seong-Jin			Dipeptide species regulate p38MAPK-Smad3 signalling to maintain chronic myelogenous leukaemia stem cells	NATURE COMMUNICATIONS			English	Article							CHRONIC MYELOID-LEUKEMIA; TRANSFER-RNA SYNTHETASE; TRANSCRIPTION FACTORS; INITIATING CELLS; DIFFERENTIAL REGULATION; METABOLIC CHECKPOINT; KINASE INHIBITION; FAMILY SLC15; BCR-ABL; IMATINIB	Understanding the specific survival of the rare chronic myelogenous leukaemia (CML) stem cell population could provide a target for therapeutics aimed at eradicating these cells. However, little is known about how survival signalling is regulated in CML stem cells. In this study, we survey global metabolic differences between murine normal haematopoietic stem cells (HSCs) and CML stem cells using metabolomics techniques. Strikingly, we show that CML stem cells accumulate significantly higher levels of certain dipeptide species than normal HSCs. Once internalized, these dipeptide species activate amino-acid signalling via a pathway involving p38MAPK and the stemness transcription factor Smad3, which promotes CML stem cell maintenance. Importantly, pharmacological inhibition of dipeptide uptake inhibits CML stem cell activity in vivo. Our results demonstrate that dipeptide species support CML stem cell maintenance by activating p38MAPK-Smad3 signalling in vivo, and thus point towards a potential therapeutic target for CML treatment.	[Naka, Kazuhito; Jomen, Yoshie; Ishihara, Kaori; Bae, Eun-Jin] Kanazawa Univ, Canc Res Inst, Exploratory Project Canc Stem Cells, Kanazawa, Ishikawa 9201192, Japan; [Naka, Kazuhito; Takihara, Yoshihiro] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Minami Ku, Hiroshima 7348553, Japan; [Kim, Junil; Bae, Eun-Jin; Ooshima, Akira; Kim, Seong-Jin] CHA Univ, CHA Canc Inst, Songnam 463400, Kyunggi Do, South Korea; [Kim, Junil; Bae, Eun-Jin; Ooshima, Akira; Kim, Seong-Jin] CHA Univ, Dept Biomed Sci, Songnam 463400, Kyunggi Do, South Korea; [Ishimoto, Takahiro; Kato, Yukio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan; [Mohney, Robert P.; Stirdivant, Steven M.] Metabolon Inc, Durham, NC 27713 USA; [Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Kim, Dong-Wook] Catholic Univ Korea, Canc Res Inst, Seoul St Marys Hosp, Dept Hematol, Seoul 137701, South Korea; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Naka, K (reprint author), Kanazawa Univ, Canc Res Inst, Exploratory Project Canc Stem Cells, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	kanaka55@hiroshima-u.ac.jp; kimsj@cha.ac.kr	KATO, Yukio/D-8396-2015		MEXT; Government of Japan [LS050]; Ministry of Science, ICT and Future Planning through the National Research Foundation, Korea [NRF-2014M3A9C4048735]	We thank D. G. Tenen for the Tal1-tTA and TRE-BCR-ABL1 transgenic mouse strains, N. Motoyama for the Foxo3a-deficient mouse strain, M. Matsubara, A. Hirao and K. Miyazono for helpful discussions, Y. Yonekawa for metabolomics, H. Kukiya and N. Sugimoto for RNA sequencing, A.B. Roberts for Smad3 cDNA, H. Honda for BCR-ABL1 cDNA and T. Kitamura for Plat-E retroviral packaging cells. K. N. was supported by a Grant-in-Aid for Scientific Research (B) from MEXT, a grant from Innovative Areas, Integrative Research on Cancer Microenvironment Network from MEXT and by a grant from the Funding Program for Next-Generation World-Leading Researchers (LS050) from the Government of Japan. S.-J.K. was supported by the Bio-Synergy Research Project (NRF-2014M3A9C4048735) of the Ministry of Science, ICT and Future Planning through the National Research Foundation, Korea.	Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Huettner CS, 2000, NAT GENET, V24, P57; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Kato Y, 2004, PHARM RES, V21, P1886, DOI 10.1023/B:PHAM.0000045244.83999.43; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Zhang HJ, 2013, PROTEIN CELL, V4, P186, DOI 10.1007/s13238-013-2115-0; Goldstein DM, 2010, J MED CHEM, V53, P2345, DOI [10.1021/jm9012906, 10.1021/jm09012906]; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Moller GMO, 2007, FEBS LETT, V581, P1329, DOI 10.1016/j.febslet.2007.02.048; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Pellicano F, 2014, STEM CELLS, V32, P2324, DOI 10.1002/stem.1748; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Luckner P, 2005, EUR J PHARM BIOPHARM, V59, P17, DOI 10.1016/j.ejpb.2004.07.008; Bae EJ, 2014, CANCER RES, V74, P6139, DOI 10.1158/0008-5472.CAN-14-0803; Benito R, 2012, PHARMACOGENET GENOM, V22, P381, DOI 10.1097/FPC.0b013e328351f3e9; Campbell RM, 2014, MOL CANCER THER, V13, P364, DOI 10.1158/1535-7163.MCT-13-0513; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Ishimoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089434; Kamaraju Anil K., 2005, Journal of Biological Chemistry, V280, P1024; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Sugiura T., 2013, PHARMACOGENOMICS HUM, P223; Thomas JD, 2014, CANCER CELL, V26, P754, DOI 10.1016/j.ccell.2014.09.008; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200	55	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8039	10.1038/ncomms9039		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1JB	WOS:000360352300001		
J	Naruto, M; Saito, S				Naruto, Masayuki; Saito, Susumu			Cationic mononuclear ruthenium carboxylates as catalyst prototypes for self-induced hydrogenation of carboxylic acids	NATURE COMMUNICATIONS			English	Article							HOMOGENEOUS HYDROGENATION; CARBON-DIOXIDE; ASYMMETRIC HYDROGENATION; BUILDING-BLOCK; AQUEOUS-MEDIA; COMPLEXES; REACTIVITY; MECHANISM; METHANOL; ESTERS	Carboxylic acids are ubiquitous in bio-renewable and petrochemical sources of carbon. Hydrogenation of carboxylic acids to yield alcohols produces water as the only byproduct, and thus represents a possible next generation, sustainable method for the production of these alternative energy carriers/platform chemicals on a large scale. Reported herein are molecular insights into cationic mononuclear ruthenium carboxylates ([Ru(OCOR)](+)) as prototypical catalysts for the hydrogenation of carboxylic acids. The substrate-derived coordinated carboxylate was found to function initially as a proton acceptor for the heterolytic cleavage of dihydrogen, and subsequently also as an acceptor for the hydride from [Ru-H](+), which was generated in the first step (self-induced catalysis). The hydrogenation proceeded selectively and at high levels of functional group tolerance, a feature that is challenging to achieve with existing heterogeneous/homogeneous catalyst systems. These fundamental insights are expected to significantly benefit the future development of metal carboxylate-catalysed hydrogenation processes of bio-renewable resources.	[Naruto, Masayuki; Saito, Susumu] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Saito, Susumu] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Saito, Susumu] JST, ACT C, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Saito, S (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	saito.susumu@f.mbox.nagoya-u.ac.jp	Saito, Susumu/E-9282-2012	Saito, Susumu/0000-0003-0749-2020	research area of Japan Science and Technology Corporation (JST), 'Creation of Advanced Catalytic Transformation for the Sustainable Manufacturing at Low Energy, Low Environmental Load (ACT-C)'; IGER (NU) fellowship; Iue memorial fellowship; Iwadare fellowship	This work was supported by the research area of Japan Science and Technology Corporation (JST), 'Creation of Advanced Catalytic Transformation for the Sustainable Manufacturing at Low Energy, Low Environmental Load (ACT-C)'. M.N. acknowledges support from a IGER (NU) fellowship, as well as from Iue memorial and Iwadare fellowships. The authors wish to thank Professor Shohei Saito (NU) for technical support with the single crystal X-ray analysis and Professor R. Noyori (NU, JST and RIKEN) for fruitful discussions.	Teichmann D, 2011, ENERG ENVIRON SCI, V4, P2767, DOI 10.1039/c1ee01454d; Yokoyama T, 2001, APPL CATAL A-GEN, V221, P227, DOI 10.1016/S0926-860X(01)00795-5; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Salvini A, 2005, J ORGANOMET CHEM, V690, P371, DOI 10.1016/j.jorganchem.2004.09.048; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; JESSOP PG, 1994, NATURE, V368, P231, DOI 10.1038/368231a0; Manyar HG, 2010, CHEM COMMUN, V46, P6279, DOI 10.1039/c0cc01365j; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Brewster TP, 2013, J AM CHEM SOC, V135, P16022, DOI 10.1021/ja408149n; Delhomme C, 2009, GREEN CHEM, V11, P13, DOI 10.1039/b810684c; Dub PA, 2012, ACS CATAL, V2, P1718, DOI 10.1021/cs300341g; BIANCHI M, 1980, J ORGANOMET CHEM, V188, P109, DOI 10.1016/S0022-328X(00)83702-X; Olah GA, 2013, ANGEW CHEM INT EDIT, V52, P104, DOI 10.1002/anie.201204995; BROWN HC, 1980, SCIENCE, V210, P485, DOI 10.1126/science.210.4469.485; JESSOP PG, 1995, CHEM REV, V95, P259, DOI 10.1021/cr00034a001; Chaplin AB, 2008, INORG CHEM, V47, P381, DOI 10.1021/ic701773a; Geilen FMA, 2011, J AM CHEM SOC, V133, P14349, DOI 10.1021/ja2034377; Wesselbaum S, 2015, CHEM SCI, V6, P693, DOI 10.1039/c4sc02087a; Geilen FMA, 2010, ANGEW CHEM INT EDIT, V49, P5510, DOI 10.1002/anie.201002060; Huff CA, 2011, J AM CHEM SOC, V133, P18122, DOI 10.1021/ja208760j; Giri R, 2007, J AM CHEM SOC, V129, P3510, DOI 10.1021/ja0701614; Sato S, 2011, J AM CHEM SOC, V133, P15240, DOI 10.1021/ja204881d; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Ostapowicz TG, 2013, ANGEW CHEM INT EDIT, V52, P12119, DOI 10.1002/anie.201304529; Tanaka R, 2009, J AM CHEM SOC, V131, P14168, DOI 10.1021/ja903574e; Wesselbaum S, 2012, ANGEW CHEM INT EDIT, V51, P7499, DOI 10.1002/anie.201202320; Smith AM, 2014, CHEM REV, V114, P5477, DOI 10.1021/cr400609m; Duan Y, 2014, J AM CHEM SOC, V136, P7688, DOI 10.1021/ja502020b; Olah GA, 2011, J AM CHEM SOC, V133, P12881, DOI 10.1021/ja202642y; ASHBY MT, 1991, J AM CHEM SOC, V113, P589, DOI 10.1021/ja00002a029; BROWN JM, 1987, ANGEW CHEM INT EDIT, V26, P190, DOI 10.1002/anie.198701901; Clarke ML, 2012, CATAL SCI TECHNOL, V2, P2418, DOI 10.1039/c2cy20601c; Elsevier C. J., 2007, HDB HOMOGENEOUS HYDR, V1, P45; HE DH, 1995, TETRAHEDRON LETT, V36, P1059, DOI 10.1016/0040-4039(94)02453-I; Hiett NP, 2011, J ORGANOMET CHEM, V696, P378, DOI 10.1016/j.jorganchem.2010.10.001; Kitamura M, 2002, J AM CHEM SOC, V124, P6649, DOI 10.1021/ja010982n; Lynam JM, 2009, ORGANOMETALLICS, V28, P1320, DOI 10.1021/om800950g; MacFarlane KS, 1998, INORG CHIM ACTA, V270, P130, DOI 10.1016/S0020-1693(97)05833-7; Rosales M, 2008, POLYHEDRON, V27, P530, DOI 10.1016/j.poly.2007.10.007; Rosi L, 2010, J ORGANOMET CHEM, V695, P1314, DOI 10.1016/j.jorganchem.2010.02.015; Saito S., 2013, JP patent, Patent No. [2013-267866, 2013267866]; Salvini A, 1999, J ORGANOMET CHEM, V582, P218, DOI 10.1016/S0022-328X(99)00038-8; Stein T. V., 2014, J AM CHEM SOC, V136, P13217; STEPHENS.TA, 1966, J INORG NUCL CHEM, V28, P945, DOI 10.1016/0022-1902(66)80191-4; Werkmeister S, 2014, ORG PROCESS RES DEV, V18, P289, DOI 10.1021/op4003278; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859.RETRIEVED; WONG WK, 1994, POLYHEDRON, V13, P2751, DOI 10.1016/S0277-5387(00)83433-6; YOSHINO K, 1990, J AM OIL CHEM SOC, V67, P21, DOI 10.1007/BF02631383	49	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8140	10.1038/ncomms9140		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1KK	WOS:000360356300001		
J	Nishina, K; Piao, WY; Yoshida-Tanaka, K; Sujino, Y; Nishina, T; Yamamoto, T; Nitta, K; Yoshioka, K; Kuwahara, H; Yasuhara, H; Baba, T; Ono, F; Miyata, K; Miyake, K; Seth, PP; Low, A; Yoshida, M; Bennett, CF; Kataoka, K; Mizusawa, H; Obika, S; Yokota, T				Nishina, Kazutaka; Piao, Wenying; Yoshida-Tanaka, Kie; Sujino, Yumiko; Nishina, Tomoko; Yamamoto, Tsuyoshi; Nitta, Keiko; Yoshioka, Kotaro; Kuwahara, Hiroya; Yasuhara, Hidenori; Baba, Takeshi; Ono, Fumiko; Miyata, Kanjiro; Miyake, Koichi; Seth, Punit P.; Low, Audrey; Yoshida, Masayuki; Bennett, C. Frank; Kataoka, Kazunori; Mizusawa, Hidehiro; Obika, Satoshi; Yokota, Takanori			DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing	NATURE COMMUNICATIONS			English	Article							IN-VIVO DELIVERY; HUMAN RNASE H1; ANTISENSE OLIGONUCLEOTIDES; SIRNA DELIVERY; APOLIPOPROTEIN-B; INTRACELLULAR TRAFFICKING; LIPID NANOPARTICLES; LIPOPHILIC SIRNAS; TARGETED DELIVERY; ALPHA-TOCOPHEROL	Antisense oligonucleotides (ASOs) are recognized therapeutic agents for the modulation of specific genes at the post-transcriptional level. Similar to any medical drugs, there are opportunities to improve their efficacy and safety. Here we develop a short DNA/RNA heteroduplex oligonucleotide (HDO) with a structure different from double-stranded RNA used for short interfering RNA and single-stranded DNA used for ASO. A DNA/locked nucleotide acid gapmer duplex with an a-tocopherol-conjugated complementary RNA (Toc-HDO) is significantly more potent at reducing the expression of the targeted mRNA in liver compared with the parent single-stranded gapmer ASO. Toc-HDO also improves the phenotype in disease models more effectively. In addition, the high potency of Toc-HDO results in a reduction of liver dysfunction observed in the parent ASO at a similar silencing effect. HDO technology offers a novel concept of therapeutic oligonucleotides, and the development of this molecular design opens a new therapeutic field.	[Nishina, Kazutaka; Piao, Wenying; Yoshida-Tanaka, Kie; Sujino, Yumiko; Nishina, Tomoko; Nitta, Keiko; Yoshioka, Kotaro; Kuwahara, Hiroya; Mizusawa, Hidehiro; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Nishina, Kazutaka; Piao, Wenying; Yoshida-Tanaka, Kie; Sujino, Yumiko; Nishina, Tomoko; Yoshioka, Kotaro; Kuwahara, Hiroya; Obika, Satoshi; Yokota, Takanori] Japan Sci & Technol Agcy JST, CREST, Sect Mol Technol, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, Tsuyoshi; Yasuhara, Hidenori; Baba, Takeshi; Obika, Satoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Bioorgan Chem, Suita, Osaka 5650871, Japan; [Ono, Fumiko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050003, Japan; [Miyata, Kanjiro; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Div Clin Biotechnol,Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Miyake, Koichi] Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan; [Seth, Punit P.; Low, Audrey; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch, Dept Life Sci & Med Eth, Bunkyo Ku, Tokyo 1138519, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan	Yokota, T (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tak-yokota.nuro@tmd.ac.jp			Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan (Molecular Technology)	We thank Takayoshi Nishiya, Yusuke Yokouchi and Makoto Koizumi (Advanced Technology Research Laboratories, Daiichi Sankyo Co., Ltd) for performing repeated injections study for adverse effects, and Mizuko Osaka (Department of Life Science and Medical Ethics, Graduate School, Tokyo Medical and Dental University) for their technical support. This study was supported by grants from Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan (Molecular Technology).	Juliano RL, 2012, BIOCONJUGATE CHEM, V23, P147, DOI 10.1021/bc200377d; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457; Laxton C, 2011, ANTIMICROB AGENTS CH, V55, P3105, DOI 10.1128/AAC.00222-11; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Patwa A, 2011, CHEM SOC REV, V40, P5844, DOI 10.1039/c1cs15038c; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Nishina K, 2008, MOL THER, V16, P734, DOI 10.1038/mt.2008.14; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Seth PP, 2010, J ORG CHEM, V75, P1569, DOI [10.1021/jo902560f, 10.1021/jo90256of]; Uno Y, 2011, HUM GENE THER, V22, P711, DOI 10.1089/hum.2010.083; Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Burel SA, 2013, NUCLEIC ACID THER, V23, P213, DOI 10.1089/nat.2013.0422; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Crooke ST, 2013, BRIT J CLIN PHARMACO, V76, P269, DOI 10.1111/j.1365-2125.2012.04469.x; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Lima WF, 2007, MOL PHARMACOL, V71, P83, DOI 10.1124/mol.106.025015; Raouane M, 2012, BIOCONJUGATE CHEM, V23, P1091, DOI 10.1021/bc200422w; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Yu RZ, 2009, BIOCHEM PHARMACOL, V77, P910, DOI 10.1016/j.bcp.2008.11.005; Lorenz C, 2004, BIOORG MED CHEM LETT, V14, P4975, DOI 10.1016/j.bmcl.2004.07.018; Chen QM, 2010, J CONTROL RELEASE, V144, P227, DOI 10.1016/j.jconrel.2010.02.011; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/nmat3765, 10.1038/NMAT3765]; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.081001; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Jiang K, 2013, NAT MED, V19, P252, DOI 10.1038/nm0313-252; Usui S, 2002, J LIPID RES, V43, P805; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Burel SA, 2012, J PHARMACOL EXP THER, V342, P150, DOI 10.1124/jpet.112.193789; Geary RS, 2015, CLIN PHARMACOKINET, V54, P133, DOI 10.1007/s40262-014-0224-4; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Haussecker D, 2014, J CONTROL RELEASE, V195, P49, DOI 10.1016/j.jconrel.2014.07.056; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Kakiuchi-Kiyota S, 2014, TOXICOL SCI, V138, P234, DOI 10.1093/toxsci/kft278; Kumar V, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.61; Kuwahara H, 2011, MOL THER, V19, P2213, DOI 10.1038/mt.2011.186; Nishina T, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.72; Pedersen L, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.72; Prakash T. P, 2014, ACS CHEM BIOL, V8, P1402; Seth PP, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.34; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tadokoro T, 2007, FEBS J, V274, P3715, DOI 10.1111/j.1742-4658.2007.05903.x; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Yamamoto T, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.16; Yokota T, 2007, BIOCHEM BIOPH RES CO, V361, P294, DOI 10.1016/j.bbrc.2007.06.182	62	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7969	10.1038/ncomms8969		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1HC	WOS:000360346900010		
J	Nowinski, SM; Solmonson, A; Rundhaug, JE; Rho, O; Cho, J; Lago, CU; Riley, CL; Lee, S; Kohno, S; Dao, CK; Nikawa, T; Bratton, SB; Wright, CW; Fischer, SM; DiGiovanni, J; Mills, EM				Nowinski, Sara M.; Solmonson, Ashley; Rundhaug, Joyce E.; Rho, Okkyung; Cho, Jiyoon; Lago, Cory U.; Riley, Christopher L.; Lee, Sunhee; Kohno, Shohei; Dao, Christine K.; Nikawa, Takeshi; Bratton, Shawn B.; Wright, Casey W.; Fischer, Susan M.; DiGiovanni, John; Mills, Edward M.			Mitochondrial uncoupling links lipid catabolism to Akt inhibition and resistance to tumorigenesis	NATURE COMMUNICATIONS			English	Article							GROWTH-FACTOR RECEPTOR; MOUSE SKIN CARCINOGENESIS; EPIDERMAL BASAL-CELLS; PROSTATE-CANCER CELLS; ATP CITRATE LYASE; LARGE GENE LISTS; GLUTAMINE-METABOLISM; AEROBIC GLYCOLYSIS; TRANSFORMED-CELLS; BETA-OXIDATION	To support growth, tumour cells reprogramme their metabolism to simultaneously upregulate macromolecular biosynthesis while maintaining energy production. Uncoupling proteins (UCPs) oppose this phenotype by inducing futile mitochondrial respiration that is uncoupled from ATP synthesis, resulting in nutrient wasting. Here using a UCP3 transgene targeted to the basal epidermis, we show that forced mitochondrial uncoupling inhibits skin carcinogenesis by blocking Akt activation. Similarly, Akt activation is markedly inhibited in UCP3 overexpressing primary human keratinocytes. Mechanistic studies reveal that uncoupling increases fatty acid oxidation and membrane phospholipid catabolism, and impairs recruitment of Akt to the plasma membrane. Overexpression of Akt overcomes metabolic regulation by UCP3, rescuing carcinogenesis. These findings demonstrate that mitochondrial uncoupling is an effective strategy to limit proliferation and tumorigenesis through inhibition of Akt, and illuminate a novel mechanism of crosstalk between mitochondrial metabolism and growth signalling.	[Nowinski, Sara M.; Rho, Okkyung; Cho, Jiyoon; Kohno, Shohei; Dao, Christine K.; Wright, Casey W.; DiGiovanni, John; Mills, Edward M.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Nowinski, Sara M.; Solmonson, Ashley; Mills, Edward M.] Univ Texas Austin, Coll Pharm, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Solmonson, Ashley; Riley, Christopher L.; Lee, Sunhee; Wright, Casey W.; DiGiovanni, John; Mills, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Rundhaug, Joyce E.; Bratton, Shawn B.; Fischer, Susan M.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX 78957 USA; [Lago, Cory U.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Nikawa, Takeshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 7708503, Japan	Mills, EM (reprint author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA.	tedmills@austin.utexas.edu			NIH [CRED ES007784, DK089224, T32 DK 091317]; Texas Higher Education Coordinating Board; NIH/NIEHS [T32 ES0247]; PhRMA Foundation	We thank K. Kiguchi for assistance with microscopy, and the MD Anderson Science Park, Smithville histology core for embedding, sectioning and staining services. We thank M. Keaton and E. Morin-Kensicki for assistance with metabolomics study design, sample and data processing and interpretation. We also thank the St David's Hospital nursery staff for their help with tissue collection. This work was supported by funding to E.M.M. from NIH CRED ES007784, NIH DK089224, and the Texas Higher Education Coordinating Board. S.M.N. and A.S. were also supported by NIH/NIEHS T32 ES0247, PI J.H. Richburg. Further support for S.M.N. was provided by the PhRMA Foundation and NIH T32 DK 091317, PI D. McClain.	Gu ZN, 2013, CARCINOGENESIS, V34, P1968, DOI 10.1093/carcin/bgt147; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; DiGiovanni J, 2000, CANCER RES, V60, P1561; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; NAITO M, 1987, CARCINOGENESIS, V8, P1807, DOI 10.1093/carcin/8.12.1807; Rodriguez-Puebla ML, 1998, CELL GROWTH DIFFER, V9, P31; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Mori S, 2008, J INVEST DERMATOL, V128, P1894, DOI 10.1038/jid.2008.20; Kretschmer M, 2012, EUKARYOT CELL, V11, P1055, DOI 10.1128/EC.00129-12; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Schuppel M, 2008, J INVEST DERMATOL, V128, P1747, DOI 10.1038/sj.jid.5701259; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Portais JC, 1996, BIOCHIMIE, V78, P155, DOI 10.1016/0300-9084(96)89500-9; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Battalora MS, 2001, CARCINOGENESIS, V22, P651, DOI 10.1093/carcin/22.4.651; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; CANNON B, 1982, FEBS LETT, V150, P129, DOI 10.1016/0014-5793(82)81319-7; Caspary F, 2005, BRIT J DERMATOL, V153, P937, DOI 10.1111/j.1365-2133.2005.06811.x; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kiguchi K, 1998, MOL CARCINOGEN, V22, P73, DOI 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L; Lago CU, 2012, ONCOGENE, V31, P4725, DOI 10.1038/onc.2011.630; Li WJ, 2015, CANCER PREV RES, V8, P487, DOI 10.1158/1940-6207.CAPR-14-0297-T; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; MORRIS RJ, 1990, CELL TISSUE KINET, V23, P587, DOI 10.1111/j.1365-2184.1990.tb01348.x; RAO S, 1989, EXP CELL RES, V180, P341, DOI 10.1016/0014-4827(89)90062-1; Rundhaug JE, 1997, MOL CARCINOGEN, V20, P125, DOI 10.1002/(SICI)1098-2744(199709)20:1<125::AID-MC14>3.3.CO;2-A; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Senapedis WT, 2011, MOL BIOL CELL, V22, P1791, DOI 10.1091/mbc.E10-10-0854; Su WP, 2012, CARCINOGENESIS, V33, P2065, DOI 10.1093/carcin/bgs253; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; WELTER JF, 1995, J BIOL CHEM, V270, P12614; XIAN WJ, 1995, CELL GROWTH DIFFER, V6, P1447	62	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8137	10.1038/ncomms9137		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1KI	WOS:000360356100001		
J	Ogata, H; Kramer, T; Wang, HX; Schilter, D; Pelmenschikov, V; van Gastel, M; Neese, F; Rauchfuss, TB; Gee, LB; Scott, AD; Yoda, Y; Tanaka, Y; Lubitz, W; Cramer, SP				Ogata, Hideaki; Kraemer, Tobias; Wang, Hongxin; Schilter, David; Pelmenschikov, Vladimir; van Gastel, Maurice; Neese, Frank; Rauchfuss, Thomas B.; Gee, Leland B.; Scott, Aubrey D.; Yoda, Yoshitaka; Tanaka, Yoshihito; Lubitz, Wolfgang; Cramer, Stephen P.			Hydride bridge in [NiFe]-hydrogenase observed by nuclear resonance vibrational spectroscopy	NATURE COMMUNICATIONS			English	Article							DENSITY-FUNCTIONAL CALCULATIONS; NICKEL-IRON HYDROGENASE; NI-FE HYDROGENASES; ACTIVE-SITE; RAMAN-SPECTROSCOPY; DESULFOVIBRIO-GIGAS; ENZYMATIC MECHANISM; AQUIFEX-AEOLICUS; CATALYTIC CYCLE; 4FE-4S CLUSTER	The metabolism of many anaerobes relies on [NiFe]-hydrogenases, whose characterization when bound to substrates has proven non-trivial. Presented here is direct evidence for a hydride bridge in the active site of the Fe-57-labelled fully reduced Ni-R form of Desulfovibrio vulgaris Miyazaki F [NiFe]-hydrogenase. A unique 'wagging' mode involving H- motion perpendicular to the Ni(mu-H)Fe-57 plane was studied using Fe-57-specific nuclear resonance vibrational spectroscopy and density functional theory (DFT) calculations. On Ni(mu-D)Fe-57 deuteride substitution, this wagging causes a characteristic perturbation of Fe-CO/CN bands. Spectra have been interpreted by comparison with Ni(mu-H/D)Fe-57 enzyme mimics [(dppe)Ni(mu-pdt)(mu-H/D)Fe-57(CO) 3](+) and DFT calculations, which collectively indicate a low-spin Ni(II)(mu-H)Fe(II) core for Ni-R, with H- binding Ni more tightly than Fe. The present methodology is also relevant to characterizing Fe-H moieties in other important natural and synthetic catalysts.	[Ogata, Hideaki; Kraemer, Tobias; van Gastel, Maurice; Neese, Frank; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Wang, Hongxin; Gee, Leland B.; Scott, Aubrey D.; Cramer, Stephen P.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wang, Hongxin; Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Phys Biosci, Berkeley, CA 94720 USA; [Schilter, David; Rauchfuss, Thomas B.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Pelmenschikov, Vladimir] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Yoda, Yoshitaka] Div Res & Utilizat, Sayo, Hyogo 6795198, Japan; [Tanaka, Yoshihito] RIKEN, Mat Dynam Lab, Sayo, Hyogo 6795148, Japan	Cramer, SP (reprint author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	spjcramer@ucdavis.edu	Ogata, Hideaki/J-4975-2013; Kraemer, Tobias/D-2793-2014; Neese, Frank/J-4959-2014	Kraemer, Tobias/0000-0001-5842-9553; 	DOE Office of Biological and Environmental Research; NIH [GM-65440]; DOE grant [DEFG02-90ER14146]; BMBF [03SF0355C]; EU/Energy Network project SOLAR-H2 (FP7) [212508]; DFG-funded Cluster of Excellence RESOLV [EXC1069]; Max Planck Society; DFG-funded 'Unifying Concepts in Catalysis' (UniCat) initiative; JASRI [2012A0032-2014B1032]; RIKEN [20120107, 20130022, 20140033]	We thank Patricia Malkowski (MPI-CEC) for her assistance with the <SUP>57</SUP>Fe [NiFe]-hydrogenase sample preparation. This work was supported by the DOE Office of Biological and Environmental Research (S.P.C.), NIH grant GM-65440 (S.P.C.), DOE grant DEFG02-90ER14146 (T.B.R.), BMBF (03SF0355C), EU/Energy Network project SOLAR-H2 (FP7 contract 212508), DFG-funded Cluster of Excellence RESOLV (EXC1069), Max Planck Society (W.L., T.K., M.v.G., F.N. and H.O.) and the DFG-funded 'Unifying Concepts in Catalysis' (UniCat) initiative (V.P.). Use of SPring-8 is supported by JASRI (proposals 2012A0032-2014B1032) and RIKEN (proposals 20120107, 20130022 and 20140033).	Dole F, 1997, BIOCHEMISTRY-US, V36, P7847, DOI 10.1021/bi963171i; Siebert E, 2013, ANGEW CHEM INT EDIT, V52, P5162, DOI 10.1002/anie.201209732; Kim JYH, 2013, KOREAN J CHEM ENG, V30, P1, DOI 10.1007/s11814-012-0208-8; Petrenko T, 2007, J AM CHEM SOC, V129, P11053, DOI 10.1021/ja070792y; Jugder BE, 2013, RSC ADV, V3, P8142, DOI 10.1039/c3ra22668a; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Ogata H, 2015, NATURE, V520, P571, DOI 10.1038/nature14110; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Yang JY, 2011, MRS BULL, V36, P39, DOI 10.1557/mrs.2010.8; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Armstrong FA, 2009, PHOTOSYNTH RES, V102, P541, DOI 10.1007/s11120-009-9428-0; Bergmann U, 2003, J AM CHEM SOC, V125, P4016, DOI 10.1021/ja028767+; Liu TB, 2009, J AM CHEM SOC, V131, P8296, DOI 10.1021/ja9016528; Bruschi M, 2005, COORDIN CHEM REV, V249, P1620, DOI 10.1016/j.ccr.2004.12.007; STURHAHN W, 1995, PHYS REV LETT, V74, P3832, DOI 10.1103/PhysRevLett.74.3832; Amara P, 1999, J AM CHEM SOC, V121, P4468, DOI 10.1021/ja983971b; Lauterbach L, 2015, CHEM SCI, V6, P1055, DOI 10.1039/c4sc02982h; Guiral M, 2006, INT J HYDROGEN ENERG, V31, P1424, DOI 10.1016/j.ijhydene.2006.06.007; Justice AK, 2008, INORG CHEM, V47, P7405, DOI 10.1021/ic8007552; Jayapal P, 2008, PHYS CHEM CHEM PHYS, V10, P1734, DOI 10.1039/b719980e; Evans RM, 2013, J AM CHEM SOC, V135, P2694, DOI 10.1021/ja311055d; Alp EE, 2002, HYPERFINE INTERACT, V144, P3, DOI 10.1023/A:1025452401501; Matsumoto T, 2013, CHEMCATCHEM, V5, P1368, DOI 10.1002/cctc.201200595; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Shafaat HS, 2012, INORG CHEM, V51, P11787, DOI 10.1021/ic3017276; Li JF, 2014, J AM CHEM SOC, V136, P18100, DOI 10.1021/ja5105766; Kamali S, 2013, ANGEW CHEM INT EDIT, V52, P724, DOI 10.1002/anie.201204616; Peng Q, 2012, J CHEM THEORY COMPUT, V8, P214, DOI 10.1021/ct2006456; Mitra D, 2011, BIOCHEMISTRY-US, V50, P5220, DOI 10.1021/bi200046p; Simmons TR, 2013, ANGEW CHEM INT EDIT, V52, P6143, DOI 10.1002/anie.201302908; Pelmenschikov V, 2011, FARADAY DISCUSS, V148, P409, DOI 10.1039/c004367m; Niu SQ, 1999, J AM CHEM SOC, V121, P4000, DOI 10.1021/ja983469r; SETO M, 1995, PHYS REV LETT, V74, P3828, DOI 10.1103/PhysRevLett.74.3828; Barton BE, 2009, J AM CHEM SOC, V131, P6942, DOI 10.1021/ja902570u; Schilter D, 2012, INORG CHEM, V51, P2338, DOI 10.1021/ic202329y; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Heinekey DM, 2009, J ORGANOMET CHEM, V694, P2671, DOI 10.1016/j.jorganchem.2009.03.047; Barton BE, 2010, J AM CHEM SOC, V132, P14877, DOI 10.1021/ja105312p; Swart I, 2008, J PHYS CHEM A, V112, P1139, DOI 10.1021/jp076702t; Mitra D, 2013, J AM CHEM SOC, V135, P2530, DOI 10.1021/ja307027n; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Bertini L, 2010, ORGANOMETALLICS, V29, P2013, DOI 10.1021/om900658b; Bruschi M, 2004, J BIOL INORG CHEM, V9, P873, DOI 10.1007/s00775-004-0588-2; Cammack, 2001, HYDROGEN FUEL LEARNI; CHAMPENEY DC, 1979, REP PROG PHYS, V42, P1017, DOI 10.1088/0034-4885/42/6/002; Fan HJ, 2002, J AM CHEM SOC, V124, P394, DOI 10.1021/ja0171310; Lill SON, 2009, BIOCHEMISTRY-US, V48, P1056, DOI 10.1021/bi801218n; Bockris JOM, 2013, INT J HYDROGEN ENERG, V38, P2579, DOI 10.1016/j.ijhydene.2012.12.026; Ogata H., 2005, STRUCTURE, V13, P1; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Park K, 2013, P NATL ACAD SCI USA, V110, P6275, DOI 10.1073/pnas.1304238110; Schilter D, 2014, CHEM COMMUN, V50, P13469, DOI 10.1039/c4cc04572f; Siegbahn PEM, 2001, J BIOL INORG CHEM, V6, P460, DOI 10.1007/s007750100226; Stein M, 2004, J INORG BIOCHEM, V98, P862, DOI 10.1016/j.jinorgbio.2004.03.002; Sturhahn W, 2004, J PHYS-CONDENS MAT, V16, pS497, DOI 10.1088/0953-8984/16/5/009; Xiao YM, 2008, BIOCHEMISTRY-US, V47, P6612, DOI 10.1021/bi701433m; Yson RL, 2013, CHEM PHYS LETT, V577, P138, DOI 10.1016/j.cplett.2013.05.059; Zampella G, 2005, J AM CHEM SOC, V127, P13180, DOI 10.1021/ja0508424	63	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7890	10.1038/ncomms8890		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1GF	WOS:000360344600002		
J	Ogawa, H; Cornelius, F; Hirata, A; Toyoshima, C				Ogawa, Haruo; Cornelius, Flemming; Hirata, Ayami; Toyoshima, Chikashi			Sequential substitution of K+ bound to Na+, K+-ATPase visualized by X-ray crystallography	NATURE COMMUNICATIONS			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; CALCIUM-PUMP; SARCOPLASMIC-RETICULUM; ACTIVE-TRANSPORT; RUBIDIUM IONS; WEB SERVER; NA+,K+-ATPASE; CA2+-ATPASE; RELEASE	Na+, K+-ATPase transfers three Na+ from the cytoplasm into the extracellular medium and two K+ in the opposite direction per ATP hydrolysed. The binding and release of Na+ and K+ are all thought to occur sequentially. Here we demonstrate by X-ray crystallography of the ATPase in E2 center dot MgF42-center dot 2K(+), a state analogous to E2 center dot Pi center dot 2K(+), combined with isotopic measurements, that the substitution of the two K+ with congeners in the extracellular medium indeed occurs at different rates, substantially faster at site II. An analysis of thermal movements of protein atoms in the crystal shows that the M3-M4E helix pair opens and closes the ion pathway leading to the extracellular medium, allowing K+ at site II to be substituted first. Taken together, these results indicate that site I K+ is the first cation to bind to the empty cation-binding sites after releasing three Na+.	[Ogawa, Haruo; Hirata, Ayami; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Cornelius, Flemming] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	Toyoshima, C (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp			JSPS [2009B0025, 2013A0049]; Danish Medical Research Foundation; FI/Danish-Japanese cooperation program from The Danish Agency for Science Technology and Innovation; Novo Nordisk Foundation	We thank K. Hasegawa and H. Okumura of the Japan Synchrotron Radiation Research Institute (JASRI) for their help in collecting diffraction data at BL41XU of SPring-8. We also thank Hanne Kidmose and Bianca Franchi for excellent technical assistance. This work is a part of long-term projects (2009B0025 and 2013A0049) at SPring-8 and was supported by a Specially Promoted Project Grant from JSPS (to C.T.), as well as by research grants from The Danish Medical Research Foundation, the FI/Danish-Japanese cooperation program from The Danish Agency for Science Technology and Innovation, and by the Novo Nordisk Foundation (to F.C.).	Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; POST RL, 1972, J BIOL CHEM, V247, P6530; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Eyal E, 2015, BIOINFORMATICS, V31, P1487, DOI 10.1093/bioinformatics/btu847; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butler SL, 1996, BIOCHEMISTRY-US, V35, P10595, DOI 10.1021/bi961107v; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17; GLYNN IM, 1989, J PHYSIOL-LONDON, V408, P57; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.biochem.59.1.171; Holmgren M, 2000, NATURE, V403, P898; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8004	10.1038/ncomms9004		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1IS	WOS:000360351200002		
J	Roeber, V; Bricker, JD				Roeber, Volker; Bricker, Jeremy D.			Destructive tsunami-like wave generated by surf beat over a coral reef during Typhoon Haiyan	NATURE COMMUNICATIONS			English	Article							BOUSSINESQ; MODEL; WIND; ZONE	Storm surges cause coastal inundation due to setup of the water surface resulting from atmospheric pressure, surface winds and breaking waves. Here we show that during Typhoon Haiyan, the setup generated by breaking waves near the fringing-reef-protected town of Hernani, the Philippines, oscillated with the incidence of large and small wave groups, and steepened into a tsunami-like wave that caused extensive damage and casualties. Though fringing reefs usually protect coastal communities from moderate storms, they can exacerbate flooding during strong events with energetic waves. Typical for reef-type bathymetries, a very short wave-breaking zone over the steep reef face facilitates the freeing of infragravity-period fluctuations (surf beat) with little energy loss. Since coastal flood planning relies on phase-averaged wave modelling, infragravity surges are not being accounted for. This highlights the necessity for a policy change and the adoption of phase-resolving wave models for hazard assessment in regions with fringing reefs.	[Roeber, Volker; Bricker, Jeremy D.] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan	Roeber, V (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, 468-1-E304 AzaAoba, Sendai, Miyagi 9800845, Japan.	roeber@irides.tohoku.ac.jp; bricker@irides.tohoku.ac.jp			IRIDeS Tokutei Project grant; JSPS-NSF Cooperative Program for Interdisciplinary Joint Research Projects in Hazards and Disasters, project entitled 'Evolution of Urban Regions in Response to Recurring Disasters'	Prof. Kwok Fai Cheung provided resources on a computer cluster at the University of Hawaii for the BOSZ computation. Shuichi Kure facilitated the IRIDeS field surveys in the Philippines. Troy Heitmann, Seth Guikema, Celso Ferreira, Hiroshi Takagi and Maarten van Ormondt contributed useful discussions. Akane Bessho provided graphic design. This work was funded by an IRIDeS Tokutei Project grant, and by the JSPS-NSF Cooperative Program for Interdisciplinary Joint Research Projects in Hazards and Disasters, project entitled 'Evolution of Urban Regions in Response to Recurring Disasters'.	Battjes JA, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001863; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; van Dongeren A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003701; Roeber V, 2010, COAST ENG, V57, P407, DOI 10.1016/j.coastaleng.2009.11.007; Pequignet ACN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036259; [Anonymous], 2014, SUN STAR; Wei G, 1999, COAST ENG, V36, P271, DOI 10.1016/S0378-3839(99)00009-5; Monserrat S, 2006, NAT HAZARD EARTH SYS, V6, P1035; LONGUETHIGGINS MS, 1984, PHILOS T R SOC A, V312, P219, DOI 10.1098/rsta.1984.0061; LONGUETHIGGINS MS, 1962, J FLUID MECH, V13, P481, DOI 10.1017/S0022112062000877; Bezdek A, 2013, COMPUT GEOSCI-UK, V56, P127, DOI 10.1016/j.cageo.2013.03.007; [Anonymous], 2013, BBC NEWS ASIA; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Mori N, 2014, GEOPHYS RES LETT, V41, P5106, DOI 10.1002/2014GL060689; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Roeber V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044419; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; Schaffer HA, 2006, COAST ENG, V53, P319, DOI 10.1016/j.coastaleng.2005.10.022; Applied Technology Council, 2008, P646 FEMA APPL TECHN; Bankoff G., 2007, WORLD WATER RAIN RIV; Bretschneider C. L., 1986, ROUGHNESS TYPICAL HA; Bricker J., 2014, J JPN SOC CIVIL E B2, V70, P231; Bricker J. D., 2015, P 36 IAHR WORLD C 28; Dean RG, 1991, WATER WAVE MECH ENG; Deltares, 2011, DELFT3D FLOW US MAN; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Fujii T., 1986, 29B1 KYOT U DIS PREV, VB-1, P229; GEBCO, 2014, GEBCO GEN BATH CHART; Gensis N., 2013, PLAN INT VIDEO TYPHO; Hibiya T., 1982, J OCEANOGR SOC JAPAN, V38, P172, DOI DOI 10.1007/BF02110288; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA, P387; Japan Meteorological Agency, 2013, BEST TRACK DAT; Li N, 2014, OCEAN MODEL, V83, P26, DOI 10.1016/j.ocemod.2014.08.005; MASSELINK G, 1995, CONT SHELF RES, V15, P1525, DOI 10.1016/0278-4343(95)00037-2; NAKAZA E, 1991, FLUID DYN RES, V7, P89, DOI 10.1016/0169-5983(91)90062-N; NASA, 2014, SHUTTL RADAR TOP MIS; Nobuoka H., 2014, J JPN SOC CIVIL E B2, V70, pI_1426; Nwogu O, 2010, J WATERW PORT C-ASCE, V136, P295, DOI 10.1061/(ASCE)WW.1943-5460.0000050; Quiring S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015011; Roeber V., 2012, P RES 2011 NTHMP MOD, P361; Roeber V, 2012, COAST ENG, V70, P1, DOI 10.1016/j.coastaleng.2012.06.001; SCHAFFER HA, 1993, J FLUID MECH, V247, P551, DOI 10.1017/S0022112093000564; Takagi H., 2015, J FLOOD RISK MANAG, DOI [10.1111/jfr3.12136, DOI 10.1111/JFR3.12136]; US Army Corps of Engineers Coastal and Hydraulics Laboratory, 2015, GLOSS COAST ENG TERM; Van Dongeren A, 2013, COAST ENG, V73, P178, DOI 10.1016/j.coastaleng.2012.11.004; Veltcheva A., 2002, 41 PORT AIRP RES I, V41, P23; Yamazaki Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047508	47	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7854	10.1038/ncomms8854		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1FU	WOS:000360343500002		
J	Suzuki, Y; Endo, M; Sugiyama, H				Suzuki, Yuki; Endo, Masayuki; Sugiyama, Hiroshi			Lipid-bilayer-assisted two-dimensional self-assembly of DNA origami nanostructures	NATURE COMMUNICATIONS			English	Article							ATOMIC-FORCE MICROSCOPY; BIOMOLECULAR PROCESSES; PHOSPHOLIPID-BILAYERS; MOLECULAR RECOGNITION; PATTERNED SURFACES; NANOSCALE SHAPES; FOLDING DNA; MEMBRANE; DIFFUSION; CRYSTALS	Self-assembly is a ubiquitous approach to the design and fabrication of novel supermolecular architectures. Here we report a strategy termed 'lipid-bilayer-assisted self-assembly' that is used to assemble DNA origami nanostructures into two-dimensional lattices. DNA origami structures are electrostatically adsorbed onto a mica-supported zwitterionic lipid bilayer in the presence of divalent cations. We demonstrate that the bilayer-adsorbed origami units are mobile on the surface and self-assembled into large micrometre-sized lattices in their lateral dimensions. Using high-speed atomic force microscopy imaging, a variety of dynamic processes involved in the formation of the lattice, such as fusion, reorganization and defect filling, are successfully visualized. The surface modifiability of the assembled lattice is also demonstrated by in situ decoration with streptavidin molecules. Our approach provides a new strategy for preparing versatile scaffolds for nanofabrication and paves the way for organizing functional nanodevices in a micrometer space.	[Suzuki, Yuki; Sugiyama, Hiroshi] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Suzuki, Yuki; Endo, Masayuki; Sugiyama, Hiroshi] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Endo, Masayuki; Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan	Endo, M (reprint author), Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan.	endo@kuchem.kyoto-u.ac.jp; hs@kuchem.kyoto-u.ac.jp	Suzuki, Yuki/H-9950-2015; Sugiyama, Hiroshi/C-7687-2011; Endo, Masayuki/J-5874-2014		JST [24104002]; JSPS KAKENHI [15K21093, 15H03837, 26620133, 24225005]; Sekisui Chemical Grant Program; Mitsubishi Foundation	This work was supported by a Grant-in-Aid for Scientific Research on Innovative areas 'Molecular Robotics' (Grant Number 24104002), Core Research for Evolutional Science and Technology (CREST) of JST and JSPS KAKENHI (Grant Numbers 15K21093, 15H03837, 26620133 and 24225005). Financial support from the Sekisui Chemical Grant Program and the Mitsubishi Foundation to M.E. is also acknowledged. We thank T. Emura, N. Sakai and Y. Uekusa for their technical assistance.	Burns JR, 2013, NANO LETT, V13, P2351, DOI 10.1021/nl304147f; Kershner RJ, 2009, NAT NANOTECHNOL, V4, P557, DOI [10.1038/nnano.2009.220, 10.1038/NNANO.2009.220]; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Gerdon AE, 2009, SMALL, V5, P1942, DOI 10.1002/smll.200900442; Endo M, 2010, CHEM-EUR J, V16, P5362, DOI 10.1002/chem.200903057; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Yang YY, 2012, J AM CHEM SOC, V134, P20645, DOI 10.1021/ja307785r; Lawrence JC, 2003, BIOPHYS J, V84, P1827; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/nchem.1070, 10.1038/NCHEM.1070]; Li Z, 2010, J AM CHEM SOC, V132, P13545, DOI 10.1021/ja106292x; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/nnano.2010.107, 10.1038/NNANO.2010.107]; Ohira A, 2003, J AM CHEM SOC, V125, P5057, DOI 10.1021/ja021351b; Suzuki Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02131; Reviakine I, 2001, LANGMUIR, V17, P8293, DOI 10.1021/la010626i; Kocabey S, 2015, ACS NANO, V9, P3530, DOI 10.1021/acsnano.5b00161; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Castro CE, 2011, NAT METHODS, V8, P221, DOI [10.1038/nmeth.1570, 10.1038/NMETH.1570]; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]; Suzuki Y, 2014, J AM CHEM SOC, V136, P1714, DOI 10.1021/ja4109819; Rafat AA, 2014, ANGEW CHEM INT EDIT, V53, P7665, DOI 10.1002/anie.201403965; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Yamamoto D, 2009, BIOPHYS J, V97, P2358, DOI 10.1016/j.bpj.2009.07.046; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Ishikawa Y, 2002, CHEM COMMUN, P2652, DOI 10.1039/b207556c; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Zhang HL, 2012, CHEM COMMUN, V48, P6405, DOI 10.1039/c2cc32204h; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Hamada S, 2009, ANGEW CHEM INT EDIT, V48, P6820, DOI 10.1002/anie.200902662; Borjesson K, 2011, ANGEW CHEM INT EDIT, V50, P8312, DOI 10.1002/anie.201103338; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; Dabkowska AP, 2015, NANOSCALE, V7, P583, DOI 10.1039/c4nr05968a; McManus JJ, 2003, J PHYS CHEM B, V107, P9869, DOI 10.1021/jp034463d; Perrault SD, 2014, ACS NANO, V8, P5132, DOI 10.1021/nn5011914; Burns JR, 2013, ANGEW CHEM INT EDIT, V52, P12069, DOI 10.1002/anie.201305765; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Theobald JA, 2003, NATURE, V424, P1029, DOI 10.1038/nature01915; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Kunitake M, 2014, CURR OPIN COLLOID IN, V19, P140, DOI 10.1016/j.cocis.2014.03.003; Wu N, 2013, J AM CHEM SOC, V135, P12172, DOI 10.1021/ja403863a; Conway JW, 2014, J AM CHEM SOC, V136, P12987, DOI 10.1021/ja506095n; Czogalla A, 2013, FARADAY DISCUSS, V161, P31, DOI 10.1039/c2fd20109g; Endo M, 2011, CHEM COMMUN, V47, P3213, DOI 10.1039/c0cc05306f; Johnson-Buck A, 2014, ACS NANO, V8, P5641, DOI 10.1021/nn500108k; Ke YG, 2014, NAT CHEM, V6, P994, DOI [10.1038/nchem.2083, 10.1038/NCHEM.2083]; Langecker M, 2014, ACCOUNTS CHEM RES, V47, P1807, DOI 10.1021/ar500051r; Lundberg EP, 2013, LANGMUIR, V29, P285, DOI 10.1021/la304178f; Mingeot-Leclercq MP, 2008, NAT PROTOC, V3, P1654, DOI 10.1038/nprot.2008.149; Mori T, 2012, J AM CHEM SOC, V134, P20254, DOI 10.1021/ja309646s; Rajendran A, 2013, CHEM COMMUN, V49, P686, DOI 10.1039/c2cc37257f; Woo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5889; Shahin V, 2008, BIOCHEMISTRY-US, V47, P2143, DOI 10.1021/bi701879g; van Hameren R, 2006, SCIENCE, V314, P1433, DOI 10.1126/science.1133004; Whitesides GM, 2005, NAN SCI TEC, P217, DOI 10.1007/0-387-25656-3_9; Yoshida A, 2015, GENES CELLS, V20, P85, DOI 10.1111/gtc.12204	68	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								8052	10.1038/ncomms9052		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1JC	WOS:000360352400006		
J	Uno, K; Yamada, T; Ishigaki, Y; Imai, J; Hasegawa, Y; Sawada, S; Kaneko, K; Ono, H; Asano, T; Oka, Y; Katagiri, H				Uno, Kenji; Yamada, Tetsuya; Ishigaki, Yasushi; Imai, Junta; Hasegawa, Yutaka; Sawada, Shojiro; Kaneko, Keizo; Ono, Hiraku; Asano, Tomoichiro; Oka, Yoshitomo; Katagiri, Hideki			A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals	NATURE COMMUNICATIONS			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; MTOR COMPLEX 1; INSULIN-RESISTANCE; TRIGLYCERIDE-METABOLISM; GENE-EXPRESSION; DIFFERENT MECHANISMS; MAMMALIAN TARGET; TRANSGENIC MICE; VAGUS NERVE; OBESITY	Metabolism is coordinated among tissues and organs via neuronal signals. Levels of circulating amino acids (AAs), which are elevated in obesity, activate the intracellular target of rapamycin complex-1 (mTORC1)/S6kinase (S6K) pathway in the liver. Here we demonstrate that hepatic AA/mTORC1/S6K signalling modulates systemic lipid metabolism via a mechanism involving neuronal inter-tissue communication. Hepatic expression of an AA transporter, SNAT2, activates the mTORC1/S6K pathway, and markedly elevates serum triglycerides (TGs), while downregulating adipose lipoprotein lipase (LPL). Hepatic Rheb or active-S6K expression have similar metabolic effects, whereas hepatic expression of dominant-negative-S6K inhibits TG elevation in SNAT2 mice. Denervation, pharmacological deafferentation and beta-blocker administration suppress obesity-related hypertriglyceridemia with adipose LPL upregulation, suggesting that signals are transduced between liver and adipose tissue via a neuronal pathway consisting of afferent vagal and efferent sympathetic nerves. Thus, the neuronal mechanism uncovered here serves to coordinate amino acid and lipid levels and contributes to the development of obesity-related hypertriglyceridemia.	[Uno, Kenji; Yamada, Tetsuya; Imai, Junta; Hasegawa, Yutaka; Sawada, Shojiro; Kaneko, Keizo; Oka, Yoshitomo; Katagiri, Hideki] Tohoku Univ, Dept Metab & Diabet, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Ishigaki, Yasushi] Iwate Med Univ, Div Diabet & Metab, Morioka, Iwate 0208505, Japan; [Ono, Hiraku] Saitama Med Univ, Dept Internal Med 4, Saitama 3500495, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima 7348553, Japan; [Katagiri, Hideki] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan	Katagiri, H (reprint author), Tohoku Univ, Dept Metab & Diabet, Grad Sch Med, Sendai, Miyagi 9808575, Japan.	katagiri@med.tohoku.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	We thank all the technical staff members for expert support. This work was supported by Grants-in-Aid (to H.K., Y.O. and K.U.) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas (to H.K.) and the Global-COE (to Y.O. and H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and CREST (to H.K.) from the Japan Science and Technology Agency.	Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; CABALLERO B, 1988, METABOLISM, V37, P672, DOI 10.1016/0026-0495(88)90089-3; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Chatterjee C, 2011, AM J PATHOL, V178, P1429, DOI 10.1016/j.ajpath.2010.12.050; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; TRAYHURN P, 1995, BIOCHEM J, V311, P729; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.CAN-03-3645; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Trost Z, 2009, ARCH MED RES, V40, P364, DOI 10.1016/j.arcmed.2009.05.001; Bortolotti M, 2012, CLIN NUTR, V31, P238, DOI 10.1016/j.clnu.2011.09.011; Henderson H, 1998, CLIN CHIM ACTA, V269, P1, DOI 10.1016/S0009-8981(97)00144-7; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li SY, 2011, BIOCHEM BIOPH RES CO, V412, P197, DOI 10.1016/j.bbrc.2011.07.038; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Adachi H, 2011, BIOCHEM BIOPH RES CO, V409, P177, DOI 10.1016/j.bbrc.2011.04.110; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; RAYNOLDS MV, 1990, MOL ENDOCRINOL, V4, P1416; Usui S, 2002, J LIPID RES, V43, P805; Torii K, 2001, PHYSIOL BEHAV, V72, P685, DOI 10.1016/S0031-9384(01)00426-7; Korsheninnikova E, 2006, DIABETOLOGIA, V49, P3049, DOI 10.1007/s00125-006-0439-5; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.106.151621; ANTRAS J, 1991, MOL CELL ENDOCRINOL, V82, P183, DOI 10.1016/0303-7207(91)90030-V; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075; Kovar J, 2008, PHYSIOL RES, V57, P555; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Qu S, 2007, J LIPID RES, V48, P1476, DOI 10.1194/jlr.M600498-JLR200; Ranganathan G, 2005, MOL ENDOCRINOL, V19, P2527, DOI 10.1210/me.2005-0144; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; SHIGETA Y, 1967, DIABETES, V16, P238; Taylor P. M., 2014, AM J CLIN NUTR, V99, p223S; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Uno K, 2012, EUR HEART J, V33, P1279, DOI 10.1093/eurheartj/ehr265; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001	70	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7940	10.1038/ncomms8940		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1GX	WOS:000360346400005		
J	Watanabe, Y; Tamura, Y; Kawano, S; Endo, T				Watanabe, Yasunori; Tamura, Yasushi; Kawano, Shin; Endo, Toshiya			Structural and mechanistic insights into phospholipid transfer by Ups1-Mdm35 in mitochondria	NATURE COMMUNICATIONS			English	Article							INTERMEMBRANE-SPACE-PROTEIN; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDIC-ACID; INTRAMITOCHONDRIAL TRANSPORT; CARDIOLIPIN BIOSYNTHESIS; BARTH-SYNDROME; TRAFFICKING; SYNTHASE; YEAST; METABOLISM	Eukaryotic cells are compartmentalized into membrane-bounded organelles whose functions rely on lipid trafficking to achieve membrane-specific compositions of lipids. Here we focused on the Ups1-Mdm35 system, which mediates phosphatidic acid (PA) transfer between the outer and inner mitochondrial membranes, and determined the X-ray structures of Mdm35 and Ups1-Mdm35 with and without PA. The Ups1-Mdm35 complex constitutes a single domain that has a deep pocket and flexible O-loop lid. Structure-based mutational analyses revealed that a basic residue at the pocket bottom and the O-loop lid are important for PA extraction from the membrane following Ups1 binding. Ups1 binding to the membrane is enhanced by the dissociation of Mdm35. We also show that basic residues around the pocket entrance are important for Ups1 binding to the membrane and PA extraction. These results provide a structural basis for understanding the mechanism of PA transfer between mitochondrial membranes.	[Watanabe, Yasunori; Kawano, Shin; Endo, Toshiya] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Watanabe, Yasunori; Kawano, Shin; Endo, Toshiya] Kyoto Sangyo Univ, JST CREST, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Watanabe, Yasunori; Tamura, Yasushi; Kawano, Shin; Endo, Toshiya] Nagoya Univ, Res Ctr Mat Sci, JST CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tamura, Yasushi] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kawano, Shin; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Endo, T (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	tendo@cc.kyoto-su.ac.jp			Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency; Platform for Drug Discovery, Informatics and Structural Life Science - Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Dr Toshiharu Suzuki for the use of a spectrofluorometer and technical advice. We thank the members of the Endo lab for discussions and critical comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) for Y.W., Y.T., S.K. and T.E., a CREST Grant from the Japan Science and Technology Agency for T.E. and by Platform for Drug Discovery, Informatics and Structural Life Science funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The synchrotron radiation experiments were performed at beam lines BL38B1 at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute Proposal 2014A1169 and NE3A and NW12A at Photon Factory, Japan. Y.W. is a Research fellow of the Japan Society of the Promotion of Science.	Adams A., 1998, METHODS YEAST GENETI; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Tamura Y, 2012, J BIOL CHEM, V287, P43961, DOI 10.1074/jbc.M112.390997; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Athenstaedt K, 1997, J BACTERIOL, V179, P7611; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Flis VV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013235; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	44	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	AUG	2015	6								7922	10.1038/ncomms8922		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1GT	WOS:000360346000004		
J	Iwasaki, Y; Dezaki, K; Kumari, P; Kakei, M; Yada, T				Iwasaki, Yusaku; Dezaki, Katsuya; Kumari, Parmila; Kakei, Masafumi; Yada, Toshihiko			Ghrelin counteracts insulin-induced activation of vagal afferent neurons via growth hormone secretagogue receptor	NEUROPEPTIDES			English	Article						Ghrelin; Insulin; Nodose ganglion; Vagal afferent nerves; Growth hormone secretagogue receptor; Cytosolic Ca2+; Cholecystokinin; Feeding	HYPOTHALAMIC ARCUATE NUCLEUS; BLOOD-BRAIN-BARRIER; PERIPHERAL GHRELIN; FOS EXPRESSION; NEUROPEPTIDE-Y; BETA-CELLS; SIGNAL-TRANSDUCTION; ACYLATED PEPTIDE; NODOSE GANGLIA; FOOD-INTAKE	Vagal afferent nerves sense meal-related gastrointestinal and pancreatic hormones and convey their information to the brain, thereby regulating brain functions including feeding. We have recently demonstrated that postprandial insulin directly acts on the vagal afferent neurons. Plasma concentrations of orexigenic ghrelin and anorexigenic insulin show reciprocal dynamics before and after meals. The present study examined interactive effects of ghrelin and insulin on vagal afferent nerves. Cytosolic Ca2+ concentration ([Ca2+](i)) in isolated nodose ganglion (NG) neurons was measured to monitor their activity. Insulin at 10(-7) M increased [Ca2+]; in NG neurons, and the insulin-induced [Ca2+](i) increase was inhibited by treatment with ghrelin at 10(-8) M. This inhibitory effect of ghrelin was attenuated by [D-Lys(3)]-GHRP-6, an antagonist of growth hormone-secretagogue receptor (GHSR). Des-acyl ghrelin had little effect on insulin-induced [Ca2+](i) increases in NG neurons. Ghrelin did not affect [Ca2+](i) increases in response to cholecystokinin (CCK), a hormone that inhibits feeding via vagal afferent neurons, indicating that ghrelin selectively counteracts the insulin action. These results demonstrate that ghrelin via GHSR suppresses insulin-induced activation of NG neurons. The action of ghrelin to counteract insulin effects on NG might serve to efficiently inform the brain of the systemic change between fasting-associated ghrelin-dominant and fed-associated insulin-dominant states for the homeostatic central regulation of feeding and metabolism. (C) 2015 Elsevier Ltd. All rights reserved.	[Iwasaki, Yusaku; Dezaki, Katsuya; Kumari, Parmila; Yada, Toshihiko] Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi 3290498, Japan; [Kakei, Masafumi] Jichi Med Univ, Sch Med, Saitama Med Ctr, Dept Med 1, Saitama 3308503, Japan; [Yada, Toshihiko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, Div Adaptat Dev, Okazaki, Aichi 4448585, Japan	Yada, T (reprint author), Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	tyada@jichi.acjp			Japan Society for the Promotion of Science (JSPS) [24790221, 26460302]; Naito Foundation; JSPS [23390044, 26670453]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [10036069]; MEXT; Ministry of Health, Labor, and Welfare, Japan; Japan Diabetes Foundation; Salt Science Research Foundation [1434]; JKA through KEIRIN RACE	This work was supported by Grant-in-Aid for Young Scientist (B) (24790221) and Scientific Research (C) (26460302) from Japan Society for the Promotion of Science (JSPS), and The Naito Foundation to YI. This work was supported by Grant-in-Aid for Scientific Research (B) (23390044) and for Challenging Exploratory Research (26670453) from JSPS, Strategic Research Program for Brain Sciences (10036069) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), MEXT-Supported Programs for Strategic Research Foundation at Private Universities 2011-2015 (Cooperative Basic and Clinical Research on Circadian Medicine) and 2013-2017, a Grant-in-Aid from Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan, a grant from Japan Diabetes Foundation, and a grant from Salt Science Research Foundation, No. 1434 to TY. This study was subsidized by JKA through its promotion funds from KEIRIN RACE to TY.	Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V390, P958, DOI 10.1016/j.bbrc.2009.10.085; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Burdyga G, 2006, AM J PHYSIOL-GASTR L, V290, pG1289, DOI 10.1152/ajpgi.00543.2005; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Maejima Y, 2011, AGING-US, V3, P1092; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Yada T, 2014, DIABETES OBES METAB, V16, P111, DOI 10.1111/dom.12344; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Wang LX, 2002, NEUROSCI LETT, V325, P47; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Gahete MD, 2014, J ENDOCRINOL, V220, pR1, DOI 10.1530/JOE-13-0391; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kobelt P, 2005, AM J PHYSIOL-REG I, V288, pR751, DOI 10.1152/ajpregu.00094.2004; Date Y, 2006, CELL METAB, V4, P323, DOI 10.1016/j.cmet.2006.09.004; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Schwartz MW, 2000, NATURE, V404, P661; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Simasko SM, 2002, AM J PHYSIOL-REG I, V283, pR1303, DOI 10.1152/ajpregu.00050.2002; Ao Y, 2005, PANCREAS, V31, P142, DOI 10.1097/01.mpa.0000172562.96168.59; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Filippi BM, 2013, REV ENDOCR METAB DIS, V14, P365, DOI 10.1007/s11154-013-9258-4; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Iwasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067198; Iwasaki Y, 2012, NEUROPEPTIDES, V46, P291, DOI 10.1016/j.npep.2012.08.009; Lankisch TO, 2002, AM J PHYSIOL-GASTR L, V282, pG1002, DOI 10.1152/ajpgi.00313.2001; Ruter J, 2003, BRAIN RES, V991, P26, DOI 10.1016/j.brainres.2003.07.005; Yada Toshihiko, 2008, Curr Diabetes Rev, V4, P18, DOI 10.2174/157339908783502352	40	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2015	52						55	60		10.1016/j.npep.2015.06.003		6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CQ2FT	WOS:000360416100006		
J	Yamauchi, S; Nishio, A; Takahashi, Y; Kondo, K; Kawakami, T; Terakawa, Y; Mitsuhashi, Y; Ohata, K				Yamauchi, Shigeru; Nishio, Akimasa; Takahashi, Yoshinobu; Kondo, Kimito; Kawakami, Taichiro; Terakawa, Yuzo; Mitsuhashi, Yutaka; Ohata, Kenji			An innovative technique for detecting the caudal end of occluded inferior petrosal sinus in cavernous arteriovenous fistula using intravascular ultrasonography-technical note	NEURORADIOLOGY			English	Article						Cavernous sinus dural arteriovenous fistula; Inferior petrosal sinus; Intravascular ultrasonography; Transvenous embolization	CHRONIC TOTAL OCCLUSION; ULTRASOUND; ANGIOPLASTY; DISSECTION; STRATEGY; IVUS	Although cavernous sinus (CS) dural arteriovenous fistulas (d-AVFs) are usually treated with transvenous embolization (TVE) via the inferior petrosal sinus (IPS), IPSs are sometimes thrombosed and angiographically invisible. In such cases, the first obstacle to TVE is detecting the entry to the IPS. We report a new technique for TVE via IPS using intravascular ultrasonography (IVUS). Three consecutive cases of CS d-AVF with ipsilateral or bilateral IPS occlusion were involved in this study. On TVE, the orifice of the IPS was investigated with IVUS placed in the jugular vein or jugular bulb. This technique has been successfully adapted in all three cases. In two of these cases, IPS was well visualized with the help of IVUS, and TVE was successfully performed. To our knowledge, this is the first report to mention the usefulness of IVUS for detecting angiographically occult IPS.	[Yamauchi, Shigeru; Nishio, Akimasa; Takahashi, Yoshinobu] Hokuto Social Med Corp Hokuto Hosp, Dept Neurosurg, Obihiro, Hokkaido 0800033, Japan; [Kondo, Kimito] Hokuto Social Med Corp Hokuto Hosp, Dept Neurol, Obihiro, Hokkaido 0800033, Japan; [Kawakami, Taichiro; Terakawa, Yuzo; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka 558, Japan; [Mitsuhashi, Yutaka] Ishikiriseiki Hosp, Dept Neurosurg, Higashiosaka, Osaka, Japan	Yamauchi, S (reprint author), Hokuto Social Med Corp Hokuto Hosp, Dept Neurosurg, 7-5 Inada, Obihiro, Hokkaido 0800033, Japan.	s-yamauchi-bigdipper@trad.ocn.ne.jp					Abizaid A, 1999, AM J CARDIOL, V84, P1298, DOI 10.1016/S0002-9149(99)00561-5; Park Y, 2011, INT J CARDIOL, V148, P174, DOI 10.1016/j.ijcard.2009.10.052; Buckley CJ, 2002, J VASC SURG, V35, P316, DOI 10.1067/mva.2002.119755; MILLER DL, 1993, AM J NEURORADIOL, V14, P1075; GUSSENHOVEN EJ, 1989, J AM COLL CARDIOL, V14, P947; Mitsuhashi Y, 2007, AM J NEURORADIOL, V28, P1179, DOI 10.3174/ajnr.A0489; Iwabuchi M, 1997, J AM COLL CARDIOL, V30, P1437, DOI 10.1016/S0735-1097(97)00356-2; Koschyk DH, 2003, J CARDIAC SURG, V18, P471, DOI 10.1046/j.1540-8191.2003.02083.x; Maehara A, 2002, AM J CARDIOL, V89, P466, DOI 10.1016/S0002-9149(01)02272-X; NEVILLE RF, 1989, AM J SURG, V158, P142, DOI 10.1016/0002-9610(89)90363-2; Nishio A, 2009, NEUROL MED-CHIR, V49, P604; Ohshima K, 2009, J CARDIOL, V54, P205, DOI 10.1016/j.jjcc.2009.05.009; Takahashi Y, 2013, J INVASIVE CARDIOL, V25, pE143; Yoshioka T, 2004, NEUROL SURG TOKYO, V32, P597	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	AUG	2015	57	8					799	804		10.1007/s00234-015-1530-8		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ2NS	WOS:000360438600006		
J	Nagai, Y				Nagai, Yasushi			Distribution of patches in tilings and spectral properties of corresponding dynamical systems	NONLINEARITY			English	Article						tiling; dynamical systems; spectral theory; aperiodic order	SELF-SIMILAR TILINGS; C-ASTERISK-ALGEBRAS; DIFFRACTION SPECTRA; SYMMETRY	A tiling is a cover of R-d by tiles such as polygons that overlap only on their borders. A patch is a configuration consisting of finitely many tiles that appears in tilings. From a tiling, we can construct a dynamical system which encodes the nature of the tiling. In the literature, properties of this dynamical system were investigated by studying how patches distribute in each tiling. In this article we conversely research distribution of patches from properties of the corresponding dynamical systems. We show periodic structures are hidden in tilings which are not necessarily periodic. Our results throw light on inverse problem of deducing information of tilings from information of diffraction measures, in quite a general setting.	Keio Univ, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Nagai, Y (reprint author), Keio Univ, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	nagai@math.keio.ac.jp					RADIN C, 1994, ANN MATH, V139, P661, DOI 10.2307/2118575; Lee JY, 2012, DISCRETE CONT DYN-A, V32, P935, DOI 10.3934/dcds.2012.32.935; Solomyak B, 1998, DISCRETE COMPUT GEOM, V20, P265, DOI 10.1007/PL00009386; Baake M, 2004, ERGOD THEOR DYN SYST, V24, P1867, DOI 10.1017/S0143385704000318; Anderson JE, 1998, ERGOD THEOR DYN SYST, V18, P509, DOI 10.1017/S0143385798100457; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Solomyak B, 1997, ERGOD THEOR DYN SYST, V17, P695, DOI 10.1017/S0143385797084988; BAAKE M, 1991, J PHYS A-MATH GEN, V24, P4637, DOI 10.1088/0305-4470/24/19/025; Baake M, 2013, APERIODIC CRYSTALS, P35; Bedaride N, 2013, Q J MATH, V64, P955, DOI 10.1093/qmath/has025; DEKKING FM, 1978, Z WAHRSCHEINLICHKEIT, V42, P23, DOI 10.1007/BF00534205; Grimm U, 2008, Z KRISTALLOGR, V223, P777, DOI 10.1524/zkri.2008.1043; HOF A, 1995, COMMUN MATH PHYS, V169, P25, DOI 10.1007/BF02101595; Lee JY, 2003, DISCRETE COMPUT GEOM, V29, P525, DOI 10.1007/s00454-003-0781-z; Moody R V, 2011, ARXIV11113617; Moody RV, 2000, CRM MONOGRAPH SERIES, V13; Priebe N, 2001, DISCRETE COMPUT GEOM, V26, P289, DOI 10.1007/s00454-001-0032-0; Priebe NM, 2000, GEOMETRIAE DEDICATA, V79, P239, DOI 10.1023/A:1005191014127; Queffelec M, 2010, LECT NOTES MATH, V1294, P1, DOI 10.1007/978-3-642-11212-6; Robinson EA, 2004, PROC SYM AP, V60, P81; Solomyak B, 2005, ZAP NAUCHN SEM S PET, V326; Solomyak B, 2005, TEOR PREDST DIN SIST, V13, P282; Solomyak B., 2007, ADV STUD PURE MATH, V49, P433; Solomyak B, 2005, TEOR PREDST DIN SIST, V13, P198; Terauds V, 2013, J STAT PHYS, V152, P954, DOI 10.1007/s10955-013-0790-0; Whittaker MF, 2010, J OPERAT THEOR, V64, P299	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	AUG	2015	28	8					2617	2638		10.1088/0951-7715/28/8/2617		22	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CQ3JV	WOS:000360499100001		
J	Teramoto, H; Toda, M; Komatsuzaki, T				Teramoto, Hiroshi; Toda, Mikito; Komatsuzaki, Tamiki			Breakdown mechanisms of normally hyperbolic invariant manifolds in terms of unstable periodic orbits and homoclinic/heteroclinic orbits in Hamiltonian systems	NONLINEARITY			English	Article						normally hyperbolic invariant manifold; hamiltonian system; chemical reaction dynamics; unstable periodic orbits; homoclinic orbits	REGULARITY; FLOWS	We analyze the mechanism of breakdown of normally hyperbolic invariant manifolds (NHIMs) based on unstable periodic orbits, homoclinic and heteroclinic orbits in NHIMs for Hamiltonian systems. First, we classify the breakdown mechanism in terms of the characteristic multipliers (the eigenvalues of the phase space Jacobian matrix) of unstable periodic orbits in the NHIM and elucidate the classification for systems of three degrees of freedom. Second, we also present an index that provides a sufficient condition under which the NHIM ceases to exist in more global regions along the homoclinic and heteroclinic orbits in the NHIM. We demonstrate local and global features of the breakdown of the NHIM for a hydrogen atom in crossed electric and magnetic fields. Our analysis of unstable periodic orbits of shorter periods indicates that local features of the breakdown are highly inhomogeneous, depending on each periodic orbit. This manifests an inherent dynamical feature for systems of more than two degrees of freedom. Contrastingly, our analysis of homoclinic orbits indicates that the energy at which the NHIM breaks down does not depend on each homoclinic orbit. This result suggests the existence of a global breakdown of the NHIM behind these homoclinic orbits since these homoclinic orbits run through broader phase space regions.	[Teramoto, Hiroshi; Komatsuzaki, Tamiki] Hokkaido Univ, Res Inst Elect Sci, Mol & Life Nonlinear Sci Lab, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Toda, Mikito] Nara Womens Univ, Fac Div Nat Sci, Nonequilibrium Dynam Lab, Res Grp Phys, Nara 6308506, Japan	Teramoto, H (reprint author), Hokkaido Univ, Res Inst Elect Sci, Mol & Life Nonlinear Sci Lab, Kita Ku, Kita 20 Nishi 10, Sapporo, Hokkaido 0010020, Japan.	teramoto@es.hokudai.ac.jp			JSPS; Cooperative Research Program of 'Network Joint Research Center for Materials and Devices'; Research Center for Computational Science, Okazaki, Japan; Priority Area 'Molecular Theory for Real Systems'; Ministry of Education, Culture, Sports, Science and Technology; Office of the President of Hokkaido University through a priority distribution fund; Nara Women's University Intramural Grant	We thank an anonymous referee for his/her comments on the classification of the breakdown around an unstable periodic orbit. This work has been supported by JSPS, the Cooperative Research Program of 'Network Joint Research Center for Materials and Devices', Research Center for Computational Science, Okazaki, Japan, and Priority Area 'Molecular Theory for Real Systems' (to TK and MT), Grant-in-Aid for Young Scientists (B) (to TH), Grant-in-Aid for challenging Exploratory Research (to TK), and Grant-in-Aid for Scientific Research (B) (to TK) from the Ministry of Education, Culture, Sports, Science and Technology, the Office of the President of Hokkaido University through a priority distribution fund for research support (to TH), Nara Women's University Intramural Grant for Project Research (to MT), Grant-in-Aid for Challenging Explatory Research (to MT) and Grant-in-Aid for Scientific Research (C) (to MT).	Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Haller G, 1998, PHYSICA D, V119, P352, DOI 10.1016/S0167-2789(98)00091-8; Allahem A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769197; HIRSCH M, 1970, INVENT MATH, V9, P121, DOI 10.1007/BF01404552; Uzer T, 2002, NONLINEARITY, V15, P957, DOI 10.1088/0951-7715/15/4/301; Koon WS, 2000, CHAOS, V10, P427, DOI 10.1063/1.166509; Komatsuzaki T, 2001, P NATL ACAD SCI USA, V98, P7666, DOI 10.1073/pnas.131627698; Komatsuzaki T, 1999, J CHEM PHYS, V110, P9160, DOI 10.1063/1.478838; Teramoto H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054101; FENICHEL N, 1971, INDIANA U MATH J, V21, P193; Li CB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.028302; Waalkens H, 2004, J CHEM PHYS, V121, P6207, DOI 10.1063/1.1789891; Jaffe C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011101; HELLER EJ, 1984, PHYS REV LETT, V53, P1515, DOI 10.1103/PhysRevLett.53.1515; Baumgartel H., 1985, ANAL PERTURBATION TH; Beyn WJ, 1990, IMA J NUMER ANAL, V9, P379; Hirsch M., 1977, LECT NOTES MATH, V583; Kato T, 1976, CLASSICS MATH; Kawahara G, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1890428; Keller H.B., 1977, APPL BIFURCATION THE, P359; Komatsuzaki T, 1996, J CHEM PHYS, V105, P10838, DOI 10.1063/1.472892; Koon W.S., 2002, CONT MATH, V292, P129; Kuznetsov YA, 2004, ELEMENTS APPL BIFURC; MANE R, 1978, T AM MATH SOC, V246, P261, DOI 10.2307/1997974; Meyer K., 2009, INTRO HAMILTONIAN DY; NOMIZU K., 1996, FDN DIFFERENTIAL GEO; Sibert EL, 2008, NEW J PHYS, V10; Simo C, 1997, MODERN METHODS ANAL; Sundaram B, 1990, PHYS REV A, V43, P3183; Wisniacki DA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094101	30	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	AUG	2015	28	8					2677	2698		10.1088/0951-7715/28/8/2677		22	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CQ3JV	WOS:000360499100004		
J	Jaerisch, J; Sumi, H				Jaerisch, Johannes; Sumi, Hiroki			Multifractal formalism for expanding rational semigroups and random complex dynamical systems	NONLINEARITY			English	Article						complex dynamical systems; rational semigroups; random complex dynamics; multifractal formalism; Julia set; Hausdorff dimension; random iterations	MAPS; DIMENSION	We consider the multifractal formalism for the dynamics of semigroups of rational maps on the Riemann sphere and random complex dynamical systems. We elaborate a multifractal analysis of level sets given by quotients of Birkhoff sums with respect to the skew product associated with a semigroup of rational maps. Applying these results, we perform a multifractal analysis of the Holder regularity of limit state functions of random complex dynamical systems.	[Jaerisch, Johannes] Shimane Univ, Dept Math, Fac Sci & Engn, Matsue, Shimane 6908504, Japan; [Sumi, Hiroki] Osaka Univ, Dept Math, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Jaerisch, J (reprint author), Shimane Univ, Dept Math, Fac Sci & Engn, Nishikawatsu 1060, Matsue, Shimane 6908504, Japan.	jaerisch@riko.shimane-u.ac.jp; sumi@math.sci.osaka-u.ac.jp			German Research Foundation (DFG) [JA 2145/1-1]; JSPS Postdoctoral Fellowship [P14321]; JSPS KAKENHI [24540211]	The authors would like to thank R Stankewitz for valuable comments. The authors would like to thank the referee for a careful reading of the manuscript and for the helpful comments. The research of the first author was supported by the research fellowship JA 2145/1-1 of the German Research Foundation (DFG) and the JSPS Postdoctoral Fellowship (ID No. P14321). The research of the second author was partially supported by JSPS KAKENHI 24540211.	ZDUNIK A, 1990, INVENT MATH, V99, P627, DOI 10.1007/BF01234434; HALSEY TC, 1986, PHYS REV A, V33, P1141, DOI 10.1103/PhysRevA.33.1141; DENKER M, 1991, T AM MATH SOC, V328, P563, DOI 10.2307/2001795; Pesin Y, 1997, J STAT PHYS, V86, P233, DOI 10.1007/BF02180206; Bowen R., 1975, LECT NOTES MATH, V470; Falconer Kenneth, 2003, FRACTAL GEOMETRY MAT; Federer H., 1969, GRUNDLEHREN MATH WIS, V153; FORNAESS JE, 1991, ERGOD THEOR DYN SYST, V11, P687; Frisch U., 1985, TURBULENCE PREDICTAB, P84; Gong Z., 1996, J FUDAN U, V35, P387; Hinkkanen A, 1996, P LOND MATH SOC, V73, P358; MANDELBR.BB, 1974, J FLUID MECH, V62, P331, DOI 10.1017/S0022112074000711; Mauldin R. D., 2003, CAMBRIDGE TRACTS MAT, V148; Pesin Yakov B., 1997, CHICAGO LECT MATH; Przytycki F., 2010, LONDON MATH SOC LECT, V371; Rockafellar RT, 1970, PRINCETON MATH SERIE, V28; Ruelle D, 1978, ENCY MATH ITS APPL; Stankewitz R, 2012, DISCRETE CONT DYN-A, V32, P2583, DOI 10.3934/dcds.2012.32.2583; Sumi H, 2005, KODAI MATH J, V28, P390, DOI 10.2996/kmj/1123767019; Sumi H, 2001, ERGOD THEOR DYN SYST, V21, P563; Sumi H, 2011, P LOND MATH SOC, V102, P50, DOI 10.1112/plms/pdq013; Sumi H, 2013, ADV MATH, V245, P137, DOI 10.1016/j.aim.2013.05.023; Sumi H, 2012, DISCRETE CONT DYN-A, V32, P2591, DOI 10.3934/dcds.2012.32.2591; Sumi H, 2014, ARXIV14084951; Sumi H, 1998, KODAI MATH J, V21, P10, DOI 10.2996/kmj/1138043831; Sumi H, 2000, NONLINEARITY, V13, P995, DOI 10.1088/0951-7715/13/4/302; Sumi H, 2009, ADV MATH, V222, P729, DOI 10.1016/j.aim.2009.04.007; Walters P., 1982, GRADUATE TEXTS MATH, V79; Young L.-S., 1982, ERGOD THEOR DYN SYST, V2, P109	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	AUG	2015	28	8					2913	2938		10.1088/0951-7715/28/8/2913		26	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CQ3JV	WOS:000360499100014		
J	Zhang, HN; Yokomine, T; Kunugi, T				Zhang, Hongna; Yokomine, Takehiko; Kunugi, Tomoaki			TURBULENCE MODULATION OF THE UPWARD TURBULENT BUBBLY FLOW IN VERTICAL DUCTS	NUCLEAR ENGINEERING AND TECHNOLOGY			English	Article						Bubble-induced turbulence; Turbulence interaction; Turbulence modeling; Upward turbulent bubbly flow; Wall-induced turbulence	PHASE-DISTRIBUTION; 2-PHASE FLOW; GAS-LIQUID; PIPE FLOWS; MODEL	The present paper aims at improving the modeling of turbulence for the upward turbulent bubbly flow through the use of experimental databases that contain data on small and large vertical ducts. First, the role of bubble-induced turbulence was analyzed, which indicated the dominant role of the bubble-induced turbulence in the duct center for relatively high void fraction cases. Therefore, the turbulence therein was mainly focused on, which indicated that the stronger turbulence could be induced by bubbles in large ducts with similar void fractions as compared to that in small ducts. Next, the turbulence of upward turbulent bubbly flow near the wall is discussed to understand the interaction between the wall-induced and bubble-induced turbulence. It showed that the existence of a wall could suppress the bubble-induced turbulence given the same void fraction, and the existence of bubbles could also suppress the solely wall-induced turbulence as compared to the single-phase turbulent flow, even though the total turbulence is enhanced. The above characteristics indicated that the current turbulence modeling method needs to be modified, especially when the bubble-induced turbulence plays a dominant role. Copyright (C) 2015, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.	[Zhang, Hongna; Yokomine, Takehiko; Kunugi, Tomoaki] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan	Kunugi, T (reprint author), Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, C3-d2S06 Kyoto Daigaku Katsura, Kyoto 6158540, Japan.	kunugi@nucleng.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) Research Fellowship	The authors are grateful for the support of the Japan Society for the Promotion of Science (JSPS) Research Fellowship.	Hosokawa S, 2004, INT J HEAT FLUID FL, V25, P489, DOI 10.1016/j.ijheatfluidflow.2004.02.001; WANG SK, 1987, INT J MULTIPHAS FLOW, V13, P327, DOI 10.1016/0301-9322(87)90052-8; Rzehak R, 2013, NUCL ENG DES, V258, P57, DOI 10.1016/j.nucengdes.2013.02.008; KATAOKA I, 1989, INT J MULTIPHAS FLOW, V15, P843, DOI 10.1016/0301-9322(89)90045-1; LANCE M, 1991, J FLUID MECH, V222, P95, DOI 10.1017/S0022112091001015; Shawkat ME, 2008, INT J MULTIPHAS FLOW, V34, P767, DOI 10.1016/j.ijmultiphaseflow.2008.01.007; LIU TJ, 1993, INT J HEAT MASS TRAN, V36, P1049, DOI 10.1016/S0017-9310(05)80289-3; Hosokawa S, 2009, CHEM ENG SCI, V64, P5308, DOI 10.1016/j.ces.2009.09.017; Troshko AA, 2001, INT J MULTIPHAS FLOW, V27, P1965, DOI 10.1016/S0301-9322(01)00043-X; Politano MS, 2003, INT J MULTIPHAS FLOW, V29, P1153, DOI 10.1016/S0301-9322(03)00065-X; Chahed J, 2003, INT J MULTIPHAS FLOW, V29, P23, DOI 10.1016/S0301-9322(02)00123-4; Rzehak R, 2013, INT J MULTIPHAS FLOW, V55, P138, DOI 10.1016/j.ijmultiphaseflow.2013.04.007; LANCE M, 1991, J FLUID ENG-T ASME, V113, P295, DOI 10.1115/1.2909495; SATO Y, 1981, INT J MULTIPHAS FLOW, V7, P167, DOI 10.1016/0301-9322(81)90003-3; LAHEY RT, 1993, NUCL ENG DES, V141, P177, DOI 10.1016/0029-5493(93)90101-E; DREW DA, 1982, J FLUID MECH, V117, P91, DOI 10.1017/S0022112082001530; Hibiki T, 1999, INT J HEAT MASS TRAN, V42, P3019, DOI 10.1016/S0017-9310(99)00014-9; Kataoka I., 1995, P 2 INT C MULT FLOW, P11; LAHEY RT, 1990, NUCL ENG DES, V122, P17, DOI 10.1016/0029-5493(90)90194-3; Lopez de Bertodano M., 1992, THESIS RESSELAER POL; DEBERTODANO ML, 1994, J FLUID ENG-T ASME, V116, P128; MICHIYOSHI I, 1986, NUCL ENG DES, V95, P253, DOI 10.1016/0029-5493(86)90052-X; Morel C., TURBULENCE MODELING; Pope S. B., 2000, TURBULENT FLOWS, P267; Serizawa A., 1975, International Journal of Multiphase Flow, V2, DOI 10.1016/0301-9322(75)90012-9; SERIZAWA A, 1990, NUCL ENG DES, V122, P1, DOI 10.1016/0029-5493(90)90193-2; Serizawa A., 1974, THESIS KYOTO U; Sun H. M., 2014, THESIS KYOTO U; THEOFANOUS TG, 1982, J FLUID MECH, V116, P343, DOI 10.1017/S0022112082000494; van Wijngaarden L, 1998, THEOR COMP FLUID DYN, V10, P449, DOI 10.1007/s001620050076	30	0	0	KOREAN NUCLEAR SOC	DAEJEON	NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA	1738-5733			NUCL ENG TECHNOL	Nucl. Eng. Technol.	AUG	2015	47	5					513	522		10.1016/j.net.2015.04.006		10	Nuclear Science & Technology	Nuclear Science & Technology	CQ1PP	WOS:000360370600001		
J	Kuriyama, S; Takeda, T; Funatani, S				Kuriyama, Shinji; Takeda, Tetsuaki; Funatani, Shumpei			STUDY ON HEAT TRANSFER CHARACTERISTICS OF THE ONE SIDE-HEATED VERTICAL CHANNEL WITH INSERTED POROUS MATERIALS APPLIED AS A VESSEL COOLING SYSTEM	NUCLEAR ENGINEERING AND TECHNOLOGY			English	Article						Natural convection; Porous material; Very high temperature reactor		In the very high temperature reactor (VHTR), which is a next generation nuclear reactor system, ceramics are used as a fuel coating material and graphite is used as a core structural material. Even if a depressurization accident occurs and the reactor power goes up instantly, the temperature of the core will change only slowly. This is because the thermal capacity of the core is so high. Therefore, the VHTR system can passively remove the decay heat of the core by natural convection and radiation from the surface of the reactor pressure vessel. The objectives of this study are to investigate the heat transfer characteristics of natural convection of a one-side heated vertical channel with inserted porous materials of high porosity and also to develop the passive cooling system for the VHTR. An experiment was carried out using a one-side heated vertical rectangular channel. To obtain the heat transfer and fluid flow characteristics of the vertical channel with inserted porous material, we have also carried out a numerical analysis using a commercial Computational Fluid Dynamics (CFD) code. This paper describes the thermal performances of the one-side heated vertical rectangular channel with an inserted copper wire of high porosity. Copyright (C) 2015, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.	[Kuriyama, Shinji] Univ Yamanashi, Grad Sch Med & Engn, Dept Educ, Mech Syst Engn, Kofu, Yamanashi 4008511, Japan; [Takeda, Tetsuaki; Funatani, Shumpei] Univ Yamanashi, Grad Sch Engn, Dept Mech Engn, Kofu, Yamanashi 4008511, Japan	Kuriyama, S (reprint author), Univ Yamanashi, Grad Sch Med & Engn, Dept Educ, Mech Syst Engn, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	g14mm015@yamanashi.ac.jp					Calmidi VV, 1999, J HEAT TRANS-T ASME, V121, P466, DOI 10.1115/1.2826001; Echigo R., 1982, T JPN SOC MECH ENG, V48, P2315; Echigo R., 1974, T JAPAN SOC MECH ENG, V40, P479; Kamiuto K., 1978, T JAPAN SOC MECH ENG, V44, P4234; Martin A.R., 1998, ASME J HEAT TRANSFER, V120, P458; Takeda T., 2012, P 20 INT C NUCL ENG; Takeda T., 2009, P 17 INT C NUCL ENG; Yamada J., 1997, T JSME, V63, P4036; Yan X, 2003, NUCL ENG DES, V222, P247, DOI 10.1016/S0029-5493(03)00030-X	9	0	0	KOREAN NUCLEAR SOC	DAEJEON	NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA	1738-5733			NUCL ENG TECHNOL	Nucl. Eng. Technol.	AUG	2015	47	5					534	545		10.1016/j.net.2015.06.002		12	Nuclear Science & Technology	Nuclear Science & Technology	CQ1PP	WOS:000360370600003		
J	Suzuki, C; Ota, K; Matsuda, M				Suzuki, Chisato; Ota, Katsumasa; Matsuda, Masami			Information-sharing ethical dilemmas and decision-making for public health nurses in Japan	NURSING ETHICS			English	Article						Decision-making process; ethical dilemma; information sharing; Japan; public health nurse	ISSUES; GUIDELINES; SERVICES	Background: Information sharing is one of the most important means of public health nurses collaborating with other healthcare professionals and community members. There are complicated ethical issues in the process. Research objectives: To describe the ethical dilemmas associated with client information sharing that Japanese public health nurses experience in daily practice and to clarify their decision-making process to resolve these dilemmas. Research design: Data were collected using a three-phase consensus method consisting of semi-structured interviews, self-administered questionnaires and a group interview. Participants and research context: We surveyed administrative public health nurses in Shizuoka Prefecture, Japan. The semi-structured interviews were carried out with 12 administrative public health nurses, and the self-administered questionnaires were sent to all 899 administrative public health nurses. The group interview was carried out with eight administrative public health nurses. Ethical considerations: Ethical approval was granted by the ethics committee of the School of Health Sciences, Nagoya University, Japan (8-158, 9-130). Findings: Information-sharing ethical dilemmas occurred most often when clients' decisions did not coincide with the nurses' own professional assessments, particularly when they faced clinical issues that were inherently ambiguous. In their decision-making processes, nurses prioritised protection of health and life'. Discussion: These findings suggest that, above all, they sought to address urgent risks to clients' lives while upholding the principle of client autonomy as much as possible. In such cases, the nurses made decisions regarding whether to share information about the client depending on the individual situation. Conclusion: Public health nurses should protect the client's health while taking into consideration their relationship with the client.	[Suzuki, Chisato; Ota, Katsumasa] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Matsuda, Masami] Tokyo Kasei Gakuin Univ, Tokyo, Japan	Suzuki, C (reprint author), Nagoya Univ, Grad Sch Med, Sch Hlth Sci, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	suzuki.chisato@a.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Science [18390571]	Part of this work was supported by the Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (grant no. 18390571).	American Public Health Association (APHA), 1996, DEF ROL PUBL HLTH NU; American Public Health Association (APHA), 2013, PUBL HLTH NURS SCOP, V2nd, P9; Richardson S, 2006, BRIT J SOC WORK, V36, P657, DOI 10.1093/bjsw/bch257; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Baum NM, 2009, AM J PUBLIC HEALTH, V99, P369, DOI 10.2105/AJPH.2008.137588; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; van Eyk H, 2002, HEALTH SOC CARE COMM, V10, P262, DOI 10.1046/j.1365-2524.2002.00369.x; AROSKAR MA, 1989, NURS CLIN N AM, V24, P967; Asahara K, 2012, PUBLIC HEALTH NURS, V29, P266, DOI 10.1111/j.1525-1446.2011.00990.x; Davis AJ, 2006, ESSENTIALS TEACHING, P55; DUNCAN SM, 1992, J ADV NURS, V17, P1035, DOI 10.1111/j.1365-2648.1992.tb02037.x; Fry S, 1992, COMMUNITY HLTH NURSI, V3rd, P69; Fry ST, 2010, ETHICS NURSING PRACT, V3rd; GREIPP ME, 1992, J ADV NURS, V17, P734, DOI 10.1111/j.1365-2648.1992.tb01972.x; Husted GL, 2009, ETHICAL DECISION MAK, V2nd; Jameton A, 1984, NURSING PRACTICE ETH; Kodama S, 2012, KOURISYUGI NYUMON HA; Lanik G, 1989, J Community Health Nurs, V6, P95, DOI 10.1207/s15327655jchn0602_5; Linestone HA, 1975, DELPHI METHOD TECHNI; MacIntyre A., 1985, AFTER VIRTUE; MacIntyre A., 1975, EVALUATION EXPLANATI, P97; Ministry of Health Labour and Welfare, HEIS 22 NEN HOK EIS; Nuffield Council on Bioethics, 2007, PUBL HLTH ETH ISS, P41; Oberle K, 2000, NURS ETHICS, V7, P425, DOI 10.1177/096973300000700507; Racher FE, 2007, J COMMUN HEALTH NURS, V24, P65; Rowlands S, 2010, J FAM PLAN REPROD H, V36, P161, DOI 10.1783/147118910791749434; Tatara K, 2009, JPN J PUBLIC HLTH, V56, P3; Thompson JE, 2004, BIOETHICAL DECISION	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0969-7330	1477-0989		NURS ETHICS	Nurs. Ethics	AUG	2015	22	5					533	547		10.1177/0969733014549879		15	Nursing	Nursing	CP7ZP	WOS:000360109500003		
J	Kobayashi, H				Kobayashi, Hiroshi			Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Article							KININ SYSTEM; MAST-CELLS; COMPLEMENT; REGISTRY	Problem Amniotic fluid embolism (AFE) is a rare but severe emergency in obstetrics. The aim of the present study was to investigate the pathophysiology of AFE. Methods A search was conducted between 1966 and 2014 through the English-language literature (online MEDLINE PubMed database) using the keyword amniotic fluid embolism combined with anaphylaxis, anaphylactoid, complement activation, mast cells, fetal antigens, and idiosyncratic. Results Amniotic fluid embolism is a rare clinical entity but a severe obstetric emergency that can be lethal even in previously healthy women in labor or in the early postpartum period. There appears to be at least 2 mechanisms. First, adverse reactions in AFE are usually unexpected and fetal antigen dose dependent. Given the disastrous entry of amniotic fluid into the maternal circulation, they experience a sudden cardiopulmonary collapse (mechanical obstruction subtype). Second, anaphylactic and anaphylactoid reactions of the remaining AFE are also relatively unexpected and fetal antigen dose independent and can occur at the first exposure to amniotic fluid components. They are associated with complement activation and subsequent postpartum hemorrhage. Cardiac mast cells constitute a central pathogenesis of anaphylactic (immunoglobulin E-dependent) and anaphylactoid (immunoglobulin E-independent) reactions. Conclusions Recent immunologic studies provide a new approach to the study of the pathophysiology of AFE. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After reading the article, the learner should be better able to diagnose women with AFE and provide information to patients as needed; describe adverse reactions associated with AFE, demonstrating that some AFE patients experience a sudden cardiopulmonary collapse (mechanical obstruction subtype) through the entry of a large amount of amniotic fluid into the maternal circulation; identify anaphylactic and anaphylactoid reactions of the remaining AFE, demonstrating that they are associated with complement activation and subsequent postpartum hemorrhage; and analyze and discuss the recent immunologic studies that provide a new approach to the study of the pathophysiology of AFE.	Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Kobayashi, H (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.						Tamura N, 2014, GYNECOL OBSTET INVES, V78, P65, DOI 10.1159/000360537; Davies S, 2001, CAN J ANAESTH, V48, P88; Genovese A, 2010, CHEM IMMUNOL ALLERGY, V95, P98, DOI 10.1159/000315945; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Szebeni J, 2007, J LIPOSOME RES, V17, P107, DOI 10.1080/01676830701375118; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Clark SL, 2014, OBSTET GYNECOL, V123, P337, DOI 10.1097/AOG.0000000000000107; Bossi F, 2008, INT IMMUNOPHARMACOL, V8, P143, DOI 10.1016/j.intimp.2007.08.006; Kanayama N, 2014, J OBSTET GYNAECOL RE, V40, P1507, DOI 10.1111/jog.12428; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; KANAYAMA N, 1992, CLIN CHEM, V38, P526; Benson MD, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/946576; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P1625, DOI 10.1111/j.1471-0528.2005.00770.x; Renne T, 2005, J IMMUNOL, V175, P3377; Aurangzeb Imran, 2004, Crit Care Clin, V20, P643, DOI 10.1016/j.ccc.2004.06.002; Benson M D, 1993, Arch Fam Med, V2, P989, DOI 10.1001/archfami.2.9.989; Busardo Francesco P, 2014, Curr Pharm Biotechnol, V14, P1195; CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1158, DOI 10.1016/0002-9378(95)91474-9; Conde-Agudelo A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.052; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Fineschi V, 2009, VIRCHOWS ARCH, V454, P283, DOI 10.1007/s00428-009-0730-1; Ghebrehiwet B, 2006, ADV EXP MED BIOL, V586, P95; Greenberger Paul A, 2012, Allergy Asthma Proc, V33 Suppl 1, pS80, DOI 10.2500/aap.2012.33.3557; HAMMERSCHMIDT DE, 1984, J LAB CLIN MED, V104, P901; Ito F, 2014, J OBSTET GYNAECOL, V27, P1; Kanayama N, 2011, J OBSTET GYNAECOL RE, V37, P58, DOI 10.1111/j.1447-0756.2010.01319.x; Knight M., 2012, BMC PREGNANCY CHILDB, V10, P7; KOBAYASHI H, 1993, AM J OBSTET GYNECOL, V168, P848; Kobayashi H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00321; Legrand M, 2012, CRIT CARE MED, V40, P2059, DOI 10.1097/CCM.0b013e31824e6737; MARONE G, 1995, IMMUNOPHARMACOLOGY, V31, P1, DOI 10.1016/0162-3109(95)00037-3; MULDER JI, 1985, AM J OBSTET GYNECOL, V152, P430; Naruse K., 2012, OPEN J OBSTET GYNECO, V2, P147; Oi H, 2010, GYNECOL OBSTET INVES, V70, P138, DOI 10.1159/000313302; Oza N B, 1979, Adv Exp Med Biol, V120A, P473; Rath Werner H, 2014, Dtsch Arztebl Int, V111, P126, DOI 10.3238/arztebl.2014.0126; Ray BK, 2004, CAN J ANAESTH, V51, P139; Thongrong Cattleya, 2013, Int J Crit Illn Inj Sci, V3, P51, DOI 10.4103/2229-5151.109422; Tsunemi T., 2012, OPEN WOMENS HLTH J, V6, P24; Yarovaya GA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P13, DOI 10.1023/A:1013991828598	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	AUG	2015	70	8					511	517		10.1097/OGX.0000000000000197		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CP8KS	WOS:000360143200018		
J	Masai, H; Yanagida, T				Masai, Hirokazu; Yanagida, Takayuki			Emission property of Ce3+-doped Li2O-B2O3-SiO2 glasses	OPTICAL MATERIALS EXPRESS			English	Article							OPTICAL BASICITY; COMPOSITIONAL DEPENDENCE; NEUTRON DETECTION; PHOSPHATE-GLASS; CE3+; SCINTILLATION; FLUORESCENCE; PHOTOLUMINESCENCE; ABSORPTION; SILICATE	Optical properties of Ce3+ -doped Li2O-B2O3-SiO2 glasses prepared in inert atmosphere have been examined. Clear splitting of 4f-5d excitation bands is observed in these glasses at room temperature. The emission decay constant depends on the excitation and emission energy, indicating the site distribution of Ce3+ in the random glass matrix. The absorption energies of Ce3+ are independent of the optical basicity, suggesting that the emission is affected by the local basicity of random network. The present findings provide the basic concepts for designing Cedoped oxide glass for luminescent applications. (C) 2015 Optical Society of America	[Masai, Hirokazu] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Yanagida, Takayuki] Nara Inst Sci & Technol, Nara 6300192, Japan	Masai, H (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	masai_h@scl.kyoto-u.ac.jp			JSPS KAKENHI [26709048]; I.C.R., Kyoto University [2014-31]	This work was partially supported by the JSPS KAKENHI Grant-in-Aid for Young Scientists (A) Number 26709048. Collaborative Research Program of I.C.R., Kyoto University (grant #2014-31), and the SPRITS program, Kyoto University.	DUFFY JA, 1993, GEOCHIM COSMOCHIM AC, V57, P3961, DOI 10.1016/0016-7037(93)90346-X; SCHREIBER HD, 1994, J NON-CRYST SOLIDS, V177, P340, DOI 10.1016/0022-3093(94)90548-7; Paulose PI, 2003, J PHYS CHEM SOLIDS, V64, P841, DOI 10.1016/S0022-3697(02)00416-X; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Bei JF, 2007, MATER RES BULL, V42, P1195, DOI 10.1016/j.materresbull.2006.10.020; BLASSE G, 1967, J CHEM PHYS, V47, P5139, DOI 10.1063/1.1701771; van Eijk CWE, 2004, NUCL INSTRUM METH A, V529, P260, DOI 10.1016/j.nima.2004.04.163; [Anonymous], 1973, STRUCT BOND; Masai H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.082102; Masai H, 2014, J MATER CHEM C, V2, P2137, DOI 10.1039/c3tc32259a; Caldino U, 2005, J PHYS-CONDENS MAT, V17, P7297, DOI 10.1088/0953-8984/17/46/013; Kouzes RT, 2010, NUCL INSTRUM METH A, V623, P1035, DOI 10.1016/j.nima.2010.08.021; BLASSE G, 1967, J CHEM PHYS, V47, P1920, DOI 10.1063/1.1712219; Combes CM, 1999, J LUMIN, V82, P299, DOI 10.1016/S0022-2313(99)00047-2; Dorenbos P, 2003, J PHYS-CONDENS MAT, V15, P511, DOI 10.1088/0953-8984/15/3/315; Kim JS, 2004, APPL PHYS LETT, V84, P2931, DOI 10.1063/1.1695441; Iwanowska J, 2011, NUCL INSTRUM METH A, V652, P319, DOI 10.1016/j.nima.2010.09.182; Duffy JA, 1996, PHYS CHEM GLASSES, V37, P45; Ebendorff-Heidepriem H, 2000, OPT MATER, V15, P7, DOI 10.1016/S0925-3467(00)00018-5; Hao JH, 2004, APPL PHYS LETT, V85, P3720, DOI 10.1063/1.1808876; Ishii M, 2005, NUCL INSTRUM METH A, V537, P282, DOI 10.1016/j.nima.2004.08.027; Masai H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819102; Masai H, 2013, CHEM LETT, V42, P132, DOI 10.1246/cl.2013.132; Mizukami K, 2004, NUCL INSTRUM METH A, V529, P310, DOI 10.1016/j.nima.2004.05.001; Murata T, 2005, J NON-CRYST SOLIDS, V351, P312, DOI 10.1016/j.jnoncrysol.2004.11.013; Yanagida T, 2014, PHYS CHEM GLASSES-B, V55, P274; Yanagida T, 2016, J NON-CRYST SOLIDS, V431, P140, DOI 10.1016/j.jnoncrysol.2015.04.033; Yen W.M., 2007, PHOSPHOR HDB	29	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	AUG 1	2015	5	8					1851	1858		10.1364/OME.5.001851		8	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CQ0WU	WOS:000360319300020		
J	Maruyama, S; Yamazaki, M; Abe, T; Babkair, H; Cheng, J; Saku, T				Maruyama, Satoshi; Yamazaki, Manabu; Abe, Tatsuya; Babkair, Hamzah; Cheng, Jun; Saku, Takashi			Paradental cyst is an inclusion cyst of the junctional/sulcular epithelium of the gingiva: histopathologic and immunohistochemical confirmation for its pathogenesis	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							KERATOCYSTIC ODONTOGENIC-TUMOR; SULFATE PROTEOGLYCAN PERLECAN; SALIVARY PLEOMORPHIC ADENOMAS; DIFFERENTIAL-DIAGNOSIS; EXPRESSION PROFILES; POCKET EPITHELIUM; GROWTH-FACTOR; ENAMEL ORGAN; JAW LESIONS; IN-VITRO	Objective. The aim of this study was to characterize the histologic and immunohistochemical profiles of paradental cystlining epithelia to clarify its histopathogenesis. Study Design. Ten surgical specimens of paradental cysts were examined for clinical profiles and to determine the histopathologic characteristics of the lining epithelia. Immunohistochemical profiles for keratin (K) subtypes, as well as for perlecan, UEA-I lectin binding, and proliferating cell nuclear antigen (PCNA), were determined and compared. Results. The paradental cyst was clinically characterized by its occurrence in young adults (mean age, 36.8 years; male, 42.8, female 27.8). Eight of the 10 cases arose in the retromolar area. The cyst wall was basically granulation tissue that was attached to the periodontal ligament space. Thin irregular anastomosing epithelial cords lined the cyst walls of immature granulation tissue with vascular dilation and hemorrhage. The intercellular space of the lining epithelia was widened with inflammatory cell infiltrates. Immunohistochemically, the lining was positive for K13, K14, K17, K19, UEA-I binding, and perlecan, suggesting its junctional/sulcular epithelial character. Conclusion. The results showed that the paradental cyst was lined by epithelial cells with characteristics of the junctional/sulcular epithelium. The cyst can thus be considered as a kind of inclusion cyst arising in the periodontal pocket, most frequently of the mandibular third molars of young adults.	[Maruyama, Satoshi] Niigata Univ Hosp, Dept Surg Pathol, Oral Pathol Sect, Niigata, Japan; [Yamazaki, Manabu; Abe, Tatsuya; Babkair, Hamzah; Cheng, Jun; Saku, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Pathol, Niigata 9518514, Japan; [Abe, Tatsuya; Saku, Takashi] Niigata Univ Hosp, Dept Surg Pathol, Oral Pathol Sect, Niigata, Japan	Saku, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	tsaku@dent.niigata-u.ac.jp					Abe T, 2014, HUM PATHOL, V45, P110, DOI 10.1016/j.humpath.2013.08.011; ABE Y, 1994, J PERIODONTAL RES, V29, P418, DOI 10.1111/j.1600-0765.1994.tb01243.x; ACKERMANN G, 1987, ORAL SURG ORAL MED O, V64, P308, DOI 10.1016/0030-4220(87)90010-7; Ahsan MS, 2011, J ORAL PATHOL MED, V40, P552, DOI 10.1111/j.1600-0714.2010.00990.x; Ida-Yonemochi H, 2011, MATRIX BIOL, V30, P379, DOI 10.1016/j.matbio.2011.08.001; Yamazaki M, 2004, J ORAL PATHOL MED, V33, P177, DOI 10.1111/j.0904-2512.2004.00087.x; Maruyama S, 2014, J ORAL PATHOL MED, V43, P627, DOI 10.1111/jop.12184; Ida-Yonemochi H, 2011, HISTOPATHOLOGY, V58, P234, DOI 10.1111/j.1365-2559.2010.03732.x; Philipsen HP, 2004, J ORAL PATHOL MED, V33, P147, DOI 10.1111/j.0904-2512.2004.00139.x; Tsuneki M, 2008, J ORAL PATHOL MED, V37, P287, DOI 10.1111/j.1600-0714.2007.00620.x; Hunter N, 2001, J ORAL PATHOL MED, V30, P178, DOI 10.1034/j.1600-0714.2001.300308.x; Alvarado CG, 2011, HISTOPATHOLOGY, V59, P283, DOI 10.1111/j.1365-2559.2011.03929.x; Pollanen MT, 2000, EUR J ORAL SCI, V108, P523, DOI 10.1034/j.1600-0722.2000.00881.x; Colgan CM, 2002, BRIT J ORAL MAX SURG, V40, P163, DOI 10.1054/bjom.2001.0750; CRAIG GT, 1976, BRIT DENT J, V141, P9, DOI 10.1038/sj.bdj.4803781; de Sousa SOM, 2001, QUINTESSENCE INT, V32, P737; FEGHALIASSALY M, 1994, J PERIODONTAL RES, V29, P185, DOI 10.1111/j.1600-0765.1994.tb01212.x; Feghali-Assaly M, 1997, EUR J ORAL SCI, V105, P599, DOI 10.1111/j.1600-0722.1997.tb00224.x; FOWLER CB, 1989, J ORAL MAXIL SURG, V47, P243, DOI 10.1016/0278-2391(89)90226-7; Ida-Yonemochi H, 2002, VIRCHOWS ARCH, V441, P165, DOI 10.1007/s00428-001-0556-y; Ikarashi T, 2004, J ORAL PATHOL MED, V33, P87, DOI 10.1111/j.1600-0714.2004.00026.x; Kobayashi T, 2012, HISTOPATHOLOGY, V61, P910, DOI 10.1111/j.1365-2559.2012.04283.x; Kobayashi T, 2010, PATHOL INT, V60, P156, DOI 10.1111/j.1440-1827.2009.02499.x; Kramer IRH, 1992, WHO INT HISTOLOGICAL, V2nd, P39; Main D M, 1970, Br J Oral Surg, V8, P114, DOI 10.1016/S0007-117X(70)80002-6; Maruyama S, 2014, HISTOCHEM CELL BIOL, V26, P390; Maruyama S, 2009, J ORAL PATHOL MED, V38, P377, DOI 10.1111/j.1600-0714.2008.00742.x; Papaioannou W, 1999, J PERIODONTOL, V70, P668, DOI 10.1902/jop.1999.70.6.668; Pritlove-Carson S, 1997, Oral Dis, V3, P19; SAKU T, 1991, J ORAL PATHOL MED, V20, P108, DOI 10.1111/j.1600-0714.1991.tb00902.x; SAKU T, 1989, J BIOL CHEM, V264, P3514; Shear M, 2007, CYSTS ORAL MAXILLOFA, P143; SHIMONO M, 1991, J PERIODONTAL RES, V26, P85, DOI 10.1111/j.1600-0765.1991.tb01630.x; Slater LJ, 2003, J ORAL MAXIL SURG, V61, P149, DOI 10.1053/joms.2003.50051; Swelam W, 2005, VIRCHOWS ARCH, V446, P653, DOI 10.1007/s00428-005-1219-1; Tsuneki M, 2010, HISTOPATHOLOGY, V57, P806, DOI 10.1111/j.1365-2559.2010.03712.x; Tsuneki M, 2012, PATHOL RES PRACT, V208, P140, DOI 10.1016/j.prp.2011.12.016; Tsuneki M, 2008, ORAL MED PATHOL, V12, P89; Tsuneki M, 2013, ORAL DIS, V19, P350; VEDTOFTE P, 1989, ORAL SURG ORAL MED O, V68, P182, DOI 10.1016/0030-4220(89)90190-4; Wu LY, 2009, HUM PATHOL, V40, P683, DOI 10.1016/j.humpath.2008.10.012	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	AUG	2015	120	2					227	237		10.1016/j.oooo.2015.04.001		11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ0QU	WOS:000360302600018		
J	Nishida, I; Oda, M; Tanaka, T; Kito, S; Seta, Y; Yada, N; Fujita, Y; Saeki, K; Morikawa, K; Matsumoto-Takeda, S; Wakasugi-Sato, N; Habu, M; Kodama, M; Miyamoto, I; Kokuryo, S; Nishimura, S; Matsuo, K; Tominaga, K; Yoshioka, I; Maki, K; Morimoto, Y				Nishida, Ikuko; Oda, Masafumi; Tanaka, Tatsurou; Kito, Shinji; Seta, Yuji; Yada, Naomi; Fujita, Yuko; Saeki, Katsura; Morikawa, Kazumasa; Matsumoto-Takeda, Shinobu; Wakasugi-Sato, Nao; Habu, Manabu; Kodama, Masaaki; Miyamoto, Ikuya; Kokuryo, Shinya; Nishimura, Shun; Matsuo, Kou; Tominaga, Kazuhiro; Yoshioka, Izumi; Maki, Kenshi; Morimoto, Yasuhiro			Detection and imaging characteristics of the gubernacular tract in children on cone beam and multidetector computed tomography	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article								Purpose. To elucidate the appearance and imaging characteristics of the gubernacular tract (GT) during the growth stage of children. Furthermore, this study evaluated the significance of the appearance of the GT. Study Design. The visualizations of the GT were retrospectively analyzed by using panoramic radiographs and computed tomography (CT) in children. Results. In patients with normal eruption who had unerupted permanent teeth, except maxillary central supernumerary teeth, the GT was clearly visualized as a well-defined low-density tract on CT but not on panoramic radiographs. In patients with obstructive eruption, including impaction, the GT was deformed and not visible on CT. Conclusions. This paper describes the frequency of detection and appearance of the GT in unerupted teeth. Preliminary data suggest that any alteration to the GT may be used to predict abnormal eruption of permanent teeth.	[Nishida, Ikuko; Fujita, Yuko; Saeki, Katsura; Morikawa, Kazumasa; Matsumoto-Takeda, Shinobu; Maki, Kenshi] Kyushu Dent Univ, Div Dev Stomatognath Funct Sci, Kitakyushu, Fukuoka 8038580, Japan; [Oda, Masafumi; Tanaka, Tatsurou; Kito, Shinji; Wakasugi-Sato, Nao; Nishimura, Shun; Morimoto, Yasuhiro] Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Kitakyushu, Fukuoka 8038580, Japan; [Seta, Yuji] Kyushu Dent Univ, Div Oral Histol & Neurobiol, Kitakyushu, Fukuoka 8038580, Japan; [Yada, Naomi; Matsuo, Kou] Kyushu Dent Univ, Div Oral Pathol, Kitakyushu, Fukuoka 8038580, Japan; [Habu, Manabu; Kodama, Masaaki; Tominaga, Kazuhiro] Kyushu Dent Univ, Div Maxillofacial Surg, Kitakyushu, Fukuoka 8038580, Japan; [Miyamoto, Ikuya; Kokuryo, Shinya; Yoshioka, Izumi] Kyushu Dent Univ, Div Oral Med, Kitakyushu, Fukuoka 8038580, Japan; [Morimoto, Yasuhiro] Kyushu Dent Univ, Ctr Oral Biol Res, Kitakyushu, Fukuoka 8038580, Japan	Morimoto, Y (reprint author), Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	Rad-mori@kyu-dent.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; alumni association of Kyushu Dental University	This study was supported in part by grants from the Grant in Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan; and a grant-in-aid for scientific research to YM from the alumni association of Kyushu Dental University.	Yoshioka I, 2010, J ORAL MAXIL SURG, V68, P3022, DOI 10.1016/j.joms.2009.09.046; CAROLLO DA, 1971, ANGLE ORTHOD, V41, P300; Brisco J, 2014, BRIT J ORAL MAX SURG, V52, P76, DOI 10.1016/j.bjoms.2013.09.011; Junqueira RB, 2013, J ENDODONT, V39, P1620, DOI 10.1016/j.joen.2013.08.031; CAHILL DR, 1980, J ORAL PATHOL MED, V9, P189, DOI 10.1111/j.1600-0714.1980.tb00377.x; Morimoto Y, 2009, CURR MED IMAGING REV, V5, P226; Yoshioka I, 2011, BRIT J ORAL MAX SURG, V49, P552, DOI 10.1016/j.bjoms.2010.09.014; Broomell IN, 1989, ANATOMY HISTOLOGY MO, P302; Eskandarloo Amir, 2013, Imaging Sci Dent, V43, P215, DOI 10.5624/isd.2013.43.3.215; Hodson J J, 1971, Dent Pract Dent Rec, V21, P423; Ide Fumio, 2011, Head Neck Pathol, V5, P123, DOI 10.1007/s12105-011-0253-3; Koenig LF, 2012, DIAGNOSTIC IMAGING O, P58; Mummery JH, 1919, MICROSCOPIC ANATOMY, P23; Nanci A, 2008, 10 CATES ORAL HISTOL, V7th, P79; Oda M, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-54; Scott JH, 1964, INTRO DENT ANATOMY, V4th, P97	16	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	AUG	2015	120	2					E109	E117		10.1016/j.oooo.2015.05.001		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ0QU	WOS:000360302600002		
J	Ueno, A; Ae, N; Terauchi, H; Fujimoto, K; Fujiwara, Y				Ueno, Atsushi; Ae, Nobuyuki; Terauchi, Hideo; Fujimoto, Koji; Fujiwara, Yuji			A Second Generation Synthesis of Benzyl Piperidine Derivatives: A Key Intermediate for the Preparation of SERT/5-HT1A Dual Inhibitor	ORGANIC PROCESS RESEARCH & DEVELOPMENT			English	Article							PALLADIUM-CATALYZED ARYLATION; SEROTONIN REUPTAKE INHIBITORS; BASE-FREE CONDITIONS; HECK-TYPE ARYLATION; AROYL CHLORIDES; ACTIVATED ALKENES	A second generation process for benzyl piperidine 10 is described. By the use of a Horner-Wadsworth-Emmons reaction and selective hydrogenation with Pt/C in ethyl acetate, 2-bromo-5-(hydroxymethyl) phenol 14 was efficiently converted to the compound 10 on a 5 kg scale. A small amount of water was found to be critical to complete the selective hydrogenation with low levels of debrominated byproduct 15. Impurities of the compound 10 were controlled by limiting the quality of 2-bromo-5-(hydroxymethyl) phenol 14 and 1-bromo-2-methoxyethane 15.	[Ueno, Atsushi; Ae, Nobuyuki; Terauchi, Hideo; Fujimoto, Koji; Fujiwara, Yuji] Sumitomo Dainippon Pharma Co Ltd, Proc Chem Res & Dev Labs, Konohana Ku, Osaka 5540022, Japan	Fujiwara, Y (reprint author), Sumitomo Dainippon Pharma Co Ltd, Proc Chem Res & Dev Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan.	yuji-fujiwara@ds-pharma.co.jp					Sugihara T, 2003, ANGEW CHEM INT EDIT, V42, P4672, DOI 10.1002/anie.200351905; SPENCER A, 1982, J ORGANOMET CHEM, V240, P209, DOI 10.1016/S0022-328X(00)82516-4; Yabe Y, 2012, ADV SYNTH CATAL, V354, P1264, DOI 10.1002/adsc.201100936; Mori A, 2008, ADV SYNTH CATAL, V350, P406, DOI 10.1002/adsc.200700571; ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248; Sugihara T, 2005, TETRAHEDRON LETT, V46, P8269, DOI 10.1016/j.tetlet.2005.09.179; BLASER HU, 1982, J ORGANOMET CHEM, V233, P267, DOI 10.1016/S0022-328X(00)82707-2; Buffat G. P. M., 2004, TETRAHEDRON, V60, P1701; Burkitt A. S., 2004, U.S. Patent, Patent No. [0,097,485, 0097485]; Miki S., 2002, PCT Int. Appl., Patent No. [WO2002/057235, 2002057235]; Nishida T, 2012, ORG PROCESS RES DEV, V16, P625, DOI 10.1021/op200357h; SPENCER A, 1984, J ORGANOMET CHEM, V265, P323, DOI 10.1016/0022-328X(84)80097-2; SPENCER A, 1983, J ORGANOMET CHEM, V247, P117, DOI 10.1016/S0022-328X(00)98836-3; Toyoda T., 2011, PCT Int. Appl., Patent No. [W02011/016468, 2011016468]; Toyoda T., 2009, PCT Int. Appl., Patent No. [WO2009/099087, 2009099087]; Weintraub M. P., 2003, TETRAHEDRON, V59, P2953; Wick A., 1987, U.S. Patent, Patent No. [4,690,931, 4690931]; Zhou DH, 2009, J MED CHEM, V52, P4955, DOI 10.1021/jm900374r	18	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1083-6160	1520-586X		ORG PROCESS RES DEV	Org. Process Res. Dev.	AUG	2015	19	8					1030	1037		10.1021/acs.oprd.5b00207		8	Chemistry, Applied; Chemistry, Organic	Chemistry	CP7XP	WOS:000360103200015		
J	Miyamoto, H; Sakumoto, C; Takekoshi, E; Maeda, Y; Hiramoto, N; Itoh, T; Kato, Y				Miyamoto, Hidetoshi; Sakumoto, Chihiro; Takekoshi, Eriko; Maeda, Yukiko; Hiramoto, Narumi; Itoh, Takahiro; Kato, Yoshiaki			Effective Method To Remove Metal Elements from Pharmaceutical Intermediates with Polychelated Resin Scavenger	ORGANIC PROCESS RESEARCH & DEVELOPMENT			English	Article							RECEPTOR ANTAGONIST; EFFICIENT SYNTHESIS; REACTION MIXTURES; COUPLING REACTION; PALLADIUM; ADSORBENTS; INGREDIENTS; FEBUXOSTAT; INHIBITOR; CANDIDATE	A catalytic reaction is an important methodology for the production of pharmaceuticals from the viewpoint of green and sustainable chemistry. Since elemental impurity levels should be controlled within acceptable limits in API, the development of removal of element is also important as well. The technology for removal of elements was developed using cost-effective polychelated resin scavenger. The precious elements were removed efficiently by passing through the packed cartridge filled with appropriate scavenger. The feasibility of the scavenger was evaluated, and the application for actual manufacturing process is described. In contrast to another type of immobilized scavengers, polychelated resin scavenger provides an inexpensive method to scavenge several elements.	[Miyamoto, Hidetoshi; Sakumoto, Chihiro; Takekoshi, Eriko; Maeda, Yukiko; Hiramoto, Narumi; Itoh, Takahiro; Kato, Yoshiaki] Teijin Pharma Ltd, Pharmaceut Prod & Technol Dept, Iwakuni 7408511, Japan	Miyamoto, H (reprint author), Teijin Pharma Ltd, Pharmaceut Prod & Technol Dept, Iwakuni 7408511, Japan.	hi.miyamoto@teijin.co.jp					Konigsberger K, 2003, ORG PROCESS RES DEV, V7, P733, DOI 10.1021/op034072x; LARSEN RD, 1994, J ORG CHEM, V59, P6391, DOI 10.1021/jo00100a048; [Anonymous], EMEACHMPSWP44462000; Rosso VW, 1997, ORG PROCESS RES DEV, V1, P311, DOI 10.1021/op970107f; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Galaffu N, 2007, ORG PROCESS RES DEV, V11, P406, DOI 10.1021/op7000172; Samiey B, 2014, MATERIALS, V7, P673, DOI 10.3390/ma7020673; Welch CJ, 2005, ORG PROCESS RES DEV, V9, P198, DOI 10.1021/op049764f; Gupta VK, 2003, IND ENG CHEM RES, V42, P6619, DOI 10.1021/ie0303146; Flahive EJ, 2008, ORG PROCESS RES DEV, V12, P637, DOI 10.1021/op600280g; Crudden CM, 2007, PURE APPL CHEM, V79, P247, DOI 10.1351/pac200779020247; Bullock KM, 2008, ORG PROCESS RES DEV, V12, P896, DOI 10.1021/op800064y; Chen CY, 2003, J ORG CHEM, V68, P2633, DOI 10.1021/jo0205614; Giguere P., 1996, PCT Int. Appl., Patent No. [WO 199640684, CAN 126131464, 199640684]; Girgis MJ, 2008, ORG PROCESS RES DEV, V12, P1209, DOI 10.1021/op800161v; Hisatome I., 2013, PCT Int. Appl, Patent No. [WO 2013111870 A1 20130801, 2013111870]; Inoue K., 2014, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2014151242 A 20140825, 2014151242]; Inoue Y., 2012, PCT Int. Appl, Patent No. [US 20120132852 A1, 20120132852]; Inoue Y., 2014, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2014050763 A 20140320, 2014050763]; Inoue Y., 2013, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2013166090 A 20130829, 2013166090]; Inoue Y., 2011, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2011056350 A 20110324, 2011056350]; Inoue Y., 2010, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2010256225 A 20101111, 2010256225]; Inoue Y., 2010, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2010254841 A 20101111, 2010254841]; Itoh T, 2006, ORG PROCESS RES DEV, V10, P822, DOI 10.1021/op0600963; Kato T., 2014, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2014014782 A 20140130, 2014014782]; Komiyama M., 2012, PCT Int. Appl, Patent No. [WO 2012026565, 2012026565]; Komiyama M., 2012, PCT Int. Appl, Patent No. [JP 2011069250, 2011069250]; Nomura J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04554; Pink CJ, 2008, ORG PROCESS RES DEV, V12, P589, DOI 10.1021/op800039g; Recho J, 2014, ORG PROCESS RES DEV, V18, P626, DOI 10.1021/op5000336; Reginato G, 2011, ORG PROCESS RES DEV, V15, P1396, DOI 10.1021/op200127y; Shirakura T., 2011, PCT Int. Appl, Patent No. [WO 2011162390 A1 20111229, 2011162390]; Urawa Y, 2003, ORG PROCESS RES DEV, V7, P191, DOI 10.1021/op0255682; Wang LJ, 2011, ORG PROCESS RES DEV, V15, P1371, DOI 10.1021/op2001657	34	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1083-6160	1520-586X		ORG PROCESS RES DEV	Org. Process Res. Dev.	AUG	2015	19	8					1054	1061		10.1021/acs.oprd.5b00161		8	Chemistry, Applied; Chemistry, Organic	Chemistry	CP7XP	WOS:000360103200019		
J	Shibata, A; Akiyama, M				Shibata, Akitaka; Akiyama, Masashi			Epidemiology, medical genetics, diagnosis and treatment of harlequin ichthyosis in Japan	PEDIATRICS INTERNATIONAL			English	Review						ABCA12; autosomal recessive congenital ichthyosis; genotype-phenotype correlation; keratinization; lipid; skin barrier; systemic retinoid	RECESSIVE CONGENITAL ICHTHYOSIS; ABNORMAL LAMELLAR GRANULES; CELL-ENVELOPE PROTEINS; AMNIOTIC-FLUID CELLS; PRENATAL-DIAGNOSIS; ABCA12 MUTATIONS; MISSENSE MUTATION; TRANSPORTER ABCA12; ERYTHRODERMA; SKIN	Ichthyoses are a group of disorders marked by whitish, brown or dark-brown scales on the skin of almost the whole body. Harlequin ichthyosis (HI) is the most severe form. Neonatal death from HI was once common. Due to intensive neonatal care and, probably, to the early introduction of oral retinoids, HI outcome has improved. For definitive diagnosis and the exclusion of other disorders, such as lamellar ichthyosis, which also shows a collodion baby phenotype, it is helpful to refer to electron microscopy of abnormal or absent lamellar granules and a heavy accumulation of lipid droplets in the keratinocytes. ATP-binding cassette transporter A12 (ABCA12) is known as the causative gene of HI. Severe ABCA12 deficiency results in malformation of intercellular lipid layers in the cornified layers and leads to epidermal lipid barrier disruption. In HI patients, at least one mutation on each allele must be a truncation or deletion mutation to cause serious loss of ABCA12 function. Identification of the gene underlying HI has enabled DNA-based prenatal diagnosis for HI at the earlier stages of pregnancy with low risk. There are no curative treatments for HI. Abca12-deficient mice were created as a model of HI. Treatment of the model mice with retinoid or steroid has not been successful.	[Shibata, Akitaka; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, Nagoya, Aichi 4668550, Japan	Shibata, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akitakashibata@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23249058]; Ministry of Health, Labor and Welfare of Japan (Health and Labor Sciences Research Grants); Ministry of Health, Labor and Welfare of Japan (Research on Intractable Diseases) [H22-Nanchi-Ippan-177]	This study was supported in part by Grant-in-Aid for Scientific Research (A) 23249058 to M.A. from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Ministry of Health, Labor and Welfare of Japan (Health and Labor Sciences Research Grants; Research on Intractable Diseases; H22-Nanchi-Ippan-177) to M.A. The authors declare no conflicts of interest.	Akiyama M, 2006, BRIT J DERMATOL, V155, P1064, DOI 10.1111/j.1365-2133.2006.07434.x; Akiyama M, 1996, J CUTAN PATHOL, V23, P571, DOI 10.1111/j.1600-0560.1996.tb01452.x; Akiyama M, 1998, PRENATAL DIAG, V18, P425, DOI 10.1002/(SICI)1097-0223(199805)18:5<425::AID-PD284>3.0.CO;2-B; Akiyama M, 2007, DERMATOLOGY, V215, P155, DOI 10.1159/000104269; Akiyama M, 2006, ARCH DERMATOL, V142, P914, DOI 10.1001/archderm.142.7.914; Akiyama M, 2008, BRIT J DERMATOL, V158, P864, DOI 10.1111/j.1365-2133.2008.08439.x; Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; AKIYAMA M, 1994, J INVEST DERMATOL, V102, P210, DOI 10.1111/1523-1747.ep12371764; Akiyama M, 2006, J INVEST DERMATOL, V126, P1518, DOI 10.1038/sj.jid.5700295; Akiyama M, 1999, PRENATAL DIAG, V19, P167, DOI 10.1002/(SICI)1097-0223(199902)19:2<167::AID-PD477>3.3.CO;2-M; Lacour M, 1996, BRIT J DERMATOL, V134, P1023, DOI 10.1111/j.1365-2133.1996.tb07936.x; Katugampola RP, 2006, BRIT J DERMATOL, V154, P267, DOI 10.1111/j.1365-2133.2005.06906.x; DALE BA, 1990, J INVEST DERMATOL, V94, P6, DOI 10.1111/1523-1747.ep12873301; Dyer JA, 2013, DERMATOL THER, V26, P1, DOI 10.1111/j.1529-8019.2012.01555.x; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI14834; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Sakai K, 2007, EXP DERMATOL, V16, P920, DOI 10.1111/j.1600-0625.2007.00614.x; Oji V, 2009, AM J CLIN DERMATOL, V10, P351, DOI 10.2165/11311070-000000000-00000; Akiyama M, 2007, J INVEST DERMATOL, V127, P568, DOI 10.1038/sj.jid.5700617; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Castiglia D, 2009, CLIN GENET, V76, P392, DOI 10.1111/j.1399-0004.2009.01198.x; Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Annilo T, 2002, CYTOGENET GENOME RES, V98, P169, DOI 10.1159/000069811; Takeichi T, 2013, J DERMATOL SCI, V69, P259, DOI 10.1016/j.jdermsci.2012.11.004; Akiyama M, 1997, DERMATOLOGY, V195, P164; BLANCHETBARDON C, 1983, LANCET, V1, P132; Bongain A, 2002, ULTRASOUND OBST GYN, V20, P82, DOI 10.1046/j.1469-0705.2002.00708.x; BUXMAN MM, 1979, ARCH DERMATOL, V115, P189, DOI 10.1001/archderm.115.2.189; Culican SM, 2002, AM J OPHTHALMOL, V134, P442, DOI 10.1016/S0002-9394(02)01567-2; Egawa T, 2005, JPN J CLIN DERMATOL, V59, P1049; Era I, 1985, OBSTET GYNECOL, V52, P1087; Fleckman P, 1997, J INVEST DERMATOL, V109, P36, DOI 10.1111/1523-1747.ep12276450; Follmann J, 2013, GENE, V531, P510, DOI 10.1016/j.gene.2013.07.046; Fukuda S, 2012, BRIT J DERMATOL, V166, P218, DOI 10.1111/j.1365-2133.2011.10516.x; Goldsmith T, 2013, EXP DERMATOL, V22, P251, DOI 10.1111/exd.12110; Harvey HB, 2010, J PERINATOL, V30, P66, DOI 10.1038/jp.2009.100; HASHIMOTO K, 1992, J CUTAN PATHOL, V19, P247, DOI 10.1111/j.1600-0560.1992.tb01666.x; Hazuku Tomonobu, 2011, Case Rep Ophthalmol, V2, P73, DOI 10.1159/000325138; Hovnanian A, 2005, J CLIN INVEST, V115, P1708, DOI 10.1172/JCI25736; Ishida-Yamamoto A, 2011, MED MOL MORPHOL, V44, P1, DOI 10.1007/s00795-010-0513-4; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Israeli S, 2013, CLIN EXP DERMATOL, V38, P911, DOI 10.1111/ced.12148; Itou Y, 2011, NISHINIHON J DERMATO, V73, P26; Kawano Y, 2009, J JPN SOC PERINATAL, V45, P914; Koochek A, 2014, PEDIATR DERMATOL, V31, pE63, DOI 10.1111/pde.12263; Kudla MJ, 2010, J ULTRAS MED, V29, P317; Matsuda K, 2011, J JPN SOC PERINATAL, V47, P664; MILNER ME, 1992, J INVEST DERMATOL, V99, P824, DOI 10.1111/1523-1747.ep12614791; Milstone LM, 2013, J AM ACAD DERMATOL, V69, P808, DOI 10.1016/j.jaad.2013.06.017; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Nakano S, 2009, JPN J CLIN DERMATOL, V63, P356; Natsuga K, 2007, J INVEST DERMATOL, V127, P2669, DOI 10.1038/sj.jid.5700885; Nawaz S, 2012, EUR J DERMATOL, V22, P178, DOI 10.1684/ejd.2011.1638; Ogami A, 2003, J JPN PEDIAT SOC, V107, P1113; Ogami T, 1983, PRACT DERMATOL, V5, P147; Peterson H, 2013, PEDIATR DERMATOL, V30, pE236, DOI 10.1111/j.1525-1470.2011.01695.x; Rajpar SF, 2006, BRIT J DERMATOL, V155, P204, DOI 10.1111/j.1365-2133.2006.07291.x; Rajpopat S, 2011, ARCH DERMATOL, V147, P681, DOI 10.1001/archdermatol.2011.9; Rubio-Gomez GA, 2014, J AM ACAD DERMATOL, V70, P506, DOI 10.1016/j.jaad.2013.11.002; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Shibata A, 2014, J AM ACAD DERMATOL, V70, P387, DOI 10.1016/j.jaad.2013.10.055; Shimizu Y, 2013, J DERMATOL, V40, P582, DOI 10.1111/1346-8138.12169; Taga S, 2008, MOD TRENDS OBSTET GY, V56, P41; Thomas AC, 2009, AM J PATHOL, V174, P970, DOI 10.2353/ajpath.2009.080860; Thomas AC, 2008, BRIT J DERMATOL, V158, P611, DOI 10.1111/j.1365-2133.2007.08277.x; Thomas AC, 2006, J INVEST DERMATOL, V126, P2408, DOI 10.1038/sj.jid.5700455; Tourette C, 2012, PRENATAL DIAG, V32, P498, DOI 10.1002/pd.3839; Udagawa Y, 1989, TOKYO J OBSTET GYNEC, V38, P411; Umemoto H, 2011, J DERMATOL SCI, V61, P136, DOI 10.1016/j.jdermsci.2010.11.010; Wada T, 1993, CASE HARLEQUIN FETUS, V34; Walsh DM, 2012, SCI CAIRO, V2012; Yamazaki O, 1998, JPN J CLIN DERMATOL, V52, P21; Yanagi T, 2010, AM J PATHOL, V177, P106, DOI 10.2353/ajpath.2010.091120; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204; Yanagi T, 2008, J AM ACAD DERMATOL, V58, P653, DOI 10.1016/j.jaad.2007.12.018	77	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					516	522		10.1111/ped.12638		7	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500002		
J	Kobayashi, R; Sunami, S; Mitsui, T; Nakazawa, A; Koga, Y; Mori, T; Tanaka, F; Ueyama, J; Osumi, T; Fukano, R; Ohki, K; Sekimizu, M; Mori, T				Kobayashi, Ryoji; Sunami, Shosuke; Mitsui, Tetsuo; Nakazawa, Atsuko; Koga, Yuhki; Mori, Takeshi; Tanaka, Fumiko; Ueyama, Jun-ichi; Osumi, Tomoo; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya		Lymphoma Comm & Japanese Pediat	Treatment of pediatric lymphoma in Japan: Current status and plans for the future	PEDIATRICS INTERNATIONAL			English	Review						adolescent and young adult; childhood; lymphoma	LARGE-CELL LYMPHOMA; NON-HODGKIN-LYMPHOMA; ACUTE-LYMPHOBLASTIC-LEUKEMIA; FRANKFURT-MUNSTER GROUP; CHEMOTHERAPY PLUS RITUXIMAB; RETROSPECTIVE ANALYSIS; CHILDRENS-CANCER; PROGNOSTIC-FACTORS; DOSE METHOTREXATE; UNITED-KINGDOM	Results of pediatric lymphoma treatment have improved markedly over the past 30years. In Hodgkin's lymphoma, the 5year event-free survival (EFS) was 81.5% in a retrospective study. In the ALB-NHL03 study, the 5year EFS according to clinical stage in patients with lymphoblastic T-cell lymphoma (T-LBL) was 70.6% for stage III and 88.9% for stage IV. In mature B-cell lymphoma, the B-NHL03 study indicated that the 4year EFS according to treatment group was 94% for group 1, 98% for group 2, 84% for group 3, and 78% for group 4. Moreover, the 2year EFS rate was 81% in Japanese advanced stage patients based on the international ALCL99 study. Thus, EFS >80% was achieved in any subtype of pediatric lymphoma. With regard to refractory or recurrent lymphoma, however, treatment methods for improvement of the survival rate in these patients still need to be developed. Also the difference between child, and adolescent and young adult patients still needs to be clarified, and treatment protocols developed. Although lymphoma treatment does not greatly change according to country, it does differ between other countries and Japan for some subtypes of lymphoma. In particular, the results of treatment of stage III T-LBL in Japan are worse than those in the USA and Europe. The priority in future studies will be to collect data on these differences, and the reasons for these differences.	[Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido 0030006, Japan; [Sunami, Shosuke] Narita Red Cross Hosp, Dept Pediat, Narita, Japan; [Mitsui, Tetsuo] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 99023, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Osumi, Tomoo] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Koga, Yuhki] Kyushu Univ, Grad Sch Med, Dept Pediat, Fukuoka 812, Japan; [Fukano, Reiji] Natl Hosp Org Kyusyu Canc Ctr, Dept Pediat, Fukuoka, Japan; [Mori, Takeshi] Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan; [Tanaka, Fumiko] Saiseikai Yokohamashi Nanbu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Ueyama, Jun-ichi] Tottori Univ, Fac Med, Div Pediat & Perinatol, Dept Multidisciplinary Internal Med, Yonago, Tottori 683, Japan; [Ohki, Kentaro] Gunma Childrens Med Ctr, Dept Hematol & Oncol, Shibukawa, Japan; [Sekimizu, Masahiro] Nagoya Med Ctr, Natl Hosp Org, Dept Pediat, Nagoya, Aichi, Japan; [Mori, Tetsuya] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan	Kobayashi, R (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Higashi Sapporo 6-6, Sapporo, Hokkaido 0030006, Japan.	r-koba@jacls.jp			Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED	The authors are grateful to the patients who participated in the JPLSG study. In addition, we thank all of the physicians, nurses, and support personnel for their dedicated care of the patients in the JPLSG study. Moreover, we are very thankful to the past members of the lymphoma committee, and especially to Dr Masahito Tsurusawa, who was the first chairman of the committee. This research is supported by the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED. The authors declare no conflicts of interest.	Windsor R, 2008, PEDIATR BLOOD CANCER, V50, P784, DOI 10.1002/pbc.21293; Le Deley MC, 2008, BLOOD, V111, P1560, DOI 10.1182/blood-2007-07-100958; HVIZDALA EV, 1988, J CLIN ONCOL, V6, P26; Bonn BR, 2013, BLOOD, V121, P3153, DOI 10.1182/blood-2012-12-474148; Reiter A, 1999, BLOOD, V94, P3294; Kobayashi R, 2010, PEDIATR BLOOD CANCER, V54, P212, DOI 10.1002/pbc.22329; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Brugieres L, 1998, BLOOD, V92, P3591; Fujita N, 2008, PEDIATR BLOOD CANCER, V51, P188, DOI 10.1002/pbc.21585; Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]; REITER A, 1994, J CLIN ONCOL, V12, P899; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Park MJ, 2009, BRIT J HAEMATOL, V145, P198, DOI 10.1111/j.1365-2141.2009.07607.x; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Mitsui T, 2009, PEDIATR BLOOD CANCER, V52, P591, DOI 10.1002/pbc.21941; Rosolen A, 2005, CANCER, V104, P2133, DOI 10.1002/cncr.21438; Le Deley MC, 2010, J CLIN ONCOL, V28, P3987, DOI 10.1200/JCO.2010.28.5999; Reiter A, 2000, BLOOD, V95, P416; REITER A, 1995, J CLIN ONCOL, V13, P359; Gerrard M, 2008, BRIT J HAEMATOL, V141, P840, DOI 10.1111/j.1365-2141.2008.07144.x; Burkhardt B, 2006, J CLIN ONCOL, V24, P491, DOI 10.1200/JCO.2005.02.2707; PATTE C, 1992, MED PEDIATR ONCOL, V20, P105, DOI 10.1002/mpo.2950200204; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Seidemann K, 2001, BLOOD, V97, P3699, DOI 10.1182/blood.V97.12.3699; Cairo MS, 2007, BLOOD, V109, P2736, DOI 10.1182/blood-2006-07-036665; Gisselbrecht C, 1998, BLOOD, V92, P76; Brugieres L, 2009, J CLIN ONCOL, V27, P897, DOI 10.1200/JCO.2008.18.1487; ANDERSON JR, 1993, J CLIN ONCOL, V11, P1024; Kobayashi R, 2014, INT J HEMATOL, V99, P743, DOI 10.1007/s12185-014-1585-z; Mologni L, 2012, EXPERT OPIN INV DRUG, V21, P985, DOI 10.1517/13543784.2012.690031; Williams DM, 2002, BRIT J HAEMATOL, V117, P812, DOI 10.1046/j.1365-2141.2002.03482.x; Hutchison RE, 2008, PEDIATR BLOOD CANCER, V51, P29, DOI 10.1002/pbc.21543; Savage KJ, 2004, ANN ONCOL, V15, P1467, DOI 10.1093/annonc/mdh392; Laver JH, 2005, J CLIN ONCOL, V23, P541, DOI 10.1200/JCO.2005.11.075; Ansell SM, 2011, EXPERT OPIN INV DRUG, V20, P99, DOI 10.1517/13543784.2011.542147; ARMITAGE JO, 1989, J CLIN ONCOL, V7, P1783; Arrowsmith ER, 2003, LEUKEMIA LYMPHOMA, V44, P241, DOI 10.1080/1042819021000030054; Burkhardt B, 2008, LEUKEMIA LYMPHOMA, V49, P451, DOI 10.1080/10428190701824551; Disease Registration Committee Japanese Society of Pediatric Hematology and Oncology, 2013, JPN J PEDIAT HEMATOL, V50, P462; Fujita A, 2011, J DERMATOL, V38, P524, DOI 10.1111/j.1346-8138.2010.01049.x; Fujita N, 2011, LEUKEMIA LYMPHOMA, V52, P223, DOI 10.3109/10428194.2010.537794; Fukano R, 2015, BRIT J HAEMATOL, V168, P557, DOI 10.1111/bjh.13167; HAIOUN C, 1992, LEUKEMIA LYMPHOMA, V7, P449, DOI 10.3109/10428199209049801; Horibe K, 1997, INT J HEMATOL, V66, P89; Ichikawa M, 2011, J PEDIAT HEMATOL ONC, V33, pE143, DOI 10.1097/MPH.0b013e3181f47040; International T cell lymphomas Project, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Kavan P, 1999, Cas Lek Cesk, V138, P40; Kikuchi A, 2008, LEUKEMIA LYMPHOMA, V49, P757, DOI 10.1080/10428190701843239; Kobayashi R, 2012, BRIT J HAEMATOL, V159, P88, DOI 10.1111/bjh.12001; Koga Yuhki, 2012, Rinsho Ketsueki, V53, P443; Lee SH, 2013, PEDIATR BLOOD CANCER, V60, P1842, DOI 10.1002/pbc.24695; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; Mori Tetsuya, 2014, Rinsho Ketsueki, V55, P526; Mori T, 2006, BRIT J HAEMATOL, V132, P594, DOI 10.1111/j.1365-2141.2005.05910.x; Ruhl U, 2001, INT J RADIAT ONCOL, V51, P1209, DOI 10.1016/S0360-3016(01)01798-9; SHIMIZU H, 1995, INT J HEMATOL, V61, P85; Sunami S, 2014, BLOOD, V124, P3049; Sunami S, 2006, PEDIAT BLOOD CANC, V46, P865; Tsurusawa M, 2009, JPN J PEDIAT HEMATOL, V23, P244; Tsurusawa M, 2008, LEUKEMIA LYMPHOMA, V49, P734, DOI 10.1080/10428190701851356	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					523	534		10.1111/ped.12725		12	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500003		
J	Somura, J; Nakagawa, M; Ukiami, M; Sagawa, H; Furukawa, O; Hoshino, S; Fujino, H; Takeuchi, Y				Somura, Junpei; Nakagawa, Masao; Ukiami, Masami; Sagawa, Hironori; Furukawa, Ouki; Hoshino, Shinsuke; Fujino, Hidetoshi; Takeuchi, Yoshihiro			Relationship between electrocardiographic signs and shunt volume in atrial septal defect	PEDIATRICS INTERNATIONAL			English	Article						atrial septal defect; electrocardiogram; pediatric; right bundle branch block; right ventricle	MAGNETIC-RESONANCE; HEMODYNAMIC CORRELATION; HEART-DISEASE; R-WAVE; ADULTS; CHILDREN; CLOSURE	Background: The aim of this study was to determine whether electrocardiographic signs correlate with hemodynamics and the magnitude of the intracardiac shunt in children with ostium secundum atrial septal defects (ASD). Methods: A total of 100 ASD patients (median age, 6 years 4 months; 54 girls) underwent cardiac catheterization between August 1980 and April 2010. We retrospectively investigated the relationship between electrocardiographic signs and the pulmonary/systemic blood flow ratio (Qp/Qs) in these patients. We also compared 63 postoperative electrocardiograms with those recorded before surgery. Results: The mean Qp/Qs ratio of the 100 patients was 2.46 0.81 (range, 1.1-5.0). The Qp/Qs ratio in patients with and without right bundle branch block (RBBB) was 2.57 +/- 0.82 (n = 73) and 2.15 +/- 0.72 (n = 27), respectively (P = 0.016). The Qp/Qs ratio in patients with and without isolated negative T-wave was 2.85 +/- 0.87 (n = 38) and 2.22 +/- 0.68 (n = 62), respectively (P = 0.0003). None of the patients with low Qp/Qs ratio (Qp/Qs ratio 1.5) had both RBBB and isolated negative T-wave. The prevalence of these two signs decreased from 73.0% (n = 46) and 36.5% (n = 23) to 15.9% (n = 10) and 15.9% (n = 10) after surgical repair, respectively. Conclusions: RBBB and isolated negative T-wave in the precordial leads are well correlated with high Qp/Qs ratio in ASD patients.	[Somura, Junpei; Nakagawa, Masao; Ukiami, Masami; Sagawa, Hironori; Furukawa, Ouki; Hoshino, Shinsuke; Fujino, Hidetoshi; Takeuchi, Yoshihiro] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan	Somura, J (reprint author), Shiga Univ Med Sci, Dept Pediat, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	jun0770@belle.shiga-med.ac.jp					Brochu MC, 2002, CIRCULATION, V106, P1821, DOI 10.1161/01.CIR.0000029924.90823.E0; SAMANEK M, 1989, PEDIATR CARDIOL, V10, P205, DOI 10.1007/BF02083294; LAFARGE CG, 1970, CARDIOVASC RES, V4, P23, DOI 10.1093/cvr/4.1.23; Arrington CB, 2007, J ELECTROCARDIOL, V40, P484, DOI 10.1016/j.jelectrocard.2007.06.001; BARBOZA ET, 1958, AM J CARDIOL, V2, P698, DOI 10.1016/0002-9149(58)90267-4; BURCH GE, 1959, AM HEART J, V58, P190, DOI 10.1016/0002-8703(59)90336-9; Cardoso CO, 2007, ARA BRAS CARDIOL, V88, P338; Debl K, 2009, BRIT J RADIOL, V82, P386, DOI 10.1259/bjr/18500608; Dill T, 2008, HEART, V94, P943, DOI 10.1136/hrt.2007.125039; Gatzoulis MA, 1996, ANN THORAC SURG, V61, P657, DOI 10.1016/0003-4975(95)01043-2; Heller J, 1996, J AM COLL CARDIOL, V27, P877, DOI 10.1016/0735-1097(95)00554-4; Izumida N, 2000, INT J CARDIOL, V74, P115, DOI 10.1016/S0167-5273(00)00248-5; Madiyono B, 1989, Paediatr Indones, V29, P199; Ohlow MA, 2009, INT J CARDIOL, V135, P66, DOI 10.1016/j.ijcard.2008.03.035; Oliveira JM, 1958, AM HEART J, V55, P694; Piaw CS, 2006, CARDIOVASC INTER RAD, V29, P230, DOI 10.1007/s00270-005-0003-6; RAUNIO H, 1978, AM HEART J, V95, P702, DOI 10.1016/0002-8703(78)90499-4; Siddiqui AM, 2010, J ELECTROCARDIOL, V43, P161, DOI 10.1016/j.jelectrocard.2009.10.001; Thomson LEJ, 2008, CIRC-CARDIOVASC IMAG, V1, P31, DOI [10.1161/CIRCIMAGING.108.769786, 10.1161/CIRCIMAGING.108.769768]; WALKER WJ, 1956, AM HEART J, V52, P547, DOI 10.1016/0002-8703(56)90044-8; Wang MX, 2012, CHINESE MED J-PEKING, V125, P1057, DOI 10.3760/cma.j.issn.0366-6999.2012.06.018	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					535	540		10.1111/ped.12569		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500004		
J	Kawakami, S; Minamisawa, S				Kawakami, Shoji; Minamisawa, Susumu			Oxygenation decreases elastin secretion from rat ductus arteriosus smooth muscle cells	PEDIATRICS INTERNATIONAL			English	Article						ductus arteriosus; elastin; hypoxia; liquid chromatography-tandem mass spectrometry; oxygen	HYPOXIA; EXPRESSION; GESTATION; GROWTH; HIF-1	Background: The ductus arteriosus (DA), a fetal arterial connection between the main pulmonary artery and the descending aorta, normally closes immediately after birth. The oxygen concentration in the blood rises after birth, and in the DA this increase in oxygen concentration causes functional closure, which is induced by smooth muscle contraction. Previous studies have demonstrated that hypoxia and/or oxygenation affect vascular remodeling of various vessels. Therefore, we hypothesized that the rise in oxygen concentration would affect the vascular structure of the DA due to production of proteins secreted from DA smooth muscle cells (SMC). Methods and Results: Liquid chromatography-tandem mass spectrometry was used to comprehensively investigate the secreted proteins in the supernatant of rat DA SMC harvested under hypoxic conditions (1% oxygen) or under normoxic conditions (21% oxygen). We found that the rise in oxygen concentration reduced the secretion of elastin from DA SMC. On reverse transcription-polymerase chain reaction, the expression of elastin mRNA was not significantly changed in DA SMC from hypoxic to normoxic conditions. Conclusions: Given that elastin forms internal elastic lamina and elastic fibers in the vascular muscle layers, and that a rise in oxygen concentration reduced the secretion of elastin, this suggests that the rise in blood oxygen concentration after birth reduces the secretion of elastin, and therefore may play a role in DA structural remodeling after birth.	[Kawakami, Shoji; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Tokyo 1058461, Japan	Minamisawa, S (reprint author), Jikei Univ, Dept Cell Physiol, Minato Ku, 3-25-8 NIshishinbashi, Tokyo 1058461, Japan.	sminamis@jikei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; High-Tech Research Center Project for Private Universities: MEXT; MEXT-Program for the Strategic Research Foundation at Private Universities; Vehicle Racing Commemorative Foundation; Shimabara Science Promotion Foundation	We thank Mr Kenji Iwai (Waseda University School of Advanced Science and Engineering, Department of Lifescience and Medical Bioscience) and Professor Hisashi Kato (Waseda University Faculty of Education) for support with the experiments and data analysis. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.M.), the High-Tech Research Center Project for Private Universities: MEXT (S.M.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S.M.), the Vehicle Racing Commemorative Foundation (S.M.), and the Shimabara Science Promotion Foundation (S.M.).	Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Wachi H, 2011, J HEALTH SCI, V57, P449; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Kocher T, 2011, PROTEOMICS, V11, P1026, DOI 10.1002/pmic.201000578; Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008; Waleh N, 2009, PEDIATR RES, V65, P285, DOI 10.1203/PDR.0b013e31819746a1; Hilgendorff A, 2012, AM J PHYSIOL-LUNG C, V303, pL215, DOI 10.1152/ajplung.00405.2011; Yokoyama U, 2014, CIRCULATION, V129, P487, DOI 10.1161/CIRCULATIONAHA.113.004726; Clyman RI, 1999, PEDIATR RES, V45, P19, DOI 10.1203/00006450-199901000-00005; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; Ambalavanan N, 2008, PEDIATR RES, V63, P26; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Berk JL, 2005, AM J PHYSIOL-LUNG C, V289, pL931, DOI 10.1152/ajplung.00037.2005; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					541	545		10.1111/ped.12684		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500005		
J	Saida, S; Watanabe, K; Kato, I; Fujino, H; Umeda, K; Okamoto, S; Uemoto, S; Hishiki, T; Yoshida, H; Tanaka, S; Adachi, S; Niwa, A; Nakahata, T; Heike, T				Saida, Satoshi; Watanabe, Ken-ichiro; Kato, Itaru; Fujino, Hisanori; Umeda, Katsutsugu; Okamoto, Shinya; Uemoto, Shinji; Hishiki, Tomoro; Yoshida, Hideo; Tanaka, Shiro; Adachi, Souichi; Niwa, Akira; Nakahata, Tatsutoshi; Heike, Toshio			Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma	PEDIATRICS INTERNATIONAL			English	Article						aminopeptidase-N/CD13; hepatoblastoma; invasion; liver tumor; pediatric oncology	EXTRACELLULAR-MATRIX DEGRADATION; CHILDHOOD HEPATOBLASTOMA; HEPATOCELLULAR-CARCINOMA; INTERNATIONAL SOCIETY; LUNG-CANCER; CELL-LINE; INVASION; TUMOR; EXPRESSION; CHILDREN	BackgroundHepatoblastoma is a rare childhood malignant tumor that originates from immature hepatic cells. Aminopeptidase-N(CD13), an ectopeptidase that promotes tumor invasion and metastasis, is expressed in fetal stage hepatic progenitor cells, although its role in hepatoblastoma remains unclear. MethodsThe expression pattern of CD13 was investigated on immunohistochemistry in 30 tissue samples from 27 hepatoblastoma patients (16 with predominantly embryonal [pE] histology and 14 with predominantly fetal [pF] histology). Immunoreactive score (IRS) was used to quantify staining data, and the relationship between CD13 expression, clinicopathological factors, and clinical outcome was investigated. The biological function of CD13 was also examined in the hepatoblastoma cell lines Huh6 and HepG2. ResultsAll specimens stained positive for CD13, with higher CD13 expression in pE than in pF hepatoblastoma samples (median IRS, 4; range, 2-9 vs 2; range, 1-4). Strong CD13 expression was correlated with vascular invasion. Fiveyear event-free survival and overall survival were better in patients with CD13(low) than in those with CD13(high) tumors (100% vs 51.0%, P = 0.026; and 100% vs 74.0%, P = 0.114, respectively). A CD13-neutralizing antibody and the potent CD13 inhibitor, Ubenimex, suppressed invasive activity in HepG2 cells in vitro. ConclusionsCD13 expression is associated with hepatoblastoma invasiveness and could be a novel prognostic marker for hepatoblastoma.	[Saida, Satoshi; Watanabe, Ken-ichiro; Kato, Itaru; Fujino, Hisanori; Umeda, Katsutsugu; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Translat Res Ctr, Kyoto, Japan; [Okamoto, Shinya; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Translat Res Ctr, Div Hepatopancreatobiliary Surg & Transplantat, Kyoto, Japan; [Tanaka, Shiro] Kyoto Univ, Grad Sch Med, Translat Res Ctr, Div Clin Trial Design & Management, Kyoto, Japan; [Niwa, Akira; Nakahata, Tatsutoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Clin Applicat, Kyoto, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Hishiki, Tomoro; Yoshida, Hideo] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan	Heike, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	heike@kuhp.kyoto-u.ac.jp					Zsíros József, 2010, J Clin Oncol, V28, P2584, DOI 10.1200/JCO.2009.22.4857; DIXON J, 1994, J CLIN PATHOL, V47, P43, DOI 10.1136/jcp.47.1.43; Perilongo G, 2004, EUR J CANCER, V40, P411, DOI 10.1016/j.ejca.2003.06.003; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; WEINBERG AG, 1983, HUM PATHOL, V14, P512, DOI 10.1016/S0046-8177(83)80005-7; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Hishiki T, 2011, PEDIATR SURG INT, V27, P1, DOI 10.1007/s00383-010-2708-0; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Surowiak P, 2006, INT J GYNECOL CANCER, V16, P1783, DOI 10.1111/j.1525-1438.2006.00657.x; Meyers RL, 2009, PEDIATR BLOOD CANCER, V53, P1016, DOI 10.1002/pbc.22088; Pritchard J, 2000, J CLIN ONCOL, V18, P3819; Roebuck DJ, 2007, PEDIATR RADIOL, V37, P123, DOI 10.1007/s00247-006-0361-5; Fuchs J, 2002, CANCER, V95, P172, DOI 10.1002/cncr.10632; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Maibach R, 2012, EUR J CANCER, V48, P1543, DOI 10.1016/j.ejca.2011.12.011; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; DOI I, 1976, GANN, V67, P1; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; HAAS JE, 1989, CANCER, V64, P1082, DOI 10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G; Inagaki Y, 2010, BIOSCI TRENDS, V4, P56; Kao YR, 2003, CLIN CANCER RES, V9, P2807; REMMELE W, 1987, PATHOLOGE, V8, P138; Rocken C, 2004, INT J ONCOL, V24, P487; Rocken C, 2005, J CLIN PATHOL, V58, P1069, DOI 10.1136/jcp.2005.026328; Saitoh Y, 2006, BIOL PHARM BULL, V29, P709, DOI 10.1248/bpb.29.709; Shang LQ, 2009, BIOORGAN MED CHEM, V17, P2775, DOI 10.1016/j.bmc.2009.02.034; Umeda K, 2006, STEM CELLS, V24, P1348, DOI 10.1634/stemcells.2005.0165; von Schweinitz D, 1997, INT J CANCER, V74, P593, DOI 10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P; VONSCHWEINITZ D, 1994, EUR J CANCER, V30A, P1052, DOI 10.1016/0959-8049(94)90454-5; YONEDA J, 1992, CLIN EXP METASTAS, V10, P49, DOI 10.1007/BF00163576	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					558	566		10.1111/ped.12597		9	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500008		
J	Mizumoto, M; Oshiro, Y; Takizawa, D; Fukushima, T; Fukushima, H; Yamamoto, T; Muroi, A; Okumura, T; Tsuboi, K; Sakurai, H				Mizumoto, Masashi; Oshiro, Yoshiko; Takizawa, Daichi; Fukushima, Takashi; Fukushima, Hiroko; Yamamoto, Tetsuya; Muroi, Ai; Okumura, Toshiyuki; Tsuboi, Koji; Sakurai, Hideyuki			Proton beam therapy for pediatric ependymoma	PEDIATRICS INTERNATIONAL			English	Article						brain; ependymoma; pediatric; proton beam therapy; radiotherapy	CONFORMAL RADIATION-THERAPY; RELATIVE BIOLOGICAL EFFECTIVENESS; LOCALIZED EPENDYMOMA; RADIOTHERAPY; CARCINOMA; SURVIVAL; OUTCOMES; TUMORS	BackgroundThe aim of this study was to evaluate the efficacy of proton beam therapy for pediatric patients with ependymoma. MethodsProton beam therapy was conducted for six patients (three boys and three girls; age, 2-6 years; median, 5 years) with ependymoma. The tumors were WHO grades 2 and 3 in two and four patients, respectively. All patients underwent surgery (subtotal and gross total resection in three patients each) and proton beam therapy at doses of 50.4-61.2 GyE (median, 56.7 GyE). The mean doses to normal brain tissue in proton beam therapy and photon radiotherapy were simulated using the same treatment planning computed tomography images. ResultsAll patients completed the planned irradiation. The follow-up period was 13-44 months (median, 24.5 months) from completion of proton beam therapy and all patients were alive at the end of this period. Local recurrence in the treatment field occurred in one patient at 4 months after proton beam therapy at 50.4 GyE. Alopecia and mild dermatitis occurred in all patients, but there was no severe toxicity. One patient had a once-off seizure after proton beam therapy and alopecia persisted in another patient for 31 months, but no patients had difficulty with daily life. The simulation showed that proton beam therapy reduces the dose to normal brain tissue by approximately half compared with photon radiotherapy. ConclusionsProton beam therapy for pediatric ependymoma is safe, does not have specific toxicities, and can reduce irradiation of normal brain tissue.	[Mizumoto, Masashi; Oshiro, Yoshiko; Takizawa, Daichi; Okumura, Toshiyuki; Tsuboi, Koji; Sakurai, Hideyuki] Univ Tsukuba, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan; [Fukushima, Takashi; Fukushima, Hiroko] Univ Tsukuba, Dept Pediat, Tsukuba, Ibaraki, Japan; [Yamamoto, Tetsuya; Muroi, Ai] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Oshiro, Yoshiko] Tsukuba Med Ctr Hosp, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan	Mizumoto, M (reprint author), Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Ibaraki 3058575, Japan.	mizumoto1717@hotmail.com			Ministry of Education, Science, Sports and Culture of Japan [24390286, 24659556, 25861064, 24591832]	This work was supported in part by Grant-in-Aid for Scientific Research (B) (24390286), Challenging Exploratory Research (24659556), Young Scientists (B) (25861064), Scientific Research (C) (24591832) from the Ministry of Education, Science, Sports and Culture of Japan. None of the authors have any actual or potential conflicts of interest regarding the work in this study.	Mizumoto M, 2013, STRAHLENTHER ONKOL, V189, P335, DOI 10.1007/s00066-012-0274-1; Mizumoto M, 2010, INT J RADIAT ONCOL, V77, P98, DOI 10.1016/j.ijrobp.2009.04.054; Mizumoto M, 2010, STRAHLENTHER ONKOL, V186, P482, DOI 10.1007/s00066-010-2079-4; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Oshiro Y, 2012, J THORAC ONCOL, V7, P370, DOI 10.1097/JTO.0b013e31823c485f; Merchant TE, 2008, PEDIATR BLOOD CANCER, V51, P110, DOI 10.1002/pbc.21530; Conklin HM, 2008, J CLIN ONCOL, V26, P3965, DOI 10.1200/JCO.2007.15.9970; Miralbell R, 2002, INT J RADIAT ONCOL, V54, P824, DOI 10.1016/S0360-3016(02)02982-6; MacDonald SM, 2008, INT J RADIAT ONCOL, V71, P979, DOI 10.1016/j.ijrobp.2007.11.065; Mizumoto M, 2011, INT J RADIAT ONCOL, V81, P1039, DOI 10.1016/j.ijrobp.2010.07.015; Gerweck LE, 1999, RADIOTHER ONCOL, V50, P135, DOI 10.1016/S0167-8140(98)00092-9; Merchant TE, 2005, INT J RADIAT ONCOL, V63, P1546, DOI 10.1016/j.ijrobp.2005.05.028; Mizumoto M, 2013, STRAHLENTHER ONKOL, V189, P656, DOI 10.1007/s00066-013-0390-6; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Netson KL, 2012, INT J RADIAT ONCOL, V84, P217, DOI 10.1016/j.ijrobp.2011.10.043; Mizumoto M, 2011, INT J RADIAT ONCOL, V81, pE601, DOI 10.1016/j.ijrobp.2011.02.041; Oshiro Y, 2013, ACTA ONCOL, V52, P600, DOI 10.3109/0284186X.2012.760849; CBTRUS, 2010, STAT REP PRIM BRAIN; Conter C, 2009, INT J RADIAT ONCOL, V74, P1536, DOI 10.1016/j.ijrobp.2008.09.051; Kanemoto A, 2012, JPN J CLIN ONCOL, V42, P552, DOI 10.1093/jjco/hys047; Koshy M, 2011, J NEURO-ONCOL, V105, P583, DOI 10.1007/s11060-011-0624-3; Landau E, 2013, INT J RADIAT ONCOL, V85, pE193, DOI 10.1016/j.ijrobp.2012.10.033; Merchant TE, 2004, J CLIN ONCOL, V22, P3156, DOI 10.1200/JCO.2004.11.142; Oshiro Y, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-142	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					567	571		10.1111/ped.12624		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500009		
J	Suzuki, R; Fukushima, H; Noguchi, E; Tsuchida, M; Kiyokawa, N; Koike, K; Ma, E; Takahashi, H; Kobayashi, C; Nakajima-Yamaguchi, R; Sakai, A; Saito, M; Iwabuchi, A; Kato, K; Nakao, T; Yoshimi, A; Sumazaki, R; Fukushima, T				Suzuki, Ryoko; Fukushima, Hiroko; Noguchi, Emiko; Tsuchida, Masahiro; Kiyokawa, Nobutaka; Koike, Kazutoshi; Ma, Enbo; Takahashi, Hideto; Kobayashi, Chie; Nakajima-Yamaguchi, Ryoko; Sakai, Aiko; Saito, Makoto; Iwabuchi, Atsushi; Kato, Keisuke; Nakao, Tomohei; Yoshimi, Ai; Sumazaki, Ryo; Fukushima, Takashi			Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia	PEDIATRICS INTERNATIONAL			English	Article						6-mercaptopurine; childhood; leukemia; methotrexate; polymorphism; SLCO1B1	ACUTE LYMPHOBLASTIC-LEUKEMIA; INOSINE-TRIPHOSPHATE-PYROPHOSPHATASE; INFLAMMATORY-BOWEL-DISEASE; CANCER-STUDY-GROUP; MERCAPTOPURINE METABOLISM; GENETIC POLYMORPHISMS; RHEUMATOID-ARTHRITIS; JAPANESE PATIENTS; METHOTREXATE; TOXICITY	BackgroundManagement of the adverse effects of chemotherapy is essential to improve outcome of children with leukemia. Some genetic polymorphisms can predict treatment-related toxicity, and be used individually in dose modification of 6-mercaptopurine (6-MP) and methotrexate (MTX) in maintenance therapy for childhood acute lymphoblastic leukemia (ALL). We investigated associations between clinical course and candidate gene polymorphisms less evaluated in Japanese patients. MethodsFifty-three children who received maintenance chemotherapy were enrolled in this study. The scheduled dose of oral 6-MP was 40mg/m(2) daily and that of oral MTX was 25mg/m(2) weekly. The doses were adjusted according to white blood cell count (target range, 2.5-3.5x10(9)/L) and aspartate aminotransferase and alanine aminotransferase level (<750IU/L). Eight polymorphisms in six candidate genes, TPMT, ITPA, MRP4, MTHFR, RFC1, and SLCO1B1, were genotyped using the Taqman PCR method. Clinical course was reviewed retrospectively from medical records. ResultsThe average dose of 6-MP was lower in the patients with at least one variant allele at SLCO1B1 c.521T>C than in the patients with wild homozygous genotype. The other analyzed polymorphisms were not associated with toxicity, 6-MP, or MTX dose. ConclusionsPolymorphism of SLCO1B1 c.521T>C could be a strong predictor of 6-MP dose reduction in maintenance chemotherapy in childhood ALL.	[Suzuki, Ryoko; Sakai, Aiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Child Hlth, Tsukuba, Ibaraki, Japan; [Fukushima, Hiroko; Kobayashi, Chie; Saito, Makoto; Iwabuchi, Atsushi; Sumazaki, Ryo; Fukushima, Takashi] Univ Tsukuba, Fac Med, Dept Child Hlth, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Fac Med, Dept Genet, Tsukuba, Ibaraki, Japan; [Ma, Enbo] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Takahashi, Hideto] Univ Tsukuba, Fac Med, Dept Epidemiol, Tsukuba, Ibaraki, Japan; [Nakajima-Yamaguchi, Ryoko] Univ Tsukuba Hosp, Dept Pediat, Tsukuba, Ibaraki, Japan; [Tsuchida, Masahiro; Koike, Kazutoshi; Kato, Keisuke; Nakao, Tomohei; Yoshimi, Ai] Ibaraki Childrens Hosp, Dept Hematol & Oncol, Mito, Ibaraki, Japan; [Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Takahashi, Hideto] Fukushima Med Univ, Sch Med, Informat Management & Stat, Fukushima, Japan	Fukushima, T (reprint author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tksfksm@md.tsukuba.ac.jp			National Center for Child Health and Development [25-2]	This work was supported by a grant from the National Center for Child Health and Development (25-2). The authors are grateful to National Center of Biotechnology Information for approval to use control genotype data. We would like to thank Mr Charles N. Jones for scientific writing assistance. The authors have no conflict of interest to declare with regards to this work.	Laverdiere C, 2002, BLOOD, V100, P3832, DOI 10.1182/blood.V100.10.3832; Woessmann W, 2005, BLOOD, V105, P948, DOI 10.1182/blood-2004-03-0973; Rosalina WRW, 2012, J CLIN PHARM THER, V37, P237, DOI 10.1111/j.1365-2710.2011.01272.x; de Beaumais TA, 2012, EUR J CLIN PHARMACOL, V68, P1233, DOI 10.1007/s00228-012-1251-4; Shimasaki N, 2008, J PEDIAT HEMATOL ONC, V30, P347, DOI 10.1097/MPH.0b013e318165b25d; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Ramsey LB, 2013, BLOOD, V121, P898, DOI 10.1182/blood-2012-08-452839; Oevermann L, 2009, INT J CANCER, V124, P2303, DOI 10.1002/ijc.24207; Radtke S, 2013, BLOOD, V121, P5145, DOI 10.1182/blood-2013-01-480335; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Stocco G, 2010, EXPERT OPIN DRUG SAF, V9, P23, DOI 10.1517/14740330903426151; Toyoda Y, 2000, J CLIN ONCOL, V18, P1508; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; de Beaumais TA, 2011, BRIT J CLIN PHARMACO, V71, P575, DOI 10.1111/j.1365-2125.2010.03867.x; Relling MV, 1999, J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Tsuchida M, 2010, LEUKEMIA, V24, P383, DOI 10.1038/leu.2009.260; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Osaki R, 2011, EXP THER MED, V2, P783, DOI 10.3892/etm.2011.287; Kato T, 2012, DRUG METAB PHARMACOK, V27, P192, DOI 10.2133/dmpk.DMPK-11-RG-066; Csordas K, 2014, BRIT J HAEMATOL, V166, P410, DOI 10.1111/bjh.12886; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; desDeus DM, 2012, LEUK RES TREAT, V2012; Drozdzik M, 2007, PHARMACOGENOMICS J, V7, P404, DOI 10.1038/sj.tpj.6500438; Fukushima H, 2013, LEUK RES TREAT, V2013; Gorlick R, 1996, NEW ENGL J MED, V335, P1041; Imanishi H, 2007, J HUM GENET, V52, P166, DOI 10.1007/s10038-006-0096-z; Moscow JA, 1998, LEUKEMIA LYMPHOMA, V30, P215; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Stocco G, 2006, DIGEST DIS SCI, V51, P474, DOI 10.1007/s10620-006-3158-3; Stuart H, 2009, ONCOLOGY INFANCY CHI, V1st; Tanaka Y, 2012, LEUKEMIA RES, V36, P560, DOI 10.1016/j.leukres.2011.11.015; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					572	577		10.1111/ped.12682		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500010		
J	Hasegawa, J; Mori, M; Showa, S; Matsushima, A; Ohnishi, H; Tsugawa, T; Yoto, Y; Tsutsumi, H				Hasegawa, Junko; Mori, Mitsuru; Showa, Satoko; Matsushima, Aiko; Ohnishi, Hirofumi; Tsugawa, Takeshi; Yoto, Yuko; Tsutsumi, Hiroyuki			Pneumococcal vaccination reduced the risk of acute otitis media: Cohort study	PEDIATRICS INTERNATIONAL			English	Article						acute otitis media; children; cohort study; effectiveness; pneumococcal conjugate vaccine	RESPIRATORY-TRACT INFECTIONS; CONJUGATE VACCINE; INFLUENZA VACCINATION; PEDIATRIC-PATIENTS; CHILDREN; IMPACT; EFFICACY; MORTALITY; SAFETY; JAPAN	BackgroundSeven-valent pneumococcal conjugate vaccine (PCV7) was introduced to Japan in 2009, and after that invasive pneumococcal disease has gradually decreased. There are few data, however, on the effectiveness of PCV7 against acute otitis media (AOM) in Japan. MethodsFrom 10 daycare centers in Sapporo, Japan, 614 parents participated in the survey. Each parent reported whether their child subject had received one or more doses of PCV7, and, if so, the exact dates of receiving PCV7 were verified by reviewing their maternal and child health handbooks marked by a pediatrician. AOM was diagnosed by otorhinolaryngologist or pediatrician. Cox's proportional hazard model was used for calculating the hazard ratio (HR) of AOM incidence reduced by PCV7 inoculation. ResultsInoculation of PCV7 significantly reduced the risk of AOM (crude HR, 0.63; 95%CI: 0.50-0.79). Adjusting for potentially confounding variables reduced the risk further (adjusted HR, 0.32; 95%CI: 0.23-0.44). On stratification by subject age on 30 April 2012, PCV7 was significantly associated with a reduced risk of AOM in both infants <3years old, and in children 3years. ConclusionPCV7 is effectiveness in reducing the risk of AOM both in infants <3years old, and in young children 3years in Japan.	[Hasegawa, Junko; Mori, Mitsuru; Showa, Satoko; Matsushima, Aiko; Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Hasegawa, Junko; Tsugawa, Takeshi; Yoto, Yuko; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan	Hasegawa, J (reprint author), Sapporo Med Univ, Sch Med, Dept Publ Hlth, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	junkohasegawa@sapmed.ac.jp			Health and Labour Sciences Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare in Japan [H23-SHINKO-IPPAN-017]	This study was supported by Health and Labour Sciences Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare in Japan [H23-SHINKO-IPPAN-017]. We thank Dr Peter Olly (Professor Emeritus, University of Alberta) for English language advice.	Adam D, 2008, VACCINE, V26, P5944, DOI 10.1016/j.vaccine.2008.08.058; TEELE DW, 1989, J INFECT DIS, V160, P83; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; O'Brien KL, 2008, PEDIATR INFECT DIS J, V27, P71, DOI 10.1097/INF.0b013e318159228f; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Uhari M, 1996, CLIN INFECT DIS, V22, P1079; Chiba N, 2013, MICROB DRUG RESIST, V19, P308, DOI 10.1089/mdr.2012.0180; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006.0492; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; desHoog MLA, 2014, BMC MED, V12, P107; Esposito S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-12; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Kamiya Hitoshi, 2007, Kansenshogaku Zasshi, V81, P59; Kato T, 2012, J JPN SOC INFECT DIS, V30, P51; Ministry of Health Labor and Welfare, 2011, NURS SCH REL SIT REP; Otsuka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068711; Rodgers GL, 2009, VACCINE, V27, P3802, DOI 10.1016/j.vaccine.2009.04.021; Sugino H, 2012, HIROSHIMA IGAKU, V65, P700	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					582	585		10.1111/ped.12587		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500012		
J	Kumagai, T; Ihara, T; Nakayama, T; Nagata, N; Kamiya, H				Kumagai, Takuji; Ihara, Toshiaki; Nakayama, Tetsuo; Nagata, Nobuo; Kamiya, Hitoshi			Reactogenicity and immunogenicity of measles-rubella combined vaccine in school-entry-aged subjects with naturally acquired measles immunity	PEDIATRICS INTERNATIONAL			English	Article						antibody; measles-rubella combined vaccine; reactogenicity	MUMPS-RUBELLA; MMR VACCINATION; FOLLOW-UP; VIRUS; ANTIBODIES; ADULTS	BackgroundThe reintroduction of measles-rubella combined (MR) vaccination to Japan raised concerns about adverse events as well as immunogenicity related to booster immunization in subjects with naturally acquired immunity to measles or rubella. MethodsThe time course of reactogenicity and antibody responses in recipients with pre-existing immunity to measles through natural infection was observed. Eighteen children aged 80-104months received MR booster vaccination; 16 of them had had previous rubella vaccination. ResultsThere were virtually no clinical reactions related to booster vaccination, and a highly significant antibody response to rubella antigen, whereas the antibody rise to measles was statistically significant but poor. ConclusionsVaccination of individuals already immune is not harmful. Booster immunization to rubella for Japanese children is vitally important.	[Kumagai, Takuji] Pediat Allergy & Infect Dis Soc Sapporo, Kumagai Pediat Clin, Sapporo, Hokkaido, Japan; [Nagata, Nobuo] Pediat Allergy & Infect Dis Soc Sapporo, Hiraoka Kohen Pediat Clin, Sapporo, Hokkaido, Japan; [Ihara, Toshiaki] Natl Hosp Org Mie Natl Hosp, Dept Pediat, Tsu, Mie, Japan; [Nakayama, Tetsuo; Kamiya, Hitoshi] Kitasato Inst Life Sci, Lab Viral Infect 1, Tokyo, Japan	Kumagai, T (reprint author), Kumagai Pediat Clin, Atsubetsu Ku, W6 Momijidai, Sapporo, Hokkaido 0040013, Japan.	tkuma@mb.infosnow.ne.jp			Ministry of Health, Labor and Welfare, Japan	The authors express their sincere appreciation to all participants/guardians who allowed their children to participate in the study. The authors are indebted to Professor Peter M. Olley (Emeritus Professor of Pediatrics, University of Alberta at Edmonton) for his invaluable help in revising the manuscript. Also, the authors thank Professor Kiyoshi Ichihara (Department of Clinical Laboratory Sciences, Faculty of Health Sciences, Yamaguchi University Medical School) for his excellent assistance in statistical analysis. Financial support was provided in part by a grant in Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare, Japan.	Tischer A, 2000, VACCINE, V18, P1382, DOI 10.1016/S0264-410X(99)00397-7; Virtanen M, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e62; Johnson CE, 1996, PEDIATR INFECT DIS J, V15, P687, DOI 10.1097/00006454-199608000-00010; Bottiger M, 1995, VACCINE, V13, P1759, DOI 10.1016/0264-410X(95)00143-O; Ceyhan M, 2001, VACCINE, V19, P4473, DOI 10.1016/S0264-410X(01)00207-9; CHEN RT, 1991, VACCINE, V9, P297, DOI 10.1016/0264-410X(91)90053-9; CHRISTENSON B, 1994, VACCINE, V12, P41, DOI 10.1016/0264-410X(94)90009-4; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; Davidkin I, 1998, VACCINE, V16, P2052, DOI 10.1016/S0264-410X(98)00081-4; Fujino M, 2007, J VIROL METHODS, V142, P15, DOI 10.1016/j.jviromet.2007.01.001; JOHNSON H, 1995, VACCINE, V13, P533, DOI 10.1016/0264-410X(94)00021-E; Miller E, 1997, Commun Dis Rep CDR Rev, V7, pR26; Pickering LK, 2006, RED BOOK 2006 REPORT, V27th, P9; Schwarzer S, 1998, VACCINE, V16, P298, DOI 10.1016/S0264-410X(97)00174-6; Wong-Chew RM, 2003, J MED VIROL, V70, P276, DOI 10.1002/jmv.10390	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					597	602		10.1111/ped.12596		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500015		
J	Wada, Y; Nakamura, T; Kaneshige, M; Takahashi, S; Fujinaga, H; Tsukamoto, K; Ito, Y; Sago, H				Wada, Yuka; Nakamura, Tomoo; Kaneshige, Masao; Takahashi, Shigehiro; Fujinaga, Hideshi; Tsukamoto, Keiko; Ito, Yushi; Sago, Haruhiko			Evaluation of two glucose meters and interference corrections for screening neonatal hypoglycemia	PEDIATRICS INTERNATIONAL			English	Article						blood glucose; blood glucose self-monitoring; critical care; neonate; point-of-care systems	INTENSIVE-CARE-UNIT; VITAMIN-C; PERFORMANCE; GLUCOMETER; OUTCOMES; NEWBORN	BackgroundMany neonatal intensive care and maternal units still use self-monitoring of blood glucose (SMBG) devices as a tool to aid diagnosis despite the introduction of point-of-care testing (POCT) devices, which are known to have higher accuracy. We evaluated the performance of two glucose meters, the StatStrip (Nova Biomedical), a POCT device, and the Medisafe Mini (Terumo), an SMBG device, to detect hypoglycemia in neonates. In addition, we evaluated the interference of hematocrit, acetaminophen and ascorbic acid. MethodsWhole blood samples were drawn from neonates who were at risk of hypoglycemia and analyzed with the StatStrip and Medisafe Mini. The results were further confirmed with blood gas analyzers ABL825 and BM6050. To evaluate the interference of hematocrit, acetaminophen and ascorbic acid, concentrated solutions of glucose and interfering substances were gravimetrically prepared and analyzed. ResultsAmong the 222 blood samples analyzed, results from the StatStrip were more closely aligned to those of the ABL825 at all levels of glucose than the Medisafe Mini. ConclusionStatStrip appears to be unaffected by hematocrit, ascorbic acid or acetaminophen. We recommend its use in neonates in hospital. Further studies are required to identify other interference effects.	[Wada, Yuka; Nakamura, Tomoo; Kaneshige, Masao; Takahashi, Shigehiro; Fujinaga, Hideshi; Tsukamoto, Keiko; Ito, Yushi] Natl Ctr Child Hlth & Dev, Div Neonatol, Tokyo 1578535, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal & Neonatal Med, Tokyo 1578535, Japan	Wada, Y (reprint author), Natl Ctr Child Hlth & Dev, Div Neonatol, Setagaya Ku, Ctr Maternal Fetal & Neonatal Med, 2-10-1 Okura, Tokyo 1578535, Japan.	wada-y@ncchd.go.jp					Padayatty SJ, 2004, ANN INTERN MED, V140, P533; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Tanaka H, 2000, ARCH SURG-CHICAGO, V135, P326, DOI 10.1001/archsurg.135.3.326; Tang ZP, 2000, AM J CLIN PATHOL, V113, P75; Rozance PJ, 2006, BIOL NEONATE, V90, P74, DOI 10.1159/000091948; Arabadjief D, 2006, CURR MED RES OPIN, V22, P2167, DOI 10.1185/030079906X148274; Balion Cynthia, 2006, BMC Pediatr, V6, P28, DOI 10.1186/1471-2431-6-28; Beardsall K, 2010, EARLY HUM DEV, V86, P263, DOI 10.1016/j.earlhumdev.2010.05.005; Committee on Fetus and Newborn Adamkin DH, 2011, PEDIATRICS, V127, P575; David B, 2013, POCT12 A3 POINT OF C, V3rd; Germagnoli L, 2008, POINT CARE J NEAR PA, V7, P165, DOI 10.1097/01.POC.0000335872.51572.bb; Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903; Hoftman N, 2005, ANESTHESIOLOGY, V102, P871, DOI 10.1097/00000542-200504000-00036; International Organization for Standardization, 2013, ISO15197; Kavsak PA, 2004, CLIN BIOCHEM, V37, P811, DOI 10.1016/j.clinbiochem.2004.06.003; Lockyer MG, 2014, CLIN BIOCHEM, V47, P840, DOI 10.1016/j.clinbiochem.2014.01.004; Nuntnarumit P, 2011, PEDIATR INT, V53, P218, DOI 10.1111/j.1442-200X.2010.03214.x; POWERS HJ, 1995, FREE RADICAL RES, V22, P57, DOI 10.3109/10715769509147528; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; Tendl KA, 2013, CLIN CHEM LAB MED, V51, P1747, DOI 10.1515/cclm-2012-0864; Wahl HG, 2008, POINT CARE J NEAR PA, V7, P218, DOI 10.1097/01.POC.0000335830.31380.3d	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					603	607		10.1111/ped.12543		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500016		
J	Kawamata, R; Suzuki, Y; Yada, Y; Koike, Y; Kono, Y; Takahashi, N				Kawamata, Ryou; Suzuki, Yume; Yada, Yukari; Koike, Yasunori; Kono, Yumi; Takahashi, Naoto			Gut hormones of preterm infants with abdominal symptoms and hypothyroxinemia	PEDIATRICS INTERNATIONAL			English	Article						glucose-dependent insulinotropic polypeptide; glucagon-like peptide-1; premature infant; peptide YY; thyroxine	GLUCAGON-LIKE PEPTIDE-1; BIRTH-WEIGHT INFANTS; TRANSIENT HYPOTHYROXINEMIA; THYROID STATUS; RATS; HYPOTHYROIDISM; POLYPEPTIDE; SECRETION; PITUITARY; APPETITE	BackgroundThe pathogenesis of abdominal symptoms in premature infants with hypothyroxinemia is not understood; therefore, we investigated changes in gut hormones before and after levothyroxine sodium (T4-Na) supplementation in preterm infants with abdominal symptoms and hypothyroxinemia. MethodsIn eight preterm study subjects and 14 gestational age-matched controls, fasting serum concentration of leptin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), peptide YY (PYY), pancreatic polypeptide, insulin, amylin and ghrelin was measured using a bead array system. ResultsSerum GLP-1, GIP and PYY in the subjects before T4-Na supplementation were lower than in controls at age 2 weeks. After improvement of abdominal symptoms and free thyroxine, serum levels of the three gut hormones in the subjects were increased and were not different from those in the control patients. ConclusionsIn preterm infants with abdominal symptoms, serum GLP-1, GIP and PYY might be related to thyroid function.	[Kawamata, Ryou; Suzuki, Yume; Yada, Yukari; Koike, Yasunori; Kono, Yumi] Jichi Med Univ, Sch Med, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan; [Takahashi, Naoto] Univ Tokyo, Dept Pediat, Tokyo, Japan	Kawamata, R (reprint author), Jichi Med Univ, Sch Med, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kawamatar@jichi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21791039]	This study was supported by Grant-in-Aid for Young Scientists (B) no. 21791039 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Sigalet DL, 2004, PEDIATR RES, V56, P371, DOI 10.1203/01.PDR.0000134250.80492.EC; Biswas S, 2002, PEDIATRICS, V109, P222, DOI 10.1542/peds.109.2.222; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JC125977; Kong WM, 2004, ENDOCRINOLOGY, V145, P5252, DOI 10.1210/en.2004-0545; Kawamata R, 2014, J PEDIATR ENDOCR MET, V27, P717, DOI 10.1515/jpem-2013-0385; Cheng JP, 2013, J PEDIATR ENDOCR MET, V26, P1029, DOI 10.1515/jpem-2013-0135; Costa-e-Sousa RH, 2011, REGUL PEPTIDES, V171, P43, DOI 10.1016/j.regpep.2011.07.001; Deason CF, 2011, REV DIABET STUD, V8, P293; desZegher F, 1995, ACTA PAEDIATR, V84, P213; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Doong ML, 1997, METABOLISM, V46, P154, DOI 10.1016/S0026-0495(97)90294-8; Franco Bagnoli, 2013, J Clin Res Pediatr Endocrinol, V5 Suppl 1, P2, DOI 10.4274/jcrpe.846; HANUKOGLU A, 1990, HORM METAB RES, V22, P41, DOI 10.1055/s-2007-1004845; Herring MJK, 2003, AM J PERINAT, V20, P333; JONES PM, 1989, ENDOCRINOLOGY, V125, P334; Kahraman H, 1997, EUR J GASTROEN HEPAT, V9, P901; Komiyama M, 2009, EARLY HUM DEV, V85, P267, DOI 10.1016/j.earlhumdev.2008.11.004; LUCAS A, 1982, BIOL NEONATE, V41, P63; Manuchehri AM, 2008, CLIN ENDOCRINOL, V68, P836, DOI 10.1111/j.1365-2265.2007.03093.x; Misra M, 2010, ENDOCR DEV, V17, P197, DOI 10.1159/000262540; Oliveira KJ, 2006, J ENDOCRINOL, V191, P459, DOI 10.1677/joe.1.06784; Osborn DA, 2001, COCHRANE DB SYST REV; Owecki M, 2007, NEUROENDOCRINOL LETT, V28, P417; Paul DA, 1998, PEDIATRICS, V101, P903, DOI 10.1542/peds.101.5.903; Pinsker JE, 2013, PEDIATR NEONATOL, V54, P128, DOI 10.1016/j.pedneo.2012.10.005; Sharman-Koendjbiharie M, 2002, J PEDIATR GASTR NUTR, V35, P674, DOI 10.1097/00005176-200211000-00017; Small CJ, 2004, TRENDS ENDOCRIN MET, V15, P259, DOI 10.1016/j.tem.2004.06.002; Tateishi K, 2002, EXP CLIN ENDOCR DIAB, V110, P361, DOI 10.1055/s-2002-34994; vansWassenaer AG, 1997, PEDIATR RES, V42, P604; Verschueren S, 2014, AM J PHYSIOL-GASTR L, V307, P122; Williams FLR, 2006, EARLY HUM DEV, V82, P797, DOI 10.1016/j.earlhumdev.2006.09.007; Yaylali O, 2009, GASTROENT RES PRACT, DOI 10.1155/2009/529802	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					614	619		10.1111/ped.12556		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500018		
J	Hayasaka, I; Cho, K; Morioka, K; Kaneshi, Y; Akimoto, T; Furuse, Y; Moriichi, A; Iguchi, A; Cho, Y; Minakami, H; Ariga, T				Hayasaka, Itaru; Cho, Kazutoshi; Morioka, Keita; Kaneshi, Yosuke; Akimoto, Takuma; Furuse, Yuta; Moriichi, Akinori; Iguchi, Akihiro; Cho, Yuko; Minakami, Hisanori; Ariga, Tadashi			Exchange transfusion in patients with Down syndrome and severe transient leukemia	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; exchange transfusion; hyperviscosity; transient abnormal myelopoiesis; transient leukemia	ABNORMAL MYELOPOIESIS TAM; TUMOR LYSIS SYNDROME; NATURAL-HISTORY; HYPERLEUKOCYTOSIS; CHILDREN; MANAGEMENT	BackgroundAmong neonates with Down syndrome (DS) and transient leukemia (TL), hyperleukocytosis (white blood cell [WBC] count >100 x 10(9)/L) is associated with increased blood viscosity, respiratory failure due to pulmonary hypertension, multiorgan failure, and increased risk of early death. There have been no previous studies focusing on the effects of exchange transfusion (ExT) on WBC count, respiratory status, and other parameters in TL patients with hyperleukocytosis. MethodsAn observational retrospective study was carried out at a single center of all five DS neonates with TL, GATA1 mutations, and hyperleukocytosis, born at a median gestational age of 34weeks (range, 30-38weeks) with birthweight 2556g (range, 1756-3268g) during a 24month study period between September 2011 and August 2013. All five neonates underwent ExT at a median age of 2days (range, 0-5days) before initiation of other cytoreductive therapy with cytarabine, which was carried out in two patients. ResultsAll patients required respiratory support before ExT. After ExT, respiration status improved in all five patients: WBC count (mean) decreased by 85% from 143 x 10(9)/L to 21 x 10(9)/L. None developed tumor lysis syndrome. Three survived and two died: one hydrops fetalis neonate born at gestational week 30 died at age 5days, and another died eventually from acute gastroenteritis 40days after leaving hospital at the age of 155days with complete remission. Two of the three surviving neonates developed acute megakaryocytic leukemia at age 90days and 222days. ConclusionExT was very effective in improving hyperleukocytosis and may have had favorable effects on respiration.	[Hayasaka, Itaru; Cho, Kazutoshi; Morioka, Keita; Kaneshi, Yosuke; Akimoto, Takuma; Furuse, Yuta; Moriichi, Akinori] Hokkaido Univ Hosp, Matern & Perinatal Care Ctr, Sapporo, Hokkaido 0608648, Japan; [Iguchi, Akihiro; Cho, Yuko; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido, Japan	Cho, K (reprint author), Hokkaido Univ Hosp, Matern & Perinatal Care Ctr, Sapporo, Hokkaido 0608648, Japan.	chotarou@med.hokudai.ac.jp					Abe Y, 2006, PEDIATR INT, V48, P489, DOI 10.1111/j.1442-200X.2006.02242.x; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Chekol SS, 2012, TRANSFUS APHER SCI, V46, P29, DOI 10.1016/j.transci.2011.10.022; Pine SR, 2007, BLOOD, V110, P2128, DOI 10.1182/blood-2007-01-069542; Massey GV, 2006, BLOOD, V107, P4606, DOI 10.1182/blood-2005-06-2448; Klusmann JH, 2008, BLOOD, V111, P2991, DOI 10.1182/blood-2007-10-118810; Ganzel C, 2012, BLOOD REV, V26, P117, DOI 10.1016/j.blre.2012.01.003; Muramatsu H, 2008, BRIT J HAEMATOL, V142, P610, DOI [10.1111/j.1365-2141.2008.07231.x, 10.1111/j.136-2141.2008.07231.x]; BUNIN NJ, 1985, J CLIN ONCOL, V3, P1590; BUNIN NJ, 1987, MED PEDIATR ONCOL, V15, P232, DOI 10.1002/mpo.2950150503; Fischer MJ, 2011, PRINCIPLES PRACTICES, P1125; Gamis AS, 2011, BLOOD, V118, P6752, DOI 10.1182/blood-2011-04-350017; Hoskote A, 2002, INTENS CARE MED, V28, P758, DOI 10.1007/s00134-002-1305-7; Koga H, 2012, J PEDIAT HEMATOL ONC, V34, pE149, DOI 10.1097/MPH.0b013e31822bf608; NAKAGAWA T, 1988, J PEDIATR-US, V112, P58, DOI 10.1016/S0022-3476(88)80122-7; Rizzari C, 1999, MED PEDIATR ONCOL, V32, P453, DOI 10.1002/(SICI)1096-911X(199906)32:6<453::AID-MPO14>3.0.CO;2-X; Rossoff LJ, 1997, CHEST, V112, P551, DOI 10.1378/chest.112.2.551; Roy A, 2012, SEMIN FETAL NEONAT M, V17, P196, DOI 10.1016/j.siny.2012.02.010; Taub JW, 1997, LEUKEMIA, V11, P1594, DOI 10.1038/sj.leu.2400747; WARRIER RP, 1981, J PEDIATR-US, V98, P338, DOI 10.1016/S0022-3476(81)80690-7	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					620	625		10.1111/ped.12586		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500019		
J	Nakagawa, M; Ishida, Y; Nagaoki, Y; Ohta, H; Shimabukuro, R; Hirata, M; Yamanaka, M; Kusakawa, I				Nakagawa, Machiko; Ishida, Yasushi; Nagaoki, Yuko; Ohta, Hidenobu; Shimabukuro, Rinshu; Hirata, Michio; Yamanaka, Michiko; Kusakawa, Isao			Correlation between umbilical cord hemoglobin and rate of jaundice requiring phototherapy in healthy newborns	PEDIATRICS INTERNATIONAL			English	Article						delayed umbilical cord clamping; neonatal jaundice; newborn; phototherapy		BackgroundDelay of umbilical cord clamping by at least 1min is recommended for newborns not requiring resuscitation in the International Liaison Committee On Resuscitation-Consensus on Science with Treatment Recommendations (ILCOR-CoSTR) 2010 guidelines. The delay in clamping improves iron status through early infancy but may increase the likelihood of jaundice requiring phototherapy. The present study investigated the relationship between umbilical cord hemoglobin and the rate of jaundice requiring phototherapy in healthy Japanese newborns. MethodsCord hemoglobin was measured in healthy newborns and the rate of infants receiving phototherapy for jaundice and other data were obtained from medical records. ResultsJaundice requiring phototherapy mostly occurred in association with high cord blood hemoglobin, which is increased by delayed cord clamping. ConclusionsHigher cord hemoglobin may increase neonatal jaundice in newborns in Japan, therefore the present results support the Japan Resuscitation Council guideline 2010, which does not recommend delay of umbilical cord clamping by at least 1min, in contrast to the ILCOR guidelines.	[Nakagawa, Machiko; Ishida, Yasushi; Nagaoki, Yuko; Shimabukuro, Rinshu; Hirata, Michio; Kusakawa, Isao] St Lukes Int Hosp, Dept Pediat, Tokyo 1048560, Japan; [Yamanaka, Michiko] St Lukes Int Hosp, Dept Integrated Womens Hlth, Tokyo 1048560, Japan; [Ohta, Hidenobu] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Tokyo, Japan	Kusakawa, I (reprint author), St Lukes Int Hosp, Dept Pediat, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	isaokusa@luke.ac.jp					YAO AC, 1974, AM J DIS CHILD, V127, P128; Gartner L M, 2001, J Perinatol, V21 Suppl 1, pS25, DOI 10.1038/sj.jp.7210629; Itoh S, 1978, SHUSANKI IGAKU, V8, P974; Kaplan M, 2011, NEONATAL PERINATAL M, P1443; Murata F, 1981, SHUSANKI IGAKU, V11, P2059; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					626	628		10.1111/ped.12583		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500020		
J	Wada, M; Tamura, M				Wada, Masaki; Tamura, Masanori			Training of neonatal cardiopulmonary resuscitation instructors	PEDIATRICS INTERNATIONAL			English	Article						instruction; medical education; neonatal cardiopulmonary resuscitation; resuscitation; simulation	AIRWAY MANAGEMENT; SIMULATION; SKILLS	BackgroundThe Consensus on Science and Treatment Recommendations 2010 supported simulation-based training for education in resuscitation. This approach has been introduced into neonatal cardiopulmonary resuscitation (NCPR) courses in Japan, but no method for teaching instructors has been established. We developed a course for training instructors of NCPR, with inclusion of an instruction practice program. The goal of the study was to evaluate the performance of instructors who completed the course. MethodsBased on problems in the conventional instructor training course (old course 1), we developed and implemented a new course. Persons who had completed an NCPR course took the new course after developing two resuscitation scenarios. The new course included lectures and instruction practice, in which participants provided instruction using these scenarios. Instruction by participants was evaluated, and knowledge, opinions and satisfaction were examined by questionnaire after the course. Activity of the participants as instructors for 6months after certification was also evaluated. The performance of trained instructors was compared between the old and new courses. ResultsOf 143 participants in the new course, >90% had confidence to teach NCPR, while only 50-60% of the 89 participants in the old course indicated that they could instruct on resuscitation procedures and practice (P<0.001). All participants in the new course recognized the value of scenario practice and all were glad they had taken the course. For 6months after certification, significantly more participants who had done the new course worked as instructors compared with those who had done the old course (60% vs 34%, P<0.001). ConclusionThis is the first trial of a resuscitation training course using scenarios that participants developed themselves. A new course including instruction practice for training NCPR instructors was effective for improving instructor performance.	[Wada, Masaki] Niigata Univ, Dept Neonatol, Uonuma Inst Community Med, Med & Dent Hosp, Niigata, Niigata 9518520, Japan; [Tamura, Masanori] Saitama Med Univ, Dept Neonatol, Saitama Med Ctr, Saitama, Japan	Wada, M (reprint author), Niigata Univ, Dept Neonatol, Uonuma Inst Community Med, Med & Dent Hosp,Chyuou Ku, 1-754 Asahimachi Dori, Niigata, Niigata 9518520, Japan.	nicuwada@med.niigata-u.ac.jp					Savoldelli GL, 2006, ANESTHESIOLOGY, V105, P279, DOI 10.1097/00000542-200608000-00010; Knudson MM, 2008, J TRAUMA, V64, P255, DOI 10.1097/TA.0b013e31816275b0; Kory PD, 2007, CHEST, V132, P1927, DOI 10.1378/chest.07-1554; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; Mayo PH, 2004, CRIT CARE MED, V32, P2422, DOI 10.1097/01.CCM.0000147768.42813.A2; Fanning Ruth M, 2007, Simul Healthc, V2, P115, DOI 10.1097/SIH.0b013e3180315539; Kattwinkel J, 2011, NRP TXB, V6th; Kirkpatrick D, 2006, EVALUATING TRAINING, P16; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Tamura M, 2013, TRAINING NEONATAL CA; Tamura M, 2011, TXB NEONATAL CARDIOP	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					629	632		10.1111/ped.12683		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500021		
J	Hayakawa, M; Taguchi, T; Urushihara, N; Yokoi, A; Take, H; Shiraishi, J; Fujinaga, H; Ohashi, K; Oshiro, M; Kato, Y; Ohfuji, S; Okuyama, H				Hayakawa, Masahiro; Taguchi, Tomoaki; Urushihara, Naoto; Yokoi, Akiko; Take, Hiroshi; Shiraishi, Jun; Fujinaga, Hideshi; Ohashi, Kensuke; Oshiro, Makoto; Kato, Yuichi; Ohfuji, Satoko; Okuyama, Hiroomi			Outcome in VLBW infants with surgical intestinal disorder at 18months of corrected age	PEDIATRICS INTERNATIONAL			English	Article						focal intestinal perforation; meconium-related ileus; necrotizing enterocolitis; outcome; very low birth weight infants	BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; NEURODEVELOPMENTAL OUTCOMES; PROSPECTIVE COHORT; PERFORATION; MORTALITY; MANAGEMENT; NETWORK; GROWTH; BRAIN	BackgroundSurgical intestinal disorders, such as necrotizing enterocolitis (NEC), focal intestinal perforation (FIP), and meconium-related ileus (MRI), are serious morbidities in very low-birthweight infants (VLBWI). The aim of this study was to compare the composite outcomes of death or neurodevelopmental impairment (NDI) in VLBWI with surgical intestinal disorders and assess independent risk factors for death and NDI at 18months of corrected age. MethodsA retrospective matched-cohort study was conducted at 11 institutes. We included VLBWI who had undergone laparotomy for NEC, FIP, and MRI. Two control subjects were chosen for every surgical patient and matched for gestational age and birthweight to form the comparison group. Death and neurodevelopmental outcome at 18months of corrected age were evaluated. ResultsThe number of infants in the NEC, FIP, MRI, and control groups was 44, 47, 42, and 261, respectively. In-hospital mortality was higher in infants with NEC and MRI relative to those in the control group (P < 0.001). The incidence rate for NDI at 18months of corrected age was higher in infants with MRI relative to those in the control group (P = 0.021). On logistic regression analysis, low gestational age, male sex, small for gestational age, intraventricular hemorrhage, and MRI were associated with increased risk of death or NDI at 18months of corrected age. ConclusionsNEC and MRI were associated with in-hospital mortality, and MRI was associated with NDI or death at 18months of corrected age.	[Hayakawa, Masahiro] Nagoya Univ Hosp, Div Neonatol, Ctr Maternal Neonatal Care, Nagoya, Aichi 4668560, Japan; [Oshiro, Makoto] Japanese Red Cross Nagoya First Hosp, Dept Neonatol, Nagoya, Aichi, Japan; [Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Grad Sch Med Sci, Fukuoka 812, Japan; [Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan; [Yokoi, Akiko] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Surg, Kobe, Hyogo, Japan; [Take, Hiroshi] Kanagawa Childrens Med Ctr, Dept Surg, Yokohama, Kanagawa, Japan; [Shiraishi, Jun] Osaka Med Ctr, Dept Neonatol, Tokyo, Japan; [Shiraishi, Jun] Res Inst Maternal & Child Hlth, Tokyo, Japan; [Take, Hiroshi] Natl Ctr Child Hlth & Dev, Div Neonatol, Ctr Maternal Fetal & Neonatal Med, Tokyo, Japan; [Ohashi, Kensuke] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Kato, Yuichi] Anjo Kosei Hosp, Dept Pediat, Anjo, Japan; [Ohfuji, Satoko] Osaka City Univ, Dept Publ Hlth, Fac Med, Osaka 558, Japan; [Okuyama, Hiroomi] Osaka Univ, Dept Pediat Surg, Grad Sch Med, Suita, Osaka, Japan; [Okuyama, Hiroomi] Hyogo Coll Med, Dept Pediat Surg, Nishinomiya, Hyogo 6638501, Japan	Hayakawa, M (reprint author), Nagoya Univ Hosp, Div Neonatol, Ctr Maternal Neonatal Care, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	masahaya@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare in Japan	This work was supported by a grant from the Ministry of Health, Labour and Welfare in Japan (Health and Labour Sciences Research Grants for Research on Intractable Diseases). The authors gratefully acknowledge the contributions of all pediatric surgery and/or tertiary perinatal care centers that assisted with the data collection for this study. The authors have no conflicts of interest to declare.	Adesanya Olubukunola A, 2005, J Perinatol, V25, P583, DOI 10.1038/sj.jp.7211360; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Kubota A, 2011, PEDIATR INT, V53, P887, DOI 10.1111/j.1442-200X.2011.03381.x; Shah TA, 2012, J PERINATOL, V32, P552, DOI 10.1038/jp.2011.176; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Cuenca AG, 2012, J SURG RES, V175, pE43, DOI 10.1016/j.jss.2012.01.029; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; Attridge JT, 2006, J PERINATOL, V26, P49, DOI 10.1038/sj.jp.7211407; Blakely ML, 2005, ANN SURG, V241, P89; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Fisher JG, 2014, J PEDIATR SURG, V49, P1215, DOI 10.1016/j.jpedsurg.2013.11.051; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Hayakawa M, 2003, PEDIATRICS, V111, P991, DOI 10.1542/peds.111.5.991; Hull MA, 2014, J AM COLL SURGEONS, V218, P1148, DOI 10.1016/j.jamcollsurg.2013.11.015; Itabashi K, 2014, PEDIATR INT, V56, P702, DOI 10.1111/ped.12331; Merhar SL, 2014, J PEDIATR-US, V164, P410, DOI 10.1016/j.jpeds.2013.09.055; MEYER CL, 1991, J PEDIATR SURG, V26, P714, DOI 10.1016/0022-3468(91)90017-N; Nowicki Philip T, 2005, Semin Pediatr Surg, V14, P152, DOI 10.1053/j.sempedsurg.2005.05.003; Okumura A, 2010, BRAIN DEV-JPN, V32, P613, DOI 10.1016/j.braindev.2009.09.011; Pumberger W, 2002, J AM COLL SURGEONS, V195, P796, DOI 10.1016/S1072-7515(02)01344-3; Roze E, 2011, PEDIATR RES, V70, P619, DOI 10.1203/PDR.0b013e31823279b1; Valcamonico A, 2007, J MATERN-FETAL NEO M, V20, P465, DOI 10.1080/14767050701398413; Wadhawan R, 2014, J PERINATOL, V34, P64, DOI 10.1038/jp.2013.128	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					633	638		10.1111/ped.12594		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500022		
J	Mizuno, K; Sakurai, M; Itabashi, K				Mizuno, Katsumi; Sakurai, Motoichiro; Itabashi, Kazuo			Necessity of human milk banking in Japan: Questionnaire survey of neonatologists	PEDIATRICS INTERNATIONAL			English	Article						donor human milk; human milk bank; other mother's milk; own mother's milk	BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; PRETERM INFANTS; OUTCOMES	BackgroundIf their own mother's milk (OMM) is not available, another mother's milk may be used for extremely low-birthweight (ELBW) infants. Human milk is a bodily fluid, however, therefore we have assumed that other mother's milk is currently seldom given to infants despite its superiority to formula. Although the World Health Organization and the American Academy of Pediatrics have recommended using donor human milk (DHM) from a human milk bank (HMB) in the case that OMM is not available, there is no HMB in Japan. To assess whether other mother's milk is used for ELBW infants and whether an HMB is necessary in Japan, we surveyed neonatal intensive care units (NICU) via questionnaire. MethodsThe questionnaire was sent by email to members of the Japanese Neonatologist Association who are responsible for NICU. ResultsIn total, 126 completed questionnaires (70.7%) were returned and analyzed. One-fourth of NICU give other mother's milk to ELBW infants. The first choice of nutrition is OMM, but other mother's milk or formula is given to infants at 19% of NICU if OMM is unavailable. Approximately three-fourths of NICU would like an HMB. ConclusionAlthough human milk contains contagious agents and authorities do not recommend giving other mother's milk as a substitute for OMM, other mother's milk is still a choice in NICU in Japan. Many neonatologists, however, would prefer a safer alternative, that is, DHM obtained from an accredited HMB. A well-regulated HMB should be established and safe DHM should be available for all preterm infants if necessary.	[Mizuno, Katsumi; Sakurai, Motoichiro] Showa Univ, Dept Pediat, Koto Toyosu Hosp, Tokyo 1358577, Japan; [Itabashi, Kazuo] Showa Univ Med, Dept Pediat, Tokyo, Japan	Mizuno, K (reprint author), Showa Univ, Dept Pediat, Koto Toyosu Hosp, Koto Ku, 5-1-38 Toyosu, Tokyo 1358577, Japan.	katsuorobi@aol.com			Ministry of Health, Labour and Welfare of Japan	This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (Health and Labour Sciences Research Grant for Research on Prevention of HTLV-1 Maternal-Infant Transmission). The authors gratefully acknowledge the contributions of the Japanese Neonatologist Association. The authors declare no conflicts of interest.	American Academy of Pediatrics, 2012, PEDIATRICS, V129, pe829; Hsiao CC, 2014, NUTR REV, V72, P532, DOI 10.1111/nure.12110; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Klingenberg C, 2012, ARCH DIS CHILD-FETAL, V97, pF56, DOI 10.1136/adc.2010.204123; Butler TJ, 2013, J PERINATOL, V33, P851, DOI 10.1038/jp.2013.66; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; Simmer K, 2009, EARLY HUM DEV, V85, P701, DOI 10.1016/j.earlhumdev.2009.08.054; Hamilton E, 2014, EARLY HUM DEV, V90, P227, DOI 10.1016/j.earlhumdev.2014.02.005; ESPGHAN Committee on Nutrition, 2013, J PEDIAT GASTROENTER, V57, P535; Hay W.W., 2013, CURRENT PEDIAT REPOR, V1, P229; Kansagra K, 2003, AM J PHYSIOL-GASTR L, V285, pG1162, DOI 10.1152/ajpgi.00243.2003; Quigley M, 2014, COCHRANE DB SYST REV, V22, P4; Shim SY, 2014, PEDIATR INT, V56, P845, DOI 10.1111/ped.12361; World Health Organization, DON HUM MILK LOW BIR	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					639	644		10.1111/ped.12606		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500023		
J	Katayama, Y; Yokota, T; Zhao, H; Wong, RJ; Stevenson, DK; Taniguchi-Ikeda, M; Nakamura, H; Iijima, K; Morioka, I				Katayama, Yoshinori; Yokota, Tomoyuki; Zhao, Hui; Wong, Ronald J.; Stevenson, David K.; Taniguchi-Ikeda, Mariko; Nakamura, Hajime; Iijima, Kazumoto; Morioka, Ichiro			Association of HMOX1 gene promoter polymorphisms with hyperbilirubinemia in the early neonatal period	PEDIATRICS INTERNATIONAL			English	Article						genetic polymorphism; heme oxygenase-1; neonatal hyperbilirubinemia	HEME OXYGENASE-1 GENE; CORONARY-ARTERY-DISEASE; MICROSATELLITE POLYMORPHISM; JAPANESE POPULATION; DIABETIC-PATIENTS; BILIRUBIN; SUSCEPTIBILITY; VARIANTS; RISK; JAUNDICE	BackgroundHeme oxygenase (HO) is the rate-limiting enzyme in the heme degradation pathway that produces bilirubin. The promoter region of human heme oxygenase-1 (HMOX1) contains a polymorphic (GT)(n) repeat that can regulate gene expression. Here, we investigated the association of (GT)(n) repeat length in the HMOX1 promoter region with neonatal hyperbilirubinemia in a population of Japanese term neonates. MethodsUsing polymerase chain reaction and fragment analysis, we determined the number of (GT)(n) repeats in 149 Japanese neonates. To omit the effects of the G71R mutation in uridine diphosphoglucuronosyltransferase on hyperbilirubinemia, we excluded 41 neonates with the G71R mutation. As a result, 25 neonates with hyperbilirubinemia and 83 non-hyperbilirubinemic controls were included in this prospective case-control study. Allele and genotype frequencies of (GT)(n) repeats in the HMOX1 gene were compared between hyperbilirubinemic and non-hyperbilirubinemic control neonates. ResultsThe prevalence of short alleles (<22 (GT)(n) repeats) was significantly higher in hyperbilirubinemic than in control neonates (18% vs 7%, P = 0.015). Hyperbilirubinemia was more frequent in homozygous or heterozygous short allele carriers than control neonates (28% vs 11%, respectively, P = 0.03). Possession of short alleles was significantly associated with the development of neonatal hyperbilirubinemia (OR, 3.1; 95%CI: 1.03-9.53). ConclusionsInfants carrying short alleles (<22 (GT)(n) repeats) in the HMOX1 gene promoter region appear to be at a higher risk for developing neonatal hyperbilirubinemia.	[Katayama, Yoshinori; Yokota, Tomoyuki; Taniguchi-Ikeda, Mariko; Nakamura, Hajime; Iijima, Kazumoto; Morioka, Ichiro] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Katayama, Yoshinori] Takatsuki Gen Hosp, Dept Pediat, Takatsuki, Osaka, Japan; [Zhao, Hui; Wong, Ronald J.; Stevenson, David K.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA	Morioka, I (reprint author), Kobe Univ, Grad Sch Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp			JSPS KAKENHI [26461632, 26461633]; Christopher Hess Research Fund; Mary L. Johnson Research Fund; H.M. Lui Research Fund; Aijinkai Healthcare Corporation	This work was supported by Grants-in-Aid for Scientific Research (C) of JSPS KAKENHI (grant numbers 26461632 and 26461633), the Christopher Hess Research Fund, the Mary L. Johnson Research Fund, the H.M. Lui Research Fund, and the Aijinkai Healthcare Corporation. The authors would like to thank Flora Kalish and Xue Jun Fu for their invaluable technical support in this study. All authors have no conflicts of interest to declare.	Rueda B, 2007, ARTHRITIS RHEUM, V56, P3953, DOI 10.1002/art.23048; Huang CS, 2002, PEDIATR RES, V52, P601, DOI 10.1203/01.PDR.0000028058.44773.24; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; FUNATO M, 1994, PEDIATRICS, V93, P50; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Watchko JF, 2010, SEMIN FETAL NEONAT M, V15, P169, DOI 10.1016/j.siny.2009.11.003; Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Yasuda S, 2003, J PERINAT MED, V31, P81, DOI 10.1515/JPM.2003.012; Hasegawa Y, 2004, CLIN CHEM, V50, P1479, DOI 10.1373/clinchem.2004.034694; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Maruo Y, 1999, PEDIATRICS, V103, P1224, DOI 10.1542/peds.103.6.1224; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Tiwari PK, 2013, EUR J PEDIATR, V172, P1627, DOI 10.1007/s00431-013-2091-7; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Gerbitz A, 2008, BIOL BLOOD MARROW TR, V14, P1180, DOI 10.1016/j.bbmt.2008.08.002; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Kanai M, 2003, PEDIATR RES, V54, P165, DOI 10.1203/01.PDR.0000072329.56635.35; Kaplan M, 2014, NEONATOLOGY, V106, P323, DOI 10.1159/000365744; Lublinghoff N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-36; Miwa A, 2012, CLIN LAB, V58, P507; Nakamura Hajime, 1992, Acta Paediatrica Japonica, V34, P642; SHIMABUKU R, 1982, Kobe Journal of Medical Sciences, V28, P91; Stevenson DK, 2011, SEMIN PERINATOL, V35, P121, DOI 10.1053/j.semperi.2011.02.005; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Yasuda H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035824; Zhou YY, 2009, NEONATOLOGY, V96, P150, DOI 10.1159/000209851	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					645	649		10.1111/ped.12591		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500024		
J	Kawasaki, Y; Ohara, S; Miyazaki, K; Kanno, S; Ono, A; Suyama, K; Sato, M; Suzuki, S; Maeda, R; Nagasawa, K; Hosoya, M				Kawasaki, Yukihiko; Ohara, Shinichiro; Miyazaki, Kyohei; Kanno, Shuto; Ono, Atsushi; Suyama, Kazuhide; Sato, Masatoki; Suzuki, Shigeo; Maeda, Ryo; Nagasawa, Katsutoshi; Hosoya, Mitsuaki			Incidence and prognosis of systemic lupus erythematosus in a 35year period in Fukushima, Japan	PEDIATRICS INTERNATIONAL			English	Article						Bredinin; clinical manifestation; epidemiology; methylprednisolone; systemic lupus erythematosus	CLINICAL-FEATURES; ADULT-ONSET; CHILDHOOD; CHILDREN; NEPHRITIS; MORTALITY; THERAPY; DISEASE; GLOMERULONEPHRITIS; EPIDEMIOLOGY	BackgroundWe examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35year period. MethodsWe collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were divided into two groups. group 1 consisted of 19 patients who were diagnosed between 1977 and 1995, and group 2 consisted of 18 patients diagnosed between 1996 and 2013. The epidemiology, clinical features, and prognosis were retrospectively compared between the two groups. ResultsThe mean number of patients per 100000 children per year for group 1 and group 2 was 0.330.25 and 0.35 +/- 0.30, respectively. The duration from onset of symptoms to treatment in group 2 was shorter than that in group 1, but the clinical and laboratory findings at onset did not differ between the two groups. All patients were treated with prednisolone, and 17 patients in group 1 and 18 in group 2 were treated with methylprednisolone pulse therapy. The frequency of cyclophosphamide treatment decreased whereas the frequency of cyclosporine, tacrolimus and mizoribine pulse therapy increased in group 2. SLE disease activity index (SLEDAI) score at the latest follow up in group 2 was lower in group 1. The survival rate was 84% in group 1 and 100% in group 2. ConclusionThe frequency and severity of SLE in group 1 were similar to those in group 2, and the prognosis of SLE in group 2 was better than that in group 1.	[Kawasaki, Yukihiko; Ohara, Shinichiro; Miyazaki, Kyohei; Kanno, Shuto; Ono, Atsushi; Suyama, Kazuhide; Hosoya, Mitsuaki] Fukushima Med Univ, Sch Med, Dept Pediat, Fukushima, Fukushima 9601295, Japan; [Sato, Masatoki] Some Gen Hosp, Dept Pediat, Fukushima, Japan; [Suzuki, Shigeo] Ohara Gen Hosp, Dept Pediat, Fukushima, Japan; [Maeda, Ryo] Hoshi Gen Hosp, Dept Pediat, Fukushima, Japan; [Nagasawa, Katsutoshi] Takeda Gen Hosp, Dept Pediat, Fukushima, Japan	Kawasaki, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Pediat, 1 Hikariga Oka, Fukushima, Fukushima 9601295, Japan.	kyuki@fmu.ac.jp					Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; Houghton KM, 2006, J RHEUMATOL, V33, P161; Carreno L, 1999, LUPUS, V8, P287, DOI 10.1191/096120399678847786; Merrill JT, 2011, LUPUS, V20, P709, DOI 10.1177/0961203310395802; Duxbury B, 2013, LUPUS, V22, P1489, DOI 10.1177/0961203313509295; TUCKER LB, 1995, BRIT J RHEUMATOL, V34, P866; Takei S, 1997, ACTA PAEDIATR JAPON, V39, P250; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; SAMANTA A, 1991, ANN RHEUM DIS, V50, P490, DOI 10.1136/ard.50.7.490; Osio-Salido E, 2010, LUPUS, V19, P1365, DOI 10.1177/0961203310374305; Doria A, 2006, AM J MED, V119, P700, DOI 10.1016/j.amjmed.2005.11.034; Kawasaki Y, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/681482; BOUMPAS DT, 1995, ANN INTERN MED, V122, P940; Bader-Meunier B, 2005, J PEDIATR-US, V146, P648, DOI 10.1016/j.peds.12.045; Bogdanovic R, 2004, PEDIATR NEPHROL, V19, P36, DOI 10.1007/s00467-003-1278-y; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Emancipator SN, 1998, HEPTINSTALLS PATHOLO, V5th, P541; Fujikawa S, 1997, ACTA PAEDIATR JAPON, V39, P242; Gonzalez B, 2005, LUPUS, V14, P918, DOI 10.1191/0961203303lu2183xx; HOPKINSON N, 1992, ANN RHEUM DIS, V51, P1292, DOI 10.1136/ard.51.12.1292; Kawasaki Y, 2008, PEDIATR INT, V50, P257, DOI 10.1111/j.1442-200X.2008.02548.x; Kone-Paut I, 2007, LUPUS, V16, P606, DOI 10.1177/0961203307079562; Ortmann RA, 2000, RHEUM DIS CLIN N AM, V26, P363, DOI 10.1016/S0889-857X(05)70143-5; HOGG RJ, 1985, KIDNEY INT, V27, P450; Tanaka H, 2008, CLIN RHEUMATOL, V27, P85, DOI 10.1007/s10067-007-0635-9; Tanaka Hiroshi, 2012, World J Nephrol, V1, P177, DOI 10.5527/wjn.v1.i6.177; Tanaka H, 2006, PEDIATR NEPHROL, V21, P962, DOI 10.1007/s00467-006-0120-8; YANG LY, 1994, PEDIATRICS, V94, P335	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					650	655		10.1111/ped.12588		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500025		
J	Ohtomo, Y; Umino, D; Takada, M; Fujinaga, S; Niijima, S; Shimizu, T				Ohtomo, Yoshiyuki; Umino, Daisuke; Takada, Masaru; Fujinaga, Shuichiro; Niijima, Shinichi; Shimizu, Toshiaki			Gradual tapering of desmopressin leads to better outcome in nocturnal enuresis	PEDIATRICS INTERNATIONAL			English	Article						nocternal enuresis; desmopressin	MONOSYMPTOMATIC ENURESIS; WITHDRAWAL; CHILDREN	BackgroundAlthough desmopressin therapy is effective in treating polyuric monosymptomatic nocturnal enuresis (MNE), the relatively high rates of recurrence are problematic. To date, the treatment protocol on the discontinuation of oral desmopressin melt (ODM) tablet, MinirinMelt, has not been established. We tested two protocols of tapering ODM when the patients achieved full response on ODM, and compared the treatment outcomes. MethodsOne hundred and fifty-seven polyuric MNE children were newly treated with ODM at the authors' outpatient clinics (Juntendo Nerima Hospital and Musashi-Murayama Hospital). When the patients did not respond to the 8 week ODM therapy, we added another options such as alarm, anti-cholinergics, and imipramine (92 patients; 58.6%). Sixty-five patients (41.4%) achieved full response on ODM alone, and 49 of them accepted gradual tapering of ODM: group B (n = 25), 240g ODM per day 120g ODM per day 120g ODM per alternate day cessation; and group C (n = 24), 240g ODM per day 120g ODM per day 60g ODM per day 60g ODM per alternate day cessation. ResultsFourteen patients in group B (56%) and four in group C (17%) had relapses of enuresis after the discontinuation of ODM (P = 0.026). ConclusionsGradual tapering of ODM therapy in MNE patients leads to better outcome.	[Ohtomo, Yoshiyuki; Umino, Daisuke; Niijima, Shinichi] Juntendo Univ, Nerima Hosp, Dept Pediat, Tokyo 1770033, Japan; [Takada, Masaru] Musashimurayama Hosp, Dept Pediat, Tokyo, Japan; [Shimizu, Toshiaki] Juntendo Univ, Dept Pediat & Adolescence, Tokyo 1770033, Japan; [Fujinaga, Shuichiro] Saitama Childrens Med Ctr, Div Nephrol, Saitama, Japan	Ohtomo, Y (reprint author), Juntendo Univ, Nerima Hosp, Dept Pediat, 3-1-10 Takanodai, Tokyo 1770033, Japan.	ohtomo_dr@hotmail.com					Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Ferrara P, 2014, J PEDIATR UROL, V10, P52, DOI 10.1016/j.jpurol.2013.05.021; Neveus T, 2010, J UROLOGY, V183, P441, DOI 10.1016/j.juro.2009.10.043; Arnold T, 2004, J UROLOGY, V171, P2545; Gokce MI, 2014, J UROLOGY, V192, P530, DOI 10.1016/j.juro.2014.01.094; Hjälmås K, 1988, Scand J Urol Nephrol Suppl, V114, P20; Marschall-Kehrel D, 2009, J UROLOGY, V182, P2022, DOI 10.1016/j.juro.2009.03.068; Ohtomo Y, 2013, PEDIATR INT, V55, P737, DOI 10.1111/ped.12158; Walle JV, 2012, EUR J PEDIATR, V171, P971; WILLE S, 1986, ARCH DIS CHILD, V61, P30	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					656	658		10.1111/ped.12614		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500026		
J	Fujita, K; Nagase, H; Nakagawa, T; Saji, Y; Maruyama, A; Uetani, Y				Fujita, Kyoko; Nagase, Hiroaki; Nakagawa, Taku; Saji, Yohsuke; Maruyama, Azusa; Uetani, Yoshiyuki			Non-convulsive seizures in children with infection-related altered mental status	PEDIATRICS INTERNATIONAL			English	Article						confusion; influenza A virus; H1N1 subtype; intensive care; pediatrics; seizure	INTENSIVE-CARE-UNIT; CRITICALLY-ILL CHILDREN; STATUS EPILEPTICUS; EEG; PREDICTORS; MORTALITY	BackgroundIn the intensive care unit, the use of continuous electroencephalography (cEEG) in children with altered mental status often results in the detection of non-convulsive seizures (NCS). Children with influenza can occasionally display altered mental status, but the prevalence of NCS in children with influenza with altered mental status is yet to be determined. This study determined the prevalence of NCS in pediatric patients with altered mental status associated with influenza A(H1N1)pdm09 infection. MethodsWe retrospectively reviewed admissions to the pediatric intensive care unit between September 2009 and February 2010 and confirmed the presence of NCS on cEEG in children with influenza A(H1N1)pdm09 and with altered mental status. ResultsOf the 15 patients (aged 41-159 months old), NCS was identified on cEEG in five children (33%). ConclusionsApproximately one-third of the children infected with influenza A(H1N1)pdm09 with altered mental status had NCS. Further research is needed to determine if the detection and management of NCS improve outcome in these children.	[Fujita, Kyoko; Nagase, Hiroaki; Maruyama, Azusa] Hyogo Prefectural Kobe Childrens Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Nakagawa, Taku; Uetani, Yoshiyuki] Hyogo Prefectural Kobe Childrens Hosp, Dept Gen Med, Kobe, Hyogo, Japan; [Saji, Yohsuke] Hyogo Prefectural Kobe Childrens Hosp, Dept Emergency & Crit Care Med, Kobe, Hyogo, Japan	Nagase, H (reprint author), Kobe Childrens Hosp, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	nagasehiroaki@msn.com					Acute encephalitis and encephalopathy associated with influenza research division of the Health and Welfare Ministry, 2009, GUID AC ENC ASS INFL; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; RABINOWICZ AL, 1995, EPILEPSIA, V36, P475, DOI 10.1111/j.1528-1157.1995.tb00489.x; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Claassen J, 2001, NEUROLOGY, V57, P1036; Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Shneker BF, 2003, NEUROLOGY, V61, P1066; Young GB, 1996, NEUROLOGY, V47, P83; Brenner RP, 2002, EPILEPSIA, V43, P103, DOI 10.1046/j.1528-1157.43.s.3.9.x; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; DOOSE H, 1988, BRAIN DEV-JPN, V10, P347; Herman S T, 2009, NONCONVULSIVE STATUS, P41; Maruyama Azusa, 2010, No To Hattatsu, V42, P23; Mirski M, 2009, NEUROCRIT CARE, P185, DOI 10.1017/CBO9780511635434.016; Nagase H, 2013, PEDIATR INT, V55, P310, DOI 10.1111/ped.12046; Walker M, 2009, NONCONVULSIVE STATUS, P263; Yamamoto N, 1996, EPILEPSIA, V37, P31, DOI 10.1111/j.1528-1157.1996.tb00508.x	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					659	664		10.1111/ped.12566		6	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500027		
J	Mizorogi, S; Kanemura, H; Sano, F; Sugita, K; Aihara, M				Mizorogi, Sonoko; Kanemura, Hideaki; Sano, Fumikazu; Sugita, Kanji; Aihara, Masao			Risk factors for seizure recurrence in children after first unprovoked seizure	PEDIATRICS INTERNATIONAL			English	Article						first unprovoked seizure; focal discharge; partial seizure; seizure recurrence; time to recurrence	EXTENDED FOLLOW-UP; FEBRILE SEIZURE; EPILEPSY; CHILDHOOD; COHORT; TIME	BackgroundThe question of whether to treat a patient after a first unprovoked seizure is controversial. This prospective study assessed the time to recurrence and risk factors for seizure recurrence after a first unprovoked seizure in children. MethodsParticipants were recruited between 1 July 1997, and 30 June 2009. Eligible candidates were children between 1 month and 15 years old who presented with their first unprovoked afebrile seizure. After enrollment, recurrence of seizures was investigated. All participants were followed for at least 2 years. Log-rank test was used for bivariate analysis to check associations, and hazard ratios were used to analyze variables and clinical outcome (recurrence) during follow-up. ResultsOf 73 subjects, 42 (57.5%) experienced recurrence. The overall product-limit estimate of recurrence was 61.9% at 6 months, 85.7% at 1 year, and 95.2% at 2 years after seizure onset, respectively. Incidence of recurrence with partial and generalized seizures was 69.0% and 31.0%, respectively. Children with partial seizures had recurrence significantly more often than those with generalized seizures (P < 0.001). Recurrent seizures occurred after normal findings on electroencephalogram (EEG) in 21.4%, after generalized spike-and-wave complexes in 16.7%, and after focal epileptic discharge in 61.9%. Children with focal epileptic discharge had recurrence significantly more often than children with normal EEG findings (P < 0.001). ConclusionThe time to seizure recurrence after first unprovoked seizure may be within 1 year, and particularly within 6 months; and partial seizure and abnormal EEG with focal epileptic discharge may be risk factors for seizure recurrence.	[Mizorogi, Sonoko; Kanemura, Hideaki; Sano, Fumikazu; Sugita, Kanji] Univ Yamanashi, Fac Med, Dept Pediat, Yamanashi 4093898, Japan; [Aihara, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan	Kanemura, H (reprint author), Univ Yamanashi, Fac Med, Dept Pediat, Chuo Ku, Yamanashi 4093898, Japan.	ykimu@yamanashi.ac.jp			 [22591124];  [22591123]	This work was supported by Grants-in-Aid for Scientific Research (C) (22591124 and 22591123).	ANNEGERS JF, 1986, EPILEPSIA, V27, P43, DOI 10.1111/j.1528-1157.1986.tb03499.x; Lizana JR, 2000, EPILEPSIA, V41, P1005, DOI 10.1111/j.1528-1157.2000.tb00286.x; CAMFIELD PR, 1985, NEUROLOGY, V35, P1657; SHINNAR S, 1994, EPILEPSIA, V35, P471, DOI 10.1111/j.1528-1157.1994.tb02464.x; Shinnar S, 2000, ANN NEUROL, V48, P140, DOI 10.1002/1531-8249(200008)48:2<140::AID-ANA2>3.0.CO;2-Y; Kanemura H, 2012, BRAIN DEV-JPN, V34, P302, DOI 10.1016/j.braindev.2011.07.007; Shinnar S, 1996, PEDIATRICS, V98, P216; Hirtz D, 2000, NEUROLOGY, V55, P616; Sapir D, 2000, BRAIN DEV-JPN, V22, P484, DOI 10.1016/S0387-7604(00)00187-X; BERG AT, 1991, NEUROLOGY, V41, P965; Berg AT, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01444.x; HAUSER WA, 1990, NEUROLOGY, V40, P1163; Winckler MIB, 2004, PEDIATR NEUROL, V30, P201, DOI 10.1016/j.pediatrneurol.2003.08.002; Shinnar S, 1999, EPILEPSIA, V40, P1378, DOI 10.1111/j.1528-1157.1999.tb02008.x; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Commission on Epidemiology and Prognosis of the International League Against Epilepsy, 1993, EPILEPSIA, V34, P592; ELWES RDC, 1988, ARCH NEUROL-CHICAGO, V45, P490; MUSICCO M, 1993, NEUROLOGY, V43, P478; HART RG, 1986, ARCH NEUROL-CHICAGO, V43, P1289; Haut SR, 2007, 1 UNPROVOKED SEIZURE, P37; HOPKINS A, 1988, LANCET, V1, P721; Kanemura H, 2012, PEDIATR INT, V54, P520, DOI 10.1111/j.1442-200X.2012.03599.x; Karasalihoglu S, 2003, PEDIATR INT, V45, P429, DOI 10.1046/j.1442-200X.2003.01758.x; Petersen I, 1968, CLIN ELECTROENCEPHAL, P167; Wiebe S, 2002, CAN J NEUROL SCI, V29, P120	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					665	669		10.1111/ped.12600		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500028		
J	Shimakawa, S; Tanabe, T; Ono, M; Nonaka, M; Nambu, M; Shinohara, T; Nishikubo, T; Fukui, M; Nomura, S; Azumagawa, K; Tamai, H				Shimakawa, Shuichi; Tanabe, Takuya; Ono, Masae; Nonaka, Michiko; Nambu, Mitsuhiko; Shinohara, Tohru; Nishikubo, Toshiya; Fukui, Miho; Nomura, Shohei; Azumagawa, Kohji; Tamai, Hiroshi			Incidence of febrile seizure in patients with Down syndrome	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; febrile seizure; incidence; sibling	CHILDREN; DYRK1A	BackgroundIt is unclear whether the incidence of febrile seizure (FS) in children with Down syndrome (DS) is higher or lower than in the general population. In this study, we investigated the incidence of FS in DS patients using mailed questionnaires. MethodsThe questionnaires were distributed to parents or caregivers of DS patients attending Osaka Medical College Hospital and six other facilities. The questionnaires were returned by mail from February 2012 to September 2013 from 323 families of DS patients (176 male, 147 female; age range, 3 months-47 years; median age, 5.0 years). To assess the incidence of FS in DS, we performed the following two analyses: (i) we calculated the incidence of FS among DS patients between the ages of 4 and 20 years (n = 199; 113 male, 86 female), and (ii) we extracted families with both DS and healthy siblings between the ages of 4 and 20 years (n = 150; 77 male, 73 female) and compared the incidence of FS in these sibling groups. ResultsFive DS patients had a past history of FS. The incidence of FS in DS was 2.5%. The incidence of FS was significantly lower in DS patients compared with healthy siblings (P < 0.003; OR, 0.14). ConclusionThe incidence of FS is lower in DS patients than in the general population.	[Shimakawa, Shuichi; Fukui, Miho; Nomura, Shohei; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Tanabe, Takuya] Tanabe Childrens Clin, Dept Pediat Neurol, Osaka, Japan; [Shinohara, Tohru] Kinki Univ Hosp, Fac Med, Dept Pediat, Osaka, Japan; [Azumagawa, Kohji] Seikeikai Hosp, Dept Pediat, Osaka, Japan; [Ono, Masae] Tokyo Teishin Hosp, Dept Pediat, Tokyo, Japan; [Nonaka, Michiko] Hyogo PrefecturalChild Dev Support Ctr, Akashi, Hyogo, Japan; [Nambu, Mitsuhiko] Tenri Hosp, Dept Pediat, Nara, Japan; [Nishikubo, Toshiya] Nara Med Univ Hosp, Perinatal Med Ctr, Div Neonatal Intens Care, Nara, Japan	Shimakawa, S (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	zvq10523@nifty.com					Reid AY, 2009, CAN J NEUROL SCI, V36, P679; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Yamamoto T, 2011, AM J MED GENET A, V155A, P113, DOI 10.1002/ajmg.a.33735; Heida JG, 2009, BRAIN DEV-JPN, V31, P388, DOI 10.1016/j.braindev.2008.11.013; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; STAFSTROM CE, 1991, DEV MED CHILD NEUROL, V33, P191; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Romano C, 1990, Am J Med Genet Suppl, V7, P298; Genton P, 2012, EPILEPTIC SYNDROMES, P554; Kajitani T, 2001, SHONIKA RINSHO TOKYO, V54, P1923; Oka E, 1996, SHONIKA RINSHO TOKYO, V49, P2353; Roberson R, 2012, AM J PERINAT, V29, P705, DOI 10.1055/s-0032-1314892; Sugai K, 2010, BRAIN DEV-JPN, V32, P64, DOI 10.1016/j.braindev.2009.09.019; TATSUNO M, 1984, BRAIN DEV-JPN, V6, P37; van Esch A, 1998, EUR J PEDIATR, V157, P340, DOI 10.1007/s004310050824	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					670	672		10.1111/ped.12601		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500029		
J	Otake, K; Uchida, K; Mori, K; Ide, S; Koike, Y; Takamura, M; Inoue, M; Kusunoki, M				Otake, Kohei; Uchida, Keiichi; Mori, Koichiro; Ide, Shozo; Koike, Yuhki; Takamura, Mitsuyuki; Inoue, Mikihiro; Kusunoki, Masato			Efficacy of the Japanese herbal medicine rikkunshito in infants with gastroesophageal reflux disease	PEDIATRICS INTERNATIONAL			English	Article						gastroesophageal reflux; infant; mosapride; prokinetics; rikkunshito	KAMPO MEDICINE; MOSAPRIDE; SYMPTOMS; TRIAL; ACID; RECEPTOR; CHILDREN	BackgroundGastroesophageal reflux disease (GERD) in infants is among the most common reason for physician consultation worldwide. A traditional Japanese medicine, rikkunshito (RKT), is effective for GERD in adult and pediatric patients. The aim of this study was to evaluate the efficacy and safety of RKT in infants with GERD. MethodsFifty-four infants were referred to between July 2004 and December 2012 for evaluation and treatment of GERD. All infants had failure to thrive. We excluded nine patients with cow's milk protein allergy, neurological impairment or surgical indications. We retrospectively reviewed the clinical records of 45 infants with GERD. Twenty-nine infants were treated with RKT (TJ-43; 0.3g/kg/day; RKT group), and 16 infants were treated with mosapride citrate at 0.5mg/kg/day (mosapride group). The primary endpoint was RKT-induced relief of clinical symptoms and bodyweight gain in infants with GERD. ResultsAfter 3 months of treatment, the frequency of vomiting per day was significantly lower in the RKT group than in the mosapride group (P = 0.0146) and the weight Z-score was significantly higher in the RKT group than in the mosapride group (RKT group, -2.5 1.5 vs mosapride group, -5.0 +/- 2.0; P = 0.0386). No adverse effects were noted in either group. ConclusionsRKT may be safe and effective for relief of GER symptoms and for bodyweight gain in infants with GERD.	[Otake, Kohei; Uchida, Keiichi; Mori, Koichiro; Ide, Shozo; Koike, Yuhki; Inoue, Mikihiro; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan; [Takamura, Mitsuyuki] Mie Univ Hosp, Kampo Med Outpatient Dept, Tsu, Mie, Japan	Uchida, K (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	kohei815@clin.medic.mie-u.ac.jp					Hayakawa T, 1999, DRUG EXP CLIN RES, V25, P211; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Kido T, 2005, J PHARMACOL SCI, V98, P161, DOI 10.1254/jphs.FPJ04056X; Fujitsuka N, 2009, BIOL PSYCHIAT, V65, P748, DOI 10.1016/j.biopsych.2008.10.031; Kawahara H, 2007, PEDIATR SURG INT, V23, P1001, DOI 10.1007/s00383-007-1986-7; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Kawahara H, 2009, PEDIATR SURG INT, V25, P987, DOI 10.1007/s00383-009-2453-4; Vandenplas Y, 2005, EARLY HUM DEV, V81, P1011, DOI 10.1016/j.earlhumdev.2005.10.011; Tominaga K, 2012, J GASTROENTEROL, V47, P284, DOI 10.1007/s00535-011-0488-5; Gunji S, 2013, J SURG RES, V185, P575, DOI 10.1016/j.jss.2013.06.010; Hattori T, 2010, BASICS EVIDENCES BAS, P149; Kamiya T, 2009, J GASTROENTEROL, V44, P183, DOI 10.1007/s00535-008-2289-z; Kawahara H, 2014, PEDIATR SURG INT, V30, P927, DOI 10.1007/s00383-014-3565-z; Madan K, 2004, DIS ESOPHAGUS, V17, P274, DOI 10.1111/j.1442-2050.2004.00424.x; Matsumura T, 2010, J GASTROENTEROL, V45, P300, DOI 10.1007/s00535-009-0166-z; Miwa H, 2011, ALIMENT PHARM THER, V33, P323, DOI 10.1111/j.1365-2036.2010.04517.x; Ruth M, 2003, EUR J GASTROEN HEPAT, V15, P1115, DOI 10.1097/01.meg.0000085480.12407.de; Schurr Patti, 2012, Neonatal Netw, V31, P229; Suzuki H, 2009, NEUROGASTROENT MOTIL, V21, P688, DOI 10.1111/j.1365-2982.2009.01290.x; Tominaga K., 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep173	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					673	676		10.1111/ped.12582		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500030		
J	Hirano, K; Kubota, A; Nakayama, M; Kawahara, H; Yoneda, A; Tazuke, Y; Tani, G; Ishii, T; Goda, T; Umeda, S; Hirno, S; Shiraishi, J; Kitajima, H				Hirano, Katsuhisa; Kubota, Akio; Nakayama, Masahiro; Kawahara, Hisayoshi; Yoneda, Akihiro; Tazuke, Yuko; Tani, Gakuto; Ishii, Tomohiro; Goda, Taro; Umeda, Satoshi; Hirno, Shinya; Shiraishi, Jun; Kitajima, Hirnoyuki			Parenteral nutrition-associated liver disease in extremely low-birthweight infants with intestinal disease	PEDIATRICS INTERNATIONAL			English	Article						extremely low-birthweight infant; functional intestinal obstruction; hepatic failure; hepatic fibrosis; intestinal perforation; parenteral nutrition-associated liver disease	HEPATIC CHOLESTASIS; PERFORATION; DYSFUNCTION; OUTCOMES; RISK; TPN	BackgroundThe aim of this study was to investigate factors associated with the development of parenteral nutrition-associated liver disease (PNALD) and to examine the clinicopathological relationship of PNALD in extremely low-birthweight infants (ELBWI). MethodsThe subjects were 13 ELBWI who had received PN because of intestinal perforation or functional ileus between 2000 and 2013. We measured the serum levels of biochemical parameters, including aspartate aminotransferase, alanine aminotransferase, and direct bilirubin. Liver histopathology was examined in relation to outcome. The subjects were categorized into two groups on liver histopathology: F(+), development of hepatic fibrosis and necrosis with/without cholestasis; and F(-), no hepatic fibrosis. ResultsOf 13 ELBWI, five died of hepatic failure, five died of sepsis, and the other three were alive at the time of the study. Of the five infants who died of hepatic failure, two developed fulminant hepatitis without cholestasis, and the other three developed chronic cholestasis and finally hepatic failure. Postmortem histopathology in F(+) indicated not only massive hepatic necrosis, but also massive hepatic fibrosis. These histopathological findings explained the clinical presentation of portal hypertension. There were significant differences in the fasting period after intestinal disease onset between the two groups. ConclusionThe prolonged fasting with PN is responsible for severe hepatocellular necrosis with fibrosis and consequent lethal portal hypertension.	[Hirano, Katsuhisa; Kubota, Akio; Kawahara, Hisayoshi; Yoneda, Akihiro; Tazuke, Yuko; Tani, Gakuto; Ishii, Tomohiro; Goda, Taro; Umeda, Satoshi] Osaka Med Ctr, Pediat Surg, Osaka, Japan; [Nakayama, Masahiro] Osaka Med Ctr, Clin Lab Med & Anat Pathol, Osaka, Japan; [Hirno, Shinya; Shiraishi, Jun; Kitajima, Hirnoyuki] Osaka Med Ctr, Neonatal Med, Osaka, Japan; Res Inst Maternal & Child Hlth, Osaka, Japan	Hirano, K (reprint author), 840 Murodocho, Izumi, Osaka 5941101, Japan.	hrnkths21@yahoo.co.jp					Puder M, 2009, ANN SURG, V250, P395, DOI 10.1097/SLA.0b013e3181b36657; Kudsk KA, 2000, JPEN-PARENTER ENTER, V24, P270, DOI 10.1177/0148607100024005270; Stanko RT, 1987, GASTROENTEROLOGY, V92, P197; Beath SV, 1996, J PEDIATR SURG, V31, P604, DOI 10.1016/S0022-3468(96)90507-2; Robinson DT, 2008, J PEDIATR, V152, P59, DOI 10.1016/j.jpeds.2007.06.002; BEALE EF, 1979, PEDIATRICS, V64, P342; KUBOTA A, 1990, J PEDIATR SURG, V25, P618, DOI 10.1016/0022-3468(90)90347-C; Genton L, 2004, JPEN-PARENTER ENTER, V28, P431, DOI 10.1177/0148607104028006431; DRONGOWSKI RA, 1989, JPEN-PARENTER ENTER, V13, P586, DOI 10.1177/0148607189013006586; Kubota A, 2011, PEDIATR INT, V53, P887, DOI 10.1111/j.1442-200X.2011.03381.x; Raptis DA, 2014, J HEPATOL, V60, P625, DOI 10.1016/j.jhep.2013.11.006; Javid PJ, 2005, J PEDIATR SURG, V40, P1015, DOI 10.1016/j.jpedsurg.2005.03.019; PEDEN VH, 1971, J PEDIATR-US, V78, P180, DOI 10.1016/S0022-3476(71)80289-5; Christensen RD, 2007, J PERINATOL, V27, P284, DOI 10.1038/sj.jp.7211686; Rangel SJ, 2012, J PEDIATR SURG, V47, P225, DOI 10.1016/j.jpedsurg.2011.10.007; Sondheimer JM, 1998, J PEDIATR GASTR NUTR, V27, P131, DOI 10.1097/00005176-199808000-00001; Kubota A, 2000, J PEDIATR SURG, V35, P1049, DOI 10.1053/jpsu.2000.7769; Buchman AL, 2006, HEPATOLOGY, V43, P9, DOI 10.1002/hep.20997; Kelly DA, 1998, NUTRITION, V14, P153, DOI 10.1016/S0899-9007(97)00232-3; Cass DL, 2000, J PEDIATR SURG, V35, P1531, DOI 10.1053/jpsu.2000.18299; Hoang V, 2008, PEDIATRICS, V121, P1152; Kubota A, 1995, J JPN SOC NEONATOL, V31, P120; Kubota A, 2007, PEDIATR SURG INT, V23, P997, DOI 10.1007/s00383-007-1984-9; Kubota A, 2013, PEDIATR INT, V55, P39, DOI 10.1111/ped.12026; Kubota A, 2006, JPN J PEDIAT SURG, V38, P609; Okuyama H, 2002, PEDIATR SURG INT, V18, P704, DOI 10.1007/s00383-002-0839-7; Pereira GR, 1981, AM J DIS CHILD, V135, P586; Spner AU, 2005, JPEN J PARENTER ENTE, V29, P337; Tatekawa Y, 1999, PEDIATR SURG INT, V15, P549, DOI 10.1007/s003830050668	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					677	681		10.1111/ped.12609		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500031		
J	Inamura, N; Usui, N; Okuyama, H; Nagata, K; Kanamori, Y; Fujino, Y; Takahashi, S; Hayakawa, M; Taguchi, T				Inamura, Noboru; Usui, Noriaki; Okuyama, Hiroomi; Nagata, Kouji; Kanamori, Yutaka; Fujino, Yuji; Takahashi, Shigehiro; Hayakawa, Masahiro; Taguchi, Tomoaki			Extracorporeal membrane oxygenation for congenital diaphragmatic hernia in Japan	PEDIATRICS INTERNATIONAL			English	Article						congenital diaphragmatic hernia; extracorporeal membrane oxygenation; mortality; oxygenation index	SURVIVAL; INFANTS; STABILIZATION; REPAIR	BackgroundThe aim of this study was to clarify how extracorporeal membrane oxygenation (ECMO) is used to treat congenital diaphragmatic hernia (CDH) in Japan. MethodsWe completed a nationwide survey of CDH involving 614 infants. The subjects included 43 patients who underwent ECMO. We compared the clinical data of the patients who did and did not survive 90 days, and analyzed the 24h blood gas data in isolated CDH cases in both groups. ResultsOf the 43 CDH patients, non-isolated CDH associated with other life-threatening or chromosomal anomalies was diagnosed in six patients. Only one of these six patients was able to discontinue ECMO and survived, and the other five died shortly after birth. The other 37 patients all had isolated CDH. The reason for initiating ECMO in 31 of these patients was persistent pulmonary hypertension of the newborn (PPHN). In the 37 patients with isolated CDH, ECMO was initiated within 24h after birth. Sixteen patients (37%) survived 90 days, and intact discharge was possible in eight cases. Among the isolated CDH patients, on ROC analysis of the lowest oxygenation index (OI) to predict 90 day survival, the cut-off was 15. ConclusionsECMO is used to treat PPHN starting from an early period after birth, but the mortality and morbidity are not favorable. For lowest OI, the index used to predict survival following ECMO, the cut-off was 15.	[Inamura, Noboru] Osaka Med Ctr, Dept Pediat Cardiol, Izumi Ku, Osaka 5941101, Japan; [Inamura, Noboru] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Usui, Noriaki] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka 565, Japan; [Fujino, Yuji] Osaka Univ Hosp, Dept Intens Care Unit, Osaka 553, Japan; [Okuyama, Hiroomi] Hyogo Coll Med, Dept Pediat Surg, Nishinomiya, Hyogo 6638501, Japan; [Nagata, Kouji; Taguchi, Tomoaki] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg Reprod & Dev Med, Fukuoka 812, Japan; [Kanamori, Yutaka] Natl Ctr Child Hlth & Dev, Dept Gen Surg, Tokyo, Japan; [Takahashi, Shigehiro] Natl Ctr Child Hlth & Dev, Div Neonatol, Tokyo, Japan; [Hayakawa, Masahiro] Nagoya Univ Hosp, Ctr Maternal Neonatal Care, Div Neonatol, Nagoya, Aichi, Japan	Inamura, N (reprint author), Osaka Med Ctr, Dept Pediat Cardiol, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	inamura@mch.pref.osaka.jp			Ministry of Health and Welfare of Japan; Ministry of Health Labour and Welfare, Japan	A part of this study was supported by a grant from the Ministry of Health and Welfare of Japan (Health and Labour Science Research Grants for Research on Intractable Diseases). Funding source: Health Labour Sciences Research Grant, the Ministry of Health Labour and Welfare, Japan. The authors have no conflicts of interest to disclose.	Javid PJ, 2004, J PEDIATR SURG, V39, P657, DOI 10.1016/j.jpedsurg.2004.01.022; Seetharamaiah R, 2009, J PEDIATR SURG, V44, P1315, DOI 10.1016/j.jpedsurg.2008.12.021; Hayakawa M, 2013, PEDIATR INT, V55, P190, DOI 10.1111/ped.12059; Flamant C, 2007, ARCH PEDIATRIE, V14, P354, DOI 10.1016/j.arcped.2007.01.007; Germain JF, 1996, J PEDIATR SURG, V31, P1634, DOI 10.1016/S0022-3468(96)90036-6; Graziano JN, 2005, J PEDIATR SURG, V40, P1045, DOI 10.1016/j.jpedsurg.2005.03.025; Kattan J, 2010, PEDIATR SURG INT, V26, P671, DOI 10.1007/s00383-010-2624-3; Kitano Y, 2011, ULTRASOUND OBST GYN, V37, P277, DOI 10.1002/uog.8892; Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040; Nagata K, 2013, J PEDIATR SURG, V48, P738, DOI 10.1016/j.jpedsurg.2012.12.017; PURI P, 1989, MOD PROBL PAEDIAT, V24, P69; Raval MV, 2011, J PEDIATR SURG, V46, P617, DOI 10.1016/j.jpedsurg.2010.09.047; Reyes C, 1998, J PEDIATR SURG, V33, P1010, DOI 10.1016/S0022-3468(98)90523-1; Shiono N, 2014, PEDIATR INT, V56, P553, DOI 10.1111/ped.12322; Suita S, 1999, J PEDIATR SURG, V34, P1652, DOI 10.1016/S0022-3468(99)90637-1; Finer N, 1997, PEDIATRICS, V99, P838	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					682	686		10.1111/ped.12554		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500032		
J	Tanaka, Y; Uchida, H; Kawashima, H; Sato, K; Takazawa, S; Deie, K; Masuko, T; Kanno, K; Shimizu, M				Tanaka, Yujiro; Uchida, Hiroo; Kawashima, Hiroshi; Sato, Kaori; Takazawa, Shinya; Deie, Kyoichi; Masuko, Takayuki; Kanno, Keiichi; Shimizu, Masaki			Influence of surgical intervention on neurodevelopmental outcome in infants with focal intestinal perforation	PEDIATRICS INTERNATIONAL			English	Article						intestinal perforation; intraventricular hemorrhage; neurodevelopment; surgery; very low-birthweight infant	LOW-BIRTH-WEIGHT; NECROTIZING ENTEROCOLITIS; PRETERM INFANTS; PERITONEAL DRAINAGE; EXPERIENCE; NETWORK; AGE	BackgroundIntestinal perforation is known to correlate with neurodevelopmental outcome in very low-birthweight (VLBW) infants, and its two major causes are necrotizing enterocolitis (NEC) and focal intestinal perforation (FIP). Infants with FIP are reported to have better neurodevelopmental outcome than infants with NEC, but outcome has not been compared with that in infants without diseases that require surgery. The aim of this study was to compare neurodevelopmental outcomes between FIP survivors and infants without diseases that require surgery. MethodsRecords of VLBW infants with FIP and infants without surgical diseases were retrospectively analyzed. Neurodevelopmental outcome was compared between eight infants with FIP and 24 case-matched control infants without surgical diseases using the Kyoto Scale of Psychological Development. Control group members were individually matched with FIP survivors for sex, gestational age, birthweight, and intraventricular hemorrhage (IVH) grade. Those with an episode of sepsis or severe IVH (grade 3-4) that occurred irrespective of FIP were excluded. ResultsThree FIP survivors and 12 infants without surgical diseases were classified as neurodevelopmentally normal (37.5% vs 50%, P = 0.69) at a corrected age of 18 months-3 years. All neurodevelopmentally normal FIP survivors were born at a gestational age 26 weeks. ConclusionExcluding the influence of sepsis or severe IVH, no significant difference was found in neurodevelopmental outcome between FIP survivors and infants without surgical diseases. None of the FIP infants born before 26 weeks of gestation, however, had normal neurodevelopment, suggesting that longer gestation might be needed to overcome the stress associated with FIP.	[Tanaka, Yujiro; Uchida, Hiroo; Kawashima, Hiroshi; Sato, Kaori; Takazawa, Shinya; Deie, Kyoichi; Masuko, Takayuki] Saitama Childrens Med Ctr, Dept Pediat Surg, Saitama, Japan; [Kanno, Keiichi; Shimizu, Masaki] Saitama Childrens Med Ctr, Dept Neonatol, Saitama, Japan; [Uchida, Hiroo] Nagoya Univ, Grad Sch Med, Dept Pediat Surg, Nagoya, Aichi 4648601, Japan; [Sato, Kaori; Takazawa, Shinya; Deie, Kyoichi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo, Japan	Tanaka, Y (reprint author), 2100 Magome, Iwatsuki, Saitama 3398551, Japan.	tanaka.yujiro@pref.saitama.lg.jp	UCHIDA, Hiroo/E-4437-2015	UCHIDA, Hiroo/0000-0002-1818-6697			Adesanya Olubukunola A, 2005, J Perinatol, V25, P583, DOI 10.1038/sj.jp.7211360; Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; Hunter CJ, 2008, J PERINATOL, V28, pS14, DOI 10.1038/jp.2008.44; Shah TA, 2012, J PERINATOL, V32, P552, DOI 10.1038/jp.2011.176; Soraisham AS, 2006, J PAEDIATR CHILD H, V42, P499, DOI 10.1111/j.1440-1754.2006.00910.x; ASCHNER JL, 1988, J PEDIATR-US, V113, P364, DOI 10.1016/S0022-3476(88)80285-3; Blakely ML, 2006, PEDIATRICS, V117, pE680, DOI 10.1542/peds.2005-1273; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; GROSFELD JL, 1991, ANN SURG, V214, P300, DOI 10.1097/00000658-199109000-00012; Kiechl-Kohlendorfer U, 2009, ACTA PAEDIATR, V98, P792, DOI 10.1111/j.1651-2227.2009.01219.x; Koivusalo A, 2010, J PEDIATR SURG, V45, P319, DOI 10.1016/j.jpedsurg.2009.10.067; Kubota A, 2007, PEDIATR SURG INT, V23, P997, DOI 10.1007/s00383-007-1984-9; Messina M, 2009, Minerva Pediatr, V61, P355; Rees CM, 2010, J PEDIATR SURG, P8; Rees CM, 2010, J PEDIATR SURG, V45, P324, DOI 10.1016/j.jpedsurg.2009.10.066; ROWE MI, 1994, J PEDIATR SURG, V29, P987, DOI 10.1016/0022-3468(94)90264-X; Society for the Kyoto Scale of Psychological Development Test, 2008, SHINP K SHIK HATT KE; Tamaru S, 2011, EARLY HUM DEV, V87, P55, DOI 10.1016/j.earlhumdev.2010.10.004	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					687	689		10.1111/ped.12599		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500033		
J	Iwadare, Y; Kamei, Y; Usami, M; Ushijima, H; Tanaka, T; Watanabe, K; Kodaira, M; Saito, K				Iwadare, Yoshitaka; Kamei, Yuichi; Usami, Masahide; Ushijima, Hirokage; Tanaka, Tetsuya; Watanabe, Kyota; Kodaira, Masaki; Saito, Kazuhiko			Behavioral symptoms and sleep problems in children with anxiety disorder	PEDIATRICS INTERNATIONAL			English	Article						anxiety disorder; child; Children's Sleep Habits Questionnaire; oppositional defiance; sleep	MENTAL-HEALTH STATUS; ADOLESCENTS; CHILDHOOD; ASSOCIATIONS; DEPRESSION; INVENTORY; DURATION	BackgroundSleep disorders are frequently associated with childhood behavioral problems and mental illnesses such as anxiety disorder. To identify promising behavioral targets for pediatric anxiety disorder therapy, we investigated the associations between specific sleep and behavioral problems. MethodsWe conducted retrospective reviews of 105 patients aged 4-12 years who met the DSM-IV criteria for primary diagnosis of generalized anxiety disorder (n = 33), separation anxiety disorder (n = 23), social phobia (n = 21), or obsessive compulsive disorder (n = 28). Sleep problems were evaluated using the Children's Sleep Habits Questionnaire (CSHQ) and behavioral problems by the Spence Children's Anxiety Scale, Oppositional Defiant Behavior Inventory (ODBI), and Depression Self-Rating Scale for Children. ResultsDepressive behavior was weakly correlated with CSHQ subscores for sleep onset delay and night waking but not with total sleep disturbance. Anxiety was correlated with bedtime resistance, night waking, and total sleep disturbance score. Oppositional defiance was correlated with bedtime resistance, daytime sleepiness, sleep onset delay, and most strongly with total sleep disturbance. On multiple regression analysis ODBI score had the strongest positive association with total sleep disturbance and the strongest negative association with total sleep duration. ConclusionsSleep problems in children with anxiety disorders are closely related to anxiety and oppositional defiant symptoms.	[Iwadare, Yoshitaka; Usami, Masahide; Ushijima, Hirokage; Tanaka, Tetsuya; Watanabe, Kyota] Kohnodai Hosp, Dept Child & Adolescent Psychiat, Natl Ctr Global Hlth & Med, Ichikawa, Chiba 2728516, Japan; [Kamei, Yuichi] Natl Ctr Hopsital, Natl Ctr Neurol & Psychiat, Dept Clin Lab, Kodaira, Tokyo, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Dept Child & Adolescent Psychiat, Minato, Japan	Iwadare, Y (reprint author), Kohnodai Hosp, Dept Child & Adolescent Psychiat, Natl Ctr Global Hlth & Med, 1-7-1 Kohnodai, Ichikawa, Chiba 2728516, Japan.	yoshi.iwadare@gmail.com			National Center for Global Health and Medicine [22-120]	This work was supported by a grant from the National Center for Global Health and Medicine (22-120).	Alfano CA, 2006, SLEEP MED, V7, P467, DOI 10.1016/j.sleep.2006.05.002; Shanahan L, 2014, J AM ACAD CHILD PSY, V53, P550, DOI 10.1016/j.jaac.2013.12.029; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Alfano CA, 2010, CHILD PSYCHIAT HUM D, V41, P156, DOI 10.1007/s10578-009-0158-5; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Owens JA, 2000, SLEEP, V23, P1043; Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; Alfano CA, 2007, J AM ACAD CHILD PSY, V46, P224, DOI 10.1097/01.chi.0000242233.06011.8e; Chervin RD, 2003, J AM ACAD CHILD PSY, V42, P201, DOI 10.1097/01.CHI.0000037012.34553.72; Kaneita Y, 2009, SLEEP MED, V10, P780, DOI 10.1016/j.sleep.2008.06.014; Gregory AM, 2004, J AM ACAD CHILD PSY, V43, P744, DOI 10.1097/01.chi/0000122798.47863.a5; Fallone G, 2005, SLEEP, V28, P1561; Ivanenko A, 2005, SLEEP MED REV, V9, P115, DOI 10.1016/j.smrv.2004.09.006; Nixon GM, 2008, SLEEP, V31, P71; BIRLESON P, 1987, J CHILD PSYCHOL PSYC, V28, P43, DOI 10.1111/j.1469-7610.1987.tb00651.x; Aronen ET, 2014, BEHAV SLEEP MED, V12, P373, DOI 10.1080/15402002.2013.821653; Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426; Carvalho Bos S, 2009, Sleep Med, V10, P66, DOI 10.1016/j.sleep.2007.10.020; Chase RM, 2011, BEHAV SLEEP MED, V9, P224, DOI 10.1080/15402002.2011.606768; Harada Y, 2008, PSYCHIAT CLIN NEUROS, V62, P120, DOI 10.1111/j.1440-1819.2007.01771.x; Harada Y, 2004, EUR CHILD ADOLES PSY, V13, P185, DOI 10.1007/s00787-004-0376-0; Ng EP, 2009, SLEEP BREATH, V13, P357, DOI 10.1007/s11325-009-0255-5; Owens Judith A, 2005, Behav Sleep Med, V3, P18, DOI 10.1207/s15402010bsm0301_4; Sampei M, 2006, BIOMED RES-TOKYO, V27, P111, DOI 10.2220/biomedres.27.111; Storch EA, 2008, J ANXIETY DISORD, V22, P877, DOI 10.1016/j.janxdis.2007.09.003; Usami M, 2012, KITASATO MED J, V42, P91	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					690	693		10.1111/ped.12620		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500034		
J	Setou, N; Sakaguchi, Y; Kurokawa, K; Takada, S				Setou, Noriko; Sakaguchi, Yukihiro; Kurokawa, Kayoko; Takada, Satoshi			Effectiveness of professional training in bereavement care: Survey of Japanese pediatricians supporting families who have lost a child	PEDIATRICS INTERNATIONAL			English	Article						bereavement care; death of a child; pediatrician; professional training; psychological distress	PARENTS	BackgroundThe aim of this study was to assess the effectiveness of professional training in bereavement care. MethodWe mailed a questionnaire to 554 Japanese pediatricians. It asked about demographic characteristics, personal support experiences, professional training, psychological distress, recognition of high risk after a child's death, and eight items relating to awareness in bereavement care. We divided the subjects into two groups based on the presence or absence of professional training and compared them on the basis of each item ((2) test), and conducted logistic regression analysis. ResultsOf the 239 respondents, 193 (80.8%) had performed bereavement care. The final number included in the analysis was 175, after excluding responses with missing data. A total of 46 respondents (26.3%) had attended bereavement care training. The subjects who had had training were more likely to recognize those at high risk for poor psychological recovery, have information about support groups, have a desire to study bereavement care, and understand the necessity of cooperation with mental health specialists. ConclusionMany pediatricians had personally provided support for the bereaved. On logistic analysis, it was considered that four factors (recognition of high risk for poor recovery, information about support, desire to study, and cooperation with professionals) were significantly associated with the professional training. There were no significant differences, however, in psychological distress, helplessness, and fatigue. Training programs related to stress management must be improved for pediatricians who feel high levels of psychological distress.	[Setou, Noriko] Konan Womens Univ, Fac Nursing & Rehabil, Kobe, Hyogo 6580001, Japan; [Sakaguchi, Yukihiro] Kwansei Gakuin Univ, Sch Human Welf Studies, Kobe, Hyogo, Japan; [Kurokawa, Kayoko] Ryukoku Univ, Jr Coll, Dept Social Welf, Kobe, Hyogo, Japan; [Takada, Satoshi] Kobe Univ, Dept Community Hlth Sci, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan	Setou, N (reprint author), Konan Womens Univ, Fac Nursing & Rehabil, Higashinada Ku, 6-2-23 Morikita Machi, Kobe, Hyogo 6580001, Japan.	noriko@konan-wu.ac.jp			Japan Society for the Promotion of Science	We are deeply grateful to all the pediatricians from the High Risk Infant Follow-Up Association and the Japanese Society of Child Neurology who cooperated with the present survey despite their busy schedules. This study was carried out with a Japan Grants-in-Aid from the Japan Society for the Promotion of Science.	Wolraich ML, 2000, PEDIATRICS, V105, P445; American Academy of Pediatrics, 2014, PEDIATRICS, V130, P1164; Jennings P, 2002, ARCH DIS CHILD, V87, P40, DOI 10.1136/adc.87.1.40; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; Funato M, 2010, CARE MED TREATMENT P; Goodkin K, 2001, HDB BEREAVEMENT RES, P671, DOI 10.1037/10436-028; LeqBroq P, 2003, ACCID EMERG NURS, V11, P85; MacKenzie Jenny, 2009, Paediatr Nurs, V21, P22; Middleton W, 1998, AUST NZ J PSYCHIAT, V32, P235, DOI 10.3109/00048679809062734; OLIVER RC, 1995, J TRAUMA, V39, P303, DOI 10.1097/00005373-199508000-00019; Sakai Y, 2009, ANN PUBLICATION RES; Setou N, 2010, JPN J HOSP PALLIAT C, V20, P338; Setou N, 2012, KOBE J MED SCI, V58, P119; Setou N, 2013, STUDY NURS REHABIL, V7, P1; Setou N, 2004, JPN J PSYCHOSOM MED, V44, P395; Shimoinaba Kaori, 2009, Palliat Support Care, V7, P245, DOI 10.1017/S1478951509000315; Stamn BH, 1995, SECONDARY TRAUMATIC; The American Academy of Pediatrics (AAP), 2015, PED BER LECT PROGR; VACHON MLS, 1995, PALLIATIVE MED, V9, P91, DOI 10.1177/026921639500900202	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					699	705		10.1111/ped.12605		7	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500036		
J	Hayashi, T; Hirata, Y; Inuzuka, R; Hirata, Y				Hayashi, Taiyu; Hirata, Yoichiro; Inuzuka, Ryo; Hirata, Yasutaka			Total anomalous pulmonary venous connection with ccTGA and VSD: Can pulmonary artery banding avert pulmonary venous obstruction?	PEDIATRICS INTERNATIONAL			English	Article						congenitally corrected transposition of the great arteries; pulmonary artery banding; pulmonary hypertension; pulmonary venous obstruction; total anomalous pulmonary venous connection	DOUBLE-SWITCH OPERATION; CORRECTED TRANSPOSITION; RETURN; MODEL	We describe a rare case of infracardiac total anomalous pulmonary venous connection (TAPVC), associated with congenitally corrected transposition of the great arteries (ccTGA) and ventricular septal defect, in which the patient had undergone pulmonary artery banding (PAB) at 16 days of age. She began to have episodes of severe cyanosis while crying, 2 weeks after PAB. Cardiac catheterization at 34 days of age showed severe pulmonary hypertension and a transhepatic pressure gradient of 7mmHg. The infant underwent TAPVC repair and conventional repair for ccTGA at 35 days of age. Although PAB might have the provisional effect of delaying the manifestation of pulmonary venous obstruction (PVO), it is unable to prevent the development of PVO due to the high resistance of the hepatic sinusoids. Signs of PVO should be closely monitored so that TAPVC can be repaired in a timely fashion.	[Hayashi, Taiyu; Hirata, Yoichiro; Inuzuka, Ryo] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Hirata, Yasutaka] Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Tokyo 1138655, Japan	Hayashi, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	taiyuhayashi@gmail.com					Nakayama Y, 2012, ANN THORAC SURG, V93, P606, DOI 10.1016/j.athoracsur.2011.09.038; Hiramatsu T, 2012, EUR J CARDIO-THORAC, V42, P1004, DOI 10.1093/ejcts/ezs118; des Levals MR, 1979, J THORAC CARDIOVASC, V78, P515; Husain SA, 2012, ANN THORAC SURG, V94, P825, DOI 10.1016/j.athoracsur.2012.04.026; LABOURENE JI, 1990, CIRC RES, V66, P438; Mommerot A, 2014, J CARDIOTHOR VASC AN, V28, P698, DOI 10.1053/j.jvca.2013.12.013; NEWFELD EA, 1980, CIRCULATION, V61, P103; Rothman A, 2011, PEDIATR CARDIOL, V32, P87, DOI 10.1007/s00246-010-9810-x; vans Geldorps IE, 2013, HEART RHYTHM, V10, P676; Yamagishi M, 1997, J THORAC CARDIOV SUR, V114, P848, DOI 10.1016/S0022-5223(97)70092-8	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					714	716		10.1111/ped.12580		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500040		
J	Imamura, T; Tanaka, Y; Ninomiya, Y; Yoshinaga, M				Imamura, Tomohiko; Tanaka, Yuji; Ninomiya, Yumiko; Yoshinaga, Masao			Combination of flecainide and propranolol for congenital junctional ectopic tachycardia	PEDIATRICS INTERNATIONAL			English	Article						amiodarone; congenital junctional ectopic tachycardia; esophageal lead; propranolol; tachyarrhythmia	AMIODARONE; CHILDREN; THERAPY; TACHYARRHYTHMIAS; MANAGEMENT; INFANCY	Congenital junctional ectopic tachycardia is a rare tachyarrhythmia with high mortality. A pharmacological approach in early infancy is regarded as the first-line therapeutic option. Pharmacologically, amiodarone alone or in combination with other drugs is the most commonly reported effective agent for congenital junctional ectopic tachycardia, but it has many adverse effects. Here we report the case of a 40-day-old infant. The clinical course suggests that combined oral flecainide and propranolol is an effective alternative therapy for early infants. Esophageal lead electrocardiography may give a clear diagnosis of junctional ectopic tachycardia.	[Imamura, Tomohiko; Tanaka, Yuji; Ninomiya, Yumiko; Yoshinaga, Masao] Kagoshima Med Ctr, Natl Hosp Org, Dept Pediat, Kagoshima 8920853, Japan	Tanaka, Y (reprint author), Kagoshima Med Ctr, Natl Hosp Org, Dept Pediat, Shiroyama Cho 8-1, Kagoshima 8920853, Japan.	yutanaka@kagomc2.hosp.go.jp					Al-Ghamdi S, 2013, J CARDIOVASC ELECTR, V24, P822, DOI 10.1111/jce.12081; Saul JP, 2005, CIRCULATION, V112, P3470, DOI 10.1161/CIRCULATIONAHA.105.534149; FENRICH AL, 1995, J AM COLL CARDIOL, V25, P1195, DOI 10.1016/0735-1097(94)00513-P; Brugada J, 2013, EUROPACE, V15, P1337, DOI 10.1093/europace/eut082; Sarubbi B, 2002, HEART, V88, P188, DOI 10.1136/heart.88.2.188; VILLAIN E, 1990, CIRCULATION, V81, P1544; Strasburger JF, 2004, CIRCULATION, V109, P375, DOI 10.1161/01.CIR.0000109494.05317.58; Collins KK, 2009, J AM COLL CARDIOL, V53, P690, DOI 10.1016/j.jacc.2008.11.019; Blaufox AD, 2011, PEDIATR CARDIOL, V32, P1110, DOI 10.1007/s00246-011-9987-7; Sampsons KJ, 2011, GOODMAN GILMANS PHAR, V12th, P816	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					716	718		10.1111/ped.12573		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500041		
J	Suga, K; Goji, A; Shono, M; Matsuura, S; Inoue, M; Toda, E; Miyazaki, T; Kawahito, M; Mori, K				Suga, Kenichi; Goji, Aya; Shono, Miki; Matsuura, Sato; Inoue, Miki; Toda, Eiko; Miyazaki, Tatsushi; Kawahito, Masami; Mori, Kazuhiro			Mumps encephalitis with akinesia and mutism	PEDIATRICS INTERNATIONAL			English	Article						akinesia; encephalitis; mumps; mutism; vaccine	JAPAN	Measles-rubella-mumps vaccination is routine in many countries, but the mumps vaccine remains voluntary and is not covered by insurance in Japan. A 5-year-old Japanese boy who had not received the mumps vaccine was affected by mumps parotitis. Several days later, he presented with various neurological abnormalities, including akinesia, mutism, dysphagia, and uncontrolled respiratory disorder. Mumps encephalitis was diagnosed. Despite steroid pulse and immunoglobulin treatment, the disease progressed. Magnetic resonance imaging showed necrotic changes in bilateral basal ganglia, midbrain, and hypothalamus. At 1 year follow up, he was bedridden and required enteral feeding through a gastric fistula and tracheostomy. Mumps vaccination should be made routine as soon as possible in Japan, because mumps encephalitis carries the risk of severe sequelae.	[Suga, Kenichi; Goji, Aya; Shono, Miki; Matsuura, Sato; Inoue, Miki; Kawahito, Masami; Mori, Kazuhiro] Tokushima Prefectural Cent Hosp, Dept Pediat, Tokushima, Tokushima 7708539, Japan; [Toda, Eiko; Miyazaki, Tatsushi] Tokushima Hosp, Natl Hosp Org, Dept Pediat, Tokushima, Japan	Suga, K (reprint author), Tokushima Prefectural Cent Hosp, Dept Pediat, 1-10-3 Kuramotocho, Tokushima, Tokushima 7708539, Japan.	ksuga@tph.gr.jp					Abrey LE, 1996, MOVEMENT DISORD, V11, P755, DOI 10.1002/mds.870110631; Ammour Y, 2013, J VIROL METHODS, V187, P57, DOI 10.1016/j.jviromet.2012.09.011; Okafuji T, 2005, J CLIN MICROBIOL, V43, P1625, DOI 10.1128/JCM.43.4.1624-1631.2005; Nagai T, 2007, VACCINE, V25, P2742, DOI 10.1016/j.vaccine.2005.11.068; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Baba K, 2011, VACCINE, V29, P3089, DOI 10.1016/j.vaccine.2010.09.022; Ishii K, 2011, AJNR Am J Neuroradiol, V32, pE139, DOI 10.3174/ajnr.A2603; Koyama S, 2000, INTERNAL MED, V39, P499, DOI 10.2169/internalmedicine.39.499; Maldonados Y, 2000, NELSON TXB PEDIAT, V16th, P954; Nakayama T, 2013, J INFECT CHEMOTHER, V19, P787, DOI 10.1007/s10156-013-0641-6; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					721	724		10.1111/ped.12581		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500043		
J	Gohda, Y; Oka, S; Matsunaga, T; Watanabe, S; Yoshiura, K; Kondoh, T; Matsumoto, T				Gohda, Yuji; Oka, Shohki; Matsunaga, Takamoto; Watanabe, Satoshi; Yoshiura, Koh-ichiro; Kondoh, Tatsuro; Matsumoto, Tadashi			Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia	PEDIATRICS INTERNATIONAL			English	Article						diazoxide; hyperinsulinism; hypoglycemia; Kabuki syndrome; KMT2D		A newborn Japanese girl with Kabuki syndrome had neonatal persistent hyperinsulinemic hypoglycemia, which seemed to be a rare complication of Kabuki syndrome. On sequence analysis she was found to have a novel heterozygous KMT2D mutation. Diazoxide therapy was effective for the hypoglycemia. Hypoglycemia should be considered when Kabuki syndrome patients have convulsion or other non-specific symptoms. Diazoxide may help to improve hypoglycemia in patients with Kabuki syndrome complicated with hyperinsulinemic hypoglycemia.	[Gohda, Yuji; Oka, Shohki] Sasebo Kyosai Hosp, Dept Pediat, Sasebo 8578575, Japan; [Matsunaga, Takamoto] Obstet & Gynecol Matsunaga Clin, Sasebo, Japan; [Watanabe, Satoshi; Yoshiura, Koh-ichiro] Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; [Watanabe, Satoshi] Nagasaki Univ, Sch Med, Dept Pediat, Nagasaki 852, Japan; [Kondoh, Tatsuro; Matsumoto, Tadashi] Misakaenosono Mutsumi Dev Med & Welf Ctr, Div Dev Disabil, Isahaya, Japan	Gohda, Y (reprint author), Sasebo Kyosai Hosp, Dept Pediat, 10-17 Shimati Cho, Sasebo 8578575, Japan.	ygouda-alg@umin.ac.jp					Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Genevieve D, 2004, AM J MED GENET A, V129A, P64, DOI 10.1002/ajmg.a.30144; NIIKAWA N, 1988, AM J MED GENET, V31, P565, DOI 10.1002/ajmg.1320310312; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Banka S, 2015, CLIN GENET, V87, P252, DOI 10.1111/cge.12363; Ewart-Toland A, 1998, AM J MED GENET, V80, P362, DOI 10.1002/(SICI)1096-8628(19981204)80:4<362::AID-AJMG11>3.0.CO;2-W; Fournet JC, 2004, ENDOCR PATHOL, V15, P233, DOI 10.1385/EP:15:3:233; Ngs SB, 2010, NAT GENET, V42, P790; Subbarayan A, 2014, AM J MED GENET A, V164, P467, DOI 10.1002/ajmg.a.36256; Zarate Y A, 2012, Mol Syndromol, V3, P180, DOI 10.1159/000342253	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					726	728		10.1111/ped.12574		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500045		
J	Ono, H; Nagamine, H; Toyoda, A; Shimizu, N; Katori, T; Sugiyama, M				Ono, Hiroshi; Nagamine, Hiroki; Toyoda, Akifumi; Shimizu, Nobutaka; Katori, Tatsuo; Sugiyama, Masahiko			Right-sided hepatic hernia of normal left lobe resembling cardiac tumor	PEDIATRICS INTERNATIONAL			English	Article						cardiac tumor; diaphragmatic hernia; hepatic hernia	LEFT ATRIAL MASS; MIMICKING	A 3-year-old boy was referred for cardiac tumor diagnosed on transthoracic echocardiography (TTE) at another hospital. The tumor appeared to be in the right atrium and obstructed inferior vena cava flow. TTE, enhanced computed tomography (CT) and angiography were done to confirm diagnosis. Subsequently, cardiac tumor was ruled out and he was diagnosed with a very rare condition of hepatic hernia containing a normal left lobe. When cardiac tumor is suspected in the right atrium on the basis of TTE, enhanced CT or magnetic resonance imaging should be done for definitive diagnosis.	[Ono, Hiroshi; Nagamine, Hiroki] Univ Tokyo, Dept Cardiol, Natl Med Ctr Children & Mothers, Tokyo, Japan; [Ono, Hiroshi; Nagamine, Hiroki; Toyoda, Akifumi; Shimizu, Nobutaka; Katori, Tatsuo] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Sugiyama, Masahiko] Univ Tokyo, Grad Sch Med, Dept Pediat Surg, Tokyo, Japan; [Toyoda, Akifumi] Teikyo Univ, Dept Pediat, Tokyo 173, Japan; [Katori, Tatsuo] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Dept Pediat, Tokyo, Japan	Ono, H (reprint author), Natl Med Ctr Children & Mothers, Dept Cardiol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ono-hr@ncchd.go.jp					BAERMAN JM, 1988, AM HEART J, V116, P198, DOI 10.1016/0002-8703(88)90272-4; Chan J, 2009, J AM COLL CARDIOL, V54, P569, DOI 10.1016/j.jacc.2009.02.081; DCRUZ IA, 1994, ECHOCARDIOGR-J CARD, V11, P523, DOI 10.1111/j.1540-8175.1994.tb01093.x; Fujimoto S, 1998, J AM SOC ECHOCARDIOG, V11, P680, DOI 10.1016/S0894-7317(98)70047-1; Kers J, 2004, CARDIOVASC J S AFR, V15, P182; Koskinas KC, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-46; NISHIMURA RA, 1985, J AM COLL CARDIOL, V5, P992; Smelleys M, 2007, J AM SOC ECHOCARDIOG, V20, p[1414, e5]	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					729	731		10.1111/ped.12579		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500046		
J	Fukuda, Y; Momoi, N; Akaihata, M; Nagasawa, K; Mitomo, M; Aoyagi, Y; Endoh, K; Hosoya, M				Fukuda, Yutaka; Momoi, Nobuo; Akaihata, Mitsuko; Nagasawa, Katsutoshi; Mitomo, Masaki; Aoyagi, Yoshimichi; Endoh, Kisei; Hosoya, Mitsuaki			Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection	PEDIATRICS INTERNATIONAL			English	Article						chronic active Epstein-Barr virus infection; coronary artery aneurysm; junctional ectopic tachycardia; pulmonary arterial hypertension	LYMPHOCYTES; DISEASE; GENOME	Chronic active Epstein-Barr virus (EBV) infection (CAEBV), characterized by persistent infectious mononucleosis-like symptoms, can lead to cardiovascular complications including coronary artery aneurysm or myocarditis. Here, we present the case of an 11-year-old boy with pulmonary arterial hypertension (PAH) and junctional ectopic tachycardia associated with CAEBV. The patient did not have any major symptoms attributed to CAEBV, such as fever, lymphadenopathy or splenomegaly when the PAH developed. Mild liver dysfunction was found at the first examination, and it persisted. Two years after the PAH symptoms appeared, CAEBV was evident, based on deteriorated liver function, hepatosplenomegaly, and coronary artery aneurysms. CAEBV should be considered as a cause of secondary PAH, particularly when liver dysfunction coexists.	[Fukuda, Yutaka; Akaihata, Mitsuko; Nagasawa, Katsutoshi] Takeda Gen Hosp, Dept Pediat, Fukushima 9658585, Japan; [Momoi, Nobuo; Mitomo, Masaki; Aoyagi, Yoshimichi; Endoh, Kisei; Hosoya, Mitsuaki] Fukushima Med Univ, Dept Pediat, Fukushima, Japan	Fukuda, Y (reprint author), Takeda Gen Hosp, Dept Pediat, 3-27 Yamagamachi Aizu Wakamatsu City, Fukushima 9658585, Japan.	yfuku@takeda.or.jp					KIKUTA H, 1988, NATURE, V333, P455, DOI 10.1038/333455a0; Kimura H, 2006, REV MED VIROL, V16, P251, DOI 10.1002/rmv.505; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Fujiwara M, 2003, J PEDIAT HEMATOL ONC, V25, P85, DOI 10.1097/00043426-200301000-00018; Hashimoto T, 2011, INTERNAL MED, V50, P119, DOI 10.2169/internalmedicine.50.4143; ISHIHARA S, 1995, ACTA PAEDIATR, V84, P1271, DOI 10.1111/j.1651-2227.1995.tb13547.x; Kanno H, 2008, CLIN EXP IMMUNOL, V151, P519, DOI 10.1111/j.1365-2249.2007.03584.x; Kimura H, 2003, J INFECT DIS, V187, P527, DOI 10.1086/367988; Muneuchi J, 2009, PEDIATR CARDIOL, V30, P274, DOI 10.1007/s00246-008-9343-8; Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI 10.1016/j.jacc.2013.10.029	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					731	734		10.1111/ped.12578		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500047		
J	Tanaka, K; Koshida, S; Yanagi, T; Tsutsui, H; Nakahara, S; Furukawa, O; Tsuji, S				Tanaka, Katsunori; Koshida, Shigeki; Yanagi, Takahide; Tsutsui, Hidemi; Nakahara, Sayuri; Furukawa, Ouki; Tsuji, Shunichiro			Suspected fetal onset of neonatal transient eosinophilic colitis and development of respiratory distress	PEDIATRICS INTERNATIONAL			English	Article						distended fetal bowel; eosinophilia; hematochezia; meconium aspiration syndrome; neonatal transient eosinophilic colitis	MECONIUM ASPIRATION	Neonatal transient eosinophilic colitis (NTEC) is a new disease concept within eosinophilic gastroenteritis, which was proposed by Ohtsuka etal. It causes hematochezia as a result of eosinophilia, in neonates who have not yet started to receive enteral nutrition, although the whole-body status of the infant is in fact relatively good. To date, there have been no reports of this disease in which abnormalities were noted during gestation, and the clinical phenomena surrounding it, along with any complications, are not yet clear. We encountered a suspected case of NTEC causing respiratory distress with aspiration of hematochezia, in which dilated bowel was noted during gestation. This case indicates that NTEC may occur at the fetal stage and be complicated by respiratory distress.	[Tanaka, Katsunori; Koshida, Shigeki; Yanagi, Takahide; Tsutsui, Hidemi; Nakahara, Sayuri; Furukawa, Ouki] Shiga Univ Med Sci Hosp, Dept Pediat, Otsu, Shiga, Japan; [Tsuji, Shunichiro] Shiga Univ Med Sci Hosp, Dept Obstet & Gynecol, Otsu, Shiga, Japan	Tanaka, K (reprint author), Shiga Univ Med Sci, Dept Pediat, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	tanakatsu0124@gmail.com					Alabsi Humam S, 2013, Neonatal Netw, V32, P316, DOI 10.1891/0730-0832.32.5.316; Balchin I, 2011, OBSTET GYNECOL, V117, P828, DOI 10.1097/AOG.0b013e3182117a26; Chen C T, 1985, Crit Care Med, V13, P233, DOI 10.1097/00003246-198504000-00005; Dargaville PA, 2001, J PEDIATR-US, V138, P113, DOI 10.1067/mpd.2001.109602; Feiterna-Sperling C, 1997, PEDIATR ALLERGY IMMU, V8, P153, DOI 10.1111/j.1399-3038.1997.tb00170.x; Mizuno Masanori, 2011, AJP Rep, V1, P53, DOI 10.1055/s-0031-1280571; Ohtsuka Y, 2007, J PEDIATR GASTR NUTR, V44, P501, DOI 10.1097/01.mpg.0000252194.06955.18; TYLER DC, 1978, PEDIATRICS, V62, P454	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					734	738		10.1111/ped.12577		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500048		
J	Tezuka, M; Ohta, M; Ochi, F; Chisaka, T; Higaki, T; Ishii, E				Tezuka, Mari; Ohta, Masaaki; Ochi, Fumihiro; Chisaka, Toshiyuki; Higaki, Takashi; Ishii, Eiichi			Successful treatment by coil embolization for infantile hemangioma with Kasabach-Meritt syndrome of newborn	PEDIATRICS INTERNATIONAL			English	Article						coil embolization; corticosteroid; infantile hemangioma; Kasabach-Meritt syndrome	INTERVENTIONAL TREATMENT; HEMANGIOENDOTHELIOMA; CELLS	Infantile hemangioma (IH) is the most common tumor of infancy, and it sometimes associated with Kasabach-Meritt syndrome (KMS) characterized by anemia, intraperitoneal hemorrhage secondary to rupture, coagulopathy, jaundice, and vascular malformations involving the brain, skin, gut, and other organs. Here, we report two newborn patients having IH with KMS at birth. The first patient had a giant hemangioma in the liver, which was successfully treated with i.v. corticosteroid and coil embolization. The second patient had a large hemangioma of the right axillary region, which was also successfully treated with i.v. corticosteroid, beta-blocker, coil embolization and local irradiation. All symptoms were controlled without any side-effects in both patients. According to these findings, combination therapy including coil embolization and corticosteroid is effective for IH patients with KMS. The indications for and timing of coil embolization should be determined further cases have been accumulated.	[Tezuka, Mari] Ehime Prefectural Cent Hosp, Div Pediat, Matsuyama, Ehime, Japan; [Ochi, Fumihiro] Yawatahama City Gen Hosp, Div Pediat, Yawatahama, Japan; [Ohta, Masaaki; Chisaka, Toshiyuki; Higaki, Takashi; Ishii, Eiichi] Ehime Univ, Grad Sch Med, Dept Pediat, Toon, Ehime 7910295, Japan	Higaki, T (reprint author), Ehime Univ, Grad Sch Med, Dept Pediat, Toon, Ehime 7910295, Japan.	higaki@m.ehime-u.ac.jp					Isaacs H, 2007, J PEDIATR SURG, V42, P1797, DOI 10.1016/j.jpedsurg.2007.07.047; Storch CH, 2010, BRIT J DERMATOL, V163, P269, DOI 10.1111/j.1365-2133.2010.09848.x; Greenberger S, 2010, NEW ENGL J MED, V362, P1005, DOI 10.1056/NEJMoa0903036; DAVENPORT M, 1995, J PEDIATR SURG, V30, P44, DOI 10.1016/0022-3468(95)90607-X; Hall GW, 2001, BRIT J HAEMATOL, V112, P851, DOI 10.1046/j.1365-2141.2001.02453.x; Klicine C, 2008, PEDIAT DERMATOL, V25, P168; Kretschmar O, 2008, CARDIOVASC INTER RAD, V31, P411, DOI 10.1007/s00270-006-0123-7; REPA I, 1989, RADIOLOGY, V170, P395; Smith SKS, 2002, IN VITRO CELL DEV-AN, V38, P298; Warmann S, 2003, J PEDIATR SURG, V38, P1177, DOI 10.1016/S0022-3468(03)00325-7	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					738	741		10.1111/ped.12618		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500049		
J	Yanagisawa, R; Nakamura, T; Ogiso, Y; Hachiya, A; Fujihara, I; Morita, D; Sakashita, K; Kitamura, M; Matsui, H; Nishijima, F; Hayashi, H; Hidaka, E; Sano, K; Shiohara, M; Yasukochi, S				Yanagisawa, Ryu; Nakamura, Tomohiko; Ogiso, Yoshifumi; Hachiya, Akira; Fujihara, Ikuko; Morita, Daisuke; Sakashita, Kazuo; Kitamura, Masatomo; Matsui, Hikoro; Nishijima, Fumie; Hayashi, Hidetaka; Hidaka, Eiko; Sano, Kenji; Shiohara, Masaaki; Yasukochi, Satoshi			Interleukin-8-producing primary cardiac undifferentiated sarcoma in a child with sustained fever	PEDIATRICS INTERNATIONAL			English	Article						interleukin-8; left atrium; metastasis; primary cardiac tumor; undifferentiated sarcoma	MALIGNANT FIBROUS HISTIOCYTOMA; HEART; EXPERIENCE; TUMORS	We report the case of a 12-year-old boy with primary undifferentiated sarcoma of the left atrium. He had sustained fever during the clinical course and multiple lung and brain metastases. Chemotherapy and irradiation were ineffective; he died 41 days after hospitalization. On retrospective analysis, interleukin-8 (IL-8) was elevated; this was supported by immunohistochemistry and gene expression analysis of tumor samples. IL-8 continued to increase with tumor progression accompanied by elevated neutrophil count and C-reactive protein. IL-8 is involved in malignant tumor proliferation, migration, and angiogenesis and may have been related to the clinical condition and prognosis in the present case.	[Yanagisawa, Ryu; Nakamura, Tomohiko; Fujihara, Ikuko; Sakashita, Kazuo] Nagano Childrens Hosp, Div Hematol Oncol, Azumino, Japan; [Nakamura, Tomohiko; Hidaka, Eiko] Nagano Childrens Hosp, Life Sci Res Ctr, Azumino, Japan; [Ogiso, Yoshifumi] Nagano Childrens Hosp, Div Clin Pathol, Azumino, Japan; [Fujihara, Ikuko; Kitamura, Masatomo; Matsui, Hikoro] Nagano Childrens Hosp, Dept Pediat Intens Care, Azumino, Japan; [Nishijima, Fumie; Hayashi, Hidetaka; Hidaka, Eiko] Nagano Childrens Hosp, Dept Lab Med, Azumino, Japan; [Yasukochi, Satoshi] Nagano Childrens Hosp, Div Pediat Cardiol, Azumino, Japan; [Yanagisawa, Ryu; Hachiya, Akira; Morita, Daisuke; Sakashita, Kazuo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Sano, Kenji] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Shiohara, Masaaki] Matsumoto Dent Univ, Sch Dent, Dept Pediat, Shiojiri, Japan	Yanagisawa, R (reprint author), Nagano Childrens Hosp, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	ryu@shinshu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [26860790]; Ministry of Health and Welfare of Japan	This work was supported in part by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26860790) and a grant for scientific research from the Ministry of Health and Welfare of Japan. The authors have no potential conflicts of interest to declare.	Orlandi A, 2010, J THORAC ONCOL, V5, P1483, DOI 10.1097/JTO.0b013e3181e59a91; De Larco JE, 2003, P NATL ACAD SCI USA, V100, P13988, DOI 10.1073/pnas.2335921100; Collins CL, 2014, J PEDIAT HEMATOL ONC, V36, pE237, DOI 10.1097/MPH.0b013e318290c3b8; Davis JS, 2013, PEDIATR SURG INT, V29, P425, DOI 10.1007/s00383-013-3261-4; Deguchi H, 1999, JPN J CLIN ONCOL, V29, P382, DOI 10.1093/jjco/29.8.382; Fletchers CDM, 2013, WHO CLASSIFICATION T, V4th; Harimotos N, 2009, HPB SURG, V2009; Matsue H, 1998, J THORAC CARDIOV SUR, V116, P522, DOI 10.1016/S0022-5223(98)70021-2; Okamoto K, 2001, INTERNAL MED, V40, P1222, DOI 10.2169/internalmedicine.40.1222; Sallee D, 1999, CARDIOL YOUNG, V9, P155; Toda R, 2002, SURG TODAY, V32, P270; Uzun O, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-11; Wang JG, 2013, ACTA HISTOCHEM, V115, P761, DOI 10.1016/j.acthis.2013.02.001; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720; Zhus YM, 2008, BMC CANCER, V8, P218; Zhus YM, 2005, FUTURE ONCOL, V1, P699	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					742	745		10.1111/ped.12621		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500050		
J	Kido, J; Mizukami, T; Ohara, O; Takada, H; Yanai, M				Kido, Jun; Mizukami, Tomoyuki; Ohara, Osamu; Takada, Hidetoshi; Yanai, Masaaki			Idiopathic disseminated bacillus Calmette-Guerin infection in three infants	PEDIATRICS INTERNATIONAL			English	Article						BCG; disseminated BCG infection; infant; neutrophil; T cell	MYCOBACTERIUM-BOVIS; BCG VACCINATION; MACROPHAGE; DISEASE	We describe the cases of three infants between 4 and 9 months of age with disseminated bacillus Calmette-Guerin (BCG) infection who developed persistent fever, skin rash, and multiple chest nodules visible on computed tomography 22-34 days after BCG vaccination. These infants were healthy before inoculation, and their detailed immunological profiles, including T cell and neutrophil levels, were within normal range. Most reported BCG cases involve impaired immunity, such as children with chronic granulomatous disease, severe combined immunodeficiency, or human immunodeficiency virus infections. Because of their immature immune systems, BCG vaccination can be hazardous even in early infants without immune abnormalities. Hence, we advise caution when administering BCG vaccines to early infants.	[Kido, Jun; Yanai, Masaaki] Kumamoto Reg Med Ctr, Dept Pediat, Kumamoto, Kumamoto 8600811, Japan; [Kido, Jun] Kumamoto Univ, Dept Pediat, Grad Sch Med Sci, Kumamoto, Japan; [Mizukami, Tomoyuki] Kumamoto Med Ctr, Dept Pediat, Natl Hosp Org, Kumamoto, Japan; [Yanai, Masaaki] Vaccinat Ctr Kumamoto Prefecture, Kumamoto, Japan; [Mizukami, Tomoyuki] Miyazaki Univ, Dept Reprod & Dev Med, Div Pediat, Fac Med, Miyazaki, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dev Technol Dept, Kisarazu, Chiba, Japan; [Takada, Hidetoshi] Kyushu Univ, Dept Perinatal & Pediat Med, Grad Sch Med Sci, Fukuoka 812, Japan	Yanai, M (reprint author), Kumamoto Reg Med Ctr, Dept Pediat, Chuo Ku, 5-16-10 Honjo, Kumamoto, Kumamoto 8600811, Japan.	bnnhh863@gmail.com					Rezai MS, 2008, J TROP PEDIATRICS, V54, P413, DOI 10.1093/tropej/fmn053; MILSTIEN JB, 1990, B WORLD HEALTH ORGAN, V68, P93; Marciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028; Aldwell FE, 2001, TUBERCULOSIS, V81, P115, DOI 10.1054/tube.2000.0280; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642; Casanova JL, 1996, PEDIATRICS, V98, P774; BANCROFT GJ, 1989, J IMMUNOL, V143, P127; Hamerman JA, 2001, J IMMUNOL, V167, P2227; Rahman FZ, 2009, IMMUNOLOGY, V128, P253, DOI 10.1111/j.1365-2567.2009.03112.x; Tans H, 2002, PEDIAT DERMATOL, V19, P323; TAYLOR S, 1985, J IMMUNOL, V134, P1493; Toida Ichiro, 2007, Kekkaku, V82, P809	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					750	753		10.1111/ped.12623		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500052		
J	Koide, T; Mochizuki, T; Kawai, N; Yashiro, K; Inoue, T; Tsujimoto, M; Nishigaki, T				Koide, Tatsuo; Mochizuki, Takahiro; Kawai, Naoki; Yashiro, Kenta; Inoue, Takeshi; Tsujimoto, Masahiko; Nishigaki, Toshinori			Collagenous gastroduodenitis with recurrent gastric ulcer in 12-year-old girl	PEDIATRICS INTERNATIONAL			English	Article						children; collagen band; collagenous gastritis; collagenous gastroduodenitis	COLITIS	This report describes a rare case of collagenous gastroduodenitis found in a 12-year-old Japanese girl who had recurrent hematemesis. Gastrointestinal endoscopy showed many lotus leaf-like lesions on the gastric mucosa surrounded by atrophic gastric mucosa in the antrum, with a cobblestone appearance and a scarred duodenal ulcer in the duodenal bulb. A biopsy of the gastric mucosa indicated subepithelial collagen band. The patient was treated with H2-blockers for her symptoms for 4 years following the endoscopic findings. Follow-up endoscopy showed the same appearance as before. The pathology, however, showed a more prominent subepithelial collagen deposition. To make the correct diagnosis, it is critical to know from which part the pathological biopsy specimens were taken because there were numerous collagen bands in the atrophic membrane. It is important to monitor the patient regularly for evaluation of the etiology, pathogenesis and prognosis of this rare disease.	[Koide, Tatsuo; Mochizuki, Takahiro; Nishigaki, Toshinori] Osaka Police Hosp, Dept Pediat, Osaka 5430035, Japan; [Tsujimoto, Masahiko] Osaka Police Hosp, Dept Pathol, Osaka 5430035, Japan; [Kawai, Naoki] Osaka Police Hosp, Endoscopy Ctr, Osaka 5430035, Japan; [Inoue, Takeshi] Osaka City Gen Hosp, Dept Pathol, Osaka, Japan; [Koide, Tatsuo] Queen Mary Univ London, London Iryo Ctr, London, England; [Yashiro, Kenta] Queen Mary Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	Koide, T (reprint author), Osaka Police Hosp, Dept Pediat, 10-31 Kitayamatyou, Osaka 5430035, Japan.	koide-osk@umin.ac.jp					LINDSTROM CG, 1976, PATHOL EUR, V11, P87; Billiemaz K, 2009, ENDOSCOPY, V41, pE233, DOI 10.1055/s-2008-1077440; BORCHARD F, 1989, DEUT MED WOCHENSCHR, V114, P1345; COLLETTI RB, 1989, GASTROENTEROLOGY, V97, P1552; Hijaz NM, 2013, WORLD J GASTROENTERO, V19, P1478, DOI 10.3748/wjg.v19.i9.1478; Kamimura K, 2007, DIGEST DIS SCI, V52, P995, DOI 10.1007/s10620-006-9278-y; Kori M, 2007, J PEDIATR GASTR NUTR, V45, P603; Rustagi T, 2011, J CLIN GASTROENTEROL, V45, P794, DOI 10.1097/MCG.0b013e31820c6018; STOLTE M, 1990, ENDOSCOPY, V22, P186, DOI 10.1055/s-2007-1012837; Vesoulis Z, 2000, MODERN PATHOL, V13, P591, DOI 10.1038/modpathol.3880101	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					754	757		10.1111/ped.12615		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500053		
J	Takahashi, S; Yamamoto, S; Okayama, A; Araki, A; Saitsu, H; Matsumoto, N; Azuma, H				Takahashi, Satoru; Yamamoto, Shiho; Okayama, Akie; Araki, Akiko; Saitsu, Hirotomo; Matsumoto, Naomichi; Azuma, Hiroshi			Electroclinical features of epileptic encephalopathy caused by SCN8A mutation	PEDIATRICS INTERNATIONAL			English	Article						epilepsy; encephalopathy; mutation; SCN8A; sodium channel	DE-NOVO MUTATIONS; SODIUM-CHANNEL SCN8A; SEIZURES; INFANCY	Voltage-gated sodium channel Na(v)1.6, encoded by the gene SCN8A, plays a crucial role in controlling neuronal excitability. SCN8A mutations that cause increased channel activity are associated with seizures. We describe a patient with epileptic encephalopathy caused by de novo SCN8A mutation (c.5614C>T, p.Arg1872Trp). Seizures began 10 days after birth at which time brain magnetic resonance imaging (MRI) and electroencephalography (EEG) were normal. Seizure recurrence increased with age, leading to the development of frequent status epilepticus from 1 year of age. Seizure type included generalized tonic seizures and focal motor seizures. EEG first showed focal epileptic activity at the age of 4 months, and thereafter showed multifocal spikes. Serial MRI demonstrated brain atrophy, which appeared to progress with seizure aggravation. Clinical features that may give a clue to the diagnosis include normal EEG despite frequent seizures in early infancy and an increase in epileptic activity that occurs with aging.	[Takahashi, Satoru; Yamamoto, Shiho; Okayama, Akie; Araki, Akiko; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan; [Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Takahashi, S (reprint author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	satoru5p@asahikawa-med.ac.jp			Japan Society for the Promotion of Science [22591118]	We thank the family members of the present patient, whose help and participation made this work possible. This work was supported in part by Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (#22591118). The authors have no conflicts of interest to disclose.	Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Ohba C, 2014, EPILEPSIA, V55, P994, DOI 10.1111/epi.12668; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Blumenfeld H, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2008.01710.x; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Estacion M, 2014, NEUROBIOL DIS, V69, P117, DOI 10.1016/j.nbd.2014.05.017; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; Vaher U, 2014, J CHILD NEUROL, V29, pNP202, DOI 10.1177/0883073813511300	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					758	762		10.1111/ped.12622		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500054		
J	Yamada, K; Shinmoto, H; Kawamura, Y; Wakamatsu, H; Kawauchi, T; Soga, S; Ogata, S; Kaji, T				Yamada, Kentaro; Shinmoto, Hiroshi; Kawamura, Yoichi; Wakamatsu, Hajime; Kawauchi, Toshio; Soga, Shigeyoshi; Ogata, Sho; Kaji, Tatsumi			Transarterial embolization for pediatric hepatocellular carcinoma with cardiac cirrhosis	PEDIATRICS INTERNATIONAL			English	Article						cardiac cirrhosis; congenital heart disease; Fontan operation; hepatocellular carcinoma; transarterial embolization	FONTAN PROCEDURE; LIVER; GUIDELINES; MANAGEMENT; SOCIETY	We describe the case of a 15-year-old boy with a history of Fontan operation and multiple intrahepatic tumors. Computed tomography showed multiple hepatic nodules with arterial enhancement. Because hepatocellular carcinoma (HCC) was not detected on biopsies and tumor markers were normal, progress was monitored on imaging. One hepatic tumor increased greatly in size during follow up. At 15 years of age, tumor markers rose rapidly, and he had upper abdominal swelling. Therefore, transarterial embolization (TAE) was performed for the largest tumor, suspected to be a HCC due to cardiac cirrhosis. This tumor had not increased at follow up 4 months later. The patient died from hepatic failure at the age of 17 years, and HCC was diagnosed at autopsy. Although pediatric HCC is rare, its incidence is likely to increase. TAE, with or without anticancer agents, is a therapeutic option for unresectable pediatric HCC, as it is for adult HCC.	[Yamada, Kentaro; Shinmoto, Hiroshi; Kawauchi, Toshio; Soga, Shigeyoshi; Kaji, Tatsumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3590042, Japan; [Kawamura, Yoichi; Wakamatsu, Hajime] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3590042, Japan; [Ogata, Sho] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 3590042, Japan	Yamada, K (reprint author), Natl Def Med Coll, Dept Radiol, 3-2 Namiki, Tokorozawa, Saitama 3590042, Japan.	yamada2962@gmail.com					Camposilvan S, 2008, ANN THORAC SURG, V86, P177, DOI 10.1016/j.athoracsur.2008.03.077; Ghaferi AA, 2005, J THORAC CARDIOV SUR, V129, P1348, DOI 10.1016/j.jtcvs.2004.10.005; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690; Izumi Y, 2005, J GASTROENTEROL, V40, P204, DOI 10.1007/s00535-004-1525-4; Duncan BW, 2003, ANN THORAC SURG, V76, P1759, DOI 10.1016/S0003-4975(03)00450-8; Ikemotos Y, 2007, J JPN PEDIAT SOC, V54, P55; Japanese Circulation Society, 2011, GUID MAN CONG HEART; Kwon BS, 2009, ANN THORAC SURG, V88, P677, DOI 10.1016/j.athoracsur.2008.12.065; Narkewicz MR, 2003, J PEDIATR GASTR NUTR, V36, P352, DOI 10.1097/00005176-200303000-00009; Rosenbaum J, 2012, J PAEDIATR CHILD H, V48, pE140, DOI 10.1111/j.1440-1754.2010.01932.x; Sekiyama T, 1994, Nihon Rinsho, V52, P229	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					766	770		10.1111/ped.12619		5	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500056		
J	Omae, T; Matsubayashi, T				Omae, Takashi; Matsubayashi, Tadashi			Lung abscess caused by Mycoplasma pneumoniae	PEDIATRICS INTERNATIONAL			English	Article						child; hypercytokinemia; lung abscess; Mycoplasma pneumoniae	CLINICAL-FEATURES; INFECTION; EPIDEMIOLOGY	A 10-year-old boy with West syndrome was referred to hospital because of high fever and cough. Chest X-ray and computed tomography showed consolidation with an abscess in the right upper lobe. Laboratory data indicated cytokine storm. Various antibacterial agents and additional corticosteroid were unable to control the hypercytokinemia, which was suppressed after cyclosporine A was started. The lung abscess remained, however, and right upper lobectomy was performed. Culture from the abscess showed no growth, while polymerase chain reaction assay indicated Mycoplasma pneumoniae DNA. Serum passive agglutinin titer for M. pneumoniae was significantly elevated in the convalescent phase. These findings are strong evidence that the lung abscess was caused by M. pneumoniae infection.	[Omae, Takashi; Matsubayashi, Tadashi] Seirei Hamamatsu Gen Hosp, Dept Pediat, Shizuoka, Japan	Omae, T (reprint author), Seirei Hamamatsu Gen Hosp, Dept Pediat, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	t-omae@sis.seirei.or.jp					Yang J, 2004, CYTOKINE GROWTH F R, V15, P157, DOI 10.1016/j.cytogfr.2004.01.001; Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022; Biondi E, 2014, PEDIATRICS, V133, P1081, DOI 10.1542/peds.2013-3729; Chiou CC, 1997, PEDIATR INFECT DIS J, V16, P327, DOI 10.1097/00006454-199703000-00015; Hoshino C, 2007, INTERNAL MED, V46, P1047, DOI 10.2169/internalmedicine.46.6378; Leonardi S, 2010, EUR J PEDIATR, V169, P1413, DOI 10.1007/s00431-010-1223-6; Moore C, 2014, CLIN MICROBIOL INFEC, V20, pO489, DOI 10.1111/1469-0691.12499	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					773	775		10.1111/ped.12644		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500058		
J	Odaka, J; Kanai, T; Ito, T; Saito, T; Aoyagi, J; Ueda, Y; Yamagata, T				Odaka, Jun; Kanai, Takahiro; Ito, Takane; Saito, Takashi; Aoyagi, Jun; Ueda, Yoshihiko; Yamagata, Takanori			Renal-limited necrotizing granulomatous vasculitis in a pediatric patient	PEDIATRICS INTERNATIONAL			English	Article						child; hypertension; proteinuria; renal artery; vasculitis		A 10-year-old girl presented with mild proteinuria and hypertension. Laboratory data indicated slightly elevated serum creatinine (0.67mg/dL) and elevated serum IgG (2111mg/dL). On renal arteriography mild stenosis over the entire length of the right renal artery and irregular stenosis of the interlobar arteries in the right kidney were seen. She was diagnosed with renovascular hypertension, and received conventional anti-hypertensive therapy, but did not respond to them. The right kidney had atrophy and dysfunction on technetium-99m-labeled dimercaptosuccinic acid renal scintigraphy, and was therefore resected. Histopathology of the kidney indicated severe necrotizing granulomatous vasculitis affecting the arteries from the renal hilus to the interlobar area. After nephrectomy plus steroid pulse therapy, blood pressure and urinary protein returned to normal. To our knowledge, this is the first report of necrotizing granulomatous vasculitis limited to the medium-sized renal arteries.	[Odaka, Jun; Kanai, Takahiro; Ito, Takane; Saito, Takashi; Aoyagi, Jun; Yamagata, Takanori] Jichi Med Univ, Jichi Childrens Med Ctr Tochigi, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan; [Ueda, Yoshihiko] Dokkyo Med Univ, Koshigaya Hosp, Dept Pathol, Saitama, Japan	Odaka, J (reprint author), Jichi Med Univ, Jichi Childrens Med Ctr Tochigi, Dept Pediat, 3311-1 Yakushiji Shimotsuke Shi, Shimotsuke, Tochigi 3290498, Japan.	mrjo@jichi.ac.jp					ALGUACILGARCIA GF, 1995, J CLIN PATHOL, V48, P579, DOI 10.1136/jcp.48.6.579; Dillon MJ, 2010, PEDIATR NEPHROL, V25, P1641, DOI 10.1007/s00467-009-1336-1; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Dillons MJ, 2006, PEDIATR NEPHROL, V26, P1219; Hailwood SJ, 1999, NEPHROL DIAL TRANSPL, V14, P952, DOI 10.1093/ndt/14.4.952; KOSS MN, 1981, AM J SURG PATHOL, V5, P21, DOI 10.1097/00000478-198101000-00005; Roussou M, 2008, UROLOGY, V71, pe1; Sahin H, 2012, IRAN J RADIOL, V9, P37, DOI 10.5812/iranjradiol.6572	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					777	780		10.1111/ped.12652		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500060		
J	Hayakawa, I; Hataya, H; Yamanouchi, H; Sakakibara, H; Terakawa, T				Hayakawa, Itaru; Hataya, Hiroshi; Yamanouchi, Hanako; Sakakibara, Hiroshi; Terakawa, Toshiro			Neonatal Staphylococcus lugdunensis urinary tract infection	PEDIATRICS INTERNATIONAL			English	Article						children; Staphylococcus lugdunensis; urinary tract infection		Staphylococcus lugdunensis is a known pathogen of infective endocarditis, but not of urinary tract infection. We report a previously healthy neonate without congenital anomalies of the kidney and urinary tract who developed urinary tract infection due to Staphylococcus lugdunensis, illustrating that Staphylococcuslugdunensis can cause urinary tract infection even in those with no urinary tract complications.	[Hayakawa, Itaru; Hataya, Hiroshi; Yamanouchi, Hanako; Sakakibara, Hiroshi; Terakawa, Toshiro] Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Tokyo 1838561, Japan	Hataya, H (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Tokyo 1838561, Japan.	hiroshi_hataya@tmhp.jp					Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168; Bonadio W, 2014, PEDIATR INFECT DIS J, V33, P342, DOI 10.1097/INF.0000000000000110; Casanova-Roman M, 2004, SCAND J INFECT DIS, V36, P149, DOI 10.1080/00365540410019255; Chihara S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-225; Haile DT, 2002, J CLIN MICROBIOL, V40, P654, DOI 10.1128/JCM.40.2.654-656.2002; Klotchko A, 2011, SOUTH MED J, V104, P509, DOI 10.1097/SMJ.0b013e31821e91b1; Lees BK, 1978, AM J MED, V65, P303	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					783	785		10.1111/ped.12645		3	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500062		
J	Muta, Y; Odaka, A; Inoue, S; Komagome, M; Beck, Y; Tamura, M; Arai, E				Muta, Yuki; Odaka, Akio; Inoue, Seiichiro; Komagome, Masahiko; Beck, Yoshifumi; Tamura, Masanori; Arai, Eiichi			Acute acalculous cholecystitis with eosinophilic infiltration	PEDIATRICS INTERNATIONAL			English	Article						acute acalculous cholecystitis; children; eosinophilic cholecystitis	DIAGNOSIS	We report a case of acute acalculous cholecystitis with eosinophilic infiltration. A previously healthy 6-year-old boy was referred with right abdominal pain. Imaging demonstrated marked thickening of the gallbladder wall and peri-cholecystic effusion. Acute acalculous cholecystitis was diagnosed. Symptoms persisted despite conservative treatment, therefore cholecystectomy was performed. Pathology indicated infiltration of eosinophils into all layers of the gallbladder wall. The postoperative course was uneventful and the patient has had no further symptoms. Eosinophilic cholecystitis is acute acalculous cholecystitis with infiltration of eosinophils. The causes include parasites, gallstones, allergies, and medications. In addition, it may be seen in conjunction with eosinophilic gastroenteritis, eosinophilic pancreatitis, or both. An allergic reaction to abnormal bile is thought to be the underlying cause. The present case did not fulfill the diagnostic criteria of eosinophilic cholecystitis, but this may have been in the process of developing.	[Muta, Yuki; Odaka, Akio; Inoue, Seiichiro; Komagome, Masahiko; Beck, Yoshifumi] Saitama Med Univ, Saitama Med Ctr, Dept Hepato Biliary Pancreat & Pediat Surg, Kawagoe, Saitama 3508550, Japan; [Tamura, Masanori] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama 3508550, Japan; [Arai, Eiichi] Saitama Med Univ, Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan	Muta, Y (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Hepato Biliary Pancreat & Pediat Surg, Kamoda 1981, Kawagoe, Saitama 3508550, Japan.	ymuta@saitama-med.ac.jp					Adusumilli PS, 2002, SURGERY, V131, P352, DOI 10.1067/msy.2002.121540; Albot G, 1949, DIGEST DIS SCI, V57, P558; SAVOCA PE, 1990, ANN SURG, V211, P433, DOI 10.1097/00000658-199004000-00009; Kalliafas S, 1998, AM SURGEON, V64, P471; DABBS DJ, 1993, AM J SURG PATHOL, V17, P497, DOI 10.1097/00000478-199305000-00009; FELMAN RH, 1994, DIGEST DIS SCI, V39, P418, DOI 10.1007/BF02090217; Imamoglu M, 2002, J PEDIATR SURG, V37, P36, DOI 10.1053/jpsu.2002.29423; Shin YH, 2007, PEDIATR INT, V49, P674, DOI 10.1111/j.1442-200X.2007.02436.x	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					788	791		10.1111/ped.12650		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500064		
J	Miyagaki, S; Imamura, T; Okumura, Y; Ito, I; Fujiki, A; Osone, S; Ishida, H; Hosoi, H				Miyagaki, Satoshi; Imamura, Toshihiko; Okumura, Yoshiki; Ito, Ikuyo; Fujiki, Atsushi; Osone, Shinya; Ishida, Hiroyuki; Hosoi, Hajime			Successful treatment of relapsed anaplastic large cell lymphoma with vinblastine monotherapy and allo-HSCT with reduced intensity conditioning regimen	PEDIATRICS INTERNATIONAL			English	Article						allogeneic hematopoietic stem cell transplantation; anaplastic large cell lymphoma; reduced intensity conditioning; vinblastine	BONE-MARROW-TRANSPLANTATION; CHILDREN; ADOLESCENTS; SERIES	Relapsed anaplastic large cell lymphoma (ALCL) is chemosensitive, but recurrence is common. Although vinblastine (VLB) monotherapy is an effective treatment for relapsed ALCL, the optimal treatment duration is unknown, and some patients experience further relapse after completing the treatment. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is also an effective treatment for relapsed ALCL, although transplant-related toxicity is a problem. Here, we report an 11-year-old patient with relapsed ALCL who underwent induction therapy with VLB monotherapy and achieved complete remission (CR) after 12 courses. CR was confirmed on positron emission tomography-computed tomography. The patient then underwent allo-HSCT with reduced intensity conditioning (fludarabine, melphalan, and low-dose total body irradiation). He developed grade II acute graft-versus-host disease (GVHD), which was successfully treated with methylprednisolone. There was no evidence of chronic GVHD. He has remained in CR without any complications for 19months after allo-HSCT.	[Miyagaki, Satoshi; Imamura, Toshihiko; Okumura, Yoshiki; Ito, Ikuyo; Osone, Shinya; Ishida, Hiroyuki; Hosoi, Hajime] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 6028566, Japan; [Fujiki, Atsushi; Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan	Imamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Pediat, Kamigyo Ku, Kajii Cho, Kyoto 6028566, Japan.	imamura@koto.kpu-m.ac.jp					Garner R, 2009, J PEDIAT HEMATOL ONC, V31, P145, DOI 10.1097/MPH.0b013e31819146f8; Brugieres L, 2000, ANN ONCOL, V11, P53, DOI 10.1023/A:1008352726155; Brugieres L, 2009, J CLIN ONCOL, V27, P5056, DOI 10.1200/JCO.2008.20.1764; Gross TG, 2010, BIOL BLOOD MARROW TR, V16, P223, DOI 10.1016/j.bbmt.2009.09.021; Dodero A, 2012, LEUKEMIA, V26, P520, DOI 10.1038/leu.2011.240; Bordon Victoria, 2005, Haematologica, V90, pECR19; Cesaro S, 2005, EUR J HAEMATOL, V75, P22, DOI 10.1111/j.1600-0609.2005.00422.x; CHAKRAVARTI V, 1990, J CLIN ONCOL, V8, P657; Chen CH, 2007, INT J HEMATOL, V85, P105, DOI 10.1532/IJH97.A10608; DeLeys ML, 2010, J CLIN ONCOL, V28, P3987; Moris T, 2005, BRIT J HAEMATOL, V132, P594; Ohta H, 2010, INT J HEMATOL, V92, P190, DOI 10.1007/s12185-010-0620-y; Shingu K, 2011, J ANESTH, V25, P240, DOI 10.1007/s00540-011-1105-8; Woessmann W, 2006, BRIT J HAEMATOL, V133, P176, DOI 10.1111/j.1365-2141.2006.06004.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					791	794		10.1111/ped.12643		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500065		
J	Inoue, T; Murakami, N; Sakadume, S; Kido, Y; Kikuchi, A; Ichinoi, N; Suzuki, K; Kure, S; Sakuta, R				Inoue, Takeshi; Murakami, Nobuyuki; Sakadume, Satoru; Kido, Yasuhiro; Kikuchi, Astuo; Ichinoi, Natsuko; Suzuki, Kensuke; Kure, Shigeo; Sakuta, Ryoichi			Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213	PEDIATRICS INTERNATIONAL			English	Article						familial; moyamoya disease; phenotype; RNF213; unilateral	C.14576G-GREATER-THAN-A VARIANT	Moyamoya disease (MMD) is a chronic steno-occlusive arteriopathy involving the development of abnormal collateral vessels. Ring finger protein (RNF213) on the 17q25.3 locus was identified as an MMD-susceptibility gene in East Asian populations. We report a 5-year-old Japanese boy diagnosed with cerebral infarction and unilateral MMD. Magnetic resonance angiography (MRA) showed severe stenosis of the left internal carotid artery (ICA), terminal portion of the left ICA, and left origin of the posterior cerebral artery. Genetic testing indicated a heterozygous c.14429G>A (formerly described as c.14576G>A) variant in RNF213. The boy's mother had no neurological symptoms, but sequencing of RNF213 showed the same variant, and MRA indicated stenosis of the terminal bilateral ICA. This is the first report, to our knowledge, of different MMD phenotypes in a familial case involving the same heterozygous c.14429G>A variant in RNF213. Genetic testing for RNF213 is suggested for family member screening.	[Inoue, Takeshi; Murakami, Nobuyuki; Sakadume, Satoru; Kido, Yasuhiro; Kikuchi, Astuo; Ichinoi, Natsuko; Suzuki, Kensuke; Kure, Shigeo; Sakuta, Ryoichi] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan	Inoue, T (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	tinoue@dokkyomed.ac.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Miyatake S, 2012, J HUM GENET, V57, P804, DOI 10.1038/jhg.2012.105; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Yeon JY, 2011, STROKE, V42, P2973, DOI 10.1161/STROKEAHA.111.622522; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Fujimura Miki, 2014, J Stroke, V16, P65, DOI 10.5853/jos.2014.16.2.65; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Yamauchi T, 1997, CLIN NEUROL NEUROSUR, V99, pS162	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2015	57	4					798	801		10.1111/ped.12689		4	Pediatrics	Pediatrics	CQ3KR	WOS:000360501500067		
J	Wang, JY; Sun, HB; Sheng, Y; Gao, F; Yin, Y; Li, Y; Pan, LJ; Zheng, YD; Shi, Y; Sekiguchi, T				Wang, Jianyu; Sun, Huabin; Sheng, Yun; Gao, Fan; Yin, Yao; Li, Yun; Pan, Lijia; Zheng, Youdou; Shi, Yi; Sekiguchi, Takashi			Spontaneous Ga incorporation in ZnO nanowires epitaxially grown on GaN substrate	PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS			English	Article						ZnO nanowires; epitaxial growth; Ga atoms; incorporation; surface diffusion; GaN substrates	CORE-SHELL NANOWIRES; SILICON NANOWIRES; SURFACE-DIFFUSION; DEPOSITION; BOUNDARY; ARRAYS	Surface-diffusion-induced spontaneous Ga incorporation process is demonstrated in ZnO nanowires grown on GaN substrate. Crucially, contrasting distributions of Ga atoms in axial and radial directions are experimentally observed. Ga atoms uniformly distribute along the similar to 10 mu m long ZnO nanowire and show a rapidly gradient distribution in the radial direction, which is attributed substantially to the difference between surface and volume diffusion. The understanding on the incorporation process can potentially modulate doping and properties in semiconductor nanomaterials. [GRAPHICS] (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Wang, Jianyu; Sun, Huabin; Sheng, Yun; Gao, Fan; Yin, Yao; Li, Yun; Pan, Lijia; Zheng, Youdou; Shi, Yi] Nanjing Univ, Key Lab Adv Photon & Elect Mat, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Jianyu; Sun, Huabin; Sheng, Yun; Gao, Fan; Yin, Yao; Li, Yun; Pan, Lijia; Zheng, Youdou; Shi, Yi] Nanjing Univ, Sch Elect Sci & Engn, Nanjing 210093, Jiangsu, Peoples R China; [Li, Yun; Pan, Lijia; Zheng, Youdou; Shi, Yi] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Sekiguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Shi, Y (reprint author), Nanjing Univ, Key Lab Adv Photon & Elect Mat, Nanjing 210093, Jiangsu, Peoples R China.	yshi@nju.edu.cn; SEKIGUCHI.Takashi@nims.go.jp	Li, Yun/D-5437-2011; takashi, Sekiguchi/D-2603-2010	Li, Yun/0000-0003-1753-7317; 	National Basic Research Program of China [2013CB932900, 2011CB922100]; NSFC [61205057, 61204050]; NSFJS [BK2011011, BK20130055]; China Scholarship Council	The authors acknowledge the financial support from the National Basic Research Program of China under Grant Nos. 2013CB932900 and 2011CB922100, NSFC under Grant Nos. 61205057 and 61204050, and NSFJS under Grant Nos. BK2011011 and BK20130055. J. Y. Wang also wants to thank China Scholarship Council for supporting his study in Japan.	Li A, 2013, CRYST GROWTH DES, V13, P878, DOI 10.1021/cg301565p; Pankoke V, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085425; Park SH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2215631; Fukata N, 2011, NANO LETT, V11, P651, DOI 10.1021/nl103773e; Li Y, 2006, MATER TODAY, V9, P18, DOI 10.1016/S1369-7021(06)71650-9; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Dillen DC, 2014, NAT NANOTECHNOL, V9, P116, DOI [10.1038/nnano.2013.301, 10.1038/NNANO.2013.301]; Jensen LE, 2004, NANO LETT, V4, P1961, DOI 10.1021/nl048825k; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wallentin J, 2013, SCIENCE, V339, P1057, DOI 10.1126/science.1230969; Duan XJ, 2013, NANO TODAY, V8, P351, DOI 10.1016/j.nantod.2013.05.001; Rozhavskaya MM, 2015, PHYS STATUS SOLIDI A, V212, P851, DOI 10.1002/pssa.201431912; Xu L, 2013, NANO LETT, V13, P746, DOI 10.1021/nl304435z; Meyer B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035403; Dai J, 2011, ADV MATER, V23, P4115, DOI 10.1002/adma.201102184; Yu LW, 2014, NANO LETT, V14, P6469, DOI 10.1021/nl503001g; Qiu ZW, 2015, J PHYS CHEM C, V119, P4371, DOI 10.1021/jp511872c; Kim DS, 2009, J CRYST GROWTH, V311, P3216, DOI 10.1016/j.jcrysgro.2009.03.026; Dubrovskii VG, 2014, J CRYST GROWTH, V401, P431, DOI [10.1016/j.jcrysgro.2014.01.015, 10.1016/j.jcrysgro.2013.01.015]; Schneider R, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2905284; Zhao QX, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135880; Boland JL, 2015, NANO LETT, V15, P1336, DOI 10.1021/nl504566t; Moutanabbir O, 2013, NATURE, V496, P78, DOI 10.1038/nature11999; Chen WH, 2012, J APPL PHYS, V111, DOI 10.1063/1.4714364; HIROTA K, 1977, J AM CERAM SOC, V60, P105, DOI 10.1111/j.1151-2916.1977.tb15481.x; MAHAN GD, 1980, J APPL PHYS, V51, P2634, DOI 10.1063/1.327994; Morshed MM, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902921; Sheng Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795317; Wada T, 1996, PHYS REV B, V53, P4770, DOI 10.1103/PhysRevB.53.4770; Wang DD, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861936; Yang ZX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6249	31	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	AUG	2015	9	8					466	469		10.1002/pssr.201510229		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CQ1TN	WOS:000360382300005		
J	Nakamura, T; Furukawa, K; Terauchi, T; Kobayashi, Y				Nakamura, Toshikazu; Furukawa, Ko; Terauchi, Takeshi; Kobayashi, Yuka			Microscopic evidence of a metallic state in the one-pot organic conductor ammonium tetrathiapentalene carboxylate	PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS			English	Article						organic conductors; self-doping; nuclear magnetic resonance; electron spin resonance; (TTPCOO)(2)NH4	TTF	H-1 NMR (nuclear magnetic resonance) and high-field ESR (electron spin resonance) measurements were carried out for self-doped organic conductors in the ammonium tetrathiapentalene carboxylate (TTPCOO)(2)[(NH41+)(1-x)(NH30)(x)] system. While the pristine TTPCOOH molecule is closed-shell, self-doped carriers are generated by substitution of the carboxyl proton by (NH30) and (NH41+), which can be regarded as a charge reservoir. The pi-extended system TTPCOO has a uniaxial g-tensor, indicating a 2D isotropic structure such as a herring-bone-like or parallel cross donor arrangement. The NMR-relaxation rate indicated the Korringa relation in the temperature dependence, and the ESR linewidth followed the Elliot mechanism. Both of these observations provide supporting evidence for a stable metallic state. In this paper, we introduce self-doped organic conductors as a branch of materials design, and emphasize that advanced magnetic resonance measurements are powerful tools for developing functional materials. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Nakamura, Toshikazu] Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Furukawa, Ko] Niigata Univ, Ctr Instrumental Anal, Nishi Ku, Niigata 9502181, Japan; [Terauchi, Takeshi; Kobayashi, Yuka] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Nakamura, T (reprint author), Inst Mol Sci, Okazaki, Aichi 4448585, Japan.	t-nk@ims.ac.jp	KOBAYASHI, Yuka/H-2838-2011		JSPS [20340095, 25287091]	This study was supported by a Grant-in-Aid for Scientific Research (B) (KAKENHI Grant Numbers 20340095 and 25287091) from JSPS.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Kobayashi Y, 2009, J AM CHEM SOC, V131, P9995, DOI 10.1021/ja809425b; Furukawa K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.053701; Kobayashi A, 2004, CHEM REV, V104, P5243, DOI 10.1021/cr030656I; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; NAKAMURA T, 1994, J PHYS SOC JPN, V63, P4110, DOI 10.1143/JPSJ.63.4110; Charles P., 1990, SLICHTER PRINCIPLES; GARIN J, 1994, SYNTHESIS-STUTTGART, P489; Ishiguro T., 1998, ORGANIC SUPERCONDUTO; Isono T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2352; Nakamura T, 2000, J PHYS SOC JPN, V69, P504, DOI 10.1143/JPSJ.69.504; TAKAHASHI T, 1984, J PHYS-PARIS, V45, P945, DOI 10.1051/jphys:01984004505094500; Terauchi T, 2014, CHEM COMMUN, V50, P7111, DOI 10.1039/c4cc00678j; YAFET Y, 1973, PHYS REV B, V7, P1263, DOI 10.1103/PhysRevB.7.1263; Yamamoto HM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3379	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	AUG	2015	9	8					480	484		10.1002/pssr.201510206		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CQ1TN	WOS:000360382300008		
J	Cartagena, JA; Seki, M; Tanaka, M; Yamauchi, T; Sato, S; Hirakawa, H; Tsuge, T				Cartagena, Joyce A.; Seki, Motoaki; Tanaka, Maho; Yamauchi, Takaki; Sato, Shusei; Hirakawa, Hideki; Tsuge, Takashi			Gene Expression Profiles in Jatropha Under Drought Stress and During Recovery	PLANT MOLECULAR BIOLOGY REPORTER			English	Article						Jatropha; Drought; Recovery; Microarray analysis	LENGTH CDNA MICROARRAY; ORYZA-SATIVA L.; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; WATER-STRESS; FUNCTIONAL-ANALYSIS; GLYCINE BETAINE; HIGH-SALINITY; NF-Y; TOLERANCE	Jatropha is known for its ability to grow in marginal lands and drought prone areas receiving limited amounts of rainfall. Accordingly, gene discovery in Jatropha will be useful for providing a source of genetic information for the improvement of drought tolerance in crops. In this study, gene expression profiling was performed using a newly developed Jatropha 44 K custom oligomicroarray on Jatropha plants subjected to drought stress and recovery from stress. When the gene expression patterns were compared between those differentially expressed during exposure to drought stress and re-watering, it was possible to identify 332 genes that are involved in the response to dehydration, while 585 genes were found to be significant during recovery, and 374 genes are associated with both dehydration and recovery. Furthermore, representative genes from the three gene categories were compared to those found in other plant species, and a basic understanding on how Jatropha copes with drought and its mechanism for survival in dry conditions is discussed. Taken together, the oligomicroarray that we developed in this study is a useful tool for analyzing expression profiles of Jatropha genes to better understand the molecular mechanism underlying drought stress responses as well as other aspects of molecular studies in Jatropha.	[Cartagena, Joyce A.; Yamauchi, Takaki; Tsuge, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Seki, Motoaki; Tanaka, Maho] RIKEN, Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki] Japan Sci & Technol, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Shusei; Hirakawa, Hideki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	Cartagena, JA (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	joyce@agr.nagoya-u.ac.jp			Japan Science and Technology Agency (JST), Core Research for Evolutionary Science and Technology (CREST); RIKEN Research Institute	This study was supported in part by Japan Science and Technology Agency (JST), Core Research for Evolutionary Science and Technology (CREST) and grants from the RIKEN Research Institute.	Achten WMJ, 2010, BIOMASS BIOENERG, V34, P667, DOI 10.1016/j.biombioe.2010.01.010; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Caldas T, 1999, MICROBIOL-SGM, V145, P2543; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Pompelli MF, 2010, BIOMASS BIOENERG, V34, P1207, DOI 10.1016/j.biombioe.2010.03.011; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Chen YL, 2013, SCI WORLD J, DOI 10.1155/2013/954640; Cho EK, 2009, BIOTECHNOL LETT, V31, P597, DOI 10.1007/s10529-008-9880-5; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Moore JP, 2008, PHYSIOL PLANTARUM, V134, P237, DOI 10.1111/j.1399-3054.2008.01134.x; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Zhang Y, 2007, ACTA BIOCH BIOPH SIN, V39, P787, DOI 10.1111/j.1745-7270.2007.00334.x; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Krishnamurthy L, 2012, BIOMASS BIOENERG, V39, P247, DOI 10.1016/j.biombioe.2012.01.015; Orfila C, 2012, PLANTA, V236, P185, DOI 10.1007/s00425-012-1596-z; Hu XL, 2010, PLANT GROWTH REGUL, V60, P225, DOI 10.1007/s10725-009-9436-2; Tang MJ, 2007, PLANT MOL BIOL, V63, P419, DOI 10.1007/s11103-006-9098-7; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Sapeta H, 2013, ENVIRON EXP BOT, V85, P76, DOI 10.1016/j.envexpbot.2012.08.012; Wang CR, 2008, PLANTA, V227, P1127, DOI 10.1007/s00425-007-0686-9; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Yang ZB, 2013, J EXP BOT, V64, P5569, DOI 10.1093/jxb/ert328; Zhang FL, 2008, PLANT SCI, V174, P510, DOI 10.1016/j.plantsci.2008.01.018; Zhang HW, 2013, PLANTA, V237, P1443, DOI 10.1007/s00425-013-1852-x; Aprile A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-821; dos Santos CM, 2013, IND CROP PROD, V41, P203, DOI 10.1016/j.indcrop.2012.04.003; Eswaran N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-23; Fornari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082043; Georges F, 2009, PLANT CELL ENVIRON, V32, P1664, DOI 10.1111/j.1365-3040.2009.02027.x; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; IPCC, 2013, CLIMATE CHANGE 2013; Jia HY, 2012, ACTA PHYSIOL PLANT, V34, P1239, DOI 10.1007/s11738-012-0969-z; Kheira AAA, 2009, BIOMASS BIOENERG, V33, P1343, DOI DOI 10.1016/J.BI0MBI0E.2008.05.015; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Li YC, 2012, J PLANT BIOL, V55, P349, DOI 10.1007/s12374-011-0032-4; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Minh-Thu PT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-38; Najafabadi MS, 2012, IRAN J BIOTECHNOL, V10, P40; Niu G., 2012, INT J AGRON, V2012, P1, DOI [10.1155/2012/632026, DOI 10.1155/2012/632026]; Perrone I, 2012, PLANTA, V235, P1383, DOI 10.1007/s00425-011-1581-y; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shan XH, 2013, PLANT MOL BIOL REP, V31, P1485, DOI 10.1007/s11105-013-0622-z; Smart LB, 2001, PLANT CELL PHYSIOL, V42, P686, DOI 10.1093/pcp/pce085; Thao NP, 2013, INT J MOL SCI, V14, P23828, DOI 10.3390/ijms141223828; YAMAGUCHISHINOZAKI K, 1993, PLANT PHYSIOL, V101, P1119, DOI 10.1104/pp.101.3.1119; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0735-9640	1572-9818		PLANT MOL BIOL REP	Plant Mol. Biol. Rep.	AUG	2015	33	4					1075	1087		10.1007/s11105-014-0815-0		13	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CQ1XA	WOS:000360392400027		
J	Rauwald, HW; Savtschenko, A; Merten, A; Rusch, C; Appel, K; Kuchta, K				Rauwald, Hans Wilhelm; Savtschenko, Alex; Merten, Alexander; Rusch, Christian; Appel, Kurt; Kuchta, Kenny			GABA(A) Receptor Binding Assays of Standardized Leonurus cardiaca and Leonurus japonicus Extracts as Well as Their Isolated Constituents	PLANTA MEDICA			English	Article						Leonurus cardiaca; Leonurus japonicus; Lamiaceae; GABA; anxiolytic; sedative; leonurine	VALERENIC ACID-DERIVATIVES; LEONOTIS-LEONURUS; DITERPENES; SYSTEM; PHARMACOKINETICS; QUANTIFICATION; HYDROXYTYROSOL; IDENTIFICATION; STACHYDRINE; ANTIOXIDANT	A main traditional use of European Leonurus cardiaca and East Asian Leonurus japonicus is in the treatment of neurological disorders such as anxiety, depression, nervousness, and as a sedative for insomnia. However, their mechanism of action is still under discussion. As anxiety and depressive disorders are increasingly being recognized as connected to dysfunctions of the gamma-aminobutyric acid system, the in vitro effects of standardized L.cardiaca and L japonicus extracts as well as five of their isolated constituents, namely, the labdane-type isoleosibirin, the novel iridoid 7R-chloro-6-desoxy-harpagide, the phenylethanoid lavandulifolioside, and the N-containing compounds stachydrine and leonurine, on this type of neuronal receptor were investigated for the first time. Extracts of L.cardiaca and L. japonicus, characterized by reversed-phase high-performance liquid chromatography determination, as well as their above named isolated, possible active constituents of different chemical nature were tested in several receptor binding assays at rat GABA(A) receptors using [H-3]-SR95531 and [H-3]-Ro-15-1788 (flumazenil)/diazepam control. The L.cardiaca and L.japonicus extracts as well as leonurine inhibited the concentration-dependent binding of [H-3]-SR95531 to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor with a high binding affinity: IC(50)s 21 mu g/ml, 46 mu g/ml, and 15 mu g/ml, respectively. In contrast, binding to the benzodiazepine site of the rat gamma-aminobutyric acid type A receptor had a 15 to 30 times lower binding affinity than to the gamma-aminobutyric acid site. The presented experiments provide hints that the neurological mechanism of action of L.cardiaca and L.japonicus may essentially be based on their interaction to the gamma-aminobutyric acid site of the gamma-aminobutyric acid type A receptor, while the benzodiazepine site most probably does not contribute to this effect. In the case of L.japonicus, these effects can be at least partially explained by its leonurine constituent, whereas the active principle of L.cardiaca, which does not contain leonurine, is subject to further research as none of the other investigated individual constituents displayed significant activity in the applied test system.	[Rauwald, Hans Wilhelm; Savtschenko, Alex; Merten, Alexander; Rusch, Christian] Univ Leipzig, Dept Pharmaceut Biol, D-04103 Leipzig, Germany; [Appel, Kurt] VivaCell Biotechnol, Denzlingen, Germany; [Kuchta, Kenny] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, Tokyo, Japan	Rauwald, HW (reprint author), Univ Leipzig, Dept Pharmaceut Biol, Johannisallee 21-23, D-04103 Leipzig, Germany.	kkuchta@rz.uni-leipzig.de					Kuchta K, 2013, PHARMAZIE, V68, P534, DOI 10.1691/ph.2013.6527; Khom S, 2010, BRIT J PHARMACOL, V161, P65, DOI 10.1111/j.1476-5381.2010.00865.x; Houghton PJ, 1999, J PHARM PHARMACOL, V51, P505, DOI 10.1211/0022357991772772; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; D'Angelo S, 2001, DRUG METAB DISPOS, V29, P1492; Schramm A, 2013, PHYTOCHEMISTRY, V96, P318, DOI 10.1016/j.phytochem.2013.08.004; Moon HI, 2010, PHYTOTHER RES, V24, P1256, DOI 10.1002/ptr.3144; Kuchta K, 2012, PHARMAZIE, V67, P973, DOI 10.1691/ph.2012.1856; Benke D, 2009, NEUROPHARMACOLOGY, V56, P174, DOI 10.1016/j.neuropharm.2008.06.013; Gonzalez-Correa JA, 2008, NEUROSCI LETT, V446, P143, DOI 10.1016/j.neulet.2008.09.022; Grundmann O, 2008, PLANTA MED, V74, P1769, DOI 10.1055/s-0028-1088322; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Kuchta K, 2014, FITOTERAPIA, V96, P8, DOI 10.1016/j.fitote.2014.03.023; He F, 2012, PHYTOCHEMISTRY, V83, P168, DOI 10.1016/j.phytochem.2012.07.014; Bruckner A, 2012, Z PHYTOTHER S, VS01, pP07; Engin E, 2008, PROG NEURO-PSYCHOPH, V32, P1399, DOI 10.1016/j.pnpbp.2008.03.020; Felter HW, 1922, ELECT MATERIA MED PH, P251; HEAULME M, 1987, J NEUROCHEM, V48, P1677, DOI 10.1111/j.1471-4159.1987.tb05723.x; Hennebelle T, 2008, PHYTOTHER RES, V22, P256, DOI 10.1002/ptr.2266; Keller K, EMAHMPC1274302010; Kopp S, 2010, CHEMMEDCHEM, V5, P678, DOI 10.1002/cmdc.201000062; Korfers A, 2009, TRADITOINELLE CHINES, P35; Kozo-Poljanskij BM, 1945, MOTHERWORT NEW PHARM, P1; Kuchta K, 2012, PLANTA MED, V78, pPJ50; Li Shizhen, 2003, COMPENDIUM MAT MED, V15, P1637; Loh KP, 2009, J ETHNOPHARMACOL, V125, P337, DOI 10.1016/j.jep.2009.05.025; Lombardi A, 1947, LEONURUS CARDIACA; Makarov V. G., 2006, Eksperimental'naya i Klinicheskaya Farmakologiya, V69, P23; Mehta AK, 1995, BRAIN RES, V704, P289, DOI 10.1016/0006-8993(95)01133-1; Mennini T., 1993, Fitoterapia, V64, P291; Nahrstedt A, 1985, Z PHYTOTHER, V6, P101; Nass R, 1996, PHYTOCHEMISTRY, V41, P489, DOI 10.1016/0031-9422(95)00477-7; Notzel I, 2013, THESIS LEIPZIG U LEI; ORLANDI E, 1950, Lattante, V21, P582; Ovanesov K. B., 2005, Eksperimental'naya i Klinicheskaya Farmakologiya, V68, P56; Ovanesov K. B., 2006, Eksperimental'naya i Klinicheskaya Farmakologiya, V69, P17; Qi J, 2010, BIOL PHARM BULL, V33, P1958, DOI 10.1248/bpb.33.1958; RACZ G, 1989, Planta Medica, V55, P97, DOI 10.1055/s-2006-961851; REUTER G, 1971, PHARMAZIE, V26, P777; Ritter M, 2010, PLANTA MED, V76, P572, DOI 10.1055/s-0029-1240602; Rusch C, 2010, PLANTA MED, V76, P1252; Shikov AN, 2011, PHYTOTHER RES, V25, P540, DOI 10.1002/ptr.3292; Sugaya K, 1998, FOOD SCI TECHNOL INT, V4, P278; Trauner G, 2008, PLANTA MED, V74, P19, DOI 10.1055/s-2007-993761; WAGNER H, 1980, PLANTA MED, V39, P358, DOI 10.1055/s-2008-1074930; Weiss RF, 1960, LEHRBUCH PHYTOTHERAP, V2nd, P213; Wu YT, 2006, J CHROMATOGR B, V844, P89, DOI 10.1016/j.jchromb.2006.07.011; Yasar SN, 2013, PHYTOTHER RES, V27, P877, DOI 10.1002/ptr.4801; Yuan CS, 2004, ANESTH ANALG, V98, P353, DOI 10.1213/01.ANE.0000096189.70405.A5; Zaugg J, 2011, J NAT PROD, V74, P1764, DOI 10.1021/np200317p	50	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	AUG	2015	81	12-13					1103	1110		10.1055/s-0035-1546234		8	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CP7UZ	WOS:000360095600017		
J	Kenzaka, T				Kenzaka, Tsuneaki			Influenza follicles in the posterior pharyngeal wall	POSTGRADUATE MEDICAL JOURNAL			English	Editorial Material									[Kenzaka, Tsuneaki] Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Tochigi 3290498, Japan; [Kenzaka, Tsuneaki] Kobe Univ, Grad Sch Med, Div Community Med & Career Dev, Kobe, Hyogo 657, Japan	Kenzaka, T (reprint author), Jichi Med Univ Hosp, Div Gen Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	smile.kenzaka@jichi.ac.jp					Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI [10.7326/0003-4819-156-7-201204030-00403, 10.1059/0003-4819-156-7-201204030-00403]; Gershon A, 2008, HARRISONS PRINCIPLES, V17th, P1217; Miyamoto A, 2011, GEN MED, V12, P51; Sukuma T, ATLAS SUKUMA PEDIAT	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0032-5473	1469-0756		POSTGRAD MED J	Postgrad. Med. J.	AUG	2015	91	1078					472	472		10.1136/postgradmedj-2015-133344		1	Medicine, General & Internal	General & Internal Medicine	CQ1PX	WOS:000360371500009		
J	Yoshimura, M; Kurokawa, E; Noda, T; Hineno, K; Tanaka, Y; Kawai, Y; Dillbeck, MC				Yoshimura, Mitsunobu; Kurokawa, Etsuko; Noda, Takayuki; Hineno, Koji; Tanaka, Yasuo; Kawai, Yuji; Dillbeck, Michael C.			DISASTER RELIEF FOR THE JAPANESE EARTHQUAKE-TSUNAMI OF 2011: STRESS REDUCTION THROUGH THE TRANSCENDENTAL MEDITATION (R) TECHNIQUE	PSYCHOLOGICAL REPORTS			English	Article							CONGOLESE REFUGEES; TRAIT ANXIETY; SYMPTOMS	This study examined changes in self-reported stress symptoms after instruction in the Transcendental Meditation (R) technique among 171 residents of two cities (Sendai and Ishinomaki) directly affected by the 2011 Japan earthquake and tsunami disaster compared with 326 non-disaster Tokyo participants previously tested before and after learning the technique and a no-treatment control group (n = 68). The participants completed a rating checklist of mental and physical symptoms. Disaster area participants who learned the Transcendental Meditation (R) technique in contrast to controls showed a significant drop in total symptom score from pre-test to post-test (effect size = -1.09). Results were comparable for an ordinal measure of symptom intensity. The findings suggest the potential value of this procedure for relief from disaster trauma.	[Yoshimura, Mitsunobu; Kurokawa, Etsuko] G Yamato, Urayasu, Japan; [Noda, Takayuki] Kensei Ltd Healthcare Corp, Sendai, Miyagi, Japan; [Hineno, Koji] Chokushi Kai Fukuroda Hosp, Daigo, Japan; [Tanaka, Yasuo] Shihonomori Clin, Tsukuba, Ibaraki, Japan; [Kawai, Yuji] Maharishi Inst Total Educ, Kyoto, Japan; [Dillbeck, Michael C.] Maharishi Univ Management, Fairfield, IA 52557 USA	Dillbeck, MC (reprint author), Maharishi Univ Management, Inst Sci Technol & Publ Policy, Fairfield, IA 52557 USA.	mdillbeck@mum.edu					EPPLEY KR, 1989, J CLIN PSYCHOL, V45, P957, DOI 10.1002/1097-4679(198911)45:6<957::AID-JCLP2270450622>3.0.CO;2-Q; Rees B, 2013, J TRAUMA STRESS, V26, P295, DOI 10.1002/jts.21790; Borenstein M, 2009, INTRO METAANALYSIS; BROOKS JS, 1985, J COUNS DEV, V64, P212; DILLBECK MC, 1987, AM PSYCHOL, V42, P879, DOI 10.1037//0003-066X.42.9.879; FERRIS E., 2013, UP FRONT; KAWAI Y., 2000, MENTAL PHYS SY UNPUB; Orme-Johnson DW, 2014, J ALTERN COMPLEM MED, V20, P330, DOI 10.1089/acm.2013.0204; Rees B, 2014, J TRAUMA STRESS, V27, P112, DOI 10.1002/jts.21883; Rosenthal JZ, 2011, MIL MED, V176, P626; ROTH R., 2002, MAHARISHI MAHESH YOG; YOGI MAHARISHI MAHESH, 1967, TRANSCENDENTAL MEDIT	12	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	AUG	2015	117	1					206	216		10.2466/02.13.PR0.117c11z6		11	Psychology, Multidisciplinary	Psychology	CP9BY	WOS:000360189900014		
J	Matsushima, R; Ozaki, H				Matsushima, Rumi; Ozaki, Hitomi			RELATIONSHIPS BETWEEN IDENTITY AND ACADEMIC MOTIVATION	PSYCHOLOGICAL REPORTS			English	Article							EGO-IDENTITY; PROCESSING STYLE; UNIVERSITY; STUDENTS; ADOLESCENTS	This study examined university students' academic motivation, focusing on individual differences in their sense of identity. The participants were 109 female Japanese students from two private universities (age range = 19-22 yr., M = 19.3, SD = 0.6). They completed four scales: the Multidimensional Ego Identity Scale, the Scale of Students' Attitude Toward Their Classes, the Academic Motivation Inventory, and the Scale of Lecture Self-Evaluation. Correlational analyses assessed the relationships between subscales. Then, path analysis was conducted to evaluate whether sense of identity affected attitude toward classes, academic motivation, and lecture self-evaluation. Differences particularly in psychosocial identity and self-identity accounted for significant variance in the students' attitudes toward classes, academic motivation, and lecture self-evaluation.	[Matsushima, Rumi; Ozaki, Hitomi] Kyoto Notre Dame Univ, Fac Psychol, Sakyo Ku, Kyoto 6060847, Japan	Matsushima, R (reprint author), Kyoto Notre Dame Univ, Fac Psychol, Sakyo Ku, 1 Minami Nonogamicho, Kyoto 6060847, Japan.	rumim@notredame.ac.jp					Berzonsky MD, 2000, J ADOLESCENT RES, V15, P81, DOI 10.1177/0743558400151005; MARCIA JE, 1966, J PERS SOC PSYCHOL, V3, P551, DOI 10.1037/h0023281; ECCLES JS, 1989, J PERS, V57, P283, DOI 10.1111/j.1467-6494.1989.tb00484.x; Faye C, 2008, CAN J BEHAV SCI, V40, P189, DOI 10.1037/a0012858; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037//0003-066X.55.5.469; Berzonsky MD, 2005, PERS INDIV DIFFER, V39, P235, DOI 10.1016/j.paid.2005.01.010; ROSENTHAL DA, 1981, J YOUTH ADOLESCENCE, V10, P525, DOI 10.1007/BF02087944; BENESSE EDUCATIONAL RESEARCH & DEVELOPMENT CENTER, 2012, DAIG DAT BOOK 2012; Boyd VS, 2003, J COLL STUDENT DEV, V44, P155, DOI 10.1353/csd.2003.0012; Erikson E., 1968, IDENTITY YOUTH CRISI; Erikson E. H., 1959, IDENTITY LIFE CYCLE; HATANO K., 2014, JAPANESE J DEV PSYCH, V25, P67; Hatano K, 2010, JPN J EDUC PSYCHOL, V58, P404; Ida K, 2003, JPN J EDUC PSYCHOL, V51, P367; Kaplan A, 2012, CONTEMP EDUC PSYCHOL, V37, P171, DOI 10.1016/j.cedpsych.2012.01.005; KASAHARA Y., 1984, APATHY SYNDROME; Lange C, 2002, ADOLESCENCE, V37, P93; Lucas M, 1997, J COUNS PSYCHOL, V44, P123, DOI 10.1037/0022-0167.44.2.123; Mahler M., 1975, PSYCHOL BIRTH HUMAN; MAKINO K., 2001, RES B TAKAMATSU U, V36, P67; MATSUSHIMA R., 2008, PSYCHE, V7, P39; MATSUSHIMA R., 2013, B KYOTO NOTRE DAME U, V43, P1; MIZOKAMI S., 2004, KYOTO U RES HIGHER E, V10, P67; MIZOKAMI S., 2006, DAIGAKUSEI NO MANABI; NAKANISHI N., 2001, SHINRI ASSESSMENT HA, P365; ONO H., 1984, JAPANESE J ED PSYCHO, V32, P100; OZAKI H., 2009, B KYOTO NOTRE DAME U, V39, P1; PROMOTION AND MUTUAL AID COOPERATION FOR PRIVATE SCHOOLS OF JAPAN, 2013, NYUUG GAN DOUK; Rosenberg M., 1965, SOC ADOLESCENT SELF; SHIMOYAMA H, 1995, JPN J EDUC PSYCHOL, V43, P145; SHIRAISHI H., 2005, JAPANESE J ADOLESCEN, V17, P1; TAKAGAKI M., 2006, B JAPANESE CURRICULU, V28, P1; Tani F, 2001, JPN J EDUC PSYCHOL, V49, P265; TANI F., 1998, JAPANESE J DEV PSYCH, V9, P35; TANI F., 2008, JIKO SHINRIGAKU, V5, P6; TETSUSHIMA K., 1993, JAPANESE J ED PSYCHO, V41, P200; UCHIDA C., 2008, 28 SURVEY ABSENTEES; WADA M., 1998, B TOKYO GAKUGEI U, V49, P133; WIGFIELD A., 2005, HDB COMPETENCE MOTIV, P222; YAMADA M., 2007, B GRADUATE SCH ED 3, V56, P199; Yamamoto M., 1982, JAPANESE J ED PSYCHO, V30, P64	41	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	AUG	2015	117	1					217	229		10.2466/07.10.PR0.117c16z7		13	Psychology, Multidisciplinary	Psychology	CP9BY	WOS:000360189900015		
J	Yamaya, M; Shimotai, Y; Hatachi, Y; Kalonji, NL; Tando, Y; Kitajima, Y; Matsuo, K; Kubo, H; Nagatomi, R; Hongo, S; Homma, M; Nishimura, H				Yamaya, Mutsuo; Shimotai, Yoshitaka; Hatachi, Yukimasa; Kalonji, Nadine Lusamba; Tando, Yukiko; Kitajima, Yasuo; Matsuo, Kaori; Kubo, Hiroshi; Nagatomi, Ryoichi; Hongo, Seiji; Homma, Morio; Nishimura, Hidekazu			The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells	PULMONARY PHARMACOLOGY & THERAPEUTICS			English	Article						Airway epithelial cell; Camostat; Cell culture; Influenza; Interleukin; Serine protease	TRYPSIN-LIKE PROTEASE; RESPIRATORY EPITHELIUM; NEUTROPHIL ELASTASE; GABEXATE MESILATE; AIRWAY EPITHELIUM; GENE-EXPRESSION; SODIUM-CHANNEL; SENDAI VIRUS; HOST-DEFENSE; A VIRUSES	Background: Serine proteases act through the proteolytic cleavage of the hemagglutinin (HA) of influenza viruses for the entry of influenza virus into cells, resulting in infection. However, the inhibitory effects of serine protease inhibitors on influenza virus infection of human airway epithelial cells, and on their production of inflammatory cytokines are unclear. Methods: Primary cultures of human tracheal epithelial cells were treated with four types of serine protease inhibitors, including camostat, and infected with A/Sendai-H/108/2009/(H1N1) pdm09 or A/New York/55/20 04(H3N2). Results: Camostat reduced the amounts of influenza viruses in the supernatants and viral RNA in the cells. It reduced the cleavage of an influenza virus precursor protein, HAO, into the subunit HA1. Camostat also reduced the concentrations of the cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha in the supernatants. Gabexate and aprotinin reduced the viral titers and RNA levels in the cells, and aprotinin reduced the concentrations of TNF-alpha in the supernatants. The proteases transmembrane protease serine Si member (TMPRSS) 2 and HAT (human trypsin-like protease: TMPRSS11D), which are known to cleave HAO and to activate the virus, were detected at the cell membrane and in the cytoplasm. mRNA encoding TMPRSS2, TMPRSS4 and TMPRSS11D was detectable in the cells, and the expression levels were not affected by camostat. Conclusions: These findings suggest that human airway epithelial cells express these serine proteases and that serine protease inhibitors, especially camostat, may reduce influenza viral replication and the resultant production of inflammatory cytokines possibly through inhibition of activities of these proteases. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamaya, Mutsuo; Kalonji, Nadine Lusamba; Tando, Yukiko; Kubo, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Adv Prevent Med Infect Dis, Sendai, Miyagi 9808575, Japan; [Shimotai, Yoshitaka; Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Yamagata 9909585, Japan; [Hatachi, Yukimasa] Kobe City Med Ctr Gen Hosp, Div Oncol, Kobe, Hyogo 6500047, Japan; [Hatachi, Yukimasa] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan; [Tando, Yukiko; Kitajima, Yasuo; Nagatomi, Ryoichi] Tohoku Univ, Med & Sci Sports & Exercise, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Matsuo, Kaori] Tohoku Univ, Dept Behavioal Med, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Homma, Morio; Nishimura, Hidekazu] Sendai Natl Hosp, Virus Res Ctr, Div Clin Res, Sendai, Miyagi 9838520, Japan	Yamaya, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Adv Prevent Med Infect Dis, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	myamaya@med.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293189]; Ono Yakuhin Co., Ltd.	Camostat mesilate, sivelestat and gabexate mesilate were provided by Ono Yakuhin Co., Ltd. This study was supported by a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25293189 and Ono Yakuhin Co., Ltd.	Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Peitsch C, 2014, J VIROL, V88, P282, DOI 10.1128/JVI.01635-13; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; TAMURA Y, 1977, BIOCHIM BIOPHYS ACTA, V484, P417, DOI 10.1016/0005-2744(77)90097-3; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Lorusso A, 2010, J VIROL METHODS, V164, P83, DOI 10.1016/j.jviromet.2009.12.002; Ohler A, 2012, BIOL CHEM, V393, P907, DOI 10.1515/hsz-2012-0155; Nakatani K, 2001, J LEUKOCYTE BIOL, V69, P241; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713; Nagai Yoshiyuki, 1993, Trends in Microbiology, V1, P81, DOI 10.1016/0966-842X(93)90112-5; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Kumar A, 2011, J ANTIMICROB CHEMOTH, V66, P959, DOI 10.1093/jac/dkr090; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Lin BY, 1999, CANCER RES, V59, P4180; Yamaya M, 2010, J PHARMACOL EXP THER, V333, P81, DOI 10.1124/jpet.109.162149; Zhirnov OP, 2011, ANTIVIR RES, V92, P27, DOI 10.1016/j.antiviral.2011.07.014; Zhirnov OP, 2002, J VIROL, V76, P8682, DOI 10.1128/JVI.76.17.8682-8689.2002; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Asimakopoulos G, 2001, J THORAC CARDIOV SUR, V122, P123, DOI 10.1067/mtc.2001.114356; Buerke M, 2007, CIRCULATION, V116, pI121, DOI 10.1161/CIRCULATIONAHA.106.680249; Condit R.C., 2006, FIELDS VIROLOGY, V1, P25; FRITZ H, 1983, ARZNEIMITTEL-FORSCH, V33-1, P479; Glezen WP, 2006, J ALLERGY CLIN IMMUN, V118, P1199, DOI 10.1016/j.jaci.2006.08.032; Hayakawa M, 2010, SHOCK, V33, P14, DOI 10.1097/SHK.0b013e3181aa95c4; Hayden F.G., 1988, TXB RESP MED, P748; Hiraku S., 1982, IYAKUHIN KENKYU, V13, P756; HOMMA M, 1971, J VIROL, V8, P619; HOSOYA M, 1992, ANTIMICROB AGENTS CH, V36, P1432; Iwadou H, 2002, J INT MED RES, V30, P99; KAWABATA K, 1991, BIOCHEM BIOPH RES CO, V177, P814, DOI 10.1016/0006-291X(91)91862-7; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kosai K, 2008, J INT MED RES, V36, P322; Lee M.G., 1996, ARCH VIROL, V141, P1979; MINOR TE, 1976, AM REV RESPIR DIS, V113, P149; NUMAZAKI Y, 1987, MICROBIOL IMMUNOL, V31, P1085; OHUCHI M, 1976, J VIROL, V18, P1147; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Sai JK, 2010, J GASTROENTEROL, V45, P335, DOI 10.1007/s00535-009-0148-1; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tumurkhuu G, 2011, INNATE IMMUN-LONDON, V17, P97, DOI 10.1177/1753425909353641; Yamaya M, 2014, RESP PHYSIOL NEUROBI, V202, P16, DOI 10.1016/j.resp.2014.07.010	54	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1094-5539			PULM PHARMACOL THER	Pulm. Pharmacol. Ther.	AUG	2015	33						66	74		10.1016/j.pupt.2015.07.001		9	Pharmacology & Pharmacy; Respiratory System	Pharmacology & Pharmacy; Respiratory System	CQ3OV	WOS:000360512900012		
J	Becker, RA; Ankley, GT; Edwards, SW; Kennedy, SW; Linkov, I; Meek, B; Sachana, M; Segner, H; Van der Burg, B; Villeneuve, DL; Watanabe, H; Barton-Maclaren, TS				Becker, Richard A.; Ankley, Gerald T.; Edwards, Stephen W.; Kennedy, Sean W.; Linkov, Igor; Meek, Bette; Sachana, Magdalini; Segner, Helmut; Van der Burg, Bart; Villeneuve, Daniel L.; Watanabe, Haruna; Barton-Maclaren, Tara S.			Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Adverse outcome pathway; Weight of evidence; Mode of action; Bradford-Hill considerations	ARYL-HYDROCARBON RECEPTOR; INDUCED DELAYED NEUROTOXICITY; OXIDATIVE STRESS-RESPONSE; HEXAVALENT CHROMIUM; ESTROGEN-RECEPTOR; GENE-EXPRESSION; REACTIVE OXYGEN; DRINKING-WATER; DAPHNIA-MAGNA; MOUSE DUODENUM	Systematic consideration of scientific support is a critical element in developing and, ultimately, using adverse outcome pathways (AOPs) for various regulatory applications. Though weight of evidence (WoE) analysis has been proposed as a basis for assessment of the maturity and level of confidence in an AOP, methodologies and tools are still being formalized. The Organization for Economic Co-operation and Development (OECD) Users' Handbook Supplement to the Guidance Document for Developing and Assessing AOPs (OECD 2014a; hereafter referred to as the OECD AOP Handbook) provides tailored Bradford-Hill (BH) considerations for systematic assessment of confidence in a given AOP. These considerations include (1) biological plausibility and (2) empirical support (dose-response, temporality, and incidence) for Key Event Relationships (KERs), and (3) essentiality of key events (KEs). Here, we test the application of these tailored BH considerations and the guidance outlined in the OECD AOP Handbook using a number of case examples to increase experience in more transparently documenting rationales for assigned levels of confidence to KEs and KERs, and to promote consistency in evaluation within and across AOPs. The major lessons learned from experience are documented, and taken together with the case examples, should contribute to better common understanding of the nature and form of documentation required to increase confidence in the application of AOPs for specific uses. Based on the tailored BH considerations and defining questions, a prototype quantitative model for assessing the WoE of an AOP using tools of multi-criteria decision analysis (MCDA) is described. The applicability of the approach is also demonstrated using the case example aromatase inhibition leading to reproductive dysfunction in fish. Following the acquisition of additional experience in the development and assessment of AOPs, further refinement of parameterization of the model through expert elicitation is recommended. Overall, the application of quantitative WoE approaches hold promise to enhance the rigor, transparency and reproducibility for AOP WoE determinations and may play an important role in delineating areas where research would have the greatest impact on improving the overall confidence in the AOP. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Becker, Richard A.] Amer Chem Council, Washington, DC 20002 USA; [Ankley, Gerald T.; Villeneuve, Daniel L.] US EPA, Off Res & Dev, Midcontinent Ecol Div, Duluth, MN USA; [Edwards, Stephen W.] US EPA, Off Res & Dev, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA; [Kennedy, Sean W.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Linkov, Igor] US Army Corps Engineers, Engineer Res & Dev Ctr, Environm Lab, Concord, MA USA; [Meek, Bette] Univ Ottawa, Ottawa, ON, Canada; [Sachana, Magdalini] European Commiss, Joint Res Ctr, I-21027 Ispra, Italy; [Segner, Helmut] Univ Bern, Ctr Fish & Wildlife Hlth, Bern, Switzerland; [Van der Burg, Bart] BioDetect Syst BV, Amsterdam, Netherlands; [Watanabe, Haruna] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki, Japan; [Barton-Maclaren, Tara S.] Hlth Canada, Existing Subst Risk Assessment Bur, Ottawa, ON K1A 0L2, Canada	Becker, RA (reprint author), Amer Chem Council, 700 2nd St NE, Washington, DC 20002 USA.	ricic_becker@americanchemistry.com			Research Council of Norway [221455]	The content of this paper is the result of an international expert workshop on Advancing Adverse Outcome Pathways (AOPs) for Integrated Toxicology and Regulatory Applications held March 2-7, 2014 in Somma Lombardo, Italy. Support for the workshop was provided by the American Chemistry Council, BioDetection Systems, European Centre for Ecotoxicology and Toxicology of Chemicals, Environment Canada, European Commission Directorate General Joint Research Center, Human Toxicology Project Consortium, International Life Sciences Institute - Health and Environmental Science Institute, The Research Council of Norway (Grant no. 221455), Society for Environmental Toxicology and Chemistry, US Army Engineer Research and Development Center, and the US Environmental Protection Agency. The authors acknowledge the workshop organizing committee (Rick Becker, Natalia Garcia-Reyero, Ksenia Groh, Marlies Halder, Sean Kennedy, Teresa Lettieri, Edward Perkins, Knut Erik Tollefsen, Bart van der Burg, Dan Villeneuve, and Maurice Whelan), and all workshop participants for both plenary and informal discussions that influenced the content presented here. The views expressed are those of the authors, and do not necessarily represent the views of the organizations the authors are affiliated with or the sponsors. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.	Abe R, 2015, AQUAT TOXICOL, V159, P44, DOI 10.1016/j.aquatox.2014.11.015; De Flora S, 2000, CARCINOGENESIS, V21, P533, DOI 10.1093/carcin/21.4.533; ALSHARIF NZ, 1994, TOXICOLOGY, V92, P39, DOI 10.1016/0300-483X(94)90166-X; Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; Shertzer HG, 1998, BIOCHEM BIOPH RES CO, V253, P44, DOI 10.1006/bbrc.1998.9753; Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345; ABOUDONIA MB, 1990, ANNU REV PHARMACOL, V30, P405; Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982; Senft AP, 2002, FREE RADICAL BIO MED, V33, P1268, DOI 10.1016/S0891-5849(02)01014-6; GILLETTE JR, 1957, J PHARMACOL EXP THER, V119, P532; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207; DeFlora S, 1997, CARCINOGENESIS, V18, P531, DOI 10.1093/carcin/18.3.531; Schlezinger JJ, 2001, AQUAT TOXICOL, V52, P101, DOI 10.1016/S0166-445X(00)00141-7; Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365; Hargreaves AJ, 2012, ADV EXP MED BIOL, V724, P189, DOI 10.1007/978-1-4614-0653-2_15; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; Weiner ML, 1999, NEUROTOXICOLOGY, V20, P653; Schlezinger JJ, 1999, MOL PHARMACOL, V56, P588; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55; Bal-Price A, 2015, CRIT REV TOXICOL, V45, P83, DOI 10.3109/10408444.2014.981331; Palace VP, 1996, ENVIRON TOXICOL CHEM, V15, P955, DOI 10.1897/1551-5028(1996)015<0955:MFOEAA>2.3.CO;2; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; Curtis LR, 2011, TOXICOL APPL PHARM, V254, P1, DOI 10.1016/j.taap.2011.04.015; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Slezak BP, 2000, TOXICOL SCI, V54, P390, DOI 10.1093/toxsci/54.2.390; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Giorgi C, 2008, CURR MOL MED, V8, P119; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Choudhary S, 2001, BIOCHEM PHARMACOL, V62, P1265, DOI 10.1016/S0006-2952(01)00762-6; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Boobis AR, 2009, CRIT REV FOOD SCI, V49, P690, DOI 10.1080/10408390903098673; Kopf PG, 2010, TOXICOL APPL PHARM, V245, P91, DOI 10.1016/j.taap.2010.02.007; Casarett L.J., 1922, CASARETT DOULLS TOXI, Vthird; Cheng L, 2003, WORLD J GASTROENTERO, V9, P2642; Chia LA, 2010, PROG MOL BIOL TRANSL, V96, P157, DOI [10.1016/B978-0-12-381280-3.00007-5, 10.1016/S1877-1173(10)96007-9]; Cohen SM, 2010, CRIT REV TOXICOL, V40, P531, DOI 10.3109/10408441003742903; Doherty JD, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/70414; EDSP, 2009, END DISR SCREEN PROG; Emerick GL, 2012, CHEM-BIOL INTERACT, V199, P177, DOI 10.1016/j.cbi.2012.07.002; Gielen S., 2005, ESTROGEN RECEPTOR SI; Gordon E, 2012, TOXICOL MECH METHOD, V22, P54, DOI 10.3109/15376516.2011.593054; Johnson L.R., 2013, GASTROINTESTINAL PHY; JOHNSON MK, 1990, TOXICOL APPL PHARM, V102, P385, DOI 10.1016/0041-008X(90)90036-T; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218; LAPADULA DM, 1985, TOXICOL APPL PHARM, V79, P83, DOI 10.1016/0041-008X(85)90370-9; Latchoumycandane C, 2002, ARCH TOXICOL, V76, P113; LeBlanc GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061715; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Mou DL, 2006, INT J NEUROSCI, V116, P1303, DOI 10.1080/00207450500519655; National Toxicology Program (NTP), 2007, TECHN RE TOX STUD SO; National Toxicology Program (NTP), 2008, NAT TOX PROGR TECH R, P1; O'Brien TJ, 2013, MUTAT RES-GEN TOX EN, V754, P15, DOI 10.1016/j.mrgentox.2013.03.008; Oda S, 2005, CHEMOSPHERE, V60, P74, DOI 10.1016/j.chemosphere.2004.12.080; OECD, 2009, TEST 455 STABL TRANS; OECD, 2012, TEST 455 PERF BAS TE; Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219; Pitot HC, 2000, ALIMENT PHARM THERAP, V14, P153, DOI 10.1046/j.1365-2036.2000.014s1153.x; Proctor DM, 2012, CHEMOSPHERE, V89, P487, DOI 10.1016/j.chemosphere.2012.04.065; Reichard J.F., 2006, DOSE-RESPONSE, V3, P306; Schlosser PM, 2014, TOXICOL APPL PHARM, V280, P352, DOI 10.1016/j.taap.2014.08.010; Thompson CM, 2015, TOXICOL SCI, V143, P16, DOI 10.1093/toxsci/kfu206; Thompson CM, 2012, TOXICOL SCI, V125, P79, DOI 10.1093/toxsci/kfr280; Thompson CM, 2013, CRIT REV TOXICOL, V43, P244, DOI 10.3109/10408444.2013.768596; Thompson CM, 2011, TOXICOL SCI, V123, P58, DOI 10.1093/toxsci/kfr164; Toyota K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-239; Tremblay A, 1998, ENDOCRINOLOGY, V139, P111, DOI 10.1210/en.139.1.111; VERONESI B, 1991, TOXICOL APPL PHARM, V108, P428, DOI 10.1016/0041-008X(91)90089-W	82	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	AUG	2015	72	3					514	537		10.1016/j.yrtph.2015.04.004		24	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CP9ZZ	WOS:000360255700010		
J	Nagayama, T				Nagayama, Takashi			Adverse drug reactions for medicine newly approved in Japan from 1999 to 2013: Syncope/loss of consciousness and seizures/convulsions	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Adverse drug reaction; Animal toxicity; Medicine; Syncope; Seizure	SEIZURES; RISK; ANTIPSYCHOTICS; POPULATION; MANAGEMENT; RELEVANCE; TOXICITY; SAFETY	Many approved medicines are used with their adverse drug reactions (ADRs) appropriately managed in the clinical setting based on their risks and benefits. In this survey, the correlation between human ADR (specifically syncope/loss of consciousness and seizures/convulsions) and safety signals reported in animal studies has been investigated for 393 Japanese medicines which were approved between September 1999 and March 2013. Clinically important drug-induced ADR, syncope/loss of consciousness and seizures/convulsions are reported in this paper. Of 393 medicines, 101 (25.7%) showed syncope/loss of consciousness and 105 (26.7%) showed seizures/convulsions. Syncope/loss of consciousness and seizures/convulsions were reported for many medicines affecting the central nervous system. The animal toxicity concordance ratio with syncope/loss of consciousness and seizures/convulsions was 4.0% (4/101) and 23.8% (25/105), respectively. The underlying cases of syncope/loss of consciousness attributed to hypotension, arrhythmia, hypoglycemia or acute toxic reaction was 16.8%, 5.0%, 4.0% or 4.0%, respectively. Mechanism of seizures/convulsions for the remaining 101 medicines was not identified except for four local anesthetics. This survey suggested that the careful attention to and understanding of medicine profiles is necessary for the appropriate use of recently approved medicines in Japan. (C) 2015 Elsevier Inc. All rights reserved.	UCB Japan Co Ltd, Nonclin Dev Sci Serv & Planning, Shinjuku Ku, Tokyo 1600023, Japan	Nagayama, T (reprint author), UCB Japan Co Ltd, Nonclin Dev Sci Serv & Planning, Shinjuku Ku, Shinjuku Grand Tower,8-17-1 Nishi Shinjuku, Tokyo 1600023, Japan.	Takashi.Nagayama@ucb.com					Vieweg WVR, 2009, DRUG AGING, V26, P997, DOI 10.2165/11318880-000000000-00000; van Dijk JG, 2003, CLIN AUTON RES, V13, P247, DOI 10.1007/s10286-003-0099-1; Piepho RW, 2002, J CLIN PSYCHIAT, V63, P20; Guengerich FP, 2011, DRUG METAB PHARMACOK, V26, P3, DOI 10.2133/dmpk.DMPK-10-RV-062; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Senard JM, 2001, DRUG AGING, V18, P495, DOI 10.2165/00002512-200118070-00003; Duermueller Niklaus, 2007, Journal of Pharmacological and Toxicological Methods, V56, P234, DOI 10.1016/j.vascn.2007.03.006; Loscher W, 2009, EUR J PHARMACOL, V610, P1, DOI 10.1016/j.ejphar.2009.03.025; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Bankstahl M, 2012, NEUROTOXICOLOGY, V33, P127, DOI 10.1016/j.neuro.2011.12.011; Behnoush B., 2012, IRAN J TOXICOL, V6, P588; Delanty N, 1998, LANCET, V352, P383, DOI 10.1016/S0140-6736(98)02158-8; Elander M, 2013, DRUG DEVELOP RES, V74, P155, DOI 10.1002/ddr.21061; Hadjikoutis S, 2004, SEIZURE-EUR J EPILEP, V13, P537, DOI 10.1016/j.seizure.2003.12.011; HANLON JT, 1990, ARCH INTERN MED, V150, P2309, DOI 10.1001/archinte.150.11.2309; Isbister GK, 2004, CRIT CARE MED, V32, P88, DOI 10.1097/01.CCM.0000104207.42729.E4; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Lemonick DM, 2010, AM J CLIN MED, V7, P11; Lertxundi U, 2013, SEIZURE-EUR J EPILEP, V22, P141, DOI 10.1016/j.seizure.2012.10.009; Li AP, 2004, CHEM-BIOL INTERACT, V150, P3, DOI 10.1016/j.cbi.2004.09.008; Lionte C., 2009, THER PHARM CLIN TOXI, V13, P400; Milazzo V, 2012, J HYPERTENS, V1, P104; Murphy K, 2000, CNS DRUGS, V14, P135, DOI 10.2165/00023210-200014020-00004; Pathak Atul, 2006, Expert Rev Neurother, V6, P1173, DOI 10.1586/14737175.6.8.1173; Perez-Lloret S., 2013, NEURODEGEN DIS MANAG, V3, P363; Pesola GR, 2002, J EMERG MED, V22, P235, DOI 10.1016/S0736-4679(01)00474-7; Sanchez-Ferro A., 2013, FRONT NEUROL, V4, P2013; Thundiyil Josef G, 2007, J Med Toxicol, V3, P15; Thundiyil Josef G, 2011, J Med Toxicol, V7, P16, DOI 10.1007/s13181-010-0096-4; Tyagi L.K., 2009, GLOBAL J PHARM, V3, P166	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	AUG	2015	72	3					572	577		10.1016/j.yrtph.2015.05.030		6	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CP9ZZ	WOS:000360255700015		
J	Nishida, H; Hirota, M; Seto, Y; Suzuki, G; Kato, M; Kitagaki, M; Sugiyama, M; Kouzuki, H; Onoue, S				Nishida, Hayato; Hirota, Morihiko; Seto, Yoshiki; Suzuki, Gen; Kato, Masashi; Kitagaki, Masato; Sugiyama, Mariko; Kouzuki, Hirokazu; Onoue, Satomi			Non-animal photosafety screening for complex cosmetic ingredients with photochemical and photobiochemical assessment tools	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Cosmetics; Complex cosmetic ingredients; Photosafety assessment; Phototoxicity; Reactive oxygen species	OXYGEN SPECIES ASSAY; CHEMICALS; CELLS	Previously, a non-animal screening approach was proposed for evaluating photosafety of cosmetic ingredients by means of in vitro photochemical and photobiochemical assays; however, complex cosmetic ingredients, such as plant extracts and polymers, could not be evaluated because their molecular weight is often poorly defined and so their molar concentration cannot be calculated. The aim of the present investigation was to establish a photosafety screen for complex cosmetic ingredients by using appropriately modified in vitro photosafety assays. Twenty plant extracts were selected as model materials on the basis of photosafety information, and their phototoxic potentials were assessed by means of ultraviolet (UV)/visible light (VIS) spectral analysis, reactive oxygen species (ROS)/micellar ROS (mROS) assays, and 3T3 neutral red uptake phototoxicity testing (3T3 NRU PT). The maximum UV/VIS absorption value was employed as a judgment factor for evaluating photoexcitability of samples, and the value of 1.0 was adopted as a tentative criterion for photosafety identification. The ROS/mROS assays were conducted at 50 mu g/mL, and no false negative prediction was obtained. Furthermore, the ROS/mROS assays at 50 mu g/mL had a similar predictive capacity to the ROS/mROS assays in the previous study. A systematic tiered approach for simple and rapid non-animal photosafety evaluation of complex cosmetic ingredients can be constructed using these modified in vitro photochemical assays. (C) 2015 Elsevier Inc. All rights reserved.	[Nishida, Hayato; Hirota, Morihiko; Kitagaki, Masato; Sugiyama, Mariko; Kouzuki, Hirokazu] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Seto, Yoshiki; Suzuki, Gen; Kato, Masashi; Onoue, Satomi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Suruga Ku, Shizuoka 4228526, Japan	Onoue, S (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	onoue@u-shizuoka-ken.ac.jp			Health Labour Sciences Research Grant from The Ministry of Health, Labour and Welfare, Japan	This work was supported in part by a Health Labour Sciences Research Grant from The Ministry of Health, Labour and Welfare, Japan.	Moore DE, 2002, DRUG SAFETY, V25, P345, DOI 10.2165/00002018-200225050-00004; Onoue S, 2006, PHARM RES, V23, P156, DOI 10.1007/s11095-005-8497-9; Epistein J.H., 1983, J AM ACAD DERMATOL, V8, P141; Henry B, 2009, J PHOTOCH PHOTOBIO B, V96, P57, DOI 10.1016/j.jphotobiol.2009.04.005; Hino R, 2008, J DERMATOL SCI, V52, P140, DOI 10.1016/j.jdermsci.2008.06.002; Hoya M, 2009, TOXICOL IN VITRO, V23, P911, DOI 10.1016/j.tiv.2009.03.010; Liebsch M, 2002, TOXICOL LETT, V127, P127, DOI 10.1016/S0378-4274(01)00492-1; OECD, 2004, OECD GUID TEST CHEM; Okamoto Y., 2002, ALTERN ANIMAL TEST E, V8, P69; Okamoto Y., 2005, AATEX, V11, P39; Onoue S, 2013, J APPL TOXICOL, V33, P1241, DOI 10.1002/jat.2776; Onoue S, 2013, TOXICOL IN VITRO, V27, P2316, DOI 10.1016/j.tiv.2013.10.003; Onoue S, 2008, J PHARMACEUT BIOMED, V47, P967, DOI 10.1016/j.jpba.2008.03.026; Onoue S, 2014, TOXICOL IN VITRO, V28, P515, DOI 10.1016/j.tiv.2013.11.014; Onoue Satomi, 2009, Curr Drug Saf, V4, P123; SCCS (Scientific Committee on Consumer Safety), 2012, SCCS150112; Seto Yoshiki, 2012, Curr Drug Saf, V7, P140; Seto Y, 2013, TOXICOL IN VITRO, V27, P1838, DOI 10.1016/j.tiv.2013.05.008; The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use Committee for Proprietary Medicinal Products (EMEA/CPMP), 2002, CPMPSWP39801 EMEACPM; The Food and Drug Administration Center for Drug Evaluation and Research (FDA/CDER), 2002, GUID IND PHOT TEST	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	AUG	2015	72	3					578	585		10.1016/j.yrtph.2015.05.029		8	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CP9ZZ	WOS:000360255700016		
J	Inoko, K; Ebihara, Y; Sakamoto, K; Miyamoto, N; Kurashima, Y; Tamoto, E; Nakamura, T; Murakami, S; Tsuchikawa, T; Okamura, K; Shichinohe, T; Hirano, S				Inoko, Kazuho; Ebihara, Yuma; Sakamoto, Keita; Miyamoto, Noriyuki; Kurashima, Yo; Tamoto, Eiji; Nakamura, Toru; Murakami, Soichi; Tsuchikawa, Takahiro; Okamura, Keisuke; Shichinohe, Toshiaki; Hirano, Satoshi			Strategic Approach to the Splenic Artery in Laparoscopic Spleen-preserving Distal Pancreatectomy	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						pancreatic benign; low-grade malignant tumor; laparoscopic distal pancreatectomy; spleen preserving; splenic vessel preserving; splenic artery; computed tomography	PRESERVATION; VESSELS; CONSERVATION; SPLENECTOMY; RESECTION; FISTULA; PATENCY; VEIN	Background:Laparoscopic spleen-preserving distal pancreatectomy (LSPDP) is an ideal procedure in selected patients with benign or low-grade malignant tumors in the body/tail of the pancreas. We describe our procedure and experience with splenic vessel-preserving LSPDP (SVP-LSPDP) in a retrospective case series.Methods:Six consecutive patients underwent SVP-LSPDP from January 2011 to September 2013. We evaluated the courses of the splenic artery by preoperative computed tomography and applied an individualized approach (the superior approach or inferior approach) to the splenic artery.Results:All of the operations were successful. The median surgical duration was 249 minutes. The median blood loss was 0 mL. Pathologic examination revealed 4 cases of insulinoma, 1 case of solid pseudopapillary tumor, and 1 case of pancreatic metastasis from renal carcinoma.Conclusions:In performing SVP-LSPDP, it is effective to make a strategic choice between 2 different approaches according to the course of splenic artery.	[Inoko, Kazuho; Ebihara, Yuma; Kurashima, Yo; Tamoto, Eiji; Nakamura, Toru; Murakami, Soichi; Tsuchikawa, Takahiro; Okamura, Keisuke; Shichinohe, Toshiaki; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0608648, Japan; [Sakamoto, Keita; Miyamoto, Noriyuki] Hokkaido Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 0608648, Japan	Inoko, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608648, Japan.	k.inoko@icloud.com					Nakamura M, 2011, SURGERY, V150, P326, DOI 10.1016/j.surg.2011.05.014; Fernandez-Cruz L, 2004, J GASTROINTEST SURG, V8, P493, DOI 10.1016/j.gassur.2003.11.014; Shoup M, 2002, ARCH SURG-CHICAGO, V137, P164, DOI 10.1001/archsurg.137.2.164; Warshaw AL, 2010, J HEPATO-BIL-PAN SCI, V17, P808, DOI 10.1007/s00534-009-0226-z; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Butturini G, 2012, J SURG ONCOL, V105, P387, DOI 10.1002/jso.22117; Melotti G, 2007, ANN SURG, V246, P77, DOI 10.1097/01.sla.0000258607.17194.2b; Choi SH, 2012, SURG ENDOSC, V26, P3149, DOI 10.1007/s00464-012-2306-4; Hwang HK, 2012, SURG ENDOSC, V26, P1765, DOI 10.1007/s00464-011-2108-0; Carrere N, 2007, WORLD J SURG, V31, P375, DOI 10.1007/s00268-006-0425-6; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Song KB, 2011, SURG ENDOSC, V25, P3364, DOI 10.1007/s00464-011-1727-9; Yoon YS, 2009, BRIT J SURG, V96, P633, DOI 10.1002/bjs.6609; Beane JD, 2011, J AM COLL SURGEONS, V212, P651, DOI 10.1016/j.jamcollsurg.2010.12.014; Ding XM, 2013, HEPATO-GASTROENTEROL, V60, P605, DOI 10.5754/hge12747; Jean-Philippe Adam, 2013, JAMA Surg, V148, P246; Kang CM, 2014, BRIT J SURG, V101, P114, DOI 10.1002/bjs.9366; Mellemkjaer L, 1995, Ugeskr Laeger, V157, P5097; Schwarz RE, 1999, J AM COLL SURGEONS, V188, P516, DOI 10.1016/S1072-7515(99)00041-1; Sylvester P A, 1995, Clin Anat, V8, P214, DOI 10.1002/ca.980080306	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	AUG	2015	25	4					E122	E125		10.1097/SLE.0000000000000182		4	Surgery	Surgery	CQ0RL	WOS:000360304400004		
J	Itano, O; Oshima, G; Kitago, M; Suzuki, K; Hayatsu, S; Shinoda, M; Abe, Y; Hibi, T; Yagi, H; Ikoma, N; Aiko, S; Kitagawa, Y				Itano, Osamu; Oshima, Go; Kitago, Minoru; Suzuki, Keiichi; Hayatsu, Shigeo; Shinoda, Masahiro; Abe, Yuta; Hibi, Taizo; Yagi, Hiroshi; Ikoma, Naruhiko; Aiko, Satoshi; Kitagawa, Yuko			Harness Traction Technique (HARNESS): Novel Method for Controlling the Transection Plane During Laparoscopic Hepatectomy	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						harness traction technique; laparoscopic hepatectomy; hanging maneuver; laparoscopic anatomic liver resection; hemostasis	INTRAHEPATIC GLISSONIAN APPROACH; HANGING MANEUVER; LIVER RESECTION; SEGMENTS	We present our experience using a novel method for controlling the transection plane, which we termed as the Harness Traction Technique (HARNESS) and evaluate its usefulness. From May 2009 to March 2012, laparoscopic hepatectomies using HARNESS were performed on 35 patients. After the superficial hepatic parenchyma on the line was transected at 1 to 2 cm depth, 5 mm tape was placed along the groove of the line and tied to prevent it from slipping off. Tape was tied and pulled using a forceps toward the best direction for minimizing the bleeding, moving the transection point to the appropriate position and creating good tension for parenchymal transection at the transection point. There were no conversions to laparotomy or intraoperative complications. HARNESS is useful for controlling the dissection line during laparoscopic hepatectomy, leading to precise and safe laparoscopic liver parenchymal dissection.	[Itano, Osamu; Kitago, Minoru; Shinoda, Masahiro; Abe, Yuta; Hibi, Taizo; Yagi, Hiroshi; Aiko, Satoshi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Oshima, Go; Ikoma, Naruhiko] Eiju Gen Hosp, Dept Surg, Tokyo, Japan; [Suzuki, Keiichi] Kitasato Inst Hosp, Dept Surg, Tokyo, Japan; [Hayatsu, Shigeo] Saitama Natl Hosp, Dept Surg, Saitama, Japan	Itano, O (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	itano@z8.keio.jp					Gayet B, 2007, AM J SURG, V194, P685, DOI 10.1016/j.amjsurg.2006.11.044; Honda G, 2013, J HEPATO-BIL-PAN SCI, V20, P435, DOI 10.1007/s00534-012-0586-7; Han HS, 2009, J HEPATO-BILIARY-PAN, V16, P427, DOI 10.1007/s00534-009-0118-2; Tzanis D, 2013, J HEPATO-BIL-PAN SCI, V20, P120, DOI 10.1007/s00534-012-0554-2; Ishizawa T, 2012, ARCH SURG-CHICAGO, V147, P393, DOI 10.1001/archsurg.2012.59; Dagher I, 2009, ANN SURG, V250, P856, DOI 10.1097/SLA.0b013e3181bcaf46; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Lin NC, 2013, ANN SURG, V257, P205, DOI 10.1097/SLA.0b013e31827da7fe; Kaneko H, 2008, HPB, V10, P219, DOI 10.1080/13651820802166831; Cho JY, 2008, SURGERY, V144, P32, DOI 10.1016/j.surg.2008.03.020; Belghiti J, 2001, J AM COLL SURGEONS, V193, P109, DOI 10.1016/S1072-7515(01)00909-7; Cho A, 2009, SURG ENDOSC, V23, P906, DOI 10.1007/s00464-008-0257-6; Dagher I, 2009, J GASTROINTEST SURG, V13, P148, DOI 10.1007/s11605-008-0602-z; Herman P, 2010, J LAPAROENDOSC ADV S, V20, P35, DOI 10.1089/lap.2009.0215; Ikeda T, 2011, SURG TODAY, V41, P1592, DOI 10.1007/s00595-010-4479-6; Itano O, 2009, J HEPATO-BILIARY-PAN, V16, P711, DOI 10.1007/s00534-009-0141-3; Machado MAC, 2010, J LAPAROENDOSC ADV S, V20, P141, DOI 10.1089/lap.2009.0458; Takahashi M, 2013, SURG ENDOSC, V27, P4732, DOI 10.1007/s00464-013-3202-2	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	AUG	2015	25	4					E117	E121		10.1097/SLE.0000000000000171		5	Surgery	Surgery	CQ0RL	WOS:000360304400003		
J	Uchida, H; Iwashita, Y; Watanabe, K; Takayama, H; Kawasaki, T; Yada, K; Ohta, M; Kitano, S; Inomata, M				Uchida, Hiroki; Iwashita, Yukio; Watanabe, Kiminori; Takayama, Hiroomi; Kawasaki, Takahide; Yada, Kazuhiro; Ohta, Masayuki; Kitano, Seigo; Inomata, Masafumi			Surgical Outcomes of Laparoscopic Liver Resection in Elderly Patients: A Comparative Study From a Single Center	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopic; elderly; liver resection	HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; MAJOR HEPATECTOMY; CANCER; METASTASES; FEASIBILITY; SAFETY	The life expectancy continues to gradually increase worldwide. Laparoscopic liver resection (LLR) was recently reported to be a relatively safe procedure for treatment of liver disease because of the development of new techniques and instruments. The aim of this study was to evaluate the surgical outcomes of elderly patients who underwent LLR. Of these 61 patients who underwent LLR in our institute from January 2010 through April 2014, 21 were aged 75 years and above (group E), and 40 were aged below 75 years (group NE). Patient characteristics were retrospectively analyzed between the 2 groups. The results showed that patient characteristics were similar between the 2 groups, although the incidence of hypertension was significantly greater among patients in group E. There were no significant differences in the incidence of postoperative complications or length of hospital stay between the 2 groups. In conclusion, LLR for elderly patients was a feasible procedure compared with nonelderly patients.	[Uchida, Hiroki; Iwashita, Yukio; Watanabe, Kiminori; Takayama, Hiroomi; Kawasaki, Takahide; Yada, Kazuhiro; Ohta, Masayuki; Inomata, Masafumi] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Yufu, Oita 8795593, Japan; [Kitano, Seigo] Oita Univ, Yufu, Oita 8795593, Japan	Uchida, H (reprint author), Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, 1-1 Hasama Machi, Yufu, Oita 8795593, Japan.	ucchy@oita-u.ac.jp					Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048; Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X; Abu Hilal M, 2010, BRIT J SURG, V97, P927, DOI 10.1002/bjs.7034; Kulik U, 2011, WORLD J SURG, V35, P2063, DOI 10.1007/s00268-011-1180-x; Topal H, 2012, SURG ENDOSC, V26, P2451, DOI 10.1007/s00464-012-2209-4; Topal B, 2008, SURG ENDOSC, V22, P2208, DOI 10.1007/s00464-008-0023-9; Mann CD, 2008, EJSO-EUR J SURG ONC, V34, P428, DOI 10.1016/j.ejso.2007.03.013; Spampinato MG, 2013, SURG ENDOSC, V27, P1881, DOI 10.1007/s00464-012-2687-4; Ceulemans R, 2004, AM J SURG, V187, P323, DOI 10.1016/j.amjsurg.2003.12.026; Ito K, 2009, J GASTROINTEST SURG, V13, P2276, DOI 10.1007/s11605-009-0993-5; Tzanis D, 2013, J HEPATO-BIL-PAN SCI, V20, P120, DOI 10.1007/s00534-012-0554-2; Dagher I, 2009, ANN SURG, V250, P856, DOI 10.1097/SLA.0b013e3181bcaf46; Pearce NW, 2011, AM J SURG, V202, pE52, DOI 10.1016/j.amjsurg.2010.08.032; Yasuda K, 2004, BRIT J SURG, V91, P1061, DOI 10.1002/bjs.4615; REICH H, 1991, OBSTET GYNECOL, V78, P956; Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Xiong JJ, 2012, WORLD J GASTROENTERO, V18, P6657, DOI 10.3748/wjg.v18.i45.6657; Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025; Wang HQ, 2014, WORLD J GASTROENTERO, V20, P6620, DOI 10.3748/wjg.v20.i21.6620; Schiergens TS, 2014, J GASTROINTEST SURG, V18, P1161, DOI 10.1007/s11605-014-2516-2; Morino M, 2003, SURG ENDOSC, V17, P1914, DOI 10.1007/s00464-003-9070-4; Reddy SK, 2011, WORLD J SURG, V35, P1478, DOI 10.1007/s00268-010-0906-5; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Belli Giulio, 2004, HPB (Oxford), V6, P236, DOI 10.1080/13651820410023941; Buell JF, 2008, ANN SURG, V250, P825, DOI [10.1097/SLA.0b013e3181b3b2d8, DOI 10.1097/SLA.0B013E3181B3B2D8]; Iwahashi S, 2014, SURG ENDOSC, V28, P80, DOI 10.1007/s00464-013-3165-3; Iwamoto M, 2014, CANCER EPIDEMIOL, V38, P511, DOI 10.1016/j.canep.2014.07.005; Koperna T, 1998, WORLD J SURG, V22, P406; Nomi T, 2015, SURG ENDOSC, V29, P1368, DOI 10.1007/s00464-014-3806-1; Pasetto LM, 2007, CRIT REV ONCOL HEMAT, V64, P10, DOI 10.1016/j.critrevonc.2007.08.001; She WH, 2013, SURG ENDOSC, V27, P308, DOI 10.1007/s00464-012-2466-2; Tanaka H, 2014, INT J CANCER, V134, P747, DOI 10.1002/ijc.28519; Uecker J, 2001, AM SURGEON, V67, P637	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	AUG	2015	25	4					E109	E112		10.1097/SLE.0000000000000183		4	Surgery	Surgery	CQ0RL	WOS:000360304400001		
J	Uchiyama, H; Morita, K; Itoh, S; Takenaka, K; Maehara, Y				Uchiyama, Hideaki; Morita, Kazutoyo; Itoh, Shinji; Takenaka, Kenji; Maehara, Yoshihiko			BiClamp-Fracture Method in Pure Laparoscopic Hepatectomy: Verifying its Efficacy Irrespective of Liver Stiffness	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						pure laparoscopic hepatectomy; vessel sealing device; cirrhosis	HEPATOCELLULAR-CARCINOMA; SINGLE-CENTER; RESECTION; EXPERIENCE; CIRRHOSIS; SURGERY; VESSEL	Background:Transecting cirrhotic liver in pure laparoscopic hepatectomy (PLH) is generally considered technically demanding. We have preferentially used BiClamp in PLH by fracturing liver parenchyma using this device. The aim of the current study was to retrospectively verify the efficacy of BiClamp-fracture method in transecting cirrhotic parenchyma.Methods:The medical records of 21 patients who underwent PLH using BiClamp-fracture method between April 2011 and September 2014 were examined. The patients were divided into the Nonstiff group (F0-F2, n=11) and the Stiff group (F3 and F4, n=10) and various surgical factors were compared between the groups.Results:The mean operation time, the mean intraoperative blood loss, and the mean postoperative hospital stay in the Stiff group were comparable with those in the Nonstiff group. There were no postoperative complications in both groups.Conclusion:BiClamp-fracture method was effective in transecting liver parenchyma irrespective of liver stiffness in PLH.	[Uchiyama, Hideaki; Morita, Kazutoyo; Itoh, Shinji; Takenaka, Kenji] Fukuoka City Hosp, Dept Hepatobiliary Pancreat Surg, Fukuoka 8120046, Japan; [Uchiyama, Hideaki; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Uchiyama, H (reprint author), Fukuoka City Hosp, Dept Hepatobiliary Pancreat Surg, Fukuoka 8120046, Japan.	huchi@surg2.med.kyushu-u.ac.jp					Bhojani FD, 2012, J AM COLL SURGEONS, V214, P184, DOI 10.1016/j.jamcollsurg.2011.10.020; Kanazawa A, 2013, SURG ENDOSC, V27, P2592, DOI 10.1007/s00464-013-2795-9; Cherqui D, 2006, ANN SURG, V243, P499, DOI 10.1097/01.sla.0000206017.29651.99; Cannon RM, 2011, J AM COLL SURGEONS, V213, P501, DOI 10.1016/j.jamcollsurg.2011.04.032; Cherqui D, 2009, ANN SURG, V250, P738, DOI 10.1097/SLA.0b013e3181bd582b; Ikeda T, 2014, SURG ENDOSC, V28, P2484, DOI 10.1007/s00464-014-3469-y; Zacharoulis D, 2013, J LAPAROENDOSC ADV S, V23, P549, DOI 10.1089/lap.2012.0464; Gumbs Andrew A, 2013, Liver Cancer, V2, P5, DOI 10.1159/000346213; Hintze J., 2013, NCSS 9, V9; Honda G, 2014, J GASTROINTEST SURG, V18, P1379, DOI 10.1007/s11605-014-2538-9; Kluger Michael D, 2014, Hepatobiliary Surg Nutr, V3, P44, DOI 10.3978/j.issn.2304-3881.2014.02.01; Long TCD, 2014, SURG ENDOSC, V28, P796, DOI 10.1007/s00464-013-3259-y; Overhaus M, 2012, MINIM INVASIV THER, V21, P396, DOI 10.3109/13645706.2011.651145; Sakuragi T, 2008, EUR J CARDIO-THORAC, V34, P505, DOI 10.1016/j.ejcts.2008.05.043; Takeuchi H, 2010, SURG TODAY, V40, P706, DOI 10.1007/s00595-009-4118-2; Tayar Claude, 2014, J Minim Access Surg, V10, P14, DOI 10.4103/0972-9941.124454; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; Uchiyama H, 2013, SURG LAPARO ENDO PER, V23, pE116, DOI 10.1097/SLE.0b013e3182806535; Uchiyama H, 2014, J AM COLL SURGEONS, V219, pe26; Yamashita Y, 2014, J AM COLL SURGEONS, V219, P1117, DOI 10.1016/j.jamcollsurg.2014.09.003	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	AUG	2015	25	4					E113	E116		10.1097/SLE.0000000000000172		4	Surgery	Surgery	CQ0RL	WOS:000360304400002		
J	Yokoyama, K; Tanigawa, N; Ogata, A; Nagai, T; Higashino, M				Yokoyama, Kazutake; Tanigawa, Nobuhiko; Ogata, Akihito; Nagai, Toshihiro; Higashino, Masayuki			Laparoscopic Technique and Initial Experiences of Choledocholithotomy Closure With Knotless Unidirectional Barbed Sutures After Surgery for Biliary Stone Disease	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						common bile duct stone; laparoscopic choledocholithotomy; laparoscopic; intracorporeal suturing; undirectional barbed suture		Background and Aim:Between January 2012 and June 2013, we performed laparoscopic choledocholithotomy on 10 cases of common bile duct stone disease. Laparoscopic surgery for common duct stone disease is technically demanding. Particularly, laparoscopic intracorporeal suturing and knot tying for repair of choledochotomy are the most difficult skills in this operative procedures. Barbed sutures has recently been proposed to facilitate laparoscopic suturing. This is the first report demonstrating that the barbed suture could potentially improve the efficacy of the intracorporeal repair of choledochotomy following extirpation of biliary tract stones with less time needed to suture.Methods:Consecutive 10 patients with common bile duct stones who underwent laparoscopic choledocholithotomy were enrolled in this study. Choledochotomy was closed with V-Loc sutures (15 cm V-Loc 180 sutures) for 7patients, and a V-20 needle (26 mm, tapered) for 3 patients.Results:The mean choledochotomy closure time was significantly shorter in the V-Loc group (15.21.6 min) than in the Vicryl group (23.5 +/- 1.5 min). The unidirectional barbed sutures allowed surgeons to use both their hands effectively and to focus exclusively on the placement of the subsequent stitches, without the need to maintain tension on preceding stitches to prevent slippage. And also the unidirectional barbed sutures were able to distribute tension evenly along the suture line, allowing good tissue apposition.Conclusion:The knotless unidirectional barbed sutures are a safe and effective tool for choledochotomy repair during surgery for common bile duct stones.	[Yokoyama, Kazutake; Tanigawa, Nobuhiko; Ogata, Akihito; Nagai, Toshihiro; Higashino, Masayuki] Tanigawa Mem Hosp, Ibaraki, Osaka 5670031, Japan	Tanigawa, N (reprint author), Tanigawa Mem Hosp, Kasuga 1 Chome, Ibaraki, Osaka 5670031, Japan.	tanigwa@tanigawa-hp.or.jp					American College of Physicians, 1993, ANN INTERN MED, V119, P620; Alessandri F, 2010, J MINIM INVAS GYN, V17, P725, DOI 10.1016/j.jmig.2010.06.007; [Anonymous], 2012, J JPN SOC ENDOSC SUR, V17, P576; Lee SW, 2010, J AM COLL SURGEONS, V211, P33, DOI 10.1016/j.jamcollsurg.2010.03.018; Shikanov S, 2009, J ENDOUROL, V23, P1157, DOI 10.1089/end.2009.0003; Sammon J, 2011, J ENDOUROL, V25, P529, DOI 10.1089/end.2010.0455; Ephrem O, 2012, BJU INT, V109, P906; Fujimura M, 2000, Nihon Geka Hokan, V68, P85; Jacobs M, 1991, J Laparoendosc Surg, V1, P79, DOI 10.1089/lps.1991.1.79; Lee S-W, 2011, J AM COLL SURGEONS, V213, P39; KALSER SC, 1993, AM J SURG, V165, P390; Robert TG, 2010, TIME MOTION STUDY CO	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	AUG	2015	25	4					E129	E133		10.1097/SLE.0000000000000122		5	Surgery	Surgery	CQ0RL	WOS:000360304400006		
J	Pogrebnjak, AD; Yakushchenko, IV; Sobol', OV; Beresnev, VM; Kupchishin, AI; Bondar, OV; Lisovenko, MA; Amekura, H; Kono, K; Oyoshi, K; Takeda, Y				Pogrebnjak, A. D.; Yakushchenko, I. V.; Sobol', O. V.; Beresnev, V. M.; Kupchishin, A. I.; Bondar, O. V.; Lisovenko, M. A.; Amekura, H.; Kono, K.; Oyoshi, K.; Takeda, Y.			Influence of residual pressure and ion implantation on the structure, elemental composition, and properties of (TiZrAlYNb)N nitrides	TECHNICAL PHYSICS			English	Article							HIGH-ENTROPY ALLOYS; NANOCOMPOSITE COATINGS; HARD COATINGS; DEPOSITION	The nitrides of high-entropy alloys, (TiZrAlYNb)N, fabricated by cathodic vacuum arc evaporation are studied with electron microscopy, atomic force microscopy, laser scanning microscopy; energy-dispersive X-ray analysis, X-ray phase analysis, time-of-flight secondary-ion mass spectrometry; and hardness measurements. It is found that the deposition parameters influence the structure, surface morphology, element distribution, and mechanical properties. The structural-phase state of the coatings before and after the ion implantation of heavy negative gold ions Au- are compared.	[Pogrebnjak, A. D.; Yakushchenko, I. V.; Bondar, O. V.; Lisovenko, M. A.] Sumy State Univ, UA-40007 Sumy, Ukraine; [Sobol', O. V.] Natl Tech Univ, Kharkiv Polytech Inst, UA-61002 Kharkov, Ukraine; [Beresnev, V. M.] Kharkov Natl Univ, UA-61022 Kharkov, Ukraine; [Kupchishin, A. I.] Kazakh Natl Pedag Univ, Alma Ata 050010, Kazakhstan; [Amekura, H.; Kono, K.; Oyoshi, K.; Takeda, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050003, Japan	Pogrebnjak, AD (reprint author), Sumy State Univ, Ul Rimskogo Korsakova 2, UA-40007 Sumy, Ukraine.	alexp@i.ua	Bondar, Oleksandr/K-9131-2015; Pogrebnjak, Alexander/O-1736-2015	Bondar, Oleksandr/0000-0003-3174-0709; 	state program "Formation of Superhard Nanostructured Multicomponent Coatings with High Physicomechanical Properties" [0112U001382]; state progra "Physical Grounds of Plasma Technology for Complex Processing of Multicomponent Materials and Coatings" [0113U000137]	This work was made in the framework of the state programs "Formation of Superhard Nanostructured Multicomponent Coatings with High Physicomechanical Properties" (no. 0112U001382) and "Physical Grounds of Plasma Technology for Complex Processing of Multicomponent Materials and Coatings" (no. 0113U000137).	Pogrebnjak AD, 2009, PHYS-USP+, V52, P29, DOI 10.3367/UFNe.0179.200901b.0035; Musil J, 2012, SURF COAT TECH, V207, P50, DOI 10.1016/j.surfcoat.2012.05.073; Mayrhofer PH, 2006, PROG MATER SCI, V51, P1032, DOI 10.1016/j.pmatsci.2006.02.002; Pogrebnjak AD, 2012, J NANOSCI NANOTECHNO, V12, P9213, DOI 10.1166/jnn.2012.6777; Braic V, 2012, SURF COAT TECH, V211, P117, DOI 10.1016/j.surfcoat.2011.09.033; Pogrebnjak AD, 2013, J NANOMATER, DOI 10.1155/2013/780125; Pogrebnjak AD, 2013, RUSS CHEM REV+, V82, P1135, DOI 10.1070/RC2013v082n12ABEH004344; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001; Beresnev V.M., 2012, NANOCOATINGS NANOSYS; Boiko V. I., 1999, Physics-Uspekhi, V42, DOI 10.1070/PU1999v042n11ABEH000471; Borisov D. P., 2007, ISVESTIYA VUZOV FIZI, V50, P13; Chang SY, 2013, JOM-US, V65, P1790, DOI 10.1007/s11837-013-0676-2; Firstov S. A., 2011, KOMPOZ NANOMATER, P5; Kishimoto N, 1999, NUCL INSTRUM METH B, V148, P1017, DOI 10.1016/S0168-583X(98)00876-3; Krause-Rehberg R, 2013, PHYS MET METALLOGR+, V114, P672, DOI 10.1134/S0031918X13080061; Okubo N, 2001, NUCL INSTRUM METH B, V175, P663, DOI 10.1016/S0168-583X(01)00344-5; Pogrebnjak A., 2013, J NANOELECTRON PHYS, V5, P01016; Pogrebnjak A. D., 2010, NANOSTRUCTURED MAT 4, V31, P127, DOI DOI 10.1002/9780470944042.CH14; Pogrebnjak AD, 2013, RUSS PHYS J+, V56, P532, DOI 10.1007/s11182-013-0065-x; Pogrebnjak AD, 2013, J SUPERHARD MATER+, V35, P356, DOI 10.3103/S106345761306004X; Pogrebnyak AD, 2013, TECH PHYS LETT+, V39, P189, DOI 10.1134/S1063785013020223; Samsonov G. V., 1969, NITRIDES; Sobol O. V., 2013, TECH PHYS LETT, V38, P616; Tsai DC, 2013, THIN SOLID FILMS, V544, P580, DOI 10.1016/j.tsf.2012.12.064; Tyurin YN, 2001, SURF COAT TECH, V142, P293, DOI 10.1016/S0257-8972(01)01207-5; Veprek S, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4818590; Yeh JW, 2007, MATER SCI FORUM, V560, P1	27	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7842	1090-6525		TECH PHYS+	Tech. Phys.	AUG	2015	60	8					1176	1183		10.1134/S1063784215080228		8	Physics, Applied	Physics	CP4QF	WOS:000359866700012		
J	Komatsu, T; Yaguchi, I; Komatsu, S; Nakahara, S; Kobayashi, S; Sakai, Y; Taguchi, I				Komatsu, Takaaki; Yaguchi, Isao; Komatsu, Sachiko; Nakahara, Shiro; Kobayashi, Sayuki; Sakai, Yoshihiko; Taguchi, Isao			Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation	TEXAS HEART INSTITUTE JOURNAL			English	Article						Blood glucose/analysis; cardiovascular diseases/complications; coronary angiography; coronary artery disease/physiopathology; coronary restenosis/prevention & control; diabetic angiopathies/prevention & control; insulin resistance/physiology; predictive value of tests; recurrence; stents	HOMEOSTASIS MODEL ASSESSMENT; CORONARY ANGIOPLASTY; DIABETES-MELLITUS; ARTERIAL INJURY; STANDARD STENT; GLUCOSE; RESTENOSIS; TRIAL; RISK; COMPLICATIONS	Percutaneous coronary intervention is established as an effective treatment for patients with ischemic heart disease; in particular, drug-eluting stent implantation is known to suppress in-stent restenosis. Diabetes mellitus is an independent risk factor for restenosis, so reducing insulin resistance is being studied as a new treatment approach. In this prospective study, we sought to clarify the factors associated with in-stent restenosis after percutaneous coronary intervention, and we evaluated the homeostasis model assessment of insulin resistance (HOMA-IR) index as a predictor of restenosis. We enrolled 136 consecutive patients who underwent elective percutaneous coronary intervention at our hospital from February 2010 through April 2013. All were implanted with a 2nd-generation drug-eluting stent. We distributed the patients in accordance with their HOMA-IR index values into insulin-resistant Group P (HOMA-IR, >= 2.5; n=77) and noninsulin-resistant Group N (HOMA-IR, <2.5; n=59). Before and immediately after stenting, we measured reference diameter, minimal lumen diameter, and percentage of stenosis, and after 8 months we measured the last 2 factors and late lumen loss, all by means of quantitative coronary angiography. After 8 months, the mean minimal lumen diameter was smaller in Group P than that in Group N (1.85 +/- 1.02 vs 2.37 +/- 0.66 mm; P=0.037), and the mean late lumen loss was larger (0.4 +/- 0.48 vs 0.16 +/- 0.21 mm; P=0.025). These results suggest that insulin resistance affects neointimal tissue proliferation after 2nd-generation drug-eluting stent implantation.	[Komatsu, Takaaki; Yaguchi, Isao; Komatsu, Sachiko; Nakahara, Shiro; Kobayashi, Sayuki; Sakai, Yoshihiko; Taguchi, Isao] Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, Koshigaya, Saitama 3438555, Japan	Komatsu, T (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, Minami Koshigaya 2-1-50, Koshigaya, Saitama 3438555, Japan.	takaaki_km2@yahoo.co.jp					ADVANCE Collaborative Group, 2008, NEW ENGL J MED, V358, P2560, DOI [10.1056/NEJMoa0802987, DOI 10.1056/NEJM0A0802987]; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Breen DM, 2009, ARTERIOSCL THROM VAS, V29, P1060, DOI 10.1161/ATVBAHA.109.185447; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Kanauchi M, 2002, DIABETES CARE, V25, P1891, DOI 10.2337/diacare.25.10.1891; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1061/CIRCULATIONHA.105.562421; Hoffmann R, 2007, AM J CARDIOL, V100, P1347, DOI 10.1016/j.amjcard.2007.06.021; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Wang CCL, 2004, DIABETES, V53, P2735, DOI 10.2337/diabetes.53.11.2735; Bruemmer D, 2006, CIRC RES, V99, P1149, DOI 10.1161/01.RES.0000251785.83860.3b; CARROZZA JP, 1993, ANN INTERN MED, V118, P344; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Hedblad B, 2002, DIABETIC MED, V19, P470, DOI 10.1046/j.1464-5491.2002.00719.x; Sekiguchi M, 2004, AM J CARDIOL, V93, P920, DOI 10.1016/j.amjcard.2003.12.036; Sinha Dhurjati P, 2009, Indian Heart J, V61, P40; UEDA M, 1991, CIRCULATION, V83, P1327; UK Prospective Diabetes Study (UKPDS) Group, 1999, LANCET, V354, P602; Turner RC, 1998, LANCET, V352, P837	21	0	0	TEXAS HEART INST	HOUSTON	PO BOX 20345, HOUSTON, TX 77225-0345 USA	0730-2347	1526-6702		TEX HEART I J	Tex. Heart Inst. J.	AUG	2015	42	4					327	332		10.14503/THIJ-14-4393		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP9KB	WOS:000360211900006		
J	Kanezaki, M; Ogawa, T; Izumi, T				Kanezaki, Masashi; Ogawa, Teruhiro; Izumi, Tadafumi			Tongue Protrusion Strength in Arousal State Is Predictive of the Airway Patency in Obstructive Sleep Apnea	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						apnea-hypopnea index; apnea index; obstructive apnea time; percentage of sleep stage 2; tongue protrusion strength	FATIGUABILITY; PATHOGENESIS; ACTIVATION; HUMANS; FORCE	Contraction of the genioglossus affects either tongue protrusion strength or dilating forces of the upper airway. The upper airway in patients with obstructive sleep apnea (OSA) is thought to collapse during sleep, at least in part because of a sleep related reduction in genioglossus muscle activity. Thus, although tongue protrusion strength by genioglossus activity during sleep contributes to the maintenance of airway patency in patients with OSA, the relationship between tongue protrusion strength in the arousal state and obstructive sleep apnea has not been fully elucidated. Conventional method of tongue protrusion strength cannot be used to evaluate in edentulous subjects and/or subjects with the decreased biting force. In this study, employing a novel measurement method that does not require biting a transducer, we investigated relationships between the tongue protrusion strength and polysomnographic findings. We enrolled twenty normal subjects and 26 subjects with OSA. All subjects completed the measurement of tongue protrusion strength. Each subject with OSA was evaluated by full polysomnography. The degree of tongue protrusion strength was assessed by maximum voluntary contraction against the tongue depressor connected with a strain gauge dynamometer. The tongue protrusion strength was negatively correlated with obstructive apnea time, apnea index (AI) and the percent of sleep stage 2 (r = -0.61, p < 0.0001, r = -0.41 p = 0.03 and r = -0.39 p =0.04, respectively). Tongue protrusion strength measured in the arousal state is predictive of the airway patency during sleep in OSA.	[Kanezaki, Masashi] Himeji Dokkyo Univ, Dept Phys Therapy, Fac Hlth Care Sci, Himeji, Hyogo 6708524, Japan; [Ogawa, Teruhiro] Himeji St Marys Hosp, Div Otolaryngol, Himeji, Hyogo, Japan; [Izumi, Tadafumi] Hlth Sci Univ Hokkaido, Grad Sch Rehabil Sci, Tobetsu, Hokkaido, Japan	Kanezaki, M (reprint author), Himeji Dokkyo Univ, Dept Phys Therapy, Fac Hlth Care Sci, 7-2-1 Kamiohno, Himeji, Hyogo 6708524, Japan.	kmasashi@gm.himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26870760]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (No. 26870760).	White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; Kim AM, 2014, AM J RESP CRIT CARE, V189, P1416, DOI 10.1164/rccm.201310-1753OC; Boyd JH, 2004, AM J RESP CRIT CARE, V170, P541, DOI 10.1164/rccm.200308-1100OC; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931; Akahoshi T, 2001, J PHYSIOL-LONDON, V531, P677, DOI 10.1111/j.1469-7793.2001.0677h.x; Jelev A, 2001, J PHYSIOL-LONDON, V532, P467, DOI 10.1111/j.1469-7793.2001.0467f.x; Mortimore IL, 2000, J SLEEP RES, V9, P389, DOI 10.1046/j.1365-2869.2000.00222.x; Fogel RB, 2003, J PHYSIOL-LONDON, V550, P899, DOI 10.1113/jphysiol.2003.038810; Kim AM, 2014, SLEEP, V37, P1639, DOI 10.5665/sleep.4072; Mortimore IL, 1999, EUR RESPIR J, V14, P191, DOI 10.1034/j.1399-3003.1999.14a32.x; Shepherd KL, 2006, CHEST, V130, P1757, DOI 10.1378/chest.130.6.175'7	11	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	AUG	2015	236	4					241	245		10.1620/tjem.236.241		5	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CP9YG	WOS:000360251200001		
J	Yazaki, Y; Sugawara, K; Honda, M; Ohnishi, H; Nagashima, S; Takahashi, M; Okamoto, H				Yazaki, Yasuyuki; Sugawara, Kenji; Honda, Mitsunori; Ohnishi, Hiroshi; Nagashima, Shigeo; Takahashi, Masaharu; Okamoto, Hiroaki			Characteristics of 20 Patients with Autochthonous Acute Hepatitis E in Hokkaido, Japan: First Report of Bilateral Facial Palsy Following the Infection with Genotype 4 Hepatitis E Virus	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						bilateral facial palsy; extrahepatic manifestation; full genome; genotype 4; hepatitis E virus	GUILLAIN-BARRE-SYNDROME; GENOME; ANTIBODIES; ENCEPHALITIS/ENCEPHALOPATHY; MANIFESTATIONS; DISORDERS; FULMINANT; SEQUENCE; FEATURES; STRAINS	Autochthonous hepatitis E is increasingly being recognized in industrialized countries, including Japan. Although neurological abnormalities have been sporadically reported as an extrahepatic manifestation of hepatitis E virus (HEV) infection, it is rare and has not been reported in Japan. The present study aimed to characterize a total of 20 patients consecutively diagnosed with sporadic acute hepatitis E at a city hospital in Hokkaido, Japan, during 2001-2014, focusing on a patient complicated with neuropathy. Seventeen patients were infected with genotype 4 HEV, while the remaining three patients were with genotype 3 HEV. Although a 67-year-old male with severe hepatitis did not have predisposing factors associated with the development of neurological disorders, such as diabetes mellitus and the use of immunosuppressive agents, he developed bilateral peripheral facial palsy six days after admission. A neurological examination revealed the inability to smile, frown, close his eyes completely or puff out his cheeks. MRI brain scans were considered to be normal. Although it took 83 days after admission for the total bilirubin levels to normalize, his neurological symptoms resolved gradually within three weeks without any sequelae following conservative therapy. A full-length genomic analysis of the HEV strain (HE-JA30) isolated from the patient belonged to genotype 4 and was closest to that currently circulating in Hokkaido, Japan. This is the first report of HEV-associated neuropathy in Japan. While all of previous reports on HEV-related neuropathy involve genotype 3 HEV, the present report is unique in that genotype 4 HEV is responsible for the neuropathy.	[Yazaki, Yasuyuki; Honda, Mitsunori] Kobayashi Hosp, Ctr Gastroenterol, Kitami, Hokkaido, Japan; [Sugawara, Kenji] Kitami Shokaki Clin, Kitami, Hokkaido, Japan; [Ohnishi, Hiroshi; Nagashima, Shigeo; Takahashi, Masaharu; Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi 3290498, Japan	Okamoto, H (reprint author), Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hokamoto@jichi.ac.jp					Kamar N, 2012, TRANSPLANTATION, V93, P617, DOI 10.1097/TP.0b013e318245f14c; Scharn N, 2014, INFECTION, V42, P171, DOI 10.1007/s15010-013-0448-5; van Eijk JJJ, 2014, NEUROLOGY, V82, P498, DOI 10.1212/WNL.0000000000000112; Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005; Chopra K, 2012, BRIT J CLIN PHARMACO, V73, P348, DOI 10.1111/j.1365-2125.2011.04111.x; GeurtsvanKessel CH, 2013, CLIN INFECT DIS, V57, P1369, DOI 10.1093/cid/cit512; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Mizuo H, 2005, J MED VIROL, V76, P341, DOI 10.1002/jmv.20364; Deniel C, 2011, J CLIN VIROL, V51, P202, DOI 10.1016/j.jcv.2011.04.009; Inoue J, 2006, J MED VIROL, V78, P476, DOI 10.1002/jmv.20565; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Takahashi M, 2008, ARCH VIROL, V153, P657, DOI 10.1007/s00705-008-0045-6; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Peltier AC, 2002, CURR OPIN NEUROL, V15, P633, DOI 10.1097/00019052-200210000-00015; Belbezier A, 2014, EMERG INFECT DIS, V20, P908, DOI 10.3201/eid2005.131551; Kamar N, 2010, AM J TRANSPLANT, V10, P1321, DOI 10.1111/j.1600-6143.2010.03068.x; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; Cheung MCM, 2012, ANN HEPATOL, V11, P618; van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111; Chen XD, 2014, NEUROL SCI, V35, P1461, DOI 10.1007/s10072-014-1731-7; Coddington CT, 2010, J NEUROL NEUROSUR PS, V81, P1155, DOI 10.1136/jnnp.2009.195313; Dixit V K, 2006, J Assoc Physicians India, V54, P418; Emerson SU, 2013, FIELDS VIROLOGY, V2, P2242; Fourquet E, 2010, J CLIN VIROL, V48, P73, DOI 10.1016/j.jcv.2010.02.016; Inagaki Y, 2015, TOHOKU J EXP MED, V235, P275, DOI 10.1620/tjem.235.275; Jha Ashish K, 2012, J Clin Exp Hepatol, V2, P88, DOI 10.1016/S0973-6883(12)60082-6; Loly JP, 2009, WORLD J GASTROENTERO, V15, P1645, DOI 10.3748/wjg.15.1645; Mahmood D, 2009, J PHARM PHARMACOL, V61, P1137, DOI [10.1211/jpp/61.09.0002, 10.1211/jpp.61.09.0002]; Nishizawa T, 2003, J GEN VIROL, V84, P1245, DOI 10.1099/vir.0.19052-0; Okamoto H, 2001, BIOCHEM BIOPH RES CO, V289, P929, DOI 10.1006/bbrc.2001.6088; Ruiz L.M., 2012, CASE REP NEUROL MED, V2012; Santos L, 2013, EUROSURVEILLANCE, V18, P6, DOI 10.2807/1560-7917.ES2013.18.34.20563; Shah SAR, 2012, J CLIN VIROL, V54, P96, DOI 10.1016/j.jcv.2012.02.002; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; STAHL N, 1989, J LARYNGOL OTOL, V103, P117, DOI 10.1017/S0022215100108199; Takahashi K, 2001, VIROLOGY, V287, P9, DOI 10.1006/viro.2001.1017; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Takeuchi S, 2015, J MED VIROL, V87, P1067, DOI 10.1002/jmv.24191; Verma R, 2012, BMJ CASE REP, V2012; Woolson KL, 2014, ALIMENT PHARM THER, V40, P1282, DOI 10.1111/apt.12986; Wu XJ, 2015, NEUROL SCI, V36, P165, DOI 10.1007/s10072-014-1854-x	44	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	AUG	2015	236	4					263	271		10.1620/tjem.236.263		9	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CP9YG	WOS:000360251200004		
J	Konishi, Y; Takahashi, S; Nishi, K; Sakamaki, T; Mitani, S; Kaneko, H; Mizutani, C; Ukyo, N; Hirata, H; Tsudo, M				Konishi, Yoshinobu; Takahashi, Satoshi; Nishi, Katsuyuki; Sakamaki, Taro; Mitani, Sachiko; Kaneko, Hitomi; Mizutani, Chisato; Ukyo, Naoya; Hirata, Hirokazu; Tsudo, Mitsuru			Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						cyclosporine A; interleukin-2; interleukin-6; multicentric Castleman's disease; TAFRO syndrome	METASTATIC MELANOMA; THERAPY	Multicentric Castlennan's disease is a systemic inflammatory disorder characterized by lymphadenopathy and excessive interleukin-6 production. A unique clinicopathologic variant of multicentric Castleman's disease, TAFRO (i.e., thronnbocytopenia, anasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome, was recently proposed in Japan. Despite the successful use of anti-interleukin-6 therapy in some patients with TAFRO syndrome, not all patients achieve remission. The pathophysiological etiology of and suitable therapeutic strategies for this variant have not been established. Here, we present our experience of a unique case of TAFRO syndrome in a 78-year-old woman whose symptoms responded differently to several therapies. Tocilizumab, an anti-interleukin-6 receptor antibody, successfully induced remission of fever and lymphadenopathy. However, severe thrombocytopenia persisted and she developed anasarca, ascites, and pleural effusion shortly thereafter. Rituximab, an anti-CD20 antibody, and glucocorticoid therapy provided no symptom relief. In contrast, cyclosporine A, an immunosuppressive agent that blocks T cell function by inhibiting interleukin-2, yielded immediate improvements in systemic fluid retention and a gradual increase in platelet count, with complete resolution of disease symptoms. Excessive serum interleukin-2, when used as an anti-cancer agent, has been reported to cause side effects such as fluid retention, thrombocytopenia, and renal failure. Our case was unique because the anti-interleukin-2 therapy successfully improved symptoms that were not relieved with anti-interleukin-6 therapy. The present report therefore provides insight into the possible role of interleukin-2, in addition to interleukin-6, in TAFRO syndrome. This report will certainly help to clarify the pathogenesis of and optimal treatment strategies for TAFRO syndrome.	[Konishi, Yoshinobu; Takahashi, Satoshi; Nishi, Katsuyuki; Sakamaki, Taro; Mitani, Sachiko; Kaneko, Hitomi; Mizutani, Chisato; Ukyo, Naoya; Hirata, Hirokazu; Tsudo, Mitsuru] Osaka Red Cross Hosp, Dept Hematol, Osaka 5430027, Japan	Konishi, Y (reprint author), Osaka Red Cross Hosp, Dept Hematol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka, Osaka 5430027, Japan.	konishi.yoshinobu@gmail.com					CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4; Petrella T, 2007, CANCER TREAT REV, V33, P484, DOI 10.1016/j.ctrv.2007.04.003; Muskardin TW, 2012, CURR OPIN RHEUMATOL, V24, P76, DOI 10.1097/BOR.0b013e32834db525; FRIZZERA G, 1983, AM J SURG PATHOL, V7, P211, DOI 10.1097/00000478-198304000-00001; Fajgenbaum DC, 2014, BLOOD, V123, P2924, DOI 10.1182/blood-2013-12-545087; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Atkins MB, 1999, J CLIN ONCOL, V17, P2105; Atkins MB, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.33077; FRIZZERA G, 1988, SEMIN DIAGN PATHOL, V5, P346; Inoue Morihiro, 2013, J Clin Exp Hematop, V53, P95; Kawabata Hiroshi, 2013, J Clin Exp Hematop, V53, P57; Koduri Prasad R, 2014, J Clin Exp Hematop, V54, P163; Masaki Yasufumi, 2013, J Clin Exp Hematop, V53, P79; Moutabarrik A, 1994, Transpl Int, V7 Suppl 1, pS552; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Takai K, 2010, JPN J CLIN HEMATOL, V51, P320	16	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	AUG	2015	236	4					289	295		10.1620/tjem.236.289		7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CP9YG	WOS:000360251200007		
J	Omoto, K; Maruhama, K; Terayama, R; Yamamoto, Y; Matsushita, O; Sugimoto, T; Oguma, K; Matsuka, Y				Omoto, Katsuhiro; Maruhama, Kotaro; Terayama, Ryuji; Yamamoto, Yumiko; Matsushita, Osamu; Sugimoto, Tomosada; Oguma, Keiji; Matsuka, Yoshizo			Cross-Excitation in Peripheral Sensory Ganglia Associated with Pain Transmission	TOXINS			English	Article							TOXIN TYPE-A; DORSAL-ROOT GANGLIA; GENE-RELATED PEPTIDE; SUBSTANCE-P; TRIGEMINAL GANGLION; NEUROTRANSMITTER RELEASE; EVOKED RELEASE; IN-VIVO; NEURONS; RAT	Despite the absence of synaptic contacts, cross-excitation of neurons in sensory ganglia during signal transmission is considered to be chemically mediated and appears increased in chronic pain states. In this study, we modulated neurotransmitter release in sensory neurons by direct application of type A botulinum neurotoxin (BoNT/A) to sensory ganglia in an animal model of neuropathic pain and evaluated the effect of this treatment on nocifensive. Unilateral sciatic nerve entrapment (SNE) reduced the ipsilateral hindpaw withdrawal threshold to mechanical stimulation and reduced hindpaw withdrawal latency to thermal stimulation. Direct application of BoNT/A to the ipsilateral L4 dorsal root ganglion (DRG) was localized in the cell bodies of the DRG and reversed the SNE-induced decreases in withdrawal thresholds within 2 days of BoNT/A administration. Results from this study suggest that neurotransmitter release within sensory ganglia is involved in the regulation of pain-related signal transmission.	[Omoto, Katsuhiro; Matsuka, Yoshizo] Univ Tokushima, Inst Biomed Sci, Dept Stomatognath Funct & Occlusal Reconstruct, Grad Sch, Tokushima 7708504, Japan; [Maruhama, Kotaro; Terayama, Ryuji; Sugimoto, Tomosada] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Dent Sch,Kita Ku, Okayama 7008525, Japan; [Maruhama, Kotaro; Terayama, Ryuji; Sugimoto, Tomosada] Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Sch Dent, Kita Ku, Okayama 7008525, Japan; [Yamamoto, Yumiko; Matsushita, Osamu; Oguma, Keiji] Okayama Univ, Dept Bacteriol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008525, Japan	Matsuka, Y (reprint author), Univ Tokushima, Inst Biomed Sci, Dept Stomatognath Funct & Occlusal Reconstruct, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	c301351011@tokushima-u.ac.jp; maruhama@okayama-u.ac.jp; ryujit@md.okayama-u.ac.jp; yumiya@md.okayama-u.ac.jp; osamu@okayama-u.ac.jp; tsugi@md.okayama-u.ac.jp; kuma@md.okayama-u.ac.jp; matsuka@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390365, 26293412, 26350499]	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 22390365, No. 26293412, No. 26350499). The authors would like to express our deepest gratitude to Professor Motohiro Ishida (Faculty of Integrated Arts and Sciences, Tokushima University), who enormously supported the statistical processing.	Marinelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047977; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Cui ML, 2004, PAIN, V107, P125, DOI 10.1016/j.pain.2003.10.008; Ma WY, 2006, J NEUROCHEM, V98, P180, DOI 10.1111/j.1471-4159.2006.03856.x; Huang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019126; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Aoki KR, 2003, HEADACHE, V43, pS9; Coderre TJ, 2005, J NEUROCHEM, V94, P1131, DOI 10.1111/j.1471-4159.2005.03263.x; Kitamura Y, 2009, NEUROSCIENCE, V159, P1422, DOI 10.1016/j.neuroscience.2009.01.066; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Amir R, 1996, J NEUROSCI, V16, P4733; Matsuka Y, 2001, BRAIN RES, V915, P248, DOI 10.1016/S0006-8993(01)02888-8; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Amir R, 2000, NEUROSCIENCE, V95, P189; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Schiavo G, 2000, PHYSIOL REV, V80, P717; Ishikawa H, 2000, JPN J OPHTHALMOL, V44, P106, DOI 10.1016/S0021-5155(99)00197-5; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; KRISHTAL OA, 1983, NEUROSCI LETT, V35, P41, DOI 10.1016/0304-3940(83)90524-4; BUNGE R, 1979, J SUPRAMOL STR CELL, V11, P175, DOI 10.1002/jss.400110207; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; BIRD MM, 1976, CELL TISSUE RES, V169, P41; Coelho A, 2014, EUR J PAIN, V18, P1480, DOI 10.1002/ejp.513; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733; Gardell LR, 2003, J NEUROSCI, V23, P8370; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lee JC, 2007, FEMS IMMUNOL MED MIC, V51, P201, DOI 10.1111/j.1574-695X.2007.00301.x; Mark MA, 1998, NEUROSCIENCE, V83, P581; Matsuka Y, 2007, NEUROSCIENCE, V144, P665, DOI 10.1016/j.neuroscience.2006.09.053; Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Neubert JK, 2000, BRAIN RES, V871, P181, DOI 10.1016/S0006-8993(00)02440-9; SKILLING SR, 1992, NEUROSCI LETT, V139, P92, DOI 10.1016/0304-3940(92)90865-5; SPIGELMAN I, 1990, J NEUROPHYSIOL, V64, P273; Takeda M, 2005, PAIN, V116, P375, DOI 10.1016/j.pain.2005.05.007; Ulrich-Lai YM, 2001, PAIN, V91, P219, DOI 10.1016/S0304-3959(00)00439-5; Zhang JM, 2000, J NEUROPHYSIOL, V84, P798	39	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	AUG	2015	7	8					2906	2917		10.3390/toxins7082906		12	Toxicology	Toxicology	CP9GU	WOS:000360202700014		
J	Kanazawa, T; Misawa, K; Misawa, Y; Uehara, T; Fukushima, H; Kusaka, G; Maruta, M; Carey, TE				Kanazawa, Takeharu; Misawa, Kiyoshi; Misawa, Yuki; Uehara, Takayuki; Fukushima, Hirofumi; Kusaka, Gen; Maruta, Mikiko; Carey, Thomas E.			G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?	TOXINS			English	Review							SQUAMOUS-CELL CARCINOMA; ABERRANT PROMOTER METHYLATION; TUMOR-SUPPRESSOR ACTIVITY; GALR2 GALANIN RECEPTOR; LUNG-CANCER; GENE-THERAPY; TACHYKININ RECEPTORS; POTENTIAL BIOMARKER; SIGNALING PATHWAYS; MOLECULAR-CLONING	Therapeutic outcome in head and neck squamous cell carcinoma (HNSCC) is poor in most advanced cases. To improve therapeutic efficiency, novel therapeutic targets and prognostic factors must be discovered. Our studies have identified several G protein-coupled receptors (GPCRs) as promising candidates. Significant epigenetic silencing of GPCR expression occurs in HNSCC compared with normal tissue, and is significantly correlated with clinical behavior. Together with the finding that GPCR activity can suppress tumor cell growth, this indicates that GPCR expression has potential utility as a prognostic factor. In this review, we discuss the roles that galanin receptor type 1 (GALR1) and type 2 (GALR2), tachykinin receptor type 1 (TACR1), and somatostatin receptor type 1 (SST1) play in HNSCC. GALR1 inhibits proliferation of HNSCC cells though ERK1/2-mediated effects on cell cycle control proteins such as p27, p57, and cyclin D1, whereas GALR2 inhibits cell proliferation and induces apoptosis in HNSCC cells. Hypermethylation of GALR1, GALR2, TACR1, and SST1 is associated with significantly reduced disease-free survival and a higher recurrence rate. Although their overall activities varies, each of these GPCRs has value as both a prognostic factor and a therapeutic target. These data indicate that further study of GPCRs is a promising strategy that will enrich pharmacogenomics and prognostic research in HNSCC.	[Kanazawa, Takeharu; Maruta, Mikiko] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Shimotsuke 3290498, Japan; [Kanazawa, Takeharu; Misawa, Kiyoshi; Misawa, Yuki; Carey, Thomas E.] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Lab Head & Neck Ctr Biol, Ann Arbor, MI 48109 USA; [Misawa, Kiyoshi; Misawa, Yuki] Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Hamamatsu, Shizuoka 431319, Japan; [Uehara, Takayuki] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 9030215, Japan; [Fukushima, Hirofumi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Head & Neck, Tokyo 1358550, Japan; [Kusaka, Gen] Jichi Med Univ, Saitama Med Ctr, Dept Neurosurg, Saitama 3308503, Japan	Kanazawa, T (reprint author), Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Shimotsuke 3290498, Japan.	kanatake@omiya.jichi.ac.jp; kiyoshim@hama-med.ac.jp; mswyuki8@hama-med.ac.jp; yataikyue@hotmail.co.jp; hfukusima@jfcr.or.jp; gkusaka@omiya.jichi.ac.jp; maruta@jichi.ac.jp; careyte@med.umich.edu		Carey, Thomas/0000-0002-5202-7518	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26462620]	Authors received a Grant-in-Aid for Scientific Research (No. 26462620) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Jee KJ, 2013, MODERN PATHOL, V26, P213, DOI 10.1038/modpathol.2012.154; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; Woods D, 1997, MOL CELL BIOL, V17, P5598; Kim JC, 2011, J CANCER RES CLIN, V137, P1571, DOI 10.1007/s00432-011-1036-7; Wang SK, 1998, BIOCHEMISTRY-US, V37, P9528, DOI 10.1021/bi9731955; Akervall J, 2003, CLIN CANCER RES, V9, P1750; Henson BS, 2005, J BIOL CHEM, V280, P22564, DOI 10.1074/jbc.M414589200; Wang S, 1998, BIOCHEMISTRY-US, V37, P6711, DOI 10.1021/bi9728405; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Doufekas K, 2013, INT J GYNECOL CANCER, V23, P1050, DOI 10.1097/IGC.0b013e3182959103; Jaafari N, 2008, EUR J PHARMACOL, V599, P121, DOI 10.1016/j.ejphar.2008.09.024; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Masuda T, 2002, CANCER RES, V62, P3819; Massarelli E, 2005, CANCER, V103, P952, DOI 10.1002/cncr.20879; Dixon BS, 2002, AM J PHYSIOL-CELL PH, V283, pC193, DOI 10.1152/ajpcell.00289.2001; Yoo GH, 2009, ARCH OTOLARYNGOL, V135, P869, DOI 10.1001/archoto.2009.122; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Jin Z, 2007, CLIN CANCER RES, V13, P6293, DOI 10.1158/1078-0432.CCR-07-0818; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Wang S, 1997, MOL PHARMACOL, V52, P337; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Verma M, 2002, LANCET ONCOL, V3, P755, DOI 10.1016/S1470-2045(02)00932-4; Kumar B, 2008, ARCH OTOLARYNGOL, V134, P363, DOI 10.1001/archotol.134.4.363; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; Hobson SA, 2006, J NEUROCHEM, V99, P1000, DOI 10.1111/j.1471-4159.2006.04143.x; Jeschke J, 2012, EPIGENETICS-US, V7, P701, DOI 10.4161/epi.20445; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Yoshino T, 2013, JPN J CLIN ONCOL, V43, P524, DOI 10.1093/jjco/hyt034; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Smith KE, 1997, J BIOL CHEM, V272, P24612, DOI 10.1074/jbc.272.39.24612; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Deng ZY, 2012, CANCER SCI, V103, P2127, DOI 10.1111/cas.12009; Berger A, 2004, ENDOCRINOLOGY, V145, P500, DOI 10.1210/en.2003-0649; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; MERINO OR, 1977, CANCER, V40, P145, DOI 10.1002/1097-0142(197707)40:1<145::AID-CNCR2820400124>3.0.CO;2-9; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Bhola NE, 2012, MOL CANCER THER, V11, P1236, DOI 10.1158/1535-7163.MCT-11-0936; Smith KE, 1998, J BIOL CHEM, V273, P23321, DOI 10.1074/jbc.273.36.23321; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; REUBI JC, 1995, TRENDS PHARMACOL SCI, V16, P110, DOI 10.1016/S0165-6147(00)88992-0; Bhola NE, 2011, CLIN CANCER RES, V17, P4996, DOI 10.1158/1078-0432.CCR-10-3406; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Kong SM, 2000, CANCER RES, V60, P249; Banerjee R, 2014, MOL CANCER THER, V13, P1323, DOI 10.1158/1535-7163.MCT-13-0904; Banerjee R, 2011, CELL SIGNAL, V23, P1110, DOI 10.1016/j.cellsig.2011.02.002; Bradford CR, 2014, LARYNGOSCOPE, V124, P179, DOI 10.1002/lary.24245; Choong N, 2008, CA-CANCER J CLIN, V58, P32, DOI 10.3322/CA.2007.0004; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; El-Salhy M, 2005, HISTOL HISTOPATHOL, V20, P745; Esposito V, 1997, CANCER RES, V57, P3381; Fathi Z, 1998, MOL BRAIN RES, V58, P156, DOI 10.1016/S0169-328X(98)00116-8; Gendron L, 2003, J BIOL CHEM, V278, P3606, DOI 10.1074/jbc.M202446200; Haddad Robert, 2006, Expert Opin Emerg Drugs, V11, P461, DOI 10.1517/14728214.11.3.461; Hoffmann MJ, 2005, INT J CANCER, V114, P406, DOI 10.1002/ijc.20749; Iishi H, 1998, INT J CANCER, V75, P396, DOI 10.1002/(SICI)1097-0215(19980130)75:3<396::AID-IJC12>3.0.CO;2-7; IISHI H, 1995, INT J CANCER, V61, P861, DOI 10.1002/ijc.2910610619; Ishiwata A, 2009, J GENE MED, V11, P1020, DOI 10.1002/jgm.1391; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Jin Z, 2008, CANCER, V112, P43, DOI 10.1002/cncr.23135; Kanazawa T, 2003, GENE THER, V10, P51, DOI 10.1038/sj.gt.3301837; Kanazawa T, 2014, MOL MED REP, V10, P1289, DOI 10.3892/mmr.2014.2362; Kanazawa T, 2010, EXPERT OPIN THER TAR, V14, P289, DOI 10.1517/14728221003598922; Kanazawa T, 2009, CLIN CANCER RES, V15, P2222, DOI 10.1158/1078-0432.CCR-08-2443; Kanazawa T, 2007, ONCOGENE, V26, P5762, DOI 10.1038/sj.onc.1210384; Kanazawa T, 2004, INT J ONCOL, V25, P729; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Lieb K, 1997, J IMMUNOL, V159, P4952; Matta A., 2009, HEAD NECK ONCOL, V1, P6, DOI DOI 10.1186/1758-3284-1-6; Misawa K, 2013, J CANCER RES CLIN, V139, P879, DOI 10.1007/s00432-013-1393-5; Misawa K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118588; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Misawa Y, 2014, CANCER-AM CANCER SOC, V120, P205, DOI 10.1002/cncr.28411; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Ozawa K, 2000, J NEURAL TRANSM-SUPP, P181; Rameshwar P, 1996, BLOOD, V88, P98; Rhee John C, 2004, Expert Opin Emerg Drugs, V9, P91, DOI 10.1517/eoed.9.1.91.32953; Rosso M, 2012, SCI WORLD J, DOI 10.1100/2012/381434; Sugimoto T, 2009, GENE CHROMOSOME CANC, V48, P132, DOI [10.1002/gcc.20626, 10.1002/20626]; Takebayashi S, 2000, CANCER RES, V60, P3397; Tofighi R, 2008, P NATL ACAD SCI USA, V105, P2717, DOI 10.1073/pnas.0712300105; Uehara T, 2014, CANCER SCI, V105, P72, DOI 10.1111/cas.12315; Watt H. L., 2012, J SIGNAL TRANSDUCT, V2012, DOI [10.1155/2012/28205022523681, DOI 10.1155/2012/282050]; Wen YH, 2015, EXPERT OPIN EMERG DR, V20, P313, DOI 10.1517/14728214.2015.1031653; Zhang YY, 2010, GENES-BASEL, V1, P85, DOI 10.3390/genes1010085; Zhao J, 2013, BRIT J CANCER, V108, P2557, DOI 10.1038/bjc.2013.263	94	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	AUG	2015	7	8					2959	2984		10.3390/toxins7082959		26	Toxicology	Toxicology	CP9GU	WOS:000360202700016		
J	Matsuo, K; Yamamoto, S; Wakamatsu, T; Takahashi, Y; Kawamura, K; Kaneko, Y; Goto, S; Kazama, JJ; Narita, I				Matsuo, Koji; Yamamoto, Suguru; Wakamatsu, Takuya; Takahashi, Yoshimitsu; Kawamura, Kazuko; Kaneko, Yoshikatsu; Goto, Shin; Kazama, Junichiro J.; Narita, Ichiei			Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate	TOXINS			English	Article							LIVER-X-RECEPTOR; CHRONIC KIDNEY-DISEASE; PLACEBO-CONTROLLED TRIAL; PROXIMAL TUBULAR CELLS; BOUND UREMIC TOXINS; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RENAL DYSFUNCTION; P-CRESOL; IN-VIVO	One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (CKD) is the accumulation of uremic toxins. Since macrophage foam cell formation is a hallmark of atherosclerosis, we examined the direct effect of indoxyl sulfate (IS), a representative uremic toxin, on macrophage function. Macrophages differentiated from THP-1 cells were exposed to IS in vitro. IS decreased the cell viability of THP-1 derived macrophages but promoted the production of inflammatory cytokines (IL-1 beta, IS 1.0 mM: 101.8 +/- 21.8 pg/mL vs. 0 mM: 7.0 +/- 0.3 pg/mL, TNF-alpha, IS 1.0 mM: 96.6 +/- 11.0 pg/mL vs. 0 mM: 15.1 +/- 3.1 pg/mL) and reactive oxygen species. IS reduced macrophage cholesterol efflux (IS 0.5 mM: 30.3% +/- 7.3% vs. 0 mM: 43.5% +/- 1.6%) and decreased ATP-binding cassette transporter G1 expression. However, lipid uptake into cells was not enhanced. A liver X receptor (LXR) agonist, T0901317, improved IS-induced production of inflammatory cytokines as well as reduced cholesterol efflux. In conclusion, IS induced inflammatory reactions and reduced cholesterol efflux in macrophages. Both effects of IS were improved with activation of LXR. Direct interactions of uremic toxins with macrophages may be a major cause of atherosclerosis acceleration in patients with CKD.	[Matsuo, Koji; Yamamoto, Suguru; Wakamatsu, Takuya; Takahashi, Yoshimitsu; Kawamura, Kazuko; Kaneko, Yoshikatsu; Goto, Shin; Kazama, Junichiro J.; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9518510, Japan; [Kazama, Junichiro J.] Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Niigata 9518520, Japan	Yamamoto, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9518510, Japan.	ko.matsu.notre@gmail.com; yamamots@med.niigata-u.ac.jp; tkywakamatsu@yahoo.co.jp; yoshimitsu2003@gmail.com; kazukawamura@hotmail.com; kanekoy@med.niigata-u.ac.jp; gotos@med.niigata-u.ac.jp; jjkaz@med.niigata-u.ac.jp; naritai@med.niigta-u.ac.jp			Japan Society for the Promotion of Science [24790837]; Takeda Science Foundation	The authors acknowledge the expert technical assistance of Takae Watanabe and Hiroko Aita. This work was supported in part by Grant No. 24790837 (to S.Y.) from the Japan Society for the Promotion of Science and another grant from the Takeda Science Foundation (to S.Y.).	Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778; Muntner P, 2002, J AM SOC NEPHROL, V13; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Muteliefu G, 2012, AM J PHYSIOL-CELL PH, V303, pC126, DOI 10.1152/ajpcell.00329.2011; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Marathe C, 2006, J BIOL CHEM, V281, P32197, DOI 10.1074/jbc.M605237200; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Kawakami T, 2010, AM J PHYSIOL-RENAL, V299, pF568, DOI 10.1152/ajprenal.00659.2009; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Kawashima RL, 2014, BIOCHEM BIOPH RES CO, V450, P1416, DOI 10.1016/j.bbrc.2014.07.015; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Yamamoto S, 2012, J AM COLL CARDIOL, V60, P2372, DOI 10.1016/j.jacc.2012.09.013; Zuo YQ, 2009, ARTERIOSCL THROM VAS, V29, P1277, DOI 10.1161/ATVBAHA.109.188995; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Yamamoto S, 2011, NEPHROL DIAL TRANSPL, V26, P2491, DOI 10.1093/ndt/gfq759; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Horl WH, 2005, NEPHROL DIAL TRANSPL, V20, pIII25, DOI 10.1093/ndt/gfh1071; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Kazawa T, 2009, PATHOL INT, V59, P152, DOI 10.1111/j.1440-1827.2009.02343.x; Liu N, 2014, MOLECULES, V19, P7516, DOI 10.3390/molecules19067516; Ng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091517; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Trojanowicz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102137	40	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	AUG	2015	7	8					3155	3166		10.3390/toxins7083155		12	Toxicology	Toxicology	CP9GU	WOS:000360202700025		
J	Kiyomi, A; Makita, M; Ozeki, T; Li, N; Satomura, A; Tanaka, S; Onda, K; Sugiyama, K; Iwase, T; Hirano, T				Kiyomi, Anna; Makita, Masujiro; Ozeki, Tomoko; Li, Na; Satomura, Aiko; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Iwase, Takuji; Hirano, Toshihiko			Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients	TRANSLATIONAL ONCOLOGY			English	Article							CELL LUNG-CANCER; STEM-CELLS; T-CELLS; MULTICELLULAR SPHEROIDS; MESSENGER-RNA; GROWTH-FACTOR; IN-VIVO; INFLAMMATION; ANGIOGENESIS; CHEMOTHERAPY	OBJECTIVES: Several cytokines secreted from breast cancer tissues are suggested to be related to disease prognosis. We examined Th1/Th2/Th17 cytokines produced from three-dimensionally cultured breast cancer tissues and related them with patient clinical profiles. METHODS: 21 tumor tissues and 9 normal tissues surgically resected from breast cancer patients were cultured in thermoreversible gelatin polymer-containing medium. Tissue growth and Th1/Th2/Th17 cytokine concentrations in the culture medium were analyzed and were related with hormone receptor expressions and patient clinical profiles. RESULTS: IL-6 and IL-10 were expressed highly in culture medium of both cancer and normal tissues. However, IFN-gamma, TNF-alpha, IL-2, and IL-17A were not detected in the supernatant of the three-dimensionally cultured normal mammary gland and are seemed to be specific to breast cancer tissues. The growth abilities of hormone receptor-negative cancer tissues were significantly higher than those of receptor-positive tissues ( P = 0.0383). Cancer tissues of stage >= IIB patients expressed significantly higher TNF-alpha levels as compared with those of patients with stage <IIB ( P = 0.0096). CONCLUSIONS: The tumor tissues resected from breast cancer patients can grow in the three-dimensional thermoreversible gelatin polymer culture system and produce Th1/Th2/Th17 cytokines. Hormone receptor-positive cancer tissues showed less growth ability. TNF-alpha is suggested to be a biomarker for the cancer stage.	[Kiyomi, Anna; Ozeki, Tomoko; Li, Na; Satomura, Aiko; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Hachioji, Tokyo 1920392, Japan; [Makita, Masujiro; Iwase, Takuji] Hosp JFCR, Inst Canc, Dept Breast Oncol, Koto Ku, Tokyo 1358550, Japan; [Makita, Masujiro] Musashi Kosugi Hosp, Nippon Med Sch, Dept Breast Surg, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Kiyomi, A (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	y064076@toyaku.ac.jp					Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Kryczek I, 2007, J IMMUNOL, V178, P6730; Howell WM, 2006, FAM CANCER, V5, P143, DOI 10.1007/s10689-005-0072-3; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Numasaki M, 2005, J IMMUNOL, V175, P6177; MOSCONA A, 1961, EXP CELL RES, V22, P455, DOI 10.1016/0014-4827(61)90122-7; Cao ZX, 2011, J HUAZHONG U SCI-MED, V31, P342, DOI 10.1007/s11596-011-0378-3; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Venetsanakos E, 1997, BRIT J CANCER, V75, P1826, DOI 10.1038/bjc.1997.311; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Green AR, 1997, INT J CANCER, V72, P937; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Hamed EA, 2012, J CANCER RES CLIN, V138, P999, DOI 10.1007/s00432-012-1176-4; Benoy Ina, 2002, Clin Breast Cancer, V2, P311, DOI 10.3816/CBC.2002.n.008; CARLSSON J, 1983, INT J CANCER, V31, P523, DOI 10.1002/ijc.2910310502; Chang Q, 2014, NEOPLASIA, V15, P848; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Filipova A, 2014, TUMORI, V100, P363, DOI 10.1700/1636.17886; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; HUANG M, 1995, CANCER RES, V55, P3847; Kim HS, 2015, BMB REP, V48, P54, DOI 10.5483/BMBRep.2015.48.1.213; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kozłowski L, 2003, Rocz Akad Med Bialymst, V48, P82; LAWLER EM, 1983, IN VITRO CELL DEV B, V19, P600; Matsushita Takashi, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P234; OKEANE JC, 1990, AM J PATHOL, V137, P1539; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sakata Hideto, 2002, Int J Clin Oncol, V7, P312; Sansone P, 2007, J CLIN INVEST, V12, P3660; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Stanilov N, 2014, BIOTECHNOL BIOTEC EQ, V28, P911, DOI 10.1080/13102818.2014.965047; Tsukikawa S, 2003, ARTIF ORGANS, V27, P598, DOI 10.1046/j.1525-1594.2003.07131.x; Zhang YM, 2015, INT J CLIN EXP MED, V8, P1051	50	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1944-7124	1936-5233		TRANSL ONCOL	Transl. Oncol.	AUG	2015	8	4					318	326		10.1016/j.tranon.2015.06.004		9	Oncology	Oncology	CQ0HP	WOS:000360276400011		
J	Yamaguchi, N; Mimoto, R; Yanaihara, N; Imawari, Y; Hirooka, S; Okamoto, A; Yoshida, K				Yamaguchi, Noriko; Mimoto, Rei; Yanaihara, Nozomu; Imawari, Yoshimi; Hirooka, Shinichi; Okamoto, Aikou; Yoshida, Kiyotsugu			DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma	TUMOR BIOLOGY			English	Article						Ovarian cancer; DYRK2; Snail; EMT; Cisplatin; Chemosensitivity	PLATINUM-BASED CHEMOTHERAPY; TRANSCRIPTION FACTOR SNAIL; GLOBAL CANCER STATISTICS; CISPLATIN RESISTANCE; GENE-EXPRESSION; CELLS; PHOSPHORYLATION; KINASES; PROGRESSION; CARCINOMAS	Epithelial-mesenchymal-transition (EMT) plays essential roles in ovarian cancer invasion, metastasis, and drug resistance. A hallmark of EMT is the loss of E-cadherin, which is regulated by Snail. Recently, it was shown that dual-specificity tyrosine-regulated kinase 2 (DYRK2) controls Snail degradation in breast cancer. The aim of this study is to clarify whether DYRK2 regulates EMT through Snail degradation in ovarian serous adenocarcinoma (SA). Expression of DYRK2 and Snail in two pairs of cisplatin-resistant and the original cisplatin-sensitive ovarian cancer cell line were analyzed by immunoblotting and real-time RT-PCR analysis. Morphological change, invasion ability, and chemosensitivity were evaluated by using DYRK2 stable knockdown cell line in 2008 (2008 shDYRK2). Immunohistochemical analyses for DYRK2 and Snail were performed with surgical specimens. The correlations between the expression of these proteins and the clinicopathological parameters, including prognosis, were determined. Moreover, we conducted a hypodermic administration test in nude mice and examined reproductive and cisplatin response activities. DYRK2 protein expression was posttranslationally reduced in cisplatin-resistant SA cell lines. 2008 shDYRK2 showed mesenchymal phenotype and resistant to cisplatin. Immunohistochemistry demonstrated that DYRK2 expression inversely correlated with Snail expression, and reduced expression of DYRK2 was associated with shorter overall survival in SA. DYRK2 may regulate EMT through Snail degradation in ovarian SA and might be a predictive marker for a favorable prognosis in the treatment of this cancer.	[Yamaguchi, Noriko; Mimoto, Rei; Imawari, Yoshimi; Yoshida, Kiyotsugu] Jikei Univ, Sch Med, Dept Biochem, Minato Ku, Tokyo 1058461, Japan; [Yamaguchi, Noriko; Yanaihara, Nozomu; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo 1058461, Japan; [Mimoto, Rei; Imawari, Yoshimi] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan; [Hirooka, Shinichi] Jikei Univ, Sch Med, Dept Pathol, Minato Ku, Tokyo 1058461, Japan	Yoshida, K (reprint author), Jikei Univ, Sch Med, Dept Biochem, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	kyoshida@jikei.ac.jp			Japan Society for the Promotion of Science; Jikei University Graduate Research Fund; Jikei University Research Fund; Takeda Science Foundation; Naito Foundation; Project Mirai Cancer Research Grants; Vehicle Racing Commemorative Foundation	This work was supported by grants from the Japan Society for the Promotion of Science, the Jikei University Graduate Research Fund, the Jikei University Research Fund, Takeda Science Foundation, the Naito Foundation, Project Mirai Cancer Research Grants, and the Vehicle Racing Commemorative Foundation.	Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Liu CM, 2005, NEW ENGL J MED, V352, P1268; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Mimoto R, 2013, CANCER LETT, V339, P214, DOI 10.1016/j.canlet.2013.06.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Zha YH, 2007, CELL BIOL INT, V31, P1089, DOI 10.1016/j.cellbi.2007.03.023; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Friedlander M, 2011, INT J GYNECOL CANCER, V21, P771, DOI 10.1097/IGC.0b013e31821bb8aa; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Colombo N, 2007, CRIT REV ONCOL HEMAT, V64, P129, DOI 10.1016/j.critrevonc.2007.04.004; Woods YL, 2001, BIOCHEM J, V355, P609; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Moore RG, 2010, CURR OPIN ONCOL, V22, P492, DOI 10.1097/CCO.0b013e32833c3351; Jia LQ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-33; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Dyall S., 2010, J ONCOL, V2010; Fishman David A, 2002, Cancer Treat Res, V107, P3; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hoskins WJ, 1994, GYNECOL ONCOL, V55, pS91; Iseri OD, 2010, CANCER CHEMOTH PHARM, V65, P447, DOI 10.1007/s00280-009-1048-z; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yamashita SI, 2009, ANTICANCER RES, V29, P2753	38	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	AUG	2015	36	8					5913	5923		10.1007/s13277-015-3264-y		11	Oncology	Oncology	CP9DL	WOS:000360193800025		
J	Takai, N; Ueda, T; Kira, N; Ishii, T; Yoshida, T; Koga, S; Nishida, M; Nasu, K; Narahara, H				Takai, Noriyuki; Ueda, Tami; Kira, Naoko; Ishii, Terukazu; Yoshida, Toshie; Koga, Satoko; Nishida, Masakazu; Nasu, Kaei; Narahara, Hisashi			Calcium/calmodulin-dependent kinase inhibitor induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells (Retraction of vol 33, pg 1053, 2012)	TUMOR BIOLOGY			English	Correction									[Takai, Noriyuki; Ueda, Tami; Kira, Naoko; Ishii, Terukazu; Yoshida, Toshie; Koga, Satoko; Nishida, Masakazu; Nasu, Kaei; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Yufu Shi, Oita 8795593, Japan	Takai, N (reprint author), Oita Univ, Fac Med, Dept Obstet & Gynecol, 1-1 Idaigaoka, Yufu Shi, Oita 8795593, Japan.	takai@oita-u.ac.jp					Takai N, 2012, TUMOR BIOL, V33, P1053, DOI 10.1007/s13277-012-0339-x	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	AUG	2015	36	8					6585	6585		10.1007/s13277-015-3666-x		1	Oncology	Oncology	CP9DL	WOS:000360193800099		
J	Nishiura, M; Guo, F; Hou, ZM				Nishiura, Masayoshi; Guo, Fang; Hou, Zhaomin			Half-Sandwich Rare-Earth-Catalyzed Olefin Polymerization, Carbometalation, and Hydroarylation	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							H BOND ADDITION; STYRENE-STYRENE SEQUENCES; FULL-SIZE RANGE; COMPLEXES BEARING; CYCLO-COPOLYMERIZATION; SCANDIUM CATALYSTS; METAL COMPLEXES; SYNDIOSPECIFIC COPOLYMERIZATION; ISOPRENE POLYMERIZATION; POLYHYDRIDE COMPLEXES	CONSPECTUS: The search for new catalysts for more efficient, selective chemical transformations and for the synthesis of new functional materials has been a long-standing research subject in both academia and industry. To develop new generations of catalysts that are superior or complementary to the existing ones, exploring the potential of untapped elements is an important strategy. Rare-earth elements, including scandium, yttrium, and the lanthanides (La-Lu), constitute one important frontier in the periodic table. Rare-earth elements possess unique chemical and physical properties that are different from those of main-group and late-transition metals. The development of rare-earth-based catalysts by taking the advantage of these unique properties is of great interest and importance. The most stable oxidation state of rare-earth metals is 3+, which is difficult to change under many reaction conditions. The oxidative addition and reductive elimination processes often observed in catalytic cycles involving late transition metals are generally difficult in the case of rare-earth complexes. The 18-electron rule that is applicable to late-transition-metal complexes does not fit rare-earth complexes, whose structures are mainly governed by the sterics (rather than the electron numbers) of the ligands. In the lanthanide series (La-Lu), the ionic radius gradually decreases with increasing atomic number because of the influence of the 4f electrons, which show poor shielding of nuclear charge. Rare-earth metal ions generally show strong Lewis acidity and oxophilicity. Rare-earth metal alkyl and hydride species are highly reactive, showing both nudeophilicity and basicity. The combination of these features, such as the strong nucleophilicity and moderate basicity of the alkyl and hydride species and the high stability, strong Lewis acidity, and unsaturated C-C bond affinity of the 3+ metal ions, can make rare-earth metals unique candidates for the formation of excellent single-site catalysts. This Account is intended to give an overview of our recent studies on organo rare-earth catalysis, in particular the synthesis and application of half-sandwich rare-earth alkyl complexes bearing monocyclopentadienyl ligands for olefin polymerization, carbometalation, and hydroarylation. Treatment of half-sandwich rare-earth dialkyl complexes having the general formula CpMR2 with an equimolar amount of an appropriate borate compound such as [Ph3C] [B(C6F5)(4)] can generate the corresponding cationic monoalkyl species, which serve as excellent single-site catalysts for the polymerization and copolymerization of a wide range of olefin monomers such as ethylene, 1-hexene, styrene, conjugated and nonconjugated dienes, and cyclic olefins. The cationic half-sandwich rare-earth alkyl complexes can also catalyze the regio- and stereoselective alkylative alumination of alkenes and alkynes through insertion of the unsaturated C-C bond into the metal alkyl bond followed by transmetalation between the resulting new alkyl or alkenyl species and an alkylaluminum compound. Moreover, a combination of deprotonative C-H bond activation of appropriate organic compounds such as anisoles and pyridines by the rare-earth alkyl species and insertion of alkenes into the resulting new metal carbon bond can lead to catalytic C-H bond alkylation of the organic substrates. Most of these transformations are unique to the rare-earth catalysts with selectivity and functional group tolerance different from those of late-transition-metal catalysts.	[Nishiura, Masayoshi; Hou, Zhaomin] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan; [Nishiura, Masayoshi; Hou, Zhaomin] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Guo, Fang; Hou, Zhaomin] Dalian Univ Technol, Sch Chem Engn, State Key Lab Fine Chem, Dalian 116012, Peoples R China	Hou, ZM (reprint author), RIKEN, Organometall Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	houz@riken.jp	Hou, Zhaomin/I-5981-2014	Hou, Zhaomin/0000-0003-2841-5120	JSPS [24350030, 26220802]; National Natural Science Foundation of China [21429201, 21204008]	We appreciate financial support through a Grant-in-Aid for Scientific Research (B) (24350030) and a Grant-in-Aid for Scientific Research (S) (26220802) from JSPS and grants from the National Natural Science Foundation of China (21429201 and 21204008).	BOOIJ M, 1993, ORGANOMETALLICS, V12, P3531, DOI 10.1021/om00033a027; Zimmermann M, 2010, CHEM REV, V110, P6194, DOI 10.1021/cr1001194; Zeimentz PM, 2006, CHEM REV, V106, P2404, DOI 10.1021/cr050574s; Shima T, 2008, CHEM LETT, V37, P298, DOI 10.1246/cl.2008.298; Kirillov E, 2004, J AM CHEM SOC, V126, P12240, DOI 10.1021/ja0455695; Valente A, 2014, ANGEW CHEM INT EDIT, V53, P4638, DOI 10.1002/anie.201311057; Hu SW, 2014, NATURE, V512, P413, DOI 10.1038/nature13624; Guo F, 2011, MACROMOLECULES, V44, P2400, DOI 10.1021/ma200441w; Luo YJ, 2004, J AM CHEM SOC, V126, P13910, DOI 10.1021/ja046063p; Zhang ZC, 2010, STRUCT BOND, V137, P49, DOI 10.1007/430_2010_16; Zhang LX, 2005, J AM CHEM SOC, V127, P14562, DOI 10.1021/ja055397r; Valente A, 2013, CHEM REV, V113, P3836, DOI 10.1021/cr300289z; Li XF, 2005, ANGEW CHEM INT EDIT, V44, P962, DOI 10.1002/anie.200461971; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Shima T, 2009, ORGANOMETALLICS, V28, P2244, DOI 10.1021/om900024q; Zhang LX, 2007, ANGEW CHEM INT EDIT, V46, P1909, DOI 10.1002/anie.200604348; WILKINSON G, 1954, J AM CHEM SOC, V76, P6210, DOI 10.1021/ja01652a114; Zhang LX, 2008, ANGEW CHEM INT EDIT, V47, P2642, DOI 10.1002/anie.200705120; Zimmermann M, 2008, ANGEW CHEM INT EDIT, V47, P775, DOI 10.1002/anie.200703514; Oyamada J, 2011, ANGEW CHEM INT EDIT, V50, P10720, DOI 10.1002/anie.201105636; Nakajima Y, 2009, ORGANOMETALLICS, V28, P6861, DOI 10.1021/om900702y; JORDAN RF, 1989, J AM CHEM SOC, V111, P778, DOI 10.1021/ja00184a081; Takimoto M, 2009, J AM CHEM SOC, V131, P18266, DOI 10.1021/ja909126k; Nishiura M, 2011, CHEM-EUR J, V17, P5033, DOI 10.1002/chem.201002998; Molander GA, 2002, CHEM REV, V102, P2161, DOI 10.1021/cr010291+; Luo Y, 2011, ORGANOMETALLICS, V30, P2908, DOI 10.1021/om100998c; Jian ZB, 2010, CHEM-EUR J, V16, P14007, DOI 10.1002/chem.201001634; DEELMAN BJ, 1994, ORGANOMETALLICS, V13, P3881, DOI 10.1021/om00022a025; Zhang H, 2008, MACROMOLECULES, V41, P1064, DOI 10.1021/ma7027006; Guo F, 2013, CHEM-ASIAN J, V8, P2471, DOI 10.1002/asia.201300599; Pan L, 2011, ANGEW CHEM INT EDIT, V50, P12012, DOI 10.1002/anie.201104011; Negishi E, 2007, B CHEM SOC JPN, V80, P233, DOI 10.1246/bcsj.80.233; Li XF, 2009, J AM CHEM SOC, V131, P13870, DOI 10.1021/ja9056213; Guan BT, 2013, ANGEW CHEM INT EDIT, V52, P4418, DOI 10.1002/anie.201208867; Shima T, 2013, SCIENCE, V340, P1549, DOI 10.1126/science.1238663; Hou ZM, 2003, B CHEM SOC JPN, V76, P2253, DOI 10.1246/bcsj.76.2253; Evans WJ, 2006, P NATL ACAD SCI USA, V103, P12678, DOI 10.1073/pnas.0602672103; Shima T, 2011, ORGANOMETALLICS, V30, P2513, DOI 10.1021/om1012055; Guo F, 2011, MACROMOLECULES, V44, P6335, DOI 10.1021/ma201271r; Oyamada J, 2012, ANGEW CHEM INT EDIT, V51, P12828, DOI 10.1002/anie.201206233; Guan BT, 2011, J AM CHEM SOC, V133, P18086, DOI 10.1021/ja208129t; Nishiura M, 2010, NAT CHEM, V2, P257, DOI 10.1038/nchem.595; Song GY, 2014, J AM CHEM SOC, V136, P12209, DOI 10.1021/ja504995f; Bambirra S, 2004, J AM CHEM SOC, V126, P9182, DOI 10.1021/ja0475297; Chen EYX, 2009, CHEM REV, V109, P5157, DOI 10.1021/cr9000258; Liu B, 2014, MACROMOLECULES, V47, P8524, DOI 10.1021/ma5019654; Yasuda H, 2002, J ORGANOMET CHEM, V647, P128, DOI 10.1016/S0022-328X(01)01357-2; Rodrigues I, 2013, J ORGANOMET CHEM, V743, P139, DOI 10.1016/j.jorganchem.2013.06.035; Cheng JH, 2011, SCI CHINA CHEM, V54, P2032, DOI 10.1007/s11426-011-4439-z; Edelmann F. T., 2007, COMPREHENSIVE ORGANO, P1; EVANS WJ, 1985, ADV ORGANOMET CHEM, V24, P131; Guo F, 2014, J POLYM SCI POL CHEM, V52, P1509, DOI 10.1002/pola.27152; Guo F, 2014, SCI CHINA CHEM, V57, P1150, DOI 10.1007/s11426-014-5132-9; Hou ZM, 2007, EUR J INORG CHEM, P2535, DOI 10.1002/ejic.200700085; Hou Z., 2002, SCI SYNTHESIS, V2, P849; Hou ZM, 2002, COORDIN CHEM REV, V231, P1, DOI 10.1016/S0010-8545(02)00111-X; Hultzsch KC, 1999, ANGEW CHEM INT EDIT, V38, P227; Ishihara N., 2013, Japan Patent, Patent No. 5259089; Kang X., 2014, ORGANOMETALLICS, V33, P1030; Kizu K., 2014, Japan Patent, Patent No. 5594712; Li XF, 2007, CHEM COMMUN, P4137, DOI 10.1039/b708534f; Li XF, 2010, MACROMOLECULES, V43, P8904, DOI 10.1021/ma101835e; Li XF, 2005, MACROMOLECULES, V38, P6767, DOI 10.1021/ma051323o; Luo G, 2012, ORGANOMETALLICS, V31, P3930, DOI 10.1021/om300147y; Luo YJ, 2006, STUD SURF SCI CATAL, V161, P95; Hong S, 2004, ACCOUNTS CHEM RES, V37, P673, DOI 10.1021/ar040051r; Marks T. J., 1982, COMPREHENSIVE ORGANO, P173, DOI 10.1016/B978-008046518-0.00029-5; Pan L, 2010, MACROMOLECULES, V43, P9591, DOI 10.1021/ma102329p; Song GY, 2015, CHEM-EUR J, V21, P8394, DOI 10.1002/chem.201501121; Urakawa N., 2014, Japan Patent, Patent No. 5626752; WATSON PL, 1985, ACCOUNTS CHEM RES, V18, P51, DOI 10.1021/ar00110a004	71	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	AUG	2015	48	8					2209	2220		10.1021/acs.accounts.5b00219		12	Chemistry, Multidisciplinary	Chemistry	CP5AC	WOS:000359892700006		
J	Ogura, T; Date, Y; Tsuboi, Y; Kikuchi, J				Ogura, Tatsuki; Date, Yasuhiro; Tsuboi, Yuuri; Kikuchi, Jun			Metabolic dynamics analysis by massive data integration: application to tsunami-affected field soils in Japan	ACS CHEMICAL BIOLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NMR-BASED METABOLOMICS; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS-THALIANA; MICROBIOTA; MIXTURES; PLANT; DEGRADATION; COMMUNITIES; DIVERSITY	A new metabolic dynamics analysis approach has been developed in which massive data sets from time-series of H-1 and C-13 NMR spectra are integrated in combination with microbial variability to Characterize the biomass degradation process using field soil microbial communities. On the basis of correlation analyses that revealed relationships between various metabolites and bacteria, we efficiently monitored the metabolic dynamics of saccharides, amino acids, and organic acids, by assessing time-course changes in the microbial and metabolic profiles during biomass degradation. Specific bacteria were found to support specific steps of metabolic pathways in the degradation process of biomass to short chain fatty acids. We evaluated samples from agricultural and abandoned fields contaminated by the tsunami that followed the Great East earthquake in Japan. Metabolic dynamics and activities in the biomass degradation process differed considerably between soil from agricultural and abandoned fields. In particular, production levels of short chain fatty acids, such as acetate and propionate, which were considered to be produced by soil bacteria such as Sedimentibacter sp. and Coprococcus sp., were higher in the soil from agricultural fields than from abandoned fields. Our approach could characterize soil activity based on the metabolic dynamics of microbial communities in the biomass degradation process and should therefore be useful in future investigations of the environmental effects of natural disasters on soils.	[Ogura, Tatsuki; Date, Yasuhiro; Tsuboi, Yuuri; Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ogura, Tatsuki; Date, Yasuhiro; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagricultural Sci, Chikusa Ku, Nagoya, Aichi 4640810, Japan	Kikuchi, J (reprint author), RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	jun.kikuchi@riken.jp	Kikuchi, Jun/M-5512-2015	Kikuchi, Jun/0000-0002-6809-394X	Ministry of Education, Culture and Sports [25513012, 200210023]; CSTI, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" - Bio-oriented Technology Research Advancement Institution (NARO)	The authors wish to thank Matsui M., Kato T., and Moriya S. (RIKEN) for their useful advice and assistance with the sequencing analysis. This research was supported in part by Grants-in-Aid for Scientific Research (Grant No. 25513012, to J.K.) and the Advanced Low Carbon Technology Research and Developmental Program (Grant No. 200210023, ALCA to J.K.) from the Ministry of Education, Culture and Sports, and also partially supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" funded from Bio-oriented Technology Research Advancement Institution (NARO).	Ito K, 2014, ANAL CHEM, V86, P1098, DOI 10.1021/ac402869b; Sekiyama Y, 2011, ANAL CHEM, V83, P719, DOI 10.1021/ac102097u; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Wei FF, 2015, ANAL CHEM, V87, P2819, DOI 10.1021/ac504211n; Yamazawa A, 2013, MOLECULES, V18, P9021, DOI 10.3390/molecules18089021; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Okamoto M, 2009, PLANT BIOTECHNOL, V26, P551, DOI 10.5511/plantbiotechnology.26.551; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Li HJ, 2011, J SOIL SEDIMENT, V11, P1234, DOI 10.1007/s11368-011-0371-2; Date Y, 2014, FOOD CHEM, V152, P251, DOI 10.1016/j.foodchem.2013.11.126; Miki T, 2010, P NATL ACAD SCI USA, V107, P14251, DOI 10.1073/pnas.0914281107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Misawa T, 2015, J PROTEOME RES, V14, P1526, DOI 10.1021/pr501194k; Schlipalius DI, 2012, SCIENCE, V338, P807, DOI 10.1126/science.1224951; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Breitenstein A, 2002, INT J SYST EVOL MICR, V52, P801, DOI 10.1099/ijs.0.01998-0; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ramirez-Puebla ST, 2013, APPL ENVIRON MICROB, V79, P2, DOI 10.1128/AEM.02553-12; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Bingol K, 2013, ANAL CHEM, V85, P6414, DOI 10.1021/ac400913m; An YJ, 2012, ACS CHEM BIOL, V7, P2012, DOI 10.1021/cb3004226; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Asakura T, 2014, ANAL CHEM, V86, P5425, DOI 10.1021/ac5005037; Asakura T., 2014, PEERJ, V2; Asano R, 2013, MICROB ECOL, V66, P639, DOI 10.1007/s00248-013-0261-9; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Date Y, 2012, J PROTEOME RES, V11, P5602, DOI 10.1021/pr3008682; Date Y, 2012, POLYM J, V44, P888, DOI 10.1038/pj.2012.105; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; Everroad RC, 2012, JOVE-J VIS EXP, DOI 10.3791/3163; Guo HD, 2011, CHINESE SCI BULL, V56, P2138, DOI 10.1007/s11434-011-4544-6; Kang DongJin, 2013, Journal of Crop Science and Biotechnology, V16, P219, DOI 10.1007/s12892-013-0049-y; Limanska N, 2013, ACTA PHYSIOL PLANT, V35, P1587, DOI 10.1007/s11738-012-1200-y; Marohn C, 2012, NAT HAZARD EARTH SYS, V12, P2879, DOI 10.5194/nhess-12-2879-2012; Ogawa DMO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110723; Ogura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066919; Piatek KB, 2010, NORTH J APPL FOR, V27, P97; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M7005499200; Watanabe T, 2002, BIOCHEM BIOPH RES CO, V297, P918, DOI 10.1016/S0006-291X(02)02313-6; Yamazawa A., 2014, METABOLITES, V4, P36; Yoshida S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07005; Yuki M, 2008, ZOOL SCI, V25, P401, DOI 10.2108/zsj.25.401	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	AUG	2015	10	8					1908	1915		10.1021/cb500609p		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CP7XO	WOS:000360103100019		
J	Jiang, NS; Endoh, MK; Koga, T; Masui, T; Kishimoto, H; Nagao, M; Satija, SK; Taniguchi, T				Jiang, Naisheng; Endoh, Maya K.; Koga, Tadanori; Masui, Tomomi; Kishimoto, Hiroyuki; Nagao, Michihiro; Satija, Sushil K.; Taniguchi, Takashi			Nanostructures and Dynamics of Macromolecules Bound to Attractive Filler Surfaces	ACS MACRO LETTERS			English	Article							SMALL-ANGLE SCATTERING; CARBON-BLACK; SPHERICAL NANOPARTICLES; POLYMER MATRICES; RUBBER; DENSITY; SILICA; LAYER; NANOCOMPOSITES; REINFORCEMENT	We report in situ nanostructures and dynamics of polybutadiene (PB) chains bound to carbon black (CB) fillers (the so-called "bound polymer layer (BPL)") in a good solvent. The BPL on the CB fillers was extracted by solvent leaching of a CB-filled PB compound and subsequently dispersed in deuterated toluene to label the BPL for small-angle neutron scattering and neutron spin echo techniques. The results demonstrate that the BPL is composed of two regions regardless of molecular weights of PB: the inner unswollen region of approximate to 0.5 nm thick and outer swollen region where the polymer chains display a parabolic profile with a diffuse tail. In addition, the results show that the dynamics of the swollen bound chains can be explained by the so-called "breathing mode" and is generalized with the thickness of the swollen BPL.	[Jiang, Naisheng; Endoh, Maya K.; Koga, Tadanori] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA; [Endoh, Maya K.; Koga, Tadanori] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Koga, Tadanori] SUNY Stony Brook, Chem & Mol Engn Program, Stony Brook, NY 11794 USA; [Masui, Tomomi; Kishimoto, Hiroyuki] Sumitomo Rubber Ind Ltd, Chuo Ku, Kobe, Hyogo 6710027, Japan; [Nagao, Michihiro; Satija, Sushil K.] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Nagao, Michihiro] Indiana Univ, Ctr Explorat Energy & Matter, Bloomington, IN 47408 USA; [Taniguchi, Takashi] Kyoto Univ, Grad Sch Engn, Dept Chem Engn, Nishikyo Ku, Kyoto 6158510, Japan	Koga, T (reprint author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.	tadanori.koga@stonybrook.edu	Taniguchi, Takashi/C-3137-2009; Koga, Tadanori/A-4007-2010		NSF [CMMI-1332499, DMR-0944772]; Sumitomo Rubber; NIST, U.S. Department Commerce [70NANB10H255]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]	We thank David Mildner for the USANS experiments and Young-Soo Han and Tae-Hwan Kim for the partial SANS experiments described in Supporting Information. T.K. acknowledges partial financial supports from NSF Grant No. CMMI-1332499 and Sumitomo Rubber. M.N. acknowledges funding support of cooperative agreement 70NANB10H255 from NIST, U.S. Department Commerce. Use of the National Synchrotron Light Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. This work utilized facilities supported in part by the NSF under Agreement No. DMR-0944772. The identification of any commercial product or trade name does not imply endorsement or recommendation by the NIST.	Ajayan P.M., 2003, NANOCOMPOSITE SCI TE; Papon A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.065702; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Ciprari D, 2006, MACROMOLECULES, V39, P6565, DOI 10.1021/ma0602270; Mujtaba A, 2014, ACS MACRO LETT, V3, P481, DOI 10.1021/mz500192r; ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300; Karasek L, 1996, J MATER SCI, V31, P281, DOI 10.1007/BF01139141; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Jiang NS, 2014, MACROMOLECULES, V47, P2682, DOI 10.1021/ma5003485; Litvinov VM, 1999, MACROMOLECULES, V32, P8476, DOI 10.1021/ma9910080; Ndoro TVM, 2011, MACROMOLECULES, V44, P2316, DOI 10.1021/ma102833u; ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462; Daoulas KC, 2005, MACROMOLECULES, V38, P5780, DOI 10.1021/ma050176r; Koga T, 2005, LANGMUIR, V21, P11409, DOI 10.1021/la051352s; Yakubov GE, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.115501; Hooper JB, 2006, MACROMOLECULES, V39, P5133, DOI 10.1021/ma060577m; ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180; KENNY JC, 1991, MACROMOLECULES, V24, P436, DOI 10.1021/ma00002a015; KARIM A, 1994, PHYS REV LETT, V73, P3407, DOI 10.1103/PhysRevLett.73.3407; Papon A, 2011, MACROMOLECULES, V44, P913, DOI 10.1021/ma102486x; Koga T, 2008, MACROMOLECULES, V41, P453, DOI 10.1021/ma0718671; Harton SE, 2010, MACROMOLECULES, V43, P3415, DOI 10.1021/ma902484d; Oberdisse J, 2006, SOFT MATTER, V2, P29, DOI 10.1039/b511959f; Litvinov VM, 2011, MACROMOLECULES, V44, P4887, DOI 10.1021/ma2007255; MEDALIA AI, 1970, J COLLOID INTERF SCI, V32, P115, DOI 10.1016/0021-9797(70)90108-6; Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0; Ashkar R, 2014, ACS MACRO LETT, V3, P1262, DOI 10.1021/mz500636s; BLOW CM, 1973, POLYMER, V14, P309, DOI 10.1016/0032-3861(73)90124-9; Blum FD, 1996, MACROMOLECULES, V29, P8740, DOI 10.1021/ma960962j; Carasso ML, 1997, J COLLOID INTERF SCI, V193, P200, DOI 10.1006/jcis.1997.5082; DANNENBERG EM, 1986, RUBBER CHEM TECHNOL, V59, P512, DOI 10.5254/1.3538213; DEGENNES PG, 1986, CR ACAD SCI II, V302, P765; de Gennes P. G., 1979, SCALING CONCEPTS POL; FARAGO B, 1993, PHYS REV LETT, V71, P1015, DOI 10.1103/PhysRevLett.71.1015; Flory P. J., 1953, PRINCIPLES POLYM CHE; Fytas G, 1996, SCIENCE, V274, P2041, DOI 10.1126/science.274.5295.2041; Goritz D, 1999, RUBBER CHEM TECHNOL, V72, P929; HEINRICH G, 1995, RUBBER CHEM TECHNOL, V68, P26, DOI 10.5254/1.3538729; Higgins J. S., 1994, POLYM NEUTRON SCATTE; Jouault N, 2013, ACS MACRO LETT, V2, P371, DOI 10.1021/mz300646a; Kanaya T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1879892; KOOPAL LK, 1975, FARADAY DISCUSS, V59, P230, DOI 10.1039/dc9755900230; Kritikos G, 2013, EUR POLYM J, V49, P613, DOI 10.1016/j.eurpolymj.2012.09.008; Krutyeva M., 2013, PHYS REV LETT, V110, P110; Lin WY, 1998, MACROMOLECULES, V31, P4135, DOI 10.1021/ma971725z; Patton D, 2011, MACROMOL CHEM PHYS, V212, P485, DOI 10.1002/macp.201000524; Stickney P B, 1964, RUBBER CHEM TECHNOL, V37, P1299, DOI 10.5254/1.3540401; Takenaka M, 2012, RUBBER CHEM TECHNOL, V85, P157, DOI 10.5254/rct.12.89960; VILLARS DS, 1956, J POLYM SCI, V21, P257, DOI 10.1002/pol.1956.120219808	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	AUG	2015	4	8					838	842		10.1021/acsmacrolett.5b00368		5	Polymer Science	Polymer Science	CP4ZN	WOS:000359891200007		
J	Itou, H; Shirakihara, Y; Araki, H				Itou, Hiroshi; Shirakihara, Yasuo; Araki, Hiroyuki			The quaternary structure of the eukaryotic DNA replication proteins Sld7 and Sld3	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						DNA replication; initiator protein; Sld3; Sld7	BUDDING YEAST; CRYSTAL-STRUCTURE; S-PHASE; COMPLEX; CDC45; GINS; CDK; REFINEMENT; PHOSPHORYLATION; PHENIX	The initiation of eukaryotic chromosomal DNA replication requires the formation of an active replicative helicase at the replication origins of chromosomes. Yeast Sld3 and its metazoan counterpart treslin are the hub proteins mediating protein associations critical for formation of the helicase. The Sld7 protein interacts with Sld3, and the complex formed is thought to regulate the function of Sld3. Although Sld7 is a non-essential DNA replication protein that is found in only a limited range of yeasts, its depletion slowed the growth of cells and caused a delay in the S phase. Recently, the Mdm2-binding protein was found to bind to treslin in humans, and its depletion causes defects in cells similar to the depletion of Sld7 in yeast, suggesting their functional relatedness and importance during the initiation step of DNA replication. Here, the crystal structure of Sld7 in complex with Sld3 is presented. Sld7 comprises two structural domains. The N-terminal domain of Sld7 binds to Sld3, and the C-terminal domains connect two Sld7 molecules in an antiparallel manner. The quaternary structure of the Sld3-Sld7 complex shown from the crystal structures appears to be suitable to activate two helicase molecules loaded onto replication origins in a head-to-head manner.	[Itou, Hiroshi; Shirakihara, Yasuo] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; [Araki, Hiroyuki] Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan	Itou, H (reprint author), Natl Inst Genet, Struct Biol Ctr, Yata 1111, Mishima, Shizuoka 4118540, Japan.	hitou@nig.ac.jp					Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Boos D, 2013, SCIENCE, V340, P981, DOI 10.1126/science.1237448; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka T, 2011, EMBO J, V30, P2019, DOI 10.1038/emboj.2011.115; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Itou H, 2014, STRUCTURE, V22, P1341, DOI 10.1016/j.str.2014.07.001; Miller JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03433; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	37	1	1	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	AUG	2015	71		8				1649	1656		10.1107/S1399004715010457		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7QC	WOS:000359354800007		
J	Fukuda, K; Yoshimura, Y; Okamoto, T; Takeda, Y; Kumaki, D; Katayama, Y; Tokito, S				Fukuda, Kenjiro; Yoshimura, Yudai; Okamoto, Tomoko; Takeda, Yasunori; Kumaki, Daisuke; Katayama, Yoshinori; Tokito, Shizuo			Reverse-Offset Printing Optimized for Scalable Organic Thin-Film Transistors with Submicrometer Channel Lengths	ADVANCED ELECTRONIC MATERIALS			English	Article							FIELD-EFFECT TRANSISTORS; HIGH-PERFORMANCE; CONTACT RESISTANCE; HIGH-MOBILITY; DERIVATIVES; ELECTRODES; OPERATION; CIRCUITS		[Fukuda, Kenjiro; Yoshimura, Yudai; Takeda, Yasunori; Kumaki, Daisuke; Tokito, Shizuo] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Fukuda, Kenjiro] PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Okamoto, Tomoko; Katayama, Yoshinori] DIC Corp, Sakura, Chiba 2858668, Japan	Fukuda, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	fukuda@yz.yamagata-u.ac.jp; tokito@yz.yamagata-u.ac.jp			Center of Innovation Program from Japan Science and Technology Agency (JST); Adaptable and Seamless Technology Transfer Program through Target-driven RD from JST [13425831]	This study was in part supported by the Center of Innovation Program from Japan Science and Technology Agency (JST) and Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Grant No. 13425831) from JST. The authors also thank Mr. C. Shepherd for his technical support and helpful discussions. This article was modified on August 12, 2015 to correct an typographical error in the title.	Naden AB, 2014, J MATER CHEM C, V2, P245, DOI 10.1039/c3tc31783h; Nakayama K, 2011, ADV MATER, V23, P1626, DOI 10.1002/adma.201004387; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Klauk H, 2010, CHEM SOC REV, V39, P2643, DOI 10.1039/b909902f; Tseng HR, 2014, ADV MATER, V26, P2993, DOI 10.1002/adma.201305084; Myny K, 2010, ORG ELECTRON, V11, P1176, DOI 10.1016/j.orgel.2010.04.013; Subramanian S, 2008, J AM CHEM SOC, V130, P2706, DOI 10.1021/ja073235k; Benor A, 2008, ORG ELECTRON, V9, P209, DOI 10.1016/j.orgel.2007.10.012; Gundlach DJ, 2008, NAT MATER, V7, P216, DOI 10.1038/nmat2122; Kang H, 2012, ADV MATER, V24, P3065, DOI 10.1002/adma.201200924; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; Smith J, 2012, ADV MATER, V24, P2441, DOI 10.1002/adma.201200088; Sekitani T, 2008, P NATL ACAD SCI USA, V105, P4976, DOI 10.1073/pnas.0708340105; Noh YY, 2007, NAT NANOTECHNOL, V2, P784, DOI 10.1038/nnano.2007.365; Mitsui C, 2014, ADV MATER, V26, P4546, DOI 10.1002/adma.201400289; Niimi K, 2011, ORG LETT, V13, P3430, DOI 10.1021/ol2010837; Wang HL, 2014, ADV MATER, V26, P4683, DOI 10.1002/adma.201400697; Klauk H, 2003, SOLID STATE ELECTRON, V47, P297, DOI 10.1016/S0038-1101(02)00210-1; Ante F, 2012, SMALL, V8, P73, DOI 10.1002/smll.201101677; Bucella SG, 2013, ORG ELECTRON, V14, P2249, DOI 10.1016/j.orgel.2013.05.002; Diao Y, 2013, NAT MATER, V12, P665, DOI [10.1038/nmat3650, 10.1038/NMAT3650]; Tu DY, 2011, IEEE T ELECTRON DEV, V58, P3574, DOI 10.1109/TED.2011.2162648; Fukuda K, 2012, PHYS STATUS SOLIDI A, V209, P2073, DOI 10.1002/pssa.201228219; Chabinyc ML, 2004, J APPL PHYS, V96, P2063, DOI 10.1063/1.1766411; Fukuda K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03947; Gili E, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3696487; Kim M., 2011, ELECTROCHEM SOLID ST, V14, pH333; Kusaka Y., 2013, P IDW, P1526; Locci S, 2008, IEEE T ELECTRON DEV, V55, P2561, DOI 10.1109/TED.2008.2003022; Moon T., 2009, SID INT S PAP, V40, P1348; Yoshimura Y, 2014, ORG ELECTRON, V15, P2696, DOI 10.1016/j.orgel.2014.08.001; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2199-160X			ADV ELECTRON MATER	Adv. Electron. Mater.	AUG	2015	1	8							1500145	10.1002/aelm.201500145		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CP4SK	WOS:000359872700015		
J	Huang, JS; Lin, YC; Tsai, HW; Yen, WC; Chen, CW; Lee, CY; Chin, TS; Chueh, YL				Huang, Jian-Shiou; Lin, Yung-Chang; Tsai, Hung-Wei; Yen, Wen-Chun; Chen, Chia-Wei; Lee, Chi-Yuan; Chin, Tsung-Shune; Chueh, Yu-Lun			Bias Polarity-Induced Transformation of Point Contact Resistive Switching Memory from Single Transparent Conductive Metal Oxide Layer	ADVANCED ELECTRONIC MATERIALS			English	Article							THIN-FILMS		[Huang, Jian-Shiou; Tsai, Hung-Wei; Yen, Wen-Chun; Chen, Chia-Wei; Lee, Chi-Yuan; Chueh, Yu-Lun] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 30013, Taiwan; [Lin, Yung-Chang] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Chin, Tsung-Shune] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan	Chin, TS (reprint author), Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan.	tschin@mx.nthu.edu.tw; ylchueh@mx.nthu.edu.tw			Ministry of Science and Technology [101-2112-M-007-015-MY3, 101-2218-E-007-009-MY3, 103-2633-M-007-001]; National Tsing Hua University [104N2022E1]	The research was supported by Ministry of Science and Technology through Grant Nos. 101-2112-M-007-015-MY3, 101-2218-E-007-009-MY3, and 103-2633-M-007-001 and the National Tsing Hua University through Grant No. 104N2022E1. Y.-L. Chueh greatly appreciates the use of facility at Center For Nanotechnology, Material Science, and Microsystem (CNMM), National Tsing Hua University through Grant No. 104N2744E1.	Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Chen YC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3457996; Janousch M, 2007, ADV MATER, V19, P2232, DOI 10.1002/adma.200602915; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Chang WY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834852; Huang JS, 2013, ELECTROCHIM ACTA, V91, P62, DOI 10.1016/j.electacta.2012.12.030; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Moreno C, 2010, NANO LETT, V10, P3828, DOI 10.1021/nl1008162; Seo S, 2004, APPL PHYS LETT, V85, P5655, DOI 10.1063/1.1831560; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Liu KC, 2010, THIN SOLID FILMS, V518, P7460, DOI 10.1016/j.tsf.2010.05.024; Capron N, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2807282; Chen LM, 2010, THIN SOLID FILMS, V518, P7352, DOI 10.1016/j.tsf.2010.04.111; Ghosh A, 2001, PHYS REV B, V64; Lin TY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243983; Moradpour A, 2011, ADV MATER, V23, P4141, DOI 10.1002/adma.201101800	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2199-160X			ADV ELECTRON MATER	Adv. Electron. Mater.	AUG	2015	1	8							1500061	10.1002/aelm.201500061		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CP4SK	WOS:000359872700016		
J	Salazar-Rios, JM; Gomulya, W; Derenskyi, V; Yang, J; Bisri, SZ; Chen, ZH; Facchetti, A; Loi, MA				Salazar-Rios, Jorge Mario; Gomulya, Widianta; Derenskyi, Vladimir; Yang, Jie; Bisri, Satria Zulkarnaen; Chen, Zhihua; Facchetti, Antonio; Loi, Maria Antonietta			Selecting Semiconducting Single-Walled Carbon Nanotubes with Narrow Bandgap Naphthalene Diimide-Based Polymers	ADVANCED ELECTRONIC MATERIALS			English	Article							FIELD-EFFECT TRANSISTORS; SIDE-CHAINS; SOLAR-CELLS; PERFORMANCE; DISPERSION; SEPARATION; MOBILITY	Noncovalent functionalization of carbon nanotubes by wrapping them using pi-conjugated polymers is one of the most promising techniques to sort, separate, and purify semiconducting nanotube species for applications in optoelectronic devices. However, wide energy bandgap polymers commonly used in this technique reduce charge transport through the nanotube network. To avoid the formation of insulating barriers between the tubes, challenging procedures for the removal of the polymer from the nanotube walls are necessary. Here, the use of two narrow bandgap polymers based on naphthalene-bis(dicarboximide) (NDI), namely, poly{[N, N'-bis(2-octyldodecyl)- naphthalene-1,4,5,8-bis(dicarboximide)-2,6-diyl]-alt-5,59-(2,29-bithiophene)}, (P(NDI2OD-T-2 or ActivInk N2200) and its molecular cousin, poly{[(N, N'-bis(2-octyldodecyl)-1,4,5,8-naphthalenedicarboximide-2,6-diyl)alt -5,5'-(2,2'-bithiophene)]-co -[(N, N'-bis(2-octyldodecyl)-1,4,5,8-naphthalenedicarboximide-2,6-diyl)-alt -5,5'-(2,2'-(4,4'-dimethoxybithiophene))]}(ActivInk PE-N-73), for selecting semiconducting single-walled carbon nanotubes (s-SWNTs) is demonstrated. The influence of the chemical structure of these polymers on the nanotube selectivity, as well as the effect of residual excess polymer and their band-gaps, are investigated through optical spectroscopy and charge transport measurements. While the electron transport of the devices fabricated with PE-N-73 and N2200 wrapped SWNTs is comparable, a substantial difference is observed in the hole transport. The better alignment of the HOMO level of PE-N-73 with that of the nanotubes allows achieving improved p-type characteristics even with a large amount of residual polymer in the network.	[Salazar-Rios, Jorge Mario; Gomulya, Widianta; Derenskyi, Vladimir; Yang, Jie; Bisri, Satria Zulkarnaen; Loi, Maria Antonietta] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Bisri, Satria Zulkarnaen] RIKEN Ctr Emergent Matter Sci RIKEN CEMS, Wako, Saitama 3510198, Japan; [Chen, Zhihua; Facchetti, Antonio] Polyera Corp, Skokie, IL 60077 USA; [Facchetti, Antonio] King Abdulaziz Univ, Ctr Excellence Mat Res, Jeddah 21589, Saudi Arabia	Loi, MA (reprint author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.a.loi@rug.nl		Bisri, Satria Zulkarnaen/0000-0002-3922-6248	Stichting voor Technische Wetenschappen (STW, Utrecht, The Netherlands); Foundation for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO); University of Groningen; Deanship of Scientific Research (DSR), King Abdulaziz University [4-130-36-HiCi]	The work in Groningen was partially supported by Stichting voor Technische Wetenschappen (STW, Utrecht, The Netherlands) and by the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO), under the framework of the FOM Focus Group "Next Generation Organic Photovoltaics." W.G. is grateful for the Bernoulli scholarship obtained from the University of Groningen. The Deanship of Scientific Research (DSR), King Abdulaziz University, under Grant No. (4-130-36-HiCi) is acknowledged.	Zhou XJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146805; Fabiano S, 2011, J MATER CHEM, V21, P5891, DOI 10.1039/c0jm03405c; Shea MJ, 2014, J PHYS CHEM LETT, V5, P3742, DOI 10.1021/jz5017813; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F; Bindl DJ, 2013, CHEM PHYS, V413, P29, DOI 10.1016/j.chemphys.2012.08.001; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Lee HW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1545; Ramuz MP, 2012, ACS NANO, V6, P10384, DOI 10.1021/nn304410w; Kim W, 2002, NANO LETT, V2, P703, DOI 10.1021/nl025602q; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Satake A, 2005, CHEM MATER, V17, P716, DOI 10.1021/cm048549a; Snow ES, 2003, APPL PHYS LETT, V82, P2145, DOI 10.1063/1.1564291; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Szendrei K, 2010, J MATER CHEM, V20, P1317, DOI 10.1039/b919596c; Chen ZH, 2009, J AM CHEM SOC, V131, P8, DOI 10.1021/ja805407g; Gao JB, 2004, J AM CHEM SOC, V126, P16698, DOI 10.1021/ja044499z; Yi WH, 2008, J PHYS CHEM B, V112, P12263, DOI 10.1021/jp804083n; Schuettfort T, 2009, NANO LETT, V9, P3871, DOI 10.1021/nl902081t; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Schubert M, 2012, ADV ENERGY MATER, V2, P369, DOI 10.1002/aenm.201100601; Choi JH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745228; Bisri SZ, 2012, ADV MATER, V24, P6147, DOI 10.1002/adma.201202699; Izard N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939560; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Gomulya W, 2013, ADV MATER, V25, P2948, DOI 10.1002/adma.201300267; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Bindl DJ, 2011, NANO LETT, V11, P455, DOI 10.1021/nl1031343; Baeg K.-J., 2013, ADV MATER, V25, P4210; Derenskyi V, 2014, ADV MATER, V26, P5969, DOI 10.1002/adma.201401395; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Gao J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30120-5; Gong X, 2004, SYNTHETIC MET, V141, P17, DOI 10.1016/j.synthmet.2003.06.003; Peeters H, 2013, MACROMOL CHEM PHYS, V214, P538, DOI 10.1002/macp.201200584; Saito M, 2014, HETEROATOM CHEM, V25, P556, DOI 10.1002/hc.21196; Saito R, 1998, PHYS PROPERTIES CARB	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2199-160X			ADV ELECTRON MATER	Adv. Electron. Mater.	AUG	2015	1	8							1500074	10.1002/aelm.201500074		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CP4SK	WOS:000359872700002		
J	Uesugi, E; Nishiyama, S; Akiyoshi, H; Goto, H; Koike, Y; Yamada, K; Kubozono, Y				Uesugi, Eri; Nishiyama, Saki; Akiyoshi, Hidehiko; Goto, Hidenori; Koike, Yoji; Yamada, Kazuyoshi; Kubozono, Yoshihiro			1D and 2D Bi Compounds in Field-Effect Transistors	ADVANCED ELECTRONIC MATERIALS			English	Article							MAGNETIC-PROPERTIES; ELECTRIC-FIELD; SUPERCONDUCTIVITY; BI2CUO4; INSULATOR; RESISTANCE; GRAPHENE; LIQUID		[Uesugi, Eri; Nishiyama, Saki; Akiyoshi, Hidehiko; Goto, Hidenori; Kubozono, Yoshihiro] Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan; [Koike, Yoji] Tohoku Univ, Dept Appl Phys, Sendai, Miyagi 9808579, Japan; [Yamada, Kazuyoshi] High Energy Accelerator Res Org KEK, IMSS, Tsukuba, Ibaraki 3050801, Japan; [Kubozono, Yoshihiro] Okayama Univ, Res Ctr New Funct Mat Energy Prod Storage & Trans, Okayama 7008530, Japan; [Kubozono, Yoshihiro] Japan Sci & Technol Agcy, ACT C, Kawaguchi, Saitama 3320012, Japan	Kubozono, Y (reprint author), Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan.	kubozono@cc.okayama-u.ac.jp	KUBOZONO, Yoshihiro/B-2091-2011		MEXT [26 . 228, 26400361, 22244045, 24654105, 26105004]; Strategic International Collaborative Research Program (JST/SICORP); Strategic International Collaborative Research Program (EU-JPN LEMSUPER); MEXT Program for Promoting the Enhancement of Research Universities; Special Project of Okayama University	This study was partly supported by Grants-in-aid (26 . 228, 26400361, 22244045, 24654105, 26105004) from MEXT, the Strategic International Collaborative Research Program (JST/SICORP, EU-JPN LEMSUPER), the MEXT Program for Promoting the Enhancement of Research Universities, and as a Special Project of Okayama University.	Taniguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740268; Wan XG, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115124; Chuang HJ, 2014, NANO LETT, V14, P3594, DOI 10.1021/nl501275p; Mizuguchi Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114725; Yuan HT, 2013, NAT PHYS, V9, P563, DOI 10.1038/NPHYS2691; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Demura S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033708; Yuan HT, 2009, ADV FUNCT MATER, V19, P1046, DOI 10.1002/adfm.200801633; Nagao M, 2014, SOLID STATE COMMUN, V178, P33, DOI 10.1016/j.ssc.2013.10.019; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Yuan HT, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3535613; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Awana VPS, 2013, SOLID STATE COMMUN, V157, P21, DOI 10.1016/j.ssc.2012.11.021; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/nmat2587, 10.1038/NMAT2587]; Mizuguchi Y, 2015, J PHYS CHEM SOLIDS, V84, P34, DOI 10.1016/j.jpcs.2014.09.003; Deguchi K, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/17004; Eguchi R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795626; Ghosh A, 1998, SOLID STATE COMMUN, V106, P677, DOI 10.1016/S0038-1098(98)00129-X; GOLDONI A, 1994, PHYS REV B, V50, P10435, DOI 10.1103/PhysRevB.50.10435; Nagano T, 2007, J PHYS CHEM C, V111, P7211, DOI 10.1021/jp0708751; ONG EW, 1990, PHYS REV B, V42, P4255, DOI 10.1103/PhysRevB.42.4255; TAKAGI H, 1987, JPN J APPL PHYS 2, V26, pL123, DOI 10.1143/JJAP.26.L123; TOKURA Y, 1989, NATURE, V337, P345, DOI 10.1038/337345a0; TROC R, 1990, J PHYS-CONDENS MAT, V2, P6989, DOI 10.1088/0953-8984/2/33/011; Uesugi E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01595; YAMADA K, 1991, J PHYS SOC JPN, V60, P2406, DOI 10.1143/JPSJ.60.2406	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2199-160X			ADV ELECTRON MATER	Adv. Electron. Mater.	AUG	2015	1	8							1500085	10.1002/aelm.201500085		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CP4SK	WOS:000359872700005		
J	Uttayamakul, S; Oudot-Mellakh, T; Nakayama, EE; Tengtrakulcharoen, P; Guergnon, J; Delfraissy, JF; Khusmith, S; Sangsajja, C; Likanonsakul, S; Theodorou, I; Shioda, T				Uttayamakul, Sumonmal; Oudot-Mellakh, Tiphaine; Nakayama, Emi E.; Tengtrakulcharoen, Pimrapat; Guergnon, Julien; Delfraissy, Jean-Francois; Khusmith, Srisin; Sangsajja, Chariya; Likanonsakul, Sirirat; Theodorou, Ioannis; Shioda, Tatsuo			Genome-Wide Association Study of HIV-Related Lipoatrophy in Thai Patients: Association of a DLGAP1 Polymorphism with Fat Loss	AIDS RESEARCH AND HUMAN RETROVIRUSES			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; PROTEIN; LIPODYSTROPHY; INFECTION; CONTRIBUTES; EXPRESSION; INTERACTS; DOMAIN; PSD-95; FAMILY	HIV-related lipoatrophy (LA) is a major adverse drug effect among HIV patients receiving the antiretroviral drug stavudine (d4T) in Southeast Asia. Although the development of LA could be observed in almost all HIV patients administered d4T for extended periods, there is considerable variation in the duration required to develop LA within this patient population. This study aimed to identify host genetic polymorphisms affecting the rate of LA onset in Thai HIV patients. We performed a genome-wide association study of HIV-related LA among patients at the Bamrasnaradura Infectious Diseases Institute, Thailand. Genotypes of HIV patients who developed LA within 2 years of treatment were compared with those of patients who did not develop LA after at least 4 years of treatment (non-LA patients). Genotypes of 49 LA and 92 non-LA patients at 578,525 single nucleotide polymorphisms (SNPs) were determined by Illumina bead arrays. The TaqMan real-time PCR method was used in a replication study. Five SNPs in the bead arrays, which showed the lowest p values in a comparison of LA with non-LA patients, were further tested in independent and sex-matched subpopulations consisting of 95 LA and 95 non-LA patients. This replication study revealed a significant association of LA with an SNP (rs12964965) in the gene encoding the Disks Large Homolog-Associated Protein 1 (DLGAP1), even after the correction for five multiple comparisons. These results strongly suggested involvement of the DLGAP1 gene product in the development of LA in Thai HIV patients.	[Uttayamakul, Sumonmal; Sangsajja, Chariya; Likanonsakul, Sirirat] Minist Publ Hlth, Dept Dis Control, Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Oudot-Mellakh, Tiphaine; Guergnon, Julien; Theodorou, Ioannis] INSERM, U1135, CIMI, Plateforme Genom ANRS, Paris, France; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Tengtrakulcharoen, Pimrapat] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Delfraissy, Jean-Francois] Hop Kremlin Bicetre, AP HP, Dept Internal Med, Le Kremlin Bicetre, France; [Delfraissy, Jean-Francois] Fac Med Paris Sud, Le Kremlin Bicetre, France; [Khusmith, Srisin] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Theodorou, Ioannis] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France	Shioda, T (reprint author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	shioda@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare, Japan; ANRS, France; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund [PHD/0094/2551]	We thank the HIV patients for their kind participation in the study. We thank Tippawan Rattanatham and Siriluk Feangvad for their excellent assistance. We also thank Drs. Wisit Prasithsirikul, Agostino Riva, Massimo Galli, and Patrice Debre for critical discussions. This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, the Ministry of Health, Labour, and Welfare, Japan, and those from ANRS, France. S.U. was a recipient of the Royal Golden Jubilee Ph.D. Program (grant PHD/0094/2551) of the Thailand Research Fund. We dedicate this research communication to Siriluk Feangvad, who passed away on November 30, 2013.	Poma BZ, 2008, AIDS, V22, P1769, DOI 10.1097/QAD.0b013e32830b3a96; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Giralt M, 2006, ANTIVIR THER, V11, P729; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Naisbitt S, 2000, J NEUROSCI, V20, P4524; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Bae JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019091; Blanco F, 2001, AIDS REV, V3, P98; Carr A, 2003, AIDS, V17, pS141; Collins ML, 2004, JAIDS-J ACQ IMM DEF, V37, P1132, DOI 10.1097/01.qai.0000131585.77530.64; Kawashima N, 1997, FEBS LETT, V418, P301, DOI 10.1016/S0014-5793(97)01399-9; Likanonsakul S, 2013, AIDS RES HUM RETROV, V29, P142, DOI [10.1089/AID.2012.0114, 10.1089/aid.2012.0114]; Maggiolo F, 2010, ANTIVIR THER, V15, P51, DOI 10.3851/IMP1483; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Moyle G, 2005, ANTIVIR THER, V10, pM47; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; van Vonderen MGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005647	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0889-2229	1931-8405		AIDS RES HUM RETROV	Aids Res. Hum. Retrovir.	AUG 1	2015	31	8					792	796		10.1089/aid.2014.0266		5	Immunology; Infectious Diseases; Virology	Immunology; Infectious Diseases; Virology	CP4OH	WOS:000359861200006		
J	Phan, CTT; Pham, HV; Bi, XQ; Ishizaki, A; Saina, M; Phung, CD; Khu, DTK; Ichimura, H				Chung Thi Thu Phan; Hung Viet Pham; Bi, Xiuqiong; Ishizaki, Azumi; Saina, Matilda; Cam Dac Phung; Dung Thi Khanh Khu; Ichimura, Hiroshi			Genetic Analyses of HIV-1 Strains Transmitted from Mother to Child in Northern Vietnam	AIDS RESEARCH AND HUMAN RETROVIRUSES			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VERTICALLY INFECTED CHILDREN; SINGLE-DOSE NEVIRAPINE; PERINATAL TRANSMISSION; RESISTANCE MUTATIONS; ANTIRETROVIRAL PROPHYLAXIS; INFANTS; PREVENTION; VARIANTS; IDENTIFICATION	We previously reported mother-to-child transmission of HIV-1 in nine (6.7%) of 135 children on nevirapine prophylaxis in Vietnam. In the current study, we investigated the appearance and profile of antiretroviral drug (ARV) resistance mutations, the predicted coreceptor usage, and the genetic diversity of HIV-1 strains isolated from the eight pairs of HIV-1-infected mothers and their children, who were followed up to 12 months after birth. Portions of the pol and env C2V3 regions of the HIV-1 strains were analyzed genetically. HIV-1 CRF01_AE RNA was detected in four (50%) children at delivery. Y181C, a nevirapine resistance mutation, appeared in two (25%) children 1 and 3 months after birth, respectively. No ARV resistance mutation was detected in the mothers, though three mothers were on ARV prophylaxis. Five mothers and their children harbored CCR5-tropic (R5) viruses. Two mothers harbored both R5 and CXCR4-tropic (X4) viruses, but their children harbored only R5 viruses even though the X4 viruses were dominant in the mothers. In the remaining one mother, HIV-1 RNA was not amplified and her child harbored both R5 and X4 viruses at birth, but only X4 virus 12 months after delivery. The infants' viruses were more homogeneous than their mothers' viruses (mean distance: 0.5% vs. 1.1%, respectively). This is the first molecular epidemiological study of vertical HIV-1 infections in Vietnam. These findings may provide useful knowledge for the prevention of mother-to-child transmission of HIV-1 and the antiretroviral treatment of children in Vietnam.	[Chung Thi Thu Phan; Hung Viet Pham; Bi, Xiuqiong; Ishizaki, Azumi; Saina, Matilda; Ichimura, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa 9208640, Japan; [Chung Thi Thu Phan; Hung Viet Pham; Dung Thi Khanh Khu] Natl Hosp Pediat, Hanoi, Vietnam; [Cam Dac Phung] Natl Inst Hyg & Epidemiol, Dept Microbiol, Hanoi, Vietnam	Ichimura, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	ichimura@med.kanazawa-u.ac.jp			Ministry of Education in Vietnam	This study was supported by the Ministry of Education in Vietnam (the 322 scholarship program). We are grateful to all participants enrolled in this study at Hanoi and Haiphong Hospitals. We thank our colleagues: Dr. Ha, Ms. Ngoc (National Institute of Hygiene and Epidemiology, Hanoi, Vietnam), Ms. Thuy (National Hospital of Pediatrics, Hanoi, Vietnam), and the members of the Viral Infection and International Health Department of the Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.	AHMAD N, 1995, J VIROL, V69, P1001; SCARLATTI G, 1993, P NATL ACAD SCI USA, V90, P1721, DOI 10.1073/pnas.90.5.1721; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; [Anonymous], 2014, HIV DRUG RES DAT; [Anonymous], 2013, CONSOLIDATED GUIDELI; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lwembe R, 2009, AIDS RES HUM RETROV, V25, P141, DOI 10.1089/aid.2008.0144; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Lihana RW, 2011, J CLIN VIROL, V52, P123, DOI 10.1016/j.jcv.2011.06.014; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Casper CHE, 2002, J INFECT DIS, V186, P914, DOI 10.1086/342948; Cavarelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003292; Ceballos A, 2008, J GEN VIROL, V89, P2773, DOI 10.1099/vir.0.83697-0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; NEWELL ML, 1992, LANCET, V339, P1007; Ha TTT, 2012, SCAND J INFECT DIS, V44, P866, DOI 10.3109/00365548.2012.690160; Huang W, 2009, AIDS, V23, P1903, DOI 10.1097/QAD.0b013e32832f1802; John GC, 1996, EPIDEMIOL REV, V18, P149; Mild M, 2006, VIROLOGY, V350, P58, DOI 10.1016/j.virol.2006.02.008; Ministry of Health, 2005, GUID DIAGN TREATM HI; Ministry of Health, 2009, VIET NAM HIV AIDS ES; Mofenson LM, 2002, J ACQ IMMUN DEF SYND, V30, P200, DOI 10.1097/01.QAI.0000018366.28828.86; Moorthy A, 2009, PLOS ONE, V4, P1; Ndembi N, 2003, AIDS RES HUM RETROV, V19, P435, DOI 10.1089/088922203765551773; Newell Marie-Louise, 2004, Expert Rev Anti Infect Ther, V2, P717, DOI 10.1586/14789072.2.5.717; Nguyen TA, 2008, AIDS RES THER, V5, P1; Nowak P, 2002, HIV Med, V3, P1, DOI 10.1046/j.1464-2662.2001.00097.x; Nyamache AK, 2013, AIDS RES HUM RETROV, V29, P1105, DOI [10.1089/AID.2012.0284, 10.1089/aid.2012.0284]; Persaud D, 2011, AIDS RES HUM RETROV, V27, P823, DOI [10.1089/AID.2010.0346, 10.1089/aid.2010.0346]; Persaud D, 2000, J CLIN INVEST, V105, P955; Phan TTC, 2010, AIDS RES HUM RETROV, V26, P233, DOI 10.1089/aid.2009.0206; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; SCARLATTI G, 1993, VIROLOGY, V197, P624, DOI 10.1006/viro.1993.1637; Stringer JS, 2010, PLOS MED, V7, P1; MSELLATI P, 1995, J ACQ IMMUN DEF SYND, V8, P506; UNAIDS/WHO, 2012, GLOB REP UNAIDS REP; UNAIDS/WHO, 2007, AIDS EP UPD; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; Viet Nam National Committee for AIDS, 2012, VIET NAM AIDS RESP P; Wade CM, 1998, J GEN VIROL, V79, P1055; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759	47	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0889-2229	1931-8405		AIDS RES HUM RETROV	Aids Res. Hum. Retrovir.	AUG 1	2015	31	8					797	805		10.1089/aid.2014.0335		9	Immunology; Infectious Diseases; Virology	Immunology; Infectious Diseases; Virology	CP4OH	WOS:000359861200007		
J	Otani, S; Hamada, A; Sasaki, J; Wada, M; Yamamoto, M; Ryuge, S; Takakura, A; Fukui, T; Yokoba, M; Mitsufuji, H; Toyooka, I; Maki, S; Kimura, M; Hayashi, N; Ishihara, M; Kasajima, M; Hiyoshi, Y; Katono, K; Asakuma, M; Igawa, S; Kubota, M; Katagiri, M; Saito, H; Masuda, N				Otani, Sakiko; Hamada, Akinobu; Sasaki, Jiichiro; Wada, Mayuko; Yamamoto, Michiko; Ryuge, Shinichiro; Takakura, Akira; Fukui, Tomoya; Yokoba, Masanori; Mitsufuji, Hisashi; Toyooka, Issei; Maki, Sachiyo; Kimura, Michiko; Hayashi, Nobuatsu; Ishihara, Mikiko; Kasajima, Masashi; Hiyoshi, Yasuhiro; Katono, Ken; Asakuma, Maiko; Igawa, Satoshi; Kubota, Masaru; Katagiri, Masato; Saito, Hideyuki; Masuda, Noriyuki			Phase I and Pharmacokinetic Study of Erlotinib Administered in Combination With Amrubicin in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer	AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS			English	Article						erlotinib; amrubicin; phase I study; non-small cell lung cancer; EGFR-TKI	TYROSINE KINASE INHIBITOR; ACTIVE METABOLITE AMRUBICINOL; ONCOLOGY GROUP WJTOG; III TRIAL; 2ND-LINE TREATMENT; SOLID TUMORS; CHEMOTHERAPY; GEMCITABINE; CARBOPLATIN; PACLITAXEL	Objectives:We conducted a phase I trial of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with amrubicin, a topoisomerase II inhibitor. The aim was to determine the maximum tolerated dose, the dose-limiting toxicities (DLTs), and the pharmacokinetics of this combination in patients with non-small cell lung cancer who had received previous chemotherapy.Methods:A total of 9 patients with stage IV disease were treated at 3-week intervals with erlotinib once daily on days 1 through 21 plus a 5-minute intravenous injection of amrubicin on days 1 through 3.Results:The dose levels evaluated were erlotinib (mg/body)/amrubicin (mg/m(2)): 100/30 (n=3), 100/35 (n=3), and 150/30 (n=3). The maximum tolerated dose of erlotinib and amrubicin was 100 mg/body and 35 mg/m(2) because 2 of the 3 patients experienced DLTs during the first cycle of treatment at the third dose level of 150 mg/body and 30 mg/m(2). Cessation of erlotinib administration for 8 days because of grade 3 leukopenia and grade 3 skin infection (erysipelas) were the DLTs. No drug-drug interactions between erlotinib and amrubicin were observed in this study. The overall response rate was 33%, including 3 partial responses, in the 9 patients. The median progression-free survival for all patients was quite long, 11.3 months, and the median overall survival has not yet been reached.Conclusions:Combined erlotinib plus amrubicin therapy seems to be highly effective, with acceptable toxicity, against non-small cell lung cancer. The recommended dose for phase II studies was erlotinib 100 mg once daily on days 1 through 21, and amrubicin 35 mg/m(2) on days 1 through 3 administered every 21 days.	[Otani, Sakiko; Sasaki, Jiichiro; Wada, Mayuko; Yamamoto, Michiko; Ryuge, Shinichiro; Takakura, Akira; Fukui, Tomoya; Mitsufuji, Hisashi; Maki, Sachiyo; Kimura, Michiko; Hayashi, Nobuatsu; Ishihara, Mikiko; Kasajima, Masashi; Hiyoshi, Yasuhiro; Katono, Ken; Asakuma, Maiko; Igawa, Satoshi; Kubota, Masaru; Masuda, Noriyuki] Kitasato Univ, Sch Med, Dept Resp Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Yokoba, Masanori; Katagiri, Masato] Kitasato Univ, Dept Clin Physiol, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520374, Japan; [Hamada, Akinobu] Natl Canc Ctr, Res Inst, Div Integrat Omics & Bioinformat, Tokyo 104, Japan; [Toyooka, Issei; Saito, Hideyuki] Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Japan	Masuda, N (reprint author), Kitasato Univ, Sch Med, Dept Resp Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	masuda@med.kitasato-u.ac.jp					Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Yamaoka T, 1998, JPN J CANCER RES, V89, P1067; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Lepper ER, 2003, J CHROMATOGR B, V796, P181, DOI 10.1016/j.jchromb.2003.08.015; Giaccone G, 2004, ANN ONCOL, V15, P831, DOI 10.1093/annonc/mdh188; Gridelli C, 2008, J THORAC ONCOL, V3, P430, DOI 10.1097/JTO.0b013e318168c815; ISHIZUMI K, 1987, J ORG CHEM, V52, P4477, DOI 10.1021/jo00229a010; Kaneda H, 2010, J THORAC ONCOL, V5, P105, DOI 10.1097/JTO.0b013e3181c07c6c; Marina CG, 2012, ANN M AM SOC CLIN ON, V30; Matsunaga Y, 2006, THER DRUG MONIT, V28, P76, DOI 10.1097/01.ftd.0000185771.82620.ee; Sawa T, 2006, INVEST NEW DRUG, V24, P151, DOI 10.1007/s10637-006-5937-2; Takeda K, 2007, INVEST NEW DRUG, V25, P377, DOI 10.1007/s10637-007-9039-6; Yamamoto Michiko, 2009, Drug Des Devel Ther, V2, P189	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3732	1537-453X		AM J CLIN ONCOL-CANC	Am. J. Clin. Oncol.-Cancer Clin. Trials	AUG	2015	38	4					405	410		10.1097/COC.0b013e3182a2d98d		6	Oncology	Oncology	CP4EQ	WOS:000359835200015		
J	Cui, FJ; Liu, XQ; Ma, L; Chiba, A; Li, BQ; Zhou, JF; Tan, JG				Cui, Fengjuan; Liu, Xiaoqiang; Ma, Lin; Chiba, Ayaka; Li, Bingqing; Zhou, Jianfeng; Tan, Jianguo			Application of ethanol improves the resin-dentin bond strength of a two-bottle, self-etching primer-adhesive	AMERICAN JOURNAL OF DENTISTRY			English	Article							HYBRID LAYER; WATER; NANOLEAKAGE; DEGRADATION; EVAPORATION; DURABILITY; INTERFACE; MATRIX	Purpose: To investigate whether the application of ethanol to a two-step self-etching adhesive can improve its resin-dentin bond performance. Methods: Four different ethanol concentrations were added to the adhesive of Clearfil SE Bond to create four ethanol primers (40, 60, 80 or 100% ethanol). 24 extracted third molars were divided into four groups. Each group corresponded to one of the four hydrophobic ethanol primer concentrations. The teeth in the control group were bonded with Clearfil SE Bond according to the manufacturer's instructions. The primed teeth in the experimental groups were treated with the ethanol primer prior to application of the solvent-free adhesive. Microtensile bond strengths (mTBS) were tested 24 hours after specimen preparation. Another 14 teeth were bonded using the same methods to evaluate mTBS after 1 year. Nanoleakage was evaluated under field-emission scanning electron microscopy before and after aging. Results: In the 24-hour group, the mTBS in the 60% ethanol/40% adhesive primer group increased significantly (21.6%, P< 0.05) over the no ethanol control. After 12-month water storage, the bond strength of that experimental group was still higher than that of the control group (19.5%, P< 0.05). Before aging, the nanoleakage was clearly seen in the control group but hardly any was seen in the experimental group. After aging, the nanoleakage increase in the experimental group was much less than that in the control group.	[Cui, Fengjuan; Liu, Xiaoqiang; Li, Bingqing; Zhou, Jianfeng; Tan, Jianguo] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100081, Peoples R China; [Ma, Lin] Beijing Union Med Coll Hosp, Dept Stomatol, Beijing, Peoples R China; [Chiba, Ayaka] Tokyo Med & Dent Univ, Dept Cariol & Operat Dent, Tokyo, Japan	Zhou, JF (reprint author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, 22 Zhongguancun Nandajie, Beijing 100081, Peoples R China.	dentistzjf@163.com			National Natural Science Foundation of China [81200807]; Science Foundation of Peking University School and Hospital of Stomatology [PKUSS20140114]	Dr. Cui and Dr. Liu contributed equally. All authors declared no conflict of interest. The study was funded by grants from the National Natural Science Foundation of China; (contract grant number: 81200807), and the Science Foundation of Peking University School and Hospital of Stomatology; (contract grant number: PKUSS20140114).	Suppa P, 2005, J BIOMED MATER RES B, V73B, P7, DOI 10.1002/jbm.b.30217; Pashley DH, 2007, AM J DENT, V20, P7; Ye Q, 2008, J DENT RES, V87, P829; Nishitani Y, 2006, EUR J ORAL SCI, V114, P160, DOI 10.1111/j.1600-0722.2006.00342.x; Tay FR, 2002, J DENT RES, V81, P472; Pashley EL, 1998, DENT MATER, V14, P6, DOI 10.1016/S0109-5641(98)00003-7; Zander-Grande C, 2011, AM J DENT, V24, P239; Tjaderhane L, 2013, DENT MATER, V29, P999, DOI 10.1016/j.dental.2013.07.016; Spencer P, 2002, J BIOMED MATER RES, V62, P447, DOI 10.1002/jbm.10364; Sadek FT, 2008, J BIOMED MATER RES A, V84A, P19, DOI 10.1002/jbm.a.31290; Sadek FT, 2010, J DENT, V38, P276, DOI 10.1016/j.jdent.2009.11.007; Tjaderhane L, 2013, DENT MATER, V29, P116, DOI 10.1016/j.dental.2012.08.004; Bourbia M, 2013, J DENT RES, V92, P989, DOI 10.1177/0022034513504436; Tay FR, 2007, J DENT RES, V86, P1034; Shin TP, 2009, DENT MATER, V25, P1050, DOI 10.1016/j.dental.2009.03.006; Ye Q, 2007, J APPL POLYM SCI, V106, P3843, DOI 10.1002/app.27044; Nishitani Y, 2006, J DENT RES, V85, P1016; Sadek FT, 2010, DENT MATER, V26, P380, DOI 10.1016/j.dental.2009.12.009; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Okuda M, 2002, OPER DENT, V27, P289; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Pashley DH, 2011, DENT MATER, V27, P1, DOI 10.1016/j.dental.2010.10.016; Miranda MEDNG, 2014, J ADHES DENT, V16, P115, DOI 10.3290/j.jad.a31813; Hashimoto M, 2011, J ADHES DENT, V13, P49, DOI 10.3290/j.jad.a18238; Hiraishi N, 2005, J DENT RES, V84, P653; KANCA J, 1992, J AM DENT ASSOC, V123, P35; Kim J, 2010, J DENT RES, V89, P575, DOI 10.1177/0022034510363380; Tay Franklin R, 2002, J Adhes Dent, V4, P255; Tay F R, 2000, J Adhes Dent, V2, P83; Tay FR, 2005, OPER DENT, V30, P561	30	0	0	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	AUG	2015	28	4					224	228				5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP4VM	WOS:000359880700008		
J	Eguchi, K; Hoshide, S; Komori, T; Nagasaka, S; Kario, K				Eguchi, Kazuo; Hoshide, Satoshi; Komori, Takahiro; Nagasaka, Shoichiro; Kario, Kazuomi			A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; home BP; hypertension; type 2 diabetes; urinary microalbumin	AMBULATORY BLOOD-PRESSURE; AMERICAN-HEART-ASSOCIATION; URINARY ALBUMIN EXCRETION; HYPERTENSIVE PATIENTS; GENERAL-POPULATION; ORGAN DAMAGE; ARTERIAL-HYPERTENSION; MANAGEMENT; RISK; GUIDELINES	OBJECTIVE The target levels of home-monitored blood pressure (BP) in patients with type 2 diabetes mellitus (T2DM) have not yet been established. We sought to examine the appropriate target home BP level in T2DM. METHODS This is a subanalysis of the Japan Morning Surge-Home Blood Pressure (J-HOP) study. We enrolled 4,310 patients who had at least 1 cardiovascular risk factor, and clinic and home BP monitoring was performed. The urinary albumin-to-creatinine ratio (UACR) was measured as a marker of microvascular disease. Quadratic equations of the relationship between clinic/home systolic BP (SBP) and log-transformed UACR were used to determine the home BP value. Home BP levels corresponding to clinic SBP/diastolic BP (DBP) level using the UACR values were calculated separately by the presence/absence of diabetes. RESULTS The mean age of the patients was 64.9 +/- 10.9 years; 47.0% were males. Of the 4,310 subjects enrolled, 1,057 (24.5%) had T2DM (the DM group) and 3,253 (75.5%) did not (non-DM group). The home BP levels equivalent to clinic BP 140/90 mm Hg were 135/84 and 135/83 mm Hg in the DM and non-DM groups, respectively. The home SBP levels equivalent to clinic SBP 130/80 mm Hg were 122/79 mm Hg in the non-DM group and 129/78 mm Hg in the DM group. CONCLUSIONS Regardless of diabetic status, the home BP level that corresponds to the clinic SBP 140/90 mm Hg was 135/85 mm Hg. In patients with T2DM, the home SBP level equivalent to clinic SBP 130/80 mm Hg was 129/78 mm Hg with regard to the extent of microvascular disease.	[Eguchi, Kazuo; Hoshide, Satoshi; Komori, Takahiro; Kario, Kazuomi] Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Nagasaka, Shoichiro] Jichi Med Univ, Dept Med, Div Endocrinol & Metab, Shimotsuke, Tochigi, Japan	Eguchi, K (reprint author), Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	ke112@jichi.ac.jp			21st Century Center of Excellence Project; Foundation for Development of the Community (Tochigi); Omron Healthcare Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21390247]; MEXT [S1101022]	The authors thank the patients for their participation in this work. The authors also thank Ms. Kimiyo Saito and Ms. Mayumi Yahata for the coordination and data management of this study and Ms. Ayako Okura for the editorial assistance. K.K. is the principal investigator of the J-HOP study, and he supervised its conduct and data analysis and had primary responsibility for the writing of this article. S.H., the secretary in general of the J-HOP, managed the data and cleaned up the database. This work was financially supported in part by a grant from the 21st Century Center of Excellence Project run by Japan's Ministry of Education, Culture, Sports, Science and Technology, a grant from the Foundation for Development of the Community (Tochigi), a grant from Omron Healthcare Co., Ltd., a grant-in-aid for scientific research (B) (21390247) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, 2009-2013, and funds from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015 "Cooperative Basic and Clinical Research on Circadian Medicine" (S1101022) (to K.K.).	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Tsuji I, 1997, AM J HYPERTENS, V10, P409; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Stratton IM, 2006, DIABETOLOGIA, V49, P1761, DOI 10.1007/s00125-006-0297-1; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Thijs L, 1998, ARCH INTERN MED, V158, P481, DOI 10.1001/archinte.158.5.481; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Noguchi Y, 2013, J HYPERTENS, V31, P1593, DOI 10.1097/HJH.0b013e328361732c; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Eguchi K, 2010, AM J HYPERTENS, V23, P522, DOI 10.1038/ajh.2010.17; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Kamoi K, 2002, DIABETES CARE, V25, P2218, DOI 10.2337/diacare.25.12.2218; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Bliziotis IA, 2012, J HYPERTENS, V30, P1289, DOI 10.1097/HJH.0b013e3283531eaf; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Anwar YA, 1998, BLOOD PRESS MONIT, V3, P261; Davis TK, 2013, AM J HYPERTENS, V26, P1057, DOI 10.1093/ajh/hpt089; Eguchi K, 2011, BLOOD PRESS MONIT, V16, P142, DOI 10.1097/MBP.0b013e328346d669; Eguchi Kazuo, 2007, J Cardiometab Syndr, V2, P114; Eguchi Kazuo, 2006, J Clin Hypertens (Greenwich), V8, P404, DOI 10.1111/j.1524-6175.2006.04739.x; Ostchega Y, 2013, AM J HYPERTENS, V26, P1086, DOI 10.1093/ajh/hpt054; Sega R, 1997, HYPERTENSION, V30, P1; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517; UK Prospective Diabetes Study Group, 1998, BMJ-BRIT MED J, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703; Yasui D, 2010, AM J HYPERTENS, V23, P508, DOI 10.1038/ajh.2010.15	37	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	AUG	2015	28	8					971	979		10.1093/ajh/hpu249		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO7OL	WOS:000359349100004		
J	Shimizu, M; Hoshide, S; Ishikawa, J; Yano, Y; Eguchi, K; Kario, K				Shimizu, Motohiro; Hoshide, Satoshi; Ishikawa, Joji; Yano, Yuichiro; Eguchi, Kazuo; Kario, Kazuomi			Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study	AMERICAN JOURNAL OF HYPERTENSION			English	Article						angiotensin receptor blockade; antihypertensive treatment; central blood pressure; blood pressure; home blood pressure; hypertension; left ventricular hypertrophy; microalbuminuria	CENTRAL AORTIC PRESSURE; LEFT-VENTRICULAR MASS; URINARY ALBUMIN EXCRETION; PULSE-WAVE VELOCITY; PROTECTION J-TOP; CENTRAL HEMODYNAMICS; AUGMENTATION INDEX; PROGNOSTIC VALUE; HOME; ASSOCIATION	BACKGROUND Some previous studies have shown that central blood pressure (BP) is more closely related to cardiovascular risks than brachial BP. This study compared the correlations between asymptomatic organ damages and each of central BP, brachial clinic BP, and home BP during antihypertensive treatment. METHODS In the Japan Morning Surge-Target Organ Protection (J-TOP) study, which compared bedtime or awakening dosing of candesartan (+diuretics as needed) among subjects with home systolic BP (SBP) higher than 135 mm Hg, we evaluated 180 hypertensive patients who successfully underwent pulse wave analysis by HEM-9000AI and measured their urinary albumin/creatinine ratio (UACR) and left ventricular mass index (LVMI) (n = 144) at baseline and after 6 months of treatment. RESULTS During antihypertensive treatment, significant reductions were found in central SBP, UACR, and LVMI (all P < 0.001). Multiple regression analyses showed that the decrease in central SBP was associated with those of log-transformed UACR (beta = 0.24, P < 0.01) and LVMI (beta = 0.23, P = 0.04), independently of the decrease in both clinic and home SBP. The goodness-of-fit of the association between the reduction in SBP and the UACR (P < 0.01) or LVMI (P = 0.04) was improved by adding central SBP to the SBP measurement. CONCLUSION These findings suggest that the change in central BP could be an important therapeutic target during antihypertensive treatment, in addition to peripheral clinic and home BP.	[Shimizu, Motohiro] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 812, Japan; [Hoshide, Satoshi; Ishikawa, Joji; Yano, Yuichiro; Eguchi, Kazuo; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan	Kario, K (reprint author), Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 812, Japan.	kkario@jichi.ac.jp			Japan Heart Foundation, Tokyo	This work was financially supported in part by a grant from the Japan Heart Foundation, Tokyo.	Williams B, 2013, HYPERTENSION, V61, P1168, DOI 10.1161/HYPERTENSIONAHA.111.00763; Boutouyrie P, 2000, CIRCULATION, V101, P2601; Hashimoto J, 2008, J HYPERTENS, V26, P1017, DOI 10.1097/HJH.0b013e3282f62a9b; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Hoshide S, 2012, HYPERTENS RES, V35, P862, DOI 10.1038/hr.2012.46; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Roman MJ, 2010, J HYPERTENS, V28, P384, DOI 10.1097/HJH.0b013e328333d228; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Hashimoto J, 2007, AM J HYPERTENS, V20, P378, DOI 10.1016/j.amjhyper.2006.09.019; Smith A, 2005, J AM SOC NEPHROL, V16, P1069, DOI 10.1681/ASN.2004090769; Huang CM, 2011, J HYPERTENS, V29, P454, DOI 10.1097/HJH.0b013e3283424b4d; SAHN DJ, 1978, CIRCULATION, V58, P1072; De Ciuceis C, 2014, J HYPERTENS, V32, P565, DOI 10.1097/HJH.0000000000000067; Masugata H, 2009, HYPERTENS RES, V32, P1136, DOI 10.1038/hr.2009.157; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Perez-Lahiguera FJ, 2012, REV ESP CARDIOL, V65, P1094, DOI [10.1016/j.recesp.2012.05.008, 10.1016/j.rec.2012.05.005]; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; de Luca N, 2004, J HYPERTENS, V22, P1623, DOI 10.1097/01.hjh.0000125448.28861.fc; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Eguchi K, 2012, CLIN EXP HYPERTENS, V34, P488, DOI 10.3109/10641963.2012.666604; Eguchi K, 2009, J HYPERTENS, V27, P1172, DOI 10.1097/HJH.0b013e32832a6e39; Hashimoto J, 2014, TOHOKU J EXP MED, V233, P1, DOI 10.1620/tjem.233.1; Hirata K, 2013, J HYPERTENS, V31, P508, DOI 10.1097/HJH.0b013e32835c1d45; Kario K, 2010, J HYPERTENS, V28, P1574, DOI 10.1097/HJH.0b013e3283395267; Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60; Protogerou AD, 2007, AM J HYPERTENS, V20, P648, DOI 10.1016/j.amjhyper.2007.02.008; Shimizu M, 2012, J HYPERTENS, V30, P1015, DOI 10.1097/HJH.0b013e328351f80b; Takazawa K, 2012, J HYPERTENS, V30, P908, DOI 10.1097/HJH.0b013e3283524910; Yano Y, 2012, AM J HYPERTENS, V25, P306, DOI 10.1038/ajh.2011.229	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	AUG	2015	28	8					980	986		10.1093/ajh/hpu250		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO7OL	WOS:000359349100005		
J	Miyamoto, Y				Miyamoto, Yasuhito			Classification of bifurcation diagrams for elliptic equations with exponential growth in a ball	ANNALI DI MATEMATICA PURA ED APPLICATA			English	Article						Bifurcation diagram; Exponential growth; Intersection number; Elliptic Dirichlet problem; Singular solution	POSITIVE SOLUTIONS; SUPERCRITICAL GROWTH; GEOMETRY	Let B subset of R-N, N >= 3, be the unit ball. We study the global bifurcation diagram of the solutions of {Delta u + lambda f (u) = 0 in B, u = 0 on partial derivative B, u > 0 in B, where f (u) = e(u) + g(u) and g(u) is a lower order term. The solution set is a curve C parametrized by the L-infinity -norm of the solution. We show that this problem has the singular solution (lambda*, u*) and that the curve C has infinitely many turning points around lambda* if 3 <= N <= 9. We show that under a certain condition on g, the curve C has no turning point if N >= 10. We also study the Morse index of u*.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Miyamoto, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	miyayan@sepia.ocn.ne.jp			Japan Society for the Promotion of Science [24740100]	This work was partially supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B) (Subject No. 24740100).	GUI CF, 1992, COMMUN PUR APPL MATH, V45, P1153, DOI 10.1002/cpa.3160450906; CRANDALL MG, 1975, ARCH RATION MECH AN, V58, P207, DOI 10.1007/BF00280741; JOSEPH DD, 1973, ARCH RATION MECH AN, V49, P241; GIDAS B, 1979, COMMUN MATH PHYS, V68, P209, DOI 10.1007/BF01221125; Jacobsen J, 2002, J DIFFER EQUATIONS, V184, P283, DOI 10.1006/jdeq.2001.4151; Bae S, 2001, MATH ANN, V320, P191, DOI 10.1007/PL00004468; Brezis H., 1997, REV MAT COMPLUT, V10, P443; BREZIS H, 1983, COMMUN PUR APPL MATH, V36, P437, DOI 10.1002/cpa.3160360405; BUDD C, 1987, J DIFFER EQUATIONS, V68, P169, DOI 10.1016/0022-0396(87)90190-2; Dancer E. N., 2000, ANN MAT PUR APPL, V178, P225, DOI 10.1007/BF02505896; Dolbeault J, 2007, T AM MATH SOC, V359, P4073, DOI 10.1090/S0002-9947-07-04397-8; Gelfand I.M., 1963, AM MATH SOC TRANSL 2, V29, P295; Gui CF, 1996, P ROY SOC EDINB A, V126, P225; Guo ZM, 2011, T AM MATH SOC, V363, P4777; Korman P, 1997, P AM MATH SOC, V125, P1997, DOI 10.1090/S0002-9939-97-04119-1; MERLE F, 1991, P ROY SOC EDINB A, V118, P49; Miyamoto Y, 2013, J MATH PURE IN PRESS; NAGASAKI K, 1994, MATH ANN, V299, P1, DOI 10.1007/BF01459770; Suzuki T, 1994, MATH SCI APPL, V3	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0373-3114	1618-1891		ANN MAT PUR APPL	Ann. Mat. Pura Appl.	AUG	2015	194	4					931	952		10.1007/s10231-014-0404-8		22	Mathematics, Applied; Mathematics	Mathematics	CP3TG	WOS:000359804400001		
J	Arakaki, N; Nagayama, A; Shimizu, Y; Yara, K				Arakaki, Norio; Nagayama, Atsushi; Shimizu, Yuko; Yara, Kazuhisa			Suppression of green chafer Anomala albopilosa (Coleoptera: Scarabaeidae) populations by mass trapping with light traps	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Sugarcane; LED; Black light; Solar power generation panel; UV	MODELS	To control one of the most destructive sugarcane pests, Anomala albopilosa (Hope) (Coleoptera: Scarabaeidae), mass trapping with light traps was conducted in the farmlands of the Miyako Islands from mid-April and early May to late July from 2008 to 2013. As a result of trapping, trap catches significantly decreased by 52, 89, and 28 % on the islands of Miyako, Irabu-Shimoji, and Tarama, respectively. The mean larval density in the sugarcane fields decreased by 91, 90, and 73 % on Miyako, Irabu-Shimoji, and Tarama, respectively, during this period; the difference was statistically significant for the first two cases. These results indicated that mass trapping with light traps effectively reduced these isolated populations of A. albopilosa. The effect of the light traps on A. albopilosa behavior is also discussed.	[Arakaki, Norio; Nagayama, Atsushi] Okinawa Prefectural Agr Res Ctr, Plant Dis & Insect Pest Management Sect, Itoman, Okinawa 9010336, Japan; [Shimizu, Yuko] Okinawa Prefectural Plant Protect Ctr, Miyako Branch, Miyakojima, Okinawa 9060012, Japan; [Yara, Kazuhisa] Konan Sisetu Kanri Co Ltd, Urasoe, Okinawa 9012114, Japan	Arakaki, N (reprint author), Okinawa Prefectural Agr Res Ctr, Plant Dis & Insect Pest Management Sect, Itoman, Okinawa 9010336, Japan.	arakkinr@pref.okinawa.lg.jp					Aino S, 1956, B GOV FOR EXP STN, V91, P1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Arakaki N, 2004, APPL ENTOMOL ZOOL, V39, P455, DOI 10.1303/aez.2004.455; Arakaki N, 2013, APPL ENTOMOL ZOOL, V48, P331, DOI 10.1007/s13355-013-0192-4; BARCLAY HJ, 1984, RES POPUL ECOL, V26, P303, DOI 10.1007/BF02515496; Fujioka M, 2007, ATLAS JAPANESE SCARA, V2, P173; Fujioka M, 2001, LIST JAPANESE LAMELL, P293; Higa T., 1978, Proceedings of the Association for Plant Protection of Kyushu, V24, P132; Hokyo N., 1980, PROCEEDINGS OF THE INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, V17, P1746; Kobayashi H, 1985, COLEOPTERA JAPAN COL, VII, P381; Muraji M, 2008, APPL ENTOMOL ZOOL, V43, P299, DOI 10.1303/aez.2008.299; Nagamine M, 1980, B OKINAWA AGR EXP ST, V5, P53; NAKASUJI F, 1980, APPL ENTOMOL ZOOL, V15, P27; Nozato K, 1963, SCI B DIV AGR HOME E, V10, P161; R Development Core Team, 2014, R LANG ENV STAT COMP; Satomi H, 1980, KONGETSU NOGYO, V24, P2; Tanaka A., 1979, Proceedings of the Association for Plant Protection of Kyushu, V25, P96; Higa T., 1978, Proceedings of the Association for Plant Protection of Kyushu, V24, P136; Yamashita T, 1988, KYUSHU PL PROT RES, V44, P67; Yara K, 2012, JPN KOKAI TOKKYO KOH	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					291	296		10.1007/s13355-015-0333-z		6	Entomology	Entomology	CP3VZ	WOS:000359812100002		
J	Osada, Y; Miyamoto, Y; Sakai, M; Yoshimatsu, S; Huang, GH; Hirowatari, T				Osada, Yohei; Miyamoto, Yasuyuki; Sakai, Makoto; Yoshimatsu, Shin-ichi; Huang, Guo-Hua; Hirowatari, Toshiya			A revision of the genus Nemapogon Schrank (Lepidoptera, Tineidae) including a stored grain pest, N-granella, from Japan	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Nemapogoninae; Taxonomy; Discrimination; Wing markings; Genital morphology; DNA barcoding	DINICA GOZMANY LEPIDOPTERA; CHINA	The Japanese species of the genus Nemapogon Schrank, 1802 (Lepidoptera, Tineidae) are taxonomically revised. In Japan, in the past only Nemapogon granella (Linnaeus, 1758), which is known as a stored grain pest, had been recorded. In the present paper, N. mesoplaca (Meyrick 1919), N. robusta Geadike, 2000 and N. bidentata Xiao & Li, 2010 are newly recorded from Japan. The adult morphology, i.e. wing venation, male and female genitalia of the four Nemapogon species is illustrated. These species are clearly separable not only by the male and female genitalia of the adults but also by the DNA barcodes.	[Osada, Yohei] Kyushu Univ, Entomol Lab, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Miyamoto, Yasuyuki] Osaka Prefecture Univ, Entomol Lab, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Sakai, Makoto] Kyosei Kagaku, Ibaraki, Osaka 5670877, Japan; [Yoshimatsu, Shin-ichi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Huang, Guo-Hua] Hunan Agr Univ, Coll Biosafety Sci & Technol, Changsha 410128, Hunan, Peoples R China; [Hirowatari, Toshiya] Kyushu Univ, Entomol Lab, Fac Agr, Fukuoka 8128581, Japan	Osada, Y (reprint author), Kyushu Univ, Entomol Lab, Grad Sch Bioresource & Bioenvironm Sci, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	borbocinnara53@hotmail.com; kaseircb3@gmail.com; yosimatu@affrc.go.jp; tineidaehgh@yahoo.co.jp; hirowat_t@agr.kyushu-u.ac.jp			National Natural Science Foundation of China (NSFC) [31411140034]	We express our thanks to Dr. S. Kobayashi, Ms. K. Nakatsuka (OPU), Dr. M. Ohara, Mr. K. Sugisima (HU), Dr. K. Kadowaki (KYU), Mr. R. Ito (KU), Mr. T. Mano (TYRI) and Mr. N. Hirano (Matsumoto-shi) for valuable specimens. Dr. M. Ishii, Dr. N. Hirai (OPU), Dr. S. Kamitani and Dr. T. Saigusa (KU) gave us kind advice and supported this study. Our cordial thanks are also due to Dr. T. Hattori (Forestry and Forest Products Research and Institute) for identification of the fungus. Sir Anthony Galsworthy (The Natural History Museum, London) kindly edited the English of this manuscript. Our cordial thanks are also due to Dr. M. Maruyama (The Kyushu University Museum), Mr. W. Kim (KU), Dr. H. Yoshitake and Dr. Y. Baba (NIAES) for instruction and help with molecular analyses based on mtDNA. This study was partly supported by the National Natural Science Foundation of China (NSFC No. 31411140034).	Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BROWN JM, 1994, MOL BIOL EVOL, V11, P128; CAPUSE IOSIF, 1967, ENTOMOL BER [AMSTERDAM], V27, P109; Davis DR, 1983, CHECK LIST LEPIDOPTE, P5; Fletcher TB, 1933, SCI MONOGRAPH IMPERI, V4, P1; Gaedike Reinhard, 2000, Beitraege zur Entomologie, V50, P357; Gaedike R., 1983, Reichenbachia, V21, P161; GAEDIKE R, 1986, Reichenbachia, V24, P23; Hirowatari T, 2004, HOUSEHOLD MICROLEPID; Huang GH, 2006, ENTOMOL NEWS, V117, P385, DOI 10.3157/0013-872X(2006)117[385:TGDGLT]2.0.CO;2; Huang GH, 2010, T AM ENTOMOL SOC, V136, P247; Hubner J, 1822, SYSTEMATISCHES ALPHA, P82; Hubner J, 1816, VERZEICHNISS BEKANNT, P1; Kobayashi Shigeki, 2011, Lepidoptera Science, V62, P75; Landry Jean-François, 2013, Zootaxa, V3749, P1, DOI 10.11646/zootaxa.3749.1.1; Linnaeus C, 1758, SYSTEMA NATURAE REGN, V1, P1; Meyrick E, 1919, EXOTIC MICROLEPIDOPT, V1-5; Miyamoto Yasuyuki, 2002, Transactions of the Lepidopterological Society of Japan, V53, P209; Moriuti S., 1982, MOTHS JAPAN, V1, P1; Nielsen ES, 1993, MONOGRAPHS AUSTR LEP, V2, P1; Petersen G., 1957, Beitraege zur Entomologie Berlin, V7, P55; PETERSEN GUNTHER, 1961, CASOPIS CESKOSLOV SPOLECNOSTI ENTOMOL, V58, P272; Petersen G, 1983, ENTOMOLOGISCHE ABHAN, V46, P177; Petersen G., 1992, SHILAP Revista de Lepidopterologia, V20, P325; Petersen G, 1953, BEITRAGE ENTOMOLOGIE, V2, P578; ROBINSON G S, 1980, Entomologist's Gazette, V31, P129; Robinson Gaden S., 1996, Occasional Papers on Systematic Entomology, V9, P1; Sakai M, 2013, STANDARD MOTHS JAPAN, V22-23, P118; Schrank FP, 2002, NURNBERG INGOLSTUDT, V2, P1; Sutter Reinhard, 2000, Reichenbachia, V33, P427; Tahara H, 2011, MANUAL CONTROLLING M, P35; Xiao YL, 2010, ZOOTAXA, P41; Zagulyaev A. K., 1963, Entomologicheskoe Obozrenie Leningrad, V42, P425; Zagulajev AK, 1964, FAUNA SSSR, V86, P1; Zagulyaev A. K., 1962, Trudy Zoologicheskogo Instituta Akademiya Nauk SSSR Leningrad, V30, P330; Zimmerman EC, 1978, INSECTS HAWAII 1, P881	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					297	309		10.1007/s13355-015-0334-y		13	Entomology	Entomology	CP3VZ	WOS:000359812100003		
J	Konagaya, T; Mutoh, N; Suzuki, M; Rutowski, RL; Watanabe, M				Konagaya, T.; Mutoh, N.; Suzuki, M.; Rutowski, R. L.; Watanabe, M.			Estimates of female lifetime fecundity and changes in the number and types of sperm stored with age and time since mating in the monandrous swallowtail butterfly, Battus philenor (Lepidoptera: Papilionidae) in the Arizona desert	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Apyrene sperm; Eupyrene sperm; Ovary; Spermatheca; Spermatophore	APYRENE SPERM; HELIOTHIS-VIRESCENS; UTETHEISA-ORNATRIX; ARCTIID MOTH; STORAGE; EUPYRENE; XUTHUS; POLYANDRY; LONGEVITY; DYNAMICS	The role of apyrene sperm in monandrous species after sperm migration to the spermatheca has not been studied, though in polyandrous species these sperm reduce re-mating receptivity. We studied the relationship between apyrene sperm numbers and age, mating history, and fecundity in females of the monandrous pipevine swallowtail butterfly, Battus philenor (L.) that were collected in the desert of central Arizona. The number of spermatophores in the bursa copulatrix and the eggs in the ovaries were counted and their relationship to female age (as indicated by wing wear) was examined. The mean number of spermatophores in the oldest females was 1.4, confirming that this species is monandrous. Average female fecundity was estimated at 430 from counts of eggs in the ovaries. Recently mated females stored many more eupyrene sperm in the spermatheca than the number of eggs in the ovaries. Apyrene sperm were also found in the spermatheca of the females with a long period elapsed after the mating, as indicated by a collapsed spermatophore. The potential role of apyrene sperm and the effect of body size on the fecundity in monandrous species is mentioned.	[Konagaya, T.; Mutoh, N.; Watanabe, M.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Suzuki, M.] Univ Tsukuba, Coll Biol Sci, Tsukuba, Ibaraki 3058572, Japan; [Rutowski, R. L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Watanabe, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	watanabe@kankyo.envr.tsukuba.ac.jp			JSPS KAKENHI [24570019]	We thank Dr. T. Yokoi, University of Tsukuba for valuable comments. This work was supported in part by JSPS KAKENHI Grant Number 24570019 (MW).	ODENDAAL FJ, 1989, J INSECT BEHAV, V2, P15, DOI 10.1007/BF01053615; SILBERGLIED RE, 1984, AM NAT, V123, P255, DOI 10.1086/284200; BISSOONDATH CJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P365, DOI 10.1007/BF00170583; WILLERS JL, 1987, J INSECT PHYSIOL, V33, P803, DOI 10.1016/0022-1910(87)90027-8; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Watanabe M, 2000, J ETHOL, V18, P91, DOI 10.1007/s101640070006; BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; DUNLAPPIANKA H, 1977, SCIENCE, V197, P487, DOI 10.1126/science.197.4302.487; Cook PA, 1999, NATURE, V397, P486, DOI 10.1038/17257; WIKLUND C, 1993, BEHAV ECOL SOCIOBIOL, V33, P25, DOI 10.1007/BF00164343; Arnqvist G, 2005, SEXUAL CONFLICT; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; BOGGS CL, 1981, OECOLOGIA, V50, P320, DOI 10.1007/BF00344970; Boggs Carol L., 1995, P215; Curril IM, 2006, J INSECT PHYSIOL, V52, P1182, DOI 10.1016/j.jinsphys.2006.08.006; HE YB, 1995, J INSECT PHYSIOL, V41, P689, DOI 10.1016/0022-1910(95)00020-U; HOLT GG, 1970, J INSECT PHYSIOL, V16, P2211, DOI 10.1016/0022-1910(70)90146-0; Kawagoe T, 2001, ECOL ENTOMOL, V26, P258, DOI 10.1046/j.1365-2311.2001.00326.x; Lamunyon CW, 2000, ANIM BEHAV, V59, P395, DOI 10.1006/anbe.1999.1294; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; Oberhauser K, 1999, 1997 N AM C MON BUTT, P67; Pegram Kimberly V., 2012, Journal of Research on the Lepidoptera, V45, P9; R Core Team, 2013, R LANG ENV STAT COMP; Roth S, 2003, P ROY SOC B-BIOL SCI, V270, pS54, DOI 10.1098/rsbl.2003.0008; RUTOWSKI RL, 1989, ETHOLOGY, V82, P244; SVARD L, 1991, J INSECT BEHAV, V4, P33, DOI 10.1007/BF01092549; TATAR M, 1991, BEHAV ECOL SOCIOBIOL, V28, P337, DOI 10.1007/BF00164383; Velde LV, 2011, ETHOLOGY, V117, P645, DOI 10.1111/j.1439-0310.2011.01914.x; Watanabe Mamoru, 2001, Journal of the Lepidopterists' Society, V54, P83; Konagaya T, 2015, APPL ENTOMOL ZOOL, V50, P41, DOI 10.1007/s13355-014-0300-0; Watanabe M, 2005, ENTOMOL SCI, V8, P65, DOI 10.1111/j.1479-8298.2005.00100.x; WATANABE M, 1988, Journal of Insect Behavior, V1, P17, DOI 10.1007/BF01052501; Watanabe Mamoru, 1996, Journal of Research on the Lepidoptera, V32, P26; WATANABE M, 1986, ZOOL SCI, V3, P509; Watanabe Mamoru, 1993, Japanese Journal of Entomology, V61, P691; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; Yan S, 2013, J ECON ENTOMOL, V106, P708, DOI 10.1603/EC12402	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					311	316		10.1007/s13355-015-0336-9		6	Entomology	Entomology	CP3VZ	WOS:000359812100004		
J	Inoue, MN; Saito-Morooka, F; Suzuki, K; Nomura, T; Hayasaka, D; Kishimoto, T; Sugimaru, K; Sugiyama, T; Goka, K				Inoue, Maki N.; Saito-Morooka, Fuki; Suzuki, Kazutaka; Nomura, Takuji; Hayasaka, Daisuke; Kishimoto, Toshio; Sugimaru, Katsuo; Sugiyama, Takashi; Goka, Koichi			Ecological impacts on native ant and ground-dwelling animal communities through Argentine ant (Linepithema humile) (Hymenoptera: Formicidae) management in Japan	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Biological invasion; Eradication; Fipronil; Linepithema humile; Non-target effects	INVASIVE ANT; LABORATORY COLONIES; HORIZONTAL TRANSFER; NORTHERN AUSTRALIA; FIRE ANT; FIPRONIL; ISLAND; HYDRAMETHYLNON; INSECTICIDES; ERADICATION	In the last 30 years some limited successes in alien ant control have been documented globally, and control programs remain challenging. Moreover, the potential non-target impacts of toxicants have not been well studied. We assessed the efficacy and non-target effects of multiple products containing the active compound fipronil in the attempted control of two populations of the invasive Argentine ant Linepithema humile (Mayr) in Tokyo, Japan. Three treatments were conducted: control, low-dose treatment (0.1 g/ha per treatment), and high-dose treatment (0.2 g/ha). Treatments were applied once per month for 11 months. The abundance of L. humile declined rapidly by up to 99.8 % in treated areas, but remained at extremely high densities in the control area. The treatments had few negative non-target effects, with the abundances of native ant species and other ground-dwelling invertebrates except for cockroaches being greater in the treated areas after L. humile suppression. Thus, fipronil is an effective compound for controlling L. humile and can be used with minimal toxic effects on non-target organisms. The treatments cost approximately US$ 575/ha for the low-dose treatment and US$ 1250/ha for the high-dose treatment. Our research supports the creation of more ambitious invasive ant management projects.	[Inoue, Maki N.; Saito-Morooka, Fuki; Suzuki, Kazutaka; Nomura, Takuji; Hayasaka, Daisuke; Goka, Koichi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; [Inoue, Maki N.] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Saito-Morooka, Fuki] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; [Hayasaka, Daisuke] Kindai Univ, Fac Agr, Nara, Nara 6318505, Japan; [Kishimoto, Toshio] Museum Nat & Environm Hist, Suruga Ku, Shizuoka 4228017, Japan; [Sugimaru, Katsuo; Sugiyama, Takashi] Fumakilla Ltd, HAT, Hiroshima 7390494, Japan	Inoue, MN (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3050053, Japan.	makimaki@cc.tuat.ac.jp			Ministry of the Environment, Japan [D-1101]	We thank Fumakilla Ltd. for donating the ant bait. We also thank W. Abe, A. Hattori, Y. Honda, A. Ishizuka, H. Imai, T. Matsuki, Y. Miyake, S. Moriguchi, T. Nagaki, M. Nishiyama, T. Osawa, S. Tanigaki, and H. Tokuda for their invaluable help in the field and Ben Hoffmann, F. Ito, T. Kameyama, and Y. Sakamoto for helpful suggestions on this manuscript. This study was supported by the Global Environment Research Fund (D-1101, Leader: K. Goka) of the Ministry of the Environment, Japan, 2011.	Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI 10.1897/1551-5028(1999)018<0138:PRCAOT>2.3.CO;2; Hooper-Bui LM, 2000, J ECON ENTOMOL, V93, P858, DOI 10.1603/0022-0493-93.3.858; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolysis.33.010802.150444; Inoue MN, 2013, DIVERS DISTRIB, V19, P29, DOI 10.1111/j.1472-4642.2012.00934.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Choe DH, 2008, J ECON ENTOMOL, V101, P1397, DOI 10.1603/0022-0493(2008)101[1397:HTOIIL]2.0.CO;2; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Sugiyama T, 2000, JPN J APPL ENTOMOL Z, V44, P127, DOI 10.1303/jjaez.2000.127; Soeprono AM, 2004, J ECON ENTOMOL, V97, P1675; Okaue M, 2007, ENTOMOL SCI, V10, P337, DOI 10.1111/j.1479-8298.2007.00228.x; Causton CE, 2005, FLA ENTOMOL, V88, P159, DOI 10.1653/0015-4040(2005)088[0159:EOTLFA]2.0.CO;2; Costa HS, 1999, J AGR URBAN ENTOMOL, V16, P37; Gaigher R, 2012, ECOL APPL, V22, P1405; Harris RJ, 2002, P 4 INT C URB PESTS, P67; Harris RJ, 2002, POTENTIAL IMPACT ARG; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hoffmann Ben, 2011, Aliens (Auckland), V31, P16; Hoffmann BD, 2010, INVASIVE ANT MANAGEM; Hoffmann BD, 2010, BIOL INVASIONS, V12, P959, DOI 10.1007/s10530-009-9516-2; Hoffmann Benjamin D., 2004, Ecological Management & Restoration, V5, P98, DOI 10.1111/j.1442-8903.2004.00182.x; Klotz JH, 2007, SOCIOBIOLOGY, V50, P391; Lowe S, 2004, SELECTION GLOBAL INV; Marr RM, 2003, ASSESSMENT NONTARGET; Plentovich S, 2011, BIOL INVASIONS, V13, P545, DOI 10.1007/s10530-010-9848-y; Plentovich S, 2010, J INSECT CONSERV, V14, P459, DOI 10.1007/s10841-010-9274-6; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Silverman J, 2008, ANNU REV ENTOMOL, V53, P231, DOI 10.1146/annurev.ento.53.103106.093450; Smilauer P., 2003, MULTIVARIATE ANAL EC; Ward DF, 2010, N Z ENTOMOL, V33, P68; Webb GA, 2013, J ECON ENTOMOL, V106, P1545, DOI 10.1603/EC13094; Wiltz BA, 2009, J ECON ENTOMOL, V102, P2279	31	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					331	339		10.1007/s13355-015-0338-7		9	Entomology	Entomology	CP3VZ	WOS:000359812100006		
J	Tabata, J; Ohno, S				Tabata, Jun; Ohno, Suguru			Enantioselective synthesis of the sex pheromone of the grey pineapple mealybug, Dysmicoccus neobrevipes (Hemiptera: Pseudococcidae), for determination of the absolute configuration	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Porcine pancreas lipase; Enantioselective acylation; Mealybug pheromone; Monoterpene synthesis	PLANOCOCCUS-KRAUNHIAE KUWANA; LAVANDULOL; THREAT	The grey pineapple mealybug, Dysmicoccus neobrevipes Beardsley, originally found on Hawaii and on Australasian islands, was recently discovered on a southwestern island (Ishigaki Island) of Japan. Because D. neobrevipes is known to attack many fruits and other crops, it is essential to establish a strategy to prevent the spread of this potential pest. Detection and monitoring by use of pheromone traps would provide important information about its distribution. The sex pheromone of D. neobrevipes has been isolated and identified as (E)-2-isopropyl-5-methylhexa-3,5-dien-1-yl acetate, although its absolute configuration was unknown. In this study, we achieved enantioselective synthesis of this compound by use of porcine pancreas lipase (PPL)-catalyzed acylation. Acetyl transfer from vinyl acetate to prochiral 2-isopropyl-1,3-propanediol in the presence of PPL in an organic solvent predominantly produced the (R) enantiomer of the monohydroxy acetate (86 % ee). In contrast, PPL-catalyzed hydrolysis of 2-isopropyl-1,3-diacetoxypropane in phosphate buffer yielded the (S) enantiomer of the monohydroxy acetate (75 % ee). Each enantiomer of the monohydroxy acetate was oxidized to a formyl acetate then coupled with a Wittig reagent, to produce the (R)-(-) and (S)-(+) pheromones. Analysis by gas chromatography with a chiral column and by polarimetry revealed the natural pheromone to be the (S)-(+) enantiomer. In a field trap experiment, the attractiveness of the pheromone produced by this route was equivalent to that of the pure (+) enantiomer (> 99 % ee).	[Tabata, Jun] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Ohno, Suguru] Okinawa Prefectural Agr Res Ctr, Ishigaki Branch, Ishigaki, Okinawa 9070003, Japan	Tabata, J (reprint author), Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	jtabata@affrc.go.jp			Japan Society for the Promotion of Science [25871089]	We appreciate the help of Drs H. Sugie and S. Hiradate (NIAES) with chemical analyses. J.T. acknowledges a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 25871089).	Fand BB, 2015, CROP PROT, V69, P34, DOI 10.1016/j.cropro.2014.12.001; Tabata J, 2015, J ESSENT OIL RES, V27, P232, DOI 10.1080/10412905.2015.1007219; Bando T, 1998, THESIS TOKUSHIMA U; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; Ben-Dov Y, 2014, SCALE NET; GUANTI G, 1990, TETRAHEDRON-ASYMMETR, V1, P721, DOI 10.1016/S0957-4166(00)82383-6; Tabata J, 2015, J CHEM ECOL, V41, P194, DOI 10.1007/s10886-015-0545-2; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Sugie H, 2008, APPL ENTOMOL ZOOL, V43, P369, DOI 10.1303/aez.2008.369; Tabata J, 2009, PLANT PROT, V63, P781; Tabata J, 2013, APPL ENTOMOL ZOOL, V48, P229, DOI 10.1007/s13355-013-0173-7; Tabata J, 2012, NATURWISSENSCHAFTEN, V99, P567, DOI 10.1007/s00114-012-0935-z; Tabata J, 2011, APPL ENTOMOL ZOOL, V46, P117, DOI 10.1007/s13355-010-0012-z; Tanaka H, 2012, APPL ENTOMOL ZOOL, V47, P413, DOI 10.1007/s13355-012-0134-6; Teshiba M, 2012, ENTOMOL EXP APPL, V142, P211, DOI 10.1111/j.1570-7458.2011.01214.x; Teshiba M, 2009, JPN J APPL ENTOMOL Z, V53, P173, DOI 10.1303/jjaez.2009.173; TOMBO GMR, 1986, TETRAHEDRON LETT, V27, P5707, DOI 10.1016/S0040-4039(00)85306-X; YASUHARA F, 1986, TETRAHEDRON LETT, V27, P4033, DOI 10.1016/S0040-4039(00)84903-5; Zada A, 2006, TETRAHEDRON-ASYMMETR, V17, P230, DOI 10.1016/j.tetasy.2005.12.021	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					341	346		10.1007/s13355-015-0337-8		6	Entomology	Entomology	CP3VZ	WOS:000359812100007		
J	Luo, Z; Honda, H				Luo, Zhixin; Honda, Hiroshi			Function of plant odors in oviposition behaviors of the yellow peach moth Conogethes punctiferalis (Lepidoptera: Crambidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Conogethes punctiferalis; Oviposition; Behavioral components; Host plant odor; Wind tunnel	FLY NEOCERATITIS-CYANESCENS; HOST-PLANT; GUENEE LEPIDOPTERA; GRAPEVINE MOTH; WIND-TUNNEL; VOLATILES; PYRALIDAE; RESPONSES; FEMALES; CUES	The effect of plant odors on the oviposition behaviors of Conogethes punctiferalis (Guen,e) female moths was explored in wind tunnel tests. The complete behavioral process leading to egg-laying was divided into five behavioral components: takeoff from the release point, halfway flight, hovering close to the source, landing and egg-laying on substrates. Host plant odors accelerated takeoff, increased orientation to the stimulus source by hovering before landing and triggered egg-laying. Never did non-host turnip taproot odors accelerate takeoff, even though behavioral components were all induced. Shortly sustained egg-laying under turnip taproot odors indicated involvement of different chemicals from those for other behavioral components. Odors from potato tubers and leaves as an absolute non-host plant never triggered oviposition responses. The detailed effects of plant odor stimuli on each behavioral component of oviposition were investigated by transient odor manipulations in a wind tunnel. A full supply of host plant odors resulted in a longer time for egg-laying, but showed no effect on the time for the laying of each egg, whereas odor cessation at specific behavioral components (e.g., takeoff) interrupted subsequent responses. Even when plant odors were removed just after halfway flight, female moths showed catenated behavioral components from hovering to egg-laying. Suitable and continuous plant olfactory stimulations are necessary to complete the oviposition process by enhancing host-finding efficiency in terms of both speed and accuracy and stimulating sustained egg-laying after landing as final oviposition site acceptance.	[Luo, Zhixin] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Honda, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Honda, H (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	honda.hiroshi.ew@alumni.tsukuba.ac.jp					De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Cha DH, 2008, J CHEM ECOL, V34, P1180, DOI 10.1007/s10886-008-9517-0; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Tasin M, 2011, CHEM SENSES, V36, P633, DOI 10.1093/chemse/bjr027; HONDA H, 1979, APPL ENTOMOL ZOOL, V14, P464; Anfora G, 2009, J CHEM ECOL, V35, P1054, DOI 10.1007/s10886-009-9686-5; Brevault T, 2009, ENTOMOL EXP APPL, V133, P165, DOI 10.1111/j.1570-7458.2009.00913.x; Brevault T, 2010, PHYSIOL ENTOMOL, V35, P9, DOI 10.1111/j.1365-3032.2009.00704.x; Brevault T, 2010, J CHEM ECOL, V36, P249, DOI 10.1007/s10886-010-9766-6; GREEN TA, 1994, J CHEM ECOL, V20, P2393, DOI 10.1007/BF02033209; Heinz CA, 2008, ENTOMOL EXP APPL, V128, P265, DOI 10.1111/j.1570-7458.2008.00717.x; Honda H, 2015, APPL ENTOMO IN PRESS; HONDA H, 1984, JPN J APPL ENTOMOL Z, V28, P82; KANEKO J, 1978, APPL ENTOMOL ZOOL, V13, P131; Masante-Roca I, 2007, ENTOMOL EXP APPL, V122, P239, DOI 10.1111/j.1570-7458.2006.00510.x; Nguyen DT, 2008, J STORED PROD RES, V44, P90, DOI 10.1016/j.jspr.2007.06.008; PHELAN PL, 1991, J CHEM ECOL, V17, P599, DOI 10.1007/BF00982129; R Development Core Team, 2010, R LANG ENV STAT COMP; Sekiguchi K, 1974, B IBARAKI HORT EXPT; Tasin M, 2007, PHYTOCHEMISTRY, V68, P203, DOI 10.1016/j.phytochem.2006.10.015; TINGLE FC, 1991, J CHEM ECOL, V17, P1621, DOI 10.1007/BF00984693; van Tilborg M, 2004, EXP APPL ACAROL, V32, P263, DOI 10.1023/B:APPA.0000023236.60727.f1; Waterhouse DF, 1993, ACIAR MONOGR, V21, p[40, 49, 81]	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					347	353		10.1007/s13355-015-0341-z		7	Entomology	Entomology	CP3VZ	WOS:000359812100008		
J	Kayukawa, T; Shinoda, T				Kayukawa, Takumi; Shinoda, Tetsuro			Functional characterization of two paralogous JH receptors, methoprene-tolerant 1 and 2, in the silkworm, Bombyx mori (Lepidoptera: Bombycidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Juvenile hormone; Methoprene-tolerant; Steroid receptor co-activator; JH response element; Kruppel homolog 1	KRUPPEL HOMOLOG 1; JUVENILE-HORMONE ACTION; BHLH-PAS FAMILY; BEETLE TRIBOLIUM-CASTANEUM; RED FLOUR BEETLE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; INSECT METAMORPHOSIS; BINDING	Methoprene-tolerant (Met) is a bHLH-PAS transcription factor that functions as a core component of juvenile hormone (JH) receptors in insects. The genome of the silkworm, Bombyx mori (L.), encodes two Met paralogs, BmMet1 and BmMet2. We have previously proposed that BmMet2 forms a functional complex with steroid receptor co-activator (BmSRC) in the presence of JH and induces Kruppel-homolog 1 (BmKr-h1). In this study, we characterized BmMet2 domains and examined the role of BmMet1. A series of reporter and two-hybrid assays on BmMet2 revealed that the bHLH domain played a critical role in the binding to the JH response element of BmKr-h1 (kJHRE), the PAS-A in the transcriptional activation, and the PAS-B in the JH recognition. Furthermore, we confirmed that the BmMet2/BmSRC complex recognizes the core kJHRE (GGCCTCCACGTG). BmMet1 was found to interact with BmSRC and weakly activated the kJHRE reporter in a JH-dependent manner. The BmMet1 transcript level was much higher than the BmMet2 transcript level in the epidermis during the larval and pupal stages. By contrast, the BmMet2 transcript was hardly detected during the larval stage, but was abundant in the adult stage. These results suggest that BmMet1 is involved in the JH-dependent induction of BmKr-h1 in larvae, whereas BmMet2 is involved in adults.	[Kayukawa, Takumi; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	Shinoda, T (reprint author), Natl Inst Agrobiol Sci, Ohwashi 1-2, Tsukuba, Ibaraki 3058634, Japan.	shinoda@affrc.go.jp			Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), JSPS KAKENHI [25850230, 25252059]; NIAS Strategic Research Fund	This study was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), JSPS KAKENHI grant nos. 25850230 and 25252059, and the NIAS Strategic Research Fund.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Dubrovsky EB, 2014, ADV INSECT PHYSIOL, V46, P305, DOI 10.1016/B978-0-12-417010-0.00004-5; Furuta K, 2013, BIOSCI BIOTECH BIOCH, V77, P988, DOI 10.1271/bbb.120883; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Cheng DJ, 2014, GENET MOL BIOL, V37, P444, DOI [10.1590/S1415-47572014005000006, 10.1590/S1415-47572014000300018]; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Jouraku A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-464; Kamimura M, 2014, APPL ENTOMOL ZOOL, V49, P443, DOI 10.1007/s13355-014-0271-1; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Riddiford LM, 2012, INTEGR COMP BIOL, V52, P477; Sailsbery JK, 2012, MOL BIOL EVOL, V29, P1301, DOI 10.1093/molbev/msr288; Wyatt GR, 1997, EUR J ENTOMOL, V94, P323; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019	45	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					383	391		10.1007/s13355-015-0345-8		9	Entomology	Entomology	CP3VZ	WOS:000359812100012		
J	Aoyama, H; Saitoh, S; Fujii, S; Nagahama, H; Shinzato, N; Kaneko, N; Nakamori, T				Aoyama, Hiroaki; Saitoh, Seikoh; Fujii, Saori; Nagahama, Hideki; Shinzato, Naoya; Kaneko, Nobuhiro; Nakamori, Taizo			A rapid method of non-destructive DNA extraction from individual springtails (Collembola)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Collembola; DNA barcoding; Non-destructive extraction; Single-individual PCR; Voucher	SPECIMENS; AMPLIFICATION; BIODIVERSITY; ARTHROPODS; SEQUENCES; BARCODE; ETHANOL	In this study, we describe an easy and rapid method for non-destructive DNA extraction from a single Collembola individual, without dissection, lysis of the specimen, or purification of extracted DNA. We demonstrate that, after a single specimen has been heat-treated in Tris-EDTA (TE) buffer using a standard thermocycler, the solution can be used for PCR amplification of the mitochondrial cytochrome c oxidase subunit 1 (COI) gene region, typically used for DNA barcoding. With this method, the morphological features of Collembola commonly used for species identification are well preserved. This DNA extraction method is preferable for DNA barcoding where the sequencing and preservation of a large number of small and fragile specimens are required.	[Aoyama, Hiroaki; Saitoh, Seikoh; Nagahama, Hideki; Shinzato, Naoya] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan; [Fujii, Saori; Kaneko, Nobuhiro; Nakamori, Taizo] Yokohama Natl Univ, Dept Environm & Nat Sci, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Saitoh, S (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan.	h109296@comb.u-ryukyu.ac.jp			MEXT/JSPS KAKENHI [25281029]	We thank Kamigamo Experimental Station, Field Science Education and Research Center (FSERC), Kyoto University, Japan, for allowing access to the study site. We are grateful to Dr. K. Ichisawa at the Tottori Prefectural Museum, Tottori, for depositing our specimens in the museum. We thank two anonymous reviewers for their careful reading of the manuscript and constructive comments. This study was partly supported by MEXT/JSPS KAKENHI grant no. 25281029.	Chang HC, 2001, J CLIN MICROBIOL, V39, P3466, DOI 10.1128/JCM.39.10.3466-3471.2001; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI [10.1111/j.1755-0998.2010.2839.x, 10.1111/j.1755-0998.2010.02839.x]; Hunter SJ, 2008, MOL ECOL RESOUR, V8, P56, DOI 10.1111/j.1471-8286.2007.01879.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Shokralla S, 2010, BIOTECHNIQUES, V48, P233, DOI 10.2144/000113362; Cruickshank RH, 2001, MOL PHYLOGENET EVOL, V19, P202, DOI 10.1006/mpev.2001.0928; Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x; Porco D, 2014, MOL ECOL RESOUR, V14, P249, DOI 10.1111/1755-0998.12172; Baker E.W., 1952, INTRO ACAROLOGY; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Carapelli A., 2014, ENTOMOLOGIA, V2, P190; Castalanelli MA, 2010, J ASIA-PAC ENTOMOL, V13, P243, DOI 10.1016/j.aspen.2010.04.003; Favret C, 2005, P ENTOMOL SOC WASH, V107, P469; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Itoh R, 1995, J COLL ARTS SCI SHOW, V26, P23; Johnson KP, 2003, SYST ENTOMOL, V28, P409, DOI 10.1046/j.1365-3113.2003.00220.x; Nakamori T, 2013, ZOOTAXA, V3641, P371; Ota Aino, 2011, Edaphologia, V89, P19; Rohland N, 2004, BIOTECHNIQUES, V36, P814; Rowley DL, 2007, MOL ECOL NOTES, V7, P915, DOI 10.1111/j.1471-8286.2007.01905.x; Sarma DK, 2014, IN T MOSQ RES, V1, P15	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	AUG	2015	50	3					419	425		10.1007/s13355-015-0340-0		7	Entomology	Entomology	CP3VZ	WOS:000359812100016		
J	Yoo, BH; Zagryazhskaya, A; Li, YL; Koomson, A; Khan, IA; Sasazuki, T; Shirasawa, S; V Rosen, K				Yoo, Byong Hoon; Zagryazhskaya, Anna; Li, Yongling; Koomson, Ananda; Khan, Iman Aftab; Sasazuki, Takehiko; Shirasawa, Senji; V Rosen, Kirill			Upregulation of ATG3 contributes to autophagy induced by the detachment of intestinal epithelial cells from the extracellular matrix, but promotes autophagy-independent apoptosis of the attached cells	AUTOPHAGY			English	Article						autophagy; apoptosis; anoikis; ATG3; ATG7; extracellular matrix	BCL-X-L; RAS-INDUCED TRANSFORMATION; BECLIN 1 PHOSPHORYLATION; DOWN-REGULATION; ANOIKIS RESISTANCE; TUMOR-SUPPRESSOR; IN-VIVO; PANCREATIC ADENOCARCINOMA; PHOTODYNAMIC THERAPY; APG3P/AUT1P HOMOLOG	Detachment of nonmalignant intestinal epithelial cells from the extracellular matrix (ECM) triggers their growth arrest and, ultimately, apoptosis. In contrast, colorectal cancer cells can grow without attachment to the ECM. This ability is critical for their malignant potential. We found previously that detachment-induced growth arrest of nonmalignant intestinal epithelial cells is driven by their detachment-triggered autophagy, and that RAS, a major oncogene, promotes growth of detached cells by blocking such autophagy. In an effort to identify the mechanisms of detachment-induced autophagy and growth arrest of nonmalignant cells we found here that detachment of these cells causes upregulation of ATG3 and that ATG3 upregulation contributes to autophagy and growth arrest of detached cells. We also observed that when ATG3 expression is artificially increased in the attached cells, ATG3 promotes neither autophagy nor growth arrest but triggers their apoptosis. ATG3 upregulation likely promotes autophagy of the detached but not that of the attached cells because detachment-dependent autophagy requires other detachment-induced events, such as the upregulation of ATG7. We further observed that those few adherent cells that do not die by apoptosis induced by ATG3 become resistant to apoptosis caused by cell detachment, a property that is critical for the ability of normal epithelial cells to become malignant. We conclude that cell-ECM adhesion can switch ATG3 functions: when upregulated in detached cells in the context of other autophagy-promoting events, ATG3 contributes to autophagy. However, when overexpressed in the adherent cells, in the circumstances not favoring autophagy, ATG3 triggers apoptosis.	[Yoo, Byong Hoon; Zagryazhskaya, Anna; Li, Yongling; Koomson, Ananda; Khan, Iman Aftab; V Rosen, Kirill] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Yoo, Byong Hoon; Zagryazhskaya, Anna; Li, Yongling; Koomson, Ananda; Khan, Iman Aftab; V Rosen, Kirill] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 81401, Japan; [Shirasawa, Senji] Fukuoka Univ, Ctr Adv Mol Med, Fukuoka 81401, Japan	V Rosen, K (reprint author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	kirill.rosen@dal.ca			Canadian Institutes of Health Research Nova Scotia Regional Partnership Program (CIHR/NSRPP) [125109]; IWK Health Centre PosDoctoral Fellowship; CIHR/NS RPP New Investigator award	This study was supported by the Canadian Institutes of Health Research Nova Scotia Regional Partnership Program (CIHR/NSRPP) operating grant 125109 and the CIHR/NS RPP New Investigator award held by Kirill Rosen. Byong Yoo was a recipient of the IWK Health Centre Research Associateship. Yongling Li was a recipient of the IWK Health Centre PosDoctoral Fellowship.	Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Coll ML, 2002, ONCOGENE, V21, P2908, DOI 10.1038/sj/onc/1205388; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Chen N, 2013, ONCOGENE, V32, P2543, DOI 10.1038/onc.2012.277; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Liang XH, 1999, NATURE, V402, P672; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Wu BX, 2006, MOL VIS, V12, P1292; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj/cgt/7700442; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Yoo BH, 2012, INT J CANCER, V131, P357, DOI 10.1002/ijc.26368; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Li BX, 2009, AUTOPHAGY, V5, P303; Frankel A, 2001, CANCER RES, V61, P4837; Wei MF, 2014, AUTOPHAGY, V10, P1179, DOI 10.4161/auto.28679; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Gilaberte Y, 2014, J INVEST DERMATOL, V134, P2428, DOI 10.1038/jid.2014.178; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Zhao H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0475-1; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Eskelinen EL, 2005, AUTOPHAGY, V1, P1; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Rak J, 2004, SEMIN CANCER BIOL, V14, P93, DOI 10.1016/j.semcancer.2003.09.014; Rak Janusz, 1999, Neoplasia (New York), V1, P23, DOI 10.1038/sj.neo.7900001; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yoo BH, 2011, J BIOL CHEM, V286, P38894, DOI 10.1074/jbc.M111.290692	63	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	AUG	2015	11	8					1230	1246		10.1080/15548627.2015.1056968		17	Cell Biology	Cell Biology	CP6DZ	WOS:000359975900005		
J	Maeda, Y; Oku, M; Sakai, Y				Maeda, Yuichiro; Oku, Masahide; Sakai, Yasuyoshi			A defect of the vacuolar putative lipase Atg15 accelerates degradation of lipid droplets through lipolysis	AUTOPHAGY			English	Article						Atg15; autophagy; lipid droplet; lipolysis; Tgl3; Tgl4; triacylglycerol	YEAST SACCHAROMYCES-CEREVISIAE; TRIACYLGLYCEROL-METABOLISM; AUTOPHAGOSOME FORMATION; SELECTIVE AUTOPHAGY; PARTICLES; PROTEIN; BODIES; CONSTRUCTION; HOMEOSTASIS; BIOGENESIS	Lipid droplets (LDs) are the conserved organelles for the deposit of neutral lipids, and function as reservoirs of membrane and energy sources. To date, functional links between autophagy and LD dynamics have not been fully elucidated. Here, we report that a vacuolar putative lipase, Atg15, required for degradation of autophagic bodies, is crucial for the maintenance of LD amount in the yeast Saccharomyces cerevisiae in the stationary phase. Mutant analyses revealed that the putative lipase motif and vacuolar localization of Atg15 are important for the maintenance of LD amount. Loss of autophagosome formation by simultaneous deletion of core ATG genes cancelled the reduction in the LD amount in ATG15-deleted cells, indicating that degradation of autophagic bodies accounts for the functional involvement of Atg15 in LD dynamics. The reduced level of LDs in the mutant strain was dependent on Tgl3 and Tgl4, major lipases for lipolysis in S. cerevisiae. An altered phosphorylation status of Tgl3, higher accumulation of Tgl4, and closer associations of Tgl3 and Tgl4 with LDs were detected in the ATG15-deleted cells. Furthermore, increased levels of downstream metabolites of lipolysis in the mutant strain strongly suggested enhanced lipolytic activity caused by loss of ATG15. Our data provide evidence for a novel link between autophagic flux and LD dynamics integrated with Atg15 activity.	[Maeda, Yuichiro; Oku, Masahide; Sakai, Yasuyoshi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Grad Sch Agr,Div Appl Life Sci,Sakyo Ku, Kyoto, Japan; [Sakai, Yasuyoshi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Sakyo Ku, Kyoto, Japan	Sakai, Y (reprint author), Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Grad Sch Agr,Div Appl Life Sci,Sakyo Ku, Kyoto, Japan.	ysakai@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26111511]; Japan Society for the Promotion of Science [26850064]	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas 26111511 (to YS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by Grant-in-Aid for Young Scientists (B) 26850064 (to MO) from the Japan Society for the Promotion of Science.	Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Teter SA, 2001, J BIOL CHEM, V276, P2083; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Wang CW, 2014, J CELL BIOL, V206, P357, DOI 10.1083/jcb.201404115; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Dong HQ, 2011, TRENDS ENDOCRIN MET, V22, P234, DOI 10.1016/j.tem.2011.02.003; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Kassan A, 2013, J CELL BIOL, V203, P985, DOI 10.1083/jcb.201305142; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; BROEKHUY.RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Chinen T, 2011, BIOSCI BIOTECH BIOCH, V75, P1588, DOI 10.1271/bbb.1103111; Dai ZY, 2013, MOL CELL ENDOCRINOL, V377, P123, DOI 10.1016/j.mce.2013.07.001; Girish V, 2004, Indian J Cancer, V41, P47; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; MOELLER CH, 1979, J ULTRA MOL STRUCT R, V68, P38, DOI 10.1016/S0022-5320(79)90140-0; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Pfisterer SG, 2014, BIOCHEM SOC T, V42, P1414, DOI 10.1042/BST20140152; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sorger D, 2002, J BACTERIOL, V184, P519	50	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	AUG	2015	11	8					1247	1258		10.1080/15548627.2015.1056969		12	Cell Biology	Cell Biology	CP6DZ	WOS:000359975900006		
J	Wiersma, VR; de Bruyn, M; Wei, YW; van Ginkel, RJ; Hirashima, M; Niki, T; Nishi, N; Zhou, J; Pouwels, SD; Samplonius, DF; Nijman, HW; Eggleton, P; Helfrich, W; Bremer, E				Wiersma, Valerie R.; de Bruyn, Marco; Wei, Yunwei; van Ginkel, Robert J.; Hirashima, Mitsuomi; Niki, Toshiro; Nishi, Nozomu; Zhou, Jin; Pouwels, Simon D.; Samplonius, Douwe F.; Nijman, Hans W.; Eggleton, Paul; Helfrich, Wijnand; Bremer, Edwin			The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux	AUTOPHAGY			English	Article						autophagy; colon cancer; galectin-9; KRAS mutation; lysosomes	COLORECTAL-CANCER; CELL-DEATH; K-RAS; B-RAF; PROGNOSTIC-FACTOR; BREAST-CANCER; IN-VITRO; C-RAF; GALECTIN-9; RESISTANCE	Oncogenic mutation of KRAS (Kirsten rat sarcoma viral oncogene homolog) in colorectal cancer (CRC) confers resistance to both chemotherapy and EGFR (epidermal growth factor receptor)-targeted therapy. We uncovered that KRAS mutant (KRAS(mut)) CRC is uniquely sensitive to treatment with recombinant LGALS9/Galectin-9 (rLGALS9), a recently established regulator of epithelial polarity. Upon treatment of CRC cells, rLGALS9 rapidly internalizes via early- and late-endosomes and accumulates in the lysosomal compartment. Treatment with rLGALS9 is accompanied by induction of frustrated autophagy in KRAS(mut) CRC, but not in CRC with BRAF (B-Raf proto-oncogene, serine/threonine kinase) mutations (BRAF(mut)). In KRAS(mut) CRC, rLGALS9 acts as a lysosomal inhibitor that inhibits autophagosome-lysosome fusion, leading to autophagosome accumulation, excessive lysosomal swelling and cell death. This antitumor activity of rLGALS9 directly correlates with elevated basal autophagic flux in KRAS(mut) cancer cells. Thus, rLGALS9 has potent antitumor activity toward refractory KRAS(mut) CRC cells that may be exploitable for therapeutic use.	[Wiersma, Valerie R.; Wei, Yunwei; van Ginkel, Robert J.; Samplonius, Douwe F.; Helfrich, Wijnand; Bremer, Edwin] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Translat Surg Oncol, Groningen, Netherlands; [de Bruyn, Marco; Nijman, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Wei, Yunwei] Harbin Med Univ, Affiliated Hosp 1, Oncol & Endoscop Surg Dept, Harbin, Peoples R China; [Hirashima, Mitsuomi; Niki, Toshiro] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 760, Japan; [Hirashima, Mitsuomi; Niki, Toshiro] GalPharma Co Ltd, Takamatsu, Kagawa, Japan; [Nishi, Nozomu] Kagawa Univ, Life Sci Res Ctr, Div Res Instrument & Equipment, Takamatsu, Kagawa 760, Japan; [Zhou, Jin; Helfrich, Wijnand] Harbin Med Univ, Affiliated Hosp 1, Dept Hematol,Key Lab Cell Transplantat, Heilongjiang Inst Hematol & Oncol,Minist Hlth, Harbin, Peoples R China; [Pouwels, Simon D.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pathol & Med Biol,Expt Pulmonol & Inflammat, Groningen, Netherlands; [Eggleton, Paul; Bremer, Edwin] Univ Exeter, Sch Med, Exeter EX4 4QJ, Devon, England	Bremer, E (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Translat Surg Oncol, Groningen, Netherlands.	e.bremer@umcg.nl			Dutch Cancer Society grant [RUG2009-4355, RUG2009-4542, RUG2011-5206, RUG2012-5541, RUG2013-6209]; Netherlands Organization for Scientific Research; Melanoma Research Alliance; Alexander von Humboldt Foundation	This work was supported by Dutch Cancer Society grants RUG2009-4355 (E.B.), RUG2009-4542, RUG2011-5206, RUG2012-5541, RUG2013-6209 (to E.B./W.H.), the Netherlands Organization for Scientific Research (E.B.), the Melanoma Research Alliance (E.B.), and the Alexander von Humboldt Foundation (E.B/M.B.).	Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Straube T, 2013, TRAFFIC, V14, P1014, DOI 10.1111/tra.12086; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/nchembio.1257, 10.1038/NCHEMBIO.1257]; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Charette N, 2014, CURR OPIN ONCOL, V26, P454, DOI 10.1097/CCO.0000000000000088; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Preto A, 2008, J PATHOL, V214, P320, DOI 10.1002/path.2295; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Mo D, 2012, MOL BIOL CELL, V23, P3636, DOI 10.1091/mbc.E12-04-0329; Wei MF, 2014, AUTOPHAGY, V10, P1179, DOI 10.4161/auto.28679; Nagahara K, 2008, J IMMUNOL, V181, P7660; Mancias JD, 2011, ONCOTARGET, V2, P1302; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.immunol.2.1.103; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; Lai K, 2014, J CLIN PATHOL, V67, P854, DOI 10.1136/jclinpath-2014-202529; Leisching G, 2015, INT J GYNECOL CANCER, V25, P380, DOI 10.1097/IGC.0000000000000365; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Morgan MJ, 2014, AUTOPHAGY, V10, P1814, DOI 10.4161/auto.32135; Nagae M, 2008, J MOL BIOL, V375, P119, DOI 10.1016/j.jmb.2007.09.060; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; ONO K, 1994, J HISTOCHEM CYTOCHEM, V42, P659; Wiersma VR, 2012, J INVEST DERMATOL, V132, P2302, DOI 10.1038/jid.2012.133; Yamauchi A, 2006, BREAST J, V12, pS196, DOI 10.1111/j.1075-122X.2006.00334.x	53	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	AUG	2015	11	8					1373	1388		10.1080/15548627.2015.1063767		16	Cell Biology	Cell Biology	CP6DZ	WOS:000359975900014		
J	Sakamoto, T; Ooe, M; Fujimoto, K				Sakamoto, Takashi; Ooe, Minako; Fujimoto, Kenzo			Critical Effect of Base Pairing of Target Pyrimidine on the Interstrand Photo-Cross-Linking of DNA via 3-Cyanovinylcarbazole Nucleoside	BIOCONJUGATE CHEMISTRY			English	Article							OLIGONUCLEOSIDE METHYLPHOSPHONATES; RNA; INHIBITION; EXPRESSION	To evaluate the effect of base pairing of the target pyrimidine on the interstrand photo-cross-linking reaction of DNA via 3-cyanovinylcarbazole nucleoside (K-CNV), a complementary base of target pyrimidine was substituted with noncanonical purine bases or 1,3-propandiol (S). As the decrease of the hydrogen bonds in the base pairing of target C accelerated the photo-cross-linking reaction markedly (3.6- to 7.7-fold), it can be concluded the that the number of hydrogen bonds in the base pairing, i.e., the stability of base pairing, of the target pyrimidine plays a critical role in the interstrand photo-cross-linking reaction. In the case of G to S substitution, the highest photoreactivity toward C was observed, whose photoreaction rate constant (k = 2.0 s(-1)) is comparable to that of K-CNV toward T paired with A (k = 3.5 s(-1)). This is the most reactive photo-cross-linking reaction toward C in the sequence specific interstrand photo-cross-linking. This might facilitate the design of the photo-cross-linkable oligodeoxyribonucleotides for various target sequences.	[Sakamoto, Takashi; Ooe, Minako; Fujimoto, Kenzo] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Fujimoto, K (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahi Dai, Nomi, Ishikawa 9231292, Japan.	kenzo@jaist.ac.jp			JSPS KAKENHI [26288077, 22220001]; MEXT KAKENHI [24104003]	This study was supported by JSPS KAKENHI Grant Number 26288077 (Grant-in-Aid for Scientific Research (B)), 22220001 (Grant-in-Aid for Scientific Research (5)) and MEXT KAKENHI Grant Number 24104003 (Grant-in-Aid for Scientific Research on Innovative Areas (Molecular Robotics)) to K.F.	Yoshimura Y, 2008, ORG LETT, V10, P3227, DOI 10.1021/ol801112j; Matsuyama Y, 2014, BIOORGAN MED CHEM, V22, P1003, DOI 10.1016/j.bmc.2013.12.044; Hartman MR, 2013, ANGEW CHEM INT EDIT, V52, P8699, DOI 10.1002/anie.201302175; Fujimoto K, 2013, J AM CHEM SOC, V135, P16161, DOI 10.1021/ja406965f; Ma ZC, 2013, P NATL ACAD SCI USA, V110, P14320, DOI 10.1073/pnas.1311334110; Gerrard SR, 2012, ACS NANO, V6, P9221, DOI 10.1021/nn3035759; PIELES U, 1989, NUCLEIC ACIDS RES, V17, P285, DOI 10.1093/nar/17.1.285; Nakamoto K, 2014, J ORG CHEM, V79, P2463, DOI 10.1021/jo402738t; Qiu ZH, 2008, J AM CHEM SOC, V130, P14398, DOI 10.1021/ja805445j; Liu JF, 2011, ACS NANO, V5, P2240, DOI 10.1021/nn1035075; Kumal SR, 2014, J PHOTOPOLYM SCI TEC, V27, P459; Rajendran A, 2011, J AM CHEM SOC, V133, P14488, DOI 10.1021/ja204546h; CHANG EH, 1991, BIOCHEMISTRY-US, V30, P8283, DOI 10.1021/bi00098a001; Fujimoto K, 2013, PHOTOCHEM PHOTOBIOL, V89, P1095, DOI 10.1111/php.12118; Hague M. M., 2014, ANGEW CHEM INT EDIT, V53, P7001; KEAN JM, 1988, BIOCHEMISTRY-US, V27, P9113, DOI 10.1021/bi00426a008; LEE BL, 1988, BIOCHEMISTRY-US, V27, P3197, DOI 10.1021/bi00409a011; LIN M, 1995, FASEB J, V9, P1371; MILLER PS, 1991, NUCLEOS NUCLEOT, V10, P37, DOI 10.1080/07328319108046434; Murakami A, 2001, EUR J PHARM SCI, V13, P25, DOI 10.1016/S0928-0987(00)00204-9; Nakamura S, 2014, J CHEM TECHNOL BIOT, V89, P1086, DOI 10.1002/jctb.4205; Sakamoto T, 2015, ORG LETT, V17, P936, DOI [10.1021/acs.orglett.5b00035, 10.1021/acs.orglett.5600035]; Sakamoto T, 2014, BIOMATER SCI-UK, V2, P1154, DOI 10.1039/c4bm00117f; Shigeno A, 2012, ORG BIOMOL CHEM, V10, P7820, DOI 10.1039/c2ob25883h; Tagawa M, 2011, SOFT MATTER, V7, P10931, DOI 10.1039/c1sm06303k; TEARE J, 1989, NUCLEIC ACIDS RES, V17, P3359, DOI 10.1093/nar/17.9.3359	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1475	1478		10.1021/acs.bioconjchem.5b00352		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900011		
J	Ogawa, K; Yu, J; Ishizaki, A; Yokokawa, M; Kitamura, M; Kitamura, Y; Shiba, K; Odani, A				Ogawa, Kazuma; Yu, Jing; Ishizaki, Atsushi; Yokokawa, Masaru; Kitamura, Masanori; Kitamura, Yoji; Shiba, Kazuhiro; Odani, Akira			Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously	BIOCONJUGATE CHEMISTRY			English	Article							SELECTIVE DRUG-DELIVERY; INTEGRIN ALPHA(V)BETA(3); IN-VIVO; RGD PEPTIDES; BISPHOSPHONATE; THERAPY; PALLIATION; TARGET; PAIN; RADIOTRACERS	Ga-68 (T-1/2 = 68 min, a generator-produced nuclide) is an interesting radionuclide for clinical positron emission tomography (PET). Recently, it was reported that radiogallium-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated (Asp)(n) peptide [Ga-DOTA-(Asp)(n)] has great potential for bone metastases imaging. In the current study, a compound containing an aspartic acid peptide linker (D-11) as a carrier to bone metastases, an RGD peptide [c(RGDfK) peptide] as a carrier to the primary cancer, and Ga-DOTA as a stable radiometal complex for imaging in one molecule, Ga-DOTA-D-11-c(RGDfK), was designed, prepared, and evaluated to detect both the primary cancer and bone metastases simultaneously using Ga-67, which is easy to handle. After DOTA-D-11-c(RGDfK) was synthesized using Fmoc-based solid-phase methodology, Ga-67-DOTA-D-11-c(RGDfK) was prepared by complexing DOTA-D-11-c(RGDfK) with Ga-67. Hydroxyapatite binding assays, integrin binding assays, biodistribution experiments, and single photon emission tomography (SPECT) imaging using tumor-bearing mice were performed using Ga-67-DOTA-D-11-c(RGDfK). Ga-67-DOTA-D-11-c(RGDfK) was prepared with a radiochemical purity of >97%. In vitro, Ga-67-DOTA-D-11-c(RGDfK) had a high affinity for hydroxyapatite and alpha(v)beta(3) integrin. In vivo, Ga-67-DOTA-D-11-c(RGDfK) exhibited high uptake in bone and tumor. The accumulation of Ga-67-DOTA-D-11-c(RGDfK) in tumor decreased when it was co-injected with c(RGDfK) peptide. Ga-68-DOTA-D-11-c(RGDfK) has great potential as a PET tracer for the diagnosis of both the primary cancer and bone metastases simultaneously.	[Ogawa, Kazuma; Yu, Jing; Ishizaki, Atsushi; Yokokawa, Masaru; Kitamura, Masanori; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Ogawa, Kazuma] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan	Ogawa, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan.	kogawa@p.kanazawa-u.ac.jp	Ogawa, Kazuma/D-8406-2015; ODANI, Akira/B-3043-2011; Kitamura, Masanori/C-3840-2015	Ogawa, Kazuma/0000-0002-1691-7302; ODANI, Akira/0000-0003-3786-6740; 	Sagawa Foundation for Promotion of Cancer Research; (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan [21791174, 23791401]; Terumo Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported in part by Sagawa Foundation for Promotion of Cancer Research, Grants-in-Aid for Young Scientists (B) (KAKENHI Grant Number 21791174 and 23791401) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Terumo Life Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Chakraborty S, 2010, BIOCONJUGATE CHEM, V21, P969, DOI 10.1021/bc900555q; Zheleznyak A, 2012, MOL IMAGING BIOL, V14, P500, DOI 10.1007/s11307-011-0512-4; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Ogawa K, 2005, BIOCONJUGATE CHEM, V16, P751, DOI 10.1021/bc040249w; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO;2-Z; Ishizaki J, 2009, J BONE MINER METAB, V27, P1, DOI 10.1007/s00774-008-0004-z; Yoshimoto M, 2008, INT J CANCER, V123, P709, DOI 10.1002/ijc.23575; Wong KK, 2013, J NUCL MED, V54, P590, DOI 10.2967/jnumed.112.114298; Niu G, 2011, THERANOSTICS, V1, P30, DOI 10.7150/thno/v01p0030; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Mundy GR, 1997, CANCER, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Dijkgraaf I, 2007, EUR J NUCL MED MOL I, V34, P267, DOI 10.1007/s00259-006-0180-9; Haubner R, 1999, J NUCL MED, V40, P1061; Haubner R, 2014, BIOMED RES INT, DOI 10.1155/2014/871609; Ogawa K, 2006, J NUCL MED, V47, P2042; Israel I, 2014, CURR CANCER DRUG TAR, V14, P371; Liu Z, 2013, CURR MOL MED, V13, P1487; Suzuki K, 2011, NUCL MED BIOL, V38, P1011, DOI 10.1016/j.nucmedbio.2011.02.015; Gaertner FC, 2012, EUR J NUCL MED MOL I, V39, P126, DOI 10.1007/s00259-011-2028-1; Bozon-Petitprin A., 2014, EUR J NUCL MED MOL I, P252; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; GALASKO CSB, 1980, CLIN NUCL MED, V5, P565; Garcia J R, 2003, Eur J Nucl Med Mol Imaging, V30, P1714, DOI 10.1007/s00259-003-1370-3; HORTON MA, 1993, J BONE MINER RES, V8, P239; Meckel M, 2013, NUCL MED BIOL, V40, P823, DOI 10.1016/j.nucmedbio.2013.04.012; Miao W., 2014, PLOS ONE, V9; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-28; Ogawa K, 2009, EUR J NUCL MED MOL I, V36, P115, DOI 10.1007/s00259-008-0925-8; Ogawa K, 2013, PLOS ONE, V8; Ogawa K, 2011, NUCL MED BIOL, V38, P631, DOI 10.1016/j.nucmedbio.2010.12.004; Ogawa K, 2007, J NUCL MED, V48, P122; Ogawa K, 2012, CURR MED CHEM, V19, P3290; Ogawa K, 2009, NUCL MED BIOL, V36, P129, DOI 10.1016/j.nucmedbio.2008.11.007; Ogawa K, 2006, NUCL MED BIOL, V33, P513, DOI 10.1016/j.nucmedbio.2006.03.006; Trajkovic-Arsic M, 2014, J NUCL MED, V55, P446, DOI 10.2967/jnumed.113.129619; Wadas TJ, 2009, J NUCL MED, V50, P1873, DOI 10.2967/jnumed.109.067140; Yanagi M, 2013, BIOCONJUGATE CHEM, V24, P1248, DOI 10.1021/bc400197f; Zhernosekov KP, 2007, J NUCL MED, V48, P1741, DOI 10.2967/jnumed.107.040378	41	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1561	1570		10.1021/acs.bioconjchem.5b00186		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900021		
J	Assal, Y; Mizuguchi, Y; Mie, M; Kobatake, E				Assal, Yasmine; Mizuguchi, Yoshinori; Mie, Masayasu; Kobatake, Eiry			Growth Factor Tethering to Protein Nanoparticles via Coiled-Coil Formation for Targeted Drug Delivery	BIOCONJUGATE CHEMISTRY			English	Article							MOLTEN GLOBULE; POLYMER THERAPEUTICS; FLUORESCENT-PROBE; POLYPEPTIDE; PEPTIDES; MATRIX; STATE	Protein-based nanoparticles are attractive carriers for drug delivery because they are biodegradable and can be genetically designed. Moreover, modification of protein-based nanoparticles with cell-specific ligands allows for active targeting abilities. Previously, we developed protein nanoparticles comprising genetically engineered elastin-like polypeptides (ELPs) with fused polyaspartic acid tails (ELP-D). Epidermal growth factor (EGF) was displayed on the surface of the ELP-D nanoparticles via genetic design to allow for active cell-targeting abilities. Herein, we focused on the coiled-coil structural motif as a means for noncovalent tethering of growth factor to ELP-D. Specifically, two peptides known to form a heterodimer via a coiled-coil structural motif were fused to ELP-D and single-chain vascular endothelial growth factor (scVEGF(121)), to facilitate noncovalent tethering upon formation of the heterodimer coiled-coil structure. Drug-loaded growth factor-tethered ELP-Ds were found to be effective against cancer cells by provoking cell apoptosis. These results demonstrate that tethering growth factor to protein nanoparticles through coiled-coil formation yields a promising biomaterial candidate for targeted drug delivery.	[Assal, Yasmine; Mizuguchi, Yoshinori; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan	Kobatake, E (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan.	kobatake.e.aa@m.titech.ac.jp	Mie, Masayasu/C-5995-2015	Mie, Masayasu/0000-0003-2255-3346	Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS Institutional Program for Young Researcher Overseas Visits	This work was financially supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and JSPS Institutional Program for Young Researcher Overseas Visits. We are also grateful to Ms. Keiko Ikeda from the Technical Department of the Tokyo Institute of Technology for technical support with the transmission electron microscope imaging.	OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Kobatake E, 2011, BIOCONJUGATE CHEM, V22, P2038, DOI 10.1021/bc200249u; Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067; Pechar M, 2011, BIOMACROMOLECULES, V12, P3645, DOI 10.1021/bm200897b; McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008; URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306; Murschel F, 2013, ACTA BIOMATER, V9, P6806, DOI 10.1016/j.actbio.2013.02.032; Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862; Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022; Pola R, 2013, BIOMACROMOLECULES, V14, P881, DOI 10.1021/bm3019592; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Fujita Y, 2009, BIOMATERIALS, V30, P3450, DOI 10.1016/j.biomaterials.2009.03.012; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Meyer DE, 2001, CANCER RES, V61, P1548; Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5; Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010; Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001; Boucher C, 2010, BIOMATERIALS, V31, P7021, DOI 10.1016/j.biomaterials.2010.05.072; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Boesen TP, 2002, J BIOL CHEM, V277, P40335, DOI 10.1074/jbc.M204107200; Matsumoto R, 2014, J BIOMED MATER RES B, V102, P1792, DOI 10.1002/jbm.b.33162; Mie M, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015004; Pechar M, 2014, BIOMACROMOLECULES, V15, P2590, DOI 10.1021/bm500436p; Urry DW, 1997, ANN NY ACAD SCI, V831, P32; VIDAL BD, 1978, J HISTOCHEM CYTOCHEM, V26, P196; Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a	28	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1672	1677		10.1021/acs.bioconjchem.5b00266		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900033		
J	Shinchi, H; Crain, B; Yao, SY; Chan, M; Zhang, SNS; Ahmadiiveli, A; Suda, YS; Hayashi, T; Cottam, HB; Carson, DA				Shinchi, Hiroyuki; Crain, Brian; Yao, Shiyin; Chan, Michael; Zhang, Shannon S.; Ahmadiiveli, Alast; Suda, Yasuo; Hayashi, Tomoko; Cottam, Howard B.; Carson, Dennis A.			Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides	BIOCONJUGATE CHEMISTRY			English	Article							DENDRITIC CELLS; INNATE IMMUNITY; RECEPTOR AGONISTS; SURFACE-CHARGE; PARTICLE-SIZE; VACCINE; RESIQUIMOD; RESPONSES; DELIVERY; DEXTRAN	Toll-like receptors (TLRs) in the innate immune system recognize specific pathogen-associated molecular patterns derived from microbes. Synthetic small molecule TLR7 agonists have been extensively evaluated as topical agents for antiviral and anticancer therapy, and as adjuvants for vaccine. However, safe and reproducible administration of synthetic TLR7 ligands has been difficult to achieve due to undesirable pharmacokinetics and unacceptable side effects. Here, we conjugated a versatile low molecular weight TLR7 ligand to various polysaccharides in order to improve its water solubility, enhance its potency, and maintain low toxicity. The synthetic TLR7 ligand, 2-methoxyethoxy-8-oxo-9-(4-carboxy benzyl)adenine, designated 1V209, was stably conjugated to primary amine functionalized Ficoll or dextran using benzoic acid functional groups. The conjugation ratios using specified equivalents of TLR7 ligand were dose responsive and reproducible. The zeta potential value of the polysaccharides was decreased in inverse proportion to the ratio of conjugated TLR7 ligand. These conjugates were highly water-soluble, stable for at least 6 months at room temperature in aqueous solution, and easy to lyophilize and reconstitute without altering potency. In vitro studies with murine mononuclear leukocytes showed that the TLR7 agonist conjugated to polysaccharides had 10- to 1000-fold higher potencies than the unconjugated TLR7 ligand. In vivo pharmacodynamics studies after injection indicate that the conjugates induced systemic cytokine production. When the conjugates were used as vaccine adjuvants, they enhanced antigen specific humoral and cellular immune responses to a much greater extent than did unconjugated TLR7 ligands. These results indicated that small molecule TLR7 ligands conjugated to polysaccharides have improved immunostimulatory potency and pharmacodynamics. Polysaccharides can be conjugated to a variety of molecules such as antigens, peptides, and TLR ligands. Therefore, such conjugates could represent a versatile platform for the development of vaccines against cancer and infectious diseases.	[Shinchi, Hiroyuki; Crain, Brian; Yao, Shiyin; Chan, Michael; Zhang, Shannon S.; Ahmadiiveli, Alast; Hayashi, Tomoko; Cottam, Howard B.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan	Hayashi, T (reprint author), Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	thayashi@ucsd.edu; dcarson@ucsd.edu			National Institutes of Health (Bethesda, MD); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science (Tokyo, Japan) [G2504]	This study was supported in part by HHSN272200900034C from the National Institutes of Health (Bethesda, MD) and Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (G2504) from Japan Society for the Promotion of Science (Tokyo, Japan).	Dewitte H, 2014, NANO TODAY, V9, P743, DOI 10.1016/j.nantod.2014.10.001; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030; Zom GGP, 2012, ADV IMMUNOL, V114, P177, DOI 10.1016/B978-0-12-396548-6.00007-X; Thielbeer F, 2011, BIOCONJUGATE CHEM, V22, P144, DOI 10.1021/bc1005015; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; TAKAKURA Y, 1990, PHARMACEUT RES, V7, P339, DOI 10.1023/A:1015807119753; Smits ELJM, 2008, ONCOLOGIST, V13, P859, DOI 10.1634/theoncologist.2008-0097; Dockrell DH, 2001, J ANTIMICROB CHEMOTH, V48, P751, DOI 10.1093/jac/48.6.751; Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112; Goldinger SM, 2012, EUR J IMMUNOL, V42, P3049, DOI 10.1002/eji.201142361; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Palamara F, 2004, J IMMUNOL, V173, P3051; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; DANON D, 1972, J ULTRA MOL STRUCT R, V38, P500, DOI 10.1016/0022-5320(72)90087-1; Erstad BL, 1996, PHARMACOTHERAPY, V16, P996; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Horscroft NJ, 2012, J ANTIMICROB CHEMOTH, V67, P789, DOI 10.1093/jac/dkr588; Oh JZ, 2010, J IMMUNOL, V185, P4602, DOI 10.4049/jimmunol.1001892; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3; Marshall JD, 2003, NUCLEIC ACIDS RES, V31, P5122, DOI 10.1093/nar/gkg700; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; BOWMAN HW, 1953, JAMA-J AM MED ASSOC, V153, P24; Chamberland M. E., 2001, EMERG INFECT DIS, V7, P752; Chan M, 2011, BIOCONJUGATE CHEM, V22, P445, DOI 10.1021/bc1004813; Chan M, 2009, BIOCONJUGATE CHEM, V20, P1194, DOI 10.1021/bc900054q; DIJKSTRA J, 1985, BIOCHIM BIOPHYS ACTA, V813, P287, DOI 10.1016/0005-2736(85)90244-5; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; LONG DM, 1961, SURGERY, V50, P12; Meyer T, 2013, EXPERT OPIN INV DRUG, V22, P149, DOI 10.1517/13543784.2013.749236; Tomai MA, 2007, EXPERT REV VACCINES, V6, P835, DOI 10.1586/14760584.6-5.835; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; YAMAOKA T, 1995, INT J PHARM, V113, P149, DOI 10.1016/0378-5173(94)00189-C	52	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1713	1723		10.1021/acs.bioconjchem.5b00285		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900038		
J	Nagahama, K; Kumano, T; Nakagawa, Y; Oyama, N; Tsuji, H; Moriyama, K; Shida, K; Nomoto, K; Chiba, K; Koumoto, K; Matsui, J				Nagahama, Koji; Kumano, Takayuki; Nakagawa, Yuichi; Oyama, Naho; Tsuji, Hirokazu; Moriyama, Kaoru; Shida, Kan; Nomoto, Koji; Chiba, Katsuyoshi; Koumoto, Kazuya; Matsui, Jun			Enhanced Immunostimulating Activity of Lactobacilli-Mimicking Materials by Controlling Size	BIOCONJUGATE CHEMISTRY			English	Article							T-CELL RESPONSES; IN-VIVO; GOLD NANOPARTICLES; ANTITUMOR IMMUNITY; PARTICLE-SIZE; CPG-DNA; STRAINS; CASEI; MICROSPHERES; PHAGOCYTOSIS	The design and synthesis of materials capable of activating the immune system in a safe manner is of great interest in immunology and related fields. Lactobacilli activate the innate immune system of a host when acting as probiotics. Here, we constructed lactobacilli-mimicking materials in which polysaccharide peptidoglycan complexes (PS PGs) derived from lactobacilli were covalently conjugated to the surfaces of polymeric microparticles with a wide variety of sizes, ranging from 200 nm to 3 mu m. The artificial lactobacilli successfully stimulated macrophages without cytotoxicity. Importantly, we found that the size of artificial lactobacilli strongly influenced their immunostimulating activities, and that artificial lactobacilli of 1 mu m exhibited 10-fold higher activity than natural lactobacilli. One major advantage of the artificial lactobacilli is facile control of size, which cannot be changed in natural lactobacilli. These findings provide new insights into the design of materials for immunology as well as the molecular biology of lactobacillus.	[Nagahama, Koji; Kumano, Takayuki; Nakagawa, Yuichi; Oyama, Naho; Koumoto, Kazuya; Matsui, Jun] Konan Univ, FIRST, Dept Nanobiochem, Kobe, Hyogo 6500047, Japan; [Tsuji, Hirokazu; Moriyama, Kaoru; Shida, Kan; Nomoto, Koji; Chiba, Katsuyoshi] Yakult Cent Inst, Kunitachi, Tokyo 1868650, Japan	Nagahama, K (reprint author), Konan Univ, FIRST, Dept Nanobiochem, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	nagahama@center.konan-u.ac.jp; koumoto@center.konan-u.ac.jp					Yuki N, 1999, INT J FOOD MICROBIOL, V48, P51, DOI 10.1016/S0168-1605(99)00029-X; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8; Suzuki C, 2008, INT J FOOD MICROBIOL, V123, P159, DOI 10.1016/j.ijfoodmicro.2007.12.022; Kim TW, 2007, J IMMUNOL, V179, P775; Schuller VJ, 2011, ACS NANO, V5, P9696, DOI 10.1021/nn203161y; Shida K, 2006, J DAIRY SCI, V89, P3306; Lee IH, 2012, ANGEW CHEM INT EDIT, V51, P8800, DOI 10.1002/anie.201203193; Tan SJ, 2011, SMALL, V7, P841, DOI 10.1002/smll.201001389; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1240; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Shukoor MI, 2009, ADV FUNCT MATER, V19, P3717, DOI 10.1002/adfm.200900635; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Rattanakiat S, 2009, BIOMATERIALS, V30, P5701, DOI 10.1016/j.biomaterials.2009.06.053; Kim JH, 2012, ANGEW CHEM INT EDIT, V51, P9670, DOI 10.1002/anie.201204989; Yu MK, 2008, ANGEW CHEM INT EDIT, V47, P5362, DOI 10.1002/anie.200800857; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259.266.2003; Chiba Y, 2010, IMMUNOLOGY, V130, P352, DOI 10.1111/j.1365-2567.2009.03204.x; Wei M, 2012, ANGEW CHEM INT EDIT, V51, P1202, DOI 10.1002/anie.201105187; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Iliev Asparouh I., 2004, FASEB Journal, V18, P412; Isolauri E, 2001, AM J CLIN NUTR, V73, p444S; Maurer T, 2013, UROL ONCOL-SEMIN ORI, V31, P1395, DOI 10.1016/j.urolonc.2011.09.002; Nagahama K, 2015, LANGMUIR, V31, P1489, DOI 10.1021/la5041757; NAGAOKA M, 1990, J BIOCHEM-TOKYO, V108, P568; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Pacheco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060989; Perdigon G, 1999, J DAIRY SCI, V82, P1108; Perdigón G, 2001, Curr Issues Intest Microbiol, V2, P27; Vabulas RM, 2000, J IMMUNOL, V164, P2372	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1775	1781		10.1021/acs.bioconjchem.5b00319		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900045		
J	Mohri, K; Morimoto, N; Maruyama, M; Nakamoto, N; Hayashi, E; Nagata, K; Miyata, K; Ochiai, K; Hiwatari, K; Tsubaki, K; Tobita, E; Ishimaru, Y; Maeda, S; Sakuma, S				Mohri, Kohta; Morimoto, Naoki; Maruyama, Megumi; Nakamoto, Norimasa; Hayashi, Emi; Nagata, Kengo; Miyata, Kohei; Ochiai, Kyohei; Hiwatari, Ken-ichiro; Tsubaki, Kazufumi; Tobita, Etsuo; Ishimaru, Yuki; Maeda, Sadaaki; Sakuma, Shinji			Potential of D-Octaarginine-Linked Polymers as an in Vitro Transfection Tool for Biomolecules	BIOCONJUGATE CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; DELIVERY; OLIGOARGININE; MECHANISM; MACROPINOCYTOSIS; INTERNALIZATION; TRANSLOCATION; CANCER; SIRNA	We have been investigating the potential use of cell-penetrating peptide-linked polymers as a novel penetration enhancer. Since previous in vivo studies demonstrated that poly(N-vinyl-acetamide-co-acrylic acid) bearing D-octaarginine, a typical cell-penetrating peptide, enhanced membrane permeation of biomolecules, its potential as an in vitro transfection tool was evaluated in this study. A plasmid DNA encoding green fluorescent protein (pGFP-C1), beta-galactosidase, and bovine serum albumin (BSA) were used as model biomolecules. Anionic pGFP-C1 interacted electrostatically with cationic D-octaarginine-linked polymers. When the ratio of mass concentration of polymers to that of pGFP-C1 reached 2.5, complexes whose size and zeta potential were approximately 200 nm and 15 mV, respectively, were obtained. GFP expression was observed in cells incubated with complexes prepared under conditions in which the polymer/pDNA concentration ratio exceeded 2.5. The expression level elevated with an increase in the concentration ratio, but physicochemical properties of the complexes remained unchanged. Results suggested that free polymers contributed to pGFP-C1 internalization. Another cell study demonstrated that beta-galactosidase premixed with polymers was taken up into cells in its active tetrameric form. Similar electrostatic interaction-driven complex formation was observed for BSA charged negatively in neutral solution. However, it appeared that the internalization processes of BSA differed from those of pGFP-C1. A mass concentration-dependent increase in internalized BSA was observed, irrespective of the polymer/protein concentration ratio. Due to frail interactions, polymers that were released from the complexes and subsequently immobilized on cell membranes might also contribute to membrane permeation of BSA.	[Mohri, Kohta; Morimoto, Naoki; Maruyama, Megumi; Nakamoto, Norimasa; Hayashi, Emi; Nagata, Kengo; Miyata, Kohei; Sakuma, Shinji] Setsunan Univ, Fac Pharmaceut Sci, Dept Drug Delivery Syst, Hirakata, Osaka 5730101, Japan; [Morimoto, Naoki; Miyata, Kohei; Ochiai, Kyohei; Hiwatari, Ken-ichiro; Tsubaki, Kazufumi; Tobita, Etsuo] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Hirakata, Osaka 5730101, Japan; [Ishimaru, Yuki; Maeda, Sadaaki] ADEKA Co, Life Sci Mat Lab, Arakawa Ku, Tokyo 1168553, Japan	Sakuma, S (reprint author), Setsunan Univ, Fac Pharmaceut Sci, Dept Drug Delivery Syst, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	sakuma@pharm.setsunan.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Seeds Validation from Japan Science and Technology Agency (JST) [AS2531303Q]	This work was financially supported in part by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Seeds Validation (Research No.: AS2531303Q) from Japan Science and Technology Agency (JST).	Sakuma S, 2010, J CONTROL RELEASE, V148, P187, DOI 10.1016/j.jconrel.2010.08.022; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Mo RH, 2012, MOL PHARMACEUT, V9, P299, DOI 10.1021/mp200481g; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Mishra R, 2009, BIOCONJUGATE CHEM, V20, P1860, DOI 10.1021/bc9000454; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Shamim N, 2006, J COLLOID INTERF SCI, V304, P1, DOI 10.1016/j.jcis.2006.08.047; Lambert JM, 2014, J MED CHEM, V57, P6949, DOI 10.1021/jm500766w; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P27, DOI 10.1093/nar/gki142; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Sakuma S, 2012, EUR J PHARM BIOPHARM, V81, P64, DOI 10.1016/j.ejpb.2012.01.008; Zaro JL, 2005, EXP CELL RES, V307, P164, DOI 10.1016/j.yexcr.2005.02.024; Mohri K, 2010, J CONTROL RELEASE, V144, P221, DOI 10.1016/j.jconrel.2010.02.018; Mohri K, 2014, EUR J PHARM SCI, V58, P26, DOI 10.1016/j.ejps.2014.03.002; Chu DF, 2015, NANOMED-NANOTECHNOL, V11, P435, DOI 10.1016/j.nano.2014.08.007; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Monroig PD, 2015, ADV DRUG DELIVER REV, V81, P104, DOI 10.1016/j.addr.2014.09.002; Nakamura T, 2014, MOL PHARMACEUT, V11, P2787, DOI 10.1021/mp500147y; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nishikawa M, 2010, ADV DRUG DELIVER REV, V62, P626, DOI 10.1016/j.addr.2010.03.006; Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394; Sakuma S, 2015, EUR J PHARM BIOPHARM, V92, P56, DOI 10.1016/j.ejpb.2015.02.010; Sakuma S, 2012, MOL PHARMACEUT, V9, P2933, DOI 10.1021/mp300329r; Takakura Y, 2002, J DRUG TARGET, V10, P99, DOI 10.1080/10611860290016694	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1782	1790		10.1021/acs.bioconjchem.5b00323		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900046		
J	Kojima, C; Kameyama, R; Yamada, M; Ichikawa, M; Waku, T; Handa, A; Tanaka, N				Kojima, Chie; Kameyama, Rina; Yamada, Manami; Ichikawa, Masahiro; Waku, Tomonori; Handa, Akihiro; Tanaka, Naoki			Ovalbumin Delivery by Guanidine-Terminated Dendrimers Bearing an Amyloid-Promoting Peptide via Nanoparticle Formulation	BIOCONJUGATE CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY; PAMAM DENDRIMER; DRUG-DELIVERY; PROTEIN; ARGININE; DESIGN	Development of protein delivery systems is important for biomedical applications such as immunotherapy. Ovalbumin (OVA) is a major component of egg whites, and is a possible cause of egg allergy. In this study, OVA was used as a model protein to develop a delivery system using guanidine-terminated dendrimers (Gdn-den) bearing an amyloid-promoting peptide derived from the helix B (hB) region of OVA (hB-Gdn-den). OVA nanoparticles (NPs) were prepared by heat treatment of OVA/hB-Gdn-den mixtures. The NP size and the surface charge were controlled by adjusting the ratio of hB-Gdn-den to OVA. The NPs were around 200 rim in diameter and stably dispersed, and their encapsulation efficiency for OVA was more than 80%. Although OVA NPs were also prepared using Gdn-den, the NPs aggregated readily. Complexation with hB-Gdn-den induced conformational changes in the OVA, and the hB peptide promoted digestion of OVA. These suggest that the hB peptide of the Gdn-den works as a possible anchor to OVA. The positively charged OVA NPs effectively associated with RAW264 cells. Thus, the amyloid-promoting Gdn-den, when mixed with OVA at a suitable molar ratio to form NPs, could act as a carrier for delivery of antigen proteins to immune cells.	[Kojima, Chie] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998570, Japan; [Kameyama, Rina; Yamada, Manami; Ichikawa, Masahiro; Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto 6068585, Japan; [Handa, Akihiro] Kewpie Corp, R&D Div, Chofu, Tokyo 182002, Japan	Kojima, C (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.	kojima@chem.osakafu-u.ac.jp; tanaka@kit.ac.jp			Japan Society for the Promotion of Science for Scientific Research [26410227]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science for Scientific Research (C) (No. 26410227).	GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Torchilin VP, 2003, DRUG DISCOV TODAY, V8, P259, DOI 10.1016/S1359-6446(03)02623-0; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Wang DJ, 2004, J AM CHEM SOC, V126, P13204, DOI 10.1021/ja0454992; Crespo L, 2005, CHEM REV, V105, P1663, DOI 10.1021/cr030449l; Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651; Tanaka N, 2011, J BIOL CHEM, V286, P5884, DOI 10.1074/jbc.M110.176396; [Anonymous], 2005, DRUG DELIV, DOI DOI 10.1016/J.ADDR.2005.09.018; Okuro K, 2009, J AM CHEM SOC, V131, P1626, DOI 10.1021/ja800491v; Giehm L, 2008, BIOPOLYMERS, V89, P522, DOI 10.1002/bip.20921; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Liu C, 2014, BIOCONJUGATE CHEM, V25, P521, DOI 10.1021/bc4005156; Lu Y, 2014, J CONTROL RELEASE, V194, P1, DOI 10.1016/j.jconrel.2014.08.015; Sadler K, 2002, MOL BIOTECHNOL, V90, P195, DOI DOI 10.1016/S1389-0352(01)00061-7; Schneider CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027665; Wells NJ, 1998, BIOPOLYMERS, V47, P381, DOI 10.1002/(SICI)1097-0282(1998)47:5<381::AID-BIP5>3.0.CO;2-F; Zhang XY, 2013, CARBOHYD POLYM, V98, P1326, DOI 10.1016/j.carbpol.2013.08.005	25	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1804	1810		10.1021/acs.bioconjchem.5b00325		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900048		
J	Yang, B; Jinnouchi, A; Usui, K; Katayama, T; Fujii, M; Suemune, H; Aso, M				Yang, Bo; Jinnouchi, Akiko; Usui, Kazuteru; Katayama, Tsutomu; Fujii, Masayuki; Suemune, Hiroshi; Aso, Mariko			Bioconjugation of Oligodeoxynucleotides Carrying 1,4-Dicarbonyl Groups via Reductive Amination with Lysine Residues	BIOCONJUGATE CHEMISTRY			English	Article							C4'-OXIDIZED ABASIC SITE; EFFICIENT AMINE MODIFICATION; REACTIVE DIALDEHYDE GROUPS; CROSS-LINK FORMATION; PHOTOCHEMICAL GENERATION; NUCLEIC-ACIDS; DNA-BINDING; DUPLEX DNA; OLIGONUCLEOTIDES; PROTEIN	We evaluated the efficacy of bioconjugation of oligodeoxynucleotides (ODNs) containing 1,4-dicarbonyl groups, a C4'-oxidized abasic site (OAS), and a newly designed 2'-methoxy analogue, via reductive amination with lysine residues. Dicarbonyls, aldehyde and ketone at C1- and C4-positions of deoxyribose in the ring-opened form of OAS allowed efficient reaction with amines. Kinetic studies indicated that reductive amination of OAS-containing ODNs with a proximal amine on the complementary strand proceeded 10 times faster than the corresponding reaction of an ODN containing an abasic site with Cl-aldehyde. Efficient reductive amination between the DNA-binding domain of Escherichia coli DnaA protein and ODNs carrying OAS in the DnaA-binding sequence proceeded at the lysine residue in proximity to the phosphate group at the 5'-position of the OAS, in contrast to unsuccessful conjugation with abasic site ODNs, even though they have similar aldehydes. Theoretical calculation indicated that the Cl-aldehyde of OAS was more accessible to the target lysine than that of the abasic site. These results demonstrate the potential utility of cross-linking strategies that use dicarbonyl-containing ODNs for the study of protein nucleic acid interactions. Conjugation with a lysine-containing peptide that lacked specific affinity for ODN was also successful, further highlighting the advantages of 1,4-dicarbonyls.	[Yang, Bo; Jinnouchi, Akiko; Usui, Kazuteru; Katayama, Tsutomu; Suemune, Hiroshi; Aso, Mariko] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Fujii, Masayuki] Kinki Univ, Sch Humanity Oriented Sci & Engn, Dept Biol & Environm Chem, Iizuka, Fukuoka 8208555, Japan	Aso, M (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	aso@phar.kyushu-u.ac.jp			JSPS KAKENHI [26410181]	M. Aso received funding from JSPS KAKENHI Grant Number 26410181.	DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cb.02.110186.002055; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Raindlova V, 2012, CHEM-EUR J, V18, P4080, DOI 10.1002/chem.201103270; Zatsepin TS, 2005, BIOCONJUGATE CHEM, V16, P471, DOI 10.1021/bc049712v; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Dutta S, 2007, J AM CHEM SOC, V129, P1852, DOI 10.1021/ja067294u; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Juliano RL, 2012, ACCOUNTS CHEM RES, V45, P1067, DOI 10.1021/ar2002123; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Sczepanski JT, 2008, J AM CHEM SOC, V130, P9646, DOI 10.1021/ja8030642; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Lu K, 2010, BIOCONJUGATE CHEM, V21, P187, DOI 10.1021/bc900158s; AMARNATH V, 1991, J ORG CHEM, V56, P6924, DOI 10.1021/jo00024a040; Sczepanski JT, 2009, J AM CHEM SOC, V131, P11132, DOI 10.1021/ja903404v; Aso M, 1999, J AM CHEM SOC, V121, P9023, DOI 10.1021/ja991574a; Aso M, 2006, ORG LETT, V8, P3183, DOI 10.1021/ol060987v; Brevnov MG, 1997, NUCLEIC ACIDS RES, V25, P3302, DOI 10.1093/nar/25.16.3302; Chen JY, 2004, BIOCHEMISTRY-US, V43, P5278, DOI 10.1021/bi0495376; Chen JY, 2007, BIOCHEMISTRY-US, V46, P3096, DOI 10.1021/bi6024269; Deceuninck A, 2009, CHEM COMMUN, P340, DOI 10.1039/b817447d; Dey S, 2001, ORG LETT, V3, P3983, DOI 10.1021/ol016626r; Golan G, 2006, J MOL BIOL, V362, P241, DOI 10.1016/j.jmb.2006.06.059; Kim J, 2003, ANGEW CHEM INT EDIT, V42, P5882, DOI 10.1002/anie.200352102; Kubo T, 2005, ORG BIOMOL CHEM, V3, P3257, DOI 10.1039/b507691a; Kupfer PA, 2007, NUCLEIC ACIDS RES, V35, P58, DOI 10.1093/nar/gkl948; Manoharan M, 1999, ORG LETT, V1, P311, DOI 10.1021/ol9906209; Manoharan M, 1997, NUCLEOS NUCLEOT, V16, P1141, DOI 10.1080/07328319708006149; Mazumder A, 1996, J BIOL CHEM, V271, P27330; Obita T, 2002, BIOCHEM BIOPH RES CO, V299, P42, DOI 10.1016/S0006-291X(02)02590-1; OKAMOTO S, 1980, J MED CHEM, V23, P827, DOI 10.1021/jm00182a003; PEOCH D, 1991, TETRAHEDRON LETT, V32, P207, DOI 10.1016/0040-4039(91)80856-2; Schrodinger, 2013, MAESTR V 9 5; SUGIYAMA H, 1985, J AM CHEM SOC, V107, P7765, DOI 10.1021/ja00311a092; Trzupek JD, 2005, ORG LETT, V7, P1493, DOI 10.1021/ol050120h; Tunitskaya VL, 1999, FEBS LETT, V442, P20, DOI 10.1016/S0014-5793(98)01625-1; Usui K, 2008, J ORG CHEM, V73, P241, DOI 10.1021/jo702080r; Weng LW, 2015, ACS CHEM BIOL, V10, P622, DOI 10.1021/cb500737y; Wickramaratne S, 2013, BIOCONJUGATE CHEM, V24, P1496, DOI 10.1021/bc400018u; Yang B, 2012, ORG LETT, V14, P5852, DOI 10.1021/ol302703m	40	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	AUG	2015	26	8					1830	1838		10.1021/acs.bioconjchem.5b00361		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CP5ZA	WOS:000359962900051		
J	Matsubara, A; Yata, K; Kaseda, Y; Sakamoto, Y				Matsubara, A.; Yata, K.; Kaseda, Y.; Sakamoto, Y.			The effect of combination treatment of low-frequency rTMS and occupational therapy	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Meeting Abstract						Neurological practice; Practice development; Practice - present and future			[Matsubara, A.; Yata, K.; Kaseda, Y.; Sakamoto, Y.] Hiroshima City Rehabil Hosp, Hiroshima, Japan		asacom50@go3.enjoy.ne.jp					Kakuda W, 2011, BRAIN INJURY, V25, P496, DOI 10.3109/02699052.2011.559610; Sasaki N, 2013, INTERNAL MED, V111, P925	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	AUG	2015	78			8		52.2	34	34				1	Rehabilitation	Rehabilitation	CP3XB	WOS:000359815000064		
J	Kumagai, Y; Gilmour, S; Ota, E; Momose, Y; Onishi, T; Bilano, VLF; Kasuga, F; Sekizaki, T; Shibuya, K				Kumagai, Yuko; Gilmour, Stuart; Ota, Erika; Momose, Yoshika; Onishi, Toshiro; Bilano, Ver Luanni Feliciano; Kasuga, Fumiko; Sekizaki, Tsutomu; Shibuya, Kenji			Estimating the burden of foodborne diseases in Japan	BULLETIN OF THE WORLD HEALTH ORGANIZATION			English	Article							ESCHERICHIA-COLI O157; HEMOLYTIC-UREMIC SYNDROME; CAMPYLOBACTER-JEJUNI ENTERITIS; INFECTIOUS INTESTINAL DISEASE; SALMONELLA REACTIVE ARTHRITIS; FOOD-BORNE DISEASES; HEMORRHAGIC COLITIS; VIBRIO-PARAHAEMOLYTICUS; MIYAGI PREFECTURE; GENERAL-PRACTICE	Objective To assess the burden posed by foodborne diseases in Japan using methods developed by the World Health Organization's Foodborne Disease Burden Epidemiology Reference Group (FERG). Methods Expert consultation and statistics on food poisoning during 2011 were used to identify three common causes of foodborne disease in Japan: Campylobacter and Salmonella species and enterohaemorrhagic Escherichia coli (EHEC). We conducted systematic reviews of English and Japanese literature on the complications caused by these pathogens, by searching Embase, the Japan medical society abstract database and Medline. We estimated the annual incidence of acute gastroenteritis from reported surveillance data, based on estimated probabilities that an affected person would visit a physician and have gastroenteritis confirmed. We then calculated disability-adjusted life-years (DALYs) lost in 2011, using the incidence estimates along with disability weights derived from published studies. Findings In 2011, foodborne disease caused by Campylobacter species, Salmonella species and EHEC led to an estimated loss of 6099, 3145 and 463 DALYs in Japan, respectively. These estimated burdens are based on the pyramid reconstruction method; are largely due to morbidity rather than mortality; and are much higher than those indicated by routine surveillance data. Conclusion Routine surveillance data may indicate foodborne disease burdens that are much lower than the true values. Most of the burden posed by foodborne disease in Japan comes from secondary complications. The tools developed by FERG appear useful in estimating disease burdens and setting priorities in the field of food safety.	[Kumagai, Yuko] Univ Tokyo, Dept Vet Med Sci, Tokyo 1130033, Japan; [Gilmour, Stuart; Bilano, Ver Luanni Feliciano; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan; [Ota, Erika] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Momose, Yoshika; Kasuga, Fumiko] Natl Inst Hlth Sci, Tokyo, Japan; [Onishi, Toshiro] Kyushu Univ, Fac Econ, Fukuoka 812, Japan; [Sekizaki, Tsutomu] Univ Tokyo, Res Ctr Food Safety, Tokyo 1130033, Japan	Shibuya, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp		Bilano, Ver/0000-0002-1220-6220	Ministry of Health, Labour and Welfare, Japan [H23-food-014]	This study was supported in part by a Health and Labour Sciences Research Grant (H23-food-014) from the Ministry of Health, Labour and Welfare, Japan.	Afza M, 2006, EPIDEMIOL INFECT, V134, P1276, DOI 10.1017/S0950268806006546; [Anonymous], 1998, INFECTIOUS AGENTS SU; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; FREEMAN J, 1980, AM J EPIDEMIOL, V112, P707; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.091101p1; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Wheeler JG, 1999, BRIT MED J, V318, P1046; Townes JM, 2008, ANN RHEUM DIS, V67, P1689, DOI 10.1136/ard.2007.083451; Ternhag A, 2008, EMERG INFECT DIS, V14, P143, DOI 10.3201/eid1401.070524; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; [Anonymous], 1998, INFECTIOUS DISEASES; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; [Anonymous], 2015, THE PATIENT SURVEY; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Angulo FJ, 1998, VET CLIN N AM-FOOD A, V14, P165; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; [Anonymous], 2012, THE GLOBAL VIEW OF C; Kubota K, 2011, J FOOD PROTECT, V74, P1592, DOI 10.4315/0362-028X.JFP-10-387; Kubota K, 2008, FOODBORNE PATHOG DIS, V5, P641, DOI 10.1089/fpd.2008.0092; ORR P, 1994, SCAND J INFECT DIS, V26, P675, DOI 10.3109/00365549409008635; [Anonymous], 2015, FOOD POISONING STATI; [Anonymous], 2012, WHO INITIATIVE TO ES; Hadler JL, 2011, CLIN INFECT DIS, V53, P269, DOI 10.1093/cid/cir377; Schiellerup P, 2008, J RHEUMATOL, V35, P480; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Laine ES, 2005, J FOOD PROTECT, V68, P1198; Majowicz SE, 2005, CAN J PUBLIC HEALTH, V96, P178; [Anonymous], 2011, VITAL STATISTICS DAT; Beutin L, 1998, EMERG INFECT DIS, V4, P635; Beutin L, 2002, DIAGN MICR INFEC DIS, V44, P337, DOI 10.1016/S0732-8893(02)00474-1; Chalmers RM, 1999, EMERG INFECT DIS, V5, P566; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Ekman P, 2000, ARTHRITIS RHEUM, V43, P1527, DOI 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.3.CO;2-7; Fischer H, 2001, PEDIATR INFECT DIS J, V20, P316, DOI 10.1097/00006454-200103000-00021; Gelman A, 2013, BAYESIAN DATA ANALYS; GUMPEL JM, 1981, ANN RHEUM DIS, V40, P64, DOI 10.1136/ard.40.1.64; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI [10.3201/eid1410.071042, 10.3201/1410.071042]; Havelaar AH, 2013, LANCET, V381, P59; JOHNSEN K, 1983, ACTA MED SCAND, V214, P165; Kemmeren JM, 2006, RIVM REPORT 33008000; KOSUNEN TU, 1981, SCAND J RHEUMATOL, V10, P77; Kumagai Y., 2011, Journal of Disaster Research, V6, P451; Lathrop S, 2009, EMERG INFECT DIS, V15, P1289, DOI [10.3201/eid1508.081616, 10.3201/eid1508.08151515]; Lee ATY, 2005, J RHEUMATOL, V32, P524; Lienemann T, 2012, EMERG INFECT DIS, V18, P577, DOI 10.3201/eid1804.111310; Liptakova A, 2004, CLIN MICROBIOL INFEC, V10, P576, DOI 10.1111/j.1469-0691.2004.00900.x; Locht H, 2002, ANN RHEUM DIS, V61, P448, DOI 10.1136/ard.61.5.448; MacDonald IAR, 1996, EPIDEMIOL INFECT, V116, P279; Mag T, 2010, EUR J CLIN MICROBIOL, V29, P249, DOI 10.1007/s10096-009-0836-z; MATTILA L, 1994, BRIT J RHEUMATOL, V33, P1136; Mattila L, 1998, J INFECTION, V36, P289, DOI 10.1016/S0163-4453(98)94243-8; McCarthy N, 1999, EPIDEMIOL INFECT, V122, P15, DOI 10.1017/S0950268898001861; McDonnell R J, 1997, Commun Dis Rep CDR Rev, V7, pR201; Momose Y, 2012, SYSTEMATIC REVIEW FO; Okabe N, 2013, STUDY FOR IMPROVING; Ono T, 2012, POLICY SITUATION ANA; PAI CH, 1984, ANN INTERN MED, V101, P738; PIERARD D, 1990, EUR J CLIN MICROBIOL, V9, P198; PITKANEN T, 1983, ARCH INTERN MED, V143, P215, DOI 10.1001/archinte.143.2.215; PITKANEN T, 1981, INFECTION, V9, P274, DOI 10.1007/BF01640990; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; PONKA A, 1984, INFECTION, V12, P175, DOI 10.1007/BF01640893; Rees JR, 2004, CLIN INFECT DIS, V38, pS311, DOI 10.1086/381601; SALMON RL, 1989, EPIDEMIOL INFECT, V103, P249; SAMUEL MP, 1995, J RHEUMATOL, V22, P1947; SANJOAQUIN VH, 1984, CLIN PEDIATR, V23, P311, DOI 10.1177/000992288402300601; Schonberg-Norio D, 2010, EPIDEMIOL INFECT, V138, P1004, DOI 10.1017/S0950268809991099; SHARP JCM, 1994, J INFECTION, V29, P343, DOI 10.1016/S0163-4453(94)91381-1; Simor A E, 1990, Can J Infect Dis, V1, P23; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; TRULL AK, 1986, BRIT J RHEUMATOL, V25, P13; Urfer E, 2000, CLIN MICROBIOL INFEC, V6, P536, DOI 10.1046/j.1469-0691.2000.00148.x; Van Lier EA, 2007, RIVM REPORT 21500100; Wells GA, 2014, THE NEWCASTLE OTTAWA	83	2	2	WORLD HEALTH ORGANIZATION	GENEVA 27	MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND	0042-9686	1564-0604		B WORLD HEALTH ORGAN	Bull. World Health Organ.	AUG	2015	93	8					540	549		10.2471/BLT.14.148056		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CP6AJ	WOS:000359966400011		
J	Adachi, K; Tamada, K				Adachi, Keishi; Tamada, Koji			Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy	CANCER SCIENCE			English	Review						Anti-PD-L1 Ab; cancer immunoediting; cancer immunosurveillance; immune checkpoint molecules; PD-1; PDL-1 pathway	T-CELLS; ANTITUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ANTI-PD-L1 ANTIBODY; CTLA-4; B7-H1; SAFETY; PD-1; IMMUNOSURVEILLANCE; MELANOMA	Recent progress in tumor immunology has revealed that tumors generate immunologically restrained milieu during the process of their growth, which facilitates the escape of tumors from host immune systems. Immune checkpoint molecules, which transduce co-inhibitory signals to immuno-competent cells, are one of the most important components conferring the immunosuppressive capacity in the tumor microenvironment. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death-1 (PD-1) are typical immune checkpoint molecules intimately involved in the suppression of anti-tumor immunity. Antibodies against those molecules have been developed, such as ipilimumab (anti-CTLA-4 antibody), nivolumab and pembrolizumab (anti-PD-1 antibody), and have been approved by regulatory agencies and used in some countries. Treatment with these antibodies demonstrates previously unobserved clinical efficacies superior to the conventional therapies. In this review, we first discuss the escape mechanisms of cancer from host immune systems, and then focus on the recent advances in immune checkpoint blockade therapy and on the new findings of related immune reactions, aiming to provide a better understanding of the novel cancer immunotherapies.	[Adachi, Keishi; Tamada, Koji] Yamaguchi Univ, Dept Immunol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Tamada, K (reprint author), Yamaguchi Univ, Dept Immunol, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	ktamada@yamaguchi-u.ac.jp			Health Labour Sciences Research Grant; Yamaguchi University Hospital	This study was supported by the Health Labour Sciences Research Grant and the translational research promotion fund from the Yamaguchi University Hospital.	ALLISON JP, 1995, SCIENCE, V270, P932, DOI 10.1126/science.270.5238.932; Anagnostou VK, 2015, CLIN CANCER RES, V21, P976, DOI 10.1158/1078-0432.CCR-14-1187; Pasero C, 2013, IMMUNOL LETT, V151, P71, DOI 10.1016/j.imlet.2013.01.008; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; ISHIDA Y, 1992, EMBO J, V11, P3887; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hirano F, 2005, CANCER RES, V65, P1089; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Kikushige Y, 2013, INT J HEMATOL, V98, P627, DOI 10.1007/s12185-013-1433-6; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Yee C, 2014, IMMUNOL REV, V257, P250, DOI 10.1111/imr.12134; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Bayry J, 2009, NAT REV RHEUMATOL, V5, P244, DOI 10.1038/nrrheum.2009.77; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Lucas S, 2008, SEMIN IMMUNOL, V20, P301, DOI 10.1016/j.smim.2008.02.001; Ostrand-Rosenberg S, 2014, J IMMUNOL, V193, P3835, DOI 10.4049/jimmunol.1401572; Raval Raju R, 2014, J Immunother Cancer, V2, P14, DOI 10.1186/2051-1426-2-14; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Whiteside TL, 2014, CANCER IMMUNOL IMMUN, V63, P67, DOI 10.1007/s00262-013-1490-y	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					945	950		10.1111/cas.12695		6	Oncology	Oncology	CP4QI	WOS:000359867000001		
J	Oue, N; Sentani, K; Sakamoto, N; Yasui, W				Oue, Naohide; Sentani, Kazuhiro; Sakamoto, Naoya; Yasui, Wataru			Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype	CANCER SCIENCE			English	Review						Escherichia coli ampicillin secretion trap; gastric cancer; mucin; phenotype; Serial Analysis of Gene Expression	AMPICILLIN SECRETION TRAP; DIFFERENTIATED-TYPE ADENOCARCINOMAS; REG-IV EXPRESSION; GENE-EXPRESSION; SERIAL ANALYSIS; STEM-CELLS; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; PRECANCEROUS LESIONS; TUMOR PROGRESSION	Gastric cancer (GC), one of the most common human cancers, can be classified into gastric or intestinal phenotype according to mucin expression. TP53 mutation, allelic deletion of the APC gene and nuclear staining of -catenin are frequently detected in the intestinal phenotype of GC, whereas CDH1 gene mutation, microsatellite instability and DNA hypermethylation of MLH1 are common events in the gastric phenotype of GC. Our Serial Analysis of Gene Expression (SAGE) and Escherichia coli ampicillin secretion trap (CAST) analyses revealed that CDH17, REG4, OLFM4, HOXA10, DSC2, TSPAN8 and TM9SF3 are upregulated in GC and that CLDN18 is downregulated in GC. Expression of CDH17, REG4, HOXA10 and DSC2 and downregulation of CLDN18 are observed in the intestinal phenotype of GC. In contrast, OLFM4 is expressed in the gastric phenotype of GC. Expression of TSPAN8, TM9SF3 and HER2 are not associated with either gastric or intestinal phenotypes. Ectopic CDX2 expression plays a key function in the GC intestinal phenotype. MUC2, CDH17, REG4, DSC2 and ABCB1 are direct targets of CDX2. Importantly, these genes encode transmembrane/secretory proteins, indicating that the microenvironment as well as cancer cells are also different between gastric and intestinal phenotypes of GC.	[Oue, Naohide; Sentani, Kazuhiro; Sakamoto, Naoya; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348551, Japan	Yasui, W (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	wyasui@hiroshima-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health and Welfare of Japan	This work was supported, in part, by Grants-in-Aid for Cancer Research from the Ministry of Education, Science, Sports and Culture of Japan and from the Ministry of Health and Welfare of Japan.	Anami K., GASTRIC CANC; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Reynolds A, 2014, GUT, V63, P610, DOI 10.1136/gutjnl-2012-304067; Uozaki H, 2011, INT J CLIN EXP PATHO, V4, P230; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Sentani K, 2014, GASTRIC CANCER, V17, P412, DOI 10.1007/s10120-013-0302-6; Shibata N, 2003, HUM PATHOL, V34, P32, DOI 10.1053/hupa.2003.2; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Oue N, 2003, CANCER SCI, V94, P901, DOI 10.1111/j.1349-7006.2003.tb01373.x; Yoshida HY, 2006, CANCER RES, V66, P889, DOI 10.1158/0008.5472.CAN-05-2828; Tani Y, 2007, J CANCER RES CLIN, V133, P263, DOI 10.1007/s00432-006-0165-x; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Ferguson DA, 2005, CANCER RES, V65, P8209, DOI 10.1158/0008-5472.CAN-04-3726; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Sanada Y, 2006, J PATHOL, V208, P633, DOI 10.1002/path.1922; Park SY, 2002, HUM PATHOL, V33, P1078, DOI 10.1053/hupa.2002.129422; Mizoshita T, 2003, J CANCER RES CLIN, V129, P727, DOI 10.1007/s00432-003-0499-6; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Oo HZ, 2014, PATHOBIOLOGY, V81, P138, DOI 10.1159/000357821; Qiu W, 2010, P NATL ACAD SCI USA, V107, P20027, DOI 10.1073/pnas.1010430107; Takakura Y, 2010, CANCER RES, V70, P6767, DOI 10.1158/0008-5472.CAN-09-4701; Takami H, 2012, PATHOBIOLOGY, V79, P154, DOI 10.1159/000335694; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; NAKAMURA K, 1968, GANN, V59, P251; Sakamoto N, 2012, CANCER SCI, V103, P1744, DOI 10.1111/j.1349-7006.2012.02353.x; Yasui W, 2004, CANCER SCI, V95, P385, DOI 10.1111/j.1349-7006.2004.tb03220.x; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Sentani K, 2012, CARCINOGENESIS, V33, P1081, DOI 10.1093/carcin/bgs121; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Yokozaki H, 1999, INT J CANCER, V83, P192, DOI 10.1002/(SICI)1097-0215(19991008)83:2<192::AID-IJC8>3.0.CO;2-E; Heiskala K, 2010, HISTOL HISTOPATHOL, V25, P63; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Anami K, 2010, J PATHOL, V221, P275, DOI 10.1002/path.2717; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Duan C, 2014, J CELL MOL MED, V18, P863, DOI 10.1111/jcmm.12232; Egashira Y, 1999, PATHOL INT, V49, P55, DOI 10.1046/j.1440-1827.1999.00824.x; Endoh Y, 2000, AM J PATHOL, V157, P717, DOI 10.1016/S0002-9440(10)64584-1; Endoh Y, 1999, J PATHOL, V189, P201, DOI 10.1002/(SICI)1096-9896(199910)189:2<201::AID-PATH409>3.0.CO;2-A; Endoh Y, 2000, J PATHOL, V191, P257; Goto A, 2011, VIRCHOWS ARCH, V458, P717, DOI 10.1007/s00428-011-1086-x; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Ito R, 2005, VIRCHOWS ARCH, V447, P717, DOI 10.1007/s00428-005-0015-2; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jiang Y, 2014, CURR PHARM DESIGN, V20, P1647; Kabashima A, 2000, HISTOPATHOLOGY, V37, P513, DOI 10.1046/j.1365-2559.2000.01008.x; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; Li BX, 2014, CELL BIOCHEM BIOPHYS, V70, P1363, DOI 10.1007/s12013-014-0065-7; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Motoshita J, 2005, CANCER SCI, V96, P474, DOI 10.1111/j.1349-7006.2005.0074.x; Naito Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047545; Nakamura T, 2005, HISTOPATHOLOGY, V47, P357, DOI 10.1111/j.1365-2559.2005.02242.x; Nakata K, 2009, MODERN PATHOL, V22, P460, DOI 10.1038/modpathol.2008.205; [Anonymous], 2001, MOL CELL BIOL, DOI 10.1128/MCB.21.21.7380-7390.2001; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Pruvot B, 2010, IMMUNOGENETICS, V62, P681, DOI 10.1007/s00251-010-0472-x; Sasahira T, 2008, HISTOPATHOLOGY, V53, P667, DOI 10.1111/j.1365-2559.2008.03188.x; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Seko N, 2010, EXP THER MED, V1, P73, DOI 10.3892/etm_00000013; Stokes DL, 2007, CURR OPIN CELL BIOL, V19, P565, DOI 10.1016/i.ceb.2007.09.003; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; Woll S, 2014, INT J CANCER, V134, P731, DOI 10.1002/ijc.28400; Wu LB, 1998, PATHOL RES PRACT, V194, P405	87	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					951	958		10.1111/cas.12706		8	Oncology	Oncology	CP4QI	WOS:000359867000002		
J	Sakakibara, Y; Wada, T; Muraoka, M; Matsuda, Y; Toma, T; Yachie, A				Sakakibara, Yasuhisa; Wada, Taizo; Muraoka, Masahiro; Matsuda, Yusuke; Toma, Tomoko; Yachie, Akihiro			Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites	CANCER SCIENCE			English	Article						Basophils; Epstein-Barr virus; hypersensitivity to mosquito bites; IgE; natural killer cells	EPSTEIN-BARR-VIRUS; ACTIVE EBV INFECTION; NK CELLS; T-CELL; NONIMMUNOCOMPROMISED HOSTS; CLINICAL-RELEVANCE; SALIVARY ALLERGEN; IGE SYNTHESIS; B-CELLS; EXPRESSION	Hypersensitivity to mosquito bites (HMB) is a cutaneous disorder belonging to the group of Epstein-Barr virus (EBV)-associated T/natural killer (NK)-cell lymphoproliferative diseases, and is primarily mediated by EBV-infected NK cells. It is characterized by intense local skin reactions accompanied by general symptoms after mosquito bites, and infiltration of EBV-infected NK cells into the bite sites. However, the mechanisms underlying these reactions have not been fully examined. We recently described the activation of circulating basophils by mosquito extracts invitro in a patient with HMB. To further investigate this finding, we studied four additional patients with HMB. All patients showed typical clinical features of HMB after mosquito bites and they had NK lymphocytosis and high peripheral blood EBV DNA loads. We found evidence of EBV infection in NK cells through insitu hybridization that detected EBV-encoded small RNA-1, and flow cytometry showed HLA-DR expression on almost all NK cells. Basophil activation tests with the extracts of epidemic mosquitoes Culex pipiens pallens and Aedes albopictus showed positive responses to one or both extracts in all samples from patients with HMB, suggesting the presence of mosquito antigen-specific IgE and its binding to basophils. In particular, the extract of Aedes albopictus was able to activate basophils in all available patient samples. These results indicate that basophils and/or mast cells activated by mosquito bites may be involved in initiation and development of severe skin reactions to mosquito bites in HMB.	[Sakakibara, Yasuhisa; Wada, Taizo; Muraoka, Masahiro; Matsuda, Yusuke; Toma, Tomoko; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Pediat, Sch Med, Kanazawa, Ishikawa 9208641, Japan	Wada, T (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Pediat, Sch Med, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	taizo@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan, Tokyo	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant from the Ministry of Health, Labour, and Welfare of Japan, Tokyo.	Suzuki R, 2004, LEUKEMIA, V18, P763, DOI 10.1038/sj.leu.2403262; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Peng Z, 2006, ALLERGY, V61, P485, DOI 10.1111/j.1398-9995.2006.00985.x; McGowan EC, 2013, CURR ALLERGY ASTHM R, V13, P101, DOI 10.1007/s11882-012-0324-x; Kimura H, 2005, J INFECT DIS, V191, P531, DOI 10.1086/427239; Callan MFC, 2004, MICROBES INFECT, V6, P937, DOI 10.1016/j.micinf.2004.04.014; Okano M, 2005, AM J HEMATOL, V80, P64, DOI 10.1002/ajh.20398; Asada H, 2005, J INVEST DERMATOL, V125, P956, DOI 10.1111/j.0022-202X.2005.23915.x; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Attygalle AD, 2014, HISTOPATHOLOGY, V64, P171, DOI 10.1111/his.12251; Sturm GJ, 2004, ALLERGY, V59, P1110, DOI 10.1111/j.1398-9995.2004.00400.x; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kasahara Y, 2001, BLOOD, V98, P1882, DOI 10.1182/blood.V98.6.1882; TOKURA Y, 1990, ARCH DERMATOL, V126, P362, DOI 10.1001/archderm.126.3.362; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Lima M, 2002, BLOOD CELL MOL DIS, V28, P181, DOI 10.1006/bcmd.2002.0506; Hausmann OV, 2009, IMMUNOL ALLERGY CLIN, V29, P555, DOI 10.1016/j.iac.2009.04.011; Cohen JI, 2009, ANN ONCOL, V20, P1472, DOI 10.1093/annonc/mdp064; Asada H, 2003, ARCH DERMATOL, V139, P1601, DOI 10.1001/archderm.139.12.1601; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kim M, 2012, J IMMUNOL, V188, P4158, DOI 10.4049/jimmunol.1103450; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Park S, 2014, J DERMATOL, V41, P29, DOI 10.1111/1346-8138.12322; Peng ZK, 1996, ANN ALLERG ASTHMA IM, V77, P238; Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Peng ZK, 2001, INT IMMUNOL, V13, P1445, DOI 10.1093/intimm/13.12.1445; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4; Pokkali S, 2009, FEMS IMMUNOL MED MIC, V55, P352, DOI 10.1111/j.1574-695X.2008.00520.x; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Seo N, 2000, CLIN EXP IMMUNOL, V120, P413, DOI 10.1046/j.1365-2249.2000.01253.x; STRAUS SE, 1993, ANN INTERN MED, V118, P45; Sugaya N, 2004, J INFECT DIS, V190, P985, DOI 10.1086/423285; Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751; TOMKINSON BE, 1987, J IMMUNOL, V139, P3802; Wada T, 2009, INT J HEMATOL, V90, P611, DOI 10.1007/s12185-009-0442-y; Wongkamchai S, 2010, ASIAN PAC J ALLERGY, V28, P162; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					965	971		10.1111/cas.12696		7	Oncology	Oncology	CP4QI	WOS:000359867000004		
J	Chen, X; Yamamoto, M; Fujii, K; Nagahama, Y; Ooshio, T; Xin, B; Okada, Y; Furukawa, H; Nishikawa, Y				Chen, Xi; Yamamoto, Masahiro; Fujii, Kiyonaga; Nagahama, Yasuharu; Ooshio, Takako; Xin, Bing; Okada, Yoko; Furukawa, Hiroyuki; Nishikawa, Yuji			Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions	CANCER SCIENCE			English	Article						Hepatocellular carcinoma; insulin-like growth factor 2; liver cirrhosis; mRNA expression; trefoil factor 3	GROWTH-FACTOR-II; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; INCREASED EXPRESSION; H19; IGF2; CANCER; RNA; CARCINOGENESIS; ENHANCER	Hepatocellular carcinoma develops in either chronically injured or seemingly intact livers. To explore the tumorigenic mechanisms underlying these different conditions, we compared the mRNA expression profiles of mouse hepatocellular tumors induced by the repeated injection of CCl4 or a single diethylnitrosamine (DEN) injection using a cDNA microarray. We identified tumor-associated genes that were expressed differentially in the cirrhotic CCl4 model (H19, Igf2, Cbr3, and Krt20) and the non-cirrhotic DEN model (Tff3, Akr1c18, Gpc3, Afp, and Abcd2) as well as genes that were expressed comparably in both models (Ly6d, Slpi, Spink3, Scd2, and Cpe). The levels and patterns of mRNA expression of these genes were validated by quantitative RT-PCR analyses. Most of these genes were highly expressed in mouse livers during the fetal/neonatal periods. We also examined the mRNA expression of these genes in mouse tumors induced by thioacetamide, another cirrhotic inducer, and those that developed spontaneously in non-cirrhotic livers and found that they shared a similar expression profile as that observed in CCl4-induced and DEN-induced tumors, respectively. There was a close relationship between the expression levels of Igf2 and H19 mRNA, which were activated in the cirrhotic models. Our results show that mouse liver tumors reactivate fetal/neonatal genes, some of which are specific to cirrhotic or non-cirrhotic modes of pathogenesis.	[Chen, Xi; Yamamoto, Masahiro; Fujii, Kiyonaga; Nagahama, Yasuharu; Ooshio, Takako; Xin, Bing; Okada, Yoko; Nishikawa, Yuji] Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Asahikawa, Hokkaido 0788510, Japan; [Furukawa, Hiroyuki] Asahikawa Med Univ, Dept Surg, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido 0788510, Japan	Nishikawa, Y (reprint author), Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	nishikwa@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ANDERVONT HB, 1950, J NATL CANCER I, V11, P581; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Ariel I, 1998, J CLIN PATHOL-MOL PA, V51, P21; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Niwa T, 2010, ADV GENET, V71, P41, DOI [10.1016/B978-0-12-380864-6.00002-X, 10.1016/S0065-2660(10)71002-6]; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Stoot JHMB, 2010, HPB, V12, P509, DOI 10.1111/j.1477-2574.2010.00222.x; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Edwards JE, 1941, J NATL CANCER I, V2, P197; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; GOTHOSKA.SV, 1970, BRIT J CANCER, V24, P498, DOI 10.1038/bjc.1970.60; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Kato T, 2003, CANCER SCI, V94, P679, DOI 10.1111/j.1349-7006.2003.tb01502.x; Liu TC, 2014, MODERN PATHOL, V27, P420, DOI 10.1038/modpathol.2013.148; Okada H, 2005, INT J ONCOL, V26, P369; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Ramakrishna Gayatri, 2013, Liver Cancer, V2, P367, DOI 10.1159/000343852; SCHIRMACHER P, 1992, CANCER RES, V52, P2549; SELL S, 1976, CANCER RES, V36, P4239; Sohda T, 1998, J HUM GENET, V43, P49, DOI 10.1007/s100380050036; Sohda T, 1996, LAB INVEST, V75, P307; Stegmaier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017738; Sun Q, 2007, CANCER BIOL THER, V6, P1532; Vernucci M, 2000, ONCOGENE, V19, P6376, DOI 10.1038/sj.onc.1204024; Vesselinovitch SD, 1980, IARC SCI PUBL, V31, P645; Yamamoto Y, 2004, J HEPATOL, V40, P808, DOI 10.1016/j.jhep.2004.01.022	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					972	981		10.1111/cas.12700		10	Oncology	Oncology	CP4QI	WOS:000359867000005		
J	Hakiri, S; Osada, H; Ishiguro, F; Murakami, H; Murakami-Tonami, Y; Yokoi, K; Sekido, Y				Hakiri, Shuhei; Osada, Hirotaka; Ishiguro, Futoshi; Murakami, Hideki; Murakami-Tonami, Yuko; Yokoi, Kohei; Sekido, Yoshitaka			Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells	CANCER SCIENCE			English	Article						BAP1; malignant mesothelioma; mutation; subcellular localization; tumor suppressor gene	STRAND BREAK REPAIR; PLEURAL MESOTHELIOMA; UBIQUITIN HYDROLASE; DEUBIQUITINASE BAP1; MUTATIONS; GENE; COMPLEX; NF2; REGULATOR; CANCER	Malignant mesothelioma (MM) shows inactivation of the BRCA1-associated protein 1 (BAP1) gene. In this study, we found BAP1 mutations in 5 (26%) of the 19 cell lines that we established from Japanese MM patients, and examined functional differences between the WT and mutant BAP1. First, we studied the subcellular localization of BAP1, demonstrating that the WT primarily resides in the nucleus and that the mutant BAP1 is found in the cytoplasm of the cells. Transduction of the WT BAP1 vector into MM cells with homozygous deletion at the BAP1 3 side resulted in both inhibition of cell proliferation and anchorage-independent cell growth, whereas BAP1 mutants of a missense or C-terminal truncated form showed impaired growth inhibitory effects. Next, we studied how BAP1 is involved in MM cell survival after irradiation (IR), which causes DNA damage. After IR, we found that both WT and mutant BAP1 were similarly phosphorylated and phospho-BAP1 localized mainly in the nucleus. Interestingly, BRCA1 proteins were decreased in the MM cells with BAP1 deletion, and transduction of the mutants as well as WT BAP1 increased BRCA1 proteins, suggesting that BAP1 may promote DNA repair partly through stabilizing BRCA1. Furthermore, using the MM cells with BAP1 deletion, we found that WT BAP1, and even a missense mutant, conferred a higher survival rate after IR compared to the control vector. Our results suggested that, whereas WT BAP1 suppresses MM cell proliferation and restores cell survival after IR damage, some mutant BAP1 may also moderately retain these functions.	[Hakiri, Shuhei; Osada, Hirotaka; Ishiguro, Futoshi; Murakami, Hideki; Murakami-Tonami, Yuko; Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 4648681, Japan; [Hakiri, Shuhei; Ishiguro, Futoshi; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4648601, Japan; [Osada, Hirotaka; Sekido, Yoshitaka] Dept Canc Genet, Program Funct Construct Med, Nagoya, Aichi, Japan; [Murakami, Hideki] Aichi Med Univ, Dept Pathol, Nagakute, Aichi 48011, Japan	Sekido, Y (reprint author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ysekido@aichi-cc.jp			Japan Society for the Promotion of Science (Kakenhi) [25290053]; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund [14-24617]; P-DIRECT	Japan Society for the Promotion of Science (Kakenhi) (25290053); Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund (14-24617); P-DIRECT	Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; SEKIDO Y, 1995, CANCER RES, V55, P1227; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Eletr ZM, 2013, FEBS LETT, V587, P3906, DOI 10.1016/j.febslet.2013.10.035; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ismail IH, 2014, CANCER RES, V74, P4282, DOI 10.1158/0008-5472.CAN-13-3109; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110; Ramos-Nino ME, 2006, J CELL BIOCHEM, V98, P723, DOI 10.1002/jcb.20828; Ladanyi M, 2012, CLIN CANCER RES, V18, P4485, DOI 10.1158/1078-0432.CCR-11-2375; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Carbone M, 2006, SEMIN DIAGN PATHOL, V23, P56, DOI 10.1053/j.semdp.2006.08.002; Pass Harvey I, 2004, Curr Probl Cancer, V28, P93, DOI 10.1016/j.currproblcancer.2004.04.001; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Tanaka I, 2015, ONCOGENE, V34, P73, DOI 10.1038/onc.2013.528; Xio S, 1995, Oncogene, V11, P511	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					990	999		10.1111/cas.12698		10	Oncology	Oncology	CP4QI	WOS:000359867000007		
J	Fukushima, K; Tsuchiya, K; Kano, Y; Horita, N; Hibiya, S; Hayashi, R; Kitagaki, K; Negi, M; Itoh, E; Akashi, T; Eishi, Y; Oshima, S; Nagaishi, T; Okamoto, R; Nakamura, T; Watanabe, M				Fukushima, Keita; Tsuchiya, Kiichiro; Kano, Yoshihito; Horita, Nobukatsu; Hibiya, Shuji; Hayashi, Ryohei; Kitagaki, Keisuke; Negi, Mariko; Itoh, Eisaku; Akashi, Takumi; Eishi, Yoshinobu; Oshima, Shigeru; Nagaishi, Takashi; Okamoto, Ryuichi; Nakamura, Tetsuya; Watanabe, Mamoru			Atonal homolog 1 protein stabilized by tumor necrosis factor induces high malignant potential in colon cancer cell line	CANCER SCIENCE			English	Article						Atonal homolog 1; cancer stem cells; colitis-associated cancer; inflammatory bowel disease; signet ring cell	INTESTINAL EPITHELIAL-CELLS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; STEM-CELLS; TNF-ALPHA; INFLAMMATION; EXPRESSION; PATHWAY; DISEASE; HATH1	Patients with inflammatory bowel disease (IBD) have an increased risk of developing colitis-associated colorectal cancer (CAC). CAC cells often develop chemoresistance, resulting in a poorer prognosis than that of sporadic colorectal cancer (CRC). The mechanism by which CAC enhances malignant potential remains unknown. We have previously reported that the proteasomal degradation of the transcription factor Atonal homolog 1 (Atoh1) protein results in the non-mucinous form of CRC. It also remains unknown whether Atoh1 protein is expressed in CAC. Therefore, in the present study, we investigated whether Atoh1 protein stabilizes in CAC. Consequently, the treatment with TNF- stabilized Atoh1 protein through the inactivation of GSK-3 via Akt, resulting in the mucinous form of CRC cell lines. Atoh1 protein also enriched cancer stem cells with upregulated Lgr5 expression and cells in G0/G1 cell cycle phase, resulting in both the chemoresistance to 5-fluorouracil and oxaliplatin and the promotion of cell migration. Immunofluorescence of the human mucinous CAC specimens showed the accumulation of NF-B p65 at nuclei with the expression of Atoh1 in mucinous cancer. In conclusion, the inflammation associated with carcinogenesis may preserve the differentiation system of intestinal epithelial cell (IEC), resulting in the acquisition of both the mucinous phenotype and high malignant potential associated with the enrichment of cancer stem cell.	[Fukushima, Keita; Kano, Yoshihito; Horita, Nobukatsu; Hibiya, Shuji; Hayashi, Ryohei; Oshima, Shigeru; Nagaishi, Takashi; Okamoto, Ryuichi; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol, Tokyo 1138519, Japan; [Fukushima, Keita; Kano, Yoshihito; Horita, Nobukatsu; Hibiya, Shuji; Hayashi, Ryohei; Oshima, Shigeru; Nagaishi, Takashi; Okamoto, Ryuichi; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Hepatol, Tokyo 1138519, Japan; [Tsuchiya, Kiichiro; Nakamura, Tetsuya] Tokyo Med & Dent Univ, Grad Sch, Adv Therapeut Gastrointestinal Dis, Tokyo 1138519, Japan; [Kano, Yoshihito] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hayashi, Ryohei] Hiroshima Univ, Dept Gastroenterol & Metab, Hiroshima, Japan; [Kitagaki, Keisuke; Negi, Mariko; Itoh, Eisaku; Akashi, Takumi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Pathol, Tokyo, Japan; [Okamoto, Ryuichi] Tokyo Med & Dent Univ, Grad Sch, Ctr Stem Cell & Regenerat Med, Tokyo, Japan	Tsuchiya, K (reprint author), Tokyo Med & Dent Univ, Dept Adv Therapeut Gastrointestinal Dis, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kii.gast@tmd.ac.jp	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	Japanese Ministry of Education, Culture, Sports, Science and Technology [23130506, 24590935, 25114703, 25130704, 26221307]; Japan Foundation for Applied Enzymology Health and Labor Sciences Research Grants Japanese Ministry of Health, Labor and Welfare (MHLW) [14526073]; Research Center Network for Realization of Regenerative Medicine from Japan Science and Technology Agency (JST)	Japanese Ministry of Education, Culture, Sports, Science and Technology (23130506). (24590935). (25114703). (25130704). (26221307). Japan Foundation for Applied Enzymology Health and Labor Sciences Research Grants Japanese Ministry of Health, Labor and Welfare (MHLW) (14526073). Research Center Network for Realization of Regenerative Medicine from Japan Science and Technology Agency (JST)	Samaan MA, 2014, GASTROENTEROL CLIN N, V43, P479, DOI 10.1016/j.gtc.2014.05.006; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Castano-Milla C, 2014, ALIMENT PHARM THER, V39, P645, DOI 10.1111/apt.12651; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Wehkamp J, 2007, J IMMUNOL, V179, P3109; Park ET, 2006, CLIN CANCER RES, V12, P5403, DOI 10.1158/1078-0432.CCR-06-0573; Hales EC, 2014, CELL SIGNAL, V26, P149, DOI 10.1016/j.cellsig.2013.09.021; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611; Watanabe T, 2011, INFLAMM BOWEL DIS, V17, P802, DOI [10.1002/ibd.21365, 10.1002/ibd21365]; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Aragaki M, 2008, BIOCHEM BIOPH RES CO, V368, P923, DOI 10.1016/j.bbrc.2008.02.011; Bamias G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072594; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Higashi D, 2011, ANTICANCER RES, V31, P2499; Horita N, 2014, BIOCHEM BIOPH RES CO, V454, P493, DOI 10.1016/j.bbrc.2014.10.091; Iwasaki M, 2011, J GASTROENTEROL, V46, P191, DOI 10.1007/s00535-010-0346-x; Kano Y, 2013, BIOCHEM BIOPH RES CO, V432, P175, DOI 10.1016/j.bbrc.2013.01.034; Kim MS, 2014, J BIOL CHEM, V289, P31349, DOI 10.1074/jbc.M114.587188; Molodecky NA, 2012, GASTROENTEROLOGY, V142, pe42; Oka Shiro, 2014, Gastrointest Endosc Clin N Am, V24, P405, DOI 10.1016/j.giec.2014.03.011; Panja A, 1998, J IMMUNOL, V161, P3675	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1000	1007		10.1111/cas.12703		8	Oncology	Oncology	CP4QI	WOS:000359867000008		
J	Takamatsu, M; Hirata, A; Ohtaki, H; Hoshi, M; Ando, T; Ito, H; Hatano, Y; Tomita, H; Kuno, T; Saito, K; Seishima, M; Hara, A				Takamatsu, Manabu; Hirata, Akihiro; Ohtaki, Hirofumi; Hoshi, Masato; Ando, Tatsuya; Ito, Hiroyasu; Hatano, Yuichiro; Tomita, Hiroyuki; Kuno, Toshiya; Saito, Kuniaki; Seishima, Mitsuru; Hara, Akira			Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice	CANCER SCIENCE			English	Article						cancer immunity; colorectal cancer; indoleamine 2; 3-dioxygenase; microenvironment; tumorigenesis	REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; ABERRANT CRYPT FOCI; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; TRYPTOPHAN CATABOLISM; COLITIS; MOUSE; IDO2; CARCINOGENESIS	Indoleamine 2,3-dioxygenase (IDO), an enzyme that degrades the essential amino acid l-tryptophan along the kynurenine pathway, exerts immunomodulatory effects in a number of diseases. IDO expression is increased in tumor tissue and in draining lymph nodes; this increase is thought to play a role in tumor evasion by suppressing the immune response. A competitive inhibitor of IDO is currently being tested in clinical trials for the treatment of relapsed or refractory solid tumors, but the efficacy of IDO inhibition in colorectal tumors remains to be fully elucidated. In this study, we investigated the effect of IDO deficiency on colon tumorigenesis in mice by genetic deletion and pharmacological inhibition. Ido1-deficient((-/-)) mice were crossed with Apc(Min/+) mice or were administered azoxymethane with or without dextran sodium sulfate. Ido1 deficiency did not lead to significant differences in the size and number of colon tumors. Similarly, the pharmacological inhibition of IDO using 1-methyltryptophan (1-mT) also resulted in no significant differences in tumor size and number in Apc(Min/+) mice. However, Ido1 deficiency altered the immune response in the tumor microenvironment, showing a significant increase in mRNA expression of pro-inflammatory cytokines and a significant decrease in the number of Foxp3-positive regulatory T cells in the colon tumors of Ido1((-/-)) mice. Importantly, 1-mT treatment also significantly altered cytokine expression in the colon tumor tissues. These results suggest that IDO inhibition alone cannot sufficiently suppress colon cancer development in mice despite its immunomodulatory activity in the tumor microenvironment.	[Takamatsu, Manabu; Hatano, Yuichiro; Tomita, Hiroyuki; Kuno, Toshiya; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu 5011194, Japan; [Ohtaki, Hirofumi; Ando, Tatsuya; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Hoshi, Masato] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Saito, Kuniaki] Fac Med, Kyoto, Japan	Hirata, A (reprint author), Gifu Univ, Div Anim Expt, Life Sci Res Ctr, Yanagido 1-1, Gifu 5011194, Japan.	akatsuki@gifu-u.ac.jp	Hatano, Yuichiro/K-7454-2013	Hatano, Yuichiro/0000-0002-5121-6325			Akeus P, 2014, CANCER IMMUNOL IMMUN, V63, P807, DOI 10.1007/s00262-014-1555-6; Ino K, 2006, BRIT J CANCER, V95, P1555, DOI 10.1038/sj.bjc.6603477; Zhou LP, 2012, EUR J GASTROEN HEPAT, V24, P695, DOI 10.1097/MEG.0b013e328351c1c2; Pantouris G, 2014, AMINO ACIDS, V46, P2155, DOI 10.1007/s00726-014-1766-3; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Papanikolaou A, 2000, CARCINOGENESIS, V21, P1567, DOI 10.1093/carcin/21.8.1567; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Chen W, 2008, J IMMUNOL, V181, P5396; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Zaher SS, 2011, INVEST OPHTH VIS SCI, V52, P2640, DOI 10.1167/iovs.10-5793; Takao M, 2007, ONCOL REP, V17, P1333; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Metz R, 2014, INT IMMUNOL, V26, P357, DOI 10.1093/intimm/dxt073; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Takamatsu M, 2013, J IMMUNOL, V191, P3057, DOI 10.4049/jimmunol.1203306; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Fallarino F, 2003, ADV EXP MED BIOL, V527, P183; Pastille E, 2014, CANCER RES, V74, P4258, DOI 10.1158/0008-5472.CAN-13-3065; Ferdinande L, 2012, BRIT J CANCER, V106, P141, DOI 10.1038/bjc.2011.513; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Austin CJD, 2010, AMINO ACIDS, V39, P565, DOI 10.1007/s00726-010-0475-9; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/S0016-5085(03)01513-0; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130; ARCHER MC, 1992, ENVIRON HEALTH PERSP, V98, P195, DOI 10.2307/3431269; Chang MY, 2011, CANCER BIOL THER, V12, P1050, DOI 10.4161/cbt.12.12.18142; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Gao YF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-71; Hata K, 2004, CANCER SCI, V95, P316, DOI 10.1111/j.1349-7006.2004.tb03209.x; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hoshi M, 2014, INFECT IMMUN, V82, P4487, DOI 10.1128/IAI.02113-14; Ishio T, 2004, J GASTROEN HEPATOL, V19, P319, DOI 10.1111/j.1440-1746.2003.03259.x; Lee YK, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.69; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Ramos RN, 2012, CARCINOGENESIS, V33, P902, DOI 10.1093/carcin/bgs103; Sakai H, 2010, CHEM-BIOL INTERACT, V184, P423, DOI 10.1016/j.cbi.2010.01.014; Thaker AI, 2013, GASTROENTEROLOGY, V145; Yu J., 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/469135	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1008	1015		10.1111/cas.12705		8	Oncology	Oncology	CP4QI	WOS:000359867000009		
J	Nakao, K; Tanaka, S; Miura, T; Sato, K; Matsumura, S; Aihara, A; Mitsunori, Y; Ban, D; Ochiai, T; Kudo, A; Arii, S; Tanabe, M				Nakao, Keisuke; Tanaka, Shinji; Miura, Tomoya; Sato, Kota; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Arii, Shigeki; Tanabe, Minoru			Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma	CANCER SCIENCE			English	Article						Angiogenesis; Aurora; dual kinase inhibitor; hepatocellular carcinoma; molecularly targeted medicine	AURORA; CANCER; HEPATECTOMY; METASTASIS; RECURRENCE; SORAFENIB; DESIGN; TRIAL; VEGF; HCC	We previously identified Aurora B kinase as the only independent factor predictive of the aggressive recurrence of hepatocellular carcinoma (HCC). In this preclinical study, JNJ-28841072, a novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor, was evaluated for treatment of HCC. In vitro and invivo effects of JNJ-28841072 were analyzed using human HCC cell cultures and xenograft models. An orthotopic liver xenograft model was used for the pharmacobiological effects on Aurora kinase and vascularization in hepatic tumors. JNJ-28841072 suppressed invitro phosphorylation of histone H3 with induction of cell polyploidy and death in a dose-dependent manner (IC50=0.8-1.2M). In s.c. human HCC xenografts, remarkable inhibition of tumor growth was observed after JNJ-28841072 treatment (P=0.0005). In orthotopic liver xenografts, the treatment with JNJ-28841072 significantly suppressed invivo phosphorylation of histone H3 (P=0.0008), vessel formation (P=0.018), normoxic area (P=0.0001), and hepatoma growth (P=0.038). Our preclinical studies indicate that JNJ-28841072 is a promising novel therapeutic approach for the treatment of HCC. It might be worthy of evaluation in further studies.	[Nakao, Keisuke; Tanaka, Shinji] Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med, Tokyo 1138519, Japan; [Nakao, Keisuke; Tanaka, Shinji; Miura, Tomoya; Sato, Kota; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Arii, Shigeki; Tanabe, Minoru] Tokyo Med & Dent Univ, Dept Hepato Biliary Pancreat Surg, Grad Sch Med, Tokyo 1138519, Japan	Tanaka, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tanaka.monc@tmd.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Japan Agency for Medical Research and Development (AMED)	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Japan Agency for Medical Research and Development (AMED)	Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Lee ECY, 2006, CANCER RES, V66, P4996, DOI 10.1158/0008-5472.CAN-05-2796; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Diamond JR, 2013, CLIN CANCER RES, V19, P291, DOI 10.1158/1078-0432.CCR-12-1611; Aihara A, 2010, J HEPATOL, V52, P63, DOI 10.1016/j.jhep.2009.10.013; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Worns MA, 2014, NAT REV GASTRO HEPAT, V11, P447, DOI 10.1038/nrgastro.2014.10; Tanaka S, 2008, BRIT J SURG, V95, P611, DOI 10.1002/bjs.6011; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Hughes TV, 2008, BIOORG MED CHEM LETT, V18, P5130, DOI 10.1016/j.bmcl.2008.07.090; Cui SY, 2013, CELL CYCLE, V12, P2849, DOI 10.4161/cc.25916; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Curtin ML, 2012, BIOORG MED CHEM LETT, V22, P3208, DOI 10.1016/j.bmcl.2012.03.035; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Li DH, 2003, CLIN CANCER RES, V9, P991; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Lu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040262; Marquardt JU, 2014, CANCER CELL, V25, P550, DOI 10.1016/j.ccr.2014.04.002; Tanaka S, 2007, J AM COLL SURGEONS, V204, P1, DOI 10.1016/j.jamcollsurg.2006.10.004; Tanaka Shinji, 2006, Int J Clin Oncol, V11, P82, DOI 10.1007/s10147-006-0566-5	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1016	1022		10.1111/cas.12701		7	Oncology	Oncology	CP4QI	WOS:000359867000010		
J	Tamura, M; Sasaki, Y; Kobashi, K; Takeda, K; Nakagaki, T; Idogawa, M; Tokino, T				Tamura, Miyuki; Sasaki, Yasushi; Kobashi, Kenta; Takeda, Kousuke; Nakagaki, Takafumi; Idogawa, Masashi; Tokino, Takashi			CRKL oncogene is downregulated by p53 through miR-200s	CANCER SCIENCE			English	Article						Cell growth; CRKL; miR-200 family; p53; p53 family	EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; BREAST-CANCER; P53-INDUCIBLE MICRORNAS; FUNCTIONAL-ANALYSIS; ADAPTER PROTEINS; GASTRIC-CANCER; LUNG-CANCER; FAMILY	Tumor suppressive miRNAs that target oncogenes are frequently downregulated in cancers, and this downregulation leads to oncogene pathway activation. Thus, tumor suppressive miRNAs and their target oncogenes have been proposed as useful targets in cancer treatment. miR-200 family downregulation has been reported in cancer progression and metastasis. The miR-200 family consists of two gene clusters, miR-200b/200a/429 and miR-200c/141, which are located on human chromosomes 1 and 12, respectively. Here, we identified that p53 response elements are located around both clusters of the miR-200 family and confirmed that miR-200s are transcriptional targets of the p53 family. Insilico analyses of miRNA targets established the CRKL oncogene as a potential target for miR-200b/200c/429. Moreover, miR-200b/200c/429 inhibited CRKL mRNA and protein expression by directly targeting its 3-UTR region. Importantly, endogenous CRKL expression was decreased in cancer cells through the introduction of p53 family and endogenous p53 activation. Moreover, the downregulation of CRKL by siRNA inhibited cancer cell growth. The Oncomine database demonstrates that CRKL is overexpressed in a subset of cancer types. Furthermore, CRKL is significantly overexpressed in primary breast cancer tissues harboring mutant TP53. Our results demonstrate that the p53 target miR-200b/200c/429 miRNAs are negative regulators of the CRKL oncogene.	[Tamura, Miyuki; Sasaki, Yasushi; Kobashi, Kenta; Takeda, Kousuke; Nakagaki, Takafumi; Idogawa, Masashi; Tokino, Takashi] Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Sapporo, Hokkaido 0608556, Japan	Sasaki, Y (reprint author), Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tokino@sapmed.ac.jp			MEXT KAKENHI [221S0001]; JSPS KAKENHI [25430115]	This research was supported in part by MEXT KAKENHI Grant Number 221S0001 and JSPS KAKENHI Grant Number 25430115.	Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Idogawa M, 2014, HUM MOL GENET, V23, P2847, DOI 10.1093/hmg/ddt673; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhao TT, 2013, TUMOR BIOL, V34, P2891, DOI 10.1007/s13277-013-0851-7; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Han B, 2013, TUMOR BIOL, V35, P4101; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kardinal C, 2000, FASEB J, V14, P1529, DOI 10.1096/fj.14.11.1529; Lin F, 2014, MOL CARCINOG S, VS1, pE35; Liu CH, 2013, MOL CELL PROTEOMICS, V12, P1335, DOI 10.1074/mcp.O112.020404; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Natsume H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-97; Prosser S, 2003, ONCOGENE, V22, P4799, DOI 10.1038/sj.onc.1206714; Sasaki Y, 2011, CANCER RES, V71, P7038, DOI 10.1158/0008-5472.CAN-11-1053; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Tamura M, 2014, ONCOGENE, V33, P4837, DOI 10.1038/onc.2013.427; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1033	1040		10.1111/cas.12713		8	Oncology	Oncology	CP4QI	WOS:000359867000012		
J	Fukuda, T; Wu, WW; Okada, M; Maeda, I; Kojima, Y; Hayami, R; Miyoshi, Y; Tsugawa, K; Ohta, T				Fukuda, Takayo; Wu, Wenwen; Okada, Maiko; Maeda, Ichiro; Kojima, Yasuyuki; Hayami, Ryosuke; Miyoshi, Yasuo; Tsugawa, Ko-ichiro; Ohta, Tomohiko			Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage	CANCER SCIENCE			English	Article						BRCA1; DNA damage response; histone deacetylase inhibitor; histone modifications; 53BP1	DOUBLE-STRAND BREAKS; UBIQUITIN-LIGASE; HOMOLOGOUS RECOMBINATION; CHROMATIN; REPAIR; BRCA1-BARD1; HDAC	BRCA1 and 53BP1 antagonistically regulate homology-directed repair (HDR) and non-homologous end-joining (NHEJ) of DNA double-strand breaks (DSB). The histone deacetylase (HDAC) inhibitor trichostatin A directly inhibits the retention of 53BP1 at DSB sites by acetylating histone H4 (H4ac), which interferes with 53BP1 binding to dimethylated histone H4 Lys20 (H4K20me2). Conversely, we recently found that the retention of the BRCA1/BARD1 complex is also affected by another methylated histone residue, H3K9me2, which can be suppressed by the histone lysine methyltransferase (HKMT) inhibitor UNC0638. Here, we investigate the effects of the class I HDAC inhibitors MS-275 and FK228 compared to UNC0638 on histone modifications and the DNA damage response. In addition to H4ac, the HDAC inhibitors induce H3K9ac and inhibit H3K9me2 at doses that do not affect the expression levels of DNA repair genes. By contrast, UNC0638 selectively inhibits H3K9me2 without affecting the levels of H3K9ac, H3K56ac or H4ac. Reflecting their effects on histone modifications, the HDAC inhibitors inhibit ionizing radiation-induced foci (IRIF) formation of BRCA1 and BARD1 as well as 53BP1 and RIF1, whereas UNC0638 suppresses IRIF formation of BRCA1 and BARD1 but not 53BP1 and RIF1. Although HDAC inhibitors suppressed HDR, they did not cooperate with the poly(ADP-ribose) polymerase inhibitor olaparib to block cancer cell growth, possibly due to simultaneous suppression of NHEJ pathway components. Collectively, these results suggest the mechanism by that HDAC inhibitors inhibit both the HDR and NHEJ pathways, whereas HKMT inhibitor inhibits only the HDR pathway; this finding may affect the chemosensitizing effects of the inhibitors.	[Fukuda, Takayo; Wu, Wenwen; Okada, Maiko; Ohta, Tomohiko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Maeda, Ichiro] St Marianna Univ, Grad Sch Med, Dept Pathol, Kawasaki, Kanagawa 2168511, Japan; [Kojima, Yasuyuki; Hayami, Ryosuke; Tsugawa, Ko-ichiro] St Marianna Univ, Grad Sch Med, Dept Surg, Div Breast & Endocrine Surg, Kawasaki, Kanagawa 2168511, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, Kobe, Hyogo, Japan	Ohta, T (reprint author), St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan.	to@marianna-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Private School Promotion Foundation	The Japan Society for the Promotion of Science, the Ministry of Education, Science, Sports, Culture and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan, and the Japan Private School Promotion Foundation.	Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Furumai R, 2002, CANCER RES, V62, P4916; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Zhang JX, 2012, HEPATOLOGY, V55, P1840, DOI 10.1002/hep.25566; Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Wu WW, 2015, CANCER RES, V75, P1311, DOI 10.1158/0008-5472.CAN-14-2796; Chao OS, 2014, MOL CANCER RES, V12, P1755, DOI 10.1158/1541-7786.MCR-14-0173; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Spiegel S, 2011, ONCOGENE, V31, P537; Tuzon CT, 2014, CELL REP, V8, P429, DOI 10.1016/j.celrep.2014.06.013	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1050	1056		10.1111/cas.12717		7	Oncology	Oncology	CP4QI	WOS:000359867000014		
J	Wakai, K; Sugawara, Y; Tsuji, I; Tamakoshi, A; Shimazu, T; Matsuo, K; Nagata, C; Mizoue, T; Tanaka, K; Inoue, M; Tsugane, S; Sasazuki, S				Wakai, Kenji; Sugawara, Yumi; Tsuji, Ichiro; Tamakoshi, Akiko; Shimazu, Taichi; Matsuo, Keitaro; Nagata, Chisato; Mizoue, Tetsuya; Tanaka, Keitaro; Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka		Res Grp Dev & Evaluation Canc Prev	Risk of lung cancer and consumption of vegetables and fruit in Japanese: A pooled analysis of cohort studies in Japan	CANCER SCIENCE			English	Article						Cohort studies; fruit; lung neoplasms; meta-analysis; vegetables	FOOD-FREQUENCY QUESTIONNAIRE; POPULATION-BASED COHORT; LARGE-SCALE COHORT; BODY-MASS INDEX; COLORECTAL-CANCER; ALCOHOL-DRINKING; GASTRIC-CANCER; MAJOR CAUSES; MUTATIONS; MORTALITY	International reviews have concluded that consumption of fruit and vegetables might decrease the risk of lung cancer. However, the relevant epidemiological evidence still remains insufficient in Japan. Therefore, we performed a pooled analysis of data from four population-based cohort studies in Japan with >200000 participants and >1700 lung cancer cases. We computed study-specific hazard ratios by quintiles of vegetable and fruit consumption as assessed by food frequency questionnaires. Summary hazard ratios were estimated by pooling the study-specific hazard ratios with a fixed-effect model. In men, we found inverse associations between fruit consumption and the age-adjusted and area-adjusted risk of mortality or incidence of lung cancer. However, the associations were largely attenuated after adjustment for smoking and energy intake. The significant decrease in risk among men remained only for a moderate level of fruit consumption; the lowest summary hazard ratios were found in the third quintile of intake (mortality: 0.71, 95% confidence interval 0.60-0.84; incidence: 0.83, 95% confidence interval 0.70-0.98). This decrease in risk was mainly detected in ever smokers. Conversely, vegetable intake was positively correlated with the risk of incidence of lung cancer after adjustment for smoking and energy intake in men (trend P, 0.024); the summary hazard ratio for the highest quintile was 1.26 (95% confidence interval 1.05-1.50). However, a similar association was not detected for mortality from lung cancer. In conclusion, a moderate level of fruit consumption is associated with a decreased risk of lung cancer in men among the Japanese population.	[Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4668550, Japan; [Sugawara, Yumi; Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Shimazu, Taichi; Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Nagata, Chisato] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Tanaka, Keitaro] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Wakai, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Prevent Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	wakai@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund Grant-in-Aid for the Third-Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan	Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Inoue M, 2009, GUT, V58, P1323, DOI 10.1136/gut.2008.166710; Inoue M, 2012, J EPIDEMIOL COMMUN H, V66, P448, DOI 10.1136/jech.2010.121830; Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Min KB, 2014, CANCER SCI, V105, P736, DOI 10.1111/cas.12405; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Liu Y, 2004, CANCER CAUSE CONTROL, V15, P349, DOI 10.1023/B:CACO.0000027507.22124.20; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Miyamoto A, 2007, PREV MED, V44, P12, DOI 10.1016/j.ypmed.2006.07.016; International Agency for Research on Cancer World Health Organization, 2003, IARC HDB CANC PREV, V8; Matsuo K, 2012, ANN ONCOL, V23, P479, DOI 10.1093/annonc/mdr143; Matsuo K, 2008, CANCER SCI, V99, P1202, DOI 10.1111/j.1349-7006.2008.00812.x; Mizoue T, 2008, AM J EPIDEMIOL, V167, P1397, DOI 10.1093/aje/kwn073; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Shimazu T, 2012, INT J CANCER, V130, P2645, DOI 10.1002/ijc.26255; Shimazu T, 2014, ANN ONCOL, V25, P1228, DOI 10.1093/annonc/mdu115; Tamakoshi A, 2005, J EPIDEMIOL, V15, pS4, DOI 10.2188/jea.15.S4; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsuji I, 2004, J EPIDEMIOL, V14, pS2, DOI 10.2188/jea.14.S2; Wakai K, 2011, JPN J CLIN ONCOL, V41, P693, DOI 10.1093/jjco/hyr027; Willett W, 1998, NUTR EPIDEMIOLOGY, P273; Willett W., 1998, NUTR EPIDEMIOLOGY, V2nd, P302; World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P75; World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P179	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1057	1065		10.1111/cas.12707		9	Oncology	Oncology	CP4QI	WOS:000359867000015		
J	Kakugawa, Y; Kawai, M; Nishino, Y; Fukamachi, K; Ishida, T; Ohuchi, N; Minami, Y				Kakugawa, Yoichiro; Kawai, Masaaki; Nishino, Yoshikazu; Fukamachi, Kayoko; Ishida, Takanori; Ohuchi, Noriaki; Minami, Yuko			Smoking and survival after breast cancer diagnosis in Japanese women: A prospective cohort study	CANCER SCIENCE			English	Article						Breast cancer; hormone receptor; menopausal status; smoking; survival	LIFE-STYLE FACTORS; CIGARETTE-SMOKING; PASSIVE SMOKING; RISK-FACTORS; ESTROGEN-RECEPTOR; PHYSICAL-ACTIVITY; MENOPAUSAL STATUS; HORMONE-RECEPTOR; PROGNOSIS; MORTALITY	The results of previous studies investigating whether there is an association between active smoking and risk of death among breast cancer patients have been inconsistent. We investigated the association between active and passive smoking and risk of all-cause and breast cancer-specific death among female breast cancer patients in relation to menopausal and tumor estrogen/progesterone receptor (ER/PR) status. The present study included 848 patients admitted to a single hospital in Japan from 1997 to 2007. Active or passive smoking status was assessed using a self-administered questionnaire. The patients were followed until 31 December 2010. We used a Cox proportional-hazard model to estimate hazard ratios (HR). During a median follow-up period of 6.7years, 170 all-cause and 132 breast cancer-specific deaths were observed. Among premenopausal patients, current smokers showed a non-significant higher risk of all-cause and breast cancer-specific death. A duration of smoking >21.5years was positively associated with all-cause (HR=3.09, 95% confidence interval [CI], 1.17-8.20) and breast cancer-specific death (HR=3.35, 95% CI: 1.22-9.23, P-trend= 0.035) among premenopausal patients. In premenopausal patients with ER+ or PR+ tumors, there was some suggestion that a longer duration of smoking was associated with higher risk of all-cause and breast cancer-specific death. Passive smoking demonstrated no significant risk. Our results suggest that a longer duration of active smoking is associated with an increased risk of all-cause and breast cancer-specific death among premenopausal patients, possibly with hormonal receptor-positive tumors. Breast cancer patients should be informed about the importance of smoking cessation.	[Kakugawa, Yoichiro; Kawai, Masaaki] Miyagi Canc Ctr Hosp, Dept Breast Oncol, Natori, Miyagi, Japan; [Kawai, Masaaki; Minami, Yuko] Tohoku Univ, Grad Sch Med, Div Community Hlth, Sendai, Miyagi 9808575, Japan; [Nishino, Yoshikazu; Minami, Yuko] Miyagi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Natori, Miyagi, Japan; [Fukamachi, Kayoko] Tohoku Kosai Hosp, Dept Surg, Natori, Miyagi, Japan; [Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 9808575, Japan	Kawai, M (reprint author), Tohoku Univ, Grad Sch Med, Div Community Hlth, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kawai@med.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [23390169]	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS) for Scientific Research (B) (23390169).	Holmes MD, 2007, INT J CANCER, V120, P2672, DOI 10.1002/ijc.22575; Sagiv SK, 2007, ANN EPIDEMIOL, V17, P385, DOI 10.1016/j.annepidem.2006.11.004; Kawai M, 2012, CANCER SCI, V103, P1861, DOI 10.1111/j.1349-7006.2012.02379.x; Hellmann SS, 2010, EUR J CANCER PREV, V19, P366, DOI 10.1097/CEJ.0b013e32833b4828; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Yamashita H, 2011, ANN ONCOL, V22, P1318, DOI 10.1093/annonc/mdq596; McTiernan A, 2010, J CLIN ONCOL, V28, P4074, DOI 10.1200/JCO.2010.27.9752; Manjer J, 2000, EUR J SURG, V166, P852, DOI 10.1080/110241500447227; Cramer DW, 2011, CURR OPIN IMMUNOL, V23, P265, DOI 10.1016/j.coi.2011.01.002; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Braithwaite D, 2012, BREAST CANCER RES TR, V136, P521, DOI 10.1007/s10549-012-2276-1; Warren GW, 2013, INT J CANCER, V132, P401, DOI 10.1002/ijc.27617; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; COX DR, 1972, J R STAT SOC B, V34, P187; Padron-Monedero A, 2015, BREAST CANCER RES TR, V150, P395, DOI 10.1007/s10549-015-3317-3; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.503; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; WELLS AJ, 1991, AM J EPIDEMIOL, V133, P208; Kawai M, 2013, CANCER CAUSE CONTROL, V24, P1033, DOI 10.1007/s10552-013-0181-5; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Tominaga K, 1998, JPN J CLIN ONCOL, V28, P36, DOI 10.1093/jjco/28.1.36; CALLE EE, 1994, AM J EPIDEMIOL, V139, P1001; Band PR, 2002, LANCET, V360, P1044, DOI 10.1016/S0140-6736(02)11140-8; EWERTZ M, 1991, INT J CANCER, V49, P526, DOI 10.1002/ijc.2910490409; Forey B, 2002, INT SMOKING STAT COL; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hozawa A, 2004, J EPIDEMIOL, V14, pS12, DOI 10.2188/jea.14.S12; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Kakugawa Yoichiro, 2007, Breast Cancer, V14, P269, DOI 10.2325/jbcs.14.269; Kawai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-149; Kushi LH, 2007, J NUTR, V137, p236S; Luo JH, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1016; Meek MD, 1999, ENVIRON RES, V80, P9, DOI 10.1006/enrs.1998.3872; Minami Y, 2008, JPN J CLIN ONCOL, V38, P205, DOI 10.1093/jjco/hym170; Minami Y, 2003, CANCER SCI, V94, P540, DOI 10.1111/j.1349-7006.2003.tb01480.x; Minami Y, 2012, CANCER CAUSE CONTROL, V23, P389, DOI 10.1007/s10552-011-9888-3; Ministry of Health Labour and Welfare, 2008, REP TOB HLTH AD PREV; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Nishino Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-65; Pierce JP, 2014, JNCI-J NATL CANCER I, V106, P359, DOI DOI 10.1093/JNCI/DJT359; Zhu BQ, 2003, CANCER CELL, V4, P191, DOI 10.1016/S1535-6108(03)00219-8	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1066	1074		10.1111/cas.12716		9	Oncology	Oncology	CP4QI	WOS:000359867000016		
J	Kurabayashi, A; Inoue, K; Fukuhara, H; Karashima, T; Fukata, S; Kawada, C; Shuin, T; Furihata, M				Kurabayashi, Atsushi; Inoue, Keiji; Fukuhara, Hideo; Karashima, Takashi; Fukata, Satoshi; Kawada, Chiaki; Shuin, Taro; Furihata, Mutsuo			Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma	CANCER SCIENCE			English	Article						Angiogenesis; bisphosphonate; interferon-alpha; osteoclasts; renal cell carcinoma	ANGIOGENESIS-RELATED GENES; INDUCE APOPTOSIS; IN-VITRO; SURVIVAL; CANCER; THERAPY; METASTASES; EXPRESSION; PROTEINS; LINES	The aim of this study was to investigate whether the third-generation nitrogen-containing bisphosphonate (YM529) can inhibit the progression of established bone renal cell carcinoma (RCC) and to elucidate its mechanism. Antiproliferative effect and apoptosis induction of RCC cells and mouse osteoclasts by YM529 and/or interferon-alpha (IFN-) were evaluated invitro using cell counting and invivo using soft X-ray, the TUNEL method and tartrate-resistant acid phosphatase stain. For the invivo study, male athymic BALB/cA Jc1-nu nude mice bearing human RCC cell line RBM1-IT4 cells were treated with YM529 and/or IFN-. The biological activity of osteoclasts was evaluated using the pit formation assay. The antiangiogenetic effect by YM529 and/or IFN- was analyzed using micro-vessel density and insitu mRNA hybridization. Osteoclast number in bone tumors was decreased in YM529-treated mouse. YM529 also inhibited osteoclast activity and proliferation invitro, whereas basic fibroblast growth factor expressions and micro-vessel density within tumors were inhibited by IFN-. Neither YM529 nor IFN- alone significantly inhibited the growth of established bone metastatic tumors. Combined treatment with YM529 and IFN- may be beneficial in patients with human RCC bone metastasis. Their effects are mediated by osteoclast recruitment inhibition and inactivation by YM529 and antiangiogenesis by IFN-.	[Kurabayashi, Atsushi; Furihata, Mutsuo] Kochi Med Sch, Dept Pathol, Nankoku, Kochi 7838505, Japan; [Inoue, Keiji; Fukuhara, Hideo; Karashima, Takashi; Fukata, Satoshi; Kawada, Chiaki; Shuin, Taro] Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan	Inoue, K (reprint author), Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan.	keiji@kochi-u.ac.jp					Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Fukata S, 2005, CANCER, V103, P931, DOI 10.1002/cncr.20887; Shinohara N, 2013, UROL ONCOL-SEMIN ORI, V31, P1276, DOI 10.1016/j.urolonc.2011.08.009; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Woodward E, 2011, BONE, V48, P160, DOI 10.1016/j.bone.2010.09.008; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Kurabayashi A, 2001, MODERN PATHOL, V14, P741, DOI 10.1038/modpathol.3880383; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530; Slaton JW, 1999, CLIN CANCER RES, V5, P2726; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2004, J CLIN ONCOL, V22, P454; Sakai I, 2014, INT J CLIN ONCOL, V19, P674, DOI 10.1007/s10147-013-0612-z; Callander NS, 2001, SEMIN HEMATOL, V38, P276, DOI 10.1053/shem.2001.26007; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Inoue K, 2005, CLIN CANCER RES, V11, P6669, DOI 10.1158/1078-0432.CCR-05-1010; AOKI J, 1988, CANCER, V62, P98, DOI 10.1002/1097-0142(19880701)62:1<98::AID-CNCR2820620118>3.0.CO;2-8; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; Benford HL, 1999, MOL PHARMACOL, V56, P131; Caraglia M, 2004, AMINO ACIDS, V26, P409, DOI 10.1007/s00726-004-0085-5; Motzer RJ, 2000, J CLIN ONCOL, V18, P1928; Mundy GR, 2001, SEMIN ONCOL, V28, P35, DOI 10.1053/sonc.2001.24158; Sasaki A, 1998, INT J CANCER, V77, P279, DOI 10.1002/(SICI)1097-0215(19980717)77:2<279::AID-IJC18>3.0.CO;2-6; Schilbach K, 2001, BLOOD, V97, P2917, DOI 10.1182/blood.V97.9.2917; Senaratne SG, 2000, BRIT J CANCER, V82, P1459; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Usumi T, 1994, J CHROMATOGR, V652, P67; Wada Y, 2012, INT J UROL, V19, P284, DOI 10.1111/j.1442-2042.2012.02962.x; Yuasa T, 2005, CLIN CANCER RES, V11, P853	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1092	1099		10.1111/cas.12711		8	Oncology	Oncology	CP4QI	WOS:000359867000019		
J	Sasaki, Y; Hamada, K; Kaneta, T; Takahashi, T; Kubota, Y; Ishida, H; Ichikawa, W				Sasaki, Yasutsuna; Hamada, Kazuyuki; Kaneta, Toshikado; Takahashi, Takehiro; Kubota, Yutaro; Ishida, Hiroo; Ichikawa, Wataru			Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?	CANCER SCIENCE			English	Letter							COLORECTAL-CANCER; GEMCITABINE; OXALIPLATIN; LEUCOVORIN; IRINOTECAN; SURVIVAL; TRIAL		[Sasaki, Yasutsuna; Hamada, Kazuyuki; Kaneta, Toshikado; Takahashi, Takehiro; Kubota, Yutaro; Ishida, Hiroo; Ichikawa, Wataru] Showa Univ, Sch Med, Dept Med, Div Med Oncol, Tokyo 142, Japan; [Sasaki, Yasutsuna] Showa Univ, Inst Mol Oncol, Tokyo, Japan	Sasaki, Y (reprint author), Showa Univ, Sch Med, Dept Med, Div Med Oncol, Tokyo 142, Japan.	yasutsuna@med.showa-u.ac.jp					Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Falcone A, 2007, J CLIN ONCOL, V25, P1670, DOI 10.1200/JCO.2006.09.0928; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Director of Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau Ministry of Health Labour and Welfare, 2007, BAS PRINC GLOB CLIN; Huinink WTB, 1997, J CLIN ONCOL, V15, P2183; Okusaka T, 2014, CANCER SCI, V105, P1321, DOI 10.1111/cas.12501; Sunakawa Y, 2012, ONCOLOGY-BASEL, V82, P242, DOI 10.1159/000337225; Wakao F, 2013, CANC STAT JAPAN	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1100	1100		10.1111/cas.12708		1	Oncology	Oncology	CP4QI	WOS:000359867000020		
J	Okusaka, T; Ikeda, M; Fukutomi, A; Ioka, T; Furuse, J; Ohkawa, S; Isayama, H; Boku, N				Okusaka, Takuji; Ikeda, Masafumi; Fukutomi, Akira; Ioka, Tatsuya; Furuse, Junji; Ohkawa, Shinichi; Isayama, Hiroyuki; Boku, Narikazu			Response to Y. Sasaki etal.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?	CANCER SCIENCE			English	Letter							OXALIPLATIN		[Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Chiba, Japan; [Fukutomi, Akira] Shizuoka Canc Ctr, Dept Gastrointestinal Oncol, Shizuoka, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Furuse, Junji] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; [Ohkawa, Shinichi] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan; [Isayama, Hiroyuki] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Boku, Narikazu] St Marianna Univ, Sch Med, Dept Clin Oncol, Kanagawa, Japan	Okusaka, T (reprint author), Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, 1-1 Tsukiji 5 Chome, Tokyo, Japan.	tokusaka@ncc.go.jp					Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Ychou M, 2003, ANN ONCOL, V14, P481, DOI 10.1093/annonc/mdg119; Mahaseth H, 2013, PANCREAS, V42, P1311, DOI 10.1097/MPA.0b013e31829e2006; Conroy T, 2005, J CLIN ONCOL, V23, P1228, DOI 10.1200/JCO.2005.06.050; Maroun J, 2014092630 ESMO; Oikonomopoulos Georgios M, 2014, JOP, V15, P103, DOI 10.6092/1590-8577/2278; Okusaka T, 2014, CANCER SCI, V105, P1321, DOI 10.1111/cas.12501; Uesugi K, 2015011517 ASCEGI; Vaccaro V, 2014, ANN ONCOL, V25, piv234	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	AUG	2015	106	8					1101	1102		10.1111/cas.12709		2	Oncology	Oncology	CP4QI	WOS:000359867000021		
J	Shirasuna, K; Shimamura, N; Seno, K; Ohtsu, A; Shiratsuki, S; Ohkuchi, A; Suzuki, H; Matsubara, S; Nagayama, S; Iwata, H; Kuwayama, T				Shirasuna, Koumei; Shimamura, Narumi; Seno, Kotomi; Ohtsu, Ayaka; Shiratsuki, Shogo; Ohkuchi, Akihide; Suzuki, Hirotada; Matsubara, Shigeki; Nagayama, Shiho; Iwata, Hisataka; Kuwayama, Takehito			Moderate Hypoxia Down-Regulates Interleukin-6 Secretion and TLR4 Expression in Human Sw.71 Placental Cells	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Hypoxia; Placenta; Interleukin-6; Inflammation	ENDOTHELIAL GROWTH-FACTOR; TISSUE OXYGEN-TENSION; IMMUNE-SYSTEM; 1ST TRIMESTER; PREECLAMPSIA; TROPHOBLAST; ACTIVATION; INDUCTION; PREGNANCY; SFLT-1	Background/Aims: The placenta is a vital organ for pregnancy. Many in vitro placental experiments are conducted under 21% O-2; however, O-2 tension could influence cellular functions, including cytokine secretion. We investigated the effects of oxygen tension between moderate hypoxia (5% O-2) and normoxia (21% O-2) by testing the hypothesis that moderate hypoxia regulates cellular phenotypes differently from normoxia in human trophoblast cells. Methods and Results: Sw.71 trophoblast cells were incubated under normoxic or moderately hypoxic conditions. Cells were also treated with lipopolysaccharide (LPS) as a Toll-like receptor 4 (TLR4) ligand inducing inflammation. Interleukin-6 (IL-6) as an inflammatory cytokine was determined, and TLR4, hypoxia-induced factor-1 alpha (HIF1 alpha), and reactive oxygen species (ROS) production were detected. Moderate hypoxia increased HIF1 alpha expression and cell proliferation and acted by two different mechanisms to decrease IL-6 secretion compared with normoxia: it limits the TLR4 expression and ROS production. Treatment with cobalt chloride as an HIF1 activator inhibited IL-6 secretion and TLR4 expression; this effect was reversed on treatment with PX-12 as an HIF1 suppressor. Conclusion: IL-6 secretion, TLR4 expression, and ROS production, classical markers of inflammation, are down-regulated by moderate hypoxia, and HIF1 alpha and ROS have a potential to regulate these responses in human trophoblast cells. Copyright (C) 2015 S. Karger AG, Basel	[Shirasuna, Koumei; Shimamura, Narumi; Seno, Kotomi; Ohtsu, Ayaka; Shiratsuki, Shogo; Iwata, Hisataka; Kuwayama, Takehito] Tokyo Univ Agr, Dept Agr, Lab Anim Reprod, Atsugi, Kanagawa 2340034, Japan; [Ohkuchi, Akihide; Suzuki, Hirotada; Matsubara, Shigeki; Nagayama, Shiho] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Shirasuna, K (reprint author), Tokyo Univ Agr, Dept Agr, Lab Anim Reprod, 1737 Funako, Atsugi, Kanagawa 2340034, Japan.	ks205312@nodai.ac.jp			Japan Society for the Promotion of Science (JSPS); Tokyo University of Agriculture	This study received grants from the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Young Scientists (B) (K.S.) and Scientific Research (C) (H.S., and H.I.), and Strategic Research Project from Tokyo University of Agriculture (K.S.).	BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; James JL, 2006, HUM REPROD UPDATE, V12, P137, DOI 10.1093/humupd/dmi043; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Lee DK, 2015, PLACENTA, V36, P125, DOI 10.1016/j.placenta.2014.11.013; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Kilburn BA, 2000, BIOL REPROD, V62, P739, DOI 10.1095/biolreprod62.3.739; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Jiang B, 2000, MOL ENDOCRINOL, V14, P1661, DOI 10.1210/me.14.10.1661; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Graham CH, 1998, BLOOD, V91, P3300; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Braun L, 2001, LIFE SCI, V69, P2533, DOI 10.1016/S0024-3205(01)01327-3; Eiland E, 2012, J PREGNANCY, V2012, DOI DOI 10.1155/2012/586578; Fafet P, 2008, ENDOCRINOLOGY, V149, P4475, DOI 10.1210/en.2008-0253; Grodzki ACG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054926; Ikejiri A, 2011, INT IMMUNOL, V24, P137; Ishida I, 2002, J IMMUNOL, V169, P2069; Kim SY, 2009, IMMUNOLOGY, V129, P516; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Liu J, 2006, J NEUROSCI, V26, P4329, DOI 10.1523/JNEUROSCI.0382-06.2006; Liu L, 2014, CELL PHYSIOL BIOCHEM, V34, P1877, DOI 10.1159/000366386; Mellembakken JR, 2001, HYPERTENSION, V38, P394; Miao ZJ, 2014, CELL PHYSIOL BIOCHEM, V34, P1701, DOI 10.1159/000366371; Miyamoto L, 2014, BIOCHIM BIOPHYS ACTA, V1850, P640; Ohkuchi A, 2010, HYPERTENS RES, V33, P422, DOI 10.1038/hr.2010.15; Orshal JM, 2004, HYPERTENSION, V43, P434, DOI 10.1161/01.HYP.0000113044.46326.98; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Shen ZJ, 2014, CELL PHYSIOL BIOCHEM, V34, P2189, DOI 10.1159/000369662; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Urner M, 2012, CLIN EXP IMMUNOL, V169, P119, DOI 10.1111/j.1365-2249.2012.04595.x	45	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.	AUG	2015	36	6					2149	2160		10.1159/000430181		12	Cell Biology; Physiology	Cell Biology; Physiology	CP6HX	WOS:000359988100006		
J	Zhang, SG; Kwon, HM; Li, Z; Ikoma, A; Dokko, K; Watanabe, M				Zhang, Shiguo; Kwon, Hoi-Min; Li, Zhe; Ikoma, Ai; Dokko, Kaoru; Watanabe, Masayoshi			Nitrogen-Doped Inverse Opal Carbons Derived from an Ionic Liquid Precursor for the Oxygen Reduction Reaction	CHEMELECTROCHEM			English	Article						inverse opal carbons; ionic liquids; nitrogen-doping; oxygen reduction reaction; precursor	METAL-FREE ELECTROCATALYSTS; MESOPOROUS CARBONS; ELECTRODE MATERIALS; POROUS CARBON; NANOPARTICLES; PERFORMANCE; SYSTEMS; SALTS	Three-dimensionally macroporous nitrogen-doped carbon materials are fabricated via carbonization of an ionic-liquid-based small molecule precursor, 1-ethyl-3-methylimidazolium dicyanamide, using opal silica colloidal crystals as a hard template. As compared to traditional polymerizable monomer-based precursors such as furfuryl alcohol, the entire process involving ionic liquid does not require any acid catalyst and prepolymerization step. More importantly, nitrogen heteroatoms can be incorporated into the carbon skeleton insitu. The obtained inverse opal carbons possess large surface areas and pore volumes, and high nitrogen content. When acting as metal-free electrocatalysts, the inverse opal carbons exhibit high catalytic activity and selectivity towards the oxygen reduction reaction in alkaline electrolyte, much better than that of the furfuryl-alcohol-derived inverse opal carbon and close to that of commercial Pt/C catalysts.	[Zhang, Shiguo; Kwon, Hoi-Min; Li, Zhe; Ikoma, Ai; Dokko, Kaoru; Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Zhang, SG (reprint author), Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	mwatanab@ynu.ac.jp	Dokko, Kaoru/A-4005-2013	Dokko, Kaoru/0000-0002-9622-4345	Japan Science and Technology Agency's (JST) Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan	This work was supported by the Japan Science and Technology Agency's (JST) Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan.	Stein A, 2013, CHEM SOC REV, V42, P2763, DOI 10.1039/c2cs35317b; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Zhang SG, 2014, J AM CHEM SOC, V136, P1690, DOI 10.1021/ja411981c; Yang QH, 2005, CHEM MATER, V17, P2940, DOI 10.1021/cm047830m; Qiu B, 2013, J MATER CHEM A, V1, P6373, DOI 10.1039/c3ta10774d; Kang DY, 2013, LANGMUIR, V29, P1192, DOI 10.1021/la304556w; Liu ZY, 2013, NANO RES, V6, P293, DOI 10.1007/s12274-013-0307-9; Paraknowitsch JP, 2010, J MATER CHEM, V20, P6746, DOI 10.1039/c0jm00869a; Fechler N, 2013, ADV MATER, V25, P75, DOI 10.1002/adma.201203422; Stein A, 2008, CHEM MATER, V20, P649, DOI 10.1021/cm702107n; Lee JS, 2009, J AM CHEM SOC, V131, P4596, DOI 10.1021/ja900686d; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Tachikawa N, 2011, CHEM COMMUN, V47, P8157, DOI 10.1039/c1cc12415c; Lee JS, 2010, ADV MATER, V22, P1004, DOI 10.1002/adma.200903403; Zhang SG, 2015, CHEMSUSCHEM, V8, P1608, DOI 10.1002/cssc.201403320; Sun ZK, 2013, ACS NANO, V7, P8706, DOI 10.1021/nn402994m; Wang YJ, 2011, CHEM REV, V111, P7625, DOI 10.1021/cr100060r; Zhang SG, 2015, ANGEW CHEM INT EDIT, V54, P1302, DOI 10.1002/anie.201410234; Lim KH, 2014, APPL CATAL B-ENVIRON, V158, P355, DOI 10.1016/j.apcatb.2014.04.038; Fellinger TP, 2012, J AM CHEM SOC, V134, P4072, DOI 10.1021/ja300038p; Yang DS, 2014, CHEMCATCHEM, V6, P1236, DOI 10.1002/cctc.201400035; Gokhale R, 2014, PHYS CHEM CHEM PHYS, V16, P4251, DOI 10.1039/c3cp55396e; Luo ZQ, 2011, J MATER CHEM, V21, P8038, DOI 10.1039/c1jm10845j; Wang XQ, 2010, ANGEW CHEM INT EDIT, V49, P6664, DOI 10.1002/anie.201003163; Gogotsi Y, 2003, NAT MATER, V2, P591, DOI 10.1038/nmat957; Sahraie NR, 2014, J AM CHEM SOC, V136, P14486, DOI 10.1021/ja506553r; Xu X, 2012, J AM CHEM SOC, V134, P16987, DOI 10.1021/ja308139s; Zhang SG, 2014, CHEM MATER, V26, P2915, DOI 10.1021/cm5006168; Zhang LJ, 2014, NANOSCALE, V6, P6590, DOI 10.1039/c4nr00348a; Liu G, 2009, APPL CATAL B-ENVIRON, V93, P156, DOI 10.1016/j.apcatb.2009.09.025; Zhang P, 2014, ENERG ENVIRON SCI, V7, P442, DOI 10.1039/c3ee42799d; Han CL, 2014, J MATER CHEM A, V2, P605, DOI 10.1039/c3ta13757k; Paraknowitsch JP, 2010, ADV MATER, V22, P87, DOI 10.1002/adma.200900965; Su FB, 2005, J PHYS CHEM B, V109, P20200, DOI 10.1021/jp0541967; Yang W, 2011, J AM CHEM SOC, V133, P206, DOI 10.1021/ja108039j; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Antonietti M., 2014, MATER HORIZ, V1, P588; Isshiki Y, 2011, POLYM ADVAN TECHNOL, V22, P1254, DOI 10.1002/pat.1910; Liang J, 2012, ANGEW CHEM, V124, P3958; Liu RL, 2010, ANGEW CHEM, V122, P2619, DOI DOI 10.1002/ANGE.200907289; Lytle J. C., 2010, ANN REV NANORESEARCH, V1, P1; Tabata S, 2008, J ELECTROCHEM SOC, V155, pK42, DOI 10.1149/1.2826266; Wang X., 2010, ANGEW CHEM, V122, P6814, DOI 10.1002/ange.201003163; Zhang SG, 2015, MATER HORIZ, V2, P168, DOI 10.1039/c4mh00141a; Zhang SG, 2015, NANO ENERGY, V13, P376, DOI 10.1016/j.nanoen.2015.03.006	45	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	AUG	2015	2	8					1080	1085		10.1002/celc.201500129		6	Electrochemistry	Electrochemistry	CP4NT	WOS:000359859700002		
J	Wang, H; Sunahiro, S; Matsui, M; Zhang, P; Takeda, Y; Yamamoto, O; Imanishi, N				Wang, Hui; Sunahiro, Shogo; Matsui, Masaki; Zhang, Peng; Takeda, Yasuo; Yamamoto, Osamu; Imanishi, Nobuyuki			A Solvate Ionic Liquid as the Anolyte for Aqueous Rechargeable Li-O-2 Batteries	CHEMELECTROCHEM			English	Article						anolyte; aqueous batteries; ionic liquids; lithium; protected lithium electrodes	LITHIUM-METAL BATTERIES; POLYMER ELECTROLYTES; DENDRITIC GROWTH; AIR BATTERIES; LI; COMPLEXES; CONDUCTIVITY; SPECTROSCOPY; ELECTRODES; DEPOSITION	A reversible high-areal-capacity metallic lithium anode is pivotal to develop high specific-energy-density lithium-metal-based batteries. A novel solvate ionic liquid has been prepared by mixing tetraethylene glycol dimethyl ether (G4) and lithium bis(fluorosulfonyl)imide (LiFSI). Raman measurements revealed that the solvent was completely complexed by lithium cations to form a solvate ionic liquid (SIL) when the molar ratio of solvent to lithium cations was lower than 2. A symmetrical Li/LiFSI-2G4/Li cell showed no short circuit for 41.2h, until the capacity of the loaded lithium anode at 1mAcm(-2) and 60 degrees C was reached. A metallic lithium anode could deliver a high areal capacity of 12mAhcm(-2) for 40 cycles in the SIL of LiFSI-2G4 with a current density as high as 6mAcm(-2) at 60 degrees C. This novel SIL of LiFSI-2G4 as an anolyte coupled with lithium metal allows favorable cyclability for a high specific-energy-density aqueous lithium-O-2 cell.	[Wang, Hui; Sunahiro, Shogo; Matsui, Masaki; Zhang, Peng; Takeda, Yasuo; Yamamoto, Osamu; Imanishi, Nobuyuki] Mie Univ, Dept Chem, Fac Engn, Tsu, Mie 5148507, Japan; [Matsui, Masaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Wang, H (reprint author), Mie Univ, Dept Chem, Fac Engn, Tsu, Mie 5148507, Japan.	wang@chem.mie-u.ac.jp; imanishi@chem.mie-u.ac.jp	Matsui, Masaki/O-6645-2015	Matsui, Masaki/0000-0003-1499-7457	Japan Science and Technology Agency (JST)	This study was supported by the Japan Science and Technology Agency (JST) under the "Advanced Low Carbon Technology Research and Development Program". The authors thank Central Glass Co., Ltd, for the supply of LiFSI.	Bouchet R, 2013, NAT MATER, V12, P452, DOI [10.1038/nmat3602, 10.1038/NMAT3602]; Ding F, 2013, J AM CHEM SOC, V135, P4450, DOI 10.1021/ja312241y; MA YP, 1995, J ELECTROCHEM SOC, V142, P1859, DOI 10.1149/1.2044206; Shin JH, 2008, J ELECTROCHEM SOC, V155, pA368, DOI 10.1149/1.2869876; Ferrari S, 2015, J ELECTROCHEM SOC, V162, pA3001, DOI 10.1149/2.0011502jes; Tamura T, 2010, J POWER SOURCES, V195, P6095, DOI 10.1016/j.jpowsour.2009.11.061; Rosso M, 2007, ELECTROCHIM ACTA, V53, P250, DOI 10.1016/j.electacta.2007.02.026; Park HE, 2008, J POWER SOURCES, V178, P765, DOI 10.1016/j.jpowsour.2007.12.081; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Yamaki J, 1998, J POWER SOURCES, V74, P219, DOI 10.1016/S0378-7753(98)00067-6; Park MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03815; Imanishi N, 2014, MATER TODAY, V17, P24, DOI 10.1016/j.mattod.2013.12.004; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Aurbach D, 2000, J POWER SOURCES, V89, P206, DOI 10.1016/S0378-7753(00)00431-6; Khurana R, 2014, J AM CHEM SOC, V136, P7395, DOI 10.1021/ja502133j; Stone GM, 2012, J ELECTROCHEM SOC, V159, pA222, DOI 10.1149/2.030203jes; Gireaud L, 2006, ELECTROCHEM COMMUN, V8, P1639, DOI 10.1016/j.elecom.2006.07.037; Yamada Y, 2013, CHEM COMMUN, V49, P11194, DOI 10.1039/c3cc46665e; Schaefer JL, 2013, CHEM MATER, V25, P834, DOI 10.1021/cm303091j; Edman L, 2000, J PHYS CHEM B, V104, P7254, DOI 10.1021/jp000082d; CHAZALVIEL JN, 1990, PHYS REV A, V42, P7355, DOI 10.1103/PhysRevA.42.7355; Monroe C, 2005, J ELECTROCHEM SOC, V152, pA396, DOI 10.1149/1.1850854; Liu S, 2011, J POWER SOURCES, V196, P7681, DOI 10.1016/j.jpowsour.2011.04.001; AURBACH D, 1990, ELECTROCHIM ACTA, V35, P625, DOI 10.1016/0013-4686(90)87055-7; Fu J, 1997, SOLID STATE IONICS, V96, P195, DOI 10.1016/S0167-2738(97)00018-0; Philippe B, 2013, J AM CHEM SOC, V135, P9829, DOI 10.1021/ja403082s; Pappenfus TM, 2004, J ELECTROCHEM SOC, V151, pA209, DOI 10.1149/1.1635384; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Yamada Y, 2014, J AM CHEM SOC, V136, P5039, DOI 10.1021/ja412807w; Lee SI, 2002, KOREAN J CHEM ENG, V19, P638, DOI 10.1007/BF02699310; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Ryou MH, 2012, ADV ENERGY MATER, V2, P645, DOI 10.1002/aenm.201100687; Borodin O, 2010, J PHYS CHEM B, V114, P6786, DOI 10.1021/jp911950q; Abraham KM, 1997, CHEM MATER, V9, P1978, DOI 10.1021/cm970075a; Zheng GY, 2014, NAT NANOTECHNOL, V9, P618, DOI [10.1038/nnano.2014.152, 10.1038/NNANO.2014.152]; Zhang P, 2015, SOLID STATE IONICS, V272, P101, DOI 10.1016/j.ssi.2015.01.004; Brouillette D, 2002, PHYS CHEM CHEM PHYS, V4, P6063, DOI 10.1039/b203776a; Stark JK, 2013, J ELECTROCHEM SOC, V160, pD337, DOI 10.1149/2.028309jes; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Wang H, 2012, J POWER SOURCES, V219, P22, DOI 10.1016/j.jpowsour.2012.07.020; Sunahiro S, 2014, J POWER SOURCES, V262, P338, DOI 10.1016/j.jpowsour.2014.03.016; Bhatt AI, 2013, J ELECTROCHEM SOC, V160, pA1171, DOI 10.1149/2.056308jes; Christensen J, 2012, J ELECTROCHEM SOC, V159, pR1, DOI 10.1149/2.086202jes; EVANS J, 1987, POLYMER, V28, P2324, DOI 10.1016/0032-3861(87)90394-6; Qian JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7362; Suo LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2513; Yamamoto O., 2014, LITHIUM AIR BATTERY, P13	47	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	AUG	2015	2	8					1144	1151		10.1002/celc.201500113		8	Electrochemistry	Electrochemistry	CP4NT	WOS:000359859700012		
J	Yokozaki, Y; Sakabe, J; Ng, B; Shimoyama, Y				Yokozaki, Yuta; Sakabe, Junichi; Ng, Brendan; Shimoyama, Yusuke			Effect of temperature, pressure and depressurization rate on release profile of salicylic acid from contact lenses prepared by supercritical carbon dioxide impregnation	CHEMICAL ENGINEERING RESEARCH & DESIGN			English	Article						Supercritical CO2; Impregnation; Contact lens; Release profile; Salicylic acid; Loaded amount in lens	SOLVENT IMPREGNATION; SOLUBILITY	Supercritical CO2 was used for the impregnation of a contact lens with salicylic acid. The supercritical CO2 impregnations were conducted at 308, 313 and 318 K from 9.0 to 15.0 MPa. The effects of the temperatures and pressures in the impregnation processing on the loaded amount of salicylic acid in the contact lenses were investigated. The loaded amounts of salicylic acid increase with the decrease of temperature and increase of pressures. It is found that the loaded amounts of salicylic acid in the lenses are correlated with the solubilities in supercritical CO2. The release profile of the salicylic acid from the contact lenses into the aqueous solution at 310 K for 8 h was studied by the released amounts measured using ultraviolet-visible spectroscopy. The higher temperature and lower pressure in the impregnation processing lead to the slow release rate of salicylic acid from the contact lenses. The release profiles were investigated by changing the depressurization rate from 0.06 to 0.18 MPa min(-1). The lower depressurization rate results in the higher release rate of the salicylic acid from the lenses. The release profile of salicylic acid from the lenses into the aqueous solution is modeled by using kinetic constant and release exponent parameter. The modeled results suggest that the release from the lenses occurred by the superimpositions of Fickian controlled and swelling controlled releases. (C) 2015 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.	[Yokozaki, Yuta; Sakabe, Junichi; Ng, Brendan; Shimoyama, Yusuke] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528550, Japan	Shimoyama, Y (reprint author), Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, 2-12-1 S1-33,Ookayama, Tokyo 1528550, Japan.	yshimo@chemeng.titech.ac.jp					KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Gonzalez-Chomon C, 2012, EUR J PHARM BIOPHARM, V82, P383, DOI 10.1016/j.ejpb.2012.07.007; Braga MEM, 2011, INT J PHARMACEUT, V420, P231, DOI 10.1016/j.ijpharm.2011.08.040; Nair KL, 2012, J APPL POLYM SCI, V124, P2030, DOI 10.1002/app.35229; Costa VP, 2010, J SUPERCRIT FLUID, V52, P306, DOI 10.1016/j.supflu.2010.02.001; Masmoudi Y, 2011, J SUPERCRIT FLUID, V60, P98, DOI 10.1016/j.supflu.2011.08.014; Costa VP, 2010, J SUPERCRIT FLUID, V53, P165, DOI 10.1016/j.supflu.2010.02.007; Nordstrom FL, 2006, J CHEM ENG DATA, V51, P1668, DOI 10.1021/je060134d; GURDIAL GS, 1991, IND ENG CHEM RES, V30, P575, DOI 10.1021/ie00051a020; Yanez F, 2011, ACTA BIOMATER, V7, P1019, DOI 10.1016/j.actbio.2010.10.003; Braga MEM, 2008, J SUPERCRIT FLUID, V44, P245, DOI 10.1016/j.supflu.2007.10.002; Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119; Pingnatello P., 2002, BIOMATERIALS, V23, P3247; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; Yamazaki Y, 2013, J APPL POLYM SCI, V127, P5022, DOI 10.1002/app.38114	15	0	0	INST CHEMICAL ENGINEERS	RUGBY	165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND	0263-8762	1744-3563		CHEM ENG RES DES	Chem. Eng. Res. Des.	AUG	2015	100						89	94		10.1016/j.cherd.2015.05.008		6	Engineering, Chemical	Engineering	CP5WU	WOS:000359956900008		
J	Murata, M; Sugiyama, S; Matsuoka, S; Matsumori, N				Murata, Michio; Sugiyama, Shigeru; Matsuoka, Shigeru; Matsumori, Nobuaki			Bioactive Structure of Membrane Lipids and Natural Products Elucidated by a Chemistry-Based Approach	CHEMICAL RECORD			English	Article						fatty acids; lipid rafts; membrane proteins; NMR spectroscopy; sphingolipids	SURFACE-PLASMON RESONANCE; ACID-BINDING PROTEIN; DINOFLAGELLATE AMPHIDINIUM-SP; MOLECULAR-DYNAMICS SIMULATION; TRUNCATED POLYHYDROXYL CHAIN; H-2 NMR-SPECTROSCOPY; MARINE DINOFLAGELLATE; AMPHOTERICIN-B; SOLID-STATE; LIGAND-BINDING	Determining the bioactive structure of membrane lipids is a new concept, which aims to examine the functions of lipids with respect to their three-dimensional structures. As lipids are dynamic by nature, their structure does not refer solely to a static picture but also to the local and global motions of the lipid molecules. We consider that interactions with lipids, which are completely defined by their structures, are controlled by the chemical, functional, and conformational matching between lipids and between lipid and protein. In this review, we describe recent advances in understanding the bioactive structures of membrane lipids bound to proteins and related molecules, including some of our recent results. By examining recent works on lipid-raft-related molecules, lipid-protein interactions, and membrane-active natural products, we discuss current perspectives on membrane structural biology.	[Murata, Michio; Sugiyama, Shigeru; Matsuoka, Shigeru] JST ERATO, Lipid Act Struct Project, Toyonaka, Osaka 5600043, Japan; [Murata, Michio; Sugiyama, Shigeru; Matsuoka, Shigeru; Matsumori, Nobuaki] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5630043, Japan	Murata, M (reprint author), JST ERATO, Lipid Act Struct Project, Toyonaka, Osaka 5600043, Japan.	murata@chem.sci.osaka-u.ac.jp			MEXT Japan [25242073]	The results presented in this review were mainly achieved by the members of the JST ERATO "Lipid Active Structure" project, including Drs. Toshiaki Hara, Satoshi Kawatake, Masanao Kinoshita, Yuichi Umekawa, Sebastian Lethu, Daisuke Masutoka, and Fuminori Satou. We are grateful to Ph.D. students Tomokazu Yasuda, Rafael Espiritu, Kimberly Cornelio, Nagy Morsy, and Respati Suwasono in our laboratory, and Drs. Ichihara and Kimura in Schrodinger Inc. for collaboration in WaterMap calculations. This research was partly supported by Grant-in-Aid No. 25242073 from MEXT Japan.	Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Oishi T, 2008, ORG LETT, V10, P5203, DOI 10.1021/ol802168r; SEELIG J, 1977, Q REV BIOPHYS, V10, P353; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Paul GK, 1997, J MAR BIOTECHNOL, V5, P124; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Morsy N, 2005, TETRAHEDRON, V61, P8606, DOI 10.1016/j.tet.2005.07.004; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hirose M, 2013, J SYNCHROTRON RADIAT, V20, P923, DOI 10.1107/S0909049513021298; Matsuoka S, 2015, ANGEW CHEM INT EDIT, V54, P1508, DOI 10.1002/anie.201409830; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; Nishimura S, 2010, NAT CHEM BIOL, V6, P519, DOI [10.1038/nchembio.387, 10.1038/NCHEMBIO.387]; SATAKE M, 1991, J AM CHEM SOC, V113, P9859, DOI 10.1021/ja00026a027; Matsumori N, 2012, BIOCHEMISTRY-US, V51, P8363, DOI 10.1021/bi3009399; PAUL GK, 1995, TETRAHEDRON LETT, V36, P6279, DOI 10.1016/0040-4039(95)01259-K; Joshi MK, 1998, BIOCHEMISTRY-US, V37, P14463, DOI 10.1021/bi980965j; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Houdai T, 2005, TETRAHEDRON, V61, P2795, DOI 10.1016/j.tet.2005.01.069; Quinn PJ, 2012, PROG LIPID RES, V51, P179, DOI 10.1016/j.plipres.2012.01.001; Mehnert T, 2006, BIOPHYS J, V90, P939, DOI 10.1529/biopyhsj.105.063271; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Takeda K, 1998, J MOL BIOL, V283, P463, DOI 10.1006/jmbi.1998.2103; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Umegawa Y, 2015, MAGN RESON CHEM, V53, P514, DOI 10.1002/mrc.4247; Sonoyama M, 2009, CHEM LETT, V38, P1134, DOI 10.1246/cl.2009.1134; BITTMAN R, 1994, BIOCHEMISTRY-US, V33, P11776, DOI 10.1021/bi00205a013; Epand RM, 2003, BIOPHYS J, V84, P3102; Doi Y, 1997, J ORG CHEM, V62, P3820, DOI 10.1021/jo970273l; Zidar J, 2009, J PHYS CHEM B, V113, P15795, DOI 10.1021/jp907138h; Mihailescu M, 2011, BIOPHYS J, V100, P1455, DOI 10.1016/j.bpj.2011.01.035; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Murata M, 1999, J AM CHEM SOC, V121, P870, DOI 10.1021/ja983655x; Li XM, 2001, BIOCHEMISTRY-US, V40, P5954, DOI 10.1021/bi002791n; Marcotte I, 2005, CONCEPT MAGN RESON A, V24A, P17, DOI 10.1002/cmr.a.20025; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Mouri R, 2008, BIOCHEMISTRY-US, V47, P7807, DOI 10.1021/bi800334p; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Morsy N, 2006, BIOORGAN MED CHEM, V14, P6548, DOI 10.1016/j.bmc.2006.06.012; Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; Cournia Z, 2007, J PHYS CHEM B, V111, P1786, DOI 10.1021/jp065172i; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Yokoyama Y, 2010, J PHYS CHEM B, V114, P15706, DOI 10.1021/jp108034n; Yasuda T, 2014, BIOPHYS J, V106, P631, DOI 10.1016/j.bpj.2013.12.034; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Khelashvili GA, 2004, J CHEM PHYS, V120, P9841, DOI 10.1063/1.1724814; Matsumori N, 2005, J AM CHEM SOC, V127, P10667, DOI 10.1021/ja051597r; Bartels T, 2008, J AM CHEM SOC, V130, P14521, DOI 10.1021/ja801789t; BRUZIK KS, 1988, BIOCHIM BIOPHYS ACTA, V939, P315, DOI 10.1016/0005-2736(88)90076-4; CALHOUN WI, 1979, BIOCHIM BIOPHYS ACTA, V555, P436, DOI 10.1016/0005-2736(79)90397-3; DENCHER NA, 1983, BIOCHEMISTRY-US, V22, P1323, DOI 10.1021/bi00275a002; Espiritu R., 2014, BIOCHEMISTRY-US, V52, P2410; Espiritu RA, 2013, BIOCHEMISTRY-US, V52, P2410, DOI 10.1021/bi4000854; ESTEP TN, 1979, BIOCHEMISTRY-US, V18, P2112, DOI 10.1021/bi00577a042; Gimpl G, 2002, TRENDS BIOCHEM SCI, V27, P596, DOI 10.1016/S0968-0004(02)02224-7; Houdai T, 2008, ORG LETT, V10, P4191, DOI [10.1021/ol8016337, 10.1021/o18016337]; Houdai T., 2004, BIOCHIM BIOPHYS ACTA, V14, P5677; Huang XC, 2004, TETRAHEDRON LETT, V45, P5501, DOI 10.1016/j.tetlet.2004.05.067; Kawatake S., COMMUNICATION; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Matsumori N, 2015, BIOPHYS J, V108, P2816, DOI 10.1016/j.bpj.2015.05.011; Matsumori N, 2010, NAT PROD REP, V27, P1480, DOI 10.1039/c0np00002g; Matsumori N, 2007, J AM CHEM SOC, V129, P14989, DOI 10.1021/ja075024l; Matsumori N, 2009, J AM CHEM SOC, V131, P11855, DOI 10.1021/ja9033473; Matsumori N, 2002, J AM CHEM SOC, V124, P4180, DOI 10.1021/ja012026b; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; Matsuoka D, 2015, J PHYS CHEM B, V119, P114, DOI 10.1021/jp510384f; Morsy N, 2008, BIOORGAN MED CHEM, V16, P3084, DOI 10.1016/j.bmc.2007.12.029; Mozsolits H, 2002, BIOPOLYMERS, V66, P3, DOI 10.1002/bip.10200; Mukhopadhyay AK, 1996, BIOCHEMISTRY-US, V35, P9245, DOI 10.1021/bi960738m; Nakagawa Y, 2015, BIOCHEMISTRY-US, V54, P303, DOI 10.1021/bi5012942; Poveda JA, 2014, BBA-BIOMEMBRANES, V1838, P1560, DOI 10.1016/j.bbamem.2013.10.023; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Talbott CM, 2000, BBA-BIOMEMBRANES, V1467, P326, DOI 10.1016/S0005-2736(00)00229-7; Tan MC, 2014, BIOORGAN MED CHEM, V22, P1804, DOI 10.1016/j.bmc.2014.02.001; Uddin M. N., 2010, LANGMUIR, V26, P12104; Umegawa Y, 2012, BIOCHEMISTRY-US, V51, P83, DOI 10.1021/bi2012542; Veach S., 2003, BIOPHYS J, V85, P3074; Veit M., 2011, ADV VIROL; Washida K, 2006, TETRAHEDRON LETT, V47, P2521, DOI 10.1016/j.tetlet.2006.02.045; Yamaguchi T, 2012, BIOORGAN MED CHEM, V20, P270, DOI 10.1016/j.bmc.2011.11.001; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	91	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	AUG	2015	15	4					675	690		10.1002/tcr.201402097		16	Chemistry, Multidisciplinary	Chemistry	CP5JN	WOS:000359917500002		
J	Sakakura, A; Ishihara, K				Sakakura, Akira; Ishihara, Kazuaki			Stereoselective Electrophilic Cyclization	CHEMICAL RECORD			English	Review						asymmetric synthesis; electrophilic cyclization; lactonization; Lewis bases; organocatalysis	CATALYTIC ASYMMETRIC IODOLACTONIZATION; ACID-SENSITIVE (-)-CAPARRAPI; INDUCED POLYENE CYCLIZATIONS; BIOMIMETIC TOTAL-SYNTHESIS; BIOGENETIC-TYPE SYNTHESIS; MARINE NATURAL-PRODUCTS; BAYLIS-HILLMAN REACTION; ENANTIOSELECTIVE IODOLACTONIZATION; BROMINATIVE CYCLIZATION; KINETIC RESOLUTION	Electrophilic cyclizations of unactivated alkenes play highly important roles in the synthesis of useful building blocks. This account describes our contributions to the rational design of monofunctionalized chiral Lewis base catalysts for enantioselective iodo- and protocyclizations. For the stereoselective promotion of electrophilic bromocyclizations, nucleophilic phosphite-urea cooperative catalysts have been designed.	[Sakakura, Akira] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Ishihara, Kazuaki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishihara, Kazuaki] Japan Sci & Technol Agcy JST, CREST, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sakakura, A (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	sakakura@okayama-u.ac.jp	Sakakura, Akira/A-6319-2013	Sakakura, Akira/0000-0002-2995-1251	MEXT KAKENHI [26105739]	The authors gratefully thank former and current co-workers, Dr. Atsushi Ukai, Dr. Hidefumi Nakatsuji, Dr. Masayuki Sakuma, Dr. Yasuhiro Sawamura and Mr. Gakujun Shomi for their valuable efforts. Financial support from MEXT KAKENHI (26105739) is also acknowledged.	WARD RS, 1982, CHEM SOC REV, V11, P75, DOI 10.1039/cs9821100075; Murai K, 2014, CHEM-ASIAN J, V9, P3511, DOI 10.1002/asia.201402865; Toda Y, 2014, J AM CHEM SOC, V136, P14734, DOI 10.1021/ja5088584; Yang YL, 2011, ORG BIOMOL CHEM, V9, P3349, DOI 10.1039/c1ob00017a; Gong JJ, 2009, TETRAHEDRON-ASYMMETR, V20, P2117, DOI 10.1016/j.tetasy.2009.07.047; Denmark SE, 2014, J ORG CHEM, V79, P140, DOI 10.1021/jo4023765; Zhou L, 2011, J AM CHEM SOC, V133, P9164, DOI 10.1021/ja201627h; Huang DS, 2013, J AM CHEM SOC, V135, P8101, DOI 10.1021/ja4010877; Wilking M, 2013, J AM CHEM SOC, V135, P8133, DOI 10.1021/ja402910d; [Anonymous], 2012, ANGEW CHEM INT ED, V51, P7771; Whitehead DC, 2010, J AM CHEM SOC, V132, P3298, DOI 10.1021/ja100502f; Hu FL, 2012, TETRAHEDRON, V68, P7911, DOI 10.1016/j.tet.2012.07.013; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Liu H, 2014, ORG LETT, V16, P1908, DOI 10.1021/ol5004109; Mullen CA, 2008, ANGEW CHEM INT EDIT, V47, P6011, DOI 10.1002/anie.200801423; Denmark SE, 2011, J AM CHEM SOC, V133, P15308, DOI 10.1021/ja2064395; Dobish MC, 2012, J AM CHEM SOC, V134, P6068, DOI 10.1021/ja301858r; Filippova L, 2014, TETRAHEDRON LETT, V55, P419, DOI 10.1016/j.tetlet.2013.11.028; Kwon HY, 2008, CHEM-EUR J, V14, P1023, DOI 10.1002/chem.200701199; Chen F, 2013, J AM CHEM SOC, V135, P1232, DOI 10.1021/ja311202e; [Anonymous], 2014, ANGEW CHEM INT ED, V53, P5161; Rauniyar V, 2011, SCIENCE, V334, P1681, DOI 10.1126/science.1213918; Arai T, 2014, CHEM COMMUN, V50, P8287, DOI 10.1039/c4cc02415j; Murai K, 2013, ORG LETT, V15, P2526, DOI 10.1021/ol401007u; Ke ZH, 2014, J AM CHEM SOC, V136, P5627, DOI 10.1021/ja5029155; Chen J, 2012, ORG BIOMOL CHEM, V10, P3808, DOI 10.1039/c2ob25327e; Tan CK, 2013, CHEM COMMUN, V49, P7985, DOI 10.1039/c3cc43950j; Kang SH, 2003, J AM CHEM SOC, V125, P15748, DOI 10.1021/ja0369921; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Sawamura Y, 2013, CHEM SCI, V4, P4181, DOI 10.1039/c3sc51432c; Yousefi R, 2011, ORG LETT, V13, P608, DOI 10.1021/ol102850m; Sawamura Y, 2014, CHIRALITY, V26, P356, DOI 10.1002/chir.22297; Cheng YA, 2014, ORG BIOMOL CHEM, V12, P2333, DOI 10.1039/c3ob42335b; Wilking M, 2014, SYNLETT, V25, P1701, DOI 10.1055/s-0034-1378278; YAMAGUCHI Y, 1985, TETRAHEDRON LETT, V26, P343, DOI 10.1016/S0040-4039(01)80813-3; Yuan K, 2010, TETRAHEDRON-ASYMMETR, V21, P903, DOI 10.1016/j.tetasy.2010.04.061; Tan CK, 2014, CHIRALITY, V26, P328, DOI 10.1002/chir.22272; [Anonymous], 2013, ANGEW CHEM INT ED, V52, P8450; Ishibashi H, 2004, J AM CHEM SOC, V126, P11122, DOI 10.1021/ja0472026; Denmark SE, 2010, P NATL ACAD SCI USA, V107, P20655, DOI 10.1073/pnas.1005296107; Xie WQ, 2013, ANGEW CHEM INT EDIT, V52, P12924, DOI 10.1002/anie.201306774; Sakakura A, 2007, NATURE, V445, P900, DOI 10.1038/nature05553; SHIEH HM, 1982, TETRAHEDRON LETT, V23, P4643, DOI 10.1016/S0040-4039(00)85676-2; [Anonymous], 2012, ANGEW CHEM INT ED, V51, P3923; Tan CK, 2012, CHEM COMMUN, V48, P5793, DOI 10.1039/c2cc31148h; Miles DH, 2013, CHEM SCI, V4, P3427, DOI 10.1039/c3sc50811k; Zhao YJ, 2010, J AM CHEM SOC, V132, P10242, DOI 10.1021/ja104119j; Sakakura A, 2011, ORG LETT, V13, P3130, DOI 10.1021/ol201032t; Lee HJ, 2012, TETRAHEDRON LETT, V53, P6984, DOI 10.1016/j.tetlet.2012.10.051; Zhang W, 2012, CHEM-EUR J, V18, P7296, DOI 10.1002/chem.201103809; Jaganathan A, 2014, ORG LETT, V16, P3616, DOI 10.1021/ol500861z; Zeng XH, 2013, CHEM COMMUN, V49, P2418, DOI 10.1039/c2cc38436a; Denmark SE, 2014, J AM CHEM SOC, V136, P8915, DOI 10.1021/ja5046296; Tan CK, 2014, TETRAHEDRON LETT, V55, P1243, DOI 10.1016/j.tetlet.2014.01.009; Brindle CS, 2013, CHEM SCI, V4, P2100, DOI 10.1039/c3sc50410g; Arai T, 2013, SYNLETT, V24, P2045, DOI 10.1055/s-0033-1339676; Yuan K, 2008, TETRAHEDRON LETT, V49, P6262, DOI 10.1016/j.tetlet.2008.08.042; Nguyen H, 2014, ACS CATAL, V4, P855, DOI 10.1021/cs401190c; Tungen JE, 2012, ORG LETT, V14, P5884, DOI 10.1021/ol302798g; [Anonymous], 2011, ANGEW CHEM INT ED, V50, P2593; Ikeuchi K, 2012, ORG LETT, V14, P6016, DOI [10.1021/ol302908a, 10.1021/o1302908a]; Shi YL, 2007, ADV SYNTH CATAL, V349, P2129, DOI 10.1002/adsc.200700155; [Anonymous], 2009, ANGEW CHEM INT ED, V48, P7899; Zhang XN, 2013, ACS CATAL, V3, P507, DOI 10.1021/cs300751a; Fang C, 2012, ORG LETT, V14, P6290, DOI 10.1021/ol3030555; Paull DH, 2012, J AM CHEM SOC, V134, P11128, DOI 10.1021/ja305117m; [Anonymous], 2014, ANGEW CHEM INT ED, V3, P6974; Fang YQ, 2008, J AM CHEM SOC, V130, P5660, DOI 10.1021/ja801344w; Surendra K, 2014, J AM CHEM SOC, V136, P642, DOI 10.1021/ja4125093; Murai K, 2012, CHEM-EUR J, V18, P8448, DOI 10.1002/chem.201200647; Denmark SE, 2014, J AM CHEM SOC, V136, P3655, DOI 10.1021/ja413270h; HOYE TR, 1978, J ORG CHEM, V43, P3693, DOI 10.1021/jo00413a012; Knowles RR, 2010, J AM CHEM SOC, V132, P5030, DOI 10.1021/ja101256v; Geier MJ, 2014, J AM CHEM SOC, V136, P3032, DOI 10.1021/ja500656k; Snyder SA, 2010, J AM CHEM SOC, V132, P14303, DOI 10.1021/ja106813s; Yin Q, 2014, ORG LETT, V16, P1810, DOI 10.1021/ol5005565; Wang YM, 2012, J AM CHEM SOC, V134, P12928, DOI 10.1021/ja305795x; TANAKA A, 1995, BIOSCI BIOTECH BIOCH, V59, P516; [Anonymous], 2010, ANGEW CHEM INT ED, V49, P7332; WARD RS, 1990, TETRAHEDRON, V46, P5029, DOI 10.1016/S0040-4020(01)87810-8; Denmark SE, 2014, CHIRALITY, V26, P344, DOI 10.1002/chir.22259; Zhang Y, 2004, J AM CHEM SOC, V126, P15038, DOI 10.1021/ja0454485; Tay DW, 2013, ORG LETT, V15, P1310, DOI 10.1021/ol400249x; [Anonymous], 2013, ANGEW CHEM INT ED, V52, P8597; Ashtekar KD, 2014, J AM CHEM SOC, V136, P13355, DOI 10.1021/ja506889c; Ayres D. C., 1990, LIGNANS CHEM BIOL CL; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; Bovino M. T., 2012, ANGEW CHEM, V124, P3989; Carter-Franklin JN, 2003, J AM CHEM SOC, V125, P3688, DOI 10.1021/ja029271v; CHASLE MF, 1971, TETRAHEDRON LETT, P963; Chen LY, 2014, EUR J ORG CHEM, P4714, DOI 10.1002/ejoc.201402396; Chung YC, 2012, ORG LETT, V14, P2766, DOI 10.1021/ol300980k; Corey E. J., 2009, J AM CHEM SOC, V131, P13928; Deng HP, 2012, EUR J ORG CHEM, P183, DOI 10.1002/ejoc.201101365; Deng HP, 2011, EUR J ORG CHEM, P1956, DOI 10.1002/ejoc.201001660; Denmark SE, 2014, NAT CHEM, V6, P1056, DOI [10.1038/nchem.2109, 10.1038/NCHEM.2109]; FUJIWARA S, 1986, CHEM LETT, P1763, DOI 10.1246/cl.1986.1763; Gong J. -J., 2011, CHEM COMMUN, P1491; GONZALEZ AG, 1976, TETRAHEDRON LETT, P137; HIRUKAWA T, 1992, CHEM LETT, P2343, DOI 10.1246/cl.1992.2343; Iwahashi H, 2008, CHEM LETT, V37, P708, DOI 10.1246/cl.2008.708; Jaganathan A, 2011, ANGEW CHEM INT EDIT, V50, P2593, DOI 10.1002/anie.201006910; Jiang X., 2012, ANGEW CHEM, V124, P7891; Jogi A, 2008, TETRAHEDRON-ASYMMETR, V19, P628, DOI 10.1016/j.tetasy.2008.01.028; Kang SH, 2004, SYNLETT, P1279, DOI 10.1055/s-2004-825593; KATO T, 1976, J CHEM SOC CHEM COMM, P518, DOI 10.1039/c39760000518; KATO T, 1980, J CHEM SOC CHEM COMM, P1106, DOI 10.1039/c39800001106; KATO T, 1984, J CHEM SOC CHEM COMM, P1077, DOI 10.1039/c39840001077; KATO T, 1975, BIOORG CHEM, V4, P188, DOI 10.1016/0045-2068(75)90007-3; Kumazawa K, 2004, ORG LETT, V6, P2551, DOI 10.1021/ol049126h; LEGUERN D, 1974, TETRAHEDRON LETT, P955; Murai K, 2014, CHEM COMMUN, V50, P12530, DOI 10.1039/c4cc05414h; Nakatsuji H., 2014, ANGEW CHEM, V126, P7094; Ning ZL, 2011, CHEM RES CHINESE U, V27, P45; NolsOe J. M. J., 2014, EUR J ORG CHEM, P3051; Recsei C, 2014, J ORG CHEM, V79, P880, DOI 10.1021/jo402790x; Sakakura A., 2011, HETEROCYCLES, V82, P249; Sakakura A, 2007, CHIM OGGI, V25, P9; Sakuma M, 2013, ORG LETT, V15, P2838, DOI 10.1021/ol401313d; Schottner M, 1998, J NAT PROD, V61, P119, DOI 10.1021/np9701743; Snyder S. A., 2009, ANGEW CHEM, V121, P8039; Snyde SA, 2011, ALDRICHIM ACTA, V44, P27; TANAKA A, 1990, AGR BIOL CHEM TOKYO, V54, P121; Tay D. W., 2014, ANGEW CHEM, V126, P5261; Tripathi Chandra Bhushan, 2014, Org Lett, V16, P3368, DOI 10.1021/ol5013982; Tripathi C. B., 2013, ANGEW CHEM, V125, P8608; Uyanik M, 2005, ORG LETT, V7, P1601, DOI 10.1021/o1050295r; Uyanik M, 2005, BIOORGAN MED CHEM, V13, P5055, DOI 10.1016/j.bmc.2005.04.029; vansTamelen E. E., 1966, CHEM COMMUN, P411; vansTamelen E. E., 1982, BIOORG CHEM, V11, P133; Veitch G. E., 2010, ANGEW CHEM, V122, P7490; WOLINSKY LE, 1976, J ORG CHEM, V41, P597, DOI 10.1021/jo00866a003; YAMAMURA S, 1977, TETRAHEDRON LETT, P2171; Zhang H, 2014, J AM CHEM SOC, V136, P16485, DOI 10.1021/ja510113s; Zhao Y., 2013, ANGEW CHEM, V125, P8759; Zhong FR, 2011, ANGEW CHEM INT EDIT, V50, P7837, DOI 10.1002/anie.201102094	136	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	AUG	2015	15	4					728	742		10.1002/tcr.201500005		15	Chemistry, Multidisciplinary	Chemistry	CP5JN	WOS:000359917500005		
J	Tayama, E				Tayama, Eiji			Recent Advances in the Base-Induced Sommelet-Hauser Rearrangement of Amino Acid Derived Ammonium Ylides	CHEMICAL RECORD			English	Article						amino acids; ammonium salts; ammonium ylides; rearrangement; synthetic methods	ORTHO-SUBSTITUTION-REARRANGEMENT; BENZYLAMMONIUM N-METHYLIDES; 2,3 STEVENS REARRANGEMENT; LIQUID-AMMONIA; TERTIARY-AMINES; SODIUM AMIDE; SIGMATROPIC REARRANGEMENT; CHIRALITY TRANSFER; RING ENLARGEMENT; SALTS	The Sommelet-Hauser rearrangement of N-benzylic ammonium ylides generated from ammonium salts is an interesting and useful transformation that enables one to convert a readily accessible C-N bond into a new C-C bond to an aromatic ring. The rearrangement was discovered by Sommelet in 1937, studied in detail by Hauser, and applied to organic synthesis by Sato until 1999. Further studies have not advanced because several competitive side reactions and structural limitations of the products severely limit the substrate scope and synthetic applications. In this Personal Account, a history of the research in problem solving and recent advances in the base-induced Sommelet-Hauser rearrangement are described. This synthetic method developed by my group provides efficient access to various types of -aryl--amino acid and -aryl--amino acid derivatives.	Niigata Univ, Fac Sci, Dept Chem, Nishi Ku, Niigata 9502181, Japan	Tayama, E (reprint author), Niigata Univ, Fac Sci, Dept Chem, Nishi Ku, 2-8050 Ikarashi, Niigata 9502181, Japan.	tayama@chem.sc.niigata-u.ac.jp			KAKENHI [23750037, 19750029, 17750034]; Mitsubishi Chemical Corporation Foundation; Asahi Glass Foundation; Union Tool Scholarship Foundation; Foundation for Japanese Chemical Research; Uchida Energy Science Promotion Foundation	I would like to thank all co-workers for their significant contributions and Prof. Dr. Takeshi Nakai for valuable support at the beginning of this research. This work was supported by KAKENHI (Grant-in-Aid for Young Scientists (B), 23750037, 19750029, 17750034), the Mitsubishi Chemical Corporation Foundation, the Asahi Glass Foundation, the Union Tool Scholarship Foundation, the Foundation for Japanese Chemical Research, and the Uchida Energy Science Promotion Foundation.	Liao MY, 2008, ORG LETT, V10, P693, DOI 10.1021/ol703058p; LEDNICER D, 1957, J AM CHEM SOC, V79, P4449, DOI 10.1021/ja01573a055; MANDER LN, 1973, J ORG CHEM, V38, P2915, DOI 10.1021/jo00956a044; SANDERS EB, 1978, J ORG CHEM, V43, P324, DOI 10.1021/jo00396a032; Narita K, 1997, J ORG CHEM, V62, P2544, DOI 10.1021/jo962226j; Klunder JM, 1995, J HETEROCYCLIC CHEM, V32, P1687; Sweeney JB, 2009, CHEM SOC REV, V38, P1027, DOI 10.1039/b604828p; Tayama E, 2010, TETRAHEDRON, V66, P9389, DOI 10.1016/j.tet.2010.09.125; Clayden J, 2011, CHEM COMMUN, V47, P4624, DOI 10.1039/c1cc00049g; Li YY, 2011, ORG LETT, V13, P1210, DOI 10.1021/ol200091k; Tayama E, 2012, TETRAHEDRON, V68, P4710, DOI 10.1016/j.tet.2012.04.015; FERGUSON JR, 1995, TETRAHEDRON LETT, V36, P8867, DOI 10.1016/0040-4039(95)01842-6; JONCZYK A, 1991, J ORG CHEM, V56, P6933, DOI 10.1021/jo00024a042; West TH, 2014, J AM CHEM SOC, V136, P4476, DOI 10.1021/ja500758n; Vargas-Sanchez M, 2006, ORG LETT, V8, P5501, DOI 10.1021/ol062128c; WEINREB SM, 1982, J AM CHEM SOC, V104, P536, DOI 10.1021/ja00366a028; Glaeske KW, 1999, ORG LETT, V1, P31, DOI 10.1021/ol9905349; TANAKA T, 1992, J ORG CHEM, V57, P5034, DOI 10.1021/jo00044a050; Tayama E, 2006, CHEM LETT, V35, P478, DOI 10.1246/cl.2006.478; Tayama E, 2007, ANGEW CHEM INT EDIT, V46, P8869, DOI 10.1002/anie.200703832; Arbore APA, 2000, SYNLETT, P236; BEARD WQ, 1961, J ORG CHEM, V26, P371, DOI 10.1021/jo01061a026; BEARD WQ, 1960, J ORG CHEM, V25, P334, DOI 10.1021/jo01073a007; Berger R, 1998, J AM CHEM SOC, V120, P841, DOI 10.1021/ja973734t; Bhat RG, 2004, TETRAHEDRON LETT, V45, P7983, DOI 10.1016/j.tetlet.2004.09.018; Blid J, 2007, J ORG CHEM, V72, P1294, DOI 10.1021/jo062178v; BRASEN WR, 1954, ORG SYNTH, V34, P61; Braun J. v., 1900, CHEM BER, V33, P1438; Braun J. v., 1918, CHEM BER, V51, P273; BUMGARDNER CL, 1979, J ORG CHEM, V44, P2348, DOI 10.1021/jo01328a003; Clark J. E., 2002, NITROGEN OXYGEN SULF; COOLEY JH, 1989, SYNTHESIS-STUTTGART, P1; Couty F, 2013, EUR J ORG CHEM, P2045, DOI 10.1002/ejoc.201201685; CRESSMAN HWJ, 1947, ORG SYNTH, V27, P56; Dave PR, 2000, J ORG CHEM, V65, P1207, DOI 10.1021/jo991525g; Drouillat B., 2014, EUR J ORG CHEM, P1103; Drouillat B, 2009, SYNLETT, P767, DOI 10.1055/s-0028-1087939; Goncalves-Farbos MH, 2008, CHEM COMMUN, P829, DOI 10.1039/b716488b; Hanessian S, 2006, SYNTHESIS-STUTTGART, P723, DOI 10.1055/s-2006-926314; HIROI K, 1980, CHEM LETT, P1077, DOI 10.1246/cl.1980.1077; JONCZYK A, 1991, SYNLETT, P493; Jones A. D., 2009, PCT Int. Appl., Patent No. [WO 2009035652, 2009035652]; JONES GC, 1963, J ORG CHEM, V28, P199, DOI 10.1021/jo01036a047; KANTOR SW, 1951, J AM CHEM SOC, V73, P4122, DOI 10.1021/ja01153a022; KITANO T, 1991, SYNTHESIS-STUTTGART, P996; KITANO T, 1992, CHEM PHARM BULL, V40, P768; KITANO T, 1992, J CHEM SOC PERK T 1, P2851, DOI 10.1039/p19920002851; KLEIN KP, 1967, J ORG CHEM, V32, P1155, DOI 10.1021/jo01279a066; Kopach ME, 1996, J AM CHEM SOC, V118, P9876, DOI 10.1021/ja961903o; Kurti L, 2005, STRATEGIC APPL NAMED; Lahm G, 2014, SYNTHESIS-STUTTGART, V46, P2413, DOI 10.1055/s-0034-1378393; MAEDA Y, 1994, J CHEM SOC PERK T 1, P393, DOI 10.1039/p19940000393; Maeda Y, 1996, J ORG CHEM, V61, P5188, DOI 10.1021/jo960492r; Marko I. E., 1991, COMPREHENSIVE ORGANI, V3; Martin R, 1997, SYNLETT, P1414; Miller MW, 1998, TETRAHEDRON LETT, V39, P3429, DOI 10.1016/S0040-4039(98)00584-X; NAKANO M, 1985, J CHEM SOC CHEM COMM, P1684, DOI 10.1039/c39850001684; NAKANO M, 1987, J ORG CHEM, V52, P1844, DOI 10.1021/jo00385a035; Nishimura T, 1999, CHEM PHARM BULL, V47, P267; Palombi L, 2011, CATAL COMMUN, V12, P485, DOI 10.1016/j.catcom.2010.10.027; PUTERBAUGH WH, 1964, J AM CHEM SOC, V86, P1105, DOI 10.1021/ja01060a028; PUTERBAUGH WH, 1964, J AM CHEM SOC, V86, P1108, DOI 10.1021/ja01060a029; SAKURAGI A, 1994, J ORG CHEM, V59, P148, DOI 10.1021/jo00080a024; SATO Y, 1980, J ORG CHEM, V45, P613, DOI 10.1021/jo01292a011; SATO Y, 1992, J ORG CHEM, V57, P6711, DOI 10.1021/jo00051a008; SATO Y, 1979, J ORGANOMET CHEM, V166, P303, DOI 10.1016/S0022-328X(00)82547-4; SHIRAI N, 1988, J CHEM SOC CHEM COMM, P370, DOI 10.1039/c39880000370; SHIRAI N, 1989, J ORG CHEM, V54, P836, DOI 10.1021/jo00265a022; SHIRAI N, 1988, J ORG CHEM, V53, P194, DOI 10.1021/jo00236a041; SHIRAI N, 1990, J ORG CHEM, V55, P2767, DOI 10.1021/jo00296a039; Sommelet M, 1937, CR HEBD ACAD SCI, V205, P56; SUGIYAMA H, 1988, SYNTHESIS-STUTTGART, P988; SUMIYA F, 1991, CHEM PHARM BULL, V39, P36; Sweeney JB, 2006, TETRAHEDRON, V62, P11506, DOI 10.1016/j.tet.2006.06.043; TANAKA T, 1992, CHEM PHARM BULL, V40, P518; Tayama E, 2005, HETEROCYCLES, V66, P95; Tayama E, 2013, HETEROCYCLES, V87, P381, DOI 10.3987/COM-12-12619; Tayama E, 2009, TETRAHEDRON-ASYMMETR, V20, P2600, DOI 10.1016/j.tetasy.2009.10.025; Tayama E, 2012, TETRAHEDRON LETT, V53, P1373, DOI 10.1016/j.tetlet.2012.01.013; Tayama E, 2014, CHEM COMMUN, V50, P6860, DOI 10.1039/c4cc02536a; Tayama E, 2008, ORG BIOMOL CHEM, V6, P3673, DOI 10.1039/b811162f; Tomooka K, 2008, SYNLETT, P683, DOI 10.1055/s-2008-1032107; Tuzina P, 2009, ORG LETT, V11, P919, DOI 10.1021/ol8028803; VEDEJS E, 1986, CHEM REV, V86, P941, DOI 10.1021/cr00075a014; VEDEJS E, 1979, J AM CHEM SOC, V101, P6452, DOI 10.1021/ja00515a061; WITTIG G, 1951, LIEBIGS ANN CHEM, V572, P1; Workman JA, 2005, J AM CHEM SOC, V127, P1066, DOI 10.1021/ja043768i; YANG BV, 1993, SYNLETT, P195, DOI 10.1055/s-1993-22398; Zhang C, 1997, J CHEM SOC PERK T 1, P25, DOI 10.1039/a605337h; Zhu TS, 2012, CHEM COMMUN, V48, P7274, DOI 10.1039/c2cc33027j	90	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	AUG	2015	15	4					789	800		10.1002/tcr.201500009		12	Chemistry, Multidisciplinary	Chemistry	CP5JN	WOS:000359917500008		
J	Sugiyama, A; Yujiri, T; Tanaka, M; Tanaka, Y; Nakamura, Y; Tanizawa, Y				Sugiyama, Akiko; Yujiri, Toshiaki; Tanaka, Mayumi; Tanaka, Yoshinori; Nakamura, Yukinori; Tanizawa, Yukio			Altered expression of circadian clock genes during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian clock; granulocyte colony-stimulating factor; noradrenaline; peripheral blood stem cell mobilization	BONE-MARROW; CD34(+) CELLS; OSCILLATIONS; MECHANISMS; IMMUNITY; RELEASE; MAMMALS; SIGNALS	Circulating hematopoietic stem cells exhibit robust circadian fluctuations, which influence the mobilized cell yield, even during enforced stem cell mobilization. However, alterations in the expression of circadian clock genes during granulocyte colony-stimulating factor (G-CSF)-induced peripheral blood stem cell (PBSC) mobilization are not fully elucidated. Therefore, we measured the expression of these genes in human peripheral blood leukocytes from 21 healthy donors. While CRY1 mRNA expression significantly increased by 3.9-fold (p < 0.01), the expression of PER3, CRY2 and BMAL1 mRNAs significantly decreased (by 0.2-fold, 0.2-fold, and 0.6-fold, respectively; p < 0.001) after G-CSF administration. Moreover, CRY1 mRNA expression was inversely correlated with the plasma level of noradrenaline (r = -0.36, p < 0.05), while PER3, CRY2, and BMAL1 mRNA expression directly correlated with the plasma level of noradrenaline (r = 0.55, r = 0.66, and r = 0.57, respectively; p < 0.001). Thus, significant correlations between the levels of circadian clock gene mRNAs and the plasma level of noradrenaline, a sympathetic nervous system neurotransmitter, were established. The modulation of sympathetic activation and of the circadian clock may be novel therapeutic targets for increasing stem cell yields in PBSC donors.	[Sugiyama, Akiko; Yujiri, Toshiaki; Tanaka, Mayumi; Tanaka, Yoshinori; Nakamura, Yukinori; Tanizawa, Yukio] Yamaguchi Univ, Grad Sch Med, Dept Biosignal Anal, Ube, Yamaguchi 7558505, Japan	Yujiri, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Biosignal Anal, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	yujirit@yamaguchi-u.ac.jp			JSPS KAKENHI Grant [26461421]	The authors declare no conflict of interest. This work was supported by JSPS KAKENHI Grant Number 26461421.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Lucas D, 2012, BLOOD, V119, P3962, DOI 10.1182/blood-2011-07-367102; Kusanagi H, 2008, NEUROSCI RES, V61, P136, DOI 10.1016/j.neures.2008.01.012; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Winkler IG, 2006, EXP HEMATOL, V34, P996, DOI 10.1016/j.exphem.2006.04.005; Levesque JP, 2003, EXP HEMATOL, V31, P109, DOI 10.1016/S0301-472X(02)01028-7; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Tang Y, 1999, J NEUROIMMUNOL, V96, P182, DOI 10.1016/S0165-5728(99)00032-6; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; Yujiri T, 2008, LEUKEMIA RES, V32, P195, DOI 10.1016/j.leukres.2007.03.020	19	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	AUG	2015	32	7					934	941		10.3109/07420528.2015.1053910		8	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CP7KL	WOS:000360066100006		
J	Morita, Y; Sasai-Sakuma, T; Asaoka, S; Inoue, Y				Morita, Yuko; Sasai-Sakuma, Taeko; Asaoka, Shoichi; Inoue, Yuichi			The impact of a delayed sleep-wake schedule on depression is greater in women - A web-based cross-sectional study in Japanese young adults	CHRONOBIOLOGY INTERNATIONAL			English	Article						Depression; delayed sleep-wake schedule; insomnia; gender differences	EXCESSIVE DAYTIME SLEEPINESS; GENERAL-POPULATION SURVEY; GENDER-DIFFERENCES; SEX-DIFFERENCES; INSOMNIA; ADOLESCENTS; PREVALENCE; PHASE; ASSOCIATIONS; DIFFERENCE	Sleep-related problems, such as symptoms of insomnia, daytime sleepiness, shorter sleep duration, or a delayed sleep-wake schedule, are known to be risk factors for depression. In general, depression is more prevalent in women than in men, but sleep-related problems do not necessarily show similar gender predominance. Hence, it can be speculated that the impact of sleep-related problems on the development process of depression differs between genders; however, so far, few studies have focused on this issue. The aim of this study was to clarify gender differences in the rates of depression of people with the above sleep-related problems, and to examine gender differences in factors associated with depression in Japanese young adults. A web-based questionnaire survey comprising assessments of demographic variables, sleep-related variables (bed time, wake time, sleep onset latency, frequency of difficulty in initiating sleep and that in maintaining sleep, i.e. symptom components of insomnia, and daytime sleepiness), and the 12-item version of the Center for Epidemiologic Studies Depression Scale was administered to 2502 participants (males: females = 1144:1358, age range = 19-25 years). Female predominance in the rate of depression was observed only in subjects with a delayed sleep-wake schedule (chi(2)((1)) = 15.44, p < 0.001). In men, daytime sleepiness and difficulty in initiating sleep were significantly associated with depression (odds ratio [OR] = 2.39, 95% confidence interval [CI] = [1.69, 3.39], p < 0.001; OR = 3.50, 95% CI = [2.29, 5.35], p < 0.001, respectively), whereas in women, significant associations were found between depression and a delayed sleep-wake schedule (OR = 1.75, 95% CI = [1.28, 2.39], p < 0.001), daytime sleepiness (OR = 2.13, 95% CI = [1.60, 2.85], p50.001), and difficulty in initiating sleep (OR = 4.37, 95% CI = [3.17, 6.03], p < 0.001). These results indicate that in younger generations, the impact of a delayed sleep-wake schedule on the development of depression is greater in women; specifically, women are vulnerable to depression when they have an eveningness-type lifestyle, which is possibly attributable to the female-specific intrinsic earlier and shorter circadian rhythm. These results suggest the necessity of gender-based approaches to treating sleep-related problems for alleviating or preventing depressive symptoms in young adults.	[Morita, Yuko; Sasai-Sakuma, Taeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Sasai-Sakuma, Taeko] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Div Biomed Lab Sci, Dept Life Sci & Bioinformat, Tokyo, Japan; [Asaoka, Shoichi] Edogawa Univ, Dept Psychol & Humanities, Chiba, Japan; [Asaoka, Shoichi] Edogawa Univ, Sleep Res Inst, Chiba, Japan; [Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan	Inoue, Y (reprint author), Japan Somnol Ctr, Neuropsychiat Res Inst, Shibuya Ku, 1-24-10 Yoyogi, Tokyo, Japan.	inoue@somnology.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [25882030]; Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare [H25-Seishin-Ippan-010]; HISAMITSU PHARMACEUTICAL CO., INC.; Philips Respironics GK; Takeda Pharmaceutical Company Limited; GlaxoSmithKline K.K.; Astellas Pharma Inc.; Sanofi-Aventis K.K.; Yoshitomiyakuhin Corporation; Otsuka Pharmaceutical Co., Ltd.; Eisai Co., Ltd.	This study was supported by The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant-in-Aid for Research Activity Start-up, No. 25882030. This study was supported by Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare (H25-Seishin-Ippan-010).; This study was not industry supported. Dr Inoue received a consultancy fee from HISAMITSU PHARMACEUTICAL CO., INC., expert testimony from Nippon Boehringer Ingelheim Co., Ltd., Philips Respironics GK, Alfresa Pharma Corporation, Takeda Pharmaceutical Company Limited, MSD K.K., Pacific Medico Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Mitsubishi Tanabe Pharma Corporation, and payment for lectures from Philips Respironics GK, Takeda Pharmaceutical Company Limited, GlaxoSmithKline K.K., Astellas Pharma Inc., Sanofi-Aventis K.K., Yoshitomiyakuhin Corporation, Otsuka Pharmaceutical Co., Ltd., and Eisai Co., Ltd. The other authors have no financial conflicts of interest.	Aalto-Setala T, 2001, PSYCHOL MED, V31, P791; Kaneita Y, 2006, J CLIN PSYCHIAT, V67, P196; Kim K, 2000, SLEEP, V23, P41; Adan A, 2002, CHRONOBIOL INT, V19, P709, DOI 10.1081/CBI-120005390; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Tonetti L, 2008, CHRONOBIOL INT, V25, P745, DOI 10.1080/07420520802394191; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Leger D, 2011, SLEEP MED, V12, P454, DOI 10.1016/j.sleep.2010.12.012; Hysing M, 2013, J SLEEP RES, V22, P549, DOI 10.1111/jsr.12055; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Zhang B, 2006, SLEEP, V29, P85; Doi Y, 2003, SOC SCI MED, V56, P883, DOI 10.1016/S0277-9536(02)00089-8; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Curry J, 2011, ARCH GEN PSYCHIAT, V68, P263, DOI 10.1001/archgenpsychiatry.2010.150; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Liu XC, 2000, PSYCHIAT RES, V93, P1, DOI 10.1016/S0165-1781(99)00119-5; Buysse DJ, 2004, GERIATRICS, V59, P47; de Souza CM, 2014, CHRONOBIOL INT, V31, P199, DOI 10.3109/07420528.2013.838575; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Do YK, 2013, SLEEP MED, V14, P195, DOI 10.1016/j.sleep.2012.09.004; SCHRADER H, 1993, J SLEEP RES, V2, P51; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Chelminski I, 1999, J AFFECT DISORDERS, V52, P19, DOI 10.1016/S0165-0327(98)00051-2; Asaoka S, 2014, SLEEP MED, V15, P1155, DOI 10.1016/j.sleep.2014.05.017; Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645; Blank M, 2015, SLEEP, V38, P197, DOI 10.5665/sleep.4396; Poulin Christiane, 2005, Chronic Dis Can, V26, P65; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Chida F, 2004, PSYCHIAT CLIN NEUROS, V58, P420, DOI 10.1111/j.1440-1819.2004.01277.x; Essau C A, 2000, MMW Fortschr Med, V142, P40; Furihata R, 2012, SLEEP MED, V13, P831, DOI 10.1016/j.sleep.2012.03.011; Glozier N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-33; Goldschmied JR, 2014, J SLEEP RES, V23, P664, DOI 10.1111/jsr.12174; Leger D, 2005, CLIN SPORT MED, V24, P269, DOI 10.1016/j.csm.2004.12.011; Morioka H, 2013, ALCOHOL, V47, P619, DOI 10.1016/j.alcohol.2013.09.041; Ramirez A, 2013, EARLY INTERV PSYCHIA, V9, P108; Roane BM, 2002, SLEEP, V31, P1351; Roehrs T, 2006, SLEEP MED, V7, P49, DOI 10.1016/j.sleep.2005.05.008	41	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	AUG	2015	32	7					952	958		10.3109/07420528.2015.1055756		7	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CP7KL	WOS:000360066100008		
J	Takao, M; Miyajima, H; Shinagawa, T				Takao, Motoharu; Miyajima, Hiroaki; Shinagawa, Takanori			Diurnal modulation of visual motion prediction	CHRONOBIOLOGY INTERNATIONAL			English	Article						Cone photoreceptor; circadian rhythm; human; retina; visual motion prediction	CIRCADIAN-RHYTHMS; TIME; PERFORMANCE; PERCEPTION	Predicting the future position of moving objects is an essential cognitive function used for many daily activities, such as driving, walking and reaching. The experiments described in this paper show a marked diurnal modulation of motion prediction in inflating image perception. This motion prediction was shown to be more accurate in the afternoon than in the morning. In contrast, such modulation could not be found in deflating image perception. Such diurnal fluctuations may be mediated by circadian properties of retinal cone photoreceptors.	[Takao, Motoharu; Miyajima, Hiroaki; Shinagawa, Takanori] Tokai Univ, Dept Human & Informat Sci, Hiratsuka, Kanagawa 2591292, Japan	Takao, M (reprint author), Tokai Univ, Sch Informat Sci & Technol, Dept Human & Informat Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	takao@keyaki.cc.u-tokai.ac.jp			Japan Society for the Promotion of Science [60225399, 90408013]	The authors have no conflicts of interest to declare. This study was supported financially by the Grants-in-Aid #60225399 and #90408013 from The Japan Society for the Promotion of Science (M.T.).	Wexler M, 2001, J EXP PSYCHOL HUMAN, V27, P48, DOI 10.1037/0096-1523.27.1.48; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Monk TH, 1997, J SLEEP RES, V6, P9, DOI 10.1046/j.1365-2869.1997.00023.x; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Kuriyama K, 2003, NEUROSCI RES, V46, P23, DOI 10.1016/S0168-0102(03)00025-7; Aschoff J, 1981, HDB BEHAVIORAL NEURO, V4, P311; Aschoff J., 1998, J BIOL RHYTHM, V13, P972; Chen C, 2014, J SAFETY RES, V51, P57, DOI 10.1016/j.jsr.2014.09.006; Cheong D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039854; Danilenko KV, 2011, CHRONOBIOL INT, V28, P407, DOI 10.3109/07420528.2011.567425; Gates AI., 1916, U CALIFORNIA PUBLICA, V1, P1; Liu X, 2012, PLOS ONE, V11, P50602; Lotze M, 2000, VISION RES, V40, P3467, DOI 10.1016/S0042-6989(00)00175-9; Maxwell S. E., 1990, DESIGNING EXPT ANAL; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Portaluppi F, 2008, CHRONOBIOL INT, V25, P999, DOI 10.1080/07420520802544530; Rodieck R. W., 1998, 1 STEPS SEEING; Slalatter-Hammel AT, 1955, PERCEPT MOTOR SKILL, V5, P201	19	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	AUG	2015	32	7					1019	1023		10.3109/07420528.2015.1053564		5	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CP7KL	WOS:000360066100014		
J	Kamakura, T; Wada, M; Nakajima, I; Ishibashi, K; Miyamoto, K; Okamura, H; Noda, T; Aiba, T; Takaki, H; Yasuda, S; Ogawa, H; Shimizu, W; Makiyama, T; Kimura, T; Kamakura, S; Kusano, K				Kamakura, Tsukasa; Wada, Mitsuru; Nakajima, Ikutaro; Ishibashi, Kohei; Miyamoto, Koji; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Takaki, Hiroshi; Yasuda, Satoshi; Ogawa, Hisao; Shimizu, Wataru; Makiyama, Takeru; Kimura, Takeshi; Kamakura, Shiro; Kusano, Kengo			Evaluation of the Necessity for Cardioverter-Defibrillator Implantation in Elderly Patients With Brugada Syndrome	CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY			English	Article						Brugada syndrome; death; sudden; cardiac; defibrillators; implantable; myocardial ischemia; syncope	PROGRAMMED ELECTRICAL-STIMULATION; VENTRICULAR-FIBRILLATION; RISK STRATIFICATION; FOLLOW-UP; ELECTROCARDIOGRAM; TESTOSTERONE; MULTICENTER; PROGNOSIS; REGISTRY; IMPACT	Background The clinical characteristics and prognosis of elderly patients with Brugada syndrome (BrS) are largely unknown. The purpose of this study was to evaluate the risks and benefits of implantable cardioverter defibrillator (ICD) in elderly patients with BrS based on a long follow-up. Methods and Results A total of 120 BrS patients with ICD (90 for aborted sudden cardiac arrest or syncope, mean age, 46.612.2 years; 50 with age 60 years at the last follow-up) were included in this study. During 102 +/- 68 months of follow-up, 31 patients (26%) experienced appropriate shocks. Age at the first attack of ventricular fibrillation (VF) was <70 years in all patients (mean, 45.0 +/- 12.1 years), the incidence of VF decreased with age, and VF did not recur after 70 years of age except in 2 patients with ischemic heart disease. Eleven of 28 patients with supraventricular tachycardia experienced inappropriate shocks. These inappropriate shocks increased with age and reached a peak in patients who were in their sixties. Lead failures occurred in later stages after implantation in 10 of 120 patients (8%). Conclusions Long-term follow-up of high-risk BrS patients with ICD showed a low incidence of VF in those aged >70 years. Considering the increasing risk of inappropriate shocks because of the relatively late onset of supraventricular tachycardia and lead failures, avoidance of ICD implantation, or replacement may be considered in elderly BrS patients who remain free from VF until 70 years of age.	[Kamakura, Tsukasa; Wada, Mitsuru; Nakajima, Ikutaro; Ishibashi, Kohei; Miyamoto, Koji; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Takaki, Hiroshi; Yasuda, Satoshi; Ogawa, Hisao; Shimizu, Wataru; Kamakura, Shiro; Kusano, Kengo] Natl Cerebral & Cardiovasc Ctr, Div Arrhythmia & Electrophysiol, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Kamakura, Tsukasa; Makiyama, Takeru; Kimura, Takeshi] Kyoto Univ, Dept Cardiovasc Med, Div Cardiol, Kyoto, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan	Kamakura, S (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Arrhythmia & Electrophysiol, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kamakura@hsp.ncvc.go.jp			Ministry of Health, Labor, and Welfare, Japan [H26-040]; National Cerebral and Cardiovascular Center [22-1-2, M25-74]	This work was supported by a research grant for the cardiovascular diseases (grant number H26-040) from the Ministry of Health, Labor, and Welfare, Japan, and intramural research funds (22-1-2, M25-74) for cardiovascular disease from National Cerebral and Cardiovascular Center.	Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Probst V, 2010, CIRCULATION, V121, P635, DOI 10.1161/CIRCULATIONAHA.109.887026; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Morrison TB, 2011, J AM COLL CARDIOL, V58, P278, DOI 10.1016/j.jacc.2011.03.027; Delise P, 2011, EUR HEART J, V32, P169, DOI 10.1093/eurheartj/ehq381; Conte G, 2014, J CARDIOVASC ELECTR, V25, P514, DOI 10.1111/jce.12359; Sarkozy A, 2007, EUR HEART J, V28, P334, DOI 10.1093/eurheartj/ehl450; Makimoto H, 2012, HEART RHYTHM, V9, P242, DOI 10.1016/j.hrthm.2011.09.053; Sacher F, 2013, CIRCULATION, V128, P1739, DOI 10.1161/CIRCULATIONAHA.113.001941; Kamakura S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P495, DOI 10.1161/CIRCEP.108.816892; Sacher F, 2006, CIRCULATION, V114, P2317, DOI 10.1161/CIRCULATIONAHA.106.628537; Conte G, 2013, EUR HEART J, V34, P319, DOI 10.1093/eurheartj/ehs415; Conte G, 2014, EUROPACE, V16, P528, DOI 10.1093/europace/eut309; De Maria E, 2013, HEART RHYTHM, V10, P1807, DOI 10.1016/j.hrthm.2013.08.008; Juang J. -M., 2005, ACTA CARDIOL SIN, V21, P62; Kells John, 2011, Int J Pharm Compd, V15, P102; Matsuo K, 2003, PACE, V26, P1551, DOI 10.1046/j.1460-9592.2003.t01-1-00227.x; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Shimizu W, 2007, J CARDIOVASC ELECTR, V18, P415, DOI 10.1111/j.1540-8167.2006.00743.x	21	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	AUG	2015	8	4					785	791		10.1161/CIRCEP.114.002705		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP2XH	WOS:000359740500008		
J	Rodriguez-Manero, M; de Asmundis, C; Sacher, F; Arbelo, E; Probst, V; Castro-Hevia, J; Maury, P; Rollin, A; Lambiase, P; Garcia-Bolao, I; Chierchia, GB; Kusano, KF; Gourraud, JB; Schilling, R; Kamakura, T; Martinez-Sande, JL; Haissaguerre, M; Gonzalez-Juanatey, JR; Brugada, J; Brugada, P				Rodriguez-Manero, Moises; de Asmundis, Carlo; Sacher, Frederic; Arbelo, Elena; Probst, Vincent; Castro-Hevia, Jesus; Maury, Philippe; Rollin, Anne; Lambiase, Pier; Garcia-Bolao, Ignacio; Chierchia, Gian-Battista; Kusano, Kengo Fukushima; Gourraud, Jean-Baptiste; Schilling, Richard; Kamakura, Tsukasa; Luis Martinez-Sande, Jose; Haissaguerre, Michel; Ramon Gonzalez-Juanatey, Jose; Brugada, Jose; Brugada, Pedro			T-Wave Oversensing in Patients With Brugada Syndrome: True Bipolar Versus Integrated Bipolar Implantable Cardioverter Defibrillator Leads Multicenter Retrospective Study	CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY			English	Article						arrhythmias; cardiac; Brugada syndrome; defibrillators; implantable; electric countershock; follow-up studies	QT SYNDROME; REPOLARIZATION; THERAPY; FAILURE; SYSTEMS	Background It is thought that dedicated bipolar are more susceptible to T-wave oversensing when compared with integrated bipolar leads. This could be of extreme importance in patients with Brugada syndrome (BrS) because T-wave oversensing in this population is more frequent when compared with other implantable cardioverter defibrillator (ICD) recipients without BrS. We aimed to compare the incidence of T-wave oversensing in patients with BrS according to the type of lead (integrated bipolar versus true/dedicated bipolar). Methods and Results All patients diagnosed with BrS with an ICD implant in 10 tertiary hospitals between 1993 and 2013 were included in the study. A total of 480 patients were included (mean age, 45.614 years). During a mean follow-up of 74.9 +/- 51.7 months (median, 69; range, 2-236), 28 patients had T-wave oversensing (5.8%), leading to inappropriate shock in 18 (3.8%). All these events occurred in patients with true bipolar ICD leads (P=0.01) and in 2 patients it was solved instantaneously by changing the configuration from a dedicated to an integrated bipolar sensing configuration. In the stepwise multivariate models, only integrated bipolar ICD leads (hazard ratio, 0.34; 95% confidence interval, 0.171-0.675; P=0.002) was independent predictor of non-T-wave oversensing. Conclusions T-wave oversensing is a potential reason of inappropriate shocks in patients with BrS receiving ICDs. In the vast majority it can be solved by reprogramming. However, in some patients it still requires invasive intervention. Importantly, incidence is significantly lower using an integrated bipolar lead system when compared with a dedicated bipolar lead system and hence the latter should be routinely used in BrS cases.	[Rodriguez-Manero, Moises; Luis Martinez-Sande, Jose; Ramon Gonzalez-Juanatey, Jose] Hosp Clin Univ Santiago de Compostela CHUS, Santiago De Compostela, Spain; [de Asmundis, Carlo; Chierchia, Gian-Battista; Brugada, Pedro] Vrije Univ Brussel, Dept Cardiol, Brussels, Belgium; [Sacher, Frederic; Haissaguerre, Michel] Bordeaux Univ Hosp, LIRYC Inst, INSERM 1045, Bordeaux, France; [Arbelo, Elena; Brugada, Jose] Hosp Clin Univ Barcelona, Inst Thorax, Barcelona, Spain; [Probst, Vincent; Gourraud, Jean-Baptiste] CHU Nantes, F-44035 Nantes 01, France; [Castro-Hevia, Jesus] Inst Cardiol & Cirugia Cardiovasc, Havana, Cuba; [Maury, Philippe; Rollin, Anne] CHU Toulouse, Toulouse, France; [Lambiase, Pier; Schilling, Richard] St Bartholomews Hosp, London, England; [Garcia-Bolao, Ignacio] Univ Navarra Clin, Pamplona, Spain; [Kusano, Kengo Fukushima; Kamakura, Tsukasa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan	Rodriguez-Manero, M (reprint author), Clin Univ Hosp Santiago de Compostela, Div Cardiac Electrophysiol, Dept Cardiol, Travesia Choupana SN, Santiago De Compostela, Spain.	moirmanero@gmail.com	probst, vincent/D-4996-2015		Biosense-Webster; Biotronik; Medtronic; Boston Scientific; St Jude Medical; Sorin Group; Sanofi-Aventis	Dr Rodriguez-Manero receives compensation for teaching purpose from Biotronik. Drs de Asmundis and Chierchia receive compensation for teaching purposes and proctoring from AF solution Medtronic. Drs Brugada, Asmundis, and Chierchia receive research grants on behalf of the center from Biotronik, Medtronic, St Jude Medical, Sorin Boston Scientific and speakers fees from Biosense-Webster, Biotronik, Medtronic, Boston Scientific. Dr Sacher receives speaking honorarium from Biosense Webster, Medtronic, St Jude Medical, Sorin Group, Boehringer Ingelheim, Bayer, Pfizer, consulting fees from St Jude Medical, Sorin Group and research grant from Medtronic, Sanofi-Aventis. Dr Probst receives consulting fees from Boston Scientific, Medtronic and St Jude Medical. Dr Garcia-Bolao receives research grant from Boston Scientific and compensation for teaching purposes and proctoring from Boston Scientific. Dr Fukushima Kusano receives speaking honorarium from Bayer, Bristol Myers, Boehringer Ingelheim, and Pfizer. The other authors report no conflicts.	Schimpf R, 2003, J CARDIOVASC ELECTR, V14, P1273, DOI 10.1046/j.1540-8167.2003.03278.x; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391; Sacher F, 2013, CIRCULATION, V128, P1739, DOI 10.1161/CIRCULATIONAHA.113.001941; Sacher F, 2006, CIRCULATION, V114, P2317, DOI 10.1161/CIRCULATIONAHA.106.628537; Degeratu FT, 2000, J CARDIOVASC ELECTR, V11, P21, DOI 10.1111/j.1540-8167.2000.tb00730.x; Frain BH, 2007, J CARDIOVASC ELECTR, V18, P192, DOI 10.1111/j.1540-8167.2006.00714.x; Freedman RA, 2009, PACE, V32, P157, DOI 10.1111/j.1540-8159.2008.02197.x; Gilliam FR, 2006, J CARDIOVASC ELECTR, V17, P553, DOI 10.1111/j.1540-8167.2005.00350.x; Goldberger JJ, 1998, J CARDIOVASC ELECTR, V9, P677, DOI 10.1111/j.1540-8167.1998.tb00954.x; Jesel L, 2004, HEART RHYTHM, V1, pS244; Koul AK, 2004, PACE, V27, P681, DOI 10.1111/j.1540-8159.2004.00509.x; Maesato A, 2011, CIRC J, V75, P2095, DOI 10.1253/circj.CJ-11-0200; Menz V, 1998, J INTERV CARD ELECTR, V2, P269, DOI 10.1023/A:1009789004697; Perry GY, 1996, PACE, V19, P863, DOI 10.1111/j.1540-8159.1996.tb03372.x; Porres JM, 2004, PACE, V27, P1563, DOI 10.1111/j.1540-8159.2004.00677.x; Powell BD, 2012, PACE, V35, P863, DOI 10.1111/j.1540-8159.2012.03407.x; Requena-Carrion J, 2007, COMPUT CARDIOL, V34, P233; Seegers J, 2010, EUROPACE, V12, P1460, DOI 10.1093/europace/euq269; Stix G, 2000, J CARDIOVASC ELECTR, V11, P516, DOI 10.1111/j.1540-8167.2000.tb00004.x; Washizuka T, 2001, JPN CIRC J, V65, P927, DOI 10.1253/jcj.65.927	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	AUG	2015	8	4					792	798		10.1161/CIRCEP.115.002871		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP2XH	WOS:000359740500009		
J	Ohya, M; Kadota, K; Tada, T; Habara, S; Shimada, T; Amano, H; Izawa, Y; Hyodo, Y; Miyake, K; Otsuru, S; Hasegawa, D; Tanaka, H; Maruo, T; Katoh, H; Fuku, Y; Goto, T; Mitsudo, K				Ohya, Masanobu; Kadota, Kazushige; Tada, Takeshi; Habara, Seiji; Shimada, Takenobu; Amano, Hidewo; Izawa, Yu; Hyodo, Yusuke; Miyake, Koshi; Otsuru, Suguru; Hasegawa, Daiji; Tanaka, Hiroyuki; Maruo, Takeshi; Katoh, Harumi; Fuku, Yasushi; Goto, Tsuyoshi; Mitsudo, Kazuaki			Stent Fracture After Sirolimus-Eluting Stent Implantation 8-Year Clinical Outcomes	CIRCULATION-CARDIOVASCULAR INTERVENTIONS			English	Article						angiography; drug-eluting stent; myocardial infarction; percutaneous coronary intervention; stent fracture	MULTISLICE COMPUTED-TOMOGRAPHY; CORONARY REVASCULARIZATION; CARDIAC EVENTS; THROMBOSIS; IMPACT; PREDICTORS	Background Stent fracture (SF) after sirolimus-eluting stent implantation is reported to be associated with target lesion revascularization (TLR) and stent thrombosis. We aimed to assess the clinical impact of SF at 8 years. Methods and Results Between 2002 and 2005, 972 patients (1795 lesions) underwent sirolimus-eluting stent implantation and follow-up angiography within 1 year after index procedure. SF, defined as the complete separation of stent segments or stent struts at follow-up angiography, was observed in 105 lesions (5.8%). The study sample comprised 954 patients (1630 lesions), excluding 147 lesions undergoing TLR and 18 patients (18 lesions) who died or in whom stent thrombosis developed within 1 year after sirolimus-eluting stent implantation. The median follow-up duration was 9.1 years (the first and third quarters, 8.7 and 9.4 years). The primary end point was defined as any TLR. The 8-year cumulative rates of adverse events were estimated by Kaplan-Meier methods with P values from log-rank tests. Between patients with and without SF, there were no significant differences in the cumulative rates of all-cause death (23.5% versus 27.6%, P=0.35) and cardiac death (4.7% versus 9.1%, P=0.14), whereas patients with SF had significantly higher cumulative rates in myocardial infarction (10.1% versus 3.3%, P=0.001), very late stent thrombosis (6.8% versus 0.7%, P<0.001), any TLR (38.1% versus 10.8%, P<0.001), and clinically driven TLR (26.2% versus 6.6%, P<0.001). Conclusions SF after sirolimus-eluting stent implantation was consistently associated with higher rates of adverse cardiac events during the 8-year follow-up.	[Ohya, Masanobu; Kadota, Kazushige; Tada, Takeshi; Habara, Seiji; Shimada, Takenobu; Amano, Hidewo; Izawa, Yu; Hyodo, Yusuke; Miyake, Koshi; Otsuru, Suguru; Hasegawa, Daiji; Tanaka, Hiroyuki; Maruo, Takeshi; Katoh, Harumi; Fuku, Yasushi; Goto, Tsuyoshi; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama 7108602, Japan	Kadota, K (reprint author), Kurashiki Cent Hosp, Dept Cardiol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	k-kadota@lapis.plala.or.jp			Boston Scientific Corporation; Abbott Vascular	Dr Mitsudo received consulting and lecture fees from Boston Scientific Corporation. Dr Kadota received lecture fees from Abbott Vascular. The other authors report no conflicts.	Lee SWL, 2011, CATHETER CARDIO INTE, V78, P1101, DOI 10.1002/ccd.23101; Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011; Kuramitsu S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000703; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Chakravarty T, 2010, AM J CARDIOL, V106, P1075, DOI 10.1016/j.amjcard.2010.06.010; Mamas MA, 2014, CATHETER CARDIO INTE, V83, pE251, DOI 10.1002/ccd.25423; Hara H, 2013, CIRC J, V77, P988, DOI 10.1253/circj.CJ-12-0570; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Kuramitsu S, 2012, CIRC-CARDIOVASC INTE, V5, P663, DOI 10.1161/CIRCINTERVENTIONS.112.969238; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Ino Y, 2009, CIRC J, V73, P2036; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Popma JJ, 2009, AM J CARDIOL, V103, P923, DOI 10.1016/j.amjcard.2008.12.022; Umeda H, 2009, INT J CARDIOL, V133, P321, DOI 10.1016/j.ijcard.2007.12.067; Umeda H, 2011, CIRC-CARDIOVASC INTE, V4, P349, DOI 10.1161/CIRCINTERVENTIONS.110.958306; Chung WS, 2008, INT J CARDIOL, V125, P325, DOI 10.1016/j.ijcard.2007.02.033; Ito T, 2014, EUR RADIOL, V24, P1006, DOI 10.1007/s00330-014-3118-9; Ito T, 2011, CIRC J, V75, P2716, DOI 10.1253/circj.CJ-11-0461; Kimura Takeshi, 2011, Cardiovasc Interv Ther, V26, P234, DOI 10.1007/s12928-011-0065-0; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Windecker S, 2014, EUR HEART J, V35, P2541, DOI 10.1093/eurheartj/ehu278; Yamaji K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113870	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7640	1941-7632		CIRC-CARDIOVASC INTE	Circ.-Cardiovasc. Interv.	AUG	2015	8	8							e002664	10.1161/CIRCINTERVENTIONS.115.002664		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CP9GC	WOS:000360200800001		
J	Hirukawa, T; Kakuta, T; Nakamura, M; Fukagawa, M				Hirukawa, Takashi; Kakuta, Takatoshi; Nakamura, Michio; Fukagawa, Masafumi			Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Review						Bone; Parathyroid; CKD-MBD; Kidney transplantation; Calcium; Phosphorus	GROWTH-FACTOR 23; SUCCESSFUL RENAL-TRANSPLANTATION; CORONARY-ARTERY CALCIFICATION; VITAMIN-D METABOLITE; PERSISTENT HYPERPARATHYROIDISM; PARATHYROID-HORMONE; CALCIUM-METABOLISM; VASCULAR CALCIFICATION; SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR EVENTS	Given the advances in medical technologies related to kidney transplantation, the post-transplant graft survival rate and quality of life have improved dramatically. Nevertheless, post-transplant mortality rate still remains high as compared to the general population due to the development of cardiovascular events. It has recently been widely recognized that chronic kidney disease-mineral and bone disorders (CKD-MBD) significantly contribute to such poor prognosis at least in part. In the majority of kidney recipients, abnormal serum parameters for mineral and bone disorder (MBD), such as phosphorus, calcium, 1,25-dihydroxyvitamin D, parathyroid hormone and fibroblast growth factor 23, gradually return toward acceptable levels following the re-establishment of kidney function after transplantation; however, some irreversible abnormalities, developed as the result of long-term dialysis, persist, require treatment, or even progress after kidney transplantation. Thus, better management of CKD-MBD during pre-dialysis and dialysis period as well as after kidney transplantation is highly appreciated.	[Hirukawa, Takashi; Fukagawa, Masafumi] Tokai Univ, Div Nephrol Endocrinol & Metab, Dept Med, Sch Med, Isehara, Kanagawa 2591193, Japan; [Kakuta, Takatoshi] Tokai Univ, Div Nephrol Endocrinol & Metab, Dept Med, Hachioji Hosp, Hachioji, Tokyo, Japan; [Nakamura, Michio] Tokai Univ, Div Transplantat, Dept Surg, Sch Med, Isehara, Kanagawa 2591193, Japan	Fukagawa, M (reprint author), Tokai Univ, Div Nephrol Endocrinol & Metab, Dept Med, Sch Med, 143 Shimo Kasuya, Isehara, Kanagawa 2591193, Japan.	fukagawa@tokai-u.jp			Kyowa Hakko Kirin	Takashi Hirukawa declared no conflict of interest. Takatoshi Kakuta received honoraria from Kyowa Hakko Kirin and Chugai Pharmaceutical Co. Ltd, Japan. Michio Nakamura declared no conflict of interest. Masafumi Fukagawa received honoraria from Kyowa Hakko Kirin, Bayer Japan and Torii, manuscript fees from Kyowa Hakko Kirin, and research funding from Kyowa Hakko Kirin.	Ambuhl PM, 1999, AM J KIDNEY DIS, V34, P875, DOI 10.1016/S0272-6386(99)70045-4; Evenepoel P, 2004, NEPHROL DIAL TRANSPL, V19, P1281, DOI 10.1093/ndt/gfh128; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Gupta AK, 2012, J NEPHROL, V25, P373, DOI 10.5301/jn.5000015; Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Casez JP, 2002, NEPHROL DIAL TRANSPL, V17, P1318, DOI 10.1093/ndt/17.7.1318; Serra AL, 2005, NEPHROL DIAL TRANSPL, V20, P1315, DOI 10.1093/ndt/gfh925; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Bellows CG, 1999, CELL TISSUE RES, V297, P249, DOI 10.1007/s004410051353; Cianciolo G, 2014, AM J NEPHROL, V39, P418, DOI 10.1159/000362492; Schwarz A, 2007, NEPHROL DIAL TRANSPL, V22, P584, DOI 10.1093/ndt/gfl583; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Felsenfeld AJ, 2012, AM J KIDNEY DIS, V60, P655, DOI 10.1053/j.ajkd.2012.03.024; Monier-Faugere MC, 2000, J AM SOC NEPHROL, V11, P1093; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Bergua C, 2008, TRANSPLANTATION, V86, P413, DOI 10.1097/TP.0b013e31817c13e1; DeLoach SS, 2009, NEPHROL DIAL TRANSPL, V24, P1314, DOI 10.1093/ndt/gfn753; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Hernandez D, 2005, KIDNEY INT, V67, P2015, DOI 10.1111/j.1523-1755.2005.00303.x; Abbott KC, 2001, ANN EPIDEMIOL, V11, P450, DOI 10.1016/S1047-2797(01)00226-5; Mazzaferro S, 2009, CLIN J AM SOC NEPHRO, V4, P685, DOI 10.2215/CJN.03930808; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Lehmann G, 2007, TRANSPL P, V39, P3153, DOI 10.1016/j.transproceed.2007.10.001; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Weisinger JR, 2006, CLIN J AM SOC NEPHRO, V1, P1300, DOI 10.2215/CJN.01510506; Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; Kandil E, 2010, AM J MED SCI, V339, P420, DOI 10.1097/MAJ.0b013e3181d8b6ff; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Carpenter TO, 2014, J CLIN INVEST, V124, P1587, DOI 10.1172/JCI72829; Serra AL, 2007, NEPHROL DIAL TRANSPL, V22, P577, DOI 10.1093/ndt/gfl560; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Nguyen PTH, 2010, NEPHROL DIAL TRANSPL, V25, P3773, DOI 10.1093/ndt/gfq268; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Kawarazaki H, 2011, THER APHER DIAL, V15, P481, DOI 10.1111/j.1744-9987.2011.00932.x; Kruse AE, 2005, NEPHROL DIAL TRANSPL, V20, P1311, DOI 10.1093/ndt/gfh924; de Sevaux RGL, 2003, NEPHRON CLIN PRACT, V93, pC21, DOI 10.1159/000066640; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Torres A, 2004, KIDNEY INT, V65, P705, DOI 10.1111/j.1523-1755.2004.00432.x; Canalis E, 2002, ANN NY ACAD SCI, V966, P73; Leca N, 2006, AM J TRANSPLANT, V6, P2391, DOI 10.1111/j.1600-6143.2006.01475.x; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; Balal M, 2005, CLIN NEPHROL, V63, P87; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Torres A, 2002, J AM SOC NEPHROL, V13, P551; Cejka D, 2008, AM J TRANSPLANT, V8, P1864, DOI 10.1111/j.1600-6143.2008.02327.x; Srinivas TR, 2006, CLIN J AM SOC NEPHRO, V1, P323, DOI 10.2215/CJN.00500705; Kanaan N, 2010, CLIN J AM SOC NEPHRO, V5, P1887, DOI 10.2215/CJN.00950110; Egbuna OI, 2007, CLIN TRANSPLANT, V21, P558, DOI 10.1111/j.1399-0012.2007.00690.x; Brandenburg VM, 2004, TRANSPLANTATION, V77, P1566, DOI 10.1097/01.tp.0000131990.13277.28; Sprague SM, 2008, AM J NEPHROL, V28, P246, DOI 10.1159/000110875; Taniguchi M, 2006, KIDNEY INT, V70, P363, DOI 10.1038/sj.ki.5001549; Evenepoel P, 2007, AM J TRANSPLANT, V7, P1193, DOI 10.1111/j.1600-6143.2007.01753.x; BAGNI B, 1994, EUR J NUCL MED, V21, P108; Bhan I, 2006, KIDNEY INT, V70, P1486, DOI 10.1038/sj.ki.5001788; Bozkaya G, 2008, TRANSPL P, V40, P151, DOI 10.1016/j.transproceed.2007.11.040; Caravaca F, 1998, NEPHROL DIAL TRANSPL, V13, P2605, DOI 10.1093/ndt/13.10.2605; Chadban S, 2010, NEPHROLOGY, V15, pS48, DOI 10.1111/j.1440-1797.2010.01234.x; Copley JB, 2011, CLIN TRANSPLANT, V25, P24, DOI 10.1111/j.1399-0012.2010.01287.x; Cruz DN, 2001, TRANSPLANTATION, V72, P83, DOI 10.1097/00007890-200107150-00017; CUNDY T, 1983, Q J MED, V52, P67; El-Agroudy AE, 2003, J AM SOC NEPHROL, V14, P2975, DOI 10.1097/01.ASN.0000093255.56474.B4; Evenepoel P, 2013, SEMIN NEPHROL, V33, P191, DOI 10.1016/j.semnephrol.2012.12.019; Fleseriu M, 2007, OSTEOPOROSIS INT, V18, P363, DOI 10.1007/s00198-006-0238-3; HAHN TJ, 1981, J CLIN ENDOCR METAB, V52, P111; Iwasaki Y, 2006, KIDNEY INT, V70, pS34, DOI 10.1038/sj.ki.5001600; KDIGO Clinical Practice Guideline for the Diagnosis, 2009, KIDNEY INT S113, V76, pS1; Komaba H, 2010, KIDNEY INT, V78, P953, DOI 10.1038/ki.2010.283; Kruse AE, 2007, NEPHROL DIAL TRANSPL, V22, P2362, DOI 10.1093/ndt/gfm270; Kunzendorf U, 2008, NEPHROL DIAL TRANSPL, V23, P450, DOI 10.1093/ndt/gfm816; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Małyszko J, 2006, Adv Med Sci, V51, P69; Malyszko J., 2003, Transplantation Proceedings, V35, P1351, DOI 10.1016/S0041-1345(03)00523-2; Nakamura M, 2013, THER APHER DIAL, V17, P551, DOI 10.1111/1744-9987.12018; Nikkel EL, 2012, AM J TRANSPLANT, V12, P649; Riella LV, 2011, AM J KIDNEY DIS, V57, P641, DOI 10.1053/j.ajkd.2010.11.024; Roe SD, 2005, OSTEOPOROSIS INT, V16, P142, DOI 10.1007/s00198-004-1653-y; SAHA HHT, 1994, SCAND J UROL NEPHROL, V28, P21; Stenman-Bareen CO, 2000, KIDNEY INT, V58, P2200; Tominaga Y, 1997, SEMIN SURG ONCOL, V13, P78, DOI 10.1002/(SICI)1098-2388(199703/04)13:2<78::AID-SSU3>3.0.CO;2-Z; Zhang R, 2012, WORLD J NEPHROL, V6, P127; Zisman AL, 2006, ADV CHRONIC KIDNEY D, V13, P35, DOI 10.1053/j.ack-d.2005.10.008	87	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					543	555		10.1007/s10157-015-1117-z		13	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800001		
J	Liu, KY; Yorozuya, T; Adachi, N; Motoki, A; Ninomiya, K; Mabuchi, H; Iwamoto, N; Nishibori, M				Liu, Keyue; Yorozuya, Toshihiro; Adachi, Naoto; Motoki, Atsuko; Ninomiya, Kanji; Mabuchi, Hisao; Iwamoto, Noriyuki; Nishibori, Masahiro			Suppression of peritoneal thickening by histamine in a mouse model of peritoneal scraping	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Histamine; Inflammation; Mice; Peritoneal dialysis; Peritonitis	GLYCATION END-PRODUCTS; RECEPTOR STIMULATION; CAPD PATIENTS; LIVER-INJURY; SCLEROSIS; RATS; ISCHEMIA; PHASE	Inflammatory reactions play an important role in peritoneal sclerosis in patients on peritoneal dialysis. Since histamine affects inflammatory reactions and immune responses, we investigated effects of intraperitoneal administration of histamine on peritonitis induced by mechanical scraping in mice. After anesthesia, the right peritoneum was scraped 90 times over 1 min, and bilateral peritonea were observed by light microscopy after 7 days. Thickness of the peritoneal membrane on the right side was 174 +/- A 77 A mu m (mean +/- A SD, n = 8), while that on the left side was 24 +/- A 19 A mu m. Intraperitoneal administration of histamine (0.3 or 1.0 mmol/L, 0.5 mL each) twice daily for 7 days after scraping decreased thickness of the right peritoneum to 42 and 43 % of that in saline-injected animals, respectively (P < 0.01), although histamine (0.1 mmol/L) did not affect it. Promethazine (5 nmol, twice daily for 7 days), a histamine H-1 receptor antagonist, abolished the amelioration caused by histamine (1.0 mmol/L). Neither ranitidine (15 nmol), a histamine H-2 receptor antagonist, nor thioperamide (7.5 nmol), a histamine H-3/H-4 receptor antagonist, affected the outcome in histamine-treated mice. These findings indicate that histamine H-1 action partly prevents the development of peritoneal fibrosis caused by mechanical scraping.	[Liu, Keyue; Nishibori, Masahiro] Okayama Univ, Dept Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Yorozuya, Toshihiro] Ehime Univ, Grad Sch Med, Dept Anesthesia & Perioperat Med, Matsuyama, Ehime 7910295, Japan; [Adachi, Naoto; Ninomiya, Kanji; Mabuchi, Hisao] Mabuchi Clin, Shimogyo Ku, Kyoto, Kyoto 6008357, Japan; [Motoki, Atsuko] Japanese Red Cross Kyoto Daini Hosp, Dept Anesthesia, Kyoto 6028026, Japan; [Iwamoto, Noriyuki] Tojinkai Toju En, Kyoto 6128154, Japan	Adachi, N (reprint author), Mabuchi Clin, Shimogyo Ku, Kakimoto Cho 590-4, Kyoto, Kyoto 6008357, Japan.	nadachi@m.ehime-u.ac.jp					Adachi N, 2005, BRAIN RES REV, V50, P275, DOI 10.1016/j.brainreserv.2005.08.002; Adachi N, 2006, EUR J PHARMACOL, V544, P181, DOI 10.1016/j.ejphar.2006.06.053; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Nishimura H, 2008, AM J PHYSIOL-RENAL, V294, pF1084, DOI 10.1152/ajprenal.00565.2007; Gutzmer R, 2005, J IMMUNOL, V174, P5224; Numata M, 2004, CLIN NEPHROL, V62, P455; Hiraga N, 2007, EUR J PHARMACOL, V557, P236, DOI 10.1016/j.ejphar.2006.11.020; Coneely J, 2010, J SURG RES, V164, pE73, DOI 10.1016/j.jss.2010.04.035; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; El-Mahdy NA, 2013, J IMMUNOTOXICOL, V10, P9, DOI 10.3109/1547691X.2012.684158; DABROWSKI R, 1981, AGENTS ACTIONS, V11, P122, DOI 10.1007/BF01991479; HIRASAWA N, 1987, J PHARMACOL EXP THER, V241, P967; ITOH Y, 1992, J NEUROCHEM, V58, P884, DOI 10.1111/j.1471-4159.1992.tb09339.x; Motoki A, 2008, BASIC CLIN PHARMACOL, V102, P394, DOI 10.1111/j.1742-7843.2008.00219.x; Nakamura S, 2004, SEMIN NEPHROL, V24, P502, DOI 10.1016/j.semnephrol.2004.06.027; Tanaka S, 2006, J PHARMACOL SCI, V101, P19, DOI 10.1254/jphs.FMJ06001X5; Weller K, 2006, FASEB J, V20, pE1628	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					562	566		10.1007/s10157-014-1027-5		5	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800003		
J	Kadoya, H; Satoh, M; Nagasu, H; Sasaki, T; Kashihara, N				Kadoya, Hiroyuki; Satoh, Minoru; Nagasu, Hajime; Sasaki, Tamaki; Kashihara, Naoki			Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Endothelial nitric oxide synthase; Mesenchymal cell; Peritoneal fibrosis; Soluble guanylate cyclase stimulator	BLOOD-FLOW; DIALYSIS; ANGIOGENESIS; MEMBRANE; DISEASE; INHIBITION; MECHANISMS; SYNTHASE; THERAPY; WOUNDS	Long-term peritoneal dialysis (PD) causes peritoneal dysfunction and structural alterations, eventually leading to peritoneal fibrosis. The endothelial nitric oxide synthase (eNOS)-NO signaling pathway contributes to the progression of organ fibrosis. However, it remains unknown whether NO signaling is involved in the process of peritoneal fibrosis. We evaluated the role of the eNOS-NO signaling pathway in the development of peritoneal fibrosis and whether stimulation of soluble guanylate cyclase (sGC), a downstream effector of NO, could attenuate peritoneal fibrosis. We used wild-type (WT) and eNOS-deficient mice (eNOSKO). The mice underwent mechanical peritoneal stripping-induced peritoneal fibrosis at day 0. At 3, 7, 14, and 28 days after peritoneal stripping, the mice were killed. In some eNOSKO mice, the sGC stimulator Bay 41-2272 was administered by intraperitoneal injection. In WT mice, granulomatous tissue formation was observed in the submesothelial area at days 3 and 7. After day 7, the peritoneal membrane thickness gradually decreased and peritoneal tissue was repaired with leaving only slight fibrosis at day 28. However, eNOSKO mice demonstrated more progression of peritoneal fibrosis than WT mice at 28 days after peritoneal stripping. Expression of vimentin in the thickened peritoneum was prolonged after day 7 in eNOSKO mice. Treatment with Bay 41-2272 significantly attenuated peritoneal vimentin expression and fibrosis in the eNOSKO mice. Disruption of the eNOS-NO signaling pathway exacerbates peritoneal fibrosis by delaying wound healing. sGC stimulation may be a useful therapy for prevention of peritoneal fibrosis.	[Kadoya, Hiroyuki; Satoh, Minoru; Nagasu, Hajime; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Univ, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan	Satoh, M (reprint author), Kawasaki Med Univ, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan.	msatoh@med.kawasaki-m.ac.jp			Kawasaki Medical School	This study was supported by a Research Project Grant from Kawasaki Medical School. We wish to thank Ms. Etsuko Yorimasa, Ms. Miki Ishihara, and Ms. Miyuki Yokohata for animal care, and Ms. Satomi Hanada, Ms. Keiko Satoh, and Ms. Yoshiko Shirakiya for help with in vitro experiments.	Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Li N, 2013, MOL CANCER THER, V12, P1848, DOI 10.1158/1535-7163.MCT-13-0048; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Pletinck A, 2012, NAT REV NEPHROL, V8, P542, DOI 10.1038/nrneph.2012.144; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Amadeu TP, 2006, J CUTAN PATHOL, V33, P465, DOI 10.1111/j.1600-0560.2006.00472.x; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; ALBINA JE, 1990, J IMMUNOL, V144, P3877; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; Schaffer MR, 1999, EUR J SURG, V165, P262; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600; BUCALA R, 1994, MOL MED, V1, P71; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Amadeu TP, 2008, J SURG RES, V149, P84, DOI 10.1016/j.jss.2007.10.015; Beyer C, 2012, ANN RHEUM DIS, V71, P1019, DOI 10.1136/annrheumdis-2011-200862; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gokal R, 1999, LANCET, V353, P823, DOI 10.1016/S0140-6736(98)09410-0; Hung KY, 2008, NEPHROL DIAL TRANSPL, V23, P3831, DOI 10.1093/ndt/gfn369; Ishii Y, 2001, NEPHROL DIAL TRANSPL, V16, P1262, DOI 10.1093/ndt/16.6.1262; Kazakov A, 2013, CARDIOVASC RES; Kim YD, 2008, J GASTROEN HEPATOL, V23, P110, DOI 10.1111/j.1440-1746.2007.05250.x; Kotzki S, 2013, J PHARMACOL EXP THER, V346, P424, DOI 10.1124/jpet.113.205484; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS19; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Meuten T, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-62; Miyamoto T, 2010, NEPHROL DIAL TRANSPL, V25, P1109, DOI 10.1093/ndt/gfp601; Pastan S, 1998, NEW ENGL J MED, V338, P1428, DOI 10.1056/NEJM199805143382006; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1; Sherif AM, 2006, NEPHROL DIAL TRANSPL, V21, P1675, DOI 10.1093/ndt/gfl054; Sun D, 2012, LIFE SCI, V90, P900, DOI 10.1016/j.lfs.2012.04.018; van Guldener C, 1998, NEPHROL DIAL TRANSPL, V13, P1782, DOI 10.1093/ndt/13.7.1782	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					567	575		10.1007/s10157-014-1029-3		9	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800004		
J	Utami, SB; Mahati, E; Li, PL; Maharani, N; Ikeda, N; Bahrudin, U; Munemura, C; Hosoyamada, M; Yamamoto, Y; Yoshida, A; Nakayama, Y; Higaki, K; Nanba, E; Ninomiya, H; Shirayoshi, Y; Ichida, K; Yamamoto, K; Hosoya, T; Hisatome, I				Utami, Sulistiyati Bayu; Mahati, Endang; Li, Peili; Maharani, Nani; Ikeda, Nobuhito; Bahrudin, Udin; Munemura, Chishio; Hosoyamada, Makoto; Yamamoto, Yasutaka; Yoshida, Akio; Nakayama, Yuji; Higaki, Katsumi; Nanba, Eiji; Ninomiya, Haruaki; Shirayoshi, Yasuaki; Ichida, Kimiyoshi; Yamamoto, Kazuhiro; Hosoya, Tatsuo; Hisatome, Ichiro			Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						FJHN; Uromodulin; Protein instability; Apoptosis; Topiroxostat	TAMM-HORSFALL GLYCOPROTEIN; JUVENILE HYPERURICAEMIC NEPHROPATHY; ENDOPLASMIC-RETICULUM; URINARY GLYCOPROTEIN; PROTEIN; MUTATIONS; DYSFUNCTION; IMPAIRMENT; MECHANISM; RELEASE	Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant disorder caused by mutations in UMOD that encodes uromodulin. Topiroxostat, a novel non-purine analog, selectively inhibits xanthine oxidase and reduces the serum uric acid levels and the urinary albuminuria. Genomic DNA of a patient was extracted from peripheral white blood. Exons and flanking sequences of UMOD were amplified by PCR with primers. Mutation analysis was performed by direct sequencing of the PCR products. The wild-type and mutant uromodulin were expressed in HEK293 cells and analyzed by western blotting, immunoprecipitation, immunofluorescence, and flow cytometry. We identified an FJHN patient who carried a novel UMOD mutation G335A (C112Y). The levels of both cytosolic and secreted C112Y protein were significantly decreased compared with the wild-type, whereas the level of ubiquitination was higher in C112Y than that in the wild type. The half-life of C112Y was shortened and it was restored by a proteasome inhibitor MG132. Immunofluorescence revealed decreased levels of C112Y in the Golgi apparatus and on the plasma membrane. Expression of C112Y induced cellular apoptosis as revealed by flow cytometry. Apoptosis induced by C112Y was suppressed by topiroxostat. C112Y causes its protein instability resulting cellular apoptosis which could be suppressed with topiroxostat.	[Utami, Sulistiyati Bayu; Mahati, Endang; Li, Peili; Maharani, Nani; Ikeda, Nobuhito; Yamamoto, Yasutaka; Yoshida, Akio; Shirayoshi, Yasuaki; Hisatome, Ichiro] Tottori Univ, Dept Genet Med & Regenerat Therapeut, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut,Grad Sch Med Sci, Yonago, Tottori 6838503, Japan; [Utami, Sulistiyati Bayu; Bahrudin, Udin] Diponegoro Univ, Dept Cardiol & Vasc Med, Fac Med, Semarang, Indonesia; [Munemura, Chishio] Tottori Univ, Dept Multidisciplinary Internal Med, Div Med & Clin Sci, Sch Med,Fac Med, Yonago, Tottori 6838503, Japan; [Hosoyamada, Makoto] Teikyo Univ, Fac Pharma Sci, Dept Human Physiol & Pathol, Tokyo 173, Japan; [Nakayama, Yuji; Higaki, Katsumi; Nanba, Eiji] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Yonago, Tottori 6838503, Japan; [Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo, Japan; [Yamamoto, Kazuhiro] Tottori Univ, Dept Mol Med & Therapeut, Div Cardiovasc Med, Yonago, Tottori 6838503, Japan; [Hosoya, Tatsuo] Jikei Univ, Sch Med, Dept Pathophysiol & Therapy Chron Kidney Dis, Minato Ku, Tokyo, Japan	Li, PL (reprint author), Tottori Univ, Dept Genet Med & Regenerat Therapeut, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut,Grad Sch Med Sci, 86 Nishichou, Yonago, Tottori 6838503, Japan.	peili-li@med.tottori-u.ac.jp			Sanwa Kagaku Kenkyusho Co., Ltd.; Fuji Yakuhin Co., Ltd.	This study was partially supported by Sanwa Kagaku Kenkyusho Co., Ltd. and Fuji Yakuhin Co., Ltd.	Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Bahrudin U, 2008, J MOL BIOL, V384, P896, DOI 10.1016/j.jmb.2008.09.070; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; BACHMANN S, 1985, HISTOCHEMISTRY, V83, P531, DOI 10.1007/BF00492456; Branza-Nichita N, 2002, BIOCHEM BIOPH RES CO, V296, P470, DOI 10.1016/S0006-291X(02)00907-5; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Hosoya T, 2014, CLIN EXP NEPHROL; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; YU CL, 1993, IMMUNOPHARMACOLOGY, V26, P249, DOI 10.1016/0162-3109(93)90041-N	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					576	584		10.1007/s10157-014-1032-8		9	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800005		
J	Yatabe, MS; Yatabe, J; Takano, K; Sanada, H; Kimura, J; Watanabe, T				Yatabe, Midori Sasaki; Yatabe, Junichi; Takano, Kozue; Sanada, Hironobu; Kimura, Junko; Watanabe, Tsuyoshi			Effects of renal Na+/Ca2+ exchanger 1 inhibitor (SEA0400) treatment on electrolytes, renal function and hemodynamics in rats	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Na+/Ca2+ exchanger 1 (NCX1); Blood pressure; Calcium; Phosphate; Aldosterone; Renal vasculature; Urinary protein	SALT-SENSITIVE HYPERTENSION; SODIUM-CALCIUM EXCHANGE; VASCULAR-RESISTANCE; CA2+ ENTRY; EXPRESSION; TYPE-1; ARTERIOLES; TUBULE; INJURY	Na+/Ca2+ exchanger 1 (NCX1) controls intracellular Ca2+ concentration in various cell types. In the kidney, NCX1 is expressed mainly in the distal tubular basolateral membrane as well as in vascular smooth muscle. Tubular NCX1 is involved in Ca2+ reabsorption, and NCX1 in renal arterioles may control intraglomerular pressure. However, the functions of renal NCX1 have not been studied in vivo. Therefore, this study examined the effects of renal NCX1 blockade on water and solute metabolism, renal function and blood pressure in rats. Wistar-Kyoto rats were uninephrectomized, and an osmotic mini pump was implanted to infuse the remnant kidney cortex with a specific NCX1 inhibitor, SEA0400 (SEA), or vehicle for 7 days. Serum Ca2+ concentration and urinary Ca2+ excretion were similar between the vehicle- and SEA-treated groups. However, serum phosphate was significantly decreased by 8 % in the SEA group, with similar urinary phosphate excretion between the two groups. Systolic blood pressure was higher in the SEA group (117 +/- A 3 vs. 126 +/- A 1 mmHg, n = 9-11), with a 1.6-fold increase in plasma aldosterone concentration. However, SEA significantly reduced urinary protein excretion and the glomerular sectional area by 16 and 8 %, respectively. Similar experiment in spontaneously hypertensive rats produced different results. Renal SEA treatment reduced serum phosphate concentration, urinary protein and glomerular size with higher systemic blood pressure compared to control Wistar-Kyoto rats. Further study on renal NCX1 may be beneficial in delineating the pathophysiology of glomerular pressure control and calcium/phosphate regulations.	[Yatabe, Midori Sasaki; Yatabe, Junichi; Takano, Kozue; Kimura, Junko] Fukushima Med Univ, Dept Pharmacol, Sch Med, Fukushima 9601295, Japan; [Yatabe, Midori Sasaki; Yatabe, Junichi; Watanabe, Tsuyoshi] Fukushima Med Univ, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Sch Med, Fukushima 9601295, Japan; [Yatabe, Junichi; Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Chron Kidney Dis Initiat, Fukushima 9601295, Japan; [Sanada, Hironobu] Fukushima Welf Federat Agr Cooperat, Div Hlth Sci Res, Fukushima, Japan	Yatabe, MS (reprint author), Fukushima Med Univ, Dept Pharmacol, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	msasaki@fmu.ac.jp			JSPS KAKENHI [23790950]; Nishinomiya Basic Research Fund; Fukushima Medical University	We gratefully acknowledge the excellent technical assistance of Hiroko Ohashi, Atsuko Hashimoto, and Ayumi Haneda. We thank Taisho Pharmaceutical for providing SEA0400 reagent. This work was supported by JSPS KAKENHI Grant Number 23790950 (M.S.Y.), Nishinomiya Basic Research Fund (M.S.Y.), and a program project grant from Fukushima Medical University (M.S.Y.).	Yoneda M, 2005, HYPERTENSION, V46, P58, DOI 10.1161/01.HYP.0000171587.44736.ba; Yatabe J, 2008, HYPERTENS RES, V31, P1455, DOI 10.1291/hypres.31.1455; Arakawa N, 2000, BIOCHEM BIOPH RES CO, V279, P354, DOI 10.1006/bbrc.2000.3968; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Ren Y, 2007, KIDNEY INT, V71, P1116, DOI 10.1038/sj.ki.5002190; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Bell PD, 2000, ACTA PHYSIOL SCAND, V168, P209; BINDELS RJM, 1992, PFLUG ARCH EUR J PHY, V420, P566, DOI 10.1007/BF00374634; TROHLER U, 1981, AM J PHYSIOL, V241, pF509; DWORKIN LD, 1986, J CLIN INVEST, V77, P797, DOI 10.1172/JCI112377; Sanada H, 2006, HYPERTENSION, V47, P1131, DOI 10.1161/01.HYP.0000222004.74872.17; Fowler BC, 1996, KIDNEY INT, V50, P1856, DOI 10.1038/ki.1996.506; Iwamoto T, 2006, KIDNEY INT, V69, P2148, DOI 10.1038/sj.ki.5000421; Nelson LD, 1996, KIDNEY INT, V50, P1889, DOI 10.1038/ki.1996.510; Nelson LD, 1999, AM J PHYSIOL-RENAL, V276, pF567; Noble D, 2007, EMBO REP, V8, P228, DOI 10.1038/sj.embor.7400914; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250; Ren Y, 2009, HYPERTENSION, V53, P319, DOI 10.1161/HYPERTENSIONAHA.108.124545; Schweda F, 2001, PFLUG ARCH EUR J PHY, V442, P693, DOI 10.1007/s004240100591; Schweda F, 2001, AM J PHYSIOL-RENAL, V280, pF155; Yatabe MS, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-160	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					585	590		10.1007/s10157-014-1053-3		6	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800006		
J	Kuwahara, M; Mandai, S; Kasagi, Y; Kusaka, K; Tanaka, T; Shikuma, S; Akita, W				Kuwahara, Michio; Mandai, Shintaro; Kasagi, Yuri; Kusaka, Keita; Tanaka, Tomomi; Shikuma, Satomi; Akita, Wataru			Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Renal anemia; Responsiveness to ESA; Renal death	HEMODIALYSIS-PATIENTS; PREDIALYSIS PATIENTS; HEMOGLOBIN LEVEL; HEART-FAILURE; EPOETIN-ALPHA; ANEMIA; MORTALITY; OUTCOMES; HYPORESPONSIVENESS; ASSOCIATION	Renal anemia of chronic kidney disease (CKD) is generally treated by erythropoiesis-stimulating agents (ESAs). However, there are individual differences in patients' responsiveness to ESA, which may affect the prognosis of CKD. The effect of ESAs on hemoglobin was followed in 297 CKD patients with renal anemia. Three types of ESA, epoetin alfa or beta, darbepoetin alfa, and epoetin beta pegol, were used in this study and dose of ESA was converted to that of epoetin using a dose conversion ratio (epoetin:darbepoetin alfa:epoetin beta pegol = 200:1:0.93). After initial 12-week administration of ESAs, the patients were divided into three groups: poor, intermediate, and good responders based on Delta Hb/week/epoetin dose as an index. Hemoglobin values were followed for 144 weeks. Initial patient characteristics-including age, body mass index, hemoglobin, estimated glomerular filtration rate, transferrin saturation, ferritin, albumin, calcium, parathyroid hormone, C-reactive protein, and urine protein-were similar in the three responder groups, except phosphate in the poor responder group was significantly higher than in the other two groups. The period from ESA use to renal death (RD) was significantly shortest in the poor responder group, and the number of RD patients was fewer in the good responder group. Multivariate Cox regression revealed that low final Delta Hb(Delta Hb from ESA use to just before dialysis)/week/epoetin dose, and low Hb after 12-week ESA use were significant factors related to responsiveness to ESA, suggesting that hyporesponsiveness to ESA was a risk factor for RD. Cox regression also found that hyperphosphatemia and diabetic nephropathy were risks for RD as well. The study results suggest that hyporesponsiveness to ESA after the first 12-week administration as well as after 12 weeks is a risk for RD in pre-dialysis CKD patients. Furthermore, hyperphosphatemia and diabetic nephropathy are risk factors for RD.	[Kuwahara, Michio; Mandai, Shintaro; Kasagi, Yuri; Kusaka, Keita; Tanaka, Tomomi; Shikuma, Satomi; Akita, Wataru] Shuuwa Gen Hosp, Dept Nephrol, Kasukabe, Saitama 3440035, Japan	Kuwahara, M (reprint author), Shuuwa Gen Hosp, Dept Nephrol, 1200 Yahara Shinden, Kasukabe, Saitama 3440035, Japan.	kuwaharam@shuuwa-gh.or.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Minutolo R, 2012, NEPHROL DIAL TRANSPL, V27, P2880, DOI 10.1093/ndt/gfs007; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONHA.105.577577; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Rossert J, 2007, NEPHROL DIAL TRANSPL, V22, P794, DOI 10.1093/ndt/gf1716; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Panichi V, 2011, NEPHROL DIAL TRANSPL, V26, P2641, DOI 10.1093/ndt/gfq802; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Robinson BM, 2005, KIDNEY INT, V68, P2323, DOI 10.1111/j.1523-1755.2005.00693.x; Kuriyama S, 1997, NEPHRON, V77, P176; Silverberg DS, 2003, NEPHROL DIAL TRANSPL, V18, P141, DOI 10.1093/ndt/18.1.141; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; de Lurdes Agostinho Cabrita A, 2011, INT UROL NEPHROL, V43, P835; KDOQI, 2007, AM J KIDNEY DIS, V2007, P471; Kuwahara M, 2013, CLIN EXP NEPHROL; Kuwahara M, 2011, CLIN EXP NEPHROL, V15, P121, DOI 10.1007/s10157-010-0360-6; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P21; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; ROTH D, 1994, AM J KIDNEY DIS, V24, P777; Walker AM, 2006, J AM SOC NEPHROL, V17, P2293, DOI 10.1681/ASN.2005020183	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					598	605		10.1007/s10157-014-1023-9		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800008		
J	Horio, M; Imai, E; Yasuda, Y; Watanabe, T; Yokoyama, H; Makino, H; Matsuo, S				Horio, Masaru; Imai, Enyu; Yasuda, Yoshinari; Watanabe, Tsuyoshi; Yokoyama, Hitoshi; Makino, Hirofumi; Matsuo, Seiichi			Effects of serum albumin and glycated albumin levels on performance of the Japanese GFR equation based on serum cystatin C	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						GFR equation; Glycated albumin; Albumin; Accuracy	GLOMERULAR-FILTRATION-RATE; IMPACT	We reported that both serum albumin (Alb) and glycated albumin (GA) levels influenced the performance of the Japanese GFR equation based on serum creatinine. In the present study, we studied the effects of both markers on the estimated GFR by Japanese GFR equation based on serum cystatin C (Eq-cys). 715 Japanese subjects were included. GFR was measured by inulin renal clearance (Cin). Correlations between estimated GFR by Eq-cys (eGFRcys) and Cin were evaluated in subjects stratified by GA (GA-1: GA a parts per thousand currency sign 16.3 % and GA-2: GA a parts per thousand yen 16.4 %) and Alb levels (Alb-1: Alb a parts per thousand currency sign 3.5 g/dl and Alb-2: Alb a parts per thousand yen 3.6 g/dl). Correlation coefficients between eGFRcys and Cin were 0.863, 0.919, 0.948 and 0.974 in GA-1, GA-2, Alb-1 and Alb-2, respectively. Slopes (95 % confidential interval) of the regression lines with zero intercepts were 1.014 (0.993-1.035), 0.989 (0.944-1.033), 1.019 (0.970-1.068) and 1.011 (0.990-1.031), respectively. The slopes were not significantly different from 1.0, suggesting that Eq-cys performed well in subjects at wide spectrum of GA and Alb levels. Single regression analysis of GA on eGFRcys/GFR was not significant in total subjects and subjects with GA > 12.4 %. Single regression analysis of Alb on eGFRcys/GFR was significant in total subjects, but the correlation coefficient was very low (r = 0.08, p = 0.03). Multiple regression analysis showed that Alb and GA were not significantly associated with eGFRcys/Cin in subjects with GA > 12.4 %. These results suggested that both parameters were not important factors affecting the performance of Eq-cys. Performance of Eq-cys was well irrespective of GA and Alb levels. Both parameters were not important factors affecting the estimated GFR by Eq-cys.	[Horio, Masaru] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo, Japan; [Yasuda, Yoshinari] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi 4648601, Japan; [Watanabe, Tsuyoshi] Fukushima Med Univ, Dept Med 3, Fukushima, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Uchinada, Ishikawa 92002, Japan; [Makino, Hirofumi] Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama 7008530, Japan	Horio, M (reprint author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	horio@sahs.med.osaka-u.ac.jp			Japanese Society of Nephrology; JSPS KAKENHI, Japan [25305029]	This study was supported in part by the grant from the Japanese Society of Nephrology and JSPS KAKENHI Grant Number 25305029, Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Inker LA, 2011, CURR OPIN NEPHROL HY, V20, P631, DOI 10.1097/MNH.0b013e32834b8850; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Tsuda A, 2014, DIABETES CARE, V37, P596, DOI 10.2337/dc13-1899; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; Horio M, 2015, CLIN EXP NEPHROL, V19, P284, DOI 10.1007/s10157-014-0988-8; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					626	630		10.1007/s10157-014-1038-2		5	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800011		
J	Soji, K; Doi, S; Nakashima, A; Sasaki, K; Kawai, T; Aoki, A; Kyuden, Y; Fujiwara, K; Yokoyama, Y; Masaki, T				Soji, Kotaro; Doi, Shigehiro; Nakashima, Ayumu; Sasaki, Kensuke; Kawai, Toru; Aoki, Asuka; Kyuden, Yasufumi; Fujiwara, Kenta; Yokoyama, Yukio; Masaki, Takao			Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Aliskiren; Angiotensin II receptor blocker; Chronic kidney disease	CARDIORENAL END-POINTS; (PRO)RENIN RECEPTOR; RENIN; NEPHROPATHY; PROTEIN; TRIAL; RISK; TELMISARTAN; EXPRESSION; INHIBITORS	Combination therapy of aliskiren and an angiotensin II receptor blocker (ARB) has been reported to be effective for reducing the level of proteinuria. However, it remains unclear whether this combination therapy contributes to suppression of kidney disease progression. The aim of this study was to investigate the effect of aliskiren on hard renal endpoints, when added to an ARB, in patients with advanced chronic kidney disease (CKD). The study design was a prospective, randomized open-label design. 83 CKD patients (52 men and 31 women) were enrolled and assigned randomly to an aliskiren add-on group (n = 42) or control group (n = 41). Entry criteria included elevated serum creatinine a parts per thousand yen1.5 mg/dl, urine protein excretion (a parts per thousand yen1+ on urine dipstick test), and hypertension. All participants were treated with an ARB. The follow-up period was 12 months. 12 participants were withdrawn during the study period and the study was terminated in January 2012 as a consequence of the results of the interim analysis of the ALTITUDE study. Nine patients in the aliskiren group and seven patients in the control group started dialysis. Doubling of the serum creatinine level occurred in one patient in the control group. A Cox proportional hazards test showed that dual blockade of the renin-angiotensin-aldosterone system with aliskiren and ARB was not associated with improvement in hard renal endpoints. We conclude that aliskiren add-on therapy to an ARB may not give any benefit and, therefore, should not be recommended in CKD patients.	[Soji, Kotaro; Sasaki, Kensuke] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Nephrol, Hiroshima, Japan; [Doi, Shigehiro] Hiroshima Univ Hosp, Dept Blood Purificat, Hiroshima 7348551, Japan; [Nakashima, Ayumu] Hiroshima Univ Hosp, Dept Regenerat & Med, Hiroshima 7348551, Japan; [Kawai, Toru] Chuou Naika Clin, Kure, Japan; [Aoki, Asuka; Kyuden, Yasufumi; Fujiwara, Kenta] Kure Kyosai Hosp, Dept Nephrol, Kure, Japan; [Yokoyama, Yukio; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, Hiroshima 7348551, Japan	Masaki, T (reprint author), Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	masakit@hiroshima-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Staessen JA, 2006, LANCET, V368, P1449, DOI 10.1016/S0140-6736(06)69442-7; Parving HH, 2009, NEPHROL DIAL TRANSPL, V24, P1663, DOI 10.1093/ndt/gfn721; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; WATANABE N, 1986, CLIN CHEM, V32, P1551; Jafar TH, 2001, ANN INTERN MED, V135, P73; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Feldman DL, 2008, HYPERTENSION, V52, P130, DOI 10.1161/HYPERTENSIONAHA.107.108845; Miao Y, 2011, DIABETOLOGIA, V54, P44, DOI 10.1007/s00125-010-1922-6; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ichihara A, 2011, J RENIN-ANGIO-ALDO S, V12, P638, DOI 10.1177/1470320311429227; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Remuzzi G, 2002, ANN INTERN MED, V136, P604; Sakoda M, 2010, AM J HYPERTENS, V23, P575, DOI 10.1038/ajh.2009.273; Yusuf S, 2008, NEW ENGL J MED, V358, P1547	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					631	638		10.1007/s10157-014-1044-4		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800012		
J	Nagayama, Y; Nishiwaki, H; Hasegawa, T; Komukai, D; Kawashima, E; Takayasu, M; Tayama, H; Inoue, Y; Inui, K; Yoshimura, A				Nagayama, Yoshikuni; Nishiwaki, Hiroki; Hasegawa, Takeshi; Komukai, Daisuke; Kawashima, Eri; Takayasu, Mamiko; Tayama, Hironori; Inoue, Yoshihiko; Inui, Kiyoko; Yoshimura, Ashio			Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; Tonsillectomy; Steroid pulse therapy; Risk	IMMUNOGLOBULIN-A NEPHROPATHY; NATURAL-HISTORY; PROTEINURIA; PROGNOSIS; PROGRESSION; NEPHRITIS; HEMATURIA; PREDICT	In 2011, the Japanese Society of Nephrology (JSN) published new clinical guidelines for IgA nephropathy (IgAN) with a new risk stratification based on clinical and histological severity. For classification, patients are divided into four groups (low, medium, high, and very high risk). However, differences in responsiveness to each treatment among different groups remain unclear. We evaluate the responsiveness of tonsillectomy plus steroid pulse (TSP) therapy using the new risk stratification. We retrospectively reviewed 111 IgAN patients with TSP therapy between January 2003 and January 2013. Study patients were divided into three groups [low- (n = 40), medium- (n = 43) and high-/very high-risk group (n = 28)]. The primary outcome was clinical remission (CR). The observation period was 1 year following tonsillectomy. 57 out of 111 patients (51.4 %) reached CR. The CR incidence was 70.0, 41.9 and 39.3 % (the low-, the medium- and the high-/very high-risk group, respectively). The incidence of CR was significantly higher in the low-risk group (P = 0.013). In a multivariate logistic regression analysis, both the medium- and the high-/very high-risk group showed significantly lower incidence of inducing CR than the low-risk group [(odds ratio 0.324; 95 % confidence interval 0.106-0.939, P = 0.041) (odds ratio 0.239; 95 % confidence interval 0.058-0.910, P = 0.040), respectively]. The new risk stratification in the 2011 JSN clinical guidelines for IgAN had a positive impact on early CR of TSP therapy.	[Nagayama, Yoshikuni; Nishiwaki, Hiroki; Hasegawa, Takeshi; Komukai, Daisuke; Kawashima, Eri; Takayasu, Mamiko; Tayama, Hironori; Inoue, Yoshihiko; Inui, Kiyoko; Yoshimura, Ashio] Showa Univ, Fujigaoka Hosp, Dept Med, Div Nephrol,Aoba Ku, Yokohama, Kanagawa 2278501, Japan; [Nishiwaki, Hiroki; Hasegawa, Takeshi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan	Nagayama, Y (reprint author), Showa Univ, Fujigaoka Hosp, Dept Med, Div Nephrol,Aoba Ku, 1-30 Fujigaoka, Yokohama, Kanagawa 2278501, Japan.	ynaga1147@hotmail.co.jp		Nishiwaki, Hiroki/0000-0001-7365-7685			Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Ieiri N, 2012, CLIN EXP NEPHROL, V16, P122, DOI 10.1007/s10157-011-0530-1; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Miura N, 2009, CLIN EXP NEPHROL, V13, P460, DOI 10.1007/s10157-009-0179-1; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Matsuzaki K, 2013, CLIN EXP NEPHROL, V17, P827, DOI 10.1007/s10157-013-0779-7; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1053/ajkd.2001.22834; CHAUVEAU D, 1993, CONTRIB NEPHROL, V104, P1; DAMICO G, 1986, Q J MED, V59, P363; Hirano K, 2013, CLIN EXP NEPHROL, V17, P555, DOI 10.1007/s10157-012-0744-x; Matsuo S, 2011, JPN J NEPHROL, V53, P123; Sakai H, 1995, Nihon Jinzo Gakkai Shi, V37, P417; Suzuki K, 2014, CLIN EXP NEPHROL, V18, P606, DOI 10.1007/s10157-013-0867-8; Tatematsu M, 2012, CLIN EXP NEPHROL, V16, P883, DOI 10.1007/s10157-012-0644-0	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					646	652		10.1007/s10157-014-1052-4		7	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800014		
J	Akiyama, S; Akiyama, M; Imai, E; Ozaki, T; Matsuo, S; Maruyama, S				Akiyama, Shin'ichi; Akiyama, Mari; Imai, Enyu; Ozaki, Takenori; Matsuo, Seiichi; Maruyama, Shoichi			Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Phospholipase A2 receptor; Antibody; Membranous nephropathy; Prevalence; Japan; Western blot	NEPHROTIC SYNDROME; RISK-FACTORS; GLOMERULONEPHRITIS; PROGNOSIS; DISEASE	Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most patients with idiopathic MN (iMN) worldwide, but the prevalence of anti-PLA2R antibodies among Japanese patients with MN is unknown. In this study, we determined the prevalence of anti-PLA2R antibodies in Japanese patients with MN. The study population of our retrospective cross-sectional consisted of 131 patients with biopsy-proven MN who had not received any immunosuppressive treatments at time of both renal biopsy and serum sample collection. Of these, 100 had iMN and 31 had secondary MN (sMN). The circulating anti-PLA2R antibodies were analyzed using a highly sensitive Western blot analysis. Analysis was performed under non-reducing conditions with a human glomerular extract at serum dilutions of 1:25, 1:10, and 1 as the primary antibody. Anti-PLA2R antibodies were detected in 53 (53 %) of 100 patients with iMN and 0 (0 %) of 31 patients with sMN. The prevalence of anti-PLA2R antibodies was higher in patients with nephrotic syndrome (61 %) than in patients without nephrotic syndrome (43 %). The number of patients with serum albumin a parts per thousand currency sign3.0 g/dL was significantly higher in those with anti-PLA2R antibodies (92 %) than that in those without them (68 %). Anti-PLA2R antibodies were found in Japanese patients with iMN; however, the prevalence was lower than that of any other Asian country. This may indicate that the presence of other pathogenic antigens plays a significant role in Japanese patients with iMN.	[Akiyama, Shin'ichi; Akiyama, Mari; Ozaki, Takenori; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo 6650861, Japan	Maruyama, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	marus@med.nagoya-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; JSPS; Nagoya University Hospital; Aichi Kidney foundation	The authors would especially like to thank Drs. David Salant and Laurence Beck, Jr. (Boston University School of Medicine, Boston, USA) for providing the patient serum for positive or negative controls and for their helpful discussion on several points in the launching of our anti-PLA2R antibody research project. We also thank the Cosmic Corporation (Japan) for providing a free trial sample of the ELISA kit from Euroimmun AG. We acknowledge the physicians, clinical research assistants, and patients of Nagoya University Hospital, Kainan Hospital, Japanese Red Cross Nagoya Daiichi Hospital, Anjo Kosei Hospital, Ichinomiya Municipal Hospital, Handa City Hospital, Ogaki City Hospital, Nagoya Kyoritsu Hospital, Toyohashi Municipal Hospital, and Tsushima City Hospital who contributed to this study. This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan, a Grant-in-Aid for KAKENHI (Grants-in-Aid for Scientific Research) from JSPS, and Grants-in-Aid from Nagoya University Hospital and Aichi Kidney foundation.	Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Timmermans SAMEG, 2014, AM J CLIN PATHOL, V142, P29, DOI 10.1309/AJCP8QMOY5GLRSFP; Imai E, 2007, CLIN J AM SOC NEPHRO, V2, P1360, DOI 10.2215/CJN.00980207; Behnert A, 2014, J IMMUNOL RES, DOI 10.1155/2014/143274; OGI M, 1994, AM J KIDNEY DIS, V24, P427; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; HONKANEN E, 1994, CLIN NEPHROL, V41, P127; KIDA H, 1986, CLIN NEPHROL, V25, P64; Kitajima S, 2015, CLIN EXP NEPHROL, V19, P278, DOI 10.1007/s10157-014-0987-9; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8	17	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					653	660		10.1007/s10157-014-1054-2		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800015		
J	Wada, T; Nakao, T; Matsumoto, H; Okada, T; Nagaoka, Y; Iwasawa, H; Gondo, A; Niwata, A; Kanno, Y				Wada, Toshikazu; Nakao, Toshiyuki; Matsumoto, Hiroshi; Okada, Tomonari; Nagaoka, Yume; Iwasawa, Hideaki; Gondo, Asako; Niwata, Ami; Kanno, Yoshihiko			Relationship between dietary protein intake and the changes in creatinine clearance and glomerular cross-sectional area in patients with IgA nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Dietary protein intake; Chronic kidney disease; Glomerular hypertrophy; Glomerular hyperfiltration; Glomerular filtration rate	CHRONIC KIDNEY-DISEASE; RENAL-FAILURE; AMINO-ACID; PROGRESSION; RATS; ABLATION; DENSITY; INJURY; DAMAGE; JAPAN	Dietary protein intake (PI) induces glomerular hyperfiltration and reduced dietary PI can be effective in preserving kidney function. However, there is limited information regarding the relationship between dietary PI and glomerular histological changes in chronic kidney disease. We investigated the relationship between changes in dietary PI and both the changes in creatinine clearance and glomerular histomorphometry in adult patients with IgA nephropathy (IgAN). A total of 24 consecutive adult patients with biopsy-confirmed IgAN were enrolled and glomerular histomorphometric variables and clinical variables were investigated. The main clinical variables were differences in creatinine clearance (Ccr) (dCcr) and in PI (dPI) which were calculated by subtracting PI and Ccr values in patients on a controlled diet during hospitalization for kidney biopsy from the respective values in patients on daily diets as outpatients. These values of PI were estimated from urinary urea excretion measured by 24-h urine collection. The main renal histomorphometric variable was glomerular tuft area (GTA) (mu m(2)). dCcr positively correlated with dPI (r = 0.726, P < 0.001). GTA correlated positively with dPI (r = 0.556, P = 0.013). Multiple regression analysis showed that dPI was independently associated with both dCcr and GTA. Additionally, GTA positively correlated with dietary PI as outpatients (r = 0.457, P = 0.043). Changes in dietary PI were associated with the changes in glomerular filtration rate. Furthermore, histomorphometric findings suggested that a greater dietary PI can affect the glomerular size at the time of the initial diagnostic biopsy for IgAN.	[Wada, Toshikazu; Nakao, Toshiyuki; Matsumoto, Hiroshi; Okada, Tomonari; Nagaoka, Yume; Iwasawa, Hideaki; Gondo, Asako; Niwata, Ami; Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, Tokyo 1600023, Japan	Wada, T (reprint author), Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	toshi-wa@tokyo-med.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; HOSTETTER TH, 1986, KIDNEY INT, V30, P509, DOI 10.1038/ki.1986.215; Tsuboi N, 2009, NEPHROL DIAL TRANSPL, V24, P892, DOI 10.1093/ndt/gfn572; Kanda E, 2014, AM J NEPHROL, V39, P145, DOI 10.1159/000358262; Ohkawa S, 2013, NUTR RES, V33, P761, DOI 10.1016/j.nutres.2013.06.003; Garibotto G, 2010, CLIN NUTR, V29, P424, DOI 10.1016/j.clnu.2010.02.005; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Kramer H, 2006, CONTRIB NEPHROL, V151, P1; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; BRENNER BM, 1982, NEW ENGL J MED, V307, P652; DWORKIN LD, 1986, J CLIN INVEST, V77, P797, DOI 10.1172/JCI112377; Fouque D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001892.pub3; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85; Jia Y, 2010, J NUTR, V140, P1646, DOI 10.3945/jn.110.123034; Kataoka H, 2011, NEPHROL DIAL TRANSPL, V26, P3937, DOI 10.1093/ndt/gfr139; Kido Y, 2012, J NUTR SCI VITAM S, V59, pS36; Kusano K, 2008, J NUTR SCI VITAMINOL, V54, P237, DOI 10.3177/jnsv.54.237; Martin William F, 2005, Nutr Metab (Lond), V2, P25, DOI 10.1186/1743-7075-2-25; MEYER TW, 1983, T ASSOC AM PHYSICIAN, V96, P76; Mitch WE, 2000, KIDNEY INT, V57, pS38; Vleming LJ, 1998, CLIN NEPHROL, V49, P337; Wakefield AP, 2011, BRIT J NUTR, V106, P656, DOI 10.1017/S0007114511000730	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					661	668		10.1007/s10157-014-1055-1		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800016		
J	Yamada, Y; Noborisaka, Y; Ishizaki, M; Yamazaki, M; Honda, R; Yokoyama, H; Kakuma, T				Yamada, Yuichi; Noborisaka, Yuka; Ishizaki, Masao; Yamazaki, Michiko; Honda, Ryumon; Yokoyama, Hitoshi; Kakuma, Tatsuyuki			Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Smoking; Obesity; eGFR; Creatinine; Cystatin C	GLOMERULAR-FILTRATION-RATE; COMMUNITY-BASED POPULATION; CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; RISK; NEPHROPATHY; PROTEINURIA; PROGRESSION; MORTALITY; NICOTINE	Previous studies have shown that GFR estimated from serum creatinine (eGFRcr) is higher in smokers although the implications remain unclear. We aimed to clarify the associations of smoking with eGFRcys (GFR estimated from serum cystatin C) and eGFRcr, cys (the surmised most precise GFR estimate based on serum creatinine and cystatin C) in a working population. Cross-sectional observation in 1,587 male workers aged 25-64 years. For eGFRcr, JEQcr proposed by the Japanese Society of Nephrology (JSN) and jEPIcr by the Chronic Kidney Disease Epidemiological Collaboration (CKD-EPI) modified for Japanese, and for eGFRcys, JEQcys proposed by JSN and EPIcys by CKD-EPI were calculated together with eGFRcr,cys of JEQaver (the average of JEQcr and JEQcys) and jEPIcr,cys by CKD-EPI modified for Japanese. Mean JEQcys was 95.1 mL/min/1.73 m(2) in contrast to 80.9 in JEQcr, with this difference considerable. Serum cystatin C was higher in smokers and obese subjects while serum creatinine was lower in smokers and slender subjects. JEQcys and EPIcys were lower in smokers while JEQcr and jEPIcr were higher in smokers adjusting for body mass index (BMI). eGFRcr,cys (JEQaver and jEPIcr,cys) did not differ between the never smokers and current smokers. eGFRcr,cys predicted by the equations composed of eGFRcr, BMI, and smoking habits showed a good accordance with calculated eGFRcr,cys. Either eGFRcr, eGFRcys or both were not reliable indicators of renal function in workers who smoked. The possibly more precise estimate of eGFRcr,cys could be predicted by eGFRcr, BMI and smoking in such a generally healthy population.	[Yamada, Yuichi; Noborisaka, Yuka; Ishizaki, Masao; Yamazaki, Michiko; Honda, Ryumon] Kanazawa Med Univ, Dept Social & Environm Med, Sch Med, Uchinada, Ishikawa 9200293, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Dept Nephrol, Sch Med, Uchinada, Ishikawa 9200293, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 8300011, Japan	Yamada, Y (reprint author), Kanazawa Med Univ, Dept Social & Environm Med, Sch Med, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	u1yamada@kanazawa-med.ac.jp					Anastasio P, 2001, KIDNEY INT, V60, P748, DOI 10.1046/j.1523-1755.2001.060002748.x; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Shaper AG, 2004, J CLIN EPIDEMIOL, V57, P195, DOI 10.1016/j.jclinepi.2003.07.001; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Rom O, 2013, MECH AGEING DEV, V134, P24, DOI 10.1016/j.mad.2012.11.004; Levey AS, 2009, ANN INTERN MED, V150, P604; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Branten AJW, 2005, NEPHROL DIAL TRANSPL, V20, P707, DOI 10.1093/ndt/gfh719; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Petersen AMW, 2007, AM J PHYSIOL-ENDOC M, V293, pE843, DOI 10.1152/ajpendo.00301.2007; Buysschaert M, 2003, DIABETES METAB, V29, P377, DOI 10.1016/S1262-3636(07)70048-4; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; EKBERG G, 1990, J INTERN MED, V228, P211; Evangelopoulos AA, 2011, CARDIOL RES PRACT, DOI [10.4061/2011/163281, DOI 10.4061/2011/163281]; Halimi JM, 1998, NEPHROL DIAL TRANSPL, V13, P940, DOI 10.1093/ndt/13.4.940; Horio M, 2015, CLIN EXP NEPHROL, V19, P284, DOI 10.1007/s10157-014-0988-8; Horio M, 2014, CLIN EXP NEPHROL, V18, P469, DOI 10.1007/s10157-013-0841-5; Itoh K, 2012, RINSHOKAGAKU, V41, P62; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Nihon Jinzo Gakkai Shi, 2012, CLIN PRACTICE GUIDEB; Noborisaka Yuka, 2013, Nephrourol Mon, V5, P655, DOI 10.5812/numonthly.3527; Noborisaka Y, 2014, NEPHROUROL MON, V6; Orth S R, 2002, Tob Induc Dis, V1, P137, DOI 10.1186/1617-9625-1-2-137; PAWLIK WW, 1985, P SOC EXP BIOL MED, V178, P585; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Tsujita M, 2014, CLIN EXP NEPHROL, V18, P130, DOI 10.1007/s10157-013-0811-y; Yamada Y, 2004, J OCCUP HEALTH, V46, P365, DOI 10.1539/joh.46.365	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					669	677		10.1007/s10157-014-1058-y		9	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800017		
J	Yoshino, A; Honda, M; Sasaki, N; Hataya, H; Ishikura, K; Sakazume, S; Tanaka, Y; Nagai, T				Yoshino, Atsunori; Honda, Masataka; Sasaki, Naomi; Hataya, Hiroshi; Ishikura, Kenji; Sakazume, Satoru; Tanaka, Yuriko; Nagai, Toshiro			Selection of infants who potentially have congenital anomalies of the kidney and urinary tract from a large cohort for a more thorough examination	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Congenital anomalies of the kidney and urinary tract; Infantile period; Clinical characteristics; Chronic kidney disease; End-stage renal disease	STAGE RENAL-DISEASE; CHILDREN; MORTALITY	Although congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of pediatric end-stage renal disease (ESRD), little is known about the characteristics exhibited in the infantile period by CAKUT patients who develop ESRD. Further, an efficient screening method for CAKUT diagnosis is not available currently. In the present study, we aimed to develop a method to select infants who potentially have CAKUT from a large group of infants. We retrospectively investigated the clinical characteristics of CAKUT patients in the infantile period. The medical records of 101 patients with CAKUT who had undergone dialysis or renal transplantation were reviewed. The data of gestational age, birth weight, oligohydramnios, poor body weight gain, asphyxia, and jaundice were recorded. We attempted to determine the ideal characteristics that could be used to select infants who potentially have CAKUT. 14 % of patients were born prematurely, 18 % had low birth weight, 79 % had poor body weight gain, 18 % had asphyxia, 8 % had oligohydramnios, and 12 % had jaundice. We found that 82 % of patients had poor body weight gain or oligohydramnios among our patients and regarded these two symptoms as ideal markers for selecting those who potentially have CAKUT (specificity, 95 %; efficacy, 95 %). Further, the age of a parts per thousand currency sign7 months was the most appropriate time for the selection. For timely diagnosis of CAKUT, we recommend that ultrasound examination and the serum creatinine test be conducted for infants showing poor body weight gain or oligohydramnios at age a parts per thousand currency sign7 months.	[Yoshino, Atsunori] Dokkyo Med Univ, Koshigaya Hosp, Dept Nephrol, Koshigaya, Saitama 3438555, Japan; [Yoshino, Atsunori; Sakazume, Satoru; Tanaka, Yuriko; Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Yoshino, Atsunori; Honda, Masataka; Sasaki, Naomi; Hataya, Hiroshi; Ishikura, Kenji; Tanaka, Yuriko] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo 1838561, Japan	Yoshino, A (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Nephrol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	ayoshino@dokkyomed.ac.jp					American Academy of Pediatrics, 2007, PEDIATRICS, V119, P618; Wong H, 2006, KIDNEY INT, V70, P585, DOI 10.1038/sj.ki.5001608; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Parekh RS, 2002, J PEDIATR-US, V141, P191, DOI 10.1067/mpd.2002.125910; Groothoff JW, 2002, KIDNEY INT, V61, P621, DOI 10.1046/j.1523-1755.2002.00156.x; Hattori S, 2002, PEDIATR NEPHROL, V17, P456; Gerson AC, 2006, MENT RETARD DEV D R, V12, P208, DOI 10.1002/mrdd.20116; Ishikura K, 2013, NEPHROL DIAL TRANSPL, V28, P2345, DOI 10.1093/ndt/gfs611; Seikaly MG, 2003, PEDIATR NEPHROL, V18, P796, DOI 10.1007/s00467-003-1158-5; Wong CJ, 2012, AM J KIDNEY DIS, V60, P1002, DOI 10.1053/j.ajkd.2012.07.018; Brady TM, 2012, CLIN J AM SOC NEPHRO, V12, P1930; Caiulo VA, 2012, PEDIATR NEPHROL, V27, P949, DOI 10.1007/s00467-011-2098-0; Honda M, 2010, ONE REPORTS SPECIAL; Lewis MA, 2010, NEPHRON CLIN PRACT, V115, pC279, DOI 10.1159/000301237; McTaggart S, 2010, PAEDIAT REPORT ANZDA; Querfeld U, 2001, PERITON DIALYSIS INT, V21, pS285; Sasaki N, 2007, J JPN PEDIAT SOC, V111, P1045; SKUSE D, 1994, J CHILD PSYCHOL PSYC, V35, P521, DOI 10.1111/j.1469-7610.1994.tb01738.x; Stralen KV, 2010, ESPN ERA EDTA REGIST; Tokyo Metropolitan Maternal and Child Health Service Center, 1993, STAT MAT NEON CAR TO; Tokyo Metropolitan Maternal and Child Health Service Center, 1992, STAT MAT NEON CAR TO; Tokyo Metropolitan Maternal and Child Health Service Center, 1994, STAT MAT NEON CAR TO; Tsuchiya M, 2003, PEDIATR INT, V45, P617, DOI 10.1046/j.1442-200X.2003.01780.x	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					678	682		10.1007/s10157-014-1036-4		5	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800018		
J	Uemura, O; Nagai, T; Ishikura, K; Ito, S; Hataya, H; Gotoh, Y; Fujita, N; Akioka, Y; Kaneko, T; Honda, M				Uemura, Osamu; Nagai, Takuhito; Ishikura, Kenji; Ito, Shuichi; Hataya, Hiroshi; Gotoh, Yoshimitsu; Fujita, Naoya; Akioka, Yuko; Kaneko, Tetsuji; Honda, Masataka			Reference glomerular filtration rate levels in Japanese children: using the creatinine and cystatin C based estimated glomerular filtration rate	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Children; Creatinine; Cystatin C; Glomerular filtration rate; Reference levels	EQUATIONS	The present study was performed to determine the reference values of glomerular filtration rate (GFR) in children by age using the new eGFR equations derived from serum creatinine (Cr) and cystatine C (cysC). A total of 1137 children (509 males and 628 females) between the ages of 3 months and 16 years presenting at our facilities between 2008 and 2009 without diseases affecting the renal function were included in this study as in our previous reports for reference values of serum Cr and cysC. We calculated eGFR with the Cr based equation in children aged 2-16 years, and with the cysC based equation in those aged 3-23 months, and determined the reference values of GFR in Japanese children by each age group. We reviewed the median, 2.5 and 97.5 percentile of GFR reference value in each age group. The medians of reference GFRs are 91.7, 98.5, 106.3, and 113.1 mL/min/1.73 m(2) in children aged 3-5, 6-11, 12-17, and 18 months-16 years, respectively. We determined the normal reference values of GFR in children. It is important for pediatricians who examine pediatric chronic kidney disease patients to know the values of normal renal function.	[Uemura, Osamu; Nagai, Takuhito; Ishikura, Kenji; Ito, Shuichi; Hataya, Hiroshi; Gotoh, Yoshimitsu; Fujita, Naoya; Akioka, Yuko; Kaneko, Tetsuji; Honda, Masataka] Japanese Soc Pediat Nephrol, Comm Measures Pediat CKD, Tokyo, Japan; [Uemura, Osamu] Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, Obu, Aichi 4748710, Japan	Uemura, O (reprint author), Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, 1-2 Osakada Morioka Cho, Obu, Aichi 4748710, Japan.	o_uemura@hkg.odn.ne.jp			Kidney Foundation, Japan	Financial support from the Kidney Foundation, Japan, enabled us to examine blood and urine specimens collected throughout Japan. We thank Takeshi Matsuyama, MD, Yohei Ikezumi, MD, Midori Awazu, MD, Takashi Sekine, MD, Takuji Yamada, MD, Yuko Akioka, MD, Hirotsugu Kitayama, MD, Mayumi Sako, MD, Masataka Hisano, MD and Kazumoto Iijima, MD, of the Committee of Measures for Pediatric CKD, for their contributions to the improvement of this manuscript.	SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Pottel H, 2010, PEDIATR NEPHROL, V25, P927, DOI 10.1007/s00467-009-1389-1; Sharma AP, 2011, CLIN J AM SOC NEPHRO, V6, P1599, DOI 10.2215/CJN.10161110; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; BRODEHL J, 1982, CLIN NEPHROL, V17, P163; Friedman A., 2009, PEDIAT NEPHROLOGY, V6th, P491, DOI 10.1007/978-3-540-76341-3_21; Nagai T, 2013, CLIN EXP NEPHROL, V17, P877, DOI 10.1007/s10157-013-0799-3; PIEPSZ A, 1994, EUR J NUCL MED, V21, P12; Uemura O, 2012, EUR J PEDIATR, V171, P1401, DOI 10.1007/s00431-012-1772-y; Uemura O, 2014, CLIN EXP NEPHROL, V18, P718, DOI 10.1007/s10157-013-0910-9; Yata N, 2013, CLIN EXP NEPHROL, V17, P872, DOI 10.1007/s10157-013-0784-x	13	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					683	687		10.1007/s10157-014-1042-6		5	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800019		
J	Koda, R; Kazama, JJ; Matsuo, K; Kawamura, K; Yamamoto, S; Wakasugi, M; Takeda, T; Narita, I				Koda, Ryo; Kazama, Junichiro James; Matsuo, Koji; Kawamura, Kazuko; Yamamoto, Suguru; Wakasugi, Minako; Takeda, Tetsuro; Narita, Ichiei			Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Intact PTH; Whole PTH; Cinacalcet hydrochloride; Hemodialysis	SECONDARY HYPERPARATHYROIDISM; DIALYSIS PATIENTS; PTH; SECRETION	The parathyroid gland secretes 1-84 and 7-84 parathyroid hormone (PTH) fragments, and its regulation is dependent on stimulation of the extracellular calcium-sensing receptor. While the intact PTH system detects both PTH fragments, the whole PTH system detects the 1-84PTH but not the 7-84PTH. Cinacalcet hydrochloride (CH) binds to calcium-sensing receptor as a calcimimetic. Here we investigated the role of CH treatment in the assessment of parathyroid gland function. Stable adult dialysis patients for whom CH therapy was planned were included. Patients for whom CH therapy was not planned were simultaneously included as the control group. The CH group (n = 44) showed significantly higher circulating levels of Ca, intact PTH, and whole PTH, before the CH treatment than the control group (n = 112). The Ca, intact PTH, and whole PTH levels decreased along with the CH therapy, and the Ca levels became comparable in the 8th week of treatment and thereafter. The CH group in the 8th week and thereafter showed significantly lower whole/intact PTH ratios than the control group, while the whole/intact PTH ratio was not significantly different between before and during the CH therapy. A multiple regression analysis revealed that the whole/intact PTH ratio was almost constant, but both the serum Ca level and a CH therapy could potentially modify the fixed number. When the whole PTH levels were estimated by intact PTH levels using the relationship between them in the control group, the levels were clearly overestimated in the CH group. Although the direct effect of CH on the whole/intact PTH ratio is masked by its hypocalcemic action, we could successfully demonstrate that the ratio in CH users is lower than that in the non-users with comparable levels of serum Ca. Evaluating parathyroid function with intact PTH according to the clinical practice guidelines in patients being treated with CH may lead to significant overestimation and subsequent overtreatment.	[Koda, Ryo; Kazama, Junichiro James; Matsuo, Koji; Kawamura, Kazuko; Yamamoto, Suguru; Wakasugi, Minako; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Nephrol & Rheumatol, Niigata, Niigata 9518510, Japan; [Koda, Ryo; Takeda, Tetsuro] Dokkyo Univ, Dept Nephrol, Koshigaya Med Ctr, Koshigaya, Japan; [Kazama, Junichiro James] Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Chuo Ku, Niigata, Niigata 9518510, Japan; [Wakasugi, Minako] Niigata Univ, Grad Sch Med & Dent Hosp, Ctr Interorgan Res, Niigata, Niigata 9518510, Japan	Kazama, JJ (reprint author), Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Chuo Ku, 1-754 Asahimachi Diri, Niigata, Niigata 9518510, Japan.	jjkaz@med.niigata-u.ac.jp			Kyowahakko-Kirin Co Ltd.	JJK, TT, and IN have received financial support for clinical research from Kyowahakko-Kirin Co Ltd., which is the supplier of cinacalcet hydrochloride.	Fukagawa M, 2008, NEPHROL DIAL TRANSPL, V23, P328, DOI 10.1093/ndt/gfm534; Souberbielle JC, 2006, KIDNEY INT, V70, P345, DOI 10.1038/sj.ki.5001606; Brown EM, 2001, PHYSIOL REV, V81, P239; Gao P, 2001, J BONE MINER RES, V16, P605, DOI 10.1359/jbmr.2001.16.4.605; de Francisco ALM, 2008, NEPHROL DIAL TRANSPL, V23, P2895, DOI 10.1093/ndt/gfn191; Arakawa T, 2006, CLIN J AM SOC NEPHRO, V1, P525, DOI 10.2215/CJN.01391005; Valle C, 2008, J AM SOC NEPHROL, V19, P2430, DOI 10.1681/ASN.2007121320; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; D'Amour P, 2006, KIDNEY INT, V70, pS29, DOI 10.1038/sj.ki.5001599; GuidelineWorking Group, 2006, THER APHER DIAL, V12, P514; Kawata T, 2005, J CLIN ENDOCR METAB, V90, P5774, DOI 10.1210/jc.2005-0243; Kazama JJ, 2005, NEPHRON CLIN PRACT, V99, pC8, DOI 10.1159/000081788; Kazama JJ, 2004, NEPHROL DIAL TRANSPL, V19, P892, DOI 10.1093/ndt/gfh038; Kazama Junichiro James, 2003, Clin Exp Nephrol, V7, P144, DOI 10.1007/s10157-003-0226-2; Kumar R, 2011, J AM SOC NEPHROL, V22, P216, DOI 10.1681/ASN.2010020186; Martin KJ, 2005, KIDNEY INT, V68, P1236, DOI 10.1111/j.1523-1755.2005.00517.x; Monier-Faugere MC, 2001, KIDNEY INT, V60, P1460, DOI 10.1046/j.1523-1755.2001.00949.x; Nagano N, 2005, J PHARMACOL SCI, V97, P355, DOI 10.1254/jphs.FMJ04007X6	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					710	717		10.1007/s10157-014-1045-3		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800023		
J	Abe, T; Kato, S; Tsuruta, Y; Sugiura, S; Katsuno, T; Kosugi, T; Tsuboi, N; Matsuo, S; Maruyama, S				Abe, Tomoko; Kato, Sawako; Tsuruta, Yoshinari; Sugiura, Sachiyo; Katsuno, Takayuki; Kosugi, Tomoki; Tsuboi, Naotake; Matsuo, Seiichi; Maruyama, Shoichi			Neutrophil/lymphocyte ratio as a predictor of cardiovascular events in incident dialysis patients: a Japanese prospective cohort study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Cardiovascular disease; Dialysis; Inflammation; Neutrophil/lymphocyte ratio	CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; LYMPHOCYTE RATIO; INFLAMMATION; NEUTROPHIL; EPIDEMIOLOGY; MORTALITY	Previous studies have suggested that high neutrophil/lymphocyte ratios are related to worse outcome in patients with cardiovascular diseases. Patients with end-stage renal disease, especially those with inflammation, are at an increased risk of premature mortality, primarily because of cardiovascular disease. We aimed to clarify if high neutrophil/lymphocyte ratio is associated with increasing cardiovascular events in Japanese patients with end-stage renal disease. We enrolled 86 incident Japanese dialysis patients (58 men, age 58 +/- A 11 years) in a prospective cohort study. The median follow-up was for 38.7 months. The association between neutrophil/lymphocyte ratio at the start of dialysis therapy and clinical biomarkers was investigated. Relative risks and cumulative cardiovascular disease events were calculated. The median neutrophil/lymphocyte ratio reported was 3.72. The duration from the start of the dialysis therapy to the first cardiovascular disease event was significantly shorter as a neutrophil/lymphocyte ratio increased (log-rank test, P = 0.003). The relative risk of cardiovascular disease events in patients with neutrophil/lymphocyte ratio > median to cardiovascular events in patients with the ratio < median as a reference was 3.02 (95 % CI 1.32-8.00) in a Cox proportional hazard model. The cumulative cardiovascular disease events during the observational period was higher in patients with neutrophil/lymphocyte ratio > median (23.0 events 100 person-years) than in patients with the ratio < median (6.8 events 100 person-years). A higher neutrophil/lymphocyte ratio is associated with increased risk of cardiovascular disease events and is a stronger predictor of future events.	[Abe, Tomoko; Kato, Sawako; Katsuno, Takayuki; Kosugi, Tomoki; Tsuboi, Naotake; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648550, Japan; [Tsuruta, Yoshinari] Meiyo Clin, Toyohashi, Aichi, Japan; [Sugiura, Sachiyo] Masuko Mem Hosp, Nagoya, Aichi, Japan	Kato, S (reprint author), Nagoya Univ, Dept Nephrol, Grad Sch Med, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4648550, Japan.	kato07@med.nagoya-u.ac.jp			Nagoya University Graduate School of Medicine; Ministry of Health, Labour and Welfare of Japan	This study was funded by Nagoya University Graduate School of Medicine. This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan.	Shah N, 2014, INT J CARDIOL, V171, P390, DOI 10.1016/j.ijcard.2013.12.019; Miyamoto T, 2011, CURR OPIN NEPHROL HY, V20, P662, DOI 10.1097/MNH.0b013e32834ad504; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Crews DC, 2011, J AM SOC NEPHROL, V22, P2279, DOI 10.1681/ASN.2011030305; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kocyigit I, 2013, J NEPHROL, V26, P358, DOI 10.5301/jn.5000152; Okyay GU, 2013, RENAL FAILURE, V35, P29, DOI 10.3109/0886022X.2012.734429; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Solak Y, 2013, CLIN EXP NEPHROL, V17, P532, DOI 10.1007/s10157-012-0728-x; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Kawaguchi T, 2011, NEPHRON CLIN PRACT, V117, pC167, DOI 10.1159/000320116; Meuwese CL, 2011, NAT REV NEPHROL, V7, P166, DOI 10.1038/nrneph.2011.2; de Mutsert R, 2009, AM J CLIN NUTR, V89, P787, DOI 10.3945/ajcn.2008.26970; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056745; [National Kidney Foundation K/DOQI], 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Turkmen K, 2012, RENAL FAILURE, V34, P1229, DOI 10.3109/0886022X.2012.723580	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					718	724		10.1007/s10157-014-1046-2		7	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800024		
J	Uozumi, J; Noguchi, M; Tokuda, Y; Tobu, S; Udo, K; Kakinoki, H; Kurata, S; Nanri, M; Ichibagase, Y; Takahara, K				Uozumi, Jiro; Noguchi, Mitsuru; Tokuda, Yuji; Tobu, Shohei; Udo, Kazuma; Kakinoki, Hiroaki; Kurata, Saya; Nanri, Maki; Ichibagase, Yuka; Takahara, Kohei			Is the eGFR formula adequate for evaluating renal function before chemotherapy in patients with urogenital cancer? A suggestion for clinical application of eGFR formula	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Creatinine clearance; eGFR formula; Renal function; Cancer chemotherapy	ORGANIC CATION TRANSPORTERS; GLOMERULAR-FILTRATION-RATE; CREATININE CLEARANCE; SERUM CREATININE; CISPLATIN; PREDICTION; OCT2	Accurate evaluation of renal function is required before cancer chemotherapy. Various kinds of formula have been developed for estimating creatinine clearance (Ccr) or glomerular filtration rate (GFR) conveniently. We retrospectively examined the reliability of the GFR estimating formula using the renal function data in cancer chemotherapy. Clinical data of 12 patients with urogenital cancer from 1998 to 2013 in Saga University Hospital were reviewed. Patients were treated with 6-21 (median 10.5) courses of chemotherapy and those patients underwent 9-29 (median 14.5) times of 24hrCcr tests before and during chemotherapy. We compared estimated GFR (eGFR) with 24hrCcr. In addition, we developed a novel method to estimate the Ccr using the patient-inherent 24hrCcr/eGFR ratio, which is calculated from initial 3 or 4 determinations of 24hrCcr and the corresponding eGFR. Those estimated Ccrs were also compared with 24hrCcr. The dissociation between 24hrCcr and eGFR was not constant, and a large dissociation was observed in some cases. The newly devised estimated Ccr demonstrated less dissociation from 24hrCcr compared with eGFR. The eGFR formula is not adequate for the clinical use in cancer chemotherapy. The absolute value of eGFR is not reliable, but clinical use of eGFR as relative value seems to be acceptable. To avoid troublesome 24hrCcr measurement in long-term cancer chemotherapy, eGFR formula can be used for estimating Ccr in combination with the specific inherent 24hrCcr/eGFR ratio, which is obtained from 3 or 4 times of actual 24hrCcr measurements.	[Uozumi, Jiro; Noguchi, Mitsuru; Tokuda, Yuji; Tobu, Shohei; Udo, Kazuma; Kakinoki, Hiroaki; Kurata, Saya; Nanri, Maki; Ichibagase, Yuka; Takahara, Kohei] Saga Univ, Dept Urol, Fac Med, Saga 8498501, Japan	Uozumi, J (reprint author), Saga Univ, Dept Urol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	uozumi@cc.saga-u.ac.jp					Aapro M, 2012, CANCER TREAT REV, V38, P235, DOI 10.1016/j.ctrv.2011.05.001; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Lichtman SM, 2007, EUR J CANCER, V43, P14, DOI 10.1016/j.ejca.2006.11.004; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Filipski KK, 2008, CLIN CANCER RES, V14, P3875, DOI 10.1158/1078-0432.CCR-07-4793; Faluyi OO, 2012, MED ONCOL, V29, P755, DOI 10.1007/s12032-011-9824-0; Yokoo S, 2007, BIOCHEM PHARMACOL, V74, P477, DOI 10.1016/j.bcp.2007.03.004; Levey AS, 1999, ANN INTERN MED, V130, P461; Barraclough LH, 2008, CLIN ONCOL-UK, V20, P721, DOI 10.1016/j.clon.2008.09.004; Brunello A, 2009, CANCER TREAT REV, V35, P493, DOI 10.1016/j.ctrv.2009.04.009; Holweger K, 2005, J CANCER RES CLIN, V131, P559, DOI 10.1007/s00432-005-0679-7; Imai E, 2012, JPN J NEPHROL, V54, P1062; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Raj GV, 2006, J CLIN ONCOL, V24, P3095, DOI 10.1200/JCO.2005.04.3091	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					738	745		10.1007/s10157-014-1037-3		8	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800027		
J	Higashihara, E; Nutahara, K; Okegawa, T; Tanbo, M; Mori, H; Miyazaki, I; Nitatori, T; Kobayashi, K				Higashihara, Eiji; Nutahara, Kikuo; Okegawa, Takatsugu; Tanbo, Mitsuhiro; Mori, Hideaki; Miyazaki, Isao; Nitatori, Toshiaki; Kobayashi, Kuninori			Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Autosomal dominant polycystic kidney disease (ADPKD); Somatostatin; Octreotide; Kidney volume; Liver volume	LONG-ACTING SOMATOSTATIN; LIVER-DISEASE; CELL-PROLIFERATION; HEPATIC CYSTOGENESIS; CYST GROWTH; CYCLIC-AMP; VASOPRESSIN; MODEL; TOLVAPTAN; CILIA	The total kidney volume (TKV) and total liver volume (TLV) increase and renal function decreases progressively in patients with autosomal dominant polycystic kidney disease (ADPKD). Somatostatin analogues, such as octreotide, reduce these increases in TKV and TLV. The aim of this study was to examine the safety of the short-term administration of octreotide long-acting release (octreotide-LAR) in a small number of cases. Four ADPKD patients with an estimated glomerular filtration rate (eGFR) > 45 mL/min/1.73 m(2), TKV > 1,000 mL, and TLV > 3,000 mL were enrolled. Two 20-mg octreotide-LAR intramuscular injections were repeated every 4 weeks for 24 weeks. Laboratory and clinical assessments were repeated every 4 weeks, and TKV and TLV were measured by magnetic resonance imaging before and after the study. In the laboratory tests, there was no abnormal variable except for a significant decrease of alanine aminotransferase. The means of TKV and TLV decreased from 2,007 to 1,903 mL and from 9,197 to 8,866 mL, respectively, but the changes were not significant. eGFR did not change significantly. Adverse events involved loose stools in two patients, as well as injection site granuloma and abdominal pain in one patient each, which resolved spontaneously. Octreotide-LAR may be safe and effective for preventing TKV and TLV increases (UMIN000009214).	[Higashihara, Eiji] Kyorin Univ, Dept ADPKD Res, Sch Med, Mitaka, Tokyo 1818611, Japan; [Higashihara, Eiji; Nutahara, Kikuo; Okegawa, Takatsugu; Tanbo, Mitsuhiro] Kyorin Univ, Dept Urol, Sch Med, Mitaka, Tokyo 1818611, Japan; [Mori, Hideaki] Kyorin Univ, Dept Gastroenter, Sch Med, Mitaka, Tokyo 1818611, Japan; [Miyazaki, Isao; Nitatori, Toshiaki; Kobayashi, Kuninori] Kyorin Univ, Dept Radiol, Sch Med, Mitaka, Tokyo 1818611, Japan; [Kobayashi, Kuninori] Kyorin Univ, Dept Med Radiol Technol, Fac Hlth Sci, Mitaka, Tokyo 1818611, Japan	Higashihara, E (reprint author), Kyorin Univ, Dept ADPKD Res, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	ehigashi@ks.kyorin-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research from the Ministry of Health, Labour and Welfare of Japan. Novartis Japan supplied Octreotide-LAR, but did not fund the study. Novartis had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Dicks E, 2006, CLIN J AM SOC NEPHRO, V1, P710, DOI 10.2215/CJN.01581105; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Chrispijn M, 2012, ALIMENT PHARM THER, V35, P266, DOI 10.1111/j.1365-2036.2011.04923.x; Caroli A, 2013, LANCET, V382, P1485, DOI 10.1016/S0140-6736(13)61407-5; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1053/S0016-5085(03)01369-6; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/01.mnh.0000088730.87142.d1; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Hogan MC, 2012, NEPHROL DIAL TRANSPL, V27, P3532, DOI 10.1093/ndt/gfs152; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Banales JM, 2009, HEPATOLOGY, V49, P160, DOI 10.1002/hep.22636; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Masyuk AI, 2006, GASTROENTEROLOGY, V131, P911, DOI 10.1053/j.gastro.2006.07.003; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Ferjoux G, 2000, J PHYSIOLOGY-PARIS, V94, P205, DOI 10.1016/S0928-4257(00)00206-0; FRIEDLANDER G, 1986, FEBS LETT, V198, P38, DOI 10.1016/0014-5793(86)81180-2; Higashihara E, 2014, CLIN EXP NEPHROL, V18, P157, DOI 10.1007/s10157-013-0834-4; HIGASHIHARA E, 1992, J UROLOGY, V147, P329; Orskov B, 2010, AM J NEPHROL, V31, P53, DOI 10.1159/000256657; WINKLER SN, 1982, MINER ELECTROL METAB, V7, P8; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					746	752		10.1007/s10157-014-1047-1		7	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800028		
J	Shimamura, Y; Koga, H; Takizawa, H				Shimamura, Yoshinosuke; Koga, Hideaki; Takizawa, Hideki			Watermelon stomach: gastric antral vascular ectasia	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material						Gastric antral vascular ectasia; Chronic kidney disease; Argon plasma coagulation			[Shimamura, Yoshinosuke; Takizawa, Hideki] Teine Keijinkai Med Ctr, Dept Nephrol, Sapporo, Hokkaido, Japan; [Koga, Hideaki] Teine Keijinkai Med Ctr, Ctr Gastrointestinal Dis, Sapporo, Hokkaido, Japan	Shimamura, Y (reprint author), Teine Keijinkai Med Ctr, Dept Nephrol, Sapporo, Hokkaido, Japan.	yoshinosukeshimamura@gmail.com					Dulai GS, 2004, ENDOSCOPY, V36, P68; Kwan V, 2006, AM J GASTROENTEROL, V101, P58, DOI 10.1111/j.1572-0241.2006.00370.x; Kilincalp S, 2015, CLIN EXP NEPHROL, V19, P150, DOI 10.1007/s10157-014-1035-5; Selinger CP, 2008, DIGESTION, V77, P131, DOI 10.1159/000124339	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					753	754		10.1007/s10157-014-1069-8		2	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800029		
J	Nagai, M; Hirayama, K; Ebihara, I; Kobayashi, M				Nagai, Miho; Hirayama, Kouichi; Ebihara, Itaru; Kobayashi, Masaki			Serum soluble levels of the transmembrane activator and calcium-modulator and cyclophilin-ligand interactor in MPO-ANCA-associated renal vasculitis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material						ANCA-associated vasculitis; Transmembrane activator and calcium-modulator and cyclophilin-ligand interactor; B cell activation factor; Atacicept	B-CELL SURVIVAL; DISEASE; APRIL; BAFF		[Nagai, Miho] Tokyo Med Univ, Dept Nephrol, Shinjyuku Ku, Ami, Ibaraki 3000395, Japan; [Hirayama, Kouichi; Kobayashi, Masaki] Tokyo Med Univ, Dept Nephrol, Ibaraki Med Ctr, Ami, Ibaraki 3000395, Japan; [Ebihara, Itaru] Mito Saiseikai Gen Hosp, Dept Nephrol, Mito, Ibaraki, Japan	Hirayama, K (reprint author), Tokyo Med Univ, Dept Nephrol, Ibaraki Med Ctr, 3-20-1 Chuo, Ami, Ibaraki 3000395, Japan.	k-hira@tokyo-med.ac.jp					Nagai M, 2011, NEPHRON CLIN PRACT, V118, pC339, DOI 10.1159/000323393; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Holden NJ, 2011, ANN RHEUM DIS, V70, P2229, DOI 10.1136/ard.2011.153890; Isenberg D, 2015, ANN RHEUM DIS, V74, P2006, DOI 10.1136/annrheumdis-2013-205067	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	AUG	2015	19	4					759	760		10.1007/s10157-015-1080-8		2	Urology & Nephrology	Urology & Nephrology	CP7TA	WOS:000360089800032		
J	Kuriyama, S; Ishikawa, M; Nakamura, S; Furu, M; Ito, H; Matsuda, S				Kuriyama, Shinichi; Ishikawa, Masahiro; Nakamura, Shinichiro; Furu, Moritoshi; Ito, Hiromu; Matsuda, Shuichi			Posterior tibial slope and femoral sizing affect posterior cruciate ligament tension in posterior cruciate-retaining total knee arthroplasty	CLINICAL BIOMECHANICS			English	Article						Total knee arthroplasty; Posterior cruciate ligament; Femoral component size; Posterior tibial slope; Rotational alignment	STRUCTURAL-PROPERTIES; COLLATERAL LIGAMENTS; FLEXION; INSTABILITY; KINEMATICS; CONTACT; IMPLANT; RELEASE; COMPLEX; FORCES	Background: During cruciate-retaining total knee arthroplasty, surgeons sometimes encounter increased tension of the posterior cruciate ligament. This study investigated the effects of femoral size, posterior tibial slope, and rotational alignment of the femoral and tibial components on forces at the posterior cruciate ligament in cruciate-retaining total knee arthroplasty using a musculoskeletal computer simulation. Methods: Forces at the posterior cruciate ligament were assessed with the standard femoral component, as well as with 2-mm upsizing and 2-mm downsizing in the anterior-posterior dimension. These forces were also determined with posterior tibial slope angles of 5, 7, and 9, and lastly, were measured in 5 increments when the femoral (tibial) components were positioned from 5 (15) of internal rotation to 5 (15) of external rotation. Findings: Forces at the posterior cruciate ligament increased by up to 718 N with the standard procedure during squatting. The 2-mm downsizing of the femoral component decreased the force at the posterior cruciate ligament by up to 47%. The 2 degrees increment in posterior tibial slope decreased the force at the posterior cruciate ligament by up to 41%. In addition, posterior cruciate ligament tension increased by 11% during internal rotation of the femoral component, and increased by 18% during external rotation of the tibial component. Interpretation: These findings suggest that accurate sizing and bone preparation are very important to maintain posterior cruciate ligament forces in cruciate-retaining total knee arthroplasty. Care should also be taken regarding malrotation of the femoral and tibial components because this increases posterior cruciate ligament tension. (C) 2015 Elsevier Ltd. All rights reserved.	[Kuriyama, Shinichi; Ishikawa, Masahiro; Nakamura, Shinichiro; Furu, Moritoshi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Kyoto 6068507, Japan	Kuriyama, S (reprint author), Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kuriyama@kuhp.kyoto-u.ac.jp					Edwards A, 2007, ARTHROSCOPY, V23, P284, DOI 10.1016/j.arthro.2006.11.005; Wijdicks CA, 2010, AM J SPORT MED, V38, P1638, DOI 10.1177/0363546510363465; HARNER CD, 1995, AM J SPORT MED, V23, P736, DOI 10.1177/036354659502300617; Jojima H, 2004, CLIN ORTHOP RELAT R, P194, DOI 10.1097/01.blo.0000138960.57680.60; Innocenti B, 2011, J BIOMECH, V44, P1573, DOI 10.1016/j.jbiomech.2011.02.081; Park SE, 2005, KNEE, V12, P377, DOI 10.1016/j.knee.2004.12.011; Wilson WT, 2012, J ORTHOP SPORT PHYS, V42, P345, DOI 10.2519/jospt.2012.3919; LaPrade RF, 2005, AM J SPORT MED, V33, P1386, DOI 10.1177/036354650427143; Liu F, 2011, KNEE SURG SPORT TR A, V19, P719, DOI 10.1007/s00167-010-1336-5; Brantigan OC, 1941, J BONE JOINT SURG, V23, P44; Robinson JR, 2005, J BIOMECH, V38, P1067, DOI 10.1016/j.jbiomech.2004.05.034; Arima J, 1998, CLIN ORTHOP RELAT R, P194; Colwell CW, 2011, CLIN BIOMECH, V26, P52, DOI 10.1016/j.clinbiomech.2010.08.009; WARREN LF, 1974, J BONE JOINT SURG AM, VA 56, P665; Singerman R, 1996, J ARTHROPLASTY, V11, P99, DOI 10.1016/S0883-5403(96)80167-7; Escamilla RF, 2009, MED SCI SPORT EXER, V41, P408, DOI 10.1249/MSS.0b013e3181882c6d; Mihalko WM, 2012, CLIN ORTHOP RELAT R, V470, P186, DOI 10.1007/s11999-011-2145-y; BLANKEVOORT L, 1991, J BIOMECH, V24, P1019, DOI 10.1016/0021-9290(91)90019-J; Sugita T, 2001, AM J SPORT MED, V29, P466; Waslewski GL, 1998, J ARTHROPLASTY, V13, P763, DOI 10.1016/S0883-5403(98)90027-4; Belvedere C, 2012, J BIOMECH, V45, P1886, DOI 10.1016/j.jbiomech.2012.05.029; Escamilla RF, 2010, MED SCI SPORT EXER, V42, P1932, DOI 10.1249/MSS.0b013e3181d966d4; INCAVO SJ, 1994, CLIN ORTHOP RELAT R, P88; Krackow K.A., 1990, TECHNIQUE TOTAL KNEE, P249; Kuriyama S, 2014, J ORTHOP RES, V32, P1658, DOI 10.1002/jor.22711; Mizu-uchi H, 2011, J ARTHROPLASTY, V26, P721, DOI 10.1016/j.arth.2010.08.002; Mizu-uchi H., 2014, J ARTHROPLASTY; Morberg P, 2002, J ARTHROPLASTY, V17, P484, DOI 10.1054/arth.2002.31071; Pagnano MT, 1998, CLIN ORTHOP RELAT R, P39; Ritter M A, 1988, J Arthroplasty, V3, P323, DOI 10.1016/S0883-5403(88)80032-9	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	AUG	2015	30	7					676	681		10.1016/j.clinbiomech.2015.05.006		6	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	CP4WJ	WOS:000359883000006		
J	Nakanishi, H; Kurosaki, M; Tsuchiya, K; Nakakuki, N; Takada, H; Matsuda, S; Gondo, K; Asano, Y; Hattori, N; Tamaki, N; Suzuki, S; Yasui, Y; Hosokawa, T; Itakura, J; Takahashi, Y; Izumi, N				Nakanishi, Hiroyuki; Kurosaki, Masayuki; Tsuchiya, Kaoru; Nakakuki, Natsuko; Takada, Hitomi; Matsuda, Shuya; Gondo, Kouichi; Asano, Yu; Hattori, Nobuhiro; Tamaki, Nobuharu; Suzuki, Shoko; Yasui, Yutaka; Hosokawa, Takanori; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki			L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Liver Fibrosis; Lipid Metabolism; Fatty Acid; Clinical Trial	LIVER-CIRRHOSIS	We performed a prospective study to evaluate the ability of L-carnitine, which is involved in the beta-oxidation of fatty acids, to reduce muscle cramps in patients with cirrhosis. Consecutive patients with cirrhosis and muscle cramps were given L-carnitine 300 mg, 3 times/day (900 mg/day, n = 19) or 4 times/day (1200 mg/day, n = 23) for 8 weeks. The frequency of muscle cramps was assessed by questionnaires, and the degree of muscle cramping was assessed by using the visual analogue scale (VAS). Muscle cramping was reduced in 88.1% of all subjects at the end of the 8-week study period and disappeared for 28.6% of patients. Overall VAS scores decreased significantly from 69.9 +/- 22.5 at baseline to 26.2 +/- 29.1 after 8 weeks (P < .0001). The dose of L-carnitine was significantly associated with percentages of patients with reduced muscle cramps after 8 weeks (43.5% in the 1200 mg/day group vs 10.5% in the 900 mg/day group, P = .037) and VAS scores at 8 weeks (9.9 +/- 13.5 in the 1200 mg/day group vs 39.6 +/- 31.9 in the 900 mg/day group, P = .003). No adverse events were reported. Therefore, L-carnitine appears to be safe and effective for reducing liver cramps in patients with cirrhosis.	[Nakanishi, Hiroyuki; Kurosaki, Masayuki; Tsuchiya, Kaoru; Nakakuki, Natsuko; Takada, Hitomi; Matsuda, Shuya; Gondo, Kouichi; Asano, Yu; Hattori, Nobuhiro; Tamaki, Nobuharu; Suzuki, Shoko; Yasui, Yutaka; Hosokawa, Takanori; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan	Izumi, N (reprint author), Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan.	izumi012@musashino.jrc.or.jp					Abrams GA, 1996, AM J GASTROENTEROL, V91, P1363; Angeli P, 1996, HEPATOLOGY, V23, P264; Marchesini G, 2001, GASTROENTEROLOGY, V120, P170, DOI 10.1053/gast.2001.21193; Barclay CJ, 2003, INT J BIOL MACROMOL, V32, P139, DOI 10.1016/S0141-8130(03)00047-3; Chatrath H, 2012, AM J MED, V125, P1019, DOI 10.1016/j.amjmed.2012.03.012; KONIKOFF F, 1986, J CLIN GASTROENTEROL, V8, P669, DOI 10.1097/00004836-198612000-00017; Malaguarnera M, 2005, WORLD J GASTROENTERO, V11, P7197; Mehta SS, 2013, CLIN GASTROENTEROL H, V11, P1385, DOI 10.1016/j.cgh.2013.03.017; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; MOLLER P, 1984, SCAND J GASTROENTERO, V19, P267; Stephens FB, 2013, NESTLE NUTR WORKS SE, V76, P13, DOI 10.1159/000350224; Vidot H, 2014, ALIMENT PHARM THER, V40, P221, DOI 10.1111/apt.12827	12	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	AUG	2015	13	8					1540	1543		10.1016/j.cgh.2014.12.005		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP7SQ	WOS:000360088800029		
J	Fukumoto, M; Yamaguchi, M; Tomoda, Y; Atsuda, K				Fukumoto, Mariko; Yamaguchi, Mami; Tomoda, Yoshinori; Atsuda, Koichiro			Acetaminophen-protein adducts and GSH levels at intake of N-acetylcysteine in acetaminophen-treated mice	CLINICAL TOXICOLOGY			English	Meeting Abstract						Acetaminophen (paracetamol); N-acetylcysteine; GSH			[Fukumoto, Mariko] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Yamaguchi, Mami] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan; [Tomoda, Yoshinori; Atsuda, Koichiro] Kitasato Univ Hosp, Dept Pharm, Kitamoto, Kanagawa, Japan		fukumotom@pharm.kitasato-u.ac.jp						0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1556-3650	1556-9519		CLIN TOXICOL	Clin. Toxicol.	AUG	2015	53	7				27	652	652				1	Toxicology	Toxicology	CP4WN	WOS:000359883400037		
J	Fukumoto, M; Yamaguchi, M; Tomoda, Y; Atsuda, K				Fukumoto, Mariko; Yamaguchi, Mami; Tomoda, Yoshinori; Atsuda, Koichiro			Acetaminophen protein adducts and GSH levels at intake of N-acetylcysteine in acetaminophen treated mice	CLINICAL TOXICOLOGY			English	Meeting Abstract						Acetaminophen (paracetamol); N-acetylcysteine; GSH			[Fukumoto, Mariko] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Yamaguchi, Mami] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan; [Tomoda, Yoshinori; Atsuda, Koichiro] Kitasato Univ Hospita, Dept Pharm, Sagamihara, Kanagawa, Japan		fukumotom@pharm.kitasato-u.ac.jp						0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1556-3650	1556-9519		CLIN TOXICOL	Clin. Toxicol.	AUG	2015	53	7				97	684	684				1	Toxicology	Toxicology	CP4WN	WOS:000359883400107		
J	Feng, T; Momihara, K; Xiang, Q				Feng, Tao; Momihara, Koji; Xiang, Qing			Constructions of strongly regular Cayley graphs and skew Hadamard difference sets from cyclotomic classes	COMBINATORICA			English	Article							ASSOCIATION SCHEMES; 2-WEIGHT CODES; GAUSS SUMS	In this paper, we give a construction of strongly regular Cayley graphs and a construction of skew Hadamard difference sets. Both constructions are based on choosing cyclotomic classes of finite fields, and they generalize the constructions given by Feng and Xiang [10,12]. Three infinite families of strongly regular graphs with new parameters are obtained. The main tools that we employed are index 2 Gauss sums, instead of cyclotomic numbers.	[Feng, Tao] Zhejiang Univ, Dept Math, Hangzhou 310027, Zhejiang, Peoples R China; [Momihara, Koji] Kumamoto Univ, Fac Educ, Kumamoto 8608555, Japan; [Xiang, Qing] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA	Feng, T (reprint author), Zhejiang Univ, Dept Math, Hangzhou 310027, Zhejiang, Peoples R China.	tfeng@zju.edu.cn; momihara@educ.kumamoto-u.ac.jp; xiang@math.udel.edu	Feng, Tao/B-7751-2012		Fundamental Research Funds for the central universities; Zhejiang Provincial Natural Science Foundation [LQ12A01019]; National Natural Science Foundation of China [11201418]; Research Fund for Doctoral Programs from the Ministry of Education of China [20120101120089]; JSPS [23840032]; NSF [DMS 1001557]; Y. C. Tang disciplinary development fund of Zhejiang University	The work of Tao Feng was supported in part by the Fundamental Research Funds for the central universities, Zhejiang Provincial Natural Science Foundation under Grant LQ12A01019, the National Natural Science Foundation of China under Grant 11201418, and the Research Fund for Doctoral Programs from the Ministry of Education of China under Grant 20120101120089. The work of K. Momihara was supported by JSPS under Grant-in-Aid for Research Activity Start-up 23840032. The work of Qing Xiang was supported in part by NSF Grant DMS 1001557 and by the Y. C. Tang disciplinary development fund of Zhejiang University.	Feng T, 2012, J COMB THEORY B, V102, P982, DOI 10.1016/j.jctb.2011.10.006; van Dam ER, 2003, J ALGEBR COMB, V17, P181, DOI 10.1023/A:1022939017002; Feng T, 2012, DESIGN CODE CRYPTOGR, V65, P247, DOI 10.1007/s10623-011-9595-9; IVANOV AA, 1994, EUR J COMBIN, V15, P105, DOI 10.1006/eujc.1994.1013; Brouwer AE, 1999, J ALGEBR COMB, V10, P25, DOI 10.1023/A:1018620002339; VANLINT JH, 1981, COMBINATORICA, V1, P63; Yang J, 2010, SCI CHINA MATH, V53, P2525, DOI 10.1007/s11425-010-3155-z; CALDERBANK R, 1986, B LOND MATH SOC, V18, P97, DOI 10.1112/blms/18.2.97; Langevin P, 1997, J NUMBER THEORY, V63, P59, DOI 10.1006/jnth.1997.2078; BAUMERT LD, 1982, J NUMBER THEORY, V14, P67, DOI 10.1016/0022-314X(82)90058-0; Berndt B., 1997, GAUSS JACOBI SUMS; Beth T., 1999, ENCY MATH ITS APPL, VI; Brouwer AE, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-1939-6; DELANGE CLM, 1995, J ALGEBR COMB, V4, P329, DOI 10.1023/A:1022481816896; Feng T, 2012, J COMB THEORY A, V119, P245, DOI 10.1016/j.jcta.2011.08.007; GODSIL C., 2001, GTM, V207; HALL Jr M., 1956, P AM MATH SOC, V7, P975, DOI 10.2307/2033024; Ikuta T, 2010, EUR J COMBIN, V31, P1513, DOI 10.1016/j.ejc.2009.08.003; LANDER E. S., 1983, SYMMETRIC DESIGNS AL; Lidl R., 1997, FINITE FIELDS; Ma S. L., 1994, Designs, Codes and Cryptography, V4, DOI 10.1007/BF01388454; Mbodj O. D., 1998, Finite Fields and their Applications, V4, DOI 10.1006/ffta.1998.0218; Meijer P, 2003, J NUMBER THEORY, V100, P381, DOI 10.1016/S0022-314X(02)00123-3; Mykkeltveit J., 1973, DSN PROGR REP, V16, P128; Storer T., 1967, LECT ADV MATH, V2; TURYN RJ, 1965, PAC J MATH, V15, P319; Van Dam ER, 2000, DESIGN CODE CRYPTOGR, V21, P83; Yang J., PREPRINT	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0209-9683	1439-6912		COMBINATORICA	Combinatorica	AUG	2015	35	4					413	434		10.1007/s00493-014-2895-8		22	Mathematics	Mathematics	CP7TD	WOS:000360090100002		
J	Kawarabayashi, K; Kobayashi, Y				Kawarabayashi, Ken-ichi; Kobayashi, Yusuke			The edge-disjoint paths problem in Eulerian graphs and 4-edge-connected graphs	COMBINATORICA			English	Article							MULTICOMMODITY FLOWS; PLANAR GRAPHS; MINORS; ALGORITHMS; TREEWIDTH; BIDIMENSIONALITY; THEOREM	In the edge-disjoint paths problem, we are given a graph and a set of k pairs of vertices, and we have to decide whether or not the graph has k edge-disjoint paths connecting given pairs of terminals. Robertson and Seymour's graph minor project gives rise to a polynomial time algorithm for this problem for any fixed k, but their proof of the correctness needs the whole Graph Minor project. We give a faster algorithm and a much simpler proof of the correctness for the edge-disjoint paths problem. Our results can be summarized as follows: If an input graph is either 4-edge-connected or Eulerian, then our algorithm only needs to look for the following three simple reductions: (i) Excluding vertices of high degree. (ii) Excluding a parts per thousand currency sign3-edge-cuts. (iii) Excluding large clique minors. When an input graph is either 4-edge-connected or Eulerian, the number of terminals k is allowed to be a non-trivially super constant number, up to k=O((log log logn)(A1/2-epsilon) ) for any epsilon > 0. In addition, if an input graph is either 4-edge-connected planar or Eulerian planar, k is allowed to be O((logn (A1/2-epsilon) ) for any epsilon > 0. We also give our own algorithm for the edge-disjoint paths problem in general graphs. We basically follow the Robertson-Seymour's algorithm, but we cut half of the proof of the correctness for their algorithm. In addition, our algorithm is faster than Robertson and Seymour's.	[Kawarabayashi, Ken-ichi] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Kobayashi, Yusuke] Univ Tokyo, Tokyo 1138656, Japan	Kobayashi, Y (reprint author), Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	k_keniti@nii.ac.jp; kobayashi@mist.i.u-tokyo.ac.jp			Japan Society for the Promotion of Science; C C Foundation; Kayamori Foundation; Inoue Research Award for Young Scientists; MEXT, Japan	Research partly supported by Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research, by C & C Foundation, by Kayamori Foundation and by Inoue Research Award for Young Scientists.; Supported by the Grant-in-Aid for Scientific Research, MEXT, Japan.	ANDREWS M, 2005, P 46 ANN IEEE S FDN, P226; Chekuri C, 2009, SIAM J COMPUT, V39, P281, DOI 10.1137/060674442; Kawarabayashi K, 2012, J COMB THEORY B, V102, P424, DOI 10.1016/j.jctb.2011.07.004; ARNBORG S, 1989, DISCRETE APPL MATH, V23, P11, DOI 10.1016/0166-218X(89)90031-0; SEYMOUR PD, 1980, DISCRETE MATH, V29, P293, DOI 10.1016/0012-365X(80)90158-2; Demaine ED, 2008, COMBINATORICA, V28, P19, DOI 10.1007/s00493-008-2140-4; Nishizeki T, 2001, DISCRETE APPL MATH, V115, P177, DOI 10.1016/S0166-218X(01)00223-2; Diestel R, 1999, J COMB THEORY B, V75, P61, DOI 10.1006/jctb.1998.1862; MIDDENDORF M, 1993, COMBINATORICA, V13, P97, DOI 10.1007/BF01202792; OKAMURA H, 1981, J COMB THEORY B, V31, P75, DOI 10.1016/S0095-8956(81)80012-3; Guruswami V, 2003, J COMPUT SYST SCI, V67, P473, DOI 10.1016/S0022-0000(03)00066-7; Bodlaender HL, 1996, SIAM J COMPUT, V25, P1305, DOI 10.1137/S0097539793251219; Chekuri C., 2004, Proceedings. 45th Annual IEEE Symposium on Foundations of Computer Science; Demaine ED, 2004, LECT NOTES COMPUT SC, V3383, P517; FRANK A., 1990, PATHS FLOWS VLSI LAY, P49; Halin R., 1976, J GEOMETRY, V8, P171, DOI DOI 10.1007/BF01917434; JOHNSON DS, 1987, J ALGORITHM, V8, P285, DOI 10.1016/0196-6774(87)90043-5; Karp R. M., 1975, Networks, V5; Kawarabayashi K, 2010, PROC APPL MATH, V135, P345; KAWARABAYASHI K, 2010, P 42 ACM S THEOR COM, P687, DOI 10.1145/1806689.1806784; KLEINBERG J, 2005, P 46 ANN IEEE S FDN, P627; Kleinberg J., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, DOI 10.1145/225058.225075; KLEINBERG J, 1995, P 36 ANN S FDN COMP, P52; Kramer M., 1984, ADV COMPUT RES, V2, P129; NAGAMOCHI H, 1992, ALGORITHMICA, V7, P583, DOI 10.1007/BF01758778; PERKOVIC L., 2000, INT J FDN COMPUTING, V11, P81; Reed B. A., 1992, Proceedings of the Twenty-Fourth Annual ACM Symposium on the Theory of Computing, DOI 10.1145/129712.129734; Reed Bruce A., 1997, LONDON MATH SOC LECT, V241, P87; ROBERTSON N, 1995, J COMB THEORY B, V63, P65, DOI 10.1006/jctb.1995.1006; ROBERTSON N, 1986, J COMB THEORY B, V41, P92, DOI 10.1016/0095-8956(86)90030-4; ROBERTSON N., 1990, PATHS FLOWS VLSI LAY, P267; ROBERTSON N, 1986, J ALGORITHM, V7, P309, DOI 10.1016/0196-6774(86)90023-4; Robertson N, 2009, J COMB THEORY B, V99, P583, DOI 10.1016/j.jctb.2008.08.003; Robertson N, 2012, J COMB THEORY B, V102, P530, DOI 10.1016/j.jctb.2007.12.007; ROBERTSON N, 1994, J COMB THEORY B, V62, P323, DOI 10.1006/jctb.1994.1073; Schrijver A., 2003, COMBINATORIAL OPTIMI; SEYMOUR PD, 1981, P LOND MATH SOC, V42, P178; Thomassen C., 1980, EUROPEAN J COMBIN, V1, P371; Thomassen C, 1997, J COMB THEORY B, V70, P306, DOI 10.1006/jctb.1997.1761	39	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0209-9683	1439-6912		COMBINATORICA	Combinatorica	AUG	2015	35	4					477	495		10.1007/s00493-014-2828-6		19	Mathematics	Mathematics	CP7TD	WOS:000360090100004		
J	Zhou, R; Kaneko, S; Tanaka, F; Kayamori, M; Shimizu, M				Zhou, Rong; Kaneko, Shun'ichi; Tanaka, Fumio; Kayamori, Miyuki; Shimizu, Motoshige			Image-based field monitoring of Cercospora leaf spot in sugar beet by robust template matching and pattern recognition	COMPUTERS AND ELECTRONICS IN AGRICULTURE			English	Article						Image processing; Foliar disease monitoring; Template matching; Pattern recognition; Machine learning; Sugar beets	DISEASES	This paper presents a novel image algorithm using template matching and pattern recognition frameworks for monitoring Cercospora leaf spot (CLS) development on sugar beets on a single leaf scale under real field conditions. Due to the variety and complexity of the open field, it is a great challenge to achieve continuous and robust foliar disease observation in real field conditions. We propose a novel and compact algorithm, composed of two frameworks and a post-processing. The algorithm has continuous and highly discriminative capabilities for observing the process of disease in a single leaf from plant-level time sequence images. The first framework is based on robust template matching by orientation code matching (OCM), which implements successive tracking of a single leaf from a beet plant against severe illumination changes and non-rigid plant movements. The second framework uses a pattern recognition method of support vector machine (SVM) for achieving further disease classification from clutter field background. Prior to SVM, we propose a three feature combination of L*, a*, Entropy x Density, which has strong discrimination power to classify CLS disease from the clutter scene containing sandy soil, leaves, leaf stalks, and specular reflection. Additionally, post-processing is introduced to filter false positive noise to enhance the precision of the classification. Field experiment results demonstrate the feasibility and applicability of the proposed algorithm for disease monitoring under real field conditions. Meanwhile, comparative results with other conventional matching methods and feature combinations show the effectiveness of our proposed algorithm in both foliage tracking and disease classification. (C) 2015 Elsevier B.V. All rights reserved.	[Zhou, Rong; Kaneko, Shun'ichi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Tanaka, Fumio; Kayamori, Miyuki; Shimizu, Motoshige] Hokkaido Res Org, Cent Agr Expt Stn, Naganuma, Hokkaido 0691395, Japan	Zhou, R (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan.	zhou@ssc.ssi.ist.hokudai.ac.jp			China Scholarship Council (CSC) [2011635044]	We would like to thank Seth Richter at Dept. of Electrical and Computer Engineering, Utah State University for improving the language of the manuscript. We would also like to thank Prof. Takayuki Tanaka at Graduate School of Information Science and Technology, Hokkaido University for helpful comments. This work is supported in part by the China Scholarship Council (CSC) to Rong Zhou under the Grant No. 2011635044, which we gratefully acknowledge.	Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; Oberti R, 2014, COMPUT ELECTRON AGR, V104, P1, DOI 10.1016/j.compag.2014.03.001; Vassiliadis S, 1998, EUROMICRO CONF PROC, P559; Briechle K, 2001, P SOC PHOTO-OPT INS, V4387, P95, DOI 10.1117/12.421129; Huang KY, 2007, COMPUT ELECTRON AGR, V57, P3, DOI 10.1016/j.compag.2007.01.015; Camargo A, 2009, BIOSYST ENG, V102, P9, DOI 10.1016/j.biosystemseng.2008.09.030; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Food and Agriculture Organization of the United Nations (FAO), 2009, AGR HDB SUG BEET WHI; Holtschulte B., 2000, ADV SUGAR BEET RES, V2, P5; Kobayashi T, 2009, THESIS TSUKUBA U; loannidis P. M., 2010, CERCOSPORA LEAF SPOT; Mahlein AK, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-3; Makhoul J., 1999, P DARPA BROADC NEWS, P249; Polder G, 2014, BIOSYST ENG, V117, P35, DOI 10.1016/j.biosystemseng.2013.05.010; Robert M, 2013, CERCOSPORA LEAF SPOT; Scholkopft B, 1999, FISHER DISCRIMINANT; TAKAUJI H, 2006, J JAPAN SOC PRECISIO, V72, P487; Ullah F, 2004, PATTERN RECOGN, V37, P201, DOI 10.1016/S0031-3203(03)00184-5; Ullah F, 2001, IEICE T INF SYST, VE84D, P999; Vapnik V., 1998, STAT LEARNING THEORY; Vereijssen J, 2003, CROP PROT, V22, P201, DOI 10.1016/S0261-2194(02)00146-1; Verleysen M, 2005, LECT NOTES COMPUT SC, V3512, P758; Windels CE, 1998, PLANT DIS, V82, P716, DOI 10.1094/PDIS.1998.82.7.716; Windels CE, 1991, MANAGEMENT MODEL CER; Ying C., 2004, SIGN PROC P ICSP 04, P1107; Zhou R, 2013, 7 INT C AGR BIOT BIO, P2014; Zhou R, 2013, 11 INT C QUAL CONTR, P99; Zhou R, 2014, COMPUT ELECTRON AGR, V108, P58, DOI 10.1016/j.compag.2014.07.004	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0168-1699	1872-7107		COMPUT ELECTRON AGR	Comput. Electron. Agric.	AUG	2015	116						65	79		10.1016/j.compag.2015.05.020		15	Agriculture, Multidisciplinary; Computer Science, Interdisciplinary Applications	Agriculture; Computer Science	CP4YC	WOS:000359887500008		
J	Sun, YF; Fujii, H; Imai, H; Kondoh, K				Sun, Y. F.; Fujii, H.; Imai, H.; Kondoh, K.			Effect of Welding Parameters on the Hydrogen Embrittlement of Cathodic Hydrogen-Charged Friction Stir Welded High Carbon Steel Joints	CORROSION			English	Article						carbon steel; friction stir welding; hydrogen embrittlement; hydrogen-induced cracking	INDUCED CRACKING; MARTENSITIC STEEL; STAINLESS-STEEL; PIPELINE STEELS; MICROSTRUCTURE; FRACTURE; DIFFUSION; ALLOY	The hydrogen embrittlement behavior in terms of hydrogen-induced surface blistering and hydrogen-induced internal cracking of the friction stir welded high carbon steel plates was evaluated by the cathodic hydrogen charging method. The welding processes were performed at different revolutionary pitches of 0.83, 0.5, and 0.25 mm/rev and therefore, the stir zones of the welds had various microstructures accordingly. After hydrogen charging for 4 hours, the base metal showed large quantities of irreversible dome-shaped blisters on the sample surface. On the contrary, the blisters were hardly observed in the stir zone regardless of the welding parameters and only a small number of microcracks were formed. Compared with the base metal, the stir zones produced at 0.83 mm/rev and 0.5 mm/rev had less ductility reduction after hydrogen charging for the same time. It revealed that the stir zones showed higher resistance to hydrogen embrittlement than the base metal. However, the specimen welded at 0.25 mm/rev showed premature failure after hydrogen charging as a result of the formation of cracks in the twin martensite structure beneath the specimen surface.	[Sun, Y. F.; Fujii, H.; Imai, H.; Kondoh, K.] Osaka Univ, Joining & Welding Res Inst, Mihogaoka, Ibaraki 5670047, Japan	Sun, YF (reprint author), Osaka Univ, Joining & Welding Res Inst, Mihongaoka 11-1, Mihogaoka, Ibaraki 5670047, Japan.	yfsun@jwri.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Global COE Programs from Ministry of Education, Sports, Culture, Science; Japan Society for Promotion of Science and Technology of Japan; ISIJ Research Promotion Grant	The authors wish to acknowledge the financial support of a Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials" by Japan Science and Technology Agency (JST), the Global COE Programs from the Ministry of Education, Sports, Culture, Science, and a Grant-in-Aid for Science Research from the Japan Society for Promotion of Science and Technology of Japan, ISIJ Research Promotion Grant.	Luu WC, 1996, CORROS SCI, V38, P239, DOI 10.1016/0010-938X(96)00109-6; Koyama M, 2012, SCRIPTA MATER, V66, P459, DOI 10.1016/j.scriptamat.2011.12.015; Sato YS, 2009, SCI TECHNOL WELD JOI, V14, P202, DOI 10.1179/136217108X386518; Shibata A, 2012, ISIJ INT, V52, P208, DOI 10.2355/isijinternational.52.208; Cui L, 2007, SCRIPTA MATER, V56, P637, DOI 10.1016/j.scriptamat.2006.12.004; Hardie D, 2006, CORROS SCI, V48, P4378, DOI 10.1016/j.corsci.2006.02.011; Nagao A, 2012, ACTA MATER, V60, P5182, DOI 10.1016/j.actamat.2012.06.040; Koh SU, 2008, CORROSION, V64, P574; Liu HJ, 2003, J MATER PROCESS TECH, V142, P692, DOI 10.1016/S0924-0136(03)00806-9; Ha HM, 2014, CORROSION-US, V70, P166, DOI 10.5006/0990; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Mohtadi-Bonab MA, 2015, MAT SCI ENG A-STRUCT, V620, P97, DOI 10.1016/j.msea.2014.10.009; Akiyama E, 2012, ISIJ INT, V52, P307, DOI 10.2355/isijinternational.52.307; Hara T, 2004, CORROSION, V60, P1113; Martin ML, 2011, ACTA MATER, V59, P1601, DOI 10.1016/j.actamat.2010.11.024; Toribio J, 2011, CORROS SCI, V53, P3346, DOI 10.1016/j.corsci.2011.06.012; Yu GH, 1997, CORROSION, V53, P762; Fujii H, 2010, MAT SCI ENG A-STRUCT, V527, P3386, DOI 10.1016/j.msea.2010.02.023; Escobar DP, 2012, CORROS SCI, V65, P199, DOI 10.1016/j.corsci.2012.08.017; [Anonymous], 2003, MR0175ISO151562 NACE; Chan SLI, 1999, J CHIN INST ENG, V22, P43, DOI 10.1080/02533839.1999.9670440; ORIANI RA, 1970, ACTA METALL MATER, V18, P147, DOI 10.1016/0001-6160(70)90078-7; Koyama M, 2013, ACTA MATER, V61, P4607, DOI 10.1016/j.actamat.2013.04.030; Michler T, 2010, INT J HYDROGEN ENERG, V35, P821, DOI 10.1016/j.ijhydene.2009.10.092; Barrera O, 2013, PHILOS MAG, V93, P2680, DOI 10.1080/14786435.2013.785638; Bernstein I. M., 1971, METALL T, V2, P2792; Birnbaum H.K., 1986, ACTA METALL, V34, P353; Chu WY, 1999, CORROSION, V55, P892; Dominguez-Aguilar M. A., 2011, CORROSION, V67; Perez Escobar D., 2011, Corrosion Science, V53, DOI 10.1016/j.corsci.2011.05.060; Hays R.A., 1993, SLOW STRAIN RATE TES, P202; Horikawa K, 2009, MATER TRANS, V50, P2532, DOI 10.2320/matertrans.M2009168; HUANG H, 1995, CORROSION, V51, P30; Khodir S, 2013, J MATER SCI, V48, P4313, DOI 10.1007/s10853-013-7246-4; Kim Y, 2013, STEEL RES INT, V84, P812, DOI 10.1002/srin.201300082; King F, 2014, CORROS ENG SCI TECHN, V49, P442, DOI 10.1179/1743278214Y.0000000189; King Fraser, 2013, Corrosion, V69, DOI 10.5006/0894; Lai J. K. L., 2012, STAINLESS STEELS INT; Lee DH, 2014, INT J HYDROGEN ENERG, V39, P1897, DOI 10.1016/j.ijhydene.2013.11.060; LYNCH SP, 1988, ACTA METALL MATER, V36, P2639, DOI 10.1016/0001-6160(88)90113-7; Newman RC, 2008, CORROSION, V64, P819, DOI 10.5006/1.3279915; Ramunni VP, 2006, MAT SCI ENG A-STRUCT, V435, P504, DOI 10.1016/j.msea.2006.07.089; Szost BA, 2013, SCRIPTA MATER, V68, P467, DOI 10.1016/j.scriptamat.2012.11.018; ROBINSON MJ, 1985, CORROSION, V41, P582; Sun YF, 2015, CORROS SCI, V94, P88, DOI 10.1016/j.corsci.2015.01.046; Sun YF, 2010, MAT SCI ENG A-STRUCT, V527, P6879, DOI 10.1016/j.msea.2010.07.030; Thomas W.M., 1991, [Great Britain Patent Application, International Patent Application], Patent No. [9125978.8, 92/02203, 91259788]; Traidia A, 2014, CORROSION, V70, P87, DOI 10.5006/1056; Yamakawa K, 1999, CORROSION, V55, P24	49	0	0	NATL ASSOC CORROSION ENG	HOUSTON	1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA	0010-9312	1938-159X		CORROSION-US	Corrosion	AUG	2015	71	8					923	936		10.5006/1671		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CP8JF	WOS:000360139100001		
J	Kanzaki, M; Masaki, Y; Kudo, T				Kanzaki, Manabu; Masaki, Yasuhiro; Kudo, Takeo			Effect of Cr and Ni on Stress Corrosion Cracking Susceptibility in Ni-Cr-Fe Alloys Under Simulated Pressurized Water Reactor Primary Conditions	CORROSION			English	Article						chromium; grain boundary oxidation; nickel; pressurized water reactor; stress corrosion cracking	HIGH-TEMPERATURE WATER; GRAIN-BOUNDARY CARBIDES; STAINLESS-STEELS; DISSOLVED HYDROGEN; INCONEL ALLOY-600; BEHAVIOR; STEAM; MECHANISM; PWSCC	The primary water stress corrosion cracking (PWSCC) susceptibility of Ni-based alloys, such as Alloy 600 (UNS N06600), has been much higher than that of Fe-based alloys, such as Type 316 stainless steel (UNS S31600). This phenomenon is generally recognized; however, the effects of Fe, Ni, and Cr are not fully understood. In this study, the effect of Cr and Ni in Ni-Cr-Fe alloys on PWSCC susceptibility was investigated using alloys with a wide range of Ni content. The role of these elements is discussed from the standpoint of grain boundary oxidation. According to the stress corrosion cracking (SCC) test results, high-Ni alloys with low Cr contents had high SCC susceptibility, and the SCC susceptibility in high Ni-content alloys was improved by increasing Cr content. On the other hand, low Ni-content alloys had low SCC susceptibility, irrespective of Cr content. These features agree with the field experience in pressurized water reactor plants. In comparison with the results of SCC tests and immersion tests, the effect of Cr and Ni on SCC susceptibility was consistent with that of these elements on grain boundary oxidation. This suggests that grain boundary oxidation plays an important role in PWSCC.	[Kanzaki, Manabu; Masaki, Yasuhiro] Nippon Steel & Sumitomo Met Corp, Amagasaki, Hyogo 6600891, Japan; [Kudo, Takeo] Sumitomo Met Ind Ltd, Tokyo, Japan	Kanzaki, M (reprint author), Nippon Steel & Sumitomo Met Corp, 1-8 Fuso Cho, Amagasaki, Hyogo 6600891, Japan.	kanzaki.r22.manabu@jp.nssmc.com			ASTM International	UNS numbers are listed in Metals and Alloys in the Unified Numbering System, published by the Society of Automotive Engineers (SAE International) and cosponsored by ASTM International.	Airey G. P., 1983, EPRINP3051 WEST EL C; Alley D., 2011, P 15 INT S ENV DEGR, P14; Andresen P. L., 2007, P 13 INT C ENV DEGR; Andresen PL, 2011, 15TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P161; Terachi T, 2008, J NUCL SCI TECHNOL, V45, P975, DOI 10.3327/jnst.45.975; ECONOMY G, 1987, CORROSION, V43, P727; Ferguson JB, 2006, METALL MATER TRANS A, V37A, P2471, DOI 10.1007/BF02586220; Rebak RB, 1996, CORROS SCI, V38, P971, DOI 10.1016/0010-938X(96)00183-7; Hwang SS, 2013, NUCL ENG TECHNOL, V45, P73, DOI 10.5516/NET.07.2012.013; [Anonymous], 2013, 753910 ISO; Scenini F, 2008, CORROSION, V64, P824, DOI 10.5006/1.3279916; LAI WK, 1991, CORROSION, V47, P40; SHEN CH, 1990, METALL TRANS A, V21, P1261, DOI 10.1007/BF02698254; Andresen PL, 2008, CORROSION, V64, P15; Staehle RW, 2004, CORROSION, V60, P115; Arioka K, 2008, CORROSION, V64, P691; Arioka K, 2014, CORROSION, V70, P695, DOI 10.5006/1205; Aspden R. G., 1989, CORROSION 89; Attanasio SA, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P49; BANDY R, 1984, CORROSION, V40, P425; Boggs R. S., 1996, PVP SERIES, V335, P5; Bruemmer S. M., 1987, CORROSION 87; Bruemmer SM, 2011, 15TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P301; Cassagne T, 1997, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS - WATER REACTORS, VOLS 1 AND 2, P307; CORIOU H, 1966, CORROSION, V22, P280; Delabrouille F., 2005, P 12 INT C ENV DEGR, P903; Economy G., 1987, CORROSION 87; Ellingham H.J.T., 1944, J SOC CHEM IND LOND, V63, P125; Feron D, 2012, J NUCL MATER, V427, P364, DOI 10.1016/j.jnucmat.2012.03.034; Foct F, 2000, METALL MATER TRANS A, V31, P2025, DOI 10.1007/s11661-000-0230-z; Garud Y. S., 1985, CORROSION 85; Gorman J., 2006, COMPANION GUIDE ASME, V3, P63; Gorman J. A., 1985, P 2 INT S ENV DEGR M, P557; HERNALSTEEN P, 1993, NUCL ENG DES, V143, P131, DOI 10.1016/0029-5493(93)90217-W; Hertzberg JL, 1997, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS - WATER REACTORS, VOLS 1 AND 2, P257; Kajimura H., 1995, P JSCE CORR 95, P287; Kanzaki M, 2015, CORROSION, V71, P57, DOI 10.5006/1285; Newman RC, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P79; Ogawa N, 1996, NUCL ENG DES, V165, P171, DOI 10.1016/0029-5493(96)01193-4; Paraventi DJ, 1997, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS - WATER REACTORS, VOLS 1 AND 2, P299; Pement F. W., 1989, CORROSION 89; Sakai S., 2001, CORROSION 01; SCOTT PM, 1993, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS - WATER REACTORS, P657; Scott P. M., 2003, P 11 INT C ENV DEGR, P29; Scott P. M., 1994, ADV FRACTURE RESISTA, P441; Scott PM, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P3; Smith K., 1985, P 2 INT S ENV DEGR M, P319; Smuk S, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P59; Staehle RW, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P69; Stein A. A., 1986, CORROSION PREVENTION, P139; Symons DM, 2001, METALL MATER TRANS A, V32, P369, DOI 10.1007/s11661-001-0268-6; Tanuma S., 2001, J SURF ANAL, V8, P17; Thomas LE, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P41; Thompson C. D., 1995, KAPLP000005 US DOE; Tsutsumi K, 2011, 15TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P41; Vaccaro F. P., 1987, CORROSION 87; Wood G. C., 1971, WERKST KORROS, V22, P491; Yonezawa T., 1985, P 2 INT S ENV DEGR M, P593; Yonezawa T., 1988, P 1988 JAIF INT C WA, V2, P490; Yonezawa T, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P15; Young G. A., 2005, P 12 INT C ENV DEGR, P913	61	0	0	NATL ASSOC CORROSION ENG	HOUSTON	1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA	0010-9312	1938-159X		CORROSION-US	Corrosion	AUG	2015	71	8					1027	1035		10.5006/1696		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CP8JF	WOS:000360139100009		
J	Yashiro, M				Yashiro, Masakazu			Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease	DIGESTIVE DISEASES AND SCIENCES			English	Review						Colorectal cancer; Ulcerative colitis; Crohn's disease; Genetic alterations; Dysplasia; Inflammatory bowel disease	CHRONIC ULCERATIVE-COLITIS; NITRIC-OXIDE SYNTHASE; GENE-ENVIRONMENT INTERACTIONS; LIFE-STYLE FACTORS; KI-RAS MUTATIONS; PRIMARY SCLEROSING CHOLANGITIS; PRACTICE PARAMETERS COMMITTEE; DYSPLASIA-ASSOCIATED LESION; EVIDENCE-BASED CONSENSUS; POPULATION-BASED COHORT	Inflammatory bowel disease (IBD) is an important etiologic factor in the development of colorectal cancer (CRC). The risk of CRC begins to increase 8 or 10 years after the diagnosis of IBD. This type of cancer is called colitis-associated CRC (CA-CRC). The molecular pathogenesis of inflammatory epithelium might play a critical role in the development of CA-CRC. Genetic alterations detected in CA-CRC such as genetic mutations, microsatellite instability, and DNA hypermethylation are also recognized in sporadic CRC; however, there are differences in the timing and frequency of molecular events between CA-CRC and sporadic CRC. Interaction between gene-environmental factors, including inflammation, lifestyle, psychological stress, and prior appendectomy, might be associated with the etiopathology of IBD. The mucosal inflammatory mediators, such as oxidant stress, free radicals, and chemokines, may cause the genetic alterations. Understanding the molecular mechanisms of CA-CRC might be important to develop clinical efficacies for patients with IBD. This review discusses the molecular characteristics of CA-CRC, especially ulcerative colitis-associated CRC, including clinical features, signaling pathways, and interactions between genetic alterations and environment involved in inflammatory carcinogenesis.	Osaka City Univ, Oncol Inst Geriatr & Med Sci, Dept Surg Oncol, Grad Sch Med,Abeno Ku, Osaka 5458585, Japan	Yashiro, M (reprint author), Osaka City Univ, Oncol Inst Geriatr & Med Sci, Dept Surg Oncol, Grad Sch Med,Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	m9312510@med.osaka-cu.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan [23390329]; Priority Research Fund of Osaka City University	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI, 23390329) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan, and by Priority Research Fund of Osaka City University.	Aldhous MC, 2007, AM J GASTROENTEROL, V102, P589, DOI 10.1111/j.1572-0241.2007.01065.x; Amre Devendra, 2005, J Pediatr Gastroenterol Nutr, V40 Suppl 1, pS39, DOI 10.1097/00005176-200504001-00023; Andersen SN, 1999, GUT, V45, P686; Umetani N, 1999, JPN J CANCER RES, V90, P1081; Brentnall TA, 1996, CANCER RES, V56, P1237; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; BOLAND CR, 1995, NAT MED, V1, P902, DOI 10.1038/nm0995-902; Slattery ML, 2002, CANCER EPIDEM BIOMAR, V11, P541; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; GYDE S, 1982, GASTROENTEROLOGY, V83, P36; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Makita H, 2007, CARCINOGENESIS, V28, P677, DOI 10.1093/carcin/bgl178; Issa JPJ, 2001, CANCER RES, V61, P3573; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462; Souza RF, 1996, NAT GENET, V14, P255, DOI 10.1038/ng1196-255; Brackmann S, 2009, SCAND J GASTROENTERO, V44, P46, DOI 10.1080/00365520801977568; WIMAN KG, 1993, FASEB J, V7, P841; Kaser A, 2010, DIGEST DIS, V28, P395, DOI 10.1159/000320393; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Kornbluth A, 2004, AM J GASTROENTEROL, V99, P1371, DOI 10.1111/j.1572-0241.2004.40036.x; SUZUKI H, 1994, CANCER RES, V54, P4841; Smalley W E, 1997, Adv Pharmacol, V39, P1, DOI 10.1016/S1054-3589(08)60067-8; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Odze RD, 2000, AM J SURG PATHOL, V24, P1209, DOI 10.1097/00000478-200009000-00003; Chambers WM, 2005, BRIT J SURG, V92, P928, DOI 10.1002/bjs.5106; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Odze RD, 2002, AM J GASTROENTEROL, V97, P1235; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; REDSTON MS, 1995, GASTROENTEROLOGY, V108, P383, DOI 10.1016/0016-5085(95)90064-0; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Paggi MG, 1996, J CELL BIOCHEM, V62, P418; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Tung BY, 2001, ANN INTERN MED, V134, P89; Ding XH, 2005, CANCER SCI, V96, P157, DOI 10.1111/j.1349-7006.2005.00024.x; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Kimura H, 1997, DIGEST DIS SCI, V42, P1047, DOI 10.1023/A:1018849405922; Bernstein CN, 2001, CANCER, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Azer SA, 2013, EUR J GASTROEN HEPAT, V25, P271, DOI 10.1097/MEG.0b013e32835b5803; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Bossard C, 2007, ONCOL REP, V18, P1093; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Leslie WD, 2008, AM J GASTROENTEROL, V103, P1451, DOI 10.1111/j.1572-0241.2007.01753.x; Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Pekow JR, 2010, INFLAMM BOWEL DIS, V16, P1352, DOI 10.1002/ibd.21184; Chen YX, 2013, J DIGEST DIS, V14, P157, DOI 10.1111/1751-2980.12043; Fleisher AS, 2000, CANCER RES, V60, P4864; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Velayos FS, 2006, GASTROENTEROLOGY, V130, P1941, DOI 10.1053/j.gastro.2006.03.028; Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664; Nair J, 1999, MUTAT RES-FUND MOL M, V424, P59, DOI 10.1016/S0027-5107(99)00008-1; Tang WH, 2009, FEBS J, V276, P581, DOI 10.1111/j.1742-4658.2008.06809.x; Eaden JA, 2002, GUT, V51, pV10, DOI 10.1136/gut.51.suppl_5.v10; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Baron S, 2005, GUT, V54, P357, DOI 10.1136/gut.2004.054353; Canavan C, 2006, ALIMENT PHARM THERAP, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Svrcek M, 2007, HISTOPATHOLOGY, V50, P574, DOI 10.1111/j.1365-2559.2007.02663.x; BLACKSTONE MO, 1981, GASTROENTEROLOGY, V80, P366; van Staa TP, 2005, GUT, V54, P1573, DOI 10.1136/gut.2005.070896; Ghadimi D, 2012, J LEUKOCYTE BIOL, V92, P895, DOI 10.1189/jlb.0611286; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Karlen P, 1998, GUT, V42, P711; Arnold CN, 2005, CANCER, V104, P2035, DOI 10.1002/cncr.21462; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Brown K, 2012, NUTRIENTS, V4, P1095, DOI 10.3390/nu4081095; Serafino A, 2014, ONCOTARGET, V5, P978; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Solem CA, 2004, INFLAMM BOWEL DIS, V10, P32, DOI 10.1097/00054725-200401000-00005; Schottelius AJ, 2006, CANC TREAT, V130, P67; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Soderlund S, 2009, GASTROENTEROLOGY, V136, P1561, DOI 10.1053/j.gastro.2009.01.064; Befrits R, 2002, DIS COLON RECTUM, V45, P615, DOI 10.1007/s10350-004-6255-4; Holzmann K, 1998, INT J CANCER, V76, P1; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Koutroubakis IE, 2002, INFLAMM BOWEL DIS, V8, P277, DOI 10.1097/00054725-200207000-00007; Hussain SP, 1998, CANCER RES, V58, P4023; Poullis A, 2004, CANCER EPIDEM BIOMAR, V13, P279, DOI 10.1158/1055-9965.EPI-03-0160; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Hsieh CJ, 1998, CANCER RES, V58, P3942; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Chen R, 2003, AM J PATHOL, V162, P665, DOI 10.1016/S0002-9440(10)63860-6; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; BERNSTEIN CN, 1994, LANCET, V343, P71; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Amit S, 2003, SEMIN CANCER BIOL, V13, P15, DOI 10.1016/S1044-579X(02)00096-2; Svrcek M, 2013, CARCINOGENESIS, V34, P828, DOI 10.1093/carcin/bgs408; KERN SE, 1989, JAMA-J AM MED ASSOC, V261, P3099, DOI 10.1001/jama.261.21.3099; YIN J, 1993, GASTROENTEROLOGY, V104, P1633; Sato F, 2002, CANCER RES, V62, P1148; Ljung T, 2006, WORLD J GASTROENTERO, V12, P3386; Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1810, DOI 10.3748/wjg.14.1810; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Biancone L, 2008, J CROHNS COLITIS, V2, P63, DOI 10.1016/j.crohns.2007.12.001; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Bressenot A, 2014, WORLD J GASTROENTERO, V20, P3164, DOI 10.3748/wjg.v20.i12.3164; Aust DE, 2002, CANCER, V94, P1421, DOI 10.1002/cncr.10334; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Nuako KW, 1998, GASTROENTEROLOGY, V115, P1079, DOI 10.1016/S0016-5085(98)70077-0; Cottliar A, 2000, AM J GASTROENTEROL, V95, P2301; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Foersch S, 2014, CELL MOL LIFE SCI, V71, P3523, DOI 10.1007/s00018-014-1636-x; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046; Jena G, 2012, FREE RADICAL RES, V46, P1339, DOI 10.3109/10715762.2012.717692; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; PINCZOWSKI D, 1994, GASTROENTEROLOGY, V107, P117; Campbell PT, 2009, GUT, V58, P661, DOI [10.1136/gut.2007.144220, 10.1136//gut.2007.144220]; Andersen NN, 2013, WORLD J GASTROENTERO, V19, P7561, DOI 10.3748/wjg.v19.i43.7561; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Garg M, 2013, INFLAMM BOWEL DIS, V19, P2634, DOI 10.1097/01.MIB.0000436957.77533.b2; POOL MO, 1995, SCAND J GASTROENTERO, V30, P784, DOI 10.3109/00365529509096328; Kamba A, 2013, CURR MOL MED, V13, P1110; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Jess T, 2004, ALIMENT PHARM THERAP, V19, P287, DOI 10.1111/j.1365-2036.2004.01858.x; CHOI PM, 1993, GASTROENTEROLOGY, V105, P418; Askling J, 2001, GASTROENTEROLOGY, V120, P1356, DOI 10.1053/gast.2001.24052; Baker SJ, 1990, CANCER RES, V50, P7722; Fan Wang, 2011, Eur J Hum Genet, V19, P432, DOI 10.1038/ejhg.2010.159; Boland CR, 2010, DIGEST DIS, V28, P590, DOI 10.1159/000320053; BURMER GC, 1991, CANCER COMMUN, V3, P167; Cawkwell L, 2000, GUT, V46, P367, DOI 10.1136/gut.46.3.367; Chan DSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020456; CHAUBERT P, 1994, AM J PATHOL, V144, P767; CHEN J, 1992, GASTROENTEROLOGY, V102, P1983; CRAVEN PA, 1987, GASTROENTEROLOGY, V92, P1998; Crohn BB, 1925, AM J MED SCI, V170, P220, DOI 10.1097/00000441-192508010-00006; DOBBINS WO, 1984, ANNU REV MED, V35, P33; EKBOM A, 1990, AM J EPIDEMIOL, V132, P1111; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; Farraye Francis A, 2010, Gastroenterology, V138, P738, DOI 10.1053/j.gastro.2009.12.037; Fogt F, 1998, HUM PATHOL, V29, P131, DOI 10.1016/S0046-8177(98)90222-2; Fogt F, 1998, ONCOL REP, V5, P477; Frisch M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b716; Fujii S, 2002, PATHOL INT, V52, P195, DOI 10.1046/j.1440-1827.2002.01333.x; Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9; Gardenbroek TJ, 2012, COLORECTAL DIS, V14, P545, DOI 10.1111/j.1463-1318.2011.02600.x; Gerrits MM, 2011, CELL ONCOL, V34, P107, DOI 10.1007/s13402-010-0006-4; GREENWALD BD, 1992, CANCER RES, V52, P741; Heinen CD, 1997, GENE CHROMOSOME CANC, V19, P170; ISBELL G, 1988, GASTROENTEROL CLIN N, V17, P773; Jess T, 2012, GASTROENTEROLOGY, V143, pe313; KERN SE, 1994, GASTROENTEROLOGY, V107, P420; Kiran RP, 2014, ANN SURG, V259, P302, DOI 10.1097/SLA.0b013e31828e7417; Knox Sarah S, 2013, Gene Regul Syst Bio, V7, P11, DOI 10.4137/GRSB.S10943; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Kohno H, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-46; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lei JY, 1996, ONCOGENE, V13, P2459; Lopez A, 2013, DIGEST DIS, V31, P248, DOI 10.1159/000353806; Matkowskyj KA, 2013, ARCH PATHOL LAB MED, V137, P338, DOI 10.5858/arpa.2012-0086-RA; Mawdsley JE, 2006, GASTROENTEROLOGY, V131, P410, DOI 10.1053/j.gastro.2006.05.017; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Mikami T, 2000, CANCER, V89, P733, DOI 10.1002/1097-0142(20000815)89:4<733::AID-CNCR3>3.0.CO;2-#; Molodecky Natalie A, 2010, Gastroenterol Hepatol (N Y), V6, P339; Moriyama T, 2007, DIS COLON RECTUM, V50, P1384, DOI 10.1007/10350-007-0302-x; Rashid A, 1997, GASTROENTEROLOGY, V113, P127, DOI 10.1016/S0016-5085(97)70087-8; SACHAR DB, 1994, GUT, V35, P1507, DOI 10.1136/gut.35.11.1507; Schnur DM, 2008, CURR OPIN DRUG DISC, V11, P375; Slattery ML, 2010, DIS COLON RECTUM, V53, P1182, DOI 10.1007/DCR.0b013e3181d325db; Slattery ML, 2000, CANCER RES, V60, P6935; Slattery ML, 2001, INT J CANCER, V93, P601, DOI 10.1002/ijc.1370; Soderlund S, 2009, GASTROENTEROLOGY, V136, P1818, DOI DOI 10.1053/J.GASTRO.2009.01.064]; Souza RF, 1997, GASTROENTEROLOGY, V112, P40, DOI 10.1016/S0016-5085(97)70217-8; Timmer A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006913.pub2; Tomasello G, 2011, Eur J Histochem, V55, pe38, DOI 10.4081/ejh.2011.e38; Tomasello G, 2014, WORLD J GASTROENTERO, V20, P18121, DOI 10.3748/wjg.v20.i48.18121; Tsaitas Christos, 2014, World J Hepatol, V6, P178, DOI 10.4254/wjh.v6.i4.178; Walsh SV, 1999, AM J SURG PATHOL, V23, P963, DOI 10.1097/00000478-199908000-00015; Wang MH, 2014, HUM GENET, V133, P547, DOI 10.1007/s00439-013-1395-z; Yang T, 2013, TRENDS MOL MED, V19, P714, DOI 10.1016/j.molmed.2013.08.005; Yashiro M, 2001, CANCER RES, V61, P2676; Yashiro M, 2005, CANCER EPIDEM BIOMAR, V14, P2253, DOI 10.1158/1055-9965.EPI-04-0790; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129	213	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	AUG	2015	60	8					2251	2263		10.1007/s10620-015-3646-4		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LF	WOS:000359998000011		
J	Mori, K; Toiyama, Y; Saigusa, S; Fujikawa, H; Hiro, J; Kobayashi, M; Ohi, M; Araki, T; Inoue, Y; Tanaka, K; Mohri, Y; Kusunoki, M				Mori, Koichiro; Toiyama, Yuji; Saigusa, Susumu; Fujikawa, Hiroyuki; Hiro, Junichiro; Kobayashi, Minako; Ohi, Masaki; Araki, Toshimitsu; Inoue, Yasuhiro; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato			Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery	DIGESTIVE DISEASES AND SCIENCES			English	Article						Recurrence; Colorectal cancer; Systemic inflammatory response; Tumor-infiltrating lymphocyte; Microsatellite instability	C-REACTIVE PROTEIN; ELEVATED PREOPERATIVE PLATELET; TUMOR-INFILTRATING LYMPHOCYTES; CD8(+) T-CELLS; COLON-CANCER; MICROSATELLITE INSTABILITY; INFLAMMATORY RESPONSE; PROGNOSTIC-FACTOR; SURVIVAL; NEUTROPHIL	Background Preoperative serum systemic inflammatory response (SIR) in patients with colorectal cancer (CRC) has been reported to be a predictive biomarker of early recurrence. The molecular status of CRC, including microsatellite instability (MSI), BRAF and KRAS mutations, and tumor-infiltrating lymphocytes (TILs), has also been associated with recurrence in CRC patients treated with curative surgery. Aim We investigated the impacts of SIR status, TILs, and MSI on recurrence in curative CRC patients. Methods In this retrospective study, we enrolled 157 patients with stage I-III CRC undergoing curative surgery, for whom preoperative neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and C-reactive protein (CRP) data were available as indicators of SIR status. Molecular status was evaluated by counting TILs as the numbers of intratumoral Foxp3- and CD8-positive T cells by immunohistochemistry. MSI status was determined using five mononucleotide repeat microsatellite markers. Results Kaplan-Meier analysis of SIR indicators revealed that higher CRP, NLR, and PLR were associated with significantly poorer disease-free survival (DFS). Low levels of infiltrating CD8-positive T cells in CRC tissue was a significant predictor of poor DFS. Multivariate analysis showed that few infiltrating CD8-positive T cells and high serum CRP levels were independent predictive factors for recurrence. Furthermore, the combination of high CRP and few infiltrating CD8-positive T cells increased the predictive accuracy in these patients. Conclusions The results of this study suggest that both CRP levels in preoperative serum and CD8 T cells in CRC tissue are useful biomarkers for predicting early relapse in CRC patients treated with curative surgery.	[Mori, Koichiro; Toiyama, Yuji; Saigusa, Susumu; Fujikawa, Hiroyuki; Hiro, Junichiro; Kobayashi, Minako; Ohi, Masaki; Araki, Toshimitsu; Inoue, Yasuhiro; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Dept Gastrointestinal & Pediat Surg, Grad Sch Med, Tsu, Mie 5148507, Japan	Toiyama, Y (reprint author), Mie Univ, Dept Gastrointestinal & Pediat Surg, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	koichiromori@clin.medic.mie-u.ac.jp; ytoi0725@clin.medic.mie-u.ac.jp; saigusa@clin.medic.mie-u.ac.jp; f0609@clin.medic.mie-u.ac.jp; hirosumi@clin.medic.mie-u.ac.jp; m-koba@clin.medic.mie-u.ac.jp; mohi1012@clin.medic.mie-u.ac.jp; taraki@clin.medic.mie-u.ac.jp; yasinoue@clin.medic.mie-u.ac.jp; qouji@clin.medic.mie-u.ac.jp; ya-mohri@clin.medic.mie-u.ac.jp; kusunoki@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [21791280]	This work was supported in part by a Grant in Aid for Scientific Research (21791280) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ali AA, 2004, EJSO, V30, P292, DOI 10.1016/j.ejso.2003.11.018; Chiang SF, 2012, INT J COLORECTAL DIS, V27, P1347, DOI 10.1007/s00384-012-1459-x; NAKAZAKI H, 1992, CANCER, V70, P709, DOI 10.1002/1097-0142(19920801)70:3<709::AID-CNCR2820700328>3.0.CO;2-O; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Szkandera J, 2014, AM J SURG, V208, P210, DOI 10.1016/j.amjsurg.2013.10.030; Roxburgh CSD, 2012, CANCER TREAT REV, V38, P451, DOI 10.1016/j.ctrv.2011.09.001; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Park JH, 2014, CANCER TREAT REV, V40, P68, DOI 10.1016/j.ctrv.2013.05.006; Kornmann M, 2008, EJSO-EUR J SURG ONC, V34, P1316, DOI 10.1016/j.ejso.2008.01.019; Sinicrope FA, 2007, INT J CANCER, V120, P1232, DOI 10.1002/ijc.22429; Dahlin AM, 2011, MODERN PATHOL, V24, P671, DOI 10.1038/modpathol.2010.234; Michel S, 2008, BRIT J CANCER, V99, P1867, DOI 10.1038/sj.bjc.6604756; Lee SY, 2012, DIGEST DIS SCI, V57, P72, DOI 10.1007/s10620-011-1825-5; Gunter MJ, 2006, CANCER RES, V66, P2483, DOI 10.1158/0008-5472.CAN-05-3631; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Zlobec I, 2008, CLIN CANCER RES, V14, P3792, DOI 10.1158/1078-0432.CCR-08-0048; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Morishima N, 2005, J IMMUNOL, V175, P1686; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Smith RA, 2008, SURGERY, V143, P658, DOI 10.1016/j.surg.2007.12.014; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Baker K, 2009, CANCER IMMUNOL IMMUN, V58, P135, DOI 10.1007/s00262-008-0534-1; Benson AB, 2006, ONCOLOGIST, V11, P973, DOI 10.1634/theoncologist.11-9-973; Edge SB, 2010, AJCC CANC STAGING MA, P237; Farid SG, 2013, COLORECTAL DIS, V15, P909, DOI 10.1111/codi.12195; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; MCMILLAN DC, 1995, AM J SURG, V170, P319, DOI 10.1016/S0002-9610(99)80296-7; Nozoe T, 2000, AM J CLIN ONCOL-CANC, V23, P263, DOI 10.1097/00000421-200006000-00011; Phan V, 2008, CANCER IMMUNOL IMMUN, V57, P281, DOI 10.1007/s00262-007-0356-6; Sobin LH, 2011, TNM CLASSIFICATION M; Warusavitarne J, 2007, INT J COLORECTAL DIS, V22, P739, DOI 10.1007/s00384-006-0228-0; Zlobec I, 2008, J CLIN PATHOL, V61, P561, DOI 10.1136/jcp.2007.054858	54	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	AUG	2015	60	8					2477	2487		10.1007/s10620-015-3648-2		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LF	WOS:000359998000038		
J	Tsuchiya, T; Itoi, T; Maetani, I; Shigoka, H; Ikeuchi, N; Umeda, J; Sofuni, A; Itokawa, F; Ishii, K; Kurihara, T; Tsuji, S; Tanaka, R; Tonozuka, R; Honjyo, M; Mukai, S; Moriyasu, F				Tsuchiya, Takayoshi; Itoi, Takao; Maetani, Iruru; Shigoka, Hiroaki; Ikeuchi, Nobuhito; Umeda, Junko; Sofuni, Atsushi; Itokawa, Fumihide; Ishii, Kentaro; Kurihara, Toshio; Tsuji, Shujiro; Tanaka, Reina; Tonozuka, Ryosuke; Honjyo, Mitsuyoshi; Mukai, Shuntaro; Moriyasu, Fuminori			Effectiveness of the J-Tip Guidewire for Selective Biliary Cannulation Compared to Conventional Guidewires (The JANGLE Study)	DIGESTIVE DISEASES AND SCIENCES			English	Article						ERCP; Biliary cannulation; Guidewire; J-tip guidewire; Wire-guided cannulation; Post-ERCP pancreatitis	POST-ERCP PANCREATITIS; BILE-DUCT CANNULATION; RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PROSPECTIVE RANDOMIZED-TRIAL; WIRE; STENT; SPHINCTEROTOMY; PLACEMENT; METAANALYSIS; ENDOSCOPISTS	Background Wire-guided cannulation has become a common biliary cannulation technique worldwide. Different guidewires with various tip shapes and materials have been reportedly used for wire-guided cannulation. However, there are apparently no studies reporting changes in the biliary cannulation rate according to the type of guidewire used. Aims We evaluated the effectiveness of the J-tip guidewire for biliary cannulation. Methods We conducted a prospective, multicenter, controlled study involving patients with a native papilla who required biliary cannulation. We allocated the patients to the J-tip guidewire or angled-tip guidewire groups (groups J and A, respectively). If biliary cannulation was not achieved within 10 min, the GW was changed and cannulation was continued. Results Groups J and A consisted of 66 and 65 enrolled patients, respectively. The biliary cannulation rate with a single guidewire for the first 10 min was 84.8 % (56/66) for group J and 80.0 %(52/65) for group A. The final success rate for biliary cannulation was 100 % in both groups. The mean times necessary for biliary cannulationwere 285.8 and 267.6 s in group J and group A, respectively. The incidence rates of complications (i.e., all mild pancreatitis) were 3.0 % (2/66) and 6.2 % (4/65) in group J and group A, respectively. The mean amylase concentrations were 168.0 and 297.7 IU/L in group J and group A, respectively. There were no significant differences in any results between both groups. Conclusion The biliary cannulation rate of the J-tip guidewire was not significantly different from those of standard guidewires.	[Tsuchiya, Takayoshi; Itoi, Takao; Sofuni, Atsushi; Itokawa, Fumihide; Ishii, Kentaro; Kurihara, Toshio; Tsuji, Shujiro; Tanaka, Reina; Tonozuka, Ryosuke; Honjyo, Mitsuyoshi; Mukai, Shuntaro; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Maetani, Iruru; Shigoka, Hiroaki] Toho Univ, Div Gastroenterol, Dept Internal Med, Ohashi Med Ctr, Tokyo, Japan; [Ikeuchi, Nobuhito] Tokyo Med Univ, Hachioji Med Ctr, Dept Gastroenterol, Hachioji, Tokyo, Japan; [Umeda, Junko] Toda Chuo Gen Hosp, Dept Gastroenterol, Toda, Saitama, Japan	Tsuchiya, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	tsuchiya@tokyo-med.ac.jp					Abu-Hamda Emad M, 2005, J Clin Gastroenterol, V39, P717, DOI 10.1097/01.mcg.0000173928.82986.56; Omuta S, 2013, WORLD J GASTROENTERO, V19, P4531, DOI 10.3748/wjg.v19.i28.4531; Tang SJ, 2005, ENDOSCOPY, V37, P58, DOI 10.1055/s-2004-826077; Maeda S, 2003, ENDOSCOPY, V35, P721; Kahaleh M, 2004, CLIN GASTROENTEROL H, V2, P971, DOI 10.1053/S1542-3565(04)00484-7; Kawakami H, 2012, GASTROINTEST ENDOSC, V75, P362, DOI 10.1016/j.gie.2011.10.012; Artifon ELA, 2007, AM J GASTROENTEROL, V102, P2147, DOI 10.1111/j.1572-0241.2007.01378.x; Bailey AA, 2008, ENDOSCOPY, V40, P296, DOI 10.1055/s-2007-995566; Goff JS, 1999, GASTROINTEST ENDOSC, V50, P642, DOI 10.1016/S0016-5107(99)80012-1; Weber A, 2008, PANCREAS, V36, P187, DOI 10.1097/MPA.0b013e31815ac54c; Cennamo V, 2009, AM J GASTROENTEROL, V104, P2343, DOI 10.1038/ajg.2009.269; Binmoeller KF, 1996, GASTROINTEST ENDOSC, V44, P689, DOI 10.1016/S0016-5107(96)70053-6; Catalano MF, 2004, GASTROINTEST ENDOSC, V60, P557, DOI 10.1016/S0016-5107(04)01877-2; Lella F, 2004, GASTROINTEST ENDOSC, V59, P830, DOI 10.1016/S0016-5107(04)00363-3; Halttunen J, 2013, SURG ENDOSC, V27, P1662, DOI 10.1007/s00464-012-2653-1; Goldberg E, 2005, GASTROINTEST ENDOSC, V62, P592, DOI 10.1016/j.gie.2005.04.046; Sofuni A, 2011, CLIN GASTROENTEROL H, V9, P851, DOI 10.1016/j.cgh.2011.06.033; Katsinelos P, 2008, ENDOSCOPY, V40, P302, DOI 10.1055/s-2007-995483; Nambu T, 2011, SCAND J GASTROENTERO, V46, P109, DOI 10.3109/00365521.2010.521889; Farrell RJ, 1996, GUT, V39, P36, DOI 10.1136/gut.39.1.36; Cheung J, 2009, GASTROINTEST ENDOSC, V70, P1211, DOI 10.1016/j.gie.2009.08.007; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; Ayala JC, 2007, GASTROINTEST ENDOSC, V65, pAB236, DOI 10.1016/j.gie.2007.03.521; Bourke MJ, 2009, ENDOSCOPY, V41, P612, DOI 10.1055/s-0029-1214859; Chan CHY, 2010, J GASTROEN HEPATOL, V25, pA66; Ito K, 2010, J GASTROENTEROL, V45, P1183, DOI 10.1007/s00535-010-0268-7; Lee TH, 2009, GASTROINTEST ENDOSC, V69, P444, DOI 10.1016/j.gie.2008.04.064; Schwacha H, 2000, GASTROINTEST ENDOSC, V52, P387, DOI 10.1067/mge.2000.107909; Tanaka R, 2013, J GASTROEN HEPATOL, V28, P1787, DOI 10.1111/jgh.12303; Tsuchiya T, 2007, J HEPATO-BILIARY-PAN, V14, P302, DOI 10.1007/s00534-006-1147-8; Vihervaara H, 2013, SURG ENDOSC, V27, P1281, DOI 10.1007/s00464-012-2596-6	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	AUG	2015	60	8					2502	2508		10.1007/s10620-015-3658-0		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CP6LF	WOS:000359998000041		
J	Murakami, K; Ohshita, J; Inagi, S; Tomita, I				Murakami, Kazuya; Ohshita, Joji; Inagi, Shinsuke; Tomita, Ikuyoshi			Synthesis, and Optical and Electrochemical Properties of Germanium-Bridged Viologen	ELECTROCHEMISTRY			English	Article						Electrochromism; Bipyridyl; Viologen Chromophore; Germole	ELECTRON-TRANSPORTING PROPERTIES; SOLAR-CELLS; POLYMERS; DITHIENOGERMOLE	A Ge-bridged methylviologen derivative (GMV(2+)2I(-)) was synthesized by dimethylation of dipyridinogermole (DPyG). Viologen GMV(2+)2I(-) showed a UV absorption band at 270 nm, similar to DPyG and longer than the corresponding bridge-free methylviologen (MV(2+)2I(-)). Electrochemical properties of GMV(2+)2I(-) were investigated with respect to cyclic voltammograms, showing highly reversible two step reduction, like MV(2+)2I(-). Interestingly, GMV(2+)2I(-) exhibited enhanced electron-affinity with higher 1st reduction potential by approximately 0.08V than that of MV(2+)2I(-), likely due to the effects Ge-bridge lowering the LUMO energy level. However, the 2nd potential was little affected by the bridge. Clear electrochromic colour changes based on the reversible electrochemical interconversion among GMV(2+)/GMV(+)/GMV were observed in acetonitrile. Monomethylated DPyG (GMV'+I-) was also prepared, whose properties are discussed in comparison with those of DPyG and GMV(2+)2I(-). (C) The Electrochemical Society of Japan, All rights reserved.	[Murakami, Kazuya; Ohshita, Joji] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Inagi, Shinsuke; Tomita, Ikuyoshi] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Ohshita, J (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	jo@hiroshima-u.ac.jp	Ohshita, Joji/C-7576-2011; Inagi, Shinsuke/F-4552-2010	Inagi, Shinsuke/0000-0002-9867-1210	Ministry of Education, Culture, Sports, Science and Technology, Japan [2401, 24102005]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (No. 2401)" (24102005) of The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hou JH, 2008, J AM CHEM SOC, V130, P16144, DOI 10.1021/ja806687u; Amb CM, 2011, J AM CHEM SOC, V133, P10062, DOI 10.1021/ja204056m; BIRD CL, 1981, CHEM SOC REV, V10, P49, DOI 10.1039/cs9811000049; Lu G, 2008, J AM CHEM SOC, V130, P7670, DOI 10.1021/ja800424m; Chen JW, 2007, MACROMOL RAPID COMM, V28, P1714, DOI 10.1002/marc.200700326; Durben S, 2011, ANGEW CHEM INT EDIT, V50, P7948, DOI 10.1002/anie.201102453; Chu TY, 2011, J AM CHEM SOC, V133, P4250, DOI 10.1021/ja200314m; Small CE, 2012, NAT PHOTONICS, V6, P115, DOI [10.1038/nphoton.2011.317, 10.1038/NPHOTON.2011.317]; Guo XG, 2012, J AM CHEM SOC, V134, P18427, DOI 10.1021/ja3081583; Ohshita J, 1999, ORGANOMETALLICS, V18, P1453, DOI 10.1021/om980918n; Ohshita J, 2014, ORGANOMETALLICS, V33, P517, DOI 10.1021/om401019b; Ohshita J, 2001, ORGANOMETALLICS, V20, P4800, DOI 10.1021/om0103254; Ohshita J, 2011, ORGANOMETALLICS, V30, P3233, DOI 10.1021/om200081b; [Anonymous], 2009, GAUSS 09W REV A 02; Banniston A. C., 2011, TETRAHEDRON LETT, V52, P5315; Benniston AC, 2012, ORG LETT, V14, P506, DOI 10.1021/ol203099h; Benniston AC, 2005, TETRAHEDRON LETT, V46, P7291, DOI 10.1016/j.tetlet.2005.08.162; Ohshita J, 2009, MACROMOL CHEM PHYSIC, V210, P1360, DOI 10.1002/macp.200900180; Li YF, 2012, ACCOUNTS CHEM RES, V45, P723, DOI 10.1021/ar2002446	19	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	AUG	2015	83	8					605	608		10.5796/electrochemistry.83.605		4	Electrochemistry	Electrochemistry	CO9RQ	WOS:000359513700005		
J	Mimachi, H; Takahashi, M; Takeya, S; Gotoh, Y; Yoneyama, A; Hyodo, K; Takeda, T; Murayama, T				Mimachi, Hiroko; Takahashi, Masahiro; Takeya, Satoshi; Gotoh, Yoshito; Yoneyama, Akio; Hyodo, Kazuyuki; Takeda, Tohoru; Murayama, Tetsuro			Effect of Long-Term Storage and Thermal History on the Gas Content of Natural Gas Hydrate Pellets under Ambient Pressure	ENERGY & FUELS			English	Article							METHANE CLATHRATE HYDRATE; SELF-PRESERVATION; ANOMALOUS PRESERVATION; ECONOMIC-EVALUATION; 1 ATM; ICE; TRANSPORTATION; TEMPERATURE; DEPENDENCE; DISSOCIATION	The use of natural gas hydrate (NGH) as a natural gas transportation and storage medium is expected to meet further energy demand in the near future. To exploit NGH for industrial porposes, it is necessary to establish NGH storage systems using their self-preservation properties. In this report, NGH pellets containing CH4, C2H6, and C3H8 were produced by continuous production using a bench-scale unit and successfully stored for 3 months at 253 K under atmospheric pressure. Qualitative and quantitative analyses [phase-contrast X-ray computed tomography (CT) by means of diffraction-enhanced imaging, cryogenic scanning electron microscopy, powder X-ray diffraction, and gas chromatography] were conducted to investigate the progression of dissociation. Some of the NGH pellets were also examined for their thermal history dependence between approximately 85 and 253 K after storage for 1 day or less to assess their stability under a rapid temperature change. The internal texture of the original NGH pellets was dense with hydrate even after 3 months of storage. On the other hand, thermal cracks covered with ice had formed in the hydrate pellet after the temperature rise (from 85 to 253 K). These cracks were assumed to be dissociation sites, but the dissociation was stopped only near the cracks. The mass fractions of NGH were larger than 70% after 3 months of storage and undergoing thermal history. These results demonstrate the excellent characteristics of NGH pellets produced by continuous production, improving their suitability for use as natural gas storage media.	[Mimachi, Hiroko; Takahashi, Masahiro; Murayama, Tetsuro] Mitsui Engn & Shipbldg Co Ltd, Ichihara, Chiba 2908531, Japan; [Takeya, Satoshi; Gotoh, Yoshito] Natl Inst Adv Ind Sci & Technol, Higashi Ku, Tsukuba, Ibaraki 3058565, Japan; [Yoneyama, Akio] Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan; [Hyodo, Kazuyuki] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Takeda, Tohoru] Kitasato Univ, Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Mimachi, H (reprint author), Mitsui Engn & Shipbldg Co Ltd, 1 Yawatakaigandori, Ichihara, Chiba 2908531, Japan.	h-mimachi@mes.co.jp					Abdalla BK, 2005, CATAL TODAY, V106, P256, DOI 10.1016/j.cattod.2005.07.184; Nakoryakov VE, 2013, CHEM ENG SCI, V104, P1, DOI 10.1016/j.ces.2013.08.049; Kida M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.018003; Falenty A, 2009, J PHYS CHEM B, V113, P15975, DOI 10.1021/jp906859a; ROTTGER K, 1994, ACTA CRYSTALLOGR B, V50, P644, DOI 10.1107/S0108768194004933; Kuhs WF, 2004, INT J OFFSHORE POLAR, V14, P305; Takeya S, 2008, ANGEW CHEM INT EDIT, V47, P1276, DOI 10.1002/anie.200703718; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Stern LA, 2003, CAN J PHYS, V81, P271, DOI 10.1139/P03-018; Pang WX, 2007, CHEM ENG SCI, V62, P2198, DOI 10.1016/j.ces.2007.01.001; Giavarini C, 2004, IND ENG CHEM RES, V43, P6616, DOI 10.1021/ie040038a; Uchida T, 2011, CHEMPHYSCHEM, V12, P1652, DOI 10.1002/cphc.201100116; Stern LA, 2001, J PHYS CHEM B, V105, P1756, DOI 10.1021/jp003061s; Zhang GH, 2008, CHEM ENG SCI, V63, P2066, DOI 10.1016/j.ces.2008.01.008; Burnham A, 2012, ENVIRON SCI TECHNOL, V46, P619, DOI 10.1021/es201942m; Rehder G, 2012, ENERGIES, V5, P2499, DOI 10.3390/en5072499; Mimachi H, 2014, CHEM ENG SCI, V118, P208, DOI 10.1016/j.ces.2014.07.050; Shimada W, 2005, J PHYS CHEM B, V109, P5802, DOI 10.1021/jp044624t; Takeya S, 2011, J PHYS CHEM C, V115, P16193, DOI 10.1021/jp202569r; Sun D, 2011, IND ENG CHEM RES, V50, P13854, DOI 10.1021/ie2017724; Takeya S, 2010, CHEMPHYSCHEM, V11, P70, DOI 10.1002/cphc.200900731; Thomas S, 2003, ENERGY, V28, P1461, DOI 10.1016/S0360-5442(03)00124-5; Kumar R, 2008, AICHE J, V54, P2132, DOI 10.1002/aic.11527; Falenty A, 2014, ENERG FUEL, V28, P6275, DOI 10.1021/ef501409g; Izumi F, 2007, SOL ST PHEN, V130, P15; Takeya S, 2012, J PHYS CHEM C, V116, P13842, DOI 10.1021/0302269v; Hao WF, 2008, ENERG CONVERS MANAGE, V49, P2546, DOI 10.1016/j.enconman.2008.05.016; Kondo W, 2014, APPL ENERG, V113, P864, DOI 10.1016/j.apenergy.2013.08.033; dos Santos SP, 2011, ENERG POLICY, V39, P4774, DOI 10.1016/j.enpol.2011.06.047; Kuhs WF, 2004, PHYS CHEM CHEM PHYS, V6, P4917, DOI 10.1039/b412866d; Takeya S, 2010, J AM CHEM SOC, V132, P524, DOI 10.1021/ja905426e; Caulton DR, 2014, ENVIRON SCI TECHNOL, V48, P9548, DOI 10.1021/es500511w; Choi JH, 2009, INT J PRECIS ENG MAN, V10, P85, DOI 10.1007/s12541-009-0098-9; Ejarque JM, 2011, ENERG ECON, V33, P44, DOI 10.1016/j.eneco.2010.04.008; Exxon Mobil Corporation, 2015, OUTL EN VIEW 2040; Gudmundsson J. S., 1996, U.S. Patent, Patent No. [5,536,893 A, 5536893]; Ismail O. S., 2012, ENERGY POWER ENG, V4, P290, DOI [10.4236/epe.2012.44039, DOI 10.4236/EPE.2012.44039]; Javanmardi A., 2005, APPL THERM ENG, V25, P1708; Katoh H., 2011, P 7 INT C GAS HYDR I; Kida M, 2011, PHYS CHEM CHEM PHYS, V13, P18481, DOI 10.1039/c1cp21656b; Kuhs WF, 2000, GEOPHYS RES LETT, V27, P2929, DOI 10.1029/2000GL006112; Lee Y. H., 2013, ADV MATER SCI ENG, V2013, P20786; Mettler Toledo International Inc., OP INSTR DENS KIT SO; Najibi H, 2009, APPL THERM ENG, V29, P2009, DOI 10.1016/j.applthermaleng.2008.10.008; Petrov V., 1999, Proceedings Thirty-First Annual North American Power Symposium; Rawn C. J., 2002, P 4 INT C GAS HYDR Y; Seo Y, 2009, J PHYS CHEM A, V113, P9641, DOI 10.1021/jp904994s; Shirota H., 2002, RECENT ADV MAR SCI T, P161; Sloan Jr E. D., 1998, CLATHRATE HYDRATES N, p[314, 602]; Stern LA, 2014, MAR PETROL GEOL, V58, P206, DOI 10.1016/j.marpetgeo.2014.07.027; Sun ZG, 2003, ENERG FUEL, V17, P1180, DOI 10.1021/ef020191m; Taheri Z, 2014, J NAT GAS SCI ENG, V21, P846, DOI 10.1016/j.jngse.2014.09.026; Takahashi M., 2014, U.S. Patent, Patent No. [8,921,626 B2, 8921626]; Takaoki T., 2003, WO Patent, Patent No. [03006308 Al, 03006308]; Tamsilian Y, 2013, J DISPER SCI TECHNOL, V34, P259, DOI 10.1080/01932691.2011.648459; Uchida T, 2015, J CHEM ENG DATA, V60, P284, DOI 10.1021/je500578d; Uchida T, 2010, ENERGIES, V3, P1960, DOI 10.3390/en3121960; Watanabe K., 2012, U.S. Patent, Patent No. [8,096,798 B2, 8096798]; Wu QB, 2012, J NAT GAS CHEM, V21, P91, DOI 10.1016/S1003-9953(11)60338-1; Yakushev V. S., 1992, PHYS CHEM ICE, P136	60	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	AUG	2015	29	8					4827	4834		10.1021/acs.energyfuels.5b00832		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CP6VQ	WOS:000360026700017		
J	Kelland, MA; Abrahamsen, E; Ajiro, H; Akashi, M				Kelland, Malcolm A.; Abrahamsen, Eirin; Ajiro, Hiroharu; Akashi, Mitsuru			Kinetic Hydrate Inhibition with N-Alkyl-N-vinylformamide Polymers: Comparison of Polymers to n-Propyl and Isopropyl Groups	ENERGY & FUELS			English	Article							PERFORMANCE; MECHANISMS	Gas hydrates in the upstream oil and gas industry often cause problems during production, such as plugged pipelines causing down time and loss of revenue. Kinetic hydrate inhibitors (KHIs) have successfully been used in the field for about 2 decades. KHIs work to delay hydrate nucleation and/or crystal growth in the hydrate-stable operating region. KHIs, such as polymers containing N-vinyl amide units, for example, methacrylamide-based KHI polymers with isopropyl groups, have been commercialized and are now used in field operations. However, there are no reports of polymers with n-propyl groups that have been commercialized as a KHI. Using a structure-II-forming natural gas, we have now investigated the KHI performance of homopolymers with n-propyl and isopropyl groups based on the N-vinylformamide (NVF) monomer. A range of copolymers with NVF with higher cloud points were also synthesized and tested because the cloud points of these homopolymers were found to be lower than preferred for most field operations. The polymer series containing nPr-NVF monomer was found to perform better as KHIs than the iPr-NVF series as KHIs at 2500 ppm concentration in deionized water at all copolymer ratios with a similar molecular weight. Two of the best polymers from each of the nPr-NVF and iPr-NVF series were tested at varying concentrations from 1500 to 5000 ppm. A similar trend was found as with the tests of the complete series, in which the nPr-NVF polymer performed better than the iPr-NVF polymer. Poly(N(n-propyl)-N-vinylformamide) homopolymer gave a similar KHI performance as a commercial sample of polyvinylcaprolactam (PVCap).	[Kelland, Malcolm A.; Abrahamsen, Eirin] Univ Stavanger, Fac Sci & Technol, Dept Math & Nat Sci, N-4036 Stavanger, Norway; [Ajiro, Hiroharu] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Ajiro, Hiroharu] Nara Inst Sci & Technol, Ctr Frontier Sci & Technol, Ikoma, Nara 6300192, Japan; [Ajiro, Hiroharu] JST PRESTO, Kawaguchi, Saitama 3320012, Japan; [Akashi, Mitsuru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kelland, MA (reprint author), Univ Stavanger, Fac Sci & Technol, Dept Math & Nat Sci, N-4036 Stavanger, Norway.	malcolm.kelland@uis.no					Creek JL, 2012, ENERG FUEL, V26, P4112, DOI 10.1021/ef300280e; Arjmandi M, 2005, CHEM ENG SCI, V60, P1313, DOI 10.1016/j.ces.2004.10.005; Ajiro H, 2010, ENERG FUEL, V24, P6400, DOI 10.1021/ef101107r; Reyes FT, 2015, ENERG FUEL, V29, P695, DOI 10.1021/ef502539u; Chua PC, 2012, ENERG FUEL, V26, P4481, DOI 10.1021/ef300688x; Mady MF, 2014, ENERG FUEL, V28, P5714, DOI 10.1021/ef501391g; Tohidi B, 2012, ENERG FUEL, V26, P4053, DOI 10.1021/ef3002179; Moon C, 2003, CAN J PHYS, V81, P451, DOI 10.1139/P03-035; Koh CA, 2002, FLUID PHASE EQUILIBR, V194, P143, DOI 10.1016/S0378-3812(01)00660-4; Koh CA, 2002, CHEM SOC REV, V31, P157, DOI 10.1039/b008672j; Kelland MA, 2006, ENERG FUEL, V20, P825, DOI 10.1021/ef050427x; Lutz JF, 2007, MACROMOLECULES, V40, P2503, DOI 10.1021/ma062925q; Bourg P., 2013, P SPE MIDDL E OIL GA; Chua PC, 2013, ENERG FUEL, V27, P183, DOI 10.1021/ef301703w; Colle K. S., 2000, U.S. Patent, Patent No. [6,028,233, 6028233]; DAVALATH J, 1995, SPE DRILL COMPLETION, V10, P115; Glenat P., 2011, P 7 INT C GAS HYDR E; Hase A., 2014, P 8 INT C GAS HYDR B; Kelland M., 2011, REV KINETIC HYDRATE, V8; Kelland M. A., 2014, PRODUCTION CHEM OIL; MacDonald A., 2006, P SPE GAS TECHN S CA; Reyes FT, 2014, ENERG FUEL, V28, P6889, DOI 10.1021/ef501779p; Rodrigues V. F., 2009, P 8 EUR FORM DAM C S; Sloan ED, 2011, NATURAL GAS HYDRATES IN FLOW ASSURANCE, P1; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Walpole R. E., 2012, PROBABILITY STAT ENG; Yang JH, 2011, CHEM ENG SCI, V66, P278, DOI 10.1016/j.ces.2010.10.025	27	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	AUG	2015	29	8					4941	4946		10.1021/acs.energyfuels.5b01251		6	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CP6VQ	WOS:000360026700031		
J	Yuan, HR; Wang, YZ; Kobayashi, N; Zhao, DD; Xine, SY				Yuan, Haoran; Wang, Yazhuo; Kobayashi, N.; Zhao, Dandan; Xine, Shiyou			Study of Fuel Properties of Torrefied Municipal Solid Waste	ENERGY & FUELS			English	Article							WOODY BIOMASS; TORREFACTION; DIBENZOFURANS; TEMPERATURE; COMBUSTION; DIOXINS	Incineration is one of the major methods for processing municipal solid waste (MSW) harmlessly; however, it could lead to low combustion efficiency and secondary pollution problems because of the high moisture content and low energy density of MSW. Torrefaction has been reported to be effective in removing moisture and improving combustion properties in various materials, such as feedstock and wood. The aim of this study was to investigate whether torrefaction could be used as a practical pretreatment method by improving the combustion properties and reducing the chloride content of MSW. Typical combustible components in MSW were chosen and torrefied at various temperatures (250, 300, 350, 400, and 450 degrees C), under a N-2 atmosphere for 30 min. The calorific values of MSW became higher after torrefaction between 250 and 350 degrees C. At a torrefaction temperature of 300 degrees C, the torrefied MSW sample produced similar calorific values to those of standard coal. Under this condition, the chlorine content of the torrefied MSW sample was 57% lower than non-torrefied samples. In addition, the grindability of the torrefied sample was better than that of synthetic MSW. The improved grindability, lower chlorine content, higher heat value, and superior combustion characteristics of torrefied MSW suggested that torrefaction may be used as an effective MSW pretreatment, and the torrefied MSW is more suitable to be used as fuel than non-torrefied MSW.	[Yuan, Haoran; Wang, Yazhuo; Zhao, Dandan; Xine, Shiyou] Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China; [Yuan, Haoran; Wang, Yazhuo; Zhao, Dandan; Xine, Shiyou] Chinese Acad Sci, Key Lab Renewable Energy, Guangzhou 510640, Guangdong, Peoples R China; [Kobayashi, N.] Nagoya Univ, Grad Sch Engn, Dept Chem Engn, Furocho,Chikusa Ku, Nagoya, Aichi 4648603, Japan	Wang, YZ (reprint author), Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China.	wangyz@ms.giec.ac.cn			National 973 Project of China [2011CB201501]; National Science and Technology Program of the Twelfth Five-Year Plan for Rural Development in China [2012BAD14B16-04]; National Natural Science Foundation of China [51161140330]; Pearl River Nova Program of Guangzhou [2013J2200008]; Guangdong Science and Technoloy Program [2012B091400011]	This work is financially supported by the National 973 Project of China (2011CB201501), the National Science and Technology Program of the Twelfth Five-Year Plan for Rural Development in China (2012BAD14B16-04), the National Natural Science Foundation of China (51161140330), the Pearl River Nova Program of Guangzhou (2013J2200008), and the Guangdong Science and Technoloy Program (2012B091400011).	BOURGOIS J, 1988, WOOD SCI TECHNOL, V22, P143; Cheng HF, 2010, BIORESOURCE TECHNOL, V101, P3816, DOI 10.1016/j.biortech.2010.01.040; Arias B, 2008, FUEL PROCESS TECHNOL, V89, P169, DOI 10.1016/j.fuproc.2007.09.002; Bridgeman TG, 2008, FUEL, V87, P844, DOI 10.1016/j.fuel.2007.05.041; Park SW, 2012, ENERGY, V45, P676, DOI 10.1016/j.energy.2012.07.024; Bergman P. C. A., 2004, P 2 WORLD C TECHN EX; Felfri FF, 2005, ENERGY SUSTAIN DEV, V9, P19; Girard P., 1991, REUR TECHNICAL SERIE, V20, P101; National Bureau of Statistics, 2012, CHIN STAT YB; RUUSKANEN J, 1994, CHEMOSPHERE, V28, P1989, DOI 10.1016/0045-6535(94)90149-X; Sun X. X., 2001, COAL FIRED BOILER CO; TAKESHITA R, 1992, CHEMOSPHERE, V24, P589, DOI 10.1016/0045-6535(92)90215-D; Vikelsoe J., 1990, ORGANOHALOGEN COMPD, V3, P193; [肖军 Xiao Jun], 2003, [煤炭转化, Coal Conversion], V26, P61; Yang W., 2012, GAS HEAT, V32, P4; Yu Q. M., 2010, N CHINA ELECT POWER, V7, P9	16	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	AUG	2015	29	8					4976	4980		10.1021/ef502277u		5	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CP6VQ	WOS:000360026700035		
J	Watanabe, H; Furuyama, T; Okazaki, K				Watanabe, Hirotatsu; Furuyama, Tomoaki; Okazaki, Ken			Carbon Surface Characteristics after Electrochemical Oxidation in a Direct Carbon Fuel Cell Using a Single Carbon Pellet and Molten Carbonates	ENERGY & FUELS			English	Article							LOW-TEMPERATURE; PERFORMANCE; DECOMPOSITION; ELECTROLYTE; CONVERSION	This study investigates carbon surface characteristics after discharge in a direct carbon fuel cell using molten carbonates. In the experiment, the top surface of a single carbon pellet is pressed on the Au electrode submerged in molten carbonates and discharge is started at a constant current. First, the effect of the press force of the carbon pellet on voltage was investigated. With a decreasing press force, voltage reduction was observed at a high current, whereas the voltage remained constant at a low current. Then, after the pellet was washed, its top and side surfaces after discharge were observed and analyzed. In Auger electron spectroscopy spectra, Na peaks were not detected on the carbon surface after discharge, indicating that the washing of the pellet was sufficient to remove the carbonates. On the top surface that was in contact with the electrode, surface roughness parameters decreased after discharge, indicating that the surface became smooth after discharge. In addition, changes in surface Morphologies were observed after discharge; smooth hemispherical particles were observed after discharge, whereas angular particles and edges were observed before discharge. Moreover, cleavages were observed after discharge. Meanwhile, on the side surface that was not in contact with the electrode, the only observed changes were thermal cracks caused by exposure to high-temperature molten carbonates. The results suggest that hemispherical particles were formed after discharge because of the combination of press force and electrochemical oxidation on the flat Au electrode, which caused edges to be smoothed during discharge. Observations indicated that the triple-phase boundary (carbon, electrolyte, and anode) played an important role in changing carbon surface morphologies during discharge.	[Watanabe, Hirotatsu; Furuyama, Tomoaki; Okazaki, Ken] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528552, Japan	Watanabe, H (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Mech & Control Engn, Meguro Ku, 2-12-1-I6-7 Ookayama, Tokyo 1528552, Japan.	watanabe.h.ak@m.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [25630064]; J-Power	This study was partly supported by a Japan Society for the Promotion of Science (JSPS) grant-in-aid for challenging exploratory research (25630064) and J-Power. Elemental analyses and AES analysis were performed at the Center for Advanced Material Analysis at Tokyo Institute of Technology.	Cherepy NJ, 2005, J ELECTROCHEM SOC, V152, pA80, DOI 10.1149/1.1836129; Li X, 2009, J POWER SOURCES, V186, P1, DOI 10.1016/j.jpowsour.2008.09.070; Desclaux P, 2011, INT J HYDROGEN ENERG, V36, P10278, DOI 10.1016/j.ijhydene.2010.10.027; Guzman F, 2011, ENERG FUEL, V25, P2179, DOI 10.1021/ef1016363; Giddey S, 2012, PROG ENERG COMBUST, V38, P360, DOI 10.1016/j.pecs.2012.01.003; Cao DX, 2007, J POWER SOURCES, V167, P250, DOI 10.1016/j.jpowsour.2007.02.034; Rady AC, 2012, ENERG FUEL, V26, P1471, DOI 10.1021/ef201694y; Kim JW, 2001, METALL MATER TRANS B, V32, P17, DOI 10.1007/s11663-001-0003-0; Li C, 2011, J POWER SOURCES, V196, P754, DOI 10.1016/j.jpowsour.2010.07.076; Guo L, 2013, ENERG FUEL, V27, P1712, DOI 10.1021/ef302100h; Li X, 2008, IND ENG CHEM RES, V47, P9670, DOI 10.1021/ie800891m; Li X, 2009, ENERG FUEL, V23, P3721, DOI 10.1021/ef900203h; PANTANO CG, 1975, APPL PHYS LETT, V26, P601, DOI 10.1063/1.88017; Wang CQ, 2013, J POWER SOURCES, V233, P244, DOI 10.1016/j.jpowsour.2013.01.016; Watanabe H, 2015, J POWER SOURCES, V273, P340, DOI 10.1016/j.jpowsour.2014.09.079	15	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	AUG	2015	29	8					5415	5422		10.1021/acs.energyfuels.5b00978		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CP6VQ	WOS:000360026700081		
J	Chikura, S; Okada, Y; Kimoto, T; Kaneko, H; Miura, D; Kasahara, Y				Chikura, S.; Okada, Y.; Kimoto, T.; Kaneko, H.; Miura, D.; Kasahara, Y.			In Vivo Genotoxicity Profiling of 1,2-dimethylhydrazine; Data on Rat Erythrocyte Pig-a Assay, Bone Marrow Micronucleus Assay and Liver Comet Assay	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Chikura, S.; Okada, Y.; Kimoto, T.; Kaneko, H.; Miura, D.; Kasahara, Y.] Teijin Pharma Ltd, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P117	S86	S86				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400224		
J	Hamada, S; Morita, T; Narumi, K; Wako, Y; Kawasako, K; Ohyama, W; Honma, M; Hayashi, M				Hamada, S.; Morita, T.; Narumi, K.; Wako, Y.; Kawasako, K.; Ohyama, W.; Honma, M.; Hayashi, M.			Detection of Hepatocarcinogens by Combination of Liver Micronucleus Assay and Histopathological Examination in 2-Week or 4-Week Repeated Dose Studies	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Hamada, S.; Wako, Y.; Kawasako, K.] LSI Medience Corp, Kamisu, Ibaraki, Japan; [Morita, T.; Honma, M.] Natl Inst Hlth Sci, Kamiyoga, Tokyo, Japan; [Narumi, K.; Ohyama, W.] Yakult Honsha Co Ltd, Kunitachi, Tokyo, Japan; [Hayashi, M.] Publ Interest Inc Fdn, Biosafety Res Ctr, Iwata, Shizuoka, Japan; [Hamada, S.] Univ Shizuoka, Shizuoka, Shizuoka 4228526, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P65	S73	S73				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400172		
J	Honma, M; Suzuki, T				Honma, M.; Suzuki, T.			DNA Double-Strand Break Repair in BLM Deficient Human Cells.	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Honma, M.; Suzuki, T.] Natl Inst Hlth Sci, Tokyo, Japan; [Suzuki, T.] Hiroshima Univ, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		2	S50	S50				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400079		
J	Itoh, S; Igarashi, M				Itoh, S.; Igarashi, M.			Validity Assessment of a Twice Dosing Regimen with Test Compound Given Both before and after Partial Hepatectomy in the Rat Liver Micronucleus Test	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Itoh, S.; Igarashi, M.] Daiichi Sankyo Co Ltd, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P63	S73	S73				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400170		
J	Saki, M; Makino, H; Tomimatsu, N; Ding, L; Story, MD; Burma, S; Nirodi, CS				Saki, M.; Makino, H.; Tomimatsu, N.; Ding, L.; Story, M. D.; Burma, S.; Nirodi, C. S.			Activating Mutations in EGFR Abrogate Hypoxia-Associated Radiation Resistance in Nonsmall Cell Lung Cancer	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Saki, M.; Makino, H.; Nirodi, C. S.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Makino, H.] Tottori Univ, Hosp Canc Ctr, Tottori 680, Japan; [Tomimatsu, N.; Ding, L.; Story, M. D.; Burma, S.] UT Southwestern Med Ctr, Dallas, TX USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P17	S61	S61				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400124		
J	Sanada, H; Ohsumi, T; Yonezawa, Y; Nakamura, M; Miyashita, T; Iriyama, M				Sanada, H.; Ohsumi, T.; Yonezawa, Y.; Nakamura, M.; Miyashita, T.; Iriyama, M.			Combined In Vivo Evaluation of Micronucleus Assay and Gene Mutation Assay Using Multi-Organs	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Sanada, H.; Ohsumi, T.; Yonezawa, Y.; Nakamura, M.; Miyashita, T.; Iriyama, M.] Kaken Pharmaceut Co Ltd, Fujieda, Shizuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P116	S86	S86				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400223		
J	Sugiyama, K; Furusawa, H; Honma, M				Sugiyama, K.; Furusawa, H.; Honma, M.			Molecular Breeding of Yeasts for Detection of DNA Methyltransferase Inhibitor	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Sugiyama, K.; Furusawa, H.; Honma, M.] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P49	S69	S69				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400156		
J	Suzuki, T; Gruz, P; Honma, M; Adachi, N; Nohmi, T				Suzuki, T.; Gruz, P.; Honma, M.; Adachi, N.; Nohmi, T.			Protective Roles of DNA Polymerase Zeta in Human Cells Against Environmental Genotoxins.	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Suzuki, T.; Gruz, P.; Honma, M.; Nohmi, T.] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Adachi, N.] Yokohama City Univ, Kanazawa Ku, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P10	S59	S59				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400117		
J	Takeiri, A; Matsuzaki, K; Motoyama, S; Tanaka, K; Harada, A; Taketo, J; Kato, C; Zeller, A; Guerard, M; Kirchner, S; Kronenberg, S; Suzuki, H; Mishima, M				Takeiri, A.; Matsuzaki, K.; Motoyama, S.; Tanaka, K.; Harada, A.; Taketo, J.; Kato, C.; Zeller, A.; Guerard, M.; Kirchner, S.; Kronenberg, S.; Suzuki, H.; Mishima, M.			Evidence for Aneugenicity of the Anticancer Drug Alectinib and Calculated Safety Margins for Clinical Studies	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Takeiri, A.; Matsuzaki, K.; Motoyama, S.; Tanaka, K.; Harada, A.; Taketo, J.; Kato, C.; Suzuki, H.; Mishima, M.] Chugai Pharmaceut Co Ltd, Div Res, Gotemba, Shizuoka, Japan; [Zeller, A.; Guerard, M.; Kirchner, S.; Kronenberg, S.] F Hoffmann La Roche & Co Ltd, pRED, CH-4002 Basel, Switzerland								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P77	S76	S76				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400184		
J	Young, JL; Wise, SS; Xie, H; Wise, CF; Fukuda, T; Guillette, L; Wise, JP				Young, J. L.; Wise, S. S.; Xie, H.; Wise, C. F.; Fukuda, T.; Guillette, L., Jr.; Wise, J. P., Sr.			A Comparison of the Cytotoxic and Genotoxic Effects of Hexavalent Chromium in Human, Aquatic Reptile, and Aquatic Mammal Skin Cells	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Meeting Abstract									[Wise, S. S.; Xie, H.; Wise, C. F.; Wise, J. P., Sr.] Univ So Maine, Wise Lab Environm & Genet Toxicol, Portland, ME 04103 USA; [Young, J. L.; Wise, S. S.; Wise, J. P., Sr.] Univ Louisville, Hlth Sci Ctr, Wise Lab Environm & Genet Toxicol, Louisville, KY 40292 USA; [Fukuda, T.] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Breeding & Genet, Aoba Ku, Sendai, Miyagi 980, Japan; [Guillette, L., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol & Marine Biomed & Environm, Charleston, SC 29425 USA; [Guillette, L., Jr.] Hollings Marine Lab, Charleston, SC USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	AUG	2015	56			1		P71	S75	S75				1	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CP9PJ	WOS:000360226400178		
J	Ubara, M; Osakabe, M				Ubara, Masashi; Osakabe, Masahiro			Suspension of Egg Hatching Caused by High Humidity and Submergence in Spider Mites	ENVIRONMENTAL ENTOMOLOGY			English	Article						delayed hatching; embryonic development; environmental adaptation; Tetranychidae; Acari	EUROPEAN RED MITE; PANONYCHUS-ULMI ACARINA; CITRI MCGREGOR ACARINA; RELATIVE-HUMIDITY; TETRANYCHIDAE; REPRODUCTION; TEMPERATURE; MECHANISM; SURVIVAL; RAINFALL	We tested the effects of high humidity and submergence on egg hatching of spider mites. In both the high humidity and submergence treatments, many Tetranychus and Panonychus eggs did not hatch until after the hatching peak of the lower humidity or unsubmerged controls. However, after humidity decreased or water was drained, many eggs hatched within 1-3 h. This was observed regardless of when high humidity or submergence treatments were implemented: either immediately after oviposition or immediately before hatching was due. Normal eyespot formation was observed in most eggs in the high humidity and submergence treatments, which indicates that spider mite embryos develop even when eggs are underwater. Therefore, delays in hatching are not caused by delayed embryonic development. A delay in hatching was always observed in Panonychus citri (McGregor) but was more variable in Tetranychus urticae Koch and Tetranychus kanzawai Kishida. The high humidity and submergence treatments affected but did not suppress larval development in these species. In contrast, many Oligonychus eggs died following the high humidity treatments. In Tetranychus and Panonychus spider mites, suspension of egg hatching may mitigate the adverse effects of rainfall.	[Ubara, Masashi; Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan	Osakabe, M (reprint author), Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan.	mhosaka@kais.kyoto-u.ac.jp					BOUDREAUX HB, 1958, J INSECT PHYSIOL, V2, P65, DOI 10.1016/0022-1910(58)90029-5; PERRING TM, 1984, ANN ENTOMOL SOC AM, V77, P581; Boulard T, 2002, AGR FOREST METEOROL, V110, P159, DOI 10.1016/S0168-1923(01)00292-1; Duso C, 2004, J PEST SCI, V77, P105, DOI 10.1007/s10340-003-0037-y; Sudo M, 2011, EXP APPL ACAROL, V55, P25, DOI 10.1007/s10493-011-9454-4; ASHIHARA W, 1987, APPL ENTOMOL ZOOL, V22, P512; BONATO O, 1995, ENVIRON ENTOMOL, V24, P841; PETERS KM, 1980, J ECON ENTOMOL, V73, P235; Ho CC, 2000, EXP APPL ACAROL, V24, P453, DOI 10.1023/A:1006443619632; Fukaya M, 2013, PHOTOCHEM PHOTOBIOL, V89, P424, DOI 10.1111/php.12001; Sakai Y, 2012, APPL ENTOMOL ZOOL, V47, P67, DOI 10.1007/s13355-011-0090-6; BOYNE JV, 1983, CAN ENTOMOL, V115, P93; DITTRICH V, 1971, ANN ENTOMOL SOC AM, V64, P1134; FERRO DN, 1979, ENVIRON ENTOMOL, V8, P701; FOOTT W. H., 1963, CANADIAN ENTOMOL, V95, P45; Gerson U, 1985, SPIDER MITES THEIR A, P223; HERNE DHC, 1968, CAN ENTOMOL, V100, P540; Ikegami Y, 2000, APPL ENTOMOL ZOOL, V35, P339, DOI 10.1303/aez.2000.339; JONES VP, 1984, J ECON ENTOMOL, V77, P810; KATO T, 1972, Japanese Journal of Applied Entomology and Zoology, V16, P154; Kitashima Yasuki, 1995, Journal of the Acarological Society of Japan, V4, P91; KLUBERTANZ TH, 1990, ENVIRON ENTOMOL, V19, P1773; Kuenen D. J., 1946, TIJDSCHR PLANTENZIEKTEN, V52, P69, DOI 10.1007/BF02347117; Lu FP, 2014, EXP APPL ACAROL, V63, P267, DOI 10.1007/s10493-014-9784-0; McENROE W. D., 1961, ANN ENT SOC AMER, V54, P883; Mori H., 1957, Journal Hokkaido Univ Fac Agric, V50, P363; Moriyama M, 2006, J INSECT PHYSIOL, V52, P1219, DOI 10.1016/j.jinsphys.2006.09.005; Oku K, 2006, ECOL RES, V21, P446, DOI 10.1007/s11284-005-0141-y; Osakabe M., 1967, B TEA RES STN, V4, P35; OSAKABE M, 1987, APPL ENTOMOL ZOOL, V22, P35; OSAKABE M, 1965, Japanese Journal of Applied Entomology and Zoology, V9, P206; Osakabe M, 2006, OECOLOGIA, V150, P496, DOI 10.1007/s00442-006-0560-7; Osakabe M, 1959, TEA RES J, V13, P53; PICKFORD R., 1960, CANADIAN ENT, V92, P1; PUTMAN WL, 1968, CAN ENTOMOL, V100, P617; PUTMAN WL, 1970, CAN ENTOMOL, V102, P955; R-Core-Development-Team, 2012, R LANG ENV STAT COMP; Rego AS, 2013, EXP APPL ACAROL, V60, P479, DOI 10.1007/s10493-013-9667-9; Sokal R., 2000, BIOMETRY	39	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0046-225X	1938-2936		ENVIRON ENTOMOL	Environ. Entomol.	AUG	2015	44	4					1210	1219		10.1093/ee/nvv080		10	Entomology	Entomology	CP1WN	WOS:000359668100031		
J	Wang, MF; Shibamoto, T; Kuda, Y; Tanida, M; Kurata, Y				Wang, Mofei; Shibamoto, Toshishige; Kuda, Yuhichi; Tanida, Mamoru; Kurata, Yasutaka			Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats	EXPERIMENTAL LUNG RESEARCH			English	Article						angiotensin II; endothelin-1; phenylephrine; pulmonary circulation; vasopressin; U46619	NITRIC-OXIDE; ARGININE-VASOPRESSIN; ANGIOTENSIN-II; ARTERY; LUNG; TACHYPHYLAXIS; VASODILATION; ENDOTHELIN-1; CONTRACTION; RESISTANCE	Purpose: The physiological responses of the pulmonary vasculature and airway to various vasoconstrictors were studied using isolated perfused lungs and pulmonary arteries, but these responses were not systematically studied in in vivo rats. We determined these responses and modulating effects of systemic circulation in anesthetized rats. Methods: We measured directly pulmonary arterial pressure (PAP), left atrial pressure (LAP), aortic blood flow, and airway pressure (AWP) to determine pulmonary vascular resistance (PVR), following injections of angiotensin II (ANG II), endothelin-1 (ET-1), vasopressin, phenylephrine and thromboxane A(2) mimetic U46619 in anesthetized SD rats. Results: ANG II, phenylephrine and vasopressin at high doses caused strong systemic vasoconstriction and left heart overload, resulting in a transient increase in LAP and pulmonary congestion, which consequently decreased PVR. Nonetheless, prior to LAP elevation, PVR was slightly but significantly increased by ANG II and phenylephrine. In contrast, ET-1 and U46619 substantially increased PVR in the absence of LAP elevation, while vasopressin did not increase PVR. In separate experiments, PAP and AWP increased when LAP was forcedly elevated. AWP was increased by U46619 through bronchoconstriction and by the other agents through increased LAP-induced pulmonary congestion. Conclusion: Airway constriction is induced by U46619, and pulmonary vasoconstriction is induced strongly by U46619 and ET-1, and weakly by ANG II and phenylephrine, but not by vasopressin in anesthetized rats. ANG II, vasopressin and phenylephrine exert indirectly a transient pulmonary vasodilatory action due to pulmonary congestion evoked by strong systemic vasoconstriction, which may account for weak pulmonary pressor responses to these agents.	[Wang, Mofei; Shibamoto, Toshishige; Kuda, Yuhichi; Tanida, Mamoru; Kurata, Yasutaka] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan; [Wang, Mofei] China Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Shenyang, Peoples R China	Shibamoto, T (reprint author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan.	shibamo@kanazawa-med.ac.jp			Kanazawa Medical University [SR2012-04]	This study was supported by a Grant from Kanazawa Medical University (SR2012-04).	Affolter JT, 2003, CLIN PHARMACOL THER, V74, P9, DOI 10.1016/S0009-9236(03)00065-1; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; GarciaVillalon AL, 1996, BRIT J PHARMACOL, V118, P1848; Wagner EM, 1996, J APPL PHYSIOL, V81, P293; Yildiz G, 2007, EUR J PHARMACOL, V556, P144, DOI 10.1016/j.ejphar.2006.11.008; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; EVORA PRB, 1993, CHEST, V103, P1241, DOI 10.1378/chest.103.4.1241; EICHINGER MR, 1994, AM J PHYSIOL-HEART C, V267, pH2413; Hussain MB, 1997, BRIT J PHARMACOL, V122, P849, DOI 10.1038/sj.bjp.0701461; EICHINGER MR, 1994, AM J PHYSIOL, V267, pH494; Enomoto M, 2014, PEDIATR RES, V75, P315, DOI 10.1038/pr.2013.221; ERWALD R, 1976, ACTA CHIR SCAND, V142, P30; Hamel C, 2005, LIFE SCI, V77, P1069, DOI 10.1016/j.lfs.2004.12.039; Hermo-Weiler CI, 1998, J APPL PHYSIOL, V85, P1655; HOMMA S, 1992, MICROVASC RES, V43, P205, DOI 10.1016/0026-2862(92)90017-J; JIN HK, 1989, J APPL PHYSIOL, V66, P151; LEE SL, 1991, J PHARMACOL EXP THER, V258, P292; LEE SL, 1989, J PHARMACOL EXP THER, V248, P44; Millette E, 1996, BRIT J PHARMACOL, V119, P899; Nonas Stephanie A, 2005, Proc Am Thorac Soc, V2, P188, DOI 10.1513/pats.200501-005AC; NOSSAMAN BD, 1994, AM J PHYSIOL, V266, pL389; RAFFESTIN B, 1991, J APPL PHYSIOL, V70, P567; Rieg AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029698; RODMAN DM, 1989, J PHARMACOL EXP THER, V248, P952; RODMAN DM, 1992, J CARDIOVASC PHARM, V20, P658, DOI 10.1097/00005344-199210000-00021; ROOS A, 1961, J APPL PHYSIOL, V16, P77; Ryan JJ, 2013, HANDB EXP PHARMACOL, V218, P105, DOI 10.1007/978-3-642-38664-0_5; SAI Y, 1995, EUR J PHARMACOL, V282, P235, DOI 10.1016/0014-2999(95)00343-J; Sakao S, 2011, RESPIRATION, V81, P253, DOI 10.1159/000322011; SANTOIAN EC, 1989, AM J PHYSIOL, V257, pH2001; Schmidt DT, 2001, N-S ARCH PHARMACOL, V364, P314; SU N, 1993, CARDIOVASC RES, V27, P284, DOI 10.1093/cvr/27.2.284; TAKESHITA H, 1991, CLIN EXP PHARMACOL P, V18, P661, DOI 10.1111/j.1440-1681.1991.tb01640.x; WALKER BR, 1989, AM J PHYSIOL, V257, pH415; YAMAGUCHI T, 1989, EUR J PHARMACOL, V161, P259, DOI 10.1016/0014-2999(89)90856-X; Zhang W, 2011, ANESTHESIOLOGY, V114, P614, DOI 10.1097/ALN.0b013e31820b8d34	36	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0190-2148	1521-0499		EXP LUNG RES	Exp. Lung Res.	AUG	2015	41	6					324	334		10.3109/01902148.2015.1032448		11	Respiratory System	Respiratory System	CP4MT	WOS:000359856900003		
J	Ota, K; Kawaguchi, M; Fujita, J; Kokubu, F; Huang, SK; Morishima, Y; Matsukura, S; Kurokawa, M; Ishii, Y; Satoh, H; Sakamoto, T; Hizawa, N				Ota, Kyoko; Kawaguchi, Mio; Fujita, Junichi; Kokubu, Fumio; Huang, Shau-Ku; Morishima, Yuko; Matsukura, Satoshi; Kurokawa, Masatsugu; Ishii, Yukio; Satoh, Hiroaki; Sakamoto, Tohru; Hizawa, Nobuyuki			Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells	EXPERIMENTAL LUNG RESEARCH			English	Article						bronchial epithelial cell; dsRNA; IL-32; NF-kappa B; p65; TAK1	NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY SMOOTH-MUSCLE; A VIRUS-INFECTION; HOUSE-DUST MITE; T-CELLS; IL-32; ACTIVATION; EXPRESSION; CYTOKINE	Objective: Interleukin (IL)-32 is a novel cytokine and is involved in the pathogenesis of various inflammatory diseases, including asthma and COPD. However, the regulatory mechanisms of IL-32 expression and its precise pathogenic role remain to be defined. Given that viral infections are known to potentially cause and exacerbate airway inflammation, in this study, we investigated the expression of IL-32 induced by synthetic double-stranded (ds) RNA, and its signaling mechanisms involved. Methods: Bronchial epithelial cells were stimulated with synthetic dsRNA poly I:C. The levels of IL-32 expression were analyzed using real-time PCR and ELISA. The involvement of transforming growth factor beta-activated kinase 1 (TAK1) and a subunit of nuclear factor-kappa B (NF-kappa B), p65 was determined by western blot analyses. TAK1 inhibitor, 5Z-7-Oxozeaenol and NF-kappa B inhibitor, BAY 11-7082 were added to the culture to identify key signaling events leading to the expression of IL-32. Finally, the effect of short interfering RNAs (siRNAs) targeting TAK1 and p65 was investigated. Results: dsRNA significantly induced IL-32 gene and protein expression, concomitant with activation of TAK1 and p65. Pretreatment of 5Z-7-Oxozeaenol diminished dsRNA-induced phosphorylation of NF-kappa B. Both 5Z-7-Oxozeaenol and BAY 117082 significantly abrogated dsRNA-induced IL-32 production. Moreover, transfection of the cells with siRNAs targeting TAK1 and p65 inhibited the expression of IL-32. Conclusions: The expression of IL-32 is induced by dsRNA via the TAK1-NF-kappa B signaling pathway in bronchial epithelial cells. IL-32 is involved in the pathogenesis of airway inflammation, and may be a novel therapeutic target for airway inflammatory diseases.	[Ota, Kyoko; Kawaguchi, Mio; Fujita, Junichi; Morishima, Yuko; Ishii, Yukio; Satoh, Hiroaki; Sakamoto, Tohru; Hizawa, Nobuyuki] Univ Tsukuba, Inst Clin Med, Dept Resp Med, Tsukuba, Ibaraki 3058575, Japan; [Kokubu, Fumio; Matsukura, Satoshi] Showa Univ, Fujigaoka Hosp, Dept Resp Med, Yokohama, Kanagawa 227, Japan; [Huang, Shau-Ku] Johns Hopkins Univ, Ctr Asthma & Allergy, Baltimore, MD 21224 USA; [Huang, Shau-Ku] Natl Hlth Res Inst, Taipei, Taiwan; [Kurokawa, Masatsugu] Showa Univ, Div Allergy & Resp Med, Tokyo, Japan	Kawaguchi, M (reprint author), Univ Tsukuba, Inst Clin Med, Dept Resp Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mkawaguchi@md.tsukuba.ac.jp			National Institute of Health [AI-052468]; National Health Research Institutes	S. K. Huang was supported, in part, by National Institute of Health (AI-052468) and National Health Research Institutes.	Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kempuraj D, 2010, EUR J DERMATOL, V20, P865, DOI 10.1684/ejd.2010.1110; DAHL CA, 1992, J IMMUNOL, V148, P597; Ioannidis I, 2012, J VIROL, V86, P5422, DOI 10.1128/JVI.06757-11; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Pera T, 2012, AM J PHYSIOL-LUNG C, V303, pL272, DOI 10.1152/ajplung.00291.2011; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Bai XY, 2011, INT IMMUNOL, V23, P679, DOI 10.1093/intimm/dxr075; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Dey N, 2011, VIROLOGY, V418, P93, DOI 10.1016/j.virol.2011.07.007; Deng XQ, 2012, EXP LUNG RES, V38, P295, DOI 10.3109/01902148.2012.689924; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Arcaroli JJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10258; Huang F, 2007, J IMMUNOL, V179, P6504; Kawaguchi M, 2009, AM J PHYSIOL-LUNG C, V296, pL804, DOI 10.1152/ajplung.90607.2008; Ko NY, 2011, IMMUNOBIOLOGY, V216, P32, DOI 10.1016/j.imbio.2010.03.007; Kudo M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-19; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Martel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059116; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Moon YM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4089; Nakayama M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3850; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Pera T, 2011, AM J PHYSIOL-LUNG C, V301, pL822, DOI 10.1152/ajplung.00017.2011; Schwarze J, 2013, THORAX, V68, P108, DOI 10.1136/thoraxjnl-2012-202291	33	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0190-2148	1521-0499		EXP LUNG RES	Exp. Lung Res.	AUG	2015	41	6					335	343		10.3109/01902148.2015.1033569		9	Respiratory System	Respiratory System	CP4MT	WOS:000359856900004		
J	Chosrowjan, H; Taniguchi, S; Tanaka, F				Chosrowjan, Haik; Taniguchi, Seiji; Tanaka, Fumio			Ultrafast fluorescence upconversion technique and its applications to proteins	FEBS JOURNAL			English	Review						charge transfer; flavoproteins; fluorescence upconversion; fluorescence upconversion microscope; FMN-binding protein; intraprotein electrostatic interactions; photoactove yellow protein; photo-isomerization; point mutants; ultrafast spectroscopy	PHOTOACTIVE YELLOW PROTEIN; RIBOFLAVIN-BINDING-PROTEIN; ELECTRON-TRANSFER; SOLVATION DYNAMICS; CHARGE SEPARATION; PHOTOISOMERIZATION REACTION; FEMTOSECOND DYNAMICS; FLAVIN CHROMOPHORES; EXCITED-STATE; SITE	The basic principles and main characteristics of the ultrafast time-resolved fluorescence upconversion technique (conventional and space-resolved), including requirements for nonlinear crystals, mixing spectral bandwidth, acceptance angle, etc., are presented. Applications to flavoproteins [wild-type (WT) FMN-binding protein and its W32Y, W32A, E13R, E13K, E13Q and E13T mutants] and photoresponsive proteins [WT photoactive yellow protein and its R52Q mutant in solution and as single crystals] are demonstrated. For flavoproteins, investigations elucidating the effects of ionic charges on ultrafast electron transfer (ET) dynamics are summarized. It is shown that replacement of the ionic amino acid Glu13 and the resulting modification of the electrostatic charge distribution in the protein chromphore-binding pocket substantially alters the ultrafast fluorescence quenching dynamics and ET rate in FMN-binding protein. It is concluded that, together with donor-acceptor distances, electrostatic interactions between ionic photoproducts and other ionic groups in the proteins are important factors influencing the ET rates. In WT photoactive yellow protein and the R52Q mutant, ultrafast photoisomerization dynamics of the chromophore (deprotonated trans-p-coumaric acid) in liquid and crystal phases are investigated. It is shown that the primary dynamics in solution and single-crystal phases are quite similar; hence, the photocycle dynamics and structural differences observed at longer time scales arise mostly from the structural restraints imposed by the crystal lattice rigidity versus the flexibility in solution.	[Chosrowjan, Haik; Taniguchi, Seiji; Tanaka, Fumio] Inst Laser Technol, Div Laser Biochem, Nishi Ku, Osaka 5500004, Japan; [Tanaka, Fumio] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok, Thailand	Chosrowjan, H (reprint author), Inst Laser Technol, Div Laser Biochem, Nishi Ku, Utsubo Honmachi 1-8-4, Osaka 5500004, Japan.	haik@ilt.or.jp			Japan Society for the Promotion of Science (JSPS) [26410029]	We thank Dr Y. Imamoto from Kyoto University and Dr M. Kitamura from Osaka City University for providing protein samples and helpful discussions. We thank also the Japan Society for the Promotion of Science (JSPS) for financial support (Grant-in-Aid for Scientific Research No. 26410029).	MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; Wan CZ, 2005, CHEM PHYS LETT, V412, P158, DOI 10.1016/j.cplett.2005.06.101; Abbyad P, 2007, J PHYS CHEM B, V111, P8269, DOI 10.1021/jp0709104; KAKITANI T, 1985, J PHYS CHEM-US, V89, P8, DOI 10.1021/j100247a004; Zhang LY, 2006, J PHYS CHEM B, V110, P18097, DOI 10.1021/jp063025e; Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l; Glasbeek M, 2004, CHEM REV, V104, P1929, DOI 10.1021/cr0206723; Changenet-Barret P, 2007, CHEM PHYS LETT, V434, P320, DOI 10.1016/j.cplett.2006.12.027; Mataga N, 2001, J AM CHEM SOC, V123, P12422, DOI 10.1021/ja010865s; Mataga N, 2000, J PHYS CHEM B, V104, P10667, DOI 10.1021/jp002145y; Mataga N, 1998, J PHYS CHEM B, V102, P7081, DOI 10.1021/jp982583t; Onidas D, 2002, J PHYS CHEM B, V106, P11367, DOI 10.1021/jp026063g; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Suto K, 2000, ACTA CRYSTALLOGR D, V56, P368, DOI 10.1107/S0907444900000111; Chosrowjan H, 2004, J PHYS CHEM B, V108, P2686, DOI 10.1021/jp031126w; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Genick UK, 1998, NATURE, V392, P206; DUGUAY MA, 1968, APPL PHYS LETT, V13, P178, DOI 10.1063/1.1652560; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398; MEYER TE, 1985, BIOCHIM BIOPHYS ACTA, V806, P175, DOI 10.1016/0005-2728(85)90094-5; DU M, 1993, BIOPHYS CHEM, V48, P101, DOI 10.1016/0301-4622(93)85002-Y; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Chosrowjan H, 1998, J PHYS CHEM B, V102, P7695, DOI 10.1021/jp982905t; Chosrowjan H, 1998, J AM CHEM SOC, V120, P9706, DOI 10.1021/ja981659w; Dux P, 1998, BIOCHEMISTRY-US, V37, P12689, DOI 10.1021/bi9806652; Fleming G.R., 1986, CHEM APPL ULTRAFAST; Gelot T, 2012, J PHYS CHEM A, V116, P2819, DOI 10.1021/jp212187m; Gu JL, 2005, ADV MATER, V17, P557, DOI 10.1002/adma.200401085; GUSTAVSSON T, 1995, CHEM PHYS LETT, V236, P587, DOI 10.1016/0009-2614(95)00276-A; Hoff WD, 1999, BIOCHEMISTRY-US, V38, P1009, DOI 10.1021/bi980504y; JARZEBA W, 1991, CHEM PHYS, V152, P57, DOI 10.1016/0301-0104(91)80034-F; KITAMURA M, 1994, J BIOL CHEM, V269, P5566; Kort R, 2003, PHOTOCHEM PHOTOBIOL, V78, P131, DOI 10.1562/0031-8655(2003)078<0131:COPIIC>2.0.CO;2; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lehninger A. L., 2000, LEHNINGER PRINCIPLES; MAHR H, 1975, OPT COMMUN, V13, P96, DOI 10.1016/0030-4018(75)90017-6; Mano E, 2003, SPECTROSC-INT J, V17, P345; NG K, 1995, BIOCHEMISTRY-US, V34, P879, DOI 10.1021/bi00003a022; Rubtsov IV, 1999, J PHYS CHEM A, V103, P10202, DOI 10.1021/jp991998r; Saha R, 2013, SCI REP, V3, P1; Saha S, 2004, PHYS CHEM CHEM PHYS, V6, P3106, DOI 10.1039/b316943j; Sajadi M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826686; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Shimizu N, 2006, BIOCHEMISTRY-US, V45, P3542, DOI 10.1021/bi051430a; Taniguchi Seiji, 2011, Review of Laser Engineering, V39; Taniguchi S, 2013, B CHEM SOC JPN, V86, P339, DOI 10.1246/bcsj.20120231; Tomi T, 2007, BBA-BIOENERGETICS, V1767, P22, DOI 10.1016/j.bbabio.2006.10.008; Wolfbeis OS, 2005, SPRINGER SERIES FLUO; Xie AH, 2001, BIOCHEMISTRY-US, V40, P1510, DOI 10.1021/bi002449a; Xu JH, 2008, METHOD ENZYMOL, V450, P159, DOI 10.1016/S0076-6879(08)03408-3; Yamada A, 2004, PROTEINS, V55, P1070, DOI 10.1002/prot.20063; Zhang XX, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3597674; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11873, DOI 10.1073/pnas.211440298	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	AUG	2015	282	16			SI		3003	3015		10.1111/febs.13180		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CP6RV	WOS:000360016700002		
J	Nishino, T; Okamoto, K; Kawaguchi, Y; Matsumura, T; Eger, BT; Pai, EF; Nishino, T				Nishino, Tomoko; Okamoto, Ken; Kawaguchi, Yuko; Matsumura, Tomohiro; Eger, Bryan T.; Pai, Emil F.; Nishino, Takeshi			The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase	FEBS JOURNAL			English	Article						endothelial cell damage; reactive oxygen species; xanthine dehydrogenase; xanthine oxidase; xanthine oxidoreductase	RAT-LIVER; ANTIMICROBIAL PROPERTIES; O-2-DEPENDENT TYPES; CRYSTAL-STRUCTURE; GLOBULE-MEMBRANE; EPITHELIAL-CELLS; DEPENDENT TYPE; OXIDOREDUCTASE; MECHANISM; MILK	Mammalian xanthine oxidoreductase can exist in both dehydrogenase and oxidase forms. Conversion between the two is implicated in such diverse processes as lactation, anti-bacterial activity, reperfusion injury and a growing number of diseases. We have constructed a variant of the rat liver enzyme that lacks the carboxy-terminal amino acids 1316-1331; it appears to assume an intermediate form, exhibiting a mixture of dehydrogenase and oxidase activities. The purified variant protein retained similar to 50-70% of oxidase activity even after prolonged dithiothreitol treatment, supporting a previous prediction that the C-terminal region plays a role in the dehydrogenase to oxidase conversion. In the crystal structure of the protein variant, most of the enzyme stays in an oxidase conformation. After 15min of incubation with a high concentration of NADH, however, the corresponding X-ray structures showed a dehydrogenase-type conformation. On the other hand, disulfide formation between Cys535 and Cys992, which can clearly be seen in the electron density map of the crystal structure of the variant after removal of dithiothreitol, goes in parallel with the complete conversion to oxidase, resulting in structural changes identical to those observed upon proteolytic cleavage of the linker peptide. These results indicate that the dehydrogenase-oxidase transformation occurs rather readily and the insertion of the C-terminal peptide into the active site cavity of its subunit stabilizes the dehydrogenase form. We propose that the intermediate form can be generated (e.g. in endothelial cells) upon interaction of the C-terminal peptide portion of the enzyme with other proteins or the cell membrane. DatabaseCoordinate sets and structure factors for the four crystal structures reported in the present study have been deposited in the Protein Data Bank under the identification numbers , , , and .	[Nishino, Tomoko; Okamoto, Ken; Kawaguchi, Yuko; Matsumura, Tomohiro; Nishino, Takeshi] Nippon Med Sch, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Eger, Bryan T.; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Pai, Emil F.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Nishino, Takeshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	Nishino, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	nishino@nms.ac.jp			Japanese Ministry of Education, Science, Sports and Culture [18570137, 24590393, 23570198]; Japanese Gout Research Foundation; Canadian Institute for Health Research [MOP-64392]; Canada Research Chairs Program	The synchrotron radiation experiments were performed at beamline NW12A of KEK in Tsukuba; we are grateful to the staff at KEK for their support. This work was supported by Grant-in Aid (T.N. 18570137, K.O. 24590393 and K.O. 23570198) for scientific research from the Japanese Ministry of Education, Science, Sports and Culture, as well as grants from the Japanese Gout Research Foundation (T.N.). E.F.P. thanks the Canadian Institute for Health Research (MOP-64392) and the Canada Research Chairs Program for support.	Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; Nishino T, 2000, J INORG BIOCHEM, V82, P43, DOI 10.1016/S0162-0134(00)00165-3; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; SAITO T, 1989, J BIOL CHEM, V264, P15930; SATO A, 1995, J BIOL CHEM, V270, P2818; JARASCH ED, 1981, CELL, V25, P67, DOI 10.1016/0092-8674(81)90232-4; Jeong J, 2013, TRAFFIC, V14, P974, DOI 10.1111/tra.12087; HUNT J, 1993, J BIOL CHEM, V268, P18685; Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WAHL RC, 1982, J BIOL CHEM, V257, P1354; HUNT J, 1992, J BIOL CHEM, V267, P21479; Battelli MG, 2014, BBA-MOL BASIS DIS, V1842, P1502, DOI 10.1016/j.bbadis.2014.05.022; Kuwabara Y, 2003, P NATL ACAD SCI USA, V100, P8170, DOI 10.1073/pnas.1431485100; NISHINO T, 1994, J BIOCHEM-TOKYO, V116, P1; SAITO T, 1989, J BIOL CHEM, V264, P10015; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Clare DA, 2008, J FOOD PROTECT, V71, P126; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; STIRPE F, 1969, J BIOL CHEM, V244, P3855; ICHIKAWA M, 1992, J HISTOCHEM CYTOCHEM, V40, P1097; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; HILLE R, 1995, FASEB J, V9, P995; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; McManaman JL, 2002, J BIOL CHEM, V277, P21261, DOI 10.1074/jbc.M200828200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; MASSEY V, 1989, J BIOL CHEM, V264, P10567; NAKAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1279; Nishino T, 2015, J BIOL INORG CHEM, V20, P195, DOI 10.1007/s00775-014-1210-x; NISHINO T, 1989, J BIOL CHEM, V264, P5468; [Anonymous], 1994, ACTA CRYST D, V50, P760; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Asai R, 2007, J BIOCHEM, V141, P525, DOI 10.1093/jb/mvm054; BARBER MJ, 1976, BIOCHEM J, V153, P297; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; BRUDER G, 1982, BIOCHIM BIOPHYS ACTA, V701, P357, DOI 10.1016/0167-4838(82)90239-4; Corte E D, 1972, Biochem J, V126, P739; DeLano WL, 2002, PYMOL MOL GRAPHYCS S; Grassi Davide, 2014, Curr Pharm Des, V20, P6089; Hancock JT, 2002, ANTIMICROB AGENTS CH, V46, P3308, DOI 10.1128/AAC.46.10.3308.2002; Houston M, 1998, ARCH BIOCHEM BIOPHYS, V355, P1, DOI 10.1006/abbi.1998.0675; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; IKEGAMI T, 1986, ARCH BIOCHEM BIOPHYS, V247, P254, DOI 10.1016/0003-9861(86)90582-5; Ishii T, 1995, BBA-GEN SUBJECTS, V1245, P285, DOI 10.1016/0304-4165(95)00102-6; Jeong J, 2009, J BIOL CHEM, V284, P22444, DOI 10.1074/jbc.M109.020446; KAMINSKI ZW, 1979, BIOCHEM J, V181, P177; KLINMAN JP, 1972, J BIOL CHEM, V247, P7977; KOOIJ A, 1994, HISTOCHEM J, V26, P889; KOOIJ A, 1992, VIRCHOWS ARCH B, V62, P143, DOI 10.1007/BF02899676; Martin HM, 2004, INFECT IMMUN, V72, P4933, DOI 10.1128/IAI.72.9.4933-4939.2004; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCCORD JM, 1982, CAN J PHYSIOL PHARM, V60, P1346; MINEO I, 1987, NEW ENGL J MED, V317, P75, DOI 10.1056/NEJM198707093170203; NISHINO T, 1989, J BIOL CHEM, V264, P6075; NISHINO T, 1986, J BIOL CHEM, V261, P1242; NISHINO T, 1983, P NATL ACAD SCI-BIOL, V80, P1826, DOI 10.1073/pnas.80.7.1826; NISHINO T, 1981, FEBS LETT, V131, P369, DOI 10.1016/0014-5793(81)80406-1; Nishino T, 2002, J BIOCHEM, V132, P597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papi A, 2008, J BIOL CHEM, V283, P28595, DOI 10.1074/jbc.M805766200; SAITO T, 1989, ADV EXP MED BIOL, V253, P179; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; STIRPE F, 1970, BIOCHIM BIOPHYS ACTA, V212, P195, DOI 10.1016/0005-2744(70)90198-1; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; Tai LA, 2001, PHOTOCHEM PHOTOBIOL, V73, P439; Tsujii A, 2008, NUCLEOS NUCLEOT NUCL, V27, P881, DOI 10.1080/15257770802146569; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P365, DOI 10.1016/0003-9861(76)90088-6; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P354, DOI 10.1016/0003-9861(76)90087-4	74	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	AUG	2015	282	16			SI		3075	3090		10.1111/febs.13277		16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CP6RV	WOS:000360016700007		
J	Guan, LJ; Lee, WC; Wang, SP; Ohshiro, T; Izumi, Y; Ohtsuka, J; Tanokura, M				Guan, Li-Jun; Lee, Woo Cheol; Wang, Shipeng; Ohshiro, Takashi; Izumi, Yoshikazu; Ohtsuka, Jun; Tanokura, Masaru			Crystal structures of apo-DszC and FMN-bound DszC from Rhodococcuserythropolis D-1	FEBS JOURNAL			English	Article						biocatalysis; crystal structure; desulfurization; dibenzothiophene monooxygenase; FMN-bound	FOSSIL-FUELS; MICROBIAL DESULFURIZATION; STRAIN IGTS8; DIBENZOTHIOPHENE; MONOOXYGENASE; BIODESULFURIZATION; PURIFICATION; PATHWAY; ENZYME	The release of SO2 from petroleum products derived from crude oil, which contains sulfur compounds such as dibenzothiophene (DBT), leads to air pollution. The 4S' metabolic pathway catalyzes the sequential conversion of DBT to 2-hydroxybiphenyl via three enzymes encoded by the dsz operon in several bacterial species. DszC (DBT monooxygenase), from Rhodococcuserythropolis D-1 is involved in the first two steps of the 4S' pathway. Here, we determined the first crystal structure of FMN-bound DszC, and found that two distinct conformations occur in the loop region (residues 131-142) adjacent to the active site. On the basis of the DszC-FMN structure and the previously reported apo structures of DszC homologs, the binding site for DBT and DBT sulfoxide is proposed. DatabaseThe atomic coordinates and structure factors for apo-DszC (PDB code: ) and DszC-FMN (PDB code: ) have been deposited in the Protein Data Bank ().	[Guan, Li-Jun; Lee, Woo Cheol; Wang, Shipeng; Ohtsuka, Jun; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Ohshiro, Takashi; Izumi, Yoshikazu] Tottori Univ, Dept Biotechnol, Koyama, Tottori, Japan	Tanokura, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp			National Project on Targeted Proteins Research Program; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	The synchrotron-radiation experiments were performed at beamline BL5A at the Photon Factory, Tsukuba, Japan (Proposal No. 2008S2-001). We thank the beamline staff at the Photon Factory for their kind assistance with data collection. This work was supported in part by the National Project on Targeted Proteins Research Program and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lei BF, 1996, J BACTERIOL, V178, P5699; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Oldfield C, 1997, MICROBIOL-UK, V143, P2961; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Ohshiro T, 1999, J BIOSCI BIOENG, V88, P610, DOI 10.1016/S1389-1723(00)87088-7; Gupta N, 2005, APPL MICROBIOL BIOT, V66, P356, DOI 10.1007/s00253-004-1755-7; Smith SJ, 2011, ATMOS CHEM PHYS, V11, P1101, DOI 10.5194/acp-11-1101-2011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.0014-2956.2001.02490.x; KABE T, 1992, IND ENG CHEM RES, V31, P1577, DOI 10.1021/ie00006a023; Kilbane JJ, 2006, CURR OPIN BIOTECH, V17, P305, DOI 10.1016/j.copbio.2006.04.005; GALLAGHER JR, 1993, FEMS MICROBIOL LETT, V107, P31, DOI 10.1111/j.1574-6968.1993.tb05999.x; Gallardo ME, 1997, J BACTERIOL, V179, P7156; Gray KA, 2003, CURR OPIN MICROBIOL, V6, P229, DOI 10.1016/S1369-5274(03)00065-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KELLOGG WW, 1972, SCIENCE, V175, P587, DOI 10.1126/science.175.4022.587; KILBANE JJ, 1989, TRENDS BIOTECHNOL, V7, P97, DOI 10.1016/0167-7799(89)90007-3; Li JC, 2009, BIORESOURCE TECHNOL, V100, P2594, DOI 10.1016/j.biortech.2008.12.009; Liu SH, 2014, PROTEINS, V82, P1708, DOI 10.1002/prot.24525; MONTICELLO DJ, 1985, ANNU REV MICROBIOL, V39, P371; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Zhang L, 2014, PROTEINS, V82, P2733, DOI 10.1002/prot.24638	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	AUG	2015	282	16			SI		3126	3135		10.1111/febs.13216		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CP6RV	WOS:000360016700010		
J	Honda, H; Ogawa, M; Murakoshi, T; Masuda, T; Utsumi, K; Park, S; Kimura, A; Nei, D; Wada, Y				Honda, Hidehito; Ogawa, Midori; Murakoshi, Takuma; Masuda, Tomohiro; Utsumi, Ken; Park, Sora; Kimura, Atsushi; Nei, Daisuke; Wada, Yuji			Effect of visual aids and individual differences of cognitive traits in judgments on food safety	FOOD POLICY			English	Article						Judgment on safety of food contaminated by pesticide residue; Visual aid; Numeracy; Cognitive reflection test; Individual differences in judgments on food safety	RISK COMMUNICATION FORMATS; DECISION-MAKING; NUMERACY SCALE; HEALTH-RISK; PROBABILITY; INFORMATION; PERCEPTION; FUTURE; COMPREHENSION; PERFORMANCE	We examined the effect of visual aids on judgments on food safety in conjunction with individual cognitive differences. In this study, participants (nine hundred Japanese women) were presented with explanations of pesticide residue either in written form only or in written form accompanied by a visual aid (functional graph or illustration), and were asked to make judgments on safety for foods that have pesticide residue. Findings through a web-based survey showed that judgments on food safety were highly difficult for laypeople since they had little knowledge of the technical terms used to describe amounts of pesticide residue. We found that although a visual aid showing their functional relationship did not improve understanding of the technical terms, an illustrated visual aid led to both improved understanding and more accurate judgments on safety. We also found that although cognitive traits measured with the subjective numeracy scale (Fagerlin et al., 2007b) and the Cognitive Reflection Test (Frederick, 2005) correlated with judgments on food safety, the judgments were improved with the use of visual aids regardless of cognitive traits. These results show that while not all visual aids enhance understanding of food safety information, appropriately designed visual aids do, and that cognitive traits producing individual differences in judgments on food safety should be taken into account when considering how food safety information should be conveyed. (C) 2015 Elsevier Ltd. All rights reserved.	[Honda, Hidehito] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Ogawa, Midori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Murakoshi, Takuma] Chiba Univ, Fac Letters, Chiba, Japan; [Masuda, Tomohiro] Bunkyo Univ, Fac Human Sci, Saitama, Japan; [Masuda, Tomohiro; Utsumi, Ken; Nei, Daisuke; Wada, Yuji] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Park, Sora] Int Univ Korea, Dept Ind Design, Gyeongnam, South Korea; [Kimura, Atsushi] Tokyo Denki Univ, Dept Informat Environm, Chiba, Japan	Wada, Y (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.				Health Labour Sciences Research Grant; JSPS-MEXT [26245073]	We appreciate Dr. Shane Frederick for his approval of translation CRT test into Japanese and using it for our research. We would like to thank Yayoi Kawasaki for her assistance. We also thank two anonymous reviewers for their insightful suggestions. This work is supported in part by the Health Labour Sciences Research Grant awarded and the JSPS-MEXT Grants-in-Aid for Scientific Research (26245073) to Y.W.	Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Manski CF, 2004, ECONOMETRICA, V72, P1329, DOI 10.1111/j.1468-0262.2004.00537.x; Peters E, 2008, ANN NY ACAD SCI, V1128, P1, DOI 10.1196/annals.1399.001; Ancker JS, 2007, J AM MED INFORM ASSN, V14, P713, DOI 10.1197/jamia.M2464; Ancker JS, 2006, J AM MED INFORM ASSN, V13, P608, DOI 10.1197/jamia.M2115; Koehler DJ, 2010, MEM COGNITION, V38, P667, DOI 10.3758/MC.38.6.667; Fagerlin A, 2007, AM J HEALTH BEHAV, V31, pS47; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Garcia-Retamero R, 2013, CURR DIR PSYCHOL SCI, V22, P392, DOI 10.1177/0963721413491570; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Oechssler J, 2009, J ECON BEHAV ORGAN, V72, P147, DOI 10.1016/j.jebo.2009.04.018; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Peters E, 2006, PSYCHOL SCI, V17, P407, DOI 10.1111/j.1467-9280.2006.01720.x; Liberali JM, 2012, J BEHAV DECIS MAKING, V25, P361, DOI 10.1002/bdm.752; Song HJ, 2008, SOC COGNITION, V26, P791; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Keller C, 2009, MED DECIS MAKING, V29, P483, DOI 10.1177/0272989X09333122; Peters E, 2007, MED CARE RES REV, V64, P169, DOI 10.1177/1077558706298290; Pachur T, 2013, J BEHAV DECIS MAKING, V26, P260, DOI 10.1002/bdm.1757; Reyna VF, 2008, LEARN INDIVID DIFFER, V18, P89, DOI 10.1016/j.lindif.2007.03.011; Lipkus IM, 2001, MED DECIS MAKING, V21, P37; Schapira MM, 2001, MED DECIS MAKING, V21, P459, DOI 10.1177/02729890122062811; Cerroni S, 2013, FOOD POLICY, V41, P112, DOI 10.1016/j.foodpol.2013.04.012; Cokely ET, 2009, JUDGM DECIS MAK, V4, P20; Peters E, 2008, JUDGM DECIS MAK, V3, P435; Nelson W, 2008, ANN BEHAV MED, V35, P261, DOI 10.1007/s12160-008-9037-8; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Fu TT, 1999, J AGR ECON, V50, P220; Feldman-Stewart D, 2000, MED DECIS MAKING, V20, P228, DOI 10.1177/0272989X0002000208; Armstrong K, 2001, J GEN INTERN MED, V16, P482, DOI 10.1046/j.1525-1497.2001.016007482.x; Cerroni S, 2012, J ECON BEHAV ORGAN, V84, P201, DOI 10.1016/j.jebo.2012.08.001; EOM YS, 1994, AM J AGR ECON, V76, P760, DOI 10.2307/1243737; Garcia-Retamero R., 2012, SCI WORLD J; Gigerenzer G., 2003, CALCULATED RISKS KNO; Hollands J. G., 1999, J NATL CANC I MONOGR, V1999, P149, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024191; Kahneman D., 2011, THINKING FAST SLOW; Okamoto M, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-104; Park S., 2014, JPN J HLTH ED PROMOT, V22, P100; Rimal A., 2001, INT J CONSUM STUD, V25, P43, DOI DOI 10.1111/J.1470-6431.2001.00162.X; Roosen J, 1998, J AGR RESOUR ECON, V23, P367	42	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-9192	1873-5657		FOOD POLICY	Food Policy	AUG	2015	55						33	40		10.1016/j.foodpol.2015.05.010		8	Agricultural Economics & Policy; Economics; Food Science & Technology; Nutrition & Dietetics	Agriculture; Business & Economics; Food Science & Technology; Nutrition & Dietetics	CP4UX	WOS:000359879200004		
J	Cohen, SM; Flikushima, S; Gooderham, NJ; Hecht, SS; Marnett, LJ; Rietjens, IMCM; Smith, RL; Astaki, M; Mcgowen, MM; Harman, C; Taylor, SV				Cohen, S. M.; Flikushima, S.; Gooderham, N. J.; Hecht, S. S.; Marnett, L. J.; Rietjens, I. M. C. M.; Smith, R. L.; Bastaki, M.; Mcgowen, M. M.; Harman, C.; Taylor, S. V.			GRAS 27 Flavoring Substances	FOOD TECHNOLOGY			English	Article							CATECHOL-O-METHYLTRANSFERASE; GREEN TEA CATECHINS; SAFETY EVALUATION; FEMA GRAS; POLYPHENOLS; INGREDIENTS; (-)-EPIGALLOCATECHIN-3-GALLATE; METHYLATION; COMPLEXES; INGESTION		[Cohen, S. M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Oncol, Omaha, NE 68198 USA; [Flikushima, S.] Japan Bioassay Res Ctr, Hadano, Japan; [Gooderham, N. J.] Univ London Imperial Coll Sci Technol & Med, Mol Toxicol, London SW7 2AZ, England; [Gooderham, N. J.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Hecht, S. S.] Univ Minnesota, Masonic Canc Ctr, Canc Prevent, Minneapolis, MN USA; [Hecht, S. S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Res, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Biomed Sci, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Canc Res, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Biochem, Nashville, TN 37212 USA; [Marnett, L. J.] Vanderbilt Univ, Sch Med, Chem, Nashville, TN 37212 USA; [Rietjens, I. M. C. M.] Wageningen Univ, Div Toxicol, Toxicol, NL-6700 AP Wageningen, Netherlands; [Smith, R. L.] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Mol Toxicol, London SW7 2AZ, England; [Bastaki, M.; Mcgowen, M. M.; Harman, C.] FEMA, Washington, DC USA; [Taylor, S. V.] FEMA Expert Panel, Washington, DC USA	Cohen, SM (reprint author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Oncol, Omaha, NE 68198 USA.						Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Chengelis CP, 2008, FOOD CHEM TOXICOL, V46, P978, DOI 10.1016/j.fct.2007.10.027; Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; EFSA, 2010, EFSA J, V8, P1623, DOI [10.2093/j.efsa.2010.1623, DOI 10.2093/J.EFSA.2010.1623]; EFSA (European Food Safety Authority), 2007, EFSA J, V578, P1; European Food Safety Authority, 2013, EFSA J, V11, P3449, DOI DOI 10.2903/J.EFSA.2013.3449; FDA (Food and Drug Administration), 2014, GUID IND ASS EFF SIG; HACKETT AM, 1982, XENOBIOTICA, V12, P447; HALLAGAN JB, 1995, REGUL TOXICOL PHARM, V21, P422, DOI 10.1006/rtph.1995.1057; Hallagan JB, 2009, FOOD CHEM TOXICOL, V47, P267, DOI 10.1016/j.fct.2008.11.011; Hallagan J. B., 1995, GENETICALLY MODIFIED; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2006, COMB COMP FOOD ADD S; Kelly J., 2014, M FEMA EXP PAN WASH; Mei S., 2010, KAGAKU TO SEIBUTSU; NIST (National Institute of Standards and Technology), 2008, NIST SPECIAL PUBLICA, V250-78; Smith RL, 2004, TOXICOL LETT, V149, P197, DOI 10.1016/j.toxlet.2003.12.031; Smith RL, 2005, FOOD CHEM TOXICOL, V43, P1141, DOI 10.1016/j.fct.2004.11.012; Smith RL, 2005, FOOD CHEM TOXICOL, V43, P345, DOI 10.1016/j.fct.2004.11.007; Smith RL, 1996, FOOD TECHNOL-CHICAGO, V50, P72; Stanford H., 2011, SUMM RIDG FARMS SUSQ; Summers D, 1998, MOL MICROBIOL, V29, P1137, DOI 10.1046/j.1365-2958.1998.01012.x; Takami S, 2008, FOOD CHEM TOXICOL, V46, P2224, DOI 10.1016/j.fct.2008.02.023; Unno T, 1996, BIOSCI BIOTECH BIOCH, V60, P2066; Xu Y., 2010, TEST REPORT CHANENG	30	0	0	INST FOOD TECHNOLOGISTS	CHICAGO	525 WEST VAN BUREN, STE 1000, CHICAGO, IL 60607-3814 USA	0015-6639			FOOD TECHNOL-CHICAGO	Food Technol.	AUG	2015	69	8					41	59				19	Food Science & Technology	Food Science & Technology	CP5AX	WOS:000359894800014		
J	Kiatkittikul, P; Nohira, T; Hagiwara, R				Kiatkittikul, P.; Nohira, T.; Hagiwara, R.			Advantages of a Polyimide Membrane Support in Nonhumidified Fluorohydrogenate-Polymer Composite Membrane Fuel Cells	FUEL CELLS			English	Article						Anions; Fluorohydrogenate; Fuel Cells; Ionic Liquids; Polyimide; Polymers	TEMPERATURE IONIC LIQUIDS; PROTON CONDUCTING MEMBRANES; ELECTROLYTE MEMBRANES; PHYSICOCHEMICAL PROPERTIES; N-METHYLPYRROLIDINIUM; OXYGEN REDUCTION; PEMFCS; CATIONS; POLYBENZIMIDAZOLES; HYDROCARBON	We have successfully prepared composite membranes consisting of the ionic liquid N-ethyl-N-methylpyrrolidinium fluorohydrogenate and the polymer 2-hydroxyethylmethacrylate and have secured them on a polyimide (PI) membrane support. The resulting EMPyr(FH)(1.7)F-HEMA (9: 1 molar ratio) composite possesses ionic conductivity of 75 mS cm(-1) at 120 degrees C when a 16-mu m support is employed, showing improved performance with elevated temperature; this marks a significant difference from devices using conventional polytetrafluoroethylene supports. In the single cell test, a maximum power density of 31 mW cm(-2) is observed at 120 degrees C. Cross-sectional SEM images of the corresponding membrane electrode assemblies reveal no significant difference in membrane thickness before and after cell testing, implying that this support does not suffer from membrane softening issues.	[Kiatkittikul, P.; Nohira, T.; Hagiwara, R.] Kyoto Univ, Dept Fundamental Energy Sci, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Nohira, T (reprint author), Kyoto Univ, Dept Fundamental Energy Sci, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	nohira@energy.kyoto-u.ac.jp					Liu S, 2014, ACS APPL MATER INTER, V6, P3195, DOI 10.1021/am404645c; Yang C, 2001, J POWER SOURCES, V103, P1, DOI 10.1016/S0378-7753(01)00812-6; Li QF, 2000, ELECTROCHIM ACTA, V45, P4219; Plackett D, 2011, J MEMBRANE SCI, V383, P78, DOI 10.1016/j.memsci.2011.08.038; Chen XB, 2011, J POWER SOURCES, V196, P1694, DOI 10.1016/j.jpowsour.2010.10.039; Higashihara T, 2009, POLYMER, V50, P5341, DOI 10.1016/j.polymer.2009.09.001; Chang JH, 2003, J POWER SOURCES, V124, P18, DOI 10.1016/S0378-7753(03)00605-0; Yasuda T, 2012, ACS APPL MATER INTER, V4, P1783, DOI 10.1021/am300031k; Lee SY, 2010, J AM CHEM SOC, V132, P9764, DOI 10.1021/ja102367x; Schulze MW, 2014, NANO LETT, V14, P122, DOI 10.1021/nl4034818; Lee SY, 2010, J POWER SOURCES, V195, P5909, DOI 10.1016/j.jpowsour.2009.11.045; Rikukawa M, 2000, PROG POLYM SCI, V25, P1463, DOI 10.1016/S0079-6700(00)00032-0; Malis J, 2013, INT J HYDROGEN ENERG, V38, P4697, DOI 10.1016/j.ijhydene.2013.01.126; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Kreuer KD, 2004, CHEM REV, V104, P4637, DOI 10.1021/cr020715f; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Lobato J, 2006, J MEMBRANE SCI, V280, P351, DOI 10.1016/j.memsci.2006.01.049; Hagiwara R, 2000, J FLUORINE CHEM, V105, P221, DOI 10.1016/S0022-1139(99)00267-5; Cho E, 2009, J ELECTROCHEM SOC, V156, pB197, DOI 10.1149/1.3031406; Angioni S, 2011, INT J HYDROGEN ENERG, V36, P7174, DOI 10.1016/j.ijhydene.2011.03.016; Hagiwara R, 1999, J FLUORINE CHEM, V99, P1, DOI 10.1016/S0022-1139(99)00111-6; Enomoto T, 2011, PHYS CHEM CHEM PHYS, V13, P12536, DOI 10.1039/c1cp20285e; Fernicola A, 2008, J APPL ELECTROCHEM, V38, P993, DOI 10.1007/s10800-008-9514-6; Fernicola A, 2007, CHEMPHYSCHEM, V8, P1103, DOI 10.1002/cphc.200600782; Gatto I, 2006, J FUEL CELL SCI TECH, V3, P361, DOI 10.1115/1.2217959; Hagiwara R, 2005, ELECTROCHEM SOLID ST, V8, pA231, DOI 10.1149/1.1870672; Hagiwara R, 2002, J ELECTROCHEM SOC, V149, pD1, DOI 10.1149/1.1421606; Hagiwara R, 2003, J ELECTROCHEM SOC, V150, pD195, DOI 10.1149/1.1621414; Jin YC, 2011, J POWER SOURCES, V196, P6042, DOI 10.1016/j.jpowsour.2011.03.094; Kanematsu S, 2009, ELECTROCHEM COMMUN, V11, P1312, DOI 10.1016/j.elecom.2009.05.002; Kiatkittikul P, 2012, J POWER SOURCES, V220, P10, DOI 10.1016/j.jpowsour.2012.07.124; Kiatkittikul P, 2014, J POWER SOURCES, V266, P193, DOI 10.1016/j.jpowsour.2014.05.019; Lakshmanan B, 2003, ELECTROCHEM SOLID ST, V6, pA282, DOI 10.1149/1.1619647; Lee JS, 2007, J POWER SOURCES, V171, P535, DOI 10.1016/j.jpowsour.2007.06.012; Matsumoto K, 2004, ELECTROCHEM SOLID ST, V7, pE41, DOI 10.1149/1.1795613; Matsumoto K, 2006, J FLUORINE CHEM, V127, P1339, DOI 10.1016/j.jfluchem.2006.04.009; Meier F, 2004, ELECTROCHIM ACTA, V49, P1731, DOI 10.1016/j.electacta.2003.12.004; Saroj AL, 2013, MATER SCI ENG B-ADV, V178, P231, DOI 10.1016/j.mseb.2012.11.007; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Sekhon SS, 2006, ELECTROCHIM ACTA, V52, P1639, DOI 10.1016/j.electacta.2006.03.095; Sekhon SS, 2006, J MATER CHEM, V16, P2256, DOI 10.1039/b602280d; Singh Lalia B., 2006, CHEM PHYS LETT, V435, P294, DOI 10.1016/j.cplett.2006.04.119; Tani Y, 2011, ELECTROCHIM ACTA, V56, P3852, DOI 10.1016/j.electacta.2011.02.038; Taniki R, 2013, CHEM LETT, V42, P1469, DOI 10.1246/cl.130722; Taniki R, 2012, ELECTROCHEM SOLID ST, V15, pF13, DOI 10.1149/2.025204esl; WAINRIGHT JS, 1995, J ELECTROCHEM SOC, V142, pL121, DOI 10.1149/1.2044337; Xiuchong H., 2008, J APPL POLYM SCI, V108, P529, DOI 10.1002/app.27676; Yamagata M, 2009, ELECTROCHEM SOLID ST, V12, pF9, DOI 10.1149/1.3117215; Yoshida SKT, 2014, PROPERTIES FLUORINE	50	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	AUG	2015	15	4					604	609		10.1002/fuce.201400150		6	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CP4PS	WOS:000359865200007		
J	Tsuda, M; Peyre, JB; Asano, T; Aigaki, T				Tsuda, Manabu; Peyre, Jean-Baptiste; Asano, Tsunaki; Aigaki, Toshiro			Visualizing Molecular Functions and Cross-Species Activity of Sex-Peptide in Drosophila	GENETICS			English	Article						sex-peptide; SP receptor; GFP-tag; postmating response	REPRODUCTIVE-BEHAVIOR; ECTOPIC EXPRESSION; HELICOVERPA-ARMIGERA; MELANOGASTER; RECEPTOR; FEMALES; DIFFERENTIATION; BIOSYNTHESIS; SYSTEM; SWITCH	The Drosophila melanogaster sex-peptide (melSP) is a seminal fluid component that induces postmating responses (PMR) of females via the sex-peptide receptor (SPR) . Although SP orthologs are found in many Drosophila species, their functions remain poorly characterized. It is unknown whether SP functions are conserved across species or rather specific to each species. Here, we developed a GFP-tagged melSP (G-SP) and used it to visualize cross-species binding activity to the female reproductive system of various species. First we demonstrated that ectopically expressed G-SP induced PMR in D. melanogaster females and bound to the female reproductive system, most notably to the common oviduct. No binding occurred in the females lacking SPR, indicating that G-SP binding was dependent on SPR. Next we tested whether G-SP binds to the common oviducts from 11 Drosophila species using dissected reproductive tracts. The binding was observed in six species belonging to the D. melanogaster species group, but not to those outside the group. Injection of melSP reduced the receptivity of females belonging to the D. melanogaster species group, but not of those outside the group, being consistent with the ability to bind G-SP. Thus the SP-mediated PMR appears to be limited to this species group. SPR was expressed in the oviducts at high levels in this group; therefore, we speculate that an enhanced expression of SPR in the oviduct was critical to establish the SP-mediated PMR during evolution.	[Tsuda, Manabu; Peyre, Jean-Baptiste; Asano, Tsunaki; Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Tsuda, Manabu] Kanagawa Univ Human Serv, Dept Liberal Arts & Human Dev, Yokosuka, Kanagawa 2388522, Japan	Aigaki, T (reprint author), Tokyo Metropolitan Univ, Dept Biol Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	aigaki-toshiro@tmu.ac.jp			Tokyo Metropolitan Government; Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank the Kyorin-fly, Tokyo, the Drosophila Genetic Resource Center, Kyoto, Japan, and the Bloomington Stock Center for providing the fly stocks. This work was supported by a special grant from the Tokyo Metropolitan Government and KAKENHI (a Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Aigaki.	AIGAKI T, 1984, EXP GERONTOL, V19, P13, DOI 10.1016/0531-5565(84)90027-5; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Poels J, 2010, CELL MOL LIFE SCI, V67, P3511, DOI 10.1007/s00018-010-0393-8; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Wolfner MF, 2009, J HERED, V100, P399, DOI 10.1093/jhered/esp013; Yamanaka N, 2010, P NATL ACAD SCI USA, V107, P2060, DOI 10.1073/pnas.0907471107; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Xue L, 2002, DEVELOPMENT, V129, P339; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Wigby S, 2008, J INSECT PHYSIOL, V54, P414, DOI 10.1016/j.jinsphys.2007.10.010; Kim YJ, 2010, P NATL ACAD SCI USA, V107, P6520, DOI 10.1073/pnas.0914764107; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Domanitskaya EV, 2007, FEBS J, V274, P5659, DOI 10.1111/j.1742-4658.2007.06088.x; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Hanin O, 2011, INSECT BIOCHEM MOLEC, V41, P537, DOI 10.1016/j.ibmb.2011.03.004; Hanin O, 2012, INSECT MOL BIOL, V21, P161, DOI 10.1111/j.1365-2583.2011.01122.x; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; KUBLI E, 1992, BIOESSAYS, V14, P779, DOI 10.1002/bies.950141111; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<363::AID-ARCH9>3.0.CO;2-T; Nakayama S, 1997, MOL GEN GENET, V254, P449; Oh Y, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001974; SCHMIDT T, 1993, J INSECT PHYSIOL, V39, P361, DOI 10.1016/0022-1910(93)90023-K; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Villella A, 2006, J COMP PHYSIOL A, V192, P1253, DOI 10.1007/s00359-006-0154-1	35	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	2015	200	4					1161	+		10.1534/genetics.115.177550		16	Genetics & Heredity	Genetics & Heredity	CP5JI	WOS:000359917000015		
J	Sakata, K; Koga, H; Ishida, T; Aimoto, J; Tokunaga, M; Okumura, M				Sakata, K.; Koga, H.; Ishida, T.; Aimoto, J.; Tokunaga, M.; Okumura, M.			Theoretical investigation for isomerization of allylic alcohols over Au-6 cluster	GOLD BULLETIN			English	Article						DFT calculation; Au cluster catalyst; Isomerization; Allylic alcohol	LOW-TEMPERATURE OXIDATION; POT N-ALKYLATION; CARBONYL-COMPOUNDS; GOLD CLUSTERS; ENANTIOSELECTIVE ISOMERIZATION; CATALYZED ISOMERIZATION; HYDROGENATION; NANOPARTICLES; COMPLEXES; ALDEHYDES	Transformation of allylic alcohols to corresponding saturated carbonyl compounds is one of the important reactions for industrial processes. Lately, Au-supported catalysts exhibit the catalytic activity for the isomerization of allylic alcohols to saturated aldehydes. However, the detail catalytic mechanism of this reaction was not elucidated in detail. Thus, theoretical calculations were carried out for the isomerization of 2-hexen-1-ol over isolated Au-6 cluster in order to elucidate the reaction over Au catalysts. From these calculation results, it was found that the rate determining step of the reaction process was the hydrogen elimination from OH group of allylic alcohol, and the substrate was converted to 1-hexen-1-ol on Au-6 cluster. Finally, it was also confirmed that 1-hexen-1-ol was converted to the corresponding aldehyde, and its activation barrier was much smaller than that of the deprotonation from OH group of allylic alcohol.	[Sakata, K.; Okumura, M.] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Koga, H.; Okumura, M.] Kyoto Univ, ESICB, Kyoto 6158245, Japan; [Ishida, T.] Tokyo Metropolitan Univ, Sch Urban Environm Sci, Dept Appl Chem, Tokyo 158, Japan; [Aimoto, J.; Tokunaga, M.] Kyushu Univ, Grad Sch Sci, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan; [Tokunaga, M.] Kyushu Univ, IRCMS, Nishi Ku, Fukuoka 8190395, Japan	Okumura, M (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	ok@chem.sci.osaka-u.ac.jp			Japan Science and Technology Agency (JST), ALCA	This work was financially supported by Japan Science and Technology Agency (JST), ALCA.	van der Drift RC, 2002, J ORGANOMET CHEM, V650, P1, DOI 10.1016/S0022-328X(02)01150-6; Sadeghmoghaddam E, 2012, ACS CATAL, V2, P1838, DOI 10.1021/cs300270d; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Tsunoyama H, 2005, J AM CHEM SOC, V127, P9374, DOI 10.1021/ja052161e; Kim JW, 2008, CHEM-EUR J, V14, P4104, DOI 10.1002/chem.200701917; Ishida T, 2009, GOLD BULL, V42, P267; Okumura M, 2008, CHEM PHYS LETT, V459, P133, DOI 10.1016/j.cplett.2008.04.120; Ito M, 2005, J AM CHEM SOC, V127, P6172, DOI 10.1021/ja050770g; Karanjit S, 2013, INT J QUANTUM CHEM, V113, P428, DOI 10.1002/qua.24056; Taketoshi A, 2014, CHEM LETT, V43, P380, DOI 10.1246/cl.131232; Takei T, 2012, ADV CATAL, V55, P1, DOI 10.1016/B978-0-12-385516-9.00001-6; Sadeghmoghaddam E, 2011, APPL CATAL A-GEN, V405, P137, DOI 10.1016/j.apcata.2011.07.038; Uma R, 2003, CHEM REV, V103, P27, DOI 10.1021/cr0103165; Shimizu K, 2013, J CATAL, V300, P242, DOI 10.1016/j.jcat.2013.01.005; Sadeghmoghaddam E, 2011, J MATER CHEM, V21, P307, DOI 10.1039/c0jm01761b; Ishida T, 2012, APPL CATAL A-GEN, V413, P261, DOI 10.1016/j.apcata.2011.11.017; Okumura M, 1998, CATAL LETT, V51, P53, DOI 10.1023/A:1019020614336; Liu X, 2013, CHEMSUSCHEM, V6, P604, DOI 10.1002/cssc.201200804; Tanaka K, 2001, J ORG CHEM, V66, P8177, DOI 10.1021/jo010792v; Fang WH, 2011, CHEM-EUR J, V17, P1247, DOI 10.1002/chem.201002469; Sakata K, 2014, MOL PHYS, V112, P385, DOI 10.1080/00268976.2013.828857; Corkum EG, 2012, RSC ADV, V2, P3473, DOI 10.1039/c2ra20197f; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Tanaka K, 2000, J AM CHEM SOC, V122, P9870, DOI 10.1021/ja002471r; Fang WH, 2010, CHEM COMMUN, V46, P1547, DOI 10.1039/b923047e; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Haruta M., 1987, CHEM LETT, V405; Ishida T, 2014, CHEM LETT, V43, P1368, DOI 10.1246/cl.140369; Menendez-Rodriguez L, 2013, J MOL CATAL A-CHEM, V366, P390, DOI 10.1016/j.molcata.2012.10.025; Moreno M, 2012, ACS CATAL, V2, P2602, DOI 10.1021/cs300361y; Musolino MG, 2004, J MOL CATAL A-CHEM, V208, P219, DOI 10.1016/j.molcata.2003.07.008; Nakamura A, 2011, ADV SYNTH CATAL, V353, P973, DOI 10.1002/adsc.201000369; Servin P, 2012, TETRAHEDRON LETT, V53, P3876, DOI 10.1016/j.tetlet.2012.05.070; Servin P, 2009, DALTON T, P4432, DOI 10.1039/b906393p; Su FZ, 2008, CHEM COMMUN, P3531, DOI 10.1039/b807608a; Zharmagambetova AK, 2001, J MOL CATAL A-CHEM, V177, P165, DOI 10.1016/S1381-1169(01)00316-8	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0017-1557			GOLD BULL	Gold Bull.	AUG	2015	48	1-2					31	37		10.1007/s13404-015-0157-1		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CP7MH	WOS:000360071700005		
J	Aziz, MA; Kim, JP; Shaikh, MN; Oyama, M; Bakare, FO; Yamani, ZH				Aziz, Md Abdul; Kim, Jong-Pil; Shaikh, M. Nasiruzzaman; Oyama, Munetaka; Bakare, Fatai Olawale; Yamani, Zain Hassan			Size-controlled preparation of fluorescent gold nanoparticles using pamoic acid	GOLD BULLETIN			English	Article						Hydrogen tetrachloroaurate; Pamoic acid; pH; Carboxylate-functionalized gold nanoparticles; Seed-mediated growth; Zeta potential; Fluorescence	DEPENDENT ELECTROCATALYTIC ACTIVITY; CATALYTIC-ACTIVITY; PROTEIN-DETECTION; NANOCRYSTALS; REDUCTION	We previously showed that pamoic acid (PA) could be utilized as a reducing and capping reagent for preparing monodispersed gold nanoparticles (AuNPs) with diameters of 10.8 nm. Here, we show that the size of these PA-capped AuNPs can be varied in a controlled manner by changing the pH used in the preparation process. By changing the added amount of NaOH in the PA solution before mixing with HAuCl4, several types of AuNPs were prepared at different pH values. The absorption spectra showed a red shift of the characteristic peak of the AuNPs with decreasing pH, indicating the formation of larger AuNPs. The TEM results confirmed this relationship between AuNP size and pH, and the zeta potentials indicated that the AuNPs capped with PA were more stable than the AuNPs prepared by citrate reduction method. Furthermore, the PA-capped AuNPs showed much higher fluorescence intensities than those of citrate-capped AuNPs, which is due to the fluorescence of PA. The sizes of PA-capped spherical AuNPs could also be controlled by a seed-mediated growth approach. However, the original PA-capped AuNPs, with diameters of 10.8 nm, exhibited the highest fluorescence intensities among the various types of PA-capped AuNPs that were grown. In addition to conferring fluorescence properties to the AuNPs, the capping by PA also provided the nanoparticles with carboxylate groups.	[Aziz, Md Abdul; Shaikh, M. Nasiruzzaman; Bakare, Fatai Olawale; Yamani, Zain Hassan] King Fahd Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia; [Kim, Jong-Pil] Korea Basic Sci Inst, Busan Ctr, Surface Properties Res Team, Busan 609735, South Korea; [Oyama, Munetaka] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158520, Japan	Aziz, MA (reprint author), King Fahd Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia.	maziz@kfupm.edu.sa					Abdelhalim MAK, 2012, J NANOMED NANOTECHOL, V3, P133, DOI 10.4172/2157-7439.1000133; Hebie S, 2013, GOLD BULL, V46, P311, DOI 10.1007/s13404-013-0119-4; Ji XH, 2007, J AM CHEM SOC, V129, P13939, DOI 10.1021/ja074447k; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Jiang C, 2007, LUMINESCENCE, V22, P430, DOI 10.1002/bio.981; Merian J, 2012, MOLECULES, V17, P5564, DOI 10.3390/molecules17055564; Brulle T, 2011, MOLECULES, V16, P10059, DOI 10.3390/molecules161210059; Duan HW, 2007, J AM CHEM SOC, V129, P2412, DOI 10.1021/ja067727t; Guo YM, 2012, ANALYST, V137, P301, DOI 10.1039/c1an15877e; Sharma V, 2009, MAT SCI ENG R, V65, P1, DOI 10.1016/j.mser.2009.02.002; Bakshi MS, 2008, CRYST GROWTH DES, V8, P1713, DOI 10.1021/cg8000043; Rawat KA, 2014, ANAL METHODS-UK, V6, P5972, DOI 10.1039/c4ay00098f; Xie JP, 2009, J AM CHEM SOC, V131, P888, DOI 10.1021/ja806804u; Mikami Y, 2013, CATAL SCI TECHNOL, V3, P58, DOI 10.1039/c2cy20068f; Dumur F, 2011, GOLD BULL, V44, P119, DOI 10.1007/s13404-011-0018-5; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Aslan K, 2005, ANAL BIOANAL CHEM, V382, P926, DOI 10.1007/s00216-005-3195-3; Aziz MA, 2008, CHEM COMMUN, P4607, DOI 10.1039/b808026g; Aziz MA, 2014, GOLD BULL, V47, P127, DOI 10.1007/s13404-014-0134-0; Baghel GS, 2009, POLYHEDRON, V28, P3507, DOI 10.1016/j.poly.2009.07.050; Cai Weibo, 2008, Nanotechnol Sci Appl, V1, P17; Cattin L, 2011, GOLD BULL, V44, P199, DOI 10.1007/s13404-011-0032-7; Chitra Kethirabalan, 2013, Journal of Nanotechnology, DOI 10.1155/2013/509628; Choi Y, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-103; FRENS G, 1973, NATURE-PHYS SCI, V241, P20; Gyanan Khatei J, 2014, SOFT NANOSCI LETT, V4, P69; Kasture M, 2010, CHEM PHYS LETT, V484, P271, DOI 10.1016/j.cplett.2009.11.052; Kumar SV, 2011, INT J GREEN NANOTECH, V3, P47; Li CF, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-440; Londhe Priyanka U., 2013, Proceedings of the International Conference on Advanced Nanomaterials & Emerging Engineering Technologies (ICANMEET-2013), DOI 10.1109/ICANMEET.2013.6609301; Matsuoka K, 2007, J PHYS CHEM C, V111, P3171, DOI 10.1021/jp065440c; Park G, 2013, LANGMUIR, V29, P13518, DOI 10.1021/la402315a; Tomar A, 2013, GLOBAL J PHARM, V7, P34; Vazquez-Gonzalez M, 2014, J BIOMED OPT, V19	34	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0017-1557			GOLD BULL	Gold Bull.	AUG	2015	48	1-2					85	92		10.1007/s13404-015-0164-2		8	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CP7MH	WOS:000360071700011		
J	Lang, FQ; Yamaguchi, H; Nakagawa, H; Sato, H				Lang, Fengqun; Yamaguchi, Hiroshi; Nakagawa, Hiroshi; Sato, Hiroshi			Deformation and Oxidation of Copper Metallization on Ceramic Substrate During Thermal Cycling From-40 degrees C to 250 degrees C	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Copper; power electronics; reliability; silicon carbide (SiC) power module; substrate; surface roughness; thermal cycling test (TCT); thermal stresses	HIGH-TEMPERATURE APPLICATIONS; CARBIDE POWER MODULES; DIE ATTACH; SIC DEVICES	The active-metal-brazed copper (AMC) on Si3N4 ceramic substrate was used to fabricate the all-silicon carbide (SiC) high-temperature power modules. Its reliability was evaluated under the conditions of high-temperature storage (HTS) at 250 degrees C and thermal cycling test (TCT) from -40 degrees C to 250 degrees C. During HTS, the AMC substrate was stable without deformation of the Cu layer. The shear strength of the Au-Ge eutectic-bonded SiC power devices slowly decreased with storage time, from the original 83 to 60 MPa after 3000 h. During TCT, no detachment of the Cu layer was observed even after 3000 cycles. However, severe plastic deformation of the Cu layer, which was induced by the cyclic thermal stresses, was observed. The plastic deformation progressed as the number of the thermal cycles increased. The deformation of the Cu layer was described by the peak-valley distance Rz of the Cu layer. Rz increased with thermal cycles. The plastic deformation of the Cu layer fractured its Ni(P) top layer, resulting in oxidation wherein. The Cu deformation degraded the bonding interface of the device with the Au-Ge solder, leading to sharp decrease of the shear strength. Another type of degradation of the AMC substrate was proposed.	[Lang, Fengqun; Yamaguchi, Hiroshi; Nakagawa, Hiroshi; Sato, Hiroshi] Natl Inst Adv Ind Sci & Technol, Res & Dev Partnership Future Power Elect Technol, Tsukuba, Ibaraki 3058568, Japan; [Yamaguchi, Hiroshi; Nakagawa, Hiroshi; Sato, Hiroshi] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan	Lang, FQ (reprint author), Natl Inst Adv Ind Sci & Technol, Res & Dev Partnership Future Power Elect Technol, Tsukuba, Ibaraki 3058568, Japan.	fengqun-lang@aist.go.jp; hiroshi-yamaguchi@aist.go.jp; h.nakagawa@aist.go.jp; hiroshi.sato@aist.go.jp			New Energy and Industrial Technology Development Organization Project through Novel Semiconductor Power Electronics Project Realizing Low Carbon Emission Society [P10022]	This work was supported by the New Energy and Industrial Technology Development Organization Project through the Novel Semiconductor Power Electronics Project Realizing Low Carbon Emission Society under Grant P10022. Recommended for publication by Associate Editor P. McCluskey upon evaluation of reviewers' comments.	Manikam VR, 2011, IEEE T COMP PACK MAN, V1, P457, DOI 10.1109/TCPMT.2010.2100432; Dupont L, 2006, MICROELECTRON RELIAB, V46, P1766, DOI 10.1016/j.microrel.2006.07.057; [Anonymous], 2010, 6074919 IEC; Mustain HA, 2010, IEEE T COMPON PACK T, V33, P563, DOI 10.1109/TCAPT.2010.2046901; Zhou Y, 2011, ADV MATER, V23, P4563, DOI 10.1002/adma.201102462; Lang FQ, 2013, J ELECTROCHEM SOC, V160, pD315, DOI 10.1149/2.114308jes; Chasserio N, 2009, J ELECTRON MATER, V38, P164, DOI 10.1007/s11664-008-0571-8; Chidambaram V, 2012, J ELECTRON MATER, V41, P2107, DOI 10.1007/s11664-012-2114-6; Colino R. P., 2005, POWER ELECT MODULES; Diaham S., 2011, SILICON CARBIDE MAT; Drevin-Bazin A, 2014, J ELECTRON MATER, V43, P695, DOI 10.1007/s11664-013-2718-5; Enlow L. R., 1998, HYBRID MICROCIRCUIT, V2nd; Funaki T, 2007, IEEE T POWER ELECTR, V22, P1321, DOI 10.1109/TPEL.2007.900561; Hopkins D. C., 2006, P 21 ANN IEEE APPL P, P871; Lang F., 2014, P 8 INT C INT POW EL, P1; Lostetter AB, 2012, MATER SCI FORUM, V717-720, P1219, DOI 10.4028/www.scientific.net/MSF.717-720.1219; Matsui K, 2012, MATER SCI FORUM, V717-720, P1233, DOI 10.4028/www.scientific.net/MSF.717-720.1233; McCluskey P., 2012, P 7 INT C INT POW EL, P1; Ning PQ, 2013, IEEE IND ELECTRON M, V7, P6, DOI 10.1109/MIE.2012.2231729; Palmer MJ, 2012, IEEE T COMP PACK MAN, V2, P208, DOI 10.1109/TCPMT.2011.2171343; Sheridan DC, 2012, MATER SCI FORUM, V717-720, P1229, DOI 10.4028/www.scientific.net/MSF.717-720.1229; Zhang R, 2012, IEEE T COMP PACK MAN, V2, P1739, DOI 10.1109/TCPMT.2012.2217142; Zhong XQ, 2014, IEEE T POWER ELECTR, V29, P5091, DOI 10.1109/TPEL.2014.2311800	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	AUG	2015	5	8					1069	1074		10.1109/TCPMT.2015.2423612		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CP6SJ	WOS:000360018200004		
J	Huang, SY; Huang, TY; Liu, CT; Wu, RB				Huang, Shih-Ya; Huang, Ting-Yi; Liu, Chia-Tsung; Wu, Ruey-Beei			Ringing Noise Suppression for Differential Signaling in Unshielded Flexible Flat Cable	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Crosstalk; differential signaling; flexible flat cable (FFC); resonance; ringing noise; signal integrity	CIRCUITS	For the system requirement of higher density and increasing data rate, flexible flat cable (FFC) becomes a popular solution. When FFC is used for differential signaling, the voltage levels on ground lines differ from each other along the length of FFC. Moreover, the resonant effect caused from crosstalk noise reduces the signal quality. Modal analysis is applied in this paper for deriving two fundamental differential modes. Time delay differences for two modes are also calculated for various FFC structures. In order to suppress the resonant ringing noise, a novel approach to eliminate the time delay difference is proposed. A design chart is also proposed to give the best design region for FFC. The frequency and time domain simulation results validate the design chart. After minimizing the delay difference, the eye height improves 29%. The crosstalk effect is also considered to elaborate the improvement of resonance suppressing. At last, scattering parameters and differential impedance of FFC are also measured for verification.	[Huang, Shih-Ya; Huang, Ting-Yi; Wu, Ruey-Beei] Natl Taiwan Univ, Grad Inst Commun Engn, Dept Elect Engn, Taipei 10617, Taiwan; [Liu, Chia-Tsung] Portwell Inc, Elect R&D Dept, New Taipei City 238, Japan	Huang, SY (reprint author), Natl Taiwan Univ, Grad Inst Commun Engn, Dept Elect Engn, Taipei 10617, Taiwan.	f00942001@ntu.edu.tw; d91942006@ntu.edu.tw; bob.liu@portwell.com.tw; rbwu@ntu.edu.tw					[Anonymous], 2010, PCI EXPRESS BASE SPE; [Anonymous], 2013, UNIVERSAL SERIAL BUS; [Anonymous], 2011, SATA IO RELEASES REV; YAMAMOTO S, 1966, IEEE T MICROW THEORY, VMT14, P446, DOI 10.1109/TMTT.1966.1126304; Cheng YS, 2010, IEEE T ADV PACKAGING, V33, P961, DOI 10.1109/TADVP.2010.2040033; Chi HJ, 2011, IEEE T CIRCUITS-II, V58, P687, DOI 10.1109/TCSII.2011.2164158; CHILO J, 1984, IEEE T ELECTRON DEV, V31, P347, DOI 10.1109/T-ED.1984.21526; Ianconescu R., 2014, P IEEE 28 CONV EL EL, P1; Mortier C., 1999, P IEE SEM EL COMP AU, p5/1; Paul C. R., 2006, INTRO ELECTROMAGNETI, V2nd; PAVLIDIS D, 1976, IEEE T MICROW THEORY, V24, P631, DOI 10.1109/TMTT.1976.1128928; Shimura T., 2014, U. S. Patent, Patent No. [8 669 483 B2, 8669483]; TRIPATHI VK, 1977, IEEE T MICROW THEORY, V25, P726, DOI 10.1109/TMTT.1977.1129202; Ueno Y., 2008, U. S. Patent, Patent No. [7 399 929 B2, 7399929]; Yeh S.-K., 2010, U. S. Patent, Patent No. [7 807 927 B2, 7807927]; YOU H, 1990, IEEE T CIRCUITS SYST, V37, P1019, DOI 10.1109/31.56075; Zwillich V., 2006, P 17 INT ZUR S EL CO, V3, P348	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	AUG	2015	5	8					1152	1159		10.1109/TCPMT.2015.2455074		8	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CP6SJ	WOS:000360018200013		
J	Yamaguchi, M; Araga, S; Mita, M; Yamasaki, K; Maekawa, K				Yamaguchi, Mitsugu; Araga, Shinji; Mita, Mamoru; Yamasaki, Kazuhiko; Maekawa, Katsuhiro			On-Demand Infrared Laser Sintering of Gold Nanoparticle Paste for Electrical Contacts	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Adhesivity; dry process; electrical contacts; gold; ink-jet printing; laser sintering; metal nanoparticles; metallization; plating	FILM; INKS	This paper discusses the formation of a conductive film from noble metal nanoparticles as an alternative to conventional electroplating for electrical components, such as connectors, switches, and memory cards. The proposed method consists in dispensing with nanoparticle paste followed by laser sintering. The aims are fourfold: 1) to establish sintering technology for gold nanoparticles placed on a nickel-electroplated phosphor-bronze substrate; 2) to characterize the laser-sintered film; 3) to discuss the laser sintering mechanism; and 4) to examine applicability to industry. The major results obtained are as follows: the laser sintering formed a gold film with a diameter of 0.3-0.8 mm and a thickness of 0.3-0.5 mu m on the nickel-electroplated phosphor-bronze substrate; a laser with a wavelength of 915 nm enabled instantaneous sintering within 1 s in air; the laser-sintered gold nanoparticle film had such a high adhesion to the substrate that no separation occurred after 90 degrees -0.5R bend-peel tests; the high adhesion was attributed to interdiffusion of gold and nickel in the course of sintering; optical properties of the gold nanoparticle paste depend on preheat conditions. A relatively high-preheat temperature around 523 K for 60 s produced a paste surface with a suitable absorbance of the infrared laser; a primary sintering of the preheated gold nanoparticles with a small amount of solvents followed by an auxiliary sintering from the substrate side made possible an efficient sintering of the nanoparticles as well as high adhesion to the substrate with a high thermal conductivity; and the film possesses such a good electrical property as that of the electroplated one in reciprocating abrasion tests.	[Yamaguchi, Mitsugu; Yamasaki, Kazuhiko; Maekawa, Katsuhiro] Ibaraki Univ, Hitachi, Ibaraki 3168511, Japan; [Araga, Shinji] Ibaraki Giken Ltd, Kitaibaraki 3191541, Japan; [Mita, Mamoru] M&M Res Lab, Hitachi, Ibaraki 3168511, Japan	Yamaguchi, M (reprint author), Ibaraki Univ, Hitachi, Ibaraki 3168511, Japan.	yamaguchi@iba-giken.co.jp; araga@iba-giken.co.jp; mmamoru@net1.jway.ne.jp; kyama@mx.ibaraki.ac.jp; mae@mx.ibaraki.ac.jp					Cai ZX, 2011, APPL SURF SCI, V258, P478, DOI 10.1016/j.apsusc.2011.08.088; Green TA, 2007, GOLD BULL, V40, P105, DOI 10.1007/BF03215566; Maekawa K, 2012, IEEE T COMP PACK MAN, V2, P868, DOI 10.1109/TCPMT.2011.2178606; Watanabe A, 2013, J PHOTOPOLYM SCI TEC, V26, P199; Peng P, 2012, APPL PHYS A-MATER, V108, P685, DOI 10.1007/s00339-012-6951-1; Cheng YT, 2009, MICROELECTRON ENG, V86, P865, DOI 10.1016/j.mee.2008.12.058; Auyeung RCY, 2007, J LASER MICRO NANOEN, V2, P21; Bieri NR, 2004, SUPERLATTICE MICROST, V35, P437, DOI 10.1016/j.spmi.2003.09.006; BUFFAT P, 1976, PHYS REV A, V13, P2287, DOI 10.1103/PhysRevA.13.2287; Bieri NR, 2005, APPL PHYS A-MATER, V80, P1485, DOI 10.1007/s00339-004-3195-8; Di Bari G. A., 2010, MODERN ELECTROPLATIN, V5th, P79; Kim M.-K., 2010, P 10 IEEE INT C NAN, P520; Kitada K., 2004, J SURF FINISHING SOC, V55, P626; Kohl P.A., 2010, MODERN ELECTROPLATIN, P115; Laakso P., 2009, P ICALEO, P1360; Maekawa K, 2009, 2009 IEEE 59TH ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE, VOLS 1-4, P1579, DOI 10.1109/ECTC.2009.5074224; Sugiyama A., 2011, J SURF FINISHING SOC, V62, P635; Terada N., 2008, J JPN I ELECT PACKAG, V11, P300	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	AUG	2015	5	8					1160	1168		10.1109/TCPMT.2015.2450312		9	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CP6SJ	WOS:000360018200014		
J	Uchida, T; Taniguchi, T; Ikeno, M; Iwasaki, Y; Saito, M; Shimazaki, S; Tanaka, MM; Taniguchi, N; Uno, S				Uchida, Tomohisa; Taniguchi, Takashi; Ikeno, Masahiro; Iwasaki, Yoshihito; Saito, Masatoshi; Shimazaki, Shoichi; Tanaka, Manobu M.; Taniguchi, Nanae; Uno, Shoji			Readout Electronics for the Central Drift Chamber of the Belle-II Detector	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Data acquisition; front-end electronics; gas detectors	TRIGGER; SYSTEM; FLOW; TIME	We have developed readout electronics for the central drift chamber (CDC) of the Belle-II detector. The space near the endplate of the CDC for installation of the electronics was limited by the detector structure. Due to the large amounts of data generated by the CDC, a high-speed data link, with a greater than one gigabit transfer rate, was required to transfer the data to a back-end computer. A new readout module was required to satisfy these requirements. This module processes 48 signals from the CDC, converts them to digital data and transfers it directly to the computer. All functions that transfer digital data via the high speed link were implemented on the single module. We have measured its electrical characteristics and confirmed that the results satisfy the requirements of the Belle-II experiment.	[Uchida, Tomohisa; Taniguchi, Takashi; Ikeno, Masahiro; Iwasaki, Yoshihito; Saito, Masatoshi; Shimazaki, Shoichi; Tanaka, Manobu M.; Taniguchi, Nanae; Uno, Shoji] KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3004205, Japan	Uchida, T (reprint author), KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3004205, Japan.	uchida@post.kek.jp					[Anonymous], 2009, DAT SHEET OCT 10 BIT; [Anonymous], 2003, 8023 IEEE; [Anonymous], 1981, RFC793; [Anonymous], 1990, 1149 IEEE, P1; Abashian A, 2002, NUCL INSTRUM METH A, V479, P117, DOI 10.1016/S0168-9002(01)02013-7; Aushev T., 2010, 200912 KEK; Dolezal Z., 2010, 20101 KEKREPORT BELL; Fries M. D., 2002, NUCL SCI S 2002 IEEE, V1, P580; Higuchi T, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/02/C02022; Itoh R, 2013, IEEE T NUCL SCI, V60, P3720, DOI 10.1109/TNS.2013.2273091; Iwasaki Y, 2011, IEEE T NUCL SCI, V58, P1807, DOI 10.1109/TNS.2011.2119329; Liu Z.-A., 2012, 18 IEEE NPSS REAL TI; Nakao M, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/12/C12004; Nakao M, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01028; Nakao M, 2013, IEEE T NUCL SCI, V60, P3729, DOI 10.1109/TNS.2013.2264727; Shimazaki S, 2014, NUCL INSTRUM METH A, V735, P193, DOI 10.1016/j.nima.2013.09.050; Spencer DF, 2006, NUCL INSTRUM METH A, V556, P291, DOI 10.1016/j.nima.2005.10.008; Stevens W. R., 1994, TCP IP ILLUSTRATED 1; Sun D., 2011, PHYS PROCEDIA, V37, P1933; Uchida T, 2008, IEEE T NUCL SCI, V55, P1631, DOI 10.1109/TNS.2008.920264; Wu JY, 2007, IEEE NUCL SCI CONF R, P281; Xilinx Inc, 2009, VIRT 5 FAM OV DS100; Xilinx Inc, 2012, VIRT 5 FPGA CONF US; Xilinx Inc, 2010, SEU STRAT VIRT 5 DEV; Xilinx Inc, 2009, VIRT 5 FPGA ROCKERIO	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	AUG	2015	62	4	2				1741	1746		10.1109/TNS.2015.2435747		6	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CP6RS	WOS:000360016400005		
J	Tian, Y; Takahashi, H; Shimazoe, K				Tian, Yang; Takahashi, Hiroyuki; Shimazoe, Kenji			Characteristics of an Energy-Resolving System Using Dynamic Time Over Threshold Method	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Dynamic time over threshold; integral nonlinearity; noise transfer; solid state detector; time over threshold	DETECTOR	The time over threshold (ToT) method can greatly simplify the data acquisition (DAQ) and control unit of a multi-channel energy-resolving system. However, the system suffers from poor linearity. The linearity can be significantly improved by superimposing a delayed exponential rising voltage waveform over the constant preset threshold after the leading-edge triggering. This is called the dynamic time over threshold (DToT) method. In this paper, a theoretical model is proposed and verified by experimental results to characterize the noise transfer, integral nonlinearity (INL), and stability of a DToT-based system. The results show that the DToT system is able to achieve an INL of 2% or better over a wide dynamic range without outstanding increments of noise contributions to the energy resolution. Both the energy resolution and stability are significantly enhanced compared with those of a normal ToT system. We suggest that the DToT method can be applied to simplify the DAQ unit of a multichannel solid state detector system requiring medium energy resolution and linearity.	[Tian, Yang; Takahashi, Hiroyuki; Shimazoe, Kenji] Univ Tokyo, Dept Nucl Engn & Management, Tokyo 1138656, Japan	Tian, Y (reprint author), Univ Tokyo, Dept Nucl Engn & Management, Tokyo 1138656, Japan.	cycjty@126.com; leo@n.t.u-tokyo.ac.jp; shimazeo@it-club.jp					[Anonymous], 2011, 74HC123 PROD DAT SHE; Becker R, 1996, NUCL INSTRUM METH A, V377, P459, DOI 10.1016/0168-9002(96)00251-3; CARIOLAR.GL, 1968, IEEE T INFORM THEORY, V14, P535, DOI 10.1109/TIT.1968.1054183; Fujiwara T, 2010, IEEE T NUCL SCI, V57, P2545, DOI 10.1109/TNS.2010.2061236; Jakubek J, 2011, NUCL INSTRUM METH A, V633, pS262, DOI 10.1016/j.nima.2010.06.183; Nicholson P. W., 1974, NUCL ELECT, P100; Orita T, 2015, NUCL INSTRUM METH A, V775, P154, DOI [10.1016/j.nima.2014.12.014, 10.1010/j.nima.2014.12.014]; Orita T., 2013, THESIS U TOKYO TOKYO; Shimazoe K, 2012, IEEE T NUCL SCI, V59, P3213, DOI 10.1109/TNS.2012.2215338	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	AUG	2015	62	4	2				1798	1804		10.1109/TNS.2015.2439312		7	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CP6RS	WOS:000360016400014		
J	Takano, A; Maehata, K; Iyomoto, N; Hara, T; Mitsuda, K; Yamasaki, N; Tanaka, K				Takano, Akira; Maehata, Keisuke; Iyomoto, Naoko; Hara, Toru; Mitsuda, Kazuhisa; Yamasaki, Noriko; Tanaka, Keiichi			X-Ray Transmission Characteristic Measurements of Polycapillary Optics Installed in an Analytical Electron Microscope	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Analytical electron microscope; energy dispersive X-ray spectroscopy; polycapillary optics	SPECTROMETER; RESOLUTION	This paper studies the polycapillary optics that are used to focus and transmit the X-rays emitted by a transmission electron microscope (TEM) specimen to an energy dispersive spectrometer using a superconducting transition edge sensor (TES) microcalorimeter. In this study, X-rays are collected from a TEM specimen and are then focused on a silicon drift detector, from which energy spectrum measurements of the polycapillary optics are taken and used to determine the transmission characteristics of the optics. When the polycapillary optics are used, an increase of 25.9 is seen in the intensity of 4.6 keV X-rays, while an increase of 6.0 is seen for 12.6 keV X-rays. The focal spot sizes of the X-ray beams from the polycapillary optics are found to be 382 mu m for the 4.6 keV X-rays and 156 mu m for the 12.6 keV X-rays. Further improvement of these characteristics can be achieved by improving the alignment of the optics to the detector and the collimator, which immediately precedes the detector, and by optimizing the collimator width.	[Takano, Akira; Maehata, Keisuke; Iyomoto, Naoko] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan; [Hara, Toru] Natl Inst Mat Sci, Ibaraki 3050044, Japan; [Mitsuda, Kazuhisa; Yamasaki, Noriko] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Tanaka, Keiichi] Hitachi High Tech Sci Corp, Shizuoka 4101393, Japan	Takano, A (reprint author), Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan.	kira42@kune2a.nucl.kyushu-u.ac.jp; HARA.Toru@nims.go.jp; mitsuda@astro.isas.jaxa.jp; tanaka-keiichi@hhs.hitachi-hitec.com	Yamasaki, Noriko/C-2252-2008		SENTAN, Japan Science and Technology Agency (JST)	This work was supported in part by SENTAN, Japan Science and Technology Agency (JST).	MOSELEY SH, 1984, J APPL PHYS, V56, P1257, DOI 10.1063/1.334129; Bandler SR, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2238752; Wollman DA, 2000, NUCL INSTRUM METH A, V444, P145, DOI 10.1016/S0168-9002(99)01351-0; KUMAKHOV MA, 1990, NUCL INSTRUM METH B, V48, P283, DOI 10.1016/0168-583X(90)90123-C; Bennett DA, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4754630; Hara T, 2010, J ELECTRON MICROSC, V59, P17, DOI 10.1093/jmicro/dfp043; James R. W., 1965, OPTICAL PRINCIPLES D, P171; MacDonald C. A., 2001, HDB OPTICS, VIII; Russell CH, 1997, P SOC PHOTO-OPT INS, V3113, P369, DOI 10.1117/12.278868; Schmaler J, 2009, AIP CONF PROC, V1185, P631, DOI 10.1063/1.3292420; Tanaka K, 2009, AIP CONF PROC, V1185, P715, DOI 10.1063/1.3292441; Wollman DA, 1997, J MICROSC-OXFORD, V188, P196, DOI 10.1046/j.1365-2818.1997.2670824.x	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	AUG	2015	62	4	2				1918	1922		10.1109/TNS.2015.2453011		5	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CP6RS	WOS:000360016400028		
J	Pilli-Sihvola, E; Aapaoja, A; Leviakangas, P; Kinnunen, T; Hautala, R; Takahashi, N				Pilli-Sihvola, Eetu; Aapaoja, Aki; Leviakangas, Pekka; Kinnunen, Tuomo; Hautala, Raine; Takahashi, Naoto			Evolving winter road maintenance ecosystems in Finland and Hokkaido, Japan	IET INTELLIGENT TRANSPORT SYSTEMS			English	Article						maintenance engineering; road building; road safety; procurement; traffic engineering computing; winter road maintenance ecosystems; Finland; Hokkaido; Japan; business ecosystems; customer requirements; synergistic benefits; total output value; safety enhancement; road conditions; mobility services; public good; public sector; ecosystem actors; road authorities; public sector restructuring; local residents; maintenance operations; procurement model; operating model	MANAGEMENT	Business ecosystems aim to develop the capabilities of its participants through collaboration supporting new offerings, better fulfil customer requirements and eventually create new innovations. Acting in an ecosystem provides synergistic benefits to actors by increasing the total value of the output - the actors can achieve more than they would have achieved working independently. The main objective of both studied winter maintenance ecosystems, Finnish and Japanese, is to enhance safety and ensure good road conditions. These ecosystems are compared to analyse and discuss the potential ways to develop current value networks. As roads and streets are publicly owned in most cases and mobility services regarded as a public good, the role of the public sector mostly dictates the topology and ecosystem actors. In Finland, the role of the road authorities is reduced because of the restructuring of the public sector, whereas in Japan it has so far remained stronger although road authorities have enhanced cooperation with local residents. For authorities in both countries, the prevailing lack of resources for maintenance operations is a strong motivating factor for finding new, more efficient procurement and operating models. Understanding the roles of all actors involved in the winter maintenance ecosystem is essential in this search for efficiency.	[Pilli-Sihvola, Eetu] Finnish Transport Safety Agcy, FI-00101 Helsinki, Finland; [Aapaoja, Aki; Leviakangas, Pekka; Kinnunen, Tuomo] Univ Oulu, Ind Engn & Management, FI-90014 Oulu, Finland; [Hautala, Raine] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Takahashi, Naoto] Civil Engn Res Inst Cold Reg, Toyohira Ku, Sapporo, Hokkaido 0628602, Japan	Pilli-Sihvola, E (reprint author), Finnish Transport Safety Agcy, POB 320, FI-00101 Helsinki, Finland.	eetu.pilli-sihvola@trafi.fi	Gomes, Leonardo/E-9980-2015				Adetola Alaba, 2013, International Journal of Procurement Management, V6; Donaldson KM, 2006, RES ENG DES, V16, P174, DOI 10.1007/s00163-006-0012-8; [Anonymous], 2008, FOLDOC FREE ON LIN D; Voss C, 2002, INT J OPER PROD MAN, V22, P195, DOI 10.1108/01443570210414329; Finnish National Road Administration, 1993, TIES RAK 1987 1992; Freeman E., 1984, STRATEGIC MANAGEMENT; Leviakangas Pekka, 2011, International Journal of Intelligent Transportation Systems Research, V9, DOI 10.1007/s13177-011-0029-x; Leviakangas P., 2014, ENG MANAG RES, V3, DOI [10.5539/emr.v3n1p56, DOI 10.5539/EMR.V3N1P56]; Leviakangas P, 2013, TRANSPORT RES REC, P45, DOI 10.3141/2329-06; Mathison S., 2005, ENCY EVALUATION; Molarius R, 2014, NAT HAZARDS, V72, P189, DOI 10.1007/s11069-013-0650-x; Peltoniemi M., 2006, E CO, V8, P10; Rubenstein-Montano B, 2001, DECIS SUPPORT SYST, V31, P5, DOI 10.1016/S0167-9236(00)00116-0	13	1	1	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-956X	1751-9578		IET INTELL TRANSP SY	IET Intell. Transp. Syst.	AUG	2015	9	6			SI		633	638		10.1049/iet-its.2014.0220		6	Transportation Science & Technology	Transportation	CP3VP	WOS:000359811000010		
J	Miyahara, K; Watamoto, T; Uto, Y; Sawase, T				Miyahara, Kenji; Watamoto, Takao; Uto, Yusuke; Sawase, Takashi			Effect of Macroscopic Grooves on Bone Formation and Osteoblastic Differentiation	IMPLANT DENTISTRY			English	Article						dental implant; human mesenchymal stem cell; rabbit tibia; bone formation	TITANIUM IMPLANTS; IN-VIVO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CELL RESPONSE; SURFACE; OSSEOINTEGRATION; INTEGRATION; DEPOSITION; MOBILITY	Objectives: The aim of this study is to investigate the effect of macroscopic grooves on bone formation in vivo and differentiation of human mesenchymal stem cells (hMSCs) in vitro. Materials and Methods: The effects of macroscopic grooves on titanium alloy implants and disks were tested in rabbit tibiae and cultured hMSCs. The bone-to-implant contact (BIC) and bone area were evaluated in rabbit tibiae at 6 and 24 weeks after implant insertion. Osteoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time reverse-transcription polymerase chain reaction (RT-PCR) on days 7, 14, and 21. All values were statically analyzed. Results: BIC and bone area inside the grooves were significantly higher than those of control implants (P < 0.05). ALP activity was significantly higher for titanium disks with macroscopic grooves than without grooves on day 14 (P < 0.05). Real-time RT-PCR showed that the expression of osteogenic genes was significantly higher for disks with grooves on day 7 (P < 0.01). Conclusions: Macroscopic grooves accelerate osteoblastic differentiation in vitro and stimulate direct bone growth and deposition within the grooves in vivo.	[Miyahara, Kenji; Watamoto, Takao; Uto, Yusuke; Sawase, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, Nagasaki 8528588, Japan	Watamoto, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, I-7-1 Sakamoto, Nagasaki 8528588, Japan.	watamoto@nagasaki-u.ac.jp			Japan Society of the Promotion of Science [B 22390368]	This work was supported by a Grant-in-Aid for Scientific Research (B 22390368) from the Japan Society of the Promotion of Science. Titanium disks and implants were provided by KYOCERA Medical Corporation (Osaka, Japan).	Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]; Al-Hamdan K, 2011, CLIN ORAL IMPLAN RES, V22, P399, DOI 10.1111/j.1600-0501.2010.02106.x; ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37; Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P373, DOI 10.1111/j.1600-0501.2010.02112.x; ROBERTS WE, 1984, AM J ORTHOD DENTOFAC, V86, P95, DOI 10.1016/0002-9416(84)90301-4; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Hall J, 2005, CLIN IMPLANT DENT R, V7, pS76, DOI 10.1111/j.1708-8208.2005.tb00078.x; Ivanoff CJ, 1996, CLIN ORAL IMPLAN RES, V7, P120; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Lee DW, 2007, CLIN ORAL IMPLAN RES, V18, P465, DOI 10.1111/j.1600-0501.2007.01302.x; Kitamura E, 2004, CLIN ORAL IMPLAN RES, V15, P401, DOI 10.1111/j.1600-0501.2004.01022.x; Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Hoshaw SJ, 1997, J BIOMECH, V30, P323, DOI 10.1016/S0021-9290(96)00159-5; Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911; Klenke FM, 2008, J BIOMED MATER RES A, V85A, P777, DOI 10.1002/jbm.a.31559; Mamalis AA, 2011, CLIN ORAL IMPLAN RES, V22, P530, DOI 10.1111/j.1600-0501.2010.02049.x; Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701; Orenstein IH, 1998, J PERIODONTOL, V69, P1404; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	AUG	2015	24	4					370	376		10.1097/ID.0000000000000257		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP3WI	WOS:000359813000002		
J	Fujita, A; Shintani, S				Fujita, Atsushi; Shintani, Satoru			Computed Tomographic Analysis of the Mandibular Body and Ramus in Japanese Patients: Relevance to Bone Harvesting From the Mandibular Ramus	IMPLANT DENTISTRY			English	Article						bone harvesting from the mandibular ramus; computed tomographic (CT) imaging; Japanese	PLACEMENT; OSTEOTOMY; DISTANCE; IMPLANTS; GRAFT	Purpose:The aims of this study were to use computed tomography (CT) imaging to determine the anatomical features of the mandibular body and ramus in Japanese subjects and to relate the findings to bone harvesting from the mandibular ramus.Materials and Methods:The mandibles of 100 patients (28 males and 72 females) under dental implant treatment plan were observed on CT imaging (slice thickness, 0.625 mm). The linear distance between the superior aspect of the inferior alveolar nerve canal and the alveolar crest (distance A), the linear distance between the buccal aspect of the inferior alveolar nerve canal and the buccal cortical bone (distance B), the thickest width of the buccal cortical bone (distance C), and the thinnest width of the buccal cortical bone (distance D) were measured in the same coronal plane at 4 specific locations (section 1: the distal aspect of the first molar, section 2: the distal aspect of the second molar, section 3: the 10 mm distal aspect of the second molar, and section 4: the 15 mm distal aspect of the second molar).Results:In the measurement of distance A, the minimum section among the male subjects was section 2 (12.55 3.00 mm), whereas among the females, the minimum section was section 3 (11.82 +/- 2.85 mm). In the distance B measurements, the maximum value was at section 2 (males: 6.36 +/- 1.33 mm, females: 6.32 +/- 1.39 mm) and the minimum value was at section 4 (males: 3.85 +/- 1.74 mm, females: 4.75 +/- 1.47 mm). Regarding the distance C measurements, the values of all subjects ranged from 3.10 to 4.41 mm, and the distance D values were approximately 2 mm.Conclusion:In Japanese patients, a rectangular piece of cortical bone up to 2 mm thickness may be harvested from the ramus, the length of the rectangular graft may approach 26 mm, and the height may be 10 mm for the safest harvesting from the mandibular ramus.	[Fujita, Atsushi] Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Ube, Yamaguchi 7558505, Japan; [Fujita, Atsushi; Shintani, Satoru] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Tokyo 142, Japan	Fujita, A (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	fujita-a@yamaguchi-u.ac.jp					Leong DJM, 2010, J PERIODONTOL, V81, P239, DOI 10.1902/jop.2009.090417; Kobayashi K, 2004, INT J ORAL MAX IMPL, V19, P228; Misch CM, 1997, INT J ORAL MAX IMPL, V12, P767; Tsuji Y, 2005, INT J ORAL MAX SURG, V34, P243, DOI 10.1016/j.ijom.2004.06.001; Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Capelli M, 2003, INT J PERIODONT REST, V23, P277; Fujita A, 2014, IMPLANT DENT, V23, P471, DOI 10.1097/ID.0000000000000105; Iwai K, 2000, DENT RADIOL, V40, P251; Misch C M, 2000, J Oral Implantol, V26, P42, DOI 10.1563/1548-1336(2000)026<0042:UOTMRA>2.3.CO;2; Misch CM, 1999, J ORAL MAXIL SURG, V57, P1376, DOI 10.1016/S0278-2391(99)90882-0; Orhan K, 2011, SURG RADIOL ANAT, V33, P501, DOI 10.1007/s00276-010-0761-y; Rajchel J, 1986, Int J Adult Orthodon Orthognath Surg, V1, P37; Sato S, 2004, QUINTESSENCE INT, V35, P525; Verdugo Fernando, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe32, DOI 10.1111/j.1708-8208.2009.00172.x; Yamada H, 1992, JAPANESE J ORAL BIOL, V34, P531; Yamamoto R, 2002, J ORAL MAXIL SURG, V60, P490, DOI 10.1053/joms.2002.31843	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	AUG	2015	24	4					402	406		10.1097/ID.0000000000000271		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP3WI	WOS:000359813000007		
J	Kawashima, Y; Sekiya, K; Sasaki, Y; Tsukioka, T; Muramatsu, T; Kaneda, T				Kawashima, Yusuke; Sekiya, Kotaro; Sasaki, Yusuke; Tsukioka, Tsuneyuki; Muramatsu, Teruaki; Kaneda, Takashi			Computed Tomography Findings of Mandibular Nutrient Canals	IMPLANT DENTISTRY			English	Article						computed tomography; mandible; nutrient canals	THREATENING AIRWAY-OBSTRUCTION; IMPLANT PLACEMENT; ENDOSSEOUS IMPLANT; HEMORRHAGE; NERVE; SURGERY; MOUTH; FLOOR	Introduction:The purpose of this study was to assess computed tomography (CT) findings of mandibular nutrient canals using CT images.Materials and Methods:We retrospectively analyzed the mandibular CT images of 194 consecutive patients. For image analysis such as canal prevalence, location, number, size, shape, and the CT value of nutrient foramina were determined using CT axial images of 0.5 and 3 mm slice thickness.Results:We revealed that the nutrient canals were seen 94.3% in the mandible, mostly seen in the anterior region. By location, nutrient canals were particularly seen between the central and lateral incisors. The mean number of nutrient canals was 2.7. The mean diameter of the nutrient foramen between the central and lateral incisors was 1.0 mm. In about 80% of the cases, foramina between the central and lateral incisors were ovoid. The mean CT value for the nutrient foramina between the central and lateral incisors was 411 HU.Discussion and Conclusions:Mandibular nutrient canals were ovoid shape, and the mean CT value was 411 HU. By preoperative knowledge of the position and anatomy of the mandibular nutrient canals, complications such as injury to the nutrient canals can be avoided.	[Kawashima, Yusuke; Sekiya, Kotaro; Sasaki, Yusuke; Tsukioka, Tsuneyuki; Muramatsu, Teruaki; Kaneda, Takashi] Nihon Univ, Sch Dent, Dept Radiol, Matsudo, Chiba 271, Japan	Kawashima, Y (reprint author), 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	yusukekawashima05@gmail.com			Department of Radiology, Nihon University School of Dentistry, Matsudo, Chiba, Japan	This study was supported by the Department of Radiology, Nihon University School of Dentistry, Matsudo, Chiba, Japan.	Mardinger O, 2000, SURG RADIOL ANAT, V22, P157, DOI 10.1007/s00276-000-0157-5; Woo BM, 2006, INT J ORAL MAX SURG, V35, P961, DOI 10.1016/j.ijom.2006.03.020; [Anonymous], 2007, ANN ICRP, V37, P73; Wismeijer D, 1997, BRIT J ORAL MAX SURG, V35, P254, DOI 10.1016/S0266-4356(97)90043-7; Kalpidis CDR, 2004, J PERIODONTOL, V75, P631, DOI 10.1902/jop.2004.75.5.631; KISHI K, 1982, ORAL SURG ORAL MED O, V54, P118, DOI 10.1016/0030-4220(82)90426-1; PATEL JR, 1976, ORAL SURG ORAL MED O, V42, P693, DOI 10.1016/0030-4220(76)90220-6; Bavitz J B, 1993, Int J Oral Maxillofac Implants, V8, P563; BRITT GN, 1977, ORAL SURG ORAL MED O, V44, P635, DOI 10.1016/0030-4220(77)90310-3; Budihardja Andi S, 2006, Implant Dent, V15, P148, DOI 10.1097/01.id.0000223224.79449.30; Darriba MA, 1997, J ORAL MAXIL SURG, V55, P1328, DOI 10.1016/S0278-2391(97)90195-6; De Andrade E, 2001, INT J PERIODONT REST, V21, P591; Enns LM, 1959, DENTAL RADIOLOGY, V6th, P402; HIRSCH JM, 1995, BRIT J ORAL MAX SURG, V33, P276, DOI 10.1016/0266-4356(95)90037-3; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016; Isaacson TJ, 2004, J AM DENT ASSOC, V135, P168; LABODA G, 1990, J AM DENT ASSOC, V121, P599; Lee CYS, 2012, IMPLANT DENT, V21, P368, DOI 10.1097/ID.0b013e318264d70d; MASON ME, 1990, J ORAL MAXIL SURG, V48, P201; McCall JO, 1957, CLIN DENTAL ROENTGEN, V4th, P186; Mordenfeld A, 1997, INT J ORAL MAX IMPL, V12, P558; Naimtu III J, 2001, ORAL SURG ORAL MED O, V92, P597; Arzouman M J, 1993, Int J Oral Maxillofac Implants, V8, P295; Shimizu N, 1977, Shigaku, V64, P941; ten Bruggenkate C M, 1993, Int J Oral Maxillofac Implants, V8, P329; White SC, 2014, ORAL RADIOLOGY PRINC, P147; Worth MK., 1963, PRINCIPLES PRACTICE, P70	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	AUG	2015	24	4					458	463		10.1097/ID.0000000000000267		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP3WI	WOS:000359813000015		
J	Ito, Y; Fujita, H; Kanou, M; Takahashi-Nakagawa, Y; Nakajima, Y; Sunano, A; Kimura, Y; Ueno, T				Ito, Yuichi; Fujita, Hiroshi; Kanou, Miwa; Takahashi-Nakagawa, Yasuko; Nakajima, Yoichiro; Sunano, Akihiro; Kimura, Yoshihiro; Ueno, Takaaki			Rapid and Easy Histological Evaluation of Alveolar Human Bone Quality at Dental Implant Sites Using a Nondecalcified Frozen Cryofilm Section Technique: A Technical Report	IMPLANT DENTISTRY			English	Article						bone histology; core samples; histologically evaluated; predictable plan		Introduction:The evaluation of bone quality at the site of the alveolar bone for a dental implant is very important. This study presents an easy technique for direct evaluation of alveolar bone quality using nondecalcified cryofilm frozen sections on human alveolar bone core samples.Materials and Methods:Core samples harvested from alveolar bone were immediately frozen in cooled hexanen and slowly cut using a disposable tungsten carbide blade; the sliced sections were collected with adhesive cryofilms. Staining was performed using von toluidine blue and von Kossa for microscopic observations.Results:All core samples clearly showed bone structure components of cortical bone, trabecular bone, bone marrow, blood vessels, and bone-related cells.Conclusion:These results suggest the efficacy of a nondecalcified cryofilm frozen section technique for histological observation of surgical implant sites.	[Ito, Yuichi; Fujita, Hiroshi; Kanou, Miwa; Takahashi-Nakagawa, Yasuko; Nakajima, Yoichiro; Kimura, Yoshihiro; Ueno, Takaaki] Osaka Med Coll, Dept Dent & Oral Surg, Takatsuki, Osaka 5698686, Japan; [Sunano, Akihiro] Osaka Med AU3 Coll, Dept Dent & Oral Surg, Takatsuki, Osaka, Japan	Ito, Y (reprint author), Osaka Med Coll, Dept Dent & Oral Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ora059@poh.osaka-med.ac.jp					Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49; Wakimoto M, 2012, CLIN ORAL IMPLAN RES, V23, P1314, DOI 10.1111/j.1600-0501.2011.02347.x; Huang, 2010, J ORAL REHABIL, V37, P346; Sarue H, 2013, CLIN IMPLANT DENT R, V15, P538	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	AUG	2015	24	4					477	479		10.1097/ID.0000000000000272		3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP3WI	WOS:000359813000018		
J	Ohba, S; Nakatani, Y; Kawasaki, T; Tajima, N; Tobita, T; Yoshida, N; Sawase, T; Asahina, I				Ohba, Seigo; Nakatani, Yuya; Kawasaki, Takako; Tajima, Nobutaka; Tobita, Takayoshi; Yoshida, Noriaki; Sawase, Takashi; Asahina, Izumi			Oral Rehabilitation With Orthognathic Surgery After Dental Implant Placement for Class III Malocclusion With Skeletal Asymmetry and Posterior Bite Collapse	IMPLANT DENTISTRY			English	Article						appropriate position; jaw deformity; older patients	OSSEOINTEGRATED IMPLANTS; ORTHODONTIC ANCHORAGE; CLINICAL REPORT; PATIENT	Increasing numbers of older patients are seeking orthognathic surgery to treat jaw deformity. However, orthodontic and orthognathic surgical treatment is difficult in cases without occlusal vertical stop. A 55-year-old man presented with Class III malocclusion and mandibular protrusion including esthetic problems and posterior bite collapse. He underwent dental implant treatment to reconstruct an occlusal vertical stop before orthognathic surgery. His occlusal function and esthetic problems improved after surgery, and his skeletal and occlusal stability has been maintained for 6 years. Dental implant placement at appropriate positions could help to determine the position of the proximal segment at orthognathic surgery and could shorten the time required to restore esthetic and occlusal function. This case demonstrates how skeletal and dental stability can be maintained long after surgery in a patient with jaw deformity and posterior bite collapse.	[Ohba, Seigo; Nakatani, Yuya; Kawasaki, Takako; Tajima, Nobutaka; Tobita, Takayoshi; Asahina, Izumi] Nagasaki Univ, Dept Regenerat Oral Surg, Unit Translat Med, Grad Sch Biochem Sci, Nagasaki 8528588, Japan; [Yoshida, Noriaki] Nagasaki Univ, Dept Appl Prosthodont, Unit Translat Med, Grad Sch Biochem Sci, Nagasaki 8528588, Japan; [Sawase, Takashi] Nagasaki Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Biomed Sci, Nagasaki 8528588, Japan	Ohba, S (reprint author), Nagasaki Univ, Dept Regenerat Oral Surg, Unit Translat Med, Grad Sch Biochem Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	sohba@nagasaki-u.ac.jp					Rose TP, 2006, BRIT DENT J, V201, P753, DOI 10.1038/sj.bdj.4814349; Balshi TJ, 1996, INT J PROSTHODONT, V9, P473; Bencharit S, 2012, J ORAL IMPLANTOL, V38, P63, DOI 10.1563/AAID-JOI-D-10-00032; Bidra AS, 2012, J ESTHET RESTOR DENT, V24, P88, DOI 10.1111/j.1708-8240.2011.00491.x; Carrion JB, 2009, INT J PERIODONT REST, V29, P333; Craddock Helen L, 2008, J Prosthodont, V17, P25; Craddock Helen L, 2007, J Prosthodont, V16, P495, DOI 10.1111/j.1532-849X.2007.00223.x; Drago CJ, 1999, J PROSTHET DENT, V82, P504, DOI 10.1016/S0022-3913(99)70045-4; Fernandez Valeron J, 1996, INT J ORAL MAXILLOF, V11, P534; Fukuda M, 2000, J ORAL REHABIL, V27, P546, DOI 10.1046/j.1365-2842.2000.00539.x; Huang LH, 2005, AM J ORTHOD DENTOFAC, V127, P713, DOI 10.1016/j.ajodo.2004.02.019; Jung MH, 2013, AM J ORTHOD DENTOFAC, V143, pS125, DOI 10.1016/j.ajodo.2011.11.022; Okumura T, 2010, JPN J JAW DEFORM, V20, P25; Orentlicher G, 2012, ORAL MAXILLOFACIAL S, V20, P53; Shifman A, 1998, J ORAL REHABIL, V25, P376; Siadat H, 2012, J Dent (Tehran), V9, P262; Verrett R G, 2001, J Prosthodont, V10, P224, DOI 10.1053/jpro.2001.28264	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	AUG	2015	24	4					487	490		10.1097/ID.0000000000000279		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CP3WI	WOS:000359813000022		
J	Hoshino, K; Isawa, H; Kuwata, R; Tajima, S; Takasaki, T; Iwabuchi, K; Sawabe, K; Kobayashi, M; Sasaki, T				Hoshino, Keita; Isawa, Haruhiko; Kuwata, Ryusei; Tajima, Shigeru; Takasaki, Tomohiko; Iwabuchi, Kikuo; Sawabe, Kyoko; Kobayashi, Mutsuo; Sasaki, Toshinori			Establishment and characterization of two new cell lines from the mosquito Armigeres subalbatus (Coquillett) (Diptera: Culicidae)	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						Cell line; Mosquito; Armigeres subalbatus; Flavivirus	JAPANESE ENCEPHALITIS-VIRUS; AEDES-AEGYPTI L; IN-VITRO; YUNNAN PROVINCE; DENGUE VIRUS; SUSCEPTIBILITY; LEPIDOPTERA; CULTURE; TISSUES; LARVAE	Armigeres subalbatus (Coquillett) is a medically important mosquito and a model species for immunology research. We successfully established two cell lines from the neonate larvae of A. subalbatus using two different media. To our knowledge, this is the first report of an established Armigeres mosquito cell line. The cell lines, designated as Ar-3 and Ar-13, consist of adherent and diploid cells with compact colonies. Both these cell lines grow slowly after passage at a split ratio of 1:5 and a population doubling time of 2.7 and 3.0 d, respectively. Random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR) was used to confirm that these lines correspond to the species of origin and are clearly distinct from seven other insect cell lines. Furthermore, reverse-transcription PCR was used to demonstrate that the Ar-3 cell line is susceptible to the Japanese encephalitis virus and two insect flaviviruses associated with Culex and Aedes mosquitoes but relatively insensitive to dengue virus. These data indicate that the newly established cell lines are cellular models of A. subalbatus as well as beneficial tools for the propagation of viruses associated with the Armigeres mosquito.	[Hoshino, Keita; Isawa, Haruhiko; Kuwata, Ryusei; Sawabe, Kyoko; Kobayashi, Mutsuo; Sasaki, Toshinori] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, Tokyo 1628640, Japan; [Hoshino, Keita; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Tajima, Shigeru; Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo 1628640, Japan	Sasaki, T (reprint author), Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tsasaki@niid.go.jp					Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666; Bello FJ, 2001, MEM I OSWALDO CRUZ, V96, P865, DOI 10.1590/S0074-02762001000600022; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Kuwata R, 2012, IN VITRO CELL DEV-AN, V48, P369, DOI 10.1007/s11626-012-9520-1; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Hoshino K, 2009, IN VITRO CELL DEV-AN, V45, P19, DOI 10.1007/s11626-008-9152-7; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Chen WJ, 2000, J MED ENTOMOL, V37, P108, DOI 10.1603/0022-2585-37.1.108; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0; GRACE TDC, 1966, NATURE, V211, P366, DOI 10.1038/211366a0; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; VARMA MGR, 1969, J MED ENTOMOL, V6, P432; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035; Aran B, 2010, IN VITRO CELL DEV-AN, V46, P356, DOI 10.1007/s11626-010-9288-0; Athawale SS, 2002, ACTA VIROL, V46, P237; Clements AN, 1992, BIOL MOSQUITOES, V1, P1; Eguchi D, 2006, IN VITRO CELL DEV-AN, V42, P1; Englund MCO, 2010, IN VITRO CELL DEV-AN, V46, P217, DOI 10.1007/s11626-010-9289-z; Feng Y, 2012, JPN J INFECT DIS, V65, P215; Hink W.F., 1976, P319; Isawa H, 2012, ARCH VIROL, V157, P975, DOI 10.1007/s00705-012-1240-z; KITAMURA S, 1970, Kobe Journal of Medical Sciences, V16, P41; Kuno G, 1980, TOXORHYNCHITES AMBOI, V16, P915; Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016; Lynn DE, 1998, MICROSCOPIC ANATOM C, V11C, P1119; Marquardt WC, 2004, BIOL DIS VECTORS, P1; Mitsuhashi Jun, 1994, P19; MITSUHASHI J, 1981, BIOMED RES-TOKYO, V2, P599; MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435; Mitsuhashi J, 1989, INVERTEBRATE CELL SY, V1, P3; Mitsuhashi J, 2002, INVERTEBRATE TISSUE, P1; Muslim A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-219; Nerome R, 2007, J GEN VIROL, V88, P2762, DOI 10.1099/vir.0.82941-0; PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6; Pudney M, 1982, INVERTEBRATE CELL CU, P159; Sasaki T, 2010, J INSECT PHYSIOL, V56, P1032, DOI 10.1016/j.jinsphys.2010.02.007; SCHNEIDE.I, 1969, J CELL BIOL, V42, P603, DOI 10.1083/jcb.42.2.603; Schneider I, 1972, J EMBRYOL EXP MORPH, V27, P363; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Segura NA, 2012, MEM I OSWALDO CRUZ, V107, P89, DOI 10.1590/S0074-02762012000100013; Simcox A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000142; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Sudeep AB, 2009, IN VITRO CELL DEV-AN, V45, P491, DOI 10.1007/s11626-009-9218-1; Tajima S, 2006, VIRUS RES, V116, P38, DOI 10.1016/j.virusres.2005.08.015; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Tanaka K, 2005, AQUATIC INSECTS JAPA, P757; Weng Ming-Hui, 1999, Journal of Microbiology Immunology and Infection, V32, P9	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	AUG	2015	51	7					672	679		10.1007/s11626-015-9883-1		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CP5NK	WOS:000359928900004		
J	Nanasato, Y; Kido, M; Kato, A; Ueda, T; Suharsono, S; Widyastuti, U; Tsujimoto, H; Akashi, K				Nanasato, Yoshihiko; Kido, Masafumi; Kato, Atsushi; Ueda, Tomoki; Suharsono, Sony; Widyastuti, Utut; Tsujimoto, Hisashi; Akashi, Kinya			Efficient genetic transformation of Jatropha curcas L. by means of vacuum infiltration combined with filter-paper wicks	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Article						A. tumefaciens transformation; Arid region; Biofuel; Filter-paper wicks; Jatropha curcas	AGROBACTERIUM-MEDIATED TRANSFORMATION; PLANT-REGENERATION; BIOFUEL PLANT; ARABIDOPSIS-THALIANA; PETIOLE EXPLANTS; BIODIESEL PLANT; DNA; ESTABLISHMENT; STRATEGY; CULTURES	Jatropha curcas L. (Jatropha) is a promising plant for the production of biodiesel in arid regions. To improve its productivity, it is important to understand the molecular functions of key genes in Jatropha, and to seek ways to modify important agronomic traits of Jatropha via molecular breeding. However, Jatropha is notorious for its recalcitrance to transformation. Thus, an improved protocol for efficient and reproducible Agrobacterium tumefaciens-mediated transformation is essential for molecular biology research and breeding in this species. Because resistance of Jatropha to A. tumefaciens infection is one of the key factors limiting transformation efficiency, we attempted to improve infection efficiency by comparing various co-culture conditions with the use of a beta-glucuronidase (GUS) assay. The LBA4404 strain of A. tumefaciens was more efficient than the EHA105 strain for transformation of Jatropha. Vacuum infiltration of an A. tumefaciens suspension with Jatropha explants, combined with co-cultivation on filter-paper wicks moistened with co-culture medium instead of on solid medium, significantly improved transformation efficiency. In these conditions, GUS-positive sectors were observed in 93.0 +/- 23.6% of infected explants. Moreover, a variant of the yellow fluorescent protein gene, Venus, was used as a visible marker, which proved effective for discrimination of candidate transgenic shoots from escape shoots. Transgene integration was confirmed by means of polymerase chain reaction and Southern hybridization analyses. Transgenic shoots were regenerated from 23% of explants from the vacuum-filter-paper treatment, which is sufficient for practical use.	[Nanasato, Yoshihiko; Kido, Masafumi; Ueda, Tomoki; Akashi, Kinya] Tottori Univ, Fac Agr, Sch Agr Biol & Environm Sci, Tottori 6808553, Japan; [Kato, Atsushi; Tsujimoto, Hisashi; Akashi, Kinya] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Suharsono, Sony; Widyastuti, Utut] Bogor Agr Univ, Res Ctr Bioresources & Biotechnol, Bogor 16680, Indonesia; [Tsujimoto, Hisashi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan	Akashi, K (reprint author), Tottori Univ, Fac Agr, Sch Agr Biol & Environm Sci, 4-101 Koyama Minami, Tottori 6808553, Japan.	akashi.kinya@muses.tottori-u.ac.jp			JST/JICA; SATREPS (Science and Technology Research Partnership for Sustainable Development); New Energy and Industrial Technology Development Organization (NEDO); Cooperative Research Grant of the Plant Transgenic Design Initiative, Gene Research Center, the University of Tsukuba; Arid Land Research Center, Tottori University	We are grateful to Ms. K. Mori and Ms. Y. Kimura for technical support with the transgenic procedures. We thank Mr. K. Kaku and Dr. K. Kawai (Kumiai Chemical Co., Ltd) for providing bispyribac-sodium salt, Dr. N. Inada (Nara Institute of Science and Technology, Japan) for providing the Venus gene, and Professor R. Motohashi (Shizuoka University) for fruitful discussions. This work was supported by JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development), the New Energy and Industrial Technology Development Organization (NEDO), Cooperative Research Grant of the Plant Transgenic Design Initiative, Gene Research Center, the University of Tsukuba, and a grant from the Arid Land Research Center, Tottori University.	AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Li MR, 2008, PLANT CELL TISS ORG, V92, P173, DOI 10.1007/s11240-007-9320-6; Cheng M, 2003, IN VITRO CELL DEV-PL, V39, P595, DOI 10.1079/IVP2003471; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Kumar N, 2012, IND CROP PROD, V39, P62, DOI 10.1016/j.indcrop.2012.02.011; Kajikawa M, 2012, PLANT BIOTECHNOL-NAR, V29, P145, DOI 10.5511/plantbiotechnology.12.0406b; Varshney A, 2010, PLANT BIOTECHNOL REP, V4, P139, DOI 10.1007/s11816-010-0129-0; Misra P, 2012, J PLANT BIOCHEM BIOT, V21, P128, DOI 10.1007/s13562-011-0072-3; Bakshi S, 2011, PLANT CELL REP, V30, P2281, DOI 10.1007/s00299-011-1133-8; Pan JL, 2010, AFR J BIOTECHNOL, V9, P6477; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; Kumar N, 2010, IND CROP PROD, V32, P41, DOI 10.1016/j.indcrop.2010.03.002; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pandey VC, 2012, RENEW SUST ENERG REV, V16, P2870, DOI 10.1016/j.rser.2012.02.004; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Ozawa K, 2009, PLANT SCI, V176, P522, DOI 10.1016/j.plantsci.2009.01.013; Kumar N, 2010, ANN APPL BIOL, V156, P367, DOI 10.1111/j.1744-7348.2010.00394.x; Deore AC, 2008, PLANT BIOTECHNOL REP, V2, P7, DOI 10.1007/s11816-008-0042-y; Sharma S, 2011, IND CROP PROD, V34, P943, DOI 10.1016/j.indcrop.2011.02.017; Khemkladngoen N, 2011, PLANT BIOTECHNOL REP, V5, P235, DOI 10.1007/s11816-011-0177-0; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; He Y, 2009, SILVAE GENET, V58, P123; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Cai L, 2011, LANDS BIOSCI GM CROP, V2, P110; Nanasato Y, 2013, PLANT BIOTECHNOL-NAR, V30, P287, DOI 10.5511/plantbiotechnology.13.0331a; Nanasato Y, 2011, PLANT CELL REP, V30, P1455, DOI 10.1007/s00299-011-1054-6; Nanasato Y, 2013, PLANT BIOTECHNOL REP, V7, P267, DOI 10.1007/s11816-012-0260-1; Ogawa Y, 2007, PLANT SCI, V172, P564, DOI 10.1016/j.plantsci.2006.11.003; Sunil N, 2013, JATROPHA CHALLENGES, V2, P137	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	AUG	2015	51	4					399	406		10.1007/s11627-015-9703-z		8	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CP5NS	WOS:000359929900003		
J	Zhang, XH; Dai, SP; da Silva, JAT; Ma, GH				Zhang, Xinhua; Dai, Seping; da Silva, Jaime A. Teixeira; Ma, Guohua			In vitro shoot organogenesis and plant regeneration in Tibouchina aspera Aubl.	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Article							SOMATIC EMBRYOGENESIS; HYDROLYZABLE TANNINS; LEAF EXPLANTS; THIDIAZURON; MELASTOMATACEAE; SEMIDECANDRA; REGULATOR; CULTURES; GROWTH; COGN		[Zhang, Xinhua; Ma, Guohua] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Dai, Seping] Guangzhou Inst Landscape Garden, Guangzhou 510405, Guangdong, Peoples R China	da Silva, JAT (reprint author), POB 7,Miki Cho PO,Ikenobe 3011-2, Miki, Kagawa 7610799, Japan.	jaimetex@yahoo.com; magh@scib.ac.cn			National Natural Science Foundation of China [31470685, 31100498, 31270720, 30972295]	This work was financially supported by the National Natural Science Foundation of China (31470685, 31100498, 31270720, and 30972295), which is gratefully acknowledged.	BOBBIO FO, 1985, FOOD CHEM, V18, P153, DOI 10.1016/0308-8146(85)90138-4; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; RENNER SS, 1993, NORD J BOT, V13, P519, DOI 10.1111/j.1756-1051.1993.tb00096.x; Yoshida T, 1999, PHYTOCHEMISTRY, V52, P1661, DOI 10.1016/S0031-9422(99)00329-5; CIAMPOLINI F, 1995, ANN BOT-LONDON, V76, P421, DOI 10.1006/anbo.1995.1115; Yoshida T, 1999, CHEM PHARM BULL, V47, P824; Gallego SM, 1996, PLANT SCI, V121, P151, DOI 10.1016/S0168-9452(96)04528-1; Mithila J, 2003, PLANT CELL REP, V21, P408, DOI 10.1007/s00299-002-0544-y; Guo B, 2011, AFR J BIOTECHNOL, V10, P8984; Laukkanen H, 1999, PHYSIOL PLANTARUM, V106, P337, DOI 10.1034/j.1399-3054.1999.106312.x; Ma GH, 2011, PLANT CELL TISS ORG, V104, P157, DOI 10.1007/s11240-010-9812-7; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Chan LK, 2008, BIOTECHNOLOGY, V7, P678; Ferreira WD, 2006, J PLANT PHYSIOL, V163, P1126, DOI 10.1016/j.jplph.2005.07.012; Funk V.A., 2007, CONTRIBUTIONS US NAT, V55, P1; He CX, 2009, PROPAG ORNAM PLANTS, V9, P59; He CX, 2010, FLORICULTURE ORNAMEN, V4, P88; Janna OA, 2006, FOOD CHEM, V101, P1640; Kumar HGA, 2007, EUR J HORTIC SCI, V72, P85; Kuster RM, 2009, BIOCHEM SYST ECOL, V37, P63, DOI 10.1016/j.bse.2009.01.005; Ma GH, 2007, FLORICULT ORNAM BIOT, V1, P27; Ma GH, 2007, J HORTIC SCI BIOTECH, V82, P428; Murthy BNS, 1998, IN VITRO CELL DEV-PL, V34, P267; The Plant List, 2015, TIB; The Plant List, 2015, MEL; Yang G, 2014, IN VITRO CELL DEV-PL, V50, P451, DOI 10.1007/s11627-014-9617-1; Yang XY, 2012, PLANT CELL TISS ORG, V109, P213, DOI 10.1007/s11240-011-0087-4; Zeng SJ, 2008, PAK J BOT, V40, P1179; Zhou W, 2009, GENES GENOMES GENOMI, V3, P68	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	AUG	2015	51	4					482	487		10.1007/s11627-015-9691-z		6	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CP5NS	WOS:000359929900012		
J	Zhang, XH; Dai, SP; da Silva, JAT; Ma, GH				Zhang, Xinhua; Dai, Seping; da Silva, Jaime A. Teixeira; Ma, Guohua			In vitro shoot organogenesis and plant regeneration in Tibouchina aspera Aubl. (vol 51, pg 482, 2015)	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Correction									[Zhang, Xinhua; Ma, Guohua] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Dai, Seping] Guangzhou Inst Landscape Garden, Guangzhou 510405, Guangdong, Peoples R China	da Silva, JAT (reprint author), POB 7,Miki Cho PO,Ikenobe 3011-2, Miki, Kagawa 7610799, Japan.	jaimetex@yahoo.com; magh@scib.ac.cn					Zhang XH, 2015, IN VITRO CELL DEV-PL, V51, P482, DOI 10.1007/s11627-015-9691-z	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	AUG	2015	51	4					488	488		10.1007/s11627-015-9712-y		1	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CP5NS	WOS:000359929900013		
J	Sasamoto, H; Murashige-Baba, T; Sato, T; Hasegawa, A; Wasano, N; Fujii, Y				Sasamoto, H.; Murashige-Baba, T.; Sato, T.; Hasegawa, A.; Wasano, N.; Fujii, Y.			Development of a Simple High-throughput Bioassay Method for Allelopathy: Protoplasts Co-culture with Image Analysis.	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Meeting Abstract	In Vitro Biology Meeting	MAY 30-JUN 03, 2015	Tucson, AZ	Soc In Vitro Biol					[Sasamoto, H.] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan; [Sasamoto, H.; Murashige-Baba, T.; Sato, T.; Hasegawa, A.] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Wasano, N.; Fujii, Y.] Tokyo Univ Agr & Technol, Fac Agr, Tokyo 1838509, Japan		sasamoto@ynu.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	AUG	2015	51	4				P-3012	497	497				1	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CP5NS	WOS:000359929900031		
J	Hara, Y; Endo, T; Kobayashi, H				Hara, Yoritoshi; Endo, Takahiro; Kobayashi, Hajime			The hidden abode of network orchestration: The case of de-legitimated diesel cars in Japan	INDUSTRIAL MARKETING MANAGEMENT			English	Article						Network orchestration; Institutional perspective; Theorization; Diesel cars; Japan	BUSINESS NETWORKS; ABSORPTIVE-CAPACITY; INNOVATION; FIELDS; NETS	The purpose of this study is to examine the failure of network orchestration blocked by peripheral actors, including governments. The paper sheds light upon the anti-diesel car campaign led by the Tokyo Metropolitan Government (TMG) in Japan around the year 2000. The campaign had a severe impact on the negative perception of diesel cars in Japan. Most importantly, due to the campaign, the network orchestration concerning diesel cars faced extreme difficulty. For the analysis, the paper employs persuasion strategies (different types of theorization) offered from the institutional perspective. The novel evidence of this study suggests the necessity to reconsider the existing treatment of boundary concerning the whole picture of network orchestration. (C) 2015 Elsevier Inc. All rights reserved.	[Hara, Yoritoshi; Kobayashi, Hajime] Meiji Univ, Sch Commerce, Chiyoda Ku, Tokyo 1018301, Japan; [Endo, Takahiro] Kobe Univ, Res Inst Econ & Business Adm, Nada Ku, Kobe, Hyogo 6578501, Japan	Hara, Y (reprint author), Meiji Univ, Sch Commerce, Chiyoda Ku, 1-1 Kanda Surugadai, Tokyo 1018301, Japan.	hara@meiji.ac.jp; endo.takahiro@gmail.com; hkoba@meiji.ac.jp					Aaboen L, 2013, IND MARKET MANAG, V42, P1033, DOI 10.1016/j.indmarman.2013.07.003; STRANG D, 1993, THEOR SOC, V22, P487, DOI 10.1007/BF00993595; Suddaby R, 2005, ADMIN SCI QUART, V50, P35, DOI 10.2189/asqu.2005.50.1.35; Rao H, 2003, AM J SOCIOL, V108, P795, DOI 10.1086/367917; Greenwood R, 2002, ACAD MANAGE J, V45, P58, DOI 10.2307/3069285; Moller K, 2005, J BUS RES, V58, P1274, DOI 10.1016/j.jbusres.2003.05.002; Ritter T, 2004, IND MARKET MANAG, V33, P175, DOI 10.1016/j.indmarman.203.10.016; Hakansson H, 2002, J BUS RES, V55, P133, DOI 10.1016/S0148-2963(00)00148-X; Moller K, 2007, IND MARKET MANAG, V36, P895, DOI 10.1016/j.indmarman.2007.05.016; Brito CM, 2001, J BUS IND MARK, V16, P150, DOI 10.1108/08858620110389777; Hurmelinna-Laukkanen P, 2012, EUR MANAG J, V30, P552, DOI 10.1016/j.emj.2012.03.002; Hurmelinna-Laukkanen P., 2012, J BUSINESS MARKET MA, V5, P244; Moller K, 2009, IND MARKET MANAG, V38, P450, DOI 10.1016/j.indmarman.2008.02.009; Moller K, 2010, IND MARKET MANAG, V39, P361, DOI 10.1016/j.indmarman.2009.03.014; Moller K., 2003, MARKETING THEORY, V3, P201; Natti S, 2014, J BUS IND MARK, V29, P173, DOI 10.1108/JBIM-08-2013-0167; Paquin RL, 2013, ORGAN STUD, V34, P1623, DOI 10.1177/0170840612470230; Ritala P, 2012, J BUS IND MARK, V27, P324, DOI 10.1108/08858621211221698; Scott W. R., 2008, I ORG IDEAS INTEREST; Scott W.R., 1995, I ORG; Wilkinson I. F., 1994, ASIA AUSTR MARKETING, V2, P67	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0019-8501	1873-2062		IND MARKET MANAG	Ind. Mark. Manage.	AUG	2015	49						15	21		10.1016/j.indmarman.2015.06.001		7	Business; Management	Business & Economics	CP4XI	WOS:000359885500003		
J	Sargent, B; Scholz, J; Reimann, H; Kubo, M; Fetters, L				Sargent, Barbara; Scholz, John; Reimann, Hendrik; Kubo, Masayoshi; Fetters, Linda			Development of infant leg coordination: Exploiting passive torques	INFANT BEHAVIOR & DEVELOPMENT			English	Article						Infant; Kinematics; Kinetics; Motor control; Motor development; Coordination	WHITE-MATTER DISORDER; FULL-TERM INFANTS; SPONTANEOUS KICKING; PRETERM INFANTS; MOVEMENTS; DYNAMICS; ORGANIZATION; HAND	Leg joint coordination systematically changes over the first months of life, yet there is minimal data on the underlying change in muscle torques that might account for this change in coordination. The purpose of this study is to investigate the contribution of torque changes to early changes in leg joint coordination. Kicking actions were analyzed of 10 full-term infants between 6 and 15-weeks of age using three-dimensional kinematics and kinetics. We found 11 of 15 joint angle pairs demonstrated a change from more in-phase intralimb coordination at 6-weeks to less in-phase coordination at 15-weeks. Although the magnitude of joint torques normalized to the mass of the leg remained relatively consistent, we noted more complex patterns of torque component contribution across ages. By focusing on the change in torques associated with hip-knee joint coordination, we found that less in-phase hip-knee joint coordination at 15-weeks was associated with decreased influence of knee muscle torque and increased influence of knee gravitational and motion-dependent torques, supporting that infants coordinate hip muscle torque with passive knee gravitational and motion-dependent torques to generate kicks with reduced active knee muscle torque. We propose that between 6 and 15-weeks of age less in-phase hip-knee coordination emerges as infants exploit passive dynamics in the coordination of hip and knee motions. (C) 2015 Elsevier Inc. All rights reserved.	[Sargent, Barbara] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90033 USA; [Scholz, John] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Scholz, John] Univ Delaware, Biomech & Movement Sci Program, Newark, DE 19716 USA; [Reimann, Hendrik] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Kubo, Masayoshi] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata 9503198, Japan; [Fetters, Linda] Univ So Calif, Keck Sch Med, Dept Pediat, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90033 USA	Sargent, B (reprint author), Univ So Calif, Div Biokinesiol & Phys Therapy, 1540 E Alcazar St,CHP 155, Los Angeles, CA 90033 USA.	bsargent@usc.edu; tuf79669@temple.edu; kubo@nuhw.ac.jp; fetters@usc.edu			Division of Biokinesiology and Physical Therapy at USC; Foundation for Physical Therapy, Inc.; Education Section of the American Physical Therapy Association	We are grateful to the parents and infants who participated in the study and to Shaveonte Graham and Robert Vogtmann who assisted with data collection. This research was supported by the Division of Biokinesiology and Physical Therapy at USC and scholarships from the Foundation for Physical Therapy, Inc. and the Education Section of the American Physical Therapy Association to Barbara Sargent.	THELEN E, 1985, DEV PSYCHOBIOL, V18, P1, DOI 10.1002/dev.420180102; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Angulo-Kinzler RM, 2002, MOTOR CONTROL, V6, P52; Bhat A, 2005, INFANT BEHAV DEV, V28, P445, DOI 10.1016/j.infbeh.2005.03.001; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; Fetters L, 2010, PHYS THER, V90, P1860, DOI 10.2522/ptj.2010090; SCHNEIDER K, 1990, J MOTOR BEHAV, V22, P493; vanEmmerik REA, 1996, J BIOMECH, V29, P1175, DOI 10.1016/0021-9290(95)00128-X; Jeng SF, 2002, PHYS THER, V82, P148; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661; SUN H, 1994, J BIOMECH, V27, P265, DOI 10.1016/0021-9290(94)90003-5; Heathcock JC, 2004, PHYS THER, V84, P808; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.1111/j.1467-8624.1993.tb04188.x; Fetters L, 2010, DEV PSYCHOBIOL, V52, P524, DOI 10.1002/dev.20455; JENSEN JL, 1994, J MOTOR BEHAV, V26, P303; Chen YP, 2002, INFANT BEHAV DEV, V25, P195, DOI 10.1016/S0163-6383(02)00121-2; Fetters L, 2004, HUM MOVEMENT SCI, V22, P729, DOI 10.1016/j.humov.2004.02.001; Galloway JC, 2004, INFANT BEHAV DEV, V27, P107, DOI 10.1016/j.infbeh.2003.06.001; Vaal J, 2000, EXP BRAIN RES, V135, P94, DOI 10.1007/s002210000508; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.1111/j.1467-8624.1993.tb04182.x; Bayley N., 2006, MANUAL BAYLEY SCALES; Bernstein N, 1967, COORDINATION REGULAT; Chen Y., 2002, ROC TAIWAN J PHYS TH, V27, P303; Dunteman G.H., 1989, PRINCIPAL COMPONENT; Dusing SC, 2014, EARLY HUM DEV, V90, P149, DOI 10.1016/j.earlhumdev.2014.01.006; Gibson E. J., 2000, ECOLOGICAL APPROACH; HERIZA CB, 1988, PHYS THER, V68, P1687; Jensen J. L., 1995, J MOTOR BEHAV, V27, P366; Kelso J. A., 1986, PHYS LETT A, V134, P8; KONCZAK J, 1995, EXP BRAIN RES, V106, P156; Murray R. M., 1994, MATH INTRO ROBOTIC M; Piek JP, 1996, HUM MOVEMENT SCI, V15, P707, DOI 10.1016/0167-9457(96)00014-0; Rosenbaum Peter, 2007, Dev Med Child Neurol Suppl, V109, P8; Sargent B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091500; SCHNEIDER K, 1992, J BIOMECH, V25, P145, DOI 10.1016/0021-9290(92)90271-2; SIQUELAN.ER, 1969, SCIENCE, V165, P1144, DOI 10.1126/science.165.3898.1144; THELEN E, 1983, J MOTOR BEHAV, V15, P353; Thelen E., 1994, DYNAMIC SYSTEMS APPR; THELEN E, 1986, CHILD DEV, V57, P1498, DOI 10.1111/j.1467-8624.1986.tb00474.x; Tseng YW, 2009, EXP BRAIN RES, V193, P239, DOI 10.1007/s00221-008-1616-1	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-6383	1879-0453		INFANT BEHAV DEV	Infant Behav. Dev.	AUG	2015	40						108	121		10.1016/j.infbeh.2015.03.002		14	Psychology, Developmental	Psychology	CP4YU	WOS:000359889300012		
J	Nakayama, H				Nakayama, Hiroko			Emergence of amae crying in early infancy as a possible social communication tool between infants and mothers	INFANT BEHAVIOR & DEVELOPMENT			English	Article						Infant crying; Amae crying; Early infancy; A longitudinal case study		Amae is defined as "wishing to be loved (Scheidlinger (1999). The Journal of the American Academy of Psychoanalysis, 27(1), p. 91)". Amae crying is known as crying of infants when seeking intimate emotional communication with caregivers. The objective of this study was to delineate when and how amae crying emerges in early infancy. Crying episodes of four infants were observed bimonthly, in the natural context of their homes, from birth to 6 months of age, for approximately 60 min per session. Crying episodes (total = 275) as determined by two coders were analyzed with respect to several behavioral measures. Results indicated that amae crying emerged at the age of 2 months, and consistently accounted for 30-40% of the total crying episodes after the ages of 3 months. Amae crying could be accurately identified when infants were not in acute discomfort and had already got the attention of their mothers. At such times, infants did not shed tears, cried with a fussy voice, and frequently looked at their mothers. Mothers responded to amae crying more promptly than they did to other types of crying behaviors. It is concluded that 3 months of age, when infants probably begin to use crying as a social communication tool is a major turning point for crying behavior from the perspective of its biological and social roles. It is suggested that amae crying might play an important role in strengthening and encouraging mother-infant interactions. (C) 2015 Elsevier Inc. All rights reserved.	Univ Sacred Heart, Dept Psychol, Shibuya Ku, Tokyo 1508938, Japan	Nakayama, H (reprint author), Univ Sacred Heart, Dept Psychol, Shibuya Ku, 4-3-1 Hiroo, Tokyo 1508938, Japan.	hnkym@hotmail.co.jp					Adamson LB., 1996, COMMUNICATION DEV IN; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443; Zeifman DM, 2001, DEV PSYCHOBIOL, V39, P265, DOI 10.1002/dev.1005; BELL SM, 1972, CHILD DEV, V43, P1171, DOI 10.1111/j.1467-8624.1972.tb02075.x; Behrens KY, 2004, HUM DEV, V47, P1, DOI 10.1159/000075366; Rothbaum F, 2004, HUM DEV, V47, P34, DOI 10.1159/000075368; Bowlby J., 1969, ATTACHMENT LOSS, V1; Chen X, 2009, INFANCY, V14, P44, DOI 10.1080/15250000802569694; Daw N. W., 2014, VISUAL DEV, P27; Del Vecchio T, 2009, INFANT BEHAV DEV, V32, P117, DOI 10.1016/j.infbeh.2008.10.005; Doi T., 2001, ANATOMY DEPENDENCE; Emde R. N., 1976, PSYCHOL ISSUES, V10; EMDE RN, 1992, INF MENTAL HLTH J, V13, P34, DOI 10.1002/1097-0355(199221)13:1<34::AID-IMHJ2280130107>3.0.CO;2-S; GUSTAFSON GE, 1991, INFANT BEHAV DEV, V14, P51, DOI 10.1016/0163-6383(91)90054-V; Lebra T., 1976, JAPANESE PATTERNS BE; Lester B. M., 1984, ADV INFANCY RES, V3, P167; Lewis M, 2008, HDB EMOTIONS, P304; Lewis M, 2014, RISE CONSCIOUSNESS D; Mesman J, 2012, ATTACH HUM DEV, V14, P337, DOI 10.1080/14616734.2012.691649; Murray A. D., 1985, INFANT CRYING THEORE, P217; Nakayama H, 2010, INFANT BEHAV DEV, V33, P463, DOI 10.1016/j.infbeh.2010.05.002; Nelson J. K., 2005, SEEING TEARS CRYING; Rochat P., 2001, THE INFANTS WORLD; Saarni C., 2011, ENCY EARLY CHILDHOOD, P1; Scheidlinger S, 1999, J Am Acad Psychoanal, V27, P91; St James-Roberts I., 2012, ORIGINS PREVENTION T; Tomasello M., 1995, JOINT ATTENTION ITS, P103; Vingerhoets A. J. J. M., 2013, WHY ONLY HUMANS WEEP; Wolff P. H., 1969, DETERMINATS INFANT B, P81; Wood RM, 2001, CHILD DEV, V72, P1287, DOI 10.1111/1467-8624.00348; Zeskind P. S., 1985, INFANT CRYING, P159; Zeskind P. S., 2013, EVOLUTION EMOTIONAL, P155; Zeskind P. S., 2001, BIOBEHAVIORAL ASSESS, P149	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-6383	1879-0453		INFANT BEHAV DEV	Infant Behav. Dev.	AUG	2015	40						122	130		10.1016/j.infbeh.2015.06.010		9	Psychology, Developmental	Psychology	CP4YU	WOS:000359889300013		
J	Kaneko, H; Funatsu, K				Kaneko, Hiromasa; Funatsu, Kimito			Classification of drug tablets using hyperspectral imaging and wavelength selection with a GAWLS method modified for classification	INTERNATIONAL JOURNAL OF PHARMACEUTICS			English	Article						Hyperspectral imaging; Classification; Tablets; k-Nearest neighbor; Wavelength selection; Variable selection	POLYMORPHIC TRANSFORMATION; APPLICABILITY DOMAIN; LEAST-SQUARES; CHEMOMETRICS; REGRESSION; SPECTROSCOPY; CALIBRATION; DIFFERENTIATION; FEASIBILITY; PREDICTION	Right drug tablets must be brought to the right places. We apply hyperspectral imaging, which can measure infrared spectra at many points on a two-dimensional plane, to classify tablets correctly. The k-nearest neighbor algorithm (kNN) is employed to classify tablets using a database including their spectra and true classes. Although classification accuracy is not 100%, we can correctly classify tablets overall, since spectra at many points are measured with spectroscopy and misclassification at some points does not have much influence on the final tablet classification result. In addition, we propose a wavelength selection method for classification. Genetic algorithm-based wavelength selection is applied to classification and combined with kNN, and thus, not wavelengths but wavelength-regions can be selected in classification problems. Through a case study, we confirmed that the proposed method could classify three kinds of tablets correctly and select appropriate wavelength-regions. (C) 2015 Elsevier B.V. All rights reserved.	[Kaneko, Hiromasa; Funatsu, Kimito] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp			Core Research for Evolutionary Science and Technology (CREST) project "Development of a knowledge-generating platform driven by big data in drug discovery through production processes" of the Japan Science and Technology Agency (JST); JFE Techno-Research Corporation	The authors acknowledge the support of the Core Research for Evolutionary Science and Technology (CREST) project "Development of a knowledge-generating platform driven by big data in drug discovery through production processes" of the Japan Science and Technology Agency (JST). The authors acknowledge the support of JFE Techno-Research Corporation. The authors are grateful for the precious support of Ms. Hitomi Onodera in data analysis.	Alvarez-Jubete L, 2013, J NEAR INFRARED SPEC, V21, P173, DOI 10.1255/jnirs.1052; Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; Muteki K, 2013, IND ENG CHEM RES, V52, P12258, DOI 10.1021/ie3034587; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Esquerre C, 2012, CHEMOMETR INTELL LAB, V117, P129, DOI 10.1016/j.chemolab.2012.02.006; Hansuld EM, 2014, INT J PHARMACEUT, V472, P192, DOI 10.1016/j.ijpharm.2014.06.027; Simone E, 2014, CHEM ENG RES DES, V92, P594, DOI 10.1016/j.cherd.2013.11.004; Kaneko H, 2013, CHEMOMETR INTELL LAB, V128, P111, DOI 10.1016/j.chemolab.2013.08.005; Arakawa M, 2011, J CHEMOMETR, V25, P10, DOI 10.1002/cem.1339; Carneiro RL, 2014, SPECTROCHIM ACTA A, V118, P215, DOI 10.1016/j.saa.2013.08.104; Roggo Y, 2007, J PHARMACEUT BIOMED, V44, P683, DOI 10.1016/j.jpba.2007.03.023; Luo JW, 2005, SIGNAL PROCESS, V85, P1429, DOI 10.1016/j.sigpro.2005.02.002; Kaneko H, 2012, AICHE J, V58, P1829, DOI 10.1002/aic.13814; Ye XJ, 2006, ECOL MODEL, V198, P426, DOI 10.1016/j.ecolmodel.2006.06.001; Leardi R, 2001, J CHEMOMETR, V15, P559, DOI 10.1002/cem.651; Ulrici A, 2013, CHEMOMETR INTELL LAB, V122, P31, DOI 10.1016/j.chemolab.2013.01.001; Rodionova OY, 2005, ANAL CHIM ACTA, V549, P151, DOI 10.1016/j.aca.2005.06.018; Kim S, 2011, INT J PHARMACEUT, V421, P269, DOI 10.1016/j.ijpharm.2011.10.007; Toher D, 2007, CHEMOMETR INTELL LAB, V89, P102, DOI 10.1016/j.chemolab.2007.06.005; Bishop C. M., 2006, PATTERN RECOGNITION; Burger J, 2006, ANALYST, V131, P1152, DOI 10.1039/b605386f; Canisius F, 2012, REMOTE SENS ENVIRON, V119, P301, DOI 10.1016/j.rse.2011.10.013; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; Edelman G, 2013, J FORENSIC SCI, V58, P881, DOI 10.1111/1556-4029.12153; Escobar MS, 2014, CHEMOMETR INTELL LAB, V137, P33, DOI 10.1016/j.chemolab.2014.06.005; Houck C., 1995, NCSU IE TR, V1; Kaneko H, 2014, J CHEM INF MODEL, V54, P2469, DOI 10.1021/ci500364e; Kaneko H, 2013, CHEMOMETR INTELL LAB, V121, P26, DOI 10.1016/j.chemolab.2012.11.017; Offroy M, 2012, CHEMOMETR INTELL LAB, V117, P183, DOI 10.1016/j.chemolab.2012.01.010; Ottavian M, 2012, CHEMOMETR INTELL LAB, V118, P13, DOI 10.1016/j.chemolab.2012.07.008; Rocha WFD, 2011, CHEMOMETR INTELL LAB, V106, P198, DOI 10.1016/j.chemolab.2010.04.015; Terra LA, 2014, CHEMOMETR INTELL LAB, V130, P91, DOI 10.1016/j.chemolab.2013.10.009; Vajna B, 2011, INT J PHARMACEUT, V419, P107, DOI 10.1016/j.ijpharm.2011.07.023; World Health Assembly, 2002, COUNT DRUGS THREAT P, V55; Yoshimura N., 2012, J COMPUT CHEM JPN, V11, P149	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5173	1873-3476		INT J PHARMACEUT	Int. J. Pharm.	AUG 1	2015	491	1-2					130	135		10.1016/j.ijpharm.2015.06.012		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CP1EM	WOS:000359619100018		
J	Dai, BM; Dang, CB; Li, MX; Tian, H; Ma, YT				Dai, Baomin; Dang, Chaobin; Li, Minxia; Tian, Hua; Ma, Yitai			Thermodynamic performance assessment of carbon dioxide blends with low-global warming potential (GWP) working fluids for a heat pump water heater	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						CO2; Low-GWP refrigerant; Zeotropic; Heat pump water heater; Pinch point; Thermal match	REFRIGERATION CYCLE; FLAMMABILITY LIMITS; CO2; SYSTEM; MIXTURES; ENERGY; PRESSURE; EXPANDER; EXERGY; GLIDE	Blends of CO2 with ten low-global warming potential (GWP) working fluids are evaluated for use in a heat pump water heater. The effects that the discharge pressure, component ratio, hot-water outlet temperature and chilled water inlet temperature have on the coefficient of performance (COP) of heat pump are analyzed when the pinch point of the heat exchange is considered. It is found that temperature glide of zeotropic mixture has a good thermal match with the temperature change of water as two pinch points appear in the gas cooler/condenser or evaporator. The good thermal match in the heat exchangers promotes the system COP. Addition of low-GWP working fluids to pure CO2 can reduce the high-side pressure. The results show that CO2/R41 and CO2/R32 are suitable candidates for heat pump water heaters because of their high COP and low high-side pressure in comparison with those of a pure CO2 cycle. (C) 2014 Elsevier Ltd and HR. All rights reserved.	[Dai, Baomin; Li, Minxia; Ma, Yitai] Tianjin Univ, MOE, Key Lab Efficient Utilizat Low & Medium Grade Ene, Tianjin 300072, Peoples R China; [Dang, Chaobin] Univ Tokyo, Dept Human & Engn Environm Studies, Chiba 2778563, Japan; [Tian, Hua] Tianjin Univ, State Key Lab Engines, Tianjin 300072, Peoples R China	Li, MX (reprint author), Tianjin Univ, MOE, Key Lab Efficient Utilizat Low & Medium Grade Ene, Tianjin 300072, Peoples R China.	dbm@tju.edu.cn; tjmxli@tju.edu.cn			National Natural Science Foundation of China [51176133]; Tianjin Municipal Science and Technology Commission Foundation [12JCYBJC13800]	This work was supported by the National Natural Science Foundation of China (No. 51176133) and the Tianjin Municipal Science and Technology Commission Foundation (No. 12JCYBJC13800).	Onaka Y, 2010, INT J REFRIG, V33, P1277, DOI 10.1016/j.ijrefrig.2010.06.014; Chen CC, 2009, J HAZARD MATER, V163, P795, DOI 10.1016/j.jhazmat.2008.07.051; [Anonymous], 2011, 161472011 EN; Zhang XP, 2013, APPL THERM ENG, V54, P176, DOI 10.1016/j.applthermaleng.2013.02.006; [Anonymous], 2006, 4702006 ANSIAHRI; LORENTZEN G, 1995, INT J REFRIG, V18, P190, DOI 10.1016/0140-7007(94)00001-E; Kondo S, 2006, J HAZARD MATER, V138, P1, DOI 10.1016/j.jhazmat.2006.05.035; Kauf F, 1999, INT J THERM SCI, V38, P325, DOI 10.1016/S1290-0729(99)80098-2; Kim SG, 2002, INT J REFRIG, V25, P1093, DOI 10.1016/S0140-7007(01)00110-4; Hakkaki-Fard A, 2014, APPL THERM ENG, V62, P714, DOI 10.1016/j.applthermaleng.2013.10.033; Liao SM, 2000, APPL THERM ENG, V20, P831, DOI 10.1016/S1359-4311(99)00070-8; Tao YB, 2010, APPL ENERG, V87, P3065, DOI 10.1016/j.apenergy.2010.03.003; Kim JH, 2008, INT J REFRIG, V31, P800, DOI 10.1016/j.ijrefrig.2007.11.009; [Anonymous], 2008, 213622008 GBT STAND; Kim MH, 2004, PROG ENERG COMBUST, V30, P119, DOI 10.1016/j.pecs.2003.09.002; Sarkar J, 2009, INT J THERM SCI, V48, P1460, DOI 10.1016/j.ijthermalsci.2008.12.002; McLinden MO, 2014, INT J REFRIG, V38, P80, DOI 10.1016/j.ijrefrig.2013.09.032; Yang JL, 2005, ENERGY, V30, P1162, DOI 10.1016/j.energy.2004.08.007; Lior N, 2007, ENERGY, V32, P281, DOI 10.1016/j.energy.2006.01.019; Yuan QX, 2011, ENERG BUILDINGS, V43, P3627, DOI 10.1016/j.enbuild.2011.09.035; [Anonymous], 2008, 231372008 GBT STAND; [Anonymous], 2009, 40602009 JRA; Dai BM, 2014, ENERGY, V64, P942, DOI 10.1016/j.energy.2013.11.019; Niu BL, 2007, INT J REFRIG, V30, P37, DOI 10.1016/j.ijrefrig.2006.06.002; [Anonymous], 2011, C92202011 JIS; ANSI/ASHRAE, 2010, 342010 ANSIASHRAE; Calm J., 2011, P 23 INT C REFR PRAG, P22; Di Nicola G, 2011, INT J REFRIG, V34, P1436, DOI 10.1016/j.ijrefrig.2011.05.004; Lemmon E. W., 2010, NIST STANDARD REFERE; LORENTZEN G, 1994, INT J REFRIG, V17, P292, DOI 10.1016/0140-7007(94)90059-0; LORENTZEN G, 1993, INT J REFRIG, V16, P4, DOI 10.1016/0140-7007(93)90014-Y; Ma Y., 2012, ANAL ENERGY EFFICIEN; Miyara A., 2012, INT J AIR COND REFRI, V20; di Nicola G, 2005, INT J REFRIG, V28, P130, DOI 10.1016/j.ijrefrig.2004.06.014; Sun FT, 2011, APPL THERM ENG, V31, P1184, DOI 10.1016/j.applthermaleng.2010.12.018; UNEP (United Nations Environment Programme), 1987, MONTR PROT SUBST DEP; UNFCCC, 1997, KYOT PROT UN FRAM CO; United Nations Environment Programme (UNEP), 2010, ASS REP TECHN EC ASS; Yang JL, 2007, ENERGY, V32, P237, DOI 10.1016/j.energy.2006.03.031	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	AUG	2015	56						1	14		10.1016/j.ijrefrig.2014.11.009		14	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CP4UH	WOS:000359877600002		
J	Enteria, N; Yoshino, H; Mochida, A; Satake, A; Takaki, R				Enteria, Napoleon; Yoshino, Hiroshi; Mochida, Akashi; Satake, Akira; Takaki, Rie			Exergoeconomic performances of the desiccant-evaporative air-conditioning system at different regeneration and reference temperatures	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						Thermodynamics; Exergoeconomic; Desiccant dehumidification; Evaporative cooling	THERMOECONOMIC ANALYSIS; ENERGY-SYSTEMS; CGAM PROBLEM; OPTIMIZATION; POWER; EXERGY; PLANT	This paper presented the exergoeconomic evaluation of the developed desiccant-evaporative air-conditioning system. The developed system was evaluated based on the steady-state conditions at different regeneration and reference temperatures. The exergoeconomic evaluation method was implemented to the system components and the whole system to evaluate the exergy efficiency, exergy destruction ratios, cost rates, relative cost differences and exergoeconomic factors. The regeneration and reference temperatures affected the exergy efficiencies, exergy destruction ratios, cost rates, relative cost differences and exergoeconomic factors. The desiccant wheel, heating coil and evaporative cooler had a high cost rate (investment cost, operation and maintenance cost, and exergy destruction cost). The exit air fan, outdoor air fan and evaporative cooler had a high relative cost difference. The exit air fan, outdoor air fan and secondary heat exchanger had a high exergoeconomic factor. Replacement of the desiccant wheel with a higher dehumidification performance could decrease the high cost rate. A higher efficiency evaporative cooler and heating coil were needed. Cheaper air fans (outdoor air fans and exit air fans) were needed. (C) 2014 Elsevier Ltd and IIR. All rights reserved.	[Enteria, Napoleon] Enteria Grun Energietech, Davao 8000, Philippines; [Enteria, Napoleon; Yoshino, Hiroshi; Mochida, Akashi] Tohoku Univ, Sendai, Miyagi 9808579, Japan; [Enteria, Napoleon] Bldg Res Inst, Tsukuba, Ibaraki 3050802, Japan; [Yoshino, Hiroshi] Architectural Inst Japan, Tokyo 1088414, Japan; [Satake, Akira] Maeda Corp, Tokyo 1798914, Japan; [Takaki, Rie] Akita Prefectural Univ, Akita 0100195, Japan	Enteria, N (reprint author), Enteria Grun Energietech, Davao 8000, Philippines.	enterian2@asme.org					Enteria N, 2011, RENEW SUST ENERG REV, V15, P2095, DOI 10.1016/j.rser.2011.01.013; Ahmadi P, 2011, ENERG CONVERS MANAGE, V52, P2296, DOI 10.1016/j.enconman.2010.12.023; Hurdogan E, 2013, ENERG CONVERS MANAGE, V69, P9, DOI 10.1016/j.enconman.2013.01.009; Valero A, 2006, J ENERG RESOUR-ASME, V128, P1, DOI 10.1115/1.2134732; Camargo JR, 2003, APPL THERM ENG, V23, P1537, DOI 10.1016/S1359-4311(03)00105-4; Kwak HY, 2003, ENERGY, V28, P343, DOI 10.1016/S0360-5442(02)00138-X; TSATSARONIS G, 1993, PROG ENERG COMBUST, V19, P227, DOI 10.1016/0360-1285(93)90016-8; VALERO A, 1994, ENERGY, V19, P279, DOI 10.1016/0360-5442(94)90112-0; Ghaebi H, 2011, INT J ENERG RES, V35, P697, DOI 10.1002/er.1721; Baghernejad A, 2011, ENERG CONVERS MANAGE, V52, P2193, DOI 10.1016/j.enconman.2010.12.019; Abusoglu A, 2009, APPL THERM ENG, V29, P234, DOI 10.1016/j.applthermaleng.2008.02.025; TSATSARONIS G, 1994, ENERGY, V19, P287, DOI 10.1016/0360-5442(94)90113-9; Sahoo PK, 2008, APPL THERM ENG, V28, P1580, DOI 10.1016/j.applthermaleng.2007.10.011; Abusoglu A, 2009, RENEW SUST ENERG REV, V13, P2295, DOI 10.1016/j.rser.2009.05.004; Bejan A., 1996, THERMAL DESIGN OPTIM; Campos-Celador A, 2012, ENERGY, V45, P228, DOI 10.1016/j.energy.2012.01.020; Enteria N, 2013, INT J REFRIG, V36, P2323, DOI 10.1016/j.ijrefrig.2013.08.005; Enteria N., 2013, SOLAR ENERGY SCI ENG; Fang L, 2008, INDOOR AIR, V18, P375, DOI 10.1111/j.1600-0668.2008.00538.x; Goswami D., 1997, T ASME J SOL ENERGY, V119, P92; Hosseini SR, 2011, DESALINATION, V278, P424, DOI 10.1016/j.desal.2011.05.061; Kong XF, 2012, ENERG BUILDINGS, V48, P155, DOI 10.1016/j.enbuild.2012.01.021; Tsatsaronis G, 1996, CHEM ENG TECHNOL, V19, P163, DOI 10.1002/ceat.270190210; Tsatsaronis G, 1997, ENERG CONVERS MANAGE, V38, P1535, DOI 10.1016/S0196-8904(96)00215-4	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	AUG	2015	56						81	98		10.1016/j.ijrefrig.2014.11.007		18	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CP4UH	WOS:000359877600009		
J	Kono, S; Kawamura, I; Yamagami, S; Araki, T; Sagara, Y				Kono, Shinji; Kawamura, Izumi; Yamagami, Shinichi; Araki, Tetsuya; Sagara, Yasuyuki			Optimum storage temperature of frozen cooked rice predicted by ice crystal measurement, sensory evaluation and artificial neural network	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						Optimum storage condition; Frozen cooked rice; Ice crystal; Sensory evaluation; Artificial neural network	STARCH RETROGRADATION; COOLING METHODS; BEEF; RECRYSTALLIZATION; SIZE; FOOD	Optimum temperature conditions of frozen cooked rice during storage have been predicted by artificial neural network (ANN) using the dataset of ice crystal measurement and sensory evaluation. Cooked rice samples were frozen and preserved at -5, -15, -30, and -45 degrees C for 1, 5, 10, 30 and 90 days. Then the cross-sectional images of the samples were captured using a fluorescence staining method to measure the equivalent diameters of ice crystals in the samples. Textural and sensory attributes of the samples thawed by microwave heating and air at room temperature were evaluated by 690 consumer panelists. The equivalent diameters of ice crystals were highly correlated with the sensory scores of textural attributes and comprehensive palatability. The ANN model analysis revealed that the room temperature thawing required the storage temperature range below -25 degrees C and microwave heating below -15 degrees C to maintain the palatability of the samples for 40 days or more. (C) 2014 Elsevier Ltd and IIR. All rights reserved.	[Kono, Shinji; Kawamura, Izumi; Yamagami, Shinichi] Mayekawa Mfg Co Ltd, Moriya City, Ibaraki 3020118, Japan; [Araki, Tetsuya] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Sagara, Yasuyuki] Food Kansei Commun Corp, Tokyo 1130022, Japan	Kono, S (reprint author), Mayekawa Mfg Co Ltd, 2000 Tatsuzawa, Moriya City, Ibaraki 3020118, Japan.	shinji-kouno@mayekawa.co.jp					MIYAWAKI O, 1992, BIOSCI BIOTECH BIOCH, V56, P953; Perdon AA, 1999, J FOOD SCI, V64, P828, DOI 10.1111/j.1365-2621.1999.tb15921.x; Russell AB, 1999, J FOOD ENG, V39, P179, DOI 10.1016/S0260-8774(98)00161-7; Zhang ZH, 2006, J FOOD ENG, V77, P269, DOI 10.1016/j.jfoodeng.2005.06.029; Hagiwara T, 2002, J AGR FOOD CHEM, V50, P3085, DOI 10.1021/jf011240g; Do GS, 2004, INT J REFRIG, V27, P184, DOI 10.1016/S0140-7007(03)00042-2; Ma Y, 2009, J FOOD PROCESS ENG, V32, P161, DOI 10.1111/j.1745-4530.2007.00206.x; BEVILACQUA AE, 1982, J FOOD SCI, V47, P1410, DOI 10.1111/j.1365-2621.1982.tb04950.x; Bevilaqua A.E., 1979, INT J FOOD SCI TECH, V14, P237; BOMBEN JL, 1982, J FOOD TECHNOL, V17, P615; Fuchigami M, 1997, J FOOD SCI, V62, P828, DOI 10.1111/j.1365-2621.1997.tb15465.x; Hartel R.W., 1998, PROPERTIES WATER FOO, P287; Hashimoto R., 2003, 21 IIR INT C REFR AU; Heldman D.R., 1997, QUALITY FROZEN FOOD, P51; Hsu CL, 2005, J FOOD PROCESS ENG, V28, P506, DOI 10.1111/j.1745-4530.2005.00036.x; Kono Shinji, 2012, Transactions of the Japan Society of Refrigerating and Air Conditioning Engineers, V29; MARTINO MN, 1988, J FOOD SCI, V53, P1631, DOI 10.1111/j.1365-2621.1988.tb07802.x; Ministry of Agriculture Forestry and Fisheries Japan (MAFF), 2013, FY2012 ANN REP FOOD; Raid D.S., 1998, QUALITY FROZEN FOODS, P10; REEVE R M, 1970, Journal of Texture Studies, V1, P247, DOI 10.1111/j.1745-4603.1970.tb00730.x; Sutton RL, 1996, J FOOD SCI, V61, P746, DOI 10.1111/j.1365-2621.1996.tb12195.x; Takahashi S., 2000, Journal of Applied Glycoscience, V47, P343; Takai R., 1997, CRYOBIOL CRYOTECHNOL, V43, P118; The Food Agency in Japan, 1968, SENS TEST METH RIC, P1; The United States Department of Agriculture (USDA), 2014, WORLD AGR PROD; Woinet B, 1998, J FOOD ENG, V35, P395, DOI 10.1016/S0260-8774(98)00036-3; Yu S.F., 2010, J FOOD ENG, V96, P412	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	AUG	2015	56						165	172		10.1016/j.ijrefrig.2014.11.011		8	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CP4UH	WOS:000359877600016		
J	Sakamoto, T; Itoh, T; Shimoda, Y; Fusazaki, T; Morino, Y				Sakamoto, Tsubasa; Itoh, Tomonori; Shimoda, Yudai; Fusazaki, Tetsuya; Morino, Yoshihiro			OCT Visualization of the Structure of Intimal Tissue After Drug-Eluting Balloon Deployment	JACC-CARDIOVASCULAR IMAGING			English	Letter							IN-STENT RESTENOSIS		[Itoh, Tomonori] Iwate Med Univ, Mem Heart Ctr, Dept Internal Med, Div Cardiol, Morioka, Iwate 0208505, Japan		tomoitoh@iwate-med.ac.jp					Lee SY, 2014, AM J CARDIOL, V113, P1468, DOI 10.1016/j.amjcard.2014.01.424; Xu B, 2014, JACC-CARDIOVASC INTE, V7, P204, DOI 10.1016/j.jcin.2013.08.011	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	AUG	2015	8	8					983	984		10.1016/j.jcmg.2014.09.013		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CP5BD	WOS:000359895400017		
J	Izumi, Y; Ikeda, S; Kitagawa, A; Katsuda, E; Hagihara, M; Kamei, S; Ota, T; Ishiguchi, T				Izumi, Yuichiro; Ikeda, Shuji; Kitagawa, Akira; Katsuda, Eisuke; Hagihara, Makiyo; Kamei, Seiji; Ota, Toyohiro; Ishiguchi, Tsuneo			Uterine artery embolization by use of porous gelatin particles for symptomatic uterine leiomyomas: comparison with hand-cut gelatin sponge particles	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Uterine fibroid; Uterine myoma; Arterial embolization; Resorbable embolization material	JAPAN INTERVENTIONAL RADIOLOGY; ONCOLOGY STUDY-GROUP; FIBROID EMBOLIZATION; EMMY TRIAL; MICROSPHERES; HYSTERECTOMY; GUIDELINES	Purpose To evaluate the results of uterine artery embolization (UAE) for symptomatic uterine leiomyoma by use of porous gelatin particles (PGP) in comparison with conventional hand-cut gelatin sponge particles. Materials and methods One hundred and fifteen consecutive patients who had undergone UAE were retrospectively assessed. The first 64 patients were treated with hand-cut gelatin sponge and the last 51 with PGP. Extent of infarction, volume reduction of the dominant leiomyoma on magnetic resonance (MR) imaging, and change in symptoms were assessed. Results UAE was successfully performed for all patients. No major complications were observed. MR images one month after UAE showed that the mean extent of infarction of the dominant leiomyoma was 97 % for patients treated with PGP and 96 % for those treated with hand-cut gelatin sponge. Volume reductions of the dominant leiomyoma after 3, 6, 12, and 24 months were, respectively, 45, 56, 62, and 66 % for use of PGP and 45, 57, 63, and 68 % for use of hand-cut gelatin sponge. Symptoms including heavy menstrual bleeding, heavy menstrual pain, and abdominal heaviness had improved by 95-100 % at 12 months. There was no difference between the two groups. Conclusion UAE with PGP is safe, and as effective as conventional gelatin sponge particles.	[Izumi, Yuichiro; Ikeda, Shuji; Kitagawa, Akira; Katsuda, Eisuke; Hagihara, Makiyo; Kamei, Seiji; Ota, Toyohiro; Ishiguchi, Tsuneo] Aichi Med Univ, Dept Radiol, Nagakute, Aichi 4801195, Japan	Ishiguchi, T (reprint author), Aichi Med Univ, Dept Radiol, 1-1 Yazako Karimata, Nagakute, Aichi 4801195, Japan.	ishiguti@aichi-med-u.ac.jp					American College of Obstetricians and Gynecologists, 2008, OBSTET GYNECOL, V112, P387, DOI DOI 10.1097/AOG.0B013E318183FBAB; Katsumori T, 2006, CARDIOVASC INTER RAD, V29, P1077, DOI 10.1007/s00270-006-0059-y; Boulleret C, 2004, CARDIOVASC INTER RAD, V27, P344, DOI 10.1007/s00270-303-2698-6; RAVINA JH, 1995, LANCET, V346, P671, DOI 10.1016/S0140-6736(95)92282-2; Bulman JC, 2012, RADIOGRAPHICS, V32, P1735, DOI 10.1148/rg.326125514; Katsumori T, 2002, AM J ROENTGENOL, V178, P135; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Katsumori T, 2011, CARDIOVASC INTER RAD, V34, P513, DOI 10.1007/s00270-010-9919-6; Kroencke TJ, 2010, RADIOLOGY, V255, P834, DOI 10.1148/radiol.10090977; Katsumori T, 2008, CARDIOVASC INTER RAD, V31, P66, DOI 10.1007/s00270-007-9187-2; Costantino M, 2010, J VASC INTERV RADIOL, V21, P829, DOI 10.1016/j.jvir.2010.01.042; Hehenkamp WJK, 2008, RADIOLOGY, V246, P823, DOI 10.1148/radiol.2463070260; Stampfl U, 2011, CARDIOVASC INTER RAD, V34, P295, DOI 10.1007/s00270-010-9986-8; Toor SS, 2012, AM J ROENTGENOL, V199, P1153, DOI 10.2214/AJR.11.8362; Lohle PNM, 2006, J VASC INTERV RADIOL, V17, P283, DOI 10.1097/01.RVI.0000195148.89573.9F; Committee on Guidelines Japanese Society of Interventional Radiology, 2012, GUID INT RAD CRIT OB; Gupta JK, 2014, UTERINE ARTERY EMBOL; Hovsepian DM, 2009, J VASC INTERV RADIOL, V20, pS193, DOI 10.1016/j.jvir.2009.04.006; McCaffery M, 1989, PAIN CLIN MANUAL NUR; Miyayama S, 2014, JPN J RADIOL, V32, P242, DOI 10.1007/s11604-014-0292-2; Osuga K, 2009, JPN J CANC CHEMOTHER, V36, P437; Osuga K, 2012, J VASC INTERV RADIOL, V23, P1278, DOI 10.1016/j.jvir.2012.06.028; Royal College of Obstetricians and Gynaecologists Royal College of Radiologists British Society of Interventional Radiology, 2007, ROL EM EL INT RAD PO; Scheurig-Muenkler C, 2011, HUM REPROD, V26, P2036, DOI 10.1093/humrep/der170; Shlansky-Goldberg RD, 2014, J VASC INTERV RADIOL, V25, P823, DOI 10.1016/j.jvir.2014.03.009; Sone M, 2010, J VASC INTERV RADIOL, V21, P1665, DOI 10.1016/j.jvir.2010.07.017; Volkers NA, 2007, AM J OBSTET GYNECOL, V196, P519, DOI 10.1016/j.ajog.2007.02.029	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					461	470		10.1007/s11604-015-0445-y		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900003		
J	Hiraki, T; Koizumi, J; Arai, Y; Sakurai, Y; Kumada, H; Nambu, Y; Hori, S				Hiraki, Takao; Koizumi, Jun; Arai, Yasuaki; Sakurai, Yasuo; Kumada, Hiromitsu; Nambu, Yoshihiro; Hori, Shinichi			Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Transcatheter arterial embolization; Hypervascular tumor; Microsphere; HepaSphere	TRISACRYL GELATIN MICROSPHERES; IN-VITRO EVALUATION; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; THERAPEUTIC EMBOLIZATION; ELUTING MICROSPHERES; DRUG; METASTASES; PARTICLES	Purpose To evaluate the feasibility and safety of transcatheter arterial embolization (TAE) with the use of HepaSphere microspheres for hypervascular tumors. Materials and methods This was a prospective multicenter open label clinical trial involving six institutions in Japan. TAE was performed with the HepaSphere microspheres for hypervascular tumors in various locations. The endpoint of the study was the feasibility and safety of the procedure. The feasibility and safety were evaluated according to technical success and adverse events, respectively. Adverse events that were related to TAE were evaluated by using the Common Terminology Criteria for Adverse Events, version 4.0. Results Twenty-four patients were enrolled. The technical success rate was 100 % (24/24). Twenty-two (92 %) patients developed a total of 50 symptomatic adverse events, including 30 grade 1 events, 17 grade 2 events, and 3 grade 3 events. The most frequent adverse event was fever with an incidence of 63 %, followed by abdominal pain (25 %). ConclusionTAE for hypervascular tumors with the HepaSphere microspheres was feasible and rarely caused major adverse events. Trial registration: This trial was registered in JAPIC Clinical Trials Information (JapicCTI-111534).	[Hiraki, Takao] Okayama Univ, Dept Radiol, Sch Med, Okayama 7008558, Japan; [Koizumi, Jun] Tokai Univ, Sch Med, Dept Radiol, Isehara, Kanagawa 25911, Japan; [Arai, Yasuaki] Natl Canc Ctr, Dept Diagnost Radiol, Tokyo, Japan; [Sakurai, Yasuo] Teine Keijinkai Hosp, Dept Diagnost Radiol, Sapporo, Hokkaido, Japan; [Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Nambu, Yoshihiro] Nippon Kayaku Co Ltd, Pharmaceut Dev Div, Tokyo 115, Japan; [Hori, Shinichi] Gate Tower Inst Image Guided Therapy, Dept Radiol, Izumisano, Japan	Hiraki, T (reprint author), Okayama Univ, Dept Radiol, Sch Med, 2-5-1 Shikatacho, Okayama 7008558, Japan.	takaoh@tc4.so-net.ne.jp			Nippon Kayaku Co., Ltd.	This study was funded by Nippon Kayaku Co., Ltd. All study sites and institutions received funding from Nippon Kayaku for clinical trial execution. We thank Hiraku Yodono, Tadashi Kimura, and Takafumi Ichida for evaluation of the technical success as members of an independent assessment committee.	Katsumori T, 2006, CARDIOVASC INTER RAD, V29, P1077, DOI 10.1007/s00270-006-0059-y; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lee KH, 2010, CARDIOVASC INTER RAD, V33, P576, DOI 10.1007/s00270-010-9794-1; UCHIDA H, 1990, CARDIOVASC INTER RAD, V13, P140, DOI 10.1007/BF02575465; Chen AP, 2012, J AM ACAD DERMATOL, V67, P1025, DOI 10.1016/j.jaad.2012.02.010; Laurent A, 1996, AM J NEURORADIOL, V17, P533; Grosso M, 2008, CARDIOVASC INTER RAD, V31, P1141, DOI 10.1007/s00270-008-9409-2; de Luis E, 2008, CARDIOVASC INTER RAD, V31, P367, DOI 10.1007/s00270-007-9240-1; YAMADA R, 1983, RADIOLOGY, V148, P397; Osuga K, 2008, CARDIOVASC INTER RAD, V31, P1108, DOI 10.1007/s00270-008-9369-6; Beaujeux R, 1996, AM J NEURORADIOL, V17, P541; Huppert P, 2014, CARDIOVASC INTER RAD, V37, P154, DOI 10.1007/s00270-013-0632-0; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; NAKAMURA H, 1989, RADIOLOGY, V170, P783; Hodaka ATY, 1992, JPN J GASTROENTEROL, V25, P3002; Hori S, 1996, JPN J INTERVENT RADI, V11, P375; Jarząbek Magdalena, 2011, Pol J Radiol, V76, P26; Jiaqi Y, 1996, Nihon Igaku Hoshasen Gakkai Zasshi, V56, P19; Khankan Azzam A, 2004, Radiat Med, V22, P384; Laurent A, 2007, Tech Vasc Interv Radiol, V10, P248, DOI 10.1053/j.tvir.2008.03.010; Lewis AL, 2006, J MATER SCI-MATER M, V17, P1193, DOI 10.1007/s10856-006-0592-x; Osuga Keigo, 2009, Gan To Kagaku Ryoho, V36, P437; Seki A, 2013, CARDIOVASC INTER RAD, V36, P1527, DOI 10.1007/s00270-013-0576-4; Seki A, 2011, CARDIOVASC INTER RAD, V34, P557, DOI 10.1007/s00270-010-9975-y; Yamada Ryusaku, 2005, Gan To Kagaku Ryoho, V32, P1431	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					479	486		10.1007/s11604-015-0448-8		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900005		
J	Ito, K; Utano, K; Kanazawa, H; Sasaki, T; Kijima, S; Lefor, AT; Sugimoto, H				Ito, Koichi; Utano, Kenichi; Kanazawa, Hidenori; Sasaki, Takahiro; Kijima, Shigeyoshi; Lefor, Alan T.; Sugimoto, Hideharu			CT prediction of the degree of ovarian torsion	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Ovarian torsion; Necrosis; Torsion angle; Mass-like swelling; Ovary-sparing treatment	ADNEXAL TORSION; IMAGING FEATURES; MANAGEMENT; TUMOR	Purpose Torsion angle determines the incidence of necrosis among patients with ovarian torsion. The purpose of this study was to evaluate the association between torsion angle and findings on CT scan. Materials and methods We retrospectively reviewed CT scan findings obtained less than 36 h before surgery for 31 patients with ovarian torsion. Ovarian torsion angles measured intraoperatively ranged from 90A degrees to 1260A degrees. Ovaries with torsion angles less than 360A degrees rarely develop necrosis. Patients were divided into two groups according to torsion angle: < 360A degrees (Group A) and a parts per thousand yen360A degrees (Group B). A lesion corresponding to an enlarged fallopian tube and mesovarium containing dilated veins between the uterus and twisted ovary is referred to as a "mass-like swelling". Results A mass-like swelling occurred more often in Group B (p < 0.05) and had the highest correlation with torsion angles a parts per thousand yen360A degrees. A mass-like swelling lacking enhancement or a high-density area was significantly different between the groups (p < 0.05) and was also indicative of torsion angles a parts per thousand yen360A degrees. Conclusion A mass-like swelling alone or with a high-density area or lack of enhancement suggests an ovarian torsion angle a parts per thousand yen360A degrees. The presence of these findings predict ovarian necrosis and may allow ovary-sparing treatment.	[Ito, Koichi; Kanazawa, Hidenori; Sasaki, Takahiro; Kijima, Shigeyoshi; Sugimoto, Hideharu] Jichi Med Univ, Dept Radiol, Shimotsuke, Tochigi 3290498, Japan; [Utano, Kenichi] Fukushima Med Univ, Dept Coloproctol, Aizu Med Ctr, Aizuwakmatsu, Fukushima 9693492, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Ito, K (reprint author), Jichi Med Univ, Dept Radiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ko_itou0820@yahoo.co.jp		Lefor, Alan/0000-0001-6673-5630			Taskin O, 1998, HUM REPROD, V13, P2823; Lubner M, 2007, RADIOGRAPHICS, V27, P109, DOI 10.1148/rg.271065042; Lee JH, 2009, J COMPUT ASSIST TOMO, V33, P872, DOI 10.1097/RCT.0b013e31819e41f3; HIBBARD LT, 1985, AM J OBSTET GYNECOL, V152, P456; NICHOLS DH, 1985, CLIN OBSTET GYNECOL, V28, P375; Parizel PM, 2001, EUR RADIOL, V11, P1770; Swenson DW, 2014, EUR J RADIOL, V83, P733, DOI 10.1016/j.ejrad.2014.01.001; ZWEIZIG S, 1993, AM J OBSTET GYNECOL, V168, P1791; Tobiume T, 2011, TOHOKU J EXP MED, V225, P211, DOI 10.1620/tjem.225.211; KIMURA I, 1994, RADIOLOGY, V190, P337; Duigenan S, 2012, AM J ROENTGENOL, V198, P122; Rha SE, 2002, RADIOGRAPHICS, V22, P283; SCHULTZ LOYD R., 1963, NEW ENGLAND JOUR MED, V268, P343, DOI 10.1056/NEJM196302142680703; Shalev J, 2001, J ULTRAS MED, V20, P849	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					487	493		10.1007/s11604-015-0452-z		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900006		
J	Haradome, H; Toda, Y; Koshinaga, T; Sugitani, M; Abe, O				Haradome, Hiroki; Toda, Yusuke; Koshinaga, Tsugumichi; Sugitani, Masahiko; Abe, Osamu			A case of kaposiform hemangioendothelioma at the sigmoid colon	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Kaposiform hemangioendothelioma; Lymphangioma; Bowel; Child	KASABACH-MERRITT PHENOMENON; HEMANGIOMA	We report a case of kaposiform hemangioendothelioma (KHE) occurring at the sigmoid colon in an 8-year-old male. He had experienced lower abdominal pain and fever for several days. Contrast-enhanced CT images revealed a well-enhanced mass involving several large and small cystic parts with thin, enhanced walls at the sigmoid colon. The diagnosis was made histopathologically after surgical resection; the cystic parts corresponded to dilated lymphatic vessels. KHE is a rare, locally aggressive, vascular tumor that usually occurs in the soft tissues of the extremities. However, a case occurring in the bowel is extremely rare, and usually appears as bowel wall thickening. This is a unique case of KHE appearing as a mass-shaped hypervascular lesion in the bowel. Dilated lymphatic vessels in KHE may appear as a cystic part of the lesion.	[Haradome, Hiroki; Toda, Yusuke; Abe, Osamu] Nihon Univ Med, Dept Radiol, Itabashi Ku, Tokyo 1738610, Japan; [Koshinaga, Tsugumichi] Nihon Univ Med, Dept Pediat Surg, Tokyo 1738610, Japan; [Sugitani, Masahiko] Nihon Univ Med, Dept Pathol, Tokyo 1738610, Japan	Haradome, H (reprint author), Nihon Univ Med, Dept Radiol, Itabashi Ku, 30-1 Ohyaguchi Kami Cho, Tokyo 1738610, Japan.	karate.b@gmail.com					Sarkar M, 1997, PLAST RECONSTR SURG, V100, P1377, DOI 10.1097/00006534-199711000-00001; Gruman A, 2005, J AM ACAD DERMATOL, V52, P616, DOI 10.1016/j.jaad.2004.10.880; ZUKERBERG LR, 1993, AM J SURG PATHOL, V17, P321, DOI 10.1097/00000478-199304000-00001; Uysal S, 2005, EUR RADIOL, V15, P633, DOI 10.1007/s00330-004-2535-6; Burgos L, 2009, Cir Pediatr, V22, P125; Ibarra RA, 2001, AM J NEURORADIOL, V22, P755; LAI FM, 1991, AM J CLIN PATHOL, V96, P660; Pratap A, 2008, UROL INT, V80, P325, DOI 10.1159/000127351	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					494	498		10.1007/s11604-015-0444-z		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900007		
J	Araki, T; Okada, H; Onishi, H				Araki, Takuji; Okada, Hiroki; Onishi, Hiroshi			Can microcatheters be cleaned for reuse after NBCA embolization? Cleaning technique with gelatin sponge particles	JAPANESE JOURNAL OF RADIOLOGY			English	Article						NBCA embolization; Cleaning technique; Reusability of microcatheter; Gelatin sponge particles	N-BUTYL-CYANOACRYLATE; TRANSCATHETER ARTERIAL EMBOLIZATION; 2-CYANOACRYLATE	Purpose To study a new technique for cleaning microcatheters for reuse after NBCA embolization ("NBCA"), and to evaluate the clinical reusability of microcatheters that were cleaned with gelatin sponge particles after NBCA. Materials and methods Four cleaning solution flushes for microcatheters after NBCA injection-5 % glucose ("glucose") only, Lipiodol-glucose, gelatin sponge particles ("gelatin")-glucose, and Lipiodol-gelatin-glucose-were examined experimentally. These solutions were evaluated by performing three examinations: a microcatheter resistance test based on the time taken to pass water through the microcatheter, a microcatheter resistance test based on the ease of insertion of a microguidewire, and observations of the inner surfaces of the cylinders after NBCA. Microcatheters that had already been used in NBCA were cleaned using this new technique and then applied in 20 clinical sessions (19 patients). Results There was no significant difference in water passage time between the controls and the groups that received a gelatin flush. In the resistance test based on the insertion of a microguidewire, groups that received a gelatin flush showed significantly less resistance than the groups that did not receive a gelatin flush. Observations of the inner surfaces of the cylinders indicated that cleaning with gelatin can lead to inner surfaces that are almost indistinguishable from control surfaces in terms of cleanliness. All clinical procedures involving Lipiodol-gelatin-glucose flushes were performed without any technical difficulties or complications. Conclusions Applying the new cleaning technique utilizing gelatin sponge particles to microcatheters after NBCA ensures that they are clean enough to be reused.	[Araki, Takuji; Okada, Hiroki; Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Yamanashi 4093898, Japan	Araki, T (reprint author), Univ Yamanashi, Dept Radiol, 1110 Shimokato Chuo, Yamanashi 4093898, Japan.	taraki@yamanashi.ac.jp; hokada@yamanashi.ac.jp; honishi@yamanashi.ac.jp					Mavili E, 2007, CARDIOVASC INTER RAD, V30, P1124, DOI 10.1007/s00270-007-9142-2; Kish JW, 2004, J VASC INTERV RADIOL, V15, P689, DOI 10.1097/01.RVI.0000133505.84588.8C; Guillevin R, 2005, AM J NEURORADIOL, V26, P929; Jae HJ, 2007, KOREAN J RADIOL, V8, P48; BROTHERS MF, 1989, AM J NEURORADIOL, V10, P777; Araki T, 2010, JPN J INTERVNT RADIO, V25, P194; Enokizono M, 2012, JPN J RADIOL, V30, P377, DOI 10.1007/s11604-012-0063-x; Lee CW, 2007, J VASC INTERV RADIOL, V18, P209, DOI 10.1016/j.jvir.2006.12.003; Purdy P, 2002, AM J NEURORADIOL, V23, P748; Numan F, 1996, CARDIOVASC INTER RAD, V19, P278, DOI 10.1007/s002709900056; Pollak JS, 2001, J VASC INTERV RADIOL, V12, P907, DOI 10.1016/S1051-0443(07)61568-1; Razavi Mahmood K, 2007, Tech Vasc Interv Radiol, V10, P276, DOI 10.1053/j.tvir.2008.03.006; Stavropoulos SW, 2009, J VASC INTERV RADIOL, V20, P1299, DOI 10.1016/j.jvir.2009.07.003; STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409; Takeuchi Y, 1995, JPN J INTERV RADIOL, V10, P69; Yamagami T, 2002, EUR RADIOL, V12, P443, DOI 10.1007/s003300100943	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					509	516		10.1007/s11604-015-0446-x		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900010		
J	Tanaka, F; Kawai, N; Sato, M; Minamiguchi, H; Nakai, M; Nakata, K; Sanda, H; Sonomura, T				Tanaka, Fumihiro; Kawai, Nobuyuki; Sato, Morio; Minamiguchi, Hiroki; Nakai, Motoki; Nakata, Kouhei; Sanda, Hiroki; Sonomura, Tetsuo			Balloon-assisted packing of wide-neck aneurysms with a mixture of n-butyl cyanoacrylate, Lipiodol, and ethanol: an experimental study	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Ethanol; n-Butyl cyanoacrylate; Lipiodol; Balloon-assisted packing; Aneurysm	DETACHABLE COILS; EMBOLIZATION	To evaluate the feasibility of balloon-assisted packing with a mixture of n-butyl cyanoacrylate (NBCA), Lipiodol, and ethanol for wide-neck aneurysms. Of 10 carotid aneurysms with wide necks created in a swine model, 3 aneurysms (long and short diameters 10.9 x 9.8 mm; neck width 8.3 +/- 1.2 mm (mean +/- SD)) and 7 aneurysms (11.2 x 9.5 mm; neck width 8.3 +/- 1.4 mm) were packed with a mixture of NBCA, Lipiodol, and ethanol in the ratios 1:1:0 (NL11) and 1:1:2 (NLE112), respectively. A microcatheter was advanced into the aneurysm and a balloon catheter was inflated at the aneurysm neck. Ten minutes after injection, the balloon catheter was deflated and its removal was attempted. For all three aneurysms in the NL11 group, the balloon catheter and the microcatheter adhered strongly to the vessel and could not be adjusted. For all seven aneurysms in the NLE112 group, both the balloon catheter and the microcatheter could be easily removed, which enabled successful full packing of the aneurysm by re-advancing the microcatheter and re-injecting NLE112 after re-inflation of the balloon catheter. Although at a preliminary stage, balloon-assisted NLE injection is feasible for packing a wide-neck aneurysm.	[Tanaka, Fumihiro; Kawai, Nobuyuki; Sato, Morio; Minamiguchi, Hiroki; Nakai, Motoki; Nakata, Kouhei; Sanda, Hiroki; Sonomura, Tetsuo] Wakayama Med Univ, Dept Radiol, Wakayama, Wakayama 6418510, Japan	Sato, M (reprint author), Wakayama Med Univ, Dept Radiol, 811-1 Kimiidera, Wakayama, Wakayama 6418510, Japan.	arida_fumi_mikan@yahoo.co.jp; nobkawai@wakayama-med.ac.jp; morisato@mail.wakayama-med.ac.jp; hiromina4@hotmail.com; momonga@wakayama-med.ac.jp; kohei0120@yahoo.co.jp; sandabird88@ybb.ne.jp; sonomura@wakayama-med.ac.jp					Yonemitsu T, 2009, J VASC INTERV RADIOL, V20, P1176, DOI 10.1016/j.jvir.2009.06.005; ZUBILLAGA AF, 1994, AM J NEURORADIOL, V15, P815; Kish JW, 2004, J VASC INTERV RADIOL, V15, P689, DOI 10.1097/01.RVI.0000133505.84588.8C; SPIEGEL SM, 1986, AM J NEURORADIOL, V7, P109; Petersen B, 2004, GASTROINTEST ENDOSC, V60, P327, DOI 10.1016/S0016-5107(04)01564-0; Debrun GM, 1998, NEUROSURGERY, V43, P1281, DOI 10.1097/00006123-199812000-00011; Debrun G M, 1997, Interv Neuroradiol, V3, P13; Gad SC., 2008, PHARM MANUFACTURING, P364; Gounis MJ, 2002, AM J NEURORADIOL, V23, P938; Kawai N, 2012, J VASC INTERV RADIOL, V23, P1516, DOI 10.1016/j.jvir.2012.08.017; MILLER CA, 1988, COLLOID SURFACE, V29, P89, DOI 10.1016/0166-6622(88)80173-2; Purdy P, 2002, AM J NEURORADIOL, V23, P748; STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409; Toyoda H, 1996, J GASTROEN HEPATOL, V11, P252, DOI 10.1111/j.1440-1746.1996.tb00071.x	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	AUG	2015	33	8					517	522		10.1007/s11604-015-0451-0		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP7AP	WOS:000360039900011		
J	Kumon, M; Tanimoto, M; Ito, A; Yano, H; Inoue, K; Yada, S; Minami, H				Kumon, Michiko; Tanimoto, Mitsuhide; Ito, Atsutoshi; Yano, Hideki; Inoue, Kazuhiro; Yada, Shuichi; Minami, Hidemi			CO-SPRAY-DRIED MANNITOL WITH POLYETHYLENE GLYCOL FOR DRY POWDER INHALATION: FACTORS AFFECTING THE POLYMORPHISM AND STABILITY	JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY			English	Meeting Abstract									[Kumon, Michiko; Tanimoto, Mitsuhide; Ito, Atsutoshi; Yano, Hideki; Inoue, Kazuhiro; Yada, Shuichi; Minami, Hidemi] Daiichi Sankyo Co Ltd, Formulat Technol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1941-2711	1941-2703		J AEROSOL MED PULM D	J. Aerosol Med. Pulm. Drug Deliv.	AUG 1	2015	28	4				29	A10	A11				2	Respiratory System	Respiratory System	CP3QJ	WOS:000359795100030		
J	Kawaguchi, M; Tanaka, Y; Furuya, H				Kawaguchi, Masahiko; Tanaka, Yuu; Furuya, Hitoshi			Improving the safety and quality of surgical patient care: what can we learn from quality management of industries?	JOURNAL OF ANESTHESIA			English	Editorial Material							HEALTH-CARE; HOME; METHODOLOGIES		[Kawaguchi, Masahiko; Tanaka, Yuu] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 6348522, Japan; [Furuya, Hitoshi] Nara Med Univ Hosp, Kashihara, Nara, Japan	Kawaguchi, M (reprint author), Nara Med Univ, Dept Anesthesiol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	drjkawa@naramed-u.ac.jp					Vetter TR, 2014, ANESTH ANALG, V118, P1131, DOI 10.1213/ANE.0000000000000228; Vetter TR, 2013, ANESTHESIOLOGY, V119, P1261, DOI 10.1097/ALN.0b013e3182a8e9e6; Nicolay CR, 2012, BRIT J SURG, V99, P324, DOI 10.1002/bjs.7803; Tanaka Y, 2014, J ANESTH, V28, P156, DOI 10.1007/s00540-013-1781-7; Dexter F, 2014, ANESTH ANALG, V118, P1062, DOI 10.1213/ANE.0000000000000173; Kain ZN, 2014, ANESTH ANALG, V118, P1126, DOI 10.1213/ANE.0000000000000190; Gayed B, 2013, JAMA SURG, V148, P1050, DOI 10.1001/jamasurg.2013.3598; Huang Jeffrey, 2014, J Med Pract Manage, V29, P235; Mason SE, 2015, SURG-J R COLL SURG E, V13, P91, DOI 10.1016/j.surge.2014.08.002; Raphael Darren R, 2014, Perioper Med (Lond), V3, P6, DOI 10.1186/2047-0525-3-6; Vetter TR, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-6	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					485	486		10.1007/s00540-014-1930-7		2	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800001		
J	Saito, J; Noguchi, S; Matsumoto, A; Jinushi, K; Kasai, T; Kudo, T; Sawada, M; Kimura, F; Kushikata, T; Hirota, K				Saito, Junichi; Noguchi, Satoko; Matsumoto, Anna; Jinushi, Kei; Kasai, Toshinori; Kudo, Tomoyuki; Sawada, Masahiro; Kimura, Futoshi; Kushikata, Tetsuya; Hirota, Kazuyoshi			Impact of robot-assisted laparoscopic prostatectomy on the management of general anesthesia: efficacy of blood withdrawal during a steep Trendelenburg position	JOURNAL OF ANESTHESIA			English	Article						Robot-assisted laparoscopic prostatectomy; Steep Trendelenburg position; Blood withdrawal	RADICAL PROSTATECTOMY	Robot-assisted laparoscopic prostatectomy (RALP) is being increasingly used. However, a steep Trendelenburg position and pneumoperitoneum during RALP has an impact on the respiratory, cardiovascular and cerebrovascular systems. To prevent complications, restrictive fluid management and blood withdrawal have been utilized in our hospital. We examined differences in the anesthetic management between RALP and radical retropubic prostatectomy (RRP), and the efficacy of blood withdrawal. Medical records of patients who underwent radical prostatectomy in our hospital between January 2012 and October 2013 were retrospectively reviewed. Demographic data, intraoperative blood and fluid administration, perioperative complications and the length of hospital stay were compared among patients receiving RRP, and those receiving RALP with and without blood withdrawal (n = 78, 46 and 68, respectively). Patients receiving RALP with and without blood withdrawal received a smaller volume of crystalloid during surgery than those receiving RRP (mean +/- A SD, 5.8 +/- A 2.3 and 4.2 +/- A 1.6 vs 14.3 +/- A 4.1 ml/kg/h, p < 0.001). Median estimated blood loss was 885 g (80-2,800 g) for RRP and 50 g for RALP (3-950 g and 3-550 g, respectively), p < 0.001. None of the patients undergoing RALP received red blood cells, but three patients undergoing RRP did so. RALP with blood withdrawal reduced postoperative hospital stay by 45 % (6 vs 11 days). Four patients receiving RALP without blood withdrawal had delayed extubation due to severe laryngeal edema, which did not occur in any of the patients receiving RALP who had blood withdrawal. Renal function did not differ among the groups. RALP was associated with less blood loss, no allogeneic transfusion and shorter postoperative hospital stay. This study indicated that blood withdrawal could prevent severe laryngeal edema.	[Saito, Junichi; Noguchi, Satoko; Matsumoto, Anna; Jinushi, Kei; Kasai, Toshinori; Kudo, Tomoyuki; Sawada, Masahiro; Kimura, Futoshi; Kushikata, Tetsuya; Hirota, Kazuyoshi] Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan	Saito, J (reprint author), Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan.	fix-you@hotmail.co.jp; satko1110@yahoo.co.jp; shitoan_410@hotmail.com; kduyuk@yahoo.co.jp; tosi_1984@yahoo.co.jp; kudotomoyuki@yahoo.co.jp; daoyandz@yahoo.co.jp; kimurafy@gmail.com; tetsuyaK@cc.hirosaki-u.ac.jp; hirotak@cc.hirosaki-u.ac.jp					Ahlering TE, 2004, NAT CLIN PRACT UROL, V1, P58, DOI 10.1038/ncpuro0040; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; D'Alonzo RC, 2009, J CLIN ANESTH, V21, P322, DOI 10.1016/j.jclinane.2008.09.005; Tewari A, 2003, BJU INT, V92, P205, DOI 10.1046/j.1464-410X.2003.04311.x; Phong SVN, 2007, ANAESTH INTENS CARE, V35, P281; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Awad H, 2012, J CLIN ANESTH, V24, P494, DOI 10.1016/j.jclinane.2012.03.003; Cho JE, 2009, UROLOGY, V73, P1056, DOI 10.1016/j.urology.2008.08.490; Danic MJ, 2007, J ROBOTIC SURG, V1, P119, DOI 10.1007/s11701-007-0024-z; Dunn MD, 2000, UROL CLIN N AM, V27, P609, DOI 10.1016/S0094-0143(05)70110-5; Farnham SB, 2006, UROLOGY, V67, P360, DOI 10.1016/j.urology.2005.08.029; Mikaeili Haleh, 2014, J Cardiovasc Thorac Res, V6, P25, DOI 10.5681/jcvtr.2014.005; Parsons JK, 2008, UROLOGY, V72, P412, DOI 10.1016/j.urology.2007.11.026; Siu W, 2003, J UROLOGY, V170, P1936, DOI 10.1097/01.ju.0000090085.31740.9a	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					487	491		10.1007/s00540-015-1989-9		5	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800002		
J	Wajima, Z; Shiga, T; Imanaga, K				Wajima, Zen'ichiro; Shiga, Toshiya; Imanaga, Kazuyuki			Pneumoperitoneum affects stroke volume variation in humans	JOURNAL OF ANESTHESIA			English	Article						Pneumoperitoneum; Stroke volume variation; Hemodynamics	INCREASED INTRAABDOMINAL PRESSURE; MECHANICALLY VENTILATED PATIENTS; UPPER ABDOMINAL-SURGERY; FLUID RESPONSIVENESS; BETA(1)-ADRENERGIC BLOCKER; INTRAVENOUS LANDIOLOL; TIDAL VOLUME; BUPRENORPHINE; HYPERTENSION; ANALGESIA	Stroke volume variation (SVV) is affected by many factors. Although elevated intra-abdominal pressure and a pneumoperitoneum have been shown to increase SVV in animals, a recent human study showed that SVV did not change as a pneumoperitoneum was established. However, we considered the results of this study questionable, and we therefore attempted to study whether SVV changes both before and after pneumoperitoneums in humans. We performed a prospective observational study in 19 patients undergoing cholecystectomy or colectomy while on mechanical ventilation. Immediately before pneumoperitoneum, baseline registrations of variables were obtained (baseline I), which were measured every min for 5 min after the pneumoperitoneum was initiated. Immediately before the pneumoperitoneum was released, another baseline registration of variables was obtained (baseline II); these variables were then measured every min for 5 min. After the pneumoperitoneum was initiated, there were significant increases in SVV at the 2- to 5-min time points. After release of the pneumoperitoneum, there were significant decreases in SVV at the 1- to 5-min time points. A pneumoperitoneum increased SVV, which is similar to the findings of previous animal studies but is different from a previous clinical study. Upon release of the pneumoperitoneum, SVV decreased significantly, which is new information. SVV values must be estimated cautiously during a pneumoperitoneum.	[Wajima, Zen'ichiro] Int Univ Hlth & Welf, Shioya Hosp, Dept Anesthesiol, Yaita, Tochigi 3292145, Japan; [Wajima, Zen'ichiro] Int Univ Hlth & Welf Hosp, Dept Anesthesiol, Nasushiobara, Tochigi 3292763, Japan; [Shiga, Toshiya] Int Univ Hlth & Welf, Kaken Hosp, Dept Anesthesiol, Ichikawa, Chiba 2720827, Japan; [Imanaga, Kazuyuki] Shonan Kamakura Gen Hosp, Dept Anesthesia, Div Cardiovasc Anesthesia, Kamakura, Kanagawa 2478533, Japan	Wajima, Z (reprint author), Int Univ Hlth & Welf, Shioya Hosp, Dept Anesthesiol, 77 Tomita, Yaita, Tochigi 3292145, Japan.	HFB01245@nifty.com					Reuter DA, 2003, INTENS CARE MED, V29, P476, DOI 10.1007/s00134-003-1649-7; Malbrain MLNG, 2009, CRIT CARE MED, V37, P781, DOI 10.1097/CCM.0b013e318194c397; Bliacheriene F, 2007, ACTA ANAESTH SCAND, V51, P1268, DOI 10.1111/j.1399-6576.2007.01432.x; Duperret S, 2007, INTENS CARE MED, V33, P163, DOI 10.1007/s00134-006-0412-2; Biais M, 2008, BRIT J ANAESTH, V101, P761, DOI 10.1093/bja/aen277; SHIBUTANI K, 1994, ANESTH ANALG, V79, P829; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Zhang ZH, 2011, J ANESTH, V25, P904, DOI 10.1007/s00540-011-1217-1; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; Hoiseth LO, 2012, ACTA ANAESTH SCAND, V56, P777, DOI 10.1111/j.1399-6576.2011.02641.x; Biais M, 2009, CRIT CARE, V13, DOI 10.1186/cc8195; Donati A, 2002, Minerva Anestesiol, V68, P549; Hahn RG, 2011, CLIN FLUID THERAPY P, P18; Jacques D, 2011, CRIT CARE, V15, DOI 10.1186/cc9980; Tournadre JP, 2000, ACTA ANAESTH SCAND, V44, P231, DOI 10.1034/j.1399-6576.2000.440303.x; Valenza F, 2007, CRIT CARE MED, V35, P1575, DOI 10.1097/01.CCM.0000266589.58118.F0; Wajima Z, 2010, J CLIN MONIT COMPUT, V24, P385, DOI 10.1007/s10877-010-9259-8; Wajima Z, 2012, J CLIN ANESTH, V24, P207, DOI 10.1016/j.jclinane.2011.07.015; Wajima Z, 1998, CAN J ANAESTH, V45, P28; Wajima Z, 2013, J ANESTH, V27, P890, DOI 10.1007/s00540-013-1622-8; Wajima Z, 2011, J CLIN ANESTH, V23, P292, DOI 10.1016/j.jclinane.2010.11.001; Wajima Z, 1997, ACTA ANAESTH SCAND, V41, P1061	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					508	514		10.1007/s00540-014-1963-y		7	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800005		
J	Kawazoe, Y; Nakashima, T; Iseri, T; Yonetani, C; Ueda, K; Fujimoto, Y; Kato, S				Kawazoe, Yu; Nakashima, Tsuyoshi; Iseri, Toshie; Yonetani, Chiaki; Ueda, Kentaro; Fujimoto, Yuka; Kato, Seiya			The impact of inspiratory pressure on stroke volume variation and the evaluation of indexing stroke volume variation to inspiratory pressure under various preload conditions in experimental animals	JOURNAL OF ANESTHESIA			English	Article						Fluid responsiveness; Inspiratory pressure; Preload; Stroke volume; Tidal volume	PREDICTING FLUID RESPONSIVENESS; TIDAL VOLUME; PULSE PRESSURE; VENTILATED DOGS; CLINICAL-PRACTICE; CARDIAC-SURGERY; BLOOD-VOLUME; HEMORRHAGE; CONTOUR; INJURY	Stroke volume variation (SVV) measures fluid responsiveness, enabling optimal fluid management under positive pressure ventilation. We aimed to investigate the effect of peak inspiratory pressure (PIP) on SVV under various preload conditions in experimental animals and to ascertain whether SVV indexed to PIP decreases the effect. Mild and moderate hemorrhage models were created in nine anesthetized, mechanically ventilated beagle dogs by sequentially removing 10 and then an additional 10 ml/kg of blood, respectively. In all the animals, PIP was incrementally increased by 4 cmH(2)O, from 5 to 21 cmH(2)O. SVV was measured by arterial pulse contour analysis. Stroke volume was derived using a thermodilution method, and central venous pressure and mean arterial pressure were also measured. SVV increased according to PIP with significant correlation at baseline, with mild hemorrhage and moderate hemorrhage. PIP regression coefficients at baseline and in the mild and moderate hemorrhage models were 0.59, 0.86, and 1.4, respectively. Two-way repeated-measures analysis of variance showed that PIP and the degree of hemorrhage had a significant interaction effect on SVV (p = 0.0016). SVV indexed to PIP reflected the hemorrhage status regardless of PIP changes a parts per thousand yen9 cmH(2)O. PIP is significantly correlated with SVV, even under hypovolemia, and the effect is enhanced with decreasing preload volumes. Compared with SVV, the indexed SVV was less susceptible to higher inspiratory pressures.	[Kawazoe, Yu; Nakashima, Tsuyoshi; Ueda, Kentaro; Kato, Seiya] Wakayama Med Univ, Dept Emergency & Crit Care Med, Wakayama 6418510, Japan; [Iseri, Toshie; Yonetani, Chiaki; Fujimoto, Yuka] Osaka Prefecture Univ, Dept Adv Clin Med, Grad Sch Life & Environm Sci, Kita Ku, Izumisano, Osaka 5988531, Japan	Kawazoe, Y (reprint author), Wakayama Med Univ, Dept Emergency & Crit Care Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	ukz411@gmail.com					Reuter DA, 2003, INTENS CARE MED, V29, P476, DOI 10.1007/s00134-003-1649-7; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Mesquida J, 2011, INTENS CARE MED, V37, P1672, DOI 10.1007/s00134-011-2304-3; BROWER R, 1985, J APPL PHYSIOL, V58, P954; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Cannesson M, 2012, CRIT CARE MED, V40, P193, DOI 10.1097/CCM.0b013e31822ea119; Preisman S, 2005, BRIT J ANAESTH, V95, P746, DOI 10.1093/bja/aei262; PEREL A, 1987, ANESTHESIOLOGY, V67, P498, DOI 10.1097/00000542-198710000-00009; Kubitz JC, 2007, BRIT J ANAESTH, V98, P591, DOI 10.1093/bja/aem062; Kramer A, 2004, CHEST, V126, P1563, DOI 10.1378/chest.126.5.1563; Lansdorp B, 2012, BRIT J ANAESTH, V108, P395, DOI 10.1093/bja/aer411; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Taguchi H, 2011, J ANESTH, V25, P563, DOI 10.1007/s00540-011-1175-7; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Renner J, 2007, ACTA ANAESTH SCAND, V51, P538, DOI 10.1111/j.1399-6576.2007.01282.x; SZOLD A, 1989, INTENS CARE MED, V15, P368; Laffey JG, 2000, NEW ENGL J MED, V343, P812; Berkenstadt H, 2005, BRIT J ANAESTH, V94, P721, DOI 10.1093/bja/aei116; Marsolais EB, 2005, J SPINAL CORD MED, V28, P259; Couto CG, 2003, SMALL ANIMAL INTERNA; Hofer CK, 2005, CHEST, V128, P848, DOI 10.1378/chest.128.2.848; Kang Woon-Seok, 2014, Korean J Anesthesiol, V66, P358, DOI 10.4097/kjae.2014.66.5.358; Maggiore S M, 2003, Eur Respir J Suppl, V42, p22s; Michard F, 2005, ANESTHESIOLOGY, V103, P419, DOI 10.1097/00000542-200508000-00026; MORGAN BC, 1966, ANESTHESIOLOGY, V27, P584, DOI 10.1097/00000542-196609000-00009; Peterson WP, 1999, SPINAL CORD, V37, P284, DOI 10.1038/sj.sc.3100818; Poelaert J I, 1994, J Cardiothorac Vasc Anesth, V8, P392, DOI 10.1016/1053-0770(94)90276-3; Vistisen ST, 2010, ACTA ANAESTH SCAND, V54, P199, DOI 10.1111/j.1399-6576.2009.02061.x; Vistisen ST, 2010, ACTA ANAESTH SCAND, V54, P191, DOI 10.1111/j.1399-6576.2009.02114.x; Vistisen ST, 2009, ACTA ANAESTH SCAND, V53, P534, DOI 10.1111/j.1399-6576.2008.01893.x; WILLIAMS RR, 1974, CARDIOLOGY, V59, P350, DOI 10.1159/000169694	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					515	521		10.1007/s00540-015-1995-y		7	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800006		
J	Satoh, K; Kamada, S; Kumagai, M; Sato, M; Kuji, A; Joh, S				Satoh, Kenichi; Kamada, Shun; Kumagai, Miho; Sato, Masahito; Kuji, Akiyoshi; Joh, Shigeharu			Effect of lidocaine on swine lingual and pulmonary arteries	JOURNAL OF ANESTHESIA			English	Article						Lidocaine; Contraction; Isometric tension; Smooth muscle; Swine artery	AORTIC SMOOTH-MUSCLE; INDUCED CONTRACTION; RAT	Lidocaine has a biphasic action on smooth muscle of peripheral blood vessels, with vasoconstriction at low concentrations and vasodilation at higher concentrations. Many in vivo studies have demonstrated the effects of lidocaine on aortic or coronary arteries in several animals, but there are few reports about the effect on peripheral vessels. This study was designed to investigate the direct effects of lidocaine on peripheral vessels, namely swine lingual and pulmonary arterial rings. Swine lingual artery and pulmonary artery segments, about 2-3 mm in diameter, were cut into 3-mm-long rings, and the lumen surface was gently rubbed to remove the endothelium. Isometric tension was measured using a displacement transducer and recorded. After a stable constriction was developed with 5 A mu M noradrenaline, 5 A mu M noradrenaline containing lidocaine (0.5, 1.0, 10, 20, 50 or 100 A mu g/ml) was perfused for 5 min, and then all drug perfusion was stopped. The strength of any isometric tension during an experiment was normalized to the strength of the isometric tension immediately before lidocaine perfusion, and expressed as a percentage. Lidocaine elicited a concentration-dependent biphasic response of lingual and pulmonary arterial rings. The lidocaine concentration at 1 A mu g/ml caused mild contraction. Dilation occurred at 10 A mu g/ml and increased with increasing dose. Lidocaine-induced vasoconstriction of swine lingual and pulmonary smooth muscle may occur at low concentration when lidocaine is infiltrated into the oral submucosa or administered intravenously for the treatment of ventricular arrhythmia.	[Satoh, Kenichi; Kamada, Shun; Sato, Masahito; Joh, Shigeharu] Iwate Med Univ, Div Dent Anesthesiol, Dept Reconstruct Oral Maxillofacial Surg, Sch Dent, Morioka, Iwate 0208505, Japan; [Kumagai, Miho; Kuji, Akiyoshi] Iwate Med Univ, Div Special Care Dent, Dept Dev Oral Hlth Sci, Sch Dent, Morioka, Iwate 0208505, Japan	Satoh, K (reprint author), Iwate Med Univ, Div Dent Anesthesiol, Dept Reconstruct Oral Maxillofacial Surg, Sch Dent, 1-3-27 Chuo Dori, Morioka, Iwate 0208505, Japan.	satoken@iwate-med.ac.jp					Abe S, 2000, CATHETER CARDIO INTE, V49, P253, DOI 10.1002/(SICI)1522-726X(200003)49:3<253::AID-CCD5>3.0.CO;2-5; Maki J, 2010, BRIT J PHARMACOL, V159, P919, DOI 10.1111/j.1476-5381.2009.00591.x; JOHNS RA, 1985, ANESTHESIOLOGY, V62, P141, DOI 10.1097/00000542-198502000-00008; Kaneko Y, 2011, LOCAL ANESTHESIA, V7th, P147; Kawaguchi T, 2010, N-S ARCH PHARMACOL, V381, P107, DOI 10.1007/s00210-009-0486-9; Konrad CJ, 2006, REGION ANESTH PAIN M, V31, P254, DOI 10.1016/j.rapm.2006.01.003; Mourouzis C, 2003, PHARMACOL TOXICOL, V93, P269, DOI 10.1111/j.1600-0773.2003.pto930604.x; PERLMUTTER NS, 1990, PHARMACOLOGY, V41, P280, DOI 10.1159/000138734; Stoelting RK, 1999, LOCAL ANESTHETIC PHA, P161; Sung HJ, 2012, CAN J PHYSIOL PHARM, V90, P863, DOI [10.1139/y2012-067, 10.1139/Y2012-067]; Tokinaga Y, 2007, ACTA ANAESTH SCAND, V51, P1155, DOI 10.1111/j.1399-6576.2007.01390.x; Yu JG, 2005, ANESTHESIOLOGY, V103, P548, DOI 10.1097/00000542-200509000-00018	12	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					529	534		10.1007/s00540-014-1965-9		6	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800008		
J	Ishida, T; Sakamoto, A; Tanaka, H; Ide, S; Ishida, K; Tanaka, S; Mori, T; Kawamata, M				Ishida, Takashi; Sakamoto, Akiyuki; Tanaka, Hidenori; Ide, Susumu; Ishida, Kumiko; Tanaka, Satoshi; Mori, Teruyo; Kawamata, Mikito			Transversus abdominis plane block with 0.25 % levobupivacaine: a prospective, randomized, double-blinded clinical study	JOURNAL OF ANESTHESIA			English	Article						Transversus abdominis plane (TAP) block; Levobupivacaine; Local anesthetic; Pharmacokinetics	PLASMA ROPIVACAINE CONCENTRATIONS; HEALTHY-VOLUNTEERS; ANALGESIA; SURGERY	Because blood concentrations of local anesthetics sometimes reach toxic levels after transversus abdominis plane (TAP) block, reduction of the dose has been necessary to reduce the risk of systemic toxicity. We therefore investigated the effects of TAP block with 0.25 % levobupivacaine (100 mg) on postoperative pain and measured its plasma concentration after gynecological surgery. Forty women undergoing elective open gynecological surgery were randomized to receive bilateral TAP block with 20 ml 0.25 % levobupivacaine on each side (TAP group) or not (non-TAP group) before surgery. Postoperative pain was treated with intravenous patient-controlled analgesia by use of morphine. Patients were evaluated 3 and 24 h after the end of surgery. Visual analog scale (VAS) for pain at rest and with movement, and morphine consumption were recorded. Plasma concentrations of levobupivacaine after TAP block were measured. Three hours after surgery, total morphine consumption was significantly lower in the TAP group (2.8 +/- A 1.6 mg) than in the non-TAP group (6.4 +/- A 4.8 mg, P = 0.03). There were no significant differences between VAS in the two groups. Mean plasma concentration of levobupivacaine peaked 10 min after TAP block (0.99 +/- A 0.43 mu g/ml), and the highest concentration was 1.99 mu g/ml. TAP block with 100 mg levobupivacaine is a safe and efficacious multimodal analgesic regimen for postoperative pain after open gynecological surgery.	[Ishida, Takashi; Sakamoto, Akiyuki; Tanaka, Hidenori; Ide, Susumu; Ishida, Kumiko; Tanaka, Satoshi; Kawamata, Mikito] Shinshu Univ, Dept Anesthesiol & Resuscitol, Sch Med, Matsumoto, Nagano 3908621, Japan; [Mori, Teruyo] Maruishi Pharmaceut Co Ltd, Cent Res Lab, Dept Preclin Dev Div ADME Toxicol, Tsurumi Ku, Osaka 5380042, Japan	Ishida, T (reprint author), Shinshu Univ, Dept Anesthesiol & Resuscitol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tisd@shinshu-u.ac.jp					Griffiths JD, 2010, BRIT J ANAESTH, V105, P853, DOI 10.1093/bja/aeq255; Hebbard P, 2007, ANAESTH INTENS CARE, V35, P616; Torup H, 2012, EUR J ANAESTH, V29, P235, DOI 10.1097/EJA.0b013e328350b0d5; McDonnell JG, 2007, ANESTH ANALG, V104, P193, DOI 10.1213/01.ane.0000250223.49963.0f; Griffiths JD, 2013, BRIT J ANAESTH, V110, P996, DOI 10.1093/bja/aet015; De Oliveira GS, 2014, ANESTH ANALG, V118, P454, DOI 10.1213/ANE.0000000000000066; Bardsley H, 1998, BRIT J CLIN PHARMACO, V46, P245, DOI 10.1046/j.1365-2125.1998.00775.x; El-Dawlatly AA, 2009, BRIT J ANAESTH, V102, P763, DOI 10.1093/bja/aep067; Carney J, 2008, ANESTH ANALG, V107, P2056, DOI 10.1213/ane.0b013e3181871313; Corvetto MA, 2012, REGION ANESTH PAIN M, V37, P633, DOI 10.1097/AAP.0b013e31826c330a; De Oliveira GS, 2011, ANESTH ANALG, V113, P218; Ra Yoon Suk, 2010, Korean J Anesthesiol, V58, P362, DOI 10.4097/kjae.2010.58.4.362; Stewert J, 2003, ANESTH ANALG, V97, P412, DOI 10.1213/01.ANE.0000069506.98137.F2; Toju K, 2014, J ANESTH, V29, P146; Weiss E, 2014, REGION ANESTH PAIN M, V39, P248, DOI 10.1097/AAP.0000000000000088	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					557	561		10.1007/s00540-015-1993-0		5	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800012		
J	Mizota, T; Matsukawa, S; Fukagawa, H; Daijo, H; Tanaka, T; Chen, FS; Date, H; Fukuda, K				Mizota, Toshiyuki; Matsukawa, Shino; Fukagawa, Hiroshi; Daijo, Hiroki; Tanaka, Tomoharu; Chen, Fengshi; Date, Hiroshi; Fukuda, Kazuhiko			The clinical course of anesthetic induction in lung transplant recipients with pulmonary complications after hematopoietic stem cell transplantation	JOURNAL OF ANESTHESIA			English	Article						Lung transplantation; Hematopoietic stem cell transplantation (HSCT); Anesthesia; Dynamic compliance; Oxygen desaturation	BRONCHIOLITIS OBLITERANS SYNDROME; PRESSURE-CONTROLLED VENTILATION; IDEAL BODY-WEIGHT; LIVING-DONOR; DISEASE; VOLUME; DIAGNOSIS; OUTCOMES; HYPOXIA; SURGERY	We examined the clinical course of anesthetic induction in lung transplant recipients with pulmonary complications after hematopoietic stem cell transplantation (post-HSCT), focusing on ventilatory management. We aimed to determine the incidence of oxygen desaturation during anesthetic induction and severe respiratory acidosis after anesthetic induction in post-HSCT lung transplant recipients, and to explore factors associated with their development. Nineteen consecutive patients who underwent lung transplantation post-HSCT at Kyoto University Hospital (Japan) were retrospectively studied. Data regarding patient characteristics, preoperative examination, and clinical course during anesthetic induction were analyzed. The incidence of oxygen desaturation (SpO(2) < 90 %) during anesthetic induction and severe respiratory acidosis (pH < 7.2) after anesthetic induction were 21.1 and 26.3 %, respectively. Reduced dynamic compliance (Cdyn) during mechanical ventilation was significantly associated with oxygen desaturation during anesthetic induction (p = 0.01), as well as severe respiratory acidosis after anesthetic induction (p = 0.01). The preoperative partial pressure of carbon dioxide in arterial blood (PaCO2; r = -0.743, p = 0.002) and body mass index (BMI; r = 0.61, p = 0.021) significantly correlated with Cdyn, and multivariate analysis revealed that both PaCO2 and BMI were independently associated with Cdyn. Oxygen desaturation during anesthetic induction and severe respiratory acidosis after anesthetic induction frequently occur in post-HSCT lung transplant recipients. Low Cdyn may, at least partially, explain oxygen desaturation during anesthetic induction and severe respiratory acidosis after anesthetic induction. Moreover, preoperative hypercapnia and low BMI were predictive of low Cdyn.	[Mizota, Toshiyuki; Matsukawa, Shino; Fukagawa, Hiroshi; Daijo, Hiroki; Tanaka, Tomoharu; Fukuda, Kazuhiko] Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, Kyoto 6068507, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 6068507, Japan	Mizota, T (reprint author), Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	mizota@kuhp.kyoto-u.ac.jp					Soubani AO, 2007, EUR RESPIR J, V29, P1007, DOI 10.1183/09031936.00052806; Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; Lemmens HJM, 2005, OBES SURG, V15, P1082, DOI 10.1381/0960892054621350; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Au BKC, 2011, BIOL BLOOD MARROW TR, V17, P1072, DOI 10.1016/j.bbmt.2010.11.018; Scohy TV, 2009, PEDIATR ANESTH, V19, P1207, DOI 10.1111/j.1460-9592.2009.03177.x; TOKUNAGA K, 1991, INT J OBESITY, V15, P1; Chen F, 2011, AM J TRANSPLANT, V11, P1509, DOI 10.1111/j.1600-6143.2011.03591.x; Balick-Weber CC, 2007, BRIT J ANAESTH, V99, P429, DOI 10.1093/bja/aem166; BARER GR, 1970, J PHYSIOL-LONDON, V211, P139; Bergeron A, 2013, BONE MARROW TRANSPL, V48, P819, DOI 10.1038/bmt.2012.241; Chen Fengshi, 2014, Ann Transplant, V19, P382, DOI 10.12659/AOT.890898; Cheng GS, 2014, BIOL BLOOD MARROW TR, V20, P1169, DOI 10.1016/j.bbmt.2014.04.008; De Campos T, 2000, NEW ENGL J MED, V342, P1301; ENSON Y, 1964, J CLIN INVEST, V43, P1146, DOI 10.1172/JCI104999; Jo YY, 2012, J NEUROSURG ANESTH, V24, P14, DOI 10.1097/ANA.0b013e31822c6523; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Myles PS, 1997, J CARDIOTHOR VASC AN, V11, P100, DOI 10.1016/S1053-0770(97)90263-9; Myles PS, 1997, J CARDIOTHOR VASC AN, V11, P177, DOI 10.1016/S1053-0770(97)90210-X; Nakaseko C, 2011, INT J HEMATOL, V93, P375, DOI 10.1007/s12185-011-0809-8; Pechet TV, 2003, J HEART LUNG TRANSPL, V22, P154, DOI 10.1016/S1053-2498(02)00671-X; QUINLAN JJ, 1993, ANESTHESIOLOGY, V78, P1177, DOI 10.1097/00000542-199306000-00024; Solh M, 2011, TRANSPLANTATION, V91, P798, DOI 10.1097/TP.0b013e31820c85fa; Takeuchi Y, 2015, HISTOPATHOLOGY, V66, P536, DOI 10.1111/his.12553; Vogl UM, 2013, TRANSPLANTATION, V95, P623, DOI 10.1097/TP.0b013e318277e29e; Yamane M, 2008, TRANSPLANTATION, V86, P1767, DOI 10.1097/TP.0b013e318190b0be	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					562	569		10.1007/s00540-015-1986-z		8	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800013		
J	Fujiwara, A; Komasawa, N; Nishihara, I; Miyazaki, S; Tatsumi, S; Nishimura, W; Minami, T				Fujiwara, Atsushi; Komasawa, Nobuyasu; Nishihara, Isao; Miyazaki, Shinichiro; Tatsumi, Shinichi; Nishimura, Wataru; Minami, Toshiaki			Muscle relaxant effects on insertion efficacy of the laryngeal mask ProSeal(A (R)) in anesthetized patients: a prospective randomized controlled trial	JOURNAL OF ANESTHESIA			English	Article						LMA-ProSeal (R); Muscle relaxant; Sealing pressure; Insertion efficacy	BOUGIE-GUIDED INSERTION; CHEST COMPRESSION; AIRWAY MANAGEMENT; SIZE SELECTION; ADULT PATIENTS; VENTILATION; CROSSOVER; SURGERY; NECK	Anesthesiologists often encounter LMA-ProSeal(A (R)) (ProSeal) insertion difficulty due to its large cuff size. We performed a randomized clinical trial to examine how insertion efficacy and sealing pressure of ProSeal are affected by muscle relaxant administration in anesthetized patients. Our adult patients were either administered rocuronium (0.9 mg kg(-1)) as a muscle relaxant (R group; 40 patients) or not (C group; 40 patients). Anesthesia was induced with propofol and fentanyl. We compared the two groups with regard to the number of attempts required for successful insertion, sealing pressure, and subjective difficulty for insertion. Total insertion attempts required for successful ventilation in the two groups were one (R group, 38 patients; C group, 28 patients), two (R group, one patient; C group, seven patients), and three (R group, one patient; C group, five patients), revealing a significant difference between groups (p < 0.001). Sealing pressure was significantly higher in the R group than in the C group (R group, 27.4 +/- A 5.4 cmH(2)O; C group, 21.2 +/- A 5.2 cmH(2)O; p < 0.001). Leakage volume by mechanical ventilation was significantly smaller in the R group than in the C group (R group, 17.4 +/- A 29.1 ml; C group, 46.8 +/- A 45.5 ml; p < 0.001). Subjective difficulty of insertion was significantly lower in the R group than in the C group (R group, 12.3 +/- A 23.1 mm; C group, 39.4 +/- A 31.9 mm; p < 0.001). Muscle relaxation appears to facilitate ProSeal insertion efficacy by enabling higher successful insertion rates, higher sealing pressure, lower leakage volume, and lower subjective difficulty of insertion in anesthetized patients.	[Fujiwara, Atsushi; Komasawa, Nobuyasu; Miyazaki, Shinichiro; Tatsumi, Shinichi; Nishimura, Wataru; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan; [Nishihara, Isao] Hokusetsu Gen Hosp, Dept Anesthesiol, Takatsuki, Osaka, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	koma21century@yahoo.co.jp					Kihara S, 2004, ANESTHESIOLOGY, V101, P340, DOI 10.1097/00000542-200408000-00014; Cook TM, 2005, CAN J ANAESTH, V52, P739; Chen BZ, 2013, J CLIN ANESTH, V25, P32, DOI 10.1016/j.jclinane.2012.06.004; Asai T, 2000, ANAESTHESIA, V55, P1179, DOI 10.1046/j.1365-2044.2000.01624.x; Goldmann K, 2008, ANESTH ANALG, V107, P1856, DOI 10.1213/ane.0b013e318189ac84; Brimacombe J, 2000, ANESTHESIOLOGY, V93, P104, DOI 10.1097/00000542-200007000-00019; Eschertzhuber S, 2008, ANESTH ANALG, V107, P1253, DOI 10.1213/ane.0b013e31817f0def; Ikeda A, 2012, ANESTHESIOLOGY, V117, P487, DOI 10.1097/ALN.0b013e3182668670; Komasawa N, 2012, RESUSCITATION, V83, P365, DOI 10.1016/j.resuscitation.2011.08.025; Keller C, 1999, BRIT J ANAESTH, V83, P480; Howath A, 2002, ANAESTH INTENS CARE, V30, P624; Warters RD, 2011, ANAESTHESIA, V66, P163, DOI 10.1111/j.1365-2044.2010.06601.x; Asai T, 2002, ANAESTHESIA, V57, P918, DOI 10.1046/j.1365-2044.2002.02783.x; Asai T, 1999, BRIT J ANAESTH, V83, P478; Brimacombe J, 2005, ANESTH ANALG, V100, P298, DOI 10.1213/01.ANE.0000145377.15812; Howath A, 2002, CAN J ANAESTH, V49, P528; Komasawa N, 2014, J ANESTH, V28, P676, DOI 10.1007/s00540-014-1802-1; Komasawa N, 2014, J CLIN ANESTH, V26, P663, DOI 10.1016/j.jclinane.2014.08.009; Kuna ST, 2000, RESP PHYSIOL, V119, P155, DOI 10.1016/S0034-5687(99)00110-3; Natalini G, 2003, J CLIN ANESTH, V15, P428, DOI 10.1016/S0952-8180(03)00085-0; Okutani R, 2010, J ANESTH, V24, P492, DOI 10.1007/s00540-010-0883-8; WRIGHT PMC, 1994, ANESTHESIOLOGY, V81, P1110, DOI 10.1097/00000542-199411000-00004	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					580	584		10.1007/s00540-015-1982-3		5	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800015		
J	Moriyama, T; Matsunaga, A; Nagata, O; Enohata, K; Kamikawaji, T; Uchino, E; Kanmura, Y				Moriyama, Takahiro; Matsunaga, Akira; Nagata, Osamu; Enohata, Kei; Kamikawaji, Tomomi; Uchino, Erika; Kanmura, Yuichi			Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia	JOURNAL OF ANESTHESIA			English	Article						Rocuronium; Continuous administration; Total intravenous anesthesia; Effect-site concentration	POSTOPERATIVE RESIDUAL PARALYSIS; CONTINUOUS-INFUSION; OBESE-PATIENTS; DOSE-RESPONSE; BODY-WEIGHT; TIME-COURSE; PHARMACOKINETICS; ISOFLURANE; ORG-9426; PHARMACODYNAMICS	Rocuronium bromide (Rb) is a rapid onset, intermediate-acting neuromuscular blocking agent that is suitable for continuous administration. The appropriate rate of rocuronium administration is, however, difficult to determine due to large interindividual differences in sensitivity to rocuronium. The aim of this study was to clarify whether the simulated rocuronium concentration at the time of recovery to %T1 > 0 % after the initial administration of rocuronium is a good indicator of optimal effect-site concentrations during continuous rocuronium administration. Twenty-one patients were anesthetized with propofol. After induction, Rb 0.6 mg/kg was administered intravenously, and nerve stimulation using the single stimulation mode was conducted every 15 s. When %T1 recovered to > 0 % after the initial administration of Rb, the effect-site concentration of rocuronium, calculated by pharmacokinetic simulation with Wierda's set of parameters, was recorded and defined as the recovery concentration (Rb r.c.). The administration rate of rocuronium was adjusted to maintain the Rb r.c. during surgery. Rb administration was discontinued just before the end of surgery, and the recovery time until %T1 > 25 % was recorded. Plasma Rb concentrations were measured at 1 and 3 h after the initiation of continuous Rb administration. The mean Rb r.c. was 1.56 +/- A 0.35 mu g/ml, with minimum and maximum values of 1.09 and 2.08 mu g/ml, respectively. The %T1 did not increase above 10 % in any of the patients during continuous administration of Rb, and the recovery period to %T1 > 25 % ranged from 9 to 29 min. The effect-site concentrations of Rb calculated with Wierda's parameters significantly correlated with plasma concentrations (P < 0.01) at both 1 and 3 h after the initial administration of Rb. The results suggest that our method may be one of the most reliable protocols for the continuous administration of Rb described to date for maintaining suitable muscle relaxation during surgery without excessively prolonged effects.	[Moriyama, Takahiro; Matsunaga, Akira; Nagata, Osamu; Enohata, Kei; Kamikawaji, Tomomi; Uchino, Erika; Kanmura, Yuichi] Kagoshima Univ Hosp, Dept Anesthesiol & Intens Care, Kagoshima, Japan	Moriyama, T (reprint author), Kagoshima Univ Hosp, Dept Anesthesiol & Intens Care, Sakuragaoka 8-35-1, Kagoshima, Japan.	takmor@m3.kufm.kagoshima-u.ac.jp			Nihon Kohden	This study was supported by a Grant for research from Nihon Kohden.	BEVAN DR, 1993, CAN J ANAESTH, V40, P127; Fuchs-Buder T, 2007, ACTA ANAESTH SCAND, V51, P789, DOI 10.1111/j.1399-6576.2007.01352.x; Eleveld DJ, 2007, ANESTH ANALG, V104, P582, DOI 10.1213/01.ane.0000250617.79166.7f; Hayes AH, 2001, ANAESTHESIA, V56, P312, DOI 10.1046/j.1365-2044.2001.01921.x; Meyhoff CS, 2009, ANESTH ANALG, V109, P787, DOI 10.1213/ane.0b013e3181b0826a; Cammu G, 2006, ANESTH ANALG, V102, P426, DOI 10.1213/01.ane.0000195543.61123.1f; Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004; Bissinger U, 2000, PHYSIOL RES, V49, P455; WIERDA JMKH, 1991, CAN J ANAESTH, V38, P430; Brock M, 2000, BRIT J ANAESTH, V84, P43; Dahaba AA, 2006, ANESTHESIOLOGY, V104, P950, DOI 10.1097/00000542-200605000-00010; Fujimoto M, 2013, CAN J ANESTH, V60, P552, DOI 10.1007/s12630-013-9914-x; Kim KS, 2002, ANESTH ANALG, V95, P1656, DOI 10.1213/01.ANE.0000037150.20930.D5; Kotake Yoshifumi, 2006, Masui, V55, P873; Leykin Y, 2004, ANESTH ANALG, V99, P1086, DOI 10.1213/01.ane.0000120081.99080.c2; McCoy EP, 1996, BRIT J ANAESTH, V76, P29; Miller DR, 2000, CAN J ANAESTH, V47, P943; OLKKOLA KT, 1994, ANESTH ANALG, V78, P691; SHANKS CA, 1993, ANESTHESIOLOGY, V78, P649, DOI 10.1097/00000542-199304000-00006; Sparr HJ, 1997, BRIT J ANAESTH, V78, P267; Takagi Syunichi, 2006, Masui, V55, P963; de Moraes NV, 2014, J PHARMACEUT BIOMED, V90, P180, DOI 10.1016/j.jpba.2013.11.032; Wulf H, 1998, CAN J ANAESTH, V45, P526; Xue FS, 1997, ANESTH ANALG, V85, P667, DOI 10.1097/00000539-199709000-00033	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					593	599		10.1007/s00540-015-1991-2		7	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800017		
J	Fukuda, T; Kakinohana, M; Takayama, C; Matsushita, M; Sugahara, K				Fukuda, Takasuke; Kakinohana, Manabu; Takayama, Chitoshi; Matsushita, Masayuki; Sugahara, Kazuhiro			Dietary supplementation with sodium nitrite can exert neuroprotective effects on global cerebral ischemia/reperfusion in mice	JOURNAL OF ANESTHESIA			English	Article						Nitrite; Neuroprotection; Global cerebral ischemia and reperfusion	VIVO ISCHEMIA-REPERFUSION; IN-VIVO; XANTHINE OXIDOREDUCTASE; MYOCARDIAL-INFARCTION; CARDIAC-ARREST; OXIDE; SURVIVAL; THERAPY; PROTECTS; INJURY	Nitrite-derived NO protects against middle cerebral artery occlusion in mice. We developed a new mouse model of global cerebral ischemia and reperfusion (GCI/R) involving reversible occlusion of the major vessels from the aortic arch supplying the brain, and investigated neuroprotection with dietary sodium nitrite supplementation against GCI/R injury. Mice received drinking water with (nitrite group) or without (control group) sodium nitrite (2 mM) for 5 days and underwent 3-min GCI/R by reversible occlusion of major vessels from the aortic arch (i.e., brachiocephalic, left common carotid, and left subclavian artery). Survival rates and neurological function scores were evaluated for up to 5 days after GCI/R. Histopathological studies were performed to detect neurological degeneration and caspase-3 activation in serial hippocampal sections. In the control group, 17/30 mice (57 %) survived 5 days after 3-min GCI/R, whereas in the nitrite group 25/30 mice (83 %) survived (p < 0.05). The neurological score at 5 days after GCI in control group was significantly higher than in the nitrite group. Cerebral blood flow (CBF) during GCI was significantly higher in the nitrite group than in the control group, while MABP did not differ significantly between groups. Degenerative changes and caspase-3 activation in hippocampal sections after GCI were observed in the control group but not in the nitrite group. Pretreatment with the NO scavenger c-PTIO abolished the neuroprotective effects of sodium nitrite. Sodium nitrite supplementation attenuated mortality and neurological impairment after 3-min GCI in mice; an effect likely mediated via vascular mechanisms involving NO.	[Fukuda, Takasuke; Kakinohana, Manabu] Univ Ryukyus, Grad Sch Med, Dept Anesthesiol, Nishihara, Okinawa 9030215, Japan; [Takayama, Chitoshi] Univ Ryukyus, Grad Sch Med, Dept Mol Anat, Nishihara, Okinawa 9030215, Japan; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Nishihara, Okinawa 9030215, Japan; [Sugahara, Kazuhiro] Univ Ryukyus, Nishihara, Okinawa 9030215, Japan	Fukuda, T (reprint author), Univ Ryukyus, Grad Sch Med, Dept Anesthesiol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	takasuke0302@gmail.com			Ministry of Education of JAPAN [25293329];  [25670559]	This work was supported by a Grant-in-aid for scientific research from the Ministry of Education of JAPAN (B) 25293329 to M. K. and Grant-in-aid for challenging exploratory research JAPAN 25670559 to M. K.	Raat NJH, 2009, FREE RADICAL BIO MED, V47, P510, DOI 10.1016/j.freeradbiomed.2009.05.015; RADOMSKI MW, 1987, LANCET, V2, P1057; Bryan NS, 2006, FREE RADICAL BIO MED, V41, P691, DOI 10.1016/j.freeradbiomed.2006.05.019; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Kumar D, 2008, P NATL ACAD SCI USA, V105, P7540, DOI 10.1073/pnas.0711480105; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Jung KH, 2006, STROKE, V37, P2744, DOI 10.1161/01.STR.0000245116.40163.1c; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Raat NJH, 2009, ADV DRUG DELIVER REV, V61, P339, DOI 10.1016/j.addr.2009.02.002; Baker JE, 2007, J MOL CELL CARDIOL, V43, P437, DOI 10.1016/j.yjymc.2007.07.057; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Tripatara P, 2007, J AM SOC NEPHROL, V18, P570, DOI 10.1681/ASN.2006050450; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Thal SC, 2010, J NEUROSCI METH, V192, P219, DOI 10.1016/j.jneumeth.2010.07.032; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeadbiomed.2005.08.025; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Fukuyama N, 1998, J CEREBR BLOOD F MET, V18, P123; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Lu Ping, 2005, Hepatobiliary Pancreat Dis Int, V4, P350; Nishida T, 2009, CRIT CARE MED, V37, P256, DOI 10.1097/CCM.0b013e318192face; Webb A, 2004, P NATL ACAD SCI USA, V101, P2; ZIVIN JA, 1992, STROKE, V23, P767	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					609	617		10.1007/s00540-014-1968-6		9	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800019		
J	Ono, Y; Okubo, Y; Hashimoto, K; Inokuchi, R; Odajima, H; Tase, C; Shinohara, K				Ono, Yuko; Okubo, Yoshinori; Hashimoto, Katsuhiko; Inokuchi, Ryota; Odajima, Hajime; Tase, Choichiro; Shinohara, Kazuaki			Massive subcutaneous emphysema, bilateral pneumothorax, pneumomediastinum, pneumoperitoneum, pneumoretroperitoneum, and pneumoscrotum after multiple direct laryngoscopies: an autopsy case report	JOURNAL OF ANESTHESIA			English	Article						Airway management; Airway trauma; Cardiopulmonary resuscitation; Iatrogenic injury	INTUBATING LARYNGEAL MASK; DIFFICULT TRACHEAL INTUBATION; MAC VIDEO LARYNGOSCOPE; ENDOTRACHEAL INTUBATION; AIRWAY MANAGEMENT; EMERGENCY; ASSOCIATION; SURGERY; COMPLICATIONS; MULTICENTER	Multiple endotracheal intubation (ETI) attempts increase the risk of airway-related adverse events. However, little is known about autopsy findings after severe ETI-related complications. We present the detailed pathological findings in a patient with severe ETI-related complications. A 77-year-old obese male suffered cardiopulmonary arrest after choking at a rehabilitation facility. Spontaneous circulation returned after chest compressions and foreign-body removal. After multiple failed direct laryngoscopies, the patient was transferred to our hospital. He had massive subcutaneous emphysema, bilateral pneumothorax, pneumomediastinum, pneumoperitoneum, pneumoretroperitoneum, and pneumoscrotum on admission, and died from hypoxic brain injury 15 h later. Autopsy revealed severe oropharyngeal, laryngeal, and left lung lower lobe injury. The likely mechanisms of diffuse emphysema were (1) oropharyngeal injury associated with multiple ETI attempts and excessive ventilation pressures and (2) left lung lower lobe injury associated with chest compressions and other resuscitative procedures. Multiple laryngoscopies can cause severe upper-airway injury, worsen respiratory status, and make ETI more difficult-a vicious circle that can be prevented by limiting ETI attempts. This is particularly important in unfavorable environments, in which backup devices and personnel are not easily obtained. The pathological findings in our patient caution against repeated attempts at ETI during resuscitation.	[Ono, Yuko; Okubo, Yoshinori; Hashimoto, Katsuhiko; Inokuchi, Ryota; Shinohara, Kazuaki] Ohta Nishinouchi Hosp, Ohta Gen Hosp Fdn, Dept Anesthesiol, Koriyama, Fukushima 9638558, Japan; [Ono, Yuko; Tase, Choichiro] Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, Fukushima, Japan; [Inokuchi, Ryota] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Odajima, Hajime] Ohta Nishinouchi Hosp, Ohta Gen Hosp Fdn, Dept Pathol, Koriyama, Fukushima 9638558, Japan	Ono, Y (reprint author), Ohta Nishinouchi Hosp, Ohta Gen Hosp Fdn, Dept Anesthesiol, 2-5-20 Nishinouchi, Koriyama, Fukushima 9638558, Japan.	windmill@fmu.ac.jp					Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Frappier J, 2003, ANESTH ANALG, V96, P1510, DOI 10.1213/01.ANE.0000057003.91393.3C; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Sakles JC, 2012, ANN EMERG MED, V60, P739, DOI 10.1016/j.annemergmed.2012.03.031; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Caponas G, 2002, ANAESTH INTENS CARE, V30, P551; Connelly NR, 2006, J CLIN ANESTH, V18, P198, DOI 10.1016/j.jclinane.2005.08.011; Aziz MF, 2012, ANESTHESIOLOGY, V116, P629, DOI 10.1097/ALN.0b013e318246ea34; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Ufberg JW, 2005, AM J EMERG MED, V23, P379, DOI 10.1016/j.ajem.2005.02.005; Jungbauer A, 2009, BRIT J ANAESTH, V102, P546, DOI 10.1093/bja/aep013; McKenzie WS, 2009, J ORAL MAXIL SURG, V67, P1265, DOI 10.1016/j.joms.2008.12.050; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Cook TM, 2012, BRIT J ANAESTH, V109, pI68, DOI 10.1093/bja/aes393; Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Cavuslu Saban, 2004, Ear Nose Throat J, V83, P485; CHORTKOFF BS, 1992, ANESTHESIOLOGY, V77, P1225, DOI 10.1097/00000542-199212000-00027; DAVIES JM, 1990, CAN J ANAESTH, V37, P112; Gries CJ, 2007, RESPIR CARE, V52, P191; Japanese Society of Anesthesiologists, 2014, J ANESTH, V28, P482; Kihara S, 2000, ANESTH ANALG, V91, P195, DOI 10.1097/00000539-200007000-00037; Kim SW, 2014, YONSEI MED J, V55, P270, DOI 10.3349/ymj.2014.55.1.270; Magni G, 2008, ANESTH ANALG, V106, P249, DOI [10.1213/01.ane.0000289634.24785.04, 10.1213/01.ane.0000289634,24785.04]; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Watters KF, 2003, J LARYNGOL OTOL, V117, P899	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					622	626		10.1007/s00540-015-1997-9		5	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800021		
J	Tachibana, S; Hayase, T; Osuda, M; Kazuma, S; Yamakage, M				Tachibana, Shunsuke; Hayase, Tomo; Osuda, Michiko; Kazuma, Satoshi; Yamakage, Michiaki			Recovery of postoperative cognitive function in elderly patients after a long duration of desflurane anesthesia: a pilot study	JOURNAL OF ANESTHESIA			English	Article						Desflurane; Geriatric surgery; Postoperative cognitive dysfunction	SEVOFLURANE; SURGERY; DYSFUNCTION; POPULATION; ISOFLURANE; ACTIVATION; IMPROVES; BYPASS; SCORE	Postoperative cognitive dysfunction (POCD) increases morbidity and mortality. The mechanisms underlying POCD remain elusive; however, systemic responses induced by anesthesia and surgery might trigger neuroinflammation and POCD. Desflurane is a preferable volatile anesthetic agent for elderly patients because it facilitates shorter recovery from general anesthesia. The aim of this study was to determine whether quality of emergence and cognitive function in elderly patients undergoing a long duration desflurane anesthesia are better than those in the case of sevoflurane anesthesia. Forty-two patients who were older than 65 years of age and scheduled for surgery of more than 4 h in duration were enrolled in this study. Patients were randomly assigned to a desflurane anesthesia group (D group) and sevoflurane anesthesia group (S group). General anesthesia was maintained with 3.5 % desflurane (D group) and 1.0 % sevoflurane (S group). The Mini-Mental State Examination (MMSE) was used for assessing cognitive function 24 h before and after surgery. Postoperative MMSE score in the D group was significantly improved compared to that in the preoperative period. In conclusion, elderly patients undergoing desflurane anesthesia have significantly better quality of emergence and may have better cognitive function than those in elderly patients undergoing sevoflurane anesthesia.	[Tachibana, Shunsuke; Hayase, Tomo; Osuda, Michiko; Kazuma, Satoshi; Yamakage, Michiaki] Sapporo Med Univ, Sch Med, Dept Anesthesiol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Tachibana, S (reprint author), Sapporo Med Univ, Sch Med, Dept Anesthesiol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	shunsuke.tachibana@gmail.com			Baxter US	This work was financially supported by Baxter US.	ALDRETE JA, 1995, J CLIN ANESTH, V7, P89, DOI 10.1016/0952-8180(94)00001-K; Chen XG, 2001, ANESTH ANALG, V93, P1489, DOI 10.1097/00000539-200112000-00029; ALDRETE JA, 1970, ANESTH ANAL CURR RES, V49, P924; McKay RE, 2010, BRIT J ANAESTH, V104, P175, DOI 10.1093/bja/aep374; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; Bailey JM, 1997, ANESTH ANALG, V85, P681, DOI 10.1097/00000539-199709000-00036; Boisson-Bertrand D, 2006, ANAESTH INTENS CARE, V34, P338; Dimaculangan D, 2006, J NEUROSURG ANESTH, V18, P78, DOI 10.1097/01.ana.0000194705.67834.09; Ebert TJ, 2001, CAN J ANAESTH, V48, P133; Hovens IB, 2014, BRAIN BEHAV IMMUN; JONES RM, 1990, ANESTH ANALG, V70, P3; Kaur Amandeep, 2013, J Anaesthesiol Clin Pharmacol, V29, P36, DOI 10.4103/0970-9185.105792; Loepke AW, 2002, ANESTHESIOLOGY, V97, P1521, DOI 10.1097/00000542-200212000-00026; Magni G, 2009, ANESTH ANALG, V109, P567, DOI 10.1213/ane.0b013e3181ac1265; Malloy PF, 1997, J NEUROPSYCH CLIN N, V9, P189; Mutoh T, 2013, LIFE SCI, V92, P821, DOI 10.1016/j.lfs.2013.02.015; Muzi M, 1996, ANESTHESIOLOGY, V84, P1035, DOI 10.1097/00000542-199605000-00004; Vlisides P, 2012, CURR PHARM DESIGN, V18, P6232; Xu T, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-204	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					627	630		10.1007/s00540-015-1979-y		4	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800022		
J	Kawano, T; Takahashi, T; Kaminaga, S; Kadono, T; Yamanaka, D; Iwata, H; Eguchi, S; Yokoyama, M				Kawano, Takashi; Takahashi, Tetsuya; Kaminaga, Satomi; Kadono, Takao; Yamanaka, Daiki; Iwata, Hideki; Eguchi, Satoru; Yokoyama, Masataka			A comparison of midazolam and dexmedetomidine for the recovery of serotonin syndrome in rats	JOURNAL OF ANESTHESIA			English	Article						Serotonin syndrome; Midazolam; Dexmedetomidine	RELEASE	Serotonin syndrome is a drug-related toxicity caused by excess serotonin within the central nervous system. We recently encountered a case of serotonin syndrome that developed in the early postoperative period that was successfully treated with intravenous dexmedetomidine. Although the prescriptive literature has commonly recommended sedation with benzodiazepines for controlling agitation in serotonin syndrome, the effectiveness of dexmedetomidine has also been reported in several clinical conditions. In the present study, we conducted a reverse translational experiment to compare the efficacy of dexmedetomidine and midazolam, at equi-sedative doses, on serotonergic toxicity-like responses in rats. Animals were subcutaneously injected with 0.75 mg/kg 8-OH-DPAT, a full 5-HT1A agonist. 8-OH-DPAT-treated rats showed serotonin syndrome-like behaviors (low body posture, forepaw treading), hyperlocomotion, and decreased body temperature, which were completely inhibited by pretreatment with WAY 100635, a selective 5-HT1A antagonist (n = 8). Intramuscular injection of midazolam (1.0 mg/kg) or dexmedetomidine (0.01 mg/kg), which comparably induced observable signs of sedation, was tested in the present study. Concomitant treatment with midazolam significantly attenuated the hyperlocomotion, but failed to affect traditional serotonin syndrome behaviors and body temperature in 8-OH-DPAT-treated rats (n = 8). On the other hand, concomitant treatment with dexmedetomidine significantly attenuated all of these parameters (n = 8). The present case and related reverse translational experiment demonstrate that dexmedetomidine may be more beneficial for the treatment of serotonin syndrome compared to the current recommended treatment with benzodiazepines.	[Kawano, Takashi; Takahashi, Tetsuya; Yamanaka, Daiki; Iwata, Hideki; Yokoyama, Masataka] Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Nankoku, Kochi 7838505, Japan; [Kawano, Takashi; Kaminaga, Satomi; Kadono, Takao; Yokoyama, Masataka] Kochi Med Sch, Ctr Innovat & Translat Med, Interdisciplinary Pain Res Team, Nankoku, Kochi 7838505, Japan; [Eguchi, Satoru] Univ Tokushima, Sch Dent, Dept Dent Anesthesiol, Tokushima 770, Japan	Kawano, T (reprint author), Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	takashika@kochi-u.ac.jp					Akingbola OA, 2012, AM J CRIT CARE, V21, P456, DOI 10.4037/ajcc2012768; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Haberzettl R, 2013, BEHAV BRAIN RES, V256, P328, DOI 10.1016/j.bbr.2013.08.045; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Sallinen J, 1998, NEUROSCIENCE, V86, P959, DOI 10.1016/S0306-4522(98)00100-6; Gillman PK, 2005, BRIT J ANAESTH, V95, P434, DOI 10.1093/bja/aei210; Altman CS, 2010, ANESTH ANALG, V110, P526, DOI 10.1213/ANE.0b013e3181c76be9; Rastogi R, 2011, ANESTHESIOLOGY, V115, P1291, DOI 10.1097/ALN.0b013e31823940c0; Rushton WF, 2014, ANN PHARMACOTHER, V48, P1651, DOI 10.1177/1060028014549184; Hopwood SE, 2001, NEUROPHARMACOLOGY, V41, P433, DOI 10.1016/S0028-3908(01)00087-9; MAURA G, 1982, N-S ARCH PHARMACOL, V320, P272, DOI 10.1007/BF00510140; Nisijima K, 2003, NEUROCHEM INT, V43, P155, DOI 10.1016/S0197-0186(02)00213-9	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					631	634		10.1007/s00540-014-1973-9		4	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800023		
J	Oshima, Y; Minami, Y; Sakamoto, S; Yamasaki, K; Mochida, S; Funaki, K; Moriyama, N; Otsuki, A; Inagaki, Y				Oshima, Yoshiaki; Minami, Yukari; Sakamoto, Seiji; Yamasaki, Kazumasa; Mochida, Shinsuke; Funaki, Kazumi; Moriyama, Naoki; Otsuki, Akihiro; Inagaki, Yoshimi			Phosphoenolpyruvate administration protects ischemia-reperfusion injury in isolated rabbit lungs	JOURNAL OF ANESTHESIA			English	Article						Phosphoenolpyruvate; Ischemia-reperfusion injury; Isolated rabbit lungs; Capillary filtration coefficient	ISCHEMIA/REPERFUSION	Phosphoenolpyruvate (PEP) is an intermediate metabolite of the glycolytic pathway and an in vivo high-energy phosphate compound. We have examined the protective effects of PEP on ischemia-reperfusion lung injury in isolated rabbits lungs perfused with a physiological salt solution. The lungs were divided into three treatment groups: (1) ischemia-reperfusion (IR), (2) ischemia-reperfusion with PEP treatment (PEP-IR), in which 1 mM PEP was pre-administered into the perfusate during the stable period, and (3) ventilation-perfusion continued without interruption (Cont). In the IR and PEP-IR groups, ventilation-perfusion was discontinued for about 60 min after a 30-min stable period and then restarted. The capillary filtration coefficients (K (fc)) and pyruvate concentration in the perfusate were determined immediately before ischemia and 30 and 60 min after reperfusion. The left lungs were dried at the end of the experiment to calculate the tissue wet-to-dry weight ratio (W/D). The K (fc) values after reperfusion were significantly higher in the IR group than in the other two groups. Pyruvate concentrations were significantly higher at three time-points in the PEP-IR group than in the other two groups. The W/D was significantly higher in the IR group than in the other two groups. Based on these results, we conclude that the administration of PEP prior to lung ischemia alleviates lung ischemia-reperfusion injury.	[Oshima, Yoshiaki; Minami, Yukari; Sakamoto, Seiji; Yamasaki, Kazumasa; Mochida, Shinsuke; Funaki, Kazumi; Moriyama, Naoki; Otsuki, Akihiro; Inagaki, Yoshimi] Tottori Univ, Fac Med, Div Anesthesiol & Crit Care Med, Dept Surg, Yonago, Tottori 6838504, Japan	Oshima, Y (reprint author), Tottori Univ, Fac Med, Div Anesthesiol & Crit Care Med, Dept Surg, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	yoshimatomo@gmail.com			Japan Society for the Promotion of Science [22591729]	The authors thank Dr. Naoto Okazaki for his assistance in the chemical analysis and the K<INF>fc</INF> measurements. This work was supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C) 22591729].	Tawadrous ZS, 2002, SHOCK, V17, P473, DOI 10.1097/00024382-200206000-00006; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Hammerschmidt S, 2002, CHEST, V121, P573, DOI 10.1378/chest.121.2.573; FISHER AB, 1981, AM J PHYSIOL, V241, pE47; Fujii H, 1983, METHOD ENZYMAT AN, V3, P496; Golbidi S, 2003, BIOL PHARM BULL, V26, P336; HAMASAKI N, 1987, TRENDS BIOCHEM SCI, V12, P183, DOI 10.1016/0968-0004(87)90089-2; Ishitsuka Y, 2013, ISRN PHARM; Liu RY, 1999, ANESTH ANALG, V89, P561, DOI 10.1097/00000539-199909000-00004; Schutte H, 1998, AM J RESP CRIT CARE, V157, P171; Thompson JS, 1997, ANESTH ANALG, V84, P359, DOI 10.1097/00000539-199702000-00022	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					635	638		10.1007/s00540-014-1972-x		4	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800024		
J	Saito, I; Osaka, Y; Shimada, M				Saito, Ikue; Osaka, Yoshimune; Shimada, Muneaki			Transient third-degree AV block following sugammadex	JOURNAL OF ANESTHESIA			English	Letter							ANAPHYLAXIS		[Saito, Ikue; Osaka, Yoshimune; Shimada, Muneaki] Tokyo Metropolitan Otsuka Hosp, Dept Anesthesiol, Toshima Ku, Tokyo 1708476, Japan	Osaka, Y (reprint author), Tokyo Metropolitan Otsuka Hosp, Dept Anesthesiol, Toshima Ku, 2-8-1 Minami Ohtsuka, Tokyo 1708476, Japan.	bluesapphire1226@gmail.com					Puhringer FK, 2008, ANESTHESIOLOGY, V109, P188, DOI 10.1097/ALN.0b013e31817f5bc7; Dai W, 2000, N-S ARCH PHARMACOL, V361, P161, DOI 10.1007/s002109900171; Patterson LJ, 1999, CAN J ANAESTH, V46, P776	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					641	641		10.1007/s00540-015-1980-5		1	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800027		
J	Murata, H; Ichinomiya, T; Hara, T				Murata, Hiroaki; Ichinomiya, Taiga; Hara, Tetsuya			Pecs block for anesthesia in breast surgery of the elderly	JOURNAL OF ANESTHESIA			English	Letter						Pecs block; Breast surgery; Anesthesia			[Murata, Hiroaki; Ichinomiya, Taiga; Hara, Tetsuya] Nagasaki Univ, Sch Med, Dept Anesthesiol, Nagasaki 8528501, Japan	Murata, H (reprint author), Nagasaki Univ, Sch Med, Dept Anesthesiol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	h-murata@nagasaki-u.ac.jp					Bashandy GMN, 2015, REGION ANESTH PAIN M, V40, P68, DOI 10.1097/AAP.0000000000000163; Blanco R, 2012, Rev Esp Anestesiol Reanim, V59, P470, DOI 10.1016/j.redar.2012.07.003	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					644	644		10.1007/s00540-015-1992-1		1	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800030		
J	Yokota, T; Asai, T; Okuda, Y				Yokota, Taisuke; Asai, Takashi; Okuda, Yasuhisa			Unilateral bronchospasm during one-lung ventilation	JOURNAL OF ANESTHESIA			English	Letter									[Yokota, Taisuke; Asai, Takashi; Okuda, Yasuhisa] Dokkyo Med Univ, Dept Anesthesiol, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan	Yokota, T (reprint author), Dokkyo Med Univ, Dept Anesthesiol, Koshigaya Hosp, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	intensive2345@yahoo.co.jp					Asai T, 2014, J ANESTH, V28, P87, DOI 10.1007/s00540-013-1672-y	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					645	645		10.1007/s00540-014-1970-z		1	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800031		
J	Yagihara, M; Uemura, A; Miyabe, M				Yagihara, Masahiro; Uemura, Aki; Miyabe, Masayuki			SUZY forceps (TM) for the removal of an esophageal coin from a child	JOURNAL OF ANESTHESIA			English	Letter						Child; Foreign body; Airway devices; General anesthesia			[Yagihara, Masahiro; Uemura, Aki; Miyabe, Masayuki] Mie Univ Hosp, Dept Clin Anesthesia, Tsu, Mie, Japan	Yagihara, M (reprint author), Mie Univ Hosp, Dept Clin Anesthesia, Tsu, Mie, Japan.	yagi@rj8.so-net.ne.jp					Suzuki Akihiro, 2013, Saudi J Anaesth, V7, P360, DOI 10.4103/1658-354X.115352	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					646	646		10.1007/s00540-015-1977-0		1	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800032		
J	Kanazawa, M; Watanabe, M; Suzuki, T				Kanazawa, Masahiro; Watanabe, Mariko; Suzuki, Toshiyasu			Yellowing of desflurane in the vaporizer	JOURNAL OF ANESTHESIA			English	Letter									[Kanazawa, Masahiro; Watanabe, Mariko] Tokai Univ, Oiso Hosp, Div Anesthesia, Oiso, Kanagawa 2590198, Japan; [Suzuki, Toshiyasu] Tokai Univ, Sch Med, Dept Anesthesiol, Isehara, Kanagawa 2591143, Japan	Kanazawa, M (reprint author), Tokai Univ, Oiso Hosp, Div Anesthesia, 21-1 Gakkyo, Oiso, Kanagawa 2590198, Japan.	kanazawa@is.icc.u-tokai.ac.jp					Lobaz S, 2014, ANAESTHESIA, V69, P190, DOI 10.1111/anae.12566; Schulte TE, 2010, ANESTH ANALG, V110, P644, DOI 10.1213/ANE.0b013e3181c68b37	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2015	29	4					648	648		10.1007/s00540-014-1971-y		1	Anesthesiology	Anesthesiology	CP7QK	WOS:000360082800034		
J	Zhu, Y; Matsuyama, Y; Ohashi, Y; Setoguchi, S				Zhu, Ying; Matsuyama, Yutaka; Ohashi, Yasuo; Setoguchi, Soko			When to conduct probabilistic linkage vs. deterministic linkage? A simulation study	JOURNAL OF BIOMEDICAL INFORMATICS			English	Article						Record linkage; Probabilistic linkage; Deterministic linkage; Simulation study; Comparative validity	RECORD LINKAGE; HOSPITAL DISCHARGE; LINKING; HEALTH; REGISTRY; IDENTIFIERS; TRANSPARENT; ACCURACY; COHORT; CLAIMS	Introduction: When unique identifiers are unavailable, successful record linkage depends greatly on data quality and types of variables available. While probabilistic linkage theoretically captures more true matches than deterministic linkage by allowing imperfection in identifiers, studies have shown inconclusive results likely due to variations in data quality, implementation of linkage methodology and validation method. The simulation study aimed to understand data characteristics that affect the performance of probabilistic vs. deterministic linkage. Methods: We created ninety-six scenarios that represent real-life situations using non-unique identifiers. We systematically introduced a range of discriminative power, rate of missing and error, and file size to increase linkage patterns and difficulties. We assessed the performance difference of linkage methods using standard validity measures and computation time. Results: Across scenarios, deterministic linkage showed advantage in PPV while probabilistic linkage showed advantage in sensitivity. Probabilistic linkage uniformly outperformed deterministic linkage as the former generated linkages with better trade-off between sensitivity and PPV regardless of data quality. However, with low rate of missing and error in data, deterministic linkage performed not significantly worse. The implementation of deterministic linkage in SAS took less than 1 min, and probabilistic linkage took 2 min to 2 h depending on file size. Discussion: Our simulation study demonstrated that the intrinsic rate of missing and error of linkage variables was key to choosing between linkage methods. In general, probabilistic linkage was a better choice, but for exceptionally good quality data (<5% error), deterministic linkage was a more resource efficient choice. (C) 2015 Elsevier Inc. All rights reserved.	[Zhu, Ying; Matsuyama, Yutaka; Ohashi, Yasuo] Univ Tokyo, Grad Sch Med, Dept Biostat, Tokyo 1130033, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; [Setoguchi, Soko] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Setoguchi, Soko] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo 1130033, Japan	Zhu, Y (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sophie@epistat.m.u-tokyo.ac.jp					Gomatam S, 2002, STAT MED, V21, P1485, DOI 10.1002/sim.1147; Tromp M, 2008, J AM MED INFORM ASSN, V15, P654, DOI 10.1197/jamia.M2265; [Anonymous], 2012, MEDICARE MANAGED CAR; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Zingmond DS, 2004, J CLIN EPIDEMIOL, V57, P21, DOI 10.1016/S0895-4356(03)00250-6; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; [Anonymous], 2011, SAS REL 9 3; [Anonymous], 2012, NATL CARDIOVASCULAR; Meray N, 2007, J CLIN EPIDEMIOL, V60, P883, DOI 10.1016/j.jclinepi.2006.11.021; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Beauchamp A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-42; BELL RM, 1994, MED CARE, V32, P1004, DOI 10.1097/00005650-199410000-00003; Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Campbell Kevin M, 2008, Health Informatics J, V14, P5, DOI 10.1177/1460458208088855; Christen P., 2007, QUALITY MEASURES DAT, P127, DOI DOI 10.1007/978-3-540-44918-8_6; Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580; Ferrante A, 2012, J BIOMED INFORM, V45, P165, DOI 10.1016/j.jbi.2011.10.006; Howe G., 1981, COMPUT BIOMED RES, V14; Howe GR, 1998, EPIDEMIOL REV, V20, P112; JAMIESON E, 1995, METHOD INFORM MED, V34, P371; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Joffe E, 2014, J AM MED INFORM ASSN, V21, P97, DOI 10.1136/amiajnl-2013-001744; Lebreton E, 2014, REV EPIDEMIOL SANTE, V62, P257, DOI 10.1016/j.respe.2014.04.006; MUSE AG, 1995, STAT MED, V14, P499, DOI 10.1002/sim.4780140511; Newcombe H. B, 1988, HDB RECORD LINKAGE M; Roos LL, 1996, MED CARE, V34, P570, DOI 10.1097/00005650-199606000-00007; Setoguchi S, 2014, CIRC-CARDIOVASC QUAL, V7, P475, DOI 10.1161/CIRCOUTCOMES.113.000294; Smith M E, 1984, J Clin Comput, V13, P52; Tromp M, 2011, J CLIN EPIDEMIOL, V64, P565, DOI 10.1016/j.jclinepi.2010.05.008; Zhu Y., 2014, ISPES 30 ANN INT C P	32	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1532-0464	1532-0480		J BIOMED INFORM	J. Biomed. Inform.	AUG	2015	56						80	86		10.1016/j.jbi.2015.05.012		7	Computer Science, Interdisciplinary Applications; Medical Informatics	Computer Science; Medical Informatics	CP3BP	WOS:000359752100008		
J	Nguyen, NTH; Miwa, M; Tsuruoka, Y; Tojo, S				Nguyen, Nhung T. H.; Miwa, Makoto; Tsuruoka, Yoshimasa; Tojo, Satoshi			Identifying synonymy between relational phrases using word embeddings	JOURNAL OF BIOMEDICAL INFORMATICS			English	Article						Word embeddings; Synonym resolution; Relational phrase clustering; Topic modeling	BIOMEDICAL TEXT; NETWORKS	Many text mining applications in the biomedical domain benefit from automatic clustering of relational phrases into synonymous groups, since it alleviates the problem of spurious mismatches caused by the diversity of natural language expressions. Most of the previous work that has addressed this task of synonymy resolution uses similarity metrics between relational phrases based on textual strings or dependency paths, which, for the most part, ignore the context around the relations. To overcome this shortcoming, we employ a word embedding technique to encode relational phrases. We then apply the k-means algorithm on top of the distributional representations to cluster the phrases. Our experimental results show that this approach outperforms state-of-the-art statistical models including latent Dirichlet allocation and Markov logic networks. (C) 2015 Elsevier Inc. All rights reserved.	[Nguyen, Nhung T. H.] Vietnam Natl Univ, Univ Sci, Ho Chi Minh City, Vietnam; [Nguyen, Nhung T. H.; Tojo, Satoshi] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan; [Miwa, Makoto] Toyota Technol Inst, Tempaku Ku, Nagoya, Aichi 4688511, Japan; [Tsuruoka, Yoshimasa] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan	Nguyen, NTH (reprint author), Vietnam Natl Univ, Univ Sci, 227 Nguyen Van Cu St,Ward 4,Dist 5, Ho Chi Minh City, Vietnam.	nthnhung@jaist.ac.jp; makoto-miwa@toyota-ti.ac.jp; tsuruoka@logos.t.u-tokyo.ac.jp; tojo@jaist.ac.jp					Amigo E, 2009, INFORM RETRIEVAL, V12, P613, DOI 10.1007/s10791-009-9106-z; Banko M, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2670; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Erosheva E, 2004, P NATL ACAD SCI USA, V101, P5220, DOI 10.1073/pnas.0307760101; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Miyao Y, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1017; Min BN, 2012, INT J SEMANT WEB INF, V8, P1, DOI 10.4018/jswis.2012070101; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Devlin J., 2014, LONG PAPERS ASS COMP, V1, P1370; Etzioni O., 2009, J ARTIFICIAL INTELLI, V34, P255; Hashimoto K., 2013, P C EMP METH NAT LAN, P1372; Heller K.A., 2008, P 25 INT C MACH LEAR, P392, DOI 10.1145/1390156.1390206; Jurgens D., 2013, 2 JOINT C LEX COMP S, P290; Kim J O, 2009, Proceedings of the 2009 34th International Conference on Infrared, Millimeter, and Terahertz Waves. IORMMW-THz 2009, DOI 10.1109/ICIMW.2009.5324773; Kok S, 2008, LECT NOTES ARTIF INT, V5211, P624, DOI 10.1007/978-3-540-87479-9_59; Lin D., 2001, NAT LANG ENG, V7, P343; Matsuzaki T, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1671; Mikolov T., 2013, P WORKSH INT C LEARN; Mikolov T., 2013, ADV NEURAL INF PROCE, V26, P3111; Mikolov T., 2013, ABS13094168 CORR; Miyao Y., 2008, P 46 ANN M ASS COMP, P46; Navigli R., 2013, P IJCAI, P2148; Nebot V., 2014, KNOWL INF SYST, V38, P369; Nguyen N.T.H., 2013, P 5 INT S LANG BIOL, P51; Nguyen NTH, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0538-8; Pyysalo S., 2013, P 5 INT S LANG BIOL, P39; Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, P237; Rei M., 2011, P BIONLP 2011 WORKSH, P10; Rimell L, 2013, J BIOMED INFORM, V46, P228, DOI 10.1016/j.jbi.2013.01.001; Rindflesch Thomas C., 2011, Information Services & Use, V31, DOI 10.3233/ISU-2011-0627; Ritter A., 2010, P 48 ANN M ASS COMP, P424; Socher R., 2011, P C EMP METH NAT LAN, P151; Socher Richard, 2011, ADV NEURAL INFORM PR, V24, P801; Sun L., 2009, P 2009 C EMP METH NA, V2, P638, DOI 10.3115/1699571.1699596; Tamura A., 2014, LONG PAPERS ASS COMP, V1, P1470; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-397; Tsuruoka Y, 2011, BIOINFORMATICS, V27, P111; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552; Wallach Hanna M., 2009, P 26 ANN INT C MACH, P1105; Zou W.Y., 2013, P C EMP METH NAT LAN, P1393	43	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1532-0464	1532-0480		J BIOMED INFORM	J. Biomed. Inform.	AUG	2015	56						94	102		10.1016/j.jbi.2015.05.010		9	Computer Science, Interdisciplinary Applications; Medical Informatics	Computer Science; Medical Informatics	CP3BP	WOS:000359752100010		
J	Numamoto, M; Tagami, S; Ueda, Y; Imabeppu, Y; Sasano, Y; Sugiyama, M; Maekawa, H; Harashima, S				Numamoto, Minori; Tagami, Shota; Ueda, Yusuke; Imabeppu, Yusuke; Sasano, Yu; Sugiyama, Minetaka; Maekawa, Hiromi; Harashima, Satoshi			Nuclear localization domains of GATA activator Gln3 are required for transcription of target genes through dephosphorylation in Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Saccharomyces cerevisiae; G1n3; Transcriptional activity; Intracellular localization; Nuclear localization signal; Nuclear export signal	YEAST; PROTEIN; TOR; PHOSPHATASE; NITROGEN; URE2P; PHOSPHORYLATION; RAPAMYCIN; KINASE; BINDING	The GATA transcription activator Gln3 in the budding yeast (Saccharomyces cerevisiae) activates transcription of nitrogen catabolite repression (NCR)-sensitive genes. In cells grown in the presence of preferred nitrogen sources, Gln3 is phosphorylated in a TOR-dependent manner and localizes in the cytoplasm. In cells grown in non-preferred nitrogen medium or treated with rapamycin, Gln3 is dephosphorylated and is transported from the cytoplasm to the nucleus, thereby activating the transcription of NCR-sensitive genes. Caffeine treatment also induces dephosphorylation of Gln3 and its translocation to the nucleus and transcription of NCR-sensitive genes. However, the details of the mechanism by which phosphorylation controls Gln3 localization and transcriptional activity are unknown. Here, we focused on two regions of Gln3 with nuclear localization signal properties (NLS-K, and NIS-C) and one with nuclear export signal (NES). We constructed various mutants for our analyses: gln3 containing point mutations in all potential phosphoacceptor sites (Thr-339, Ser-344, Ser-347, Ser-355, Ser-391) in the NLS and NES regions to produce non-phosphorylatable (alanine) or mimic-phosphorylatable (aspartic acid) residues; and deletion mutants. We found that phosphorylation of Gln3 was impaired in all of these mutations and that the aspartic acid substitution mutants showed drastic reduction of Gln3mediated transcriptional activity despite the fact that the mutations had no effect on nuclear localization of Gln3. Our observations suggest that these regions are required for transcription of target genes presumably through dephosphorylation. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Numamoto, Minori; Tagami, Shota; Ueda, Yusuke; Imabeppu, Yusuke; Sasano, Yu; Sugiyama, Minetaka; Harashima, Satoshi] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Maekawa, Hiromi] Osaka Univ, Yeast Genet Resources Lab, Grad Sch Engn, Suita, Osaka 5650871, Japan	Harashima, S (reprint author), Osaka Univ, Dept Biotechnol, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	harashima@bio.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19380193]	This work was partially supported by a Grant-in-Aid for Scientific Research B [19380193], 2007 to 2009, to S. H. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. M. N. expresses special thanks to the Global Center of Excellence (COE) Program "Global Education and Research Center for Bio-Environment Chemistry" of Osaka University. The authors thank Prof. Y. Kaneko for helpful discussions.	Beck T, 1999, NATURE, V402, P689; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Spellman PT, 1998, MOL BIOL CELL, V9, P3273; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; SUTTON A, 1991, MOL CELL BIOL, V11, P2133; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Blinder D, 1996, J BACTERIOL, V178, P4734; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Carvalho J., 2001, J BIOL CHEM, V276, P25359; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162; Hirasaki M, 2008, GENE, V409, P34, DOI 10.1016/j.gene.2007.11.005; NOJIMA H, 1994, NUCLEIC ACIDS RES, V22, P5279, DOI 10.1093/nar/22.24.5279; Numamoto M, 2015, J BIOCHEM, V157, P53, DOI 10.1093/jb/mvu055; Sambrook E. F., 1989, MOL CLONING LAB MANU	26	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					121	127		10.1016/j.jbiosc.2014.12.017		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400001		
J	Nakaya, Y; Iijima, H; Takanobu, J; Watanabe, A; Hirai, MY; Osanai, T				Nakaya, Yuka; Iijima, Hiroko; Takanobu, Junko; Watanabe, Atsuko; Hirai, Masami Yokota; Osanai, Takashi			One day of nitrogen starvation reveals the effect of sigE and rre37 overexpression on the expression of genes related to carbon and nitrogen metabolism in Synechocystis sp PCC 6803	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Cyanobacteria; Gene expression; Genetic engineering; Metabolism; Transcription	SP STRAIN PCC-6803; CYANOBACTERIUM SYNECHOCYSTIS; RESPONSE REGULATOR; SYNECHOCOCCUS; IDENTIFICATION; NTCA; ASSIMILATION; ACTIVATION; PROTEIN; RNA	Acclimation to nitrogen starvation is indispensable for the survival of cyanobacteria under natural environmental conditions. SigE and Rre37 are transcriptional regulators whose transcript and protein levels increase during nitrogen starvation. Previous work has shown that overexpression of either sigE or rre37 in the unicellular cyanobacterium Synechocystis sp. PCC 6803 activates the expression of genes related to sugar catabolism and polyhydroxybutyrate (PHB) biosynthesis, although their transcript levels were measured using the cells grown under nitrogen-replete conditions or after 4 h of nitrogen depletion. In this study, the transcript levels were quantified at one day after nitrogen depletion in the wild-type, sigE-overexpressing, and rre37-overexpressing cells. The results showed decreased expression of sugar catabolic enzymes after one day of nitrogen depletion in the wild-type strain. The levels of transcripts related to glycogen catabolism, glycolysis, and PHB biosynthesis were not increased by either sigE or rre37 overexpression after one day of nitrogen depletion. The expression of genes related to nitrogen assimilation and nitrate/nitrite transport was also reduced by either sigE or rre37 overexpression after nitrogen starvation, suggesting the genetic engineering had a phase-dependent effect on gene expression during nitrogen starvation. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Nakaya, Yuka; Iijima, Hiroko; Takanobu, Junko; Watanabe, Atsuko; Hirai, Masami Yokota; Osanai, Takashi] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Osanai, T (reprint author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	takashi.osanai.aa@riken.jp	Hirai, Masami/D-5319-2009	Hirai, Masami/0000-0003-0802-6208	Ministry of Education, Culture, Sports, Science, and Technology, Japan; CREST from Japan Science and Technology Agency; ALCA from Japan Science and Technology Agency	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by a grant to T.O. from CREST from the Japan Science and Technology Agency and ALCA from the Japan Science and Technology Agency (Project name "Production of cyanobacterial succinate by the genetic engineering of transcriptional regulators and circadian clocks"). We have no conflict of interest to declare.	Aichi M, 2001, J BACTERIOL, V183, P5840, DOI 10.1128/JB.183.20.5840-5847.2001; Miyake M, 1997, J BACTERIOL, V179, P5009; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Osanai T, 2013, PLANT J, V76, P456, DOI 10.1111/tpj.12310; Hein S, 1998, ARCH MICROBIOL, V170, P162, DOI 10.1007/s002030050629; VEGAPALAS MA, 1992, MOL MICROBIOL, V6, P1853, DOI 10.1111/j.1365-2958.1992.tb01357.x; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Tanigawa R, 2002, P NATL ACAD SCI USA, V99, P4251, DOI 10.1073/pnas.072587199; Vazquez-Bermudez MF, 2002, FEBS LETT, V512, P71, DOI 10.1016/S0014-5793(02)02219-6; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Osanai T, 2014, PLANT PHYSIOL, V164, P1831, DOI 10.1104/pp.113.232025; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Osanai T, 2013, DNA RES, V20, P525, DOI 10.1093/dnares/dst028; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Zorina A, 2011, DNA RES, V18, P137, DOI 10.1093/dnares/dsr006; ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Montesinos ML, 1998, J BIOL CHEM, V273, P31463, DOI 10.1074/jbc.273.47.31463; Diaz-Troya S, 2014, MOL PLANT, V7, P87, DOI 10.1093/mp/sst137; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Fang FC, 2005, P NATL ACAD SCI USA, V102, P4933, DOI 10.1073/pnas.0501417102; Fu J, 2006, FEMS MICROBIOL LETT, V260, P201, DOI 10.1111/j.1574-6968.2006.00312.x; Garcia-Dominguez M, 1997, PLANT MOL BIOL, V35, P723, DOI 10.1023/A:1005846626187; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Koksharova M., 1998, PLANT MOL BIOL, V36, P183; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; MuroPastor MI, 1996, J BACTERIOL, V178, P4070; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/ds1010; Osanai T, 2014, ENVIRON MICROBIOL, V16, P3304, DOI 10.1111/1462-2920.12554; Reyes JC, 1997, J BACTERIOL, V179, P2678; Shimakawa G., 2014, BIOSCI BIOTECH BIOCH, V5, P1; SUZUKI I, 1995, J BACTERIOL, V177, P290; Tabei Y, 2007, BIOCHEM BIOPH RES CO, V355, P1045, DOI 10.1016/j.bbrc.2007.02.065; Taroncher-Oldenberg G, 2000, APPL ENVIRON MICROB, V66, P4440, DOI 10.1128/AEM.66.10.4440-4448.2000; VEGAPALAS MA, 1990, J BACTERIOL, V172, P643	41	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					128	134		10.1016/j.jbiosc.2014.12.020		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400002		
J	Kajihata, S; Matsuda, F; Yoshimi, M; Hayakawa, K; Furusawa, C; Kanda, A; Shimizu, H				Kajihata, Shuichi; Matsuda, Fumio; Yoshimi, Mika; Hayakawa, Kenshi; Furusawa, Chikara; Kanda, Akihisa; Shimizu, Hiroshi			C-13-based metabolic flux analysis of Saccharomyces cerevisiae with a reduced Crabtree effect	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						C-13-based metabolic flux analysis; Crabtree effect; Central carbon metabolism; Saccharomyces cerevisiae; Redox balance	OXIDATIVE-PHOSPHORYLATION; YEAST; IDENTIFICATION; GLUCOSE; STRAINS; NETWORK; GROWTH; ENZYME	Saccharomyces cerevisiae shows a Crabtree effect that produces ethanol in a high glucose concentration even under fully aerobic condition. For efficient production of cake yeast or compressed yeast for baking, ethanol by-production is not desired since glucose limited chemostat or fed-batch cultivations are performed to suppress the Crabtree effect. In this study, the C-13-based metabolic flux analysis (C-13-MFA) was performed for the S288C derived S. cerevisiae strain to characterize a metabolic state under the reduced Crabtree effect. S. cerevisiae cells were cultured at a low dilution rate (0.1 h(-1)) under the glucose-limited chemostat condition. The estimated metabolic flux distribution showed that the acetyl-CoA in mitochondria was mainly produced from pyruvate by pyruvate dehydrogenase (PDH) reaction and that the level of the metabolic flux through the pentose phosphate pathway was much higher than that of the Embden-Meyerhof-Parnas pathway, which contributes to high biomass yield at low dilution rate by supplying NADPH required for cell growth. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Kajihata, Shuichi; Matsuda, Fumio; Yoshimi, Mika; Furusawa, Chikara; Shimizu, Hiroshi] Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Hayakawa, Kenshi] Osaka Univ, KANEICA Fundamental Technol Res Alliance Labs, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan; [Kanda, Akihisa] KANEKA Corp, New & Fundamental Technol Grp, Proc Technol Labs, Takasago, Hyogo 6768688, Japan	Shimizu, H (reprint author), Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	s-kajihata@istosaka-u.ac.jp; fmatsuda@istosaka-u.ac.jp; mika_yoshimi@bio.eng.osaka-u.ac.jp; Kenshi.Hayakawa@kaneka.co.jp; chikaralurusawa@riken.jp; Akihisa_Kanda@kn.kaneka.co.jp; shimizu@istosaka-u.ac.jp					Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Kajihata S, 2014, BIOMED RES INT, DOI 10.1155/2014/627014; Brachmann CB, 1998, YEAST, V14, P115; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149; Rigoulet M, 2004, MOL CELL BIOCHEM, V256, P73, DOI 10.1023/B:MCBI.0000009888.79484.fd; Larsson C, 1998, YEAST, V14, P347, DOI 10.1002/(SICI)1097-0061(19980315)14:4<347::AID-YEA226>3.3.CO;2-0; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; BOITEUX A, 1970, FEBS LETT, V9, P293, DOI 10.1016/0014-5793(70)80381-7; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; Costenoble R, 2007, FEMS YEAST RES, V7, P511, DOI 10.1111/j.1567-1364.2006.00199.x; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Mori E, 2011, BIOTECHNOL J, V6, P1377, DOI 10.1002/biot.201000446; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; ITO H, 1983, J BACTERIOL, V153, P163; Bruinenberg P M, 1986, Yeast, V2, P117, DOI 10.1002/yea.320020207; dos Santos MM, 2003, EUKARYOT CELL, V2, P599, DOI 10.1128/EC.2.3.599-608.2003; Hong KK, 2012, FEMS YEAST RES, V12, P741, DOI 10.1111/j.1567-1364.2012.00823.x; KRESZE GB, 1981, EUR J BIOCHEM, V119, P573, DOI 10.1111/j.1432-1033.1981.tb05646.x; Kummel A., 2010, FEMS YEAST RES, V10, P322; Lahtvee PJ, 2014, MICROBIOL-SGM, V160, P1501, DOI 10.1099/mic.0.078089-0; Okahashi Nobuyuki, 2014, Metabolites, V4, P408, DOI 10.3390/metabo4020408; OUHABI R, 1989, FEBS LETT, V254, P199, DOI 10.1016/0014-5793(89)81038-5	27	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					140	144		10.1016/j.jbiosc.2014.12.014		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400004		
J	Nurdiani, D; Ito, M; Maruyama, T; Terahara, T; Mori, T; Ugawa, S; Takeyama, H				Nurdiani, Dini; Ito, Michihiro; Maruyama, Toru; Terahara, Takeshi; Mori, Tetsushi; Ugawa, Shin; Takeyama, Haruko			Analysis of bacterial xylose isomerase gene diversity using gene-targeted metagenomics	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Xylose; Xylose isomerase; Metagenome; Next generation sequencing; Biodiversity; Lignocellulosic biomass; Bioethanol production	RECOMBINANT SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; GUT MICROBIOTA; FERMENTATION; SOIL; FORESTS; QUALITY; STRAIN; ERRORS	Bacterial xylose isomerases (XI) are promising resources for efficient biofuel production from xylose in lignocellulosic biomass. Here, we investigated xylose isomerase gene (xylA) diversity in three soil metagenomes differing in plant vegetation and geographical location, using an amplicon pyrosequencing approach and two newly-designed primer sets. A total of 158,555 reads from three metagenomic DNA replicates for each soil sample were classified into 1127 phylotypes, detected in triplicate and defined by 90% amino acid identity. The phylotype coverage was estimated to be within the range of 84.0-92.7%. The xylA gene phylotypes obtained were phylogenetically distributed across the two known xylA groups. They shared 49-100% identities with their closest-related XI sequences in GenBank. Phylotypes demonstrating <90% identity with known Xis in the database accounted for 89% of the total xylA phylotypes. The differences among xylA members and compositions within each soil sample were significantly smaller than they were between different soils based on a UniFrac distance analysis, suggesting soil-specific xylA genotypes and taxonomic compositions. The differences among xylA members and their compositions in the soil were strongly correlated with 16S rRNA variation between soil samples, also assessed by amplicon pyrosequencing. This is the first report of xylA diversity in environmental samples assessed by amplicon pyrosequencing. Our data provide information regarding xylA diversity in nature, and can be a basis for the screening of novel xylA genotypes for practical applications. 2015, The Society for Biotechnology, Japan. All rights reserved.	[Nurdiani, Dini; Maruyama, Toru; Terahara, Takeshi; Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Ito, Michihiro; Takeyama, Haruko] Waseda Univ, Inst Nanosci & Nanotechnol, Tokyo 1620041, Japan; [Ito, Michihiro; Maruyama, Toru; Mori, Tetsushi; Takeyama, Haruko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Terahara, Takeshi] Waseda Univ, ICSEP, Tokyo 1698555, Japan; [Ugawa, Shin] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Takeyama, H (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsucho, Tokyo 1628480, Japan.	haruko-takeyama@waseda.jp			New Energy and Industrial Technology Development Organization (NEDO); Global COE Program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) Center for Practical Chemical Wisdom; High-Tech Research Center Project for Private Universities: matching fund subsidy from MEXT; Core Research for Evolutionary Science and Technology Project (CREST)	This work was partially supported by grants from the New Energy and Industrial Technology Development Organization (NEDO), Global COE Program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) Center for Practical Chemical Wisdom, High-Tech Research Center Project for Private Universities: matching fund subsidy from MEXT, and Core Research for Evolutionary Science and Technology Project (CREST). We thank Dr. Yuko Ito to support the soil sampling.	Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; JOHANSSON MB, 1995, FORESTRY, V68, P49, DOI 10.1093/forestry/68.1.49; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Bao ZH, 2012, MICROBES ENVIRON, V27, P72, DOI 10.1264/jsme2.ME11281; Woodhouse JN, 2013, ISME J, V7, P1842, DOI 10.1038/ismej.2013.65; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Harhangi HR, 2003, ARCH MICROBIOL, V180, P134, DOI 10.1007/s00203-003-0565-0; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Karhumaa K, 2005, YEAST, V22, P359, DOI 10.1002/yea.1216; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; Zheng H, 2013, MICROBES ENVIRON, V28, P491, DOI 10.1264/jsme2.ME13082; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; CHAO A, 1984, SCAND J STAT, V11, P265; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Howard EC, 2011, APPL ENVIRON MICROB, V77, P524, DOI 10.1128/AEM.01457-10; HSIAO HY, 1982, ENZYME MICROB TECH, V4, P25, DOI 10.1016/0141-0229(82)90006-0; Ishii S, 2011, ISME J, V5, P1936, DOI 10.1038/ismej.2011.69; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; Lema KA, 2014, ENVIRON MICROBIOL, V16, P3345, DOI 10.1111/1462-2920.12366; Nagata Y, 2011, ENZYME MICROB TECH, V49, P499, DOI 10.1016/j.enzmictec.2011.10.005; Ono K., 2003, J FOR RES, V8, P191, DOI DOI 10.1007/S10310-003-0026-2; Parachin NS, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-9; Park JH, 2004, APPL ENVIRON MICROB, V70, P4318, DOI 10.1128/AEM.70.7.4318-4325.2004; Shannon C. E., 1984, MATH THEORY COMMUNIC; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simberloff D., 1978, BIOL DATA WATER POLL, P150, DOI 10.1520/STP35663S; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; Wang Q., 2013, MBIO, V4; Zhang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-198	43	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					174	180		10.1016/j.jbiosc.2014.12.022		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400009		
J	Fujiki, Y; Kumada, Y; Kishimoto, M				Fujiki, Yuya; Kumada, Yoichi; Kishimoto, Michimasa			Phase analysis in single-chain variable fragment production by recombinant Pichia pastoris based on proteomics combined with multivariate statistics	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Phase analysis; Single-chain variable fragment; Pichia pastoris; Proteomics; Cancerd2; Two-dimensional gel electrophoresis; Peptide mass fingerprinting	METHANOL CONCENTRATION; ANTIBODY FRAGMENT; FED-BATCH; EXPRESSION; CULTURE; ELECTROPHORESIS; STATE	The proteomics technique, which consists of two-dimensional gel electrophoresis (2-DE), peptide mass fingerprinting (PMF), gel image analysis, and multivariate statistics, was applied to the phase analysis of a fed-batch culture for the production of a single-chain variable fragment (scFv) of an anti-C-reactive protein (CRP) antibody by Pichia pastoris. The time courses of the fed-batch culture were separated into three distinct phases: the growth phase of the batch process, the growth phase of the fed-batch process, and the production phase of the fed-batch process. Multivariate statistical analysis using 2-DE gel image analysis data clearly showed the change in the culture phase and provided information concerning the protein expression, which suggested a metabolic change related to cell growth and production during the fed-batch culture. Furthermore, specific proteins, such as alcohol oxidase, which is strongly related to scFv expression, and proteinase A, which could biodegrade scFv in the latter phases of production, were identified via the PMF method. The proteomics technique provided valuable information about the effect of the methanol concentration on scFv production. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Fujiki, Yuya; Kumada, Yoichi; Kishimoto, Michimasa] Kyoto Inst Technol, Dept Chem & Mat, Sakyo Ku, Kyoto 6068585, Japan; [Fujiki, Yuya; Kumada, Yoichi; Kishimoto, Michimasa] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan	Kishimoto, M (reprint author), Kyoto Inst Technol, Dept Chem & Mat, Sakyo Ku, Kyoto 6068585, Japan.	kishimoto@kit.jp					Yamawaki S, 2007, J BIOSCI BIOENG, V104, P403, DOI 10.1263/jbb.104.403; Damasceno LM, 2007, APPL MICROBIOL BIOT, V74, P381, DOI 10.1007/s00253-006-0652-7; [Anonymous], 1983, IEEE COMPUT, DOI DOI 10.1109/MC.1983.1654163; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Ciaccio C, 2006, BIOCHEM J, V395, P295, DOI 10.1042/BJ20051385; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Freyre FM, 2000, J BIOTECHNOL, V76, P157, DOI 10.1016/S0168-1656(99)00183-2; Guarna MM, 1997, BIOTECHNOL BIOENG, V56, P279, DOI 10.1002/(SICI)1097-0290(19971105)56:3&lt;279::AID-BIT5&gt;3.0.CO;2-G; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Horiuchi J., 1999, J BIOSCI BIOENG, V87, P358; Izawa N, 2006, PROTEOMICS, V6, P3730, DOI 10.1002/pmic.200500542; Katakura Y, 1998, J FERMENT BIOENG, V86, P482, DOI 10.1016/S0922-338X(98)80156-6; Kharti N. K., 2006, BIOTECHNOL BIOENG, V93, P871; KISHIMOTO M, 1991, J FERMENT BIOENG, V72, P110, DOI 10.1016/0922-338X(91)90319-C; Kishimoto M., 2010, J ELECTROPHOR, V51, P1; Kuroda K, 2007, FEMS YEAST RES, V7, P1307, DOI 10.1111/j.1567-1364.2007.00291.x; Lee CY, 2003, ENZYME MICROB TECH, V33, P358, DOI 10.1016/S0141-0229(03)00146-7; Wan L, 2008, APPL MICROBIOL BIOT, V81, P33, DOI 10.1007/s00253-008-1568-1	18	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					187	192		10.1016/j.jpiosc.2014.12.015		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400011		
J	Honjo, H; Tsuruno, K; Tatsuke, T; Sato, M; Hanai, T				Honjo, Hiroshi; Tsuruno, Keigo; Tatsuke, Tsuneyuki; Sato, Masaki; Hanai, Taizo			Dual synthetic pathway for 3-hydroxypropionic acid production in engineered Escherichia coli	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						3-Hydroxypropionic acid; Dual synthetic pathway; Escherichia coli; Metabolic engineering; Synthetic biology	GLYCEROL METABOLISM; KLEBSIELLA-PNEUMONIAE; BIOSYNTHESIS; 1,3-PROPANEDIOL; STRAIN; ALDH	3-Hydroxypropionic acid (3-HP) is an important platform C3 chemical; production of 3-HP in recombinant Escherichia coli by synthetic pathways has been the focus of a lot of research. When glycerol is used as a substrate to produce 3-HP in E. coli, only the ALDH pathway (employing aldehyde dehydrogenase (ALDH) for conversion of 3-hydroxypropionaldehyde (3-HPA) into 3-HP) has been utilized as a synthetic pathway. However, several bacteria (including Klebsiena pneumoniae) are known to have the ability to produce 3-HP by the Pdu pathway (employing the PduP, PduL, and PduW enzymes). Here, we report the production of 3-HP in E. con by using the Pdu pathway from K. pneumoniae as a synthetic pathway. Moreover, a strain harboring a dual synthetic pathways (ALDH and Pdu) exhibited a 70% increase in 3-HP titer compared to one harboring the ALDH pathway alone (56.1 +/- 0.736 mM and 33.1 +/- 0.920 mM, respectively). To our knowledge, this is the first report of 3-HP production by E. con harboring the Pdu pathway, with the dual synthetic pathway showing the highest yield ever reported by batch culture [54.1% (mol/mol)]. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Honjo, Hiroshi; Tsuruno, Keigo; Tatsuke, Tsuneyuki; Sato, Masaki; Hanai, Taizo] Kyushu Univ, Grad Sch Syst Life Sci, Lab Bioinformat, Higashi Ku, Fukuoka 8128582, Japan	Hanai, T (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Lab Bioinformat, Higashi Ku, 804 Westwing,3-1-1 Maidashi, Fukuoka 8128582, Japan.	taizo@brs.kyushu-u.ac.jp			JSPS [23119002]	This research was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas Grant number 23119002.	Connor MR, 2008, APPL ENVIRON MICROB, V74, P5769, DOI 10.1128/AEM.00468-08; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; Inokuma K, 2010, J BIOSCI BIOENG, V110, P696, DOI 10.1016/j.jbiosc.2010.07.010; McKenna R, 2011, METAB ENG, V13, P544, DOI 10.1016/j.ymben.2011.06.005; Huang YN, 2013, BIORESOURCE TECHNOL, V128, P505, DOI 10.1016/j.biortech.2012.10.143; Bobik TA, 1999, J BACTERIOL, V181, P5967; TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854; Nishizaki T, 2007, APPL ENVIRON MICROB, V73, P1355, DOI 10.1128/AEM.02268-06; Kwak S, 2013, BIORESOURCE TECHNOL, V135, P432, DOI 10.1016/j.biortech.2012.11.063; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Ashok S, 2013, METAB ENG, V15, P10, DOI 10.1016/j.ymben.2012.09.004; Zhao YR, 2011, APPL MICROBIOL BIOT, V90, P1915, DOI 10.1007/s00253-011-3199-1; Shen CR, 2013, METAB ENG, V17, P12, DOI 10.1016/j.ymben.2013.01.008; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/nchembio.970, 10.1038/NCHEMBIO.970]; Ishii M, 2004, APPL MICROBIOL BIOT, V64, P605, DOI 10.1007/s00253-003-1540-z; Soma Y, 2014, METAB ENG, V23, P175, DOI 10.1016/j.ymben.2014.02.008; Ainala SK, 2013, APPL MICROBIOL BIOT, V97, P5001, DOI 10.1007/s00253-013-4726-z; Luo LH, 2012, BIORESOURCE TECHNOL, V103, P1, DOI 10.1016/j.biortech.2011.09.099; Raj SM, 2008, PROCESS BIOCHEM, V43, P1440, DOI 10.1016/j.procbio.2008.04.027; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Jung WS, 2014, METAB ENG, V23, P116, DOI 10.1016/j.ymben.2014.03.001; Chu HS, 2015, BIOTECHNOL BIOENG, V112, P356, DOI 10.1002/bit.25444; Hu SJ, 2012, J AGR FOOD CHEM, V60, P5915, DOI 10.1021/jf3008629; Johnson DT, 2007, ENVIRON PROG, V26, P338, DOI 10.1002/ep.10225; Kumar V, 2013, BIOTECHNOL ADV, V31, P945, DOI 10.1016/j.biotechadv.2013.02.008; Kim K, 2014, BIORESOURCE TECHNOL, V156, P170, DOI 10.1016/j.biortech.2014.01.009; Sankaranarayanan M, 2014, J IND MICROBIOL BIOT, V41, P1039, DOI 10.1007/s10295-014-1451-2; SLININGER PJ, 1983, APPL ENVIRON MICROB, V46, P62; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64; Valdehuesa L. N., 2013, APPL MICROBIOL BIOT, V97, P3309; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859.RETRIEVED; Yasuda S., 2007, US patent, Patent No. [US20070148749, 20070148749]	34	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					199	204		10.1016/j.jbiosc.2014.12.023		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400013		
J	Honda, S; Nagamune, T; Kawahara, M				Honda, Shingo; Nagamune, Teruyuki; Kawahara, Masahiro			Selection of cDNA candidates that induce oligomerization of NLRP3 using a chimeric receptor approach	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Protein oligomer; Chimeric receptor; Tyrosine phosphorylation; cDNA library; Mammalian cell	NOD-LIKE RECEPTORS; INFLAMMASOME ACTIVATION; MAMMALIAN-CELLS; TYROSINE KINASE; GENE; KIT; IMMUNITY; DEATH; DESTABILIZATION; DIMERIZATION	Since diverse cellular events are regulated by protein oligomerization, identification of molecules that affect oligomerization of a target protein is important for understanding cellular physiology and developing therapeutics. In this study, we aimed to screen cDNA candidates that induce oligomerization of NLRP3, which is one of the important inflammatory sensor proteins, in mammalian cytoplasm. In our screening method, the chimera composed of NLRP3 and the kinase domain of c-kit, one of the receptor tyrosine kinases (RTKs) activated by oligomerization, is expressed in cytoplasm of an IL-3-dependent mammalian cell line. The cells are then transduced with a cDNA library, and cultured in the absence of IL-3. If the transduced cDNA is a NLRP3 activator, the kinase domain of the NLRP3-c-kit chimera is activated by oligomerization, which induces cell growth even in the absence of IL-3. Using this system, constitutive oligomers of two NLRP3 variants were clearly detected by cell growth. Furthermore, cDNA screening resulted in identification of three distinct cDNAs that are potential candidates of NLRP3 activators. These results demonstrate the utility of our chimeric receptor-based system for screening candidates that induce oligomerization of a target protein. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Honda, Shingo; Nagamune, Teruyuki; Kawahara, Masahiro] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Kawahara, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kawahara@bio.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23656516]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Global COE Program for Chemistry Innovation	We are grateful to Dr. Toshio Kitamura (The University of Tokyo) for the retroviral expression system, and ARIAD Pharmaceuticals for the ARGENT dimerization kit and dimerizer reagent. This work was supported by Grant-in-Aid for Challenging Exploratory Research 23656516 (M.K.) from Japan Society for the Promotion of Science (JSPS), by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (M.K.), and by the Global COE Program for Chemistry Innovation.	Lupfer C, 2013, IMMUNOL REV, V255, P13, DOI 10.1111/imr.12089; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Aganna E, 2002, ARTHRITIS RHEUM, V46, P2445, DOI 10.1002/art.10509; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Horng T, 2014, TRENDS IMMUNOL, V35, P253, DOI 10.1016/j.it.2014.02.007; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; Kaneko E, 2012, J BIOSCI BIOENG, V113, P641, DOI 10.1016/j.jbiosc.2011.12.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Bandyopadhyay S, 2013, BIOCHEM BIOPH RES CO, V439, P407, DOI 10.1016/j.bbrc.2013.08.056; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Kawahara M, 2004, BIOCHEM BIOPH RES CO, V315, P132, DOI 10.1016/j.bbrc.2004.01.030; Kent A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00185; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Liu D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00486; Mabe S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06127; Maranon F., 2006, NATURE, V440, P237; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sutterwala F. S., 2014, ANN NY ACAD SCI, V2014, P12458; Takahashi M, 2014, INT HEART J, V55, P101; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Yoshida R, 2014, BIOTECHNOL BIOENG, V111, P1170, DOI 10.1002/bit.25173	50	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					223	230		10.1016/j.jbiosc.2014.12.021		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400017		
J	Ye, J; Shirakigawa, N; Ijima, H				Ye, Jingjia; Shirakigawa, Nana; Ijima, Hiroyuki			Hybrid organoids consisting of extracellular matrix gel particles and hepatocytes for transplantation	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Immobilization; Tissue engineering; Organoid; Animal cell culture; Growth factor; Hepatocyte transplantation	ENDOTHELIAL GROWTH-FACTOR; LIVER-REGENERATION; ARTIFICIAL LIVER; CELL-CULTURE; IN-VITRO; ANGIOGENESIS; EXPRESSION; HEPARIN; VIVO	Hepatocyte transplantation is a potential therapy for treating various liver diseases. However, oxygen shortage leading to loss of hepatocyte function becomes a limitation following hepatocyte transplantation. To overcome this problem, we developed a hybrid organoid, consisting of growth factor (GF)-immobilizable gel particles combined with hepatocytes. Benefits of the hybrid organoid were evaluated in three groups: (i) hybrid organoid consisting of cells and GF-immobilizable gel particles (HG-C); (ii) hybrid organoid consisting of cells and gel particles (G-C); and (iii) cells suspended in collagen (C-C). We found liver-specific functions of HG-C were maintained longer than in the other conditions during in vitro culture. Furthermore, after transplantation, HG-C was effective in maintaining viability of transplanted hepatocytes and promoting angiogenesis around the hepatocytes. In summary, transplantation of HG-C is a potential method for future liver tissue engineering. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Ye, Jingjia; Shirakigawa, Nana; Ijima, Hiroyuki] Kyushu Univ, Grad Sch, Fac Engn, Dept Chem Engn, Fukuoka 8190395, Japan	Ijima, H (reprint author), Kyushu Univ, Grad Sch, Fac Engn, Dept Chem Engn, 744 Motooka,Nishi ku, Fukuoka 8190395, Japan.	ijima@chem-eng.kyushu-u.acjp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22360348]	This work was supported by a Grant-in-Aid for Scientific Research (B) (22360348) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018; KOCH AE, 1994, J IMMUNOL, V152, P4149; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; UNEMORI EN, 1992, J CELL PHYSIOL, V153, P557, DOI 10.1002/jcp.1041530317; DUNN JCY, 1989, FASEB J, V3, P174; Hou YT, 2010, J BIOSCI BIOENG, V110, P208, DOI 10.1016/j.jbiosc.2010.01.016; Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013; Ohashi K, 2001, J MOL MED-JMM, V79, P617; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Ijima H, 2009, BIOCHEM ENG J, V47, P19, DOI 10.1016/j.bej.2009.06.012; Ijima H, 1998, TISSUE ENG, V4, P213, DOI 10.1089/ten.1998.4.213; Hou YT, 2011, J BIOSCI BIOENG, V112, P265, DOI 10.1016/j.jbiosc.2011.05.003; Hou YT, 2012, BIOCHEM ENG J, V69, P172, DOI 10.1016/j.bej.2012.09.007; Ijima H, 2010, BIOCHEM ENG J, V48, P332, DOI 10.1016/j.bej.2009.10.003; Ijima H, 1998, J BIOMAT SCI-POLYM E, V9, P765, DOI 10.1163/156856298X00136; KATO S, 1994, EXP CELL RES, V211, P53, DOI 10.1006/excr.1994.1058; Mizumoto S., 2012, GLYCOCONJUGATE J, V30, P619; Sakai Y, 2001, CELL TRANSPLANT, V10, P479; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Weise F, 2013, BIOTECHNOL BIOENG, V110, P2504, DOI 10.1002/bit.24912; Yao C, 2004, CELLS TISSUES ORGANS, V178, P189, DOI 10.1159/000083730; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	27	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	AUG	2015	120	2					231	237		10.1016/j.jbiosc.2015.01.004		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CP4TB	WOS:000359874400018		
J	Imada, T; Kannibayashi, T; Ota, C; Shibata, SC; Iritakenishi, T; Sawa, Y; Fujino, Y				Imada, Tatsuyuki; Kannibayashi, Takahiko; Ota, Chiho; Shibata, Sho Carl; Iritakenishi, Takeshi; Sawa, Yoshiki; Fujino, Yuji			Intraoperative Right Ventricular Fractional Area Change Is a Good Indicator of Right Ventricular Contractility: A Retrospective Comparison Using Two- and Three-Dimensional Echocardiography	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						right ventricular fractional area change; RVFAC; right ventricular ejection fraction; right ventricular function; three-dimensional echocardiography	HEART-FAILURE	Objective: Intraoperative two-dimensional echocardiography is technically challenging, given the unique geometry of the right ventricle (RV). It was hypothesized that the RV fractional area change (RVFAC) could be used as a simple method to evaluate RV function during surgery. Therefore, the correlation between the intraoperative RVFAC and the true right ventricular ejection fraction (RVEF), as measured using newly developed three-dimensional (3D) analysis software, was evaluated. Design: Retrospective study. Setting: University hospital. Participants: Patients who underwent cardiac surgery with transesophageal echocardiography monitoring between March 2014 and June 2014. Interventions: None. Measurements and Main Results: Sixty-two patients were included in this study. After the exclusion of poor imaging data and patients with arrhythmias, 54 data sets were analyzed. RVFAC was measured by one anesthesiologist during surgery, and full-volume 3D echocardiographic data were recorded simultaneously. The 3D data were analyzed postoperatively using off-line 3D analysis software by a second anesthesiologist, who was blinded to the RVFAC results. The mean RVFAC was 38.8% +/- 8.7%, the mean RVEF was 41.4% +/- 8.3%, and there was a good correlation between the RVFAC and the RVEF (r(2) = 0.638; p < 0.0001). Conclusions: The RVFAC was well-correlated with the RVEF calculated using 3D echocardiography; therefore, RVFAC provides a simple and useful method for anesthesiologists to evaluate intraoperative RV function. (C) 2015 Elsevier Inc. All rights reserved.	[Imada, Tatsuyuki; Kannibayashi, Takahiko; Ota, Chiho; Shibata, Sho Carl; Iritakenishi, Takeshi; Sawa, Yoshiki; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Suita, Osaka 5650871, Japan	Imada, T (reprint author), Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	imada@anes.ined.osaka-u.ac.jp					Maslow AD, 2002, ANESTH ANALG, V95, P1507, DOI 10.1213/01.ANE.0000035641.42408.33; Niemann PS, 2007, J AM COLL CARDIOL, V50, P1668, DOI 10.1016/j.jacc.2007.07.031; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Anavekar NS, 2007, ECHOCARDIOGR-J CARD, V24, P452, DOI 10.1111/j.1540-8175.2007.00424.x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Haddad F, 2009, ANESTH ANALG, V108, P422, DOI 10.1213/ane.0b013e31818d8b92; Zhang QB, 2013, INT J CARDIOL, V168, P3991, DOI 10.1016/j.ijcard.2013.06.088; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; Jainandunsing JS, 2013, J CARDIOTHOR VASC AN, V27, P367, DOI 10.1053/j.jvca.2012.08.012	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2015	29	4					831	835		10.1053/j.jvca.2014.12.005		5	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CP4AY	WOS:000359825600002		
J	Iritakenishi, T; Kamibayashi, T; Torikai, K; Maeda, K; Kuratani, T; Sawa, Y; Fujino, Y				Iritakenishi, Takeshi; Kamibayashi, Takahiko; Torikai, Kei; Maeda, Koichi; Kuratani, Toru; Sawa, Yoshiki; Fujino, Yuji			Predictors of Prolonged Hemodynamic Compromise After Valve Deployment During Transcatheter Aortic Valve Implantation	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						rapid pacing; transcatheter aortic valve implantation; aortic stenosis; mixed venous oxygen saturation	VENOUS OXYGEN-SATURATION; CRITICALLY-ILL; SURGICAL-PATIENTS; REPLACEMENT; MANAGEMENT; OXIMETRY; CONSENSUS; STENOSIS; CATHETER; UPDATE	Objective: To identify the risk factors of prolonged hemodynamic compromise caused by rapid pacing for valve deployment during transcatheter aortic valve implantation. Design: A retrospective study. Setting: Academic hospital. Participants: Forty-seven patients with severe aortic stenosis who underwent transcatheter aortic valve implantation.. Interventions: The time after the end of rapid pacing until systolic arterial pressure and SvO(2) recovery (systolic arterial pressure >90 mmHg and SvO(2) >65%) was defined as "the hemodynamic recovery time" and was measured from online anesthetic charts. The total study population was divided into 2 groups according to the recovery time (third quartile in all patients; 33 and 14 patients in the early and delayed recovery groups, respectively). Subsequently, the factors associated with prolonged hemodynamic compromise after rapid pacing for valve deployment were identified by univariate and multivariate analyses. Measurements and Main Results: Multivariate analysis identified left ventricular end-diastolic diameter (odds ratio, 0.774; 95% confidence interval, 0.608-0.915) and SvO(2) (odds ratio, 0.748; 95% confidence interval, 0.590-0.868) as independent factors associated with prolonged hemodynamic compromise after rapid pacing for valve deployment. Conclusions: SvO(2) and left ventricular end-diastolic diameter were found to be significant independent predictors of prolonged hemodynamic compromise immediately after rapid pacing for valve deployment during transcatheter aortic valve implantation. (C) 2015 Elsevier Inc. All rights reserved.	[Iritakenishi, Takeshi; Kamibayashi, Takahiko; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Suita, Osaka 5650871, Japan; [Torikai, Kei; Maeda, Koichi; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Iritakenishi, T (reprint author), Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iritake@anes.med.osaka-u.ac.jp					Covello RD, 2010, MINERVA ANESTESIOL, V76, P100; Barbash IM, 2013, AM J CARDIOL, V111, P1337, DOI 10.1016/j.amjcard.2012.12.059; Rodes-Cabau J, 2012, NAT REV CARDIOL, V9, P15, DOI 10.1038/nrcardio.2011.164; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Dueck MH, 2005, ANESTHESIOLOGY, V103, P249, DOI 10.1097/00000542-200508000-00007; Reinhart K, 2004, INTENS CARE MED, V30, P1572, DOI 10.1007/s00134-004-2337-y; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Zamorano JL, 2011, J AM SOC ECHOCARDIOG, V24, P937, DOI 10.1016/j.echo.2011.07.003; Polonen P, 2000, ANESTH ANALG, V90, P1052; Carrabba N, 2013, AM J CARDIOL, V111, P1475; Elahi Maqsood M, 2014, Ann Transl Med, V2, P10, DOI 10.3978/j.issn.2305-5839.2013.06.05; El Masry A, 2009, ANAESTHESIA, V64, P378, DOI 10.1111/j.1365-2044.2008.05793.x; Holmes DR, 2012, J THORAC CARDIOV SUR, V144, pE29, DOI 10.1016/j.jtcvs.2012.03.001; Huffmyer Julie, 2012, Semin Cardiothorac Vasc Anesth, V16, P25, DOI 10.1177/1089253211434966; Kim Eun Hee, 2013, Korean J Anesthesiol, V64, P360, DOI 10.4097/kjae.2013.64.4.360; Marx G, 2006, CURR OPIN CRIT CARE, V12, P263, DOI 10.1097/01.ccx.0000224872.09077.dc; NELSON LD, 1986, ANN SURG, V203, P329, DOI 10.1097/00000658-198603000-00020; Paarmann H, 2012, INTERACT CARDIOV TH, V14, P268, DOI 10.1093/icvts/ivr102; Price LC, 2010, CRIT CARE, V14, DOI 10.1186/cc9264; Rex S, 2013, CURR OPIN ANESTHESIO, V26, P456, DOI 10.1097/ACO.0b013e3283628d1e; Rivers E P, 2001, Curr Opin Crit Care, V7, P204, DOI 10.1097/00075198-200106000-00011; Selle A, 2014, CLIN RES CARDIOL, V103, P902, DOI 10.1007/s00392-014-0728-9; Spenceley N, 2010, PEDIATR CRIT CARE ME, V11, P26, DOI 10.1097/PCC.0b013e3181a63e0c; Stork T, 1995, CARDIOVASC DRUG THER, V3, P533; van Beest P, 2011, CRIT CARE, V15, DOI 10.1186/cc10351; Vincent JL, 2011, CRIT CARE, V15, DOI 10.1186/cc10291; Webb JG, 2006, CATHETER CARDIO INTE, V68, P199, DOI 10.1002/ccd.20829	30	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2015	29	4					868	874		10.1053/j.jvca.2015.02.019		7	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CP4AY	WOS:000359825600007		
J	Minami, K; Yoshitani, K; Inatomi, Y; Sugiyama, Y; Iida, H; Ohnishi, Y				Minami, Kimito; Yoshitani, Kenji; Inatomi, Yuzuru; Sugiyama, Yoko; Iida, Hiroki; Ohnishi, Yoshihiko			A Retrospective Examination of the Efficacy of Paravertebral Block for Patients Requiring Intraoperative High-Dose Unfractionated Heparin Administration During Thoracoabdominal Aortic Aneurysm Repair	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						paravertebral block; thoracoabdominal aortic aneurysm repair; anticoagulation; unfractionated heparin; pulmonary complications; analgesia	PULMONARY COMPLICATIONS; ANALGESIA; SURGERY; ANESTHESIA	Objective: Postoperative respiratory complications are serious and frequently observed among patients who undergo thoracoabdominal aortic aneurysm (TAAA) repair. Paravertebral block (PVB) can provide effective analgesia for relief of postoperative thoracotomy pain and may reduce respiratory complications. However, the impact of PVB on postoperative pain and respiratory function in patients who undergo TAAA repair requiring intraoperative high-dose heparin administration is unknown. This study examined the efficacy of PVB on postoperative pain and respiratory function after TAAA repairs. Design: Retrospective, observational cohort study. Setting: Single center in Japan. Participants: Fifty-eight consecutive patients who underwent TAAA repair from March 2013 to October 2014. Interventions: Application of thoracic PVB. Measurement and Main Results: A total of 56 patients were analyzed. Two patients were excluded because 1 patient was dead within 24 hours after surgery and 1 patient was 9 years old. Patients with PVB were defined as group P (n = 17), and patients without PVB as group C (n = 39). There was no significant difference in baseline characteristics between the 2 groups. Both postoperative pain at rest and postoperative pain while coughing were assessed using a numeric rating scale (NRS); the incidence of reintubation and noninvasive positive-pressure ventilation (NPPV) also were compared between the 2 groups. The NRS score of postoperative pain at rest was significantly lower in group P (group P: Median 2, interquartile range 1 to 3; group C: Median 6, interquartile range 5 to 7; p = 0.000), and the NRS score of postoperative pain while coughing was significantly lower in group P (group P: Median 5, interquartile range 3.5 to 6.5; group C: Median 8, interquartile range 7 to 10; p = 0.000). Reintubation rate was significantly lower in group P (group P: 0%, group C: 23%, p = 0.045); the incidences of NPPV (group P: 12%, group C: 46%, p = 0.016) and postoperative pneumonia were significantly lower in group P (group P: 0%, group C: 28%, p = 0.024). Conclusions: PVB significantly reduced postoperative pain at rest and while coughing and significantly reduced the reintubation rate, the rate of NPPV use, and postoperative pneumonia without complications. PVB could be a safe and an effective analgesic method that reduces postoperative respiratory exacerbation in patients who undergo TAAA repair. (C) 2015 Elsevier Inc. All rights reserved.	[Minami, Kimito; Yoshitani, Kenji; Inatomi, Yuzuru; Ohnishi, Yoshihiko] Gifu Univ, Grad Sch Med, Dept Anesthesiol, Natl Cerebral & Cardiovasc Ctr, Gifu, Gifu 5011194, Japan; [Sugiyama, Yoko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu, Gifu 5011194, Japan	Minami, K (reprint author), Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	nann_5115@ybb.ne.jp					ALEXANDE.JI, 1972, CLIN SCI, V43, P137; Joshi GP, 2008, ANESTH ANALG, V107, P1026, DOI [10.1213/01.ane.0000333274.63501.ff, 10.1213/ane.0b013e31817e7b40]; Cambria RP, 2002, ANN SURG, V236, P471, DOI 10.1097/01.SLA.0000031240.26001.E2; Arozullah AM, 2001, ANN INTERN MED, V135, P847; Richardson J, 1998, BRIT J ANAESTH, V81, P230; Rosen DA, 2004, ANESTH ANALG, V98, P966, DOI 10.1213/01.ANE.0000103267.37895.5B; Ben-Ari A, 2009, ANESTH ANALG, V109, P1691, DOI 10.1213/ANE.0b013e3181b72d50; Rectenwald JE, 2002, J VASC SURG, V35, P640, DOI 10.1067/mva.2002.119238; Raveglia F, 2014, J THORAC CARDIOV SUR, V147, P469, DOI 10.1016/j.jtcvs.2013.09.024; Calenda E, 2012, J CLIN ANESTH, V24, P227, DOI 10.1016/j.jclinane.2011.07.017; CUSCHIERI RJ, 1985, BRIT J SURG, V72, P495, DOI 10.1002/bjs.1800720631; Enneking FK, 2010, REG ANESTH PAIN MED, V35, P64; Etz CD, 2007, ANN THORAC SURG, V83, pS870, DOI 10.1016/j.athoracsur.2006.10.099; GAY GR, 1971, ANESTH ANAL CURR RES, V50, P344; JAYR C, 1993, ANESTHESIOLOGY, V78, P666, DOI 10.1097/00000542-199304000-00009; Molitch M, 1931, JAMA-J AM MED ASSOC, V97, P247; Tryba M, 1993, P ANAETHESIOL INTENS, V28, P179; WAHBA WM, 1972, CAN ANAESTH SOC J, V19, P8	18	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2015	29	4					937	941		10.1053/j.jvca.2014.12.009		5	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CP4AY	WOS:000359825600018		
J	Mizota, T; Matsukawa, S; Fukagawa, H; Daijo, H; Tanaka, T; Chen, FS; Date, H; Fukuda, K				Mizota, Toshiyuki; Matsukawa, Shino; Fukagawa, Hiroshi; Daijo, Hiroki; Tanaka, Tomoharu; Chen, Fengshi; Date, Hiroshi; Fukuda, Kazuhiko			Preoperative Hypercapnia as a Predictor of Hypotension During Anesthetic Induction in Lung Transplant Recipients	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						lung transplantation; anesthetic induction; hypotension; hypercapnia	VENTRICULAR DYSFUNCTION; PULMONARY-HYPERTENSION; GENERAL-ANESTHESIA; PROPOFOL	Objective: To determine the incidence and predisposing factors of hypotension during anesthetic induction in lung transplant recipients. Design: Retrospective study. Setting: University hospital. Participants: Patients who underwent lung transplantation between 2008 and 2013 (n = 68). Interventions: None. Measurements and Main Results: The authors analyzed the mean arterial pressure (MAP) from administration of anesthetic drugs to 10 minutes after endotracheal intubation (ie, the anesthetic induction) among participants who underwent lung transplantation. Patients were considered to have clinically significant hypotension (CSH) when the following criteria were fulfilled: An MAP decrease of >40% from baseline and MAP of <60 mmHg. Overall, 41.2% of patients experienced CSH during the induction of anesthesia. The preoperative partial pressure of carbon dioxide (PaCO2) was significantly higher in patients who experienced CSH during anesthetic induction than in those who did not (p = 0.005). Preoperative PaCO2 predicted the development of CSH during anesthetic induction (area under the curve = 0.702; p = 0.002), with an optimal cut-off point of 55 mmHg determined by maximizing the Youden index. The incidences of CSH during anesthetic induction for patients with (PaCO2 >= 55) and without (PaCO2 < 55) preoperative hypercapnia were 75.0% (95% confidence interval [CI] [53.8-89.2]) and 30.8% (95% CI 26.4-37.3), respectively. After adjustment for known predicting factors, the odds ratio for the relationship between preoperative hypercapnia and CSH during anesthetic induction was 12.54 (95% CI 3.10-66.66). Conclusions: Hypotension during anesthetic induction is common in lung transplant recipients, and is independently predicted by preoperative hypercapnia. (C) 2015 Elsevier Inc. All rights reserved.	[Mizota, Toshiyuki; Matsukawa, Shino; Fukagawa, Hiroshi; Daijo, Hiroki; Tanaka, Tomoharu; Fukuda, Kazuhiko] Kyoto Univ Hosp, Dept Anesthesia, Kyoto 6068507, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 6068507, Japan	Mizota, T (reprint author), Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	mizota@kuhp.kyoto-u.ac.jp					Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Tsuchiya M, 2010, ACTA ANAESTH SCAND, V54, P596, DOI 10.1111/j.1399-6576.2010.02225.x; Feltracco P, 2007, TRANSPL P, V39, P1976, DOI 10.1016/j.transproceed.2007.05.006; CALVIN JE, 1989, J CRIT CARE, V4, P239, DOI 10.1016/0883-9441(89)90064-6; HUG CC, 1993, ANESTH ANALG, V77, pS21; Miranda Allen, 2005, Semin Cardiothorac Vasc Anesth, V9, P205, DOI 10.1177/108925320500900303; Morley AP, 2010, ANESTH ANALG, V111, P1373, DOI 10.1213/ANE.0b013e3181f62a2b; Myles P S, 1994, J Cardiothorac Vasc Anesth, V8, P678, DOI 10.1016/1053-0770(94)90203-8; Myles PS, 1998, SEMIN CARDIOTHORAC V, V2, P140, DOI 10.1177/108925329800200207; MYLES PS, 1992, ANAESTH INTENS CARE, V20, P358; PREWITT RM, 1983, CRIT CARE MED, V11, P346, DOI 10.1097/00003246-198305000-00005; Rabadi D, 2013, REV BRAS ANESTESIOL, V63, P258, DOI 10.1590/S0034-70942013000300005	14	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2015	29	4					967	971		10.1053/j.jvca.2014.10.027		5	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CP4AY	WOS:000359825600022		
J	Fujita, N; Miyasaka, K; Okada, O; Katayama, M; Miyasaka, K				Fujita, Nobuko; Miyasaka, Kiyoyuki; Okada, Osamu; Katayama, Masao; Miyasaka, Katsuyuki			Localized Pulmonary Edema in the Middle and Inferior Lobes of the Right Lung after One-lung Ventilation for Minimally Invasive Mitral Valve Surgery	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						localized pulmonary edema; minimally invasive mitral valve surgery; one lung ventilation	INJURY; REGURGITATION; PREVALENCE; FLOW		[Fujita, Nobuko; Miyasaka, Kiyoyuki; Okada, Osamu; Katayama, Masao; Miyasaka, Katsuyuki] St Lukes Int Hosp, Dept Anesthesiol, Tokyo 1048560, Japan	Fujita, N (reprint author), St Lukes Int Hosp, Dept Anesthesiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	nobu116upa@hotmail.com					Achar Shreepathi Krishna, 2011, J Anaesthesiol Clin Pharmacol, V27, P556, DOI 10.4103/0970-9185.86609; Sakao Y, 2001, ANN THORAC SURG, V71, P1825, DOI 10.1016/S0003-4975(01)02489-4; Attias D, 2010, CIRCULATION, V122, P1109, DOI 10.1161/CIRCULATIONAHA.109.934950; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Sohara Y, 2008, ANN THORAC CARDIOVAS, V14, P205; Madershahian N, 2009, J CARDIAC SURG, V24, P693, DOI 10.1111/j.1540-8191.2009.00813.x; Modi P, 2008, EUR J CARDIO-THORAC, V34, P943, DOI 10.1016/j.ejcts.2008.07.057; Iqbal M, 2000, ANN THORAC SURG, V70, P669, DOI 10.1016/S0003-4975(00)01455-7; Barbetakis Nikolaos, 2008, Interact Cardiovasc Thorac Surg, V7, P532, DOI 10.1510/icvts.2007.167312; Breunig A, 2011, J INFLAMM, V8, P32; Echevarria Carlos, 2008, Interact Cardiovasc Thorac Surg, V7, P485, DOI 10.1510/icvts.2008.178087; GURNEY JW, 1989, RADIOLOGY, V171, P397; JOHNSON D, 1994, J THORAC CARDIOV SUR, V107, P1193; Komatsu Y, 2012, INFLAMMATION, V35, P1844, DOI 10.1007/s10753-012-9505-y; MIYATAKE K, 1982, BRIT HEART J, V48, P449; Schlensak C, 2002, J THORAC CARDIOV SUR, V123, P1199, DOI 10.1067/mtc.2002.121977; SCHNYDER PA, 1993, AM J ROENTGENOL, V161, P33; Shires AL, 2009, J CARDIOTHOR VASC AN, V23, P549, DOI 10.1053/j.jvca.2009.04.009; Sivrikoz MC, 2002, EUR J CARDIO-THORAC, V22, P721, DOI 10.1016/S1010-7940(02)00447-5; Takenaka K, 2006, J CRIT CARE, V21, P48, DOI 10.1016/j.jcrc.2005.07.001	20	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	AUG	2015	29	4					1009	1012		10.1053/j.jvca.2014.04.006		4	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CP4AY	WOS:000359825600031		
J	Wu, LM; Liao, LB; Lv, GC; Qin, FX				Wu, Limei; Liao, Libing; Lv, Guocheng; Qin, Faxiang			Stability and pH-independence of nano-zero-valent iron intercalated montmorillonite and its application on Cr(VI) removal	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Nanoscale zerovalent iron; Hexavalent chromium; Montmorillonite; Intercalated; Redox reaction	SOCIETY SOURCE CLAYS; HEXAVALENT CHROMIUM; ACTIVATED CARBON; BASE-LINE; CHLORINATED HYDROCARBONS; TCE DECHLORINATION; AQUEOUS-SOLUTIONS; H-2 EVOLUTION; WASTE-WATER; REMEDIATION	Composite of nano-zero-valent iron and montmorillonite (NZVI/MMT) was prepared by inserting NZVI into the interlayer of montmorillonite. The unique structure montmorillonite with isolated exchangeable Fe(III) cations residing near the sites of structural negative charges inhibited the agglomeration of ZVI and result in the formation of ZVI particles in the montmorillonite interlayer regions. NZVI/MMT was demonstrated to possess large specific surface area and outstanding reducibility that encourage rapid and stable reaction with Cr (VI). Besides, the intercalation also makes NZVI well dispersed and more stable in the interlayer, thereby improving the reaction capacity by 16 times. The effects of pH value, initial concentration of Cr (VI) and reaction time on Cr (VI) removal have also been investigated in detail. According to PXRD and XPS characterization, NZVI/Cr (VI) redox reaction occurred in the interlayer of MMT. The study of NZVI/MMT is instrumental to the development of remediation technologies for persistent environmental contaminants. (C) 2015 Elsevier B.V. All rights reserved.	[Wu, Limei; Liao, Libing; Lv, Guocheng] China Univ Geosci, Sch Mat Sci & Technol, Beijing 100083, Peoples R China; [Qin, Faxiang] Natl Inst Mat Sci, Nanomat Grp 1D, Tsukuba, Ibaraki 3050047, Japan	Liao, LB (reprint author), China Univ Geosci, Sch Mat Sci & Technol, Beijing 100083, Peoples R China.	lbliao@cugb.edu.cn; guochenglv@cugb.edu.cn					ALAERTS GJ, 1989, WATER SCI TECHNOL, V21, P1701; Yuan P, 2009, J HAZARD MATER, V166, P821, DOI 10.1016/j.jhazmat.2008.11.083; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Costa M, 2003, TOXICOL APPL PHARM, V188, P1, DOI 10.1016/S0041-008X(03)00011-5; Muftikian R, 1996, ENVIRON SCI TECHNOL, V30, P3593, DOI 10.1021/es960289d; Gu C, 2010, ENVIRON SCI TECHNOL, V44, P4258, DOI 10.1021/es903801r; Liu Y, 2007, ENVIRON SCI TECHNOL, V41, P7881, DOI 10.1021/es0711967; Chipera SJ, 2001, CLAY CLAY MINER, V49, P398, DOI 10.1346/CCMN.2001.0490507; Liu BP, 2001, J MOL CATAL A-CHEM, V172, P227, DOI 10.1016/S1381-1169(01)00121-2; Li SL, 2009, GREEN CHEM, V11, P1618, DOI 10.1039/b913056j; Zhan JJ, 2011, ENVIRON SCI TECHNOL, V45, P1949, DOI 10.1021/es103493e; Mondal MK, 2009, J ENVIRON MANAGE, V90, P3266, DOI 10.1016/j.jenvman.2009.05.025; Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420; Zheng TH, 2008, ENVIRON SCI TECHNOL, V42, P4494, DOI 10.1021/es702214x; Shi LN, 2011, CHEM ENG J, V171, P612, DOI 10.1016/j.cej.2011.04.038; Wang QA, 2010, J CONTAM HYDROL, V114, P35, DOI 10.1016/j.jconhyd.2010.02.006; Ling XF, 2012, CHEMOSPHERE, V87, P655, DOI 10.1016/j.chemosphere.2012.02.002; He F, 2005, ENVIRON SCI TECHNOL, V39, P3314, DOI 10.1021/es048743y; Yim SD, 2004, J CATAL, V221, P601, DOI 10.1016/j.jcat.2003.09.026; Sunkara B, 2011, LANGMUIR, V27, P7854, DOI 10.1021/la200657m; Cundy AB, 2008, SCI TOTAL ENVIRON, V400, P42, DOI 10.1016/j.scitotenv.2008.07.002; Buerge IJ, 1999, ENVIRON SCI TECHNOL, V33, P4285, DOI 10.1021/es981297s; Liu YQ, 2006, ENVIRON SCI TECHNOL, V40, P6085, DOI 10.1021/es060685o; Ponder SM, 2001, CHEM MATER, V13, P479, DOI 10.1021/cm000288r; Zhan JJ, 2008, ENVIRON SCI TECHNOL, V42, P8871, DOI 10.1021/es800387p; Phenrat T, 2007, ENVIRON SCI TECHNOL, V41, P284, DOI 10.1021/es0614349a; Hoch LB, 2008, ENVIRON SCI TECHNOL, V42, P2600, DOI 10.1021/es702589u; Wu LM, 2013, J HAZARD MATER, V254, P277, DOI 10.1016/j.jhazmat.2013.03.009; POWELL RM, 1995, ENVIRON SCI TECHNOL, V29, P1913, DOI 10.1021/es00008a008; Borden D, 2001, CLAY CLAY MINER, V49, P444, DOI 10.1346/CCMN.2001.0490510; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; Mohan D, 2006, J HAZARD MATER, V135, P280, DOI 10.1016/j.jhazmat.2005.11.075; Fang ZQ, 2011, DESALINATION, V280, P224, DOI 10.1016/j.desal.2011.07.011; Li XQ, 2006, CRIT REV SOLID STATE, V31, P111, DOI 10.1080/10408430601057611; Li XQ, 2008, IND ENG CHEM RES, V47, P2131, DOI 10.1021/ie061655x; Zhu JH, 2012, ENVIRON SCI TECHNOL, V46, P977, DOI 10.1021/es2014133; Olmez T, 2009, J HAZARD MATER, V162, P1371, DOI 10.1016/j.jhazmat.2008.06.017; Geng B, 2009, CHEMOSPHERE, V75, P825, DOI 10.1016/j.chemosphere.2009.01.009; Lee T, 2003, CHEMOSPHERE, V53, P479, DOI 10.1016/S0045-6535(03)00548-4; Kantar C, 2008, J HAZARD MATER, V159, P287, DOI 10.1016/j.jhazmat.2008.02.022; Lalvani SB, 1998, CARBON, V36, P1219, DOI 10.1016/S0008-6223(98)00102-X; Lee KJ, 2009, ENVIRON TECHNOL, V30, P1425, DOI 10.1080/09593330903186240; Li H, 2007, ENVIRON SCI TECHNOL, V41, P1251, DOI 10.1021/es062274d; Mermut AR, 2001, CLAY CLAY MINER, V49, P393, DOI 10.1346/CCMN.2001.0490506; Qian H., 2008, FRONT ENVIRON SCI EN, V2, P51, DOI 10.1007/s11783-008-0010-3; Rao JM, 1999, J CATAL, V184, P105, DOI 10.1006/jcat.1999.2441; Rivero-Huguet M, 2009, CHEMOSPHERE, V76, P1240, DOI 10.1016/j.chemosphere.2009.05.040; Sakulchaicharoen N, 2010, J CONTAM HYDROL, V118, P117, DOI 10.1016/j.jconhyd.2010.09.004; Serpone N., 1988, PHOTOCATALYSIS ENV N; Shi Z., 2011, ENVIRON SCI TECHNOL, V45, P586; [唐文清 TANG Wen-Qing], 2009, [应用化学, Chinese Journal of Applied Chemistry], V26, P807; Wei YT, 2012, J HAZARD MATER, V211, P373, DOI 10.1016/j.jhazmat.2011.11.018	52	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	AUG	2015	179						1	9		10.1016/j.jconhyd.2015.05.001		9	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CP5ZX	WOS:000359965200001		
J	Tachi, Y; Ebina, T; Takeda, C; Saito, T; Takahashi, H; Ohuchi, Y; Martin, AJ				Tachi, Yukio; Ebina, Takanori; Takeda, Chizuko; Saito, Toshihiko; Takahashi, Hiroaki; Ohuchi, Yuji; Martin, Andrew James			Matrix diffusion and sorption of Cs+, Na+, I- and HTO in granodiorite: Laboratory-scale results and their extrapolation to the in situ condition	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						matrix diffusion; sorption; porosity; Grimsel granodiorite; in situ experiment; extrapolation approach	PORE-SPACE GEOMETRY; CRYSTALLINE ROCKS; TRACER DIFFUSION; POROSITY; GRANITE; MONTMORILLONITE; RADIONUCLIDE; MIGRATION; JAPAN; RETARDATION	Matrix diffusion and sorption are important processes controlling radionuclide transport in crystalline rocks. Such processes are typically studied in the laboratory using borehole core samples however there is still much uncertainty on the changes to rock transport properties during coring and decompression. It is therefore important to show how such laboratory-based results compare with in situ conditions. This paper focuses on laboratory-scale mechanistic understanding and how this can be extrapolated to in situ conditions as part of the Long Term Diffusion (LTD) project at the Grimsel Test Site, Switzerland. Diffusion and sorption of Cs-137(+), Na-22(+), I-125(-) and tritiated water (HTO) in Grimsel granodiorite were studied using through-diffusion and batch sorption experiments. Effective diffusivities (De) of these tracers showed typical cation excess and anion exclusion effects and their salinity dependence, although the extent of these effects varied due to the heterogeneous pore networks in the crystalline rock samples. Rock capacity factors (a) and distribution coefficients (K-d) for Cs+ and Na+ were found to be sensitive to porewater salinity. Through-diffusion experiments indicated dual depth profiles for Cs+ and Na+ which could be explained by a near-surface K-d increment. A microscopic analysis indicated that this is caused by high porosity and sorption capacities in disturbed biotite minerals on the surface of the samples. The Kd values derived from the dual profiles are likely to correspond to Kd dependence on the grain sizes of crushed samples in the batch sorption experiments. The results of the in situ LTD experiments were interpreted reasonably well by using transport parameters derived from laboratory data and extrapolating them to in situ conditions. These comparative experimental and modelling studies provided a way to extrapolate from laboratory scale to in situ condition. It is well known that the difference in porosity between laboratory and in situ conditions is a key factor to scale laboratory-derived De to in situ conditions. We also show that cation excess diffusion is likely to be a key mechanism in crystalline rocks and that high Kd in the disturbed surfaces is critically important to evaluate transport in both laboratory and in situ tests. (C) 2015 Elsevier B.V. All rights reserved.	[Tachi, Yukio; Takahashi, Hiroaki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191194, Japan; [Ebina, Takanori] NESI Inc, Tokai, Ibaraki 3191112, Japan; [Takeda, Chizuko; Saito, Toshihiko] Tokyo Nucl Serv Inc, Tsukuba, Ibaraki 3002646, Japan; [Ohuchi, Yuji] Inspct Dev Co Ltd, Tokai, Ibaraki 3191112, Japan; [Martin, Andrew James] Nagra, CH-5430 Wettingen, Switzerland	Tachi, Y (reprint author), Japan Atom Energy Agcy, Muramatsu 4-33, Tokai, Ibaraki 3191194, Japan.	tachi.yukio@jaea.go.jp			Ministry of Economy, Trade and Industry (METI) of Japan	This study was partly funded by the Ministry of Economy, Trade and Industry (METI) of Japan. The authors greatly appreciate the partners of the LTD project, in particularly Maria Siitari-Kauppi, University of Helsinki, Finland and Vaclava Havlova, UJV Rez of Czech Republic for their contributions to the in situ LTD experiments and many fruitful discussions during partner meetings. The authors also thank Josep M. Soler, IDAEA-CSIC of Spain for discussions on modelling diffusion of the LTD in-situ test. Constructive and helpful comments by Paul Sardini, reviewers and editors are thankfully acknowledged.	Tullborg EL, 2006, ENG GEOL, V84, P75, DOI 10.1016/j.enggeo.2005.12.001; Ota K, 2003, J CONTAM HYDROL, V61, P131, DOI 10.1016/S0169-7722(02)00139-0; Vilks P, 2003, J CONTAM HYDROL, V61, P191, DOI 10.1016/S0169-7722(02)00135-3; BRADBURY MH, 1985, J HYDROL, V82, P39, DOI 10.1016/0022-1694(85)90045-9; Yamaguchi T, 1997, J CONTAM HYDROL, V26, P109, DOI 10.1016/S0169-7722(96)00062-9; Sardini P, 2007, J CONTAM HYDROL, V93, P21, DOI 10.1016/j.jconhyd.2007.01.011; Altmann S, 2012, APPL GEOCHEM, V27, P463, DOI 10.1016/j.apgeochem.2011.09.015; Tachi Y, 2010, RADIOCHIM ACTA, V98, P711, DOI 10.1524/ract.2010.1772; Boving TB, 2001, J CONTAM HYDROL, V53, P85, DOI 10.1016/S0169-7722(01)00138-3; Kelokaski M, 2006, J GEOCHEM EXPLOR, V90, P45, DOI 10.1016/j.gexplo.2005.09.005; Archie GE, 1942, T AM I MIN MET ENG, V146, P54; Jokelainen L, 2013, J RADIOANAL NUCL CH, V295, P2153, DOI 10.1007/s10967-012-2268-y; Andre M, 2009, J CONTAM HYDROL, V110, P1, DOI 10.1016/j.jconhyd.2009.05.003; Yoshida H, 2009, ENG GEOL, V106, P116, DOI 10.1016/j.enggeo.2009.03.008; SKAGIUS K, 1986, WATER RESOUR RES, V22, P389, DOI 10.1029/WR022i003p00389; Van Loon LR, 2007, APPL GEOCHEM, V22, P2536, DOI 10.1016/j.apgeochem.2007.07.008; Navarre-Sitchler A, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001060; Glaus MA, 2007, ENVIRON SCI TECHNOL, V41, P478, DOI 10.1021/es061908d; HSIEH PA, 1981, INT J ROCK MECH MIN, V18, P245, DOI 10.1016/0148-9062(81)90979-7; Schild M, 2001, GEOPHYS J INT, V146, P111, DOI 10.1046/j.0956-540x.2001.01427.x; Autio J., 2003, P EUR COMM CLUST C W, P149; Autio J, 1998, J CONTAM HYDROL, V35, P19, DOI 10.1016/S0169-7722(98)00112-0; Bajo C., 1989, GRIMSEL TEST SITE LA; Bossart P., 1991, 9112 NTB NAGR; Bradbury M.H., 1986, MATER RES SOC S P, V50, P81; Byegard J., 1998, 9818 SKB TR; Crawford J., 2006, R0675 SKB; Crawford J., 2010, R1048 SKB; Cvetkovic V, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006797; Eriksen T.E., 1996, 9616 SKB; EUR, 2005, FIKWCT200120201 EUR; Glaus MA, 2010, GEOCHIM COSMOCHIM AC, V74, P1999, DOI 10.1016/j.gca.2010.01.010; GoldSim Technology Group, 2010, GOLDSIM VERS 10 1; Grathwohl P., 1998, DIFFUSION NATURAL PO; Hakanen M., 2014, 201241 POS; Hansen F.D., 2011, INT HIGH LEV RAD WAS, P934; IDEMITSU K, 1992, J NUCL SCI TECHNOL, V29, P454; Johansson H., 1998, Journal of Contaminant Hydrology, V35, P41, DOI 10.1016/S0169-7722(98)00114-4; KATO H, 1995, MATER RES SOC SYMP P, V353, P277; Kelokaski M., 2010, 0503 NAGR; Kyllonen J., 2008, 200862 POS; Liu J., 2006, R06111 SKB; Martin A.J., 2009, MATER RES SOC S P, V1193, P159; Martin A.J., 2013, MIGR 2013 C BRIGHT U; Meyer J., 1989, GRIMSEL TEST SITE LA; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Missana T., 2006, J IBER GEOL, V32, P55; Mori A., 2007, 0742 NAB NAGR; Mori A., 2000, 0124 SKB TR, P181; Mori A., 2005, 0519 NAB NAGR; Muurinen A., 1994, VTT PUBLICATIONS, V168; NEA, 2012, SEA SORP PROJ PHAS 3; NERETNIEKS I, 1980, J GEOPHYS RES, V85, P4379, DOI 10.1029/JB085iB08p04379; Ohlsson Y, 1998, J CONTAM HYDROL, V35, P91, DOI 10.1016/S0169-7722(98)00118-1; Posiva Oy, 2013, 201301 POS; Rasmuson A., 1983, 8337 SKB; Robinet JC, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011352; Sardini P, 2006, AM MINERAL, V91, P1069, DOI 10.2138/am.2006.1939; SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004; Seida Y, 2009, MATER RES SOC SYMP P, V1124, P543; Skagius K., 1986, THESIS R I TECHN STO; SKB, 2010, TR1052 SKB; SKB, 2004, R0448 SKB; Smith P.A., 2001, 0009 NTB NAGR; Soler J.M., 2014, MATER RES SOC S P, V1665, P543; Tachi Y, 2014, GEOCHIM COSMOCHIM AC, V132, P75, DOI 10.1016/j.gca.2014.02.004; Tachi Y., 2014, J NUCL SCI TECHNOL, V29, P454; Tachi Y, 2011, GEOCHIM COSMOCHIM AC, V75, P6742, DOI 10.1016/j.gca.2011.08.039; TSUKAMOTO M, 1993, CHEM GEOL, V107, P29, DOI 10.1016/0009-2541(93)90100-W; Valkiainen M., 1996, VTT RES NOTES; VANBRAKE.J, 1974, INT J HEAT MASS TRAN, V17, P1093, DOI 10.1016/0017-9310(74)90190-2; Van Loon L.R., 2004, ENVIRON SCI TECHNOL, V41, P478; Vilks P., 2005, 06819REP0130010111R0; Voutilainen M, 2013, TRANSPORT POROUS MED, V96, P319, DOI 10.1007/s11242-012-0090-1; Widestrand H, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005277; Witthuser K., 2006, GEOTECH GEOLOGIC ENG, V24, P325, DOI DOI 10.1007/S10706-004-7549-Y; Xu SL, 1999, WATER RESOUR RES, V35, P3429, DOI 10.1029/1999WR900213; Zhang M, 2006, MATER RES SOC SYMP P, V932, P135	78	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	AUG	2015	179						10	24		10.1016/j.jconhyd.2015.05.003		15	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CP5ZX	WOS:000359965200002		
J	Soler, JM; Landa, J; Havlova, V; Tachi, Y; Ebina, T; Sardini, P; Siitari-Kauppi, M; Eikenberg, J; Martin, AJ				Soler, Josep M.; Landa, Jiri; Havlova, Vaclava; Tachi, Yukio; Ebina, Takanori; Sardini, Paul; Siitari-Kauppi, Marja; Eikenberg, Jost; Martin, Andrew J.			Comparative modeling of an in situ diffusion experiment in granite at the Grimsel Test Site	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Grimsel; Diffusion; Granite; Modeling	EFFECTIVE MATRIX DIFFUSION; OPALINUS CLAY FORMATION; SOLUTE TRANSPORT; MONT-TERRI; FRACTURED ROCK; CRYSTALLINE ROCKS; LABORATORY EXPERIMENTS; INVERSION PROCEDURE; TRACER DIFFUSION; FIELD-SCALE	An in situ diffusion experiment was performed at the Grimsel Test Site (Switzerland). Several tracers (H-3 as HTO, Na-22(+), Cs-134(+), I-131(-) with stable I- as carrier) were continuously circulated through a packed-off borehole and the decrease in tracer concentrations in the liquid phase was monitored for a period of about 2 years. Subsequently, the borehole section was overcored and the tracer profiles in the rock analyzed (H-3, Na-22(+), Cs-134(+)) H-3 and Na-22(+) showed a similar decrease in activity in the circulation system (slightly larger drop for H-3). The drop in activity for Cs-134(+) was much more pronounced. Transport distances in the rock were about 20 cm for H-3, 10 cm for Na-22(+), and 1 cm for Cs-134(+). The dataset (except for I-131(-) because of complete decay at the end of the experiment) was analyzed with different diffusion-sorption models by different teams (IDAEA-CSIC, UJV-Rez, JAEA) using different codes, with the goal of obtaining effective diffusion coefficients (D-e) and porosity (phi) or rock capacity (alpha) values. From the activity measurements in the rock, it was observed that it was not possible to recover the full tracer activity in the rock (no activity balance when adding the activities in the rock and in the fluid circulation system). A Borehole Disturbed Zone (BDZ) had to be taken into account to fit the experimental observations. The extension of the BDZ (1-2 mm) is about the same magnitude than the mean grain size of the quartz and feldspar grains. IDAEA-CSIC and UJV-Rez tried directly to match the results of the in situ experiment, without forcing any laboratory-based parameter values into the models. JAEA conducted a predictive modeling based on laboratory diffusion data and their scaling to in situ conditions. The results from the different codes have been compared, also with results from small-scale laboratory experiments. Outstanding issues to be resolved are the need for a very large capacity factor in the BDZ for H-3 and the difference between apparent diffusion coefficients (D-a) from the in situ experiment and out-leaching laboratory tests. (C) 2015 Elsevier B.V. All rights reserved.	[Soler, Josep M.] IDAEA CSIC, Barcelona 08034, Catalonia, Spain; [Landa, Jiri; Havlova, Vaclava] UJV Rez, Rez 25068, Czech Republic; [Tachi, Yukio; Ebina, Takanori] JAEA, Tokai, Ibaraki 3191194, Japan; [Sardini, Paul] Univ Poitiers, HYDRASA IC2MP, F-86073 Poitiers 9, France; [Siitari-Kauppi, Marja] Univ Helsinki, Dept Chem, Lab Radiochem, FIN-00014 Helsinki, Finland; [Eikenberg, Jost] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Martin, Andrew J.] NAGRA, CH-5430 Wettingen, Switzerland	Soler, JM (reprint author), IDAEA CSIC, Jordi Girona 18-26, Barcelona 08034, Catalonia, Spain.	josep.soler@idaea.csic.es; hvl@ujv.cz; tachi.yukio@jaea.go.jp; paul.sardini@univ-poitiers.fr; marja.siitari-kauppi@helsinki.fi; jost.eikenberg@psi.ch; andrew.martin@nagra.ch					Aalto P., 2009, 200931 POS OY; Ota K, 2003, J CONTAM HYDROL, V61, P131, DOI 10.1016/S0169-7722(02)00139-0; MALOSZEWSKI P, 1990, WATER RESOUR RES, V26, P1517, DOI 10.1029/WR026i007p01517; GRISAK GE, 1980, WATER RESOUR RES, V16, P719, DOI 10.1029/WR016i004p00719; Vilks P, 2003, J CONTAM HYDROL, V61, P191, DOI 10.1016/S0169-7722(02)00135-3; Sardini P, 2007, J CONTAM HYDROL, V93, P21, DOI 10.1016/j.jconhyd.2007.01.011; Waber HN, 2011, J HYDROL, V405, P316, DOI 10.1016/j.jhydrol.2011.05.029; Wersin P, 2004, APPL CLAY SCI, V26, P123, DOI 10.1016/j.clay.2003.09.007; Shapiro AM, 2001, WATER RESOUR RES, V37, P507, DOI 10.1029/2000WR900301; Guimera J, 2000, J CONTAM HYDROL, V41, P261, DOI 10.1016/S0169-7722(99)00080-7; Tachi Y, 2015, J CONTAM HYDROL, V179, P10, DOI 10.1016/j.jconhyd.2015.05.003; Jokelainen L, 2013, J RADIOANAL NUCL CH, V295, P2153, DOI 10.1007/s10967-012-2268-y; Zhou QL, 2007, J CONTAM HYDROL, V93, P161, DOI 10.1016/j.jconhyd.2007.02.002; Cvetkovic V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043445; SKAGIUS K, 1986, WATER RESOUR RES, V22, P389, DOI 10.1029/WR022i003p00389; Delay F, 2002, CR GEOSCI, V334, P967, DOI 10.1016/S1631-0713(02)01835-7; Carrera J, 1998, HYDROGEOL J, V6, P178, DOI 10.1007/s100400050143; BIRGERSSON L, 1990, WATER RESOUR RES, V26, P2833, DOI 10.1029/WR026i011p02833; Haggerty R, 2000, WATER RESOUR RES, V36, P3467, DOI 10.1029/2000WR900214; FOSTER SSD, 1975, J HYDROL, V25, P159, DOI 10.1016/0022-1694(75)90045-1; Anthony C, 2007, ENVIRON SCI TECHNOL, V41, P5002, DOI 10.1021/es0629256; Astudillo Pastor J., 2001, ALMACENAMIENTO GEOLO; BIBBY R, 1981, WATER RESOUR RES, V17, P1075, DOI 10.1029/WR017i004p01075; Byegard J., 1998, 9818 SKB TR; COMSOL Inc, 2011, COMSOL MULT VERS 42; Cramer J.J., 1997, 11756 AECL WHIT LAB; Gimmi T, 2014, GEOCHIM COSMOCHIM AC, V125, P373, DOI 10.1016/j.gca.2013.10.014; Gimmi T, 2011, ENVIRON SCI TECHNOL, V45, P1443, DOI 10.1021/es1027794; Glueckauf E, 1980, R9823 AERE; GRISAK GE, 1981, J HYDROL, V52, P47, DOI 10.1016/0022-1694(81)90095-0; Hartikainen J., 1996, 9622 POS OY; Haviova V., 2011, LTD PHASE 1 EXPT TRA; Hodgkinson D, 2009, HYDROGEOL J, V17, P1035, DOI 10.1007/s10040-008-0416-9; IDEMITSU K, 1992, J NUCL SCI TECHNOL, V29, P454; Jakob A, 2004, 0408 PSI; Mader UK, 2006, J GEOCHEM EXPLOR, V90, P68, DOI 10.1016/j.gexplo.2005.09.006; Mori A, 2009, THESIS U BERN; Mori A, 2005, 0519 NAB; Neretnieks I, 2002, J CONTAM HYDROL, V55, P175, DOI 10.1016/S0169-7722(01)00195-4; NERETNIEKS I, 1980, J GEOPHYS RES, V85, P4379, DOI 10.1029/JB085iB08p04379; Ohlsson Y, 2001, J CONTAM HYDROL, V47, P117, DOI 10.1016/S0169-7722(00)00142-X; Palut JM, 2003, J CONTAM HYDROL, V61, P203, DOI 10.1016/S0169-7722(02)00134-1; Polak A, 2003, J CONTAM HYDROL, V67, P95, DOI 10.1016/S0169-7722(03)00069-X; Robinet JC, 2008, TRANSPORT POROUS MED, V72, P393, DOI 10.1007/s11242-007-9159-7; Robinet J.C., 2012, WATER RESOURCES RES, V48; Samper J, 2006, PHYS CHEM EARTH, V31, P531, DOI 10.1016/j.pce.2006.04.017; Sardini P, 2003, J CONTAM HYDROL, V61, P339, DOI 10.1016/S0169-7722(02)00124-9; Savage D, 2011, APPL GEOCHEM, V26, P1138, DOI 10.1016/j.apgeochem.2011.04.004; Soler J.M., 2015, 15033 NAB; Soler J.M., 2013, 1253 NAB; Soler J.M., 2014, 1391 NAB; Soler J.M., 2006, 0501 NTB; Soler JM, 2008, PHYS CHEM EARTH, V33, pS196, DOI 10.1016/j.pce.2008.10.010; Soler JM, 2013, APPL GEOCHEM, V33, P191, DOI 10.1016/j.apgeochem.2013.02.012; Steefel C.I., 2014, COMPUT GEOSCI; Steefel C.I., 2009, CRUNCHFLOW SOFTWARE; Tachi Y, 2014, GEOCHIM COSMOCHIM AC, V132, P75, DOI 10.1016/j.gca.2014.02.004; Tachi Y, 2011, GEOCHIM COSMOCHIM AC, V75, P6742, DOI 10.1016/j.gca.2011.08.039; Teng YG, 2011, J ENVIRON RADIOACTIV, V102, P212, DOI 10.1016/j.jenvrad.2010.12.002; Tevissen E, 2004, RADIOCHIM ACTA, V92, P781, DOI 10.1524/ract.92.9.781.54989; Van Loon LR, 2004, RADIOCHIM ACTA, V92, P757, DOI 10.1524/ract.92.9.757.54988; Wersin P., 2006, 200306 MONT TERR PRO; Wersin P., 2010, 200904 MONT TERR PRO; Wersin P, 2008, APPL GEOCHEM, V23, P678, DOI 10.1016/j.apgeochem.2001.11.004; Widestrand H., 2010, R1067 SKB; WOOD WW, 1990, SCIENCE, V247, P1569, DOI 10.1126/science.247.4950.1569; Yi SP, 2012, TRANSPORT POROUS MED, V93, P415, DOI 10.1007/s11242-012-9960-9; Yi SP, 2012, J HYDROL, V446, P70, DOI 10.1016/j.jhydrol.2012.04.032; Yllera A, 2004, APPL CLAY SCI, V26, P181, DOI 10.1016/j.clay.2003.12.007	69	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	AUG	2015	179						89	101		10.1016/j.jconhyd.2015.06.002		13	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CP5ZX	WOS:000359965200009		
J	Omoto, K; Shigemoto, S; Suzuki, Y; Nakamura, M; Okura, K; Nishigawa, K; Goto, N; Rodis, OMM; Matsuka, Y				Omoto, Katsuhiro; Shigemoto, Shuji; Suzuki, Yoshitaka; Nakamura, Mayumi; Okura, Kazuo; Nishigawa, Keisuke; Goto, Nami; Rodis, Omar Marianito Maningo; Matsuka, Yoshizo			A preliminary investigation of reproducibility of EMG signals during daytime masticatory muscle activity using a portable EMG logging device	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Daytime masseter muscle activity; Teeth grinding; Clenching	SELF-REPORTED BRUXISM; SLEEP BRUXISM; TEMPOROMANDIBULAR DISORDERS; PAIN; TEETH	Continuous parafunctional masseter muscle activities (MMA) that are associated with daytime bruxism have been suspected to be one of the main pathoetiology for orofacial pain. The purpose of this study was to examine the long-term stability and reliability of daytime EMG measurement of MMA using a portable device (Actiwave; CamNtech Ltd). Daytime masseter muscle EMG of five subjects were recorded for four days in their normal living environment. There was no significant time dependent effect on EMG amplitude during recording period. A total of 4923 MMA events were detected in all analysis periods (129.4 h) and classified into phasic type (1209 events, 24.6%), tonic type (1759 events, 37.0%), and mixed type (1377 events, 28.0%). There was no significant difference in the number of occurrence among three MMA types. With respect to the duration and peak MMA, there were significant differences among three MMA types. The result of this study indicated that Actiwave can be used to measure MMA events during daytime with high stability and reliability under the normal living environment and it was suspected that parafunctional habits may be associated with the occurrence patterns of MMA during daytime. (C) 2015 Elsevier Ltd. All rights reserved.	[Omoto, Katsuhiro; Shigemoto, Shuji; Suzuki, Yoshitaka; Nakamura, Mayumi; Okura, Kazuo; Nishigawa, Keisuke; Goto, Nami; Matsuka, Yoshizo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stomatognath Funct & Occlusal Reconstruct, Tokushima 7708504, Japan; [Rodis, Omar Marianito Maningo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan; [Shigemoto, Shuji] Tsurumi Univ, Sch Dent Med, Dept Fixed Prosthodont, Yokohama, Kanagawa, Japan	Matsuka, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Fixed Prosthodont, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	matsuka@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25861848]	This study was supported by Grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25861848).	Kato T, 2006, J OROFAC PAIN, V20, P317; Lavigne GJ, 2008, J ORAL REHABIL, V35, P476, DOI 10.1111/j.1365-2842.2008.01881.x; Fujisawa M, 2013, J ORAL REHABIL, V40, P731, DOI 10.1111/joor.12087; Sato Fumiaki, 2006, Journal of Medical and Dental Sciences, V53, P103; Lavigne GJ, 1996, J DENT RES, V75, P546; Nishigawa K, 2001, J ORAL REHABIL, V28, P485, DOI 10.1046/j.1365-2842.2001.00692.x; Miyamoto K, 1996, AM J ORTHOD DENTOFAC, V110, P394, DOI 10.1016/S0889-5406(96)70041-0; ROSELL J, 1995, IEEE T BIO-MED ENG, V42, P1044, DOI 10.1109/10.464380; Tsiggos N, 2008, J PROSTHET DENT, V100, P41, DOI 10.1016/S0022-3913(08)60135-3; Kato T, 2003, J OROFAC PAIN, V17, P191; Rompre PH, 2007, J DENT RES, V86, P837; Endo Hiroshi, 2011, J Prosthodont Res, V55, P159, DOI 10.1016/j.jpor.2010.11.003; Gallo LM, 1998, J DENT RES, V77, P1539; Ikeda Takashi, 1996, Journal of Orofacial Pain, V10, P270; Kato T, 2001, Dent Clin North Am, V45, P657; Kato T, 2003, J PROSTHODONT RES, V57, P69; Klasser GD, 2013, OROFACIAL PAIN GUIDE, V5th, P254; Lavigne GJ, 2005, PRINCIPLES PRACTICE, P946, DOI 10.1016/B0-72-160797-7/50086-0; Manfredini D, 2012, J ORAL REHABIL, V39, P319, DOI 10.1111/j.1365-2842.2011.02281.x; OKURA K, 1999, DENT JPN TOKYO, V35, P53; Piquero K, 2000, J ORAL REHABIL, V27, P473, DOI 10.1046/j.1365-2842.2000.00555.x; Rugh J D, 1988, Adv Neurol, V49, P329; Shetty Shilpa, 2010, J Indian Prosthodont Soc, V10, P141, DOI 10.1007/s13191-011-0041-5; Watanabe Akira, 2011, J Prosthodont Res, V55, P75, DOI 10.1016/j.jpor.2010.09.003	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	AUG	2015	25	4					603	611		10.1016/j.jelekin.2015.04.012		9	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	CP7VO	WOS:000360097400005		
J	Suehiro, T; Mizutani, M; Ishida, H; Kobara, K; Osaka, H; Watanabe, S				Suehiro, Tadanobu; Mizutani, Masatoshi; Ishida, Hiroshi; Kobara, Kenichi; Osaka, Hiroshi; Watanabe, Susumu			Individuals with chronic low back pain demonstrate delayed onset of the back muscle activity during prone hip extension	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Chronic low back pain; Prone hip extension; Muscle activity onset time; Lumbopelvic stability; Back muscle	LIMB MOVEMENT; MOTOR CONTROL; LUMBAR SPINE; CONTRACTION; RECRUITMENT; ACTIVATION; STABILITY; PATTERNS	Prone hip extension (PHE) is commonly used in the evaluation of the stability of the lumbopelvic region. There is little evidence of difference in muscle activity onset timing between healthy individuals and individuals with chronic low back pain (CLBP) during PHE. The purpose of this study was to determine if individuals with and without CLBP differ in the onset time of the trunk and hip extensor muscles activity during PHE. The participants were 20 patients with CLBP and 20 healthy individuals. Electromyography data of the erector spinae, multifidus, gluteus maximus, and semitendinosus were collected during PHE using a surface electromyograph. Relative differences in the onset times between each muscle and the prime mover (i.e., the semitendinosus) were calculated. The onsets of the bilateral multifidus and contralateral erector spinae were significantly delayed in the CLBP group compared with the healthy group (p < 0.001), despite the onset timings of leg movement not being significantly different between the groups. The onset times of the gluteus maximus and ipsilateral erector spinae showed no significant differences between the groups. These results suggest that individuals with CLBP use an altered, and possibly inadequate, trunk muscle recruitment pattern. (C) 2015 Elsevier Ltd. All rights reserved.	[Suehiro, Tadanobu; Mizutani, Masatoshi] Kibi Int Univ, Grad Sch Hlth Sci, Takahashi City 7168508, Japan; [Suehiro, Tadanobu; Ishida, Hiroshi; Kobara, Kenichi; Osaka, Hiroshi; Watanabe, Susumu] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Kurashiki, Okayama 7010193, Japan	Suehiro, T (reprint author), 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	suehiro@mw.kawasaki-m.ac.jp					Hodges PW, 1997, ERGONOMICS, V40, P1220, DOI 10.1080/001401397187469; Takasaki H, 2009, MANUAL THER, V14, P484, DOI 10.1016/j.math.2008.11.003; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Thomas JS, 2007, SPINE, V32, pE801; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Hodges PW, 1998, J SPINAL DISORD, V11, P46; MacDonald DA, 2006, MANUAL THER, V11, P254, DOI 10.1016/j.math.2006.02.004; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Crow J, 2011, PHYS THER SPORT, V12, P199, DOI 10.1016/j.ptsp.2010.12.002; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Kang SY, 2013, MANUAL THER, V18, P303, DOI 10.1016/j.math.2012.11.006; Silfies SP, 2009, ARCH PHYS MED REHAB, V90, P1159, DOI 10.1016/j.apmr.2008.10.033; Chance-Larsen K, 2010, MANUAL THER, V15, P61, DOI 10.1016/j.math.2009.07.001; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Bruno PA, 2008, CLIN CHIROPR, V11, P4, DOI 10.1016/j.clch.2008.01.001; Bruno PA, 2007, CLIN CHIROPRACTIC, V10, P68, DOI 10.1016/j.clch.2006.10.002; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0921-884X(96)95190-5; GARDNERMORSE M, 1995, J ORTHOPAED RES, V13, P802, DOI 10.1002/jor.1100130521; Guimaraes CQ, 2010, REV BRAS FISIOTER, V14, P351, DOI 10.1590/S1413-35552010005000017; Hodges PW, 1997, PHYS THER, V77, P132; Lehman GJ, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-3; Masse-Alarie H, 2014, GAIT POSTURE, DOI [http://dx.doi.org/10.1016/j.gaitpost.2014.11.006, DOI 10.1016/J.GAITP0ST.2014.11.006.[]; Moseley GL, 2002, SPINE, V15, P29, DOI DOI 10.1097/00007632-200201150-00013; Moseley GL, 2004, BRAIN, V127, P2339, DOI 10.1093/brain/awh248; PIERCE M N, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P2; Richardson CA, 2004, THERAPEUTIC EXERCISE; Richardson CA, 1999, THERAPEUTIC EXERCISE; Roach KE, 1997, J ORTHOP SPORT PHYS, V26, P253; Sahrmann SA, 2002, DIAGNOSIS TREATMENT; Sakarnoto ACL, 2009, J ELECTROMYOGR KINES, V19, P105, DOI 10.1016/j.jelekin.2007.07.004; Tateuchi H, 2012, J ELECTROMYOGR KINES, V22, P391, DOI 10.1016/j.jelekin.2012.03.003; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; Vogt L, 1997, CLIN BIOMECH, V12, P122, DOI 10.1016/S0268-0033(96)00055-1; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	AUG	2015	25	4					675	680		10.1016/j.jelekin.2015.04.013		6	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	CP7VO	WOS:000360097400014		
J	Narita, A; Sagae, M; Suzuki, K; Fujita, T; Sotokawa, T; Nakano, H; Naganuma, M; Sato, T; Fujii, H; Nito, M; Hashizume, W; Ogino, T; Naito, A				Narita, Aya; Sagae, Masaaki; Suzuki, Katsuhiko; Fujita, Takaaki; Sotokawa, Tasuku; Nakano, Haruki; Naganuma, Makoto; Sato, Toshiaki; Fujii, Hiromi; Nito, Mitsuhiro; Hashizume, Wataru; Ogino, Toshihiko; Naito, Akira			Strict actions of the human wrist flexors: A study with an electrical neuromuscular stimulation method	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Humans; Wrist flexor muscles; Electrical neuromuscular stimulation; Motion; Force	SPINAL-CORD-INJURY; TENDON TRANSFERS; FOREARM; RESTORATION; EXTENSION; EXCURSION; MUSCLES	In order to elucidate strict actions of the human wrist flexors, motion and force produced by electrical neuromuscular stimulation (ENS) to each of musculus (m.) flexsor carpi radialis (FCR) and m. flexsor carpi ulnaris (FCU) with the prone, semiprone, and supine forearm were studied in ten healthy human subjects. Abduction, extension, adduction, and flexion directions were represented by, respectively, 0 degrees, 90 degrees, 180 degrees, and 270 degrees. ENS to FCR and FCU produced motion in direction of, respectively, 273 degrees (mean) and 265 degrees with the prone, 249 degrees and 232 degrees with the semiprone, and 242 degrees and 229 degrees with the supine forearm to the maximal range. Direction/strength (N m) of force by ENS to FCR and FCU were, respectively, 298 degrees/1.16 and 239 degrees/1.70 with the prone, 279 degrees/1.30 and 241 degrees/1.62 with the semiprone, and 267 degrees/1.24 and 227 degrees/2.04 with the supine forearm. ENS to FCR exhibited force of 20-29% of maximal flexion and 7-15% of maximal abduction or 1-4% of maximal adduction and that to FCU force of 24-28% of maximal flexion and 15-25% of maximal adduction. The force study results suggest that FCU is a flexor rather than an adductor with every forearm position. FCR should be a flexor rather than an abductor with the prone and semiprone and a flexor with the supine forearm. The action of FCR as the abductor should diminish with supinating the forearm. (C) 2015 Elsevier Ltd. All rights reserved.	[Narita, Aya; Ogino, Toshihiko] Yamagata Univ, Sch Med, Dept Orthopaed Surg, Yamagata 99023, Japan; [Sagae, Masaaki] Sagae Orthoped Clin, Yamagata, Japan; [Suzuki, Katsuhiko] Yamagata Prefectural Univ Hlth Sci, Dept Phys Therapy, Yamagata, Japan; [Fujita, Takaaki] Sendai Rehabil Coll, Dept Occupat Therapy, Sendai, Miyagi, Japan; [Sotokawa, Tasuku] Niigata Univ Hlth & Welf, Dept Occupat Therapy, Niigata, Japan; [Nakano, Haruki] Osaka Med Coll, Dept Rehabil Med, Osaka, Japan; [Naganuma, Makoto] Yamagata Coll Med Arts Sci, Dept Phys Therapy, Yamagata, Japan; [Sato, Toshiaki; Fujii, Hiromi] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata, Japan; [Nito, Mitsuhiro; Hashizume, Wataru; Naito, Akira] Yamagata Univ, Sch Med, Dept Anat & Struct Sci, Yamagata 99023, Japan	Naito, A (reprint author), Yamagata Univ, Sch Med, Dept Anat & Struct Sci, Yamagata 99023, Japan.				Japanese Ministry of Education, Science, Sports, and Culture [24590230]; Yamagata Health Support Foundation	The authors thank Mr. Katsuhiko Kato in Gigatex Corporation, Mr. Inazo Eguchi in Koshika Corporation, and Ms. Saori Yoshida in our Department for their kind assistance. We also thank students of Yamagata University School of Medicine. This work was supported, in part, by the Grant-in-Aid from Japanese Ministry of Education, Science, Sports, and Culture (24590230) and by Grants from Yamagata Health Support Foundation.	HORII E, 1993, J HAND SURG-AM, V18A, P83, DOI 10.1016/0363-5023(93)90250-7; Loren GJ, 1996, J BIOMECH, V29, P331, DOI 10.1016/0021-9290(95)00055-0; Delp SL, 1996, J BIOMECH, V29, P1371, DOI 10.1016/0021-9290(96)00029-2; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; Basmajian JV, 1969, MUSCLES MOVEMENTS BA, P218; Basmajian JV, 1982, PRIMARY ANATOMY, V8th; Brand PW, 1985, CLIN MECH HAND; BUCHANAN TS, 1993, J BIOMECH, V26, P547, DOI 10.1016/0021-9290(93)90016-8; BACKDAHL M., 1961, ACTA MORPHOL NEERLANDO SCAND, V4, P136; Fagarasanu M, 2004, CLIN BIOMECH, V19, P671, DOI 10.1016/j.clinbiomech.2004.05.004; Fujii H, 2007, J ELECTROMYOGR KINES, V17, P80, DOI 10.1016/j.jelekin.2005.11.013; Fujita T, 2007, STRUCT FUNCT, V6, P11; HOSHIMIYA N, 1989, IEEE T BIO-MED ENG, V36, P754, DOI 10.1109/10.32108; Keith MW, 1996, J HAND SURG-AM, V21A, P89, DOI 10.1016/S0363-5023(96)80160-2; Naganuma M, 2014, STRUCT FUNCT, V13, P8; Naito A, 1994, TOHOKU J EXP MED, V174, P3433; Naito A, 2002, J ELECTROMYOGR KINES, V12, P259, DOI 10.1016/S1050-6411(02)00009-3; OHNISHI N, 1991, Hokkaido Journal of Orthopedic and Traumatology, V35, P73; Sagae M, 2010, J ELECTROMYOGR KINES, V20, P1178, DOI 10.1016/j.jelekin.2010.06.003; Shiota E, 2006, PHYSL ARTICULAIRE, V6th, P146; Sotokawa T, 2014, STRUCT FUNCT, V13, P2; Standring S, 2005, GRAYS ANATOMY; YOUM Y, 1984, J HAND SURG-AM, V9A, P202	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	AUG	2015	25	4					689	696		10.1016/j.jelekin.2015.04.004		8	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	CP7VO	WOS:000360097400016		
J	Obata, D; Tasaka, H; Katsuki, S; Akiyama, H				Obata, Daichi; Tasaka, Hiroshi; Katsuki, Sunao; Akiyama, Hidenori			Formation of liquid cone jet dependent on rise time of driving voltage	JOURNAL OF ELECTROSTATICS			English	Article						Electrospray; EHD spray; Laser shadowgraph; Drop-on-demand process	TAYLOR CONES; ELECTROSPRAY-IONIZATION; MODES; FLOWS	This paper reports on transient dynamics of electrospray driven by high step voltage and its dependence on voltage rise time. Three rise times (50 ns, 1.8 mu s, and 400 mu s) were used to compare influence on liquid dynamics. It was found that, when the applied voltage exceeds a certain level, minute differences in voltage rise time significantly affect jet formation time. A rise time of 50 ns accelerates the jet ejection by about 20% compared with other rise times. These results indicate that optimization of rise time may enable drastic improvement of controllability of drop-on-demand electrospray. (C) 2015 Elsevier B.V. All rights reserved.	[Obata, Daichi; Tasaka, Hiroshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Katsuki, Sunao; Akiyama, Hidenori] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Obata, D (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	d.obata@st.cs.kumamoto-u.ac.jp					Chen CH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191733; Krpoun R, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/4/045019; Yogi O, 2001, ANAL CHEM, V73, P1896, DOI 10.1021/ac0012039; Tran SBQ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026318; Loeb LB, 1941, PHYS REV, V60, P714, DOI 10.1103/PhysRev.60.714; de la Mora JF, 2007, ANNU REV FLUID MECH, V39, P217, DOI 10.1146/annurev.fluid.39.050905.110159; Barrero A, 1998, PHYS REV E, V58, P7309, DOI 10.1103/PhysRevE.58.7309; Kim J, 2008, J AEROSOL SCI, V39, P819, DOI 10.1016/j.jaerosci.2008.05.001; Jaworek A, 1999, J AEROSOL SCI, V30, P873, DOI 10.1016/S0021-8502(98)00787-3; VANZOMEREN AA, 1994, J AEROSOL SCI, V25, P1229, DOI 10.1016/0021-8502(94)90211-9; CLOUPEAU M, 1994, J AEROSOL SCI, V25, P1021, DOI 10.1016/0021-8502(94)90199-6; Mishra S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/9/095026; Juraschek R, 1998, INT J MASS SPECTROM, V177, P1, DOI 10.1016/S1387-3806(98)14025-3; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Paine MD, 2009, MICROFLUID NANOFLUID, V6, P775, DOI 10.1007/s10404-008-0350-0; Rayleigh L., 1879, P R SOC LONDON, V29, P71, DOI DOI 10.1098/RSPL.1879.0015; SHTERN V, 1994, J AEROSOL SCI, V25, P1049, DOI 10.1016/0021-8502(94)90201-1; TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151; Yeo LY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.133902	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	AUG	2015	76						274	277		10.1016/j.elstat.2015.05.011		4	Engineering, Electrical & Electronic	Engineering	CP5XY	WOS:000359960000038		
J	Soliev, AB; Hosokawa, K; Enomoto, K				Soliev, Azamjon B.; Hosokawa, Kakushi; Enomoto, Keiichi			Effects of prodigiosin family compounds from Pseudoalteromonas sp 1020R on the activities of protein phosphatases and protein kinases	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY			English	Article						Cytotoxicity; enzyme inhibition; structure-activity relationship	COLON-CANCER CELLS; ANTICANCER; INHIBITORS; EXPRESSION; DISCOVERY; APOPTOSIS; PTP1B	Pseudoalteromonas sp. strain 1020R produces prodigiosin and its closely related congeners, which differ in the length of their alkyl side chains. These red-pigmented compounds were found to exhibit cytotoxicity against human leukemia cell lines. The compounds also showed dose-dependent inhibitory effects on protein phosphatase 2A and protein tyrosine phosphatase 1B (PTP1B), while remaining relatively inactive against protein kinases, including protein tyrosine kinase, Ca2+/calmodulin-dependent protein kinase and protein kinases A and C. Comparative studies of the individual pigmented compounds on PTP1B inhibition showed that as the chain length of the alkyl group at the C-3 position of the compound increased, the inhibitory effect on PTP1B decreased. These results suggest that protein phosphatases but not protein kinases might be involved in the cytotoxicity of the prodigiosin family of compounds against malignant cells.	[Soliev, Azamjon B.; Hosokawa, Kakushi; Enomoto, Keiichi] Kochi Univ Technol, Dept Environm Syst Engn, Kochi, Japan	Enomoto, K (reprint author), Kochi Univ Technol, Dept Environm Syst Engn, Kochi, Japan.	enomoto.keiichi@kochi-tech.ac.jp					Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Ju JF, 1998, CLIN CANCER RES, V4, P1315; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; Furstner A, 2004, CHEMBIOCHEM, V5, P1575, DOI 10.1002/cbic.200400135; Montaner B, 2000, BRIT J PHARMACOL, V131, P585, DOI 10.1038/sj.bjp.0703614; Castillo-Avila W, 2005, LIFE SCI, V78, P121, DOI 10.1016/j.lfs.2005.04.059; FEINSTEIN E, 1992, ONCOGENE, V7, P1853; Montaner B, 2003, CURR CANCER DRUG TAR, V3, P57, DOI 10.2174/1568009033333772; Pandey R, 2009, CURR PHARM DESIGN, V15, P732; Ramoneda BM, 2002, BIOCHEM PHARMACOL, V63, P463, DOI 10.1016/S0006-2952(01)00850-4; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Toomik R, 1997, BIOCHEM J, V322, P455; Wang Y, 2012, BIOSCI BIOTECH BIOCH, V76, P1229, DOI 10.1271/bbb.110984	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1475-6366	1475-6374		J ENZYM INHIB MED CH	J. Enzym. Inhib. Med. Chem.	AUG	2015	30	4					533	538		10.3109/14756366.2014.951347		6	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CP3XQ	WOS:000359816600004		
J	Nagaoka, E; Karino, K				Nagaoka, Erika; Karino, Kenji			Female presence promotes male-male aggression among Tanichthys albonubes, a fish species without intense combat	JOURNAL OF ETHOLOGY			English	Article						Aggressive behavior; Aggressive display; Body size difference; Female presence; Courtship behavior; Tanichthys albonubes	SEQUENTIAL ASSESSMENT GAME; MALE-MALE COMPETITION; FIGHTING BEHAVIOR; RESOURCE VALUE; SEXUAL SELECTION; MATE CHOICE; CONTESTS; ASYMMETRIES; EVOLUTION; CONFLICTS	Males often compete with other males to acquire mates. When females are present, males of some animals are known to intensify their aggressive behavior against other males. However, studies demonstrating such male-male aggression in the presence of females have been conducted mainly among species with intense aggressive behavior, for example direct combat. In this study, we examined the effect of female presence on male-male aggressive behavior among fish of the species Tanichthys albonubes, among which intense male-male combat is not typically observed. When a female was present, two contesting males performed aggressive displays and chased each other more frequently than in absence of the female. Males also frequently fled from competitors when a female was present. In addition, when a female was present, differences between the aggressive behavior of two males were greater than when the female was absent, suggesting that the presence of females may emphasize male dominance. Irrespective of the female, large males chased small males more often, and small males more frequently fled contests. Inconsistent with theory, however, size-matched male pairs did not increase their aggressive behavior compared with size-mismatched male pairs in the absence or presence of a female.	[Nagaoka, Erika; Karino, Kenji] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan	Karino, K (reprint author), Tokyo Gakugei Univ, Dept Biol, Nukui Kita 4-1-1, Koganei, Tokyo 1848501, Japan.	kkarino@u-gakugei.ac.jp					Andersson M., 1994, SEXUAL SELECTION; Forsgren E, 1997, P ROY SOC B-BIOL SCI, V264, P1283, DOI 10.1098/rspb.1997.0177; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Kitchen DM, 2005, INT J PRIMATOL, V26, P105, DOI 10.1007/s10764-005-0725-y; Kemp DJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P429, DOI 10.1007/s002650100318; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Sultana Z, 2013, J ETHOL, V31, P203, DOI 10.1007/s10164-013-0367-z; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; McGhee KE, 2007, BEHAV ECOL, V18, P822, DOI 10.1093/beheco/arm051; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; YOKEL DA, 1989, BEHAV ECOL SOCIOBIOL, V24, P209, DOI 10.1007/BF00295200; Ladich F, 1998, ETHOLOGY, V104, P517; Kekalainen J, 2010, ETHOLOGY, V116, P895, DOI 10.1111/j.1439-0310.2010.01802.x; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; LEIMAR O, 1984, J THEOR BIOL, V111, P475, DOI 10.1016/S0022-5193(84)80235-0; Reaney LT, 2011, BEHAV ECOL SOCIOBIOL, V65, P217, DOI 10.1007/s00265-010-1030-0; Bowyer RT, 2011, BEHAV ECOL SOCIOBIOL, V65, P2251, DOI 10.1007/s00265-011-1234-y; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Huntingford FA, 1987, ANIMAL CONFLICT; Judge KA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1971, DOI 10.1007/s00265-010-1008-y; Kotiaho Janne S., 1999, Acta Ethologica, V2, P13, DOI 10.1007/PL00012227; LEIMAR O, 1991, EVOLUTION, V45, P862, DOI 10.2307/2409694; MAGURRAN AE, 1990, J FISH BIOL, V37, P77, DOI 10.1111/j.1095-8649.1990.tb05929.x; Nijman V, 2000, BEHAV PROCESS, V49, P77, DOI 10.1016/S0376-6357(00)00078-4; Petersson E, 1999, ANIM BEHAV, V57, P777, DOI 10.1006/anbe.1998.1043; Petruskova T, 2007, NATURWISSENSCHAFTEN, V94, P643, DOI 10.1007/s00114-007-0237-z; Pizzari T, 2001, P ROY SOC B-BIOL SCI, V268, P181, DOI 10.1098/rspb.2000.1348; ROBINSON SK, 1985, BEHAV ECOL SOCIOBIOL, V18, P39; SMITH IP, 1994, MAR BIOL, V120, P579, DOI 10.1007/BF00350078	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	AUG	2015	33	3					189	195		10.1007/s10164-015-0430-z		7	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP3ZW	WOS:000359822800003		
J	Takata, M; Hayashi, S; Thomas, CE; Koyama, S				Takata, Mamoru; Hayashi, Shinya; Thomas, Cathleen E.; Koyama, Satoshi			The proximate cause of asynchronous hatching in the burying beetle Nicrophorus quadripunctatus	JOURNAL OF ETHOLOGY			English	Article						Nicrophorus; Burying beetle; Asynchronous hatching; Proximate cause; Parent-offspring conflict	EMBRYONIC-DEVELOPMENT TIME; EGG SIZE; BROOD REDUCTION; CLUTCH SIZE; INCUBATION-TEMPERATURE; BIRDS; INSECTS; FITNESS; EVOLUTION; FAILURE	In some species, a brood hatches or is born asynchronously over an extended period of time. This asynchronous hatching establishes competitive asymmetries between offspring, and younger offspring usually exhibit a higher mortality risk and/or lower growth rate. A large body of research suggests that selection favours asynchronous hatching, though a consensus is yet to be reached on the nature of its adaptive benefits. One of the possible causes of this is that previous studies have focused mostly on avian species, who must incubate their eggs. Thus, studying non-avian species may provide an opportunity to improve our understanding of the wider importance of asynchronous hatching, for example in invertebrates, which do not incubate their eggs. In the burying beetle, Nicrophorus quadripunctatus, asynchronous hatching has been shown to maximize parental fitness. However, there is currently no information on the proximate cause of asynchronous hatching in this species. Here we investigated the influence of timing of egg-laying and the duration of embryonic development on the timing of hatching. We found that the timing of egg-laying by the parent was a major determinant of the timing of hatching, although the duration of embryonic development was also important. Our results suggest that the principal proximate cause of asynchronous hatching is parental asynchronous egg-laying.	[Takata, Mamoru] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan; [Hayashi, Shinya; Koyama, Satoshi] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo, Japan; [Thomas, Cathleen E.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Koyama, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, 3-5-8 Saiwai, Fuchu, Tokyo, Japan.	mamorururu2000@yahoo.co.jp; cathleen.thomas@ncl.ac.uk; skoyama@cc.tuat.ac.jp			Japan Science Society	This work is supported by the Sasakawa Scientific Research Grant from The Japan Science Society.	Steiger S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1225; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Stoleson Scott H., 1995, Current Ornithology, V12, P191; Ryan TJ, 2004, OECOLOGIA, V140, P46, DOI 10.1007/s00442-004-1563-x; Schenk K, 2005, ECOL ENTOMOL, V30, P456, DOI 10.1111/j.0307-6946.2005.00707.x; Forbes S, 2000, BEHAV ECOL SOCIOBIOL, V48, P413, DOI 10.1007/s002650000239; Gillooly JF, 2000, FRESHWATER BIOL, V44, P595, DOI 10.1046/j.1365-2427.2000.00607.x; GUTZKE WHN, 1985, CAN J ZOOL, V63, P67; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; Bernardo J, 1996, AM ZOOL, V36, P216; PACKARD GC, 1989, HERPETOLOGICA, V45, P385; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Gilbert JDJ, 2010, AM NAT, V176, P212, DOI 10.1086/653661; HUSSELL DJT, 1972, ECOL MONOGR, V42, P317, DOI 10.2307/1942213; Stenning MJ, 1996, TRENDS ECOL EVOL, V11, P243, DOI 10.1016/0169-5347(96)10030-6; Smiseth PT, 2002, ANIM BEHAV, V63, P577, DOI 10.1006/anbe.2001.1944; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; ARNOLD TW, 1987, AM NAT, V130, P643, DOI 10.1086/284736; Bates D., 2010, LME4 LINEAR MIXED EF; BEISSINGER SR, 1991, AUK, V108, P863; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Forbes S, 1997, NATURE, V390, P351, DOI 10.1038/37025; Gillooly JF, 2000, J ZOOL, V251, P369, DOI 10.1111/j.1469-7998.2000.tb01087.x; HAHN DC, 1981, ANIM BEHAV, V29, P421, DOI 10.1016/S0003-3472(81)80101-7; Lack D. L., 1954, NATURAL REGULATION A; Mock DW, 1997, EVOLUTION SIBLING RI; Monteith KM, 2012, J EVOLUTION BIOL, V25, P1815, DOI 10.1111/j.1420-9101.2012.02567.x; NALEPA CA, 1988, ANN ENTOMOL SOC AM, V81, P637; Potti J, 1996, CONDOR, V98, P328, DOI 10.2307/1369151; SLAGSVOLD T, 1989, AM NAT, V134, P239, DOI 10.1086/284978; Smiseth PT, 2006, FUNCT ECOL, V20, P151, DOI 10.1111/j.1365-2435.2006.01072.x; STINSON CH, 1979, EVOLUTION, V33, P1219, DOI 10.2307/2407480; Takata M, 2014, J EVOLUTION BIOL, V27, P1830, DOI 10.1111/jeb.12433; Takata M, 2013, J ETHOL, V31, P249, DOI 10.1007/s10164-013-0373-1; While GM, 2007, FUNCT ECOL, V21, P513, DOI 10.1111/j.1365-2435.2007.01272.x	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	AUG	2015	33	3					197	203		10.1007/s10164-015-0431-y		7	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP3ZW	WOS:000359822800004		
J	Danaisawadi, P; Asami, T; Ota, H; Sutcharit, C; Panha, S				Danaisawadi, Patchara; Asami, Takahiro; Ota, Hidetoshi; Sutcharit, Chirasak; Panha, Somsak			Subtle asymmetries in the snail-eating snake Pareas carinatus (Reptilia: Pareatidae)	JOURNAL OF ETHOLOGY			English	Article						Coiling direction; Dentition; Handedness; Mandible; Predation	LEFT-RIGHT REVERSAL; HANDED SNAILS; EVOLUTION; SPECIATION; ADVANTAGE; SELECTION; CLAWS; GENE	The snail-eating snake Pareas carinatus tilts its head and strikes leftward or rightward, successfully preying on both dextral and sinistral snails. Striking direction does not depend on prey size or coiling direction. Neither the time from striking until dropping of the shell nor the number of mandibular retractions during feeding was affected by the snake's striking direction or by the snail's coiling direction. Mandibular dentition was only slightly right-handed. Unlike previously studied congeneric species, which are more specialized for feeding on dextral snails, P. carinatus may prey on dextral and sinistral snails with similar efficiency.	[Danaisawadi, Patchara] Chulalongkorn Univ, Dept Biol, Biol Sci Program, Fac Sci, Bangkok 10330, Thailand; [Danaisawadi, Patchara; Sutcharit, Chirasak; Panha, Somsak] Chulalongkorn Univ, Dept Biol, Anim Systemat Res Unit, Bangkok 10330, Thailand; [Asami, Takahiro] Shinshu Univ, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo 6691546, Japan; [Ota, Hidetoshi] Museum Nat & Human Act, Sanda, Hyogo 6691546, Japan	Panha, S (reprint author), Chulalongkorn Univ, Dept Biol, Anim Systemat Res Unit, Bangkok 10330, Thailand.	somsak.pan@chula.ac.th			Thailand Research Fund, through the Royal Golden Jubilee PhD Program [PHD/0082/2552]; Thailand Research Fund Senior Research Scholar [RTA 5580001]; Japan Society for the Promotion of Science [KAKENHI 24255004, 26650161]	This research was funded by the Thailand Research Fund, through the Royal Golden Jubilee PhD Program (PHD/0082/2552). The main research funding support was from the Thailand Research Fund Senior Research Scholar (RTA 5580001). This research was also partially funded by Grants-in-Aid for Scientific Research (KAKENHI 24255004, 26650161) from the Japan Society for the Promotion of Science. We thank members of the Animal Systematics Research Unit, Chulalongkorn University, for assistance with fieldwork.	Okumura T, 2008, DEV DYNAM, V237, P3497, DOI 10.1002/dvdy.21788; Gotz M, 2002, AMPHIBIA-REPTILIA, V23, P487, DOI 10.1163/15685380260462383; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; NG PKL, 1985, CRUSTACEANA, V49, P98, DOI 10.1163/156854085X00288; Benkman CW, 1996, EVOL ECOL, V10, P119, DOI 10.1007/BF01239352; Ota H, 1997, J HERPETOL, V31, P79, DOI 10.2307/1565332; Inoda T, 2003, AM NAT, V162, P811, DOI 10.1086/378903; Utsuno H, 2011, EVOLUTION, V65, P2399, DOI 10.1111/j.1558-5646.2011.01293.x; GOVIND CK, 1989, AM SCI, V77, P468; Dietl GP, 2008, BIOL LETTERS, V4, P290, DOI 10.1098/rsbl.2008.0031; Shigemiya Y, 2003, J ZOOL, V260, P259, DOI 10.1017/S095283690300373X; BAY EC, 1974, ANNU REV ENTOMOL, V19, P441, DOI 10.1146/annurev.en.19.010174.002301; Dietl GP, 2006, BIOL LETTERS, V2, P439, DOI 10.1098/rsbl.2006.0465; Gittenberger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034005; Guo YH, 2011, ZOOTAXA, P57; Hoso M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1133; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Tweedie MWF, 1983, THE SNAKES OF MALAYA; Vogel G, 2015, TAPROBANICA, V7, P1; Wallach V., 2014, SNAKES WORLD CATALOG; You CW, 2015, ZOOLOGICA S IN PRESS	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	AUG	2015	33	3					243	246		10.1007/s10164-015-0432-x		4	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CP3ZW	WOS:000359822800009		
J	Nam, DH; Han, JH; Lee, TJ; Shishido, T; Lim, JH; Kim, GY; Woo, CH				Nam, Dae-Hwan; Han, Jung-Hwa; Lee, Tae-Jin; Shishido, Tetsuro; Lim, Jae Hyang; Kim, Geun-Young; Woo, Chang-Hoon			CHOP deficiency prevents methylglyoxal-induced myocyte apoptosis and cardiac dysfunction	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Methylglyoxal; CHOP; ER stress; Diabetes; Cardiac dysfunction	ENDOPLASMIC-RETICULUM STRESS; C/EBP HOMOLOGOUS PROTEIN; GLYOXALASE-I OVEREXPRESSION; GLYCATION END-PRODUCTS; SPRAGUE-DAWLEY RATS; ER STRESS; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HEART-DISEASE	Epidemiological studies indicate that methylglyoxal (MGO) plasma levels are closely linked to diabetes and the exacerbation of diabetic cardiovascular complications. Recently, it was established that endoplasmic reticulum (ER) stress importantly contributes to the pathogenesis of diabetes and its cardiovascular complications. The objective of this study was to explore the mechanism by which diabetes instigates cardiomyocyte apoptosis and cardiac dysfunction via MGO-mediated myocyte apoptosis. Intriguingly, the MGO activated unfolded protein response pathway accompanying apoptotic events, such as cleavages of PARP-1 and caspase-3. In addition, Western blot analysis revealed that MGO-induced myocyte apoptosis was inhibited by depletion of CHOP with siRNA against Ddit3, the gene name for rat CHOP. To investigate the physiologic roles of CHOP in vivo, glucose tolerance and cardiac dysfunction were assessed in CHOP-deficient mice. No significant difference was observed between CHOP KO and littermate naive controls in terms of the MGO-induced impairment of glucose tolerance. In contrast, myocyte apoptosis, inflammation, and cardiac dysfunction were significantly diminished in CHOP KO compared with littermate na ve controls. These results showed that CHOP is the key signal for myocyte apoptosis and cardiac dysfunction induced by MGO. These findings suggest a therapeutic potential of CHOP inhibition in the management of diabetic cardiovascular complications including diabetic cardiomyopathy. (C) 2015 Elsevier Ltd. All rights reserved.	[Nam, Dae-Hwan; Han, Jung-Hwa; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea; [Lee, Tae-Jin] Yeungnam Univ, Coll Med, Dept Anat, Daegu, South Korea; [Shishido, Tetsuro] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan; [Lim, Jae Hyang] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Kim, Geun-Young] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Cheongju, Chungcheongbuk, South Korea	Woo, CH (reprint author), Yeungnam Univ, Coll Med, Dept Pharmacol, 317-1 Daemyung Dong, Daegu, South Korea.	changhoon_woo@yu.ac.kr			National Research Foundation of Korea [NRF-2013R1A1A1011264]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111520]	This study was supported by a grant of the National Research Foundation of Korea (NRF-2013R1A1A1011264) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111520).	Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Palsamy P, 2014, FREE RADICAL BIO MED, V72, P134, DOI 10.1016/j.freeradbiomed.2014.04.010; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Wu TT, 2011, EUR J PHARM SCI, V42, P496, DOI 10.1016/j.ejps.2011.02.005; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Bourajjaj M, 2003, BIOCHEM SOC T, V31, P1400; Li SY, 2007, LIFE SCI, V80, P1051, DOI 10.1016/j.lfs.2006.11.035; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JC1200214550; MCLELLAN AC, 1994, CLIN SCI, V87, P21; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Mukohda M, 2012, J PHARMACOL SCI, V118, P303, DOI 10.1254/jphs.11R12CP; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; HWANG IS, 1987, HYPERTENSION, V10, P512; Doroudgar S, 2013, J MOL CELL CARDIOL, V55, P85, DOI 10.1016/j.yjmcc.2012.10.006; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Domanski M, 2003, J AM COLL CARDIOL, V42, P914, DOI 10.1016/S0735-1097(03)00856-8; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Xu JC, 2012, EXP DIABETES RES, DOI 10.1155/2012/827971; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Endo M, 2006, J IMMUNOL, V176, P6245; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; He ZH, 2012, EXP NEUROL, V238, P218, DOI 10.1016/j.expneurol.2012.08.025; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Toriguchi K, 2014, J GASTROEN HEPATOL, V29, P1109, DOI 10.1111/jgh.12481; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kumagai T, 2009, AM J PHYSIOL-RENAL, V296, pF912, DOI 10.1152/ajprenal.90575.2008; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013007; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Dhar A, 2010, BRIT J PHARMACOL, V159, P166, DOI 10.1111/j.1476-5381.2009.00469.x; Dhar I, 2014, AM J HYPERTENS, V27, P308, DOI 10.1093/ajh/hpt281; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8017.2004; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Liu R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-105; Liu ZW, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-158; Mao WK, 2008, J MOL CELL CARDIOL, V45, P250, DOI 10.1016/j.yjmcc.2008.05.010; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Ramasamy R, 2005, GLYCOBIOLOGY, V15, P16; Randell E. W., 2005, Journal of Pharmacological and Toxicological Methods, V51, P153, DOI 10.1016/j.vascn.2004.08.005; Shen MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088389; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Thornalley PJ, 1996, GEN PHARMACOL, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Vulesevic B, 2014, CARDIOVASC RES, V101, P306, DOI 10.1093/cvr/cvt259; Vulesevic B, 2014, BIOCHEM SOC T, V42, P523, DOI 10.1042/BST20130254; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636	64	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	AUG	2015	85						168	177		10.1016/j.yjmcc.2015.05.016		10	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CP4UO	WOS:000359878300019		
J	Yoshida, Y; Shimizu, I; Katsuumi, G; Jiao, S; Suda, M; Hayashi, Y; Minamino, T				Yoshida, Yohko; Shimizu, Ippei; Katsuumi, Goro; Jiao, Shuang; Suda, Masayoshi; Hayashi, Yuka; Minamino, Tohru			p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Heart failure; Inflammation; Bone marrow cells; Endothelial cells	CHRONIC HEART-FAILURE; INTERCELLULAR-ADHESION MOLECULE-1; MARROW-DERIVED CELLS; BONE-MARROW; INSULIN-RESISTANCE; STEM-CELLS; BETA(2)-ADRENERGIC RECEPTOR; ENDOTHELIAL INFLAMMATION; MYOCARDIAL-INFARCTION; TUMOR SUPPRESSION	The rates of death and disability caused by severe heart failure are still unacceptably high. There is evidence that the sterile inflammatory response has a critical role in the progression of cardiac remodeling in the failing heart. The p53 signaling pathway has been implicated in heart failure, but the pathological link between p53 and inflammation in the failing heart is largely unknown. Here we demonstrate a critical role of p53-induced inflammation in heart failure. Expression of p53 was increased in cardiac endothelial cells and bone marrow cells in response to pressure overload, leading to up-regulation of intercellular adhesion molecule-1 (ICAM1) expression by endothelial cells and integrin expression by bone marrow cells. Deletion of p53 from endothelial cells or bone marrow cells significantly reduced ICAM1 or integrin expression, respectively, as well as decreasing cardiac inflammation and ameliorating systolic dysfunction during pressure overload. Conversely, overexpression of p53 in bone marrow cells led to an increase of integrin expression and cardiac inflammation that reduced systolic function. Norepinephrine markedly increased p53 expression in endothelial cells and macrophages. Reducing beta(2)-adrenergic receptor expression in endothelial cells or bone marrow cells attenuated cardiac inflammation and improved systolic dysfunction during pressure overload. These results suggest that activation of the sympathetic nervous system promotes cardiac inflammation by up-regulating ICAM1 and integrin expression via p53 signaling to exacerbate cardiac dysfunction. Inhibition of p53-induced inflammation may be a novel therapeutic strategy for heart failure. (C) 2015 Elsevier Ltd. All rights reserved.	[Yoshida, Yohko; Shimizu, Ippei; Katsuumi, Goro; Jiao, Shuang; Suda, Masayoshi; Hayashi, Yuka; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata 9518510, Japan; [Yoshida, Yohko; Shimizu, Ippei] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata 9518510, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Minamino, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Chuo Ku, 1-757 Asahimachidori, Niigata 9518510, Japan.	t_minamino@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24390195, 25126706, 25670382, 26115008]; Ono Medical Research Foundation; Japan Diabetes Foundation; Takeda Science Foundation; Takeda Medical Research Foundation; Daiichi-Sankyo Foundation of Life Science; MEXT [26893080, 26860548]; Uehara Memorial Foundation; Kowa Life Science Foundation; Manpei Suzuki Diabetes Foundation; Kanae Foundation; Japan Heart Foundation; Senri Life Science Foundation; SENSHIN Medical Research Foundation; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; SENSHIN Medical Research Foundation grant; Bourbon	This work was supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Scientific Research on Innovative Areas (Stem Cell Aging and Disease), and a Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Research project number: 24390195, 25126706, 25670382, 26115008) of Japan, as well as grants from the Ono Medical Research Foundation, the Japan Diabetes Foundation, the Takeda Science Foundation, the Takeda Medical Research Foundation, and the Daiichi-Sankyo Foundation of Life Science (to T.M.); by a Grant-in-Aid for Scientific Research from MEXT (Research Project Number: 26893080) and grants from the Uehara Memorial Foundation, Takeda Science Foundation, Kowa Life Science Foundation, Manpei Suzuki Diabetes Foundation, Kanae Foundation, Japan Heart Foundation, Senri Life Science Foundation, SENSHIN Medical Research Foundation (to I.S.); by a Grant-in-Aid for Young Scientists from MEXT (Research Project Number: 26860548), a Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant, and a SENSHIN Medical Research Foundation grant (to Y.Y.); and by a grant from Bourbon (to T.M., I.S. and Y.Y.).	Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nakamura K, 2002, CIRCULATION, V105, P2867, DOI 10.1161/01.CIR.0000018605.14470.DD; Endo J, 2007, CIRCULATION, V116, P1176, DOI 10.1161/CIRCULATIONAHA.106.650903; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Damilano F, 2011, CIRCULATION, V123, P391, DOI 10.1161/CIRCULATIONAHA.110.950543; Devaux B, 1997, EUR HEART J, V18, P470; Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Glezeva N, 2014, HEART FAIL REV, V19, P681, DOI 10.1007/s10741-013-9405-8; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Chan PS, 2013, NEW ENGL J MED, V368, P1019, DOI 10.1056/NEJMoa1200657; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Kizaki T, 2009, MOL IMMUNOL, V46, P1195, DOI 10.1016/j.molimm.2008.11.005; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; Liao YL, 2012, EUR HEART J, V33, P3124, DOI 10.1093/eurheartj/ehr246; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Kavelaars A, 1997, J NEUROIMMUNOL, V77, P211, DOI 10.1016/S0165-5728(97)00076-3; Molenaar P, 2006, CARDIOVASC RES, V69, P128, DOI 10.1016/j.cardiores.2005.08.024; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Dandona P, 2000, CIRCULATION, V101, P122; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Kuwahara F, 2003, HYPERTENSION, V41, P819, DOI 10.1161/01.HYP.0000056108.73219.0A; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Blyszczuk P, 2009, CIRC RES, V105, P912, DOI 10.1161/CIRCRESAHA.109.199802; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Cohn JN, 1995, CLIN CARDIOL, V18, pI9; de Gaetano M, 2013, J IMMUNOL, V191, P4326, DOI 10.4049/jimmunol.1300990; Guirao X, 1997, AM J PHYSIOL-ENDOC M, V273, pE1203; Iaccarino G, 2005, CIRC RES, V97, P1182; Jobe SO, 2011, HYPERTENSION, V58, P874, DOI 10.1161/HYPERTENSIONAHA.111.178046; Kondo H, 2012, AM J PHYSIOL-ENDOC M, V304, pE507; Li P, 2003, CELL MOL LIFE SCI, V60, P2200, DOI 10.1007/s00018-003-3178-5; López-Otín Carlos, 2013, Cell, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Majmudar MD, 2005, CIRCULATION, V127, P2038; McAlees JW, 2009, MOL CELL BIOL, V29, P675, DOI 10.1128/MCB.01466-08; Rodrigues SF, 2010, AM J PHYSIOL-HEART C, V299, pH25, DOI 10.1152/ajpheart.00620.2009; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Schnitzler N, 1999, NAT MED, V5, P231; Schrier RW, 1999, NEW ENGL J MED, V341, P577; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Yepuri G, 2012, AGING CELL, V11, P1005, DOI 10.1111/acel.12001	71	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	AUG	2015	85						183	198		10.1016/j.yjmcc.2015.06.001		16	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CP4UO	WOS:000359878300021		
J	Oda, T; Yang, Y; Uchinoumi, H; Thomas, DD; Chen-Izu, Y; Kato, T; Yamamoto, T; Yano, M; Cornea, RL; Bers, DM				Oda, Tetsuro; Yang, Yi; Uchinoumi, Hitoshi; Thomas, David D.; Chen-Izu, Ye; Kato, Takayoshi; Yamamoto, Takeshi; Yano, Masafumi; Cornea, Razvan L.; Bers, Donald M.			Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Calmodulin; FKBP12.6; Ryanodine receptor; Reactive oxygen species; Dantrolene	POLYMORPHIC VENTRICULAR-TACHYCARDIA; RETICULUM CALCIUM LEAK; HEART-FAILURE; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; INTERDOMAIN INTERACTION; MALIGNANT HYPERTHERMIA; THERAPEUTIC AGENT; KEY ROLE; CHANNEL	Oxidative stress may contribute to cardiac ryanodine receptor (RyR2) dysfunction in heart failure (HF) and arrhythmias. Altered RyR2 domain-domain interaction (domain unzipping) and calmodulin (CaM) binding affinity are allosterically coupled indices of RyR2 conformation. In HF RyR2 exhibits reduced CaM binding, increased domain unzipping and greater SR Ca leak, and dantrolene can reverse these changes. However, effects of oxidative stress on RyR2 conformation and leak in myocytes are poorly understood. We used fluorescent CaM, FKBP12.6, and domain-peptide biosensor (F-DPc10) to measure, directly in cardiac myocytes, (1) RyR2 activation by hydrogen peroxide (H2O2)-induced oxidation, (2) RyR2 conformation change caused by oxidation, (3) CaM-RyR2 and FK506-binding protein (FKBP12.6)-RyR2 interaction upon oxidation, and (4) whether dantrolene affects 1-3. H2O2 was used to mimic oxidative stress. H2O2 significantly increased the frequency of Ca2+ sparks and spontaneous Ca2+ waves, and dantrolene almost completely blocked these effects. H2O2 pretreatment significantly reduced CaM-RyR2 binding, but had no effect on FKBP12.6-RyR2 binding. Dantrolene restored CaM-RyR2 binding but had no effect on intracellular and RyR2 oxidation levels. H2O2 also accelerated F-DPc10-RyR2 association while dantrolene slowed it. Thus, H2O2 causes conformational changes (sensed by CaM and DPc10 binding) associated with Ca leak, and dantrolene reverses these RyR2 effects. In conclusion, in cardiomyocytes, H2O2 treatment markedly reduces the CaM-RyR2 affinity, has no effect on FKBP12.6-RyR2 affinity, and causes domain unzipping. Dantrolene can correct domain unzipping, restore CaM-RyR2 affinity, and quiet pathological RyR2 channel gating. F-DPc10 and CaM are useful biosensors of a pathophysiological RyR2 state. (C) 2015 Elsevier Ltd. All rights reserved.	[Oda, Tetsuro; Yang, Yi; Uchinoumi, Hitoshi; Chen-Izu, Ye; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Oda, Tetsuro; Kato, Takayoshi; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan; [Yang, Yi; Thomas, David D.; Cornea, Razvan L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	Bers, DM (reprint author), Univ Calif Davis, Dept Pharmacol, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu			National Institutes of Health [R01-HL092097, R37HL30077, R37AG26160]; JSPS KAKENHI Grant [26670403]; SENSHIN Medical Research Foundation [J25025]	This work was supported by National Institutes of Health R01-HL092097 (DMB and RLC), R37HL30077 (DMB) and R37AG26160 (DDT), by JSPS KAKENHI Grant Number 26670403, and by SENSHIN Medical Research Foundation (TO) Grant Number J25025.	Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; MCMURRAY J, 1993, EUR HEART J, V14, P1493; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Uchinoumi Hitoshi, 2010, Circ Res, V106, P1413, DOI 10.1161/CIRCRESAHA.109.209312; Greensmith DJ, 2010, CELL CALCIUM, V48, P341, DOI 10.1016/j.ceca.2010.10.007; Kinugawa S, 2000, CIRC RES, V87, P392; Bers DM, 2012, CIRC RES, V110, P796, DOI 10.1161/CIRCRESAHA.112.265579; Kobayashi S, 2010, CIRC J, V74, P2579, DOI 10.1253/circj.CJ-10-0680; Xu XJ, 2010, BIOCHEM BIOPH RES CO, V394, P660, DOI 10.1016/j.bbrc.2010.03.046; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Belevych AE, 2011, CARDIOVASC RES, V90, P493, DOI 10.1093/cvr/cvr025; Maxwell JT, 2012, AM J PHYSIOL-HEART C, V302, pH953, DOI 10.1152/ajpheart.00936.2011; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Oda T, 2013, CIRC RES, V112, P487, DOI 10.1161/CIRCRESAHA.111.300290; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Curran J, 2010, J MOL CELL CARDIOL, V49, P25, DOI 10.1016/j.yjmcc.2010.03.013; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Mallat Z, 1998, CIRCULATION, V97, P1536; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Marks AR, 2000, CIRC RES, V87, P8; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; BORASO A, 1994, AM J PHYSIOL, V267, pH1010; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Diaz-Sylvester PL, 2008, AM J PHYSIOL-CELL PH, V294, pC1103, DOI 10.1152/ajpcell.90642.2007; Donoso P, 2014, J MOL CELL CARDIOL, V68, P38, DOI 10.1016/j.yjmcc.2013.12.028; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Houser SR, 2014, CIRC RES, V114, P1320, DOI 10.1161/CIRCRESAHA.114.300569; Ikemoto N., 2004, RYANODINE RECEPTORS, P53; Ikemoto N, 2002, FRONT BIOSCI, V7, pD671, DOI 10.2741/ikemoto; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; Paul-Pletzer K, 2005, BIOCHEM J, V387, P905, DOI 10.1042/BJ20041336; Prestle J, 2001, CIRC RES, V88, P188; Qin FZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000184; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Tsutsui H, 2001, CARDIOVASC RES, V49, P103, DOI 10.1016/S0008-6363(00)00197-8; Yamamoto T, 2000, J BIOL CHEM, V275, P11618, DOI 10.1074/jbc.275.16.11618; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623	54	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	AUG	2015	85						240	248		10.1016/j.yjmcc.2015.06.009		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CP4UO	WOS:000359878300027		
J	Takenoya, F; Wang, LH; Kageyama, H; Hirako, S; Wada, N; Hashimoto, H; Ueta, Y; Sakagami, J; Nonaka, N; Shioda, S				Takenoya, Fumiko; Wang, Lihua; Kageyama, Haruaki; Hirako, Satoshi; Wada, Nobuhiro; Hashimoto, Hirofumi; Ueta, Yoichi; Sakagami, Junichi; Nonaka, Naoko; Shioda, Seiji			Neuropeptide W-Induced Hypophagia is Mediated Through Corticotropin-Releasing Hormone-Containing Neurons	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Neuropeptide W (NPW); Immunohistochemistry; Hypothalamus; Mouse	PROTEIN-COUPLED RECEPTORS; PARAVENTRICULAR NUCLEUS; FEEDING-BEHAVIOR; RAT-BRAIN; STRESS; GPR7; HYPOTHALAMUS; SECRETION; IDENTIFICATION; LIGANDS	Neuropeptide W (NPW), which was originally isolated from the porcine hypothalamus, has been identified as the endogenous ligand for both the NPBWR1 (GPR7) and NPBWR2 (GPR8) receptors. These receptors, which belong to the orphan G protein-coupled receptor (GPCR) family, share a high sequence homology with the opioid and somatostatin receptor families. NPW and NPBWR1 are widely distributed in the rat central nervous system (CNS). While the intracerebroventricular (i.c.v.) injection of NPW elevates plasma corticosterone levels, the intravenous administration of NPW in conjunction with a corticotropin-releasing hormone (CRH) antagonist blocks NPW-induced corticosterone secretion. It has been reported that NPW is involved in regulating the hypothalamus-pituitary-adrenal cortex (HPA) axis and that i.c.v. administration of NPW decreases feeding behavior. The aim of the present study was to ascertain if NPW's role in feeding regulation is mediated (or not) through corticotropin-releasing hormone (CRH)-containing neurons. We found that NPW-containing axon terminals make synapses with CRH-immunoreactive cell bodies and dendritic processes in the hypothalamic paraventricular nucleus (PVN). The central infusion of NPW significantly induced c-Fos expression in CRH-immunoreactive neurons in the mouse PVN, but not in vasopressin-or oxytocin-immunoreactive neurons. To determine if NPW regulates feeding behavior through CRH neurons, the feeding behavior of mice was studied following the i.c.v. administration NPW in the presence or absence of pretreatment with a CRH antagonist. While NPW administration decreased feeding activity, the CRH antagonist inhibited this effect. These results strongly suggest that NPW regulates feeding behavior through CRH neurons in the mouse brain.	[Takenoya, Fumiko; Wang, Lihua; Kageyama, Haruaki; Hirako, Satoshi; Wada, Nobuhiro; Sakagami, Junichi; Nonaka, Naoko; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 142, Japan; [Takenoya, Fumiko] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Exercise & Sports Physiol, Shinagawa Ku, Tokyo 1428555, Japan; [Kageyama, Haruaki] Kiryu Univ, Fac Hlth Care, Dept Nutr, Gunma, Japan; [Hashimoto, Hirofumi; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 807, Japan	Shioda, S (reprint author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 142, Japan.	shioda@med.showa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26350912, 24590241, 90644261, 2126004];  [25670767]	This study was supported in part by grants for the Grant-in-Aid for Scientific Research (C) and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to FT 26350912, HK 24590241, and SH 90644261). This study was supported in part by Grant-in-Aid for challenging Exploratory Research for the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to SS 22126004). The study was also supported in part by Grant-in-Aid for Challenging Exploratory Research of Japan (to SS 25670767).	Aikawa S, 2008, REGUL PEPTIDES, V151, P147, DOI 10.1016/j.regpep.2008.08.001; Takenoya F, 2005, REGUL PEPTIDES, V126, P79, DOI 10.1016/j.regpep.2004.10.004; Dun SL, 2003, NEUROSCI LETT, V349, P71, DOI 10.1016/S0304-3940(03)00804-8; Skrzypski M, 2012, REGUL PEPTIDES, V176, P51, DOI 10.1016/j.regpep.2012.03.004; Samson WK, 2004, J NEUROENDOCRINOL, V16, P842, DOI 10.1111/j.1365-2826.2004.01239.x; Richard D, 2002, EUR J PHARMACOL, V440, P189, DOI 10.1016/S0014-2999(02)01428-0; Hochol A, 2007, INT J MOL MED, V19, P207; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; MOURI T, 1993, NEUROENDOCRINOLOGY, V57, P34, DOI 10.1159/000126339; Schulz S, 2012, APPETITE, V58, P457, DOI 10.1016/j.appet.2011.12.007; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Mondal MS, 2003, ENDOCRINOLOGY, V144, P4729, DOI 10.1210/en.2003-0536; Baker JR, 2003, ENDOCRINOLOGY, V144, P2816, DOI 10.1210/en.2002-0161; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Shimomura Y, 2002, J BIOL CHEM, V277, P35826, DOI 10.1074/jbc.M205337200; ODOWD BF, 1995, GENOMICS, V28, P84, DOI 10.1006/geno.1995.1109; Brezillon S, 2003, J BIOL CHEM, V278, P776, DOI 10.1074/jbc.M206396200; ARASE K, 1989, PHYSIOL BEHAV, V45, P565, DOI 10.1016/0031-9384(89)90074-7; Beck B, 2010, APPETITE, V55, P319, DOI 10.1016/j.appet.2010.07.002; Date Y, 2010, ENDOCRINOLOGY, V151, P2200, DOI 10.1210/en.2009-1153; DRESCHER VS, 1994, J NUTR, V124, P524; Guan JL, 2001, NEUROREPORT, V12, P547, DOI 10.1097/00001756-200103050-00023; HARBUZ MS, 1993, BRAIN RES, V609, P167, DOI 10.1016/0006-8993(93)90870-S; Kawasaki M, 2006, J ENDOCRINOL, V190, P213, DOI 10.1677/joe.1.06636; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; KRAHN DD, 1990, BIOL PSYCHIAT, V27, P1094, DOI 10.1016/0006-3223(90)90046-5; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lee DK, 1999, MOL BRAIN RES, V71, P96, DOI 10.1016/S0169-328X(99)00171-0; Levine AS, 2005, AM J PHYSIOL-REG I, V288, pR1727, DOI 10.1152/ajpregu.00638.2003; Mazzocchi G, 2005, J CLIN ENDOCR METAB, V90, P3466, DOI 10.1210/jc.2004-2132; Niimi M, 2005, ENDOCRINE, V27, P51, DOI 10.1385/ENDO:27:1:051; Seki M, 2008, REGUL PEPTIDES, V145, P147, DOI 10.1016/j.regpep.2007.08.011; Singh G, 2004, BRAIN RES, V1017, P222, DOI 10.1016/j.brainres.2004.03.079; Takenoya F, 2010, NEUROPEPTIDES, V44, P99, DOI 10.1016/j.npep.2009.10.007; Takenoya F, 2010, ANN NY ACAD SCI, V1200, P162, DOI 10.1111/j.1749-6632.2010.05642.x; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR270, DOI 10.1152/ajpregu.00396.2004; Yogo K, 2012, ENDOCR J, V59, P547	37	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	AUG	2015	56	4					789	798		10.1007/s12031-015-0501-1		10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP7MU	WOS:000360073100006		
J	Ueda, A; Ueda, M; Nagatoshi, A; Hirano, T; Ito, T; Arai, N; Uyama, E; Mori, K; Nakamura, M; Shinriki, S; Ikeda, K; Ando, Y				Ueda, Akihiko; Ueda, Mitsuharu; Nagatoshi, Akihito; Hirano, Teruyuki; Ito, Takaaki; Arai, Nobutaka; Uyama, Eiichiro; Mori, Kota; Nakamura, Masaaki; Shinriki, Satoru; Ikeda, Katsuyoshi; Ando, Yukio			Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014	JOURNAL OF NEUROLOGY			English	Article						CADASIL; Genotype; NOTCH3; Phenotype; Diagnosis	AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; LEUKOENCEPHALOPATHY CADASIL; NOTCH3 MUTATIONS; DIAGNOSTIC STRATEGIES; CYSTEINE RESIDUE; SKIN BIOPSY; FAMILIES; DEMENTIA; FEATURES	This study elucidates the genotypic and phenotypic spectrum and histopathological findings related to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in Japan. For this single-center retrospective observational study, we enrolled 215 patients who were clinically suspected of having CADASIL and were examined at Kumamoto University from 1997 to 2014, and we diagnosed CADASIL in 70 patients. We found 19 different NOTCH3 mutations in the patients, with the NOTCH3 Arg133Cys mutation being found most frequently. We also found the Arg75Pro mutation, a cysteine-sparing NOTCH3 mutation. CADASIL patients with this Arg75Pro mutation were frequently found throughout Japan, and fewer patients with the Arg75Pro mutation showed MRI hyperintensity in the anterior temporal pole compared with patients with other NOTCH3 mutations. Significantly more CADASIL patients with the NOTCH3 Arg133Cys mutation had hyperintensity in the external capsule compared with CADASIL patients with the other mutations not including the NOTCH3 Arg75Pro mutation. We also showed postmortem pathological findings of the first Japanese CADASIL case with the NOTCH3 Arg133Cys mutation, and histopathological findings of fresh frozen skin biopsy specimens of CADASIL patients. In conclusions, the spectrum of NOTCH3 mutations in Japanese CADASIL patients may be partially explained by founder effects. Genotype-phenotype correlations may exist in CADASIL, which should be considered so as to make an accurate diagnosis of CADASIL in each population. Fresh frozen skin biopsy specimens may aid detection of Notch3 deposits on vascular walls for an improved diagnosis of CADASIL.	[Ueda, Akihiko; Ueda, Mitsuharu; Nagatoshi, Akihito; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, Kumamoto 8600811, Japan; [Ueda, Mitsuharu; Ikeda, Katsuyoshi; Ando, Yukio] Kumamoto Univ Hosp, Dept Clin Lab, Kumamoto, Japan; [Hirano, Teruyuki] Kyorin Univ, Dept Stroke & Cerebrovasc Med, Mitaka, Tokyo, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8600811, Japan; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Neuropathol Lab, Tokyo 113, Japan; [Uyama, Eiichiro] Kumamoto Takumadai Rehabil Hosp, Dept Neurol, Kumamoto, Japan; [Mori, Kota] Natl Hosp Org, Kyushu Med Ctr, Dept Cerebrovasc Med & Neurol, Fukuoka, Japan; [Nakamura, Masaaki] Natl Inst Minamata Dis, Dept Clin Med, Minamata, Japan; [Shinriki, Satoru] Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka, Japan	Ueda, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8600811, Japan.	mitt@rb3.so-net.ne.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24249036, 25860717]	We are indebted to Dr. Ikuko Mizuta and Prof. Toshiki Mizuno for kind assistance in the NOTCH3 gene analysis, Ms. Hiroko Katsura and Ms. Mika Oka for excellent technical assistance, and Ms. Judith B. Gandy for providing professional English editing of the manuscript. This research was supported by Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (numbers 24249036 and 25860717).	Abe K, 2002, ANN NY ACAD SCI, V977, P266; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Pescini F, 2012, STROKE, V43, P2871, DOI 10.1161/STROKEAHA.112.665927; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364; Lee YC, 2009, J NEUROL, V256, P249, DOI 10.1007/s00415-009-0091-3; Mykkanen K, 2004, EUR J HUM GENET, V12, P813, DOI 10.1038/sj.ejhg.5201221; Scheid R, 2008, NEUROLOGY, V71, P774, DOI 10.1212/01.wnl.0000324928.44694.f7; Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; SCHELTENS P, 1992, BRAIN, V115, P735, DOI 10.1093/brain/115.3.735; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Bersano A, 2012, FUNCT NEUROL, V27, P247; Brass SD, 2009, NEW ENGL J MED, V360, P1656, DOI 10.1056/NEJMcpc0810839; Ge W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104533; Headache Classification Committee of the International Headache Society (IHS), 2013, CEPHALALGIA, V33, P629, DOI DOI 10.1177/0333102413485658; Ishida C, 2006, INTERNAL MED, V45, P981, DOI 10.2169/internalmedicine.45.1692; Kim Y, 2006, NEUROLOGY, V66, P1511, DOI 10.1212/01.wnl.0000216259.99811.50; Kim YE, 2014, NEUROBIOL AGING, V35; Malandrini A, 2007, NEUROLOGY, V68, P1430, DOI 10.1212/01.wnl.0000264018.46335.c8; Markus HS, 2002, NEUROLOGY, V59, P1134; Mizuno T, 2008, INTERNAL MED, V47, P2067, DOI 10.2169/internalmedicine.47.1391; Oberstein SAJL, 2003, ACTA NEUROPATHOL, V106, P107, DOI 10.1007/s00401-003-0701-6; Pantoni L, 2010, NEUROLOGY, V74, P57, DOI 10.1212/WNL.0b013e3181c7da7c; Peters N, 2005, ARCH NEUROL-CHICAGO, V62, P1091, DOI 10.1001/archneur.62.7.1091; Tikka S, 2014, BRAIN PATHOL, V24, P525, DOI 10.1111/bpa.12181; Uchino M, 2002, ANN NY ACAD SCI, V977, P273; Ueda A, 2009, NEUROPATH APPL NEURO, V35, P618, DOI 10.1111/j.1365-2990.2009.01029.x; Uyama E, 2000, INTERNAL MED, V39, P732, DOI 10.2169/internalmedicine.39.732	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	AUG	2015	262	8					1828	1836		10.1007/s00415-015-7782-8		9	Clinical Neurology	Neurosciences & Neurology	CP4CI	WOS:000359829200004		
J	Koga, M; Takahashi, M; Yokoyama, K; Kanda, T				Koga, Michiaki; Takahashi, Masaki; Yokoyama, Keiko; Kanda, Takashi			Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barre syndrome and its variants	JOURNAL OF NEUROLOGY			English	Article						Guillain-Barre syndrome; IgM; Anti-ganglioside antibody; Diagnostic marker; Campylobacter jejuni; Lipo-oligosaccharide	N-ACETYLGALACTOSAMINYL GD1A; ACUTE CYTOMEGALOVIRUS-INFECTION; CAMPYLOBACTER-JEJUNI INFECTION; POSSIBLE TARGET MOLECULE; MOTOR AXONAL NEUROPATHY; ANTECEDENT INFECTIONS; MYCOPLASMA-INFECTION; ANTIBODIES; JAPAN; GANGLIOSIDE	Anti-ganglioside autoantibodies of the IgG type are detected in a half of patients with Guillain-Barr, syndrome (GBS), and their detection strongly supports the diagnosis of GBS. In contrast, anti-ganglioside IgM antibodies are also often detected in GBS patients, but it remains unclear whether IgM antibodies indicate a diagnosis of GBS. We identified four GBS patients (3.3 %) who tested positive for IgM antibodies but negative for IgG antibodies among 122 patients with GBS and its variants. These four patients were all adolescents or young adults (age 13-22 years), experienced preceding gastrointestinal symptoms, and had serological and/or bacterial evidence of recent Campylobacter jejuni enteritis. Serum IgG reacted strongly with the lipo-oligosaccharide (LOS) of the C. jejuni isolates from these patients' stool specimens. Thin-layer chromatography with immunostaining showed that their serum IgG reacted with resorcinol-positive portion of LOS, suggesting that these patients had IgG autoantibodies against sialic acid-containing epitopes, probably unrecognized ganglioside-like structures on the bacterial LOS. We also examined anti-ganglioside autoantibodies in 22 patients with C. jejuni enteritis without subsequent neurological disorders and detected IgM antibodies in seven (32 %) patients. Our data indicate that anti-ganglioside IgM antibodies can be detected in C. jejuni enteritis without complication of GBS, and that the detection of anti-ganglioside IgM antibodies does not always support a diagnosis of GBS. IgG autoantibodies against unrecognized gangliosides might play a role in the development of disease in patients with GBS in whom only anti-ganglioside IgM antibodies are detected by routine clinical testing.	[Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 7558505, Japan; [Takahashi, Masaki; Yokoyama, Keiko] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo 1690073, Japan	Koga, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	kogamrk@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 15K08464]; Ministry of Health, Labour and Welfare of Japan	Dr Koga received a Grant-in-Aid for Scientific Research (C) (KAKENHI 15K08464) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Prof Kanda received a Research Grant for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan.	Kusunoki S, 2001, NEUROLOGY, V57, P736; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566; Ang CW, 2002, J NEUROIMMUNOL, V130, P179, DOI 10.1016/S0165-5728(02)00209-6; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025; Jacobs BC, 1998, NEUROLOGY, V51, P1110; Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Ang CW, 2000, NEUROLOGY, V54, P1453; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; ILYAS AA, 1988, J BIOL CHEM, V263, P4369; Irie S, 1996, J NEUROIMMUNOL, V68, P19, DOI 10.1016/0165-5728(96)00059-8; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Jacobs BC, 1997, J NEUROL NEUROSUR PS, V62, P641, DOI 10.1136/jnnp.62.6.641; Kaida K, 2000, BRAIN, V123, P116, DOI 10.1093/brain/123.1.116; Kaida K, 2001, J NEUROIMMUNOL, V113, P260, DOI 10.1016/S0165-5728(00)00451-3; Kaida K, 2003, NEUROLOGY, V61, P465; Kaida K, 2013, CLIN EXP NEUROIMMUNO, V4, P60; Kaji R, 2000, MUSCLE NERVE, V23, P702, DOI 10.1002/(SICI)1097-4598(200005)23:5<702::AID-MUS6>3.0.CO;2-A; Kamakura K, 2005, J PERIPHER NERV SYST, V10, P190, DOI 10.1111/j.1085-9489.2005.0010209.x; Koga M, 2012, J NEUROL, V259, P1366, DOI 10.1007/s00415-011-6360-y; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Koga M, 2012, J NEUROL NEUROSUR PS, V83, P1210, DOI 10.1136/jnnp-2012-303060; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; KUSUNOKI S, 1994, ANN NEUROL, V35, P570, DOI 10.1002/ana.410350510; KUSUNOKI S, 1995, MUSCLE NERVE, V18, P409, DOI 10.1002/mus.880180407; Kuwabara S, 2002, J NEUROL SCI, V25, P297; Miyaji K, 2014, NEUROLOGY, V83, P2314, DOI 10.1212/WNL.0000000000001090; Nobile-Orazio E, 2008, J NEUROL SCI, V266, P156, DOI 10.1016/j.jns.2007.09.020; Ogawara K, 2003, J NEUROL SCI, V210, P41, DOI 10.1016/S0022-510X(03)00013-3; Taguchi K, 2004, J NEUROL SCI, V225, P91, DOI 10.1016/j.jns.2004.07.011; Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005; Visser LH, 1996, NEUROLOGY, V47, P668; Yoshino H, 2005, BRAIN RES, V1057, P177, DOI 10.1016/j.brainres.2005.07.063; Yuki N, 1998, J NEUROL SCI, V154, P14, DOI 10.1016/S0022-510X(97)00174-3	36	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	AUG	2015	262	8					1954	1960		10.1007/s00415-015-7806-4		7	Clinical Neurology	Neurosciences & Neurology	CP4CI	WOS:000359829200018		
J	Yoshinaga, K; Tamaki, N				Yoshinaga, Keiichiro; Tamaki, Nagara			Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence	JOURNAL OF NUCLEAR CARDIOLOGY			English	Review						I-123 BMIPP; Japanese Society of Nuclear Cardiology; I-123 MIBG; multicenter trial; positron emission tomography; risk assessment; sarcoidosis; single-photon emission computed tomography	POSITRON-EMISSION-TOMOGRAPHY; FATTY-ACID-METABOLISM; SUSPECTED CARDIAC SARCOIDOSIS; ARTIFICIAL NEURAL-NETWORK; CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; ASSOCIATION TASK-FORCE; MYOCARDIAL BLOOD-FLOW; AMERICAN-COLLEGE; PROGNOSTIC VALUE	Nuclear cardiology imaging tests are widely performed in Japan as clinical practice. The Japanese nuclear cardiology community has developed new diagnostic imaging tests using I-123-beta-methyl-p-iodophenyl-pentadecanoic acid, I-123-metaiodobenzylguanidine, and F-18-fluorodeoxyglucose PET for detecting cardiac involvement in sarcoidosis. These tests have become popular worldwide. The Japanese Circulation Society and the Japanese Society of Nuclear Cardiology have published clinical imaging guidelines showing indications and standards for the new imaging tests. JSNC is currently striving to improve the standard of clinical practice and is promoting research activities.	[Yoshinaga, Keiichiro] Natl Inst Radiol Sci, Mol Imaging Res Ctr, Inage Ku, Chiba, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan	Yoshinaga, K (reprint author), Natl Inst Radiol Sci, Mol Imaging Res Ctr, Inage Ku, 4-9-1 Anagawa, Chiba, Japan.	kyoshi@nirs.go.jp					Anderson GF, 2008, HEALTH AFFAIR, V27, P1718, DOI 10.1377/hlthaff.27.6.1718; Manabe O, 2013, EUR J NUCL MED MOL I, V40, P1558, DOI 10.1007/s00259-013-2460-5; Travin MI, 2013, J NUCL CARDIOL, V20, P128, DOI 10.1007/s12350-012-9655-1; Gulati V, 2013, J NUCL CARDIOL, V20, P1173, DOI 10.1007/s12350-013-9776-1; Cerqueira MD, 2010, J NUCL CARDIOL, V17, P709, DOI 10.1007/s12350-010-9244-0; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Thackeray JT, 2013, J NUCL CARDIOL, V20, P150, DOI 10.1007/s12350-012-9644-4; Nishimura T, 2008, EUR J NUCL MED MOL I, V35, P319, DOI 10.1007/s00259-007-0608-x; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Manabe O, 2014, ANN NUCL MED, V28, P656, DOI 10.1007/s12149-014-0860-7; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; Bengel FM, 2009, J AM COLL CARDIOL, V54, P1, DOI 10.1016/j.jacc.2009.02.065; Yoshinaga K, 2014, EUR J NUCL MED MOL I, V41, P384, DOI 10.1007/s00259-013-2615-4; Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025; Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/S0735-1097(03)01090-8; Moroi M, 2013, AM J KIDNEY DIS, V61, P466, DOI 10.1053/j.ajkd.2012.09.017; Nakata T, 1998, J NUCL CARDIOL, V5, P579, DOI 10.1016/S1071-3581(98)90112-X; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Youssef G, 2012, J NUCL MED, V53, P241, DOI 10.2967/jnumed.111.090662; Tamaki N, 2011, J NUCL CARDIOL, V18, P135, DOI 10.1007/s12350-010-9305-4; Dorbala S, 2013, J AM COLL CARDIOL, V61, P176, DOI 10.1016/j.jacc.2012.09.043; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Mc Ardle BA, 2013, J NUCL CARDIOL, V20, P297, DOI 10.1007/s12350-012-9668-9; YASUE H, 1979, CIRCULATION, V59, P938; Ishida Y, 2014, ANN NUCL MED, V28, P393, DOI 10.1007/s12149-014-0806-0; Bateman TM, 2012, J NUCL CARDIOL, V19, P3, DOI 10.1007/s12350-011-9490-9; Birnie David H, 2014, Heart Rhythm, V11, P1305, DOI 10.1016/j.hrthm.2014.03.043; Chatterjee A, 2015, J NUCL CARDIOL, V22, P158, DOI 10.1007/s12350-014-9992-3; Chikamori T, 2007, J NUCL CARDIOL, V14, P111, DOI 10.1016/j.nuclcard.2006.11.007; Gulenchyn KY, 2006, CAN J CARDIOL, V22, P827; Hashimoto J, 2013, J NUCL CARDIOL, V20, P396, DOI 10.1007/s12350-013-9699-x; JCS Joint Working Group, 2010, CIRC J, V2012, P761; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Kawasaki T, 1967, Arerugi, V16, P178; Kinuya S, 2014, ANN NUCL MED, V28, P1032, DOI 10.1007/s12149-014-0893-y; Koshino K, 2012, J NUCL CARDIOL, V19, P524, DOI 10.1007/s12350-012-9522-0; Matsumoto N, 2011, CIRC J, V75, P1573, DOI 10.1253/circj.CJ-11-0512; Nakajima K, 2013, J NUCL CARDIOL, V20, P234, DOI 10.1007/s12350-012-9656-0; Nakajima K, 2010, ANN NUCL MED, V24, P99, DOI 10.1007/s12149-009-0331-8; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83; Ohira Hiroshi, 2011, Eur J Nucl Med Mol Imaging, V38, P1773, DOI 10.1007/s00259-011-1832-y; Ronan G, 2014, J NUCL CARDIOL, V21, P192, DOI 10.1007/s12350-013-9841-9; Sarazawa K, 2012, J NUCL CARDIOL, V19, P507, DOI 10.1007/s12350-012-9525-x; Yamauchi T, 2012, CIRC J, V76, P2832, DOI 10.1253/cirej.CJ-12-0222; Yoshinaga K, 2011, CIRC J, V75, P2628, DOI 10.1253/circj.CJ-11-0502; Yoshinaga K, 2013, NUCL CARDIOL, V15, P31; Yoshinaga K, 2014, ANN NUCL MED, V28, P761, DOI 10.1007/s12149-014-0868-z; Yoshinaga K, 2010, J CARDIOL, V55, P163, DOI 10.1016/j.jjcc.2010.01.001; Yoshinaga K, 2011, CIRC J, V75, P2187, DOI 10.1253/circj.CJ-10-1272	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-3581	1532-6551		J NUCL CARDIOL	J. Nucl. Cardiol.	AUG	2015	22	4					690	699		10.1007/s12350-015-0136-1		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CP5QE	WOS:000359937800014		
J	Hayase, T; Morimoto, A; Kawahara, Y; Yagi, M; Kanai, N; Nobusawa, S; Hirato, J; Gomi, A				Hayase, Tomomi; Morimoto, Akira; Kawahara, Yuta; Yagi, Masaki; Kanai, Nobuyuki; Nobusawa, Sumito; Hirato, Junko; Gomi, Akira			An Infant With Medulloepithelioma Successfully Treated by High-dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation Without Radiotherapy	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						medulloepithelioma; high-dose chemotherapy; autologous peripheral blood stem cell transplantation; radiotherapy	NERVOUS-SYSTEM MEDULLOEPITHELIOMA; MALIGNANT BRAIN-TUMORS; CEREBRAL MEDULLOEPITHELIOMA; LONG SURVIVAL; RESCUE; AMPLIFICATION; CHILDHOOD; ROSETTES; COMPRISE; ENTITY	Medulloepithelioma of the central nervous system (CNS) is a rare primitive neuroectodermal tumor characterized by highly malignant behavior occurring in early childhood. Few cases have been reported and optimal management remains unknown. Here, we report a case of CNS medulloepithelioma successfully treated with high-dose chemotherapy (HDCTX) followed by autologous stem cell transplantation (auto-SCT) without radiotherapy. At the last follow-up, 3.0 years after onset, the patient was alive with no sign of relapse and normal development. To the best of our knowledge, this is the first reported case of long-term survival of CNS medulloepithelioma treated by HDCTX/auto-PBSCT without radiotherapy.	[Hayase, Tomomi; Morimoto, Akira; Kawahara, Yuta; Yagi, Masaki] Jichi Med Univ, Sch Med, Jichi Childrens Med Ctr Tochigi, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan; [Kanai, Nobuyuki] Jichi Med Univ, Sch Med, Diagnost Pathol, Shimotsuke, Tochigi 3290498, Japan; [Gomi, Akira] Jichi Med Univ, Sch Med, Jichi Childrens Med Ctr Tochigi, Dept Pediat Neurosurg, Shimotsuke, Tochigi 3290498, Japan; [Nobusawa, Sumito] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gumma 371, Japan; [Hirato, Junko] Gunma Univ Hosp, Dept Pathol, Maebashi, Gumma, Japan	Morimoto, A (reprint author), Jichi Med Univ, Sch Med, Jichi Childrens Med Ctr Tochigi, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	akira@jichi.ac.jp					Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; Geyer JR, 2005, J CLIN ONCOL, V23, P7621, DOI 10.1200/JCO.2005.09.095; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Sun CL, 2010, BLOOD, V116, P3129, DOI 10.1182/blood-2009-06-229369; Nobusawa S, 2012, BRAIN PATHOL, V22, P689, DOI 10.1111/j.1750-3639.2012.00574.x; Padovani L, 2012, NAT REV NEUROL, V8, P578, DOI 10.1038/nrneurol.2012.182; Moftakhar P, 2008, J NEUROS-PEDIATR, V2, P339, DOI 10.3171/PED.2008.2.11.349; Spence T, 2014, ACTA NEUROPATHOL, V128, P291, DOI 10.1007/s00401-014-1291-1; Kalifa C, 2005, J NEURO-ONCOL, V75, P279, DOI 10.1007/s11060-005-6752-x; LOLOVA I, 1972, J NEUROL SCI, V15, P173, DOI 10.1016/0022-510X(72)90005-6; Marachelian A, 2008, BONE MARROW TRANSPL, V41, P167, DOI 10.1038/sj.bmt.1705953; Matsumoto M, 2007, NEUROL MED-CHIR, V47, P428, DOI 10.2176/nmc.47.428; Molloy PT, 1996, J NEUROSURG, V84, P430, DOI 10.3171/jns.1996.84.3.0430; Muller K, 2011, STRAHLENTHER ONKOL, V187, P757, DOI 10.1007/s00066-011-2256-0; Norris LS, 2005, J PEDIAT HEMATOL ONC, V27, P264, DOI 10.1097/01.mph.0000165498.24989.9a; Sands SA, 2010, PEDIATR BLOOD CANCER, V54, P429, DOI 10.1002/pbc.22318; SCHEITHAUER BW, 1979, CHILD BRAIN, V5, P62; Vincent S, 2002, CLIN NEUROPATHOL, V21, P197; Weinstein JL, 2009, CANCER TREAT RES, V150, P239, DOI 10.1007/b109924_16	20	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	AUG	2015	37	6					e394	e398		10.1097/MPH.0000000000000381		5	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CP4GX	WOS:000359841100015		
J	Ishida, A; Ohto, H; Yasuda, H; Negishi, Y; Tsuiki, H; Arakawa, T; Yagi, Y; Uchimura, D; Miyazaki, T; Ohashi, W; Takamoto, S				Ishida, Atsushi; Ohto, Hitoshi; Yasuda, Hiroyasu; Negishi, Yutaka; Tsuiki, Hideki; Arakawa, Takeshi; Yagi, Yoshihito; Uchimura, Daisuke; Miyazaki, Toru; Ohashi, Wataru; Takamoto, Shigeru			Anti-M Antibody Induced Prolonged Anemia Following Hemolytic Disease of the Newborn Due to Erythropoietic Suppression in 2 Siblings	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						anti-M antibody; MNSs blood group; anemia; hemolytic disease of the newborn; erythropoietic suppression		Hemolytic disease of the newborn (HDN) arising from MNSs incompatibility is rare, with few reports of prolonged anemia and reticulocytopenia following HDN. We report the younger of 2 male siblings, both of whom had anti-M-induced HDN and anemia persisting for over a month. Peripheral reticulocytes remained inappropriately low for the degree of anemia, and they needed multiple red cell transfusions. Viral infections were ruled out. Corticosteroids were given for suspected pure red cell aplasia. Anemia and reticulocytopenia subsequently improved. Colony-forming unit erythroid assay revealed erythropoietic suppression of M antigen-positive erythroid precursor cells cultured with maternal or infant sera containing anti-M. In conclusion, maternal anti-M caused HDN and prolonged anemia by erythropoietic suppression in 2 siblings.	[Ishida, Atsushi; Negishi, Yutaka; Tsuiki, Hideki; Arakawa, Takeshi] Gifu Prefectural Tajimi Hosp, Dept Pediat, Tajimi City, Gifu 5078522, Japan; [Yagi, Yoshihito] Gifu Prefectural Tajimi Hosp, Div Cent Labs, Tajimi City, Gifu 5078522, Japan; [Ohto, Hitoshi; Yasuda, Hiroyasu] Fukushima Med Univ, Dept Blood Transfus & Transplantat Immunol, Fukushima, Japan; [Uchimura, Daisuke; Miyazaki, Toru; Ohashi, Wataru; Takamoto, Shigeru] Japanese Red Cross Hokkaido Block Blood Ctr, Sapporo, Hokkaido, Japan	Ishida, A (reprint author), Gifu Prefectural Tajimi Hosp, Dept Pediat, 5-161 Maehata Cho, Tajimi City, Gifu 5078522, Japan.	ishida-atsushi@tajimi-hospital.jp					Vlachos A, 2010, BLOOD, V116, P3715, DOI 10.1182/blood-2010-02-251090; Wikman A, 2007, TRANSFUSION, V47, P911, DOI 10.1111/j.1537-2995.2007.01209.x; Vaughan JI, 1998, NEW ENGL J MED, V338, P798, DOI 10.1056/NEJM199803193381204; Arndt PA, 2005, TRANSFUSION MED, V15, P125, DOI 10.1111/j.1365-3148.2005.00562.x; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; DUGUID JKM, 1995, VOX SANG, V68, P195; Hinchliffe RF, 2006, ARCH DIS CHILD-FETAL, V91, pF467, DOI 10.1136/adc.2006.102954; Kanra T, 1996, AM J HEMATOL, V53, P280, DOI 10.1002/1096-8652(199612)53:4<280::AID-AJH2830530403>3.0.CO;2-#; Southcott MJ, 1993, BLOOD, V93, P4425; Thompson D J, 1989, Obstet Gynecol Surv, V44, P637, DOI 10.1097/00006254-198909000-00001; Yasuda H, 2014, TRANSFUS MED REV, V28, P1, DOI 10.1016/j.tmrv.2013.10.002; Young-Owens AD, 1997, OBSTET GYNECOL, V90, P962	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	AUG	2015	37	6					e375	e377		10.1097/MPH.0000000000000341		3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CP4GX	WOS:000359841100009		
J	Kobayashi, S; Ito, M; Sano, H; Mochizuki, K; Akaihata, M; Waragai, T; Ohara, Y; Hosoya, M; Kikuta, A				Kobayashi, Shogo; Ito, Masaki; Sano, Hideki; Mochizuki, Kazuhiro; Akaihata, Mitsuko; Waragai, Tomoko; Ohara, Yoshihiro; Hosoya, Mitsuaki; Kikuta, Atsushi			Idiopathic Hyperammonemia That Developed During Initial Treatment With Steroid in a Patient With Newly Diagnosed Leukemia	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						idiopathic hyperammonemia; encephalopathy; acute lymphoblastic leukemia; children	ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-DOSE 5-FLUOROURACIL; TRANSIENT HYPERAMMONEMIA; CONTINUOUS-INFUSION; ENCEPHALOPATHY; CHEMOTHERAPY; ASPARAGINASE; COMPLICATION; CHILDREN; THERAPY	Idiopathic hyperammonemia (IHA) has been described as a complication of intensive chemotherapy for the treatment of hematologic malignancy but has subsequently been found in patients undergoing bone marrow transplantation and in those with solid tumors treated with 5-fluorouracil. Although IHA is a rare complication, it is sometimes associated with high mortality in hematologic malignancies. Here we report the case of a 15-year-old boy in whom hyperammonemia developed during the initial treatment with prednisolone for newly diagnosed acute lymphoblastic leukemia and who survived after early detection and oral lactulose therapy. To the best of our knowledge, this is the first report of IHA that was not induced by intensive chemotherapy, stem cell transplantation, or asparaginase therapy in a patient with newly diagnosed leukemia, but developed during an initial treatment with a steroid. Early detection of IHA by measuring the plasma ammonia level in patients with neurological symptoms may improve the outcome.	[Kobayashi, Shogo; Ito, Masaki; Akaihata, Mitsuko; Waragai, Tomoko; Ohara, Yoshihiro; Hosoya, Mitsuaki] Fukushima Med Univ, Sch Med, Dept Pediat, Fukushima 9601295, Japan; [Sano, Hideki; Mochizuki, Kazuhiro; Kikuta, Atsushi] Fukushima Med Univ, Sch Med, Pediatr Oncol, Fukushima 9601295, Japan	Kobayashi, S (reprint author), Fukushima Med Univ, Sch Med, Dept Pediat, 1 Hikarigaoka, Fukushima 9601295, Japan.	shogo@fmu.ac.jp					Clay AS, 2007, CHEST, V132, P1368, DOI 10.1378/chest.06-2940; Heitink-Polle KMJ, 2013, JIMD REP, V7, P103, DOI 10.1007/8904_2012_156; Cohn RM, 2004, CLIN PEDIATR, V43, P683, DOI 10.1177/000992280404300801; Cavicchi C, 2014, ORPHANET J RARE DIS; Davies SM, 1996, BONE MARROW TRANSPL, V17, P1119; del Rosario M, 1997, J CLIN GASTROENTEROL, V25, P682, DOI 10.1097/00004836-199712000-00026; FELIG DM, 1995, GASTROENTEROLOGY, V109, P282, DOI 10.1016/0016-5085(95)90295-3; FLANNERY DB, 1982, HEPATOLOGY, V2, P495; Jorck C, 2011, PEDIATR HEMAT ONCOL, V28, P3, DOI 10.3109/08880018.2010.484852; LEONARD JV, 1986, LANCET, V1, P162; LIAW CC, 1993, ANTI-CANCER DRUG, V4, P311, DOI 10.1097/00001813-199306000-00003; Liaw CC, 1999, ANTI-CANCER DRUG, V10, P275, DOI 10.1097/00001813-199903000-00004; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; MATSUZAKI H, 1990, ACTA HAEMATOL-BASEL, V84, P130; Metzeler KH, 2009, LEUKEMIA RES, V33, P69; MITCHELL RB, 1988, AM J MED, V85, P662; Nott L, 2007, LEUKEMIA LYMPHOMA, V48, P1702, DOI 10.1080/10428190701509822; WATSON AJ, 1985, LANCET, V2, P1271; Yeh KH, 1997, BRIT J CANCER, V75, P464, DOI 10.1038/bjc.1997.79	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	AUG	2015	37	6					e361	e363		10.1097/MPH.0000000000000255		3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CP4GX	WOS:000359841100005		
J	Okano, S; Takase, M; Iseki, K; Toriumi, N; Kaneda, M; Kunishima, S				Okano, Satomi; Takase, Masashi; Iseki, Kenichi; Toriumi, Naohisa; Kaneda, Makoto; Kunishima, Shinji			Genotype-phenotype Correlation of the p.R1165C Mutation in the MYH9 Disorder: Report of a Japanese Pedigree	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						MYH9; p.R1165C mutation; nonmuscle myosin heavy chain IIA; thrombocytopenia; Alport-like symptoms	MYH9-RELATED DISORDERS; INHERITED THROMBOCYTOPENIAS; LEUKOCYTE INCLUSIONS; MACROTHROMBOCYTOPENIA; FECHTNER; DISEASE; MANAGEMENT; EPSTEIN; PATIENT	MYH9 disorder is a rare autosomal dominant disease characterized by congenital thrombocytopenia with giant platelets and leukocyte inclusion bodies and is often associated with Alport-like symptoms, such as glomerulonephritis, sensorineural hearing loss, and cataracts. We report a Japanese pedigree wherein the MYH9 p.R1165C mutation was present in over 4 generations. Three individuals were misdiagnosed as Bernard-Soulier syndrome carriers. Among the 12 patients with abnormal hematological features, the proband's mother, aunt, and grandaunt presented with sensorineural hearing impairment, and the mother presented with presenile cataract, and nephritis. This case report confirms the previously established genotype-phenotype correlations of the MYH9 disorder that p.R1165C is associated with variable expression of nonhematological manifestations. Careful detection of leukocyte inclusion bodies in peripheral blood smears is necessary to prevent misdiagnosis.	[Okano, Satomi; Takase, Masashi; Iseki, Kenichi] Fukagawa Municipal Hosp, Dept Pediat, Fukagawa, Japan; [Okano, Satomi; Takase, Masashi; Iseki, Kenichi; Toriumi, Naohisa; Kaneda, Makoto] Asahikawa Med Univ, Dept Pediat, Asahikawa, Japan; [Kunishima, Shinji] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Dept Adv Diag, Nagoya, Aichi, Japan	Okano, S (reprint author), 6-6-10 Fukagawa, Fukagawa, Hokkaido 0740006, Japan.	s-okano@ceres.dti.ne.jp			Research on Measures for Intractable Diseases Project; Japan Society for the Promotion of Science KAKENHI	Supported in part by Research on Measures for Intractable Diseases Project and a grant from the Japan Society for the Promotion of Science KAKENHI to S.K.	Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Pujol-Moix N, 2004, HAEMATOLOGICA, V89, P330; Kunishima S, 2008, BLOOD, V111, P3015, DOI 10.1182/blood-2007-10-116194; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Kunishima S, 2006, BLOOD REV, V20, P111, DOI 10.1016/j.blre.2005.08.001; Pecci A, 2014, HUM MUTAT, V35, P236, DOI 10.1002/humu.22476; Arthaus K, 2009, SEMIN THROMB HEMOST, V35, P189; Eckly A, 2010, J THROMB HAEMOST, V8, P2243, DOI 10.1111/j.1538-7836.2010.04009.x; Economou M, 2012, J PEDIAT HEMATOL ONC, V34, P412, DOI 10.1097/MPH.0b013e318257a64b; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Kunishima S, 2001, J HUM GENET, V46, P722, DOI 10.1007/s100380170007; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; Nishiyama Yutaka, 2008, Journal of Nippon Medical School, V75, P228, DOI 10.1272/jnms.75.228; Noris P, 2014, BLOOD, V124, pE4, DOI 10.1182/blood-2014-03-564328; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; Saposnik Béatrice, 2014, Mol Genet Genomic Med, V2, P297, DOI 10.1002/mgg3.68; Selleng K, 2007, EUR J HAEMATOL, V79, P263, DOI 10.1111/j.1600-0609.2007.00913.x; Sirachainan N, 2015, ANN HEMATOL, V94, P707, DOI 10.1007/s00277-014-2234-6; Suzuki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071187	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	AUG	2015	37	6					e352	e355		10.1097/MPH.0000000000000379		4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CP4GX	WOS:000359841100003		
J	Suzuki, R; Kobayashi, C; Sakai, A; Fukushima, H; Tagawa, M; Satomi, K; Nanmoku, T; Sumazaki, R; Fukushima, T				Suzuki, Ryoko; Kobayashi, Chie; Sakai, Aiko; Fukushima, Hiroko; Tagawa, Manabu; Satomi, Kaishi; Nanmoku, Toru; Sumazaki, Ryo; Fukushima, Takashi			Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						imatinib; hepatocellular necrosis; child; Ph+ ALL	CHRONIC MYELOID-LEUKEMIA; MESYLATE; CHILDREN	Imatinib mesylate has dramatically improved the outcome of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and is now included as first-line therapy. Uncommon adverse effects of this drug for pediatric use, however, are largely unknown. We report the first case of a 9-year-old child who developed severe acute hepatitis with grade 4 transaminases and bilirubin elevation during imatinib treatment for Ph+ ALL. Liver biopsy showed extensive lobular and pericentral necrosis of hepatocytes. Liver function recovered after discontinuing imatinib with a 4-week prednisolone. Extensive hepatic necrosis should be considered not only in adults but also in children under imatinib administration.	[Suzuki, Ryoko; Sakai, Aiko] Univ Tsukuba, Dept Child Hlth, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kobayashi, Chie; Fukushima, Hiroko; Tagawa, Manabu; Sumazaki, Ryo; Fukushima, Takashi] Univ Tsukuba Hosp, Fac Med, Dept Child Hlth, Tsukuba, Ibaraki 3058575, Japan; [Satomi, Kaishi] Univ Tsukuba Hosp, Fac Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nanmoku, Toru] Univ Tsukuba Hosp, Clin Lab, Tsukuba, Ibaraki 3058575, Japan	Fukushima, T (reprint author), Univ Tsukuba Hosp, Dept Child Hlth, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	tksfksm@md.tsukuba.ac.jp					Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Regev A, 2014, GASTROENTEROLOGY, V147, P20, DOI 10.1053/j.gastro.2014.05.027; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Al Sobhi E, 2007, HEMATOLOGY, V12, P49, DOI 10.1080/10245330600937929; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Schultz KR, 2014, LEUKEMIA, V28, P1467, DOI [10.1038/leu.2014.30, 10.1038/1eu.2014.30]; Dhalluin-Venier V, 2006, EUR J GASTROEN HEPAT, V18, P1235; Shah RR, 2013, DRUG SAFETY, V36, P491, DOI 10.1007/s40264-013-0048-4; Deininger MWN, 2003, J CLIN ONCOL, V21, P1637, DOI 10.1200/JCO.2003.11.143; Yamaguchi M, 2011, ANN HEMATOL, V90, P1209, DOI 10.1007/s00277-011-1277-1; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Arico M, 2010, J CLIN ONCOL, V28, P4755, DOI 10.1200/JCO.2010.30.1325; Asnacios Amani, 2009, Eur J Cancer, V45 Suppl 1, P332, DOI 10.1016/S0959-8049(09)70047-4; Champagne MA, 2004, BLOOD, V104, P2655, DOI 10.1182/blood-2003-09-3032; Gupta S, 2011, BMJ CASE REP, V2011, DOI [10.1136/bcr.11.2010.3516, DOI 10.1136/BCR.11.2010.3516]; Mahmoud SSA, 2013, PEDIATR HEMAT ONCOL, V30, P216, DOI 10.3109/08880018.2012.760021; Orkin SH, 2009, ONCOLOGY INFANCY CHI; Spataro V, 2011, J CLIN ONCOL, V29, pE50, DOI 10.1200/JCO.2010.30.5359; Stamer UM, 2011, ANESTH ANALG, V113, P48, DOI 10.1213/ANE.0b013e31821d01bc; Tonyali O, 2010, MED ONCOL, V27, P768, DOI 10.1007/s12032-009-9284-y; Yachoui Ralph, 2014, Am J Ther, V21, pe148, DOI 10.1097/MJT.0b013e31826fc5d1	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	AUG	2015	37	6					e368	e371		10.1097/MPH.0000000000000337		4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CP4GX	WOS:000359841100007		
J	Nakajima, N; Ohki, K; Kamiya, M				Nakajima, Noboru; Ohki, Kaori; Kamiya, Mitsunobu			DEFENSE MECHANISMS OF SARGASSACEAN SPECIES AGAINST THE EPIPHYTIC RED ALGA NEOSIPHONIA HARVEYI	JOURNAL OF PHYCOLOGY			English	Article						basiphyte; cuticle peeling; epiphytism; host specificity; phlorotannin	GRACILARIA-CHILENSIS RHODOPHYTA; EELGRASS ZOSTERA-MARINA; KELP ECKLONIA-RADIATA; NODOSUM L LEJOL; BROWN ALGA; ASCOPHYLLUM-NODOSUM; FUCUS-VESICULOSUS; OXIDATIVE BURST; POLYSIPHONIA-LANOSA; SEASONAL-VARIATION	Flora diversity and abundance of epiphytes are specific to their basiphyte species and may relate to variations in the defensive abilities of basiphytes. Thus, investigating the interactions between epiphytes and basiphytes is useful for a better understanding of the biological impact of epiphytism and the survival strategies of basiphytes. We examined the epiphyte density on five sargassacean species at six locations between two study sites, which showed that the epiphytic red alga Neosiphonia harveyi was remarkably less abundant on Sargassum siliquastrum at all locations. To assess its defense mechanism against N. harveyi, we performed bioassays of phlorotannins, which are considered effective in deterring fouling, by culturing sargassacean blades with N. harveyi carpospores and observed the process by which sargassacean blades remove epiphytes. When the carpospores were incubated with various concentrations of dissolved phlorotannins, settlement and germination were inhibited only at the highest concentrations (>0.1 g . L-1), and this effect did not significantly differ among the five sargassacean species. When the carpospores were combined with blades from the five species, many of the spores attached and germinated on every blade. Because N. harveyi penetrated rhizoids into basiphyte tissues, cuticle peeling observed in all five sargassacean species could not remove this epiphyte after germination. However, in S. siliquastrum, the blade tissues around the germlings became swollen and disintegrative, and were removed together with the germlings. The spores normally grew on the dead blades, suggesting that the tissue degradation of S. siliquastrum is triggered by the infection of N. harveyi.	[Nakajima, Noboru] Fukui Prefectural Univ, Grad Sch Biosci & Biotechnol, Obama, Fukui 9170003, Japan; [Ohki, Kaori; Kamiya, Mitsunobu] Fukui Prefectural Univ, Fac Marine Biosci, Obama, Fukui 9170003, Japan	Kamiya, M (reprint author), Fukui Prefectural Univ, Fac Marine Biosci, 1-1 Gakuen Cho, Obama, Fukui 9170003, Japan.	mkamiya@fpu.ac.jp			Fujiwara Natural History Foundation; JSPS KAKENHI [19570092]	The authors acknowledge the staffs of the Fukui Prefectural Kaihin Shizen Center and Ohshima Fisheries Cooperative Association for supporting sampling. We also appreciate Dr. Shinya Yoshikawa for support of anatomical analyses and useful discussion. This study was supported in part by a grant from the Fujiwara Natural History Foundation and JSPS KAKENHI (19570092).	Ank G, 2013, AQUAT BOT, V111, P125, DOI 10.1016/j.aquabot.2013.06.007; Kamiya M, 2010, PHYCOL RES, V58, P53, DOI 10.1111/j.1440-1835.2009.00558.x; Berger R, 2003, AQUAT ECOL, V37, P1, DOI 10.1023/A:1022136900630; Jones E, 2010, MAR ECOL PROG SER, V400, P87, DOI 10.3354/meps08391; WAHL M, 1995, OECOLOGIA, V102, P329, DOI 10.1007/BF00329800; Karez R, 2000, MAR ECOL PROG SER, V205, P85, DOI 10.3354/meps205085; Nagayama K, 2003, AQUACULTURE, V218, P601, DOI 10.1016/S0044-8486(02)00255-7; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; Brush MJ, 2002, MAR ECOL PROG SER, V238, P73, DOI 10.3354/meps238073; Brock E, 2007, MAR ECOL PROG SER, V337, P165, DOI 10.3354/meps337165; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Garbary David J., 2009, Algae, V24, P239, DOI 10.4490/ALGAE.2009.24.4.239; Nagayama K, 2002, J ANTIMICROB CHEMOTH, V50, P889, DOI 10.1093/jac/dkf222; Bhadury P, 2004, PLANTA, V219, P561, DOI 10.1007/s00425-004-1307-5; Longtin CM, 2009, J PHYCOL, V45, P820, DOI 10.1111/j.1529-8817.2009.00710.x; Twigg MS, 2014, ENVIRON MICROBIOL, V16, P445, DOI 10.1111/1462-2920.12203; Nylund GM, 2005, MAR ECOL PROG SER, V299, P111, DOI 10.3354/meps299111; CARLSON DJ, 1984, LIMNOL OCEANOGR, V29, P1077; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Jennings JG, 1997, OECOLOGIA, V109, P461, DOI 10.1007/s004420050106; AGUILARROSAS R, 1990, HYDROBIOLOGIA, V204, P185, DOI 10.1007/BF00040232; Hellio C, 2004, MAR BIOTECHNOL, V6, P67, DOI 10.1007/s10126-003-0020-x; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; Wikstrom SA, 2004, OECOLOGIA, V138, P223, DOI 10.1007/s00442-003-1427-9; JENNINGS JG, 1994, MAR BIOL, V121, P349, DOI 10.1007/BF00346744; Wisespongpand P, 2003, J APPL PHYCOL, V15, P225, DOI 10.1023/A:1023831131735; PENHALE PA, 1977, LIMNOL OCEANOGR, V22, P400; SIEBURTH JM, 1965, NATURE, V208, P52, DOI 10.1038/208052a0; Littler MM, 1999, ECOLOGY, V80, P1736; SILBERSTEIN K, 1986, AQUAT BOT, V24, P355, DOI 10.1016/0304-3770(86)90102-6; Michael TS, 2008, J ENVIRON BIOL, V29, P629; Honkanen T, 2005, OECOLOGIA, V144, P196, DOI 10.1007/00442-005-0053-0; Kupper FC, 2002, J CHEM ECOL, V28, P2057, DOI 10.1023/A:1020706129624; Steinberg PD, 2002, J CHEM ECOL, V28, P1935, DOI 10.1023/A:1020789625989; Thieltges DW, 2005, HYDROBIOLOGIA, V541, P241, DOI 10.1007/s10750-004-4671-z; ARRONTES J, 1990, BOT MAR, V33, P205, DOI 10.1515/botm.1990.33.2.205; Borowitzka MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P441; BROOKS WR, 1985, J EXP MAR BIOL ECOL, V87, P111, DOI 10.1016/0022-0981(85)90084-X; BUSCHMANN AH, 1993, HYDROBIOLOGIA, V261, P345; Cho JY, 2001, J APPL PHYCOL, V13, P117, DOI 10.1023/A:1011139910212; Ciciotte SL, 1997, AM J BOT, V84, P1614, DOI 10.2307/2446623; Fuse S, 1962, PHYSL ECOLOGY, V11, P23; Garbary David J., 2005, Algae, V20, P353; GONZALEZ MA, 1989, J PHYCOL, V25, P558, DOI 10.1111/j.1529-8817.1989.tb00262.x; Harder T, 2008, MARINE IND BIOFOULIN, V4, P1; SIEBURTH J M, 1969, Journal of Experimental Marine Biology and Ecology, V3, P275, DOI 10.1016/0022-0981(69)90051-3; Jormalainen V, 2008, OECOLOGIA, V155, P559, DOI 10.1007/s00442-007-0939-0; Jormalainen V, 2003, OIKOS, V103, P640, DOI 10.1034/j.1600-0706.2003.12635.x; Keats DW, 1997, J EXP MAR BIOL ECOL, V213, P281, DOI 10.1016/S0022-0981(96)02771-2; Kraberg AC, 2007, PHYCOL RES, V55, P17, DOI 10.1111/j.1440-1835.2006.00441.x; Lau SCK, 2000, BIOFOULING, V16, P47; Leonardi PI, 2006, EUR J PHYCOL, V41, P247, DOI 10.1080/09670260600645659; LEVIN PS, 1991, MAR ECOL PROG SER, V77, P271, DOI 10.3354/meps077271; PENOT M, 1993, PHYSIOL PLANTARUM, V87, P291, DOI 10.1034/j.1399-3054.1993.870307.x; Plouguerne E, 2012, J APPL PHYCOL, V24, P1629, DOI 10.1007/s10811-012-9826-0; Ragan M. A., 1986, PROG PHYCOL RES, V4, P177; RAGAN MA, 1979, J EXP MAR BIOL ECOL, V36, P91, DOI 10.1016/0022-0981(79)90102-3; Railkin A I, 2004, MARINE BIOFOULING CO; Reyes J, 1998, BOT MAR, V41, P543, DOI 10.1515/botm.1998.41.1-6.543; Richmond M.D., 1991, Biofouling, V3, P151; RONNBERG O, 1986, ANN BOT FENN, V23, P317; SIEBURTH JM, 1981, J PHYCOL, V17, P57, DOI 10.1111/j.0022-3646.1981.00057.x; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; STEWART JG, 1982, PAC SCI, V36, P45; TOKIDA J., 1960, BULL FAC FISH HOKKAIDO UNIV, V11, P73; TROCINE RP, 1981, PLANT PHYSIOL, V68, P74, DOI 10.1104/pp.68.1.74; Weinberger F, 2000, J PHYCOL, V36, P1079, DOI 10.1046/j.1529-8817.2000.00003.x; Yamamoto K, 2013, AQUAT BOT, V105, P11, DOI 10.1016/j.aquabot.2012.10.008; Yamamoto K, 2012, PHYCOL RES, V60, P70, DOI 10.1111/j.1440-1835.2011.00638.x; Yamamoto K., 2003, LIA WIN32 LIA32 VER; Yatsuya K, 2005, FISHERIES SCI, V71, P1098, DOI 10.1111/j.1444-2906.2005.01069.x; Yotsui T., 1980, SPECIAL REP NAGASAKI, V7, P1	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	AUG	2015	51	4					695	705		10.1111/jpy.12311		11	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CP5JY	WOS:000359918800010		
J	Teng, ST; Lim, PT; Lim, HC; Rivera-Vilarelle, M; Quijano-Scheggia, S; Takata, Y; Quilliam, MA; Wolf, M; Bates, SS; Leaw, CP				Teng, Sing Tung; Lim, Po Teen; Lim, Hong Chang; Rivera-Vilarelle, Maria; Quijano-Scheggia, Sonia; Takata, Yoshinobu; Quilliam, Michael A.; Wolf, Matthias; Bates, Stephen S.; Leaw, Chui Pin			A NON-TOXIGENIC BUT MORPHOLOGICALLY AND PHYLOGENETICALLY DISTINCT NEW SPECIES OF PSEUDO-NITZSCHIA, P. SABIT SP NOV (BACILLARIOPHYCEAE)	JOURNAL OF PHYCOLOGY			English	Article						domoic acid; ITS2; Malaysia; Mexico; Pseudo-nitzschia sabit; ribosomal RNA genes; secondary structure; sexual reproduction	F-MULTISERIES HASLE; DOMOIC ACID; COMPLEX BACILLARIOPHYCEAE; SECONDARY STRUCTURES; MARINE DIATOM; PSEUDODELICATISSIMA COMPLEX; PUNGENS BACILLARIOPHYCEAE; MOLECULAR SYSTEMATICS; PROFILE DISTANCES; COASTAL WATERS	A new species of Pseudo-nitzschia (Bacillariophyceae) is described from plankton samples collected from Port Dickson (Malacca Strait, Malaysia) and Manzanillo Bay (Colima, Mexico). The species possesses a distinctive falcate cell valve, from which they form sickle-like colonies in both environmental samples and cultured strains. Detailed observation of frustules under TEM revealed ultrastructure that closely resembles P. decipiens, yet the new species differs by the valve shape and greater ranges of striae and poroid densities. The species is readily distinguished from the curve-shaped P. subcurvata by the presence of a central interspace. The morphological distinction is further supported by phylogenetic discrimination. We sequenced and analyzed the nuclear ribosomal RNA genes in the LSU and the second internal transcribed spacer, including its secondary structure, to infer the phylogenetic relationship of the new species with its closest relatives. The results revealed a distinct lineage of the new species, forming a sister cluster with its related species, P. decipiens and P. galaxiae, but not with P. subcurvata. We examined the domoic acid (DA) production of five cultured strains from Malaysia by Liquid chromatography-mass spectrometry (LC-MS), but they showed no detectable DA. Here, we present the taxonomic description of the vegetative cells, document the sexual reproduction, and detail the molecular phylogenetics of Pseudo-nitzschia sabit sp. nov.	[Teng, Sing Tung; Leaw, Chui Pin] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan 94300, Sarawak, Malaysia; [Lim, Po Teen] Univ Malaya, Inst Ocean & Earth Sci, Bachok Marine Res Stn, Bachok 16310, Kelantan, Malaysia; [Lim, Hong Chang] Tunku Abdul Rahman Univ Coll, Segamat 85000, Johor, Malaysia; [Rivera-Vilarelle, Maria] Univ Colima, Fac Ciencias Quim, Colima, Mexico; [Quijano-Scheggia, Sonia] Univ Colima, Ctr Univ Invest Oceanol, Manzanillo 28860, Colima, Mexico; [Takata, Yoshinobu] Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan; [Quilliam, Michael A.] Natl Res Council Canada, Measurement Sci & Stand, Biotoxin Metrol, Halifax, NS B3H 3Z1, Canada; [Wolf, Matthias] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany; [Bates, Stephen S.] Fisheries & Oceans Canada, Gulf Fisheries Ctr, Moncton, NB E1C 9B6, Canada	Leaw, CP (reprint author), Univ Malaya, Inst Ocean & Earth Sci, Bachok Marine Res Stn, Bachok 16310, Kelantan, Malaysia.	cpleaw@um.edu.my	Wolf, Matthias/A-5580-2008; Lim, Hong Chang/J-8761-2012	Lim, Hong Chang/0000-0003-0013-7819	Malaysian government through the Ministry of Education under JSPS COMSEA Matching Fund [GA002-2014]; Malaysian government through the Ministry of Education under RACE; Malaysian government through the Ministry of Education under HiCoE [IOES-2014C]; University of Malaya under UMRP [RU006A-2014, RU006B-2014]; University of Malaya under BKP [BK013-2014]; Ministry of Higher Education My-PhD Scholarship	This work was funded by the Malaysian government through the Ministry of Education under JSPS COMSEA Matching Fund (GA002-2014), RACE, and HiCoE (IOES-2014C); the University of Malaya under UMRP (RU006A-2014, RU006B-2014) and BKP (BK013-2014). S.T. Teng was supported by the Ministry of Higher Education My-PhD Scholarship, and this work formed part of his PhD project. Technical assistance of Pat LeBlanc (NRC) is appreciated.	Ake-Castillo J. A., 2009, HARMFUL ALGAE NEWS, V40, P6; Almandoz GO, 2008, POLAR BIOL, V31, P429, DOI 10.1007/s00300-007-0369-9; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Amato A, 2008, PHYCOLOGIA, V47, P487, DOI 10.2216/07-92.1; Lundholm N, 2002, PHYCOLOGIA, V41, P594, DOI 10.2216/i0031-8884-41-6-594.1; Wolf M, 2014, GENE, V546, P145, DOI 10.1016/j.gene.2014.05.065; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Moschandreou KK, 2010, BOT MAR, V53, P159, DOI 10.1515/BOT.2010.014; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Hillebrand H, 1996, J PLANKTON RES, V18, P295, DOI 10.1093/plankt/18.2.295; Orive E, 2013, J PHYCOL, V49, P1192, DOI 10.1111/jpy.12130; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.ha1.2007.08.004; Lundholm N, 2002, EUR J PHYCOL, V37, P115, DOI 10.1017/S096702620100347X; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; GARRISON DL, 1992, J PHYCOL, V28, P604, DOI 10.1111/j.0022-3646.1992.00604.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; BATES SS, 1989, CAN J FISH AQUAT SCI, V46, P1203, DOI 10.1139/f89-156; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Rhodes LL, 1998, NEW ZEAL J MAR FRESH, V32, P537; Moschandreou KK, 2012, EUR J PHYCOL, V47, P321, DOI 10.1080/09670262.2012.713998; Teng ST, 2014, HARMFUL ALGAE, V34, P17, DOI 10.1016/j.hal.2014.02.005; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Teng ST, 2013, BOT MAR, V56, P375, DOI 10.1515/bot-2012-0194; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Rivera-Vilarelle M, 2013, BOT MAR, V56, P357, DOI 10.1515/bot-2012-0176; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bajarias F. F. A., 2006, COAST MAR SCI, V30, P121; Baugh K. A., 2006, AFR J MAR SCI, V28, P393; Couture J. Y., 2001, CAN TECH REP FISH AQ, V2375; Dao V. H., 2015, VIETNAM FISH SCI, V81, P533; Dao V. H., 2006, COAST MAR SCI, V30, P130; Dao VH, 2009, FISHERIES SCI, V75, P507; Dao VH, 2014, ASIAN FISH SCI, V27, P16; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Fryxell G. A., 1990, BEIH NOVA HEDW, V100, P171; Guillard R. R. L., 1975, CULTURE MARINE INVER, P29; Hasle G. R., 1964, SKR NOR VIDENSK AKAD, V16, P1; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hasle Grethe R., 2002, Harmful Algae, V1, P137, DOI 10.1016/S1568-9883(02)00014-8; Hasle GR, 1996, HELGOLANDER MEERESUN, V50, P131, DOI 10.1007/BF02367149; Hubbard KA, 2008, J PHYCOL, V44, P637, DOI 10.1111/j.1529-8817.2008.00518.x; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Lim HC, 2013, J PHYCOL, V49, P902, DOI 10.1111/jpy.12101; Lim HC, 2012, J APPL PHYCOL, V24, P1465, DOI 10.1007/s10811-012-9803-7; Lim HC, 2014, HARMFUL ALGAE, V37, P142, DOI 10.1016/j.hal.2014.06.004; Lim HC, 2012, J PHYCOL, V48, P1232, DOI 10.1111/j.1529-8817.2012.01213.x; Lundholm N, 2002, PHYCOLOGIA, V41, P480, DOI 10.2216/i0031-8884-41-5-480.1; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; Mafra LL, 2009, J CHROMATOGR A, V1216, P6003, DOI 10.1016/j.chroma.2009.06.050; McDonald SM, 2007, HARMFUL ALGAE, V6, P849, DOI 10.1016/j.hal.2007.03.003; Merget B., 2012, JOVE-J VIS EXP, V61, P3806; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Parsons ML, 2012, ACTA BOT MEX, V98, P51; Priisholm K, 2002, DIATOM RES, V17, P153; Quijano-Scheggia SI, 2009, PHYCOLOGIA, V48, P492, DOI 10.2216/08-21.1; R Development Core Team, 2011, R LANG ENV STAT COMP; RAO DVS, 1990, BOT MAR, V33, P545; RAO DVS, 1991, J PHYCOL, V27, P21; Reap M. E., 1991, THESIS TEXAS A M U T; Rhodes Lesley, 1998, Natural Toxins, V6, P105, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<105::AID-NT13>3.3.CO;2-0; Rivera R. P., 1985, GAVANA BOT, V42, P9; Sarno D, 2010, DEEP-SEA RES PT II, V57, P248, DOI 10.1016/j.dsr2.2009.09.012; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Scott F. P., 2005, ANTARCTIC MARINE PRO, P13; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Smith J. C., 1990, B AQUACULT ASS CAN, V90, P27; Sorhannus U, 2010, PROTIST, V161, P237, DOI 10.1016/j.protis.2009.10.003; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Takata Y, 2009, FISHERIES SCI, V75, P473, DOI 10.1007/s12562-009-0073-5; VILLAC MC, 1993, HYDROBIOLOGIA, V269, P213, DOI 10.1007/BF00028020; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Wolf Matthias, 2005, In Silico Biol, V5, P291	92	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	AUG	2015	51	4					706	725		10.1111/jpy.12313		20	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CP5JY	WOS:000359918800011		
J	Ubukata, H; Maruyama, H; Huo, M				Ubukata, Hitomi; Maruyama, Hitoshi; Huo, Ming			Reliability of measuring pelvic floor elevation with a diagnostic ultrasonic imaging device	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Bladder base; Pelvic floor muscles (PFMs); Stress urinary incontinence	TRANSPERINEAL; WOMEN	[Purpose] The purpose of this study was to investigate the reliability of measuring the amount of pelvic floor elevation during pelvic and abdominal muscle contraction with a diagnostic ultrasonic imaging device. [Subjects] The study group comprised 11 healthy women without urinary incontinence or previous birth experience. [Methods] We measured the displacement elevation of the bladder base during contraction of the abdominal and pelvic floor muscles was measured using a diagnostic ultrasonic imaging device. The exercise was a four-part operation undertaken with the subjects in the lateral position. The reliability analysis included use of the interclass correlation coefficient (ICC) was used to assess the reliability. [Results] ICC (1.1) values for the pelvic floor elevation measurement with a diagnostic ultrasonic imaging device were 0.98 [contraction of the transversus abdominis (TrA) muscle], 0.99 [contraction of pelvic floor muscles (PFMs)], 0.98 (co-contraction of the TrA and PFMs), and 0.98 (resistance of the TrA and PFMs). This study proved the reliability of the method because the coefficient of reliability was 0.97 or more for all of the measurements, even for those during exercise. [Conclusion] The diagnostic ultrasonic imaging device measures pelvic floor elevation with high reliability.	[Ubukata, Hitomi] Takasaki Univ Hlth & Welf, Fac Hlth Sci, Dept Phys Therapy, Takasaki, Gunma 3700033, Japan; [Ubukata, Hitomi; Maruyama, Hitoshi] Int Univ Hlth & Welf, Grad Sch, Hlth & Welf Sci Course, Dept Phys Therapy, Nasushiobara, Japan; [Huo, Ming] Himeji Dokkyo Univ, Fac Hlth Care Sci, Dept Phys Therapy, Himeji, Hyogo, Japan	Ubukata, H (reprint author), Takasaki Univ Hlth & Welf, Fac Hlth Sci, Dept Phys Therapy, 501 Nakaoorui, Takasaki, Gunma 3700033, Japan.	ubukata@takasaki-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [26870537]	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 26870537.	Sherburn M, 2005, AUST J PHYSIOTHER, V51, P167; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI 10.1007/s00192-009-0976-9; Chehrehrazi M, 2009, INT UROGYNECOL J, V20, P1491, DOI 10.1007/s00192-009-0977-8; Thompson JA, 2005, INT UROGYNECOL J, V16, P285, DOI 10.1007/s00192-005-1308-3; Thompson JA, 2007, INT UROGYNECOL J, V18, P779, DOI 10.1007/s00192-006-0225-4; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Rao SSC, 2007, CLIN GASTROENTEROL H, V5, P331, DOI 10.1016/j.cgh.2006.12.023; Kim BI, 2014, J PHYS THER SCI, V26, P427, DOI 10.1589/jpts.26.427; Kim Hunkyung, 2008, Nihon Ronen Igakkai Zasshi, V45, P315, DOI 10.3143/geriatrics.45.315	9	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2495	2497				3	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600020		
J	Morino, A; Shida, M; Tanaka, M; Sato, K; Seko, T; Ito, S; Ogawa, S; Yokoi, Y; Takahashi, N				Morino, Akira; Shida, Masahiro; Tanaka, Masashi; Sato, Kimihiro; Seko, Toshiaki; Ito, Shunsuke; Ogawa, Shunichi; Yokoi, Yuka; Takahashi, Naoaki			Upper extremity muscle tone and response of tidal volume during manually assisted breathing for patients requiring prolonged mechanical ventilation	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Manually assisted breathing; Muscle tone; Prolonged mechanical ventilation	PULMONARY REHABILITATION; PRESSURE	[Purpose] The aim of the present study was to examine, in patients requiring prolonged mechanical ventilation, if the response of tidal volume during manually assisted breathing is dependent upon both upper extremity muscle tone and the pressure intensity of manually assisted breathing. [Subjects] We recruited 13 patients on prolonged mechanical ventilation, and assessed their upper extremity muscle tone using the modified Ashworth scale (MAS). The subjects were assigned to either the low MAS group (MAS less than or similar to 2, n=7) or the high MAS group (MAS >= 3, n=6). [Methods] The manually assisted breathing technique was applied at a pressure of 2 kgf and 4 kgf. A split-plot ANOVA was performed to compare the tidal volume of each pressure during manually assisted breathing between the low and the high MAS groups. [Results] Statistical analysis showed there were main effects of the upper extremity muscle tone and the pressure intensity of the manually assisted breathing technique. There was no interaction between these factors. [Conclusion] Our findings reveal that the tidal volume during the manually assisted breathing technique for patients with prolonged mechanical ventilation depends upon the patient's upper extremity muscle tone and the pressure intensity.	[Morino, Akira; Shida, Masahiro; Tanaka, Masashi; Sato, Kimihiro; Seko, Toshiaki; Ito, Shunsuke; Ogawa, Shunichi] Hokkaido Chitose Inst Rehabil Technol, Dept Phys Therapy, Chitose 0660055, Japan; [Yokoi, Yuka] Koriyama Inst Hlth Sci, Sch Phys Therapy, Koriyama, Fukushima, Japan; [Takahashi, Naoaki] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Dept Phys Therapy, Sapporo, Hokkaido, Japan	Morino, A (reprint author), Hokkaido Chitose Inst Rehabil Technol, Dept Phys Therapy, 10 Satomi 2 Chome, Chitose 0660055, Japan.	a-morino@chitose-reha.ac.jp					AARC, 1991, RESP CARE, V36, P1418; TEASDALE G, 1974, LANCET, V2, P81; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Ries AL, 2008, RESP CARE, V53, P1203; Bohannon R. W., 1987, PHYS THER, V67, P206; Ihashi K, 2008, ANN REP TOHOKU SECT, V20, P1; Kihara K, 2012, HOME HLTH CARE PEOPL, V17, P39; Kurita H, 2010, J PHYS THER SCI, V22, P209; Lu Q, 2000, CRIT CARE, V4, P91, DOI 10.1186/cc662; McCarren B, 2006, AUST J PHYSIOTHER, V52, P267; Miyagawa T, 1993, JAPANESE J PHYS THER, V27, P678; Ries AL, 2007, CHEST, V131, P4, DOI DOI 10.1378/CHEST.06-2418; Sadamori E, 1999, PHYS THER JPN, V26, P151; Tabira K, 2007, PHYS THER JPN, V34, P59; Tatara K, 2009, J JP SOC RESP CARE R, V19, P151; Unoki Takeshi, 2005, Respir Care, V50, P1430	17	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2509	2513				5	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600024		
J	Morino, A; Murase, K; Yamada, K				Morino, Akira; Murase, Kazuma; Yamada, Katsuo			Complications after video-assisted thoracic surgery in patients with pulmonary nontuberculous mycobacterial lung disease who underwent preoperative pulmonary rehabilitation	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Nontuberculous mycobacteria; Video-assisted thoracic surgery; Complication	CANCER RESECTION; LOBECTOMY; PAIN; PHYSIOTHERAPY; THORACOTOMY	[Purpose] Video-assisted thoracic surgery and preoperative pulmonary rehabilitation are effective in preventing postoperative complications in patients with cardiopulmonary disease. The present study aims to elucidate the presence of postoperative pneumonia and atelectasis in patients with nontuberculous mycobacterial lung disease who underwent lung resection with video-assisted thoracic surgery and preoperative pulmonary rehabilitation. [Subjects and Methods] Nineteen patients with nontuberculous mycobacterial lung disease who had undergone lung resection with video-assisted thoracic surgery and preoperative pulmonary rehabilitation were enrolled in this study. The presence of postoperative pneumonia and atelectasis was evaluated, and preoperative and postoperative pulmonary functions were compared. [Results] Postoperative pneumonia and postoperative atelectasis were not observed. Decreases of pulmonary function were 5.9% (standard deviation, 8.5) in forced vital capacity (percent predicted) and 9.6% (standard deviation, 11.1) in forced expiratory volume in 1 s (percent predicted). [Conclusion] The present study indicates that the combination of lung resection with video-assisted thoracic surgery and preoperative pulmonary rehabilitation in patients with nontuberculous mycobacterial lung disease may be effective in preventing postoperative complications.	[Morino, Akira] Hokkaido Chitose Inst Rehabil Technol, Dept Phys Therapy, Chitose, Hokkaido 0660055, Japan; [Murase, Kazuma] Higashinagoya Natl Hosp, Natl Org Hosp, Dept Phys Therapy, Nagoya, Aichi, Japan; [Yamada, Katsuo] Higashinagoya Natl Hosp, Natl Org Hosp, Dept Thorac Surg, Nagoya, Aichi, Japan	Morino, A (reprint author), Hokkaido Chitose Inst Rehabil Technol, Dept Phys Therapy, 10 Satomi 2 Chome, Chitose, Hokkaido 0660055, Japan.	a-morino@chitose-reha.ac.jp					Algar FJ, 2003, EUR J CARDIO-THORAC, V23, P201, DOI 10.1016/S1010-7940(02)00719-4; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Varela G, 2006, EUR J CARDIO-THORAC, V29, P216, DOI 10.1016/j.ejcts.2005.11.002; Park DJ, 2013, J PHYS THER SCI, V25, P253; Benzo R, 2011, LUNG CANCER, V74, P441, DOI 10.1016/j.lungcan.2011.05.011; Zhang ZR, 2013, EUR J CARDIO-THORAC, V44, P407, DOI 10.1093/ejcts/ezt015; Kaseda S, 2000, ANN THORAC SURG, V70, P1644, DOI 10.1016/S0003-4975(00)01909-3; Nagahiro I, 2001, ANN THORAC SURG, V72, P362, DOI 10.1016/S0003-4975(01)02804-1; McAlister FA, 2005, AM J RESP CRIT CARE, V171, P514, DOI 10.1164/rccm.200408-1069OC; Jeong JH, 2015, J PHYS THER SCI, V27, P489, DOI 10.1589/jpts.27.489; Muraoka Masashi, 2006, Jpn J Thorac Cardiovasc Surg, V54, P49, DOI 10.1007/BF02744600; National Cancer Institute, NATL CANC I COMMON T; Santambrogio L, 2001, EUR J CARDIO-THORAC, V20, P684, DOI 10.1016/S1010-7940(01)00886-7; Sato S, 2008, GENDAI IGAKU, V56, P317; Spyratos D, 2014, J THORAC DIS, V6, pS162, DOI 10.3978/j.issn.2072-1439.2014.03.06; [the Japanese Respiratory Society The Japanese Society for Tuberculosis], 2008, KEKKAKU, V83, P525; The Japanese Society for Tuberculosis, 2008, KEKKAKU, V83, P527; Yu JA, 2011, EUR J CARDIO-THORAC, V40, P671, DOI 10.1016/j.ejcts.2010.12.028	19	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2541	2544				4	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600032		
J	Batbayar, Y; Uga, D; Nakazawa, R; Sakamoto, M				Batbayar, Yanjinsuren; Uga, Daisuke; Nakazawa, Rie; Sakamoto, Masaaki			Effect of various hand position widths on scapular stabilizing muscles during the push-up plus exercise in healthy people	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Push-up plus exercise; Hand position; Serratus anterior	SERRATUS ANTERIOR; SHOULDER IMPINGEMENT; ACTIVATION; KINEMATICS; SYMPTOMS; SUPPORT; SURFACE; BALANCE	[Purpose] The purpose of this study was to determine the effect of various hand position widths during the push-up plus (PUP) exercise on the activity of the scapular stabilizing muscles and other upper-extremity muscles involved in the exercise. [Subjects and Methods] Nine healthy men participated in our study. The PUP exercise was performed on a stable surface in seven different hand positions, namely shoulder width (SW), and narrower SW (NSW) and wider SW (WSW) at 10%, 20%, and 30%. Surface electromyography was used to measure the muscle activities and muscle ratio of the upper trapezius (UT), middle trapezius, lower trapezius (LT), serratus anterior (SA), pectoralis major, deltoid anterior, latissimus dorsi (LD), and triceps muscles. [Results] The SA and LD muscle activities significantly decreased in the 30% NSW and 20% WSW hand positions, respectively. The UT/LT muscle ratio significantly increased in the 30% WSW hand position. [Conclusion] The results of this study suggest that during the PUP exercise, the SW hand position should be used. In the 30% NSW hand position, the SA muscle activity decreased, and the UT/LT ratio increased in the 30% WSW hand position.	[Batbayar, Yanjinsuren] Mongolian Natl Univ Med Sci, Ulaanbaatar, Mongol Peo Rep; [Uga, Daisuke; Nakazawa, Rie; Sakamoto, Masaaki] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718514, Japan	Sakamoto, M (reprint author), Gunma Univ, Grad Sch Hlth Sci, 3-39-22 Showa, Maebashi, Gunma 3718514, Japan.	msaka@gunma-u.ac.jp					Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Cools AM, 2007, SCAND J MED SCI SPOR, V17, P25, DOI 10.1111/j.1600-0838.2006.00570.x; Ludewig PM, 2000, PHYS THER, V80, P276; Ludewig PM, 2004, AM J SPORT MED, V32, P484, DOI 10.1177/0363546503258911; Cogley RM, 2005, J STRENGTH COND RES, V19, P628, DOI 10.1519/15094.1; Calatayud J, 2014, J SPORT SCI MED, V13, P502; Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808; Lukasiewicz AC, 1999, J ORTHOP SPORT PHYS, V29, P574; Decker MJ, 1999, AM J SPORT MED, V27, P784; Lear LJ, 1998, J ORTHOP SPORT PHYS, V28, P146; Lehman GJ, 2008, MANUAL THER, V13, P500, DOI 10.1016/j.math.2007.05.016; Matthews D, 2013, J ELECTROMYOGR KINES, V23, P1370, DOI 10.1016/j.jelekin.2013.06.007; Seo SH, 2013, J PHYS THER SCI, V25, P833, DOI 10.1589/jpts.25.833; WATSON CJ, 1995, PHYS THER, V75, P194	14	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2573	2576				4	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600039		
J	Kobara, K; Takahashi, H; Fujita, D; Osaka, H; Ito, T; Suehiro, T; Watanabe, S				Kobara, Kenichi; Takahashi, Hisashi; Fujita, Daisuke; Osaka, Hiroshi; Ito, Tomotaka; Suehiro, Tadanobu; Watanabe, Susumu			Investigation of effect of leg support elevation timing on the horizontal force acting on the buttocks in a reclining wheelchair	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Elevate the leg support; Horizontal force; Decubitus ulcer	OCCUPIED WHEELCHAIRS; SHEAR FORCE; PRESSURE; POSTURE; DESIGN; TILT	[Purpose] The purpose of this study was to investigate the effect of the timing of leg support elevation on the horizontal force acting on the buttocks in a reclining wheelchair. [Subjects and Methods] The participants were 17 healthy men. Two experimental conditions were tested: the leg-down and leg-up conditions. The back support was reclined at increasing angles, from the initial upright position (IUP), proceeding to the fully reclined position (FRP), and returned to the upright position (RUP). The posterior inclination phase was from IUP to FRP, and the returning inclination phase was from FRP to RUP. [Results] The horizontal force under the leg-up condition was significantly higher than that under the leg-down condition in all positions of back support. [Conclusion] The leg supports should be positioned downward before reclining the back support of a wheelchair.	[Kobara, Kenichi; Takahashi, Hisashi; Fujita, Daisuke; Osaka, Hiroshi; Ito, Tomotaka; Suehiro, Tadanobu; Watanabe, Susumu] Kawasaki Univ Med Welfare, Fac Hlth Sci & Technol, Dept Rehabil, Kurashiki, Okayama 7010193, Japan	Kobara, K (reprint author), Kawasaki Univ Med Welfare, Fac Hlth Sci & Technol, Dept Rehabil, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	rptkob@mw.kawasaki-m.ac.jp			JSPS KAKENHI [26750234]	This study was supported by JSPS KAKENHI Grant Number 26750234. All authors contributed equally to the preparation of this manuscript.	ABEL EW, 1991, PROSTHET ORTHOT INT, V15, P38; Aissaoui R, 2000, IEEE T REHABIL ENG, V8, P140, DOI 10.1109/86.830958; Kemmoku T, 2013, PROSTHET ORTHOT INT, V37, P282, DOI 10.1177/0309364612465429; Aissaoui R, 2001, IEEE T NEUR SYS REH, V9, P215, DOI 10.1109/7333.928581; KIRBY RL, 1989, ARCH PHYS MED REHAB, V70, P681; Jan YK, 2013, ARCH PHYS MED REHAB, V94, P667, DOI 10.1016/j.apmr.2012.11.019; Kobara K, 2014, J PHYS THER SCI, V26, P701, DOI 10.1589/jpts.26.701; CARLSON JM, 1995, J PROSTHET ORTHOT, V7, P51, DOI 10.1097/00008526-199500720-00005; GILSDORF P, 1990, Journal of Rehabilitation Research and Development, V27, P239, DOI 10.1682/JRRD.1990.07.0239; Hirose H, 2005, J REHABIL RES DEV, V42, P437, DOI 10.1682/JRRD.2004.09.0125; HOBSON DA, 1992, J REHABIL RES DEV, V29, P21, DOI 10.1682/JRRD.1992.10.0021; Huang HC, 2013, EUR J PHYS REHAB MED, V49, P619; Kobara Kenichi, 2013, Disabil Rehabil Assist Technol, V8, P220, DOI 10.3109/17483107.2012.713434; Kobara K, 2008, J PHYS THER SCI, V20, P157, DOI 10.1589/jpts.20.157; Kobara K, 2015, PROSTHET OR IN PRESS, V38; MCLAURIN CA, 1991, PROSTHET ORTHOT INT, V15, P24; National Pressure Ulcer Advisory Panel: Shear, 2007, SHEAR CONTR FACT PRE; Park Un Jin, 2011, Ann Rehabil Med, V35, P897, DOI 10.5535/arm.2011.35.6.897; Sabol TP, 2006, CLIN GERIATR MED, V22, P355, DOI 10.1016/j.cger.2005.12.013; Ward DE, 1994, PRESCRIPTIVE SEATING, P101	20	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2605	2610				6	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600046		
J	Nagano, K; Nagano, Y				Nagano, Katsuhito; Nagano, Yumi			The improvement effect of limited mental practice in individuals with poststroke hemiparesis: the influence of mental imagery and mental concentration	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Mental practice; Imagery vividness; Mental concentration	MOTOR IMAGERY; STROKE PATIENTS; SUBACUTE STROKE; PERFORMANCE; FATIGUE; ABILITY; BALANCE; ACTIVATION; SKILL	[Purpose] This study examined whether limited mental practice improves the motor performance of poststroke individuals with hemiparesis. [Subjects] Twenty-three participants with poststroke hemiparesis (4082 years of age) participated in this study. [Methods] The subjects were divided into four groups with respect to a dart-throwing task: the no-practice, physical practice only, mental practice only, and mental and physical practice groups. The groups were compared in terms of gains in motor performance, mental imagery vividness, and level of concentration during mental practice. [Results] No statistically significant difference was found for gains in motor performance among groups, and there was no correlation between imagery vividness and motor performance gains. However, a correlation was found between gains in motor performance and mental concentration during mental practice. [Conclusion] The results suggested that limited mental practice for individuals with poststroke hemiparesis may not improve motor performance. However, a higher degree of concentration during mental practice may improve motor performance.	[Nagano, Katsuhito] Fukui Coll Hlth Sci, Fac Rehabil, Dept Phys Therapy, Fukui, Fukui 9103190, Japan	Nagano, K (reprint author), Fukui Coll Hlth Sci, Fac Rehabil, Dept Phys Therapy, Egami Cho 13-1, Fukui, Fukui 9103190, Japan.	nagano@xg8.so-net.ne.jp					Battaglia C, 2014, HUM MOVEMENT SCI, V38, P225, DOI 10.1016/j.humov.2014.10.001; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Dickstein R, 2007, PHYS THER, V87, P942, DOI 10.2522/ptj.20060331; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guttman A, 2012, TOP STROKE REHABIL, V19, P306, DOI [10.1310/tsr1904-306, 10.1310/tscir1904-306]; Page SJ, 2001, PHYS THER, V81, P1455; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Deco G, 2005, PROG NEUROBIOL, V76, P236, DOI 10.1016/j.pneurobio.2005.08.004; Lee H, 2015, J PHYS THER SCI, V27, P1, DOI 10.1589/jpts.27.1; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Park EC, 2015, J PHYS THER SCI, V27, P341, DOI 10.1589/jpts.27.341; Butler AJ, 2006, ARCH PHYS MED REHAB, V87, pS2, DOI 10.1016/j.apmr.2006.08.326; Baeck JS, 2012, BEHAV BRAIN RES, V234, P26, DOI 10.1016/j.bbr.2012.06.001; Betts GH, 1909, CONTRIBUTION ED SERI, V26, P20; Boter H, 2014, J REHABIL MED, V46, P684, DOI 10.2340/16501977-1814; Chevalier-Girard N, 1983, Can J Appl Sport Sci, V8, P246; CLARK LV, 1960, RES QUART, V31, P560; Denis M., 1985, CANADIAN J APPL SPOR, V10, P4; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25; Gaggioli A, 2013, PSYCH, V4, P1; Inoue K, 2007, J PHYS THER SCI, V19, P283, DOI 10.1589/jpts.19.283; Lee G, 2011, J PHYS THER SCI, V23, P197; Liu H, 2014, BEHAV NEUROL, V2014; Malouin F, 2010, ARCH PHYS MED REHAB, V91, P1122, DOI 10.1016/j.apmr.2010.03.007; Mehta RK, 2014, HUM FACTORS, V56, P645, DOI 10.1177/0018720813507279; Oostra KM, 2015, J REHABIL MED, V47, P204, DOI 10.2340/16501977-1908; Park J, 2015, J PHYS THER SCI, V27, P1075, DOI 10.1589/jpts.27.1075; RICHARDSON A, 1967, RES QUART, V38, P263; Saito M, 2013, J PHYS THER SCI, V25, P138; Taube W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00972; Weinberg RS, 1982, QUEST, V33, P195	32	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2015	27	8					2641	2644				4	Rehabilitation	Rehabilitation	CP6SX	WOS:000360019600055		
J	Kamei, Y; Nishida, J; Mimata, Y; Shiraishi, H; Ehara, S; Satoh, T; Shimamura, T				Kamei, Yoichi; Nishida, Jun; Mimata, Yoshikuni; Shiraishi, Hideo; Ehara, Shigeru; Satoh, Takashi; Shimamura, Tadashi			Core Needle Percutaneous Transpedicular Vertebral Body Biopsy A Study of 128 Cases	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						core needle biopsy; transpedicular; percutaneous; vertebral body; metastasis	RADIOLOGISTS; LESIONS; SPINE	Study Design:We report an accurate technique for percutaneous transpedicular core needle biopsy of vertebral body lesions, and evaluate its effectiveness for histologic diagnosis retrospectively.Objective:The purpose of this study is to evaluate the effectiveness and accuracy of this method retrospectively.Summary of Background Data:Better knowledge of vertebral pedicle morphometry has led to the development of transpedicular fixation techniques in spinal surgery. After experience with these techniques, we have been performing percutaneous transpedicular vertebral body core needle biopsies (transpedicular biopsy) for histologic diagnosis since 1993.Methods:A total of 128 patients who had undergone transpedicular biopsy for T1-L5 vertebral body lesions were evaluated. The biopsies were carried out under local anesthesia, except in children, for whom general anesthesia was used. Biopsy specimens were obtained by passing 8 or 11 G needle biopsy instruments percutaneously through the pedicle into the site of the lesion under C-arm fluoroscopy guidance. Histologic analyses were performed, and the accuracy and effectiveness of this technique were evaluated.Results:The pathologic evaluations were definitive in 120 patients (93.8%) and not diagnostic in 8. The accuracy of the results differed among the diagnostic categories. Diagnostic accuracy was 78.6% for primary neoplasms and 97.0% for metastatic neoplasms. There was a significant difference in the diagnostic criteria and spinal segment. True positive rate was higher in the thoracic spine (92.2%) than that of lumbar spine (76.6%).Conclusions:Transpedicular biopsy is a useful procedure for evaluation of thoracic and lumbar vertebral body lesions.	[Kamei, Yoichi; Nishida, Jun; Mimata, Yoshikuni; Shiraishi, Hideo; Shimamura, Tadashi] Iwate Med Univ, Sch Med, Dept Orthopaed Surg, Morioka, Iwate 020, Japan; [Ehara, Shigeru] Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 020, Japan; [Satoh, Takashi] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate 020, Japan	Nishida, J (reprint author), Iwate Med Univ, Sch Med, Dept Orthopaed Surg, 19-1 Uchimaru, Morioka, Iwate 020, Japan.	jnishida@f2.dion.ne.jp			Pfizer Inc.	Jun Nishida received a departmental grant from Pfizer Inc. that ended in 2013. The other authors declare no conflict of interest.	CRAIG FS, 1956, J BONE JOINT SURG AM, V38, P93; BRUGIERES P, 1991, J NEURORADIOLOGY, V18, P351; Dave BR, 2009, SPINAL CORD, V47, P384, DOI 10.1038/sc.2008.108; DEBNAM JW, 1975, RADIOLOGY, V116, P607; Duncan GA, 1936, J BONE JOINT SURG, V18, P769; FIDLER MW, 1990, J BONE JOINT SURG BR, V72, P884; FYFE IS, 1983, J BONE JOINT SURG BR, V65, P140; GHELMAN B, 1991, SPINE, V16, P736, DOI 10.1097/00007632-199107000-00008; KATTAPURAM SV, 1991, AM J ROENTGENOL, V157, P935; Kattapurum SV, 1992, SPINE, V17, P562; Komblum MB, 1998, SPINE, V23, P81; MISENHIMER GR, 1989, SPINE, V14, P367, DOI 10.1097/00007632-198904000-00004; MURPHY WA, 1981, RADIOLOGY, V139, P545; Robertson RC, 1935, J BONE JOINT SURG, V17, P749; SAILLANT G, 1976, REV CHIR ORTHOP, V62, P151; Shiraishi H, 1998, J JPN ORTHOP ASSOC, V72, pS974; STRINGHAM DR, 1994, SPINE, V19, P1985, DOI 10.1097/00007632-199409000-00021; Stroker DJ, 1985, CLIN RADIOL, V36, P569; VALLS J, 1948, JAMA-J AM MED ASSOC, V136, P376; Zendrick MR, 1987, SPINE, V12, P160	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	AUG	2015	28	7					E394	E399		10.1097/BSD.0b013e31829c077a		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CP4AG	WOS:000359823800003		
J	Cha, BS; Kanashima, T; Lee, SM; Okuyama, M				Cha, Bu-Sang; Kanashima, Takeshi; Lee, Seung-Mok; Okuyama, Masanori			Air damping effect on the air-based CMUT operation	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						CMUT; Vibration; Air damping; Damping ratio; Quality factor	MICROMACHINED ULTRASONIC TRANSDUCERS; PERFORATED PLANAR MICROSTRUCTURES; SQUEEZE; MODEL; MEMS	The vibration amplitude, damping ratio and viscous damping force in capacitive micromachinedultrasonic transducers (CMUTs) with a perforated membrane have been calculated theoretically and compared with the experimental data on its vibration behavior. The electrical bias of the DC and the AC voltages and the operation frequency conditions influence the damping effect because leads to variations in the gap height and the vibration velocity of the membrane. We propose a new estimation method to determine the damping ratio by the decay rate of the vibration amplitudes of the perforated membrane plate are measured using a laser vibrometer at each frequency, and the damping ratios were calculated from those results. The influences of the vibration frequency and the electrostatic force on the damping effect under the various operation conditions have been studied.	[Cha, Bu-Sang; Kanashima, Takeshi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Lee, Seung-Mok] Ingen MSL Inc, Sakai, Osaka 5900113, Japan; [Okuyama, Masanori] Osaka Univ, Inst Nanosci Design, Toyonaka, Osaka 5608531, Japan	Cha, BS (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	smlee@ingen.co.jp					De Pasquale G, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/1/015010; Ergun AS, 2003, J AEROSPACE ENG, V16, P76, DOI 10.1061/(ASCE)0893-1321(2003)16:2(76); ANDREWS M, 1993, SENSOR ACTUAT A-PHYS, V36, P79, DOI 10.1016/0924-4247(93)80144-6; BLECH JJ, 1983, J LUBRIC TECH-T ASME, V105, P615; GRIFFIN WS, 1966, J BASIC ENG-T ASME, V88, P451; Mohite SS, 2008, J MICROELECTROMECH S, V17, P709, DOI 10.1109/JMEMS.2008.921675; Ladabaum I, 1998, IEEE T ULTRASON FERR, V45, P678, DOI 10.1109/58.677612; Bao MH, 2007, SENSOR ACTUAT A-PHYS, V136, P3, DOI 10.1016/j.sna.2007.01.008; Bao MH, 2003, J MICROMECH MICROENG, V13, P795, DOI 10.1088/0960-1317/13/6/301; Bao MH, 2003, SENSOR ACTUAT A-PHYS, V108, P212, DOI 10.1016/S0924-4247(03)00263-2; Beards CF, 1996, STRUCTURAL VIBRATION; Cha BS, 2011, SENSOR ACTUAT A-PHYS, V171, P191, DOI 10.1016/j.sna.2011.08.021; Homentcovschi D, 2008, J ACOUST SOC AM, V124, P175, DOI 10.1121/1.2918542; Homentcovschi D, 2004, J ACOUST SOC AM, V116, P2939, DOI 10.1121/1.1798331; Homentcovschi D, 2005, SENSOR ACTUAT A-PHYS, V119, P544, DOI 10.1016/j.sna.2004.10.032; Hunt F. V., 1982, ELECTROACOUSTICS ANA; Lee SM, 2010, J APPL PHYS, V108, DOI 10.1063/1.3481418; Piersol A. G., 2002, SHOCK VIBRATION HDB, V5th; Pratap Rudra, 2007, Journal of the Indian Institute of Science, V87; Senturia S., 2000, MICROSYSTEM DESIGN; Soma A, 2008, ANALOG INTEGR CIRC S, V57, P213, DOI 10.1007/s10470-008-9165-x; Veijola T, 2009, MICROSYST TECHNOL, V15, P1121, DOI 10.1007/s00542-009-0793-6; Veijola T, 2006, MICROFLUID NANOFLUID, V2, P249, DOI 10.1007/s10404-005-0072-5	23	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	AUG	2015	67	3					486	495		10.3938/jkps.67.486		10	Physics, Multidisciplinary	Physics	CP5QU	WOS:000359939600011		
J	Okumura, H; Uchikado, Y; Matsumoto, M; Omoto, I; Sasaki, K; Kita, Y; Arigami, T; Uenosono, Y; Nakajo, A; Owaki, T; Mori, S; Ishigami, S; Natsugoe, S				Okumura, Hiroshi; Uchikado, Yasuto; Matsumoto, Masataka; Omoto, Itaru; Sasaki, Ken; Kita, Yoshiaki; Arigami, Takaaki; Uenosono, Yoshikazu; Nakajo, Akihiro; Owaki, Tetsuhiro; Mori, Shinichiro; Ishigami, Sumiya; Natsugoe, Shoji			Clinical significance of mediastinoscope-assisted transhiatal esophagectomy in patients with esophageal cancer	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Esophageal cancer; Mediastinoscope; Transhiatal esophagectomy; Minimally invasive surgery	CARCINOMA; LYMPHADENECTOMY; ENDODISSECTION	Mediastinoscope-assisted transhiatal esophagectomy (MATHE) is a useful surgical procedure in esophageal cancer patients who have limited indications for transthoracic operations due to preoperative complications. In the last 10 years, 63 patients underwent MATHE at our department. We examined the clinical data of these patients and assessed the indications, postoperative outcomes, and prognostic factors of MATHE. The 5-year overall survival (OS) rate was 53.4 %, and disease-free survival (DFS) rate was 66.0 %. Postoperative complications were observed in 22 cases (34.9 %), and recurrent disease occurred in 17 cases (27.0 %). On univariate analyses of OS, location of the tumor, tumor depth, lymph node metastasis, clinical stage, simultaneous resection of other organs, postoperative pneumonia, and blood loss were significant prognostic factors. On multivariate analyses, location of the tumor and lymph node metastasis were independent prognostic factors of OS. On univariate analyses, location of the tumor, tumor depth, lymph node metastasis, clinical stage, and blood loss were significant prognostic factors of DFS, while on multivariate analyses of DFS, lymph node metastasis and blood loss were independent prognostic factors. MATHE is a useful procedure for the middle to lower thoracic esophageal cancer patients without clinical lymph node metastasis with serious complications who were unable to undergo thoracotomy.	[Okumura, Hiroshi; Uchikado, Yasuto; Matsumoto, Masataka; Omoto, Itaru; Sasaki, Ken; Kita, Yoshiaki; Arigami, Takaaki; Uenosono, Yoshikazu; Nakajo, Akihiro; Owaki, Tetsuhiro; Mori, Shinichiro; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan	Okumura, H (reprint author), Kagoshima Univ, Grad Sch Med Sci, Dept Digest Surg Breast & Thyroid Surg, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	hokumura@m.kufm.kagoshima-u.ac.jp					Feng MX, 2012, SURG ENDOSC, V26, P1573, DOI 10.1007/s00464-011-2073-7; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.245561c; Bumm R, 1997, WORLD J SURG, V21, P822; BUMM R, 1993, ANN SURG, V218, P97, DOI 10.1097/00000658-199307000-00015; Manncke K, 1994, Endosc Surg Allied Technol, V2, P10; Natsugoe S, 2001, ANN SURG, V234, P613, DOI 10.1097/00000658-200111000-00005; Natsugoe S, 2010, LANGENBECK ARCH SURG, V395, P341, DOI 10.1007/s00423-010-0592-7; Osugi H, 2003, BRIT J SURG, V90, P108, DOI 10.1002/bjs.4022; Ozawa S, 2010, ESOPHAGUS-TOKYO, V7, P7, DOI 10.1007/s10388-010-0228-6; Sakamoto F, 2004, J GASTROENTEROL, V39, P7, DOI 10.1007/s00535-003-1238-0; Shichinohe T, 2008, SURG TODAY, V38, P206, DOI 10.1007/s00595-007-3606-5; Sobin LH, 2009, INT UNION CANC UICC; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Tangoku A, 2004, SURG ENDOSC, V18, P383, DOI 10.1007/s00464-003-8181-2	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	AUG	2015	400	6					699	706		10.1007/s00423-015-1330-y		8	Surgery	Surgery	CP6NG	WOS:000360003600007		
J	Nagata, S; Nishimura, H; Abe, T				Nagata, Shuji; Nishimura, Hiroshi; Abe, Toshi			MR Imaging of Soft-Tissue Tumors of the Upper Extremity	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Upper extremity; Soft-tissue tumor; Benign; Malignancy; MR imaging	RADIOLOGIC-PATHOLOGICAL CORRELATION; SYNOVIAL SARCOMA; ANGIOLEIOMYOMA; PILOMATRICOMAS; HAMARTOMA; CHONDROMA; ARCHIVES; FEATURES; SHEATH; TENDON	Certain soft-tissue tumors seem to be specific to the upper extremity; most are benign. Knowledge of key magnetic resonance features, with clinical history and epidemiologic knowledge, can assist the radiologist in establishing optimal diagnosis. Indeterminate lesions require biopsy to exclude malignancy.	[Nagata, Shuji; Abe, Toshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 8300011, Japan; [Nishimura, Hiroshi] Saiseikai Futsukaichi Hosp, Dept Radiol, Fukuoka 8180058, Japan	Nagata, S (reprint author), Kurume Univ, Sch Med, Dept Radiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	sn4735@med.kurume-u.ac.jp					AMADIO PC, 1988, J HAND SURG-AM, V13A, P67, DOI 10.1016/0363-5023(88)90203-1; HACHISUGA T, 1984, CANCER, V54, P126, DOI 10.1002/1097-0142(19840701)54:1<126::AID-CNCR2820540125>3.0.CO;2-F; DRAPE JL, 1995, RADIOLOGY, V195, P507; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Dinauer PA, 2007, RADIOGRAPHICS, V27, P173, DOI 10.1148/rg.271065065; Morel M, 2011, SKELETAL RADIOL, V40, P271, DOI 10.1007/s00256-009-0855-y; Murphey MD, 2008, RADIOGRAPHICS, V28, P1493, DOI 10.1148/rg.285085134; SILVERMAN TA, 1985, AM J SURG PATHOL, V9, P7, DOI 10.1097/00000478-198501000-00004; KRANSDORF MJ, 1995, AM J ROENTGENOL, V164, P129; Murphey MD, 2004, RADIOGRAPHICS, V24, P1433, DOI 10.1148/rg.245045120; Beaman FD, 2007, RADIOGRAPHICS, V27, P509, DOI 10.1148/rg.272065082; Ramesh P, 2004, INT J CLIN PRACT, V58, P587, DOI 10.1111/j.1368-5031.2004.00085.x; Lim HW, 2007, PEDIATR RADIOL, V37, P549, DOI 10.1007/s00247-007-0461-x; Murphey MD, 1999, RADIOGRAPHICS, V19, P1253; Antonescu CR, 2013, WHO CLASSIFICATION T, P170; Blacksin MF, 1997, J COMPUT ASSIST TOMO, V21, P785, DOI 10.1097/00004728-199709000-00025; CHUNG EB, 1978, CANCER, V41, P1414, DOI 10.1002/1097-0142(197804)41:4<1414::AID-CNCR2820410429>3.0.CO;2-O; Coyle J, 2013, SKELETAL RADIOL, V42, P975, DOI 10.1007/s00256-013-1620-9; De Maeseneer M, 2014, SKELETAL RADIOL, V43, P399, DOI 10.1007/s00256-013-1743-z; Gupte C, 2008, SKELETAL RADIOL, V37, P1003, DOI 10.1007/s00256-008-0518-4; Hanna SL, 2002, SKELETAL RADIOL, V31, P400, DOI 10.1007/s00256-002-0509-9; Jee WH, 2004, AM J ROENTGENOL, V183, P629; Jourjon R, 2013, CLIN IMAG, V37, P965, DOI 10.1016/j.clinimag.2013.04.003; KADDU S, 1994, INT J DERMATOL, V33, P705, DOI 10.1111/j.1365-4362.1994.tb01515.x; Le Corroller T, 2008, JOINT BONE SPINE, V75, P479, DOI 10.1016/j.jbspin.2007.06.019; Masih S, 2000, SKELETAL RADIOL, V29, P54; McCarville MB, 2002, AM J ROENTGENOL, V179; MORRISON WB, 1994, RADIOLOGY, V193, P841; Murphey Mark D, 2009, Radiographics, V29, P2143, DOI 10.1148/rg.297095138; MYHREJENSEN O, 1981, ACTA ORTHOP SCAND, V52, P287, DOI 10.3109/17453678109050105; Reilly KE, 1999, J HAND SURG-AM, V24A, P1298; Rotenberg M, 1996, AM J OTOLARYNG, V17, P133, DOI 10.1016/S0196-0709(96)90010-1; Sciot R, 2013, WHO CLASSIFICATION T, P19; Shankman Steven, 2004, Magn Reson Imaging Clin N Am, V12, P349, DOI 10.1016/j.mric.2004.02.003; SHUGART RR, 1963, SURG GYNECOL OBSTET, V117, P334; Smida Mahmoud, 2011, Tunis Med, V89, P379; Wang XL, 2002, SKELETAL RADIOL, V31, P155, DOI 10.1007/s00256-001-0462-z; Weiss SW, 2001, ENZINGER WEISSS SOFT; Yoo HJ, 2009, AM J ROENTGENOL, V192, pW291, DOI 10.2214/AJR.07.3952	39	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	AUG	2015	23	3					457	+		10.1016/j.mric.2015.04.002		13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CP5YW	WOS:000359962500010		
J	Astuti, W; Hirajima, T; Sasaki, K; Okibe, N				Astuti, W.; Hirajima, T.; Sasaki, K.; Okibe, N.			Kinetics of nickel extraction from Indonesian saprolitic ore by citric acid leaching under atmospheric pressure	MINERALS & METALLURGICAL PROCESSING			English	Article						Leaching; Kinetics; Nickel extraction; Saprolitic ore; Citric acid; Shrinking core model	SULFURIC-ACID; LATERITE	The kinetics of leaching of a saprolitic ore from Indonesia by citric acid solution under atmospheric pressure was investigated An examination of the effects of leaching temperature, citric acid concentration, pulp density and ore particle size on the dissolution rate of nickel found that they all had significant influence on the rate. The highest nickel recovery (95.6 percent) was achieved under the leaching conditions of ore particle size of 212-355 microns, citric acid concentration of 1 M, leaching time of 15 days, pulp density of 20 weight/volume percent, leaching temperature of 40 degrees C and shaker speed of 200 rpm. The shrinking core model was found to be appropriate for describing the leaching kinetics of this ore in citric acid solutions at atmospheric pressure. The experimental data were well interpreted by this model with rate of reaction controlled by diffusion through the solid product layer. Using the Arrhenius expression, the apparent activation energy for nickel dissolution was evaluated as 12.38 kJ/mol. Finally, on the basis of the shrinking core model, a proposed empirical kinetic model for the leaching of nickel from this Indonesian saprolitic ore was expressed as a mathematical model, which was verified as consistent with the observed experimental results.	[Astuti, W.; Hirajima, T.; Sasaki, K.; Okibe, N.] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 812, Japan	Hirajima, T (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, 6-10-1 Hakozaki, Fukuoka 812, Japan.	hirajima@mine.kyushu-u.ac.jp			JSPS [15H02333]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan;  [24246149]	The authors gratefully acknowledge a Grant-in-Aid for Science Research (No. 24246149), a JSPS Kakenhi - Grant-in-Aid for Scientific Research (A) - Grant No. 15H02333, the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan, for financial and other support and Dr. M. Zaki Mubarok at Bandung Institute of Technology, Indonesia, for support with regards to saprolitic ore samples.	Luo W, 2010, MINER ENG, V23, P458, DOI 10.1016/j.mineng.2009.10.006; McDonald RG, 2008, HYDROMETALLURGY, V91, P56, DOI 10.1016/j.hydromet.2007.11.010; Fan R, 2013, HYDROMETALLURGY, V134, P102, DOI 10.1016/j.hydromet.2013.02.004; TZEFERIS PG, 1994, HYDROMETALLURGY, V36, P345, DOI 10.1016/0304-386X(94)90031-0; Behera SK, 2011, INT BIODETER BIODEGR, V65, P1035, DOI 10.1016/j.ibiod.2011.08.004; Tang JA, 2006, MINER ENG, V19, P1274, DOI 10.1016/j.mineng.2006.04.009; Gharabaghi M, 2010, HYDROMETALLURGY, V103, P96, DOI 10.1016/j.hydromet.2010.03.002; Guo XY, 2009, HYDROMETALLURGY, V99, P144, DOI 10.1016/j.hydromet.2009.07.012; Habashi F., 1969, PRINCIPLES EXTRACTIV; Hou XC, 2010, HYDROMETALLURGY, V104, P76, DOI 10.1016/j.hydromet.2010.04.012; Levenspiel O., 1999, CHEM REACTION ENG; Liu K, 2012, HYDROMETALLURGY, V125, P125, DOI 10.1016/j.hydromet.2012.06.001; Lu J, 2013, MINER ENG, V49, P154, DOI 10.1016/j.mineng.2013.05.023; Merchant Research and Consulting Ltd, 2014, NICK 2014 MARK REV F; Mubarok M.Z., 2011, P INT MIN PROC S TUR; Romankiw L.T., 1964, HYDROMETALLURGY, P62; Sohn H.Y., 1979, RATE PROCESS EXTRACT; Sufriadin, 2011, J SE ASIAN APPL GEOL, V3, P23; Veglio F, 2001, HYDROMETALLURGY, V60, P167, DOI 10.1016/S0304-386X(00)00197-3	19	0	0	SOC MINING METALLURGY EXPLORATION INC	ENGLEWOOD	12999 E ADAM AIRCRAFT CIRCLE, ENGLEWOOD, CO 80112 USA	0747-9182			MINER METALL PROC	Miner. Metall. Process.	AUG	2015	32	3			SI		176	185				10	Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	CP4TO	WOS:000359875700007		
J	Kum, R; Tsukiyama, T; Inagaki, H; Saito, H; Teraishi, M; Okumoto, Y; Tanisaka, T				Kum, Rise; Tsukiyama, Takuji; Inagaki, Haruka; Saito, Hiroki; Teraishi, Masayoshi; Okumoto, Yutaka; Tanisaka, Takatoshi			The active miniature inverted-repeat transposable element mPing posttranscriptionally produces new transcriptional variants in the rice genome	MOLECULAR BREEDING			English	Article						Rice; Transposable element; mPing; Alternative splicing; Alternative polyadenylation; Posttranscriptional regulation	MESSENGER-RNA STABILITY; BASIC VEGETATIVE GROWTH; ALTERNATIVE POLYADENYLATION; PHOTOPERIOD SENSITIVITY; DNA METHYLATION; GENE-EXPRESSION; ARABIDOPSIS; MOBILIZATION; PROTEIN; COMPLEXITY	Posttranscriptional RNA processing inclusive of alternative splicing and alternative polyadenylation, as well as transcriptional regulation, plays important regulatory roles in eukaryotic gene expression. In eukaryotic genomes, transposable elements can alter gene expression at both transcriptional and posttranscriptional levels. Miniature Ping (mPing) is an active miniature inverted-repeat TE discovered in the rice genome, and its insertion renders adjacent genes stress inducible. In this study, we examined the effect of mPing insertion into coding sequences on RNA processing. The 30 RACE (rapid amplification of cDNA ends) analysis of mutant alleles, each harboring an mPing insertion, revealed that mPing induced various alternative splicing events. Furthermore, it was found that mPing induced alternative polyadenylation within its sequence. In the mutant allele, the body region of mPing was heavily methylated, whereas the mPing-flanking regions were moderately methylated. These results indicate that mPing alters transcript structures posttranscriptionally via induction of alternative splicing that most likely depends on DNA methylation. Based on these results, we discuss the availability of mPing as an insertional mutagen in rice.	[Kum, Rise; Tsukiyama, Takuji; Inagaki, Haruka; Saito, Hiroki; Teraishi, Masayoshi; Okumoto, Yutaka; Tanisaka, Takatoshi] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan; [Tanisaka, Takatoshi] Kibi Int Univ, Dept Agr Reg Vitalizat, Minami Awaji 6560484, Japan	Tsukiyama, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan.	takuji@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan [17380003, 25292006]	This work was supported by grants from the Ministry of Education, Culture, Sports and Technology of Japan in the form of Grants-in-Aid for Scientific Research, 17380003 and 25292006.	Aguilar-Hernandez V, 2013, BMC PLANT BIOL, V13, P179; Shen YJ, 2008, NUCLEIC ACIDS RES, V36, P3150, DOI 10.1093/nar/gkn158; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.078196.108, 10.1101/gr.07816.108]; Cazzola M, 2000, BLOOD, V95, P3280; Lin XY, 2006, J EXP BOT, V57, P2313, DOI 10.1093/jxb/erj203; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Xing DH, 2011, WIRES RNA, V2, P445, DOI 10.1002/wrna.59; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Tsuchiya T, 2013, P NATL ACAD SCI USA, V110, pE3535, DOI 10.1073/pnas.1312545110; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Tsukiyama T, 2013, MOL PLANT, V6, P790, DOI 10.1093/mp/sst042; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Chan MT, 1998, P NATL ACAD SCI USA, V95, P6543, DOI 10.1073/pnas.95.11.6543; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Wu XH, 2011, P NATL ACAD SCI USA, V108, P12533, DOI 10.1073/pnas.1019732108; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ngezahayo F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-91; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Huang CF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003779; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Mazumder B, 2005, MOL CELLS, V20, P167; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Nishida H, 2002, CROP SCI, V42, P348; ORTIZ DF, 1990, MOL CELL BIOL, V10, P2090; Saito H, 2009, THEOR APPL GENET, V119, P315, DOI 10.1007/s00122-009-1040-3; Shen SL, 2006, SCI CHINA SER C, V49, P97, DOI 10.1007/s11427-006-0097-3; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; TANISAKA T, 1992, JPN J BREED, V42, P657; Teramoto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004396; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; Wang H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-63; WESSLER SR, 1991, MOL CELL BIOL, V11, P6192; WESSLER SR, 1987, SCIENCE, V237, P916; WU L, 1995, PLANT J, V8, P323, DOI 10.1046/j.1365-313X.1995.08030323.x; Yasuda K, 2013, MOL BREEDING, V32, P505, DOI 10.1007/s11032-013-9885-1; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	67	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	AUG	2015	35	8							159	10.1007/s11032-015-0353-y		11	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CP6NU	WOS:000360005100010		
J	Nakamura, S; Makiko, C; Stehno, Z; Holubec, V; Morishige, H; Pourkheirandish, M; Kanamori, H; Wu, JZ; Matsumoto, T; Komatsuda, T				Nakamura, Shingo; Makiko, Chono; Stehno, Zdenek; Holubec, Vojtech; Morishige, Hiromi; Pourkheirandish, Mohammad; Kanamori, Hiroyuki; Wu, Jianzhong; Matsumoto, Takashi; Komatsuda, Takao			Diversification of the promoter sequences of wheat Mother of FT and TFL1 on chromosome 3A	MOLECULAR BREEDING			English	Article						Wheat; Pre-harvest sprouting; Seed dormancy; MFT; Promoter sequence; CAPS marker	SEED DORMANCY; RICE GENOME; IDENTIFICATION; GERMINATION; QTLS	Mother of FT and TFL1 (MFT) participates in the regulation of seed dormancy in wheat. A single-nucleotide polymorphism (SNP) in the promoter of MFT on chromosome 3A (MFT-3A) can explain the difference in the levels of MFT-3A expression, and the difference in seed dormancy, between Chinese Spring (CS) and the CS line with a substituted chromosome 3A from Zenkoujikomugi (Zen) (CS(Zen3A)). Using a cleaved amplified polymorphic sequence (CAPS) marker for this SNP, we analyzed the distribution of the SNP in 694 cultivars, including 117 Japanese cultivars and 551 cultivars from a wheat core collection. The Zen-type SNP predominantly occurs in cultivars used in Japan, where the rainy season overlaps with the wheat harvest season. We also sequenced the similar to 800 bp genomic fragment amplified by the CAPS marker and categorized the sequences into 16 groups, G1-G16. Only G11 has the Zen-type SNP; all the others have the CS-type SNP. This indicates that the CS-type allele (T) is ancestral, and during cultivation, nucleotide substitution occurred to give the Zen-type allele (C), which has been adopted to improve pre-harvest sprouting tolerance. Phylogenetic analysis indicates that G11 is derived from G3, which occurs worldwide. Our results suggest that the CAPS marker provides a valuable tool to select the Zen-type MFT-3A allele in wheat breeding programs for improving pre-harvest sprouting tolerance.	[Nakamura, Shingo; Makiko, Chono; Morishige, Hiromi; Pourkheirandish, Mohammad] NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Stehno, Zdenek; Holubec, Vojtech] Gene Bank Crop Res Inst, Prague 16106 6, Ruzyne, Czech Republic; [Kanamori, Hiroyuki; Wu, Jianzhong; Matsumoto, Takashi; Komatsuda, Takao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Nakamura, S (reprint author), NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan.	shingo@affrc.go.jp; mchono@affrc.go.jp; stehnoz@seznam.cz; holubec@vurv.cz; mrsg@affrc.go.jp; mohammad.pourkheirandish@sydney.edu.au; kanamo@affrc.go.jp; jzwu@nias.affrc.go.jp; mat@affrc.go.jp; takao@affrc.go.jp			Japanese Ministry of Agriculture, Forestry and Fisheries [TRC-1001, TRG-1001, TRS-1001]	We thank Dr. Ludmila Papouskova (Gene bank, Crop Research Institute, Czech Republic), Dr. Yasuhiro Yoshimura (Kitami Experimental Station, Japan), Dr. Tadashi Tabiki (Hokkaido Research Center, Japan) and Dr. Eiko Himi (Okayama University, Japan) for kindly providing their wheat seeds. This research was supported by a grant from the Japanese Ministry of Agriculture, Forestry and Fisheries (Genomics for Agricultural Innovation, TRC-1001, TRG-1001 and Genomics-based Technology for Agriculture Improvement, TRS-1001).	Amano N, 2010, DNA RES, V17, P271, DOI 10.1093/dnares/dsq017; Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SB, 2013, GENETICS, V195, P263, DOI 10.1534/genetics.113.152330; Saito M, 2004, THEOR APPL GENET, V108, P1205, DOI 10.1007/s00122-003-1549-9; REDDY LV, 1985, CROP SCI, V25, P455; Nakamura S, 2007, THEOR APPL GENET, V114, P1129, DOI 10.1007/s00122-007-0502-8; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Mori M, 2005, THEOR APPL GENET, V110, P1315, DOI 10.1007/s00122-005-1972-1; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Chono M, 2013, BREEDING SCI, V63, P104, DOI 10.1270/jsbbs.63.104; FUKUNAGA K, 1985, JPN J BREED, V35, P89; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073330; Lunn GD, 2002, EUPHYTICA, V126, P89, DOI 10.1023/A:1019651117813; Martynov SP, 2003, RUSS J GENET+, V39, P917, DOI 10.1023/A:1025382807351; Nakazono K., 2013, Japanese Journal of Crop Science, V82, P183, DOI 10.1626/jcs.82.183; Sakata K, 2002, NUCLEIC ACIDS RES, V30, P98, DOI 10.1093/nar/30.1.98; Stehno Z., 2003, Czech Journal of Genetics and Plant Breeding, V39, P99; Stehno Z, 2007, USE GENETIC RESOURCE, P130; Stehno Z., 2006, Czech Journal of Genetics and Plant Breeding, V42, P117	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	AUG	2015	35	8							164	10.1007/s11032-015-0358-6		9	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CP6NU	WOS:000360005100014		
J	Aihara, K; Aoki, T				Aihara, Kazuaki; Aoki, Terumasa			Motion dense sampling and component clustering for action recognition	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Action recognition; YouTube detaset; Bag-of-features; Interest point detection; Clustering	HISTOGRAMS	In this paper, we propose Motion Dense Sampling (MDS) for action recognition, which detects very informative interest points from video frames. MDS has three advantages compared to other existing methods. The first advantage is that MDS detects only interest points which belong to action regions of all regions of a video frame. The second one is that it can detect the constant number of points even when the size of action region in an image drastically changes. The Third one is that MDS enables to describe scale invariant features by computing sampling scale for each frame based on the size of action regions. Thus, our method detects much more informative interest points from videos unlike other methods. We also propose Category Clustering and Component Clustering, which generate the very effective codebook for action recognition. Experimental results show a significant improvement over existing methods on YouTube dataset. Our method achieves 87.5 % accuracy for video classification by using only one descriptor.	[Aihara, Kazuaki] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Aoki, Terumasa] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9800845, Japan	Aihara, K (reprint author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, 6-6-10 Aramaki, Sendai, Miyagi 9800845, Japan.	aihara@riec.tohoku.ac.jp; aoki@riec.tohoku.ac.jp					Messing R, 2009, IEEE I CONF COMP VIS, P104, DOI 10.1109/ICCV.2009.5459154; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Bregonzio M, 2009, PROC CVPR IEEE, P1948; Dalal N, 2005, PROC CVPR IEEE, P886; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Liu JG, 2009, PROC CVPR IEEE, P1996; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428; Dollar P., 2005, VISUAL SURVEILLANCE, V2, P65, DOI DOI 10.1109/VSPETS.2005.1570899; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363; Fei-Fei L., 2005, CVPR; Felzenszwalb P, 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587597; Guha S, 1998, ACM SIGMOD RECORD, V27, P73, DOI DOI 10.1145/276304.276312; Ikizler-Cinbis N, 2010, LECT NOTES COMPUT SC, V6311, P494, DOI 10.1007/978-3-642-15549-9_36; Laptev I., 2008, IEEE C COMP VIS PATT, P1; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Matikainen P, 2009, INT C COMP VIS WORKS, P514; Nagendar G., 2013, Computer Vision - ACCV 2012. 11th Asian Conference on Computer Vision. Revised Selected Papers, DOI 10.1007/978-3-642-37431-9_37; Nowak E., 2006, ECCV; Ullah MM, 2010, BMVC; Wang H., 2011, IEEE C COMP VIS PATT, P3169	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	AUG	2015	74	16					6303	6321		10.1007/s11042-014-2112-1		19	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CP4PN	WOS:000359864700012		
J	Cao, Y; Mishchenko, A; Yu, GL; Khestanova, E; Rooney, AP; Prestat, E; Kretinin, AV; Blake, P; Shalom, MB; Woods, C; Chapman, J; Balakrishnan, G; Grigorieva, IV; Novoselov, KS; Piot, BA; Potemski, M; Watanabe, K; Taniguchi, T; Haigh, SJ; Geim, AK; Gorbachev, RV				Cao, Y.; Mishchenko, A.; Yu, G. L.; Khestanova, E.; Rooney, A. P.; Prestat, E.; Kretinin, A. V.; Blake, P.; Shalom, M. B.; Woods, C.; Chapman, J.; Balakrishnan, G.; Grigorieva, I. V.; Novoselov, K. S.; Piot, B. A.; Potemski, M.; Watanabe, K.; Taniguchi, T.; Haigh, S. J.; Geim, A. K.; Gorbachev, R. V.			Quality Heterostructures from Two-Dimensional Crystals Unstable in Air by Their Assembly in Inert Atmosphere	NANO LETTERS			English	Article						Phosphorene; niobium diselenide; transition metal dichalcogenides; superconductivity; field effect; electronic transport	FIELD-EFFECT TRANSISTORS; BLACK PHOSPHORUS; STRONTIUM-TITANATE; ATOMIC CRYSTALS; THIN-FILMS; SUPERCONDUCTIVITY; ELECTRONICS; TRANSPORT; LAYERS; LIMIT	Many layered materials can be cleaved down to individual atomic planes, similar to graphene, but only a small minority of them are stable under ambient conditions. The rest react and decompose in air, which has severely hindered their investigation and potential applications. Here we introduce a remedial approach based on cleavage, transfer, alignment, and encapsulation of air-sensitive crystals, all inside a controlled inert atmosphere. To illustrate the technology, we choose two archetypal two-dimensional crystals that are of intense scientific interest but are unstable in air: black phosphorus and niobium diselenide. Our field-effect devices made from their monolayers are conductive and fully stable under ambient conditions, which is in contrast to the counterparts processed in air. NbSe2 remains superconducting down to the monolayer thickness. Starting with a trilayer, phosphorene devices reach sufficiently high mobilities to exhibit Landau quantization. The approach offers a venue to significantly expand the range of experimentally accessible two-dimensional crystals and their heterostructures.	[Cao, Y.; Mishchenko, A.; Yu, G. L.; Khestanova, E.; Kretinin, A. V.; Shalom, M. B.; Woods, C.; Chapman, J.; Grigorieva, I. V.; Novoselov, K. S.; Geim, A. K.; Gorbachev, R. V.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Cao, Y.; Khestanova, E.; Kretinin, A. V.; Shalom, M. B.; Geim, A. K.; Gorbachev, R. V.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Rooney, A. P.; Prestat, E.; Haigh, S. J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Blake, P.] Graphene Ind Ltd, Manchester M13 9HQ, Lancs, England; [Balakrishnan, G.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Piot, B. A.; Potemski, M.] CNRS UJF UPS INSA, Lab Natl Champs Magnet Intenses, F-38042 Grenoble, France; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Gorbachev, RV (reprint author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.		Kretinin, Andrey/L-5122-2013; Geim, Andre/J-7888-2012; Novoselov, Kostya/G-9581-2014; Mishchenko, Artem/C-7561-2011; Haigh, Sarah/D-1309-2014; 	Geim, Andre/0000-0003-2861-8331; Novoselov, Kostya/0000-0003-4972-5371; Mishchenko, Artem/0000-0002-0427-5664; Haigh, Sarah/0000-0001-5509-6706; Prestat, Eric/0000-0003-1340-0970			Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Favron A, 2015, NAT MATER, V14, P826, DOI [10.1038/nmat4299, 10.1038/NMAT4299]; BROWN A, 1965, ACTA CRYSTALLOGR, V19, P684, DOI 10.1107/S0365110X65004140; El-Bana MS, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/12/125020; Avsar A, 2015, ACS NANO, V9, P4138, DOI 10.1021/acsnano.5b00289; FRINDT RF, 1972, PHYS REV LETT, V28, P299, DOI 10.1103/PhysRevLett.28.299; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Xu MS, 2013, CHEM REV, V113, P3766, DOI 10.1021/cr300263a; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Wood JD, 2014, NANO LETT, V14, P6964, DOI 10.1021/nl5032293; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Koenig SP, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868132; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Staley NE, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.184505; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Qin SY, 2009, SCIENCE, V324, P1314, DOI 10.1126/science.1170775; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Knap W, 2004, J PHYS-CONDENS MAT, V16, P3421, DOI 10.1088/0953-8984/16/20/013; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/nnano.2014.35, 10.1038/NNANO.2014.35]; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Gillgren N, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/1/011001; Gorbachev RV, 2011, SMALL, V7, P465, DOI 10.1002/smll.201001628; Koster G, 1998, APPL PHYS LETT, V73, P2920, DOI 10.1063/1.122630; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/2/025001; Dec J, 1999, J PHYS-CONDENS MAT, V11, pL379, DOI 10.1088/0953-8984/11/32/101; Ge J.-F., 2014, NAT MATER, V14, P285, DOI [DOI 10.1038/NMAT4153, 10.1038/nmat4153]; Island JO, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/1/011002; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08989; Kong X.H., 2014, NAT COMMUN, V5, P5475, DOI DOI 10.1038/NC0MMS5475; Low T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.106802; Mason N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.220505; MYERS GE, 1971, J PHYS CHEM SOLIDS, V32, P2645, DOI 10.1016/S0022-3697(71)80111-7; STRONGIN M, 1970, PHYS REV B-SOLID ST, V1, P1078, DOI 10.1103/PhysRevB.1.1078; Tayari N. H., 2014, ARXIV14120259; Xia FN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5458; Ye G. J., 2015, NAT NANOTECHNOL, DOI [10.1038/nnano.2015.91, DOI 10.1038/NNAN0.2015.91]	42	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					4914	4921		10.1021/acs.nanolett.5b00648		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700011		
J	Tang, DM; Ren, CL; Lv, RT; Yu, WJ; Hou, PX; Wang, MS; Wei, XL; Xu, Z; Kawamoto, N; Bando, Y; Mitome, M; Liu, C; Cheng, HM; Golberg, D				Tang, Dai-Ming; Ren, Cui-Lan; Lv, Ruitao; Yu, Wan-Jing; Hou, Peng-Xiang; Wang, Ming-Sheng; Wei, Xianlong; Xu, Zhi; Kawamoto, Naoyuki; Bando, Yoshio; Mitome, Masanori; Liu, Chang; Cheng, Hui-Ming; Golberg, Dmitri			Amorphization and Directional Crystallization of Metals Confined in Carbon Nanotubes Investigated by in Situ Transmission Electron Microscopy	NANO LETTERS			English	Article						In situ electron microscopy; molecular dynamics simulations; carbon nanotubes; phase transition; amorphization	SUB-MICRON SPHERES; ORDER; SOLIDIFICATION; GLASSES; LIQUID; NICKEL	The hollow core of a carbon nanotube (CNT) provides a unique opportunity to explore the physics, chemistry, biology, and metallurgy of different materials confined in such nanospace. Here, we investigate the nonequilibrium metallurgical processes taking place inside CNTs by in situ transmission electron microscopy using CNTs as nanoscale resistively heated crucibles having encapsulated metal nanowires/crystals in their channels. Because of nanometer size of the system and intimate contact between the CNTs and confined metals, an efficient heat transfer and high cooling rates (similar to 10(13) K/s) were achieved as a result of a flash bias pulse followed by system natural quenching, leading to the formation of disordered amorphous-like structures in iron, cobalt, and gold. An intermediate state between crystalline and amorphous phases was discovered, revealing a memory effect of local short-to-medium range order during these phase transitions. Furthermore, subsequent directional crystallization of an amorphous iron nano wire formed by this method was realized under controlled Joule heating. High-density crystalline defects were generated during crystallization due to a confinement effect from the CNT and severe plastic deformation involved.	[Tang, Dai-Ming] Natl Inst Mat Sci, Int Ctr Young Scientists, Tsukuba, Ibaraki 3050044, Japan; [Tang, Dai-Ming; Wang, Ming-Sheng; Wei, Xianlong; Xu, Zhi; Kawamoto, Naoyuki; Bando, Yoshio; Mitome, Masanori; Golberg, Dmitri] Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Ren, Cui-Lan; Yu, Wan-Jing; Hou, Peng-Xiang; Liu, Chang; Cheng, Hui-Ming] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Ren, Cui-Lan] Chinese Acad Sci, Shanghai Inst Appl Phys, Div Nucl Mat Sci & Engn, Shanghai 201800, Peoples R China; [Ren, Cui-Lan] Chinese Acad Sci, Shanghai Inst Appl Phys, Key Lab Interfacial Phys & Technol, Shanghai 201800, Peoples R China; [Lv, Ruitao] Tsinghua Univ, Dept Mat Sci & Engn, Lab Adv Mat, Beijing 100084, Peoples R China	Tang, DM (reprint author), Natl Inst Mat Sci, Int Ctr Young Scientists, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	TANG.Daiming@nims.go.jp; cliu@imr.ac.cn; GOLBERG.Dmitri@nims.go.jp	Liu, Chang/G-4667-2012; Golberg, Dmitri/H-2776-2011; Wei, Xianlong/B-5816-2008; Tang, Dai-Ming/B-6641-2011	Golberg, Dmitri/0000-0003-2298-6539; 	JSPS Kakenhi [25820336]; International Center for Young Scientists (ICYS), World Premier International (WPI) Center for Materials Nanoarchitectonics (MANA) of the National Institute for Materials Science (NIMS), Tsukuba, Japan; Ministry of Science and Technology of China [2011CB932601]; National Natural Science Foundation of China [51221264, 51272257, 51102242]; Chinese Academy of Sciences [KGZD-EW-T06]; Shenyang Supercomputing Center, Chinese Academy of Sciences	The work was supported by JSPS Kakenhi Grant 25820336; International Center for Young Scientists (ICYS), World Premier International (WPI) Center for Materials Nanoarchitectonics (MANA) of the National Institute for Materials Science (NIMS), Tsukuba, Japan; Ministry of Science and Technology of China (Grant 2011CB932601); National Natural Science Foundation of China (Grants 51221264, 51272257, and 51102242); Chinese Academy of Sciences (Grant KGZD-EW-T06); and Shenyang Supercomputing Center, Chinese Academy of Sciences. The authors thank Dr. Isamu Yamada for a technical support; Professors Koichi Tsuchiya, Takahito Ohmura, Dmitri V. Louzguine, Drs. Li-Chang Yin, and Hao Wang for fruitful discussions; and Professor Peter Thrower for reading the manuscript and providing valuable editorial suggestions.	Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Tang DM, 2014, ACS NANO, V8, P292, DOI 10.1021/nn403927y; Tang DM, 2011, ACS NANO, V5, P7362, DOI 10.1021/nn202283a; Wang MS, 2010, ADV MATER, V22, P93, DOI 10.1002/adma.200901113; Koga K, 2001, NATURE, V412, P802, DOI 10.1038/35090532; Zhong L, 2014, NATURE, V512, P177, DOI 10.1038/nature13617; Pan XL, 2007, NAT MATER, V6, P507, DOI 10.1038/nmat1916; Tang DM, 2012, NANO LETT, V12, P1898, DOI 10.1021/nl204282y; Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Gao YH, 2002, NATURE, V415, P599, DOI 10.1038/415599a; Tang DM, 2013, NANO LETT, V13, P1034, DOI 10.1021/nl304244h; Wang MS, 2010, ADV MATER, V22, P5350, DOI 10.1002/adma.201003010; AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Golberg D, 2012, ADV MATER, V24, P177, DOI 10.1002/adma.201102579; Sun L, 2006, SCIENCE, V312, P1199, DOI 10.1126/science.1124594; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; BROUGHTON JQ, 1982, PHYS REV LETT, V49, P1496, DOI 10.1103/PhysRevLett.49.1496; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; DAVIES HA, 1976, J MATER SCI, V11, P215, DOI 10.1007/BF00551430; de la Fuente OR, 1998, PHYS REV LETT, V81, P3159; Kawamoto N, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/48/485707; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; KIM YW, 1988, ACTA METALL MATER, V36, P2525, DOI 10.1016/0001-6160(88)90198-8; Sun LT, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156101; Tang DM, 2010, P NATL ACAD SCI USA, V107, P9055, DOI 10.1073/pnas.0914970107; Tang DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4631; Valley R, 2004, NAT MATER, V3, P511; Xie KY, 2011, SCRIPTA MATER, V65, P1037, DOI 10.1016/j.scriptamat.2011.08.023; Zhang L, 2012, SCRIPTA MATER, V67, P388, DOI 10.1016/j.scriptamat.2012.05.032	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					4922	4927		10.1021/acs.nanolett.5b00664		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700012		
J	Zhu, XD; Kawaharamura, T; Stieg, AZ; Biswas, C; Li, L; Ma, Z; Zurbuchen, MA; Pei, QB; Wang, KL				Zhu, Xiaodan; Kawaharamura, Toshiyuki; Stieg, Adam Z.; Biswas, Chandan; Li, Lu; Ma, Zhu; Zurbuchen, Mark. A.; Pei, Qibing; Wang, Kang L.			Atmospheric and Aqueous Deposition of Polycrystalline Metal Oxides Using Mist-CVD for Highly Efficient Inverted Polymer Solar Cells	NANO LETTERS			English	Article						Mist chemical vapor deposition; zinc oxide; inverted polymer solar cells; transparent electron transport layer	ATOMIC LAYER DEPOSITION; ZNO THIN-FILMS; LOW-TEMPERATURE; SPECTROSCOPY; TRANSISTORS; DROPLETS; GROWTH	Large scale, cost-effective processing of metal oxide thin films is critical for the fabrication of many novel thin film electronics. To date, however, most of the reported solution-based techniques require either extended thermal anneals or additional synthetic steps. Here we report mist chemical vapor deposition as a solution-based, readily scalable, and open-air method to produce high-quality polycrystalline metal oxide thin films. Continuous, smooth, and conformal deposition of metal oxide thin films is achieved by tuning the solvent chemistry of Leidenfrost droplets to promote finer control over the surface-local dissociation process of the atomized zinc-bearing precursors. We demonstrate the deposited ZnO as highly efficient electron transport layers for inverted polymer solar cells to show the power of the approach. A highest efficiency of 8.7% is achieved with a fill factor of 73%, comparable to that of conventional so-gel ZnO, which serves as an indication of the efficient vertical transport and electron collection achievable using this material.	[Zhu, Xiaodan; Biswas, Chandan; Ma, Zhu; Zurbuchen, Mark. A.; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Zhu, Xiaodan; Li, Lu; Zurbuchen, Mark. A.; Pei, Qibing; Wang, Kang L.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Kawaharamura, Toshiyuki] Kochi Univ Technol, Inst Nanotechnol, Kochi 7828502, Japan; [Stieg, Adam Z.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Stieg, Adam Z.] Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Li, Lu] Chongqing Univ Arts & Sci, Res Inst New Mat Technol, Coinnovat Ctr Micro Nano Optoelect Mat & Devices, Chongqing 402160, Sichuan, Peoples R China; [Zurbuchen, Mark. A.; Wang, Kang L.] KACST UCLA Ctr Excellence NanoSci & Engn Green &, Los Angeles, CA 90095 USA	Wang, KL (reprint author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	wang@ee.ucla.edu	Stieg, Adam/C-5816-2009	Stieg, Adam/0000-0001-7312-9364			Alias A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.01BG05; Alzate JG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869152; SZORENYI T, 1995, J APPL PHYS, V78, P6211; Greiner MT, 2012, NAT MATER, V11, P76, DOI [10.1038/nmat3159, 10.1038/NMAT3159]; Piao JC, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090201; FAN JCC, 1977, J APPL PHYS, V48, P3524, DOI 10.1063/1.324149; Davis RJ, 2011, J MATER CHEM, V21, P1721, DOI 10.1039/c0jm02349c; Betancur R, 2013, NAT PHOTONICS, V7, P995, DOI [10.1038/nphoton.2013.276, 10.1038/NPHOTON.2013.276]; Zhang XH, 2007, ORG ELECTRON, V8, P718, DOI 10.1016/j.orgel.2007.06.009; Chen S, 2012, ADV ENERGY MATER, V2, P1333, DOI 10.1002/aenm.201200184; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Blom PWM, 2007, ADV MATER, V19, P1551, DOI 10.1002/adma.200601093; Cheun H, 2010, J PHYS CHEM C, V114, P20713, DOI 10.1021/jp106641j; Ellmer K, 2012, NAT PHOTONICS, V6, P808, DOI [10.1038/nphoton.2012.282, 10.1038/NPHOTON.2012.282]; Ohta H, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00288-3; Zeng CF, 2013, NANO LETT, V13, P2370, DOI 10.1021/nl304541s; BAHNEMANN DW, 1987, J PHYS CHEM-US, V91, P3789, DOI 10.1021/j100298a015; Moliton A, 2006, POLYM INT, V55, P583, DOI 10.1002/pi.2038; Yu GQ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907677; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Chen M, 2000, APPL SURF SCI, V158, P134, DOI 10.1016/S0169-4332(99)00601-7; Shin KS, 2011, J MATER CHEM, V21, P12274, DOI 10.1039/c1jm10914f; Uchida T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.021303; Small CE, 2012, NAT PHOTONICS, V6, P115, DOI [10.1038/nphoton.2011.317, 10.1038/NPHOTON.2011.317]; Zimmermann E, 2014, NAT PHOTONICS, V8, P669; White MS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2359579; Fortunato E, 2012, ADV MATER, V24, P2945, DOI 10.1002/adma.201103228; Wang JC, 2010, J MATER CHEM, V20, P862, DOI 10.1039/b921396a; Chen S, 2012, J MATER CHEM, V22, P24202, DOI 10.1039/c2jm33838f; Kawaharamura T, 2013, PHYS STATUS SOLIDI C, V10, P1565, DOI 10.1002/pssc.201300247; Shirakawa T, 2004, J PHYS D APPL PHYS, V37, P847, DOI 10.1088/0022-3727/37/6/007; Lee JH, 2012, J PHYS CHEM C, V116, P26342, DOI 10.1021/jp3081468; BARR TL, 1978, J PHYS CHEM-US, V82, P1801, DOI 10.1021/j100505a006; GOTTFRIE.BS, 1966, IND ENG CHEM FUND, V5, P561, DOI 10.1021/i160020a023; Burton JC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.074301; Celestini F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.034501; Cherepov S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865916; GOTTFRIE.BS, 1966, INT J HEAT MASS TRAN, V9, P1167, DOI 10.1016/0017-9310(66)90112-8; Hau SK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945281; Jouane Y, 2013, ORG ELECTRON, V14, P1861, DOI 10.1016/j.orgel.2013.04.024; Kawaharamura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FF08; Kim KH, 2010, J NANOELECTRON OPTOE, V5, P247, DOI 10.1166/jno.2010.1103; LANG RJ, 1962, J ACOUST SOC AM, V34, P6, DOI 10.1121/1.1909020; Lee J. B., 2003, THIN SOLID FILMS, V423, P262, DOI 10.1016/S0040-6090(02)00977-X; LEIDENFR.JG, 1966, INT J HEAT MASS TRAN, V9, P1153, DOI 10.1016/0017-9310(66)90111-6; Wong WS, 2009, ELECTRON MATER SCI T, P143, DOI 10.1007/978-0-387-74363-9_6; Zhu F., 2014, MATER RES EXPRESS, V1	47	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					4948	4954		10.1021/acs.nanolett.5b01157		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700016		
J	Rathi, S; Lee, I; Lim, D; Wang, JW; Ochiai, Y; Aoki, N; Watanabe, K; Taniguchi, T; Lee, GH; Yu, YJ; Kim, P; Kim, GH				Rathi, Servin; Lee, Inyeal; Lim, Dongsuk; Wang, Jianwei; Ochiai, Yuichi; Aoki, Nobuyuki; Watanabe, Kenji; Taniguchi, Takashi; Lee, Gwan-Hyoung; Yu, Young-Jun; Kim, Philip; Kim, Gil-Ho			Tunable Electrical and Optical Characteristics in Mono layer Graphene and Few-Layer MoS2 Heterostructure Devices	NANO LETTERS			English	Article						2D semiconductor; graphene; molybdenum disulfide; heterostructure; Schottky barrier; field-effect transistor	SCHOTTKY-BARRIER; TRANSISTORS; MONOLAYER; PHOTODETECTORS; JUNCTIONS; DIODES; GATE; PHOTOTRANSISTORS; PHOTORESPONSE; TRANSPARENT	Lateral and vertical two-dimensional heterostructure devices, in particular graphene-MoS2, have attracted profound interest as they offer additional functionalities over normal two-dimensional devices. Here, we have carried out electrical and optical characterization of graphene-MoS2 heterostructure. The few-layer MoS2 devices with metal electrode at one end and monolayer graphene electrode at the other end show nonlinearity in drain current with drain voltage sweep due to asymmetrical Schottky barrier height at the contacts and can be modulated with an external gate field. The doping effect of MoS2 on graphene was observed as double Dirac points in the transfer characteristics of the graphene field-effect transistor (FET) with a few-layer MoS2 overlapping the middle part of the channel, whereas the underlapping of graphene have negligible effect on MoS2 FET characteristics, which showed typical n-type behavior. The heterostructure also exhibits a strongest optical response for 520 nm wavelength, which decreases with higher wavelengths. Another distinct feature observed in the heterostructure is the peak in the photocurrent around zero gate voltage. This peak is distinguished from conventional MoS2 FETs, which show a continuous increase in photocurrent with back-gate voltage. These results offer significant insight and further enhance the understanding of the graphene-MoS2 heterostructure.	[Rathi, Servin; Lee, Inyeal; Wang, Jianwei; Kim, Gil-Ho] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon 440746, South Korea; [Rathi, Servin; Lee, Inyeal; Wang, Jianwei; Kim, Gil-Ho] Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotechnol SAINT, Suwon 440746, South Korea; [Lim, Dongsuk] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea; [Ochiai, Yuichi; Aoki, Nobuyuki] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Lee, Gwan-Hyoung] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea; [Yu, Young-Jun] Creat Res Ctr Graphene Elect & Telecommun Res Ins, Taejon 305700, South Korea; [Kim, Philip] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Kim, GH (reprint author), Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon 440746, South Korea.	ghkim@skku.edu			National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2013R1A2A2A01069023]; National Research Foundation (NRF) - Korean government Ministry of Science, ICT, and Future [NRF-2014R1A1A1004632]; Yonsei University Future-leading Research Initiative	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2013R1A2A2A01069023). G.H.L. acknowledges support from the Basic Science Research Program (NRF-2014R1A1A1004632) through the National Research Foundation (NRF) funded by the Korean government Ministry of Science, ICT, and Future and in part by the Yonsei University Future-leading Research Initiative of 2014.	Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/nnano.2013.100, 10.1038/NNANO.2013.100]; Nistor RA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.041409; Yu LL, 2014, NANO LETT, V14, P3055, DOI 10.1021/nl404795z; Di Bartolomeo A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/27/275702; Yu WJ, 2013, NAT MATER, V12, P246, DOI [10.1038/nmat3518, 10.1038/NMAT3518]; Bao WZ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789365; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Das S, 2014, NANO LETT, V14, P2861, DOI 10.1021/nl5009037; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Gabor NM, 2011, SCIENCE, V334, P648, DOI 10.1126/science.1211384; Tsai DS, 2013, ACS NANO, V7, P3905, DOI 10.1021/nn305301b; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/nnano.2012.224, 10.1038/NNANO.2012.224]; Kwak JY, 2014, NANO LETT, V14, P4511, DOI 10.1021/nl5015316; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Shih CJ, 2014, ACS NANO, V8, P5790, DOI 10.1021/nn500676t; Ozyilmaz B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166804; Mueller T, 2010, NAT PHOTONICS, V4, P297, DOI 10.1038/NPHOTON.2010.40; Herring PK, 2014, NANO LETT, V14, P901, DOI 10.1021/nl4042627; Makarova M, 2012, J PHYS CHEM C, V116, P22411, DOI 10.1021/jp307267h; Choi W, 2012, ADV MATER, V24, P5832, DOI 10.1002/adma.201201909; Lin YF, 2014, NANOSCALE, V6, P795, DOI 10.1039/c3nr03677d; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Hui YY, 2013, ACS NANO, V7, P7126, DOI 10.1021/nn4024834; Sinha D, 2014, NANO LETT, V14, P4660, DOI 10.1021/nl501735k; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Di Bartolomeo A, 2013, DIAM RELAT MATER, V38, P19, DOI 10.1016/j.diamond.2013.06.002; Barraza-Lopez S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076807; Zhang WJ, 2013, ADV MATER, V25, P3456, DOI 10.1002/adma.201301244; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Ganatra R, 2014, ACS NANO, V8, P4074, DOI 10.1021/nn405938z; Lee YT, 2014, SMALL, V10, P2356, DOI 10.1002/smll.201303908; Laroche D, 2011, NAT NANOTECHNOL, V6, P793, DOI [10.1038/nnano.2011.182, 10.1038/NNANO.2011.182]; Britnell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2817; Chu L., 2014, SCI REP, V4, P1; Fontana M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01634; Li H., 2014, SCI REP, V4, P1; Lu CP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.156804; Nam Y, 2012, CARBON, V50, P1987, DOI 10.1016/j.carbon.2011.12.056; Tian H., 2014, SCI REP, V4, P1; Yu Z., 2014, NAT COMMUN, V5, P1; Zhang Q, 2015, ACS NANO, V9, P1561, DOI 10.1021/acsnano.5b00437; Zhang W., 2014, SCI REP, V4, P1	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5017	5024		10.1021/acs.nanolett.5b01030		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700026		
J	He, G; Ghosh, K; Singisetti, U; Ramamoorthy, H; Somphonsane, R; Bohra, G; Matsunaga, M; Higuchi, A; Aoki, N; Najmaei, S; Gong, Y; Zhang, X; Vajtai, R; Ajayan, PM; Bird, JP				He, G.; Ghosh, K.; Singisetti, U.; Ramamoorthy, H.; Somphonsane, R.; Bohra, G.; Matsunaga, M.; Higuchi, A.; Aoki, N.; Najmaei, S.; Gong, Y.; Zhang, X.; Vajtai, R.; Ajayan, P. M.; Bird, J. P.			Conduction Mechanisms in CVD-Grown Monolayer MoS2 Transistors: From Variable-Range Hopping to Velocity Saturation	NANO LETTERS			English	Article						Molybdenum disulfide; transition metal dichalcogenides; 2D transistors; high-field transport; velocity saturation	CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS; MOLYBDENUM-DISULFIDE; TRANSPORT-PROPERTIES; VALLEY POLARIZATION; MULTILAYER MOS2; ATOMIC LAYERS; BILAYER MOS2; MOBILITY; TRANSITION	We fabricate transistors from chemical vapor deposition-grown monolayer MoS2 crystals and demonstrate excellent current saturation at large drain voltages (V-d). The low-field characteristics of these devices indicate that the electron mobility is likely limited by scattering from charged impurities. The current-voltage characteristics exhibit variable range hopping at low V-d and evidence of velocity saturation at higher V-d. This work confirms the excellent potential of MoS2 as a possible channel-replacement material and highlights the role of multiple transport phenomena in governing its transistor action.	[He, G.; Ghosh, K.; Singisetti, U.; Ramamoorthy, H.; Bohra, G.; Bird, J. P.] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA; [Somphonsane, R.] King Mongkuts Inst Technol Ladkrabang, Dept Phys, Bangkok 10520, Thailand; [Matsunaga, M.; Higuchi, A.; Aoki, N.] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan; [Najmaei, S.; Gong, Y.; Zhang, X.; Vajtai, R.; Ajayan, P. M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA	Bird, JP (reprint author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	jbird@buffalo.edu	Bird, Jonathan/G-4068-2010; Bohra, Girish/P-6541-2015	Bird, Jonathan/0000-0002-6966-9007; 	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-04ER46180]; U.S. Army Research Office MURI [W911NF-11-1-0362]	Device fabrication and electrical characterization were performed in the group of J.P.B. under the support of the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (Award # DE-FG02-04ER46180). Computations of MoS<INF>2</INF> transistor operation were undertaken in the group of U.S. and were supported by the Department of Electrical Engineering at the University at Buffalo. CVD growth of the MoS<INF>2</INF> was performed in the group of P.M.A. and was supported by the U.S. Army Research Office MURI Grant W911NF-11-1-0362.	Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/nnano.2013.100, 10.1038/NNANO.2013.100]; Li Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801844; Wang H, 2012, NANO LETT, V12, P4674, DOI 10.1021/nl302015v; Baugher BWH, 2013, NANO LETT, V13, P4212, DOI 10.1021/nl401916s; Ma N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011043; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Amani M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804546; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Yoon Y, 2011, NANO LETT, V11, P3768, DOI 10.1021/nl2018178; Fiori G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4840175; Yuan H, 2015, ACS APPL MATER INTER, V7, P1180, DOI 10.1021/am506921y; Ghatak S, 2011, ACS NANO, V5, P7707, DOI [10.1021/nn202852j, 10.1021/nn202852J]; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Zhang F, 2015, NANO LETT, V15, P301, DOI [10.1021/nl503586v, 10.1021/n1503586y]; Amani M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873680; Late DJ, 2012, ACS NANO, V6, P5635, DOI 10.1021/nn301572c; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Yin ZY, 2012, ACS NANO, V6, P74, DOI 10.1021/nn2024557; Qiu H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3696045; Chang HY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868536; Schmidt H, 2014, NANO LETT, V14, P1909, DOI 10.1021/nl4046922; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; [Anonymous], ATL US MAN; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; Zhan YJ, 2012, SMALL, V8, P966, DOI 10.1002/smll.201102654; Das S, 2013, PHYS STATUS SOLIDI-R, V7, P268, DOI 10.1002/pssr.201307015; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/nmat3687, 10.1038/NMAT3687]; Wu W, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801861; Jariwala D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803920; Fuhrer MS, 2013, NAT NANOTECHNOL, V8, P146, DOI 10.1038/nnano.2013.30; Liu H, 2012, ACS NANO, V6, P8563, DOI 10.1021/nn303513c; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Castellanos-Gomez A, 2012, NANO LETT, V12, P3187, DOI 10.1021/nl301164v; Castellanos-Gomez A, 2013, ADV MATER, V25, P899, DOI 10.1002/adma.201203731; Kim S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2018; Kwon HJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898584; Qiu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3642; Sik Hwang W., 2013, APPL PHYS LETT, V102; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Thomas R. E., 1967, P IEEE, V55, P2192; Walla S., 2013, APPL PHYS LETT, V103	43	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5052	5058		10.1021/acs.nanolett.5b01159		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700031		
J	Zhang, HM; Tsuchiya, T; Lang, CH; Terabe, K				Zhang, Hemin; Tsuchiya, Takashi; Lang, Changhao; Terabe, Kazuya			Size-Controlled Agl/Ag Heteronanowires in Highly Ordered Alumina Membranes: Superionic Phase Stabilization and Conductivity	NANO LETTERS			English	Article						Silver iodide; heteronanowire; size dependence; phase transition; conductivity	SPACE-CHARGE REGIONS; IONIC-CONDUCTIVITY; ROOM-TEMPERATURE; AGI NANOPARTICLES; TRANSPORT; TEMPLATE; SYSTEMS; NANOTECHNOLOGY; BATTERIES; AGI-AL2O3	Nanoscaled ionic conductors are crucial for future nanodevices. A well-known ionic conductor, AgI, exhibited conductivity greater than 1 Omega(-1) cm(-1) in alpha-phase and transformed into poorly conducting beta-/gamma-phase below 147 degrees C, thereby limiting applications. Here, we report that transition temperatures both from the beta-/gamma- to alpha-phase (T-c up arrow) and the alpha- to beta-/gamma-phase (T-c down arrow) are tuned by AgI/Ag heteronanowires embedded in anodic aluminum oxide (AAO) membranes with 10-30 nm pores. T-c up arrow and T-c down arrow to correspondingly higher and lower temperature as pore size decreases, generating a progressively enlarged thermal hysteresis. T-c up arrow and T-c down arrow specifically achieve 185 and 52 degrees C in 10 nm pores, and the final survived conductivity reaches, similar to 8.3 x 10(-3) Omega(-1) cm(-1) at room temperature. Moreover, the low-temperature stabilizing alpha-phase (down to 21 degrees C, the lowest in state of the art temperatures) is reproducible and survives further thermal cycling. The low-temperature phase stabilization and enhancement conductivity reported here suggest promising applications in silver-ion-based future nanodevices.	[Zhang, Hemin; Tsuchiya, Takashi; Terabe, Kazuya] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Lang, Changhao] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei 230031, Peoples R China; [Lang, Changhao] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Solid State Phys, Anhui Key Lab Nanomat & Nanotechnol, Hefei 230031, Peoples R China	Zhang, HM (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	zhang.hemin@nims.go.jp; terabe.kazuya@nims.go.jp			World Premier International (WPI) Center for Materials Nanoarchitectonics (MANA); National Key Basic Research; National Nature Science Foundation of China [2014CB931704, 11204308, 11174287, 51371166]	We thank M. Nakatsu for the assistance in DSC and in situ XRD measurements. This work was supported by the World Premier International (WPI) Center for Materials Nanoarchitectonics (MANA), and the National Key Basic Research and National Nature Science Foundation of China (No. 2014CB931704, 11204308, 11174287, and 51371166).	Makiura R, 2009, NAT MATER, V8, P476, DOI [10.1038/nmat2449, 10.1038/NMAT2449]; MAIER J, 1985, J PHYS CHEM SOLIDS, V46, P309, DOI 10.1016/0022-3697(85)90172-6; SHAHI K, 1980, APPL PHYS LETT, V37, P757, DOI 10.1063/1.92023; Agrawal RC, 1999, J MATER SCI, V34, P1131, DOI 10.1023/A:1004598902146; Moyen E, 2012, ADV MATER, V24, P5094, DOI 10.1002/adma.201200648; THOMPSON GE, 1978, NATURE, V272, P433, DOI 10.1038/272433a0; THOMPSON GE, 1981, NATURE, V290, P230, DOI 10.1038/290230a0; Hull S, 2004, REP PROG PHYS, V67, P1233, DOI 10.1088/0034-4885/67/7/R05; Chadwick AV, 2000, NATURE, V408, P925, DOI 10.1038/35050201; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; BRUMLIK CJ, 1991, J AM CHEM SOC, V113, P3174, DOI 10.1021/ja00008a057; Tian ML, 2005, NANO LETT, V5, P697, DOI 10.1021/nl0501112; BRADLEY JN, 1967, T FARADAY SOC, V63, P424, DOI 10.1039/tf9676300424; BURLEY G, 1967, ACTA CRYSTALLOGR, V23, P1, DOI 10.1107/S0365110X67002014; Delaizir G, 2012, SOLID STATE IONICS, V207, P57, DOI 10.1016/j.ssi.2011.11.012; Guo YG, 2005, ADV MATER, V17, P2815, DOI 10.1002/adma.200501215; Guo Y.-G., 2007, J ELECTROCHEM SOC, V154, pK51; Piao YZ, 2003, CHEM COMMUN, P2898, DOI 10.1039/b310212b; Ko S, 2006, THIN SOLID FILMS, V515, P1932, DOI 10.1016/j.tsf.2006.07.169; Lee JS, 2000, J ELECTROCHEM SOC, V147, P2407, DOI 10.1149/1.1393545; Lee JS, 2000, SOLID STATE IONICS, V136, P1261, DOI 10.1016/S0167-2738(00)00583-X; Liang CH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2828141; Liang CH, 2005, SMALL, V1, P971, DOI 10.1002/smll.200500155; Limo C., 2007, ADV FUNCT MATER, V17, P1466; Liu LF, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/49/495706; MAIER J, 1995, PROG SOLID STATE CH, V23, P171, DOI 10.1016/0079-6786(95)00004-E; Murugaraj R, 2002, J POWER SOURCES, V112, P184, DOI 10.1016/S0378-7753(02)00355-5; SHAHI K, 1981, J ELECTROCHEM SOC, V128, P6, DOI 10.1149/1.2127390; TAKADA K, 1990, SOLID STATE IONICS, V40-1, P988, DOI 10.1016/0167-2738(90)90170-V; TATSUMISAGO M, 1991, NATURE, V354, P217, DOI 10.1038/354217a0; Yamada H, 2006, ADV FUNCT MATER, V16, P525, DOI 10.1002/adfm.200500538; Yamasaki S, 2013, CHEM-ASIAN J, V8, P73, DOI 10.1002/asia.201200790	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5161	5167		10.1021/acs.nanolett.5b01388		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700047		
J	Dienel, T; Kawai, S; Sode, H; Feng, XL; Mullen, K; Ruffieux, P; Fasel, R; Groning, O				Dienel, Thomas; Kawai, Shigeki; Soede, Hajo; Feng, Xinliang; Muellen, Klaus; Ruffieux, Pascal; Fasel, Roman; Groening, Oliver			Resolving Atomic Connectivity in Graphene Nanostructure Junctions	NANO LETTERS			English	Article						Two-dimensional material; graphene nanoribbon; noncontact atomic force microscopy; nc-AFM; scanning tunneling microscopy; tight binding	NANORIBBON HETEROJUNCTIONS; SURFACE; AROMATICITY; MICROSCOPY; DEFECTS	We report on the structural characterization of junctions between atomically well-defined graphene nanoribbons (GNRs) by means of low-temperature, noncontact scanning probe microscopy. We show that the combination of simultaneously acquired frequency shift and tunneling current maps with tight binding (TB) simulations allows a comprehensive characterization of the atomic connectivity in the GNR junctions. The proposed approach can be generally applied to the investigation of graphene nanomaterials and their interconnections and is thus expected to become an important tool in the development of graphene-based circuitry.	[Dienel, Thomas; Soede, Hajo; Ruffieux, Pascal; Fasel, Roman; Groening, Oliver] Empa Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland; [Kawai, Shigeki] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Kawai, Shigeki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Feng, Xinliang; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Feng, Xinliang] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Dienel, T (reprint author), Empa Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, Ueberlandstr 129, CH-8600 Dubendorf, Switzerland.	thomas.dienel@empa.ch; oliver.groening@empa.ch	Dienel, Thomas/F-2356-2010; Groning, Oliver/J-9727-2012; Ruffieux, Pascal/E-8227-2010	Dienel, Thomas/0000-0001-8146-8841; Ruffieux, Pascal/0000-0001-5729-5354	Swiss National Science Foundation (SNSF); Office of Naval Research BRC program; Japan Science and Technology Agency (JST)	The authors gratefully acknowledge financial support by the Swiss National Science Foundation (SNSF), by the Office of Naval Research BRC program, and by the Japan Science and Technology Agency (JST) "Precursory Research for Embryonic Science and Technology (PRESTO)" for the project "Molecular technology and creation of new function".	Koch M, 2012, NAT NANOTECHNOL, V7, P713, DOI [10.1038/nnano.2012.169, 10.1038/NNANO.2012.169]; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Ruffieux P, 2012, ACS NANO, V6, P6930, DOI 10.1021/nn3021376; Treier M, 2011, NAT CHEM, V3, P61, DOI [10.1038/nchem.891, 10.1038/NCHEM.891]; Lehtinen O, 2015, NANO LETT, V15, P235, DOI [10.1021/nl503453u, 10.1021/01503453u]; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Matsuo Y, 2003, ORG LETT, V5, P3181, DOI 10.1021/ol0349514; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; Fujii S, 2012, ANGEW CHEM INT EDIT, V51, P7236, DOI 10.1002/anie.201202560; Basagni A, 2015, J AM CHEM SOC, V137, P1802, DOI 10.1021/ja510292b; Cai JM, 2014, NAT NANOTECHNOL, V9, P896, DOI [10.1038/nnano.2014.184, 10.1038/NNANO.2014.184]; Gross L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086101; Blankenburg S, 2012, ACS NANO, V6, P2020, DOI 10.1021/nn203129a; Talirz L, 2013, J AM CHEM SOC, V135, P2060, DOI 10.1021/ja311099k; Wassmann T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096402; Wei YJ, 2012, NAT MATER, V11, P759, DOI [10.1038/nmat3370, 10.1038/NMAT3370]; BARTH JV, 1990, PHYS REV B, V42, P9307, DOI 10.1103/PhysRevB.42.9307; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Chen YC, 2015, NAT NANOTECHNOL, V10, P156, DOI [10.1038/nnano.2014.307, 10.1038/NNANO.2014.307]; Collins P G., 2010, DEFECTS DISORDER CAR; da Silva-Araujo J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035708; Gross L., 2015, NONCONTACT ATOMIC FO, V3, P223; Hamalainen SK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.186102; Huang H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00983; Ijas M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075429; Li YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5311; Martin-Martinez FJ, 2013, PHYS CHEM CHEM PHYS, V15, P12637, DOI 10.1039/c3cp51293b; Sode H, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045429; van der Lit J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3023; Yazyev OV, 2014, NAT NANOTECHNOL, V9, P755, DOI [10.1038/nnano.2014.166, 10.1038/NNANO.2014.166]	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5185	5190		10.1021/acs.nanolett.5b01403		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700050		
J	Tanigaki, T; Shibata, K; Kanazawa, N; Yu, XZ; Onose, Y; Park, HS; Shindo, D; Tokura, Y				Tanigaki, Toshiaki; Shibata, Kiyou; Kanazawa, Naoya; Yu, Xiuzhen; Onose, Yoshinori; Park, Hyun Soon; Shindo, Daisuke; Tokura, Yoshinori			Real-Space Observation of Short-Period Cubic Lattice of Skyrmions in MnGe	NANO LETTERS			English	Article						Skyrmion; short-period; three-dimensional structure; Lorentz microscopy	MAGNETIC SKYRMIONS; MNSI; DENSITY; ALLOYS; MOTION; PHASE	Three-dimensional forms of skyrmion aggregate, such as a cubic lattice of skyrmions, are anticipated to exist, yet their direct observations remain elusive. Here, we report real-space observations of spin configurations of the skyrmion-antiskyrmion cubic-lattice in MnGe with a very short period (similar to 3 nm) and hence endowed with the largest skyrmion number density. The skyrmion lattices parallel to the {100} atomic lattices are directly observed using high-resolution Lorentz transmission electron microscopes, simultaneously with underlying atomic-lattice fringes.	[Tanigaki, Toshiaki; Yu, Xiuzhen; Park, Hyun Soon; Shindo, Daisuke; Tokura, Yoshinori] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Tanigaki, Toshiaki] Hitachi Ltd, Res & Dev Grp, Hatoyama, Saitama 3500395, Japan; [Shibata, Kiyou; Kanazawa, Naoya; Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Onose, Yoshinori] Univ Tokyo, Dept Basic Sci, Tokyo 1538902, Japan; [Shindo, Daisuke] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tanigaki, T (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	toshiaki.tanigaki.mv@hitachi.com	Tokura, Yoshinori/C-7352-2009; Shindo, Daisuke/I-3865-2012		Japan Society for the Promotion of Science (JSPS); Council for Science, Technology and Innovation (CSTI); MEXT, Japan [24224009, 15H05456]	The authors are grateful to the late Dr. A. Tonomura, Dr. T. Matsuda, Dr. Y. Murakami, the late Mr. S. Aizawa, Mr. K. Yanagisawa, and Dr. Y. A. Ono for valuable discussions and supports. This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science, Technology and Innovation (CSTI) under the programs "Development and Application of an Atomic-resolution Holography Electron Microscope" and "Quantum Science on Strong Correlation", and Grant-in-Aids for Scientific Research (Grants 24224009 and 15H05456) from MEXT, Japan.	Sampaio J, 2013, NAT NANOTECHNOL, V8, P839, DOI [10.1038/nnano.2013.210, 10.1038/nnano.2013.233, 10.1038/NNANO.2013.210]; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Kanazawa N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156603; Ishizuka K, 2005, J ELECTRON MICROSC, V54, P191, DOI 10.1093/jmicro/dfi024; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Park JH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184406; Shibata K, 2013, NAT NANOTECHNOL, V8, P723, DOI 10.1038/nnano.2013.174; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Yu XZ, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.054411; Kanazawa N, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134425; BEILLE J, 1983, SOLID STATE COMMUN, V47, P399, DOI 10.1016/0038-1098(83)90928-6; ISHIKAWA Y, 1976, SOLID STATE COMMUN, V19, P525, DOI 10.1016/0038-1098(76)90057-0; Tonomura A, 2012, NANO LETT, V12, P1673, DOI 10.1021/nl300073m; Yi SD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054416; Iwasaki J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2442; Makarova OL, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205205; NAKANISHI O, 1980, SOLID STATE COMMUN, V35, P995, DOI 10.1016/0038-1098(80)91004-2; Neubauer A., 2009, PHYS REV LETT, V102; Uchida M, 2006, SCIENCE, V311, P359, DOI 10.1126/science.1120639; Uchida M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184402; Yu XZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1990	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5438	5442		10.1021/acs.nanolett.5b02653		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700088		
J	Miyata, M; Holsteen, A; Nagasaki, Y; Brongersma, ML; Takahara, J				Miyata, Masashi; Holsteen, Aaron; Nagasaki, Yusuke; Brongersma, Mark L.; Takahara, Junichi			Gap Plasmon Resonance in a Suspended Plasmonic Nanowire Coupled to a Metallic Substrate	NANO LETTERS			English	Article						gap plasmon; nanowire; optical antenna; Fabry-Perot resonance; Fano resonance; pick-and-place method	BOWTIE NANOANTENNA; FIELD ENHANCEMENT; FANO RESONANCE; WAVE-GUIDE; FILM; NANOSTRUCTURES; NANOPARTICLE; ANTENNAS; METAMATERIALS; SPECTROSCOPY	We present an experimental demonstration of nanoscale gap plasmon resonators that consist of an individual suspended plasmonic nanowire (NW) over a metallic substrate. Our study demonstrates that the NW supports strong gap plasmon resonances of various gap sizes including single-nanometer-scale gaps. The obtained resonance features agree well with intuitive resonance models for near- and far-field regimes. We also illustrate that our suspended NW geometry is capable of constructing plasmonic coupled systems dominated by quasi-electrostatics.	[Miyata, Masashi; Nagasaki, Yusuke; Takahara, Junichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Holsteen, Aaron; Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Takahara, Junichi] Osaka Univ, Adv Photon Res Ctr, Suita, Osaka 5650871, Japan	Takahara, J (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	takahara@ap.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25286007]; Japan Society for the Promotion of Science (JSPS); DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; U.S. Airforce Office for Scientific Research [FA9550-14-1-0389]	We would like to thank Dr. Juhyung Kang and Hamidreza Chalabi (Stanford University) for helpful discussions and technical support on this project. We thank Tatsuya Fujimoto (Osaka University) for his help with fabrication. This work was supported by Grant-in-Aid for Scientific Research B (25286007) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). One of the authors (M. Miyata) is supported by Research Fellowships of Japan Society for the Promotion of Science (JSPS) for Young Scientists. The work at Stanford was conducted with Government support under and awarded by DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a, and the U.S. Airforce Office for Scientific Research Grant # FA9550-14-1-0389.	Ahlfors L, 1972, PHYS REV B; Kim JH, 2014, NANO LETT, V14, P1687, DOI 10.1021/nl5006355; Jung J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035401; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Ward DR, 2010, NAT NANOTECHNOL, V5, P732, DOI 10.1038/nnano.2010.176; Mock JJ, 2008, NANO LETT, V8, P2245, DOI 10.1021/nl080872f; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/nmat2630, 10.1038/NMAT2630]; Bozhevolnyi SI, 2007, OPT EXPRESS, V15, P10869, DOI 10.1364/OE.15.010869; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Fan PY, 2014, NAT MATER, V13, P471, DOI [10.1038/nmat3927, 10.1038/NMAT3927]; Hatab NA, 2010, NANO LETT, V10, P4952, DOI 10.1021/nl102963g; Knight MW, 2009, NANO LETT, V9, P2188, DOI 10.1021/nl900945q; Barnard ES, 2011, NAT NANOTECHNOL, V6, P588, DOI [10.1038/nnano.2011.131, 10.1038/NNANO.2011.131]; Duan HG, 2011, ACS NANO, V5, P7593, DOI 10.1021/nn2025868; Hu M, 2010, J PHYS CHEM C, V114, P7509, DOI 10.1021/jp911416a; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Savage KJ, 2012, NATURE, V491, P574, DOI 10.1038/nature11653; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Dionne JA, 2009, NANO LETT, V9, P897, DOI 10.1021/nl803868k; Lassiter JB, 2013, NANO LETT, V13, P5866, DOI 10.1021/nl402660s; Siegfried T, 2013, NANO LETT, V13, P5449, DOI 10.1021/nl403030g; Moreau A, 2012, NATURE, V492, P86, DOI 10.1038/nature11615; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Luk'yanchuk B, 2010, NAT MATER, V9, P707, DOI [10.1038/nmat2810, 10.1038/NMAT2810]; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; Romero I, 2006, OPT EXPRESS, V14, P9988, DOI 10.1364/OE.14.009988; Novotny L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266802; Chandran A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085416; Barnard ES, 2008, OPT EXPRESS, V16, P16529, DOI 10.1364/OE.16.016529; Scholl JA, 2013, NANO LETT, V13, P564, DOI 10.1021/nl304078v; Choo H, 2012, NAT PHOTONICS, V6, P837, DOI 10.1038/NPHOTON.2012.277; HOLLAND WR, 1984, PHYS REV LETT, V52, P1041, DOI 10.1103/PhysRevLett.52.1041; Lindquist NC, 2011, NANO LETT, V11, P3526, DOI 10.1021/nl2005737; Miyazaki HT, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397037; Novotny L, 2006, PRINCIPLES NANOOPTIC; Stosch R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105303	38	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5609	5616		10.1021/acs.nanolett.5b02307		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700115		
J	Miyadera, T; Shibata, Y; Koganezawa, T; Murakami, TN; Sugita, T; Tanigaki, N; Chikamatsu, M				Miyadera, Tetsuhiko; Shibata, Yosei; Koganezawa, Tomoyuki; Murakami, Takurou N.; Sugita, Takeshi; Tanigaki, Nobutaka; Chikamatsu, Masayuki			Crystallization Dynamics of Organolead Halide Perovskite by Real-Time X-ray Diffraction	NANO LETTERS			English	Article						organolead halide perovskite; solar cell; crystallization; synchrotron-radiation X-ray diffraction; grazing incident wide-angle X-ray scattering; anomalous diffusion	HYBRID SOLAR-CELLS; LEAD IODIDE; EFFICIENCY; PERFORMANCE; DEPOSITION; TRANSPORT; CHLORIDE; GROWTH	We analyzed the crystallization process of the CH3NH3PbI3 perovskite by observing real-time X-ray diffraction immediately after combining a PbI, thin film with a CH3NH3I solution. A detailed analysis of the transformation kinetics demonstrated the fractal diffusion of the CH3NH3I solution into the PM, film. Moreover, the perovskite crystal was found to be initially oriented based on the PbI2 crystal orientation but to gradually transition to a random orientation. The fluctuating characteristics of the crystallization process of perovskites, such as fractal penetration and orientational transformation, should be controlled to allow the fabrication of high-quality perovsidte crystals. The characteristic reaction dynamics observed in this study should assist in establishing reproducible fabrication processes for perovsidte solar cells.	[Miyadera, Tetsuhiko; Shibata, Yosei; Murakami, Takurou N.; Sugita, Takeshi; Tanigaki, Nobutaka; Chikamatsu, Masayuki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Miyadera, Tetsuhiko] Japan Sci & Technol Agcy JST, Kawaguchi, Saitama 3320012, Japan; [Koganezawa, Tomoyuki] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan	Miyadera, T (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	tetsuhiko-miyadera@aist.go.jp			Japan Science and Technology Agency (JST) through funding program for Precursory Research for Embryonic Science and Technology (PRESTO)	We thank A. Wakamiya in Kyoto Univ. for helpful discussion. The GIWAXS measurement was performed at SPring-8 BL46XU with the approval of the Japan Synchrotron Radiation Research Institute (JASRI, proposal nos. 2014B1614 and 2015A1689). This work is financially supported by Japan Science and Technology Agency (JST) through its funding program for Precursory Research for Embryonic Science and Technology (PRESTO).	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Beckmann PA, 2010, CRYST RES TECHNOL, V45, P455, DOI 10.1002/crat.201000066; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Shen DH, 2014, J MATER CHEM A, V2, P20454, DOI 10.1039/c4ta05635c; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Hao F, 2014, J AM CHEM SOC, V136, P16411, DOI 10.1021/ja509245x; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; Yella A, 2014, NANO LETT, V14, P2591, DOI 10.1021/nl500399m; Unger EL, 2014, CHEM MATER, V26, P7158, DOI 10.1021/cm503828b; Colella S, 2013, CHEM MATER, V25, P4613, DOI 10.1021/cm402919x; Pistor P, 2014, J PHYS CHEM LETT, V5, P3308, DOI 10.1021/jz5017312; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Wakamiya A, 2014, CHEM LETT, V43, P711, DOI 10.1246/cl.140074; Tidhar Y, 2014, J AM CHEM SOC, V136, P13249, DOI 10.1021/ja505556s; Wu YZ, 2014, ENERG ENVIRON SCI, V7, P2934, DOI 10.1039/c4ee01624f; Bandyopadhyay R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228302; Tan KW, 2014, ACS NANO, V8, P4730, DOI 10.1021/nn500526t; Grancini G, 2014, J PHYS CHEM LETT, V5, P3836, DOI 10.1021/jz501877h; Hatano Y, 1998, WATER RESOUR RES, V34, P1027, DOI 10.1029/98WR00214; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Xiao ZG, 2014, ADV MATER, V26, P6503, DOI 10.1002/adma.201401685	26	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	AUG	2015	15	8					5630	5634		10.1021/acs.nanolett.5b02402		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CP1CO	WOS:000359613700118		
J	Taniai, Y; Nishii, J				Taniai, Yoshiaki; Nishii, Jun			Optimality of Upper-Arm Reaching Trajectories Based on the Expected Value of the Metabolic Energy Cost	NEURAL COMPUTATION			English	Article							SIGNAL-DEPENDENT NOISE; TORQUE-CHANGE MODEL; MOVEMENTS; COCONTRACTION; WALKING; SYSTEM; MUSCLE	When we move our body to perform a movement task, our central nervous system selects a movement trajectory from an infinite number of possible trajectories under constraints that have been acquired through evolution and learning. Minimization of the energy cost has been suggested as a potential candidate for a constraint determining locomotor parameters, such as stride frequency and stride length; however, other constraints have been proposed for a human upper-arm reaching task. In this study, we examined whether the minimum metabolic energy cost model can also explain the characteristics of the upper-arm reaching trajectories. Our results show that the optimal trajectory that minimizes the expected value of energy cost under the effect of signal-dependent noise on motor commands expresses not only the characteristics of reaching movements of typical speed but also those of slower movements. These results suggest that minimization of the energy cost would be a basic constraint not only in locomotion but also in upper-arm reaching.	[Taniai, Yoshiaki] Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan; [Nishii, Jun] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan	Taniai, Y (reprint author), Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan.	taniai@rbt.his.u-fukui.ac.jp; nishii@sci.yamaguchi-u.ac.jp					Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Huang HJ, 2012, J NEUROSCI, V32, P2182, DOI 10.1523/JNEUROSCI.4003-11.2012; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn00943.2001; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; UNO Y, 1989, BIOL CYBERN, V61, P89; KOIKE Y, 1995, BIOL CYBERN, V73, P291, DOI 10.1007/BF00199465; Nishii J, 2000, BIOL CYBERN, V83, P435, DOI 10.1007/s004220000175; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140; Bernstein N, 1967, COORDINATION REGULAT; Berret B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002183; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; FLASH T, 1985, J NEUROSCI, V5, P1688; Gill PE, 2005, SIAM REV, V47, P99, DOI 10.1137/S0036144504446096; HILL AV, 1964, PROC R SOC SER B-BIO, V159, P297, DOI 10.1098/rspb.1964.0004; HOGAN N, 1984, J NEUROSCI, V4, P2745; Julier SJ, 1997, P SOC PHOTO-OPT INS, V3068, P182, DOI 10.1117/12.280797; MA SP, 1991, J BIOMECH, V24, P21, DOI 10.1016/0021-9290(91)90323-F; Miyamoto H., 2004, Systems and Computers in Japan, V35, DOI 10.1002/scj.10377; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nishii J, 2012, ROBOT AUTON SYST, V60, P679, DOI 10.1016/j.robot.2011.12.006; Nishii J, 2009, NEURAL COMPUT, V21, P2634, DOI 10.1162/neco.2009.06-08-798; Nishii J, 2006, J THEOR BIOL, V238, P636, DOI 10.1016/j.jtbi.2005.06.027; Nishii J., 2002, P INT C BIOM MAN, P30; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; Tanaka H, 2004, NEURAL COMPUT, V16, P2021, DOI 10.1162/0899766041732431; van der Helm FCT, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P164; Van Leeuwen J.L., 1992, MECH ANIMAL LOCOMOTI, P191; Woledge R.C., 1985, ENERGETIC ASPECTS MU	36	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	AUG	2015	27	8					1721	1737		10.1162/NECO_a_00757		17	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CP7TW	WOS:000360092200006		
J	Katayama, S; Matsumura, A; Sunagawa, H				Katayama, Soichiro; Matsumura, Akitaka; Sunagawa, Hideaki			Energy decay for systems of semilinear wave equations with dissipative structure in two space dimensions	NODEA-NONLINEAR DIFFERENTIAL EQUATIONS AND APPLICATIONS			English	Article						Nonlinear wave equations; Energy decay	SMALL INITIAL DATA; GLOBAL-SOLUTIONS; NULL CONDITION; LIFE-SPAN; EXISTENCE; NONLINEARITIES	We consider the Cauchy problem for systems of semilinear wave equations in two space dimensions. We present a structural condition on the nonlinearity under which the energy decreases to zero as time tends to infinity if the Cauchy data are sufficiently small, smooth and compactly-supported.	[Katayama, Soichiro] Wakayama Univ, Dept Math, Wakayama 6408510, Japan; [Matsumura, Akitaka] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan; [Sunagawa, Hideaki] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Katayama, S (reprint author), Wakayama Univ, Dept Math, 930 Sakaedani, Wakayama 6408510, Japan.	katayama@center.wakayama-u.ac.jp; akitaka@ist.osaka-u.ac.jp; sunagawa@math.sci.osaka-u.ac.jp			JSPS [23540241, 23340036, 25400161]	The work of S.K. is partially supported by JSPS, Grant-in-Aid for Scientific Research (C) (No. 23540241). The work of A.M. is partially supported by JSPS, Grant-in-Aid for Scientific Research (B) (No. 23340036). The work of H.S. is partially supported by JSPS, Grant-in-Aid for Scientific Research (C) (No. 25400161).	Agemi R., COMMUNICATION; Alinhac S., 2000, AM J MATH, V123, P1071; Alinhac S, 2004, MATH ANN, V329, P707, DOI 10.1007/s00208-004-0534-1; Katayama S, 1995, PUBL RES I MATH SCI, V31, P645, DOI 10.2977/prims/1195163919; [Anonymous], 1995, ADV MATH SCI APPL; Lindblad H, 2008, AM J MATH, V130, P115, DOI 10.1353/ajm.2008.0009; Alinhac S, 2001, INVENT MATH, V145, P597, DOI 10.1007/s002220100165; LINDBLAD H, 1990, COMMUN PUR APPL MATH, V43, P445, DOI 10.1002/cpa.3160430403; CHRISTODOULOU D, 1986, COMMUN PUR APPL MATH, V39, P267, DOI 10.1002/cpa.3160390205; GODIN P, 1993, COMMUN PART DIFF EQ, V18, P895, DOI 10.1080/03605309308820955; Hormander L., 1988, ANAL MATH APPL, P211; Hoshiga A, 2006, FUNKC EKVACIOJ-SER I, V49, P357, DOI 10.1619/fesi.49.357; Hoshiga A, 2004, DIFFER INTEGRAL EQU, V17, P593; Hoshiga A., 2008, HOKKAIDO MATH J, V37, P669; Hoshiga A, 2000, SIAM J MATH ANAL, V31, P486, DOI 10.1137/S0036141097326064; Katayama S, 2015, MATH ANN, V361, P275, DOI 10.1007/s00208-014-1071-1; KATAYAMA S, 1993, PUBL RES I MATH SCI, V29, P1021, DOI 10.2977/prims/1195166427; Katayama S., 2008, HOKKAIDO MATH J, V37, P689; Katayama S, 2014, DIFFER INTEGRAL EQU, V27, P301; Katayama S, 2012, J EVOL EQU, V12, P891, DOI 10.1007/s00028-012-0160-4; Kim D, 2014, NONLINEAR ANAL-THEOR, V97, P94, DOI 10.1016/j.na.2013.11.025; Klainerman S., 1986, LECTURES APPL MATH, V23, P293; Kubo H., 2007, DISCRETE CONTIN DY S, P602; MOCHIZUKI K, 1995, J MATH SOC JPN, V47, P405, DOI 10.2969/jmsj/04730405; Sogge C. D., 1995, LECT NONLINEAR WAVE; Todorova G, 2007, INDIANA U MATH J, V56, P389, DOI 10.1512/iumj.2007.56.2963	26	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1021-9722	1420-9004		NODEA-NONLINEAR DIFF	NoDea-Nonlinear Differ. Equ. Appl.	AUG	2015	22	4					601	628		10.1007/s00030-014-0297-7		28	Mathematics, Applied	Mathematics	CP6OF	WOS:000360006200005		
J	Matsuda, Y; Kan, S; Uematsu, H; Shibata, M; Fujino, Y				Matsuda, Yoichi; Kan, Shigeyuki; Uematsu, Hironobu; Shibata, Masahiko; Fujino, Yuji			Pain-Related Brain Activity Evoked by Active and Dynamic Arm Movement: Delayed-Onset Muscle Soreness as a Promising Model for Studying Movement-Related Pain in Humans	PAIN MEDICINE			English	Article						Functional Magnetic Resonance Imaging; Movement-Evoked Pain; Delayed-Onset Muscle Soreness; Motor Adaptation	PRIMARY MOTOR CORTEX; HUMAN PARIETAL OPERCULUM; STIMULATION; MECHANISMS; POTENTIALS; MAPS; AREA	ObjectiveTo demonstrate delayed-onset muscle soreness (DOMS) is a suitable model for the study of movement-evoked pain, we attempted to identify brain regions specifically involved in pain evoked by active and dynamic movement under DOMS condition. SubjectTwelve healthy volunteers MethodsDOMS was induced in the left upper-arm flexor muscles by an eccentric elbow contraction exercise. Movement-evoked pain in the affected muscles was evaluated just before (day 0) and after (days 1-7 and 30) the exercise using a visual analog scale. Subjects underwent functional magnetic resonance imaging scans while performing repeated elbow flexion on day 2 (DOMS condition) and day 30 (painless condition). We compared brain activity between the DOMS and painless conditions. ResultsMovement-evoked pain reached peak intensity on day 2 and disappeared by day 30 in all subjects. No subject felt pain at rest on either of these days. Contralateral primary motor cortex (M1), parietal operculum and bilateral presupplementary motor area (pre-SMA) showed greater activity during active and dynamic arm movement with DOMS than during the same movement without pain. There was no difference in activation of brain regions known collectively as the pain matrix, except for the parietal operculum, between the two conditions. ConclusionActive and dynamic movement with pain selectively evoked activation of M1, pre-SMA, and parietal operculum, as assessed using DOMS. Our results demonstrate that DOMS is a promising experimental model for the study of movement-evoked pain in humans.	[Matsuda, Yoichi; Uematsu, Hironobu; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Osaka, Japan; [Kan, Shigeyuki; Shibata, Masahiko] Osaka Univ, Grad Sch Med, Pain Med, Osaka, Japan	Shibata, M (reprint author), 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mshiba-ta@pain.med.osaka-u.ac.jp			Tanabe Seiyaku Co., Ltd.	The authors thank Ishikawa Hospital for use of the MRI device, Tamotsu Nomura for help with imaging procedures, and Kazuyuki Sumiya and Mutsumi Sato for help with exercise for induction of DOMS. This work was supported by an unrestricted grant of Tanabe Seiyaku Co., Ltd.	Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Canedo A, 1997, PROG NEUROBIOL, V51, P287, DOI 10.1016/S0301-0082(96)00058-5; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Zainuddin Z, 2005, J ATHL TRAINING, V40, P174; Zedka M, 1999, J PHYSIOL-LONDON, V520, P591, DOI 10.1111/j.1469-7793.1999.00591.x; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Schreckenberger M, 2005, NEUROLOGY, V64, P1175; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.jbrainres.2004.12.043; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; Perini I, 2013, J NEUROSCI, V33, P15930, DOI 10.1523/JNEUROSCI.3135-12.2013; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Ikeda A, 1999, BRAIN, V122, P915, DOI 10.1093/brain/122.5.915; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; MILES MP, 1994, J SPORT MED PHYS FIT, V34, P203; ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Ciubotariu A, 2004, EUR J APPL PHYSIOL, V91, P604, DOI 10.1007/s00421-003-1026-9; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Ervilha UF, 2005, EXP BRAIN RES, V164, P215, DOI 10.1007/s00221-005-2244-7; GravenNielsen T, 1997, ELECTROMYOGR MOTOR C, V105, P156, DOI 10.1016/S0924-980X(96)96554-6; Graven-Nielsen Thomas, 2003, Curr Pain Headache Rep, V7, P443, DOI 10.1007/s11916-003-0060-y; Henderson LA, 2006, PAIN, V120, P286, DOI 10.1016/j.pain.2005.11.003; JONES DA, 1987, ADV PAIN RES THER, V10, P207; Maihofner C, 2006, EUR J NEUROSCI, V23, P1377; Nash PG, 2010, J OROFAC PAIN, V24, P379; Zimmermann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047230	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-2375	1526-4637		PAIN MED	Pain Med.	AUG	2015	16	8					1528	1539		10.1111/pme.12771		12	Medicine, General & Internal	General & Internal Medicine	CP7FR	WOS:000360053100010		
J	Ducruet, C; Itoh, H; Joly, O				Ducruet, Cesar; Itoh, Hidekazu; Joly, Olivier			Ports and the local embedding of commodity flows	PAPERS IN REGIONAL SCIENCE			English	Article						Freight flows; regional development; value chain; port hinterlands; maritime transport; transport geography	TRANSPORT COSTS; ECONOMIC-GEOGRAPHY; CITIES; EVOLUTION; TRADE; HUB; GLOBALIZATION; AGGLOMERATION; CITY; CONTAINERIZATION	Empirical evidence remains lacking about the territorial embedding of material flows. An analysis of 189 port regions in advanced economic areas (Europe, Japan, and the United States), validates a number of ideas proposed by regional science and transport geography. Core economic regions such as large urban tertiary centres concentrate most valued, diversified, and weighty traffic, while more peripheral and traditional ones tend to specialize in bulky traffic. Moreover, the level of industry relatedness of port traffic appears as a key component of the socio-economic wealth of port regions. The research also underlines noticeable linkages between types of port regions and types of port-related policies across the three studied areas.	[Ducruet, Cesar] CNRS, Paris, France; [Ducruet, Cesar] UMR 8504 Geog Cites, Paris, France; [Itoh, Hidekazu] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan; [Joly, Olivier] Univ Le Havre, Le Havre, France; [Joly, Olivier] UMR 6063 IDEES, Paris, France	Ducruet, C (reprint author), CNRS, Paris, France.	cdu@parisgeo.cnrs.fr; hito@kwansei.ac.jp; olivier.joly@univ-lehavre.fr			European Commission in the framework of the European Spatial Planning Observatory Network (ESPON); European Research Council under the European Union [313847]; JSPS KAKENHI, Japan [24730259]	This research has benefited financial support from the European Commission in the framework of the European Spatial Planning Observatory Network (ESPON) project on Territorial Impact of Globalization on Europe and its Regions (TIGER). In addition, the research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. [313847] 'World Seastems'. Moreover, the research was supported by JSPS KAKENHI Grant Number 24730259, Japan.	Leslie D, 1999, PROG HUM GEOG, V23, P401; Neffke F, 2011, ECON GEOGR, V87, P237, DOI 10.1111/j.1944-8287.2011.01121.x; Fujita M, 1996, J DEV ECON, V49, P93, DOI 10.1016/0304-3878(95)00054-2; Glaeser EL, 2004, PAP REG SCI, V83, P197, DOI 10.1007/s10110-003-0183-x; Jacobs W, 2010, GLOBAL NETW, V10, P92; TAAFFE EJ, 1963, GEOGR REV, V53, P503, DOI 10.2307/212383; Clark XM, 2004, J DEV ECON, V75, P417, DOI 10.1016/j.jdeveco.2004.06.005; Grobar LM, 2008, GROWTH CHANGE, V39, P497, DOI 10.1111/j.1468-2257.2008.00435.x; Leamer EE, 2001, J INT BUS STUD, V32, P641, DOI 10.1057/palgrave.jibs.84909988; Feenstra RC, 1998, J ECON PERSPECT, V12, P31; Lee SW, 2008, GEOFORUM, V39, P372, DOI 10.1016/j.geoforum.2007.07.010; Wang JJ, 2010, J TRANSP GEOGR, V18, P104, DOI 10.1016/j.jtrangeo.2009.02.009; Ferrari C, 2010, INT J TRANSP ECON, V37, P9; Limao N, 2001, WORLD BANK ECON REV, V15, P451, DOI 10.1093/wber/15.3.451; Puga D, 1999, EUR ECON REV, V43, P303, DOI 10.1016/S0014-2921(98)00061-0; Wang CJ, 2012, J TRANSP GEOGR, V25, P58, DOI 10.1016/j.jtrangeo.2012.07.008; Behrens K, 2006, PAP REG SCI, V85, P379, DOI 10.1111/j.1435-5957.2006.00093.x; Behrens K, 2007, REG SCI URBAN ECON, V37, P22, DOI 10.1016/j.regsciurbeco.2006.04.003; Behrens K, 2006, J ECON GEOGR, V6, P347, DOI 10.1093/jeg/lbi024; Bird J., 1963, MAJOR SEAPORTS UK; Campbell S, 1993, TRADING IND TRADING; Carter RE, 1962, ECON GEOGR, V38, P162, DOI 10.2307/142275; Cheung SMS, 2011, TRANSPORT J, V50, P162; Combes P.-P., 2008, EC GEOGRAPHY INTEGRA; De Langen PW, 2004, SHIPPING PORTS 21 CE; De Langen PW, 2007, PORTS CITIES GLOBAL; Debrie J., 2008, ESPACE GEOGRAPHIQUE, V37, P45; Ducruet C., 2009, PORTS PROXIMITY COMP; Ducruet C., 2006, GEOJOURNAL, V67, P107; Ducruet C, 2010, REG STUD, V44, P1221, DOI 10.1080/00343400903167904; Ducruet C, 2012, CITIES REGIONS FLOWS; Dunford M, 2009, INT ENCY HUMAN GEOGR; Faini R, 1999, EUR ECON REV, V43, P457, DOI 10.1016/S0014-2921(98)00062-2; FNAU, 2009, OBS PORT; Fujita M., 2002, EC AGGLOMERATION CIT; Fujita M, 2006, INT ECON REV, V47, P811, DOI 10.1111/j.1468-2354.2006.00397.x; Fujita M., 1999, SPATIAL EC CITIES RE; Fujita M, 2005, PORT ECON J, V4, P129, DOI 10.1007/s10258-005-0042-6; Garnier J, 2004, AIRE METROPOLITAINE; Goetz AR, 2009, PROF GEOGR, V61, P323, DOI 10.1080/00330120902931960; Gouvernal E, 2010, J TRANSP GEOGR, V18, P97, DOI 10.1016/j.jtrangeo.2009.05.004; Guerrero D, 2010, THESIS PARIS DIDEROT; Haddad EA, 2010, INT REGIONAL SCI REV, V33, P239, DOI 10.1177/0160017610368690; Haefner LE, 1980, TRANSPORT RES REC, V763, P2; Hall P. V., 2009, GEOJOURNAL, V74, P67, DOI 10.1007/s10708-008-9215-z; Hall PV, 2002, I INFRASTRUCTURE DEV; Hall PV, 2012, MARIT POLICY MANAG, V39, P189, DOI 10.1080/03088839.2011.650721; Hayuth Y, 1981, ECON GEOGR, V57, P161; Hesse M, 2010, GLOBAL NETW, V10, P75; HOARE AG, 1986, GEOGR ANN B, V68, P29, DOI 10.2307/490915; HOYLE BS, 1989, GEOFORUM, V20, P429, DOI 10.1016/0016-7185(89)90026-2; Itoh H, 2002, REV URBAN REGIONAL D, V15, P133; Jacobs W, 2011, URBAN STUD, V48, P2749, DOI 10.1177/0042098010391294; Janelle D.G., 1997, J TRANSP GEOGR, V5, P199, DOI 10.1016/S0966-6923(97)00017-3; Konishi H, 2000, J URBAN ECON, V48, P1, DOI 10.1006/juec.1999.2150; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; KRUGMAN P, 1995, Q J ECON, V110, P857, DOI 10.2307/2946642; Krugman P., 1995, DEV GEOGRAPHY EC THE; KUBY M, 1992, ECON GEOGR, V68, P272, DOI 10.2307/144186; Lafourcade M, 2011, HANDBOOK OF TRANSPORT ECONOMICS, P67; Lee SW, 2009, URBAN GEOGR, V30, P161; Lever WF, 1995, P 5 INT C CIT PORTS; MARTI BE, 1985, PROF GEOGR, V37, P320, DOI 10.1111/j.0033-0124.1985.00320.x; McCalla RJ, 2001, CAN GEOGR-GEOGR CAN, V45, P404, DOI 10.1111/j.1541-0064.2001.tb01190.x; McCalla RJ, 2004, CAN GEOGR-GEOGR CAN, V48, P473, DOI 10.1111/j.0008-3658.2004.00072.x; Merk O, 2011, OECD REGIONAL DEV WO; MLIT, 2009, BULK CARG FLOW SURV; Mori T, 2002, REG SCI URBAN ECON, V32, P167, DOI 10.1016/S0166-0462(01)00078-3; Musso E., 2000, INT J MARIT ECON, V2, P283; Ng AKY, 2013, PROF GEOGR, V65, P65, DOI 10.1080/00330124.2012.679441; Notteboom T, 2010, DOCK LABOUR PORT REL; Ottaviano GIP, 2005, J INT ECON, V67, P25, DOI 10.1016/j.jinteco.2004.08.010; Prokop D, 2007, P CTRF C; Robert-Nicoud F, 2008, 5617 CTR EC POL RES; Rodrigue J. P., 2004, J TRANSP GEOGR, V12, P171, DOI [DOI 10.1016/J.JTRANGEO.2003.12.004, DOI 10.1016/J.JTRANGE0.2003.12.004]; Rodrigue JP, 2003, CAHIERS SCI TRANSPOR, V44, P55; Rodrigue J-P, 2009, GEOGRAPHY TRANSPORT; Rodrigue J.P., 2005, MARIT POLICY MANAG, V32, P297, DOI 10.1080/03088830500139885; Rodrigue J-P, 2010, RES TRANSP ECON, V27, P19; Shinohara M, 2009, PORTS PROXIMITY COMP; Spulber DF, 2007, GLOBAL COMPETITIVE S; Stern E, 1984, SEAPORT SYSTEMS SPAT; Tabuchi T, 2002, 3542 CTR EC POL RES; Vallega A, 1996, CITYPORTS COASTAL ZO; Wang J J, 2007, PORTS CITIES GLOBAL; Woxenius J, 2010, 12 WORLD C TRANSP RE, P11	86	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1056-8190	1435-5957		PAP REG SCI	Pap. Reg. Sci.	AUG	2015	94	3					607	627		10.1111/pirs.12083		22	Economics; Environmental Studies; Geography	Business & Economics; Environmental Sciences & Ecology; Geography	CP4SF	WOS:000359872200008		
J	Takizawa, H; Yamaguchi, S; Aoyagi, M; Ezaki, N; Mizuno, S				Takizawa, Hotaka; Yamaguchi, Shotaro; Aoyagi, Mayumi; Ezaki, Nobuo; Mizuno, Shinji			Kinect cane: an assistive system for the visually impaired based on the concept of object recognition aid	PERSONAL AND UBIQUITOUS COMPUTING			English	Article						Assistive system; Visually impaired user; Object recognition aid; Microsoft Kinect; Depth data; User study	TRAVEL AID; BLIND; PEOPLE	This paper proposes a novel concept to assist visually impaired individuals in recognizing three-dimensional objects in everyday environments. This concept is realized as a portable system that consists of a white cane, a Microsoft Kinect sensor, a numeric keypad, a tactile feedback device, and other components. By the use of the Kinect sensor, the system searches for an object that a visually impaired user instructs the system to find and then returns a searching result to the user via the tactile feedback device. The major advantage of the system is the ability to recognize the objects of various classes, such as chairs and staircases, out of detectable range of white canes. Furthermore, the system is designed to return minimum required information related to the instruction of a user so that the user can obtain necessary information more efficiently. The system is evaluated through two types of experiment: object recognition test and user study. The experimental results indicate that the system is promising as a means of helping visually impaired users recognize objects.	[Takizawa, Hotaka; Yamaguchi, Shotaro] Univ Tsukuba, Tsukuba, Ibaraki 3058573, Japan; [Aoyagi, Mayumi] Aichi Univ Educ, Kariya, Aichi 4488542, Japan; [Ezaki, Nobuo] Toba Natl Coll Maritime Technol, Toba, Mie 5178501, Japan; [Mizuno, Shinji] Aichi Inst Technol, Toyota, Aichi 4700392, Japan	Takizawa, H (reprint author), Univ Tsukuba, I-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	takizawa@cs.tsukuba.ac.jp			JSPS KAKENHI Grant [25560278]	This work was supported in part by the JSPS KAKENHI Grant Number 25560278.	Bradley NA, 2005, PERS UBIQUIT COMPUT, V9, P395, DOI 10.1007/s00779-005-0350-y; Lee YH, 2011, RETINA-J RET VIT DIS, V31, P1287, DOI 10.1097/IAE.0b013e3182003ccd; Takizawa H, 2012, 2012 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P740, DOI 10.1109/SII.2012.6426936; [Anonymous], 1986, WORKING GROUP MOBILI; Kim D, 2014, SENSORS-BASEL, V14, P10412, DOI 10.3390/s140610412; Dakopoulos D, 2010, IEEE T SYST MAN CY C, V40, P25, DOI 10.1109/TSMCC.2009.2021255; Kurata T, 2011, IEEE INT SYM WRBL CO, P123, DOI 10.1109/ISWC.2011.30; Saegusa S, 2011, MICROSYST TECHNOL, V17, P1169, DOI 10.1007/s00542-010-1219-1; Okayasu M, 2010, J MECH SCI TECHNOL, V24, P1261, DOI 10.1007/s12206-010-0332-5; Shoval S, 1998, IEEE T BIO-MED ENG, V45, P1376, DOI 10.1109/10.725334; Lin Q, 2014, SENSORS-BASEL, V14, P18670, DOI 10.3390/s141018670; Bahadir SK, 2012, SENSOR ACTUAT A-PHYS, V179, P297, DOI 10.1016/j.sna.2012.02.027; Cardin S, 2007, VISUAL COMPUT, V23, P109, DOI 10.1007/s00371-006-0032-4; Molton N, 1998, IMAGE VISION COMPUT, V16, P251, DOI 10.1016/S0262-8856(97)00087-5; Balakrishnan G, 2006, WORLD ACADEMY OF SCI, V20, P206; Balakrishnan G, 2007, ENGINEERING LETTERS, V14, P1; Benjamin JM, 1973, P SAN DIEG BIOM S, V12, P53; Bernabei D, 2011, INT C IND POS IND NA, P21; Bharathi S, 2012, INT J POWER CONTROL, V3, P51; Ulrich I, 2001, IEEE T SYST MAN CY A, V31, P131, DOI 10.1109/3468.911370; Dambhare S, 2011, IJCA P 2 NAT C INF C, P31; BOLGIANO DR, 1967, IEEE J QUANTUM ELECT, VQE 3, P268, DOI 10.1109/JQE.1967.1074528; Dunai L, 2010, IECON 2010 - 36th Annual Conference of IEEE Industrial Electronics, DOI 10.1109/IECON.2010.5675535; Filipe V, 2012, PROCEDIA COMPUT SCI, V14, DOI 10.1016/j.procs.2012.10.011; GOMEZ JD, 2011, P 13 INT ACM SIGACCE, P293; Halabi O, 2012, P NICOGRAPH INT 2012, P120; Hersh M., 2008, ASSISTIVE TECHNOLOGY; Ikarashi M, 2000, PROCEEDINGS OF THE I, V2, P337; Imadu A, 2011, PROCEEDINGS OF THE 4, P34; Kajimoto H, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P303; Kajimoto H, 1999, 9 INT C ART REAL TEL; Kawai Y, 2002, P 16 INT C PATT REC, V3, P974; Khan A, 2012, 13 INT C COMP HELP P, V7383, P588; Kotani S, 1996, ROBOT AUTON SYST, V17, P119, DOI 10.1016/0921-8890(95)00067-4; Kulyukin V, 2004, PROCEEDINGS OF THE 2, P2004; Lee HP, 2014, 6 INT C FUT COMP TEC, P13; Malvern Benjamin J, 1974, J REHABIL RES DEV BP, V10-22, P443; Manduchi R, 2008, LECT NOTES COMPUT SC, V5105, P1135, DOI 10.1007/978-3-540-70540-6_170; Manning C., 2008, INTRO INFORM RETRIEV; Massie HT, 1994, P ASME WINT ANN M S, P295; Matusiak K, 2013, 6 INT C HUM SYST INT, P1; Meers S, 2007, 2007 AUSTR C ROB AUT, P1; MORRISSETTE DL, 1981, J VISUAL IMPAIR BLIN, V75, P244; Muhammad A, 2010, J AM SCI, V7, P480; Paul R, 2010, 12 INT C MOB TRANSP; Pressey N., 1977, FOCUS, V11, P35; Rohan P, 2007, 11 INT C MOB TRANSP; Saito T, 2002, PROCEEDINGS OF THE I, V2, P316; Salerno M, 2013, INT J HUM-COMPUT INT, V4, P25; Gomez JV, 2012, PROCEDIA COMPUT SCI, V14, DOI 10.1016/j.procs.2012.10.025; Shirai Y, 1987, 3 DIMENSIONAL COMPUT; Takizawa H, 2013, 6 INT C HUM SYST INT, P1; Tatsumi H, 2007, IEEE INT C SYST MAN, P3719; Ueda T, 2006, 32 ANN C IEEE IND EL, P3058, DOI [10.1109/IECON.2006.347767, DOI 10.1109/IEC0N.2006.347767]; Velzquez R, 2003, PROCEEDINGS OF EUROH, V2003, P456; Vera P, 2014, PATTERN ANAL APPL, V17, P623, DOI 10.1007/s10044-013-0328-8; Wahab MHA, 2011, INTERNATIONAL JOURNA, V8, P21; Wang Z, 2014, LECT NOTES COMPUTER, V8325, P449, DOI [10.1007/978-3-319-04114-8_38, DOI 10.1007/978-3-319-04114-8_]; WHO, 2014, WHO MED CTR VIS IMP; Yasumuro Y, 2003, LECT NOTES COMPUT SC, V2615, P409; Zollner M., 2011, LECT NOTES COMPUTER, V6949, P584	61	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1617-4909	1617-4917		PERS UBIQUIT COMPUT	Pers. Ubiquitous Comput.	AUG	2015	19	5-6					955	965		10.1007/s00779-015-0841-4		11	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CP3UV	WOS:000359809000014		
J	Suralta, RR; Lucob, NB; Perez, LM; Niones, JM; Nguyen, HT				Suralta, Roel R.; Lucob, Nonawin B.; Perez, Loida M.; Niones, Jonathan M.; Nguyen, Henry T.			Developmental and Quantitative Trait Loci Analyses of Root Plasticity in Response to Soil Moisture Fluctuation in Rice	PHILIPPINE JOURNAL OF CROP SCIENCE			English	Article						doubled-haploid lines; quantitative trait loci; rice; root plasticity; soil moisture fluctuations	ORYZA-SATIVA L.; DRY-MATTER PRODUCTION; SEGMENT SUBSTITUTION LINES; DROUGHT-RESISTANCE; AERENCHYMA DEVELOPMENT; GENOTYPIC VARIATION; VEGETATIVE STAGE; OXYGEN-TRANSPORT; MAPPING QTLS; GROWTH	Soil moisture fluctuation (SMF) stress, such as transient waterlogged-to-drought conditions and vice versa, negatively affect the productivity of rainfed lowland rice. This study was conducted to quantify root plastic developmental responses of doubled-haploid lines (DHLs) to soil moisture fluctuation stress and analyze the quantitative trait loci (QTL) associated with such plasticity. Ninety DHLs and their parents, CT9993 and IR62266, were grown under continuously waterlogged (CWL) and SMF conditions. Plasticity was calculated as the difference between the mean values of the trait between SMF and CWL grown plants for each DHL. Among component root traits, the number of L-type lateral roots (LR) had the greatest promotion under SMF, which greatly contributed to the plasticity in total LR length. and hence total root length especially at deeper soil layer. Thirty QTLs for different root plasticity traits under SMF were detected at different soil depths, which explained about 8.3 to 20.9% of the total phenotypic variations. Three QTLs (qPLLR(20)-3 and qPTLLR(20)-7 at 10-20 cm soil depth, and qPLLR(30)-2 at 20-30 cm soil depth) associated with the plasticity in the number of L-type LR were detected in chromosomes 3, 7 and 2, respectively. The plasticity of correlated component-root traits, such as between the number of nodal roots and total nodal root length, and between total lateral root length and total root length at certain soil depth, have QTLs overlapping in the same regions, suggesting their possible similar genetic controls under SMF. The root plasticity QTLs for the number and length of L-type LR did not overlap in any of the chromosomal regions, indicating that the plasticity expressions of these two traits have different genetic controls under SMF.	[Suralta, Roel R.; Perez, Loida M.; Niones, Jonathan M.] Philippine Rice Res Inst, Cent Expt Stn, Sci City Of Munoz 3119, Nueva Ecija, Philippines; [Lucob, Nonawin B.] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nguyen, Henry T.] Univ Missouri, Columbia, MO 65211 USA	Suralta, RR (reprint author), Philippine Rice Res Inst, Cent Expt Stn, Sci City Of Munoz 3119, Nueva Ecija, Philippines.	rrsmfs@yahoo.com			Department of Agriculture-Biotechnology Project Implementation Unit (DA-Biotech PIU) research grant [DABIOTECH-F1114]	We acknowledge research funding from the Department of Agriculture-Biotechnology Project Implementation Unit (DA-Biotech PIU) research grant (DABIOTECH-F1114). We thank the International Rice Research Institute (IRRI) for providing the seeds of CT9993 and IR62266 and their DHLs.	Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Siopongco JDLC, 2006, PLANT PROD SCI, V9, P141, DOI 10.1626/pps.9.141; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Serraj R, 2009, ADV AGRON, V103, P41, DOI 10.1016/S0065-2113(09)03002-8; Kamoshita A, 2008, FIELD CROP RES, V109, P1, DOI 10.1016/j.fcr.2008.06.010; Kamoshita A, 2002, CROP SCI, V42, P255; Zhang J, 2001, THEOR APPL GENET, V103, P19, DOI 10.1007/s001220000534; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Cairns JE, 2009, FIELD CROP RES, V114, P108, DOI 10.1016/j.fcr.2009.07.009; Babu RC, 2003, CROP SCI, V43, P1457; Banoc Dionisio M., 2000, Plant Production Science, V3, P335; Ito K, 2006, PHYSIOL PLANTARUM, V127, P260, DOI 10.1111/j.1399-3054.2006.00657.x; Kameoka E, 2015, PLANT PROD IN PRESS; Kano M, 2011, PLANT SOIL, V342, P189; KANO-NAKATA M, 2011, PLANT PROD SCI, V14, P329; Kano-Nakata M, 2012, METHODOLOGIES ROOT D, P3; Kato Y, 2006, PLANT PROD SCI, V10, P3; Niones JM, 2013, PLANT PROD SCI, V16, P205, DOI 10.1626/pps.16.205; Niones JM, 2012, PLANT SOIL, V359, P107, DOI 10.1007/s11104-012-1178-7; Niones JM, 2015, PLANT SOIL, V391, P63, DOI 10.1007/s11104-015-2404-x; Siopongco JDLC, 2005, PLANT PROD SCI, V8, P497, DOI 10.1626/pps.8.497; Siopongco JDLC, 2009, PLANT PROD SCI, V12, P17, DOI 10.1626/pps.12.17; Srinivasan S, 2008, PLANT GROWTH REGUL, V56, P245, DOI 10.1007/s10725-008-9304-5; Suralta RR, 2008, ENVIRON EXP BOT, V64, P75, DOI 10.1016/j.envexpbot.2008.01.004; Suralta RR, 2012, PHILIPP J CROP SCI, V37, P1; Suralta RR, 2008, PLANT PROD SCI, V11, P457, DOI 10.1626/pps.11.457; Suralta RR, 2008, PLANT PROD SCI, V11, P324, DOI 10.1626/pps.11.324; Suralta RR, 2010, PHILIPP AGRIC SCI, V93, P458; Suralta RR, 2010, PLANT SOIL, V332, P87, DOI 10.1007/s11104-009-0275-8; Wang H., 2006, PLANT ENV INTERACTIO, P271, DOI 10.1201/9781420019346.ch10; Wang H, 2004, P WORLD RIC RES C TS, P464; Yamauchi A., 1996, DYNAMICS ROOTS NITRO, P211; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53	35	0	0	CROP SCIENCE SOC PHILLIPPINES	COLLEGE LAGUNA	PO BOX 165, COLLEGE LAGUNA, 4031, PHILIPPINES	0115-463X			PHILIPP J CROP SCI	Philipp. J. Crop Sci.	AUG	2015	40	2					12	24				13	Agronomy	Agriculture	CP7XE	WOS:000360102100002		
J	Ohmaru, T; Fujita, Y; Sugitani, M; Shimokawa, M; Fukushima, K; Kato, K				Ohmaru, Takako; Fujita, Yasuyuki; Sugitani, Maiko; Shimokawa, Mototsugu; Fukushima, Kotaro; Kato, Kiyoko			Placental elasticity evaluation using virtual touch tissue quantification during pregnancy	PLACENTA			English	Article						Acoustic radiation force impulse; Fetal growth restriction; Placental elasticity; Placental histological change; Pregnancy induced hypertension; Virtual touch tissue quantification	ACOUSTIC RADIATION FORCE; IMPULSE TECHNOLOGY; INDEXES; LIVER	Introduction: Virtual touch tissue quantification (VTTQ) has been developed to evaluate tissue elasticity. Our previous study using delivered placentas showed increased elasticity in fetal growth restriction (FGR). Therefore, we investigated changes in placental elasticity during pregnancy, including complicated pregnancies. Methods: Based on complications, 199 women were divided into 5 groups (normal, FGR, pregnancy induced hypertension (PIH), diabetes mellitus and collagen disease), and shear wave velocity (SWV) of the placenta, measured using VTTQ was compared. A cross-sectional study was performed with the 143 normal cases to construct the reference range. The association between placental SWV and the expression ratio of collagen fibers in the placenta stained with Masson's trichrome was determined. Results: The SWV was safely measured for all participants. The correlation between SWV and gestational weeks was not significant. The mean +/- SD SWVs in the normal, FGR, and PIH groups were 0.98 +/- 0.21, 1.28 +/- 0.39, and 1.60 +/- 0.45 m/sec, respectively. The FGR and PIH groups had significantly higher SWVs than that of the normal group. SWV and the expression ratio of collagen fibers were significantly correlated. Discussion: Based on the present findings, changes in SWV during pregnancy were associated with placental fibrosis, and increased SWV in PIH and/or FGR cases might be influenced by infarction, ischemic changes, and inflammation, as well as fibrosis. In conclusion, the measurement of placental SWV is potentially useful to evaluate the condition of the placenta during pregnancy. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohmaru, Takako; Fujita, Yasuyuki; Sugitani, Maiko; Fukushima, Kotaro; Kato, Kiyoko] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka 812, Japan; [Shimokawa, Mototsugu] Kyushu Natl Canc Ctr, Clin Res Inst, Dept Canc Informat Res, Fukuoka, Japan	Fujita, Y (reprint author), Kyushu Univ Hosp, Matern & Perinatal Care Ctr, Maidashi 3-1-1, Fukuoka 8128582, Japan.	yfujita@med.kyushu-u.ac.jp			"FUKUOKA" OBGYN Researcher's Charity Foundation Fund, Japan	This work was supported by grants-in-aid of the "FUKUOKA" OBGYN Researcher's Charity Foundation Fund, Japan.	Sugitani M, 2013, PLACENTA, V34, P1009, DOI 10.1016/j.placenta.2013.08.014; Palmeri ML, 2006, IEEE T ULTRASON FERR, V53, P2065, DOI 10.1109/TUFFC.2006.146; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Fahey BJ, 2005, ULTRASOUND MED BIOL, V31, P1185, DOI 10.1016/j.ultrasmedbio.2005.05.004; Gu JY, 2012, J ULTRAS MED, V31, P763; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Kurmanavicius J, 1997, ULTRASOUND OBST GYN, V10, P112, DOI 10.1046/j.1469-0705.1997.10020112.x; D'Onofrio M, 2013, WORLD J GASTROENTERO, V19, P4841, DOI 10.3748/wjg.v19.i30.4841; Bai M, 2012, J ULTRAS MED, V31, P289; Apel-Sarid L, 2009, ARCH GYNECOL OBSTET, V280, P549, DOI 10.1007/s00404-009-0937-z; D'Onofrio M, 2010, PANCREAS, V39, P684, DOI 10.1097/MPA.0b013e3181c34d19; Furuya Mitsuko, 2008, Vasc Health Risk Manag, V4, P1301; Kovo M., 2010, AM J OBSTET GYNECOL, V202, DOI DOI 10.1016/J.AJOG.2010.01.012; Majumdar S., 2005, J ANAT SOC INDIA, V54, P1; Mateen Mohammad Abdul, 2012, JOP, V13, P36; Nightingale K, 2002, ULTRASONIC IMAGING, V24, P129; Seino Y., 2010, J DIABETES INVEST, V1, P212; Shinozuka N., 2002, ULTRASOUND REV OBSTE, V2, P156, DOI 10.1080/14722240208500478; Sin J., 2014, PLOS PATHOG, V10; THOMPSON RS, 1988, BRIT J OBSTET GYNAEC, V95, P581, DOI 10.1111/j.1471-0528.1988.tb09487.x; Watanabe K, 2013, HYPERTENS RES PREGNA, V1, P3	21	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	AUG	2015	36	8					915	920		10.1016/j.placenta.2015.06.008		6	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CP4TH	WOS:000359875000020		
J	d'Arezzo, FB; Haigh, S; Talesnick, M; Ishihara, Y				d'Arezzo, Francesca Burali; Haigh, Stuart; Talesnick, Mark; Ishihara, Yukihiro			Measuring horizontal stresses during jacked pile installation	PROCEEDINGS OF THE INSTITUTION OF CIVIL ENGINEERS-GEOTECHNICAL ENGINEERING			English	Article						granular materials; piles & piling; stress analysis	CAVITY EXPANSION; SHAFT FRICTION; SOIL PRESSURE; SAND; TESTS; DISPLACEMENT	Jacking is an installation technique for displacement piles which is commonly used onshore in urban environments owing to its low noise and vibration. During pile jacking, stress changes occur in the soil which are substantial close to the pile, but also extend a significant radial distance. These stresses are difficult to measure accurately owing to arching around stress sensors. In the field, stress measurements are commonly made by means of an adjacent pile whose stiffness changes the stress field within the soil. Accurate measurements of stresses due to the installation of a single pile under laboratory conditions are needed in order to quantify this error. In this paper, null gauges that do not suffer from membrane deflection are used to measure horizontal stress changes during the jacked installation of a cylindrical pile in dry sand. Stresses are measured by means of both an adjacent pre-installed square pile and in-soil sensors. The paper also presents a comparison between the centrifuge results and the radial stress distribution estimated using conventional methods, such as Boussinesq's elastic analysis and elasto-plastic spherical cavity expansion.	[d'Arezzo, Francesca Burali; Haigh, Stuart] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Talesnick, Mark] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel; [Ishihara, Yukihiro] Giken Ltd, Kochi, Japan	d'Arezzo, FB (reprint author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.				Giken Ltd; Coleman-Cohen Exchange Programme	The authors would like to acknowledge the efforts of Mr M. Ringle of the Technion - Israel Institute of Technology for the design and production of the square pile. The research was funded by Giken Ltd and the Coleman-Cohen Exchange Programme, which the authors gratefully acknowledge.	Ahlvin RG, 1962, BULLETIN, V342; KISHIDA H, 1987, GEOTECHNIQUE, V37, P45; Jardine RJ, 2013, GEOTECHNIQUE, V63, P1, DOI 10.1680/geot.9.P.137; Salgado R, 1997, J GEOTECH GEOENVIRON, V123, P344, DOI 10.1061/(ASCE)1090-0241(1997)123:4(344); RANDOLPH MF, 1994, GEOTECHNIQUE, V44, P427; YU HS, 1991, GEOTECHNIQUE, V41, P173; White DJ, 2004, GEOTECHNIQUE, V54, P375, DOI 10.1680/geot.2004.54.6.375; CARTER JP, 1986, GEOTECHNIQUE, V36, P349; SCHOFIELD AN, 1980, GEOTECHNIQUE, V30, P227; White DJ, 2004, GEOTECHNIQUE, V54, P645, DOI 10.1680/geot.54.10.645.56344; Bolton MD, 1999, GEOTECHNIQUE, V49, P543; Basu P, 2010, INT J NUMERICAL ANAL, V35, P1605; BOLTON MD, 1986, GEOTECHNIQUE, V36, P65; Chow FC, 1996, THESIS IMPERIAL COLL; Fioravante V, 2002, SOILS FOUND, V42, P23; Foray P, 1991, P 1 INT S CAL CHAMB, P147; Haigh SK, 2010, PHYS MODELLING GEOTE; Ko HY, 1984, ANAL DESIGN PILE FDN, P21; LEHANE BM, 1993, J GEOTECH ENG-ASCE, V119, P19, DOI 10.1061/(ASCE)0733-9410(1993)119:1(19); Lehane BM, 1992, THESIS IMPERIAL COLL; Madabhushi SPG, 2006, P PHYS MOD GEOT 6 IC; Porcino D., 2003, GEOTECH TEST J, V26, P1; POULOS HG, 1987, J GEOTECH ENG-ASCE, V113, P216; Talesnick M, 2013, CAN GEOTECH J, V50, P716, DOI 10.1139/cgj-2012-0347; Talesnick M, 2005, GEOTECH TEST J, V28, P171, DOI 10.1520/GTJ12484; Talesnick ML, 2014, INT J PHYS MODEL GEO, V14, P3, DOI 10.1680/ijpmg.13.00008; Taylor R.N., 1994, GEOTECHNICAL CENTRIF; WEILER WA, 1982, J GEOTECH ENG-ASCE, V108, P1529; Zhu BT, 2009, SOILS FOUND, V49, P675, DOI 10.3208/sandf.49.675	29	0	0	ICE PUBLISHING	WESTMINISTER	INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND	1353-2618			P I CIVIL ENG-GEOTEC	Proc. Inst. Civil Eng.-Geotech. Eng.	AUG	2015	168	4					306	318		10.1680/geng.14.00069		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CP7QQ	WOS:000360083400004		
J	Liao, HJ; Cheng, SH; Wong, RKN; You, CF; Masaoka, A; Hsieh, CD				Liao, Hung-Jiun; Cheng, Shih-Hao; Wong, Ricky K. N.; You, Chen-Fa; Masaoka, Akihiro; Hsieh, Cheng-Da			Grouting to remove piles from a tunnelling machine cutter-head	PROCEEDINGS OF THE INSTITUTION OF CIVIL ENGINEERS-GEOTECHNICAL ENGINEERING			English	Article						geotechnical engineering; grouting; tunnels & tunnelling		This paper provides a summary report on measures taken to remove embedded steel 'H' pile obstacles from the cutter head of an advancing tunnel-boring machine. The piles were part of the soil-mixing retaining wall built for the cut-and-cover tunnel construction of a Taiwan high-speed rail tunnel and a Taiwan railways administration tunnel, which were directly above the mass rapid transit tunnel that was to be constructed. The collision zone between the boring machine and piles was below groundwater level and was approximately 23 m below the ground surface in a silty sand layer. To remove the piles safely from the cutter head, horizontal grouting from two adjacent work pits was conducted for waterproofing and solidification purposes. By controlling the amount of soil being flushed out during the grout hole drilling first, and also the pressure used for grouting later, the measured tunnel settlement resulting from grouting was negligible. Because of the favourable watertightness of the grouted zone and the dewatering influence of a nearby construction site, pile removal was conducted under particularly dry working conditions. In total, 12 piles were identified in the collision zone and were successfully removed from the cutter head by hand tools.	[Liao, Hung-Jiun; Hsieh, Cheng-Da] Natl Taiwan Univ Sci & Technol, Dept Civil & Construct Engn, Taipei, Taiwan; [Cheng, Shih-Hao] Natl Taiwan Univ Sci & Technol, Taiwan Bldg Technol Ctr, Taipei, Taiwan; [Wong, Ricky K. N.] SanShin Corp, Taipei Branch, Taipei, Taiwan; [You, Chen-Fa] Cent Dist Project Off, Civil Engn Site Off 4, Dept Rapid Transit Syst, Taipei, Taiwan; [Masaoka, Akihiro] Maeda Corp, Dept Civil Engn, Int Operat Div, Tokyo, Japan	Liao, HJ (reprint author), Natl Taiwan Univ Sci & Technol, Dept Civil & Construct Engn, Taipei, Taiwan.				Ministry of Science and Technology of the Taiwan government; SanShin Corporation [NSC 100-2622-E-011-013-CC3]; Department of Rapid Transit Systems; Maeda Construction Company; Taipei City government	The authors thank the Ministry of Science and Technology of the Taiwan government and SanShin Corporation for providing financial support for this study (NSC 100-2622-E-011-013-CC3). Support from the Department of Rapid Transit Systems, the Taipei City government and the Maeda Construction Company is also greatly appreciated.	ASCE SmartBrief, 2014, BERTH SEAL FIX COMP; Chen KJ, 2008, PROCEEDINGS OF FIRST INTERNATIONAL CONFERENCE OF MODELLING AND SIMULATION, VOL V, P1; Ho TY, 2008, CHINESE J UNDERGROUN, V4, P749; MAA (Moh and Associates), 2011, INV REP DET H PIL OB; Maeda (Maeda Construction Company Taiwan Office), 2012, CG590A MAED CONSTR C; SanShin (SanShin Corporation Taipei Branch), 2011, CONSTR PLAN GROUT WO; Yamamura K, 1977, ENG PROBLEMS GROUNDW	7	0	0	ICE PUBLISHING	WESTMINISTER	INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND	1353-2618			P I CIVIL ENG-GEOTEC	Proc. Inst. Civil Eng.-Geotech. Eng.	AUG	2015	168	4					358	370		10.1680/geng.14.00095		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CP7QQ	WOS:000360083400008		
J	de Oliveira, JAP				Puppim de Oliveira, Jose A.			Governance for Pro-poor Urban Development: Lessons from Ghana	PUBLIC ADMINISTRATION AND DEVELOPMENT			English	Book Review									[Puppim de Oliveira, Jose A.] United Nations Univ UNU IAS, Tokyo, Japan; [Puppim de Oliveira, Jose A.] Getulio Vargas Fdn FGV EBAPE, Brazilian Sch Publ & Business Adm, Rio De Janeiro, Brazil	de Oliveira, JAP (reprint author), United Nations Univ UNU IAS, Tokyo, Japan.	japo3@yahoo.com					Obeng-Odoom F., 2013, GOVERNANCE PROPOOR U	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-2075	1099-162X		PUBLIC ADMIN DEVELOP	Public Adm. Dev.	AUG	2015	35	3					219	220		10.1002/pad.1720		2	Planning & Development; Public Administration	Public Administration	CP7MB	WOS:000360071000005		
J	Esposito, G; Valenzi, S; Islam, T; Bornstein, MH				Esposito, Gianluca; Valenzi, Stefano; Islam, Tanvir; Bornstein, Marc H.			Three physiological responses in fathers and non-fathers' to vocalizations of typically developing infants and infants with Autism Spectrum Disorder	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						ASD cry; Atypical cry; Communication; Atypical development	YOUNG-CHILDREN; DISTRESS; EXPRESSION; CRY; DELAY; RISK	Children with ASD, even before receiving a formal diagnosis, express atypical patterns of distress vocalizations (namely, episodes of crying). Their cries have higher fundamental frequencies, shorter inter-bout pauses, and fewer utterances. Cries of children with ASD are also perceived differently from other cries, and these perceptual differences may alter parent-infant interaction. This study assessed multiple physiological responses in fathers and non-fathers to atypical distress vocalizations (cries of children with ASD), acoustically matched typical distress vocalizations (cries of typically developing children), and positive vocalizations (laughter of typically developing children). The experimental procedures were designed to measure how components of the autonomic nervous system respond to typical and atypical infant vocalizations. Three convergent methodologies (Galvanic Skin Response-GSR; cardiac dynamics via Inter-Beat Interval-IBI; right hand temperature change-RHTC) were performed on two groups with contrasting caregiving experience: fathers of typically developing children (n = 10) and non-fathers (n = 10). Inferential statistical analysis compared the two groups (fathers, non-fathers) and three stimulus types (ASD cry, typical cry, laughter) for the three measures (GSR, IBI, RHTC). Both fathers and non-fathers showed greater negative responses (increased GSR) to ASD cries compared to typical cries and laughter. Fathers showed higher IBI and greater temperature increases (RHTC) than non-fathers while listening to typical and atypical cries. Fathers and non-fathers showed more emotional arousal mediated by sympathetic activation while listening to cries of children with ASD. Fathers were calmer and acted more promptly than non-fathers while listening to typical cries, perhaps because the fathers had more experience in caring for crying infants. These findings point to similarities and differences in fathers' and non-fathers' physiological responsiveness to cries of children with ASD and might guide specific intervention programs for parents of children at risk of ASD. (C) 2015 Elsevier Ltd.. All rights reserved.	[Esposito, Gianluca] Univ Trent, Affiliat Behav & Physiol Lab, Dept Psychol & Cognit Sci, I-38068 Rovereto, TN, Italy; [Esposito, Gianluca] Nanyang Technol Univ, Div Psychol, Early Cognit Lab, Singapore 639798, Singapore; [Valenzi, Stefano; Islam, Tanvir] RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Saitama, Japan; [Islam, Tanvir] RIKEN Brain Sci Inst, Lab Dev Gene Regulat, Saitama, Japan; [Bornstein, Marc H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Esposito, G (reprint author), Univ Trent, Affiliat Behav & Physiol Lab, Dept Psychol & Cognit Sci, I-38068 Rovereto, TN, Italy.	gianluca.esposito@unitn.it	Esposito, Gianluca/K-9353-2013	Esposito, Gianluca/0000-0002-9442-0254	Japan Society for the Promotion of Science [JSPS PE09064, 24730563, 2402747]; FPR Program (RIKEN Brain Science Institute); NIH-NICHD (USA)	All participants in this study are gratefully acknowledged. This research was supported by the ST fellowship from Japan Society for the Promotion of Science (JSPS PE09064), Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (Projects # 24730563 and #2402747), the FPR Program (RIKEN Brain Science Institute), and the Intramural Research Program of the NIH-NICHD (USA).	Adachi T., 1985, JAPANESE J ED PSYCHO, V33, P146; Pleck JH, 2012, PARENT-SCI PRACT, V12, P243, DOI 10.1080/15295192.2012.683365; RimmKaufman SE, 1996, MOTIV EMOTION, V20, P63, DOI 10.1007/BF02251007; Oller DK, 2010, P NATL ACAD SCI USA, V107, P13354, DOI 10.1073/pnas.1003882107; LaGasse LL, 2005, MENT RETARD DEV D R, V11, P83, DOI 10.1002/mrdd.20050; Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; BARR RG, 1991, DEV MED CHILD NEUROL, V33, P601; Bieberich AA, 1998, J AUTISM DEV DISORD, V28, P333, DOI 10.1023/A:1026016804357; Boersma Paul, 2005, PRAAT DOING PHONETIC; Bornstein M. H., 2015, HDB CHILD PSYCHOL DE, V4, P55; Esposito G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106705; Esposito G, 2015, EARLY CHILD DEV CARE, V185, P438, DOI 10.1080/03004430.2014.932153; Esposito G, 2011, RES AUTISM SPECT DIS, V5, P1510, DOI 10.1016/j.rasd.2011.02.013; Esposito G, 2015, JPN PSYCHOL RES, V57, P126, DOI 10.1111/jpr.12072; Esposito G, 2012, RES DEV DISABIL, V33, P1059, DOI 10.1016/j.ridd.2012.01.014; Esposito G, 2014, J AUTISM DEV DISORD, V44, P975, DOI 10.1007/s10803-013-1940-6; Esposito G, 2008, RES AUTISM SPECT DIS, V2, P371, DOI 10.1016/j.rasd.2007.09.003; Esposito G., 2010, EARLY CHILD DEV CARE, V180, P1093, DOI DOI 10.1080/03004430902775633; Esposito G, 2009, FOCUS AUTISM DEV DIS, V24, P240, DOI 10.1177/1088357609336449; Esposito G, 2013, RES DEV DISABIL, V34, P2717, DOI 10.1016/j.ridd.2013.05.036; Fox J., 1997, APPL REGRESSION ANAL; Gray P. B., 2010, FATHERHOOD EVOLUTION; Griffiths R., 1996, GRIFFITHS MENTAL DEV; HANSON R, 1982, CHILD CARE HLTH DEV, V8, P151, DOI 10.1111/j.1365-2214.1982.tb00278.x; Hollingshead A, 1975, 4 FACTOR INDEX SOCIA; Lester B. M., 1990, NONVERBAL VOCAL COMM, P41; Lester B. M., 2008, ENCY INFANT EARLY CH, P332; Lin HC, 2007, INFANCY, V11, P175; Luiz D. M., 2004, GRIFFITHS MENTAL DEV; Maupin A. N., 2015, PARENT-SCI PRACT, V15, P1; Ozturk Y, 2014, RES AUTISM SPECT DIS, V8, P1295, DOI 10.1016/j.rasd.2014.07.001; Parke R. D., 2002, HDB PARENTING, V3, P27; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Sheinkopf SJ, 2000, J AUTISM DEV DISORD, V30, P345, DOI 10.1023/A:1005531501155; Venuti P, 2012, RES DEV DISABIL, V33, P2255, DOI 10.1016/j.ridd.2012.06.011; von Eye A., 2002, CONFIGURAL FREQUENCY; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wolff P., 1969, DETERMINANTS INFANT, V4; Wood RM, 2001, CHILD DEV, V72, P1287, DOI 10.1111/1467-8624.00348; Zeskind P. S., 2001, BIOBEHAVIORAL ASSESS, P149	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	AUG-SEP	2015	43-44						43	50		10.1016/j.ridd.2015.06.007		8	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	CP4TS	WOS:000359876100005		
J	Ueno, S; Kawano, K; Ito, Y; Ra, E; Nakanishi, A; Nagaya, M; Terasaki, H				Ueno, Shinji; Kawano, Kenichi; Ito, Yasuki; Ra, Eimei; Nakanishi, Ayami; Nagaya, Masatoshi; Terasaki, Hiroko			NEAR-INFRARED REFLECTANCE IMAGING IN EYES WITH ACUTE ZONAL OCCULT OUTER RETINOPATHY	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						acute zonal outer retinopathy; adaptive optics fundus camera; confocal scanning laser ophthalmoscopy; near-infrared reflectance; photoreceptor damage; photoreceptor inner segment ellipsoid band; spectral-domain optical coherence tomography; visual field defect	SCANNING LASER OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; ADAPTIVE OPTICS; ABNORMALITIES; SEGMENT; FUNDUS	Purpose:To investigate the confocal scanning laser ophthalmoscopic images obtained with near-infrared (IR) light in eyes with acute zonal occult outer retinopathy (AZOOR).Methods:Observational case series. The medical records of 12 eyes of 10 patients with AZOOR were reviewed. Scanning laser ophthalmoscopic images obtained from the AZOOR eyes were compared with images obtained by spectral-domain optical coherence tomography, by fundus autofluorescence, and by an adaptive optics fundus camera.Results:In 8 of 12 eyes, abnormal hyporeflective areas were detected in the IR images, and the other 4 eyes did not have specific abnormalities in the IR images. The boundaries of the abnormal hyporeflective areas corresponded with the border of the irregularity of photoreceptor inner segment ellipsoid band in the spectral-domain optical coherence tomography images. The cone mosaics of the adaptive optics fundus image were disrupted in the abnormal hyporeflective area of the IR image. However, the areas of fundus autofluorescence abnormalities did not coincide with the hyporeflective areas in the IR images.Conclusion:The presence of hyporeflective areas in the IR images of patients with AZOOR suggests impairment of the photoreceptors area. The IR images would be useful to evaluate eyes with AZOOR.	[Ueno, Shinji; Kawano, Kenichi; Ito, Yasuki; Ra, Eimei; Nakanishi, Ayami; Nagaya, Masatoshi; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4668550, Japan	Ueno, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	ueno@med.nagoya-u.ac.jp	Ueno, Shinji/M-5063-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [25462709 SU]	Supported by Scientific Research C (25462709 SU) from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahn SJ, 2013, JAMA OPHTHALMOL, V131, P880, DOI 10.1001/jamaophthalmol.2013.172; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Elsner AE, 1996, VISION RES, V36, P191, DOI 10.1016/0042-6989(95)00100-E; Mkrtchyan M, 2012, AM J OPHTHALMOL, V153, P757, DOI 10.1016/j.ajo.2011.09.007; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; GASS JDM, 1993, J CLIN NEURO-OPHTHAL, V13, P79; Diniz B, 2013, BRIT J OPHTHALMOL, V97, P285, DOI 10.1136/bjophthalmol-2012-302575; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P70, DOI 10.1136/bjo.2004.042416; JACOBSON SG, 1995, OPHTHALMOLOGY, V102, P1187; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; MANIVANNAN A, 1994, BRIT J OPHTHALMOL, V78, P84, DOI 10.1136/bjo.78.2.84; Miyake Y, 1996, AM J OPHTHALMOL, V122, P644; Mrejen S, 2014, JAMA OPHTHALMOL, V132, P1089, DOI 10.1001/jamaophthalmol.2014.1683; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Takai Y, 2009, ACTA OPHTHALMOL, V87, P408, DOI 10.1111/j.1755-3768.2008.01269.x; Wolf-Schnurrbusch UEK, 2008, INVEST OPHTH VIS SCI, V49, P3095, DOI 10.1167/iovs.07-1460; Yamamoto Motoshi, 2009, International Ophthalmology, V29, P503, DOI 10.1007/s10792-008-9274-7; Yanagi Y, 2003, BRIT J OPHTHALMOL, V87, P509, DOI 10.1136/bjo.87.4.509; Yasunari T, 2000, LANCET, V356, P988, DOI 10.1016/S0140-6736(00)02716-1	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	AUG	2015	35	8					1521	1530		10.1097/IAE.0000000000000502		10	Ophthalmology	Ophthalmology	CP4HX	WOS:000359843700004		
J	Gomi, F; Oshima, Y; Mori, R; Kano, M; Saito, M; Yamashita, A; Iwata, E; Maruko, R				Gomi, Fumi; Oshima, Yuji; Mori, Ryusaburo; Kano, Mariko; Saito, Masaaki; Yamashita, Ayana; Iwata, Eiji; Maruko, Ruka		Fujisan Study Grp	INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY The Fujisan Study	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						polypoidal choroidal vasculopathy; photodynamic therapy; ranibizumab; combination	MACULAR DEGENERATION; JAPANESE PATIENTS; INTRAVITREAL RANIBIZUMAB; NEOVASCULARIZATION SECONDARY; VERTEPORFIN; EFFICACY; BEVACIZUMAB; INJECTIONS; SAFETY; LAPTOP	Purpose:To compare the 1-year results of initial or deferred photodynamic therapy (PDT) combined with intravitreal ranibizumab (IVR) for eyes with polypoidal choroidal vasculopathy.Methods:Prospectively, 72 men with treatment-naive polypoidal choroidal vasculopathy were randomized to initial or later PDT combined with IVR. In both groups, 2 additional monthly IVR followed. From Month 3, PDT and IVR were administered according to the retreatment criteria. Mean changes in the best-corrected visual acuity between baseline and Month 12 and central retinal thickness, the rate of eyes showing regression of polypoidal lesions, and number of additional treatments were compared.Results:The best-corrected visual acuity increased by a mean of 8.1 Early Treatment of Diabetic Retinopathy Study (ETDRS) letters in the initial PDT group and 8.8 ETDRS letters in the later PDT group, and there was a no significant difference (P = 0.59). The mean central retinal thickness decreased significantly in both groups but more so with combination therapy within the first 4 months; the difference was not significant at Month 12 (P = 0.30). The rate of eyes showing resolution of polypoidal lesions at 12 months was 62.1% in the initial PDT group and 54.8% in the later PDT group and again, there was no significant difference (P = 0.53). The mean number of additional IVR was 1.5 in initial PDT and 3.8 in later PDT; that of additional PDTs was 0.14 and 0.45, respectively, and they were significantly different (P < 0.001 and P = 0.013, respectively).Conclusion:Both initial and deferred PDT combined with IVR to treat polypoidal choroidal vasculopathy show the similar visual and anatomical improvements at 12 months. Initial PDT combination leads to significantly fewer additional treatments.	[Gomi, Fumi] Sumitomo Hosp, Dept Ophthalmol, Osaka 5300005, Japan; [Gomi, Fumi] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan; [Oshima, Yuji] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan; [Mori, Ryusaburo] Surugadai Nihon Univ Hosp, Dept Ophthalmol, Fukuoka, Japan; [Kano, Mariko; Saito, Masaaki] Fukushima Med Univ, Dept Ophthalmol, Fukuoka, Japan; [Yamashita, Ayana] Kagawa Univ, Dept Ophthalmol, Fac Med, Takamatsu, Kagawa 760, Japan; [Iwata, Eiji; Maruko, Ruka] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Gomi, F (reprint author), Sumitomo Hosp, Dept Ophthalmol, Kita Ku, 5-3-20 Nakanoshima, Osaka 5300005, Japan.	gomi.fumi@gmail.com					Mori R, 2013, JPN J OPHTHALMOL, V57, P365, DOI 10.1007/s10384-013-0245-9; Hikichi T, 2012, AM J OPHTHALMOL, V154, P117, DOI 10.1016/j.ajo.2011.12.019; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophta.2003.12.056; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Oishi A, 2014, OPHTHALMOLOGY, V121, P1151, DOI 10.1016/j.ophtha.2013.12.037; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Nowak-Sliwinska P, 2013, PROG RETIN EYE RES, V37, P182, DOI 10.1016/j.preteyeres.2013.09.003; Ogino K, 2013, INVEST OPHTH VIS SCI, V54, P3771, DOI 10.1167/iovs.12-11494; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Hatz K, 2014, BRIT J OPHTHALMOL, V98, P188, DOI 10.1136/bjophthalmol-2013-303444; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Tano Yasuo, 2009, Nippon Ganka Gakkai Zasshi, V113, P1098; Lai TYY, 2011, RETINA-J RET VIT DIS, V31, P1581, DOI 10.1097/IAE.0b013e31820d3f3f; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Gomi F, 2010, AM J OPHTHALMOL, V150, P48, DOI 10.1016/j.ajo.2010.02.008; Honda S, 2009, OPHTHALMOLOGICA, V223, P333, DOI 10.1159/000221837; Tano Y, 2003, AM J OPHTHALMOL, V136, P1049, DOI 10.1016/S0002-9394(03)00576-2; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038; Kokame GT, 2014, OPHTHALMOLOGICA, V231, P94, DOI 10.1159/000354072; Liu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07018; Sato T, 2010, AM J OPHTHALMOL, V149, P947, DOI 10.1016/j.ajo.2009.12.038; Spaide RF, 2006, AM J OPHTHALMOL, V141, P149, DOI 10.1016/j.ajo.2005.07.025; Tano Y, 2010, ACTA OPHTHALMOL, V88, P309, DOI 10.1111/j.1755-3768.2009.01843.x; Ueno C, 2012, RETINA-J RET VIT DIS, V32, P2006, DOI 10.1097/IAE.0b013e31825c1c31	37	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	AUG	2015	35	8					1569	1576		10.1097/IAE.0000000000000526		8	Ophthalmology	Ophthalmology	CP4HX	WOS:000359843700010		
J	Kathiravan, P; Dubey, PK; Goyal, S; Mishra, BP; Singh, G; Deb, SM; Sadana, DK; Joshi, BK; Kataria, RS				Kathiravan, P.; Dubey, P. K.; Goyal, S.; Mishra, B. P.; Singh, G.; Deb, S. M.; Sadana, D. K.; Joshi, B. K.; Kataria, R. S.			Marker assisted evaluation of morphological and genetic attributes of sub-populations of Nili-Ravi buffalo: A vulnerable dairy type riverine breed of India	RUSSIAN JOURNAL OF GENETICS			English	Article							SIMULATION	In the present study, we report the distribution of true to type and atypical Nili-Ravi buffalo, a vulnerable dairy type riverine breed of North India and its underlying genetic structure. Out of total investigated buffaloes 73.5% had bilateral wall eyes while 5.4% had unilateral wall eyes and 21.1% had no wall eyes. 41.15% of Nili-Ravi buffaloes maintained in the breeding farm were having typical true to the type characteristics (both eyes walled, white markings in forehead, muzzle/chin, all the four legs and tail) while only 28.5% of Nili-Ravi buffaloes were true to the type under field conditions. Genotypic data were generated in four groups of Nili-Ravi buffalo (FMTNR-Typical Nili-Ravi from farm; FMANR-Atypical Nili-Ravi from farm; FDTNR-Typical Nili-Ravi from field; FDANR-Atypical Nili-Ravi from field) at 16 microsatellite loci. Comparative genetic analysis of various groups of Nili-Ravi buffaloes with Murrah revealed significant between group differences with an estimated global F (ST) of 0.063. Pair-wise F (ST) values ranged from 0.003 (between FDTNR and FDANR) to 0.112 (between FMTNR and FDTNR). Phylogenetic analysis and multi-dimensional scaling revealed clustering of FDTNR and FDANR together while FMTNR and FMANR clustered separately with Murrah in between farm and field Nili-Ravi buffaloes. Based on the results, the paper also proposes three pronged strategy for conservation and sustainable genetic improvement of Nili-Ravi buffalo in India.	[Kathiravan, P.; Dubey, P. K.; Goyal, S.; Mishra, B. P.; Sadana, D. K.; Joshi, B. K.; Kataria, R. S.] Natl Bur Anim Genet Resources, Karnal 132001, Haryana, India; [Singh, G.; Deb, S. M.] Cent Inst Res Buffaloes, Ludhiana, Punjab, India; [Kathiravan, P.] IAEA, Anim Prod & Hlth Sect, A-1400 Vienna, Austria; [Dubey, P. K.] Osaka Univ, Immune Regulat, WPI IFREC, Osaka, Japan; [Goyal, S.] RIKEN Ctr Life Sci, Yokohama, Kanagawa, Japan; [Mishra, B. P.] Indian Vet Res Inst, Div Anim Biotechnol, Bareilly 243122, Uttar Pradesh, India	Kathiravan, P (reprint author), Natl Bur Anim Genet Resources, GT Rd By Pass, Karnal 132001, Haryana, India.	katariaranji@yahoo.co.in			Indian Council of Agricultural Research, New Delhi	The authors are grateful to Directors of National Bureau of Animal Genetic Resources, Karnal and Central Institute for Research on Buffalo, Hisar for providing necessary facilities for the study. The study was undertaken as part of Inter-Institutional project funded by Indian Council of Agricultural Research, New Delhi.	Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Pritchard JK, 2000, GENETICS, V155, P945; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; BAUDOUIN L, 2000, ACTA HORTICULTURA, V546, P81; Borghese A, 2005, BUFFALO PRODUCTION R; Chopra S.C., 2005, P 7 NAT C AN GEN BRE; Das AK, 2008, BUFFALO BULL, V27, P265; Kathiravan P., 2010, RUSS J GENET, V46, P998; Kathiravan P., 2007, MONOGRAPH NBAGR; Kumar S, 2006, MOL ECOL, V15, P593, DOI 10.1111/j.1365-294X.2006.02837.x; Misk N. A., 1998, Veterinary Ophthalmology, V1, P195; Rischkowsky Barbara, 2007, STAT WORLDS AN GEN R; Sambrook J, 2001, MOL CLONING LAB MANU; Vij P.K., 2005, ANIM GENET RESOUR IN, V37, P75	18	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1022-7954	1608-3369		RUSS J GENET+	Russ. J. Genet.	AUG	2015	51	8					799	806		10.1134/S1022795415070054		8	Genetics & Heredity	Genetics & Heredity	CP7NY	WOS:000360076100010		
J	Islam, MP; Morimoto, T				Islam, M. P.; Morimoto, T.			Evaluation of a new heat transfer and evaporative design for a zero energy storage structure	SOLAR ENERGY			English	Article						Solar radiation; Evaporative medium; Solar chimney; Storage chamber	SYSTEMS; HOT	A passive evaporative zero energy storage structure (ZESS) has been developed as a low cost and eco-friendly cooler for storing perishable fruit and vegetables with moderate respiration rates. Evaporation is influenced by weather conditions (air temperature, relative humidity, and the direction and speed of the outside air) and the porous nature of the heat exchanging and evaporative media (pore space of gravel stone with thermal-hydraulic conductivity and vapor diffusion properties of the porous medium). The ZESS consists of two heat exchanging media (outside wall made of porous volcanic lava stone and inside wall made of solid clay brick), one evaporative medium (sand-zeolite-gravel stone), and one natural humidifier (detachable clay water tank) inside the storage area. The results obtained from the performance tests revealed that the temperature inside the ZESS was 15 degrees C lower than the outside air temperature, while the inside relative humidity was 20% higher than the outside relative humidity. As a result, the shelf life of stored tomato and eggplant inside the ZESS increased from 7 to 19 days and 4 to 9 days, respectively, with maximum watering of 29 L day(-1). Thus, a ZESS provides an excellent means of short-term preservation of fruit and vegetables soon after harvest. (C) 2015 Elsevier Ltd. All rights reserved.	[Islam, M. P.; Morimoto, T.] Ehime Univ, Fac Agr, Dept Biomech Syst, Matsuyama, Ehime 7908566, Japan	Islam, MP (reprint author), Ehime Univ, Fac Agr, Dept Biomech Syst, 3-5-7 Tarumi, Matsuyama, Ehime 7908566, Japan.	engr_parvezfpm@agr.ehime-u.ac.jp			Japan Society for the Promotion of Science [26450354]	The authors would like to acknowledge the financial support provided by the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 26450354).	Rincon J, 2001, SOL ENERGY, V71, P71, DOI 10.1016/S0038-092X(01)00010-X; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Lurie S, 1998, POSTHARVEST BIOL TEC, V14, P257, DOI 10.1016/S0925-5214(98)00045-3; Camargo JR, 2003, APPL THERM ENG, V23, P1537, DOI 10.1016/S1359-4311(03)00105-4; HUNT KJ, 1992, AUTOMATICA, V28, P1083, DOI 10.1016/0005-1098(92)90053-I; ASHRAE I-P, 2007, ASHRAE HDB, P1; Ben-Yehoshua S., 1987, POSTHARVEST PHYSL VE, P113; Bradshaw P., 1964, PROG AERO SCI, V5, P1, DOI DOI 10.1016/0376-0421(64)90003-X; Chakraborty J., 2005, P MULT SIGN PROC, P1; Coney H.M., 1989, HORTSCIENCE, V24, P198; Costelloe B, 2003, ENERG BUILDINGS, V35, P573, DOI 10.1016/S0378-7788(02)00161-5; Dadhich S.M., 2008, INT J FOOD ENG, V4, P1; Dossat J.R., 1981, PRINCIPLES REFRIGERA; Dvizama A.U., 2010, THESIS U IBADAN IBAD; Falayi F.R., 2011, J AGR ENG TECHNOL, V19, P35; Fallik E, 1996, PLANT PATHOL, V45, P644, DOI 10.1046/j.1365-3059.1996.d01-175.x; Ganesan M., 2004, J INDIAN I SCI, V84, P107; Gugino B, 2010, PLANT DIS HIGH TUNNE, P80; Incropera F.P., 2006, FUNDAMENTALS HEAT MA, Vsixth, P1024; Islam MP, 2012, JARQ-JPN AGR RES Q, V46, P257; Khanal R, 2014, SOL ENERGY, V107, P461, DOI 10.1016/j.solener.2014.05.032; Liu S, 2008, THESIS ZHEJIANG U HA, P1; Liu XL, 2009, SUSTAINABILITY IN ENERGY AND BUILDINGS, P255, DOI 10.1007/978-3-642-03454-1_26; Lu J.J., 2007, STEWART POSTHARVEST, V3, P41; Morimoto T., 2003, ENV CONTROL BIOL, V41, P29; Musa M, 2008, THESIS U NOTTINGHAM; Odesola I.F., 2009, PACIFIC J SCI TECHNO, V10, P935; Olosunde W.A., 2006, THESIS U IBADAN IBAD; Ray RC, 2005, CRIT REV FOOD SCI, V45, P623, DOI 10.1080/10408390500455516; Roy S.K., 1991, ACTA HORTIC, V291, P519; Stoitchkov NJ, 1998, INT J REFRIG, V21, P463, DOI 10.1016/S0140-7007(98)00004-8; Sushmita M.D., 2008, INT J FOOD ENG, V4; Tarutani T., 1982, DISTRIBUTION STORAGE; Veronika U, 2011, MODERN ENERGY SERVIC; World Health Organization, 2003, WHO TECH REP SER, V916, P1; Zahra G., 1996, BUILD ENVIRON, V31, P503	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-092X			SOL ENERGY	Sol. Energy	AUG	2015	118						469	484		10.1016/j.solener.2015.06.006		16	Energy & Fuels	Energy & Fuels	CO4YL	WOS:000359166700045		
J	Naganuma, T; Takemoto, Y; Shoji, T; Ishimura, E; Okamura, M; Nakatani, T				Naganuma, Toshihide; Takemoto, Yoshiaki; Shoji, Tetsuo; Ishimura, Eiji; Okamura, Mikio; Nakatani, Tatsuya			Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients	STROKE			English	Article						cerebral hemorrhage; cerebral microbleeds; dialysis; magnetic resonance imaging; stroke	CHRONIC KIDNEY-DISEASE; PROPENSITY SCORE METHODS; ISCHEMIC-STROKE; ANTITHROMBOTIC THERAPY; RISK-FACTORS; SIGNAL LOSS; MRI; METAANALYSIS; ASSOCIATION; PREVALENCE	Background and Purpose-In hemodialysis patients, previous reports have described a high prevalence of cerebral microbleeds (CMBs), but no longitudinal studies have been performed to determine the clinical significance of CMBs in these patients. In this study, we investigated whether the presence of CMBs was a predictor of future strokes in hemodialysis patients. Methods-Cranial MRI, including T2*-weighted magnetic resonance imaging, was performed on 179 hemodialysis patients with no past history of cerebrovascular events. The patients were followed prospectively until death or renal transplantation. We used the Cox proportional hazards model with inverse probability of treatment weighting using the propensity score to compare the event-free survivals of patients with/without CMBs. For sensitivity analyses, stratification by propensity score quintile and regression adjustment were used. Results-CMBs were detected in 45 of the 179 patients. During a median follow-up period of 5.0 years, stroke occurred in 24 patients, including 12 with intracerebral hemorrhage and 12 with cerebral infarctions. Cox proportional hazards analysis with inverse probability of treatment weighting using the propensity score revealed that the presence of CMBs was a strong and significant predictor of intracerebral hemorrhage (hazard ratio, 26.53; 95% confidence interval, 2.88-244.90) but not cerebral infarction (hazard ratio, 0.91; 95% confidence interval, 0.25-3.34). Sensitivity analyses yielded similar results. Conclusions-This study showed that the presence of CMBs was an independent and strong predictor of intracerebral hemorrhage in stroke-free hemodialysis patients, indicating that hemodialysis patients with CMBs should be carefully monitored for future onset of intracerebral hemorrhage.	[Naganuma, Toshihide; Takemoto, Yoshiaki; Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka 5458585, Japan; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 5458585, Japan; [Ishimura, Eiji] Osaka City Univ, Grad Sch Med, Dept Nephrol, Osaka 5458585, Japan; [Okamura, Mikio] Ohno Mem Hosp, Dept Nephrol, Osaka, Japan	Naganuma, T (reprint author), Osaka City Univ, Sch Med, Dept Urol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	spxd48k9@aria.ocn.ne.jp			Osaka City University Medical Research Foundation	This work was supported by grants from the Osaka City University Medical Research Foundation.	ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Charidimou A, 2013, STROKE, V44, P995, DOI 10.1161/STROKEAHA.111.000038; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Ovbiagele B, 2013, STROKE, V44, P2409, DOI 10.1161/STROKEAHA.113.001958; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Lee SH, 2002, STROKE, V33, P2845, DOI 10.1161/01.STR.0000036092.23649.2E; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Offenbacher H, 1996, AM J NEURORADIOL, V17, P573; Greenberg SM, 1996, STROKE, V27, P1333; Charidimou A, 2014, INT J STROKE, V9, P457, DOI 10.1111/ijs.12280; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Tanaka A, 1999, STROKE, V30, P1637; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Wang ZL, 2014, STROKE, V45, P2811, DOI 10.1161/STROKEAHA.114.004286; Shima H, 2010, NEPHROL DIAL TRANSPL, V25, P1554, DOI 10.1093/ndt/gfp694; Gavin JR, 1997, DIABETES CARE, V20, P1183; Naganuma T, 2011, CLIN NEPHROL, V75, P346, DOI 10.5414/CNP75346; Nishikawa T, 2009, CLIN NEUROL NEUROSUR, V111, P825, DOI 10.1016/j.clineuro.2009.08.011; ONOYAMA K, 1986, JPN HEART J, V27, P685; Vernooij MW, 2012, INT J STROKE, V7, P565, DOI 10.1111/j.1747-4949.2012.00886.x; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Watanabe Akira, 2007, J Stroke Cerebrovasc Dis, V16, P30, DOI 10.1016/j.jstrokecerebrovasdis.2006.08.004; Yokoyama S, 2005, NEUROL MED-CHIR, V45, P556, DOI 10.2176/nmc.45.556	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2015	46	8					2107	2112		10.1161/STROKEAHA.115.009324		6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CP6CP	WOS:000359972200028		
J	Yagi, K; Lidington, D; Wan, H; Fares, JC; Meissner, A; Sumiyoshi, M; Ai, JL; Foltz, WD; Nedospasov, SA; Offermanns, S; Nagahiro, S; Macdonald, RL; Bolz, SS				Yagi, Kenji; Lidington, Darcy; Wan, Hoyee; Fares, Jessica C.; Meissner, Anja; Sumiyoshi, Manabu; Ai, Jinglu; Foltz, Warren D.; Nedospasov, Sergei A.; Offermanns, Stefan; Nagahiro, Shinji; Macdonald, R. Loch; Bolz, Steffen-Sebastian			Therapeutically Targeting Tumor Necrosis Factor-alpha/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage	STROKE			English	Article						inflammation; muscle, smooth, vascular; signal transduction; sphingosine kinase-1	DELAYED CEREBRAL-ISCHEMIA; FACTOR-ALPHA; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; INFLAMMATORY RESPONSE; RECEPTOR ANTAGONIST; CEREBROSPINAL-FLUID; SPHINGOSINE KINASE; MICROVASCULAR TONE; HEART-FAILURE	Background and Purpose-Subarachnoid hemorrhage (SAH) is a complex stroke subtype characterized by an initial brain injury, followed by delayed cerebrovascular constriction and ischemia. Current therapeutic strategies nonselectively curtail exacerbated cerebrovascular constriction, which necessarily disrupts the essential and protective process of cerebral blood flow autoregulation. This study identifies a smooth muscle cell autocrine/paracrine signaling network that augments myogenic tone in a murine model of experimental SAH: it links tumor necrosis factor-alpha (TNF alpha), the cystic fibrosis transmembrane conductance regulator, and sphingosine-1-phosphate signaling. Methods-Mouse olfactory cerebral resistance arteries were isolated, cannulated, and pressurized for in vitro vascular reactivity assessments. Cerebral blood flow was measured by speckle flowmetry and magnetic resonance imaging. Standard Western blot, immunohistochemical techniques, and neurobehavioral assessments were also used. Results-We demonstrate that targeting TNF alpha and sphingosine-1-phosphate signaling in vivo has potential therapeutic application in SAH. Both interventions (1) eliminate the SAH-induced myogenic tone enhancement, but otherwise leave vascular reactivity intact; (2) ameliorate SAH-induced neuronal degeneration and apoptosis; and (3) improve neurobehavioral performance in mice with SAH. Furthermore, TNF alpha sequestration with etanercept normalizes cerebral perfusion in SAH. Conclusions-Vascular smooth muscle cell TNF alpha and sphingosine-1-phosphate signaling significantly enhance cerebral artery tone in SAH; anti-TNF alpha and anti-sphingosine-1-phosphate treatment may significantly improve clinical outcome.	[Lidington, Darcy; Fares, Jessica C.; Meissner, Anja; Bolz, Steffen-Sebastian] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Wan, Hoyee] Univ Toronto, Sunnybrook Res Inst & Med Biophys, Phys Sci, Toronto, ON M5S 1A8, Canada; [Bolz, Steffen-Sebastian] Univ Toronto, Richard Lewar Ctr Excellence Cardiovasc Res, Heart & Stroke, Toronto, ON M5S 1A8, Canada; [Yagi, Kenji; Sumiyoshi, Manabu; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Dept Neurosurg, Toronto, ON M5B 1W8, Canada; [Yagi, Kenji; Sumiyoshi, Manabu; Nagahiro, Shinji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Neurosurg, Tokushima, Japan; [Lidington, Darcy; Bolz, Steffen-Sebastian] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto Ctr Microvasc Med, Toronto, ON M5S 1A8, Canada; [Wan, Hoyee; Ai, Jinglu; Macdonald, R. Loch; Bolz, Steffen-Sebastian] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Foltz, Warren D.] Princess Margaret Canc Ctr, STTARR Innovat Ctr, Dept Radiat Oncol, Toronto, ON, Canada; [Nedospasov, Sergei A.] VA Engelhardt Mol Biol Inst, Moscow 117984, Russia; [Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Bolz, SS (reprint author), Univ Toronto, Dept Physiol, Med Sci Bldg,Room 3326,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	sts.bolz@utoronto.ca	Nedospasov, Sergei/L-1990-2015; 	Meissner, Anja/0000-0002-0793-7213	Canadian Institutes of Health Research [FRN-119345]; Physicians Services Incorporated Foundation; Canadian Foundation for Innovation and Ontario Research Fund [RI-11810]; Canadian Stroke Network; Brain Aneurysm Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Russian Academy of Sciences (Molecular and Cellular Biology); Heart and Stroke Foundation of Ontario (HSFO) [G13-0002813, NIA-6581]; University of Toronto [CI-7432]; Spatio-Temporal Targeting and Amplification of Radiation	We acknowledge Shakira Brathwaite, Michael K. Tso, and Bert Bosche for their assistance with data collection. We gratefully acknowledge the following organizations for providing Operating, Salary, and Infrastructure Funding: the Canadian Institutes of Health Research (Dr Bolz, FRN-119345), Physicians Services Incorporated Foundation (Dr Macdonald), the Canadian Foundation for Innovation and Ontario Research Fund (Dr Bolz, RI-11810), the Canadian Stroke Network (Dr Bolz and Dr Macdonald), the Brain Aneurysm Foundation (Dr Macdonald), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Dr Nagahiro), the Russian Academy of Sciences (Molecular and Cellular Biology; Dr Nedospasov), the Heart and Stroke Foundation of Ontario (HSFO; Drs Macdonald and Bolz, G13-0002813), HSFO New (Dr Bolz, NIA-6581) and Career (Dr Bolz, CI-7432) Investigator Awards and Start-up Funding from the University of Toronto (Dr Bolz). We would like to acknowledge the Spatio-Temporal Targeting and Amplification of Radiation Response program and its affiliated funding agencies.	Yang JL, 2012, CIRCULATION, V126, P196, DOI 10.1161/CIRCULATIONAHA.111.039644; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Hop JW, 1997, STROKE, V28, P660; Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Brilstra EH, 2000, NEUROLOGY, V55, P1656; Lad SP, 2012, J STROKE CEREBROVASC, V21, P30, DOI 10.1016/j.jstrokecerebrovasdis.2010.04.004; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Dhar R, 2012, STROKE, V43, P1788, DOI 10.1161/STROKEAHA.111.646836; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Hanafy KA, 2010, J NEUROL SCI, V291, P69, DOI 10.1016/j.jns.2009.12.023; Velat GJ, 2011, WORLD NEUROSURG, V76, P446, DOI 10.1016/j.wneu.2011.02.030; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Sumbria RK, 2013, MOL PHARMACEUT, V10, P1425, DOI 10.1021/mp400004a; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Scherer EQ, 2010, STROKE, V41, P2618, DOI 10.1161/STROKEAHA.110.593327; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Yu ZQ, 2014, NEUROPATH APPL NEURO, V40, P270, DOI 10.1111/nan.12091; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Lidington D, 2009, ARTERIOSCL THROM VAS, V29, P1916, DOI 10.1161/ATVBAHA.109.194803; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Bos A, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-47; Chen JJ, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/516359; Hanafy KA, 2010, J CLIN NEUROSCI, V17, P853, DOI 10.1016/j.jocn.2009.11.041; Iwanami J, 2011, HYPERTENSION, V58, P404, DOI 10.1161/HYPERTENSIONAHA.111.177873; Kawai S, 2006, J CLIN PHARMACOL, V46, P418, DOI 10.1177/0091270006286435; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Muroi C, 2011, ACTA NEUROCHIR SUPPL, V110, P191, DOI 10.1007/978-3-7091-0353-1_33; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Zu Heringdorf D. M., 2013, HDB EXP PHARM, V215, P239, DOI 10.1007/978-3-7091-1368-4_13	51	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2015	46	8					2260	2270		10.1161/STROKEAHA.114.006365		11	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CP6CP	WOS:000359972200051		
J	Toyoda, K				Toyoda, Kazunori			Response to Letter Regarding Article, "Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials"	STROKE			English	Letter									Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan.		Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Toyoda K, 2015, STROKE, V46, P1474, DOI 10.1161/STROKEAHA.115.008781; Chi NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114909; Hsieh CY, 2015, STROKE, V46, pE198, DOI 10.1161/STROKEAHA.115.010253; Pandian JD, 2011, INT J STROKE, V6, P541, DOI 10.1111/j.1747-4949.2011.00680.x; Venketasubramanian N, 2015, CEREBROVASC DIS, V39, P309, DOI 10.1159/000382082	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2015	46	8					E199	E199		10.1161/STROKEAHA.115.010325		1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CP6CP	WOS:000359972200014		
J	Kurosato, F; Ishikawa, T; Yamada, Y; Hanamoto, T				Kurosato, Fumihiro; Ishikawa, Takuya; Yamada, Yasunori; Hanamoto, Takeshi			Convenient Synthesis of N-Tosyl-2-(difluoromethyl)aziridine and Its Application to the Preparation of Difluoromethyl-beta-tryptamine Analogues	SYNLETT			English	Article						organofluorine; aziridine; ring-opening; indole; tryptamine	MEDICINAL CHEMISTRY; STEREOSELECTIVE-SYNTHESIS; TRIFLUOROMETHYL GROUP; AZIRIDINYL ANIONS; SULFONIUM SALT; AMINO ACIDS; FLUORINE; CYCLOADDITION; 2-TRIFLUOROMETHYL-N-TOSYLAZIRIDINE; HETEROCYCLES	N-Tosyl-2-(difluoromethyl) aziridine was easily prepared from p-toluenesulfonamide (TsNH2) and beta-(difluoromethyl) vinyl sulfonium salt in excellent yield. The reaction of the aziridine and a wide range of indoles in the presence of Et2Zn proceeded smoothly to give the corresponding difluoromethyl-beta-tryptamine analogues in good to excellent yields and with excellent regioselectivity.	[Kurosato, Fumihiro; Ishikawa, Takuya; Yamada, Yasunori; Hanamoto, Takeshi] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Saga 8408502, Japan	Hanamoto, T (reprint author), Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Honjyo Machi 1, Saga 8408502, Japan.	hanamoto@cc.saga-u.ac.jp					Rinaudo G, 2006, TETRAHEDRON LETT, V47, P2065, DOI 10.1016/j.tetlet.2006.01.142; Watson IDG, 2006, ACCOUNTS CHEM RES, V39, P194, DOI 10.1021/ar050038m; TANAKA K, 1988, J FLUORINE CHEM, V39, P39, DOI 10.1016/S0022-1139(00)82735-9; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Katagiri T, 1999, J ORG CHEM, V64, P7323, DOI 10.1021/jo990207e; Kenis S, 2011, ORG BIOMOL CHEM, V9, P7217, DOI 10.1039/c1ob05813d; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Akiyama T, 2003, TETRAHEDRON LETT, V44, P4011, DOI 10.1016/S0040-4039(03)00854-2; Ojima I, 2013, J ORG CHEM, V78, P6358, DOI 10.1021/jo400301u; Kuzmich D, 2013, BIOORG MED CHEM LETT, V23, P6640, DOI 10.1016/j.bmcl.2013.10.052; ERICKSON JA, 1995, J ORG CHEM, V60, P1626, DOI 10.1021/jo00111a021; Yang YM, 2013, TETRAHEDRON LETT, V54, P3826, DOI 10.1016/j.tetlet.2013.05.048; Singh GS, 2007, CHEM REV, V107, P2080, DOI 10.1021/cr0680033; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Moens M, 2014, J ORG CHEM, V79, P5558, DOI 10.1021/jo5007448; Yamauchi Y, 2003, TETRAHEDRON, V59, P9839, DOI 10.1016/j.tet.2003.09.019; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; Kenis S, 2013, CHEM-EUR J, V19, P5966, DOI 10.1002/chem.201204485; Crousse B, 2001, SYNLETT, P679; Dolfen J, 2014, CHEM-EUR J, V20, P10650, DOI 10.1002/chem.201304759; Edman K, 2014, BIOORG MED CHEM LETT, V24, P2571, DOI 10.1016/j.bmcl.2014.03.070; Florio S, 2010, CHEM REV, V110, P5128, DOI 10.1021/cr100032b; Ha HJ, 2014, ASIAN J ORG CHEM, V3, P1020, DOI 10.1002/ajoc.201402098; Hirotaki K, 2014, ASIAN J ORG CHEM, V3, P285, DOI 10.1002/ajoc.201300286; Ishikawa T, 2015, TETRAHEDRON, V71, P1254, DOI 10.1016/j.tet.2014.12.102; Jung N, 2012, ANGEW CHEM INT EDIT, V51, P5538, DOI 10.1002/anie.201200966; Kasai N, 2012, SYNTHESIS-STUTTGART, V44, P3489, DOI 10.1055/s-0032-1316792; Katagiri T, 1997, TETRAHEDRON-ASYMMETR, V8, P2933, DOI 10.1016/S0957-4166(97)00320-0; Mae M, 2002, TETRAHEDRON LETT, V43, P2069, DOI 10.1016/S0040-4039(02)00205-8; Maeda R, 2010, ORG LETT, V12, P2548, DOI 10.1021/ol100768s; Maeda R, 2011, ORG LETT, V13, P6240, DOI 10.1021/ol202697y; QUINZE K, 1989, J FLUORINE CHEM, V44, P233, DOI 10.1016/S0022-1139(00)83942-1; Rassukana YV, 2013, J FLUORINE CHEM, V148, P14, DOI 10.1016/j.jfluchem.2013.01.019; SCHIRLIN D, 1988, J MED CHEM, V31, P30, DOI 10.1021/jm00396a007; Schweitzer-Chaput B, 2012, TETRAHEDRON, V68, P7028, DOI 10.1016/j.tet.2012.06.093; Takehiro Y, 2013, TETRAHEDRON, V69, P7448, DOI 10.1016/j.tet.2013.06.044; TANAKA K, 1994, B CHEM SOC JPN, V67, P589, DOI 10.1246/bcsj.67.589; Volonterio A, 2002, EUR J ORG CHEM, P3336; Waki M, 2014, TETRAHEDRON LETT, V55, P6915, DOI 10.1016/j.tetlet2014.10.107; Yamauchi Y, 2003, TETRAHEDRON LETT, V44, P6319, DOI 10.1016/S0040-4039(03)01520-X; Yoshiki M, 2014, ORG LETT, V16, P5509, DOI 10.1021/ol502331a	42	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	AUG	2015	26	13					1827	1830		10.1055/s-0034-1381008		4	Chemistry, Organic	Chemistry	CP6LE	WOS:000359997900013		
J	Nishii, Y; Akiyama, S; Kita, Y; Mashima, K				Nishii, Yuji; Akiyama, Shoko; Kita, Yusuke; Mashima, Kazushi			Manganese(II)-Catalyzed Esterification of N-beta-Hydroxyethylamides	SYNLETT			English	Article						amides; esterification; manganese; selective reaction; acyl rearrangement	TETRANUCLEAR-ZINC-CLUSTER; NMR CHEMICAL-SHIFTS; C-H ACTIVATION; MILD CONDITIONS; TWISTED AMIDES; PRIMARY CARBOXAMIDES; CARBOXYLIC-ACIDS; BOND FORMATION; TRANSESTERIFICATION; ESTERS	A catalyst system of manganese with 2,2-bipyridine for amide alcoholysis of N-beta-hydroxyethylamides is described. This protocol enabled selective cleavage of the amide bond through a mechanism involving sequential N,O-acyl rearrangement and transesterification.	[Nishii, Yuji; Akiyama, Shoko; Kita, Yusuke; Mashima, Kazushi] Osaka Univ, Dept Chem, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Mashima, K (reprint author), Osaka Univ, Dept Chem, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	mashima@chem.es.osaka-u.ac.jp			MEXT, Japan [25810062]; JSPS	This work is financially supported by a Grant-in-Aid for Young Scientists (B) (No. 25810062) from MEXT, Japan. Y.N. expresses his special thanks for the financial support provided by the JSPS Research Fellowship for Young Scientists.	Albela B, 1998, INORG CHEM, V37, P788, DOI 10.1021/ic970935p; Anelli PL, 1997, TETRAHEDRON LETT, V38, P2367, DOI 10.1016/S0040-4039(97)00350-X; Raycroft MAR, 2012, INORG CHEM, V51, P10325, DOI 10.1021/ic301454y; Ohshima T, 2008, J AM CHEM SOC, V130, P2944, DOI 10.1021/ja711349r; Hayashi Y, 2013, J AM CHEM SOC, V135, P6192, DOI 10.1021/ja400367h; Haag B, 2011, ANGEW CHEM INT EDIT, V50, P9794, DOI 10.1002/anie.201101960; Aube J, 2012, ANGEW CHEM INT EDIT, V51, P3063, DOI 10.1002/anie.201108173; Brohmer MC, 2011, ANGEW CHEM INT EDIT, V50, P6175, DOI 10.1002/anie.201100271; Li Y, 2014, ADV SYNTH CATAL, V356, P1412, DOI 10.1002/adsc.201400101; Zhu C, 2012, CHEM-ASIAN J, V7, P1502, DOI 10.1002/asia.201200035; Kirby AJ, 1998, ANGEW CHEM INT EDIT, V37, P785, DOI 10.1002/(SICI)1521-3773(19980403)37:6<785::AID-ANIE785>3.0.CO;2-J; Dastbaravardeh N, 2014, SYNTHESIS-STUTTGART, V46, P1421, DOI 10.1055/s-0033-1338625; Yamada S, 1996, J ORG CHEM, V61, P5932, DOI 10.1021/jo9522015; Hutchby M, 2012, ANGEW CHEM INT EDIT, V51, P548, DOI 10.1002/anie.201107117; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Harford PJ, 2014, DALTON T, V43, P14181, DOI 10.1039/c4dt01130a; Maegawa Y, 2011, ACS CATAL, V1, P1178, DOI 10.1021/cs200224b; Hatano M, 2011, ORG LETT, V13, P426, DOI 10.1021/ol102753n; Kanomata N, 2003, TETRAHEDRON LETT, V44, P3599, DOI 10.1016/S0040-4039(03)00698-1; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Gothelf KV, 1996, J ORG CHEM, V61, P346, DOI 10.1021/jo951204e; NANJAPPAN P, 1987, J AM CHEM SOC, V109, P1826, DOI 10.1021/ja00240a037; Atkinson BN, 2014, TETRAHEDRON LETT, V55, P6935, DOI 10.1016/j.tetlet.2014.10.124; Brohmer MC, 2008, EUR J ORG CHEM, P4412, DOI 10.1002/ejoc.200800642; Berreau LM, 2000, INORG CHEM, V39, P4390, DOI 10.1021/ic000547e; Charette AB, 1998, SYNLETT, P163; Evans D. A., 1997, ANGEW CHEM INT EDIT, V36, P2737; FISHER LE, 1994, CAN J CHEM, V72, P142; Fukuzawa S, 1998, TETRAHEDRON LETT, V39, P3521, DOI 10.1016/S0040-4039(98)00521-8; Iwasaki T, 2009, SYNLETT, P1659, DOI 10.1055/s-0029-1217335; Iwasaki T, 2010, CHEM-EUR J, V16, P11567, DOI 10.1002/chem.201000960; Iwasaki T, 2008, J ORG CHEM, V73, P5147, DOI 10.1021/jo800625v; Kawaguchi S, 1999, B CHEM SOC JPN, V72, P2729, DOI 10.1246/bcsj.72.2729; Kawaguchi S, 2005, INORG CHIM ACTA, V358, P947, DOI 10.1016/j.ica.2004.10.008; Kita Y, 2012, ANGEW CHEM INT EDIT, V51, P5723, DOI 10.1002/anie.201201789; Kita Y, 2013, ADV SYNTH CATAL, V355, P3391, DOI 10.1002/adsc.201300819; Maegawa Y, 2012, SYNLETT, V23, P137, DOI 10.1055/s-0031-1290096; Magnier-Bouvier C, 2008, SYNLETT, P1211, DOI 10.1055/s-2008-1072587; Orita A, 2001, SYNLETT, P637; OTERA J, 1991, J ORG CHEM, V56, P5307, DOI 10.1021/jo00018a019; Siddiki SMAH, 2014, RSC ADV, V4, P35803, DOI 10.1039/c4ra07419j; Szajna-Fuller E, 2007, INORG CHEM, V46, P2353, DOI 10.1021/ic0622813; YAMADA S, 1993, ANGEW CHEM INT EDIT, V32, P1083, DOI 10.1002/anie.199310831; YAMADA S, 1995, ANGEW CHEM INT EDIT, V34, P1113, DOI 10.1002/anie.199511131; Yamada S, 1996, J ORG CHEM, V61, P941, DOI 10.1021/jo9516953; Yashiro M, 2003, ORG BIOMOL CHEM, V1, P629, DOI 10.1039/b209565c; Zhang FZ, 2014, CHEM SOC REV, V43, P6906, DOI 10.1039/c4cs00137k	47	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	AUG	2015	26	13					1831	1834		10.1055/s-0034-1380428		4	Chemistry, Organic	Chemistry	CP6LE	WOS:000359997900014		
J	Matsumoto, A; Asano, K; Matsubara, S				Matsumoto, Akira; Asano, Keisuke; Matsubara, Seijiro			Diastereoselective Reduction of beta-(1,3-Dioxan-4-yl)ketones	SYNLETT			English	Article						diastereoselective reduction; chiral acetal; 1,3-dioxane; 1,3-polyol; polyketide	ASYMMETRIC HYDRATION; DIACETATE	Stereoselective reduction of beta-(1,3-dioxan-4-yl) ketones is an important step in the efficient synthesis of chiral 1,3-polyols, a typical structure of polyketides. In this study, we carried out investigations to optimize the conditions for diastereoselective reduction.	[Matsumoto, Akira; Asano, Keisuke; Matsubara, Seijiro] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan	Asano, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	asano.keisuke.5w@kyoto-u.ac.jp; matsubara.seijiro.2e@kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	We thank Professor Takuya Kurahashi (Kyoto University) for X-ray crystallographic analysis. This work was supported financially by the Japanese Ministry of Education, Culture, Sports, Science, and Technology. K. A. also acknowledges the Asahi Glass Foundation, Toyota Physical and Chemical Research Institute, and Tokyo Institute of Technology Foundation.	Fukata Y, 2013, SYNTHESIS-STUTTGART, V45, P1627, DOI 10.1055/s-0032-1316920; MORI Y, 1988, TETRAHEDRON LETT, V29, P5419, DOI 10.1016/S0040-4039(00)82884-1; Asano K, 2012, ORG LETT, V14, P1620, DOI 10.1021/ol3003755; Wang YP, 2013, J AM CHEM SOC, V135, P9334, DOI 10.1021/ja404401f; Evans PA, 2012, J AM CHEM SOC, V134, P2856, DOI 10.1021/ja208668u; Wang YP, 2011, CHEM COMMUN, V47, P8493, DOI 10.1039/c1cc11791b; Li MS, 2006, ORG LETT, V8, P6087, DOI 10.1021/ol062595u; ALEXAKIS A, 1990, TETRAHEDRON-ASYMMETR, V1, P477, DOI 10.1016/S0957-4166(00)80536-4; Carreira E. M., 2009, CLASSICS STEREOSELEC; Guo H, 2008, ORG LETT, V10, P3149, DOI 10.1021/ol801055b; Hunter TJ, 2001, ORG LETT, V3, P2777, DOI 10.1021/ol016399t; Rohr J, 2000, ANGEW CHEM INT EDIT, V39, P2847, DOI 10.1002/1521-3773(20000818)39:16<2847::AID-ANIE2847>3.0.CO;2-0; Smith CM, 2003, ORG LETT, V5, P1959, DOI 10.1021/ol0345529	13	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	AUG	2015	26	13					1872	1874		10.1055/s-0034-1378725		3	Chemistry, Organic	Chemistry	CP6LE	WOS:000359997900022		
J	Aoyama, T; Furukawa, T; Hayakawa, M; Takido, T; Kodomari, M				Aoyama, Tadashi; Furukawa, Takuya; Hayakawa, Mamiko; Takido, Toshio; Kodomari, Mitsuo			Novel Route for the Construction of Chroman Ring System Using Cross-Coupling between Benzylic and Aliphatic Alcohols in the Presence of NaHSO4/SiO2	SYNLETT			English	Article						chroman; tandem reaction; heterogeneous reaction; coupling reaction; solid acid	DNA-POLYMERASE-BETA; ONE-POT SYNTHESIS; C-C; OXYGEN HETEROCYCLES; ALLYLIC ALCOHOLS; PHENOLS; CATALYST; BOND; (+)-MYRISTININ-A; AGENT	Novel route for the construction of chromans from benzylic and aliphatic alcohols in the presence of NaHSO4/SiO2 has been developed. In this reaction, substituted olefins are formed from benzylic and aliphatic alcohols and then converted to chromans through intramolecular cyclization. Twenty novel chromans were synthesized by this simple procedure.	[Aoyama, Tadashi; Furukawa, Takuya; Hayakawa, Mamiko; Takido, Toshio] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan; [Aoyama, Tadashi] Nihon Univ, Coll Sci & Technol, Res Inst Sci & Technol, Ctr Creat Mat Res, Tokyo 1018308, Japan; [Kodomari, Mitsuo] Nihon Univ, Coll Humanities & Sci, Inst Nat Sci, Tokyo 1568550, Japan	Aoyama, T (reprint author), Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan.	aoyama.tadashi@nihon-u.ac.jp			Nihon University College of Science and Technology	This work was financially supported by the Nihon University College of Science and Technology Grants-in-Aid for Fundamental Science Research.	Adrio LA, 2008, CHEM COMMUN, P2325, DOI 10.1039/b719465j; Youn SW, 2006, J ORG CHEM, V71, P6705, DOI 10.1021/jo061221b; Deng JZ, 2005, J NAT PROD, V68, P1625, DOI 10.1021/np058064g; Liang DQ, 2010, ADV SYNTH CATAL, V352, P1593, DOI 10.1002/adsc.201000062; Taylor RRR, 2013, J ORG CHEM, V78, P1404, DOI 10.1021/jo302328s; Coutant E, 2013, BEILSTEIN J ORG CHEM, V9, P1797, DOI 10.3762/bjoc.9.209; Aoyama T, 2013, CHEM COMMUN, V49, P6605, DOI 10.1039/c3cc42746c; PARHAM WE, 1976, J ORG CHEM, V41, P1184, DOI 10.1021/jo00869a022; Palucki M, 1996, J AM CHEM SOC, V118, P10333, DOI 10.1021/ja962408v; Naik MM, 2014, TETRAHEDRON, V70, P5221, DOI 10.1016/j.tet.2014.05.093; Ishino Y, 2001, SYNTHETIC COMMUN, V31, P439, DOI 10.1081/SCC-100000537; COHEN N, 1981, J ORG CHEM, V46, P2445, DOI 10.1021/jo00325a004; INOUE S, 1987, J ORG CHEM, V52, P5495, DOI 10.1021/jo00233a047; Maloney DJ, 2005, J AM CHEM SOC, V127, P4140, DOI 10.1021/ja042727j; SANKARAN MS, 1974, CONTRACEPTION, V9, P279, DOI 10.1016/0010-7824(74)90019-5; Suchand B, 2014, RSC ADV, V4, P13941, DOI 10.1039/c4ra00048j; Vece V, 2010, EUR J ORG CHEM, P6239, DOI 10.1002/ejoc.201000738; Yamamoto Y, 2009, ORG LETT, V11, P717, DOI 10.1021/ol802800s	18	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	AUG	2015	26	13					1875	1879		10.1055/s-0034-1380863		5	Chemistry, Organic	Chemistry	CP6LE	WOS:000359997900023		
J	Tayama, E; Saito, S				Tayama, Eiji; Saito, Shun			Copper-Catalyzed Regiospecific and 1,2-Regioselective Cyclopropanation of (1Z)-1-Amino- and (1Z)-1-Oxy-1,3-butadienyl Derivatives	SYNLETT			English	Article						cycloaddition; diastereoselectivity; diazo compounds; regioselectivity; stereoselective synthesis	AZA-FERRIER REACTION; STEREOSELECTIVE PREPARATION; SYNTHETIC METHOD; CYCLOPENTENE REARRANGEMENT; ORGANIC-SYNTHESIS; BUILDING-BLOCKS; DIAZO-COMPOUNDS; FACILE METHOD; PART 97; 1,4-ELIMINATION	The copper-catalyzed regiospecific and 1,2-regioselective cyclopropanation of (1Z)-1-amino- and (1Z)-1-oxy-1,3-butadienyl derivatives, which could be prepared by Z-stereoselective 1,4-elimination with a-aryl diazoesters was successfully demonstrated. This successful regiospecific protocol enabled the preparation of the corresponding 1-amino- and 1-oxy-2-vinylcyclopropane derivatives as almost single stereoisomers.	[Tayama, Eiji; Saito, Shun] Niigata Univ, Fac Sci, Dept Chem, Niigata 9502181, Japan	Tayama, E (reprint author), Niigata Univ, Fac Sci, Dept Chem, Niigata 9502181, Japan.	tayama@chem.sc.niigata-u.ac.jp			JGC-S Scholarship Foundation [1307]	This work was supported by the JGC-S Scholarship Foundation (No. 1307).	ANCIAUX AJ, 1983, TETRAHEDRON, V39, P2169, DOI 10.1016/S0040-4020(01)91934-9; Crane ZD, 2011, J ORG CHEM, V76, P277, DOI 10.1021/jo101504e; MAXWELL JL, 1992, ORGANOMETALLICS, V11, P645, DOI 10.1021/om00038a023; Lou S, 2013, ORG BIOMOL CHEM, V11, P6796, DOI 10.1039/c3ob41394b; de Meijere A, 2010, CHEM-EUR J, V16, P13862, DOI 10.1002/chem.201001550; DAVIES HML, 1992, J ORG CHEM, V57, P4309, DOI 10.1021/jo00041a050; Hudlicky T, 2010, ANGEW CHEM INT EDIT, V49, P4864, DOI 10.1002/anie.200906001; Tayama E, 2014, TETRAHEDRON LETT, V55, P3041, DOI 10.1016/j.tetlet.2014.03.115; Davies HML, 2004, ORG LETT, V6, P2117, DOI 10.1021/ol049525c; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Davies H. M. L., 2001, ORG REACTIONS; Davies HML, 1998, J ORG CHEM, V63, P657, DOI 10.1021/jo971577a; Doyle M. P., 1998, MODERN CATALYTIC MET; DOYLE MP, 1984, ORGANOMETALLICS, V3, P53, DOI 10.1021/om00079a011; Gareev VF, 2008, RUSS CHEM B+, V57, P1784, DOI 10.1007/s11172-008-0238-x; Hahn ND, 2004, EUR J ORG CHEM, P1049, DOI 10.1002/ejoc.200300687; Kirmse W, 2003, ANGEW CHEM INT EDIT, V42, P1088, DOI 10.1002/anie.200390290; Guzman PE, 2014, ANGEW CHEM INT EDIT, V53, P13083, DOI 10.1002/anie.201406440; Lu T, 2008, ORG LETT, V10, P541, DOI 10.1021/ol702824s; McGaffin G, 2001, EUR J ORG CHEM, P3559; MILITZER HC, 1993, SYNTHESIS-STUTTGART, P998; Qu ZH, 2001, J ORG CHEM, V66, P8139, DOI 10.1021/jo0107352; DEMEIJERE A, 1991, SYNTHESIS-STUTTGART, P547; Tang WJ, 2011, ORG PROCESS RES DEV, V15, P1207, DOI 10.1021/op200038y; Tayama E, 2008, CHEM COMMUN, P4216, DOI 10.1039/b806492j; Tayama E, 2007, TETRAHEDRON LETT, V48, P6163, DOI 10.1016/j.tetlet.2007.06.140; Tayama E, 2013, TETRAHEDRON, V69, P2745, DOI 10.1016/j.tet.2013.01.088; Tayama E, 2007, TETRAHEDRON LETT, V48, P7950, DOI 10.1016/j.tetlet.2007.09.049; Tayama E, 2006, TETRAHEDRON LETT, V47, P7533, DOI 10.1016/j.tetlet.2006.08.100; Tayama E, 2015, TETRAHEDRON, V71, P554, DOI 10.1016/j.tet.2014.12.039; Tayama E, 2006, SYNLETT, P849, DOI 10.1055/s-2006-939053; Werle T, 2001, ADV SYNTH CATAL, V343, P37; Wiedemann S, 2004, EUR J ORG CHEM, P631, DOI 10.1002/ejoc.200300454; Williams CM, 1998, TETRAHEDRON LETT, V39, P7695, DOI 10.1016/S0040-4039(98)01665-7	34	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	AUG	2015	26	13					1880	1884		10.1055/s-0034-1380426		5	Chemistry, Organic	Chemistry	CP6LE	WOS:000359997900024		
J	Sugie, C; Manabe, Y; Hayashi, A; Murai, T; Takaoka, T; Hattori, Y; Iwata, H; Takenaka, R; Shibamoto, Y				Sugie, Chikao; Manabe, Yoshihiko; Hayashi, Akihiro; Murai, Taro; Takaoka, Taiki; Hattori, Yukiko; Iwata, Hiromitsu; Takenaka, Ran; Shibamoto, Yuta			Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer	TECHNOLOGY IN CANCER RESEARCH & TREATMENT			English	Article						dynamic jaw mode; static tomotherapy delivery; breast cancer	MODULATED RADIATION-THERAPY; POSITIVE LYMPH-NODES; RADIOTHERAPY; IRRADIATION; EXPERIENCE; TOXICITY; COUCH	The recently developed dynamic jaw technology of tomotherapy can reduce craniocaudal dose spread without much prolonging the treatment time. This study aimed to investigate the efficacy of the dynamic jaw mode for tomotherapy of breast cancer. Static tomotherapy plans of the whole breast and supraclavicular regional lymph nodes, and plans for the whole breast only were generated in 25 patients with left-sided breast cancer. Plans with a field width of 2.5 or 5 cm with the dynamic or fixed jaw modes were made for each patient. The prescribed dose was 50 Gy in 25 fractions. In whole breast and supraclavicular nodal radiotherapy, dose distributions and homogeneity of the planning target volume (PTV) with the dynamic jaw mode were slightly inferior to those with the fixed jaw mode with a 5-cm field width (P < .05). However, lung low-dose volumes and mean doses of the larynx, thyroid, skin, and all the healthy tissues combined were smaller with the dynamic jaw mode than with the fixed jaw mode with a 5-cm field width (P < .001). In whole breast radiotherapy, mean doses of the skin and healthy tissues were lower with the dynamic jaw mode than with the fixed jaw mode with a 5-cm field width (P < .001) without significant differences in PTV dose distributions, homogeneity, and conformity. The dynamic jaw mode provided better sparing of organs at risks with minimal disturbance of dose-volume indices of PTV. Considering the treatment time, the 5-cm-field dynamic jaw mode is more efficient than the 2.5-cm fixed jaw mode.	[Sugie, Chikao; Manabe, Yoshihiko; Hayashi, Akihiro; Murai, Taro; Takaoka, Taiki; Hattori, Yukiko; Takenaka, Ran; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Hayashi, Akihiro] Okazaki City Hosp, Dept Radiol, Okazaki, Aichi, Japan; [Hattori, Yukiko; Iwata, Hiromitsu] Nagoya Proton Therapy Ctr, Dept Radiat Oncol, Nagoya, Aichi, Japan; [Takenaka, Ran] Narita Mem Hosp, Dept Radiol, Toyohashi, Aichi, Japan	Sugie, C (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi, Japan.	chikao@bg8.so-net.ne.jp					Aibe N, 2014, J RADIAT RES, V55, P575, DOI 10.1093/jrr/rrt146; Truong PT, 2004, CAN MED ASSOC J, V170, P1263, DOI 10.1503/cmaj.1031000; Schubert LK, 2011, RADIOTHER ONCOL, V100, P241, DOI 10.1016/j.radonc.2011.01.004; Sugie C, 2011, TECHNOL CANCER RES T, V10, P187; Grills IS, 2003, INT J RADIAT ONCOL, V56, P658, DOI 10.1016/S0360-3016(03)00017-8; Pignol JP, 2008, J CLIN ONCOL, V26, P2085, DOI 10.1200/JCO.2007.15.2488; Kissick MW, 2005, MED PHYS, V32, P1414, DOI 10.1118/1.1896453; Keller LMM, 2012, INT J RADIAT ONCOL, V84, P881, DOI 10.1016/j.ijrobp.2012.01.069; Feuvret L, 2006, INT J RADIAT ONCOL, V64, P333, DOI 10.1016/j.ijrobp.2005.09.028; Goddu SM, 2009, INT J RADIAT ONCOL, V73, P1243, DOI 10.1016/j.ijrobp.2008.11.004; [Anonymous], 2010, J ICRU, DOI [10.doi:10.1093/jicru/ndq002, DOI 10.1093/JICRU/NDQ002]; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731; Sterzing F, 2010, INT J RADIAT ONCOL, V76, P1266, DOI 10.1016/j.ijrobp.2009.07.1686; Reynders T, 2009, RADIOTHER ONCOL, V93, P71, DOI 10.1016/j.radonc.2009.07.005; Abe O, 2005, LANCET, V366, P2087; Krause S, 2013, TECHNOL CANCER RES T, V12, P421, DOI 10.7785/tcrt.2012.500335; Krause S, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-191; Manabe Y, 2014, TECHNOL CANCER RES T, DOI [10.7785/tcrtexpress.2013.600280, DOI 10.7785/TCRTEXPRESS.2013.600280]; Murai T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-68; Piotrowski T, 2014, TECHNOL CANCER RES T, V13, P233, DOI 10.7785/tcrt.2012.500374; Shibamoto Y, 2007, RADIOTHER ONCOL, V84, P52, DOI 10.1016/j.radonc.2007.05.015; Tatekawa K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-8; Yang ZZ, 2013, TECHNOL CANCER RES T, V12, P115, DOI 10.7785/tcrt.2012.500309; Zhou GX, 2011, TECHNOL CANCER RES T, V10, P15	24	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-0346	1533-0338		TECHNOL CANCER RES T	Technol. Cancer Res. Treat.	AUG	2015	14	4					459	465		10.1177/1533034614558746		7	Oncology	Oncology	CP4IN	WOS:000359845300011		
J	Hanamura, T; Ito, K; Uehara, T; Fukushima, T; Sasaki, S; Koizumi, T				Hanamura, Toru; Ito, Ken-ichi; Uehara, Takeshi; Fukushima, Toshirou; Sasaki, Shigeru; Koizumi, Tomonobu			Chemosensitivity in Carcinoma Showing Thymus-Like Differentiation: A Case Report and Review of the Literature	THYROID			English	Article							PHASE-II; CARBOPLATIN; PACLITAXEL; CASTLE	Background: Carcinoma showing thymus-like differentiation (CASTLE) is an extremely rare malignant neoplasm of the thyroid that originates from ectopic thymic tissue. No sufficient evidence exists regarding the efficacy of chemotherapy for cases with distant metastases or advanced disease because of the rarity of the disease itself. Patient: We report a case of CASTLE with lung metastasis that showed good responses to first-line (cisplatin, doxorubicin, vincristine, and cyclophosphamide) and second-line (carboplatin and paclitaxel) chemotherapies. Summary: This is the first case of CASTLE reported to show a good response to two serial chemotherapies. Conclusion: This case suggests that CASTLE is a chemosensitive tumor and that chemotherapy should be attempted in patients with advanced or metastatic CASTLE.	[Hanamura, Toru; Ito, Ken-ichi] Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano 3908621, Japan; [Uehara, Takeshi] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Fukushima, Toshirou; Sasaki, Shigeru; Koizumi, Tomonobu] Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, Matsumoto, Nagano 3908621, Japan	Koizumi, T (reprint author), Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tomonobu@shinshu-u.ac.jp					Abeni Chiara, 2014, World J Clin Oncol, V5, P1117, DOI 10.5306/wjco.v5.i5.1117; Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Cappelli C, 2008, ENDOCR J, V55, P685, DOI 10.1507/endocrj.K07E-147; Chan JK, 1991, HUM PATHOL, V4, P349; Chow SM, 2007, EJSO-EUR J SURG ONC, V33, P83, DOI 10.1016/j.ejso.2006.09.016; Hirai F, 2015, ANN ONCOL, V26, P363, DOI 10.1093/annonc/mdu541; Hirokawa M, 2012, DIAGN CYTOPATHOL, V40, pE16, DOI 10.1002/dc.21511; Ito Y, 2007, AM J CLIN PATHOL, V127, P230, DOI 10.1309/VM7E52B6U9Q729DQ; KAKUDO K, 1988, J SURG ONCOL, V38, P187, DOI 10.1002/jso.2930380311; Komatsu Y, 2006, ANTICANCER RES, V26, P1851; Kusada N, 2005, THYROID, V15, P1383, DOI 10.1089/thy.2005.15.1383; Liu Z, 2013, INT SURG, V98, P95, DOI 10.9738/INTSURG-D-12-00034.1; Roka S, 2004, BRIT J SURG, V91, P142, DOI 10.1002/bjs.4510; Sun TQ, 2011, WORLD J SURG, V35, P1840, DOI 10.1007/s00268-011-1151-2; Watanabe Keisuke, 2013, Tumori, V99, pe172, DOI 10.1700/1361.15119; Yamamoto Y, 2013, J CLIN ULTRASOUND, V41, P574, DOI 10.1002/jcu.21997	17	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	AUG 1	2015	25	8					969	972		10.1089/thy.2015.0155		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CP4CD	WOS:000359828700015		
J	Kawamura, M; Miyagawa, S; Fukushima, S; Saito, A; Toda, K; Daimon, T; Shimizu, T; Okano, T; Sawa, Y				Kawamura, Masashi; Miyagawa, Shigeru; Fukushima, Satsuki; Saito, Atsuhiro; Toda, Koichi; Daimon, Takashi; Shimizu, Tatsuya; Okano, Teruo; Sawa, Yoshiki			Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model	TISSUE ENGINEERING PART A			English	Article							RESTORE CARDIAC-FUNCTION; HEART-FAILURE; MYOCARDIAL-INFARCTION; IN-VITRO; THERAPY; REPAIR; IMMUNOSUPPRESSION; SURVIVAL; DISEASE	Introduction: Bone marrow-derived autologous human mesenchymal stem cells (MSCs) are one of the most promising cell sources for cell therapy to treat heart failure. The cell sheet technique has allowed transplantation of a large number of cells and enhanced the efficacy of cell therapy. We hypothesized that the transplantation of MSC sheets may be a feasible, safe, and effective treatment for ischemic cardiomyopathy (ICM). Methods and Results: Human MSCs acquired from bone marrow were positive for CD73, CD90, and CD105 and negative for CD11b and CD45 by flow cytometry. Ten MSC sheets were created from a total cell number of 1x10(8) MSCs using temperature-responsive culture dishes. These were successfully transplanted over the infarct myocardium of porcine ICM models induced by placing an ameroid constrictor on the left anterior descending coronary artery without any procedural-related complications (MSC group=6: sheet transplantation; sham group=6, oral intake of tacrolimus in both groups). Premature ventricular contractions were rarely detected by Holter electrocardiogram (ECG) in the MSC group in the first week after transplantation. On echocardiography, the cardiac performance of the MSC group was significantly better than that of the sham group at 8 weeks after transplantation. On histological examination 8 weeks after transplantation, left ventricular (LV) remodeling was significantly attenuated compared with the sham group (cardiomyocyte size and interstitial fibrosis were measured). Immunohistochemistry of the von Willebrand factor showed that the vascular density in the infarct border area was significantly greater in the MSC group than the sham group. Expression of angiogenesis-related factors in the infarct border area of the MSC group was significantly greater than that of the sham group, as measured by real-time polymerase chain reaction. Conclusions: Bone marrow-derived MSC sheets improved cardiac function and attenuated LV remodeling in ICM without major complications, indicating that this strategy would be applicable in clinical settings.	[Kawamura, Masashi; Miyagawa, Shigeru; Fukushima, Satsuki; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Saito, Atsuhiro] Osaka Univ Hosp, Med Ctr Translat Res, Osaka 553, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan; [Shimizu, Tatsuya; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 E1 Yamada Oka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.med.osaka-u.ac.jp			JSPS; Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development, AMED	The authors appreciate Shigeru Matsumi, Tsuyoshi Ishikawa, and Akima Harada for their excellent technical assistance. This work was supported by the JSPS Core-to-Core Program (JSPS; Japan Society for the Promotion of Science), and by the Research Project for Practical Applications of Regenerative Medicine from the Japan Agency for Medical Research and Development, AMED.	Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Teramoto N, 2011, J NUCL MED, V52, P761, DOI 10.2967/jnumed.110.084848; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Huang CC, 2013, BIOMATERIALS, V34, P4582, DOI 10.1016/j.biomaterials.2013.03.003; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Zvibel I, 2002, CELL TRANSPLANT, V11, P621; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Hsiao LC, 2013, CELL TRANSPLANT, V22, P663, DOI 10.3727/096368912X655109; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Fukui S, 2008, ANN THORAC SURG, V85, P562, DOI 10.1016/j.athoracsur.2007.06.002; Horiguchi K, 2002, J HEART LUNG TRANSPL, V21, P1090, DOI 10.1016/S1053-2498(02)00443-6; Martinez Eliana C, 2009, Expert Rev Cardiovasc Ther, V7, P921, DOI 10.1586/erc.09.81; Narita T, 2013, MOL THER, V21, P860, DOI 10.1038/mt.2013.9; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	37	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	AUG 1	2015	21	15-16					2272	2280		10.1089/ten.tea.2014.0036		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP3WF	WOS:000359812700013		
J	Zhang, YL; Kasai, E				Zhang, Yan-ling; Kasai, Eiki			Vapor pressure measurement of lead and lead chlorides in FeOT-CaO-SiO2-Al2O3 system	TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA			English	Article						vapor pressure; Knudsen effusion method; metallic Pb; lead chlorides; smelting process	KNUDSEN-EFFUSION-METHOD; SOLID-WASTE INCINERATION; HEAVY-METALS; THERMAL-TREATMENT; SLAG SYSTEM; VAPORIZATION; BEHAVIOR; MELTS; ASH	Vapor pressure of lead and lead chlorides from FeOT-CaO-SiO2-Al2O3 slag system was measured by using Knudsen effusion method. The results suggest that the vapor pressures of lead and lead chlorides increase with increasing temperature. For the slag systems without chlorine, the logarithm of vapor pressure (lnp) shows highly linear dependency on the reciprocal of temperature (1/T), and higher vapor pressure is observed in the condition where more metallic lead vapor is formed. In this case, the vapor pressure of lead increases with increasing slag basicity (w(CaO)/w(SiO2)), increasing FeO content and w(Fe2+)/w(Fe3+) ratio. For the case of slag system with chlorine addition, the total pressures of PbCl2 and PbCl increase with decreasing basicity and FeO content of slag.	[Zhang, Yan-ling] Univ Sci & Technol Beijing, State Key Lab Adv Met, Beijing 100083, Peoples R China; [Kasai, Eiki] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Zhang, YL (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met, Beijing 100083, Peoples R China.	zhangyanling@metall.ustb.edu.cn			Japan Oil, Gas and Metals National Corporation (JOGMEC); National Natural Science Foundation of China [51474021]	Project supported by the Japan Oil, Gas and Metals National Corporation (JOGMEC); Project (51474021) supported by the National Natural Science Foundation of China	Wu K, 2012, CEMENT CONCRETE COMP, V34, P322, DOI 10.1016/j.cemconcomp.2011.11.016; Matsuzaki K, 2000, METALL MATER TRANS B, V31, P1261, DOI 10.1007/s11663-000-0013-3; Luan JD, 2013, WASTE MANAGE RES, V31, P1012, DOI 10.1177/0734242X13493955; Zhang YG, 2012, WASTE MANAGE, V32, P2278, DOI 10.1016/j.wasman.2012.07.007; Yu J, 2012, CHEMOSPHERE, V86, P1122, DOI 10.1016/j.chemosphere.2011.12.010; ARLSON K D, 1967, CHARACTERIZATION HIG, P115; CATER E D, 1970, PHYSICOCHEMICAL ME 1, P22; Falcoz Q, 2010, PROCESS SAF ENVIRON, V88, P125, DOI 10.1016/j.psep.2009.11.009; Fonseca JMS, 2014, J CHEM THERMODYN, V73, P148, DOI 10.1016/j.jct.2013.11.038; FU Jin-xia, 2013, J CHEM THERMODYN, V43, P1660; Hirosumi T, 2000, ISIJ INT, V40, P943, DOI 10.2355/isijinternational.40.943; Liu Jing-yong, 2010, Chinese Journal of Nonferrous Metals, V20; Miwa M, 2002, ISIJ INT, V42, P1065, DOI 10.2355/isijinternational.42.1065; Nakajoh K, 2006, ENVIRON TOXICOL CHEM, V25, P327, DOI 10.1897/05-215R.1; TASKINEN P, 1982, CAN METALL QUART, V21, P163; Yan Jian-hua, 2008, Journal of Zhejiang University, V42, DOI 10.3785/j.issn.1008-973X.2008.10.031; Yoshiie R, 2002, FUEL, V81, P1335, DOI 10.1016/S0016-2361(02)00041-8; YU Jie, 2012, WASTE MANAGE, V33, P340; Zhang Yan-ling, 2011, Chinese Journal of Nonferrous Metals, V21; ZHANG Yan-ling, 2010, P AISTECH, P255; Zhang YL, 2006, MATER TRANS, V47, P1341, DOI 10.2320/matertrans.47.1341; Zhang YL, 2008, J UNIV SCI TECHNOL B, V15, P671; Zhang YL, 2005, MATER TRANS, V46, P1348, DOI 10.2320/matertrans.46.1348	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1003-6326	2210-3384		T NONFERR METAL SOC	Trans. Nonferrous Met. Soc. China	AUG	2015	25	8					2772	2780		10.1016/S1003-6326(15)63902-4		9	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CP7FJ	WOS:000360052300037		
J	Sellin, ME; Maslowski, KM; Maloy, KJ; Hardt, WD				Sellin, Mikael E.; Maslowski, Kendle M.; Maloy, Kevin J.; Hardt, Wolf-Dietrich			Inflammasomes of the intestinal epithelium	TRENDS IN IMMUNOLOGY			English	Review						innate immunity; intestinal epithelial cell (IEC); caspase-1; NLRP3; extrusion; mucus	IMMUNE EFFECTOR MECHANISM; NF-KAPPA-B; INFLAMMATORY CASPASES; HOST-DEFENSE; PHAGOSOME MATURATION; BACTERIAL PATHOGENS; SEROVAR TYPHIMURIUM; COLON INFLAMMATION; INDUCED ACTIVATION; INTRACELLULAR LPS	While the functional importance of inflammasomes in blood-derived cell types is well established, it remains poorly understood how inflammasomes in nonhematopoietic cells contribute to mucosa! immunity. Recent studies have revealed functional roles of inflammasomes particularly NAIP/NLRC4, NLRP6, and noncanonical caspase-4 (caspase-11) within epithelial cells of the gut in mucosal immune defense, inflammation, and tumorigenesis. Here, we review and discuss these findings in the broader context of tissue compartment-specific mucosa! immunity. We propose several models whereby activities of the intestinal epithelial inflammasomes converge on mechanisms to remove compromised epithelial cells, maintain host microbiota mutualism, and communicate with immune cells of the underlying lamina propria.	[Sellin, Mikael E.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Maslowski, Kendle M.] RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Maloy, Kevin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Sellin, ME (reprint author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	msellin@micro.bioLethz.ch; hardt@micro.biol.ethz.ch			Swiss National Science Foundation [310030_153074/1]; Swedish Research Council fellowship [2012-262]; RIKEN Program for Junior Scientists; Wellcome Trust [102972]	Work in the W-D.H. laboratory is funded by the Swiss National Science Foundation (310030_153074/1). M.E.S. is supported by a Swedish Research Council fellowship (2012-262), K.M.M. by the RIKEN Program for Junior Scientists, and K.J.M. by the Wellcome Trust (Investigator Award 102972). We thank Boas Felmy for input on figure design.	Allam R, 2015, J EXP MED, V212, P369, DOI 10.1084/jem.20140474; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Duerr CU, 2012, SEMIN IMMUNOL, V24, P25, DOI 10.1016/j.smim.2011.11.002; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI [10.1016/j.coi.2015.01.010, 10.1016/j.coi.2015.01.910]; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Song-Zhao GX, 2014, MUCOSAL IMMUNOL, V7, P763, DOI 10.1038/mi.2013.94; Man SM, 2014, P NATL ACAD SCI USA, V111, P17588, DOI [10.1073/pnas.1419925111, 10.1073/pnas.1419925111/-/DCSupplemental]; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Chavarria-Smith J, 2015, IMMUNOL REV, V265, P22, DOI 10.1111/imr.12283; Koch S, 2012, ANNU REV PATHOL-MECH, V7, P35, DOI 10.1146/annurev-pathol-011811-120905; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Peterson CT, 2015, CLIN EXP IMMUNOL, V179, P363, DOI 10.1111/cei.12474; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chae JJ, 2000, MAMM GENOME, V11, P428, DOI 10.1007/s003350010082; Chen C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.532; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1480, DOI 10.1038/mi.2014.36; Dihlmann S, 2014, INT J CANCER, V135, P2387, DOI 10.1002/ijc.28891; Gu YP, 2012, CURR OPIN CELL BIOL, V24, P865, DOI 10.1016/j.ceb.2012.09.003; Harrison O. J., 2015, MUCOSAL IMMUNOL; Hedl M, 2014, J IMMUNOL, V192, P5924, DOI 10.4049/jimmunol.1302727; Lage SL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00309; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; Laughlin R.C., 2014, MBIO, V5; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Oficjalska K, 2015, J IMMUNOL, V194, P1252, DOI 10.4049/jimmunol.1400501; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Sun YD, 2013, GASTROENTEROLOGY, V144, P1478, DOI 10.1053/j.gastro.2013.02.038; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Williams TM, 2015, J IMMUNOL, V194, P3369, DOI 10.4049/jimmunol.1402098; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026	81	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4906	1471-4981		TRENDS IMMUNOL	Trends Immunol.	AUG	2015	36	8					442	450		10.1016/j.it.2015.06.002		9	Immunology	Immunology	CP4WI	WOS:000359882900003		
J	Ishii, T				Ishii, Tetsuya			Germline genome-editing research and its socioethical implications	TRENDS IN MOLECULAR MEDICINE			English	Review						germline genome editing; CRISPR/Cas9; ethics; genome engineering; embryonic stem cells	ONE-STEP GENERATION; IN-VITRO FERTILIZATION; MOUSE ZYGOTES; HUMAN OOCYTES; EFFICIENT GENERATION; EFFECTOR NUCLEASES; CRISPR/CAS SYSTEM; GENE MODIFICATION; HUMAN-CELLS; MICE	Genetically modifying eggs, sperm, and zygotes ('germline' modification) can impact on the entire body of the resulting individual and on subsequent generations. With the advent of genome-editing technology, human germline gene modification is no longer theoretical. Owing to increasing concerns about human germline gene modification, a voluntary moratorium on human genome-editing research and/or the clinical application of human germline genome editing has recently been called for. However, whether such research should be suspended or encouraged warrants careful consideration. The present article reviews recent research on mammalian germline genome editing, discusses the importance of public dialogue on the socioethical implications of human germline genome-editing research, and considers the relevant guidelines and legislation in different countries.	Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan	Ishii, T (reprint author), Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan.	tishii@general.hokudai.ac.jp		Ishii, Tetsuya/0000-0002-7085-7750	Japan Society for the Promotion of Science (JSPS) KAKENHI [26460586]	The author thanks Motoko Araki for her help in the preparation of the figures. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grant 26460586 (T.I.).	Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Fujii W, 2014, BIOCHEM BIOPH RES CO, V445, P791, DOI 10.1016/j.bbrc.2014.01.141; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; EDWARDS RG, 1969, NATURE, V221, P632, DOI 10.1038/221632a0; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Li CL, 2014, MOL CELL BIOL, V34, P1649, DOI 10.1128/MCB.00023-14; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Low BE, 2014, INVEST OPHTH VIS SCI, V55, P387, DOI 10.1167/iovs.13-13278; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barritt J. A., 2001, ONLINE, V3, P47; Chapman A., 2000, HUMAN INHERITABLE GE; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; EDWARDS RG, 1971, NATURE, V231, P87, DOI 10.1038/231087a0; FLOOD JT, 1990, FERTIL STERIL, V53, P1049; Ishii T, 2013, CELL STEM CELL, V13, P145, DOI 10.1016/j.stem.2013.07.005; Ishii T, 2014, REPROD BIOMED ONLINE, V29, P150, DOI 10.1016/j.rbmo.2014.04.001; ISSCR, 2015, ISSCR STAT HUM GERML; Johnson MH, 2010, HUM REPROD, V25, P2157, DOI 10.1093/humrep/deq155; Kasparek P, 2014, FEBS LETT, V588, P3982, DOI 10.1016/j.febslet.2014.09.014; Levron J, 1996, HUM REPROD, V11, P1287; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Liu Z, 2014, NEUROSCI BULL, V30, P381, DOI 10.1007/s12264-014-1434-8; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Neocleous V., 2014, CASE REP GENET, V2014; PALERMO GD, 1995, FERTIL STERIL, V63, P1231; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Reddy Pradeep, 2015, Cell, V161, P459, DOI 10.1016/j.cell.2015.03.051; Stern Harvey J, 2014, J Clin Med, V3, P280, DOI 10.3390/jcm3010280; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; UK Government, 2015, HUM FERT EMBR MIT DO; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wu Yuxuan, 2015, Cell Res, V25, P67, DOI 10.1038/cr.2014.160; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zhang J., 2003, FERTIL STERIL S3, V80, P56, DOI DOI 10.1016/S0015-0282(03)01953-8	64	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	AUG	2015	21	8					473	481		10.1016/j.molmed.2015.05.006		9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CP4YJ	WOS:000359888200004		
J	Nakao, M; Lavikainen, A; Hoberg, E				Nakao, Minoru; Lavikainen, Antti; Hoberg, Eric			Is Echinococcus intermedius a valid species?	TRENDS IN PARASITOLOGY			English	Letter						Echinococcus; evolution; taxonomy	CESTODA TAENIIDAE; GENUS; CANADENSIS; PHYLOGENY; TAPEWORMS		[Nakao, Minoru] Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan; [Lavikainen, Antti] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Immunobiol Program, FIN-00014 Helsinki, Finland; [Lavikainen, Antti] HUSLAB, Div Clin Microbiol, Espoo, Finland; [Hoberg, Eric] ARS, USDA, US Natl Parasite Collect, Anim Parasit Dis Lab, Beltsville, MD USA	Nakao, M (reprint author), Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan.	nakao@asahikawa-med.ac.jp					Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; THOMPSON RCA, 1995, ADV PARASIT, V35, P145; Nakao M, 2013, PARASITOLOGY, V140, P1625, DOI 10.1017/S0031182013000565; RAUSCH RL, 1967, J PARASITOL, V53, P484, DOI 10.2307/3276706; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Thompson RCA, 2008, EXP PARASITOL, V119, P439, DOI 10.1016/j.exppara.2008.04.016; SWEATMAN GK, 1963, PARASITOLOGY, V53, P339; Rausch RL, 2003, PARASITOLOGY, V127, pS73, DOI 10.1017/S0031182003003664; Brooks D.R., 2002, NATURE DIVERSITY EVO; LÓPEZ-NEYRA C. R., 1943, Revista Iberica de Parasitologia, V3, P169; Lymbery AJ, 2015, TRENDS PARASITOL, V31, P23, DOI 10.1016/j.pt.2014.11.003; Terefe Y, 2014, INT J PARASITOL, V44, P533, DOI 10.1016/j.ijpara.2014.03.013	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4922	1471-5007		TRENDS PARASITOL	Trends Parasitol.	AUG	2015	31	8					342	343		10.1016/j.pt.2015.04.012		2	Parasitology	Parasitology	CP4TY	WOS:000359876700002		
J	Tanaka, K				Tanaka, Kiyoyasu			Firm Heterogeneity and FDI in Distribution Services	WORLD ECONOMY			English	Article							FOREIGN DIRECT-INVESTMENT; INTERNATIONAL-TRADE; INTERMEDIATED TRADE; LOCATION CHOICE; PRODUCTIVITY; LEVEL; DETERMINANTS; EXPORTS	Distribution services play a large role in intermediating production and consumption across borders. Using firm-level data on Japanese multinationals in wholesale and retail sectors, this study examines FDI decisions of distribution firms for local distribution services at the extensive and intensive margin. Consistent with the model of heterogeneous firms on multinational production, I find that more productive multinationals are more likely than less productive multinationals to enter a larger number of markets, to penetrate less attractive markets and to generate larger sales per each market. While these findings are consistent with previous evidence on manufacturing multinationals, I find some distinctive determinants of FDI in distribution services.	JETRO, Inst Dev Econ, Chiba, Chiba, Japan	Tanaka, K (reprint author), JETRO, Inst Dev Econ, Chiba, Chiba, Japan.						Akerman A., 2011, THEORY ROLE WH UNPUB; HEAD K, 1995, J INT ECON, V38, P223, DOI 10.1016/0022-1996(94)01351-R; Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Francois J, 2010, J ECON LIT, V48, P642, DOI 10.1257/jel.48.3.642; Bernard AB, 2007, J ECON PERSPECT, V21, P105, DOI 10.1257/jep.21.3.105; Wagner J, 2007, WORLD ECON, V30, P60, DOI 10.1111/j.1467-9701.2007.00872.x; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Ahn J, 2011, J INT ECON, V84, P73, DOI 10.1016/j.jinteco.2010.12.003; Bernard AB, 2010, AM ECON REV, V100, P408, DOI 10.1257/aer.100.2.408; Lancaster T, 2000, J ECONOMETRICS, V95, P391, DOI 10.1016/S0304-4076(99)00044-5; Muuls M, 2009, WORLD ECON, V32, P692, DOI 10.1111/j.1467-9701.2009.01172.x; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Rauch JE, 1999, J INT ECON, V48, P7, DOI 10.1016/S0022-1996(98)00009-9; Buch CM, 2011, J INT ECON, V85, P329, DOI 10.1016/j.jinteco.2011.07.001; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Eaton J, 2011, ECONOMETRICA, V79, P1453, DOI 10.3982/ECTA8318; Belderbos R, 2002, J JPN INT ECON, V16, P194, DOI 10.1006/jjie.2001.0491; Blum BS, 2010, AM ECON REV, V100, P419, DOI 10.1257/aer.100.2.419; Chen MX, 2010, J INT ECON, V80, P188, DOI 10.1016/j.jinteco.2009.08.007; Aw BY, 2008, J INT ECON, V75, P167, DOI 10.1016/j.jinteco.2008.02.002; Head K, 2004, REV ECON STAT, V86, P959, DOI 10.1162/0034653043125257; Head K, 2009, EUR ECON REV, V53, P429, DOI 10.1016/j.euroecorev.2008.08.001; Barro Robert, 2010, 15902 NBER; Bernard A. B., 2011, 17711 NBER; Bhattacharya R, 2012, WORLD ECON, V35, P61, DOI 10.1111/j.1467-9701.2011.01385.x; Breinlich H, 2011, J INT ECON, V84, P188, DOI 10.1016/j.jinteco.2011.03.006; Antras P, 2011, Q J ECON, V126, P1319, DOI 10.1093/qje/qjr019; disGiovanni J, 2005, J INT ECON, V65; Greenaway D, 2007, ECON J, V117, pF134, DOI 10.1111/j.1468-0297.2007.02018.x; Hayakawa K, 2012, J ECON SURV, V26, P332, DOI 10.1111/j.1467-6419.2010.00653.x; Helpman E, 2008, Q J ECON, V123, P441, DOI 10.1162/qjec.2008.123.2.441; Kalirajan K., 2000, RESTRICTIONS TRADE D; Kato Y., 2007, INTRO MODERN DISTRIB; Kimura F, 2006, REV WORLD ECON, V142, P92, DOI 10.1007/s10290-006-0058-8; Markusen J. R., 2002, MULTINATIONAL FIRMS; Nordas H. K., 2008, MARKET STRUCTURE DIS; Ramasamy B, 2010, WORLD ECON, V33, P573, DOI 10.1111/j.1467-9701.2009.01256.x; Stein E, 2007, J INT ECON, V71, P96, DOI 10.1016/j.jinteco.2006.01.003; Tanaka A., 2013, 13E007 RIETI; Todo Y, 2011, WORLD ECON, V34, P355, DOI 10.1111/j.1467-9701.2011.01331.x; Urban D., 2005, REV INT ECON, V13, P770, DOI 10.1111/j.1467-9396.2005.00536.x; Yeaple SR, 2009, J INT ECON, V78, P206, DOI 10.1016/j.jinteco.2009.03.002	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-5920	1467-9701		WORLD ECON	World Econ.	AUG	2015	38	8					1295	1311		10.1111/twec.12252		17	Business, Finance; Economics; International Relations	Business & Economics; International Relations	CP4RK	WOS:000359870000006		
J	Aoki, Y; Cortese, S; Tansella, M				Aoki, Yuta; Cortese, Samuele; Tansella, Michele			Neural bases of atypical emotional face processing in autism: A meta-analysis of fMRI studies	WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY			English	Article						Asperger's syndrome; autistic disorder; functional magnetic resonance imaging; human; pervasive developmental disorders	OBSESSIVE-COMPULSIVE DISORDER; LIKELIHOOD ESTIMATION METAANALYSIS; DEFICIT HYPERACTIVITY DISORDER; RANDOMIZED CONTROLLED-TRIALS; VOXEL-WISE METAANALYSIS; AGE-RELATED-CHANGE; SPECTRUM DISORDERS; FACIAL EXPRESSIONS; FUNCTIONAL NEUROANATOMY; REPETITIVE BEHAVIOR	Objectives. We aim to outline the neural correlates of atypical emotional face processing in individuals with ASD. Methods. A comprehensive literature search was conducted through electronic databases to identify functional magnetic resonance imaging (fMRI) studies of whole brain analysis with emotional-face processing tasks in individuals with ASD. The Signed Differential Mapping with random effects model was used to conduct meta-analyses. Identified fMRI studies were further divided into sub-groups based on contrast ("emotional-face vs. non-emotional-face" or "emotional-face vs. non-face") to confirm the results of a meta-analysis of the whole studies. Results. Thirteen studies with 226 individuals with ASD and 251 typically developing people were identified. We found ASD-related hyperactivation in subcortical structures, including bilateral thalamus, bilateral caudate, and right precuneus, and ASD-related hypoactivation in the hypothalamus during emotional-face processing. Sub-analyses with more homogeneous contrasts preserved the findings of the main analysis such as hyperactivation in sub-cortical structure. Jackknife analyses showed that hyperactivation of the left caudate was the most robust finding. Conclusions. Abnormalities in the subcortical structures, such as amygdala, hypothalamus and basal ganglia, are associated with atypical emotional-face processing in individuals with ASD.	[Aoki, Yuta] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; [Cortese, Samuele] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Cortese, Samuele] Univ Nottingham, Div Psychiat, Inst Mental Hlth, Nottingham NG7 2RD, England; [Cortese, Samuele] NYU, Langone Med Ctr, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY USA; [Tansella, Michele] Univ Verona, Dept Publ Hlth & Community Med, I-37100 Verona, Italy; [Tansella, Michele] Univ Verona, WHO, Collaborating Ctr Res & Training Mental Hlth, I-37100 Verona, Italy; [Tansella, Michele] Univ Verona, Serv Evaluat, I-37100 Verona, Italy	Aoki, Y (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan.	yuaoki-tky@umin.ac.jp					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Andrzejewski ME, 2013, NEUROSCI BIOBEHAV R, V37, P2071, DOI 10.1016/j.neubiorev.2013.03.019; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; SIGMAN MD, 1992, CHILD DEV, V63, P796, DOI 10.1111/j.1467-8624.1992.tb01662.x; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Aoki Y, 2013, NEUROSCI BIOBEHAV R, V37, P1692, DOI 10.1016/j.neubiorev.2013.04.019; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Horder J, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.53; Bornstein AM, 2011, CURR OPIN NEUROBIOL, V21, P374, DOI 10.1016/j.conb.2011.02.009; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Philip RCM, 2012, NEUROSCI BIOBEHAV R, V36, P901, DOI 10.1016/j.neubiorev.2011.10.008; Radua J, 2012, EUR PSYCHIAT, V27, P605, DOI 10.1016/j.eurpsy.2011.04.001; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Nair A, 2013, BRAIN, V136, P1942, DOI 10.1093/brain/awt079; Norbury R, 2010, PSYCHOL MED, V40, P425, DOI 10.1017/S0033291709990596; Hubl D, 2003, NEUROLOGY, V61, P1232; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Liljeholm M, 2012, TRENDS COGN SCI, V16, P467, DOI 10.1016/j.tics.2012.07.007; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; Greimel E, 2010, NEUROIMAGE, V49, P1055, DOI 10.1016/j.neuroimage.2009.07.057; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Celani G, 1999, J AUTISM DEV DISORD, V29, P57, DOI 10.1023/A:1025970600181; Peron J, 2013, NEUROSCI BIOBEHAV R, V37, P358, DOI 10.1016/j.neubiorev.2013.01.001; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Fusar-Poli P, 2012, J PSYCHIATR NEUROSCI, V37, P106, DOI 10.1503/jpn.110021; Corbett BA, 2009, PSYCHIAT RES-NEUROIM, V173, P196, DOI 10.1016/j.pscychresns.2008.08.005; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Weng SJ, 2011, J CHILD PSYCHOL PSYC, V52, P296, DOI 10.1111/j.1469-7610.2010.02317.x; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Fombonne E, 2003, JAMA-J AM MED ASSOC, V289, P87, DOI 10.1001/jama.289.1.87; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Delvecchio G, 2013, PSYCHOL MED, V43, P553, DOI 10.1017/S0033291712001432; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Bellani M, 2011, EPIDEMIOL PSYCH SCI, V20, P235, DOI 10.1017/S2045796011000448; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Pelphrey KA, 2007, SOC COGN AFFECT NEUR, V2, P140, DOI 10.1093/scan/nsm010; Wicker B, 2008, SOC COGN AFFECT NEUR, V3, P135, DOI 10.1093/scan/nsn007; Pelphrey KA, 2008, DEV PSYCHOPATHOL, V20, P1081, DOI 10.1017/S0954579408000515; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Deeley Q, 2007, BIOL PSYCHIAT, V62, P207, DOI 10.1016/j.biopsych.2006.09.037; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.65; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Aoki Y., 2013, MOL AUTISM, V22, P25, DOI DOI 10.1186/2040-2392-4-25; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.78; Aoki Y, 2013, SOC COGN AFFECT NEUR; Bora E, 2011, PSYCHOL MED, V11, P1, DOI DOI 10.1017/S0033291711001450; Brambilla P, 2004, FUNCT NEUROL, V19, P9; Dickstein DP, 2013, J AM ACAD CHILD PSY, V52, P279, DOI 10.1016/j.jaac.2012.12.012; Ishitobi M, 2011, RES AUTISM SPECT DIS, V5, P910, DOI 10.1016/j.rasd.2010.10.005; Langen M., 2013, BIOL PSYCHIAT; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Lin IF, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-20; Morita T, 2011, SOC NEUROSCI, V7, P223, DOI 10.1080/17470919.2011.598945; Perlman SB, 2011, SOC NEUROSCI-UK, V6, P22, DOI 10.1080/17470911003683185; Rahko JS, 2012, J AUTISM DEV DISORD, V42, P1011, DOI 10.1007/s10803-011-1332-8; Roland P. E., 1993, Human Brain Mapping, V1, P3, DOI 10.1002/hbm.460010103; YIRMIYA N, 1992, CHILD DEV, V63, P150, DOI 10.1111/j.1467-8624.1992.tb03603.x	77	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1562-2975	1814-1412		WORLD J BIOL PSYCHIA	World J. Biol. Psychiatry	AUG	2015	16	5					291	300		10.3109/15622975.2014.957719		10	Psychiatry	Psychiatry	CP6FP	WOS:000359980800003		
J	Shibasaki, S; Takahashi, N; Homma, S; Nishida, M; Shimokuni, T; Yoshida, T; Kawamura, H; Oyama-Manabe, N; Kudo, K; Taketomi, A				Shibasaki, Susumu; Takahashi, Norihiko; Homma, Shigenori; Nishida, Mutsumi; Shimokuni, Tatsushi; Yoshida, Tadashi; Kawamura, Hideki; Oyama-Manabe, Noriko; Kudo, Kohsuke; Taketomi, Akinobu			Use of transabdominal ultrasonography to preoperatively determine T-stage of proven colon cancers	ABDOMINAL IMAGING			English	Article							GASTROINTESTINAL-TRACT; GASTRIC-CANCER; COLORECTAL-CANCER; RECTAL-CANCER; ENDORECTAL ULTRASONOGRAPHY; COMPUTED-TOMOGRAPHY; SONOGRAPHY; TUMORS; CT; DIAGNOSIS	Purpose: Although noninvasive and highly informative, transabdominal ultrasonography (US) is not yet an accepted means of staging colorectal cancer preoperatively. This prospective study evaluated the diagnostic accuracy of US in preoperative staging of patients with resectable colon cancers. Methods: A total of 98 patients with primary colon cancer diagnosed by colonoscopy at our institute between January, 2011 and June, 2014 underwent preoperative ultrasonographic tumor staging. Depth of tumor infiltration (T-stage) was assessed by standard means (i.e., extent of mural involvement), analyzing agreement in US and histopathology determinations. Results: All but two colon cancers (at splenic flexure) were detected by US (98%, 96/98). Compared with histopathology, overall accuracy of US in determining T-stage was 64% (61/96), indicating moderate reproducibility (kappa coefficient 0.48; 95% CI 0.35-0.62; p < 0.001). Using a three-tier approach of graded muscularis propria (MP) involvement (Tis/T1, below MP; T2, within MP; and T3/T4, beyond MP), diagnostic agreement increased to 89% (85/96), with good agreement (kappa coefficient 0.77; 95% CI 0.64-0.90; p < 0.001). No tumor characteristics or patient demographics influenced diagnostic agreement at any site in the colon. Conclusions: Given the potential to yield valuable information while limiting patient discomfort, US should be reconsidered as a means of assessing colon cancer.	[Shibasaki, Susumu; Takahashi, Norihiko; Homma, Shigenori; Shimokuni, Tatsushi; Yoshida, Tadashi; Kawamura, Hideki; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishida, Mutsumi] Hokkaido Univ Hosp, Diagnost Ctr Sonog, Div Lab & Transfus Med, Sapporo, Hokkaido 060, Japan; [Oyama-Manabe, Noriko; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 060, Japan	Shibasaki, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	susumushi48@mist.ocn.ne.jp					ACUNAS B, 1990, EUR J RADIOL, V11, P150, DOI 10.1016/0720-048X(90)90166-9; Liao SR, 2004, WORLD J GASTROENTERO, V10, P3399; Smith NJ, 2007, BRIT J CANCER, V96, P1030, DOI 10.1038/sj.bjc.6603646; Tomizawa M, 2013, HEPATO-GASTROENTEROL, V60, P517, DOI 10.5754/hge12722; Ishigami S, 2004, HEPATO-GASTROENTEROL, V51, P1202; Santoro GA, 2009, DIS COLON RECTUM, V52, P1837, DOI 10.1007/DCR.0b013e3181b16ce9; Sinha R, 2006, CLIN RADIOL, V61, P924, DOI 10.1016/j.crad.2006.03.019; O'Malley ME, 2003, RADIOGRAPHICS, V23, P59, DOI 10.1148/rg.231025078; Garcia-Aguilar J, 2002, DIS COLON RECTUM, V45, P10, DOI 10.1007/s10350-004-6106-3; Martinez-Ares D, 2009, REV ESP ENFERM DIG, V101, P773, DOI 10.4321/s1130-01082009001100005; SHIRAHAMA M, 1994, J CLIN ULTRASOUND, V22, P359, DOI 10.1002/jcu.1870220602; Fujii Y, 2008, J CLIN ULTRASOUND, V36, P59, DOI 10.1002/jcu.20393; Maconi G, 2009, AM J ROENTGENOL, V193, P700, DOI 10.2214/AJR.08.1979; Chaubal N, 2006, J ULTRAS MED, V25, P87; Harewood GC, 2005, AM J GASTROENTEROL, V100, P808, DOI 10.1111/j.1572-0241.2005.41035.x; LIM JH, 1994, ABDOM IMAGING, V19, P527, DOI 10.1007/BF00198255; Lin SY, 2011, J ULTRAS MED, V30, P1051; Mainenti PP, 2006, EUR J RADIOL, V60, P453, DOI 10.1016/j.ejrad.2006.08.001; Nesbakken A, 2003, Scand J Surg, V92, P125; Segura JM, 1999, J CLIN ULTRASOUND, V27, P499, DOI 10.1002/(SICI)1097-0096(199911/12)27:9<499::AID-JCU3>3.0.CO;2-U; Tezcan D, 2013, CLIN IMAG, V37, P1048, DOI 10.1016/j.clinimag.2013.08.003; Watanabe T, 2010, INT J CLIN ONCOL, V17, P1, DOI DOI 10.1007/S10147-011-0315-2	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1441	1450		10.1007/s00261-014-0296-5		10	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300011		
J	Ishii, M; Kazaoka, J; Fukushima, J; Gunji, M; Aoyama, T; Fukusato, T; Sano, K; Kondo, F; Takeshita, T; Furui, S; Akahane, M				Ishii, Masaya; Kazaoka, Junichi; Fukushima, Junichi; Gunji, Mariko; Aoyama, Toru; Fukusato, Toshio; Sano, Keiji; Kondo, Fukuo; Takeshita, Toru; Furui, Shigeru; Akahane, Masaaki			A case of beta-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition	ABDOMINAL IMAGING			English	Article						beta-Catenin-positive hepatocellular adenoma; Hepatocellular adenoma; Diffuse intratumoral fat deposition; Diffuse intratumoral steatosis	FOCAL NODULAR HYPERPLASIA; GADOXETATE DISODIUM; FEATURES	Hepatocellular adenoma (HCA) is a rare primary benign tumor of the liver, which occurs predominantly in young and middle-aged women. Recently, the subclassification of HCA was proposed by the Bordeaux group. Subsequently, characteristic radiological and clinical features have been revealed in each HCA subtype. According to the previous literature, diffuse intratumoral fat deposition is a very common finding in hepatocyte nuclear factor 1 alpha-negative HCA, but this finding has been reported in beta-catenin-positive HCA in the literature for only one case. In this case report, we report the second case of beta-catenin-positive HCA with MR imaging sign of diffuse intratumoral fat deposition, confirmed immunohistologically on the basis of a surgical specimen. In addition, our case showed hypovascularity and isointensity on the hepatobiliary phase which have been reported as characteristic findings in beta-catenin-positive HCA. Diffuse intratumoral fat deposition can be observed in beta-catenin-positive HCA, which has a greater probability of malignant transformation than other types of HCA.	[Ishii, Masaya; Kazaoka, Junichi; Akahane, Masaaki] NTT Med Ctr Tokyo, Dept Radiol, Shinagawa Ku, Tokyo 1410022, Japan; [Fukushima, Junichi] Gyoda Gen Hosp, Dept Pathol, Gyoda, Saitama 3610056, Japan; [Gunji, Mariko] NTT Med Ctr Tokyo, Dept Diagnost Pathol, Shinagawa Ku, Tokyo 1410022, Japan; [Aoyama, Toru] Saitama Med Univ, Saitama Med Ctr, Div Gastroenterol & Hepatol, Kawagoe, Saitama 3508550, Japan; [Fukusato, Toshio; Kondo, Fukuo] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738606, Japan; [Sano, Keiji] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738606, Japan; [Takeshita, Toru; Furui, Shigeru] Teikyo Univ, Sch Med, Dept Radiol, Itabashi Ku, Tokyo 1738606, Japan	Ishii, M (reprint author), NTT Med Ctr Tokyo, Dept Radiol, Shinagawa Ku, 5-9-22 Higashigotanda, Tokyo 1410022, Japan.	masayaishii-tky@umin.ac.jp					Laumonier H, 2012, AM J ROENTGENOL, V199, P341, DOI 10.2214/AJR.11.7046; Grazioli L, 2012, RADIOLOGY, V262, P520, DOI 10.1148/radiol.11101742; van Aalten SM, 2011, RADIOLOGY, V261, P172, DOI 10.1148/radiol.11110023; Laumonier H, 2008, HEPATOLOGY, V48, P808, DOI 10.1002/hep.22417; Bieze M, 2012, AM J ROENTGENOL, V199, P26, DOI 10.2214/AJR.11.7750; Kim GJ, 2014, GUT LIVER, V8, P452, DOI 10.5009/gnl.2014.8.4.452; Yoneda N, 2012, JPN J RADIOL, V30, P777, DOI 10.1007/s11604-012-0115-2; Manichon AF, 2012, HPB SURG, V2012, DOI DOI 10.1155/2012/418745; Purysko AS, 2012, AM J ROENTGENOL, V198, P115, DOI 10.2214/AJR.11.6836; Ronot M, 2011, HEPATOLOGY, V53, P1182, DOI 10.1002/hep.24147; Soejima Y, 2012, KANZO, V53, P779	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1487	1491		10.1007/s00261-014-0342-3		5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300018		
J	Tsunematsu, S; Chuma, M; Kamiyama, T; Miyamoto, N; Yabusaki, S; Hatanaka, K; Mitsuhashi, T; Kamachi, H; Yokoo, H; Kakisaka, T; Tsuruga, Y; Orimo, T; Wakayama, K; Ito, J; Sato, F; Terashita, K; Nakai, M; Tsukuda, Y; Sho, T; Suda, G; Morikawa, K; Natsuizaka, M; Nakanishi, M; Ogawa, K; Taketomi, A; Matsuno, Y; Sakamoto, N				Tsunematsu, Seiji; Chuma, Makoto; Kamiyama, Toshiya; Miyamoto, Noriyuki; Yabusaki, Satoshi; Hatanaka, Kanako; Mitsuhashi, Tomoko; Kamachi, Hirofumi; Yokoo, Hideki; Kakisaka, Tatsuhiko; Tsuruga, Yousuke; Orimo, Tatsuya; Wakayama, Kenji; Ito, Jun; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Tsukuda, Yoko; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Natsuizaka, Mitsuteru; Nakanishi, Mitsuru; Ogawa, Koji; Taketomi, Akinobu; Matsuno, Yoshihiro; Sakamoto, Naoya			Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma	ABDOMINAL IMAGING			English	Article						Intrahepatic cholangiocarcinoma; Intratumoral artery; Poorly differentiated hepatocellular carcinoma; Contrast-enhanced CT; Differential diagnosis	PERIPHERAL CHOLANGIOCARCINOMA; GROWTH-PATTERN; CT; MANAGEMENT; LIVER	Differentiating intrahepatic cholangiocarcinoma (ICC) from poorly differentiated hepatocellular carcinoma (p-HCC) is often difficult, but it is important for providing appropriate treatments. The purpose of this study was to examine the features differentiating ICC from p-HCC on contrast-enhanced dynamic-computed tomography (CT). This study examined 42 patients with pathologically confirmed ICC (n = 19) or p-HCC (n = 23) for which contrast-enhanced dynamic CT data were available. CT images were analyzed for enhancement patterns during the arterial phase, washout pattern, delayed enhancement, satellite nodules, capsular retraction, lesion shape, and presence of an intratumoral hepatic artery, intratumoral hepatic vein, intratumoral portal vein, and bile duct dilation around the tumor, portal vein tumor thrombus, lobar atrophy, or lymphadenopathy. Univariate analysis revealed the presence of rim enhancement (p = 0.037), lobulated shape (p = 0.004), intratumoral artery (p < 0.001), and bile duct dilation (p = 0.006) as parameters significantly favoring ICC, while a washout pattern significantly favored p-HCC (p < 0.001). Multivariate analysis revealed intratumoral artery as a significant, independent variable predictive of ICC (p = 0.037), and 15 ICCs (78.9%) showed this feature. Washout pattern was a significant, independent variable favoring p-HCC (p = 0.049), with 15 p-HCCs (65.2%) showing this feature. The presence of an intratumoral artery in the arterial phase on contrast-enhanced dynamic CT was a predictable finding for ICC, and the presence of a washout pattern was a predictable finding for p-HCC, differentiating between ICC and p-HCC.	[Tsunematsu, Seiji; Chuma, Makoto; Ito, Jun; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Tsukuda, Yoko; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Natsuizaka, Mitsuteru; Nakanishi, Mitsuru; Ogawa, Koji; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kamiyama, Toshiya; Kamachi, Hirofumi; Yokoo, Hideki; Kakisaka, Tatsuhiko; Tsuruga, Yousuke; Orimo, Tatsuya; Wakayama, Kenji; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol, Sapporo, Hokkaido 0608638, Japan; [Miyamoto, Noriyuki; Yabusaki, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 0608638, Japan; [Hatanaka, Kanako; Mitsuhashi, Tomoko; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Chuma, Makoto] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan	Chuma, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kita Ku, 15 Kita,7 Nishi, Sapporo, Hokkaido 0608638, Japan.	chuma@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan; Ministry of Health, Labour and Welfare-Japan; Japan Health Sciences Foundation	This study was supported by Grants from the Ministry of Education, Culture, Sports, Science and Technology-Japan; Ministry of Health, Labour and Welfare-Japan; and Japan Health Sciences Foundation.	Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; UEDA K, 1992, HUM PATHOL, V23, P619, DOI 10.1016/0046-8177(92)90316-U; Kim TK, 1997, RADIOLOGY, V204, P539; Valls C, 2000, ABDOM IMAGING, V25, P490, DOI 10.1007/s002610000079; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Hertl M, 2005, ONCOLOGIST, V10, P269, DOI 10.1634/theoncologist.10-4-269; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Singh P, 2006, CURR OPIN GASTROEN, V22, P294, DOI 10.1097/01.mog.0000218967.60633.64; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Lim JH, 2003, AM J ROENTGENOL, V181, P819; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Han JK, 2002, RADIOGRAPHICS, V22, P173; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Jarnagin WR, 2004, SEMIN LIVER DIS, V24, P189, DOI 10.1055/s-2004-828895; Baheti A D, 2014, Clin Radiol, V69, pe463, DOI 10.1016/j.crad.2014.08.003; CHOI BI, 1995, ABDOM IMAGING, V20, P357, DOI 10.1007/BF00203371; FAN ZM, 1993, AM J ROENTGENOL, V161, P313; Hirohashi S, 2000, WHO CLASSIFICATION T, P159; Kham SA, 2005, LANCET, V366, P1303; Khan SA, 2002, GUT, V61, P1657; Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x; Lee WJ, 2001, RADIOGRAPHICS, V21, P97; Miura F, 2004, ABDOM IMAGING, V29, P467, DOI 10.1007/s00261-004-0177-4; NAGORNEY DM, 1993, ARCH SURG-CHICAGO, V128, P871; Nakanuma Y, 2000, WHO CLASSIFICATION T, P173; ROS PR, 1988, RADIOLOGY, V167, P689	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1492	1499		10.1007/s00261-015-0352-9		8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300019		
J	Yamada, Y; Mori, H; Matsumoto, S; Kiyonaga, M; Sai, M; Takaji, R; Tomonari, K; Tanoue, R				Yamada, Yasunari; Mori, Hiromu; Matsumoto, Shunro; Kiyonaga, Maki; Sai, Michiaki; Takaji, Ryo; Tomonari, Kenichiro; Tanoue, Rika			Lymphatic pathway around the pancreatic head and extrahepatic bile duct: evaluation using MR imaging at 3.0-T	ABDOMINAL IMAGING			English	Article						Pancreas; Extrahepatic bile duct; Lymphatic system; Anatomy; Magnetic resonance imaging	SPIN-ECHO SEQUENCES; CISTERNA-CHYLI; THORACIC-DUCT; 3 T; CARCINOMA; CANCER; CHOLANGIOPANCREATOGRAPHY; IMPACT; ADENOCARCINOMA; LYMPHOGRAPHY	To evaluate the utility of spectral presaturation with inversion recovery (SPIR) T2-weighted images with 3-dimensional (3D) volume isotropic turbo spin echo acquisition (VISTA) at 3.0-T for the detection of the normal lymphatic systems located around the pancreatic head and extrahepatic bile duct. Fifty-six patients with suspected hepatic or pancreaticobiliary diseases and diagnosed as normal or benign pathologies were evaluated as having normal lymphatic systems. The protocol consisted of SPIR T2-weighted sequences with 3D-VISTA. The lymphatic systems were defined as fluid signal intensity structures and divided into eight portions and interobserver agreement was evaluated using weighted kappa statistics. Three readers graded the visualization of each portion using a five-point scale. The detectability of each portion was calculated by defining grades 1-2 as detectable and grades 3-5 as undetectable. Interobserver agreement regarding the visualization grades was moderate to almost perfect. All readers rated the detectability of the lymphatic systems of the superior and posterior portions of the pancreatic head, pericholedochal, right abdominoaortic, and interaorticovenous portions as 100%, and that of the anterior portion of the pancreatic head as 98.2%. For the inferior portion of the pancreatic head, the detectability was 100% for reader 2 and 96.4% for readers 1 and 3. The lymphatic systems located around the pancreatic head and extrahepatic bile duct could be sufficiently visualized on SPIR T2-weighted images with 3D-VISTA at 3.0-T.	[Yamada, Yasunari; Mori, Hiromu; Matsumoto, Shunro; Kiyonaga, Maki; Sai, Michiaki; Takaji, Ryo] Oita Univ, Fac Med, Dept Radiol, Yufu, Oita 8795593, Japan; [Tomonari, Kenichiro; Tanoue, Rika] Oita Diagnost Imaging Ctr, Beppu, Oita 8740023, Japan	Yamada, Y (reprint author), Oita Univ, Fac Med, Dept Radiol, Yufu, Oita 8795593, Japan.	yasunari@oita-u.ac.jp					Pinto PS, 2004, RADIOGRAPHICS, V24, P809, DOI 10.1148/rg.243035086; Zacharias T, 2007, J GASTROINTEST SURG, V11, P350, DOI 10.1007/s11605-007-0113-3; Furukawa H, 2008, EUR RADIOL, V18, P2841, DOI 10.1007/s00330-008-1062-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Sai M, 2010, ABDOM IMAGING, V35, P154, DOI 10.1007/s00261-008-9461-z; Kauhanen SP, 2009, ANN SURG, V250, P957, DOI 10.1097/SLA.0b013e3181b2fafa; Sugiura T, 2013, SURGERY, V154, P1078, DOI 10.1016/j.surg.2013.04.015; Weigel M, 2010, MAGN RESON MED, V63, P230, DOI 10.1002/mrm.22145; Ito K, 2010, ANN SURG, V251, P675, DOI 10.1097/SLA.0b013e3181d3d2b2; Hori M, 2009, RADIOLOGY, V251, P96, DOI 10.1148/radiol.2511081265; Lichy MP, 2005, INVEST RADIOL, V40, P754, DOI 10.1097/01.rli.0000185880.92346.9e; Yang RK, 2010, RADIOGRAPHICS, V30, P185, DOI 10.1148/rg.301095076; Samra JS, 2008, ANZ J SURG, V78, P228, DOI 10.1111/j.1445-2197.2008.04426.x; Park HS, 2009, J MAGN RESON IMAGING, V30, P586, DOI 10.1002/jmri.21889; Kim HY, 2008, RADIOLOGY, V246, P596, DOI 10.1148/radiol.2461061907; Busse RF, 2006, MAGN RESON MED, V55, P1030, DOI 10.1002/mrm.20863; Fulcher AS, 1998, RADIOLOGY, V207, P21; Pomianowska E, 2013, ANN SURG ONCOL, V20, P233, DOI 10.1245/s10434-012-2592-z; Arrive L, 2007, AM J ROENTGENOL, V189, P1051, DOI 10.2214/AJR.07.2047; Cornfeld DM, 2008, J MAGN RESON IMAGING, V28, P121, DOI 10.1002/jmri.21402; DEKI H, 1988, SURG RADIOL ANAT, V10, P121, DOI 10.1007/BF02307820; DONATINI B, 1992, SURG RADIOL ANAT, V14, P35, DOI 10.1007/BF01628041; Erden A, 2005, AM J ROENTGENOL, V184, P35; Gadzijev Eldar M, 2002, J Hepatobiliary Pancreat Surg, V9, P531, DOI 10.1007/s005340200068; Harisinghani MG, 2004, RADIOGRAPHICS, V24, P867, DOI 10.1148/rg.243035190; Hayashi S, 1999, RADIOLOGY, V212, P598; Ito K, 2012, J MAGN RESON IMAGING, V35, P624, DOI 10.1002/jmri.22875; KAYAHARA M, 1993, CANCER, V72, P2112, DOI 10.1002/1097-0142(19931001)72:7<2112::AID-CNCR2820720709>3.0.CO;2-X; Morakkabati-Spitz N, 2006, RADIOLOGY, V241, P538, DOI 10.1148/radiol.2412050877; NAGAKAWA T, 1993, HEPATO-GASTROENTEROL, V40, P457; PANUSH D, 1993, RADIOLOGY, V187, P421; Pissas A, 1984, SURG RADIOL ANAT, V6, P255; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P634, DOI 10.2214/AJR.09.2994; Sahani DV, 2012, RADIOGRAPHICS, V32, P1158, DOI [10.1148/rg.324115143, DOI 10.1148/RG.324115143]]; Sahani DV, 2012, RADIOGRAPHICS, V32, P1133, DOI 10.1148/rg.324115143; Sobin LH, 2009, TNM CLASSIFICATION M; Takayama Y, 2015, J MAGN RESON IMAGING, V41, P339, DOI 10.1002/jmri.24554; TAUPITZ M, 1995, RADIOLOGY, V194, P439; Vitellas KM, 2000, RADIOGRAPHICS, V20, P939; Wagner M, 2008, ACTA RADIOL, V49, P376, DOI 10.1080/02841850801894806; Yu DX, 2010, J MAGN RESON IMAGING, V32, P94, DOI 10.1002/jmri.22128	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1617	1628		10.1007/s00261-014-0346-z		12	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300030		
J	Nakajo, M; Nakajo, M; Fukukura, Y; Jinguji, M; Shindo, T; Nakabeppu, Y; Kamimura, K; Yoneyama, T; Takumi, K; Yoshiura, T				Nakajo, Masatoyo; Nakajo, Masayuki; Fukukura, Yoshihiko; Jinguji, Megumi; Shindo, Toshikazu; Nakabeppu, Yoshiaki; Kamimura, Kiyohisa; Yoneyama, Tomohide; Takumi, Koji; Yoshiura, Takashi			Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors	ABDOMINAL IMAGING			English	Article						Adrenal tumor; Pheochromocytoma; FDG; SUV; ADC	POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCED CT; CHEMICAL-SHIFT; MAGNETIC-RESONANCE; F-18-FDG PET/CT; LESIONS; MASSES; UTILITY; MRI; FLUORODEOXYGLUCOSE	Purpose: The purpose of this study is to compare diagnostic performances of F-18-fluorodeoxyglucose (FDG) visual score, maximum standardized uptake value (SUVmax), ratio of adrenal SUVmax to liver SUVmax (A/L SUVmax), apparent diffusion coefficient (ADC) from diffusion-weighted imaging, and SUVmax/ADC ratio to differentiate adrenal pheochromocytoma from other benign tumors. Methods: Eleven pheochromocytomas and 22 other benign tumors in 30 patients were included. FDG-based indices, ADC, and SUVmax/ADC ratio were compared between groups using the Mann-Whitney U test, and sensitivity, specificity, accuracy, and area under the curve (AUC) for diagnosing pheochromocytoma by receiver operating characteristic analyses. The correlation between SUVmax and ADC was analyzed using the Spearman's rank test. Results: Pheochromocytoma showed significantly higher visual score (2.8 +/- A 0.4 vs. 1.3 +/- A 0.9), SUVmax (11.0 +/- A 8.9 vs. 3.2 +/- A 1.4), A/L SUVmax ratio (3.96 +/- A 3.48 vs. 0.96 +/- A 0.51), and SUVmax/ADC ratio (10.6 +/- A 8.09 vs. 2.28 +/- A 0.98) (each P < 0.001) and significantly lower ADC (1.08 +/- A 0.23 x 10(-3) mm(2)/s vs. 1.43 +/- A 0.29 x 10(-3) mm(2)/s, P = 0.003) than other benign tumors. Sensitivity, specificity, and accuracy for diagnosing pheochromocytoma were 100, 73, and 82% for visual score, 100, 86, and 91% for both SUVmax and A/L SUVmax ratio, and 64, 100, and 88% for ADC and 82, 95, and 91% for SUVmax/ADC ratio. No significant differences in AUC were found between FDG-based indices, ADC, and SUVmax/ADC ratio. A significant negative correlation was noted between SUVmax and ADC (rho = -0.36, P = 0.039). Conclusion: FDG-based indices and ADC appear comparably useful for differentiating pheochromocytoma from other benign adrenal tumors.	[Nakajo, Masatoyo; Nakajo, Masayuki; Fukukura, Yoshihiko; Jinguji, Megumi; Shindo, Toshikazu; Nakabeppu, Yoshiaki; Kamimura, Kiyohisa; Yoneyama, Tomohide; Takumi, Koji; Yoshiura, Takashi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 8908544, Japan; [Nakajo, Masayuki] Nanpuh Hosp, Dept Radiol, Kagoshima 8928512, Japan	Nakajo, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	toyo.nakajo@dolphin.ocn.ne.jp					Adas S, 2013, CASE REP GASTROENTER, V7, P420; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Boland GWL, 2008, RADIOLOGY, V249, P756, DOI 10.1148/radiol.2493070976; Boland GWL, 1998, AM J ROENTGENOL, V171, P201; Castinetti F, 2012, J CLIN ENDOCR METAB, V97, P2577, DOI 10.1210/jc.2012-1713; Metser U, 2006, J NUCL MED, V47, P32; Sinha S, 2002, J MAGN RESON IMAGING, V15, P693, DOI 10.1002/jmri.10116; Boland GWL, 2009, AM J ROENTGENOL, V192, P956, DOI 10.2214/AJR.08.1431; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Groussin L, 2009, J CLIN ENDOCR METAB, V94, P1713, DOI 10.1210/jc.2008-2302; Rigo P, 1996, EUR J NUCL MED, V23, P1641, DOI 10.1007/BF01249629; Sandrasegaran K, 2011, AM J ROENTGENOL, V197, P132, DOI 10.2214/AJR.10.4583; Low G, 2012, CLIN RADIOL, V67, P988, DOI 10.1016/j.crad.2012.02.005; Taieb D, 2009, J NUCL MED, V50, P711, DOI 10.2967/jnumed.108.060731; Bagheri B, 2004, J NUCL MED, V45, P1340; Blake MA, 2006, RADIOLOGY, V238, P970, DOI 10.1148/radio.2383042164; Havekes B, 2010, CLIN ENDOCRINOL, V72, P137, DOI 10.1111/j.1365-2265.2009.03648.x; Shulkin BL, 1999, RADIOLOGY, V212, P35; Caoili EM, 2000, AM J ROENTGENOL, V175, P1411; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Fujiyoshi F, 2003, AM J ROENTGENOL, V180, P1649; Park BK, 2007, EUR RADIOL, V17, P2804, DOI 10.1007/s00330-007-0695-x; Szolar DH, 2005, RADIOLOGY, V234, P479, DOI 10.1148/radiol.2342031876; Chong S, 2006, RADIOGRAPHICS, V26, P1811, DOI 10.1148/rg.266065057; Dong Y, 2012, J COMPUT ASSIST TOMO, V36, P361, DOI 10.1097/RCT.0b013e31825975f8; Halefoglu AM, 2012, J COMPUT ASSIST TOMO, V36, P367, DOI 10.1097/RCT.0b013e3182597613; Ilias L, 2007, ENDOCR-RELAT CANCER, V14, P587, DOI 10.1677/ERC-07-0045; Ludwig Vinicius, 2002, Mol Imaging Biol, V4, P355, DOI 10.1016/S1536-1632(02)00018-5; Mamede M, 2006, NUCL MED COMMUN, V27, P31, DOI 10.1097/01.mnm.0000189780.54658.e8; Miller FH, 2010, AM J ROENTGENOL, V194, pW179, DOI 10.2214/AJR.09.2891; Song JQ, 2012, EUR J RADIOL, V81, P2137, DOI 10.1016/j.ejrad.2011.09.016; Tsushima Y, 2009, J MAGN RESON IMAGING, V29, P112, DOI 10.1002/jmri.21616; Wong KK, 2011, NUCL MED COMMUN, V32, P764, DOI 10.1097/MNM.0b013e3283478a2a	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1655	1665		10.1007/s00261-014-0291-x		11	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300033		
J	Akita, H; Yamada, Y; Ito, Y; Mikami, S; Sugiura, H; Okuda, S; Jinzaki, M				Akita, Hirotaka; Yamada, Yoshitake; Ito, Yoshiaki; Mikami, Shuji; Sugiura, Hiroaki; Okuda, Shigeo; Jinzaki, Masahiro			Retroperitoneal low-flow vascular malformations: characteristic MRI findings correlated with histopathological findings	ABDOMINAL IMAGING			English	Article						Retroperitoneal low-flow vascular malformation; Breath-hold T2-weighted single-shot fast spin-echo image; Phantom sign; Centripetal filling pattern	CLASSIFICATION; HEMANGIOMAS; TUMORS; PHEOCHROMOCYTOMA; TERMINOLOGY; NEOPLASMS; ANOMALIES; CT	Purpose: To evaluate the MRI findings of retroperitoneal low-flow vascular malformations (RLVMs) correlated with histopathological findings. Methods: Two radiologists reviewed the MRI findings of 4 RLVMs (3 with capillary malformations and 1 with a venous malformation). First, they evaluated the visibility, signal intensities, and signal homogeneity of each lesion on non-fat-suppressed breath-hold T2-weighted single-shot fast spin-echo (non-FS SSFSE) images and fat-suppressed T2-weighted fast spin-echo (FS T2-weighted FSE) images. Second, the kinetic patterns and the internal enhancement patterns were analyzed for each lesion on multi-phasic contrast-enhanced (CE) images. After these image analyses, the MRI findings were correlated with the histopathological findings. Result: Histopathologically, the 4 RLVMs did not exhibit remarkable degeneration and were present in the retroperitoneal fat tissue without clear capsules. On the non-FS SSFSE images, 3 of the 4 RLVMs could not be discriminated from the surrounding retroperitoneal fat tissue (invisible), and the remaining lesion was barely visible with an indistinct margin. On the FS T2-weighted FSE images, however, all the RLVMs were clearly visualized as homogeneous high-signal intensities. On the multi-phasic CE images, all the capillary malformations exhibited fast enhancement, while a venous malformation showed slow enhancement. Furthermore, the RLVMs tended to exhibit a centripetal filling pattern. Conclusion: The RLVMs blended in with the surrounding retroperitoneal fat tissue on non-FS SSFSE images, like phantoms, whereas they were clearly visualized on FS T2-weighted FSE images. On multi-phasic CE images, the RLVMs tended to exhibit a centripetal filling pattern. These imaging features may be useful diagnostic clues for RLVMs.	[Akita, Hirotaka; Yamada, Yoshitake; Sugiura, Hiroaki; Okuda, Shigeo; Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1608582, Japan; [Ito, Yoshiaki] Natl Hosp Org, Tokyo Med Ctr, Dept Radiol, Meguro Ku, Tokyo 1528902, Japan; [Mikami, Shuji] Keio Univ Hosp, Div Diagnost Pathol, Shinjuku Ku, Tokyo 1608582, Japan	Jinzaki, M (reprint author), Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jinzaki@rad.med.keio.ac.jp		Yamada, Yoshitake/0000-0002-5842-5349			Rha SE, 2003, RADIOGRAPHICS, V23, P29, DOI 10.1148/rg.231025050; MEYER JS, 1991, AM J ROENTGENOL, V157, P559; Lowe LH, 2012, SEMIN ROENTGENOL, V47, P106, DOI 10.1053/j.ro.2011.11.002; Vilanova JC, 2004, RADIOGRAPHICS, V24, P367, DOI 10.1148/rg.242035079; van Rijswijk CSP, 2002, AM J ROENTGENOL, V178, P1181; Hassanein AH, 2011, PLAST RECONSTR SURG, V127, P347, DOI 10.1097/PRS.0b013e3181f95b83; JACKSON IT, 1993, PLAST RECONSTR SURG, V91, P1216, DOI 10.1097/00006534-199306000-00006; Nishino M, 2003, RADIOGRAPHICS, V23, P45, DOI 10.1148/rg/231025037; Donnelly LF, 2000, AM J ROENTGENOL, V174, P597; Goodwin RW, 2007, CLIN RADIOL, V62, P843, DOI 10.1016/j.crad.2007.04.009; Moukaddam H, 2009, SKELETAL RADIOL, V38, P535, DOI 10.1007/s00256-008-0609-2; Hyodoh H, 2005, RADIOGRAPHICS, V25, pS159, DOI 10.1148/rg.25si055509; Elsayes KM, 2005, AM J ROENTGENOL, V184, P860; Blake MA, 2004, RADIOGRAPHICS, V24, pS87, DOI 10.1148/rg.24si045506; Elsayes Khaled M, 2007, Curr Probl Diagn Radiol, V36, P97, DOI 10.1067/j.cpradiol.2006.12.003; Enjolras Odile, 1997, Journal of Dermatology (Tokyo), V24, P701; Flors L, 2011, RADIOGRAPHICS, V31, P1321, DOI 10.1148/rg.315105213; Igarashi J, 1998, AM J GASTROENTEROL, V93, P2292; LANE RH, 1989, AM J ROENTGENOL, V152, P83; Morris EA, 2013, ACR BI RADS ATLAS BR; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1713	1720		10.1007/s00261-014-0319-2		8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300040		
J	Tasaki, A; Asatani, MO; Umezu, H; Kashima, K; Enomoto, T; Yoshimura, N; Aoyama, H				Tasaki, Akiko; Asatani, Mina O.; Umezu, Hajime; Kashima, Katsunori; Enomoto, Takayuki; Yoshimura, Norihiko; Aoyama, Hidefumi			Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density	ABDOMINAL IMAGING			English	Article						Leiomyoma; Leiomyosarcoma; DWI/ADC; Correlation; Cell density	METASTATIC OVARIAN-CANCER; MALIGNANT BREAST-LESIONS; IN-VIVO; MR; BENIGN; LEIOMYOMAS; SARCOMAS; SIGNAL; MYOMETRIAL; PERFUSION	The purpose of this study is to investigate the utility of the apparent diffusion coefficient (ADC) in differentiating benign and malignant uterine smooth muscle tumors classified by signal intensity (SI) on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), and to determine the correlation between ADC and tumor cell density. This retrospective study reviewed 168 lesions in 134 cases with pathologically confirmed uterine smooth muscle tumors, including 6 leiomyosarcomas and 3 smooth muscle tumors of uncertain malignant potential, and preoperative magnetic resonance imaging examinations performed between October 2009 and November 2012. T2WI and DWI were also performed for each subject. Tumors were then classified according to SI on T2WI and DWI relative to myometrial SI. The correlation between ADC and tumor cell density was also determined. In Group 1 (high on both T2WI/DWI), mean ADC was significantly lower for leiomyosarcoma (0.91 x 10(-3) mm(2)/s) than for leiomyoma (1.30 x 10(-3) mm(2)/s; p < 0.05) and mean cell density significantly higher for leiomyosarcoma (42.9%) than for leiomyoma (22.4%; p < 0.05). A strong negative correlation was seen between ADC and tumor cell density in Group 1 (Spearman, R = -0.72; p < 0.05). ADC may help to differentiate benign from malignant uterine smooth muscle tumors, particularly tumors with high SI on T2WI and DWI.	[Tasaki, Akiko; Asatani, Mina O.; Yoshimura, Norihiko; Aoyama, Hidefumi] Niigata Univ, Sch Med, Dept Radiol, Chuo Ku, Niigata 9518510, Japan; [Umezu, Hajime] Niigata Univ, Med & Dent Hosp, Div Pathol, Chuo Ku, Niigata 9518510, Japan; [Kashima, Katsunori; Enomoto, Takayuki] Niigata Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Niigata 9518510, Japan	Tasaki, A (reprint author), Niigata Univ, Sch Med, Dept Radiol, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	asat1002@med.niigata-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (First Program); Council for Science and Technology Policy of Japan; Japanese Society for the Promotion of Science [21591602]	This study was partially supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (First Program) initiated by the Council for Science and Technology Policy of Japan, as well as a Grant-in Aid for Scientific Research (21591602) from the Japanese Society for the Promotion of Science.	Sala E, 2012, RADIOLOGY, V263, P149, DOI 10.1148/radiol.11110175; Takeuchi M, 2013, EUR RADIOL, V23, P2358, DOI 10.1007/s00330-013-2856-4; Ogura A, 2011, EUR J RADIOL, V77, P185, DOI 10.1016/j.ejrad.2009.06.031; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; LEBIHAN D, 1986, RADIOLOGY, V161, P401; Sahdev A, 2001, AM J ROENTGENOL, V177, P1307; Namimoto T, 2009, EUR RADIOL, V19, P2756, DOI 10.1007/s00330-009-1471-x; Sala E, 2010, EUR RADIOL, V20, P491, DOI 10.1007/s00330-009-1543-y; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Shimada K, 2004, J MAGN RESON IMAGING, V20, P97, DOI 10.1002/jmri.20063; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; Peters NHGM, 2010, J MAGN RESON IMAGING, V31, P1100, DOI 10.1002/jmri.22152; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Tamai K, 2008, EUR RADIOL, V18, P723, DOI 10.1007/s00330-007-0787-7; Takeuchi M, 2009, J COMPUT ASSIST TOMO, V33, P834, DOI 10.1097/RCT.0b013e318197ec6f; YAMASHITA Y, 1993, RADIOLOGY, V189, P721; Tamura T, 2012, MAGN RESON MED, V68, P890, DOI 10.1002/mrm.23277; Maldjian JA, 2001, AM J NEURORADIOL, V22, P112; Charles-Edwards Elizabeth M, 2006, Cancer Imaging, V6, P135, DOI 10.1102/1470-7330.2006.0021; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Hiwatashi A, 2003, AM J ROENTGENOL, V181, P1705; HRICAK H, 1986, RADIOLOGY, V158, P385; Li TQ, 1999, MAGNET RESON MED, V41, P143, DOI 10.1002/(SICI)1522-2594(199901)41:1<143::AID-MRM20>3.0.CO;2-O; Liu KF, 2001, STROKE, V32, P1897; McLean MA, 2009, MAGN RESON MED, V62, P855, DOI 10.1002/mrm.22067; SMOOT JS, 1995, CLIN LAB MED, V15, P545; TOGASHI K, 1989, RADIOLOGY, V171, P531; Yamashita Y, 1998, JMRI-J MAGN RESON IM, V8, P367, DOI 10.1002/jmri.1880080216	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1742	1752		10.1007/s00261-014-0324-5		11	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300043		
J	Irie, K; Morimoto, M; Numata, K; Kondo, M; Moriya, S; Shimoyama, Y; Nozaki, A; Goda, Y; Kobayashi, S; Ueno, M; Ohkawa, S; Tanaka, K; Maeda, S				Irie, Kuniyasu; Morimoto, Manabu; Numata, Kazushi; Kondo, Masaaki; Moriya, Satoshi; Shimoyama, Yu; Nozaki, Akito; Goda, Yoshihiro; Kobayashi, Satoshi; Ueno, Makoto; Ohkawa, Shinichi; Tanaka, Katsuaki; Maeda, Shin			Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents	ABDOMINAL IMAGING			English	Article						Radiofrequency; Embolization; Microspheres; Hepatocellular carcinoma; Coagulation; Combination	TRANSCATHETER ARTERIAL EMBOLIZATION; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; GELATIN SPONGE; LESION SIZE; IODIZED OIL; BLOOD-FLOW; PIG MODEL; CHEMOEMBOLIZATION; OCCLUSION; INJECTION	Reducing blood flow in the liver during radiofrequency ablation causes enlargement of the ablation area. In this animal study, we evaluated the extended effects of radiofrequency ablation combined with transarterial embolization using various embolic agents. We treated 38 radiofrequency ablation lesions after embolization in 13 pigs using the following embolic agents: gelatin sponge (Group A); iodized oil followed by gelatin sponge (Group B); 700-900 A mu m calibrated microspheres (Group C); and 100-300 A mu m calibrated microspheres (Group D). Lesion size and pathological evaluations of these ablation lesions were compared with those receiving radiofrequency ablation alone (control). Both the long- and short-axis diameters of the ablation lesions for Groups A, B, C, and D were significantly longer than those of controls (long axis/short axis for Groups A, B, C, D, and controls were 27.2/23.2, 30.2/26.0, 28.2/22.2, 32.0/24.4, and 23.2 mm/18.5 mm, respectively) (P < 0.05). The long-axis of the ablation lesion for Group D was significantly longer than those for both Groups A and C (P < 0.05). At pathological examination, the central ablation lesions showed coagulative necrosis with a surrounding hemorrhagic rim, and the microspheres were fitted to occlude the small arteries in peripheral liver parenchyma in Groups C and D. The extended effects of embolization with small microspheres may be stronger than those with large microspheres and were equal to those with iodized oil followed by gelatin sponge.	[Irie, Kuniyasu; Morimoto, Manabu; Goda, Yoshihiro; Kobayashi, Satoshi; Ueno, Makoto; Ohkawa, Shinichi] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Morimoto, Manabu; Numata, Kazushi; Kondo, Masaaki; Shimoyama, Yu; Nozaki, Akito; Tanaka, Katsuaki] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Moriya, Satoshi; Maeda, Shin] Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Yokohama, Kanagawa 232, Japan	Morimoto, M (reprint author), Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	m-morimoto@kcch.jp					Goldberg SN, 1998, J VASC INTERV RADIOL, V9, P101, DOI 10.1016/S1051-0443(98)70491-9; Tanaka T, 2013, CARDIOVASC INTER RAD, V36, P773, DOI 10.1007/s00270-012-0497-7; Stampfl S, 2009, J VASC INTERV RADIOL, V20, P1597, DOI 10.1016/j.jvir.2009.08.018; Bonomo G, 2010, CARDIOVASC INTER RAD, V33, P552, DOI 10.1007/s00270-009-9752-y; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Lewis AL, 2012, J CONTROL RELEASE, V161, P338, DOI 10.1016/j.jconrel.2012.01.018; Llovet JM, 2001, HEPATOLOGY, V33, P1124, DOI 10.1053/jhep.2001.24233; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Morimoto M, 2010, J VASC INTERV RADIOL, V21, P1716, DOI 10.1016/j.jvir.2010.06.020; Lencioni R, 2012, CARDIOVASC INTER RAD, V35, P980, DOI 10.1007/s00270-011-0287-7; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Livraghi T, 2000, RADIOLOGY, V214, P761; Rossi S, 2000, RADIOLOGY, V217, P119; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Laeseke PF, 2009, J VASC INTERV RADIOL, V20, P1224, DOI 10.1016/j.jvir.2009.05.029; Goldberg SN, 2000, CANCER, V88, P2452, DOI 10.1002/1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3; Sugimori K, 2002, HEPATOL RES, V24, P164, DOI 10.1016/S1386-6346(02)00030-X; Yamakado K, 2002, J VASC INTERV RADIOL, V13, P1225, DOI 10.1016/S1051-0443(07)61969-1; Livraghi T, 1999, RADIOLOGY, V210, P655; Patterson EJ, 1998, ANN SURG, V227, P559, DOI 10.1097/00000658-199804000-00018; Aschoff AJ, 2001, J MAGN RESON IMAGING, V13, P57, DOI 10.1002/1522-2586(200101)13:1<57::AID-JMRI1009>3.0.CO;2-N; Bonomo G, 2012, CARDIOVASC INTER RAD, V35, P1372, DOI 10.1007/s00270-012-0341-0; Chinn SB, 2001, AM J ROENTGENOL, V176, P789; de Baere T, 2002, AM J ROENTGENOL, V178, P53; Goldberg SN, 1998, AM J ROENTGENOL, V170, P1023; Gonda T, 2000, J SURG RES, V94, P43, DOI 10.1006/jsre.2000.5978; NAKAMURA H, 1990, ACTA RADIOL, V31, P347; Rossi S, 1995, Cancer J Sci Am, V1, P73; Sommer CM, 2012, EUR J RADIOL, V81, P1165, DOI 10.1016/j.ejrad.2011.03.022; Sugimori K, 2005, J VASC INTERV RADIOL, V16, P849, DOI 10.1097/01.RVI.0000157780.44868.78	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	AUG	2015	40	6					1821	1828		10.1007/s00261-014-0332-5		8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CO8QM	WOS:000359435300052		
J	Saidalimu, I; Tokunaga, E; Shibata, N				Saidalimu, Ibrayim; Tokunaga, Etsuko; Shibata, Norio			Carbene-Induced Intra- vs Intermolecular Transfer-Fluoromethylation of Aryl Fluoromethylthio Compounds under Rhodium Catalysis	ACS CATALYSIS			English	Article						trifluoromethylation reagent; difluoromethylation reagent; rhodium catalyst; intramolecular; intermolecular	QUATERNARY AMMONIUM-SALTS; BOND-FORMING REACTIONS; TRIFLUOROMETHYLTHIOLATION REACTIONS; ELECTROPHILIC TRIFLUOROMETHYLATION; ENANTIOSELECTIVE FLUORINATION; C/O-REGIOSELECTIVITY; BETA-KETOESTERS; REARRANGEMENT; REAGENTS; YLIDES	The intra- vs intermolecular transfer-fluoromethylation of aryl fluoromethylthio compounds is proposed. Finely designed ArSCF3 (la) nicely releases its trifluoromethyl (CF3) group intermolecularly under rhodium catalysis, whereas a difluoromethylated analogue, ArSCF2H compound lb shows intramolecular reaction.	[Saidalimu, Ibrayim; Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan	Shibata, N (reprint author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan; Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency; Hoansha Foundation	This research was financially supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan, the Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency, and Hoansha Foundation.	Prakash GKS, 2002, J ORG CHEM, V67, P3718, DOI 10.1021/jo011116w; Umemoto T, 2007, J ORG CHEM, V72, P6905, DOI 10.1021/jo070896r; Gao B, 2014, CHEM-EUR J, V20, P7803, DOI 10.1002/chem.201402183; YE T, 1994, CHEM REV, V94, P1091, DOI 10.1021/cr00028a010; Wang F, 2014, ANGEW CHEM INT EDIT, V53, P1881, DOI 10.1002/anie.201309991; UMEMOTO T, 1990, TETRAHEDRON LETT, V31, P3579; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Zhang C, 2014, ORG BIOMOL CHEM, V12, P6580, DOI 10.1039/c4ob00671b; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Padwa A, 1996, CHEM REV, V96, P223, DOI 10.1021/cr950022h; Wu J, 2014, TETRAHEDRON LETT, V55, P4289, DOI 10.1016/j.tetlet.2014.06.006; Xu JB, 2014, ORG LETT, V16, P3942, DOI 10.1021/ol501742a; Altenburger JM, 2004, BIOORGAN MED CHEM, V12, P1713, DOI 10.1016/j.bmc.2004.01.016; Huang YY, 2015, CHEM-EUR J, V21, P8664, DOI 10.1002/chem.201500361; Smits R, 2008, CHEM SOC REV, V37, P1727, DOI 10.1039/b800310f; Liu GK, 2013, ORG LETT, V15, P1044, DOI 10.1021/ol4000313; Weintraub PM, 2003, BIOORGAN MED CHEM, V11, P427, DOI 10.1016/S0968-0896(02)00434-0; Arimori S, 2015, ORG LETT, V17, P1632, DOI 10.1021/acs.orglett.5b00164; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Matsnev A, 2010, ANGEW CHEM INT EDIT, V49, P572, DOI 10.1002/anie.200905225; Umemoto T, 1996, CHEM REV, V96, P1757, DOI 10.1021/cr941149u; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; UMEMOTO T, 1993, J AM CHEM SOC, V115, P2156, DOI 10.1021/ja00059a009; HUHEEY JE, 1965, J PHYS CHEM-US, V69, P3284, DOI 10.1021/j100894a011; Li Y, 2005, ANGEW CHEM INT EDIT, V44, P5882, DOI 10.1002/anie.200501769; Nie J, 2011, CHEM REV, V111, P455, DOI 10.1021/cr100166a; Narjes F, 2002, BIOORG MED CHEM LETT, V12, P701, DOI 10.1016/S0960-894X(01)00842-3; ERICKSON JA, 1995, J ORG CHEM, V60, P1626, DOI 10.1021/jo00111a021; MOODY CJ, 1988, TETRAHEDRON LETT, V29, P6005, DOI 10.1016/S0040-4039(00)82252-2; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Shibata N, 2007, J FLUORINE CHEM, V128, P469, DOI 10.1016/j.jfluchem.2006.12.014; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Yang YD, 2012, CHEMISTRYOPEN, V1, P221, DOI 10.1002/open.201200032; Campbell MG, 2014, ORG PROCESS RES DEV, V18, P474, DOI 10.1021/op400349g; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; PIRRUNG MC, 1986, J AM CHEM SOC, V108, P6060, DOI 10.1021/ja00279a076; Prakash GKS, 2006, ANGEW CHEM INT EDIT, V45, P2172, DOI 10.1002/anie.200503783; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Liu YF, 2015, ORG LETT, V17, P2752, DOI 10.1021/acs.orglett.5b01170; Mace Y, 2010, TETRAHEDRON LETT, V51, P5388, DOI 10.1016/j.tetlet.2010.07.154; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Campbell MG, 2015, CHEM REV, V115, P612, DOI 10.1021/cr500366b; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; Chu LL, 2014, ACCOUNTS CHEM RES, V47, P1513, DOI 10.1021/ar4003202; Cresswell AJ, 2015, CHEM REV, V115, P566, DOI 10.1021/cr5001805; Gouverneur V., 2012, FLUORINE PHARM MED C; Ibrahim H, 2004, CHEM COMMUN, P1147, DOI 10.1039/b317004g; Kirsch P., 2013, MODERN FLUOROORGANIC; Kondratenko N. V., 1984, J ORG CHEM USSR, V20, P103; Liu X, 2015, CHEM REV, V115, P683, DOI 10.1021/cr400473a; Maeda Y, 1997, J CHEM SOC PERK T 1, P1491, DOI 10.1039/a608492c; Noritake S, 2008, EUR J ORG CHEM, P3465, DOI 10.1002/ejoc.200800419; Nyffeler PT, 2005, ANGEW CHEM INT EDIT, V44, P192, DOI 10.1002/anie.200400648; Ojima I., 2009, FLUORINE MED CHEM CH; OLLIS WD, 1983, J CHEM SOC PERK T 1, P1009, DOI 10.1039/p19830001009; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Shibata N., 2010, BEILSTEIN J ORG CHEM, V6; Stevens TS, 1928, J CHEM SOC, P3193, DOI 10.1039/jr9280003193; Thomson T, 1932, J CHEM SOC, P69, DOI 10.1039/jr9320000069; Xu XH, 2015, CHEM REV, V115, P731, DOI 10.1021/cr500193b; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Yang YD, 2014, B KOREAN CHEM SOC, V35, P1851, DOI 10.5012/bkcs.2014.35.6.1851	63	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	AUG	2015	5	8					4668	4672		10.1021/acscatal.5b00853		5	Chemistry, Physical	Chemistry	CO8DL	WOS:000359395100020		
J	Okumura, M; Fujitani, T; Huang, JH; Ishida, T				Okumura, Mitsutaka; Fujitani, Tadahiro; Huang, Jiahui; Ishida, Tamao			A Career in Catalysis: Masatake Haruta	ACS CATALYSIS			English	Article						gold nanoparticles; gold clusters; CO oxidation; propylene epoxidation; alcohol oxidation	SUPPORTED GOLD CATALYSTS; LOW-TEMPERATURE OXIDATION; VAPOR-PHASE EPOXIDATION; POROUS COORDINATION POLYMERS; CO OXIDATION; PROPYLENE EPOXIDATION; SELECTIVE OXIDATION; PROPENE EPOXIDATION; AEROBIC OXIDATION; GLUCOSE-OXIDATION	Professor Masatake Haruta's distinguished scientific achievements are highlighted in heterogeneous catalysis by gold (Au). In 1982, he discovered that Au became highly active for CO oxidation even at 200 K when gold was deposited as nanoparticles (NPs) smaller than 5 nm on 3d transition metal oxides. After this finding, he and his co-workers have developed many preparation methods for the deposition of Au as NPs and clusters onto a wide variety of supports. By kinetic, theoretical, and surface science studies, Haruta and co-workers revealed interesting catalytic features of Au, including reaction mechanisms which are greatly different from those of Pd and Pt. Haruta and co-workers also found that supported Au NPs catalyzed direct oxidation of propylene to propylene oxide using O-2 and H-2, and subsequently O-2 alone in the presence of H2O.	[Okumura, Mitsutaka] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Okumura, Mitsutaka] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Kyoto 6158245, Japan; [Fujitani, Tadahiro] Natl Inst Adv Ind Sci & Technol, Interdisciplinary Res Ctr Catalyt Chem, Tsukuba, Ibaraki 3058565, Japan; [Huang, Jiahui] Chinese Acad Sci, Gold Catalysis Res Ctr, State Key Lab Catalysis, Dalian Inst Chem Phys, Dalian 116023, Peoples R China; [Ishida, Tamao] Tokyo Metropolitan Univ, Res Ctr Gold Chem, Grad Sch Urban Environm Sci, Hachioji, Tokyo 1920397, Japan	Ishida, T (reprint author), Tokyo Metropolitan Univ, Res Ctr Gold Chem, Grad Sch Urban Environm Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	tamao@tmu.ac.jp					Akita T, 2000, J ELECTRON MICROSC, V49, P657; Zhu HG, 2006, J PHYS CHEM B, V110, P10842, DOI 10.1021/jp060637q; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; Bamwenda GR, 1997, CATAL LETT, V44, P83, DOI 10.1023/A:1018925008633; Qi CX, 2001, APPL CATAL A-GEN, V218, P81, DOI 10.1016/S0926-860X(01)00621-4; Cavani F, 2009, CHEMSUSCHEM, V2, P508, DOI 10.1002/cssc.200900020; Shimada S, 2010, STUD SURF SCI CATAL, V175, P843, DOI 10.1016/S0167-2991(10)75174-0; Widmann D, 2011, ANGEW CHEM INT EDIT, V50, P10241, DOI 10.1002/anie.201102062; Biella S, 2002, J CATAL, V206, P242, DOI 10.1006/jcat.2001.3497; HUTCHINGS GJ, 1985, J CATAL, V96, P292, DOI 10.1016/0021-9517(85)90383-5; Prati L, 1999, GOLD BULL, V32, P96; Jiang HL, 2011, CHEM-EUR J, V17, P78, DOI 10.1002/chem.201002088; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Huang JH, 2009, ANGEW CHEM INT EDIT, V48, P7862, DOI 10.1002/anie.200903011; Ishida T, 2010, APPL CATAL A-GEN, V377, P42, DOI 10.1016/j.apcata.2010.01.017; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Zanella R, 2002, J PHYS CHEM B, V106, P7634, DOI 10.1021/jp0144810; Chowdhury B, 2006, J PHYS CHEM B, V110, P22995, DOI 10.1021/jp066008y; Date M, 2007, CATAL TODAY, V122, P222, DOI 10.1016/j.cattod.2007.01.032; Ishida T, 2012, CHEMSUSCHEM, V5, P2243, DOI 10.1002/cssc.201200324; Qi CX, 2011, J CATAL, V281, P12, DOI 10.1016/j.jcat.2011.03.028; Qi C, 2004, APPL CATAL A-GEN, V263, P19, DOI 10.1016/j.apcata.2003.11.034; Onal Y, 2004, J CATAL, V223, P122, DOI 10.1016/j.jcat.2004.01.010; Tsubota S, 1995, STUD SURF SCI CATAL, V91, P227; Date M, 2002, CATAL TODAY, V72, P89, DOI 10.1016/S0920-5861(01)00481-3; Ishida T, 2008, ANGEW CHEM INT EDIT, V47, P9265, DOI 10.1002/anie.200802845; Vogel W, 1996, CATAL LETT, V40, P175, DOI 10.1007/BF00815279; Prati L, 1998, J CATAL, V176, P552, DOI 10.1006/jcat.1998.2078; Haruta M, 2014, ANGEW CHEM INT EDIT, V53, P52, DOI 10.1002/anie.201305987; Ishida T, 2009, GOLD BULL, V42, P267; Moreau F, 2005, J CATAL, V231, P105, DOI 10.1016/j.jcat.2005.01.030; Haruta M, 2011, FARADAY DISCUSS, V152, P11, DOI 10.1039/c1fd00107h; Taketoshi A, 2014, APPL CATAL A-GEN, V474, P257, DOI 10.1016/j.apcata.2013.12.012; [Anonymous], 2015, CATAL REV, V28, P8; Kuroda K, 2009, J MOL CATAL A-CHEM, V298, P7, DOI 10.1016/j.molcata.2008.09.009; Abad A, 2005, ANGEW CHEM INT EDIT, V44, P4066, DOI 10.1002/anie.200500382; Zanella R, 2006, J PHYS CHEM B, V110, P8559, DOI 10.1021/jp060601y; Jorgensen B, 2007, J CATAL, V251, P332, DOI 10.1016/j.jcat.2007.08.004; Suzuki K, 2013, ACS CATAL, V3, P1845, DOI 10.1021/cs4004084; Huang JH, 2010, APPL CATAL B-ENVIRON, V95, P430, DOI 10.1016/j.apcatb.2010.01.023; Chen JQ, 2011, FARADAY DISCUSS, V152, P321, DOI 10.1039/c1fd00014d; Ikegami M, 2013, APPL CATAL B-ENVIRON, V134, P130, DOI 10.1016/j.apcatb.2012.12.018; Porta F, 2000, CATAL TODAY, V61, P165, DOI 10.1016/S0920-5861(00)00370-9; Haruta M, 2004, GOLD BULL, V37, P27; Takei T, 2012, ADV CATAL, V55, P1, DOI 10.1016/B978-0-12-385516-9.00001-6; Zhu HG, 2007, APPL CATAL A-GEN, V326, P89, DOI 10.1016/j.apcata.2007.04.004; Fujitani T, 2009, ANGEW CHEM INT EDIT, V48, P9515, DOI 10.1002/anie.200905380; Haruta M, 1998, RES CHEM INTERMEDIAT, V24, P329, DOI 10.1163/156856798X00276; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Uphade BS, 2001, APPL CATAL A-GEN, V215, P137, DOI 10.1016/S0926-860X(01)00527-0; Dimitratos N, 2006, APPL CATAL A-GEN, V311, P185, DOI 10.1016/j.apcata.2006.06.026; Yamane Y, 2009, ORG LETT, V11, P5162, DOI 10.1021/ol902061j; Nijhuis TA, 1999, IND ENG CHEM RES, V38, P884, DOI 10.1021/ie980494x; Date M, 2001, J CATAL, V201, P221, DOI 10.1006/jcat.2001.3254; Takei T, 2011, NEW J CHEM, V35, P2227, DOI 10.1039/c1nj20297a; Li BD, 2009, CATAL LETT, V133, P33, DOI 10.1007/s10562-009-0171-0; Sinha AK, 2004, ANGEW CHEM INT EDIT, V43, P1546, DOI 10.1002/anie.200352900; Bonelli R, 2011, APPL CATAL A-GEN, V400, P54, DOI 10.1016/j.apcata.2011.04.014; Uphade BS, 2002, J CATAL, V209, P331, DOI 10.1006/jcat.2002.3642; Huang JH, 2011, J CATAL, V278, P8, DOI 10.1016/j.jcat.2010.11.012; Okumura M, 1997, SOLID STATE IONICS, V95, P143, DOI 10.1016/S0167-2738(96)00574-7; Takei T, 2010, CHEM PHYS LETT, V493, P207, DOI 10.1016/j.cplett.2010.05.024; Wolf A, 2002, APPL CATAL A-GEN, V226, P1, DOI 10.1016/S0926-860X(01)00772-4; Okumura M, 1998, CATAL LETT, V51, P53, DOI 10.1023/A:1019020614336; Ishida T, 2008, CHEM-EUR J, V14, P8456, DOI 10.1002/chem.200800980; Sinha AK, 2004, TOP CATAL, V29, P95, DOI 10.1023/B:TOCA.0000029791.69935.53; Ishida T, 2008, J COLLOID INTERF SCI, V323, P105, DOI 10.1016/j.jcis.2008.02.046; Corti CW, 2007, TOP CATAL, V44, P331, DOI 10.1007/s11244-007-0307-7; Tsubota S, 1998, CATAL LETT, V56, P131, DOI 10.1023/A:1019069315071; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; Carrettin S, 2002, CHEM COMMUN, P696, DOI 10.1039/b201112n; Lee S, 2009, ANGEW CHEM INT EDIT, V48, P1467, DOI 10.1002/anie.200804154; Hayashi T, 1998, J CATAL, V178, P566, DOI 10.1006/jcat.1998.2157; Bravo-Suarez JJ, 2008, J PHYS CHEM C, V112, P1115, DOI 10.1021/jp077501s; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Huang JH, 2012, APPL CATAL A-GEN, V435, P115, DOI 10.1016/j.apcata.2012.05.040; Xie XW, 2009, NATURE, V458, P746, DOI 10.1038/nature07877; Tada K, 2014, MOL PHYS, V112, P365, DOI 10.1080/00268976.2013.822113; Biella S, 2003, CATAL LETT, V90, P23, DOI 10.1023/A:1025808024943; Boccuzzi F, 2001, J CATAL, V202, P256, DOI 10.1006/jcat.2001.3290; Bond G. C., 1973, J CHEM SOC CHEM COMM, p444b; BRADY JT, 2006, Patent No. 2006074126; Brey L. A., 2005, WO Patent, Patent No. [2005/030382, 20050303823]; Buijink J. K. F., 2008, MECH HOMOGENEOUS HET, P355, DOI 10.1016/B978-0-444-53188-9.00013-4; Chowdhitry B, 2006, ANGEW CHEM INT EDIT, V45, P412, DOI 10.1002/anie.200502382; Christensen CH, 2006, ANGEW CHEM INT EDIT, V45, P4648, DOI 10.1002/anie.200601180; Cumaranatunge L, 2005, J CATAL, V232, P38, DOI 10.1016/j.jcat.2005.02.006; Cunningham D. A. H., 1996, ULTRA CLEAN TECHNOL, V8, P117; Hammer N, 2007, CATAL TODAY, V123, P245, DOI 10.1016/j.catttod.2007.03.001; Haruta Masatake, 2003, Chem Rec, V3, P75, DOI 10.1002/tcr.10053; Haruta M., 1984, SHOKUBAI, V26, P140; Haruta M., 1988, CHEM EXPRESS, V3, P159; Haruta M., 1983, STUD SURF SCI CATAL, V16, P225; Haruta M, 2003, CATALYSIS AND ELECTROCATALYSIS AT NANOPARTICLE SURFACES, P645; HARUTA M, 1984, J COLLOID INTERF SCI, V101, P59, DOI 10.1016/0021-9797(84)90008-0; Harutal M., 1989, STUD SURF SCI CATAL, V44, P33, DOI 10.1016/S0167-2991(09)61278-7; Huang JH, 2012, RES CHEM INTERMEDIAT, V38, P1, DOI 10.1007/s11164-011-0424-6; Iizuka Y, 1999, J CATAL, V187, P50, DOI 10.1006/jcat.1999.2604; Ishida T, 2009, APPL CATAL A-GEN, V353, P243, DOI 10.1016/j.apcata.2008.10.049; Ishino M., 2006, SHOKUBAI, V48, P511; Kahlich D., 2012, ULLMANNS ENCY IND CH; Kapoor MP, 2002, CHEM COMMUN, P2902, DOI 10.1039/b209392h; McCoy M, 2001, CHEM ENG NEWS, V79, P19, DOI 10.1021/cen-v079n051.p019; Meiers R, 1998, J CATAL, V176, P376, DOI 10.1006/jcat.1998.2036; Moreau F, 2007, CATAL TODAY, V122, P260, DOI 10.1016/j.cattod.2007.01.017; NKOSI B, 1988, J CHEM SOC CHEM COMM, P71, DOI 10.1039/c39880000071; Ojeda M., 2009, CHEM COMMUN, V48, P352; Okumura M, 2001, J CATAL, V203, P168, DOI 10.1006/jcat.2001.3307; Okumura M, 1998, CHEM LETT, P315; Okumura M, 2000, CHEM LETT, P396, DOI 10.1246/cl.2000.396; Prati L, 1997, STUD SURF SCI CATAL, V110, P509; Qi C. X., 2003, APPL CATAL A-GEN, V253, P75; Saavedra J, 2014, SCIENCE, V345, P1599, DOI 10.1126/science.1256018; Sakurai H, 2013, APPL CATAL A-GEN, V462, P236, DOI 10.1016/j.apcata.2013.05.016; Sato A., 1992, SHOKUBAI, V34, P132; Sinha AK, 2005, J PHYS CHEM B, V109, P3956, DOI 10.1021/jp0465229; Sinha AK, 2003, APPL CATAL A-GEN, V240, P243, DOI 10.1016/S0926-860X(02)00451-9; Sinha S. K., 2003, CATAL LETT, V85, P223; Sunagawa Y, 2008, CATAL TODAY, V132, P81, DOI 10.1016/j.cattod.2007.12.008; Takei T, 2015, TOP CATAL, V58, P295, DOI 10.1007/s11244-015-0370-4; Taylor B, 2007, CATAL TODAY, V123, P50, DOI 10.1016/j.cattod.2007.01.005; TSUBOTA S, 1991, STUD SURF SCI CATAL, V63, P695; Tsubota S., 1991, CHEM EXPRESS, V5, P349; Uphade BS, 1998, CHEM LETT, P1277, DOI 10.1246/cl.1998.1277; Uphade BS, 2000, APPL CATAL A-GEN, V190, P43, DOI 10.1016/S0926-860X(99)00285-9; Villa A, 2010, APPL CATAL B-ENVIRON, V96, P541, DOI 10.1016/j.apcatb.2010.03.017; Yuan YZ, 1996, CHEM LETT, P755, DOI 10.1246/cl.1996.755; Zanella R., 2005, APPL CATAL A-GEN, V291, P62	130	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	AUG	2015	5	8					4699	4707		10.1021/acscatal.5b01122		9	Chemistry, Physical	Chemistry	CO8DL	WOS:000359395100024		
J	Park, S; Okamura, I; Sakashita, S; Yum, JH; Acharya, C; Gao, L; Sugiyama, H				Park, Soyoung; Okamura, Izumi; Sakashita, Sohei; Yum, Ji Hye; Acharya, Chiranjit; Gao, Li; Sugiyama, Hiroshi			Development of DNA Metalloenzymes Using a Rational Design Approach and Application in the Asymmetric Diels-Alder Reaction	ACS CATALYSIS			English	Article						DNA; metalloenzyme; asymmetric catalysis; Diels-Alder reaction; Cu(II) ion; ligand freedom; enantiomeric preference	HYBRID CATALYSTS; ENANTIOSELECTIVE CATALYSIS; ARTIFICIAL METALLOENZYMES; COPPER-COMPLEXES; WATER; CYTOSINE	We report here DNA metalloenzymes that catalyzed the asymmetric Diels-Alder reactions with high conversion, excellent endo/exo selectivities, and enantioselectivities up to -97% ee. Their catalytic-pocket architectures were organized using a rational design strategy based on the Cu(II) ion, the composition of nucleobases, and the incorporation of flexible linkers. Without using the mirror image of B-DNA, DNA metalloenzymes afforded the opposite enantiomer of the Diels-Alder product compared with those obtained using a supramolecular Cu(II)-dmbpy/st-DNA catalyst system. Furthermore, we devised DNA metalloenzymes without the incorporation of an artificial binding ligand and successfully performed Diels-Alder carbon-carbon bond-forming reactions. This study provides a new perspective on the catalytic repertoire of nucleic acids in the realm of protein-dominated metalloenzymes.	[Park, Soyoung; Okamura, Izumi; Sakashita, Sohei; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Yum, Ji Hye] Kyungpook Natl Univ, Dept Chem, Taegu 702701, South Korea; [Acharya, Chiranjit] CSIR, Indian Inst Chem Biol, Dept Chem, Kolkata 700032, India; [Gao, Li] Univ Munich, Dept Chem, D-81377 Munich, Germany	Park, S (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	hs@kuchem.kyoto-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011		Japan Society for the Promotion of Science (JSPS); WPI program (iCeMS, Kyoto University)	We express sincere thanks for a Grant-in-Aid Priority Research from Japan Society for the Promotion of Science (JSPS) and the grant from the WPI program (iCeMS, Kyoto University).	Cho KH, 2008, B KOREAN CHEM SOC, V29, P69; Wilking M, 2013, ORG BIOMOL CHEM, V11, P6940, DOI 10.1039/c3ob41366g; Wang CH, 2012, ANGEW CHEM INT EDIT, V51, P9352, DOI 10.1002/anie.201204850; Park S, 2010, ANGEW CHEM INT EDIT, V49, P3870, DOI 10.1002/anie.200905382; Roe S, 2010, CHEM COMMUN, V46, P4309, DOI 10.1039/c0cc00194e; Wang J, 2013, ANGEW CHEM INT EDIT, V52, P11546, DOI 10.1002/anie.201306232; Davis BG, 2003, CURR OPIN BIOTECH, V14, P379, DOI 10.1016/S0958-1669(03)00098-3; Roelfes G, 2005, ANGEW CHEM INT EDIT, V44, P3230, DOI 10.1002/anie.200500298; Jakobsen U, 2007, NUCLEOS NUCLEOT NUCL, V26, P1419, DOI 10.1080/15257770701539260; Park S, 2012, MOLECULES, V17, P12792, DOI 10.3390/molecules171112792; Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274; Coquiere D, 2007, ANGEW CHEM INT EDIT, V46, P9308, DOI 10.1002/anie.200703459; Roelfes G, 2007, MOL BIOSYST, V3, P126, DOI 10.1039/b614527b; Gjonaj L, 2013, CHEMCATCHEM, V5, P1718, DOI 10.1002/cctc.201300082; Fournier P, 2009, ANGEW CHEM INT EDIT, V48, P4426, DOI 10.1002/anie.200900713; Wang CH, 2012, CHEM COMMUN, V48, P6232, DOI 10.1039/c2cc31320k; Boersma AJ, 2010, NAT CHEM, V2, P991, DOI [10.1038/nchem.819, 10.1038/NCHEM.819]; Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c; Boersma AJ, 2009, ANGEW CHEM INT EDIT, V48, P3346, DOI 10.1002/anie.200900371; Silverman SK, 2010, ANGEW CHEM INT EDIT, V49, P7180, DOI 10.1002/anie.200906345; Oelerich J, 2013, CHEM SCI, V4, P2013, DOI 10.1039/c3sc00100h; Thomas CM, 2005, CHEM SOC REV, V34, P337, DOI 10.1039/b314695m; Park S, 2012, CHEM COMMUN, V48, P10398, DOI 10.1039/c2cc35625b; Benedetti E, 2015, CHEM COMMUN, V51, P6076, DOI 10.1039/c4cc10190a; Boersma AJ, 2012, CHEM COMMUN, V48, P2394, DOI 10.1039/c2cc17350f; Garcia-Raso A, 2002, POLYHEDRON, V21, P1197, DOI 10.1016/S0277-5387(02)01010-0; Garcia-Raso A, 1998, J CHEM SOC DALTON, P1031, DOI 10.1039/a709272e; Kramer R, 2006, ANGEW CHEM INT EDIT, V45, P858, DOI 10.1002/anie.200502907; Krilov D, 2008, SPECTROCHIM ACTA A, V70, P1238, DOI 10.1016/j.saa.2008.01.013; Letondor C, 2006, CHEMBIOCHEM, V7, P1845, DOI 10.1002/cbic.200600264; Lu Y, 2006, ANGEW CHEM INT EDIT, V45, P5588, DOI 10.1002/anie.200600168; Mihovilovic MD, 2007, J CHEM TECHNOL BIOT, V82, P1067, DOI 10.1002/jctb.1752; QUI DT, 1990, ACTA CRYSTALLOGR C, V46, P1220; Park S, 2013, BIOMATER SCI-UK, V1, P1034, DOI 10.1039/c3bm60134j; Petrova GP, 2014, CHEM PHYS LETT, V600, P87, DOI 10.1016/j.cplett.2014.03.060; Oltra NS, 2008, CHEM COMMUN, P6039, DOI 10.1039/b814489c; Roelfes G, 2006, CHEM COMMUN, P635, DOI 10.1039/b516552k; SAMASUNDARAM I, 1991, J CHEM SOC DALTON, P2083, DOI 10.1039/dt9910002083; Shibata N, 2007, SYNLETT, P1153, DOI 10.1055/s-2007-977429; Park S, 2014, ACS CATAL, V4, P4070, DOI 10.1021/cs501086f	40	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	AUG	2015	5	8					4708	4712		10.1021/acscatal.5b01046		5	Chemistry, Physical	Chemistry	CO8DL	WOS:000359395100025		
J	Nambo, M; Crudden, CM				Nambo, Masakazu; Crudden, Cathleen M.			Recent Advances in the Synthesis of Triarylmethanes by Transition Metal Catalysis	ACS CATALYSIS			English	Article						triarylmethane; transition metal catalysis; arylation; enantioselectivity; enantiospecificity	CROSS-COUPLING REACTIONS; C-H BOND; SUBSTITUTED UNSYMMETRICAL BIARYLS; ALLYLIC BORONIC ESTERS; ELECTRON-RICH ARENES; TERT-BUTYL SULFONES; GRIGNARD-REAGENTS; EQUILIBRIUM ACIDITIES; SEQUENTIAL ARYLATION; ASYMMETRIC ARYLATION	Triarylmethanes and related compounds are fascinating molecules because of their structural and physical properties, many potential applications in organic functional materials, and high biological activity. Recently, catalysis has provided new synthesis routes to triarylmethanes with high selectivity and diversity, including the possibility of preparing enantiomerically enriched derivatives, which is typically challenging using classical methods. This Perspective reviews recent advances in new synthesis approaches to triarylmethanes using well-defined catalysts. These methods will allow the development of new, unexplored triarylmethane structures.	[Nambo, Masakazu; Crudden, Cathleen M.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan; [Crudden, Cathleen M.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Nambo, M (reprint author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan.	mnambo@itbm.nagoya-u.ac.jp; cruddenc@chem.queensu.ca			KAKENHI from JSPS [26810056]; Hattori Hokokai Foundation; JSPS; NU; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	This work was supported by KAKENHI from JSPS (26810056 to M.N.). M.N. thanks the Hattori Hokokai Foundation for financial support. JSPS and NU are acknowledged for funding of this research through The World Premier International Research Center Initiative (WPI) program. The Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Foundation for Innovation (CFI) are thanked for funding of this research.	Al-Qawasmeh RA, 2004, BIOORG MED CHEM LETT, V14, P347, DOI 10.1016/j.bmcl.2003.11.004; ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; Bauer I, 2015, CHEM REV, V115, P3170, DOI 10.1021/cr500425u; Nair V, 2006, TETRAHEDRON, V62, P6731, DOI 10.1016/j.tet.2006.04.081; Cao LL, 2011, ADV SYNTH CATAL, V353, P3352, DOI 10.1002/adsc.201100577; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; MATTHEWS WS, 1975, J AM CHEM SOC, V97, P7006, DOI 10.1021/ja00857a010; Xia Y, 2013, ORG LETT, V15, P1784, DOI 10.1021/ol400690t; Yu JY, 2008, ORG LETT, V10, P973, DOI 10.1021/ol800078j; Song GY, 2011, ORG LETT, V13, P1968, DOI 10.1021/ol200345a; Esquivias J, 2006, ANGEW CHEM INT EDIT, V45, P629, DOI 10.1002/anie.200503305; Prakash GKS, 2009, J ORG CHEM, V74, P8659, DOI 10.1021/jo901668j; Thirupathi P, 2010, J ORG CHEM, V75, P5240, DOI 10.1021/jo1010137; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Nolan EM, 2008, CHEM REV, V108, P3443, DOI 10.1021/cr068000q; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Bellomo A, 2013, CHEM SCI, V4, P849, DOI 10.1039/c2sc21673f; Glasspoole BW, 2012, CHEM COMMUN, V48, P1230, DOI 10.1039/c2cc16076e; MASON CD, 1951, J ORG CHEM, V16, P722, DOI 10.1021/jo01145a011; Bagutski V, 2010, ANGEW CHEM INT EDIT, V49, P5142, DOI 10.1002/anie.201001371; Denmark SE, 2013, J ORG CHEM, V78, P12593, DOI 10.1021/jo402246h; Zhou Q, 2013, J AM CHEM SOC, V135, P3307, DOI 10.1021/ja312087x; Shirakawa S, 2014, ANGEW CHEM INT EDIT, V53, P6220, DOI 10.1002/anie.201403046; Nambo M, 2015, ORG LETT, V17, P50, DOI 10.1021/ol503213z; GHAISAS VV, 1958, J ORG CHEM, V23, P560, DOI 10.1021/jo01098a016; Niwa T, 2007, ORG LETT, V9, P2373, DOI 10.1021/ol0708119; Harris MR, 2013, J AM CHEM SOC, V135, P3303, DOI 10.1021/ja311783k; Segawa Y, 2015, ANGEW CHEM INT EDIT, V54, P66, DOI 10.1002/anie.201403729; Panda G, 2004, BIOORGAN MED CHEM, V12, P5269, DOI 10.1016/j.bmc.2004.07.058; Dothager RS, 2005, J AM CHEM SOC, V127, P8686, DOI 10.1021/ja042913p; Mai CK, 2010, ORG LETT, V12, P2306, DOI 10.1021/ol100666v; Zheng B, 2013, ORG LETT, V15, P1690, DOI 10.1021/ol400472v; Sun YY, 2014, CHEM COMMUN, V50, P11060, DOI 10.1039/c4cc05376a; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Tobisu M, 2014, ORG LETT, V16, P5572, DOI 10.1021/ol502583h; Taylor BLH, 2012, ANGEW CHEM INT EDIT, V51, P7790, DOI 10.1002/anie.201202527; Kang T, 2014, J AM CHEM SOC, V136, P4141, DOI 10.1021/ja501014b; Huang XY, 2014, J AM CHEM SOC, V136, P6842, DOI 10.1021/ja5039819; Wang H, 2013, J AM CHEM SOC, V135, P971, DOI 10.1021/ja3110818; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d; Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; Lopez-Perez A, 2009, ORG LETT, V11, P5514, DOI 10.1021/ol902335c; Kotha S, 2002, TETRAHEDRON, V58, P9633, DOI 10.1016/S0040-4020(02)01188-2; McGrew GI, 2010, ANGEW CHEM INT EDIT, V49, P5541, DOI 10.1002/anie.201000957; Wang DH, 2011, J AM CHEM SOC, V133, P5767, DOI 10.1021/ja2010225; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Gevorgyan V, 2000, J ORG CHEM, V65, P6179, DOI 10.1021/jo000726d; Niwa T, 2009, TETRAHEDRON, V65, P1971, DOI 10.1016/j.tet.2009.01.030; Zhang JD, 2012, J AM CHEM SOC, V134, P13765, DOI 10.1021/ja3047816; Hu XL, 2011, CHEM SCI, V2, P1867, DOI 10.1039/c1sc00368b; Guo XX, 2015, CHEM REV, V115, P1622, DOI 10.1021/cr500410y; Imao D, 2009, J AM CHEM SOC, V131, P5024, DOI 10.1021/ja8094075; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Allen SE, 2013, CHEM REV, V113, P6234, DOI 10.1021/cr300527g; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Sawadjoon S, 2013, ACS CATAL, V3, P635, DOI 10.1021/cs300785r; Moure AL, 2012, J AM CHEM SOC, V134, P7219, DOI 10.1021/ja300627s; MUTHYALA R, 1994, DYES PIGMENTS, V25, P303, DOI 10.1016/0143-7208(94)87017-9; Abe H, 2008, BIOCONJUGATE CHEM, V19, P1219, DOI 10.1021/bc800014d; Molander GA, 2006, J ORG CHEM, V71, P9198, DOI 10.1021/jo061699f; DUXBURY DF, 1993, CHEM REV, V93, P381, DOI 10.1021/cr00017a018; Jiang PJ, 2004, COORDIN CHEM REV, V248, P205, DOI 10.1016/j.cct.2003.10.013; Li YZ, 2009, ANGEW CHEM INT EDIT, V48, P3817, DOI 10.1002/anie.200900341; Palchaudhuri R, 2008, J AM CHEM SOC, V130, P10274, DOI 10.1021/ja8020999; Czaplik WM, 2009, CHEMSUSCHEM, V2, P396, DOI 10.1002/cssc.200900055; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Nishimura T, 2012, J AM CHEM SOC, V134, P5056, DOI 10.1021/ja300697c; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; Zhang JD, 2014, J AM CHEM SOC, V136, P6276, DOI 10.1021/ja411855d; Zhang C, 2012, CHEM SOC REV, V41, P3464, DOI 10.1039/c2cs15323h; Dai HX, 2011, J AM CHEM SOC, V133, P7222, DOI 10.1021/ja201708f; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Chen XQ, 2012, CHEM REV, V112, P1910, DOI 10.1021/cr200201z; Nishimura T, 2013, ANGEW CHEM INT EDIT, V52, P1777, DOI 10.1002/anie.201208593; Sun CL, 2011, CHEM REV, V111, P1293, DOI 10.1021/cr100198w; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Tabuchi S, 2014, J ORG CHEM, V79, P5401, DOI 10.1021/jo5010636; IRIE M, 1983, J AM CHEM SOC, V105, P2078, DOI 10.1021/ja00345a075; Shacklady-McAtee DM, 2014, TETRAHEDRON, V70, P4257, DOI 10.1016/j.tet.2014.03.039; Zhao X, 2011, J AM CHEM SOC, V133, P3296, DOI 10.1021/ja111249p; Lin SH, 2007, J ORG CHEM, V72, P9757, DOI 10.1021/jo071232k; Chemler SR, 2001, ANGEW CHEM INT EDIT, V40, P4544, DOI 10.1002/1521-3773(20011217)40:24<4544::AID-ANIE4544>3.0.CO;2-N; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Cao LL, 2012, TETRAHEDRON LETT, V53, P3873, DOI 10.1016/j.tetlet.2012.05.056; Chausset-Boissarie L, 2013, CHEM-EUR J, V19, P17698, DOI 10.1002/chem.201303683; CLAYDEN J, 1993, J CHEM SOC CHEM COMM, P1682, DOI 10.1039/c39930001682; CLAYDEN J, 1995, J CHEM SOC PERK T 1, P7, DOI 10.1039/p19950000007; FABRE JL, 1982, TETRAHEDRON LETT, V23, P2469, DOI 10.1016/S0040-4039(00)87370-0; Haugland R. P, 2005, HDB GUIDE FLUORESCEN; Jia F, 2014, ORG CHEM FRONT, V1, P194; Llamas T, 2004, ADV SYNTH CATAL, V346, P1651, DOI 10.1002/adsc.200404180; Matthew SC, 2014, J AM CHEM SOC, V136, P5828, DOI 10.1021/ja412159g; Mizoguchi TJ, 1998, J AM CHEM SOC, V120, P11022, DOI 10.1021/ja982417z; Mondal S, 2014, RSC ADV, V4, P28317, DOI 10.1039/c4ra01341g; Nambo M, 2014, ANGEW CHEM INT EDIT, V53, P742, DOI 10.1002/anie.201307019; ONO A, 1987, SYNTHESIS-STUTTGART, P736; Parai MK, 2008, BIOORG MED CHEM LETT, V18, P289, DOI 10.1016/j.bmcl.2007.10.083; Rasik CM, 2014, ANGEW CHEM INT EDIT, V53, P14522, DOI 10.1002/anie.201408055; Rathore R, 2004, J ORG CHEM, V69, P1524, DOI 10.1021/jo035598; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Sekizawa H, 2014, ACS MED CHEM LETT, V5, P582, DOI 10.1021/ml500024s; Shchepinov MS, 2003, CHEM SOC REV, V32, P170, DOI 10.1039/b0089001; Sherry BD, 2008, ACCOUNTS CHEM RES, V41, P1500, DOI 10.1021/ar800039x; Someya CI, 2013, CATAL LETT, V143, P424, DOI 10.1007/s10562-013-0979-5; Shagufta, 2006, BIOORGAN MED CHEM, V14, P1497, DOI 10.1016/j.bmc.2005.10.002; Stymiest JL, 2008, NATURE, V456, P778, DOI 10.1038/nature07592; Suzuki A., 2011, ANGEW CHEM INT EDIT, V50, P6723; Thirupathi P, 2009, J ORG CHEM, V74, P7755, DOI 10.1021/jo9014613; Thirupathi P, 2010, EUR J ORG CHEM, P1798, DOI 10.1002/ejoc.200901186; Thirupathi P, 2011, TETRAHEDRON, V67, P7301, DOI 10.1016/j.tet.2011.07.041; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Wu JC, 2012, ANGEW CHEM INT EDIT, V51, P9909, DOI 10.1002/anie.201205969	119	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	AUG	2015	5	8					4734	4742		10.1021/acscatal.5b00909		9	Chemistry, Physical	Chemistry	CO8DL	WOS:000359395100028		
J	Ogino, I; Suzuki, Y; Mukai, SR				Ogino, Isao; Suzuki, Yukei; Mukai, Shin R.			Tuning the Pore Structure and Surface Properties of Carbon-Based Acid Catalysts for Liquid-Phase Reactions	ACS CATALYSIS			English	Article						solid acid catalyst; carbon; mesoporous; esterification; condensation; oleic acid; furfural	SULFONATED HYDROTHERMAL CARBON; ION-EXCHANGE RESINS; HIGH-QUALITY DIESEL; AMORPHOUS-CARBON; BEARING SO3H; ACETIC-ACID; FORMALDEHYDE; RESORCINOL; ESTERIFICATION; CELLULOSE	A series of sulfonic-acid-containing carbon catalysts were synthesized through the pyrolyzation of resorcinol-formaldehyde resins and subsequent sulfonation to investigate the tunability of their pore structure and surface properties. These catalysts were characterized by nitrogen gas adsorption, water vapor adsorption, elemental analysis, Boehm titration, and IR spectroscopy. Catalytic consequences of these properties were examined using two esterification reactions in which reactants of substantially different sizes (oleic acid vs acetic acid) are involved as well as the condensation of furfural with 2-methylfuran. The esterification of acetic acid with ethanol proceeded at nearly the same activity (TOF similar to 0.02 s(-1)) for all synthesized catalysts regardless of the variation of their surface and pore properties. Poisoning experiments of acid groups in the synthesized catalysts with NaCl indicate that nearly all -SO3H groups are accessible to the reactants. However, the esterification of oleic acid with methanol requires a large volume of mesopores (>0.4 cm(3) g(-1)) to proceed as efficiently as that using p-toluenesuffonic acid (p-TSA) as the catalyst. The condensation reaction requires both hydrophobic surfaces and a large volume of mesopores. A synthesized carbon-based catalyst having a large mesopore volume (1.1 cm(3) g(-1)) and surfaces with a relatively high hydrophobicity catalyzes this reaction at a much higher rate and higher selectivity (>90%) than Amberlyst-15. The results reported here show that the pore structure and surface properties of phenolic-resin-derived carbon catalysts can be easily tuned to maximize their catalytic performance in the reaction for which they are intended.	[Ogino, Isao; Suzuki, Yukei; Mukai, Shin R.] Hokkaido Univ, Div Appl Chem, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Ogino, I (reprint author), Hokkaido Univ, Div Appl Chem, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	iogino@eng.hokudai.ac.jp					Okuhara T, 2002, CHEM REV, V102, P3641, DOI 10.1021/cr0103569; Lopez-Ruiz JA, 2014, GREEN CHEM, V16, P683, DOI 10.1039/c3gc41287c; Goertzen SL, 2010, CARBON, V48, P1252, DOI 10.1016/j.carbon.2009.11.050; Hara M, 2010, TOP CATAL, V53, P805, DOI 10.1007/s11244-010-9458-z; Hara M, 2004, ANGEW CHEM INT EDIT, V43, P2955, DOI 10.1002/anie.200453947; Mo X, 2008, J CATAL, V254, P332, DOI 10.1016/j.jcat.2008.01.011; Kobayashi H, 2013, ACS CATAL, V3, P581, DOI 10.1021/cs300845f; Nakajima K, 2012, ACS CATAL, V2, P1296, DOI 10.1021/cs300103k; Inagaki M, 2015, CARBON, V87, P128, DOI 10.1016/j.carbon.2015.02.021; MEARS DE, 1971, IND ENG CHEM PROC DD, V10, P541, DOI 10.1021/i260040a020; Thommes M, 2012, J PHYS CHEM C, V116, P18816, DOI 10.1021/jp3051214; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Roldan L, 2015, CATAL TODAY, V249, P153, DOI 10.1016/j.cattod.2014.11.008; Oickle AM, 2010, CARBON, V48, P3313, DOI 10.1016/j.carbon.2010.05.004; Tanabe K, 2003, CATAL TODAY, V78, P65, DOI 10.1016/S0920-5861(02)00343-7; Fraile JM, 2012, J CATAL, V289, P73, DOI 10.1016/j.jcat.2012.01.017; Fukuhara K, 2011, CHEMSUSCHEM, V4, P778, DOI 10.1002/cssc.201000431; Corma A, 2012, ENERG ENVIRON SCI, V5, P6328, DOI 10.1039/c2ee02778j; Balakrishnan M, 2014, CHEMSUSCHEM, V7, P1078, DOI 10.1002/cssc.201300931; Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c; Chung PW, 2014, ACS CATAL, V4, P302, DOI 10.1021/cs400939p; Gounder R, 2013, AICHE J, V59, P3349, DOI 10.1002/aic.14016; PEKALA RW, 1989, J MATER SCI, V24, P3221, DOI 10.1007/BF01139044; BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0; Teo HTR, 2004, J CATAL, V228, P174, DOI 10.1016/j.jcat.2004.08.018; Mo XH, 2008, CATAL LETT, V123, P1, DOI 10.1007/s10562-008-9456-y; Constantino DSM, 2015, AICHE J, V61, P1263, DOI 10.1002/aic.14701; PEKALA RW, 1992, J NON-CRYST SOLIDS, V145, P90, DOI 10.1016/S0022-3093(05)80436-3; Harmer MA, 2001, APPL CATAL A-GEN, V221, P45, DOI 10.1016/S0926-860X(01)00794-3; Corma A, 2011, ANGEW CHEM INT EDIT, V50, P2375, DOI 10.1002/anie.201007508; Rolison DR, 2003, SCIENCE, V299, P1698, DOI 10.1126/science.1082332; Onda A, 2009, TOP CATAL, V52, P801, DOI 10.1007/s11244-009-9237-x; Toda M, 2005, NATURE, V438, P178, DOI 10.1038/438178a; Suganuma S, 2008, J AM CHEM SOC, V130, P12787, DOI 10.1021/ja803983h; CHAKRABARTI A, 1993, REACT POLYM, V20, P1, DOI 10.1016/0923-1137(93)90064-M; Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8; Tanabe K, 1999, APPL CATAL A-GEN, V181, P399, DOI 10.1016/S0926-860X(98)00397-4; Mukai SR, 2005, CARBON, V43, P1563, DOI 10.1016/j.carbon.2004.12.029; Kitano M, 2009, CATAL LETT, V131, P242, DOI 10.1007/s10562-009-0062-4; Nishihara H, 2004, CARBON, V42, P899, DOI 10.1016/j.carbon.2004.01.075; Peters TA, 2006, APPL CATAL A-GEN, V297, P182, DOI 10.1016/j.apcata.2005.09.006; WEISZ PB, 1954, ADV CATAL, V6, P143, DOI 10.1016/S0360-0564(08)60390-9; Tsuchiya T, 2014, CARBON, V76, P240, DOI 10.1016/j.carbon.2014.04.074; Hanzawa Y, 1996, LANGMUIR, V12, P6167, DOI 10.1021/la960481t; Al-Muhtaseb SA, 2003, ADV MATER, V15, P101, DOI 10.1002/adma.200390020; Ogino I, 2014, J PHYS CHEM C, V118, P6866, DOI 10.1021/jp412781d; Stein A, 2009, ADV MATER, V21, P265, DOI 10.1002/adma.200801492; Arata K, 2003, CATAL TODAY, V81, P17, DOI 10.1016/S0920-5861(03)00098-1; Bruno JE, 2015, APPL CATAL A-GEN, V497, P176, DOI 10.1016/j.apcata.2015.03.009; Davis M. E., 2003, FUNDAMENTALS CHEM RE; Davis R. J., 2013, CATALYSIS CONVERSION, P255; Fraile JM, 2015, J CATAL, V324, P107, DOI 10.1016/j.jcat.2014.12.032; Gates B. C., 2008, HDB HETEROGENEOUS CA, V1, P278; Krasovskii A. N., 1977, J APPL SPECTROSC, V26, P745, DOI 10.1007/BF01124478; Mukai SR, 2005, CARBON, V43, P2628, DOI 10.1016/j.carbon.2005.05.004; Murakami K, 2013, IND ENG CHEM RES, V52, P15372, DOI 10.1021/ie400656x; TIPSON RS, 1952, J AM CHEM SOC, V74, P1354, DOI 10.1021/ja01125a515; Yati I, 2015, APPL CATAL A-GEN, V495, P200, DOI 10.1016/j.apcata.2015.02.002	58	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	AUG	2015	5	8					4951	4958		10.1021/acscatal.5b01022		8	Chemistry, Physical	Chemistry	CO8DL	WOS:000359395100056		
J	Nomura, S; Endo-Urneda, K; Aoyarna, A; Makishima, M; Hashimoto, Y; Ishikawat, M				Nomura, Sayaka; Endo-Urneda, Kaori; Aoyarna, Atsushi; Makishima, Makoto; Hashimoto, Yuichi; Ishikawat, Minoru			Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Liver X receptor; transrepression; inhibition of interleukin-6 level; stytylphenylphthalimide	CRYSTAL-STRUCTURE; ANTIINFLAMMATORY ACTIVITY; OXYSTEROL RECEPTORS; TERTIARY-AMINES; ALPHA; BETA; INFLAMMATION; DISCOVERY; GENE; ANTAGONISTS	Anti-inflammatory effects of liver X receptor (LXR) ligands are thought to be largely due to LXR-mediated transrepression, whereas side effects are caused by activation of LXR-responsive gene expression (transactivation). Therefore, selective LXR modulators that preferentially exhibit transrepression activity should exhibit anti-inflammatory properties with fewer side effects. Here, we synthesized a series of styrylphenylphthalirnide analogues and evaluated their structure activity relationships focusing on LXRs-transactivating-agonistic/antagonistic activities and transrepressional activity. Among the compounds examined, 171 showed potent LXR-transrepressional activity with high selectivity over transactivating activity and did not show characteristic side effects of LXR-transactivating agonists in cells. This representative compound, 171, was confirmed to have LXR-dependent transrepressional activity and to bind directly to LXR beta. Compound 171 should be useful not only as a chemical tool for studying the biological functions of LXRs transrepression but also as a candidate for a safer agent to treat inflammatory diseases.	[Nomura, Sayaka; Aoyarna, Atsushi; Hashimoto, Yuichi; Ishikawat, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Endo-Urneda, Kaori; Makishima, Makoto] Nihon Univ, Sch Med, Itabashi Ku, Tokyo 1738610, Japan	Ishikawat, M (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	m-ishikawa@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Platform for Drug Discovery, Informatics, and Structural Life Science	The work described in this Letter was partially supported by Grants-in Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science, and Platform for Drug Discovery, Informatics, and Structural Life Science.	Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Griffett K, 2013, ACS CHEM BIOL, V8, P559, DOI 10.1021/cb300541g; Laurencikiene J, 2012, INT J OBESITY, V36, P1494, DOI 10.1038/ijo.2012.21; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Asquith DL, 2009, ARTHRITIS RHEUM, V60, P2655, DOI 10.1002/art.24717; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Aoyama A, 2012, J MED CHEM, V55, P7360, DOI 10.1021/jm3002394; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wang YY, 2006, SHOCK, V25, P141, DOI 10.1097/01.shk.0000191377.78144.d9; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Farnegardh M, 2003, J BIOL CHEM, V278, P38821, DOI 10.1074/jbc.M304842200; Chao EY, 2008, J MED CHEM, V51, P5758, DOI 10.1021/jm800612u; Fradera X, 2010, J MOL BIOL, V399, P120, DOI 10.1016/j.jmb.2010.04.005; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jaye MC, 2005, J MED CHEM, V48, P5419, DOI 10.1021/jm050532w; Jiao XY, 2012, BIOORG MED CHEM LETT, V22, P5966, DOI 10.1016/j.bmcl.2012.07.048; Li LP, 2006, BIOORG MED CHEM LETT, V16, P1638, DOI 10.1016/j.bmcl.2005.12.015; Molteni V, 2007, J MED CHEM, V50, P4255, DOI 10.1021/jm070453f; Motoshima K, 2009, BIOORGAN MED CHEM, V17, P5001, DOI 10.1016/j.bmc.2009.05.066; Noguchi-Yachide T, 2007, BIOORG MED CHEM LETT, V17, P3957, DOI 10.1016/j.bmcl.2007.04.090; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Tice CM, 2014, J MED CHEM, V57, P7182, DOI 10.1021/jm500442z; Wang YY, 2011, SURG INFECT, V12, P283, DOI 10.1089/sur.2010.066; Zuercher WJ, 2010, J MED CHEM, V53, P3412, DOI 10.1021/jm901797p	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	AUG	2015	6	8					902	907		10.1021/acsmedchemlett.5b00170		11	Chemistry, Medicinal	Pharmacology & Pharmacy	CP2CJ	WOS:000359684800014		
J	Doi, A; Nakamura, H; Shiro, Y; Sugimoto, H				Doi, Akihiro; Nakamura, Hiro; Shiro, Yoshitsugu; Sugimoto, Hiroshi			Structure of the response regulator ChrA in the haem-sensing two-component system of Corynebacterium diphtheriae	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						transcription factor; X-ray crystallography; haem; helix-turn-helix; phosphorylation	SIGNAL-TRANSDUCTION SYSTEM; CONFORMATIONAL-CHANGES; RECEIVER DOMAIN; GENE-EXPRESSION; IRON SOURCES; NARL; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; HEMOGLOBIN	ChrA is a response regulator (RR) in the two-component system involved in regulating the degradation and transport of haem (Fe-porphyrin) in the pathogen Corynebacterium diphtheriae. Here, the crystal structure of full-length ChrA is described at a resolution of 1.8 angstrom. ChrA consists of an N-terminal regulatory domain, a long linker region and a C-terminal DNA-binding domain. A structural comparison of ChrA with other RRs revealed substantial differences in the relative orientation of the two domains and the conformation of the linker region. The structural flexibility of the linker could be an important feature in rearrangement of the domain orientation to create a dimerization interface to bind DNA during haem-sensing signal transduction.	[Doi, Akihiro; Nakamura, Hiro; Shiro, Yoshitsugu; Sugimoto, Hiroshi] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Sugimoto, H (reprint author), RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	sugimoto@spring8.or.jp					Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Schmitt MP, 1997, J BACTERIOL, V179, P838; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137; Birck C, 1999, STRUCT FOLD DES, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; SCHMITT MP, 1991, INFECT IMMUN, V59, P1899; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Bibb LA, 2005, INFECT IMMUN, V73, P7406, DOI 10.1128/IaAI.73.11.7406-7412.2005; Burgos JM, 2012, J BACTERIOL, V194, P1717, DOI 10.1128/JB.06801-11; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Ito Y, 2009, FEBS LETT, V583, P2244, DOI 10.1016/j.febslet.2009.06.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park AK, 2013, BIOCHEM BIOPH RES CO, V434, P65, DOI 10.1016/j.bbrc.2013.03.065; Schmitt MP, 1999, J BACTERIOL, V181, P5330; Schnell R, 2008, ACTA CRYSTALLOGR F, V64, P1096, DOI 10.1107/S1744309108035203	23	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				966	971		10.1107/S2053230X15009838		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700007		
J	Fujii, T; Yamauchi, T; Ishiyama, M; Gogami, Y; Oikawa, T; Hata, Y				Fujii, Tomomi; Yamauchi, Takae; Ishiyama, Makoto; Gogami, Yoshitaka; Oikawa, Tadao; Hata, Yasuo			Crystallographic studies of aspartate racemase from Lactobacillus sakei NBRC 15893	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						aspartate racemase; Lactobacillus sakei; D-amino acid; crystallization	D-AMINO ACIDS; GAS-CHROMATOGRAPHIC DETERMINATION; ENANTIOMERS; MECHANISM	Aspartate racemase catalyzes the interconversion between L-aspartate and D-aspartate and belongs to the PLP-independent racemases. The enzyme from the lactic acid bacterium Lactobacillus sakei NBRC 15893, isolated from kimoto, is considered to be involved in D-aspartate synthesis during the brewing process of Japanese sake at low temperatures. The enzyme was crystallized at 293K by the sitting-drop vapour-diffusion method using 25%(v/v) PEG MME 550, 5%(v/v) 2-propanol. The crystal belonged to space group P3(1)21, with unit-cell parameters a = b = 104.68, c = 97.29 angstrom, and diffracted to 2.6 angstrom resolution. Structure determination is under way.	[Fujii, Tomomi; Yamauchi, Takae; Ishiyama, Makoto; Hata, Yasuo] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Gogami, Yoshitaka; Oikawa, Tadao] Kansai Univ, Dept Life Sci & Biotechnol, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan	Hata, Y (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	hata@scl.kyoto-u.ac.jp			Collaborative Research Program of the Institute for Chemical Research, Kyoto University [2012-3]; Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by the Collaborative Research Program of the Institute for Chemical Research, Kyoto University (grant No. 2012-3), the Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN, 2008-2012) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017. X-ray diffraction experiments were performed at Photon Factory with the approval of the Photon Factory Advisory Committee, KEK, Japan (proposal No. 2012G745).	Ali HSM, 2010, AMINO ACIDS, V38, P951, DOI 10.1007/s00726-009-0304-1; OSBORN MJ, 1969, ANNU REV BIOCHEM, V38, P501, DOI 10.1146/annurev.bi.38.070169.002441; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gogami Y, 2011, J CHROMATOGR B, V879, P3259, DOI 10.1016/j.jchromb.2011.04.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ota N, 2012, AMINO ACIDS, V43, P1873, DOI 10.1007/s00726-012-1364-1; Conti P, 2011, CHEM REV, V111, P6919, DOI 10.1021/cr2000702; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Ohtaki A, 2008, PROTEINS, V70, P1167, DOI 10.1002/prot.21528; Erbe T, 2000, J CHROMATOGR A, V881, P81, DOI 10.1016/S0021-9673(00)00255-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Morikawa A, 2007, BIOCHEM BIOPH RES CO, V355, P872, DOI 10.1016/j.bbrc.2007.02.056; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; YAMAUCHI T, 1992, J BIOL CHEM, V267, P18361; Liu LJ, 2002, J MOL BIOL, V319, P479, DOI 10.1016/S0022-2836(02)00296-6; BRUCKNER H, 1991, CHROMATOGRAPHIA, V31, P123, DOI 10.1007/BF02274558; Gogami Y., 2011, IUMS 2011 SAPPORO UN, P255; Gogami Y., 2012, TRACE NUTR RES, V29, P1; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Katagiri H., 1934, NIPPON NOGEIKAGAKU K, V10, P965; Kitahara K., 1959, NIPPON NOGEIKAGAKU K, V33, P839; Marceau A, 2003, RES MICROBIOL, V154, P37, DOI 10.1016/S0923-2508(02)00010-4; Okada K, 2013, AMINO ACIDS, V44, P489, DOI 10.1007/s00726-012-1359-y; Patzold R, 2006, AMINO ACIDS, V31, P63, DOI 10.1007/s00726-006-0330-1; Rubio-Barroso S, 2006, J DAIRY SCI, V89, P82; Wolosker Herman, 2006, Sci STKE, V2006, ppe41, DOI 10.1126/stke.3562006pe41	30	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				1012	1016		10.1107/S2053230X15010572		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700015		
J	Komori, H; Inaka, K; Furubayashi, N; Honda, M; Higuchi, Y				Komori, Hirofumi; Inaka, Koji; Furubayashi, Naoki; Honda, Michinari; Higuchi, Yoshiki			Crystallographic analysis of FAD-dependent glucose dehydrogenase	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						glucose dehydrogenase; FAD; glucose sensor	ANGSTROM RESOLUTION	An FAD-dependent glucose dehydrogenase (GDH) from Aspergillus terreus was purified and crystallized at 293K using the sitting-drop vapour-diffusion method. A data set was collected to a resolution of 1.6 angstrom from a single crystal at 100K using a rotating-anode X-ray source. The crystal belonged to space group P2(1), with unit-cell parameters a = 56.56, b = 135.74, c = 74.13 angstrom, = 90.37 degrees. The asymmetric unit contained two molecules of GDH. The Matthews coefficient was calculated to be 2.2 angstrom(3)Da(-1) and the solvent content was estimated to be 44%.	[Komori, Hirofumi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795198, Japan; [Inaka, Koji; Furubayashi, Naoki] Maruwa Foods & Biosci Inc, Nara 6391123, Japan; [Honda, Michinari] Ikeda Tohka Ind Co Ltd, Fukuyama, Hiroshima 7210956, Japan; [Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	Komori, H (reprint author), Kagawa Univ, Fac Educ, 1-1 Saiwai Cho, Takamatsu, Kagawa 7608522, Japan.	komori@ed.kagawa-u.ac.jp; hig@sci.u-hyogo.ac.jp					Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Sygmund C, 2011, MICROBIOL-SGM, V157, P3203, DOI 10.1099/mic.0.051904-0; Tsuboi H, 2005, BIOSCI BIOTECH BIOCH, V69, P206, DOI 10.1271/bbb.69.206	10	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				1017	1019		10.1107/S2053230X15010742		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700016		
J	Sakurai, S; Ohto, U; Shimizu, T				Sakurai, Shunya; Ohto, Umeharu; Shimizu, Toshiyuki			Structure of human Roquin-2 and its complex with constitutive-decay element RNA	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						Roquin; mRNA degradation; winged-helix motif; stem-loop structure	MESSENGER-RNA; RECOGNITION; DEGRADATION; REPRESS	Roquin mediates mRNA degradation by recognizing the constitutive-decay element (CDE) in the 3 untranslated region of the target gene followed by recruitment of the deadenylation machinery. Deficiency or dysfunction of Roquin has been associated with autoimmunity and inflammation. To establish the structural basis for the recognition of CDE RNA by Roquin, the crystal structure of the ROQ domain of human Roquin-2 was determined in ligand-free and CDE-derived RNA-bound forms. The ROQ domain of Roquin-2 folded into a winged-helix structure in which the wing region showed structural flexibility and acted as a lid for RNA binding. The CDE RNA, forming a stem-loop structure, bound to the positively charged surface of the ROQ domain and was mainly recognized via direct interactions with the phosphate backbone in the 5 half of the stem-loop and its triloop and via indirect water-mediated interactions. Structural comparison with Roquin-1 revealed conserved features of the RNA-binding mode. Therefore, it is suggested that the Roquin proteins function redundantly in mRNA degradation.	[Sakurai, Shunya; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimizu, Toshiyuki] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Shimizu, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	We acknowledge Dr Yusuke Sekine and Professor Hidenori Ichijo for providing the cDNA of human Roquin-2. We also thank the beamline staff members at the Photon Factory and SPring-8 for their assistance with data collection. This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (UO and TS), the Takeda Science Foundation (UO and TS) and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (UO).	Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Schlundt A, 2014, NAT STRUCT MOL BIOL, V21, P671, DOI 10.1038/nsmb.2855; DeLano W. L., 2002, PYMOL; Maruyama T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004822; Otwinowski A., 1997, METHOD ENZYMOL, V276, P307; Schuetz A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6701; Srivastava M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7253; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003	17	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				1048	1054		10.1107/S2053230X15011887		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700022		
J	Miyano, N; Igarashi, T; Kawano, H; Miyamoto, K; Tsuchiya, T; Tomoo, K; Tsujibo, H				Miyano, Nao; Igarashi, Tomoko; Kawano, Hiroaki; Miyamoto, Katsushiro; Tsuchiya, Takahiro; Tomoo, Koji; Tsujibo, Hiroshi			Expression, purification, crystallization and X-ray crystallographic analysis of the periplasmic binding protein VatD from Vibrio vulnificus M2799	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						Vibrio vulnificus; periplasmic binding protein; siderophore; iron; desferrioxamine B	VULNIBACTIN; SIDEROPHORE; INFECTIONS; VIRULENCE; FEATURES; SYSTEM	Vibrio vulnificus is a halophilic marine microorganism which causes gastroenteritis and primary septicaemia in humans. An important factor that determines the survival of V. vulnificus in the human body is its ability to acquire iron. VatD is a periplasmic siderophore-binding protein from V. vulnificus M2799. The current study reports the expression, purification and crystallization of VatD. Crystals of both apo VatD and a VatD-desferrioxamine B-Fe3+ (VatD-FOB) complex were obtained. The crystal of apo VatD belonged to space group P6(4)22, while the crystal of the VatD-FOB complex belonged to space group P2(1). The difference in the two crystal forms could be caused by the binding of FOB to VatD.	[Miyano, Nao; Igarashi, Tomoko; Kawano, Hiroaki; Miyamoto, Katsushiro; Tsuchiya, Takahiro; Tsujibo, Hiroshi] Osaka Univ Pharmaceut Sci, Dept Microbiol, Takatsuki, Osaka 5691094, Japan; [Tomoo, Koji] Osaka Univ Pharmaceut Sci, Dept Phys Chem, Takatsuki, Osaka 5691094, Japan	Tomoo, K (reprint author), Osaka Univ Pharmaceut Sci, Dept Phys Chem, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	tomoo@gly.oups.ac.jp; tsujibo@gly.oups.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101031]	We thank the beamline staff members at BL38B1 of SPring-8, Hyogo, Japan for their support during data collection. The synchrotron-radiation experiments were performed at BL38B1 of SPring-8, Japan with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal Nos. 2014B1176 and 2014A1139). This study was supported in part by a Grant-in-Aid for the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, 2011-2015 (S1101031). We thank Professor Shin-ichi Miyoshi for supplying the V. vulnificus clinical isolate strain M2799.	BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; TACKET CO, 1984, J INFECT DIS, V149, P558; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; JOHNSTON JM, 1985, JAMA-J AM MED ASSOC, V253, P2850, DOI 10.1001/jama.253.19.2850; Kawano H, 2013, MICROB PATHOGENESIS, V65, P73, DOI 10.1016/j.micpath.2013.10.002; Kawano H, 2014, MICROB PATHOGENESIS, V75, P59, DOI 10.1016/j.micpath.2014.09.001; KLONTZ KC, 1988, ANN INTERN MED, V109, P318; Litwin CM, 1996, INFECT IMMUN, V64, P2834; MORRIS JG, 1987, FEMS MICROBIOL LETT, V40, P55; OKUJO N, 1994, BIOMETALS, V7, P109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Webster ACD, 2000, INFECT IMMUN, V68, P526, DOI 10.1128/IAI.68.2.526-534.2000	15	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				1078	1082		10.1107/S2053230X15011759		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700027		
J	Hayashi, M; Suzuki, R; Colleoni, C; Ball, SG; Fujita, N; Suzuki, E				Hayashi, Mari; Suzuki, Ryuichiro; Colleoni, Christophe; Ball, Steven G.; Fujita, Naoko; Suzuki, Eiji			Crystallization and crystallographic analysis of branching enzymes from Cyanothece sp ATCC 51142	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						cyanobacteria; Cyanothece; glycogen; amylopectin; branching enzyme	RICE ENDOSPERM; CRYSTAL-STRUCTURE; AMYLOPECTIN BIOSYNTHESIS; CYANOBACTERIAL STARCH; I BEI	Several cyanobacterial species, including Cyanothece sp. ATCC 51142, remarkably have four isoforms of -glucan branching enzymes (BEs). Based on their primary structures, they are classified into glycoside hydrolase (GH) family 13 (BE1, BE2 and BE3) or family 57 (GH57 BE). In the present study, GH13-type BEs from Cyanothece sp. ATCC 51142 (BE1, BE2 and BE3) have been overexpressed in Escherichia coli and biochemically characterized. The recombinant BE1 was crystallized by the hanging-drop vapour-diffusion method. Crystals of BE1 were obtained at 293K in the presence of 0.2M Mg2+, 7-10%(w/v) ethanol, 0.1M HEPES-NaOH pH 7.2-7.9. The crystals belonged to the tetragonal space group P4(1)2(1)2, with unit-cell parameters a=b=133.75, c = 185.90 angstrom, and diffracted to beyond 1.85 angstrom resolution. Matthews coefficient calculations suggested that the crystals of BE1 contained two molecules in the asymmetric unit.	[Hayashi, Mari; Suzuki, Ryuichiro; Fujita, Naoko; Suzuki, Eiji] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan; [Colleoni, Christophe; Ball, Steven G.] Univ Sci Technol Lille, Ctr Natl Rech Sci, Unite Mixte Rech 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Suzuki, R (reprint author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan.	ryuichi@akita-pu.ac.jp; esuzuki@akita-pu.ac.jp			Shimadzu Science Foundation [120003]; JSPS KAKENHI [25440193]	We thank Drs Takuya Ishida, Kiyohiko Igarashi and Zui Fujimoto for their help in conducting this study. We also thank the staff of the Biotechnology Center, Akita Prefectural University for DNA-sequencing analysis and the Photon Factory for X-ray data collection. Hayashibara Co. generously provided us with Pseudomonas isoamylase. This work was supported in part by Shimadzu Science Foundation Grant No. 120003 and JSPS KAKENHI Grant No. 25440193.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI 10.1104/pp.127.2.459; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAUDWELL FB, 1980, EUR J BIOCHEM, V109, P391, DOI 10.1111/j.1432-1033.1980.tb04806.x; Colleoni C., 2012, STARCH ORIGINS STRUC, P217; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sawada T., 2013, J APPL GLYCOSCI, V60, P69; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Suzuki E, 2013, PLANT CELL PHYSIOL, V54, P465, DOI 10.1093/pcp/pcs190; Suzuki R, 2015, BBA-PROTEINS PROTEOM, V1854, P476, DOI 10.1016/j.bbapap.2015.02.012; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z	23	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	AUG	2015	71		8				1109	1113		10.1107/S2053230X1501198X		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CO7PK	WOS:000359352700032		
J	Moon, SY; Ogasawara, T; Hanamitsu, S; Shioda, K; Inoue, Y				Moon, S. Y.; Ogasawara, T.; Hanamitsu, S.; Shioda, K.; Inoue, Y.			Efficient and Simple Surface Modification of Carbon Nanotubes by Dry Process Using hydrogen	ADVANCED ENGINEERING MATERIALS			English	Article							NONCOVALENT FUNCTIONALIZATION; POLYMER COMPOSITES	We study a novel method to modify carbon nanotubes (CNT) surfaces using hydrogen and develop a composite with epoxy resin. This method is effective for functionalization of CNT surfaces and for chemical and physical interactions with other materials. The C=C/C-C ratio increased until 20min and decreased thereafter. In addition, the C-O peak decreased until 20min and increased after 20min. This indicates that the CNT surface was transferred with H. SEM observation revealed that excellent interfacial bonding is achieved between CNTs and epoxy resin. It affected the mechanical properties to CNT/Epoxy nanocomposite.	[Moon, S. Y.; Ogasawara, T.] JAXA, Aerosp Res & Dev Directorate, Adv Composite Ctr, Mitaka, Tokyo 1810015, Japan; [Hanamitsu, S.; Shioda, K.] Aoyama Gakuin Univ, Grad Sch Mech Engn, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Inoue, Y.] Shizuoka Univ, Fac Engn, Naka Ku, Hamamatsu, Shizuoka 4238561, Japan	Moon, SY (reprint author), JAXA, Aerosp Res & Dev Directorate, Adv Composite Ctr, 6-13-1 Osawa, Mitaka, Tokyo 1810015, Japan.		Ogasawara, Toshio/O-1238-2014	Ogasawara, Toshio/0000-0003-1074-0427			Akai Y, 2003, JPN J APPL PHYS 1, V42, P640, DOI 10.1143/JJAP.42.640; Inoue Y, 2011, CARBON, V49, P2437, DOI 10.1016/j.carbon.2011.02.010; Assali M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/8/085604; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Hou PX, 2003, CARBON, V41, P2471, DOI 10.1016/S0008-6223(03)00271-9; Matthews MJ, 1999, PHYS REV B, V59, pR6585, DOI 10.1103/PhysRevB.59.R6585; Bilalis P, 2014, RSC ADV, V4, P2911, DOI 10.1039/c3ra44906h; Esumi K, 1996, CARBON, V34, P279, DOI 10.1016/0008-6223(96)83349-5; Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4; Wardle BL, 2008, ADV MATER, V20, P2707, DOI 10.1002/adma.200800295; Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X; Lee CJ, 2001, CHEM PHYS LETT, V343, P33, DOI 10.1016/S0009-2614(01)00680-7; Inoue Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937082; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; Ogasawara T, 2011, COMPOS SCI TECHNOL, V71, P73, DOI 10.1016/j.compscitech.2010.10.001; Schadler LS, 1998, APPL PHYS LETT, V73, P3842, DOI 10.1063/1.122911; Rao AM, 2000, PHYS REV LETT, V84, P1820, DOI 10.1103/PhysRevLett.84.1820; Ghosh A, 2010, CHEM PHYS LETT, V488, P198, DOI 10.1016/j.cplett.2010.02.021; Nikitin A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225507; Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Ogasawara T., 2001, COMP SCI TECHNOL, V71, P1826; Panchakarla LS, 2008, J CHEM SCI, V120, P607, DOI 10.1007/s12039-008-0092-2; Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v; Usrey M. L., 2009, J PHYS CHEM C, VC 28, P12443	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1438-1656	1527-2648		ADV ENG MATER	Adv. Eng. Mater.	AUG	2015	17	8					1220	1225		10.1002/adem.201400495		6	Materials Science, Multidisciplinary	Materials Science	CO8ND	WOS:000359425300018		
J	Ikeda, T; Atobe, T; Fujimoto, D; Inasawa, A; Asai, M				Ikeda, Tomoaki; Atobe, Takashi; Fujimoto, Daisuke; Inasawa, Ayumu; Asai, Masahito			Self-Noise Effects on Aerodynamics of Cambered Airfoils at Low Reynolds Number	AIAA JOURNAL			English	Article							TRAILING-EDGE NOISE; FREQUENCY SELECTION; FLOW; INSTABILITY; WAKE; GENERATION; SIMULATION; AEROFOIL; BODY	Aerodynamics of cambered airfoils are investigated numerically, using a NACA four-digit series of 6% thickness at low Reynolds number Re = 10; 000 and moderate Mach number M = 0.2, by focusing on the relation of aeroacoustic effects and hydrodynamic flow unsteadiness. Two-dimensional numerical simulations show that the onset of an acoustic feedback loop leads to an abrupt increase in lift force. Associated with the feedback process, the evolution of two-dimensional vortices in the suction-side boundary layer shifts a separation bubble toward the leading edge, which causes a relatively steep pressure recovery near the trailing edge. Through a parametric study on airfoil shape, the aerodynamically favorable feature of aft camber is further enhanced with the presence of an acoustic feedback loop. In addition, the aft camber airfoil successfully forms a laminar separation bubble in three-dimensional calculations at the present Reynolds number, developing transitional behavior on the suction side, supposedly prompted by the airfoil tones. Although the boundary layer shows three-dimensional complexity, still the formation of an acoustic feedback loop is strongly suggested, via the comparison of spanwise correlations.	[Ikeda, Tomoaki; Atobe, Takashi] Japan Aerosp Explorat Agcy, Aerodynam Res Grp, Chofu, Tokyo 1828522, Japan; [Fujimoto, Daisuke; Inasawa, Ayumu; Asai, Masahito] Tokyo Metropolitan Univ, Dept Aerosp Engn, Tokyo 1910065, Japan	Ikeda, T (reprint author), Japan Aerosp Explorat Agcy, Aerodynam Res Grp, 7-44-1 Jindaijihigashimachi, Chofu, Tokyo 1828522, Japan.				Japan Society for the Promotion of Science [5420139]	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant 5420139). Computational resources were provided by the Japan Aerospace Exploration Agency Supercomputer System.	Adams NA, 1998, THEOR COMP FLUID DYN, V12, P109, DOI 10.1007/s001620050102; Nash EC, 1999, J FLUID MECH, V382, P27, DOI 10.1017/S002211209800367X; Jones LE, 2010, J FLUID MECH, V648, P257, DOI 10.1017/S0022112009993089; LISSAMAN PBS, 1983, ANNU REV FLUID MECH, V15, P223, DOI 10.1146/annurev.fl.15.010183.001255; Pier B, 1998, PHYS FLUIDS, V10, P2433, DOI 10.1063/1.869784; Inasawa A, 2013, AIAA J, V51, P1695, DOI 10.2514/1.J052203; Ikeda T, 2009, AIAA J, V47, P2658, DOI 10.2514/1.42110; Sunada S, 2002, J AIRCRAFT, V39, P331, DOI 10.2514/2.2931; McAlpine A, 1999, J SOUND VIB, V222, P753, DOI 10.1006/jsvi.1998.2085; Chomaz JM, 2005, ANNU REV FLUID MECH, V37, P357, DOI 10.1146/annurev.fluid.37.061903.175810; Desquesnes G, 2007, J FLUID MECH, V591, P155, DOI 10.1017/S0022112007007896; Pier B, 2002, J FLUID MECH, V458, P407, DOI 10.1017/S0022112002008054; Pier B, 2001, J FLUID MECH, V435, P145; ROBERTS WB, 1980, AIAA J, V18, P25, DOI 10.2514/3.50726; Okamoto M, 1996, J EXP BIOL, V199, P281; Lian YS, 2007, AIAA J, V45, P1501, DOI 10.2514/1.25812; MONKEWITZ PA, 1988, PHYS FLUIDS, V31, P999, DOI 10.1063/1.866720; ARBEY H, 1983, J FLUID MECH, V134, P33, DOI 10.1017/S0022112083003201; Anyoji M., 2011, 20110852 AIAA; Asai M, 2011, J FLUID MECH, V675, P574, DOI 10.1017/jfm.2011.37; Ikeda T., 2012, 20120700 AIAA; Ikeda T, 2012, J SOUND VIB, V331, P556, DOI 10.1016/j.jsv.2011.09.019; Itoh N, 2012, T JPN SOC AERONAUT S, V55, P356; Jones LE, 2011, J SOUND VIB, V330, P6137, DOI 10.1016/j.jsv.2011.07.009; Kojima R, 2013, J AIRCRAFT, V50, P187, DOI 10.2514/1.C031849; Kunz P. J, 2003, THESIS STANFORD U ST; Liebeck R. H, 1992, 19922735 AIAA; LONGHOUSE RE, 1977, J SOUND VIB, V53, P25, DOI 10.1016/0022-460X(77)90092-X; MAUGHMER MD, 1989, J AIRCRAFT, V26, P148, DOI 10.2514/3.45736; Paterson R. W., 1973, J AIRCRAFT, V10, P296, DOI DOI 10.2514/3.60229; Shyy W., 2008, AERODYNAMICS LOW REY, p[29, 45, 144]	31	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	AUG	2015	53	8					2256	2269		10.2514/1.J053664		14	Engineering, Aerospace	Engineering	CO7BX	WOS:000359313600015		
J	Wang, ML; Kuchiba, A; Ogino, S				Wang, Molin; Kuchiba, Aya; Ogino, Shuji			A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						causal inference; genomics; heterogeneity test; molecular diagnosis; omics; transdisciplinary epidemiology	MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; TUMOR MICROSATELLITE INSTABILITY; ISLAND METHYLATOR PHENOTYPE; COLORECTAL-CANCER RISK; LIFE-STYLE FACTORS; MLH1-93G-GREATER-THAN-A PROMOTER POLYMORPHISM; COLON-CANCER; CIGARETTE-SMOKING; BRAF MUTATIONS; ALCOHOL-CONSUMPTION	In interdisciplinary biomedical, epidemiologic, and population research, it is increasingly necessary to consider pathogenesis and inherent heterogeneity of any given health condition and outcome. As the unique disease principle implies, no single biomarker can perfectly define disease subtypes. The complex nature of molecular pathology and biology necessitates biostatistical methodologies to simultaneously analyze multiple biomarkers and subtypes. To analyze and test for heterogeneity hypotheses across subtypes defined by multiple categorical and/or ordinal markers, we developed a meta-regression method that can utilize existing statistical software for mixed-model analysis. This method can be used to assess whether the exposure-subtype associations are different across subtypes defined by 1 marker while controlling for other markers and to evaluate whether the difference in exposure-subtype association across subtypes defined by 1 marker depends on any other markers. To illustrate this method in molecular pathological epidemiology research, we examined the associations between smoking status and colorectal cancer subtypes defined by 3 correlated tumor molecular characteristics (CpG island methylator phenotype, microsatellite instability, and the B-Raf protooncogene, serine/threonine kinase (BRAF), mutation) in the Nurses' Health Study (1980-2010) and the Health Professionals Follow-up Study (1986-2010). This method can be widely useful as molecular diagnostics and genomic technologies become routine in clinical medicine and public health.	[Wang, Molin; Kuchiba, Aya; Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wang, Molin] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Wang, Molin] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Wang, Molin; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Kuchiba, Aya] Natl Canc Ctr, Ctr Res Adm & Support, Div Biostat, Tokyo 104, Japan; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Wang, ML (reprint author), Harvard Univ, Brigham & Womens Hosp, Dept Biostat, Sch Med, 677 Huntington Ave, Boston, MA 02115 USA.	stmow@channing.harvard.edu			US National Institutes of Health [R01 CA151993, R35 CA197735, P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, P50 CA127003]; Paula and Russell Agrusa Fund for Colorectal Cancer Research; Dana-Farber Cancer Institute	This work was supported by US National Institutes of Health grants (R01 CA151993 and R35 CA197735 to S.O., P01 CA87969 to S. E. Hankinson, UM1 CA186107 to M. J. Stampfer, P01 CA55075 and UM1 CA167552 to W. C. Willett, and P50 CA127003 to C. S. Fuchs); grants from The Paula and Russell Agrusa Fund for Colorectal Cancer Research (to C. S. Fuchs); and the Friends of the Dana-Farber Cancer Institute (to S. O.).	Kuller LH, 2013, AM J EPIDEMIOL, V178, P1350, DOI 10.1093/aje/kwt239; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Limsui D, 2010, J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Curtin K, 2009, INT J CANCER, V125, P158, DOI 10.1002/ijc.24338; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244; Raptis S, 2007, J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/erm.12.46, 10.1586/ERM.12.46]; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Nishihara R, 2013, AM J EPIDEMIOL, V178, P84, DOI 10.1093/aje/kws431; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Campbell PT, 2010, J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Ogino S, 2012, AM J EPIDEMIOL, V176, P659, DOI 10.1093/aje/kws226; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Rosner B, 2013, AM J EPIDEMIOL, V178, P296, DOI 10.1093/aje/kws457; Chatterjee N, 2010, BIOMETRIKA, V97, P683, DOI 10.1093/biomet/asq036; Begg CB, 2013, STAT MED, V32, P5039, DOI 10.1002/sim.5902; Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Campbell PT, 2009, GUT, V58, P661, DOI [10.1136/gut.2007.144220, 10.1136//gut.2007.144220]; Poynter JN, 2009, CANCER EPIDEM BIOMAR, V18, P2745, DOI 10.1158/1055-9965.EPI-09-0517; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Julin B, 2013, EPIDEMIOLOGY, V24, P880, DOI 10.1097/EDE.0b013e3182a777c9; Caiazza F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00019; Campbell PT, 2014, CANCER EPIDEM BIOMAR, V23, P2694, DOI 10.1158/1055-9965.EPI-14-0541; Chatterjee N, 2004, J AM STAT ASSOC, V99, P127, DOI 10.1198/016214504000000124; Eaton AM, 2005, CANCER EPIDEM BIOMAR, V14, P2023, DOI 10.1158/1055-9965.EPI-05-0131; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Jeong Inchul, 2014, J Occup Health, V55, P385; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI; Leng SG, 2011, CLIN CANCER RES, V17, P2014, DOI 10.1158/1078-0432.CCR-10-3026; Lindor NM, 2010, MOL GENET METAB, V99, P157, DOI 10.1016/j.ymgme.2009.09.010; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Perez OD, 2005, ANN NY ACAD SCI, V1062, P155, DOI 10.1196/annals.1358.018; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Phipps AI, 2011, CANCER-AM CANCER SOC, V117, P4948, DOI 10.1002/cncr.26114; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Ritz J, 2008, J STAT PLAN INFER, V138, P1919, DOI 10.1016/j.jspi.2007.07.004; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Takamoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040107; Wild CP, 2014, JNCI-J NATL CANCER I, V107, P353; Wu AH, 2001, CARCINOGENESIS, V22, P1681, DOI 10.1093/carcin/22.10.1681	62	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	AUG 1	2015	182	3					263	270		10.1093/aje/kwv040		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CO7BC	WOS:000359311500009		
J	Matsushige, T; Akiyama, Y; Okazaki, T; Shinagawa, K; Ichinose, N; Awai, K; Kurisu, K				Matsushige, T.; Akiyama, Y.; Okazaki, T.; Shinagawa, K.; Ichinose, N.; Awai, K.; Kurisu, K.			Vascular Wall Imaging of Unruptured Cerebral Aneurysms with a Hybrid of Opposite-Contrast MR Angiography	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TIME-OF-FLIGHT; BLACK-BLOOD SEQUENCES; INTRACRANIAL ANEURYSMS; VESSEL WALL; ENDOVASCULAR TREATMENT; EXPERIENCE; RUPTURE; SAFETY; BRAIN	BACKGROUND AND PURPOSE: Inflammation and degeneration of the intracranial saccular aneurysm wall play a major role in aneurysm formation, development and subsequent rupture. The aim of this study was to characterize the walls of unruptured intracranial aneurysms by using a hybrid of opposite-contrast MRA at 3T. MATERIALS AND METHODS: Fourteen consecutive patients with 17 unruptured intracranial aneurysms who initially underwent clipping surgery were prospectively evaluated. All aneurysms were scanned preoperatively by using a hybrid of opposite-contrast MRA in 3T high-resolution MR imaging. We classified intraoperative findings of atherosclerotic plaques in the aneurysms into 3 grades: grade A (major plaques), grade B (minor plaques), and grade C (no plaques). The contrast ratio of the high-intensity area was also measured relative to the background low-intensity area inside the carotid artery. RESULTS: Findings from preoperative plaque imaging of the aneurysm corresponded to the intraoperative findings in 15 of 16 aneurysms (excluding 1 that was impossible to visualize in its entirety due to anatomic reasons). Overall sensitivity and specificity of the hybrid of opposite-contrast MRA were 88.9% and 100%, respectively. During the operation, 4 aneurysms were classified as grade A; 5, as grade B; and 7, as grade C. The means of the contrast ratio for grades A, B, and C were 0.72 +/- 0.03, 0.34 +/- 0.30, and -0.02 +/- 0.09, respectively. CONCLUSIONS: The hybrid of opposite-contrast MRA can detect visible atherosclerotic plaques in the unruptured aneurysm wall, and the contrast ratio in intracranial aneurysms correlated with their presence and extent. A study including a larger series is needed to validate the diagnostic potential of this imaging technique.	[Matsushige, T.; Okazaki, T.; Shinagawa, K.; Ichinose, N.; Kurisu, K.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan; [Matsushige, T.] Univ Hosp Essen, Dept Neurosurg, D-45147 Essen, Germany; [Akiyama, Y.; Awai, K.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Diagnost Radiol, Hiroshima, Japan	Matsushige, T (reprint author), Univ Hosp Essen, Dept Neurosurg, Hufelandstr 55, D-45147 Essen, Germany.	teruteru728@hiroshima-u.ac.jp			Toshiba Medical Systems; Eizai; Bayer; Yakuhin; Diichi Sankyo	Kazuo Awai-RELATED: Grant: Toshiba Medical Systems (research grant)*; Consulting Fee or Honorarium: Toshiba Medical Systems (consultant); Grants/Grants Pending: Eizai,* Bayer,* Yakuhin*, Diichi Sankyo.* *Money paid to the institution.	Krings T, 2005, NEURORADIOLOGY, V47, P931, DOI 10.1007/s00234-005-1438-9; KOSIERKIEWICZ TA, 1994, J NEUROPATH EXP NEUR, V53, P399, DOI 10.1097/00005072-199407000-00012; Hasan DM, 2012, ARTERIOSCL THROM VAS, V32, P1032, DOI 10.1161/ATVBAHA.111.239871; Tsuchiya K, 2010, J COMPUT ASSIST TOMO, V34, P242, DOI 10.1097/RCT.0b013e3181b8aff4; Kimura T, 2009, MAGN RESON MED, V62, P450, DOI 10.1002/mrm.22021; Naggara ON, 2012, RADIOLOGY, V263, P828, DOI 10.1148/radiol.12112114; Tsuchiya K, 2010, J MAGN RESON IMAGING, V31, P56, DOI 10.1002/jmri.21997; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Kataoka K, 1999, STROKE, V30, P1396; Klein IF, 2010, STROKE, V41, P1405, DOI 10.1161/STROKEAHA.110.583534; Kotowski M, 2013, J NEUROL NEUROSUR PS, V84, P42, DOI 10.1136/jnnp-2011-302068; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Edjlali M, 2014, STROKE, V45, P3704, DOI 10.1161/STROKEAHA.114.006626; Frösen Juhana, 2013, Acta Neuropathol Commun, V1, P71, DOI 10.1186/2051-5960-1-71; Grigorian AA, 2003, J NEUROSURG, V99, P452, DOI 10.3171/jns.2003.99.3.0452; Kleinloog R, 2014, NEUROSURGERY, V75, P614, DOI 10.1227/NEU.0000000000000559; Matouk CC, 2013, NEUROSURGERY, V72, P492, DOI 10.1227/NEU.0b013e31827d1012; Morita A, 2012, NEW ENGL J MED, V366, P2474; Park JK, 2009, J MAGN RESON IMAGING, V30, P1179, DOI 10.1002/jmri.21942; Song HK, 2002, MAGNET RESON MED, V47, P616, DOI 10.1002/mrm.10094; Szelenyi A, 2011, CLIN NEUROL NEUROSUR, V113, P129, DOI 10.1016/j.clineuro.2010.10.012	23	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	AUG	2015	36	8					1507	1511		10.3174/ajnr.A4318		5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CP1TC	WOS:000359657400021		
J	Takenaka, T; Inoue, T; Miyazaki, T; Nishiyama, A; Ishii, N; Hayashi, M; Suzuki, H				Takenaka, Tsuneo; Inoue, Tsutomu; Miyazaki, Takashi; Nishiyama, Akira; Ishii, Naohito; Hayashi, Matsuhiko; Suzuki, Hiromichi			Antialbuminuric actions of calcilytics in the remnant kidney	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						calcium-sensing receptor; phosphate; vitamin D; klotho; transient receptor potential channel 6	CALCIUM-SENSING RECEPTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RENAL INJURY; KLOTHO GENE; CA2+-SENSING RECEPTOR; ANGIOTENSIN-II; RATS; EXPRESSION; PHOSPHATE; HYPERTENSION	Hyperphosphatemia accelerates the progression of chronic kidney diseases. In the present study, the effects of ronacaleret, a calcilytic agent, on renal injury were assessed in the following four groups of rats: 5/6-nephrectomized Wistar rats as a control (C group), rats treated with ronacaleret (3 mg.kg(-1).day(-1); R group), rats treated with calcitriol (30 ng.kg(-1).day(-1); V group), and rats treated with both ronacaleret and calcitriol (R+V group). Three months later, rats were euthanized under anesthesia, and the remnant kidneys were harvested for analysis. Albuminuria was lower in the R and V groups than in the C group (P<0.05). Creatinine clearance was elevated in the R and V groups compared with the C group (P<0.05). Serum Ca2+ and renal ANG II were higher in the R+V group than in the C group (P<0.05 for each), and serum phosphate was reduced in the R group compared with the C group (P<0.05). Fibroblast growth factor-23 was lower in the R group and higher in the V and R+V groups than in the C group. However, parathyroid hormone did not differ significantly among the four groups. Renal klotho expression was elevated in the R and V groups compared with the C group (P < 0.05). The present data indicate that ronacaleret preserves klotho expression and renal function with reductions in serum phosphate and albuminuria in 5/6-nephrectomized rats. Our findings demonstrate that vitamin D prevents declines in klotho expression and renal function, suppressing albuminuria.	[Takenaka, Tsuneo] Int Univ Hlth & Welf, Clin Res Ctr, Sanno Hosp, Tokyo 1070042, Japan; [Inoue, Tsutomu; Miyazaki, Takashi; Suzuki, Hiromichi] Saitama Med Univ, Iruma, Saitama, Japan; [Nishiyama, Akira] Kagawa Univ, Kagawa, Japan; [Ishii, Naohito] Kitasato Univ, Sagamihara, Kanagawa 228, Japan; [Hayashi, Matsuhiko] Keio Univ, Tokyo, Japan	Takenaka, T (reprint author), Int Univ Hlth & Welf, Clin Res Ctr, Sanno Hosp, 8-10-16 Akasaka, Tokyo 1070042, Japan.	takenaka@iuhw.ac.jp	Hayashi, Matsuhiko/J-4748-2013		Saitama Medical University Grant [20-1-2-07]; Japan Kidney Foundation Grant [JKFB10-34]; Japan Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grant [25461229]	This work was supported by Saitama Medical University Grant 20-1-2-07, Japan Kidney Foundation Grant JKFB10-34, and Japan Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grant 25461229.	JOHNSON RJ, 1992, HYPERTENSION, V19, P464; Brown EM, 2001, PHYSIOL REV, V81, P239; Mukerji N, 2007, BBA-MOL BASIS DIS, V1772, P859, DOI 10.1016/j.bbadis.2007.03.005; Takenaka T, 2012, AM J PHYSIOL-REG I, V303, pR495, DOI 10.1152/ajpregu.00217.2012; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Montenegro J, 2012, NEPHROLOGY, V17, P26, DOI 10.1111/j.1440-1797.2011.01530.x; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; BIDANI AK, 1990, KIDNEY INT, V38, P28, DOI 10.1038/ki.1990.163; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Topala CN, 2009, CELL CALCIUM, V45, P331, DOI 10.1016/j.ceca.2008.12.003; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Finne K, 2014, NEPHROL DIAL TRANSPL, V29, P2217, DOI 10.1093/ndt/gfu268; Hirahara I, 2009, NEPHROL DIAL TRANSPL, V24, P437, DOI 10.1093/ndt/gfn495; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; Guo Q, 2014, HYPERTENS RES, V37, P116, DOI 10.1038/hr.2013.129; Deb DK, 2011, J BIOL CHEM, V286, P32011, DOI 10.1074/jbc.M111.269118; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Wada M, 1997, J CLIN INVEST, V100, P2977, DOI 10.1172/JCI119851; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Yang HC, 2009, J AM SOC NEPHROL, V20, P2380, DOI 10.1681/ASN.2008111138; Balan G, 2009, BIOORG MED CHEM LETT, V19, P3328, DOI 10.1016/j.bmcl.2009.04.044; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Inoue T, 2015, KIDNEY INT, V87, P233, DOI 10.1038/ki.2014.235; Kriz W, 2003, NEPHROL DIAL TRANSPL, V18, P39, DOI 10.1093/ndt.gfg1064; Kurdian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032516; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Miyazaki T, 2009, TRACE NUTR RES, V26, P74; Nagasawa Y, 2000, KIDNEY INT, V57, P717, DOI 10.1046/j.1523-1755.2000.00894.x; Oh J, 2011, KIDNEY INT, V80, P483, DOI 10.1038/ki.2011.105; Okada H, 2000, AM J PHYSIOL-RENAL, V278, pF110; Ortiz-Capisano MC, 2013, AM J PHYSIOL-RENAL, V304, pF248, DOI 10.1152/ajprenal.00451.2012; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; Takenaka T, 2013, INT J HYPERTENS, V2013; Takenaka T, 2014, KIDNEY BLOOD PRESS R, V39, P17, DOI 10.1159/000355773; Takenaka T, 2013, PFLUG ARCH EUR J PHY, V465, P935, DOI 10.1007/s00424-013-1226-z; Takenaka T, 2008, KIDNEY INT, V73, P415, DOI 10.1038/sj.ki.5002673; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Zhang H, 2008, KIDNEY INT, V74, P732, DOI 10.1038/ki.2008.244	45	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	AUG 1	2015	309	3					F216	F226		10.1152/ajprenal.00003.2015		11	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	CP2TZ	WOS:000359731400004		
J	Tanaka, K; Kanazawa, I; Yamasaki, H; Hasegawa, H; Ichida, K; Sugimoto, T				Tanaka, Ken-ichiro; Kanazawa, Ippei; Yamasaki, Haruka; Hasegawa, Hiroshi; Ichida, Kimiyoshi; Sugimoto, Toshitsugu			Xanthinuria Type I With a Novel Mutation of Xanthine Dehydrogenase	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Letter							HEREDITARY XANTHINURIA; ARTHRITIS; PATIENT		[Tanaka, Ken-ichiro; Kanazawa, Ippei; Yamasaki, Haruka; Hasegawa, Hiroshi; Ichida, Kimiyoshi; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med, Matsue, Shimane, Japan	Tanaka, K (reprint author), Shimane Univ, Fac Med, Dept Internal Med, Matsue, Shimane, Japan.	ippei.k@med.shimane-u.ac.jp	Kanazawa, Ippei/F-8609-2010				Ichida K, 2012, INT J MOL SCI, V13, P15475, DOI 10.3390/ijms131115475; Kudo M, 2008, PHARMACOGENET GENOM, V18, P243, DOI 10.1097/FPC.0b013e3282f55e2e; BRADFORD MJ, 1969, AM J MED, V46, P137, DOI 10.1016/0002-9343(69)90065-5; Ichida K, 1997, J CLIN INVEST, V99, P2391, DOI 10.1172/JCI119421; Jurecka A, 2010, J INHERIT METAB DIS, V33, pS21, DOI 10.1007/s10545-009-9011-z; KAWACHI M, 1992, NEPHRON, V61, P428, DOI 10.1159/000186961; KOJIMA T, 1984, CLIN CHIM ACTA, V137, P189; Mraz M, 2015, UROLITHIASIS, V43, P61, DOI 10.1007/s00240-014-0734-4	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-9629	1538-2990		AM J MED SCI	Am. J. Med. Sci.	AUG	2015	350	2					155	156		10.1097/MAJ.0000000000000498		2	Medicine, General & Internal	General & Internal Medicine	CP4JO	WOS:000359848000018		
J	Sasagawa, E; Aiga, H; Soriano, EYC; Marroquin, BLC; Ramirez, MAH; de Aguilar, AVG; Chevez, JER; Hernandez, HMR; Cedillos, RA; Misago, C; Kita, K				Sasagawa, Emi; Aiga, Hirotsugu; Corado Soriano, Edith Yanira; Cuyuch Marroquin, Blanca Leticia; Hernandez Ramirez, Marta Alicia; Guevara de Aguilar, Ana Vilma; Romero Chevez, Jose Eduardo; Ramos Hernandez, Hector Manuel; Antonio Cedillos, Rafael; Misago, Chizuru; Kita, Kiyoshi			Mother-to-Child Transmission of Chagas Disease in El Salvador	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TRYPANOSOMA-CRUZI INFECTION; LATIN-AMERICAN WOMEN; PREGNANT-WOMEN; RISK-FACTORS; BLOOD; DIAGNOSIS; BOLIVIA; PREVALENCE; NEWBORNS; TESTS	To estimate the incidence (any mother to child) and rate (from seropositive mother to child) of mother-to-child transmission of Trypanosoma cruzi, a serological census was conducted, targeting pregnant women and infants born to seropositive mothers, in four municipalities of El Salvador. Of 943 pregnant women, 36 (3.8%) were seropositive for T. cruzi. Of 36, 32 proceeded to serological tests of their infants when they became 6-8 months of age. Six infants seropositive at the age of 6-8 months further proceeded to second-stage serological test at the age of 9-16 months. As the result, one infant was congenitally infected. Thus, serological tests at the age of 6-8 months produced five false positives. To ensure earlier effective medication only for true positives, identification of seropositive infants at the age of 9-16 months is crucial. Incidence and rate of mother-to-child transmission were 0.14 (per 100 person-years) and 4.0%, respectively. Estimated number of children infected through mother-to-child transmission in El Salvador (170 per year) was much higher than that of human immunodeficiency virus (HIV; seven per year). It is recommended that serological testing for T. cruzi be integrated into those for HIV and syphilis as part of antenatal care package.	[Sasagawa, Emi; Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Sch Int Hlth, Grad Sch Med, Tokyo 1130033, Japan; [Aiga, Hirotsugu] Japan Int Cooperat Agcy, Dept Human Dev, Tokyo, Japan; [Aiga, Hirotsugu] George Washington Univ, Dept Global Hlth, Milken Inst Sch Publ Hlth, Washington, DC USA; [Corado Soriano, Edith Yanira] Minist Salud El Salvador MINSAL, Secc Epidemiol, SIBASI Sonsonate, Sonsonate, El Salvador; [Cuyuch Marroquin, Blanca Leticia] Minist Salud El Salvador MINSAL, Programa Materno Infantil, Direcc Reg Salud Zona Occidente, Santa Ana, El Salvador; [Hernandez Ramirez, Marta Alicia; Guevara de Aguilar, Ana Vilma] Minist Salud El Salvador MINSAL, Unidad Vigilancia Lab, San Salvador, El Salvador; [Romero Chevez, Jose Eduardo] Minist Salud El Salvador MINSAL, Unidad Vigilancia Enfermedades Vectorizadas, San Salvador, El Salvador; [Ramos Hernandez, Hector Manuel] Minist Salud El Salvador MINSAL, Direcc Vigilancia Sanitaria, San Salvador, El Salvador; [Antonio Cedillos, Rafael] UES, CIC, San Salvador, El Salvador; [Misago, Chizuru] Tsuda Coll, Dept Int & Cultural Studies, Tokyo, Japan	Sasagawa, E (reprint author), Univ Tokyo, Dept Biomed Chem, Sch Int Hlth, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	e-sasagawa@umin.ac.jp; aiga.hirotsugu@jica.go.jp; edith_corado@yahoo.es; cuyuch@gmail.com; martah_ramirez@yahoo.es; anavilmadeaguilar@yahoo.es; eromerochevez@yahoo.es; el.cadejo@gmail.com; rcedillos@navegante.com.sv; cmisago@tsuda.ac.jp; kitak@m.u-tokyo.ac.jp			Ministry of Health, El Salvador; Japan International Cooperation Agency (JICA)	This work was supported by the Ministry of Health, El Salvador, and Japan International Cooperation Agency (JICA).	Aiga H, 2012, AM J TROP MED HYG, V86, P972, DOI 10.4269/ajtmh.2012.11-0652; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Gamboa-Leon R, 2014, AM J TROP MED HYG, V91, P348, DOI 10.4269/ajtmh.13-0527; Verani JR, 2009, AM J TROP MED HYG, V80, P410; Barona-Vilar C, 2012, EPIDEMIOL INFECT, V140, P1896, DOI 10.1017/S0950268811002482; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Salas NA, 2007, TROP MED INT HEALTH, V12, P1498, DOI 10.1111/j.1365-3156.2007.01958.x; Carlier Y, 2010, ELSEV INSIGHT, P539, DOI 10.1016/B978-0-12-384876-5.00022-8; Apt W, 2010, DRUG DES DEV THER, V4, P243, DOI 10.2147/DDDT.S8338; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Cedillos RA, 2011, MINERVA REV LINEA CI, V2, P35; Chippaux JP, 2009, TROP MED INT HEALTH, V15, P87; Dias JCP, 1999, MEM I OSWALDO CRUZ, V94, P103, DOI 10.1590/S0074-02761999000700011; Di Pentima MC, 1999, CLIN INFECT DIS, V28, P1281, DOI 10.1086/514790; Gamboa-Leon R, 2011, J PARASITOL, V97, P338, DOI 10.1645/GE-2545.1; Luquetti AO, 2003, DIAGN MICR INFEC DIS, V46, P265, DOI 10.1016/S0732-8893(03)00051-8; Merino FJ, 2013, REV ESP QUIM, V26, P253; Ministerio de Economia de El Salvador, 2008, 6 CENS POBL V VIV 20; Ministerio de Salud de El Salvador, 2011, NORM TECN PREV CONTR, V2nd; Ministerio de Salud de El Salvador, 2011, INFORM NAC EST SIT V; Ministerio de Salud de El Salvador Japan International Cooperation Agency, 2010, INF EV FIN PROJ CONT; Olivera MA, 2006, ARCH MED RES, V37, P774; PAHO, 2006, OPSHDMCD42506 PAHO; PAHO, 2013, PROGR REP EL MOTH TO; Ponce C, 2005, J CLIN MICROBIOL, V43, P5065, DOI 10.1128/JCM.43.10.5065-5068.2005; Sanchez NO, 2005, PEDIATRICS, V115, pe668; Sasagawa E, 2014, J INFECT DEV COUNTR, V13, P1029; Sasagawa E, 2015, TROP MED INT HEALTH, V20, P268, DOI 10.1111/tmi.12440; Schmunis GA, 2008, AM J TROP MED HYG, V79, P803; Schmunis GA, 2001, AM J TROP MED HYG, V65, P924; Schmunis GA, 1998, EMERG INFECT DIS, V4, P5; Sosa-Estani S, 2008, AM J TROP MED HYG, V79, P755; UNICEF (United Nations Children's Fund), 2013, STAT WORLDS CHILDR C; World Health Organization, 2012, ACC WORK OV GLOB IMP; Yadon ZE, 2009, AM J TROP MED HYG, V81, P927, DOI 10.4269/ajtmh.2009.09-0257	35	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	AUG	2015	93	2					326	333		10.4269/ajtmh.14.0425		8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CO7GK	WOS:000359327400025		
J	Barroso, PA; Marco, JD; Locatelli, FM; Cardozo, RM; Hoyos, CL; Mora, MC; Bustos, MFG; Lopez-Quiroga, I; Mimori, T; Gentile, AG; Barrio, AB; Korenaga, M; Hashiguchi, Y; Basombrio, MA				Barroso, Paola A.; Marco, Jorge D.; Locatelli, Fabricio M.; Cardozo, Ruben M.; Hoyos, Carlos L.; Mora, Maria C.; Garcia Bustos, Maria F.; Lopez-Quiroga, Ines; Mimori, Tatsuyuki; Gentile, Alberto G.; Barrio, Alejandra B.; Korenaga, Masataka; Hashiguchi, Yoshihisha; Basombrio, Miguel A.			Visceral Leishmaniasis Caused by Leishmania infantum in Salta, Argentina: Possible Reservoirs and Vectors	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							AMERICAN TEGUMENTARY LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; MULTILOCUS ENZYME ELECTROPHORESIS; CYTOCHROME-B GENE; LUTZOMYIA-LONGIPALPIS; CANINE LEISHMANIASIS; IDENTIFICATION; EPIDEMIOLOGY; INFECTION; TRANSMISSION	Cases of human visceral leishmaniasis (HVL) were not recorded until recently in the Chaco region of northwestern Argentina. Dogs were surveyed at the sites of infection of two HVL index cases in the Chaco region of Salta province. Canine cases (CanL) were diagnosed by two parasitological methods, two molecular methods targeting mini- and maxicircle DNA, and immunochromatographic dipstick. Among 77 dogs studied, 10 (13%) were found infected with Leishmania spp. In seven dogs and two humans, the infecting species was typed as Leishmania (Leishmania) infantum. The same genotype was detected in the human and two of the CanL. Although several diagnostic methods displayed weak or moderate agreement, the concordance values for serology versus maxicircle PCR were very good (Kappa index = 0.84). Sandflies captured in the area were identified as Lutzomyia migonei and Lu. cortelezziau. sallesi (cortelezzii complex). The focal appearance of leishirnaniasis in dogs and humans in a sylvatic region and its relatively low prevalence of infection suggests that L. (L.) infantum transmission to dogs and humans may, in this region, stem from sylvatic reservoirs.	[Barroso, Paola A.; Marco, Jorge D.; Mora, Maria C.; Garcia Bustos, Maria F.; Barrio, Alejandra B.; Basombrio, Miguel A.] Univ Nacl Salta, Inst Patol Expt, CONICET, RA-4400 Salta, Argentina; Univ Nacl Salta, Catedra Microbiol, Fac Ciencias Exactas, RA-4400 Salta, Argentina; Kochi Univ, Dept Parasitol, Kochi Med Sch, Kochi 780, Japan; Minist Salud Publ, Direcc Epidemiol, Salta, Argentina; [Mimori, Tatsuyuki] Kumamoto Univ, Dept Microbiol, Fac Life Sci, Grad Sch Hlth Sci, Kumamoto 860, Japan; [Hashiguchi, Yoshihisha] Univ Cent Ecuador, Ctr Biomed, Quito, Ecuador	Basombrio, MA (reprint author), Univ Nacl Salta, Inst Patol Expt, Ave Bolivia 5150, RA-4400 Salta, Argentina.	paobarar@yahoo.com.ar; diegomarcoar@yahoo.com.ar; fm.locatelli@gmail.com; cardozorm@gmail.com; carloshoyos@gmail.com; mariaceliamora@yahoo.com.ar; mariafernandagarcia2008@yahoo.com.ar; ineslq@hotmail.com; mimori@kumamoto-u.ac.jp; agentile@salta.gov.ar; aleba05@yahoo.com.ar; korenaga@kochi-u.ac.jp; yhashiguchi42@yahoo.co.jp; basombri@unsa.edu.ar			National Agency for Science and Technology, Argentina [PICT-2009-0135]; Research Council of the National University of Salta [2041]; Japanese Society for the Promotion of Science (JSPS) [KAKENHI 18-06242]; Ministry of Education, Science, Culture and Sports of Japan [23256002]	This work was supported by grant PICT-2009-0135 of the National Agency for Science and Technology, Argentina, grant no. 2041 of Research Council of the National University of Salta, grant KAKENHI 18-06242 of Japanese Society for the Promotion of Science (JSPS), and grant no. 23256002 of the Ministry of Education, Science, Culture and Sports of Japan.	Santini MS, 2012, MEM I OSWALDO CRUZ, V107, P767, DOI 10.1590/S0074-02762012000600010; Bravo AG, 2013, MEM I OSWALDO CRUZ, V108, P1071, DOI 10.1590/0074-0276130358; Rosa J, 2012, ACTA TROP, V123, P128, DOI 10.1016/j.actatropica.2012.04.008; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Silva ES, 2005, TRENDS PARASITOL, V21, P550, DOI 10.1016/j.pt.2005.09.008; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024; Padilla AM, 2002, VET PARASITOL, V110, P1, DOI 10.1016/S0304-4017(02)00330-8; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Asato Y, 2009, EXP PARASITOL, V121, P352, DOI 10.1016/j.exppara.2008.12.013; Foulet F, 2007, J CLIN MICROBIOL, V45, P2110, DOI 10.1128/JCM.02555-06; Barrio A, 2012, EMERG INFECT DIS, V18, P354, DOI [10.3291/eid1802.110924, 10.3201/eid1802.110924]; Marco JD, 2005, AM J TROP MED HYG, V72, P606; Barrouin-Melo SM, 2006, VET J, V171, P331, DOI 10.1016/j.tvjl.2004.11.010; Marco JD, 2006, AM J TROP MED HYG, V75, P256; Barrio A, 2007, AM J TROP MED HYG, V77, P636; Basombrio MA, 2000, ANIM BIOL, V9, P131; Higuchi H, 1990, PERKIN ELMER CETUS A, V2, P1; Kato H, 2005, AM J TROP MED HYG, V72, P87; Marco JD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-191; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2010, GUIDE CARE USE LAB A, V8th, P248; Quinnell RJ, 2009, PLOS NEGLECT TROP D, V7, pe1992; Souza TD, 2014, VET PARASITOL, V200, P233, DOI 10.1016/j.vetpar.2013.12.025; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	28	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	AUG	2015	93	2					334	339		10.4269/ajtmh.14-0267		6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CO7GK	WOS:000359327400026		
J	Yamanaka, T; Kyono, A; Nakamoto, Y; Kharlamova, S; Struzhkin, VV; Gramsch, SA; Mao, HK; Hemley, RJ				Yamanaka, Takamitsu; Kyono, Atsushi; Nakamoto, Yuki; Kharlamova, Svetlana; Struzhkin, Viktor V.; Gramsch, Stephen A.; Mao, Ho-Kwang; Hemley, Russell J.			New structure of high-pressure body-centered orthorhombic Fe2SiO4	AMERICAN MINERALOGIST			English	Article						New high-pressure structure; Fe2SiO4 ringwoodite; X-ray emission spectra; spin transition; martensitic transition	X-RAY-EMISSION; SPINEL SOLID-SOLUTIONS; LOWER-MANTLE; SYSTEM MG2SIO4-FE2SIO4; PHASE-RELATIONS; SEISMIC DISCONTINUITY; CRYSTAL-STRUCTURES; HIGH-TEMPERATURE; SPECTROSCOPY; OLIVINE	A structural change in Fe(2)SiO(4)spinel (ringwoodite) has been found by synchrotron powder diffraction study and the structure of a new high-pressure phase was determined by Monte-Carlo simulation method and Rietveld profile fitting of X-ray diffraction data up to 64 GPa at ambient temperature. A transition from the cubic spinel structure to a body centered orthorhombic phase (I-Fe2SiO4) with space group Imma and Z = 4 was observed at approximately 34 GPa. The structure of I-Fe2SiO4 has two crystallographically independent FeO6 octahedra. Iron resides in two different sites of sixfold coordination: Fe1 and Fe2, which are arranged in layers parallel to (101) and (011) and are very similar to the layers of FeO6 octahedra in the spinel structure. Silicon is located in the sixfold coordination in I-Fe2SiO4. The transformation to the new high-pressure phase is reversible under decompression at ambient temperature. A martensitic transformation of each slab of the spinel structure with translation vector <1/8 over right arrow 1/8 over right arrow 1/8 over right arrow> generates the I-Fe2SiO4 structure. Laser heating of I-Fe2SiO4 at 1500 K results in a decomposition of the material to rhombohedral FeO and SiO2 stishovite. FeK beta X-ray emission measurements at high pressure up to 65 GPa show that the transition from a high spin (HS) to an intermediate spin (IS) state begins at 17 GPa in the spinel phase. The IS electron spin state is gradually enhanced with pressure. The Fe2+ ion at the octahedral site changes the ion radius under compression at the low spin, which results in the changes of the lattice parameter and the deformation of the octahedra of the spinel structure. The compression curve of the lattice parameter of the spinet is discontinuous at similar to 20 GPa. The spin transition induces an isostructural change.	[Yamanaka, Takamitsu; Kyono, Atsushi; Nakamoto, Yuki; Kharlamova, Svetlana; Struzhkin, Viktor V.; Gramsch, Stephen A.; Mao, Ho-Kwang; Hemley, Russell J.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Mao, Ho-Kwang] Carnegie Inst Sci, Geophys Lab, High Pressure Collaborat Access Team, Argonne, IL 60439 USA; [Kyono, Atsushi] Univ Tsukuba, Grad Sch Life & Environm Sci, Div Earth Evolut Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakamoto, Yuki] Osaka Univ, Ctr Quantum Sci & Technol Extreme Condit, Toyonaka, Osaka 5608531, Japan	Yamanaka, T (reprint author), Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA.	tyamanaka@ciw.edu			Carnegie/DOE Alliance Center (CDAC) [DE-FC52-08NA28554]; DOE-BES Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science [DE-FG02-06ER46280]	We express our great thanks to E. Ito of Okayama University, Japan, for providing us Fe<INF>2</INF>SiO<INF>4</INF> spinet samples. This work was sponsored by the Carnegie/DOE Alliance Center (CDAC, DE-FC52-08NA28554). Support from DOE-BES (DE-FG02-06ER46280) Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science. The present investigation was also performed under the auspices of KEK proposal no. 2004G229 for powder diffraction at BL-13A and BL-18C of the Photon Factory, Tsukuba, Japan.	AKIMOTO SI, 1968, J GEOPHYS RES, V73, P1467, DOI 10.1029/JB073i004p01467; BIRCH F, 1947, PHYS REV, V71, P809, DOI 10.1103/PhysRev.71.809; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; Badro J, 1999, PHYS REV LETT, V83, P4101, DOI 10.1103/PhysRevLett.83.4101; RINGWOOD AE, 1988, NATURE, V331, P131, DOI 10.1038/331131a0; PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957; Fei YW, 1999, AM MINERAL, V84, P203; Boultif A, 2004, J APPL CRYSTALLOGR, V37, P724, DOI 10.1107/S0021889804014876; Shim SH, 2001, NATURE, V411, P571, DOI 10.1038/35079053; MADON M, 1983, PHYS EARTH PLANET IN, V33, P31, DOI 10.1016/0031-9201(83)90005-5; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Irifune T, 1998, SCIENCE, V279, P1698, DOI 10.1126/science.279.5357.1698; PRICE GD, 1982, NATURE, V296, P729, DOI 10.1038/296729a0; Kiefer B, 1997, GEOPHYS RES LETT, V24, P2841, DOI 10.1029/97GL02975; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Woodland AB, 2000, CONTRIB MINERAL PETR, V139, P734, DOI 10.1007/s004100000168; Vanko G, 2006, J PHYS CHEM B, V110, P11647, DOI 10.1021/jp0615961; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Lin JF, 2010, AM MINERAL, V95, P1125, DOI 10.2138/am.2010.3495; ITO E, 1987, NATURE, V328, P514, DOI 10.1038/328514a0; Mattila A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196404; Li J, 2006, PHYS CHEM MINER, V33, P575, DOI 10.1007/s00269-006-0105-y; Armentrout M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046949; Bassett W. A., 1972, Physics of the Earth and Planetary Interiors, V6, DOI 10.1016/0031-9201(72)90048-9; BURNLEY PC, 1991, J GEOPHYS RES-SOLID, V96, P425, DOI 10.1029/90JB01937; Derzsi M, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/10/105401; Ding Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045508; FEI Y, 1991, J GEOPHYS RES-SOLID, V96, P2157, DOI 10.1029/90JB02164; Greenberg E, 2011, AM MINERAL, V96, P833, DOI 10.2138/am.2011.3647; HAZEN RM, 1993, SCIENCE, V259, P206, DOI 10.1126/science.259.5092.206; Izumi F., 2000, MATER SCI FORUM, V321-324, P198; Kontny A, 2004, PHYS CHEM MINER, V31, P28, DOI 10.1007/s00269-003-0333-3; LEVEN JH, 1981, NATURE, V289, P234, DOI 10.1038/289234a0; Li L, 2007, AM MINERAL, V92, P174, DOI 10.2138/am.2007.2210; Lin JF, 2005, J SYNCHROTRON RADIAT, V12, P637, DOI 10.1107/S0909049505020741; Liu Q, 2008, HIGH PRESSURE RES, V28, P405, DOI 10.1080/08957950802296287; MA CB, 1975, Z KRISTALLOGR, V141, P126, DOI 10.1524/zkri.1975.141.1-2.126; MARUMO F, 1974, ACTA CRYSTALLOGR B, V30, P1904, DOI 10.1107/S0567740874006078; MARUMO F, 1977, ACTA CRYSTALLOGR B, V33, P713, DOI 10.1107/S0567740877004531; Matsuzaka K, 2000, PHYS CHEM MINER, V27, P310, DOI 10.1007/s002690050260; MORIMOTO N, 1974, AM MINERAL, V59, P475; Morimoto N., 1970, PHYS EARTH PLANET IN, V3, P161, DOI 10.1016/0031-9201(70)90049-X; Nestola F, 2011, MINERAL MAG, V75, P2649, DOI 10.1180/minmag.2011.075.5.2649; Ohtaka O, 1997, PHYS CHEM MINER, V24, P555, DOI 10.1007/s002690050072; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Woodland A., 2010, GEOPH RES ABSTR, V12; YAGI T, 1974, AM MINERAL, V59, P486; YAGI T, 1987, J GEOPHYS RES-SOLID, V92, P6207, DOI 10.1029/JB092iB07p06207; Yamanaka T, 2001, PHYS CHEM MINER, V28, P110, DOI 10.1007/s002690000137; Yamanaka T, 2013, AM MINERAL, V98, P736, DOI 10.2138/am.2013.4182; Yamanaka T, 2001, PHYS CHEM MINER, V28, P102, DOI 10.1007/s002690000135	53	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	AUG-SEP	2015	100	8-9					1736	1743		10.2138/am-2015-4744		8	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CO9RB	WOS:000359512100007		
J	Kyono, A; Gramsch, SA; Nakamoto, Y; Sakata, M; Kato, M; Tamura, T; Yamanaka, T				Kyono, Atsushi; Gramsch, Stephen A.; Nakamoto, Yuki; Sakata, Masafumi; Kato, Masato; Tamura, Tomoya; Yamanaka, Takamitsu			High-pressure behavior of cuprospinel CuFe2O4: Influence of the Jahn-Teller effect on the spinel structure	AMERICAN MINERALOGIST			English	Article						Cuprospinel; CuFe2O4; high-pressure single-crystal synchrotron X-ray diffraction; Jahn-Teller effect	TRANSITION ZONE; PHASE-TRANSITION; CRYSTAL-CHEMISTRY; CATION DISTRIBUTION; OXYGEN FUGACITY; SOLID-SOLUTIONS; MANTLE; MAGNETITE; DISCONTINUITIES; TOPOGRAPHY	The Jahn-Teller effect at Cu2+ in cuprospinel CuFe2O4 was investigated using high-pressure single-crystal synchrotron X-ray diffraction techniques at beamline BL10A at the Photon Factory, KEK, Japan. Six data sets were collected in the pressure range from ambient to 5.9 GPa at room temperature. Structural refinements based on the data were performed at 0.0, 1.8, 2.7, and 4.6 GPa. The unit-cell volume of cuprospinel decreases continuously from 590.8(6) to 579.5(8) angstrom(3) up to 3.8 GPa. Least-squares fitting to a third-order Birch-Murnaghan equation of state yields the zero-pressure volume V-0 = 590.7(1) angstrom(3) and bulk modulus K-0 = 188.1(4.4) GPa with K' fixed at 4.0. The structural formula determined by electron microprobe analysis and site occupancy refinement is represented as (T)(Fe0.903+Cu0.102+)(M)(Fe1.103+Fe0.402+Cu0.502+)O-4. Most of the Cu2+ are preferentially distributed onto the octahedrally coordinated (M) site of the spine! structure. With pressure, the arrangement of the oxygen atoms around the M cation approaches a regular octahedron. This leads to an increase in the electrostatic repulsion between the coordinating oxygen ions and the 3d(z)(2) orbital of Cu-M(2+). At 4.6 GPa, a cubic-tetragonal phase transition is indicated by a splitting of the a axis of the cubic structure into a smaller a axis and a longer c axis, with unit-cell parameters a = 5.882(1) angstrom and c = 8.337(1) angstrom. The tetragonal structure with space group I4(1)/amd was refined to R1= 0.0332 and wR2 = 0.0703 using 38 observed reflections. At the M site, the two M-0 bonds parallel to the c-axis direction of the unit cell are stretched with respect to the four M-O bonds parallel to the a-b plane, which leads to an elongated octahedron along the c-axis. The cubic-to-tetragonal transition induced by the Jahn-Teller effect at Cu2+ is attributable to this distortion of the CuO6 octahedron and involves Cu 3d(z)(2) orbital, ab initio quantum chemical calculations support the observation. At the tetrahedrally coordinated (7) site, on the other hand, the tetrahedral O-T-O bond angle increases from 109.47 degrees to 111.7(7)degrees, which generates a compressed tetrahedral geometry along the c-axis. As a result of the competing distortions between the elongated octahedron and the compressed tetrahedron, the a unit-cell parameter is shortened with respect to the c unit-cell parameter, giving a c/a' ratio (a' = root 2 a) slightly greater than unity as referred to cubic lattice (c/a' = 1.002). The c/a' value increases to 1.007 with pressure, suggesting further distortions of the elongated octahedron and compressed tetrahedron.	[Kyono, Atsushi; Kato, Masato; Tamura, Tomoya] Univ Tsukuba, Grad Sch Life & Environm Sci, Div Earth Evolut Sci, Tsukuba, Ibaraki 3058572, Japan; [Gramsch, Stephen A.; Yamanaka, Takamitsu] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Nakamoto, Yuki; Sakata, Masafumi] Osaka Univ, Ctr Sci & Technol Extreme Condit, Osaka 5608531, Japan	Kyono, A (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Div Earth Evolut Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	kyono@geol.tsukuba.ac.jp			Japan Society for the Promotion of Science [24740352]	The authors thank F. Bosi and two anonymous reviewers for their many constructive and helpful comments that significantly improved the quality of this paper. H. Kojitani is acknowledged for editorial handling and useful suggestions. The authors thank N. Chino for kindly providing technical help with the EPMA analyses. This work was supported by a Grant-in-Aid for Young Scientists (13) from the Japan Society for the Promotion of Science (project no. 24740352). The synchrotron XRD measurements were performed at the KEK-PF with the approval of the Photon Factory Program Advisory Committee (proposal no. 2013G046 and no. 2013G554).	Angel RJ, 2003, J APPL CRYSTALLOGR, V36, P295, DOI 10.1107/S0021889803001134; Angel R.J., 2002, EOSFIT V5 2; Canil D, 1996, J PETROL, V37, P609, DOI 10.1093/petrology/37.3.609; Shoemaker DP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214107; SACK RO, 1991, CONTRIB MINERAL PETR, V106, P474, DOI 10.1007/BF00321989; Angel RJ, 2007, J APPL CRYSTALLOGR, V40, P26, DOI 10.1107/S0021889806045523; Asbrink S, 1999, PHYS REV B, V60, P12651, DOI 10.1103/PhysRevB.60.12651; Kennedy BJ, 2008, J SOLID STATE CHEM, V181, P2227, DOI 10.1016/j.jssc.2008.05.018; Lin Y, 2011, J PHYS CHEM C, V115, P9844, DOI 10.1021/jp112289h; Barnes SJ, 2001, J PETROL, V42, P2279, DOI 10.1093/petrology/42.12.2279; Suchomel MR, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.054406; SACK RO, 1991, AM MINERAL, V76, P827; Hetenyi G, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040171; Balagurov AM, 2013, CRYSTALLOGR REP+, V58, P710, DOI 10.1134/S1063774513040044; Cornwell DG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047575; KUNDIG W, 1969, SOLID STATE COMMUN, V7, P223, DOI 10.1016/0038-1098(69)90729-7; Harrison RJ, 1998, AM MINERAL, V83, P1092; RIGDEN SM, 1991, NATURE, V354, P143, DOI 10.1038/354143a0; Bosi F, 2009, AM MINERAL, V94, P181, DOI 10.2138/am.2009.3002; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Lakhani VK, 2011, SOLID STATE SCI, V13, P539, DOI 10.1016/j.solidstatesciences.2010.12.023; Tsuda K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180102; Gu Y, 1998, EARTH PLANET SC LETT, V157, P57, DOI 10.1016/S0012-821X(98)00027-2; Li XQ, 2003, EARTH PLANET SC LETT, V216, P679, DOI 10.1016/S0012-821X(03)00555-7; Crottaz O, 1997, J MATER CHEM, V7, P143, DOI 10.1039/a604758k; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; Dollase WA, 1997, ACTA CRYSTALLOGR C, V53, P657, DOI 10.1107/S0108270197000486; Helffrich G, 2000, REV GEOPHYS, V38, P141, DOI 10.1029/1999RG000060; DUNITZ JD, 1960, ADV INORG CHEM, V2, P1, DOI 10.1016/S0065-2792(08)60186-7; Nii Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125142; DUNITZ JD, 1957, J PHYS CHEM SOLIDS, V3, P20, DOI 10.1016/0022-3697(57)90043-4; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Lenaz D, 2004, PHYS CHEM MINER, V31, P633, DOI 10.1007/s00269-004-0420-0; FINGER LW, 1986, PHYS CHEM MINER, V13, P215, DOI 10.1007/BF00308271; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; McCammon C, 2004, CONTRIB MINERAL PETR, V148, P55, DOI 10.1007/s00410-004-0583-1; Waskowska A, 2001, J PHYS-CONDENS MAT, V13, P2549, DOI 10.1088/0953-8984/13/11/311; ROBINSON K, 1971, SCIENCE, V172, P567, DOI 10.1126/science.172.3983.567; Lavina B, 2002, PHYS CHEM MINER, V29, P10, DOI 10.1007/s002690100198; Arima T, 2007, J MAGN MAGN MATER, V310, P807, DOI 10.1016/j.jmmm.2006.10.342; Ballhausen C.J., 1962, INTRODUCTION LIGAND; Bosi F, 2002, AM MINERAL, V87, P1121; Bosi F, 2010, AM MINERAL, V95, P602, DOI 10.2138/am.2010.3336; Bush AA, 2013, INORG MATER+, V49, P296, DOI 10.1134/S0020168513030011; Choi HC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.172103; Dennington R., 2009, GAUSS VIEW VER 5; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gabal MA, 2011, POLYHEDRON, V30, P1185, DOI 10.1016/j.poly.2011.01.032; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; ICDD, 2013, POWD DIFFR FIL DAT I; Irvine T.N., 1967, CAN J EARTH SCI, V4, P71, DOI DOI 10.1139/E67-004; Irvine T.N., 1965, CAN J EARTH SCI, V2, P648, DOI DOI 10.1139/E65-046; ISHIKAWA Y, 1971, PHYS REV LETT, V26, P1335, DOI 10.1103/PhysRevLett.26.1335; Ivanov VV, 2001, INORG MATER+, V37, P839, DOI 10.1023/A:1017999702037; Kennedy B.J., 1999, MAT RES B, V34, P135; Kudoh Y., 2007, J MINERALOGICAL PETR, V75, P2649; Kyono A, 2012, PHYS CHEM MINER, V39, P131, DOI 10.1007/s00269-011-0468-6; Kyono A, 2011, AM MINERAL, V96, P1193, DOI 10.2138/am.2011.3707; Matsubara S., 1979, MINERAL J, V9, P383, DOI 10.2465/minerj.9.383; MEXMAIN J, 1971, ANN CHIMIE, V1971; Nestola F, 2011, MINERAL MAG, V75, P2649, DOI 10.1180/minmag.2011.075.5.2649; Ohtani S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/17/176003; Pasternak MP, 2004, J PHYS CHEM SOLIDS, V65, P1531, DOI 10.1016/j.jpcs.2003.12.013; PETERSEN N, 1993, GEOPHYS RES LETT, V20, P281, DOI 10.1029/92GL02961; PRINCE E, 1956, ACTA CRYSTALLOGR, V9, P1025, DOI 10.1107/S0365110X56002977; Rozenberg GK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.020102; Schmerr N, 2011, EARTH PLANET SC LETT, V311, P101, DOI 10.1016/j.epsl.2011.09.002; Sheldrick G.M., 1997, SHELXL97 RELEASE 97; Thapa D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/19/195004; Uchida H, 2007, AM MINERAL, V92, P1031, DOI 10.2138/am.2007.2445; Wang BS, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006608; Woodland AB, 2003, EARTH PLANET SC LETT, V214, P295, DOI 10.1016/S0012-821X(03)00379-0; Yamanaka T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134120	73	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	AUG-SEP	2015	100	8-9					1752	1761		10.2138/am-2015-5224		10	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CO9RB	WOS:000359512100009		
J	Matsukage, KN; Nishihara, Y; Noritake, F; Kawamura, K; Tsujino, N; Sakurai, M; Higo, Y; Nakajima, J; Hasegawa, A; Takahashi, E				Matsukage, Kyoko N.; Nishihara, Yu; Noritake, Fumiya; Kawamura, Katsuyuki; Tsujino, Noriyoshi; Sakurai, Moe; Higo, Yuji; Nakajima, Junichi; Hasegawa, Akira; Takahashi, Elichi			Elastic wave velocity anomalies of anorthite in a subducting plate: In situ experiments	AMERICAN MINERALOGIST			English	Article						Anorthite; plagioclase; elastic wave velocities; subduction; oceanic crust	CA-RICH PLAGIOCLASE; HIGH-PRESSURE; SPONTANEOUS STRAIN; PHASE-TRANSITION; OCEANIC-CRUST; SEISMIC EVIDENCE; ORDER-DISORDER; X-RADIATION; THERMODYNAMICS; TEMPERATURE	To understand the origin of observed low velocities in the crustal portion of subducting plates, we performed in situ measurements of elastic wave velocities of anorthite at temperatures up to 1373 K at pressure of similar to 1 GPa and up to 773 K at 2.0-7.0 GPa. A fine-grained polycrystalline anorthite, which was synthesized using a gas pressure apparatus, was used for the measurements. The high-pressure experiments were performed using the multi-anvil apparatus installed on beamline BL04B1 at SPring-8. The elastic wave velocity was measured by the ultrasonic pulse method with synchrotron X-ray radiographic imaging and X-ray diffraction techniques. At similar to 1.0 GPa, elastic wave velocities exhibited a sharp temperature-induced kink at similar to 500 K. Below 500 K, the elastic wave velocities decrease with increasing temperature. In contrast, above 500 K, the elastic wave velocities show an increasing trend in the range of 500-900 K, and then revert back to a decreasing trend at above 900 K. We also found a pressure-induced velocity anomaly of anorthite. At 300-373 K, v(p) is constant up to 4 GPa, but decrease above 4 GPa with increasing pressure, while vs decreases monotonously with increasing pressure. These elastic anomalies are considered to be attributable to the tilting behavior of the corner-sharing TO4 (T = Al, Si) tetrahedra in three-dimensional frameworks of anorthite. Our results suggest the presence of plagioclase feldspar has the potential to causes low-velocity anomaly in the subducting oceanic crust when it survives as a metastable phase in the slab at higher pressure and lower temperature conditions.	[Matsukage, Kyoko N.] Kobe Univ, Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Nishihara, Yu] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Noritake, Fumiya; Kawamura, Katsuyuki] Okayama Univ, Environm Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Tsujino, Noriyoshi] Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 6820193, Japan; [Sakurai, Moe; Takahashi, Elichi] Tokyo Inst Technol, Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Higo, Yuji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Nakajima, Junichi; Hasegawa, Akira] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Sendai, Miyagi 9808578, Japan	Matsukage, KN (reprint author), Tokyo Inst Technol, Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	matsukage.k.aa@m.titech.ac.jp			Women's Future Development Center in Ehime University;  [21109004]	We thank T. Ohuchi, M.L. Whitaker, S. Greaux, and K. Funakoshi for technical support in experiments. The comments made by anonymous reviewers are appreciated. This study was supported by the grant in aid for scientific research on innovative areas (21109004), and by Women's Future Development Center in Ehime University. The in situ experiments were performed at BL04B1 of SPring-8 (Proposal Nos. 2011A1362 and 2011B1365).	Angel RJ, 2012, AM MINERAL, V97, P765, DOI 10.2138/am.2012.4011; Prior DJ, 1999, AM MINERAL, V84, P1741; Iwamori H, 2007, CHEM GEOL, V239, P182, DOI 10.1016/j.chemgeo.2006.08.011; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Connolly JAD, 2002, EARTH PLANET SC LETT, V204, P61, DOI 10.1016/S0012-821X(02)00957-3; [Anonymous], 1992, AM MINERALOGIST, V77, P923; [Anonymous], 2004, CONTRIBUTIONS MINERA, V146, P506; Rondenay S, 2008, GEOLOGY, V36, P275, DOI 10.1130/G24112A.1; Ohuchi T, 2011, EARTH PLANET SC LETT, V304, P55, DOI 10.1016/j.epsl.2011.01.015; ANGEL RJ, 1988, AM MINERAL, V73, P1114; GREEN DH, 1967, GEOCHIM COSMOCHIM AC, V31, P767, DOI 10.1016/S0016-7037(67)80031-0; KOZIOL AM, 1988, AM MINERAL, V73, P216; [Anonymous], 2002, J GEOPHYS RES-SOL EA, DOI DOI 10.1029/2001JB000522; [Anonymous], PHYS EARTH PLANETARY, V244, P32; Higo Y, 2009, J SYNCHROTRON RADIAT, V16, P762, DOI 10.1107/S0909049509034980; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; BIRCH F, 1961, J GEOPHYS RES, V66, P2199, DOI 10.1029/JZ066i007p02199; Li BS, 2004, PHYS EARTH PLANET IN, V143, P559, DOI 10.1016/j.pepi.2003.09.020; CARPENTER MA, 1991, AM MINERAL, V76, P1120; Connolly J.A.D., 2012, PERPLEX667 REPORT; FOIT FF, 1973, AM MINERAL, V58, P665; FUKAO Y, 1983, NATURE, V303, P413, DOI 10.1038/303413a0; GIBBS GV, 1982, AM MINERAL, V67, P421; HACKWELL TP, 1995, AM MINERAL, V80, P239; HASEGAWA A, 1994, J GEOPHYS RES-SOL EA, V99, P22295, DOI 10.1029/93JB02797; Hays J.F., 1966, LIME ALUMINA SHILICA, V65, P234; Jamieson J. C., 1982, HIGH PRESSURE RES GE, P27; Kono Y, 2008, AM MINERAL, V93, P558, DOI 10.2138/am.2008.2591; Kung J, 2002, EARTH PLANET SC LETT, V203, P557, DOI 10.1016/S0012-821X(02)00838-5; Larson A. C., 2000, 86748 LAUR LOS AL NA, P86; Li BS, 1998, SCIENCE, V281, P675, DOI 10.1126/science.281.5377.675; LIEBERMANN RC, 1976, EARTH PLANET SC LETT, V31, P69, DOI 10.1016/0012-821X(76)90097-2; Matsukage KN, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-29; Matsukage KN, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003504; Nakajima J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036865; NEWTON MD, 1980, PHYS CHEM MINER, V6, P221, DOI 10.1007/BF00309858; Noritake F., 2013, M JAP ASS MIN SCI, VR2, P14; Paul W., 1963, SOLIDS UNDER PRESSUR, P137; REDFERN SAT, 1988, PHYS CHEM MINER, V16, P157; REDFERN SAT, 1987, PHYS CHEM MINER, V14, P189, DOI 10.1007/BF00308224; Ryzhova T.V., 1964, B ACAD SCI USSR GEOP, V7, P633; SERONT B, 1993, J GEOPHYS RES-SOL EA, V98, P2209, DOI 10.1029/92JB01743; Shiina T, 2013, GEOPHYS RES LETT, V40, P2006, DOI 10.1002/grl.50468; Tribaudino M, 2011, AM MINERAL, V96, P992, DOI 10.2138/am.2011.3722; Tribaudino M, 2012, PHYS CHEM MINER, V39, P699, DOI 10.1007/s00269-012-0524-x; Utsumi W., 1998, REV HIGH PRESSURE SC, V7, P1484; Wang H., 1973, P 4 LUN SCI C S4, V3, P2663	47	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	AUG-SEP	2015	100	8-9					1856	1865		10.2138/am-2015-5240		10	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CO9RB	WOS:000359512100017		
J	Fukami, H				Fukami, H.			Regional specific approach is a next step for setting evolutionary-based conservation priorities in the scleractinian corals	ANIMAL CONSERVATION			English	Editorial Material							ANTHOZOA	Read the Feature Paper: ; other Commentaries on this paper: ; and the Response from the authors:	Miyazaki Univ, Dept Marine Biol & Environm Sci, Fac Agr, Miyazaki 8892192, Japan	Fukami, H (reprint author), Miyazaki Univ, Dept Marine Biol & Environm Sci, Fac Agr, Miyazaki 8892192, Japan.	hirofukami@cc.miyazaki-u.ac.jp					Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Curnick DJ, 2015, ANIM CONSERV, V18, P303, DOI 10.1111/acv.12185; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Benzoni F, 2012, CONTRIB ZOOL, V81, P125; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; Huang DW, 2013, ECOL EVOL, V3, P1184, DOI 10.1002/ece3.527; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Keshavmurthy S., 2013, SCI REP, V3, P1	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1367-9430	1469-1795		ANIM CONSERV	Anim. Conserv.	AUG	2015	18	4					318	319		10.1111/acv.12224		2	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CP0XZ	WOS:000359601500004		
J	Nakai, K; Yoneda, K; Murakami, Y; Koura, A; Maeda, R; Tamai, A; Ishikawa, E; Yokoi, I; Moriue, J; Moriue, T; Kubota, Y				Nakai, Kozo; Yoneda, Kozo; Murakami, Yumi; Koura, Ayako; Maeda, Reiko; Tamai, Asuka; Ishikawa, Emiko; Yokoi, Ikumi; Moriue, Junko; Moriue, Tetsuya; Kubota, Yasuo			Effects of Topical N-Acetylcysteine on Skin Hydration/Transepidermal Water Loss in Healthy Volunteers and Atopic Dermatitis Patients	ANNALS OF DERMATOLOGY			English	Letter									[Nakai, Kozo; Yoneda, Kozo; Murakami, Yumi; Koura, Ayako; Maeda, Reiko; Tamai, Asuka; Ishikawa, Emiko; Yokoi, Ikumi; Moriue, Junko; Moriue, Tetsuya; Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Miki, Kagawa 7610793, Japan	Nakai, K (reprint author), Kagawa Univ, Fac Med, Dept Dermatol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kozo@kms.ac.jp					WERNER Y, 1985, ACTA DERM-VENEREOL, V65, P102; WERNER Y, 1986, ACTA DERM-VENEREOL, V66, P281; Nakai K, 2012, AM J PATHOL, V181, P969, DOI 10.1016/j.ajpath.2012.06.005; Redondo P, 1999, LANCET, V354, P1880, DOI 10.1016/S0140-6736(99)04245-2; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Velez A, 2002, J AM ACAD DERMATOL, V46, P469, DOI 10.1067/mjd.2002.118557	6	0	0	KOREAN DERMATOLOGICAL ASSOC	SEOUL	305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL, 137-858, SOUTH KOREA	1013-9087			ANN DERMATOL	Ann. Dermatol.	AUG	2015	27	4					450	451		10.5021/ad.2015.27.4.450		2	Dermatology	Dermatology	CP1BS	WOS:000359611500018		
J	Gillessen, S; Omlin, A; Attard, G; de Bono, JS; Efstathiou, E; Fizazi, K; Halabi, S; Nelson, PS; Sartor, O; Smith, MR; Soule, HR; Akaza, H; Beer, TM; Beltran, H; Chinnaiyan, AM; Daugaard, G; Davis, ID; De Santis, M; Drake, CG; Eeles, RA; Fanti, S; Gleave, ME; Heidenreich, A; Hussain, M; James, ND; Lecouvet, FE; Logothetis, CJ; Mastris, K; Nilsson, S; Oh, WK; Olmos, D; Padhani, AR; Parker, C; Rubin, MA; Schalken, JA; Scher, HI; Sella, A; Shore, ND; Small, EJ; Sternberg, CN; Suzuki, H; Sweeney, CJ; Tannock, IF; Tombal, B				Gillessen, S.; Omlin, A.; Attard, G.; de Bono, J. S.; Efstathiou, E.; Fizazi, K.; Halabi, S.; Nelson, P. S.; Sartor, O.; Smith, M. R.; Soule, H. R.; Akaza, H.; Beer, T. M.; Beltran, H.; Chinnaiyan, A. M.; Daugaard, G.; Davis, I. D.; De Santis, M.; Drake, C. G.; Eeles, R. A.; Fanti, S.; Gleave, M. E.; Heidenreich, A.; Hussain, M.; James, N. D.; Lecouvet, F. E.; Logothetis, C. J.; Mastris, K.; Nilsson, S.; Oh, W. K.; Olmos, D.; Padhani, A. R.; Parker, C.; Rubin, M. A.; Schalken, J. A.; Scher, H. I.; Sella, A.; Shore, N. D.; Small, E. J.; Sternberg, C. N.; Suzuki, H.; Sweeney, C. J.; Tannock, I. F.; Tombal, B.			Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015	ANNALS OF ONCOLOGY			English	Article						advanced prostate cancer; castration-resistant prostate cancer; therapeutics; consensus; castration-naive prostate cancer	METASTASIS-FREE SURVIVAL; INTERMITTENT ANDROGEN SUPPRESSION; PLACEBO-CONTROLLED TRIAL; SPINAL-CORD COMPRESSION; III EXTENSION TRIAL; ABIRATERONE ACETATE; BONE METASTASES; PHASE-III; RANDOMIZED-TRIAL; ZOLEDRONIC ACID	The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified and reviewed the available evidence for the ten most important areas of controversy in advanced prostate cancer (APC) management. The successful registration of several drugs for castration-resistant prostate cancer and the recent studies of chemo-hormonal therapy in men with castration-naive prostate cancer have led to considerable uncertainty as to the best treatment choices, sequence of treatment options and appropriate patient selection. Management recommendations based on expert opinion, and not based on a critical review of the available evidence, are presented. The various recommendations carried differing degrees of support, as reflected in the wording of the article text and in the detailed voting results recorded in supplementary Material, available at Annals of Oncology online. Detailed decisions on treatment as always will involve consideration of disease extent and location, prior treatments, host factors, patient preferences as well as logistical and economic constraints. Inclusion of men with APC in clinical trials should be encouraged.	[Gillessen, S.; Omlin, A.] Kantonsspital St Gallen, Dept Oncol Haematol, St Gallen, Switzerland; [Attard, G.; de Bono, J. S.] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England; [Attard, G.; de Bono, J. S.] Royal Marsden NHS Fdn Trust, Drug Dev Unit, Sutton, Surrey, England; [Attard, G.; de Bono, J. S.] Inst Canc Res, Sutton, Surrey, England; [Efstathiou, E.; Logothetis, C. J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Efstathiou, E.; Logothetis, C. J.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Efstathiou, E.] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Sch Med, Athens 11528, Greece; [Fizazi, K.] Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, Villejuif, France; [Halabi, S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Nelson, P. S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Sartor, O.] Tulane Univ, Tulane Canc Ctr, New Orleans, LA 70118 USA; [Smith, M. R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Soule, H. R.] Prostate Canc Fdn, Santa Monica, CA USA; [Akaza, H.] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Beer, T. M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beltran, H.; Scher, H. I.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Dept Pathol, Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Urol, Ann Arbor, MI USA; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Daugaard, G.] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [Davis, I. D.] Monash Univ & Eastern Hlth, Eastern Hlth Clin Sch, Box Hill, Vic, Australia; [De Santis, M.] Univ Warwick, Canc Res Ctr, Warwick, England; [De Santis, M.] Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria; [Drake, C. G.] Johns Hopkins Univ, Sch Med, Johns Hopkins Sidney Kimmel Canc Ctr, Baltimore, MD USA; [Drake, C. G.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD USA; [Eeles, R. A.] Inst Canc Res, London SW3 6JB, England; [Eeles, R. A.] Royal Marsden NHS Fdn Trust, London, England; [Fanti, S.] Univ Bologna, Policlin S Orsola, Dept Nucl Med, Bologna, Italy; [Gleave, M. E.] Univ British Columbia, Vancouver Prostate Ctr, Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Heidenreich, A.] Rhein Westfal TH Aachen, Klinik & Poliklin Urol, Aachen, Germany; [Hussain, M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [James, N. D.] Univ Hosp Birmingham, Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England; [Lecouvet, F. E.] Clin Univ St Luc, Ctr Canc, Dept Radiol, B-1200 Brussels, Belgium; [Lecouvet, F. E.] Clin Univ St Luc, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Mastris, K.] Europa Uomo Prostate Patients, Clayhall Ilford, Essex, England; [Nilsson, S.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Oh, W. K.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Haematol & Med Oncol, New York, NY 10029 USA; [Olmos, D.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain; [Olmos, D.] Hosp Univ Virgen Victoria & Reg Malaga, CNIO IBIMA Genitourinary Canc Unit, Malaga, Spain; [Olmos, D.] Ctr Integral Onco Clara Campal CIOCC, Madrid, Spain; [Padhani, A. R.] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Northwood, Middx, England; [Parker, C.] Royal Marsden NHS Fdn Trust, Acad Urol Unit, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England; [Parker, C.] Royal Marsden NHS Fdn Trust, Dept Diagnost Radiol, Sutton, Surrey, England; [Parker, C.] Inst Canc Res, Sutton, Surrey, England; [Rubin, M. A.] Weill Cornell Med Coll & NewYork Presbyterian, Dept Pathol & Urol, Meyer Canc Ctr, Inst Precis Med, New York, NY USA; [Schalken, J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Scher, H. I.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10021 USA; [Sella, A.] Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Oncol, Zerifin, Israel; [Shore, N. D.] Carolina Urol Res Ctr, Dept Urol, Myrtle Beach, SC USA; [Small, E. J.] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Sternberg, C. N.] San Camillo & Forlanini Hosp, Dept Med Oncol, Rome, Italy; [Suzuki, H.] Toho Univ, Sakura Med Ctr, Dept Urol, Chiba 2748510, Japan; [Sweeney, C. J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sweeney, C. J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Tannock, I. F.] Princess Margaret Canc Ctr, Dept Med Oncol & Haematol, Toronto, ON, Canada; [Tombal, B.] Catholic Univ Louvain, Inst Rech Clin, Serv Urol, B-1200 Brussels, Belgium	Gillessen, S (reprint author), Kantonsspital St Gallen, Dept Oncol Haematol, Rorschacherstr 95, St Gallen, Switzerland.	silke.gillessen@kssg.ch	Schalken, Jack/B-1277-2014	Schalken, Jack/0000-0001-8274-7797	Cantonal Hospital St Gallen; City and Canton of St Gallen; Swiss Cancer Research Organisation; European School of Oncology (ESO); Swiss Cancer League; Swiss Oncology Research Network SAKK; Swiss Cancer Foundation; Prostate Cancer Foundation (PCF); Gunter and Regine Kelm Foundation; Movember Foundation	We gratefully acknowledge the financial support of the following non-profit organisations for the Advanced Prostate Cancer Consensus Conference (APCCC): Cantonal Hospital St Gallen, City and Canton of St Gallen, Swiss Cancer Research Organisation, European School of Oncology (ESO), Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation (PCF) and the Gunter and Regine Kelm Foundation. We thank the Movember Foundation for the sponsoring of the travel grants (no grant number).	AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; Akaza H, 2014, ANN ONCOL         S4, V25, piv255; Al Nakouzi N, 2014, EUR UROL, DOI [10.1016/j.eururo.2014.04.015, DOI 10.1016/J.EURUR0.2014.04.015]; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Armstrong AJ, 2012, EUR UROL, V61, P549, DOI 10.1016/j.eururo.2011.11.009; Saad F, 2004, J NATL CANCER I, V96, P879, DOI 10.1093/jnci/djh141; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Angelergues A, 2014, EUR J CANCER, V50, P1602, DOI 10.1016/j.ejca.2014.03.015; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Lecouvet FE, 2012, EUR UROL, V62, P68, DOI 10.1016/j.eururo.2012.02.020; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; TOLIS G, 1982, P NATL ACAD SCI-BIOL, V79, P1658, DOI 10.1073/pnas.79.5.1658; Lecouvet FE, 2014, EUR J CANCER, V50, P2519, DOI 10.1016/j.ejca.2014.07.002; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Smith MR, 2013, J CLIN ONCOL, V31, P3800, DOI 10.1200/JCO.2012.44.6716; Akaza H, 2009, CANCER, V115, P3437, DOI 10.1002/cncr.24395; Ryan CJ, 2011, CLIN CANCER RES, V17, P4854, DOI 10.1158/1078-0432.CCR-11-0815; Evangelista L, 2013, CLIN NUCL MED, V38, P305, DOI 10.1097/RLU.0b013e3182867f3c; Dalesio O, 2000, LANCET, V355, P1491; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1097/01.ju.0000042482.18153.30; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Lecouvet FE, 2013, EUR RADIOL, V23, P1986, DOI 10.1007/s00330-013-2792-3; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; Padhani AR, 2014, J MAGN RESON IMAGING, V39, P1049, DOI 10.1002/jmri.24548; KAISARY AV, 1991, BRIT J UROL, V67, P502, DOI 10.1111/j.1464-410X.1991.tb15195.x; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Barchetti F, 2014, BIOMED RES INT, DOI 10.1155/2014/316272; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Wu LM, 2013, CLIN ONCOL-UK, V25, P252, DOI 10.1016/j.clon.2012.11.010; Fizazi K, 2014, LANCET ONCOL, V15, P1147, DOI 10.1016/S1470-2045(14)70303-1; Cheng HH, 2015, PROSTATE CANCER P D, V18, P122, DOI 10.1038/pcan.2014.53; Suzman DL, 2014, PROSTATE, V74, P1278, DOI 10.1002/pros.22844; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Smith MR, 2014, J CLIN ONCOL, V32, P1143, DOI 10.1200/JCO.2013.51.6500; Schweizer MT, 2013, ANN ONCOL, V24, P2881, DOI 10.1093/annonc/mdt335; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Logothetis CJ, 2012, LANCET ONCOL, V13, P1210, DOI 10.1016/S1470-2045(12)70473-4; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; Sartor O, 2014, LANCET ONCOL, V15, P738, DOI 10.1016/S1470-2045(14)70183-4; LABRIE F, 1982, CLIN INVEST MED, V5, P267; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Mezynski J, 2012, ANN ONCOL, V23, P2943, DOI 10.1093/annonc/mds119; HUGGINS C, 1945, ANN SURG, V122, P1031, DOI 10.1097/00000658-194512260-00012; Pezaro CJ, 2014, EUR UROL, V66, P459, DOI 10.1016/j.eururo.2013.11.044; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Crawford ED, 2014, UROLOGY, V83, P664, DOI 10.1016/j.urology.2013.10.026; Messiou C, 2011, ACTA RADIOL, V52, P557, DOI 10.1258/ar.2011.100342; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; Crawford ED, 2014, UROLOGY, V83, P1122, DOI 10.1016/j.urology.2014.01.013; Niraula S, 2013, J CLIN ONCOL, V31, P2029, DOI 10.1200/JCO.2012.46.5492; Bayley A, 2001, CANCER, V92, P303, DOI 10.1002/1097-0142(20010715)92:2<303::AID-CNCR1323>3.0.CO;2-F; Saad F, 2002, J NATL CANCER I, V94, P1458; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Aggarwal R, 2013, CANCER-AM CANCER SOC, V119, P3636, DOI 10.1002/cncr.28285; Morris MJ, 2015, J CLIN ONCOL, V33, P1356, DOI 10.1200/JCO.2014.55.3875; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Nelson JB, 2008, CANCER, V113, P2478, DOI 10.1002/cncr.23864; Blackledge MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091779; Brasso K, 2014, EUR UROL, DOI [10.1016/j.eururo.2014.07.028, DOI 10.1016/J.EURUR0.2014.07.028]; Burgio SL, 2015, CLIN GENITOURIN CANC, V13, P39, DOI 10.1016/j.clgc.2014.06.010; Caubet JF, 1997, UROLOGY, V49, P71, DOI 10.1016/S0090-4295(96)00325-1; Cooperberg MR, 2016, BJU INT, V117, P102, DOI 10.1111/bju.12937; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Ferraldeschi R, 2015, EUR UROL, V67, P795, DOI 10.1016/j.eururo.2014.10.027; Gleave M, 1998, EUR UROL, V34, P37, DOI 10.1159/000052297; Gravis G, 2015, J CLIN ONCOL S7, V33; Hsu C. C., 2007, RES EVALUAT, V12, P1; James ND, 2015, J CLIN ONCOL S, V33; KLOTZ LH, 1986, CANCER, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO;2-N; Miller K, 2013, PROSTATE CANCER P D, V16, P187, DOI 10.1038/pcan.2013.2; Ost P, 2015, EUR UROL, V67, P852, DOI 10.1016/j.eururo.2014.09.004; Petrelli F, 2015, CLIN GENITOURIN CANC, V13, P193, DOI 10.1016/j.clgc.2014.10.006; Pezaro CJ, 2014, EUR UROL, V65, P270, DOI 10.1016/j.eururo.2013.10.055; Poulsen MH, 2014, BJU INT, V114, P818, DOI 10.1111/bju.12599; Sella A, 2014, CLIN GENITOURIN CANC, V12, P428, DOI 10.1016/j.clgc.2014.06.007; Shen GH, 2014, SKELETAL RADIOL, V43, P1503, DOI 10.1007/s00256-014-1903-9; Spritzer CE, 2013, RADIOLOGY, V269, P816, DOI 10.1148/radiol.13121782; Sweeney C, 2014, J CLIN ONCOL S, V32; Thuret R, 2008, ANN ONCOL, V19, P1308, DOI 10.1093/annonc/mdn062; Tombal B, 2005, PROSTATE, V65, P178, DOI 10.1002/pros.20280; Venkitaraman R, 2007, CLIN ONCOL-UK, V19, P528, DOI 10.1016/j.clon.2007.04.001; VOGELZANG NJ, 1995, UROLOGY, V46, P220, DOI 10.1016/S0090-4295(99)80197-6	88	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	AUG	2015	26	8					1589	1604		10.1093/annonc/mdv257		16	Oncology	Oncology	CO7BI	WOS:000359312100011		
J	Togashi, Y; Mizuuchi, H; Kobayashi, Y; Hayashi, H; Terashima, M; Sakai, K; Banno, E; Mizukami, T; Nakamura, Y; de Velasco, MA; Fujita, Y; Tomida, S; Mitsudomi, T; Nishio, K				Togashi, Y.; Mizuuchi, H.; Kobayashi, Y.; Hayashi, H.; Terashima, M.; Sakai, K.; Banno, E.; Mizukami, T.; Nakamura, Y.; de Velasco, M. A.; Fujita, Y.; Tomida, S.; Mitsudomi, T.; Nishio, K.			An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancer	ANNALS OF ONCOLOGY			English	Letter							IMMUNOHISTOCHEMISTRY; FISH		[Togashi, Y.; Hayashi, H.; Terashima, M.; Sakai, K.; Banno, E.; Mizukami, T.; Fujita, Y.; Tomida, S.; Nishio, K.] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Mizuuchi, H.; Kobayashi, Y.; Mitsudomi, T.] Kinki Univ, Fac Med, Thorac Surg, Osaka, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan.	knishio@med.kindai.ac.jp					Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Ilie MI, 2015, ANN ONCOL, V26, P238, DOI 10.1093/annonc/mdu484; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	AUG	2015	26	8					1800	1801		10.1093/annonc/mdv240		3	Oncology	Oncology	CO7BI	WOS:000359312100039		
J	Igari, K; Kudo, T; Toyofuku, T; Inoue, Y				Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahiro; Inoue, Yoshinori			Controlled Antegrade and Retrograde Subintimal Tracking Technique for Endovascular Treatment of the Superficial Femoral Artery with Chronic Total Occlusion	ANNALS OF VASCULAR SURGERY			English	Article							D LESIONS; TASC C; ANGIOPLASTY; DISEASE; CONSENSUS; EFFICACY	Although providing endovascular treatment for chronic total occlusion (CTO) in patients with peripheral arterial disease is challenging, subintimal angioplasty (SIA) has proven to be an effective procedure. However, the SIA device may not cross CTO lesions because of the inability to achieve re-entry into the distal true lumen in some cases. We herein describe 2 cases of CTO of the superficial femoral artery (SFA) segment in which we failed to cross the site of CTO using the SIA technique and therefore employed the controlled antegrade and retrograde subintimal tracking (CART) technique to successfully treat the CTO lesions of SFA. When using the CART technique, there is no need to perform extension of the region of subintimal dissection beyond the occluded lesion, which may be useful for managing CTO lesions.	[Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahiro; Inoue, Yoshinori] Tokyo Med & Dent Univ, Dept Surg, Div Vasc & Endovasc Surg, Tokyo 1138519, Japan	Igari, K (reprint author), Tokyo Med & Dent Univ, Dept Surg, Div Vasc & Endovasc Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	igari.srg1@tmd.ac.jp					Met R, 2008, CARDIOVASC INTER RAD, V31, P687, DOI 10.1007/s00270-008-9331-7; Rabellino M, 2009, CATHETER CARDIO INTE, V73, P701, DOI 10.1002/ccd.21971; Jacobs DL, 2006, J VASC SURG, V43, P1291, DOI 10.1016/j.jvs.2006.02.051; Schmidt A, 2012, J ENDOVASC THER, V19, P23, DOI 10.1583/11-3645.1; Setacci C, 2009, EUR J VASC ENDOVASC, V38, P76, DOI 10.1016/j.ejvs.2009.03.020; Kimura M, 2009, JACC-CARDIOVASC INTE, V2, P1135, DOI 10.1016/j.jcin.2009.09.008; Ye M, 2013, J VASC SURG, V58, P84, DOI 10.1016/j.jvs.2013.03.038; Rogers RK, 2010, CATHETER CARDIO INTE, V75, P673, DOI 10.1002/ccd.22403; Shin SH, 2011, J VASC SURG, V53, P1260, DOI 10.1016/j.jvs.2010.10.127; Dattilo PB, 2012, CATHETER CARDIO INTE, V80, P644, DOI 10.1002/ccd.23469; Baril Donald T, 2010, J Vasc Surg, V51, P1406, DOI 10.1016/j.jvs.2010.01.062; Kim JS, 2006, J ENDOVASC THER, V13, P514, DOI 10.1583/05-1798MR.1; Klein AJ, 2014, CATHETER CARDIO INTE, V84, P529, DOI 10.1002/ccd.25504; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Surmely Jean-François, 2006, J Invasive Cardiol, V18, P334	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2015	29	6							1320.e7	10.1016/j.avsg.2015.03.054		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CO7BH	WOS:000359312000053		
J	Mihara, M; Hara, H; Tsubaki, H; Suzuki, T; Yamada, N; Kawahara, M; Murai, N				Mihara, Makoto; Hara, Hisako; Tsubaki, Hiromi; Suzuki, Takiko; Yamada, Naomi; Kawahara, Mari; Murai, Noriyuki			Combined Conservative Treatment and Lymphatic Venous Anastomosis for Severe Lower Limb Lymphedema with Recurrent Cellulitis	ANNALS OF VASCULAR SURGERY			English	Article								Background: Lymphedema may be treated either conservatively or surgically. Although conservative therapy is the first-line treatment, some patients are refractory to it and repeat severe cellulitis. We usually perform lymphaticovenous anastomosis (LVA) for lymphedema patients, and LVA can reduce the frequency of cellulitis. Case Report: A 67-year-old woman who had undergone a radical hysterectomy, pelvic lymphadenectomy, and postoperative radiotherapy for cervical cancer at the age 50 years. She developed lymphedema in both legs, and high-pressure compression stockings caused lymphorrhea in the groin and thigh, resulting in recurrent episodes of cellulitis. Lymphoscintigraphy revealed dilation of the lymphatic vessels in both legs. Results of an indocyanine green test revealed dermal backflow throughout the lower body. After wearing low-pressure stocking, we performed LVA to reduce cellulitis. After confirming the result of LVA, the patients started wearing high-pressure stocking. The patient underwent a subsequent LVA, 3 months after the first, to further improve edema. The lymphorrhea resolved, and cellulitis did not recur. Conclusions: The combination of surgical treatment and conservative treatment is important for severe lymphedema treatment. Although conservative treatment is usually said to be the first-line treatment, LVA can antecede in cases refractory to conservative treatment.	[Mihara, Makoto; Hara, Hisako; Kawahara, Mari; Murai, Noriyuki] Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Saitama, Japan; [Hara, Hisako] Tokyo Univ Hosp, Dept Plast & Reconstruct Surg, Tokyo 113, Japan; [Tsubaki, Hiromi] Saiseikai Kawaguchi Gen Hosp, Dept Nursing, Saitama, Japan; [Suzuki, Takiko; Yamada, Naomi] Saiseikai Kawaguchi Gen Hosp, Dept Nutr, Saitama, Japan	Mihara, M (reprint author), Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, 332-0021 Nishi Kawaguchi 5-11-5, Kawaguchi, Saitama, Japan.	mihara.plasticsurgery@gmail.com					Hara H, 2013, PLAST RECONSTR SURG, V132, P1612, DOI 10.1097/PRS.0b013e3182a97edc; Fu MR, 2013, PSYCHO-ONCOLOGY, V22, P1466, DOI 10.1002/pon.3201; Olszewski WL, 2005, LYMPHOLOGY, V38, P66; Maegawa J, 2010, MICROSURG, V30, P437, DOI 10.1002/micr.20772; Liu NF, 2009, J VASC SURG, V49, P980, DOI 10.1016/j.jvs.2008.11.029; Foldi E, 1998, CANCER, V83, P2833, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3; Campisi C, 2011, INT ANGIOL, V30, P504; Mihara M, 2014, BRIT J SURG, V101, P1391, DOI 10.1002/bjs.9588; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041126; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Suami H, 2010, PLAST RECONSTR SURG, V126, P1853, DOI 10.1097/PRS.0b013e3181f44658; Teerachaisakul M, 2013, LYMPHOLOGY, V46, P150	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2015	29	6							1318.e11	10.1016/j.avsg.2015.01.037		5	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CO7BH	WOS:000359312000047		
J	Mihara, M; Hara, H; Shibasaki, J; Seki, Y; Hayashi, A; Iida, T; Adachi, S; Uchida, Y; Kaneko, H; Haragi, M; Murakami, A				Mihara, Makoto; Hara, Hisako; Shibasaki, Jun; Seki, Yukio; Hayashi, Akitatsu; Iida, Takuya; Adachi, Shinya; Uchida, Yasushi; Kaneko, Hideo; Haragi, Makiko; Murakami, Arata			Indocyanine Green Lymphography and Lymphaticovenous Anastomosis for Generalized Lymphatic Dysplasia with Pleural Effusion and Ascites in Neonates	ANNALS OF VASCULAR SURGERY			English	Article							NONCONTACT VEIN VISUALIZATION; LOWER-EXTREMITY LYMPHEDEMA; DERMAL BACKFLOW PATTERNS; CHYLOUS ASCITES; VENOUS ANASTOMOSIS; ICG LYMPHOGRAPHY; LOWER LEG; CHYLOTHORAX; LYMPHOSCINTIGRAPHY; THROMBOSIS	Background: The fatality rate of generalized lymphatic dysplasia (GLD) with chylous pleural effusion and ascites is particularly high when it persists over a prolonged period. The purpose of this report was to determine the utility of indocyanine green (ICG) lymphography and lymphaticovenous anastomosis (LVA) in GLD with chylous pleural effusion and ascites in neonates. Methods: We tested the lymphatic function in the 4 extremities for 8 GLD neonate patients using ICG lymphography, and on the basis of the results, we performed LVA for 5 of them. LVA was performed at the extremities under general anesthesia using incisions <1 cm in length. The outcome of LVA was evaluated with the amount of ascites discharged from thoracostomy tube or abdominal tube, except for 1 patient who had no drainage tube. Results: In all cases, ICG lymphography showed varying degrees of dermal backflow in the limbs with lymphostasis. After LVA surgery, effusion stopped in 2 cases and decreased in 1 case. In the cases where effusion stopped, backflow as observed with ICG lymphography was minimal, and in the case where effusion decreased but did not stop, backflow was moderate. Conclusions: The application of ICG and LVA could possibly be used to diagnose and treat lymphatic pleural effusion or ascites.	[Mihara, Makoto; Hara, Hisako] Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Saitama 3320021, Japan; [Hara, Hisako; Hayashi, Akitatsu; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Shibasaki, Jun] Kanagawa Childrens Med Ctr, Dept Neonatol, Kanagawa, Japan; [Seki, Yukio] St Marianna Univ, Dept Plast & Reconstruct Surg, Sch Med, Kanagawa, Japan; [Adachi, Shinya] Natl Ctr Child Hlth & Dev, Dept Intens Care Unit, Tokyo, Japan; [Uchida, Yasushi; Kaneko, Hideo] Nagara Med Ctr, Dept Neonatol, Gifu, Japan; [Haragi, Makiko] Univ Tokyo, Sch Publ Hlth, Dept Hlth Commun, Tokyo, Japan; [Murakami, Arata] Gunma Childrens Med Ctr, Dept Cardiac Surg, Gunma, Japan	Mihara, M (reprint author), Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Lymphat Team, Nishi Kawaguchi 5-11-5, Saitama 3320021, Japan.	mihara.plasticsurgery@gmail.com			Japanese funding program for Next-Generation World-Leading Research (NEXT program) [LS039];  [24791898]	The report was supported by the Japanese funding program for Next-Generation World-Leading Research (NEXT program; LS039) and Grant-in-Aid for Scientific Research (grant no, 24791898).	Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; Maegawa J, 2012, J VASC SURG, V55, P753, DOI 10.1016/j.jvs.2011.08.062; KINMONTH JB, 1976, J CARDIOVASC SURG, V17, P329; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Onoda S, 2014, MICROSURG, V34, P372, DOI 10.1002/micr.22204; Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54; Pui MH, 1998, J NUCL MED, V39, P1292; Cardenas A, 2002, AM J GASTROENTEROL, V97, P1896; Lippi G, 2012, SEMIN THROMB HEMOST, V38, P213, DOI 10.1055/s-0032-1301418; Todokoro T, 2013, GYNECOL ONCOL, V128, P209, DOI 10.1016/j.ygyno.2012.11.014; Mihara M, 2012, J MINIM INVAS GYN, V19, P125, DOI 10.1016/j.jmig.2011.09.012; Hara H, 2013, J PLAST RECONSTR AES, V66, P1780, DOI 10.1016/j.bjps.2013.04.043; KINMONTH JB, 1978, BRIT J SURG, V65, P829, DOI 10.1002/bjs.1800651202; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Campisi C, 2010, MICROSURG, V30, P256, DOI 10.1002/micr.20737; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; BROWSE NL, 1992, BRIT J SURG, V79, P1145, DOI 10.1002/bjs.1800791110; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Bellini C, 2005, LYMPHOLOGY, V38, P9; Campisi C, 2011, INT ANGIOL, V30, P504; Campisi C, 1999, INT ANGIOL, V18, P10; Campisi C, 2006, J VASC SURG, V43, P1244, DOI 10.1016/j.jvs.2005.11.064; Huang PM, 2011, THORAC CARDIOV SURG, V59, P436, DOI 10.1055/s-0030-1270737; Khandwalla HE, 2009, AM J GASTROENTEROL, V104, P1401, DOI 10.1038/ajg.2009.117; Kuroiwa Minoru, 2007, J Pediatr Surg, V42, pE15, DOI 10.1016/j.jpedsurg.2007.02.036; Mihara M, 2014, BRIT J SURG, V101, P1391, DOI 10.1002/bjs.9588; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041126; Mihara M, 2014, MICROSURG, V34, P64, DOI 10.1002/micr.22141; Mihara M, 2012, J RECONSTR MICROSURG, V28, P327, DOI 10.1055/s-0032-1311691; Mihara M, 2012, MICROSURG, V32, P227, DOI 10.1002/micr.20977; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Mitchell I. M., 1995, Perfusion, V10, P197, DOI 10.1177/026765919501000402; Opie EL, 1913, J MED RES, V29, P131; Shibasaki J, 2014, J PEDIATR-US, V164, P1116, DOI 10.1016/j.jpeds.2013.12.052; SHIMIZU J, 1994, THORAC CARDIOV SURG, V42, P233, DOI 10.1055/s-2007-1016494; TEBA L, 1985, CRIT CARE MED, V13, P49, DOI 10.1097/00003246-198501000-00013; ULIBARRI JI, 1990, LANCET, V336, P258, DOI 10.1016/0140-6736(90)91793-A; UNGER SW, 1983, SURGERY, V93, P455; White W F, 1966, Clin Radiol, V17, P92, DOI 10.1016/S0009-9260(66)80134-4; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2014, ANN PLAS SURG, V73, P706, DOI 10.1097/SAP.0b013e318285875f; Yamamoto T, 2013, ANN PLAS SURG, V71, P591, DOI 10.1097/SAP.0b013e318255168a; Yamamoto T, 2015, EUR J VASC ENDOVASC, V49, P95, DOI 10.1016/j.ejvs.2014.10.023	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2015	29	6					1111	1122		10.1016/j.avsg.2015.02.013		12	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CO7BH	WOS:000359312000008		
J	Nakano, M; Hirano, K; Iida, O; Yamauchi, Y; Soga, Y; Kawasaki, D; Tazaki, J; Suzuki, K; Fujiwara, M; Yamaoka, T				Nakano, Masatsugu; Hirano, Keisuke; Iida, Osamu; Yamauchi, Yasutaka; Soga, Yoshimitsu; Kawasaki, Daizo; Tazaki, Junichi; Suzuki, Kenji; Fujiwara, Masahiko; Yamaoka, Terutoshi			Clinical Efficacy of Infrapopliteal Endovascular Procedures for Hemodialysis Patients with Critical Limb Ischemia	ANNALS OF VASCULAR SURGERY			English	Article							STAGE RENAL-DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; BALLOON-ANGIOPLASTY; ANGIOSOME CONCEPT; ARTERIAL-DISEASE; REVASCULARIZATION; OUTCOMES; PROGNOSIS; INSUFFICIENCY; PREDICTORS	Purpose: To investigate 5-year clinical outcomes after infrapopliteal endovascular therapy (EVT) for critical limb ischemia (CLI) patients on or not on hemodialysis (HD), and compare the clinical efficacy of EVT between the 2 groups. Methods: The subjects were 1091 CLI patients (1310 limbs) who underwent EVT for isolated infrapopliteal lesions from 2004 to 2012, and were classified into 2 groups for comparative study: the patients on HD group (670 patients, 830 limbs) and not on HD group (421 patients, 480 limbs). Results: The HD group had a significantly lower rate of freedom from major adverse limb events or perioperative death (HD 78.4% vs. non-HD 86.0% at 1 year, HD 70.3% vs. non-HD 82.4% at 5 years, P = 0.01), or amputation-free survival (AFS) rate (HD 65.7% vs. non-HD 78.7% at 1 year, HD 34.4% vs. non-HD 59.8% at 5 years, P < 0.01) after EVT compared with the non-HD group. Independent predictors of AFS in HD patients were nonambulatory, diabetes mellitus, albumin < 3.0 g/dL, ejection fraction <= 0.48, and no patent pedal arch arteries before EVT. AFS at 1 year was 81% in patients with 0 or 1 predictor, surpassing the suggested AFS objective performance goal (OPG) end points of 68%, but AFS in patients with 2 or more predictors failed to reach the OPG. Conclusions: In comparison with non-HD patients, the clinical efficacy of infrapopliteal EVT for HD patients was poor. Preoperative risk stratification based on AFS predictors can be used as an index for predicting the prognosis.	[Nakano, Masatsugu; Hirano, Keisuke] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2300012, Japan; [Iida, Osamu] Kansai Rosai Hosp, Dept Cardiol, Amagasaki, Hyogo, Japan; [Yamauchi, Yasutaka] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Kawasaki, Daizo] Morinomiya Hosp, Dept Cardiol, Osaka, Japan; [Tazaki, Junichi] Kyoto Univ Hosp, Dept Cardiol, Kyoto 606, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Fujiwara, Masahiko] Kishiwada Tokushukai Hosp, Dept Cardiol, Kishiwada, Japan; [Yamaoka, Terutoshi] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan	Nakano, M (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2300012, Japan.	m_nakano@tobu.saiseikai.or.jp					Schmidt A, 2010, CATHETER CARDIO INTE, V76, P1047, DOI 10.1002/ccd.22658; Nakano M, 2013, J ENDOVASC THER, V20, P113, DOI 10.1583/11-3782.1; Gray BH, 2010, ANN VASC SURG, V24, P349, DOI 10.1016/j.avsg.2009.07.034; O'Hare AM, 2004, J VASC SURG, V39, P709, DOI 10.1016/j.jvs.2003.11.038; Simons JP, 2010, J VASC SURG, V51, P1419, DOI 10.1016/j.jvs.2010.01.083; DOSSA CD, 1994, J VASC SURG, V20, P14; Kawarada O, 2012, CATHETER CARDIO INTE, V80, P861, DOI 10.1002/ccd.24370; Iida O, 2010, CATHETER CARDIO INTE, V75, P830, DOI 10.1002/ccd.22319; Ohtake T, 2011, J VASC SURG, V53, P676, DOI 10.1016/j.jvs.2010.09.070; Brosi P, 2005, J ENDOVASC THER, V12, P704, DOI 10.1583/05-1638MR.1; Schmidt A, 2011, J AM COLL CARDIOL, V58, P1105, DOI 10.1016/j.jacc.2011.05.034; Orimoto Y, 2013, J VASC SURG, V58, P1291, DOI 10.1016/j.jvs.2013.05.027; Engelhardt M, 2012, EUR J VASC ENDOVASC, V43, P55, DOI 10.1016/j.ejvs.2011.09.010; Iida O, 2012, J VASC SURG, V55, P363, DOI 10.1016/j.jvs.2011.08.014; Bradbury AW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14140; Takahara M, 2010, DIABETES CARE, V33, P2538, DOI [10.2337/dc10-0939, 10.2337/dc10.0939]; Varela C, 2014, ANN VASC SURG, V28, P284, DOI 10.1016/j.avsg.2013.04.014; Liistro F, 2013, CIRCULATION, V128, P615, DOI 10.1161/CIRCULATIONAHA.113.001811; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Fernandez N, 2011, J VASC SURG, V54, P722, DOI 10.1016/j.jvs.2011.03.232; Otsuka Y, 2011, EUR HEART J, V32, P829, DOI 10.1093/eurheartj/ehq480; Dormandy JA, 2000, J VASC SURG, V31, pS1; Feiring AJ, 2010, J AM COLL CARDIOL, V55, P1580; Geraghty PJ, 2009, J VASC SURG, V50, P1459, DOI 10.1016/j.jvs.2009.10.041; Grolman RE, 2001, AM SURGEON, V67, P1072; Kumada Y, 2008, NEPHROL DIAL TRANSPL, V23, P3996, DOI 10.1093/ndt/gfn378; Lin CW, 2010, DIABETES RES CLIN PR, V90, P167, DOI 10.1016/j.diabres.2010.08.002; Pua U, 2008, ANN ACAD MED SINGAP, V37, P224; Soderstrom MI, 2010, ANN SURG, V252, P765; Stoner MC, 2007, J VASC SURG, V46, P289, DOI 10.1016/j.jvs.2007.04.019; Willenberg T, 2011, J VASC SURG, V53, P1589, DOI 10.1016/j.jvs.2011.01.062	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2015	29	6					1225	1234		10.1016/j.avsg.2015.03.034		10	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CO7BH	WOS:000359312000023		
J	Liu, JF; Chi, DC; Lu, HT; Zhang, TH; Yamakawa, T				Liu, Jianfeng; Chi, Decai; Lu, Haitao; Zhang, Tianhua; Yamakawa, Tatsuo			Reversion-inducing-cysteine-rich Protein with Kazal Motif Is Involved in Intimal Hyperplasia in Carotid Arteries: A New Insight in the Prevention of Restenosis after Vascular Angioplasty	ANNALS OF VASCULAR SURGERY			English	Article							NEOINTIMAL HYPERPLASIA; CANCER CELLS; RECK; ATHEROSCLEROSIS; INVASION; INJURY; PROLIFERATION	Background: Overexpression of matrix metalloproteinase (MMP) has been implicated in the incidence of restenosis after vascular angioplasty. Reversion-inducing cysteine-rich protein with kazal motifs (RECK) is a membrane-anchored glycoprotein that negatively regulates the activity of MMPs, such as MMP-9 and MMP-2, which play a key role in the angiogenesis during tumor growth. This study was designed to investigate the potential association between RECK and restenosis after vascular angioplasty. Methods: Balloon-injured rabbit carotid arterialmodels were established. Arterialmorphology was assessed by hematoxylineeosin staining. The area of intimal hyperplasia was measured using image microscopy and image analyzer. The messenger RNA (mRNA) expression levels of RECK, MMP-9, and MMP-2 were detected using reverse transcription-polymerase chain reaction (RTPCR) at 7, 14, and 21 days. Vascular smooth muscle cells (VSMCs) were transfected with RECK small interfering RNA (siRNA). VSMC proliferation rate was detected by MTT assay at 24, 48 and 72 hr. The protein expression of RECK, MMP-9, and MMP-2 was determined by Western blot. Results: MMP-2 and MMP-9 in carotid artery of rats were significantly overexpressed in the injured-artery group, compared with unmanipulated control and contralateral uninjured groups (P < 0.05). With the time of the injury extended, MMP-2 and MMP-9 mRNA levels gradually increased. RECK showed a marked peak of mRNA level at 7 days after injury, compared with unmanipulated control and contralateral uninjured groups (P < 0.001). However, the increasing trend gradually decreased at 14 days after the balloon surgery. RECK mRNA was still detectable at 21 days postoperatively, but the expression level of RECK mRNA in injured and contralateral uninjured groups was significantly lower than that in unmanipulated control group (P < 0.001). The expression level of RECK protein in VSMCs in transfected group was significantly lower compared with that in untransfected group, whereas the expression of MMP-2 and MMP-9 proteins in transfected group was significantly higher compared with that in untransfected group.Over the extension of transfection time, the proliferation of VSMCs in transfected group was increased gradually, compared with negative and blank plasmid controls (P < 0.05). Conclusions: RECK, as siRNA-mediated RECK silencing regulation of MMP-9 and MMP-2, plays an important role in intimal hyperplasia, which provides a new target for prevention and treatment of restenosis after vascular angioplasty.	[Liu, Jianfeng] Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, Harbin 150086, Peoples R China; [Chi, Decai; Zhang, Tianhua] Harbin Med Univ, Affiliated Hosp 2, Dept Vasc Surg, Harbin 150086, Peoples R China; [Lu, Haitao] Chinae Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China; [Yamakawa, Tatsuo] Teikyo Univ, Mizonokuchi Hosp, Dept Surg, Kawasaki, Kanagawa, Japan	Zhang, TH (reprint author), Harbin Med Univ, Affiliated Hosp 2, Dept Vasc Surg, 246 Xuefu Rd, Harbin 150086, Peoples R China.	hunterzth@163.com			Research Fund for the Doctoral Program of the Second Affiliated Hospital of Harbin Medical University [BS2010-08]	This work was supported by the Research Fund for the Doctoral Program of the Second Affiliated Hospital of Harbin Medical University (No.: BS2010-08).	Motwani JG, 1998, CIRCULATION, V97, P916; Fogelstrand P, 2011, J VASC RES, V48, P307, DOI 10.1159/000322175; Charles R, 2000, CIRC RES, V87, P282; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Rabien A, 2012, PROSTATE, V72, P948, DOI 10.1002/pros.21498; Chang CK, 2008, J CELL MOL MED, V12, P2781, DOI 10.1111/j.1582-4934.2008.00215.x; Kundi R, 2009, CARDIOVASC RES, V84, P326, DOI 10.1093/cvr/cvp220; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Park SH, 2001, CIRCULATION, V104, P815, DOI 10.1161/hc3301.092789; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Omura A, 2009, J BIOL CHEM, V284, P3461, DOI 10.1074/jbc.M806212200; Wittschieber D, 2011, PATHOBIOLOGY, V78, P123, DOI 10.1159/000323563; Kher N, 2004, SEMIN THROMB HEMOST, V30, P665, DOI 10.1055/s-2004-861509; CERCEK B, 1991, AM J CARDIOL, V68, pC24; De Meyer G R, 1997, Vasc Med, V2, P179	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2015	29	6					1293	1299		10.1016/j.avsg.2015.01.032		7	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CO7BH	WOS:000359312000031		
J	Tomonaga, M				Tomonaga, Masamichi			Proceedings of the 18th Annual Meeting of the Society of Biotherapeutic Approaches, 13 December 2014, Takamatsu, Japan Preface	ANTICANCER RESEARCH			English	Editorial Material									Soc Biotherapeut Approaches, Fukuoka, Japan	Tomonaga, M (reprint author), Soc Biotherapeut Approaches, Fukuoka, Japan.							0	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	AUG	2015	35	8					4383	4383				1	Oncology	Oncology	CO6VL	WOS:000359294900001		
